PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	FLOMBAUM, CD				FLOMBAUM, CD			URIC-ACID STONES IN CROHNS-DISEASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Note											FLOMBAUM, CD (corresponding author), MEM SLOAN KETTERING CANC CTR,NEW YORK,NY 10021, USA.								0	0	0	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 30	1994	330	26					1870	1870						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NT530	8196731				2022-12-28	WOS:A1994NT53000006
J	HERMANSON, T; ARO, S; BENNETT, CL				HERMANSON, T; ARO, S; BENNETT, CL			FINLAND HEALTH-CARE SYSTEM - UNIVERSAL ACCESS TO HEALTH-CARE IN A CAPITALISTIC DEMOCRACY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NORDIC COUNTRIES; PROGRAM		VET AFFAIRS MED CTR,HLTH SERV RES & DEV 152,DURHAM,NC 27705; UNIV HELSINKI,DEPT PUBL HLTH,HELSINKI,FINLAND; NATL RES & DEV CTR WELF & HLTH,HELSINKI,FINLAND; DUKE UNIV,DIV HEMATOL ONCOL,DURHAM,NC; DUKE UNIV,CTR HLTH POLICY RES & EDUC,DURHAM,NC	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Helsinki; Duke University; Duke University								ARO S, 1993, STAKES102 REP; ARO S, 1993, STAKES120 REP; BERG MA, 1993, KANSANTERVEYSLAIT B; HEIKKILA J, 1992, SUOM LAAKARIL, V47, P1412; HERMANSON T, 1986, U HELSINKI MONOGRAPH, V96; HERMANSON T, 1989, LAAKINTOHALLITUKSEN; JAATTELA A, 1990, SUOM LAAKARIL, V45, P1668; KOKKONEN P, 1989, INT DIGEST HLTH LEGI, V40, P241; KONTULA O, IN PRESS INT J ADDIC; Koonin Lisa M., 1992, Morbidity and Mortality Weekly Report, V41, P1; LAARA E, 1987, LANCET, V1, P1247; LONNQVIST J, 1988, PSYCHIATR FENN, V19, P125; LOYTONEN M, 1991, ANN ASSOC AM GEOGR, V81, P127, DOI 10.1111/j.1467-8306.1991.tb01683.x; PAUNIO M, 1991, AM J EPIDEMIOL, V133, P1152, DOI 10.1093/oxfordjournals.aje.a115827; RIMPELA AH, 1992, BRIT MED J, V305, P1053, DOI 10.1136/bmj.305.6861.1053; RISKA E, 1988, MILBANK Q, V66, P133, DOI 10.2307/3349919; SALMELA R, 1993, HEALTH POLICY, V24, P83, DOI 10.1016/0168-8510(93)90090-C; Saltman R B, 1992, Health Care Financ Rev, V13, P157; Saltman RB., 1992, PLANNED MARKETS PUBL; TEPERI J, 1993, 121ST AM PUBL HLTH A; VALKONEN T, 1991, 176 CENTR STAT OFF F; VOHLONEN I, 1989, HEALTH POLICY, V13, P65, DOI 10.1016/0168-8510(89)90111-5; 1991, HLTH ALL POLICY FINL; 1994, POISTOPROJEKTIN LOPP; 1992, LAAKAREIDEN TYOAIKAT; 1993, TYORYHMAMUISTIO; 1993, STATISTICAL ABSTRACT; 1989, HLTH SERVICES 1987; 1993, SOSIAALI TERVEYS MIN; 1991, EC SURVEYS FINLAND 1; 1993, HLTH STATISTICS NORD; 1993, 7 ORG EC COOP DEV SO; 1993, PHYSICIANS FINLAND; 1993, STATISTICAL YB FINLA, P88; 1993, MMWR-MORBID MORTAL W, V42, P547	35	49	49	1	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	1994	271	24					1957	&		10.1001/jama.271.24.1957	http://dx.doi.org/10.1001/jama.271.24.1957			0	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NR598	8201743				2022-12-28	WOS:A1994NR59800036
J	NORTHROP, JP; HO, SN; CHEN, L; THOMAS, DJ; TIMMERMAN, LA; NOLAN, GP; ADMON, A; CRABTREE, GR				NORTHROP, JP; HO, SN; CHEN, L; THOMAS, DJ; TIMMERMAN, LA; NOLAN, GP; ADMON, A; CRABTREE, GR			NF-AT COMPONENTS DEFINE A FAMILY OF TRANSCRIPTION FACTORS TARGETED IN T-CELL ACTIVATION	NATURE			English	Article							NUCLEAR FACTOR; ANTIGEN RECEPTOR; MAMMALIAN-CELLS; LYMPHOCYTE; IDENTIFICATION; CALCINEURIN; COMPLEX; INVITRO; EVENTS; ASSAY	THE NF-AT transcription complex(1) is required far the expression of a group of proteins that collectively coordinate the immune response(2-4). Here we purify two proteins encoded by separate genes that represent the pre-existing (p) and cytosolic (c) components of NF-AT. Expression of the full-length complementary DNA encoding NF-AT(c) activates the interleukin (IL-2) promoter in non-T lymphocytes, whereas a dominant negative of NF-AT(c), specifically blocks activation of the IL-2 promoter in T lymphocytes, indicating that NF-AT(c) is required for IL-2 gene expression. NF-AT(c) RNA expression is largely restricted to lymphoid tissues and is induced upon T-cell activation. The other protein, NF-AT(p), is highly homologous to NF-AT(c) over a limited domain which shows similarity to the Dorsal/Rel family(5), but has a wider tissue distribution. Agents that increase intracellular Ca2+ or activate protein kinase C independently modify NF-AT(c), indicating that distinct signalling pathways converge on NF-AT(c) to regulate its function.	STANFORD UNIV,SCH MED,DEPT PATHOL,STANFORD,CA 94305; STANFORD UNIV,SCH MED,DEPT MOLEC PHARMACOL,STANFORD,CA 94305; UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720	Stanford University; Stanford University; University of California System; University of California Berkeley	NORTHROP, JP (corresponding author), STANFORD UNIV,SCH MED,HOWARD HUGHES MED INST,DEPT DEV BIOL,STANFORD,CA 94305, USA.		Nolan, Garry/AAE-7903-2019	Nolan, Garry/0000-0002-8862-9043				CHEN D, 1993, MOL CELL BIOL, V13, P228, DOI 10.1128/MCB.13.1.228; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MENDEL DB, 1991, GENE DEV, V5, P1042, DOI 10.1101/gad.5.6.1042; MIYATA T, 1979, J MOL EVOL, V12, P214; Nolan GP, 1992, CURR OPIN GENET DEV, V2, P211, DOI 10.1016/S0959-437X(05)80276-X; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; RIEGEL JS, 1990, J IMMUNOL, V144, P3611; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; VERWEIJ CL, 1990, J BIOL CHEM, V265, P15788; WEISS A, 1993, CELL, V73, P209, DOI 10.1016/0092-8674(93)90221-B; YASEEN NR, 1993, J BIOL CHEM, V268, P14285	20	544	561	1	8	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 9	1994	369	6480					497	502		10.1038/369497a0	http://dx.doi.org/10.1038/369497a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ286	8202141				2022-12-28	WOS:A1994NQ28600061
J	SNIDER, WD				SNIDER, WD			FUNCTIONS OF THE NEUROTROPHINS DURING NERVOUS-SYSTEM DEVELOPMENT - WHAT THE KNOCKOUTS ARE TEACHING US	CELL			English	Review							DORSAL-ROOT GANGLION; GROWTH-FACTOR FAMILY; EXPRESSING MESSENGER-RNA; PROTEIN-TYROSINE KINASE; NEURAL CREST CELLS; SENSORY NEURONS; CORTICAL-NEURONS; RAT TRKC; RECEPTOR; BDNF				SNIDER, WD (corresponding author), WASHINGTON UNIV,SCH MED,DEPT NEUROL,CTR STUDY NERVOUS SYST INJURY,ST LOUIS,MO 63110, USA.							ALLENDOERFERKL, 1994, J NEUROSCI, V14, P1795; ARENAS E, 1994, NATURE, V367, P368, DOI 10.1038/367368a0; AVILA MA, 1993, DEV BIOL, V159, P266, DOI 10.1006/dbio.1993.1239; BAIMBRIDGE KG, 1992, TRENDS NEUROSCI, V15, P303, DOI 10.1016/0166-2236(92)90081-I; Barbacid Mariano, 1993, P123; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; BARRES BA, 1994, NATURE, V367, P371, DOI 10.1038/367371a0; BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; BUCHMAN VL, 1993, DEVELOPMENT, V118, P989; CARROLL SL, 1992, NEURON, V9, P779, DOI 10.1016/0896-6273(92)90040-K; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; DAVIES AM, 1992, SENSORY NEURONS DIVE, P194; DAVIS BM, 1993, NEUROSCIENCE, V56, P789, DOI 10.1016/0306-4522(93)90127-2; DIAMOND J, 1992, J NEUROSCI, V12, P1454; DICICCOBLOOM E, 1993, NEURON, V11, P1101, DOI 10.1016/0896-6273(93)90223-E; EIDE FF, 1993, EXP NEUROL, V121, P200, DOI 10.1006/exnr.1993.1087; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; ERNFORS P, 1990, NEURON, V5, P511, DOI 10.1016/0896-6273(90)90090-3; ERNFORS P, 1991, EUR J NEUROSCI, V3, P953, DOI 10.1111/j.1460-9568.1991.tb00031.x; FRANKLIN JL, 1992, TRENDS NEUROSCI, V15, P501, DOI 10.1016/0166-2236(92)90103-F; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; HALLBOOK F, 1991, NEURON, V6, P845, DOI 10.1016/0896-6273(91)90180-8; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; HOLTZMAN DM, 1992, NEURON, V9, P465, DOI 10.1016/0896-6273(92)90184-F; HORYLEE F, 1993, P NATL ACAD SCI USA, V90, P2613, DOI 10.1073/pnas.90.7.2613; HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0; IBANEZ CF, 1993, DEVELOPMENT, V117, P1345; IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060; IP NY, 1993, J NEUROSCI, V13, P3394; IP NY, 1993, NEURON, V10, P137, DOI 10.1016/0896-6273(93)90306-C; JOHNSON EM, 1993, ANNU REV NEUROSCI, V16, P31, DOI 10.1146/annurev.ne.16.030193.000335; JOHNSON EM, 1980, SCIENCE, V210, P916, DOI 10.1126/science.7192014; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KALCHEIM C, 1992, P NATL ACAD SCI USA, V89, P1661, DOI 10.1073/pnas.89.5.1661; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KNUSEL B, 1994, J NEUROSCI, V14, P1542, DOI 10.1523/JNEUROSCI.14-03-01542.1994; KNUSEL B, 1991, P NATL ACAD SCI USA, V88, P961, DOI 10.1073/pnas.88.3.961; KORSCHING S, 1993, J NEUROSCI, V13, P2739; LAMBALLE F, 1993, EMBO J, V12, P3083, DOI 10.1002/j.1460-2075.1993.tb05977.x; LAMBALLE F, 1994, J NEUROSCI, V14, P14; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE KF, 1994, SCIENCE, V263, P1447, DOI 10.1126/science.8128229; LEWIN GR, 1993, TRENDS NEUROSCI, V16, P353, DOI 10.1016/0166-2236(93)90092-Z; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; MAFFEI L, 1992, J NEUROSCI, V12, P4651; MARTINZANCA D, 1986, NATURE, V319, P743, DOI 10.1038/319743a0; MEAKIN SO, 1992, TRENDS NEUROSCI, V15, P323, DOI 10.1016/0166-2236(92)90047-C; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; MU XJ, 1993, J NEUROSCI, V13, P4029; NAWA H, 1993, J NEUROCHEM, V60, P772, DOI 10.1111/j.1471-4159.1993.tb03216.x; NELF NT, 1993, J NEUROBIOL, V24, P1578; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; PEARSON J, 1983, DEV BIOL, V96, P32, DOI 10.1016/0012-1606(83)90308-1; PHILLIPS HS, 1990, SCIENCE, V250, P290, DOI 10.1126/science.1688328; PURVES D, 1988, NATURE, V336, P123, DOI 10.1038/336123a0; QINWEI Y, 1994, IN PRESS J NEUROSCI; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RIDDLE DR, 1993, J NEUROSCI, V13, P4193; RUIT KG, 1992, NEURON, V8, P573, DOI 10.1016/0896-6273(92)90284-K; SCHECTERSON LC, 1992, NEURON, V9, P449, DOI 10.1016/0896-6273(92)90183-E; SCHNELL L, 1994, NATURE, V367, P170, DOI 10.1038/367170a0; SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0; SIEBERBLUM M, 1991, NEURON, V6, P949, DOI 10.1016/0896-6273(91)90235-R; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; SNIDER WD, 1989, ANN NEUROL, V26, P489, DOI 10.1002/ana.410260402; SNIDER WD, 1988, J NEUROSCI, V8, P2628; TESSAROLLO L, 1993, DEVELOPMENT, V118, P463; TSOULFAS P, 1993, NEURON, V10, P975, DOI 10.1016/0896-6273(93)90212-A; VALENZUELA DM, 1993, NEURON, V10, P963, DOI 10.1016/0896-6273(93)90211-9; VERDI JM, 1994, NEURON, V12, P733, DOI 10.1016/0896-6273(94)90327-1; YAN Q, 1992, NATURE, V360, P753, DOI 10.1038/360753a0; YAN Q, 1993, J NEUROBIOL, V24, P1555, DOI 10.1002/neu.480241202	79	1330	1367	0	56	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUN 3	1994	77	5					627	638		10.1016/0092-8674(94)90048-5	http://dx.doi.org/10.1016/0092-8674(94)90048-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NQ123	8205613				2022-12-28	WOS:A1994NQ12300004
J	SVOBODA, K; BLOCK, SM				SVOBODA, K; BLOCK, SM			FORCE AND VELOCITY MEASURED FOR SINGLE KINESIN MOLECULES	CELL			English	Article							BOVINE BRAIN KINESIN; OPTICAL TWEEZERS; MOTILITY; MOVEMENT; IDENTIFICATION; MICROTUBULES; ATPASE; MICROSCOPY; TRAP	We measured the farce-velocity curves of single kinesin molecules attached to silica beads moving in an in vitro motility assay. Optical trapping interferometry was used to track movement with subnanometer precision and to apply calibrated, pN-sized forces to the beads. Velocity decreased linearly with increasing force, and kinesin molecules moved against applied loads of up to 5-6 pN. Comparison of force-velocity curves at limiting and saturating ATP concentrations suggests that the load-dependent diminution in kinesin velocity may be due to a decrease in the net displacement per molecule of ATP hydrolyzed, not simply to a slowing of the ATP turnover rate; kinesin would therefore appear to be a loosely coupled motor.	HARVARD UNIV, GRAD COMM BIOPHYS, CAMBRIDGE, MA 02138 USA; PRINCETON UNIV, DEPT MOLEC BIOL, PRINCETON, NJ 08544 USA	Harvard University; Princeton University	SVOBODA, K (corresponding author), ROWLAND INST SCI INC, 100 EDWIN LAND BLVD, CAMBRIDGE, MA 02142 USA.							ASHKIN A, 1992, BIOPHYS J, V61, P569, DOI 10.1016/S0006-3495(92)81860-X; ASHKIN A, 1986, OPT LETT, V11, P288, DOI 10.1364/OL.11.000288; Bagshaw CR., 1993, MUSCLE CONTRACTION, DOI 10.1007/978-94-015-6839-5; Bevington P. R, 1969, DATA REDUCTION ERROR; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; BLOOM GS, 1988, BIOCHEMISTRY-US, V27, P3409, DOI 10.1021/bi00409a043; BRENNEN C, 1977, ANNU REV FLUID MECH, V9, P339, DOI 10.1146/annurev.fl.09.010177.002011; BURTON K, 1992, J MUSCLE RES CELL M, V13, P590, DOI 10.1007/BF01738249; COHN SA, 1987, NATURE, V328, P160, DOI 10.1038/328160a0; DENK W, 1990, APPL OPTICS, V29, P2382, DOI 10.1364/AO.29.002382; Fenn WO, 1924, J PHYSIOL-LONDON, V58, P0373, DOI 10.1113/jphysiol.1924.sp002141; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; GILBERT SP, 1993, BIOCHEMISTRY-US, V32, P4677, DOI 10.1021/bi00068a028; HACKNEY DD, 1992, J BIOL CHEM, V267, P8696; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; HACKNEY DD, 1991, BIOCHEM BIOPH RES CO, V174, P810, DOI 10.1016/0006-291X(91)91490-4; HACKNEY DD, 1989, J BIOL CHEM, V264, P15943; HACKNEY DD, 1994, BIOPHYS J, V66, pA311; HALL K, 1993, NATURE, V364, P457, DOI 10.1038/364457a0; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; HOWARD J, 1989, NATURE, V342, P154, DOI 10.1038/342154a0; HOYT MA, 1994, CURR OPIN CELL BIOL, V6, P63, DOI 10.1016/0955-0674(94)90117-1; HUNT AJ, 1993, P NATL ACAD SCI USA, V90, P11653, DOI 10.1073/pnas.90.24.11653; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; ISHIJIMA A, 1994, BIOCHEM BIOPH RES CO, V199, P1057, DOI 10.1006/bbrc.1994.1336; Johnson K. A., 1992, ENZYMES, V20, P1, DOI DOI 10.1016/S1874-6047(08)60019-0; KAMIMURA S, 1992, J CELL BIOL, V118, P865, DOI 10.1083/jcb.118.4.865; KUO SC, 1993, SCIENCE, V260, P232, DOI 10.1126/science.8469975; KUZNETSOV SA, 1986, P NATL ACAD SCI USA, V83, P8530, DOI 10.1073/pnas.83.22.8530; LEIBLER S, 1993, J CELL BIOL, V121, P1357, DOI 10.1083/jcb.121.6.1357; LUBYPHELPS K, 1994, CURR OPIN CELL BIOL, V6, P3, DOI 10.1016/0955-0674(94)90109-0; MITCHISON T, 1984, NATURE, V312, P232, DOI 10.1038/312232a0; Oosawa F, 1986, Adv Biophys, V22, P151, DOI 10.1016/0065-227X(86)90005-5; RAY S, 1993, J CELL BIOL, V121, P1083, DOI 10.1083/jcb.121.5.1083; SCHNAPP BJ, 1986, METHOD ENZYMOL, V134, P561; SCHOLEY JM, 1989, NATURE, V338, P355, DOI 10.1038/338355a0; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; TAYLOR EW, 1993, NATURE, V361, P115, DOI 10.1038/361115a0; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; WAST RC, 1987, CRC HDB CHEM PHYSICS; YANAGIDA T, 1985, NATURE, V316, P366, DOI 10.1038/316366a0; YANAGIDA T, 1993, TRENDS BIOCHEM SCI, V18, P319, DOI 10.1016/0968-0004(93)90064-T	44	698	706	4	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	1994	77	5					773	784		10.1016/0092-8674(94)90060-4	http://dx.doi.org/10.1016/0092-8674(94)90060-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NQ123	8205624				2022-12-28	WOS:A1994NQ12300016
J	GERADTS, J; MCLENDON, WW				GERADTS, J; MCLENDON, WW			PATHOLOGY AND LABORATORY MEDICINE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL UTILITY; FLOW-CYTOMETRY; IMAGE-ANALYSIS; DNA CYTOMETRY; CANCER; ESTROGEN; TUMORS; BREAST				GERADTS, J (corresponding author), UNIV N CAROLINA, CHAPEL HILL, NC USA.							Battifora H, 1993, APPL IMMUNOHISTO M M, V1, P39; BAUER KD, 1993, CYTOMETRY, V14, P486, DOI 10.1002/cyto.990140506; DANQUE POV, 1993, MODERN PATHOL, V6, P270; ESTEBAN JM, 1993, AM J CLIN PATHOL, V99, P32, DOI 10.1093/ajcp/99.1.32; HEDLEY DW, 1993, CYTOMETRY, V14, P482, DOI 10.1002/cyto.990140505; KERNS BJM, 1994, AM J CLIN PATHOL, V101, P192, DOI 10.1093/ajcp/101.2.192; SHANKEY TV, 1993, CYTOMETRY, V14, P497, DOI 10.1002/cyto.990140508; TESCH M, 1993, AM J CLIN PATHOL, V99, P8, DOI 10.1093/ajcp/99.1.8; VERSALOVIC J, 1993, ARCH PATHOL LAB MED, V117, P1088; WHEELESS LL, 1993, CYTOMETRY, V14, P478, DOI 10.1002/cyto.990140504; WOODS GL, 1993, ARCH PATHOL LAB MED, V117, P876	11	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1700	1701						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182860				2022-12-28	WOS:A1994NN11700039
J	SKLAR, DP				SKLAR, DP			EMERGENCY-MEDICINE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIAC-ARREST; HURRICANE-ANDREW; RISK FACTOR				SKLAR, DP (corresponding author), UNIV NEW MEXICO,SCH MED,ALBUQUERQUE,NM 87131, USA.							ALSON R, 1993, ANN EMERG MED, V22, P1721, DOI 10.1016/S0196-0644(05)81312-5; BECKER LB, 1993, NEW ENGL J MED, V329, P600, DOI 10.1056/NEJM199308263290902; BONNIN MJ, 1993, JAMA-J AM MED ASSOC, V270, P1457, DOI 10.1001/jama.270.12.1457; CUMMINS RO, 1993, NEW ENGL J MED, V328, P1377, DOI 10.1056/NEJM199305133281903; FOUST D, 1993, ANN EMERG MED, V22, P583, DOI 10.1016/S0196-0644(05)81946-8; KELLERMANN AL, 1993, NEW ENGL J MED, V329, P1084, DOI 10.1056/NEJM199310073291506; LEE LE, 1993, JAMA-J AM MED ASSOC, V270, P591, DOI 10.1001/jama.270.5.591; LILLIBRIDGE SR, 1993, ANN EMERG MED, V22, P1715, DOI 10.1016/S0196-0644(05)81311-3; LOWE RA, 1993, ANN EMERG MED, V22, P829, DOI 10.1016/S0196-0644(05)80801-7; MAGNUSSON AR, 1993, ANN EMERG MED, V22, P560; MCLAUGHLIN E, 1993, MMWR MORB MORTAL WKL, V42, P817; RIVARA FP, 1993, JAMA-J AM MED ASSOC, V270, P1962, DOI 10.1001/jama.270.16.1962; ROSEMURGY AS, 1993, J TRAUMA, V35, P468, DOI 10.1097/00005373-199309000-00022; TODD KH, 1993, JAMA-J AM MED ASSOC, V269, P1537, DOI 10.1001/jama.269.12.1537	14	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1665	1666						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182840				2022-12-28	WOS:A1994NN11700019
J	GRINSTAFF, MW; HILL, MG; LABINGER, JA; GRAY, HB				GRINSTAFF, MW; HILL, MG; LABINGER, JA; GRAY, HB			MECHANISM OF CATALYTIC OXYGENATION OF ALKANES BY HALOGENATED IRON PORPHYRINS	SCIENCE			English	Article							TERT-BUTYL HYDROPEROXIDE; SELECTIVE AIR-OXIDATION; MOLECULAR-OXYGEN; HYDROXYLATION; COMPLEXES; SUBSTITUENTS	Halogenation of an iron porphyrin causes severe saddling of the macrocyclic structure and a large positive shift in the iron(III)/(II) redox couple. Although perhalogenated iron(II) porphyrins such as Fe(TFPPBr8) [H2TFPPBr8, beta-octabromo-tetrakis(pentafluorophenyl)-porphyrin] are relatively resistant to autoxidation, they rapidly reduce alkyl hydroperoxides. These and related reactivity studies suggest that catalysis of alkane oxygenation by Fe(TFPPBr8)Cl occurs through a radical-chain mechanism in which the radicals are generated by oxidation and reduction of alkyl hydroperoxides.	CALTECH,ARTHUR AMOS NOYES LAB CHEM PHYS,PASADENA,CA 91125	California Institute of Technology			Grinstaff, Mark/U-2829-2017	Grinstaff, Mark/0000-0002-5453-3668				BARKIGIA KM, 1990, J AM CHEM SOC, V112, P8851, DOI 10.1021/ja00180a029; BARTOLI JF, 1991, J CHEM SOC CHEM COMM, P440, DOI 10.1039/c39910000440; BOTTOMLEY LA, 1981, INORG CHEM, V20, P1348, DOI 10.1021/ic50219a003; BRUICE TC, 1991, J AM CHEM SOC, V113, P2747; CHANG CK, 1981, J CHEM SOC CHEM COMM, P778, DOI 10.1039/c39810000778; DAWSON JH, 1988, SCIENCE, V240, P433, DOI 10.1126/science.3358128; de Montellano P. R. Ortiz, 1986, CYTOCHROME P 450 STR; ELLIS PE, 1989, J CHEM SOC CHEM COMM, P1315, DOI 10.1039/c39890001315; ELLIS PE, 1990, COORDIN CHEM REV, V105, P181, DOI 10.1016/0010-8545(90)80022-L; ELLIS PE, 1989, CATAL LETT, V3, P389, DOI 10.1007/BF00771267; FUJII H, 1993, J AM CHEM SOC, V115, P4641, DOI 10.1021/ja00064a027; GOLD A, 1988, INORG CHIM ACTA, V150, P177, DOI 10.1016/S0020-1693(00)90594-2; GRAY HK, UNPUB; GRINSTAFF MW, UNPUB; LABINGER JA, IN PRESS CATAL LETT; LYONS JE, 1993, J CATAL, V141, P311, DOI 10.1006/jcat.1993.1139; LYONS JE, 1991, CATAL LETT, V8, P45, DOI 10.1007/BF00764382; MANDON D, 1992, INORG CHEM, V31, P2044, DOI 10.1021/ic00037a012; MANSUY D, 1993, COORDIN CHEM REV, V125, P129, DOI 10.1016/0010-8545(93)85013-T; MARSH RE, 1993, ACTA CRYSTALLOGR C, V49, P1339, DOI 10.1107/S0108270193000642; NAPPA MJ, 1985, INORG CHEM, V24, P4711, DOI 10.1021/ic00220a056; SCHAEFER WP, 1993, ACTA CRYSTALLOGR C, V49, P1342, DOI 10.1107/S0108270193000587; SCHAEFER WP, 1993, ACTA CRYSTALLOGR, V49, P1743; Sheldon R A., 1981, METAL CATALYZED OXID; TRAYLOR PS, 1984, J CHEM SOC CHEM COMM, P279, DOI 10.1039/c39840000279; TRAYLOR TG, 1993, J AM CHEM SOC, V115, P2775, DOI 10.1021/ja00060a027; TRAYLOR TG, 1987, INORG CHEM, V26, P1338, DOI 10.1021/ic00255a028; TRAYLOR TG, 1992, J AM CHEM SOC, V114, P1398; WIJESEKERA T, 1990, ANGEW CHEM, V29, P1928	29	323	327	2	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 27	1994	264	5163					1311	1313		10.1126/science.8191283	http://dx.doi.org/10.1126/science.8191283			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NN767	8191283				2022-12-28	WOS:A1994NN76700040
J	MARTENSEN, RL				MARTENSEN, RL			FOR DELIBERATE ELECTION - CESAREAN-SECTIONS IN THE 1890S	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									HARVARD UNIV,SCH MED,DEPT SOCIAL MED,BOSTON,MA 02115	Harvard University; Harvard Medical School	MARTENSEN, RL (corresponding author), HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,DEPT EMERGENCY MED,641 HUNTINGTON AVE,BOSTON,MA 02115, USA.							CAMERON M, 1891, BMJ             0307, P519; HARRIS RP, 1893, NY J GYNECOL OBS APR, P272; HARRIS RP, 1890, BMJ             0111, P68; HARRIS RP, 1891, T AM GYNECOL SOC, V16, P111; KEELER EB, 1993, MILBANK Q, V71, P365, DOI 10.2307/3350407; KELLY HA, 1890, AM J OBSTET, V23, P229; LOCALIO AR, 1993, JAMA-J AM MED ASSOC, V269, P366, DOI 10.1001/jama.269.3.366; NOTZON FC, 1990, JAMA-J AM MED ASSOC, V263, P3286, DOI 10.1001/jama.263.24.3286; PORRECO RP, 1990, OBSTET GYNECOL, V75, P133	9	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	1994	271	20					1557	1557						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NL758	8182792				2022-12-28	WOS:A1994NL75800002
J	NAIR, APK; HAHN, S; BANHOLZER, R; HIRSCH, HH; MORONI, C				NAIR, APK; HAHN, S; BANHOLZER, R; HIRSCH, HH; MORONI, C			CYCLOSPORINE-A INHIBITS GROWTH OF AUTOCRINE TUMOR-CELL LINES BY DESTABILIZING INTERLEUKIN-3 MESSENGER-RNA	NATURE			English	Article							MAST-CELLS; GM-CSF; EXPRESSION; CLONING; TRANSFORMATION; ACTIVATION; INVITRO; TRANSCRIPTION; CALCINEURIN; PROMOTER	IN T cells, cyclosporin A (CsA) exerts its immunosuppressive effect by preventing transcriptional induction of the expression of interleukin(IL)-2. This is achieved by a mechanism that involves binding of a CsA-cyclophilin complex to calcineurin, which in turn inhibits the phosphatase-controlled translocation of transcription factor NFAT to the nucleus(1-8). We have previously identified IL-3 as an autocrine oncogenic regulator in tumour cell lines generated by introducing the v-H-ras oncogene into IL-3-dependent mast cells(9-12). Here we report that CsA specifically blocks autocrine tumour cell growth. The mechanism involves down-regulation of IL-3 expression by destabilization of the messenger RNA and requires ongoing transcription. Transcripts from exogenous IL-3 genes lacking the (A + U)-rich element (ARE) in the 3' untranslated terminal repeat could not be destabilized, suggesting that at least part of this sequence, which is known to mediate decay of short-lived mRNA(13), participates in a CsA-sensitive regulatory mechanism.			NAIR, APK (corresponding author), UNIV BASEL,INST MED MICROBIOL,PETERSPL 10,CH-4003 BASEL,SWITZERLAND.			Hirsch, Hans H./0000-0003-0883-0423				ABRAMS JS, 1988, J IMMUNOL, V140, P131; ANDREJAUSKAS E, 1989, EMBO J, V8, P2575, DOI 10.1002/j.1460-2075.1989.tb08396.x; BALL PE, 1983, DIFFERENTIATION, V24, P74, DOI 10.1111/j.1432-0436.1983.tb01305.x; BLOCHLINGER K, 1984, MOL CELL BIOL, V4, P2929, DOI 10.1128/MCB.4.12.2929; CAMPBELL HD, 1985, EUR J BIOCHEM, V150, P297, DOI 10.1111/j.1432-1033.1985.tb09020.x; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COCKERILL PN, 1993, P NATL ACAD SCI USA, V90, P2466, DOI 10.1073/pnas.90.6.2466; DIAMANTIS ID, 1989, P NATL ACAD SCI USA, V86, P9299, DOI 10.1073/pnas.86.23.9299; ERB P, 1990, J IMMUNOL, V144, P790; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; GOUGH NM, 1984, NATURE, V309, P763, DOI 10.1038/309763a0; HIRSCH HH, 1993, J EXP MED, V178, P403, DOI 10.1084/jem.178.2.403; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; Kelso A, 1989, GROWTH FACTORS, V1, P165, DOI 10.3109/08977198909029126; KRONKE M, 1984, P NATL ACAD SCI-BIOL, V81, P5214, DOI 10.1073/pnas.81.16.5214; LIU J, 1993, IMMUNOL TODAY, V14, P290, DOI 10.1016/0167-5699(93)90048-P; MCCAFFREY PG, 1993, J BIOL CHEM, V268, P3747; NAIR APK, 1992, ONCOGENE, V7, P1963; NAIR APK, 1989, MOL CELL BIOL, V9, P1183, DOI 10.1128/MCB.9.3.1183; NOMA Y, 1986, NATURE, V319, P640, DOI 10.1038/319640a0; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SIGAL NH, 1992, ANNU REV IMMUNOL, V10, P519, DOI 10.1146/annurev.iy.10.040192.002511; VANSNICK J, 1988, EUR J IMMUNOL, V18, P193; WODNARFILIPOWICZ A, 1989, NATURE, V339, P150, DOI 10.1038/339150a0; WODNARFILIPOWICZ A, 1990, P NATL ACAD SCI USA, V87, P777, DOI 10.1073/pnas.87.2.777; YOKOTA T, 1985, P NATL ACAD SCI USA, V82, P68, DOI 10.1073/pnas.82.1.68	28	105	107	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 19	1994	369	6477					239	242		10.1038/369239a0	http://dx.doi.org/10.1038/369239a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NM067	8183344				2022-12-28	WOS:A1994NM06700058
J	LAUHIO, A				LAUHIO, A			REACTIVE ARTHRITIS - CONSIDER COMBINATION TREATMENT	BRITISH MEDICAL JOURNAL			English	Letter											LAUHIO, A (corresponding author), UNIV HELSINKI, CENT HOSP, DEPT MED 4, DIV RHEUMATOL, UNIONINKATU 38, SF-00170 HELSINKI 17, FINLAND.							LAUHIO A, 1991, ARTHRITIS RHEUM-US, V34, P6, DOI 10.1002/art.1780340103; LAUHIO A, 1992, ARTHRITIS RHEUM, V35, P195, DOI 10.1002/art.1780350211; LAUHIO A, 1993, ARTHRITIS RHEUM, V36, P1335, DOI 10.1002/art.1780360924; LAUHIO A, IN PRESS ANN NY ACAD; SVENUNGSSON B, 1994, BRIT MED J, V308, P671, DOI 10.1136/bmj.308.6930.671	5	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 14	1994	308	6939					1302	1303						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM147	8205036				2022-12-28	WOS:A1994NM14700054
J	TANG, JL; LAW, M; WALD, N				TANG, JL; LAW, M; WALD, N			HOW EFFECTIVE IS NICOTINE REPLACEMENT THERAPY IN HELPING PEOPLE TO STOP SMOKING	BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED TRIAL; PLACEBO CONTROLLED TRIAL; DOUBLE-BLIND TRIAL; CHEWING-GUM; TRANSDERMAL NICOTINE; FOLLOW-UP; RELAPSE PREVENTION; TOBACCO DEPENDENCE; CIGARETTE-SMOKING; GENERAL-PRACTICE	Objective-To assess the efficacy of nicotine replacement therapy in helping people to stop smoking. Design-Analysis of the results of 28 randomised trials of nicotine 2 mg chewing gum, six trials of nicotine 4 mg chewing gum, and six trials of nicotine transdermal patch. Subjects and setting-Subjects were self referred (responding to advertisements or attending anti-smoking clinics) in 20 trials and invited (general practice or hospital patients) in 20. Therapists in self referred trials were generally experienced in helping people stop smoking but not in invited trials. Main outcome measure-Efficacy was defined as difference in percentages of treated and control subjects who had stopped smoking at one year. Results-Efficacy was highly significant (P < 0.001) for both gum and patch. Nicotine 2 mg chewing gum had an overall efficacy of 6% (95% confidence interval 4% to 8%), greater in self referred subjects than in invited subjects (11% v 3%). Efficacy depended on the extent of dependence on nicotine as assessed by a simple questionnaire; it was 16% (7% to 25%) in ''high dependence'' smokers, but in ''low dependence'' smokers there was no significant effect. The 4 mg gum was effective in about one third ''high dependence'' smokers. The efficacy of the nicotine patch (9% (6% to 13%) overall) was less strongly related to nicotine dependence, perhaps because the patch cannot deliver a bolus of nicotine to satisfy craving. Conclusions-Both gum and patch are effective aids to help nicotine dependent smokers who seek help in stopping. Among the most highly nicotine dependent smokers (those craving a cigarette on waking) the 4 mg gum is the most effective form of replacement therapy; it could enable one third to stop. In less highly dependent smokers the different preparations are comparable in their efficacy but the patch offers greater convenience and minimal need for instruction in its use. Overall, nicotine replacement therapy could enable about 15% of smokers who seek help in stopping smoking to give up the habit.	ST BARTHOLOMEWS HOSP,COLL MED,WOLFSON INST PREVENT MED,DEPT ENVIRONM & PREVENT MED,LONDON EC1M 6BQ,ENGLAND	University of London; Queen Mary University London			Tang, Jin-Ling/AAJ-4090-2021; Tang, JL/G-1759-2013; Wald, Nicholas/AAY-8924-2021; Wald, Nicholas/AAY-2814-2021					ABELIN T, 1989, LANCET, V1, P7; AREECHON W, 1988, CLIN THER, V10, P183; BELCHER M, 1989, BRIT MED J, V298, P570, DOI 10.1136/bmj.298.6673.570; BENOWITZ NL, 1987, CLIN PHARMACOL THER, V41, P467, DOI 10.1038/clpt.1987.58; BENOWITZ NL, 1991, CLIN PHARMACOL THER, V50, P286, DOI 10.1038/clpt.1991.138; BENOWITZ NL, 1990, J PHARMACOL EXP THER, V254, P1000; BENOWITZ NL, 1991, JAMA-J AM MED ASSOC, V266, P3174, DOI 10.1001/jama.266.22.3174; BLONDAL T, 1989, ARCH INTERN MED, V149, P1818, DOI 10.1001/archinte.149.8.1818; CAMPBELL IA, 1987, PRACTITIONER, V231, P114; CLAVEL F, 1985, BRIT MED J, V291, P1538, DOI 10.1136/bmj.291.6508.1538; DAUGHTON DM, 1991, ARCH INTERN MED, V151, P749, DOI 10.1001/archinte.151.4.749; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; FAGERSTROM KO, 1978, ADDICT BEHAV, V3, P235, DOI 10.1016/0306-4603(78)90024-2; FAGERSTROM KO, 1982, J BEHAV MED, V5, P343, DOI 10.1007/BF00846161; FAGERSTROM KO, 1984, PREV MED, V13, P517, DOI 10.1016/0091-7435(84)90020-3; FEE WM, 1982, PRACTITIONER, V226, P148; FERNO O, 1973, PSYCHOPHARMACOLOGIA, V31, P201, DOI 10.1007/BF00422510; FIORE MC, 1992, JAMA-J AM MED ASSOC, V268, P2687, DOI 10.1001/jama.268.19.2687; GILBERT JR, 1989, J FAM PRACTICE, V28, P49; HAJEK P, 1988, JAMA-J AM MED ASSOC, V260, P2593; HALL SM, 1987, J CONSULT CLIN PSYCH, V55, P603, DOI 10.1037/0022-006X.55.4.603; HALL SM, 1988, J CONSULT CLIN PSYCH, V10, P183; HARACKIEWICZ JM, 1988, ADDICT BEHAV, V13, P319, DOI 10.1016/0306-4603(88)90038-X; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; HJALMARSON AIM, 1984, JAMA-J AM MED ASSOC, V252, P2835, DOI 10.1001/jama.252.20.2835; HUGHES JR, 1987, AM J PSYCHIAT, V144, P205; HUGHES JR, 1989, JAMA-J AM MED ASSOC, V261, P1300, DOI 10.1001/jama.261.9.1300; HUGHES JR, 1990, J PHARMACOL EXP THER, V252, P1175; HUHTASAARI F, 1992, BRIT MED J, V305, P1252, DOI 10.1136/bmj.305.6864.1252; JAMROZIK K, 1984, BRIT MED J, V289, P794, DOI 10.1136/bmj.289.6448.794; JARVIK ME, 1984, AM J PSYCHIAT, V141, P790; JARVIS MJ, 1982, BRIT MED J, V285, P537, DOI 10.1136/bmj.285.6341.537; JENSEN EJ, 1990, THORAX, V45, P831, DOI 10.1136/thx.45.11.831; KILLEN JD, 1990, J CONSULT CLIN PSYCH, V58, P85, DOI 10.1037/0022-006X.58.1.85; KILLEN JD, 1984, BEHAV THER, V15, P234, DOI 10.1016/S0005-7894(84)80026-X; KORNITZER M, 1987, J PSYCHOSOM RES, V31, P171, DOI 10.1016/0022-3999(87)90073-0; MALCOLM RE, 1980, PSYCHOPHARMACOLOGY, V70, P295, DOI 10.1007/BF00427889; MULLER P, 1990, LUNG, V168, P445, DOI 10.1007/BF02718163; OCKENE JK, 1991, J GEN INTERN MED, V6, P1, DOI 10.1007/BF02599381; PAGE AR, 1986, ADDICT BEHAV, V11, P443, DOI 10.1016/0306-4603(86)90025-0; PIRIE PL, 1992, AM J PUBLIC HEALTH, V82, P1238, DOI 10.2105/AJPH.82.9.1238; PUSKA P, 1979, ADDICT BEHAV, V4, P141, DOI 10.1016/0306-4603(79)90048-0; RUSSELL MAH, 1983, BRIT MED J, V287, P1782, DOI 10.1136/bmj.287.6407.1782; RUSSELL MAH, 1976, BRIT MED J, V1, P1043, DOI 10.1136/bmj.1.6017.1043; RUSSELL MAH, 1983, BRIT MED J, V286, P683, DOI 10.1136/bmj.286.6366.683; RUSSELL MAH, 1993, BRIT MED J, V306, P1308, DOI 10.1136/bmj.306.6888.1308; SEGNAN N, 1991, CANCER CAUSE CONTROL, V2, P239, DOI 10.1007/BF00052140; SUTHERLAND G, 1992, LANCET, V340, P324, DOI 10.1016/0140-6736(92)91403-U; SUTTON S, 1988, PREV MED, V17, P48, DOI 10.1016/0091-7435(88)90071-0; SUTTON S, 1987, AM J PUBLIC HEALTH, V77, P1210, DOI 10.2105/AJPH.77.9.1210; TONNESEN P, 1993, JAMA-J AM MED ASSOC, V269, P1268, DOI 10.1001/jama.269.10.1268; TONNESEN P, 1991, NEW ENGL J MED, V325, P311, DOI 10.1056/NEJM199108013250503; TONNESEN P, 1988, NEW ENGL J MED, V318, P15, DOI 10.1056/NEJM198801073180104; TONNESEN P, 1988, ADDICT BEHAV, V13, P17, DOI 10.1016/0306-4603(88)90021-4; WALD NJ, 1981, LANCET, V2, P775; 1993, BMJ, V306, P1304; 1983, BMJ, V286, P595; 1991, JAMA-J AM MED ASSOC, V266, P3133	58	177	180	0	8	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 1	1994	308	6920					21	26		10.1136/bmj.308.6920.21	http://dx.doi.org/10.1136/bmj.308.6920.21			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ096	8179658	Green Published			2022-12-28	WOS:A1994MQ09600024
J	BROSI, R; GRONING, K; BEHRENS, SE; LUHRMANN, R; KRAMER, A				BROSI, R; GRONING, K; BEHRENS, SE; LUHRMANN, R; KRAMER, A			INTERACTION OF MAMMALIAN SPLICING FACTOR SF3A WITH U2 SNRNP AND RELATION OF ITS 60-KD SUBUNIT TO YEAST PRP9	SCIENCE			English	Article							NUCLEAR RIBONUCLEOPROTEIN-PARTICLES; HEAT-SHOCK; COMPLEX-FORMATION; HELA-CELLS; RNA; PROTEINS; U1; PURIFICATION; SPLICEOSOME; PRECURSORS	In the assembly of a prespliceosome, U2 small nuclear ribonucleoprotein (snRNP) functions in pre-messenger RNA (mRNA) splicing together with splicing factors (SFs) 3a, SF3b, and several other proteins. The 17S but not the 12S form of U2 snRNP is active in splicing-complex formation. Here it is shown that the SF3a subunits correspond to three of the 17S U2 snRNP-specific polypeptides. SF3a interacts with U2 snRNP in the presence of SF3b to generate a structure similar to 17S U2 snRNP, which suggests a function for SF3a and SF3b in the incorporation of U2 snRNP into the spliceosome. Furthermore, the 60-kilodalton subunit of SF3a is related to the yeast splicing protein PRP9.	UNIV GENEVA,DEPT BIOL CELLULAIRE,30 QUAI ERNEST ANSERMET,CH-1211 GENEVA,SWITZERLAND; PHILIPPS UNIV,INST MOLEK BIOL & TUMORFORSCH,D-35037 MARBURG,GERMANY	University of Geneva; Philipps University Marburg								ABOVICH N, 1990, MOL CELL BIOL, V10, P6417, DOI 10.1128/MCB.10.12.6417; BACH M, 1990, METHOD ENZYMOL, V181, P232; BEHRENS SE, 1991, GENE DEV, V5, P1439, DOI 10.1101/gad.5.8.1439; BEHRENS SE, 1993, MOL CELL BIOL, V13, P307, DOI 10.1128/MCB.13.1.307; BEHRENS SE, UNPUB; BEHRENS SE, IN PRESS P NATL ACAD; BENNETT M, 1992, GENE DEV, V6, P1986, DOI 10.1101/gad.6.10.1986; BENNETT M, 1993, SCIENCE, V262, P105, DOI 10.1126/science.8211113; BENNETT MA, UNPUB; BLACK DL, 1985, CELL, V42, P737, DOI 10.1016/0092-8674(85)90270-3; BOND U, 1988, EMBO J, V7, P3509, DOI 10.1002/j.1460-2075.1988.tb03227.x; BROSI R, 1993, J BIOL CHEM, V268, P17640; BROSI R, UNPUB; CHANG TH, 1988, MOL CELL BIOL, V8, P2379, DOI 10.1128/MCB.8.6.2379; CHAPON C, 1992, EMBO J, V11, P3279, DOI 10.1002/j.1460-2075.1992.tb05406.x; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FRENDEWEY D, 1985, CELL, V42, P355, DOI 10.1016/S0092-8674(85)80131-8; FU XD, 1992, P NATL ACAD SCI USA, V89, P1725, DOI 10.1073/pnas.89.5.1725; GRABOWSKI PJ, 1985, CELL, V42, P345, DOI 10.1016/S0092-8674(85)80130-6; KONARSKA MM, 1987, CELL, V49, P763, DOI 10.1016/0092-8674(87)90614-3; KONARSKA MM, 1986, CELL, V46, P845, DOI 10.1016/0092-8674(86)90066-8; KRAMER A, 1991, EMBO J, V10, P1503, DOI 10.1002/j.1460-2075.1991.tb07670.x; KRAMER A, 1988, GENE DEV, V2, P1155, DOI 10.1101/gad.2.9.1155; KRAMER A, 1990, METHOD ENZYMOL, V181, P215; KRAMER A, UNPUB; KYHSEANDERSEN J, 1984, J BIOCHEM BIOPH METH, V10, P203, DOI 10.1016/0165-022X(84)90040-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMOND AI, 1989, CELL, V58, P383, DOI 10.1016/0092-8674(89)90852-0; LEGRAIN P, 1993, SCIENCE, V262, P108, DOI 10.1126/science.8211114; LEGRAIN P, INPRESS GENES DEV; LEHMEIER T, 1990, NUCLEIC ACIDS RES, V18, P6475, DOI 10.1093/nar/18.22.6475; LUHRMANN R, 1990, BIOCHIM BIOPHYS ACTA, V1087, P265, DOI 10.1016/0167-4781(90)90001-I; Moore M., 1993, RNA WORLD, P303; RUBY SW, IN PRESS GENES DEV; Sambrook J, 1989, MOL CLONING LABORATO; SHUKLA RR, 1990, J BIOL CHEM, V265, P20377; TEMSAMANI J, 1991, J BIOL CHEM, V266, P20356; UTANS U, 1992, GENE DEV, V6, P631, DOI 10.1101/gad.6.4.631; ZAMORE PD, 1989, P NATL ACAD SCI USA, V86, P9243, DOI 10.1073/pnas.86.23.9243	39	127	127	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 1	1993	262	5130					102	105		10.1126/science.8211112	http://dx.doi.org/10.1126/science.8211112			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ635	8211112				2022-12-28	WOS:A1993LZ63500032
J	SILLITO, AM; JONES, HE; GERSTEIN, GL; WEST, DC				SILLITO, AM; JONES, HE; GERSTEIN, GL; WEST, DC			FEATURE-LINKED SYNCHRONIZATION OF THALAMIC RELAY CELL FIRING INDUCED BY FEEDBACK FROM THE VISUAL-CORTEX	NATURE			English	Article							LATERAL GENICULATE-NUCLEUS; DEPENDENT NEURONAL OSCILLATIONS; CROSS-CORRELATION ANALYSIS; PRINCIPAL CELLS; CAT; INTERNEURONS; MORPHOLOGY; EXCITATION; DYNAMICS; PATHWAY	THE function of the massive feedback projection from visual cortex to its thalamic relay nucleus(1,2) has so far eluded any clear overview. This feedback exerts a range of effects(3-6), including an increase in the inhibition elicited by moving contours(7,8), but the functional logic of the direct connections to the thalamic cells that relay the retinal input to the cortex(9-11) remains largely unknown. In contrast to its thalamic nucleus, the visual cortex is characterized by cells that are strongly sensitive to the orientation of moving contours. Here we report that when driven by moving oriented visual stimuli the cortical feedback induces correlated firing in relay cells. This cortically induced correlation of relay cell activity produces coherent firing in those groups of relay cells with receptive field alignments appropriate to signalling the particular orientation of the moving contour to the cortex. Synchronization of relay cell firing means that they will elicit temporally overlapping excitatory postsynaptic potentials in their cortical target cells, thus increasing the chance that the cortical cells will fire. Effectively this increases the gain of the input for feature-linked events detected by the cortex. We propose that this feedback loop serves to lock or focus the appropriate circuitry onto the stimulus feature.	UNIV PENN,SCH MED,DEPT NEUROSCI,PHILADELPHIA,PA 19104	University of Pennsylvania	SILLITO, AM (corresponding author), INST OPHTHALMOL,DEPT VISUAL SCI,BATH ST,LONDON EC1V 9EL,ENGLAND.							ABELES M, 1988, J NEUROPHYSIOL, V60, P909, DOI 10.1152/jn.1988.60.3.909; ABELES M, 1982, J NEUROSCI METH, V5, P317, DOI 10.1016/0165-0270(82)90002-4; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; AHLSEN G, 1982, BRAIN RES, V234, P454, DOI 10.1016/0006-8993(82)90886-1; ENGEL AK, 1990, EUR J NEUROSCI, V2, P588, DOI 10.1111/j.1460-9568.1990.tb00449.x; GRAY CM, 1990, EUR J NEUROSCI, V2, P607, DOI 10.1111/j.1460-9568.1990.tb00450.x; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; HUBEL DH, 1962, J PHYSL, V160, P16; LINDSTROM S, 1990, EXP BRAIN RES, V79, P313, DOI 10.1007/BF00608240; MARROCCO RT, 1985, EXP BRAIN RES, V59, P50; MONTERO VM, 1991, EXP BRAIN RES, V86, P257; MURPHY PC, 1987, NATURE, V329, P727, DOI 10.1038/329727a0; PALM G, 1988, BIOL CYBERN, V59, P1, DOI 10.1007/BF00336885; ROBSON JA, 1983, J COMP NEUROL, V216, P89, DOI 10.1002/cne.902160108; SILLITO A M, 1992, P349; SILLITO AM, 1993, EXP BRAIN RES, V93, P6; TSO DY, 1986, J NEUROSCI, V6, P1160; TSUMOTO T, 1978, BRAIN RES, V345, P364; VARELA FJ, 1987, EXP BRAIN RES, V66, P10; WEBER AJ, 1989, J COMP NEUROL, V289, P156, DOI 10.1002/cne.902890113; WILSON JR, 1984, PROC R SOC SER B-BIO, V221, P411, DOI 10.1098/rspb.1984.0042	21	447	451	0	7	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 9	1994	369	6480					479	482		10.1038/369479a0	http://dx.doi.org/10.1038/369479a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ286	8202137				2022-12-28	WOS:A1994NQ28600055
J	HARLAN, WR				HARLAN, WR			CREATING AN NIH CLINICAL-TRIALS REGISTRY - A USER-FRIENDLY APPROACH TO HEALTH-CARE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											HARLAN, WR (corresponding author), NIH,BETHESDA,MD 20892, USA.							1993, JAMA-J AM MED ASSOC, V269, P3096; 1992, JAMA-J AM MED ASSOC, V268, P240	2	7	9	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	1994	271	22					1729	1729		10.1001/jama.271.22.1729	http://dx.doi.org/10.1001/jama.271.22.1729			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NN725	8196103				2022-12-28	WOS:A1994NN72500003
J	PETRONIS, KR; CARROLL, CE; HELD, PJ; PORT, FK				PETRONIS, KR; CARROLL, CE; HELD, PJ; PORT, FK			EFFECT OF RACE ON ACCESS TO RECOMBINANT-HUMAN-ERYTHROPOIETIN IN LONG-TERM HEMODIALYSIS-PATIENTS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIALYSIS	Objective.-To quantify access to recombinant human erythropoietin (EPO) among patients with dialysis-dependent end-stage renal disease (ESRD). Design.-National random sample of hemodialysis patients from a random sample of dialysis units, using data abstracted from patients' medical records. Setting.-All US hemodialysis units. Participants.-A total of 4024 Medicare-entitled in-center hemodialysis patients. Main Outcome Measures.-The relative odds that black patients received EPO (compared with white patients). Results.-There was no evidence in this national study that black hemodialysis patients were more or less likely to receive EPO than white patients (P=.74) Conclusions.-Three years after Food and Drug Administration approval and Medicare coverage of EPO, there was no evidence of racial disparity in access to EPO among Medicare patients with ESRD who were receiving long-term hemodialysis. However, there was evidence of greater need for EPO among black patients.	URBAN INST,CTR HLTH POLICY,WASHINGTON,DC; UNIV MICHIGAN,SCH MED,DEPT INTERNAL MED,ANN ARBOR,MI; UNIV MICHIGAN,SCH PUBL HLTH,DEPT EPIDEMIOL,ANN ARBOR,MI 48109	Urban Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [N01DK082234] Funding Source: NIH RePORTER; NIDDK NIH HHS [N01-DK-8-2234] Funding Source: Medline; PHS HHS [17-C-90085/3-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		DAUGIRDAS JT, 1993, AM J KIDNEY DIS, V22, P267, DOI 10.1016/S0272-6386(12)70317-7; GAYLIN DS, 1993, JAMA-J AM MED ASSOC, V269, P603, DOI 10.1001/jama.269.5.603; GOTCH FA, 1985, KIDNEY INT, V28, P526, DOI 10.1038/ki.1985.160; Hosmer D., 2000, APPL LOGISTIC REGRES, V2; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES; POWE NR, 1992, JAMA-J AM MED ASSOC, V268, P1434, DOI 10.1001/jama.268.11.1434; 1991, USRDS1991 NIH NAT I, pCH2; 1993, USRDS1993 NIH NAT I, pCH11; 1991, USRDS1991 NIH NAT I, pCH11	9	21	21	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	1994	271	22					1760	1763		10.1001/jama.271.22.1760	http://dx.doi.org/10.1001/jama.271.22.1760			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN725	8196119				2022-12-28	WOS:A1994NN72500025
J	JOHNS, ME; RICHTSMEIER, WJ				JOHNS, ME; RICHTSMEIER, WJ			OTOLARYNGOLOGY-HEAD AND NECK-SURGERY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NECK-CANCER; HEARING-LOSS; NASAL		DUKE UNIV,MED CTR,DURHAM,NC	Duke University	JOHNS, ME (corresponding author), JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD, USA.							BOYLE JO, 1993, CANCER RES, V53, P4477; BRIZEL DM, IN PRESS INT J RAD O; CHANG KW, 1993, ARCH OTOLARYNGOL, V119, P276; GATES GA, 1993, ARCH OTOLARYNGOL, V119, P156; HARRIS JP, 1990, LARYNGOSCOPE, V100, P516; HONG WK, 1993, CANCER RES, V53, P5113; KASHIMA HK, 1993, HEAD NECK CANC, V3, P181; LIPPMAN SM, 1993, NEW ENGL J MED, V328, P15, DOI 10.1056/NEJM199301073280103; LOURY MC, 1993, LARYNGOSCOPE, V103, P455, DOI 10.1002/lary.5541030417; MILCZUK HA, 1993, LARYNGOSCOPE, V103, P247; PATTEN C, 1993, ARCH OTOLARYNGOL, V119, P215; SCHAITKIN B, 1993, LARYNGOSCOPE, V103, P1117; SCHRIJVERS AHG, 1993, CANCER RES, V53, P1433; SCHWABER MK, 1993, AM J OTOL, V14, P252; TARVER CP, 1993, OTOLARYNG HEAD NECK, V109, P653, DOI 10.1177/019459989310900404; VANDONGEN GAMS, 1992, CANCER RES, V52, P2569; WILSON BS, 1991, NATURE, V352, P236, DOI 10.1038/352236a0; WRAY A, 1993, ARCH OTOLARYNGOL, V119, P929; 1993, EARLY IDENTIFICATION, V11, P1	19	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1698	1700						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182859				2022-12-28	WOS:A1994NN11700038
J	LEACH, RE				LEACH, RE			ORTHOPEDICS AND SPORTS MEDICINE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CRUCIATE LIGAMENT RECONSTRUCTION; ANTERIOR; STRENGTH				LEACH, RE (corresponding author), BOSTON UNIV,SCH MED,BOSTON,MA 02118, USA.							COOPER DE, 1993, AM J SPORT MED, V21, P818, DOI 10.1177/036354659302100610; EWALD FC, 1993, J BONE JOINT SURG AM, V75A, P498, DOI 10.2106/00004623-199304000-00004; FISHER SE, 1993, AM J SPORT MED, V21, P558, DOI 10.1177/036354659302100413; KASTEN MD, 1993, CLIN ORTHOPAEDICS, V290, P177; LEPHART SM, 1993, AM J SPORT MED, V21, P738, DOI 10.1177/036354659302100519; MALONEY WJ, 1993, J BONE JOINT SURG AM, V75A, P1627, DOI 10.2106/00004623-199311000-00007; NELSON CL, 1993, CLIN ORTHOP RELAT R, V295, P96; NOYES FR, 1984, J BONE JOINT SURG AM, V66A, P344, DOI 10.2106/00004623-198466030-00005; O'Driscoll, 1993, J Am Acad Orthop Surg, V1, P106; OSTERMANN PAW, 1993, CLIN ORTHOP RELAT R, V295, P102; SANGAY BKS, 1993, J BONE JOINT SURG AM, V75, P1466; SHINO K, 1993, AM J SPORT MED, V21, P206, DOI 10.1177/036354659302100208; TIMONEY JM, 1993, AM J SPORT MED, V21, P887, DOI 10.1177/036354659302100623; VANDERGRIEND RA, 1993, J BONE JOINT SURG AM, V75A, P899, DOI 10.2106/00004623-199306000-00011	14	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1697	1698						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182858				2022-12-28	WOS:A1994NN11700037
J	GHEZZI, P; MAGNANINI, S; RINALDINI, M; BERARDI, F; DIBIAGIO, G; TESTORE, F; TAVONI, N; SCHITTULLI, F; DAMICO, C; PEDICINI, T; FUMAGALLI, M; GRITTI, G; BRAGA, M; MARINI, G; ZANIBONI, A; COSENTINO, D; EPIFANI, C; GINI, G; PERRONI, D; PERADOTTO, F; INDELLI, M; SANTINI, A; ISA, L; AITINI, E; CAVAZZINI, G; SMERIERI, F; NASCIMBEN, O; BUSOLIN, R; PAPACCIO, G; LOCATELLI, E; MONTI, M; GHISLANDI, E; GOTTARDI, O; MAJNO, M; PLUCHINOTTA, A; ARMAROLI, L; CONFALONIERI, C; VIOLA, P; GALLETTO, L; SUSSIO, M; TROLLI, B; BIASIO, M; ROLFO, A; VAUDANO, G; GIOLITO, MR; AMBROSINI, G; BUSANA, L; MOLTENI, M; RICHETTI, A; MARUBINI, E; PIFFANELLI, A; SALVADORI, B; TOGNONI, G; ZOLA, P; LIBERATI, A; FOSSATI, R; MEYEROWITZ, BE; TORRI, V; APOLONE, G; MOSCONI, P; MARSONI, S; LIBERATI, MC; ALEXANIAN, A; GRILLI, R; NICOLUCCI, A; MONFERRONI, N				GHEZZI, P; MAGNANINI, S; RINALDINI, M; BERARDI, F; DIBIAGIO, G; TESTORE, F; TAVONI, N; SCHITTULLI, F; DAMICO, C; PEDICINI, T; FUMAGALLI, M; GRITTI, G; BRAGA, M; MARINI, G; ZANIBONI, A; COSENTINO, D; EPIFANI, C; GINI, G; PERRONI, D; PERADOTTO, F; INDELLI, M; SANTINI, A; ISA, L; AITINI, E; CAVAZZINI, G; SMERIERI, F; NASCIMBEN, O; BUSOLIN, R; PAPACCIO, G; LOCATELLI, E; MONTI, M; GHISLANDI, E; GOTTARDI, O; MAJNO, M; PLUCHINOTTA, A; ARMAROLI, L; CONFALONIERI, C; VIOLA, P; GALLETTO, L; SUSSIO, M; TROLLI, B; BIASIO, M; ROLFO, A; VAUDANO, G; GIOLITO, MR; AMBROSINI, G; BUSANA, L; MOLTENI, M; RICHETTI, A; MARUBINI, E; PIFFANELLI, A; SALVADORI, B; TOGNONI, G; ZOLA, P; LIBERATI, A; FOSSATI, R; MEYEROWITZ, BE; TORRI, V; APOLONE, G; MOSCONI, P; MARSONI, S; LIBERATI, MC; ALEXANIAN, A; GRILLI, R; NICOLUCCI, A; MONFERRONI, N			IMPACT OF FOLLOW-UP TESTING ON SURVIVAL AND HEALTH-RELATED QUALITY-OF-LIFE IN BREAST-CANCER PATIENTS - A MULTICENTER RANDOMIZED CONTROLLED TRIAL	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHEST-X-RAY; SURVEILLANCE; CARE	Objective.-To assess prospectively the impact on survival and health-related quality of life of two follow-up protocols in patients with early breast cancer. Design.-Randomized controlled clinical trial. Setting.-Multicenter study involving 26 general hospitals in Italy.	MARIO NEGRI INST PHARMACOL RES, GIVIO COORDINATING CTR, CLIN EPIDEMIOL LAB, I-20157 MILAN, ITALY	Istituto di Ricerche Farmacologiche Mario Negri IRCCS			Fossati, Roldano/ABF-2460-2020; Torri, Valter/H-7550-2015; Grilli, Roberto/K-1444-2016	Torri, Valter/0000-0001-9541-9354; Grilli, Roberto/0000-0001-9425-7170	NCI NIH HHS [CA 45638-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA045638] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1971, EITS MANUAL PROFILE; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; DELTURCO MR, 1994, JAMA-J AM MED ASSOC, V271, P1593, DOI 10.1001/jama.1994.03510440053032; GELMAN R, 1990, J CLIN ONCOL, V8, P548, DOI 10.1200/JCO.1990.8.3.548; Gross AJ, 1975, SURVIVAL DISTRIBUTIO; HANNISDAL E, 1993, EUR J CANCER, V29A, P992, DOI 10.1016/S0959-8049(05)80208-4; HAYES DF, 1993, ANN ONCOL, V4, P807, DOI 10.1093/oxfordjournals.annonc.a058385; KAGAN AR, 1991, J CLIN ONCOL, V9, P837, DOI 10.1200/JCO.1991.9.5.837; KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI, P170; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KINNE DW, 1991, CANCER, V67, P1196, DOI 10.1002/1097-0142(19910215)67:4+<1196::AID-CNCR2820671515>3.0.CO;2-4; LIBERATI A, 1988, BRIT J CANCER, V57, P630; LIBERATI A, 1986, TUMORI, V72, P273; LIBERATI A, 1988, TUMORI, V74, P377; LOGAGER VB, 1990, EUR J CANCER, V26, P553, DOI 10.1016/0277-5379(90)90073-3; LOOMER L, 1991, CANCER, V67, P55, DOI 10.1002/1097-0142(19910101)67:1<55::AID-CNCR2820670111>3.0.CO;2-N; MOSCONI P, 1991, ANN ONCOL, V2, P273, DOI 10.1093/oxfordjournals.annonc.a057936; MUSS HB, 1991, AM J CLIN ONCOL-CANC, V14, P55, DOI 10.1097/00000421-199102000-00013; ORMISTON MC, 1985, J ROY SOC MED, V78, P920, DOI 10.1177/014107688507801108; RUTGERS EJT, 1989, BRIT J SURG, V76, P187, DOI 10.1002/bjs.1800760227; SCANLON EF, 1980, CANCER, V46, P977, DOI 10.1002/1097-0142(19800815)46:4+<977::AID-CNCR2820461320>3.0.CO;2-0; SCHAG C C, 1983, Journal of Psychosocial Oncology, V1, P11, DOI 10.1300/J077v01n04_02; SCHAPIRA DV, 1991, JAMA-J AM MED ASSOC, V265, P380, DOI 10.1001/jama.265.3.380; SCHAPIRA DV, 1993, BREAST CANCER RES TR, V25, P107, DOI 10.1007/BF00662135; SCHIPPER H, 1984, J CLIN ONCOL, V2, P472, DOI 10.1200/JCO.1984.2.5.472; TOMIAK E, 1993, ANN ONCOL, V4, P199, DOI 10.1093/oxfordjournals.annonc.a058456; VESTERGAARD A, 1989, EUR J CANCER CLIN ON, V25, P687, DOI 10.1016/0277-5379(89)90205-8; Ware J. E., 1993, SF36 HLTH SURVEY MAN; WERTHEIMER MD, 1991, JAMA-J AM MED ASSOC, V265, P396, DOI 10.1001/jama.265.3.396; WICKERHAM L, 1984, BREAST CANCER RES TR, V4, P303, DOI 10.1007/BF01806043; 1986, NUOVI ARGOMENTI MED, V2, P182; 1986, BRIT J CANCER, V54, P319	32	452	458	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	1994	271	20					1587	1592		10.1001/jama.1994.03510440047031	http://dx.doi.org/10.1001/jama.1994.03510440047031			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NL758	8182811				2022-12-28	WOS:A1994NL75800026
J	FENTEM, P				FENTEM, P			BENEFITS OF EXERCISE IN HEALTH AND DISEASE	BRITISH MEDICAL JOURNAL			English	Article											FENTEM, P (corresponding author), UNIV NOTTINGHAM,NOTTINGHAM,ENGLAND.								0	78	79	0	25	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 14	1994	308	6939					1291	1295		10.1136/bmj.308.6939.1291	http://dx.doi.org/10.1136/bmj.308.6939.1291			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM147	8205026	Green Published			2022-12-28	WOS:A1994NM14700027
J	SCHLAPPI, M; RAINA, R; FEDOROFF, N				SCHLAPPI, M; RAINA, R; FEDOROFF, N			EPIGENETIC REGULATION OF THE MAIZE SPM TRANSPOSABLE ELEMENT - NOVEL ACTIVATION OF A METHYLATED PROMOTER BY TNPA	CELL			English	Article							SUPPRESSOR-MUTATOR ELEMENT; DNA METHYLATION; TRANSGENE EXPRESSION; BINDING-PROTEIN; ZEA-MAYS; TOBACCO; TRANSPOSITION; SEQUENCE; TRANSFORMATION; EXCISION	Spm is epigenetically inactivated by C-methylation near its transcription start site. We have investigated the interaction between TnpA, an autoregulatory protein that can reactivate a silent Spm, and the promoter of the element. The promoter undergoes rapid de novo methylation and inactivation in stably transformed plants, but only if it includes a GC-rich sequence downstream of the promoter. TnpA activates the inactive, methylated promoter and leads to reduced methylation. By contrast, TnpA represses the active, unmethylated Spm promoter. Only the internal DNA-binding and dimerization domains of the protein are required for repression, while activation requires an additional C-terminal sequence. TnpA is therefore a unique regulatory protein with a conventional transcriptional repressor activity and a novel ability to activate a methylated, inactive promoter.			SCHLAPPI, M (corresponding author), CARNEGIE INST WASHINGTON, DEPT EMBRYOL, BALTIMORE, MD 21210 USA.				NIGMS NIH HHS [GM4296] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AINLEY WM, 1990, PLANT MOL BIOL, V14, P949, DOI 10.1007/BF00019392; BANKS JA, 1988, GENE DEV, V2, P1364, DOI 10.1101/gad.2.11.1364; BANKS JA, 1989, DEV GENET, V10, P425, DOI 10.1002/dvg.1020100604; BOLKER M, 1989, EMBO J, V8, P2403, DOI 10.1002/j.1460-2075.1989.tb08370.x; BOYES J, 1991, CELL, V64, P1123, DOI 10.1016/0092-8674(91)90267-3; BRAATEN BA, 1994, CELL, V76, P577, DOI 10.1016/0092-8674(94)90120-1; BRAUN RE, 1986, MOL GEN GENET, V202, P246, DOI 10.1007/BF00331644; BREYNE P, 1992, PLANT CELL, V4, P463, DOI 10.1105/tpc.4.4.463; COMAI L, 1990, PLANT MOL BIOL, V15, P373, DOI 10.1007/BF00019155; COOK D, 1992, MAIZE GEN COOP NEWSL, V66, P11; FEDOROFF N, 1989, GENETICS, V121, P591; FEDOROFF NV, 1988, GENETICS, V120, P559; FEDOROFF NV, 1994, IN PRESS HOMOLOGOUS; FREY M, 1990, EMBO J, V9, P4037, DOI 10.1002/j.1460-2075.1990.tb07625.x; GATZ C, 1992, PLANT J, V2, P397, DOI 10.1046/j.1365-313X.1992.t01-37-00999.x; GIERL A, 1988, EMBO J, V7, P4045, DOI 10.1002/j.1460-2075.1988.tb03298.x; GRANT SR, 1990, EMBO J, V9, P2029, DOI 10.1002/j.1460-2075.1990.tb07369.x; HAUGHN GW, 1988, MOL GEN GENET, V211, P266, DOI 10.1007/BF00330603; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; JANE SM, 1993, MOL CELL BIOL, V13, P3272, DOI 10.1128/MCB.13.6.3272; JOST JP, 1992, P NATL ACAD SCI USA, V89, P9499, DOI 10.1073/pnas.89.20.9499; LEWIS J, 1991, FEBS LETT, V285, P155, DOI 10.1016/0014-5793(91)80795-5; MASSON P, 1989, P NATL ACAD SCI USA, V86, P2219, DOI 10.1073/pnas.86.7.2219; MASSON P, 1991, PLANT CELL, V3, P73, DOI 10.1105/tpc.3.1.73; MASSON P, 1989, CELL, V58, P755, DOI 10.1016/0092-8674(89)90109-8; MASSON P, 1987, GENETICS, V117, P117; MCBRIDE KE, 1990, PLANT MOL BIOL, V14, P269, DOI 10.1007/BF00018567; McClintock B., 1959, Yearbook of the Carnegie Institution of Washington 1958-59, P452; McClintock B., 1957, Year Book of the Carnegie Institution of Washington 1956-1957, P393; MCCLINTOCK B, 1961, AM NAT, V45, P265; MCCLINTOCK B, 1958, CARNEGIE I WASHINGTO, V57, P415; McClintock B, 1971, CARNEGIE I WASHINGTO, V70, P5; McClintock B., 1954, CARNEGIE I WASH YB, V53, P254; McClintock B., 1956, CARNEGIE I WASHINGTO, V55, P323; MCCLINTOCK B, 1961, CARNEGIE I WASHINGTO, V60, P469; McClintock B, 1955, CARNEGIE I WASH YB, V54, P245; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; NOU XW, 1993, MOL MICROBIOL, V7, P545, DOI 10.1111/j.1365-2958.1993.tb01145.x; PEACH C, 1991, PLANT MOL BIOL, V17, P49, DOI 10.1007/BF00036805; RAINA R, 1993, P NATL ACAD SCI USA, V90, P6355, DOI 10.1073/pnas.90.13.6355; RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991; ROBERTS D, 1985, CELL, V43, P117, DOI 10.1016/0092-8674(85)90017-0; ROGERS SG, 1988, METHODS PLANT MOL BI, P425; RUSSELL JA, 1992, IN VITRO CELL DEV-PL, V28P, P97; SCHIEFELBEIN JW, 1985, P NATL ACAD SCI USA, V82, P4783, DOI 10.1073/pnas.82.14.4783; SCHLAPPI M, 1993, GENETICS, V133, P1009; SCHLAPPI M, 1992, MAIZE GENET COOP NEW, V66, P12; SCHULE R, 1991, TRENDS GENET, V7, P377, DOI 10.1016/0168-9525(91)90259-S; SCHWARZSOMMER Z, 1985, EMBO J, V4, P2439, DOI 10.1002/j.1460-2075.1985.tb03953.x; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; TRENTMANN SM, 1993, MOL GEN GENET, V238, P201, DOI 10.1007/BF00279548; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; YIN JCP, 1988, J MOL BIOL, V199, P35, DOI 10.1016/0022-2836(88)90377-4	54	72	72	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	1994	77	3					427	437		10.1016/0092-8674(94)90157-0	http://dx.doi.org/10.1016/0092-8674(94)90157-0			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NK970	8181061				2022-12-28	WOS:A1994NK97000013
J	JONES, BN; TENG, EL; FOLSTEIN, MF; HARRISON, KS				JONES, BN; TENG, EL; FOLSTEIN, MF; HARRISON, KS			A NEW BEDSIDE TEST OF COGNITION FOR PATIENTS WITH HIV-INFECTION	ANNALS OF INTERNAL MEDICINE			English	Article						HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS; COGNITION DISORDERS; MENTAL STATUS SCHEDULE; ACQUIRED IMMUNODEFICIENCY SYNDROME	AIDS DEMENTIA COMPLEX; DISORDERS	Objective: To compare the Mental Alternation Test, a new 60-second bedside test of cognition, with the Mini-Mental State Exam (MMSE) and the Trailmaking Test, parts A and B, in patients with human immunodeficiency virus (HIV) infection. Design: Cohort study. Participants: Sixty-two inpatients with HIV infection. Setting: The AIDS service of a referral hospital. Measurements: Scores on the MMSE; the Trailmaking Test, parts A and B; and the Mental Alternation Test were compared using correlation calculations and analyses of variance. Receiver operating curves were constructed to identify the best cutoff score on the Mental Alternation Test for detecting impaired performance on the MMSE and the Trailmaking Test. Main Results: The Mental Alternation Test score correlated significantly with MMSE (r = 0.68, P < 0.01) and Trailmaking Test, part B, scores (r = -0.54, P < 0.01). The receiver operating curves showed that a Mental Alternation Test cutoff score of 15 yielded the best results for the detection of abnormal performance on the MMSE (sensitivity, 95% [95% CI, 90% to 100%]; specificity, 79% [CI, 69% to 89%]) and the Trailmaking Test, part B (sensitivity, 78% [CI, 68% to 88%]; specificity 93% [CI, 90% to 100%]). Patients making fewer than 15 alternations in 30 seconds were significantly more likely to have abnormal MMSE (P < 0.0001) and Trailmaking Test, part B, scores (P < 0.0001). The Mental Alternation Test had good reproducibility; analyses of reliability included test-retest correlation (r = 0.80) and inter-rater reliability (r = 0.85, kappa = 0.84). Time of administration was approximately 60 seconds. Conclusions: The Mental Alternation Test of cognition has good sensitivity and specificity and is easily administered. It is a valuable test to identify patients who may need further cognitive evaluation.	JOHNS HOPKINS UNIV, DIV INFECT DIS, ROSS BLDG 1159, 720 RUTLAND AVE, BALTIMORE, MD 21205 USA	Johns Hopkins University					NIA NIH HHS [AGO-149] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BORNSTEIN RA, 1985, J CLIN PSYCHOL, V41, P651, DOI 10.1002/1097-4679(198509)41:5<651::AID-JCLP2270410511>3.0.CO;2-C; CRUM RM, 1993, JAMA-J AM MED ASSOC, V269, P2386, DOI 10.1001/jama.269.18.2386; FITZGIBBON ML, 1989, PERCEPT MOTOR SKILL, V68, P1331, DOI 10.2466/pms.1989.68.3c.1331; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hilton G, 1990, J Neurosci Nurs, V22, P36; HO DD, 1989, ANN INTERN MED, V111, P400, DOI 10.7326/0003-4819-111-5-400; HOLLAND JC, 1985, ANN INTERN MED, V103, P760, DOI 10.7326/0003-4819-103-5-760; JANSSEN RS, 1989, ANN NEUROL, V26, P592, DOI 10.1002/ana.410260503; KNIGHTS EB, 1977, ANN INTERN MED, V87, P723, DOI 10.7326/0003-4819-87-6-723; LUNN S, 1991, ARCH GEN PSYCHIAT, V48, P139; Marotta R, 1989, J Neuropsychiatry Clin Neurosci, V1, P225; MOSSMAN D, 1991, J NEUROPSYCH CLIN N, V3, P330; NAVIA BA, 1986, ANN NEUROL, V19, P517, DOI 10.1002/ana.410190602; PERRY SW, 1990, AM J PSYCHIAT, V147, P696; PRICE RW, 1988, ANN NEUROL, V23, pS27, DOI 10.1002/ana.410230711; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; RUBINOW DR, 1988, ANN NEUROL, V23, pS24, DOI 10.1002/ana.410230710; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; TROSS S, 1988, AIDS, V2, P81, DOI 10.1097/00002030-198804000-00002; VNAGORP WG, 1989, NEUROPSY NEUROPSY BE, V2, P5	20	57	57	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1993	119	10					1001	1004		10.7326/0003-4819-119-10-199311150-00006	http://dx.doi.org/10.7326/0003-4819-119-10-199311150-00006			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MG672	8214976				2022-12-28	WOS:A1993MG67200006
J	FRAIMOW, HS; JUNGKIND, DL; LANDER, DW; DELSO, DR; DEAN, JL				FRAIMOW, HS; JUNGKIND, DL; LANDER, DW; DELSO, DR; DEAN, JL			URINARY-TRACT INFECTION WITH AN ENTEROCOCCUS-FAECALIS ISOLATE THAT REQUIRES VANCOMYCIN FOR GROWTH	ANNALS OF INTERNAL MEDICINE			English	Article						URINARY TRACT INFECTIONS; ENTEROCOCCUS FAECALIS; VANCOMYCIN; DRUG RESISTANCE, MICROBIAL; MICROBIAL SENSITIVITY	GLYCOPEPTIDE ANTIBIOTICS; PEPTIDOGLYCAN PRECURSOR; RESISTANT ENTEROCOCCI; FAECIUM; VANB; TEICOPLANIN; GENES	Objective: To characterize the nutritional requirements and potential origin of a fastidious urinary tract Enterococcus faecalis isolate that apparently requires the antimicrobial agent vancomycin to grow. Design: Case report and detailed microbiologic and molecular epidemiologic analysis. Setting: University teaching hospital. Measurements: Growth of the vancomycin-dependent strain was monitored using various standard laboratory media with and without supplementation with vancomycin and other substrates. This strain was compared with other vancomycin-resistant but nondependent E. faecalis strains by examining plasmid profiles and pulsed-field gel electrophoresis patterns of genomic DNA and by analyzing vancomycin-resistance genes identified by the polymerase chain reaction. Results: An E. faecalis isolate, strain TJ310, was isolated repeatedly from the urine of a patient receiving long-term vancomycin therapy. This strain grew in primary culture but not on subculture, suggesting an unusual growth requirement, and ultimately was found to require the glycopeptide antibiotic vancomycin to grow. Strain TJ310 appeared to be closely related to other vancomycin-resistant but nondependent E. faecalis isolates with the vanB genotype previously isolated from the same patient, suggesting that vancomycin dependence may have evolved in vivo in a vancomycin-resistant enterococcal strain during continuous exposure to high concentrations of vancomycin in the urine. Conclusions: This is the first reported example of a clinical bacterial isolate that requires an antimicrobial agent to grow.	THOMAS JEFFERSON UNIV HOSP, CLIN MICROBIOL LAB, PHILADELPHIA, PA 19107 USA; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DIV INFECT DIS, PHILADELPHIA, PA 19107 USA	Jefferson University; Jefferson University								BARNA JCJ, 1984, ANNU REV MICROBIOL, V38, P339, DOI 10.1146/annurev.mi.38.100184.002011; BILLOTKLEIN D, 1992, ANTIMICROB AGENTS CH, V36, P1487, DOI 10.1128/AAC.36.7.1487; BUGG TDH, 1991, BIOCHEMISTRY-US, V30, P10408, DOI 10.1021/bi00107a007; CLARK NC, 1993, ANTIMICROB AGENTS CH, V37, P2311, DOI 10.1128/AAC.37.11.2311; EVERS S, 1993, GENE, V124, P143, DOI 10.1016/0378-1119(93)90779-3; GOLD HS, 1993, ANTIMICROB AGENTS CH, V37, P1604, DOI 10.1128/AAC.37.8.1604; GOLDMANN DA, 1992, INFECT CONT HOSP EP, V13, P695; GORINI L, 1964, P NATL ACAD SCI USA, V51, P487, DOI 10.1073/pnas.51.3.487; GREEN M, 1991, 33RD INT C ANT AG CH, P241; HANDWERGER S, 1992, J BACTERIOL, V174, P5982, DOI 10.1128/jb.174.18.5982-5984.1992; HAYDEN MK, 1993, J INFECT DIS, V167, P1224, DOI 10.1093/infdis/167.5.1224; MURRAY BE, 1990, J CLIN MICROBIOL, V28, P2059, DOI 10.1128/JCM.28.9.2059-2063.1990; REYNOLDS PE, 1989, EUR J CLIN MICROBIOL, V8, P943, DOI 10.1007/BF01967563; ROBERTS RB, 1979, REV INFECT DIS, V1, P955; SAMBROOK J, 1989, MOL CLONING LABORATO, P185; SPERA RV, 1992, JAMA-J AM MED ASSOC, V268, P2563, DOI 10.1001/jama.268.18.2563; WALSH CT, 1989, J BIOL CHEM, V264, P2393; WALSH CT, 1993, SCIENCE, V261, P308, DOI 10.1126/science.8392747; WILLIAMSON R, 1989, J INFECT DIS, V159, P1095, DOI 10.1093/infdis/159.6.1095	19	85	87	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1994	121	1					22	26		10.7326/0003-4819-121-1-199407010-00004	http://dx.doi.org/10.7326/0003-4819-121-1-199407010-00004			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PN271	8198343				2022-12-28	WOS:A1994PN27100004
J	OMEARA, JJ; MCNUTT, RA; EVANS, AT; MOORE, SW; DOWNS, SM				OMEARA, JJ; MCNUTT, RA; EVANS, AT; MOORE, SW; DOWNS, SM			A DECISION-ANALYSIS OF STREPTOKINASE PLUS HEPARIN AS COMPARED WITH HEPARIN ALONE FOR DEEP-VEIN THROMBOSIS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; VENOUS THROMBOSIS; THROMBOLYTIC THERAPY; PROSPECTIVE TRIAL; RANDOMIZED TRIAL; COMPLICATIONS; MANAGEMENT; STROKE	It is uncertain whether patients with proximal deep-vein thrombosis should be treated with streptokinase followed by intravenous heparin or with intravenous heparin alone. Published reports indicate that streptokinase plus heparin increases the risk of bleeding, including central nervous system bleeding and death, but decreases the risk of postphlebitic syndrome. Previous recommendations regarding these treatments have not considered patients' preferences or the values they attach to the possible outcomes of therapy. Methods. We used decision analysis to combine published estimates of the probabilities of various adverse outcomes of treatment (bleeding, pulmonary embolism, postphlebitic syndrome, and death) with the values patients placed on these outcomes. We questioned 36 patients about the values they attached to each outcome. Sixteen patients had had deep-vein thrombosis, and 20 had not. Results. By the values they attached to the outcomes, all 36 patients indicated that they were unwilling to accept an increased risk of death to avoid postphlebitic syndrome. According to the decision analysis, heparin alone was the better treatment for all 36 patients. As compared with streptokinase plus heparin, heparin alone provided 29 days of additional life expectancy over the predicted life expectancy of 20 years. Although the difference between the two treatments was small, heparin alone remained the better treatment in sensitivity analyses that examined the reasonable ranges of probabilities of the clinical outcomes. Conclusions. The values patients placed on the outcomes of treatment for deep-vein thrombosis support the use of heparin alone over the combined use of streptokinase and heparin.	UNIV N CAROLINA, DIV GEN MED, CHAPEL HILL, NC 27599 USA; UNIV N CAROLINA, DIV CLIN EPIDEMIOL, CHAPEL HILL, NC USA; UNIV N CAROLINA, DEPT PEDIAT, CHAPEL HILL, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill								ARNESEN H, 1982, ACTA MED SCAND, V211, P65; ARNESEN H, 1978, ACTA MED SCAND, V203, P457; BECK JR, 1982, AM J MED, V73, P889, DOI 10.1016/0002-9343(82)90787-2; BIEGER R, 1976, ACTA MED SCAND, V199, P81; BOYD NF, 1990, MED DECIS MAKING, V10, P58, DOI 10.1177/0272989X9001000109; BROWSE NL, 1968, BRIT MED J, V3, P717, DOI 10.1136/bmj.3.5620.717; COMMON HH, 1976, ANGIOLOGY, V27, P645, DOI 10.1177/000331977602701105; DEXTER L, 1974, HEART ARTERIES VEINS, P1264; DUCKERT F, 1975, BRIT MED J, V1, P479, DOI 10.1136/bmj.1.5956.479; ELLIOT MS, 1979, BRIT J SURG, V66, P838, DOI 10.1002/bjs.1800661203; FAGHER B, 1981, ACTA MED SCAND, V210, P357; FENNERTY AG, 1989, CHEST, V95, pS88; GLAZIER RL, 1976, JAMA-J AM MED ASSOC, V236, P1365, DOI 10.1001/jama.236.12.1365; GOLDHABER SZ, 1993, LANCET, V341, P507, DOI 10.1016/0140-6736(93)90274-K; GOLDHABER SZ, 1991, CHEST, V99, pS173, DOI 10.1378/chest.99.4.173S; GOLDHABER SZ, 1984, AM J MED, V76, P393, DOI 10.1016/0002-9343(84)90656-9; GORE JM, 1991, CIRCULATION, V83, P448, DOI 10.1161/01.CIR.83.2.448; HOLM HA, 1984, ACTA MED SCAND, V215, P47; HULL RD, 1992, ARCH INTERN MED, V152, P1589, DOI 10.1001/archinte.152.8.1589; HUNT D, 1992, LANCET, V339, P753; HYERS TM, 1992, CHEST, V102, pS408, DOI 10.1378/chest.102.4_Supplement.408S; HYERS TM, 1993, CHEST, V103, P1636, DOI 10.1378/chest.103.5.1636a; JOHANSSON E, 1976, ACTA MED SCAND, V199, P89; JOHANSSON L, 1979, ACTA MED SCAND, V206, P93; KAKKAR VV, 1985, AM J SURG, V150, P54; KAKKAR VV, 1969, BRIT MED J, V1, P806, DOI 10.1136/bmj.1.5647.806; LANDEFELD CS, 1987, AM J MED, V82, P703, DOI 10.1016/0002-9343(87)90004-0; MAGGIONI AP, 1992, NEW ENGL J MED, V327, P1, DOI 10.1056/NEJM199207023270101; MANT MJ, 1977, LANCET, V1, P1133; MARDER VJ, 1988, NEW ENGL J MED, V318, P1585, DOI 10.1056/NEJM198806163182406; MARDER VJ, 1988, NEW ENGL J MED, V318, P1512, DOI 10.1056/NEJM198806093182306; Matsumoto N, 1973, STROKE, V4, P20, DOI 10.1161/01.STR.4.1.20; MCNUTT RA, 1989, PATIENT EDUC COUNS, V13, P271, DOI 10.1016/0738-3991(89)90021-9; MEISSNER AJ, 1987, BRIT J SURG, V74, P991, DOI 10.1002/bjs.1800741111; OCONNOR CM, 1990, J AM COLL CARDIOL, V16, P533, DOI 10.1016/0735-1097(90)90338-P; OTT P, 1986, ACTA MED SCAND, V219, P295; PORTER JM, 1975, AM SURGEON, V41, P511; ROBERTSO.BR, 1970, ACTA CHIR SCAND, V136, P173; ROGERS LQ, 1990, AM J MED, V88, P389, DOI 10.1016/0002-9343(90)90494-X; SACKETT DL, 1978, J CHRON DIS, V31, P697, DOI 10.1016/0021-9681(78)90072-3; SALZMAN EW, 1975, NEW ENGL J MED, V292, P1046, DOI 10.1056/NEJM197505152922002; SHERRY S, 1991, ANN EMERG MED, V20, P396, DOI 10.1016/S0196-0644(05)81662-2; SHERRY S, 1980, ANN INTERN MED, V93, P141, DOI 10.7326/0003-4819-93-1-141; STIEGLER H, 1989, SEMIN THROMB HEMOST, V15, P250, DOI 10.1055/s-2007-1002715; TIBBUTT DA, 1974, BRIT J HAEMATOL, V27, P407, DOI 10.1111/j.1365-2141.1974.tb06807.x; TRUBESTEIN G, 1986, HAEMOSTASIS, V16, P38; TSAPOGAS MJ, 1973, SURGERY, V74, P973; VERSTRAETE M, 1989, DRUGS, V38, P801, DOI 10.2165/00003495-198938050-00006; WATZ R, 1979, ACTA MED SCAND, V205, P293; WILSON JR, 1979, AM HEART J, V97, P155, DOI 10.1016/0002-8703(79)90349-1	50	131	132	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	1994	330	26					1864	1869		10.1056/NEJM199406303302605	http://dx.doi.org/10.1056/NEJM199406303302605			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NT530	8196729				2022-12-28	WOS:A1994NT53000005
J	GUI, JF; LANE, WS; FU, XD				GUI, JF; LANE, WS; FU, XD			A SERINE KINASE REGULATES INTRACELLULAR-LOCALIZATION OF SPLICING FACTORS IN THE CELL CYCLE	NATURE			English	Article							RICH DOMAINS; SR PROTEINS; PHOSPHORYLATION; IDENTIFICATION; NUCLEUS; COMPARTMENT; INVITRO; FAMILY; SITES	Small nuclear ribonucleoprotein particles (snRNPs) and non-snRNP splicing factors containing a serine/arginine-rich domain (SR proteins) concentrate in 'speckles' in the nucleus of interphase cells(1). It is believed that nuclear speckles act as storage sites for splicing factors while splicing occurs on nascent transcripts(2). Splicing factors redistribute in response to transcription inhibition(3,4) or viral infection(5), and nuclear speckles break down and reform as cells progress through mitosis(6). We have now identified and cloned a kinase, SRPK1, which is regulated by the cell cycle and is specific for SR proteins; this kinase is related to a Caenorhabditis elegans kinase and to the fission yeast kinase Dsk1 (ref. 7). SRPK1 specifically induces the disassembly of nuclear speckles, and a high level of SRPK1 inhibits splicing in vitro. Our results indicate that SRPK1 mag have a central role in the regulatory network for splicing, controlling the intranuclear distribution of splicing factors in interphase cells, and the reorganization of nuclear speckles during mitosis.	UNIV CALIF SAN DIEGO, DIV CELLULAR & MOLEC MED, LA JOLLA, CA 92093 USA; HARVARD UNIV, CAMBRIDGE, MA 02138 USA; CHINESE ACAD SCI, INST HYDROBIOL, WUHAN 430072, PEOPLES R CHINA	University of California System; University of California San Diego; Harvard University; Chinese Academy of Sciences; Institute of Hydrobiology, CAS								AMREIN H, 1994, CELL, V76, P735, DOI 10.1016/0092-8674(94)90512-6; ANDRADE LEC, 1993, P NATL ACAD SCI USA, V90, P1947, DOI 10.1073/pnas.90.5.1947; BAKER SJ, 1992, MOL CELL BIOL, V12, P4694, DOI 10.1128/MCB.12.10.4694; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P111; CACERES JF, 1993, EMBO J, V12, P4715, DOI 10.1002/j.1460-2075.1993.tb06160.x; CARMOFONSECA M, 1992, J CELL BIOL, V117, P1, DOI 10.1083/jcb.117.1.1; FU XD, 1993, NATURE, V365, P82, DOI 10.1038/365082a0; FU XD, 1990, NATURE, V343, P437, DOI 10.1038/343437a0; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HOGNER D, 1988, EXP CELL RES, V176, P281, DOI 10.1016/0014-4827(88)90331-X; JIMINEZGARCIA LF, 1993, CELL, V73, P47; KOHTZ JD, 1994, NATURE, V368, P119, DOI 10.1038/368119a0; KRANIER AR, 1990, GENE DEV, V4, P1158; LEW DJ, 1991, CELL, V66, P1197, DOI 10.1016/0092-8674(91)90042-W; LI H, 1991, CELL, V67, P335, DOI 10.1016/0092-8674(91)90185-2; MERMOUD JE, 1992, NUCLEIC ACIDS RES, V20, P5263, DOI 10.1093/nar/20.20.5263; MITTNACHT S, 1991, CELL, V65, P381, DOI 10.1016/0092-8674(91)90456-9; MORENO S, 1990, CELL, V61, P549, DOI 10.1016/0092-8674(90)90463-O; NAKAGAWA J, 1989, J CELL SCI, V94, P449; OKEEFE RT, 1994, J CELL BIOL, V124, P249, DOI 10.1083/jcb.124.3.249; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; SPECTOR DL, 1991, EMBO J, V10, P3467, DOI 10.1002/j.1460-2075.1991.tb04911.x; SPECTOR DL, 1993, ANNU REV CELL BIOL, V9, P265, DOI 10.1146/annurev.cellbio.9.1.265; TAKEUCHI M, 1993, MOL BIOL CELL, V4, P247, DOI 10.1091/mbc.4.3.247; TAZI J, 1993, NATURE, V363, P283, DOI 10.1038/363283a0; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; WOPPMANN A, 1993, NUCLEIC ACIDS RES, V21, P2815, DOI 10.1093/nar/21.12.2815; WU JY, 1993, CELL, V75, P1061, DOI 10.1016/0092-8674(93)90316-I; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0	30	451	475	2	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	1994	369	6482					678	682		10.1038/369678a0	http://dx.doi.org/10.1038/369678a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NT459	8208298				2022-12-28	WOS:A1994NT45900064
J	HOSENPUD, JD; BREEN, TJ; EDWARDS, EB; DAILY, OP; HUNSICKER, LG				HOSENPUD, JD; BREEN, TJ; EDWARDS, EB; DAILY, OP; HUNSICKER, LG			THE EFFECT OF TRANSPLANT CENTER VOLUME ON CARDIAC TRANSPLANT OUTCOME - A REPORT OF THE UNITED-NETWORK-FOR-ORGAN-SHARING-SCIENTIFIC-REGISTRY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERNATIONAL-SOCIETY; HEART-TRANSPLANTATION; OFFICIAL REPORT	Objective.-The number of cardiac transplant programs continues to increase despite no increase in the number of hearts available for transplantation. As a result, the majority of heart transplant centers perform extremely small numbers of transplant operations annually. To determine the effect of small transplantation volume on transplant outcome, the following study was performed. Design.-Using the Scientific Registry of the United Network for Organ Sharing, all cardiac transplant procedures from October 1987 through December 1991 were analyzed to determine whether center volumes affected cardiac transplant outcome.Patient survival rates for each center were determined, and the survival rates were modeled for the following patient variables: first transplantation or retransplantation, patient condition at the time of transplantation, patient underlying cardiac disease (congenital vs all others), and time. Setting.-All cardiac transplant centers in the United States were included in the analysis. Patients.-All patients undergoing cardiac transplantation in the United States from October 1987 through December 1991 were included in the analysis. Main Outcome Measure.-The primary end point in this analysis was mortality. Results.-Throughout the entire study, of the 150 cardiac transplant centers, 35.3% of the centers were performing fewer than five cardiac transplantations per year, 53.3% were performing fewer than nine transplantations per year, and 61.3% were performing fewer than 12 transplantations per year, the minimum required for Medicare payment eligibility. Using the modeled survival rates, the risk of mortality decreased to a basal level in those centers performing between eight and 10 transplant operations per year. In centers performing fewer than nine transplantations, mortality increased sharply and exponentially. Dividing centers into those that performed nine or more transplantations per year (70 centers) and fewer than nine transplantations per year (80 centers), the increased risk of mortality at 1 month and 12 months was 40.3% and 33.1%, respectively, in centers performing fewer than nine cardiac transplantations per year (P<.001). Once the threshold of nine transplant procedures was met, those centers that were eligible for Medicare payment did not have significantly better survival than those centers not eligible for Medicare coverage. Conclusions.-These data demonstrate that the risk of mortality at early and intermediate time points is substantially higher in low-volume cardiac transplant centers, which make up more than half of the centers performing cardiac transplantation in the United States.	UNITED NETWORK ORGAN SHARING,DEPT RES,RICHMOND,VA; OREGON HLTH SCI UNIV,DEPT MED,PORTLAND,OR 97201; UNIV IOWA,MED CTR,DEPT MED,IOWA CITY,IA	United Network for Organ Sharing; Oregon Health & Science University; University of Iowa								BOURGE RC, IN PRESS J HEART LUN; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; COSTARDJACKLE A, 1991, CIRCULATION, V84, P329; ENSLEY RD, 1992, J HEART LUNG TRANSPL, V11, P142; Evans RW, 1992, CLIN TRANSPLANTS 199, P45; Hastie TJ., 2017, GEN ADDITIVE MODELS; HECK CF, 1989, J HEART TRANSPLANT, V8, P271; KIRKLIN JK, 1988, J AM COLL CARDIOL, V11, P917, DOI 10.1016/S0735-1097(98)90045-6; KRIETT JM, 1991, J HEART LUNG TRANSPL, V10, P491; LAFFEL GL, 1992, NEW ENGL J MED, V327, P1220, DOI 10.1056/NEJM199210223271707; 1992, 1991 US DEP HLTH HUM, P1	11	107	107	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	1994	271	23					1844	1849		10.1001/jama.271.23.1844	http://dx.doi.org/10.1001/jama.271.23.1844			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NP959	8196141				2022-12-28	WOS:A1994NP95900028
J	NAYLOR, CD				NAYLOR, CD			PHYSICAL-EXAMINATION OF THE LIVER	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SIZE; ULTRASOUND; DIAGNOSIS; DISEASE		SUNNYBROOK HLTH SCI CTR, DIV GEN INTERNAL MED, TORONTO, ON, CANADA; UNIV TORONTO, GRAD DEPT COMMUNITY HLTH, TORONTO, ON, CANADA; UNIV TORONTO, DEPT MED, TORONTO, ON, CANADA; UNIV TORONTO, DEPT SURG, TORONTO, ON, CANADA	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto	NAYLOR, CD (corresponding author), SUNNYBROOK HLTH SCI CTR, CLIN EPIDEMIOL UNIT, TORONTO M4N 3M5, ON, CANADA.							ARIEL I M, 1976, Medical and Pediatric Oncology, V2, P69, DOI 10.1002/mpo.2950020108; Bhatia M. L., 1974, INDIAN HEART J, V26, P165; BLENDIS LM, 1970, BMJ-BRIT MED J, V1, P727, DOI 10.1136/bmj.1.5698.727; BOKHARI SI, 1979, CHEST, V76, P89, DOI 10.1378/chest.76.1.89; CASTELL DO, 1969, ANN INTERN MED, V70, P1183, DOI 10.7326/0003-4819-70-6-1183; CLAIN D, 1966, LANCET, V2, P516; DACOSTA JC, 1915, PRINCIPLES PRACTICE, P542; ESPINOZA P, 1987, DIGEST DIS SCI, V32, P244, DOI 10.1007/BF01297048; FENSTER LF, 1961, AM J MED, V31, P238, DOI 10.1016/0002-9343(61)90112-7; FULLER GN, 1988, LANCET, V1, P181; GEORGE DS, 1988, CLIN CARDIOL, V11, P349, DOI 10.1002/clc.4960110515; HALPERN S, 1974, ARCH INTERN MED, V134, P123, DOI 10.1001/archinte.134.1.123; HARDING SMR, 1987, CAN MED ASSOC J, V136, P921; HARDISON JE, 1977, ARCH INTERN MED, V137, P1623, DOI 10.1001/archinte.137.11.1623; KINGSTON M, 1985, CANCER, V55, P1579, DOI 10.1002/1097-0142(19850401)55:7<1579::AID-CNCR2820550728>3.0.CO;2-D; MALCHOWMOLLER A, 1984, DAN MED BULL, V31, P63; MANGA P, 1984, BRIT HEART J, V52, P465; MEYHOFF HH, 1979, ACTA CHIR SCAND, V145, P479; MOTOKI T, 1978, LANCET, V2, P259; MOTOKI T, 1979, AM J GASTROENTEROL, V71, P582; MULLER O, 1954, BRIT HEART J, V16, P195; NAFFALIS J, 1963, AM J DIG DIS, V8, P236; NAYLOR C D, 1988, Clinical and Investigative Medicine, V11, pC90; NAYLOR CD, 1987, CAN MED ASSOC J, V136, P48; OSLER W, 1893, PRINCIPLES PRACTICE, P428; PALMER E D, 1958, U S Armed Forces Med J, V9, P1685; PELTERET RM, 1988, S AFR MED J, V74, P74; PETERNEL WW, 1966, AM J DIG DIS, V11, P346, DOI 10.1007/BF02233628; RALPHS DNL, 1983, ANN ROY COLL SURG, V65, P159; RAMAKRISHNAN T, 1978, ARCH INTERN MED, V138, P826, DOI 10.1001/archinte.1978.03630290106043; ROSENFIELD AT, 1974, AM J ROENTGENOL, V122, P313, DOI 10.2214/ajr.122.2.313; SAPIRA JD, 1989, SOUTHERN MED J, V82, P364, DOI 10.1097/00007611-198903000-00020; SAPIRA JD, 1979, ARCH INTERN MED, V139, P971, DOI 10.1001/archinte.139.9.971; SAPIRA JD, 1989, ART SCI BEDSIDE DIAG, P377; SHERMAN HI, 1979, JAMA-J AM MED ASSOC, V241, P1495, DOI 10.1001/jama.241.14.1495; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; SKRAINKA B, 1986, J CLIN GASTROENTEROL, V8, P267, DOI 10.1097/00004836-198606000-00013; SULLIVAN S, 1976, BMJ-BRIT MED J, V2, P1042, DOI 10.1136/bmj.2.6043.1042; THEODOSSI A, 1981, Liver, V1, P21; THEODOSSI A, 1983, LIVER, V3, P315; THEODOSSI A, 1985, CLIN GASTROENTEROL, V14, P545; WALK L, 1983, RADIOLOGE, V23, P189; ZONERAICH S, 1971, ANGIOLOGY, V22, P197, DOI 10.1177/000331977102200405; ZUIDEMA PJ, 1966, TROP GEOGR MED, V18, P265	44	28	28	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	1994	271	23					1859	1865		10.1001/jama.271.23.1859	http://dx.doi.org/10.1001/jama.271.23.1859			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NP959	8196144				2022-12-28	WOS:A1994NP95900031
J	CRESPO, P; XU, NZ; SIMONDS, WF; GUTKIND, JS				CRESPO, P; XU, NZ; SIMONDS, WF; GUTKIND, JS			RAS-DEPENDENT ACTIVATION OF MAP KINASE PATHWAY MEDIATED BY G-PROTEIN BETA-GAMMA-SUBUNITS	NATURE			English	Article							NIH 3T3 CELLS; ALPHA-SUBUNITS; RECEPTOR; EXPRESSION; TRANSFORMATION; PROLIFERATION; STIMULATION; FIBROBLASTS; INHIBITION; SIGNALS	MITOGEN-ACTIVATED protein kinases, MAP kinases or ERKs (extracellular signal-regulated kinases) are rapidly stimulated by growth-promoting factors acting on a variety of cell-surface receptors (1,2). In turn, ERKs phosphorylate and regulate key intracellular enzymes and transcription factors involved in the control of cellular proliferation(3,4). The tyrosine-kinase class of growth-factor receptors transmits signals to ERKs in a multistep process that involves Ras and a limited number of defined molecules(5). In contrast, ERK activation by G-protein-coupled receptors is poorly understood(3,6), as is the role of ras in this signalling pathway(7,8). We have explored in COS-7 cells the mechanism of ERKs activation by m1 and m2 muscarinic receptors, typical examples of receptors coupled through Gq proteins to induce phosphatidylinositol hydrolysis and to G(i) proteins to inhibit adenylyl cyclase, respectively(9). Here we present evidence that ERK activation is mediated by beta gamma subunits of heterotrimeric G proteins acting on a ras-dependent pathway.	NIDR, CELLULAR DEV & ONCOL LAB, MOLEC SIGNALLING UNIT, BETHESDA, MD 20892 USA; NIDDKD, METAB DIS BRANCH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)			Gutkind, J. Silvio/J-1201-2016; Gutkind, J. Silvio/A-1053-2009; Crespo, Piero/M-3273-2014	Gutkind, J. Silvio/0000-0002-5150-4482; Crespo, Piero/0000-0003-2825-7783				BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; CLAPHAM DE, 1993, NATURE, V365, P403, DOI 10.1038/365403a0; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; COOK SJ, 1993, EMBO J, V12, P3475, DOI 10.1002/j.1460-2075.1993.tb06022.x; COUGHLIN SR, 1985, CELL, V43, P243, DOI 10.1016/0092-8674(85)90029-7; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; Errede B, 1993, CURR OPIN CELL BIOL, V5, P254, DOI 10.1016/0955-0674(93)90112-4; FEDERMAN AD, 1992, NATURE, V356, P159, DOI 10.1038/356159a0; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HER JH, 1993, BIOCHEM J, V296, P25, DOI 10.1042/bj2960025; HERMOUET S, 1991, P NATL ACAD SCI USA, V88, P10455, DOI 10.1073/pnas.88.23.10455; INIGUEZLLUHI JA, 1992, J BIOL CHEM, V267, P23409; KAHAN C, 1992, J BIOL CHEM, V267, P13369; KALINEC G, 1992, MOL CELL BIOL, V12, P4687, DOI 10.1128/MCB.12.10.4687; KITAYAMA H, 1989, CELL, V56, P77, DOI 10.1016/0092-8674(89)90985-9; LANGECARTER CA, 1993, SCIENCE, V260, P315, DOI 10.1126/science.8385802; LEFKOWITZ RJ, 1993, CELL, V74, P409, DOI 10.1016/0092-8674(93)80042-D; MUSSACHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343; PELECH SL, 1993, CURR BIOL, V3, P513, DOI 10.1016/0960-9822(93)90043-N; PERALTA EG, 1987, EMBO J, V6, P3923, DOI 10.1002/j.1460-2075.1987.tb02733.x; PRONIN AN, 1993, FEBS LETT, V328, P89, DOI 10.1016/0014-5793(93)80971-V; QIAN NX, 1993, P NATL ACAD SCI USA, V90, P4077, DOI 10.1073/pnas.90.9.4077; RAY LB, 1987, P NATL ACAD SCI USA, V84, P1502, DOI 10.1073/pnas.84.6.1502; SCHLESSINGER J, 1993, TRENDS BIOCHEM SCI, V18, P273, DOI 10.1016/0968-0004(93)90031-H; SIMONDS WF, 1991, J BIOL CHEM, V266, P5363; STRATHMANN MP, 1991, P NATL ACAD SCI USA, V88, P5582, DOI 10.1073/pnas.88.13.5582; UI M, 1990, ADV SEC MESS PHOSPH, V24, P63	30	783	791	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 2	1994	369	6479					418	420		10.1038/369418a0	http://dx.doi.org/10.1038/369418a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NP174	8196770				2022-12-28	WOS:A1994NP17400062
J	BOWMAN, MA; SCHWENK, TL				BOWMAN, MA; SCHWENK, TL			FAMILY MEDICINE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FECAL OCCULT BLOOD; COLORECTAL-CANCER; SCREENING SIGMOIDOSCOPY; MORTALITY; THERAPY; TRIAL; WOMEN		UNIV MICHIGAN, SCH MED, ANN ARBOR, MI USA	University of Michigan System; University of Michigan	BOWMAN, MA (corresponding author), WAKE FOREST UNIV, BOWMAN GRAY SCH MED, WINSTON SALEM, NC USA.		bowman, marjorie/F-7235-2013	bowman, marjorie/0000-0002-1945-9212				AHLQUIST DA, 1993, JAMA-J AM MED ASSOC, V269, P1262, DOI 10.1001/jama.269.10.1262; BAKER MD, 1993, NEW ENGL J MED, V329, P1437, DOI 10.1056/NEJM199311113292001; EISENBERG DM, 1993, NEW ENGL J MED, V328, P246, DOI 10.1056/NEJM199301283280406; EWIGMAN BG, 1993, NEW ENGL J MED, V329, P821, DOI 10.1056/NEJM199309163291201; FALKEBORN M, 1993, ARCH INTERN MED, V153, P1201, DOI 10.1001/archinte.153.10.1201; GREENBERG PE, 1993, J CLIN PSYCHIAT, V54, P405; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; NEWCOMB PA, 1992, JNCI-J NATL CANCER I, V84, P1572, DOI 10.1093/jnci/84.20.1572; RAZ R, 1993, NEW ENGL J MED, V329, P753, DOI 10.1056/NEJM199309093291102; SCHAAD UB, 1993, LANCET, V342, P457, DOI 10.1016/0140-6736(93)91592-A; SELBY JV, 1992, NEW ENGL J MED, V326, P653, DOI 10.1056/NEJM199203053261001; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SIBAI BM, 1993, NEW ENGL J MED, V329, P1213, DOI 10.1056/NEJM199310213291701; STAMPFER MJ, 1993, JAMA-J AM MED ASSOC, V270, P2726, DOI 10.1001/jama.270.22.2726; STOVALL TG, 1993, AM J OBSTET GYNECOL, V168, P1759, DOI 10.1016/0002-9378(93)90687-E	15	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1670	1671						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182843				2022-12-28	WOS:A1994NN11700022
J	HIRVELA, ER; ORGAN, CH				HIRVELA, ER; ORGAN, CH			GENERAL-SURGERY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MONOCLONAL-ANTIBODY; CANCER; LAPAROSCOPY; THERAPY				HIRVELA, ER (corresponding author), UNIV CALIF DAVIS E BAY,OAKLAND,CA 94608, USA.							ASCHER SM, 1992, RADIOLOGY, V185, P493, DOI 10.1148/radiology.185.2.1410361; BUMM R, 1993, ANN SURG, V218, P97, DOI 10.1097/00000658-199307000-00015; CHANG AE, 1993, ARCH SURG-CHICAGO, V128, P1281; DANIEL TM, 1993, ANN SURG, V217, P566, DOI 10.1097/00000658-199305010-00018; DAVIDSON BR, 1993, ARCH SURG-CHICAGO, V128, P1274; DONAHUE PE, 1993, SURG GYNECOL OBSTET, V176, P39; FABIAN TC, 1993, ANN SURG, V217, P557, DOI 10.1097/00000658-199305010-00017; GREENE FL, 1992, SURG CLIN N AM, V72, P1125; Larsson C, 1992, Henry Ford Hosp Med J, V40, P159; LYERLY HK, 1993, ARCH SURG-CHICAGO, V128, P1197; PALMER RMJ, 1993, ARCH SURG-CHICAGO, V128, P396; PARKER SH, 1991, RADIOLOGY, V180, P403, DOI 10.1148/radiology.180.2.1648757; PELTIER P, 1993, ANN ONCOL, V4, P307, DOI 10.1093/oxfordjournals.annonc.a058488; PETERSEN BM, 1993, AM J SURG, V165, P137, DOI 10.1016/S0002-9610(05)80417-9; ROSENBERG SA, 1993, ANN SURG, V218, P455, DOI 10.1097/00000658-199310000-00006	15	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1674	1675						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182845				2022-12-28	WOS:A1994NN11700024
J	OBRIEN, SJ; PAN, WS; LU, Z				OBRIEN, SJ; PAN, WS; LU, Z			PANDAS, PEOPLE AND POLICY	NATURE			English	Editorial Material							POPULATIONS		BEIJING UNIV,DEPT BIOL,BEIJING 100871,PEOPLES R CHINA	Peking University	OBRIEN, SJ (corresponding author), NCI,VIRAL CARCINOGENESIS LAB,FREDERICK,MD 21702, USA.		OBRIEN, STEPHEN/ABD-1346-2020	OBRIEN, STEPHEN/0000-0001-7857-0757				BEAGLEY S, 1993, NEWSWEEK        0412, V121, P50; BLACK FL, 1992, SCIENCE, V258, P1739, DOI 10.1126/science.1465610; CHEN M, IN PRESS ZOO BIOL; DIAMOND J, 1988, CONS BIOL, V2, P121; Foose T.J., 1987, P304; Hu J., 1990, RES PROGR BIOL GIANT; JOHNSON KG, 1988, NATL GEOGR RES, V4, P161; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; LU Z, 1992, THESIS PEKING U BEIJ; MAINKA SA, IN PRESS J WILD DIS; OBRIEN SJ, 1985, SCIENCE, V227, P1428, DOI 10.1126/science.2983425; OBRIEN SJ, 1987, NATURE, V325, P758, DOI 10.1038/325758a0; OBRIEN SJ, 1984, SCIENCE, V223, P1127, DOI 10.1126/science.6701515; OBRIEN SJ, 1988, TRENDS ECOL EVOL, V3, P254, DOI 10.1016/0169-5347(88)90058-4; Pan W., 1988, GIANT PANDAS NATURAL; RALLS K, 1979, SCIENCE, V206, P1101, DOI 10.1126/science.493997; ROBERTS L, 1988, SCIENCE, V241, P1594; ROBERTS L, 1988, SCIENCE, V241, P529, DOI 10.1126/science.241.4865.529; ROELKE ME, 1993, CURR BIOL, V3, P340, DOI 10.1016/0960-9822(93)90197-V; Schaller G.B., 1985, GIANT PANDAS WOLONG; Schaller G.B., 1993, LAST PANDA; Soule M.E, 1987, CONSERV BIOL, V1, P173, DOI [10.1111/j.1523-1739.1987.tb00027.x, DOI 10.1111/J.1523-1739.1987.TB00027.X]; ZHAO Q, 1993, GIANT PANDA STUDBOOK; 1993, IN PRESS SEP P INT G; 1989, NATIONAL CONSERVATIO	25	31	41	1	11	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 19	1994	369	6477					179	180		10.1038/369179a0	http://dx.doi.org/10.1038/369179a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NM067	8183334				2022-12-28	WOS:A1994NM06700024
J	SIEVERS, D; VONKIEDROWSKI, G				SIEVERS, D; VONKIEDROWSKI, G			SELF REPLICATION OF COMPLEMENTARY NUCLEOTIDE-BASED OLIGOMERS	NATURE			English	Article							HEXADEOXYNUCLEOTIDE; SYSTEMS; LINKAGE; GROWTH	THE development of non-enzymatic self-replicating systems based on autocatalytic template-directed reactions is a current objective of bioorganic chemistry(1-6). Typically, a self-complementary template molecule AB is synthesized autocatalytically from two complementary template fragments A and B7-16. Natural replication of nucleic acids, however, utilizes complementary rather than self-complementary strands. Here we report on a minimal implementation of this type of replication(17) based on cross-catalytic template-directed syntheses of hexadeoxynucleotide derivatives from amino-trideoxynucleotides. In our experiments, two self-complementary and two complementary templates compete for their combinatorial synthesis from four common trimeric precursors. We provide kinetic evidence that cross-catalytic self-replication of complementary templates can proceed with an efficiency similar to that of autocatalytic self-replication of self-complementary templates. We observe selective stimulation of template synthesis, and thus information transfer, on seeding the reaction mixtures with one of four chemically labelled templates bearing the sequence of the reaction products. Our results bring a stage closer the development of schemes that might explain how replicating systems based on nucleic acids arose on the prebiotic Earth.	UNIV FREIBURG,DEPT ORGAN CHEM & BIOCHEM,D-79104 FREIBURG,GERMANY	University of Freiburg								ACHILLES T, 1993, ANGEW CHEM INT EDIT, V32, P1198, DOI 10.1002/anie.199311981; BACHMANN PA, 1992, NATURE, V357, P57, DOI 10.1038/357057a0; BOHLER C, 1993, HELV CHIM ACTA, V76, P2313, DOI 10.1002/hlca.19930760616; DOLINNAYA NG, 1991, NUCLEIC ACIDS RES, V19, P3073, DOI 10.1093/nar/19.11.3073; Eigen M, 1979, THE HYPERCYCLE, P60; ESCHENMOSER A, 1992, CHEM SOC REV, V21, P1, DOI 10.1039/cs9922100001; FAMULOK M, 1992, ACTA CHEM SCAND, V46, P315, DOI 10.3891/acta.chem.scand.46-0315; FENG Q, 1992, SCIENCE, V256, P1179, DOI 10.1126/science.256.5060.1179; FERRIS JP, 1993, J AM CHEM SOC, V115, P12270, DOI 10.1021/ja00079a006; HOFFMANN S, 1992, ANGEW CHEM INT EDIT, V31, P1013, DOI 10.1002/anie.199210131; HONG JI, 1992, SCIENCE, V255, P848, DOI 10.1126/science.255.5046.848; INOUE T, 1983, SCIENCE, V219, P859, DOI 10.1126/science.6186026; KANAVARIOTI A, 1992, J THEOR BIOL, V158, P207, DOI 10.1016/S0022-5193(05)80719-2; Kauffman S. A., 1993, ORIGINS ORDER; LI T, 1994, NATURE, V369, P218, DOI 10.1038/369218a0; ORGEL LE, 1992, NATURE, V358, P203, DOI 10.1038/358203a0; SZATHMARY E, 1991, TRENDS ECOL EVOL, V6, P366, DOI 10.1016/0169-5347(91)90228-P; TERFORT A, 1992, ANGEW CHEM INT EDIT, V31, P654, DOI 10.1002/anie.199206541; TJIVIKUA T, 1990, J AM CHEM SOC, V112, P1249, DOI 10.1021/ja00159a057; von Kiedrowski G., 1993, BIOORG CHEM FRONT, V3, P113; VONKIEDROWSKI G, 1991, ANGEW CHEM INT EDIT, V30, P423, DOI 10.1002/anie.199104231; VONKIEDROWSKI G, 1986, ANGEW CHEM INT EDIT, V25, P932, DOI 10.1002/anie.198609322; VONKIEDROWSKI G, 1989, ANGEW CHEM INT EDIT, V28, P1235, DOI 10.1002/anie.198912351; Wlotzka B., 1992, THESIS U GOTTINGEN; ZIELINSKI WS, 1987, NATURE, V327, P346, DOI 10.1038/327346a0	25	364	378	2	37	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 19	1994	369	6477					221	224		10.1038/369221a0	http://dx.doi.org/10.1038/369221a0			4	Multidisciplinary Sciences	Index Chemicus (IC); Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NM067	8183342				2022-12-28	WOS:A1994NM06700052
J	SCHEFFNER, M; HUIBREGTSE, JM; VIERSTRA, RD; HOWLEY, PM				SCHEFFNER, M; HUIBREGTSE, JM; VIERSTRA, RD; HOWLEY, PM			THE HPV-16 E6 AND E6-AP COMPLEX FUNCTIONS AS A UBIQUITIN-PROTEIN LIGASE IN THE UBIQUITINATION OF P53	CELL			English	Article							HUMAN PAPILLOMAVIRUS TYPE-16; N-END RULE; RETINOBLASTOMA GENE-PRODUCT; CELLULAR TUMOR-ANTIGEN; CARRIER PROTEIN; SV40-TRANSFORMED CELLS; INVITRO MUTAGENESIS; HUMAN KERATINOCYTES; CONJUGATING ENZYME; TRANSFORMED-CELLS	The ubiquitin-dependent proteolytic pathway plays a major role in selective protein degradation. Ubiquitination of proteins requires the sequential action of the ubiquitin-activating enzyme (E1), ubiquitin-conjugating enzymes (E2), and in some cases ubiquitin-protein ligases (E3s). The oncogenic human papillomavirus (HPV) types 16 and 18 utilize this cellular proteolytic system to target the tumor suppressor protein p53. The HPV E6 oncoprotein binds to a cellular protein of 100 kd, termed E6-associated protein (E6-AP). The E6-E6-AP complex specifically interacts with p53, resulting in the rapid ubiquitin-dependent degradation of p53. Here we report the purification and identification of the factors necessary for the E6-E6-AP-mediated ubiquitination of p53. The ubiquitination of p53 requires the E1 enzyme and a novel E2 in mammalian cells, while E3 activity is conferred by the E6-E6-AP complex. Furthermore, E6-AP appears to have ubiquitin-protein ligase activity in the absence of E6.	UNIV WISCONSIN, DEPT HORT, MADISON, WI 53706 USA; NCI, TUMOR VIRUS BIOL LAB, BETHESDA, MD 20892 USA	University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Scheffner, Martin/K-2940-2012	Scheffner, Martin/0000-0003-2229-0128; Howley, Peter/0000-0002-8668-9579				BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; CIECHANOVER A, 1991, P NATL ACAD SCI USA, V88, P139, DOI 10.1073/pnas.88.1.139; CROOK T, 1991, ONCOGENE, V6, P873; DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; FINLEY D, 1991, ANNU REV CELL BIOL, V7, P25, DOI 10.1146/annurev.cb.07.110191.000325; GIROD PA, 1993, J BIOL CHEM, V268, P955; GIROD PA, 1993, IN PRESS PLANT J, V3; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867; GOLDBERG AL, 1976, ANNU REV BIOCHEM, V45, P747, DOI 10.1146/annurev.bi.45.070176.003531; GONDA DK, 1989, J BIOL CHEM, V264, P16700; HAAS AL, 1988, J BIOL CHEM, V263, P13258; HATFIELD PM, 1992, J BIOL CHEM, V267, P14799; HAUSEN HZ, 1991, VIROLOGY, V184, P9, DOI 10.1016/0042-6822(91)90816-T; HAWLEYNELSON P, 1989, EMBO J, V8, P3905, DOI 10.1002/j.1460-2075.1989.tb08570.x; HELLER H, 1990, J BIOL CHEM, V265, P6532; HERSHKO A, 1992, ANNU REV BIOCHEM, V61, P761, DOI 10.1146/annurev.bi.61.070192.003553; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; HUBBERT NL, 1992, J VIROL, V66, P6237, DOI 10.1128/JVI.66.10.6237-6241.1992; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P775, DOI 10.1128/MCB.13.2.775; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; JABBEN M, 1989, J BIOL CHEM, V264, P4998; JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0; JENTSCH S, 1991, BIOCHIM BIOPHYS ACTA, V1089, P127, DOI 10.1016/0167-4781(91)90001-3; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; LIN JY, 1990, VIROLOGY, V176, P302, DOI 10.1016/0042-6822(90)90258-S; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; MIETZ JA, 1992, EMBO J, V11, P5013, DOI 10.1002/j.1460-2075.1992.tb05608.x; MUNGER K, 1989, J VIROL, V63, P4417; OREN M, 1981, MOL CELL BIOL, V1, P101, DOI 10.1128/MCB.1.2.101; PICKART CM, 1988, J BIOL CHEM, V263, P12028; QIN S, 1991, J BIOL CHEM, V266, P15549; RECHSTEINER M, 1991, CELL, V66, P615, DOI 10.1016/0092-8674(91)90104-7; REICH NC, 1983, MOL CELL BIOL, V3, P2143, DOI 10.1128/MCB.3.12.2143; REISS Y, 1990, J BIOL CHEM, V265, P3685; SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1992, EMBO J, V11, P2425, DOI 10.1002/j.1460-2075.1992.tb05307.x; SCHEFFNER M, 1991, P NATL ACAD SCI USA, V88, P5523, DOI 10.1073/pnas.88.13.5523; SCHEFFNER M, 1992, J VIROL, V66, P5100, DOI 10.1128/JVI.66.8.5100-5105.1992; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; SEUFERT W, 1990, EMBO J, V9, P4535, DOI 10.1002/j.1460-2075.1990.tb07905.x; SULLIVAN ML, 1991, J BIOL CHEM, V266, P23878; TOBIAS JW, 1991, J BIOL CHEM, V266, P12021; VIERSTRA RD, 1993, IN PRESS ANN REV PLA; WERNESS BA, 1990, SCIENCE, V248, P76, DOI 10.1126/science.2157286; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; WING SS, 1992, J BIOL CHEM, V267, P6495; YEW PR, 1992, NATURE, V357, P82, DOI 10.1038/357082a0	57	1897	1986	3	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	1993	75	3					495	505		10.1016/0092-8674(93)90384-3	http://dx.doi.org/10.1016/0092-8674(93)90384-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MF830	8221889				2022-12-28	WOS:A1993MF83000012
J	CHANG, C; KWOK, SF; BLEECKER, AB; MEYEROWITZ, EM				CHANG, C; KWOK, SF; BLEECKER, AB; MEYEROWITZ, EM			ARABIDOPSIS ETHYLENE-RESPONSE GENE ETR1 - SIMILARITY OF PRODUCT TO 2-COMPONENT REGULATORS	SCIENCE			English	Article							SIGNAL-TRANSDUCTION PROTEINS; ESCHERICHIA-COLI; BACTERIAL CHEMOTAXIS; AGROBACTERIUM-TUMEFACIENS; PLANT TRANSFORMATION; ADAPTIVE RESPONSES; LINKAGE MAP; THALIANA; EXPRESSION; FAMILY	Ethylene behaves as a hormone in plants, regulating such aspects of growth and development as fruit ripening, flower senescence, and abscission. Ethylene insensitivity is conferred by dominant mutations in the ETR1 gene early in the ethylene signal transduction pathway of Arabidopsis thaliana. The ETR1 gene was cloned by the method of chromosome walking. Each of the four known etr1 mutant alleles contains a missense mutation near the amino terminus of the predicted protein. Although the sequence of the amino-terminal half of the deduced ETR1 protein appears to be novel, the carboxyl-terminal half is similar in sequence to both components of the prokaryotic family of signal transducers known as the two-component systems. Thus, an early step in ethylene signal transduction in plants may involve transfer of phosphate as in prokaryotic two-component systems. The dominant etr1-1 mutant gene conferred ethylene insensitivity to wild-type Arabidopsis plants when introduced by transformation.			CHANG, C (corresponding author), CALTECH, DIV BIOL 15629, PASADENA, CA 91125 USA.		Meyerowitz, Elliot M/A-7118-2009					Abeles F, 1992, ETHYLENE PLANT BIOL; ALEST LV, 1993, P NATL ACAD SCI USA, V90, P6213; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; AMASINO RM, 1984, MOL GEN GENET, V197, P437, DOI 10.1007/BF00329940; ARICO B, 1991, MOL MICROBIOL, V5, P2481, DOI 10.1111/j.1365-2958.1991.tb02093.x; ARTYMIUK PJ, 1990, PROTEIN ENG, V4, P39, DOI 10.1093/protein/4.1.39; BLEECKER AB, 1988, SCIENCE, V241, P1086, DOI 10.1126/science.241.4869.1086; BORKOVICH KA, 1990, CELL, V63, P1339, DOI 10.1016/0092-8674(90)90429-I; BURG SP, 1967, PLANT PHYSIOL, V42, P144, DOI 10.1104/pp.42.1.144; CHANG C, 1988, P NATL ACAD SCI USA, V85, P6856, DOI 10.1073/pnas.85.18.6856; Chang C. H., UNPUB; CHEN JM, 1990, INT J PEPT PROT RES, V36, P1; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; FRYXELL KJ, 1991, J MOL EVOL, V33, P367, DOI 10.1007/BF02102867; GOESCHL JD, 1966, PLANT PHYSIOL, V41, P877, DOI 10.1104/pp.41.5.877; GRILL E, 1991, MOL GEN GENET, V226, P484, DOI 10.1007/BF00260662; GUZMAN P, 1990, PLANT CELL, V2, P513, DOI 10.1105/tpc.2.6.513; HARPHAM NVJ, 1991, ANN BOT-LONDON, V68, P55, DOI 10.1093/oxfordjournals.aob.a088218; HAUGE BM, 1993, PLANT J, V3, P745, DOI 10.1111/j.1365-313X.1993.00745.x; HERMAN L, 1990, MOL GEN GENET, V224, P248, DOI 10.1007/BF00271558; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; HOLSTERS M, 1978, MOL GEN GENET, V163, P181, DOI 10.1007/BF00267408; HRABAK EM, 1992, J BACTERIOL, V174, P3011, DOI 10.1128/JB.174.9.3011-3020.1992; HUA J, UNPUB; KENED H, ANN REV PLANT PHYSL, V44, P283; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; KOORNNEEF M, 1983, J HERED, V74, P265, DOI 10.1093/oxfordjournals.jhered.a109781; Koornneef M., 1987, ARABID INF SERV, V1987, P46; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LUCHI S, 1990, MOL MICROBIOL, V4, P715; LUKAT GS, 1991, J BIOL CHEM, V266, P8348; MA H, 1992, GENE, V117, P161, DOI 10.1016/0378-1119(92)90725-5; MARX J, 1993, SCIENCE, V260, P1588, DOI 10.1126/science.8503004; MCBRIDE KE, 1990, PLANT MOL BIOL, V14, P269, DOI 10.1007/BF00018567; MEYEROWITZ EM, 1993, METHODS ARABIDOPSIS, V3, P745; MONSON EK, 1992, P NATL ACAD SCI USA, V89, P4280, DOI 10.1073/pnas.89.10.4280; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; NAGASAWA S, 1992, MOL MICROBIOL, V6, P799, DOI 10.1111/j.1365-2958.1992.tb01530.x; NAGY F, 1985, EMBO J, V4, P3063, DOI 10.1002/j.1460-2075.1985.tb04046.x; OTA I, 1993, SCIENCE, V262, P124; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; POPOV KM, 1992, J BIOL CHEM, V267, P13127; ROGERS SG, 1987, METHOD ENZYMOL, V153, P253; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Sambrook J, 1989, MOL CLONING LABORATO; SCHNEIDERPOETSCH HAW, 1992, PHOTOCHEM PHOTOBIOL, V56, P839, DOI 10.1111/j.1751-1097.1992.tb02241.x; SISLER E C, 1977, Tobacco Science, V21, P43; STOCK AM, 1989, NATURE, V337, P745, DOI 10.1038/337745a0; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; STOUT V, 1990, J BACTERIOL, V172, P659, DOI 10.1128/jb.172.2.659-669.1990; SWANSON RV, 1993, MOL MICROBIOL, V8, P435, DOI 10.1111/j.1365-2958.1993.tb01588.x; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; VAN DER STRAETEN D, 1993, PLANT PHYSIOL, V102, P401, DOI 10.1104/pp.102.2.401; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; VOLZ K, 1991, J BIOL CHEM, V266, P15511; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; WEINSTEIN JN, 1982, J MEMBRANE BIOL, V66, P203, DOI 10.1007/BF01868495; WOLFE AJ, 1993, P NATL ACAD SCI USA, V90, P1518, DOI 10.1073/pnas.90.4.1518; YANG Y, 1991, P NATL ACAD SCI USA, V88, P11057, DOI 10.1073/pnas.88.24.11057; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	65	1182	1274	6	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	1993	262	5133					539	544		10.1126/science.8211181	http://dx.doi.org/10.1126/science.8211181			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC935	8211181				2022-12-28	WOS:A1993MC93500031
J	BROWN, KE; ANDERSON, SM; YOUNG, NS				BROWN, KE; ANDERSON, SM; YOUNG, NS			ERYTHROCYTE-P ANTIGEN - CELLULAR RECEPTOR FOR B19 PARVOVIRUS	SCIENCE			English	Article							VIRUS; INFECTION; ANTIBODIES; GLOBOSIDE; SYSTEM; FETUS; CELLS	The pathogenic human parvovirus B19 replicates only in erythroid progenitor cells. This virus was shown to bind to blood-group P antigen, as measured by hemagglutination. Erythrocytes lacking P antigen were not agglutinated with B19. Purified P antigen (globoside) blocked the binding of the virus to erythroid cells and the infectivity of the virus in a hematopoietic colony assay. Target cells were protected from infection by preincubation with monoclonal antibody to globoside. Knowledge of a parvovirus receptor has implications for understanding the pathogenesis of parvovirus infections and for the use of parvoviruses in gene therapy.			BROWN, KE (corresponding author), NHLBI, HEMATOL BRANCH, BETHESDA, MD 20892 USA.			Brown, Kevin/0000-0002-1568-683X				ANDERSON MJ, 1983, LANCET, V1, P1378; BROWN KE, 1992, J GEN VIROL, V73, P2147, DOI 10.1099/0022-1317-73-8-2147; BROWN KE, 1989, BRIT J OBSTET GYNAEC, V96, P764, DOI 10.1111/j.1471-0528.1989.tb03313.x; BROWN KS, UNPUB; Christie W. W., 1987, HIGH PERFORMANCE LIQ; COCUZZA G, 1969, B I SIEROTER MILAN, V48, P204; COTMORE SF, 1987, ADV VIRUS RES, V33, P91, DOI 10.1016/S0065-3527(08)60317-6; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRICKHOFEN N, 1990, ANN INTERN MED, V113, P926, DOI 10.7326/0003-4819-113-12-926; KAJIGAYA S, 1991, P NATL ACAD SCI USA, V88, P4646, DOI 10.1073/pnas.88.11.4646; LENTZ TL, 1990, J GEN VIROL, V71, P751, DOI 10.1099/0022-1317-71-4-751; LEVINE P, 1963, TRANSFUSION, V3, P278, DOI 10.1111/j.1537-2995.1963.tb04643.x; LIU JM, 1992, J VIROL, V66, P4686, DOI 10.1128/JVI.66.8.4686-4692.1992; MARCUS DM, 1981, SEMIN HEMATOL, V18, P63; MOCHIZUKI M, 1978, JPN J VET SCI, V40, P375; MOREY AL, 1992, BRIT J OBSTET GYNAEC, V99, P566, DOI 10.1111/j.1471-0528.1992.tb13822.x; MORTIMER PP, 1983, NATURE, V302, P426, DOI 10.1038/302426a0; NAIDES SJ, 1989, PRENATAL DIAG, V9, P105, DOI 10.1002/pd.1970090205; ROSE HG, 1965, J LIPID RES, V6, P428; ROUGER P, 1987, REV FR TRANSFUS IMMU, V30, P699, DOI 10.1016/S0338-4535(87)80138-1; SHIMOMURA S, 1992, BLOOD, V79, P18; TONEGAWA Y, 1977, BIOCHEM BIOPH RES CO, V76, P9, DOI 10.1016/0006-291X(77)91661-8; VONDEMBORNE AEGK, 1986, BRIT J HAEMATOL, V63, P35; WALSH CE, 1992, P NATL ACAD SCI USA, V89, P7257, DOI 10.1073/pnas.89.15.7257; YOUNG N, 1988, SEMIN HEMATOL, V25, P159	26	613	656	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	1993	262	5130					114	117		10.1126/science.8211117	http://dx.doi.org/10.1126/science.8211117			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ635	8211117				2022-12-28	WOS:A1993LZ63500036
J	ALEXANDER, M				ALEXANDER, M			CONTROVERSIES IN TREATMENT - SHOULD A SEXUAL OFFENDER BE ALLOWED CASTRATION - ETHICAL CONSIDERATIONS IN USING ORCHIECTOMY FOR SOCIAL-CONTROL	BRITISH MEDICAL JOURNAL			English	Editorial Material											ALEXANDER, M (corresponding author), SOUTHWARK COMMUNITY HLTH COUNCIL,LONDON SE5 8RS,ENGLAND.								0	14	14	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 25	1993	307	6907					790	790		10.1136/bmj.307.6907.790	http://dx.doi.org/10.1136/bmj.307.6907.790			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LZ478	8219956	Green Published, Bronze			2022-12-28	WOS:A1993LZ47800031
J	PETRIDOU, E; KASSIMOS, D; KALMANTI, M; KOSMIDIS, H; HAIDAS, S; FLYTZANI, V; TONG, D; TRICHOPOULOS, D				PETRIDOU, E; KASSIMOS, D; KALMANTI, M; KOSMIDIS, H; HAIDAS, S; FLYTZANI, V; TONG, D; TRICHOPOULOS, D			AGE OF EXPOSURE TO INFECTIONS AND RISK OF CHILDHOOD LEUKEMIA	BRITISH MEDICAL JOURNAL			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA		HARVARD UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,677 HUNTINGTON AVE,BOSTON,MA 02115; AGLAIA KYRIAKOU CHILDRENS HOSP,DEPT PAEDIAT HAEMATOL ONCOL,ATHENS,GREECE; AGIA SOPHIA CHILDRENS HOSP,DEPT PAEDIAT HAEMATOL ONCOL,ATHENS,GREECE; UNIV ATHENS,SCH MED,DEPT HYG & EPIDEMIOL,ATHENS,GREECE; UNIV CRETE,DEPT PAEDIAT HAEMATOL ONCOL,IRAKLION,GREECE	Harvard University; Harvard T.H. Chan School of Public Health; The Aghia Sophia Children's Hospital; Athens Medical School; National & Kapodistrian University of Athens; University of Crete				Cassimos, Dimitrios/0000-0001-8738-0285; PETRIDOU, ELENI/0000-0003-3695-3439				DARBY SC, 1987, BMJ-BRIT MED J, V294, P603, DOI 10.1136/bmj.294.6572.603; GREAVES MF, 1988, LEUKEMIA, V2, P120; KASSIMOS D, 1992, THESIS ATHENS U MED; KINLEN L, 1988, LANCET, V2, P1323; MACMAHON B, 1992, AM J EPIDEMIOL, V136, P916, DOI 10.1093/oxfordjournals.aje.a116564	5	83	83	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 25	1993	307	6907					774	774		10.1136/bmj.307.6907.774	http://dx.doi.org/10.1136/bmj.307.6907.774			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LZ478	8219951	Green Published, Bronze			2022-12-28	WOS:A1993LZ47800026
J	CHRISTIE, CDC; MARX, ML; MARCHANT, CD; REISING, SF				CHRISTIE, CDC; MARX, ML; MARCHANT, CD; REISING, SF			THE 1993 EPIDEMIC OF PERTUSSIS IN CINCINNATI - RESURGENCE OF DISEASE IN A HIGHLY IMMUNIZED POPULATION OF CHILDREN	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; EFFICACY; VACCINE; OUTBREAK; BORDETELLA; INFECTION; COMMUNITY; DIAGNOSIS; ANTIBODY; CULTURE	Background. In 1993 there was a resurgence of pertussis in the United States. Altogether, 6335 cases were reported, the most in 26 years. Methods. Using active microbiologic surveillance, we investigated the epidemic of pertussis in Greater Cincinnati in 1993. The population of 1.7 million in this area is served by a single children's hospital and pertussis laboratory. We prospectively followed patients given a new diagnosis of pertussis in July through September 1993 to determine the characteristics of the epidemic. Results. From 1979 to 1992, there was a cumulative total of 542 cases of pertussis. In 1993, 352 cases were diagnosed, an increase of 259 percent over the 1992 total. Sixty-three percent of the cases had positive cultures for Bordetella pertussis, 18 percent were positive on direct fluorescent-antibody testing only, and 19 percent were diagnosed clinically. The outbreak began in the suburbs during the summer and spread through Greater Cincinnati. Of 255 total cases diagnosed in July through September (195 excess cases over the maximal base-line level of 20 per month in the previous 14 years), 75 percent were in white patients and 67 percent of the patients had private insurance or paid for care out of pocket. In 1993, as compared with 1979 through 1992, there was a shift in incidence from younger infants to older children; the percentages of cases according to age group were as follows: 0 to 6 months, 53 percent from 1979 through 1992 and 35 percent in 1993 (P<0.001); 7 months to 5 years, 33 percent and 43 percent (P<0.002); 6 to 12 years, 5 percent and 11 percent (P<0.001); and more than 12 years, 5 percent and 11 percent (P<0.003). Immunization records revealed that 74 percent (75 of 101) of the children with pertussis who were 19 months to 12 years old had received four or five doses of the combined diphtheria-pertussis-tetanus (DPT) vaccine, and that 82 percent (103 of 126) of those 7 to 71 months old had received at least three doses of DPT vaccine. The whole-cell vaccines used came from both of the major manufacturers (Connaught Laboratories and Lederle Laboratories), Disease was not severe, but 80 of the 255 children (31 percent) given diagnoses during the three epidemic months were hospitalized. There were no deaths. Conclusions. Since the 1993 pertussis epidemic in Cincinnati occurred primarily among children who had been appropriately immunized, it is clear that the whole-cell pertussis vaccine failed to give full protection against the disease.	UNIV CINCINNATI,COLL MED,DEPT PEDIAT,CINCINNATI,OH; CHILDRENS HOSP,MED CTR,DIV EPIDEMIOL,CINCINNATI,OH 45229; CHILDRENS HOSP,MED CTR,DIV CLIN MICROBIOL,CINCINNATI,OH 45229; TUFTS UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02111; TUFTS UNIV NEW ENGLAND MED CTR,BOSTON,MA 02111; DEPT PUBL HLTH,MASSACHUSETTS PUBL HLTH BIOL LABS,BOSTON,MA	University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Tufts University; Tufts Medical Center; Massachusetts Department of Public Health	CHRISTIE, CDC (corresponding author), CHILDRENS HOSP,MED CTR,DIV INFECT DIS,3333 BURNET AVE,CINCINNATI,OH 45229, USA.			Christie, Celia DC/0000-0002-8981-3934; Marchant, Colin/0000-0002-9710-6228				BASS JW, 1987, PEDIATR INFECT DIS J, V6, P141, DOI 10.1097/00006454-198702000-00001; BERGQUIST SO, 1987, PEDIATR INFECT DIS J, V6, P458, DOI 10.1097/00006454-198705000-00009; BERGQUIST SO, 1987, PEDIATR INFECT DIS J, V6, P1035; BIELLIK RJ, 1988, J INFECT DIS, V157, P1134, DOI 10.1093/infdis/157.6.1134; BROOME CV, 1981, J INFECT DIS, V144, P187, DOI 10.1093/infdis/144.2.187; BROOME CV, 1978, DHEW NIH791830 PUBL, P19; Cherry J D, 1984, Curr Probl Pediatr, V14, P1; CHERRY J D, 1988, Pediatrics, V81, P939; CHRISTIE CD, 1994, 1994 ANN M SOC HOSP, P31; CHRISTIE CD, 1990, J PEDIATR, V80, P23; CHRISTIE CDC, 1989, AM J DIS CHILD, V143, P1199, DOI 10.1001/archpedi.1989.02150220097027; DEAN J, 1991, EPI INFO VERSION 5 0; EDMONSON MB, 1990, JAMA-J AM MED ASSOC, V263, P2467, DOI 10.1001/jama.263.18.2467; EDWARDS KM, 1991, PEDIATRICS, V88, P1019; EWANOWICH CA, 1993, J CLIN MICROBIOL, V31, P1715, DOI 10.1128/JCM.31.7.1715-1725.1993; FARIZO KM, 1992, CLIN INFECT DIS, V14, P708, DOI 10.1093/clinids/14.3.708; FINE PEM, 1987, REV INFECT DIS, V9, P866; GILCHRIST MJR, 1991, MANUAL CLIN MICROBIO, P471; GILLIGAN PH, 1983, CLIN MICROBIOL NEWSL, V5, P115; HALPERIN SA, 1989, J CLIN MICROBIOL, V27, P752, DOI 10.1128/JCM.27.4.752-757.1989; HALSEY N, 1985, B WORLD HEALTH ORGAN, V63, P1151; HEININGER U, 1993, 33RD INT C ANT AG CH, P372; HERWALDT LA, 1991, ARCH INTERN MED, V151, P1510, DOI 10.1001/archinte.151.8.1510; HOPPE JE, 1988, EUR J CLIN MICROBIOL, V7, P616, DOI 10.1007/BF01964238; JENKINSON D, 1988, BRIT MED J, V296, P612, DOI 10.1136/bmj.296.6622.612; KRAMER MS, 1989, CLIN PHARMACOL THER, V46, P309; KRAMER MS, 1981, CLIN PHARMACOL THER, V29, P111, DOI 10.1038/clpt.1981.18; LINNEMANN CC, 1977, ANNU REV MED, V28, P179, DOI 10.1146/annurev.me.28.020177.001143; MARCHANT CD, 1994, J INFECT DIS, V169, P1297, DOI 10.1093/infdis/169.6.1297; MINK CM, 1992, CLIN INFECT DIS, V14, P464, DOI 10.1093/clinids/14.2.464; NELSON JD, 1978, AM J DIS CHILD, V132, P371, DOI 10.1001/archpedi.1978.02120290043006; ONORATO IM, 1987, PEDIATR INFECT DIS J, V6, P145, DOI 10.1097/00006454-198702000-00002; ONORATO IM, 1992, JAMA-J AM MED ASSOC, V267, P2745, DOI 10.1001/jama.267.20.2745; REGAN J, 1977, J CLIN MICROBIOL, V6, P303; VEASY LG, 1987, NEW ENGL J MED, V316, P421, DOI 10.1056/NEJM198702193160801; 1984, MMWR-MORBID MORTAL W, V33, P573; 1994, MMWR-MORBID MORTAL W, V43, P57; 1991, REPORT COMMITTEE INF, P360; 1993, MMWR-MORBID MORTAL W, V42, P959; 1990, MMWR-MORBID MORTAL W, V39, P57; 1993, MMWR-MORBID MORTAL W, V42, P952; 1987, MMWR-MORBID MORTAL W, V36, P168; 1987, WORLD HLTH       JAN, P7; 1982, MMWR-MORBID MORTAL W, V31, P333	44	96	97	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	1994	331	1					16	21		10.1056/NEJM199407073310104	http://dx.doi.org/10.1056/NEJM199407073310104			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NU951	8202096				2022-12-28	WOS:A1994NU95100004
J	GOODMAN, SN; BERLIN, J; FLETCHER, SW; FLETCHER, RH				GOODMAN, SN; BERLIN, J; FLETCHER, SW; FLETCHER, RH			MANUSCRIPT QUALITY BEFORE AND AFTER PEER-REVIEW AND EDITING AT ANNALS OF INTERNAL-MEDICINE	ANNALS OF INTERNAL MEDICINE			English	Article							CONFIDENCE-INTERVALS; CLINICAL-TRIALS; STATISTICAL SIGNIFICANCE; JOURNALS; AGENDA	Objective: To evaluate the effects of peer review and editing on manuscript quality. Setting: Editorial offices of Annals of Internal Medicine. Design: Masked before-after study. Manuscripts: 111 consecutive original research manuscripts accepted for publication at Annals between March 1992 and March 1993. Measurements: We used a manuscript quality assessment tool of 34 items to evaluate the quality of the research report, not the quality of the research itself. Each item was scored on al to 5 scale. Forty-four expert assessors unaware of the design or aims of the study evaluated the manuscripts, with different persons evaluating the two versions of each manuscript (before and after the editorial process). Results: 33 of the 34 items changed in the direction of improvement, with the largest improvements seen in the discussion of study limitations, generalizations, use of confidence intervals, and the tone of conclusions. Overall, the percentage of items scored three or more increased by an absolute 7.3% (95% CI, 3.3% to 11.3%) from a baseline of 75%. The average item score improved by 0.23 points (CI, 0.07 to 0.39) from a baseline mean of 3.5. Manuscripts rated in the bottom 50% showed two- to threefold larger improvements than those in the top 50%, after correction for regression to the mean. Conclusions: Peer review and editing improve the quality of medical research reporting, particularly in those areas that readers rely on most heavily to decide on the importance and generalizability of the findings.	UNIV PENN, SCH MED, CTR CLIN EPIDEMIOL & BIOSTAT, PHILADELPHIA, PA 19104 USA; HARVARD UNIV, SCH MED, DEPT AMBULATORY CARE & PREVENT, BOSTON, MA 02215 USA	University of Pennsylvania; Pennsylvania Medicine; Harvard University; Harvard Medical School	GOODMAN, SN (corresponding author), JOHNS HOPKINS UNIV, CTR ONCOL, DIV BIOSTAT, 550 N BROADWAY, SUITE 1103, BALTIMORE, MD 21205 USA.			Goodman, Steven/0000-0002-3872-5723				ALTMAN LK, 1990, ETHICS POLICY SCI PU; BAILAR JC, 1985, NEW ENGL J MED, V312, P654, DOI 10.1056/NEJM198503073121023; BAILAR JC, 1988, ANN INTERN MED, V108, P266, DOI 10.7326/0003-4819-108-2-266; BAILAR JC, 1990, ETHICS POLICY SCI PU; BERRY G, 1986, MED J AUSTRALIA, V144, P618, DOI 10.5694/j.1326-5377.1986.tb112339.x; BOWER B, 1991, SCI NEWS        0622, P394; BRAITMAN LE, 1988, ANN INTERN MED, V108, P296, DOI 10.7326/0003-4819-108-2-296; BRAITMAN LE, 1991, ANN INTERN MED, V114, P515, DOI 10.7326/0003-4819-114-6-515; CHALMERS TC, 1981, CONTROL CLIN TRIALS, V2, P31, DOI 10.1016/0197-2456(81)90056-8; Chubin DE, 1990, PEERLESS SCI PEER RE, P83; CICCHETTI DV, 1991, BEHAV BRAIN SCI, V14, P119, DOI 10.1017/S0140525X00065675; CONCATO J, 1993, ANN INTERN MED, V118, P201, DOI 10.7326/0003-4819-118-3-199302010-00009; DETSKY AS, 1992, J CLIN EPIDEMIOL, V45, P255, DOI 10.1016/0895-4356(92)90085-2; DeVita V T, 1991, Important Adv Oncol, P241; ERNST E, 1993, NATURE, V363, P296, DOI 10.1038/363296a0; FEINBERG BA, 1989, JAMA-J AM MED ASSOC, V261, P695, DOI 10.1001/jama.261.5.695; Fleiss JL, 1981, STAT METHODS RATES P; GARDNER MJ, 1986, BRIT MED J, V292, P810, DOI 10.1136/bmj.292.6523.810; GARDNER MJ, 1990, JAMA-J AM MED ASSOC, V263, P1355, DOI 10.1001/jama.263.10.1355; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; GREENLAND S, 1994, IN PRESS AM J EPIDEM; HORROBIN DF, 1990, JAMA-J AM MED ASSOC, V263, P1438, DOI 10.1001/jama.263.10.1438; LOCK S, 1986, DIFFICULT BALANCE ED, P1; MEINERT CL, 1984, CONTROL CLIN TRIALS, V5, P328, DOI 10.1016/S0197-2456(84)80013-6; MEINERT CL, 1986, CLIN TRIALS DESIGN C, P1; MOSTELLER F, 1980, CONTROL CLIN TRIALS, V1, P37, DOI 10.1016/S0197-2456(80)80006-7; PETERS DP, 1982, BEHAV BRAIN SCI, V5, P187, DOI 10.1017/S0140525X00011183; POCOCK SJ, 1987, NEW ENGL J MED, V317, P426, DOI 10.1056/NEJM198708133170706; RELMAN AS, 1990, WESTERN J MED, V153, P520; RELMAN AS, 1989, NEW ENGL J MED, V321, P827, DOI 10.1056/NEJM198909213211211; RENNIE D, 1990, JAMA-J AM MED ASSOC, V263, P1317, DOI 10.1001/jama.1990.03440100011001; RENNIE D, 1986, JAMA-J AM MED ASSOC, V256, P2391, DOI 10.1001/jama.256.17.2391; SIMON R, 1985, CANCER TREAT REP, V69, P1; SOFFER A, 1992, CHEST, V101, P1417, DOI 10.1378/chest.101.5.1417; WILSON JD, 1978, J CLIN INVEST, V61, P1697, DOI 10.1172/JCI109091; 1991, WASHINGTON POST 0125, pA25	36	225	228	0	21	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1994	121	1					11	21		10.7326/0003-4819-121-1-199407010-00003	http://dx.doi.org/10.7326/0003-4819-121-1-199407010-00003			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PN271	8198342				2022-12-28	WOS:A1994PN27100003
J	CARETHERS, JM; MCDONNELL, WM				CARETHERS, JM; MCDONNELL, WM			EXTRAINTESTINAL MANIFESTATIONS OF CROHNS-DISEASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Note											CARETHERS, JM (corresponding author), UNIV MICHIGAN,MED CTR,ANN ARBOR,MI 48109, USA.								0	2	2	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 30	1994	330	26					1870	1870		10.1056/NEJM199406303302607	http://dx.doi.org/10.1056/NEJM199406303302607			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NT530	8196730				2022-12-28	WOS:A1994NT53000007
J	HANDT, O; RICHARDS, M; TROMMSDORFF, M; KILGER, C; SIMANAINEN, J; GEORGIEV, O; BAUER, K; STONE, A; HEDGES, R; SCHAFFNER, W; UTERMANN, G; SYKES, B; PAABO, S				HANDT, O; RICHARDS, M; TROMMSDORFF, M; KILGER, C; SIMANAINEN, J; GEORGIEV, O; BAUER, K; STONE, A; HEDGES, R; SCHAFFNER, W; UTERMANN, G; SYKES, B; PAABO, S			MOLECULAR-GENETIC ANALYSES OF THE TYROLEAN ICE MAN	SCIENCE			English	Article							HUMAN MITOCHONDRIAL-DNA; ANCIENT DNA; ENZYMATIC AMPLIFICATION; SEQUENCE; EXTRACTION	An approximately 5000-year-old mummified human body was recently found in the Tyrolean Alps. The DNA from tissue samples of this Late Neolithic individual, the so-called ''ice Man,'' has been extracted and analyzed. The number of DNA molecules surviving in the tissue was on the order of 10 genome equivalents per gram of tissue, which meant that only multi-copy sequences could be analyzed. The degradation of the DNA made the enzymatic amplification of mitochondrial DNA fragments of more than 100 to 200 base pal rs difficult. One DNA sequence of a hypervariable segment of the mitochondrial control region was determined independently in two different laboratories from internal samples of the body. This sequence showed that the mitochondrial type of the Ice Man fits into the genetic variation of contemporary Europeans and that it was most closely related to mitochondrial types determined from central and northern European populations.	UNIV MUNICH, INST ZOOL, D-80021 MUNICH, GERMANY; UNIV OXFORD, INST MOLEC MED, OXFORD OX3 9DU, ENGLAND; UNIV INNSBRUCK, INST MED BIOL & GENET, A-6020 INNSBRUCK, AUSTRIA; UNIV ZURICH, INST MOLEK BIOL 2, CH-8057 ZURICH, SWITZERLAND; UNIV OXFORD, ARCHAEOL RES LAB, OXFORD OX1 3QJ, ENGLAND	University of Munich; University of Oxford; University of Innsbruck; University of Zurich; University of Oxford			Stone, Anne C/B-5719-2009	Stone, Anne/0000-0001-8021-8314; RICHARDS, MARTIN/0000-0003-3118-0967				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BACHMANN B, 1990, NUCLEIC ACIDS RES, V18, P1309, DOI 10.1093/nar/18.5.1309; BAHN PG, 1993, NATURE, V362, P11, DOI 10.1038/362011a0; BAUER K, UNPUB; Bonani G., 1992, MANN EIS, V187, P108; CANO RJ, 1993, NATURE, V363, P536, DOI 10.1038/363536a0; COOPER A, 1992, P NATL ACAD SCI USA, V89, P8741, DOI 10.1073/pnas.89.18.8741; DESALLE R, 1992, SCIENCE, V257, P1933, DOI 10.1126/science.1411508; DIRIENZO A, 1991, P NATL ACAD SCI USA, V88, P1597, DOI 10.1073/pnas.88.5.1597; DIRIENZO A, UNPUB; GOLENBERG EM, 1990, NATURE, V344, P656, DOI 10.1038/344656a0; HEIM M, 1993, OTZTAL FALSCHUNG, P147; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAWLOR DA, 1991, NATURE, V349, P785, DOI 10.1038/349785a0; LINDAHL T, 1993, NATURE, V365, P700, DOI 10.1038/365700a0; LUNDSTROM R, 1992, P NATL ACAD SCI USA, V89, P5961, DOI 10.1073/pnas.89.13.5961; MONNAT RJ, 1985, P NATL ACAD SCI USA, V82, P2895, DOI 10.1073/pnas.82.9.2895; PAABO S, 1989, J BIOL CHEM, V264, P9709; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; PAABO S, 1990, J BIOL CHEM, V265, P4718; PAABO S, 1993, SCI AM, V269, P86; PIERCY R, 1993, INT J LEGAL MED, V106, P85, DOI 10.1007/BF01225046; RICHARDS MP, UNPUB; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; VIGILANT L, 1990, THESIS U CALIFORNIA; WARD RH, 1993, P NATL ACAD SCI USA, V90, P10663, DOI 10.1073/pnas.90.22.10663; WARD RH, 1991, P NATL ACAD SCI USA, V88, P8720, DOI 10.1073/pnas.88.19.8720; [No title captured]	29	181	192	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 17	1994	264	5166					1775	1778		10.1126/science.8209259	http://dx.doi.org/10.1126/science.8209259			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR600	8209259				2022-12-28	WOS:A1994NR60000047
J	SCHIEBER, RA; BRANCHEDORSEY, CM; RYAN, GW				SCHIEBER, RA; BRANCHEDORSEY, CM; RYAN, GW			COMPARISON OF IN-LINE SKATING INJURIES WITH ROLLERSKATING AND SKATEBOARDING INJURIES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note								Objective.-To describe the estimated relative frequency, types of injuries, and demographic features of people injured while in-line skating, rollerskating, and skateboarding in the United States. Design.-Case series. Setting.-Emergency department visits to hospitals participating in the National Electronic Injury Surveillance System. Participants.-All persons treated for a product-related injury involving in-line skates, rollerskates, or a skateboard between July 1, 1992, and June 30, 1993. Results.-Approximately 30 863 persons (95% confidence interval, 23 073 to 38 653) were treated for in-line skating injuries during the study period. For every in-line skating injury, approximately 3.3 rollerskating and 1.2 skateboarding injuries occurred (P<.0001). The median age of those injured in these three sports was 15, 12, and 13 years, respectively (P<.0001). Sixty-three percent of injured in-line skaters had a musculoskeletal injury, including 37% with a wrist injury, of which two thirds were fractures and/or dislocations. Five percent of all injured in-line skaters had head injury and 3.5% of the injured in-line skaters required hospitalization. Conclusions.-In-line skating and skateboarding injuries resulted in a similar number of emergency department visits, but fewer than that for rollerskating injuries. Because wrist fractures were the most common type of injury in all three sports, wrist protection is needed. Head protection by helmets is recommended.			SCHIEBER, RA (corresponding author), US DEPT HHS,PUBL HLTH SERV,CTR DIS CONTROL & PREVENT,NATL CTR INJURY PREVENT & CONTROL,ATLANTA,GA 30333, USA.							Baker S., 1993, INJURIES BICYCLISTS; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; THOMPSON RS, 1989, NEW ENGL J MED, V320, P1361, DOI 10.1056/NEJM198905253202101; Zar JH, 1974, BIOSTATISTICAL ANAL; 1992, GUIDELINES ESTABLISH; 1992, NEISS SAMPLE DESIGN; 1993, AM SPORTS ANAL REPOR; 1993, SPEEDSKATING TI 0901, V4, P2	8	76	76	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	1994	271	23					1856	1858		10.1001/jama.271.23.1856	http://dx.doi.org/10.1001/jama.271.23.1856			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NP959	8196143				2022-12-28	WOS:A1994NP95900030
J	SEALOCK, R; FROEHNER, SC				SEALOCK, R; FROEHNER, SC			DYSTROPHIN-ASSOCIATED PROTEINS AND SYNAPSE FORMATION - IS ALPHA-DYSTROGLYCAN THE AGRIN RECEPTOR	CELL			English	Review							NEUROMUSCULAR-JUNCTIONS; ACETYLCHOLINE-RECEPTOR; SKELETAL-MUSCLE; GLYCOPROTEIN; LOCALIZATION; MEMBRANE; FORMS				SEALOCK, R (corresponding author), UNIV N CAROLINA,DEPT PHYSIOL,CB 7545,CHAPEL HILL,NC 27599, USA.							ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; BEWICK GS, 1992, NEUROREPORT, V3, P857, DOI 10.1097/00001756-199210000-00009; BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7; CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; GEE SH, 1993, J BIOL CHEM, V268, P14972; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; HOCH W, 1994, IN PRESS EMBO J; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; MA JY, 1993, J BIOL CHEM, V268, P25108; MCMAHAN UJ, 1989, DEV NEUROSCI-BASEL, V11, P227, DOI 10.1159/000111903; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; PHILLIPS WD, 1993, J CELL BIOL, V123, P729, DOI 10.1083/jcb.123.3.729; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; RUPP F, 1992, J NEUROSCI, V12, P3535; SUZUKI A, 1994, IN PRESS EUR J BIOCH; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q	22	65	65	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUN 3	1994	77	5					617	619		10.1016/0092-8674(94)90045-0	http://dx.doi.org/10.1016/0092-8674(94)90045-0			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NQ123	8205610				2022-12-28	WOS:A1994NQ12300001
J	DOVER, JS; ARNDT, KA				DOVER, JS; ARNDT, KA			DERMATOLOGY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRETINOIN RETINOIC ACID; ACNE-VULGARIS; SKIN; ISOTRETINOIN; INFLAMMATION; SUNSCREENS; NEED		HARVARD UNIV,SCH MED,BOSTON,MA; BETH ISRAEL HOSP,BOSTON,MA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	DOVER, JS (corresponding author), NEW ENGLAND DEACONESS HOSP,BOSTON,MA, USA.							BULENGORANSBY SM, 1993, NEW ENGL J MED, V328, P1438, DOI 10.1056/NEJM199305203282002; EADY EA, 1993, BRIT MED J, V306, P555, DOI 10.1136/bmj.306.6877.555; FOLEY P, 1993, BRIT J DERMATOL, V128, P512, DOI 10.1111/j.1365-2133.1993.tb00227.x; GRIFFITHS CEM, 1993, BRIT J DERMATOL, V129, P415, DOI 10.1111/j.1365-2133.1993.tb03169.x; GRIFFITHS CEM, 1993, NEW ENGL J MED, V329, P530, DOI 10.1056/NEJM199308193290803; LAYTON AM, 1993, BRIT J DERMATOL, V129, P292, DOI 10.1111/j.1365-2133.1993.tb11849.x; MITCHELL AA, 1993, 3 BOST U SCH MED SLO; RAFAL ES, 1992, NEW ENGL J MED, V326, P368, DOI 10.1056/NEJM199202063260603; STAINFORTH JM, 1993, BRIT J DERMATOL, V129, P297, DOI 10.1111/j.1365-2133.1993.tb11850.x; THOMPSON SC, 1993, NEW ENGL J MED, V329, P1147, DOI 10.1056/NEJM199310143291602; WEISS JS, 1988, JAMA-J AM MED ASSOC, V259, P527, DOI 10.1001/jama.259.4.527; WOLF P, 1993, J INVEST DERMATOL, V101, P523, DOI 10.1111/1523-1747.ep12365902	12	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1662	1663						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182838				2022-12-28	WOS:A1994NN11700017
J	RUOSLAHTI, E; REED, JC				RUOSLAHTI, E; REED, JC			ANCHORAGE DEPENDENCE, INTEGRINS, AND APOPTOSIS	CELL			English	Review							RECEPTOR; CELLS				RUOSLAHTI, E (corresponding author), LA JOLLA CANC RES FDN,CANC RES CTR,10901 N TORREY PINES RD,LA JOLLA,CA 92037, USA.							ADAMS JC, 1993, DEVELOPMENT, V117, P1183; BARTFELD NS, 1993, J BIOL CHEM, V268, P17270; CHAN BM, 1992, CELL, V68, P1051, DOI 10.1016/0092-8674(92)90077-P; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; GUADAGNO TM, 1993, SCIENCE, V262, P1572, DOI 10.1126/science.8248807; HOCKENBERY DM, 1991, P NATL ACAD SCI USA, V88, P6961, DOI 10.1073/pnas.88.16.6961; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; Juliano RL, 1993, CURR OPIN CELL BIOL, V5, P812, DOI 10.1016/0955-0674(93)90030-T; LINDBERG FP, 1993, J CELL BIOL, V123, P485, DOI 10.1083/jcb.123.2.485; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; MORTARINI R, 1992, CANCER RES, V52, P4499; ONEILL C, 1986, CELL, V44, P489, DOI 10.1016/0092-8674(86)90470-8; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; SCHWARTZ MA, 1993, CANCER RES, V53, P1503; STREULI CH, 1991, J CELL BIOL, V115, P1383, DOI 10.1083/jcb.115.5.1383	17	956	979	0	25	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 20	1994	77	4					477	478		10.1016/0092-8674(94)90209-7	http://dx.doi.org/10.1016/0092-8674(94)90209-7			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NM832	8187171				2022-12-28	WOS:A1994NM83200002
J	CONNETT, GJ; LEE, BW				CONNETT, GJ; LEE, BW			TREATING CHILDHOOD ASTHMA IN SINGAPORE - WHEN WEST MEETS EAST	BRITISH MEDICAL JOURNAL			English	Article							ESOPHAGEAL	Though Western medicines and ideas about asthma have become popular in many Asian nations, local beliefs about treatment prevail. The multiracial society of Singapore shows a variety of beliefs about causes of asthma attacks (for example, the balance of yin and yang) and types of treatment-herbal remedies, inhaled versus eaten medicines, the influence of Ramadan. Many of the cultural practices mentioned are probably preserved among south east Asian minorities residing in the United Kingdom. Eastern treatments typically take a holistic approach to asthma and do not ignore the psychosomatic component of the disorder.	NATL UNIV SINGAPORE,DEPT PAEDIAT,SINGAPORE 0511,SINGAPORE	National University of Singapore			Connett, Gary/AAU-3686-2020	Connett, Gary/0000-0003-1310-3239				de San Lazaro C, 1986, Arch Dis Child, V61, P97; FITCH KD, 1971, BRIT MED J, V4, P577, DOI 10.1136/bmj.4.5787.577; KONG XT, 1993, ARCH DIS CHILD, V68, P468, DOI 10.1136/adc.68.4.468; RAUSCHER H, 1989, RESPIRATION, V55, P11; SHEEHAN MP, 1992, BRIT J DERMATOL, V126, P179, DOI 10.1111/j.1365-2133.1992.tb07817.x; WILSON NM, 1985, EUR J RESPIR DIS, V66, P25; WILSON NM, 1985, THORAX, V40, P592, DOI 10.1136/thx.40.8.592; ZHU SL, 1989, ASIAN PAC J ALLERGY, V7, P5	8	13	14	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 14	1994	308	6939					1282	1284		10.1136/bmj.308.6939.1282	http://dx.doi.org/10.1136/bmj.308.6939.1282			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM147	8205023	Green Published			2022-12-28	WOS:A1994NM14700023
J	NEUFELD, TP; RUBIN, GM				NEUFELD, TP; RUBIN, GM			THE DROSOPHILA PEANUT GENE IS REQUIRED FOR CYTOKINESIS AND ENCODES A PROTEIN SIMILAR TO YEAST PUTATIVE BUD NECK FILAMENT PROTEINS	CELL			English	Article							CEREVISIAE CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; CONTRACTILE RING; BUDDING YEAST; COMPOUND EYE; LOCALIZATION; MORPHOGENESIS; MELANOGASTER; PRODUCT; SITE	We have identified a Drosophila gene, peanut (pnut), that is related in sequence to the CDC3, CDC10, CDC11, and CDC12 genes of S. cerevisiae. These genes are required for cytokinesis, and their products are present at the bud neck during cell division. We find that pnut is also required for cytokinesis: in pnut mutants, imaginal tissues fail to proliferate and instead develop clusters of large, multinucleate cells. Pnut protein is localized to the cleavage furrow of dividing cells during cytokinesis and to the intercellular bridge connecting postmitotic daughter cells. In addition to its role in cytokinesis, pnut displays genetic interactions with seven in absentia, a gene required for neuronal fate determination in the compound eye, suggesting that pnut may have pleiotropic functions. Our results suggest that this class of proteins is involved in aspects of cytokinesis that have been conserved between flies and yeast.			NEUFELD, TP (corresponding author), UNIV CALIF BERKELEY, HOWARD HUGHES MED INST, DEPT MOLEC & CELL BIOL, BERKELEY, CA 94720 USA.			Neufeld, Thomas/0000-0001-5659-4811; Rubin, Gerald/0000-0001-8762-8703				BERK AJ, 1977, CELL, V12, P721, DOI 10.1016/0092-8674(77)90272-0; BYERS B, 1968, PROTOPLASMA, V66, P413, DOI 10.1007/BF01255868; BYERS B, 1976, J CELL BIOL, V70, pA35; BYERS B, 1976, J CELL BIOL, V69, P717, DOI 10.1083/jcb.69.3.717; BYERS TJ, 1987, J CELL BIOL, V105, P2103, DOI 10.1083/jcb.105.5.2103; CARTHEW RW, 1990, CELL, V63, P561, DOI 10.1016/0092-8674(90)90452-K; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; EDAMATSU M, 1992, J BIOCHEM-TOKYO, V112, P637, DOI 10.1093/oxfordjournals.jbchem.a123952; FLESCHER EG, 1993, J CELL BIOL, V122, P373, DOI 10.1083/jcb.122.2.373; FORD SK, 1991, DEV GENET, V12, P281, DOI 10.1002/dvg.1020120405; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; GATTI M, 1989, GENE DEV, V3, P438, DOI 10.1101/gad.3.4.438; HAARER BK, 1987, MOL CELL BIOL, V7, P3678, DOI 10.1128/MCB.7.10.3678; HARLOW E, 1988, ANTIBODIES LABORATOR; HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0; HARTWELL LH, 1974, BACTERIOL REV, V38, P164, DOI 10.1128/MMBR.38.2.164-198.1974; HAY B, 1990, DEVELOPMENT, V109, P425; HIME G, 1992, DEVELOPMENT, V114, P165; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; KARESS RE, 1991, CELL, V65, P1177, DOI 10.1016/0092-8674(91)90013-O; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; KATO K, 1991, J NEUROSCI, V2, P704; KIM HB, 1991, J CELL BIOL, V112, P535, DOI 10.1083/jcb.112.4.535; KLEMENZ R, 1987, NUCLEIC ACIDS RES, V15, P3947, DOI 10.1093/nar/15.10.3947; LEHNER CF, 1992, J CELL SCI, V103, P1021; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MLODZIK M, 1992, METHODS NEUROSCIENCE, V9, P397; MOSES K, 1989, NATURE, V340, P531, DOI 10.1038/340531a0; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; MULLINS MC, 1991, P NATL ACAD SCI USA, V88, P9387, DOI 10.1073/pnas.88.21.9387; NOTTENBURG C, 1990, GENE, V95, P279, DOI 10.1016/0378-1119(90)90372-X; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; PICKETTHEAPS JD, 1966, J CELL SCI, V1, P109; Pirrotta V., 1986, DROSOPHILA PRACTICAL, P83; Pirrotta V, 1988, VECTORS SURVEY MOL C, P437; RAPPAPORT R, 1986, INT REV CYTOL, V105, P245, DOI 10.1016/S0074-7696(08)61065-7; RICKOLL WL, 1980, ROUX ARCH DEV BIOL, V188, P163, DOI 10.1007/BF00849045; ROBERTSON HM, 1988, GENETICS, V118, P461; SANGER F, 1977, P NATL ACAD SCI USA, V86, P8333; SANGER JM, 1985, CELL TISSUE RES, V240, P287; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SCHEJTER ED, 1993, ANNU REV CELL BIOL, V9, P67, DOI 10.1146/annurev.cellbio.9.1.67; SCHROEDER TE, 1990, ANN NY ACAD SCI, V582, P78; SCHROEDER TE, 1972, J CELL BIOL, V53, P419, DOI 10.1083/jcb.53.2.419; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SNYDER M, 1991, J CELL BIOL, V114, P515, DOI 10.1083/jcb.114.3.515; WOLFF T, 1991, DEVELOPMENT, V113, P841; XU T, 1993, DEVELOPMENT, V117, P1223; YONEMURA S, 1991, J CELL SCI, V100, P73; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373	51	277	284	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	1994	77	3					371	379		10.1016/0092-8674(94)90152-X	http://dx.doi.org/10.1016/0092-8674(94)90152-X			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NK970	8181057				2022-12-28	WOS:A1994NK97000008
J	VANDERLEI, J; DUISTERHOUT, JS; WESTERHOF, HP; VANDERDOES, E; CROMME, PVM; BOON, WM; VANBEMMEL, JH				VANDERLEI, J; DUISTERHOUT, JS; WESTERHOF, HP; VANDERDOES, E; CROMME, PVM; BOON, WM; VANBEMMEL, JH			THE INTRODUCTION OF COMPUTER-BASED PATIENT RECORDS IN THE NETHERLANDS	ANNALS OF INTERNAL MEDICINE			English	Article							MEDICAL RECORDS	Computer-based patient records, although an area of active research, are not in widespread use. In June 1992, 38% of Dutch general practitioners had introduced computer-based patient records. Of these, 70% had replaced the paper patient record with a computer-based record to retrieve and record clinical data during consultations. Possible reasons for the use of computer-based patient records include the nature of Dutch general practice and the early and active role of professional organizations in recognizing the potential of computer-stored patient records. Professional organizations issued guidelines for information systems in general practice, evaluated available systems, and provided postgraduate training that prepares physicians to use the systems. In addition, professional organizations successfully urged the government to reimburse general practitioners part of the expenses related to the introduction of computer-based patient records. Our experience indicates that physicians are willing and able to integrate information technology in their practices and that professional organizations can play an active role in the introduction of information technology.	DUTCH COLL GEN PRACTITIONERS,UTRECHT,NETHERLANDS; DUTCH ASSOC GEN PRACTITIONERS,UTRECHT,NETHERLANDS		VANDERLEI, J (corresponding author), ERASMUS UNIV ROTTERDAM,FAC MED & HLTH SCI,DEPT MED INFORMAT,POB 1738,3000 DR ROTTERDAM,NETHERLANDS.		Tao, Youyou/D-2367-2014					BLUM BI, 1990, HIST MED INFORMATICS; BRANGER PJ, 1992, BRIT MED J, V305, P1068, DOI 10.1136/bmj.305.6861.1068; BRANGER PJ, 1991, 15TH P SCAMC S NEW Y, P58; Cromme P V, 1985, Ned Tijdschr Geneeskd, V129, P1576; DEGEUS CA, 1987, SYSTEM ANAL AMBULART, P91; DeSmet P, 1988, J SOC ADMIN PHARM, V5, P49; Dick R.S., 1991, COMPUTER BASED PATIE; DUISTERHOUT JS, 1991, TELEMATICS IN MEDICINE, P151; ESCH AR, 1992, KIJKER, V1, P9; GREENES RA, 1990, JAMA-J AM MED ASSOC, V263, P1114; HOPPENER P, 1990, THESIS U LIMBURG MAA; Lamberts H., 1987, ICPC INT CLASSIFICAT; MCDONALD CJ, 1988, JAMA-J AM MED ASSOC, V259, P3433, DOI 10.1001/jama.259.23.3433; MCDONALD CJ, 1990, MED INFORMATICS COMP, P81; SCHMITTLING GT, 1989, J FAM PRACTICE, V29, P198; SCHWARTZ WB, 1970, NEW ENGL J MED, V283, P1257, DOI 10.1056/NEJM197012032832305; SHORTLIFFE EH, 1991, ANN INTERN MED, V115, P979, DOI 10.7326/0003-4819-115-12-979; SHORTLIFFE EH, 1990, MED INFORMATIONS COM; VANDERLEI J, 1991, COMPUT BIOMED RES, V24, P344, DOI 10.1016/0010-4809(91)90034-T; VANDERLEI J, 1993, METHOD INFORM MED, V32, P146; VANDERLEI J, 1991, LANCET, V338, P1505; Weed, 1971, MED RECORDS MED ED P; WEED LL, 1984, COMPUTERS MED INFORM, P83; WESTERHOF HP, 1987, PRESENT STATUS COMPU, P1; WESTERHOF HP, 1990, WERKGROEP COORDINATI; 1985, REFERENTIEMODEL HUIS; 1993, GEZONDHEIDSRAAD; 1990, HUISARTS WET, V33, P114; 1983, BASIS TAKENPAKKET HU; 1988, ISO9735	30	196	196	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572	0003-4819			ANN INTERN MED	Ann. Intern. Med.	NOV 15	1993	119	10					1036	1041		10.7326/0003-4819-119-10-199311150-00011	http://dx.doi.org/10.7326/0003-4819-119-10-199311150-00011			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MG672	8214981				2022-12-28	WOS:A1993MG67200011
J	SISCOVICK, DS; RAGHUNATHAN, TE; PSATY, BM; KOEPSELL, TD; WICKLUND, KG; LIN, XH; COBB, L; RAUTAHARJU, PM; COPASS, MK; WAGNER, EH				SISCOVICK, DS; RAGHUNATHAN, TE; PSATY, BM; KOEPSELL, TD; WICKLUND, KG; LIN, XH; COBB, L; RAUTAHARJU, PM; COPASS, MK; WAGNER, EH			DIURETIC THERAPY FOR HYPERTENSION AND THE RISK OF PRIMARY CARDIAC-ARREST	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY HEART-DISEASE; BLOOD-PRESSURE; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; SERUM MAGNESIUM; SKELETAL-MUSCLE; ARRHYTHMIAS; POTASSIUM; ABNORMALITIES; TRIAMTERENE	Background. The results of trials of the primary prevention of coronary heart disease have suggested that treating hypertension with high doses of thiazide diuretic drugs might increase the risk of sudden death from cardiac causes. In contrast, treatment with low doses of thiazide reduces the risk of coronary heart disease. Methods. To examine the association between thiazide treatment for hypertension and the occurrence of primary cardiac arrest, we conducted a population-based case-control study among enrollees of a health maintenance organization. The case patients were 114 persons with hypertension who had a primary cardiac arrest from 1977 through 1990. The control patients were a stratified random sample of 535 persons with hypertension. The patients' treatment was assessed with the use of a computerized pharmacy data base. Records of their ambulatory care were reviewed to determine other clinical characteristics. Results. The risk of primary cardiac arrest among patients receiving combined thiazide and potassium-sparing diuretic therapy was lower than that among patients treated with a thiazide without potassium-sparing therapy (odds ratio, 0.3; 95 percent confidence interval, 0.1 to 0.7). As compared with low-dose thiazide therapy (25 mg daily), moderate-dose therapy (50 mg daily) was associated with a moderate increase in risk (odds ratio, 1.7; 95 percent confidence interval, 0.7 to 4.5), and high-dose therapy (100 mg daily) was associated with a larger increase in risk (odds ratio, 3.6; 95 percent confidence interval, 1.2 to 10.8) (P value for trend, 0.02). The addition of a potassium-sparing drug to low-dose thiazide therapy was associated with a reduced risk of cardiac arrest (odds ratio, 0.4; 95 percent confidence interval, 0.1 to 1.5). Conclusions. Both the dose of thiazide drugs and the addition of potassium-sparing drugs influence the risk of primary cardiac arrest. These results may explain the differences in the effect of antihypertensive therapy on mortality from coronary heart disease in previous clinical trials.	UNIV WASHINGTON, DEPT MED, SEATTLE, WA USA; UNIV WASHINGTON, DEPT EPIDEMIOL, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT BIOSTAT, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT HLTH SERV, SEATTLE, WA 98195 USA; UNIV ALBERTA, CTR EPICORE, DIV CARDIOL, EDMONTON, AB, CANADA; GRP HLTH COOPERAT PUGET SOUND, CTR HLTH STUDIES, SEATTLE, WA 98101 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Alberta; Group Health Cooperative	SISCOVICK, DS (corresponding author), UNIV WASHINGTON, CARDIOVASC HLTH RES UNIT, METROPOLITAN PK 2 BLDG, SUITE 1360, 1730 MINOR AVE, SEATTLE, WA 98101 USA.				NHLBI NIH HHS [HL42456-03] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042456] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSSON PO, 1984, CLIN PHARMACOL THER, V36, P197, DOI 10.1038/clpt.1984.162; [Anonymous], 1991, JAMA, V265, P3255; [Anonymous], 1979, Circulation, V59, P607; BLACKBURN H, 1960, CIRCULATION, V21, P1160, DOI 10.1161/01.CIR.21.6.1160; CARLSEN JE, 1990, BRIT MED J, V300, P975, DOI 10.1136/bmj.300.6730.975; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; DORUP I, 1988, BRIT MED J, V296, P455, DOI 10.1136/bmj.296.6620.455; DYCKNER T, 1980, ACTA MED SCAND, V207, P59; ELMFELDT D, 1983, ACTA MED SCAND, P79; FARNETT L, 1991, JAMA-J AM MED ASSOC, V265, P489, DOI 10.1001/jama.265.4.489; FISCH C, 1973, CIRCULATION, V47, P408, DOI 10.1161/01.CIR.47.2.408; GIFFORD RW, 1993, ARCH INTERN MED, V153, P154; HOLLIFIELD JW, 1989, AM J CARDIOL, V63, pB21, DOI 10.1016/0002-9149(89)90934-X; HOLLIFIELD JW, 1984, AM J MED, V77, P28, DOI 10.1016/S0002-9343(84)80005-4; KJELSBERG MO, 1985, AM J CARDIOL, V55, P1; KJELSBERG MO, 1982, JAMA-J AM MED ASSOC, V248, P1465; KULLER L, 1985, AM J EPIDEMIOL, V122, P1045, DOI 10.1093/oxfordjournals.aje.a114186; KULLER LH, 1986, CIRCULATION, V73, P114, DOI 10.1161/01.CIR.73.1.114; LITTLE R, 1987, STATISTICAL ANAL MIS; MACMAHON SW, 1986, PROG CARDIOVASC DIS, V29, P99, DOI 10.1016/0033-0620(86)90038-1; MARTIN BJ, 1987, ARCH INTERN MED, V147, P1768, DOI 10.1001/archinte.147.10.1768; MCCLOSKEY LW, 1992, ARCH INTERN MED, V152, P513, DOI 10.1001/archinte.152.3.513; MEADE TW, 1992, BMJ-BRIT MED J, V304, P405; MIALL WE, 1983, BMJ-BRIT MED J, V287, P1249; PSATY BM, 1989, JAMA-J AM MED ASSOC, V261, P2087, DOI 10.1001/jama.261.14.2087; RAUTAHARJU PM, 1981, CIRCULATION, V64, P249, DOI 10.1161/01.CIR.64.2.249; SIEGEL D, 1992, JAMA-J AM MED ASSOC, V267, P1083, DOI 10.1001/jama.267.8.1083; SISCOVICK DS, 1993, ANN EMERG MED, V22, P92, DOI 10.1016/S0196-0644(05)80258-6; SPENCE JD, 1985, LANCET, V2, P73; WIDMANN L, 1988, EUR J CLIN PHARMACOL, V33, P577, DOI 10.1007/BF00542490	31	346	351	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	1994	330	26					1852	1857		10.1056/NEJM199406303302603	http://dx.doi.org/10.1056/NEJM199406303302603			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NT530	8196728				2022-12-28	WOS:A1994NT53000003
J	MARTENSEN, RL				MARTENSEN, RL			CANCER - MEDICAL HISTORY AND THE FRAMING OF A DISEASE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									HARVARD UNIV,SCH MED,DEPT SOCIAL MED,BOSTON,MA 02115	Harvard University; Harvard Medical School	MARTENSEN, RL (corresponding author), BRIGHAM & WOMENS HOSP,DEPT EMERGENCY MED,641 HUNTINGTON AVE,BOSTON,MA 02115, USA.							Burn I, 1993, Eur J Surg Oncol, V19, P507; CURTIS BF, 1894, MED REC, V45, P225; MCGRAW TA, 1895, JAMA-J AM MED ASSOC, V25, P387; OLDHOFF J, 1992, EUR J SURG ONCOL, V18, P205; OSLER W, 1894, NY STATE MED J  0303, P260; OSLER W, 1894, NY STATE MED J  0203, P130; OSLER W, 1894, NY STATE MED J  0217, P193; OSLER W, 1894, NY STATE MED J  0210, P161; Pilcher L S, 1894, Ann Surg, V20, P1, DOI 10.1097/00000658-189407000-00001; REINEKING H, 1894, JAMA-J AM MED ASSOC, V23, P98; RODMAN WL, 1893, AM PRACT NEWS, V16, P409; RUSH BF, 1991, ARCH SURG-CHICAGO, V126, P302; SONTAG S, 1990, ILLNESS AS METAPHOR	13	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	1994	271	24					1901	1901		10.1001/jama.271.24.1901	http://dx.doi.org/10.1001/jama.271.24.1901			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR598	8201723				2022-12-28	WOS:A1994NR59800005
J	GABRIEL, SE; OFALLON, WM; KURLAND, LT; BEARD, CM; WOODS, JE; MELTON, LJ				GABRIEL, SE; OFALLON, WM; KURLAND, LT; BEARD, CM; WOODS, JE; MELTON, LJ			RISK OF CONNECTIVE-TISSUE DISEASES AND OTHER DISORDERS AFTER BREAST IMPLANTATION	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN ADJUVANT DISEASE; SYSTEMIC LUPUS-ERYTHEMATOSUS; AUGMENTATION MAMMOPLASTY; COSMETIC SURGERY; AUTOIMMUNE-DISEASE; REVISED CRITERIA; SILICONE; SCLERODERMA; CLASSIFICATION; HYPERTENSION	Background. We conducted a population-based, retrospective study to examine the risk of a variety of connective-tissue diseases and other disorders after breast implantation. Methods. All women in Olmsted County, Minnesota, who received a breast implant between January 1, 1964, and December 31, 1991 (the case subjects), were studied. For each case subject, two women of the same age (within three years) from the same population who had not received a breast implant and who underwent a medical evaluation within two years of the date of the implantation in the case subject were selected as control subjects. Each woman's inpatient and outpatient medical record was reviewed for the occurrence of various connective-tissue diseases, certain other disorders thought to have an autoimmune pathogenesis (e.g., Hashimoto's thyroiditis), and cancer other than breast cancer, as well as related symptoms and abnormal results of laboratory tests. The case subjects were categorized according to whether they received implants for cosmetic reasons, for reconstruction after mastectomy for breast cancer, or for reconstruction after subcutaneous mastectomy for cancer prophylaxis. Additional control subjects (women treated for breast cancer who did not have breast reconstruction) were studied for comparison with the case subjects. Results. A total of 749 women who had received a breast implant were followed for a mean of 7.8 years, and 1498 community controls were followed for a mean of 8.3 years. In 5 case subjects, as compared with 10 subjects in the control group, one of the specified connective-tissue diseases was diagnosed (relative risk, 1.06; 95 percent confidence interval, 0.34 to 2.97). Twenty-five case subjects had signs or symptoms of arthritis, as compared with 39 control subjects (relative risk, 1.35; 95 percent confidence interval, 0.81 to 2.23). Among the various signs or symptoms examined, only morning stiffness was significantly increased among the women who had received a breast implant (relative risk, 1.81; 95 percent confidence interval, 1.11 to 2.95). Conclusions. We found no association between breast implants and the connective-tissue diseases and other disorders that were studied.	MAYO CLIN & MAYO FDN,DIV RHEUMATOL & INTERNAL MED,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT SURG,ROCHESTER,MN 55905	Mayo Clinic; Mayo Clinic	GABRIEL, SE (corresponding author), MAYO CLIN & MAYO FDN,DEPT HLTH SCI RES,200 1ST ST SW,ROCHESTER,MN 55905, USA.				NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR030582] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR30582] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALUSIK S, 1989, COR VASA, V31, P139; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BRIDGES AJ, 1993, ANN INTERN MED, V118, P929, DOI 10.7326/0003-4819-118-12-199306150-00003; BROZENA SJ, 1988, ARCH DERMATOL, V124, P1383, DOI 10.1001/archderm.124.9.1383; COLLINS N, 1988, CLIN EPIDEMIOLOGY ES, P208; COX DR, 1953, BIOMETRIKA, V40, P354, DOI 10.1093/biomet/40.3-4.354; COX DR, 1972, J R STAT SOC B, V34, P187; DEAPEN DM, 1986, PLAST RECONSTR SURG, V77, P361, DOI 10.1097/00006534-198603000-00001; DUGOWSON CE, 1992, ARTHRITIS RHEUM, V35, pS66; ENDO LP, 1987, SEMIN ARTHRITIS RHEU, V17, P112, DOI 10.1016/0049-0172(87)90033-3; FOCK KM, 1984, J RHEUMATOL, V11, P98; GABRIEL SE, IN PRESS J CLIN EPID; GOLDMAN JA, 1992, ARTHRITIS RHEUM, V35, pS65; GUTIERREZ FJ, 1990, AM J MED, V89, P390; HITOSHI S, 1991, JPN J MED, V30, P97; KUMAGAI Y, 1984, ARTHRITIS RHEUM-US, V27, P1, DOI 10.1002/art.1780270101; KUMAGAI Y, 1979, ARTHRITIS RHEUM, V22, P532, DOI 10.1002/art.1780220514; KURLAND LT, 1981, SCI AM, V245, P54, DOI 10.1038/scientificamerican1081-54; LEIBSON CL, 1992, MILBANK Q, V70, P127, DOI 10.2307/3350087; MAY DS, 1991, PLAST RECONSTR SURG, V87, P193, DOI 10.1097/00006534-199101000-00045; MCCULLAGH P, 1983, MONOGRAPHS STATISTIC, P181; MICHET CJ, 1985, MAYO CLIN PROC, V60, P105, DOI 10.1016/S0025-6196(12)60294-8; OKANO Y, 1984, ANN RHEUM DIS, V43, P520, DOI 10.1136/ard.43.3.520; PHILLIPS SJ, 1990, MAYO CLIN PROC, V65, P344, DOI 10.1016/S0025-6196(12)62535-X; Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, ARTHRITIS RHEUM, V23, P581; SAHN EE, 1990, ARCH DERMATOL, V126, P1198, DOI 10.1001/archderm.126.9.1198; SCHUSTERMAN MA, 1993, ANN PLAS SURG, V31, P1; SPIERA H, 1988, JAMA-J AM MED ASSOC, V260, P236, DOI 10.1001/jama.260.2.236; SPIERA H, 1993, J RHEUMATOL, V20, P958; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TAURA N, 1976, J JAP SOC INTERN MED, V65, P840; VANNUNEN SA, 1982, ARTHRITIS RHEUM, V25, P694, DOI 10.1002/art.1780250613; VARGA J, 1989, ANN INTERN MED, V111, P377, DOI 10.7326/0003-4819-111-5-377; WALSH FW, 1989, ARCH INTERN MED, V149, P1194, DOI 10.1001/archinte.149.5.1194; WEISMAN MH, 1988, PLAST RECONSTR SURG, V82, P626, DOI 10.1097/00006534-198810000-00011; WIGLEY FM, 1992, ARTHRITIS RHEUM, V35, pS46; Ziegler V, 1986, Dermatol Monatsschr, V172, P86	37	403	408	0	15	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 16	1994	330	24					1697	1702		10.1056/NEJM199406163302401	http://dx.doi.org/10.1056/NEJM199406163302401			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR109	8190133				2022-12-28	WOS:A1994NR10900001
J	HU, SH; PARKER, MW; LEI, JY; WILCE, MCJ; BENIAN, GM; KEMP, BE				HU, SH; PARKER, MW; LEI, JY; WILCE, MCJ; BENIAN, GM; KEMP, BE			INSIGHTS INTO AUTOREGULATION FROM THE CRYSTAL-STRUCTURE OF TWITCHIN KINASE	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; CATALYTIC SUBUNIT; CAENORHABDITIS-ELEGANS; PEPTIDE INHIBITOR; SEQUENCE; BINDING; PRODUCE	MANY protein kinases are self-regulated by an intrasteric mechanism where part of the enzyme's structure directly inhibits the active site(1,2). This inhibitory structure is called a pseudosubstrate and specific regulators are required to remove it from the active site to allow substrates access. Removal of the pseudosubstrate sequence from members of the myosin light-chain kinase subfamily(1), including twitchin kinase, activates them but it is not known whether the pseudosubtrate sequence binds to the active site. Native twitchin is a 753K protein (6,839 residues) located in muscle A-bands of the nematode Caenorhabditis elegans(3,4) and because of its size has not been easy to study. We have determined the crystal structure, refined to 2.8 Angstrom resolution, of a recombinant fragment (residues 5,890 to 6,262) of twitchin kinase(3,4) that contains the catalytic core and a 60 residue carboxy-terminal tail. The C-terminal tail extends through the active site, wedged between the small and large lobes of the structure and making extensive contacts with the catalytic core which accounts for autoinhibition and provides direct support for the intrasteric mechanism of protein kinase regulation.	ST VINCENTS INST MED RES,FITZROY,VIC 3065,AUSTRALIA; EMORY UNIV,DEPT PATHOL,ATLANTA,GA 30322	St. Vincent's Institute of Medical Research; Emory University			Parker, Michael W/F-9069-2013; Kemp, Bruce E/L-2633-2014; Kemp, Bruce/G-9602-2019	Parker, Michael W/0000-0002-3101-1138; Kemp, Bruce E/0000-0001-6735-5082; Kemp, Bruce/0000-0001-6735-5082	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BENIAN GM, 1993, GENETICS, V134, P1097; BENIAN GM, 1989, NATURE, V342, P45, DOI 10.1038/342045a0; BOSSEMEYER D, 1993, EMBO J, V12, P849, DOI 10.1002/j.1460-2075.1993.tb05725.x; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; GERSTEIN M, 1993, J MOL BIOL, V234, P357, DOI 10.1006/jmbi.1993.1592; HENDRICKSON WA, 1980, COMPUTING CRYSTALLOG; HU SH, 1994, J MOL BIOL, V236, P1259, DOI 10.1016/0022-2836(94)90026-4; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KEMP BE, 1991, BIOCHIM BIOPHYS ACTA, V1094, P67, DOI 10.1016/0167-4889(91)90027-U; KEMP BE, IN PRESS FRONTIERS M; KNIGHTON DR, 1993, ACTA CRYSTALLOGR D, V49, P357, DOI 10.1107/S0907444993000502; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; OLAH GA, 1993, BIOCHEMISTRY-US, V32, P3649, DOI 10.1021/bi00065a018; VELLIEUX FMD, 1993, P NATL ACAD SCI USA, V90, P2355, DOI 10.1073/pnas.90.6.2355; WATERSTON RH, 1980, DEV BIOL, V77, P271, DOI 10.1016/0012-1606(80)90475-3; ZHENG JH, 1993, ACTA CRYSTALLOGR D, V49, P362, DOI 10.1107/S0907444993000423; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	22	182	187	1	11	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 16	1994	369	6481					581	584		10.1038/369581a0	http://dx.doi.org/10.1038/369581a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR294	8202162				2022-12-28	WOS:A1994NR29400056
J	BATTERSBY, AR				BATTERSBY, AR			HOW NATURE BUILDS THE PIGMENTS OF LIFE - THE CONQUEST OF VITAMIN-B-12	SCIENCE			English	Article							ADENOSYL-L-METHIONINE; UROPORPHYRINOGEN-III METHYLTRANSFERASE; ACID A,C-DIAMIDE SYNTHASE; 5 COB GENES; PSEUDOMONAS-DENITRIFICANS; COBYRINIC ACID; HYDROGENOBYRINIC ACID; RING CONTRACTION; PRECORRIN-6X REDUCTASE; NUCLEOTIDE-SEQUENCE	In part because humans cannot synthesize vitamin B-12 and must obtain it from organisms that produce it and because B-12 deficiency leads to pernicious anemia, it has been important to understand how microorganisms build this quite complex substance. As shown here, an interdisciplinary attack was needed, which combined the strengths of genetics, molecular biology, enzymology, chemistry, and spectroscopy. This allowed the step-by-step synthetic pathway of B-12 to be elucidated, and this approach has acted as a model for future research on the synthesis of substances in living organisms. One practical outcome of such an approach has been the improved availability of B-12 for animal feedstuffs and human health.			BATTERSBY, AR (corresponding author), UNIV CAMBRIDGE,CHEM LAB,LENSFIELD RD,CAMBRIDGE CB2 1EW,ENGLAND.							ALANINE AID, 1994, J CHEM SOC CHEM COMM, P103; ARIGONI D, 1994, CIBA F SYMP, V180, P280; BALACHANDRAN S, 1994, J CHEM SOC PERK T 1, P487, DOI 10.1039/p19940000487; BATTERSBY AR, 1993, ACCOUNTS CHEM RES, V26, P15, DOI 10.1021/ar00025a003; BATTERSBY AR, 1986, ACCOUNTS CHEM RES, V19, P147, DOI 10.1021/ar00125a004; BATTERSBY AR, 1994, CIBA F SYMP, V180, P267; BATTERSBY AR, 1981, P NATL ACAD SCI USA, V78, P13, DOI 10.1073/pnas.78.1.13; BATTERSBY AR, 1990, CHEM REV, V90, P1261, DOI 10.1021/cr00105a009; BATTERSBY AR, 1982, B12, V1, P107; BLANCHE F, 1992, J CHEM SOC CHEM COMM, P138, DOI 10.1039/c39920000138; BLANCHE F, 1993, ANGEW CHEM INT EDIT, V32, P1651, DOI 10.1002/anie.199316511; BLANCHE F, 1989, J BACTERIOL, V171, P4222, DOI 10.1128/JB.171.8.4222-4231.1989; BLANCHE F, 1990, ANGEW CHEM INT EDIT, V29, P884, DOI 10.1002/anie.199008841; BLANCHE F, 1992, J BACTERIOL, V174, P1036, DOI 10.1128/jb.174.3.1036-1042.1992; BLANCHE F, 1992, J BACTERIOL, V174, P1050, DOI 10.1128/jb.174.3.1050-1052.1992; BREY RN, 1986, J BACTERIOL, V167, P623, DOI 10.1128/jb.167.2.623-630.1986; CAMERON B, 1989, J BACTERIOL, V171, P547, DOI 10.1128/jb.171.1.547-557.1989; CROUZET J, 1991, J BACTERIOL, V173, P6074, DOI 10.1128/jb.173.19.6074-6087.1991; CROUZET J, 1990, J BACTERIOL, V172, P5980, DOI 10.1128/jb.172.10.5980-5990.1990; CROUZET J, 1990, J BACTERIOL, V172, P5968, DOI 10.1128/jb.172.10.5968-5979.1990; DEBUSSCHE L, 1990, J BACTERIOL, V172, P6239, DOI 10.1128/jb.172.11.6239-6244.1990; DEBUSSCHE L, 1993, J CHEM SOC CHEM COMM, P1100, DOI 10.1039/c39930001100; DEBUSSCHE L, 1992, J BACTERIOL, V174, P7445, DOI 10.1128/jb.174.22.7445-7451.1992; DEBUSSCHE L, 1993, J BACTERIOL, V175, P7439; ESCHENMOSER A, 1988, ANGEW CHEM INT EDIT, V27, P6; HODGKIN DC, 1956, NATURE, V178, P64, DOI 10.1038/178064a0; HODGKIN DC, 1955, CHEM SOC SPEC PUBL, V3, P109; ICHINOSE K, 1993, J CHEM SOC CHEM COMM, P515, DOI 10.1039/c39930000515; KIUCHI F, 1992, J CHEM SOC CHEM COMM, P306, DOI 10.1039/c39920000306; LEEPER FJ, 1989, NAT PROD REP, V6, P171, DOI 10.1039/np9890600171; MIN CH, 1993, J AM CHEM SOC, V115, P10380, DOI 10.1021/ja00075a072; MOMBELLI L, 1981, P NATL ACAD SCI USA, V78, P11, DOI 10.1073/pnas.78.1.11; MULLER B, 1989, J CHEM SOC CHEM COMM, P1119, DOI 10.1039/c39890001119; MULLER G, 1991, J AM CHEM SOC, V113, P9893; ROTH JR, 1993, BACILLUS MEGATERIUM, V175, P3303; SCOTT AI, 1993, FEBS LETT, V331, P105, DOI 10.1016/0014-5793(93)80306-F; SCOTT AI, 1993, ANGEW CHEM INT EDIT, V32, P1223, DOI 10.1002/anie.199312233; SCOTT AI, 1984, BIOORG CHEM, V12, P356, DOI 10.1016/0045-2068(84)90017-8; SCOTT AI, 1994, CIBA F SYMP, V180, P285; SCOTT AI, 1990, ACCOUNTS CHEM RES, V23, P308, DOI 10.1021/ar00177a007; THIBAUT D, 1990, J BACTERIOL, V172, P6245, DOI 10.1128/jb.172.11.6245-6251.1990; THIBAUT D, 1990, P NATL ACAD SCI USA, V87, P8800, DOI 10.1073/pnas.87.22.8800; THIBAUT D, 1990, P NATL ACAD SCI USA, V87, P8795, DOI 10.1073/pnas.87.22.8795; THIBAUT D, 1992, J BACTERIOL, V174, P1043, DOI 10.1128/jb.174.3.1043-1049.1992; THIBAUT D, 1992, J CHEM SOC CHEM COMM, P139, DOI 10.1039/c39920000139; THIBAUT D, 1993, J CHEM SOC CHEM COMM, P513, DOI 10.1039/c39930000513; THIBAUT D, 1992, J CHEM SOC CHEM COMM, P982, DOI 10.1039/c39920000982; UZAR HC, 1987, J CHEM SOC PERK T 1, P1689, DOI 10.1039/p19870001689; UZAR HC, 1982, J CHEM SOC CHEM COMM, P1204, DOI 10.1039/c39820001204; UZAR HC, 1985, J CHEM SOC CHEM COMM, P585, DOI 10.1039/c39850000585; WARREN MJ, 1994, CIBA F SYMP, V180, P26; WEAVER GW, 1991, J CHEM SOC CHEM COMM, P976, DOI 10.1039/c39910000976; WHITTINGHAM WG, 1989, J CHEM SOC CHEM COMM, P1116, DOI 10.1039/c39890001116; WOLF JB, 1986, J BACTERIOL, V166, P51, DOI 10.1128/jb.166.1.51-58.1986	54	129	135	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 10	1994	264	5165					1551	1557		10.1126/science.8202709	http://dx.doi.org/10.1126/science.8202709			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ285	8202709				2022-12-28	WOS:A1994NQ28500024
J	SCHNEIDER, JW; GU, W; ZHU, L; MAHDAVI, V; NADALGINARD, B				SCHNEIDER, JW; GU, W; ZHU, L; MAHDAVI, V; NADALGINARD, B			REVERSAL OF TERMINAL DIFFERENTIATION MEDIATED BY P107 IN RB(-/-) MUSCLE-CELLS	SCIENCE			English	Article							RETINOBLASTOMA GENE-PRODUCT; LARGE T-ANTIGEN; CYCLIN-A; MYOGENIC DIFFERENTIATION; SUSCEPTIBILITY GENE; PROTEIN; EXPRESSION; RHABDOMYOSARCOMAS; PROLIFERATION; SUPPRESSION	The terminal differentiation of mammalian muscle cells requires the tumor suppressor retinoblastoma protein (Rb). Unlike their wild-type counterparts, multinucleated myotubes from mouse cells deficient in Rb (Rb--/-) were induced by serum to reenter the cell cycle. Development of the myogenic phenotype in Rb--/- cells correlated with increased expression of p107, which interacted with myogenic transcription factors. Serum-induced cell cycle reentry, on the other hand, correlated with decreased p107 expression. Thus, although p107 could substitute for Rb as a cofactor for differentiation, it could not maintain the terminally differentiated state in Rb--/- myotubes.	HARVARD UNIV,CHILDRENS HOSP,SCH MED,DEPT CARDIOL,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,CTR CANC,BOSTON,MA 02129	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital								AMACHER SL, 1993, MOL CELL BIOL, V13, P2753, DOI 10.1128/MCB.13.5.2753; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; CARDOSO MC, 1993, CELL, V74, P979, DOI 10.1016/0092-8674(93)90721-2; CLARKE AR, 1992, NATURE, V359, P328, DOI 10.1038/359328a0; COPPOLA JA, 1990, ONCOGENE, V5, P1731; CRESCENZI M, 1990, P NATL ACAD SCI USA, V87, P8442, DOI 10.1073/pnas.87.21.8442; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DECHIARA A, 1993, J NATL CANCER I, V85, P152, DOI 10.1093/jnci/85.2.152; ENDO T, 1992, J BIOCHEM-TOKYO, V112, P427, DOI 10.1093/oxfordjournals.jbchem.a123916; EWEN ME, 1992, SCIENCE, V255, P85, DOI 10.1126/science.1532457; EWEN ME, 1991, CELL, V66, P1155, DOI 10.1016/0092-8674(91)90038-Z; EWEN ME, 1989, CELL, V58, P257, DOI 10.1016/0092-8674(89)90840-4; FAHA B, 1992, SCIENCE, V255, P87, DOI 10.1126/science.1532458; FARMER K, 1992, J BIOL CHEM, V267, P5631; FURUKAWA Y, 1990, P NATL ACAD SCI USA, V87, P2770, DOI 10.1073/pnas.87.7.2770; GARFINKEL LI, 1982, J BIOL CHEM, V257, P1078; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; Gu W.Q., UNPUB; HAMEL PA, 1992, TRENDS GENET, V8, P180, DOI 10.1016/0168-9525(92)90221-O; HAMEL PA, 1993, FASEB J, V7, P846, DOI 10.1096/fasebj.7.10.8344484; HITI AL, 1989, MOL CELL BIOL, V9, P4722, DOI 10.1128/MCB.9.11.4722; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; JACKS T, 1992, NATURE, V359, P296; KAELIN WG, 1991, CELL, V64, P521, DOI 10.1016/0092-8674(91)90236-R; LASSAR AB, 1992, TRANSCRIPTIONAL REGU, P1037; LEE EYHP, 1992, NATURE, V359, P288, DOI 10.1038/359288a0; MAIONE R, 1994, CELL GROWTH DIFFER, V5, P231; MCALLISTER RM, 1969, CANCER-AM CANCER SOC, V24, P520, DOI 10.1002/1097-0142(196909)24:3<520::AID-CNCR2820240313>3.0.CO;2-M; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; Sambrook J, 1989, MOL CLONING LABORATO; SCHWARZ JK, 1993, EMBO J, V12, P1013, DOI 10.1002/j.1460-2075.1993.tb05742.x; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; SORRENTINO V, 1990, NATURE, V345, P813, DOI 10.1038/345813a0; SZEKELY L, 1992, CELL GROWTH DIFFER, V3, P149; TAPSCOTT SJ, 1993, SCIENCE, V259, P1450, DOI 10.1126/science.8383879; WANG CY, 1993, SCIENCE, V260, P1330, DOI 10.1126/science.8493578; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741; WIMAN KG, 1993, FASEB J, V7, P841, DOI 10.1096/fasebj.7.10.8393817; WRIGHT WE, 1989, CELL, V56, P607, DOI 10.1016/0092-8674(89)90583-7; ZAMANIAN M, 1993, MOL BIOL CELL, V4, P389, DOI 10.1091/mbc.4.4.389; ZHU L, 1993, GENE DEV, V7, P1111, DOI 10.1101/gad.7.7a.1111	42	355	361	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 3	1994	264	5164					1467	1471		10.1126/science.8197461	http://dx.doi.org/10.1126/science.8197461			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NP221	8197461				2022-12-28	WOS:A1994NP22100045
J	GOODWIN, FK				GOODWIN, FK			PSYCHIATRY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEPRESSION; DISORDER; STRESS				GOODWIN, FK (corresponding author), NIMH,BETHESDA,MD 20892, USA.							CHOUINARD G, 1993, J CLIN PSYCHOPHARM, V13, P25; COIE JD, 1992, J CONSULT CLIN PSYCH, V60, P783, DOI 10.1037/0022-006X.60.5.783; FRASURESMITH N, 1994, JAMA-J AM MED ASSOC, V271, P1082; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; GARLAND AF, 1993, AM PSYCHOL, V48, P169, DOI 10.1037/0003-066X.48.2.169; HAUSER P, 1993, NEW ENGL J MED, V328, P997, DOI 10.1056/NEJM199304083281403; IRWIN M, 1991, FASEB J, V5, P3100, DOI 10.1096/fasebj.5.15.1743441; LIPSKA BK, 1993, NEUROPSYCHOPHARMACOL, V9, P67, DOI 10.1038/npp.1993.44; MOFFITT T, 1993, DEV PSYCHOL, V5, P155; MONTGOMERY SA, 1993, J CLIN PSYCHIAT, V54, P119; REGIER DA, 1993, ARCH GEN PSYCHIAT, V50, P85; REIMHERR FW, 1984, PSYCHOPHARMACOL BULL, V20, P70; SPIEGEL D, 1993, J NATL CANCER I, V85, P1198, DOI 10.1093/jnci/85.15.1198; SWEDO SE, 1994, PEDIATRICS, V93, P323; Vestergaard P, 1993, Psychopharmacol Ser, V10, P190; 1993, AM J PSYCHIAT, V150, P1447; 1993, PHS AHCPR930550 US D; 1993, PHS AHCPR930551 US D	18	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1707	1708		10.1001/jama.271.21.1707	http://dx.doi.org/10.1001/jama.271.21.1707			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NN117	8182864				2022-12-28	WOS:A1994NN11700043
J	WOLFFE, AP				WOLFFE, AP			ARCHITECTURAL TRANSCRIPTION FACTORS	SCIENCE			English	Editorial Material							DNA; BINDING				WOLFFE, AP (corresponding author), NICHHD,MOLEC EMBRYOL LAB,BETHESDA,MD 20892, USA.							BAUER WR, 1994, J MOL BIOL, V236, P685, DOI 10.1006/jmbi.1994.1180; BAZETTJONES DP, 1994, SCIENCE, V264, P1134, DOI 10.1126/science.8178172; BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; CULLEN KE, 1993, SCIENCE, V261, P203, DOI 10.1126/science.8327891; DUNAWAY M, 1989, GENE DEV, V3, P1768, DOI 10.1101/gad.3.11.1768; ECHOLS H, 1986, SCIENCE, V233, P1050, DOI 10.1126/science.2943018; GOODMAN SD, 1989, NATURE, V341, P251, DOI 10.1038/341251a0; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; HU CH, 1994, MOL CELLBIOL, V14, P281; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; KIM S, 1992, SCIENCE, V256, P198, DOI 10.1126/science.1533056; LAYBOURN PJ, 1992, SCIENCE, V257, P1682, DOI 10.1126/science.1388287; LEE DY, 1993, CELL, V72, P75; OMAHONY DJ, 1992, J BIOL CHEM, V267, P35; PERLMANN T, 1988, EMBO J, V7, P3073, DOI 10.1002/j.1460-2075.1988.tb03172.x; SCHILD C, 1993, EMBO J, V12, P423, DOI 10.1002/j.1460-2075.1993.tb05674.x; WEIR HM, 1993, EMBO J, V12, P1311, DOI 10.1002/j.1460-2075.1993.tb05776.x; WEIR HM, 1993, EMBO J, V12, P513; WOLFFE AP, 1994, CELL, V77, P15	19	172	174	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 20	1994	264	5162					1100	1101		10.1126/science.8178167	http://dx.doi.org/10.1126/science.8178167			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NM146	8178167				2022-12-28	WOS:A1994NM14600019
J	CARMICHAEL, J				CARMICHAEL, J			CANCER-CHEMOTHERAPY - IDENTIFYING NOVEL ANTICANCER DRUGS	BRITISH MEDICAL JOURNAL			English	Article							EXPRESSION; TRANSDUCTION; ELEMENTS; QUALITY; LIFE	There are now around 60 cytotoxic drugs licensed for use in cancer therapy in the United Kingdom. For certain malignancies such as childhood cancers, haematological malignancies and germ cell tumours chemotherapy has been pivotal to the substantial improvement in therapeutic outcome achieved over the past 10 years. In contrast, improvements in the systemic management of adult solid tumours have been less dramatic. There is a clear and urgent need for new, more effective drugs for lung, breast, and colorectal malignancies. This paper examines the processes in identifying, developing, and evaluating new drugs with anticancer activity.			CARMICHAEL, J (corresponding author), CITY HOSP NOTTINGHAM,CRC,ACAD UNIT CLIN ONCOL,HUCKNALL RD,NOTTINGHAM NG5 1PB,ENGLAND.							AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Boyd M. R., 1989, CANCER PRINCIPLES PR, V3, P1; BROGGINI M, 1989, NUCLEIC ACIDS RES, V17, P1051, DOI 10.1093/nar/17.3.1051; BROWN PD, 1993, J NATL CANCER I, V85, P547; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CARMICHAEL J, 1987, CANCER RES, V47, P936; DINCALCI M, 1992, ESO MONOGRAPHS, P5; FARBER S, 1948, NEW ENGL J MED, V238, P787, DOI 10.1056/NEJM194806032382301; FIDLER IJ, 1987, CURR PROB SURG, V24, P137, DOI 10.1016/0011-3840(87)90002-5; GESCHER A, 1989, ANTI-CANCER DRUG DES, V4, P93; HEIDELBERGER C, 1975, PROG NUCLEIC ACID MO, V4, P1; HELENE C, 1990, BIOCHIM BIOPHYS ACTA, V1049, P99, DOI 10.1016/0167-4781(90)90031-V; MERCER WE, 1991, P NATL ACAD SCI USA, V88, P1958, DOI 10.1073/pnas.88.5.1958; PETIT G R, 1982, Journal of the American Chemical Society, V104, P6846; POON MA, 1989, J CLIN ONCOL, V7, P1407, DOI 10.1200/JCO.1989.7.10.1407; ROSENBERG SA, 1990, NEW ENGL J MED, V323, P570, DOI 10.1056/NEJM199008303230904; ROWINSKY EK, 1990, JNCI-J NATL CANCER I, V82, P1247, DOI 10.1093/jnci/82.15.1247; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; SCHWARTSMANN G, 1991, EUR J CANCER, V27, P1162, DOI 10.1016/0277-5379(91)90317-7; SELBY P, 1987, CANCER SURV, V6, P521; SKEHAN P, 1991, EUR J CANCER, V27, P1162; Suffness M, 1989, BIOORGANIC MARINE CH, V3, P131; SWINNEN LJ, 1991, CANCER RES, V51, P1984; WILLIAMS GT, 1993, CELL, V74, P777, DOI 10.1016/0092-8674(93)90457-2; WU CH, 1989, J BIOL CHEM, V264, P16985; 1991, J CLIN ONCOL, V9, P4	26	10	10	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 14	1994	308	6939					1288	1290		10.1136/bmj.308.6939.1288	http://dx.doi.org/10.1136/bmj.308.6939.1288			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM147	8205025	Green Published			2022-12-28	WOS:A1994NM14700025
J	QIAN, F; VAUX, DL; WEISSMAN, IL				QIAN, F; VAUX, DL; WEISSMAN, IL			EXPRESSION OF THE INTEGRIN ALPHA-4-BETA-1 ON MELANOMA-CELLS CAN INHIBIT THE INVASIVE STAGE OF METASTASIS FORMATION	CELL			English	Article							ADHESION MOLECULES; MONOCLONAL-ANTIBODY; MALIGNANT-MELANOMA; COUNTER-RECEPTOR; HOMING RECEPTOR; FUNCTIONAL-ROLE; BINDING-SITE; VLA-4; FIBRONECTIN; PROTEINS	Among a series of adhesion molecules, expression of integrin alpha 4 beta 1 showed a unique inverse correlation with the invasive potential of B16 melanoma cell lines. When an alpha 4 cDNA was introduced into an alpha 4(-)beta 1(+) highly invasive melanoma line, alpha 4 beta 1 heterodimers were expressed on the surface. Matrigel invasion by the alpha 4(+)beta 1(+) cells was reduced. Pulmonary metastasis was also suppressed when the transfectants were placed subcutaneously, but not when injected intravenously. Expression of alpha 4 beta 1 promoted homotypic intercellular adhesion. The homotypic adhesion was abrogated, and the alpha 4(+)beta 1(+) (less invasive cell lines) increased matrigel invasion following the anti-alpha 4 MAb treatment. These results suggest that integrin alpha 4 beta 1 could play a role in controlling melanoma cell metastasis at the invasive stage.			QIAN, F (corresponding author), STANFORD UNIV, SCH MED, DEPT PATHOL, EXPTL ONCOL LAB, STANFORD, CA 94305 USA.		Vaux, David L/C-7249-2013	Vaux, David L/0000-0003-2703-1651				ARIHIRO K, 1993, JPN J CANCER RES, V84, P726, DOI 10.1111/j.1349-7006.1993.tb02036.x; BEDNARCZYK JL, 1990, J IMMUNOL, V144, P777; BEDNARCZYK JL, 1992, CLIN EXP METASTAS, V10, P281; BEDNARCZYK JL, 1993, J CELL BIOCHEM, V51, P465, DOI 10.1002/jcb.2400510412; CAMPANERO MR, 1992, EUR J IMMUNOL, V22, P3111, DOI 10.1002/eji.1830221213; CAMPANERO MR, 1990, J CELL BIOL, V110, P157; CARTER WG, 1990, J CELL BIOL, V110, P1387, DOI 10.1083/jcb.110.4.1387; CHAN BMC, 1991, SCIENCE, V251, P1600, DOI 10.1126/science.2011740; Coman DR, 1944, CANCER RES, V4, P625; DAMJANOVICH L, 1992, AM J RESP CELL MOL, V6, P197, DOI 10.1165/ajrcmb/6.2.197; DENTON KJ, 1992, J PATHOL, V167, P187, DOI 10.1002/path.1711670205; ELICES MJ, 1990, CELL, V60, P577, DOI 10.1016/0092-8674(90)90661-W; FIDLER IJ, 1975, CANCER RES, V35, P218; GALLATIN WM, 1983, NATUURE, V304, P233; GIANCOTTI FG, 1990, CELL, V60, P849, DOI 10.1016/0092-8674(90)90098-Y; GROUX H, 1989, NATURE, V339, P152, DOI 10.1038/339152a0; GUAN JL, 1990, CELL, V60, P53, DOI 10.1016/0092-8674(90)90715-Q; GUTMAN GA, 1972, IMMUNOLOGY, V23, P465; Hariharan I K, 1988, Oncogene Res, V3, P387; HAUSMAN RE, 1983, INT J CANCER, V32, P603, DOI 10.1002/ijc.2910320514; HEMLER ME, 1990, IMMUNOL REV, V114, P45, DOI 10.1111/j.1600-065X.1990.tb00561.x; HEMLER ME, 1987, J BIOL CHEM, V262, P11478; HEMLER ME, 1990, ANNU REV IMMUNOL, V8, P365, DOI 10.1146/annurev.iy.08.040190.002053; HOLERS VM, 1989, J EXP MED, V169, P1589, DOI 10.1084/jem.169.5.1589; HOLZMANN B, 1989, EMBO J, V8, P1735, DOI 10.1002/j.1460-2075.1989.tb03566.x; HOLZMANN B, 1989, CELL, V56, P37, DOI 10.1016/0092-8674(89)90981-1; HU MCT, 1992, P NATL ACAD SCI USA, V89, P8254, DOI 10.1073/pnas.89.17.8254; HYNES RO, 1973, P NATL ACAD SCI USA, V70, P3170, DOI 10.1073/pnas.70.11.3170; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; HYNES RO, 1989, J CELL BIOL, V109, P409, DOI 10.1083/jcb.109.1.409; KAUFMANN R, 1989, J CELL BIOL, V109, P1807, DOI 10.1083/jcb.109.4.1807; KILSHAW PJ, 1991, EUR J IMMUNOL, V21, P2591, DOI 10.1002/eji.1830211041; KOBAYASHI H, 1992, CANCER RES, V52, P3610; KORETZ K, 1991, AM J PATHOL, V138, P741; KOUKOULIS GK, 1991, AM J PATHOL, V139, P787; LARJAVA H, 1990, J CELL BIOL, V110, P803, DOI 10.1083/jcb.110.3.803; LESLEY J, 1982, IMMUNOGENETICS, V15, P313, DOI 10.1007/BF00364339; LETARTE M, 1993, LEUKEMIA, V7, P93; LIOTTA LA, 1991, CELL, V64, P327, DOI 10.1016/0092-8674(91)90642-C; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MARCANTONIO EE, 1988, J CELL BIOL, V106, P1765, DOI 10.1083/jcb.106.5.1765; MIYAKE K, 1991, J EXP MED, V173, P599, DOI 10.1084/jem.173.3.599; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NEUHAUS H, 1991, J CELL BIOL, V115, P1149, DOI 10.1083/jcb.115.4.1149; NIGAM AK, 1993, BRIT J CANCER, V68, P507, DOI 10.1038/bjc.1993.377; PAPAYANNOPOULOU T, 1992, BLOOD, V79, P1686; PELTONEN J, 1989, J CLIN INVEST, V84, P1916, DOI 10.1172/JCI114379; PIGNATELLI M, 1991, J PATHOL, V165, P25, DOI 10.1002/path.1711650106; PIGNATELLI M, 1990, BRIT J CANCER, V61, P636, DOI 10.1038/bjc.1990.141; PULIDO R, 1991, J BIOL CHEM, V266, P10241; QIAN F, 1989, CANCER RES, V49, P4870; REEVES ME, 1992, CANCER RES, V52, P1546; RINCON J, 1992, INT J CANCER, V51, P452, DOI 10.1002/ijc.2910510319; ROSEN GD, 1992, CELL, V69, P1107, DOI 10.1016/0092-8674(92)90633-N; RUIZ P, 1993, CELL ADHES COMMUN, V1, P67, DOI 10.3109/15419069309095682; SHORE EM, 1991, J BIOL CHEM, V266, P19672; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410; SUNKARA PS, 1987, CANCER RES, V47, P933; SUZUKI S, 1993, JPN J CANCER RES, V84, P168, DOI 10.1111/j.1349-7006.1993.tb02851.x; TAKADA Y, 1989, EMBO J, V8, P1361, DOI 10.1002/j.1460-2075.1989.tb03516.x; VONDERHEIDE RH, 1992, J EXP MED, V175, P1433, DOI 10.1084/jem.175.6.1433; WANG N, 1993, SCIENCE, V260, P124; WAYNER EA, 1989, J CELL BIOL, V109, P1321, DOI 10.1083/jcb.109.3.1321; ZUTTER MM, 1990, AM J PATHOL, V137, P863	66	218	233	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 6	1994	77	3					335	347		10.1016/0092-8674(94)90149-X	http://dx.doi.org/10.1016/0092-8674(94)90149-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NK970	8181055				2022-12-28	WOS:A1994NK97000005
J	MUNDINGER, MO				MUNDINGER, MO			ADVANCED-PRACTICE NURSING - GOOD MEDICINE FOR PHYSICIANS	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PRIMARY CARE; PRACTITIONER; CHOICES; TRIAL; TIME				MUNDINGER, MO (corresponding author), COLUMBIA UNIV,SCH NURSING,NEW YORK,NY 10027, USA.							AVORN J, 1991, ARCH INTERN MED, V151, P694, DOI 10.1001/archinte.151.4.694; BESSMAN AN, 1974, J CHRON DIS, V27, P115, DOI 10.1016/0021-9681(74)90080-0; BRIDER P, 1992, AM J NURS, V92, P34, DOI 10.1097/00000446-199203000-00011; BROOTEN D, 1986, NEW ENGL J MED, V315, P934, DOI 10.1056/NEJM198610093151505; BROWN SA, 1993, META ANAL PROCESS CA; CINTRON G, 1983, HEART LUNG, V12, P237; COLWILL JM, 1992, NEW ENGL J MED, V326, P387, DOI 10.1056/NEJM199202063260606; Crosby F, 1987, Nurse Pract, V12, P75; DAVIS C, 1993, AUG ANN C COMM FUND; GREENFIELD S, 1992, JAMA-J AM MED ASSOC, V267, P1624, DOI 10.1001/jama.267.12.1624; KASSEBAUM DG, 1992, ACAD MED, V67, P700, DOI 10.1097/00001888-199210000-00018; KNICKMAN JR, 1992, ACAD MED, V67, P429, DOI 10.1097/00001888-199207000-00003; LEVINSKY NG, 1993, NEW ENGL J MED, V328, P656, DOI 10.1056/NEJM199303043280913; LUNDERG GD, 1993, JAMA-J AM MED ASSOC, V270, P380, DOI 10.1001/jama.270.3.380; MANDELBLATT J, 1993, J GEN INTERN MED, V8, P173, DOI 10.1007/BF02599260; MULLAN F, 1993, HEALTH AFFAIR, V12, P138, DOI 10.1377/hlthaff.12.suppl_1.138; Nichols L M, 1992, Nurs Econ, V10, P343; Pearson L J, 1993, Nurse Pract, V18, P23, DOI 10.1097/00006205-199301000-00006; PETERSDORF RG, 1993, AM J PUBLIC HEALTH, V83, P328, DOI 10.2105/AJPH.83.3.328; Record J C, 1981, Springer Ser Health Care Soc, V6, P87; Safriet B.J., 1992, YALE J REGUL, V9; SALKEVER DS, 1982, MED CARE, V20, P143, DOI 10.1097/00005650-198202000-00002; SOX HC, 1979, ANN INTERN MED, V91, P459, DOI 10.7326/0003-4819-91-3-459; SPITZER WO, 1974, NEW ENGL J MED, V290, P251, DOI 10.1056/NEJM197401312900506; STIMMEL B, 1992, JAMA-J AM MED ASSOC, V268, P2060, DOI 10.1001/jama.268.15.2060; WELCH WP, 1993, NEW ENGL J MED, V328, P621, DOI 10.1056/NEJM199303043280906; WENNBERG J, 1982, SCI AM, V246, P120, DOI 10.1038/scientificamerican0482-120; 1986, HLTH TECHNOLOGY CASE, V37; 1993, NURSING FACTS ADV PR; 1992, COGME3RD DEP HLTH HU	30	108	109	0	6	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 20	1994	330	3					211	214		10.1056/NEJM199401203300314	http://dx.doi.org/10.1056/NEJM199401203300314			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MQ863	8192754				2022-12-28	WOS:A1994MQ86300014
J	CARR, PL; FRIEDMAN, RH; MOSKOWITZ, MA; KAZIS, LE				CARR, PL; FRIEDMAN, RH; MOSKOWITZ, MA; KAZIS, LE			COMPARING THE STATUS OF WOMEN AND MEN IN ACADEMIC MEDICINE	ANNALS OF INTERNAL MEDICINE			English	Article							FEMALE PHYSICIANS; INTERNAL-MEDICINE; FACULTY; RANK	Objective: To explore the status and academic productivity of women compared with men in academic internal medicine. Design: Mail survey done in 1986. Setting: A total of 107 major teaching hospitals in the United States. Participants: Full-time (1693 of 2510) faculty in cardiology, rheumatology, and general internal medicine; 67% of eligible men and 70% of eligible women. Measurements: Academic productivity defined as research grants awarded, abstracts accepted, and papers published in refereed journals; academic advancement as determined by academic rank and tenure status; and monetary compensation. Results: Women entered academic medicine with shorter periods of fellowship training and were less likely to be members in the Alpha Omega Alpha honor society, but they had job descriptions similar to those of men, with similar allocation of work between research, clinical, and teaching activities. After adjustment, women and men were similar in the numbers of research grants funded as principal investigator (1.9 compared with 2.0), abstracts accepted (6.8 compared with 6.1), and papers published in refereed journals (28.8 compared with 29.2; all with P > 0.20). Women were as likely as men to have tenure, but they had lower academic rank (full or associate professor; 33% compared with 47%, P < 0.001) and received less compensation ($72 000 compared with $79 600 annually; P < 0.001). Conclusion: Although women do similar professional tasks and achieve similar levels of academic productivity, they receive fewer rewards for their work, both in academic rank and monetary compensation.	BOSTON UNIV, SCH MED, BOSTON, MA 02118 USA; BOSTON UNIV, SCH PUBL HLTH, BOSTON, MA 02215 USA; HARVARD UNIV, MASSACHUSETTS GEN HOSP, SCH MED, BOSTON, MA 02114 USA	Boston University; Boston University; Harvard University; Harvard Medical School; Massachusetts General Hospital	CARR, PL (corresponding author), MASSACHUSETTS GEN HOSP, GEN MED UNIT, BULFINCH 1, FRUIT ST, BOSTON, MA 02114 USA.			Kazis, Lewis/0000-0003-1800-5849; Friedman, Robert/0000-0002-9440-2443				BICKEL J, 1988, NEW ENGL J MED, V319, P1579, DOI 10.1056/NEJM198812153192405; BOBULA JD, 1980, J MED EDUC, V55, P826; BOWMAN M, 1986, PUBLIC HEALTH REP, V101, P513; CARR P, 1992, J GEN INTERN MED, V7, P418, DOI 10.1007/BF02599159; DIAL TH, 1989, ACAD MED, V64, P198, DOI 10.1097/00001888-198904000-00007; Heins M, 1985, J Am Med Womens Assoc (1972), V40, P43; JAMES JB, 1990, EXPERIENCE MEANING W; JOLLY P, 1981, J MED EDUC, V56, P151; LANSKA MJ, 1984, J MED EDUC, V59, P849; NICKERSON KG, 1990, JAMA-J AM MED ASSOC, V264, P1813, DOI 10.1001/jama.264.14.1813; WHITE LJ, 1991, ANN INTERN MED, V114, P63, DOI 10.7326/0003-4819-114-1-63; WILSON MP, 1981, J AM MED WOMEN ASSOC, V36, P62; ZUCKERMAN H, 1987, WOMEN THEIR UNDERREP, P6	13	106	107	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	1993	119	9					908	913		10.7326/0003-4819-119-9-199311010-00008	http://dx.doi.org/10.7326/0003-4819-119-9-199311010-00008			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MD711	8215004				2022-12-28	WOS:A1993MD71100008
J	EMPTAGE, NJ; CAREW, TJ				EMPTAGE, NJ; CAREW, TJ			LONG-TERM SYNAPTIC FACILITATION IN THE ABSENCE OF SHORT-TERM FACILITATION IN APLYSIA NEURONS	SCIENCE			English	Article							PLEURAL SENSORY NEURONS; HETEROSYNAPTIC FACILITATION; TRANSMITTER RELEASE; PROTEIN-SYNTHESIS; K+ CURRENTS; CAMP; SEROTONIN; SENSITIZATION; EXCITABILITY; MODULATION	Serotonin (5-HT) induces both short-term and long-term facilitation of the identified synaptic connections between sensory and motor neurons of Aplysia. Three independent experimental approaches showed that long-term facilitation can normally be expressed in the absence of short-term facilitation: (i) The 5-HT antagonist cyproheptadine blocked the induction of short-term but not long-term facilitation; (ii) concentrations of 5-HT below threshold for the induction of short-term facilitation nonetheless induced long-term facilitation; and (iii) localized application of 5-HT to the sensory neuron cell body and proximal synapses induced long-term facilitation in distal synapses that were not exposed to 5-HT and had not expressed short-term facilitation. These results suggest that short-term and long-term synaptic facilitation are induced in parallel in the sensory neurons and that the short-term process, because it is induced and expressed at the synapse, can occur locally, but the long-term process, because of its dependence on a nuclear signal, is expressed throughout the neuron.	YALE UNIV, DEPT PSYCHOL, NEW HAVEN, CT 06520 USA; YALE UNIV, DEPT BIOL, NEW HAVEN, CT 06520 USA	Yale University; Yale University					NIMH NIH HHS [R01-MH-14-1083] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Atkinson R. C., 1968, PSYCHOL LEARNING MOT, V2, P89, DOI [DOI 10.1016/S0079-7421(08)60422-3, 10.1016/S0079-7421(08)60422-3]; BADDELEY AD, 1970, J VERB LEARN VERB BE, V9, P176, DOI 10.1016/S0022-5371(70)80048-2; BAILEY CH, 1989, J NEUROSCI, V9, P1774; BAXTER DA, 1990, J NEUROPHYSIOL, V64, P978, DOI 10.1152/jn.1990.64.3.978; BAXTER DA, 1989, J NEUROPHYSIOL, V62, P665, DOI 10.1152/jn.1989.62.3.665; BUONOMANO DV, 1990, SCIENCE, V249, P420, DOI 10.1126/science.2165631; BYRNE JH, 1993, ADV SEC MESS PHOSPH, V27, P47; CAREW TJ, 1986, ANNU REV NEUROSCI, V9, P345; CLARK G A, 1987, Society for Neuroscience Abstracts, V13, P390; CLARK GA, 1984, P NATL ACAD SCI-BIOL, V81, P2577, DOI 10.1073/pnas.81.8.2577; CLEARY LJ, 1985, SOC NEUR ABSTR, V11, P692; CROW T, 1993, J NEUROPHYSIOL, V69, P636, DOI 10.1152/jn.1993.69.2.636; DALE N, 1987, J NEUROSCI, V7, P2232; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; EMPTAGE NJ, UNPUB; GHIRARDI M, 1992, NEURON, V9, P479, DOI 10.1016/0896-6273(92)90185-G; GOLDSMITH BA, 1992, P NATL ACAD SCI USA, V89, P11481, DOI 10.1073/pnas.89.23.11481; HAMMER M, 1989, NEUROSCI LETT, V104, P235, DOI 10.1016/0304-3940(89)90360-1; HAWKINS RD, 1984, PSYCHOL REV, V91, P375, DOI 10.1037/0033-295X.91.3.375; HEBB DO, 1949, ORG BEHAVIOR; HOCHNER B, 1992, P NATL ACAD SCI USA, V89, P11476, DOI 10.1073/pnas.89.23.11476; James W., 1890, PRINCIPLES PSYCHOL, P449, DOI [https://doi.org/10.1037/11059-009, DOI 10.1037/11059-009]; MERCER AR, 1991, SCIENCE, V254, P1811, DOI 10.1126/science.1662413; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; NAZIF FA, 1991, BRAIN RES, V539, P324, DOI 10.1016/0006-8993(91)91638-H; OCORR KA, 1985, P NATL ACAD SCI USA, V82, P2548, DOI 10.1073/pnas.82.8.2548; SCHACHER S, 1988, SCIENCE, V240, P1667, DOI 10.1126/science.2454509; SCHOLZ KP, 1987, SCIENCE, V235, P685, DOI 10.1126/science.2433766; SCHOLZ KP, 1988, SCIENCE, V240, P1664, DOI 10.1126/science.2837826; SCHWARTZ JH, 1981, J NEUROSCI, V1, P606; SHALLICE T, 1970, Q J EXP PSYCHOL, V22, P261, DOI 10.1080/00335557043000203; Squire L. R., 1987, MEMORY BRAIN; SQUIRE LR, 1993, ANNU REV PSYCHOL, V44, P453, DOI 10.1146/annurev.ps.44.020193.002321; STARK LL, UNPUB; SUGITA S, 1992, J NEUROPHYSIOL, V68, P643, DOI 10.1152/jn.1992.68.2.643; WALTERS ET, 1987, J NEUROSCI, V7, P408; WALTERS ET, 1983, J NEUROPHYSIOL, V50, P1543, DOI 10.1152/jn.1983.50.6.1543; ZHANG ZS, 1991, J COMP NEUROL, V311, P259, DOI 10.1002/cne.903110207; [No title captured]	39	181	183	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	1993	262	5131					253	256		10.1126/science.8211146	http://dx.doi.org/10.1126/science.8211146			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA665	8211146				2022-12-28	WOS:A1993MA66500039
J	BENNETT, M; REED, R				BENNETT, M; REED, R			CORRESPONDENCE BETWEEN A MAMMALIAN SPLICEOSOME COMPONENT AND AN ESSENTIAL YEAST SPLICING FACTOR	SCIENCE			English	Article							SMALL NUCLEAR RIBONUCLEOPROTEIN; RNA POLYMERASE-II; BINDING DOMAIN; SNRNP PROTEIN; U2 SNRNP; SUBUNIT; GENE; RECOGNITION; REGULATORS; ACTIVATOR	None of the mammalian splicing factors that have been cloned corresponds to the yeast pre-messenger RNA splicing factors, the PRP proteins. Here, a generalizable strategy was used to isolate a complementary DNA encoding the mammalian spliceosome-associated protein (SAP) SAP 62. It is demonstrated that SAP 62 is the likely functional homolog of the yeast PRP11 protein. Both PRP11 and SAP 62 associate stably with the spliceosome, contain a single zinc finger, and display significant amino acid sequence similarity. Unlike PRP11, SAP 62 contains 22 proline-rich heptapeptide repeats at the carboxyl-terminus.	HARVARD UNIV,SCH MED,DEPT CELL BIOL,BOSTON,MA 02115	Harvard University; Harvard Medical School					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043375, R56GM043375] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM43375] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABOVICH N, 1990, MOL CELL BIOL, V10, P6417, DOI 10.1128/MCB.10.12.6417; ANDERSON GJ, 1989, NATURE, V342, P819, DOI 10.1038/342819a0; ARENAS JE, 1993, P NATL ACAD SCI USA, V90, P6771, DOI 10.1073/pnas.90.14.6771; BEHRENS SE, 1993, MOL CELL BIOL, V13, P307, DOI 10.1128/MCB.13.1.307; BEHRENS SE, IN PRESS P NATL ACAD; BENNETT M, 1992, GENE DEV, V6, P1986, DOI 10.1101/gad.6.10.1986; BENNETT MA, UNPUB; BROSI R, 1993, SCIENCE, V262, P102, DOI 10.1126/science.8211112; BROSI R, IN PRESS J BIOL CHEM; CHAMPIONARNAUD P, UNPUB; CHANG TH, 1988, MOL CELL BIOL, V8, P2379, DOI 10.1128/MCB.8.6.2379; CHAPON C, 1992, EMBO J, V11, P3279, DOI 10.1002/j.1460-2075.1992.tb05406.x; DREYFUSS G, 1988, TRENDS BIOCHEM SCI, V13, P86, DOI 10.1016/0968-0004(88)90046-1; EVANS RM, 1988, CELL, V52, P1, DOI 10.1016/0092-8674(88)90522-3; FU XD, 1992, SCIENCE, V256, P535, DOI 10.1126/science.1373910; GARCIABLANCO MA, 1990, P NATL ACAD SCI USA, V87, P3082, DOI 10.1073/pnas.87.8.3082; GE H, 1991, CELL, V66, P373, DOI 10.1016/0092-8674(91)90626-A; KOLODZIEJ PA, 1990, MOL CELL BIOL, V10, P1915, DOI 10.1128/MCB.10.5.1915; KRAINER AR, 1991, CELL, V66, P383, DOI 10.1016/0092-8674(91)90627-B; LEGRAIN P, 1990, EMBO J, V9, P2775, DOI 10.1002/j.1460-2075.1990.tb07465.x; LEGRAIN P, 1993, SCIENCE, V262, P108, DOI 10.1126/science.8211114; LU H, 1992, NATURE, V358, P641, DOI 10.1038/358641a0; LUHRMANN R, 1990, BIOCHIM BIOPHYS ACTA, V1087, P265, DOI 10.1016/0167-4781(90)90001-I; MADHANI HD, 1992, CELL, V71, P803, DOI 10.1016/0092-8674(92)90556-R; MCPHEETERS DS, 1992, CELL, V71, P819, DOI 10.1016/0092-8674(92)90557-S; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; PARKER R, 1987, CELL, V49, P229, DOI 10.1016/0092-8674(87)90564-2; PINTO AL, 1989, P NATL ACAD SCI USA, V86, P8742, DOI 10.1073/pnas.86.22.8742; QUERY CC, 1989, CELL, V57, P89, DOI 10.1016/0092-8674(89)90175-X; REED RW, UNPUB; ROKEACH LA, 1989, J BIOL CHEM, V264, P5024; RUBY S, COMMUNICATION; RUBY SW, IN PRESS GENES DEV; Sambrook J, 1989, MOL CLONING LABORATO; SCHAPPERT K, 1991, MOL GEN GENET, V226, P277, DOI 10.1007/BF00273613; SILLEKENS PTG, 1988, NUCLEIC ACIDS RES, V16, P8307, DOI 10.1093/nar/16.17.8307; STAKNIS D, UNPUB; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212; USHEVA A, 1992, CELL, V69, P871, DOI 10.1016/0092-8674(92)90297-P; WELLS SP, COMMUNICATION; WU J, 1989, GENE DEV, V3, P1553, DOI 10.1101/gad.3.10.1553; ZAHLER AM, 1992, GENE DEV, V6, P837, DOI 10.1101/gad.6.5.837; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; ZHANG M, 1992, P NATL ACAD SCI USA, V89, P8769, DOI 10.1073/pnas.89.18.8769; ZHUANG Y, 1989, GENE DEV, V3, P1545, DOI 10.1101/gad.3.10.1545	46	78	81	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 1	1993	262	5130					105	108		10.1126/science.8211113	http://dx.doi.org/10.1126/science.8211113			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ635	8211113				2022-12-28	WOS:A1993LZ63500033
J	DRISCOLL, PA; ROSS, R; NICHOLSON, DA				DRISCOLL, PA; ROSS, R; NICHOLSON, DA			ABC OF EMERGENCY RADIOLOGY - CERVICAL-SPINE .1.	BRITISH MEDICAL JOURNAL			English	Article											DRISCOLL, PA (corresponding author), HOPE HOSP,SALFORD M6 8HD,LANCS,ENGLAND.								0	2	2	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 25	1993	307	6907					785	789		10.1136/bmj.307.6907.785	http://dx.doi.org/10.1136/bmj.307.6907.785			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LZ478	8219955	Bronze, Green Published			2022-12-28	WOS:A1993LZ47800030
J	BOURNE, HR				BOURNE, HR			G-PROTEINS - THE IMPORTANCE OF BEING GTP	NATURE			English	Editorial Material							ALPHA-SUBUNIT; TRANSDUCIN; ACTIVATION; MUTATION; GAMMA		UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	BOURNE, HR (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PHARMACOL,SAN FRANCISCO,CA 94143, USA.							BERLOT CH, 1992, CELL, V68, P911, DOI 10.1016/0092-8674(92)90034-A; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1993, NATURE, V366, P628, DOI 10.1038/366628a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; FUNG BKK, 1983, J BIOL CHEM, V258, P495; ITOH H, 1991, J BIOL CHEM, V266, P16226; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.bi.60.070191.002025; LAMBRIGHT DG, 1994, NATURE, V369, P621, DOI 10.1038/369621a0; LEE E, 1992, J BIOL CHEM, V267, P1212; MARKBY DW, 1993, SCIENCE, V262, P1895, DOI 10.1126/science.8266082; MILLER RT, 1988, NATURE, V334, P712, DOI 10.1038/334712a0; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; RARICK HM, 1992, SCIENCE, V256, P1031, DOI 10.1126/science.1317058; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; THOMAS TC, 1993, P NATL ACAD SCI USA, V90, P10295, DOI 10.1073/pnas.90.21.10295	16	9	9	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 23	1994	369	6482					611	612		10.1038/369611a0	http://dx.doi.org/10.1038/369611a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NT459	8208286				2022-12-28	WOS:A1994NT45900032
J	BAKER, DW; STEVENS, CD; BROOK, RH				BAKER, DW; STEVENS, CD; BROOK, RH			REGULAR SOURCE OF AMBULATORY CARE AND MEDICAL-CARE UTILIZATION BY PATIENTS PRESENTING TO A PUBLIC HOSPITAL EMERGENCY DEPARTMENT	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CITY MINORITY POPULATION; HEALTH-CARE; ACCESS; ROOM; CONSEQUENCES; HYPERTENSION	Objective.-To determine the regular source of care and the relationship between usual provider and use of medical services among ambulatory emergency department patients. Design.-Cross-sectional survey. Setting.-A public hospital in Los Angeles County, California. Patients.-A total of 1190 stable, ambulatory adults presenting to the emergency department during a 2-week period. Main Outcome Measures.-Self-reported regular source of care, usual health status, and recent physician visits. Results.-A total of 16% of the patients identified ah emergency department as their regular source of care. One fourth of this group reported fair or poor health. African Americans and Latinos were more likely than whites to identify an emergency department as their regular source of care. Patients who identified an emergency department as their regular source of care had 25% fewer physician visits and were less likely to have seen a physician during the preceding 3 months than patients who were usually seen in an office or clinic (relative risk, 0.45;95% confidence interval, 0.28 to 0.70). Of all patients, 56% identified; a regular source of care other than an emergency department, but 24% to 36% of all their recent physician visits still occurred in an emergency department. Conclusion.-Our patients rely heavily on emergency departments for ambulatory physician visits, regardless of their reported regular source of care. However, patients who identify an emergency department as their regular source of ambulatory care used physician services less frequently than patients with access to providers in other settings. These issues require further evaluation with population-based surveys.	UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DEPT EMERGENCY MED,TORRANCE,CA; VALUE HLTH SCI,SANTA MONICA,CA; UNIV CALIF LOS ANGELES,CTR HLTH SCI,DEPT MED,LOS ANGELES,CA 90024; UNIV CALIF LOS ANGELES,CTR HLTH SCI,DEPT HLTH SERV,LOS ANGELES,CA 90024; RAND CORP,HLTH SCI PROGRAM,SANTA MONICA,CA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; RAND Corporation	BAKER, DW (corresponding author), UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DEPT MED,DIV GEN INTERNAL MED,TORRANCE,CA 90509, USA.							ADAY LA, 1984, AM J PUBLIC HEALTH, V74, P1331, DOI 10.2105/AJPH.74.12.1331; ADAY LA, 1975, ACCESS MED CARE; Aday LA, 1980, HLTH CARE US EQUITAB; ALPERT JJ, 1969, MED CARE, V7, P55, DOI 10.1097/00005650-196901000-00007; BAKER DW, 1991, JAMA-J AM MED ASSOC, V266, P1085, DOI 10.1001/jama.266.8.1085; BINDMAN AB, 1991, JAMA-J AM MED ASSOC, V266, P1091, DOI 10.1001/jama.266.8.1091; BLOOM BL, 1981, VITAL HLTH STAT 10, V148; BUESCHING DP, 1985, ANN EMERG MED, V14, P672, DOI 10.1016/S0196-0644(85)80886-6; CORNELIUS L, 1991, USUAL SOURCES MED CA, V2; DAVIS K, 1981, ANNU REV PUBL HEALTH, V2, P159, DOI 10.1146/annurev.pu.02.050181.001111; FLEMING NS, 1983, MED CARE, V21, P892, DOI 10.1097/00005650-198309000-00006; GOUGH HG, 1977, MED EDUC, V11, P380, DOI 10.1111/j.1365-2923.1977.tb00636.x; GRUMBACH K, 1993, AM J PUBLIC HEALTH, V83, P372, DOI 10.2105/AJPH.83.3.372; GUTTERMAN JJ, 1985, ANN EMERG MED, V14, P1191; HABENSTREIT B, 1986, NEW YORK STATE J MED, V86, P517; HAYWARD RA, 1991, AM J PUBLIC HEALTH, V81, P434, DOI 10.2105/AJPH.81.4.434; JACOBS AR, 1991, JAMA-J AM MED ASSOC, V216, P307; Jones S L, 1985, J Emerg Nurs, V11, P145; KELLERMAN AL, 1991, JAMA-J AM MED ASSOC, V266, P1123, DOI 10.1001/jama.266.8.1123; PERKOFF GT, 1970, MED CARE, V8, P309, DOI 10.1097/00005650-197008040-00007; SCHOENBORN CA, 1988, VITAL HLTH STAT 10, V166; SHEA S, 1992, AM J PUBLIC HEALTH, V82, P1607, DOI 10.2105/AJPH.82.12.1607; SHEA S, 1992, NEW ENGL J MED, V327, P776, DOI 10.1056/NEJM199209103271107; STEWART AL, 1988, MED CARE, V26, P724, DOI 10.1097/00005650-198807000-00007; STOCK LM, 1994, ANN EMERG MED, V23, P294, DOI 10.1016/S0196-0644(94)70043-5; VAYDA E, 1975, CAN MED ASSOC J, V112, P961; WEINERMAN RE, 1966, AM J PUBLIC HEALTH, V56, P1037; WOLCOTT BW, 1979, JACEP-J AM COLL EMER, V8, P241; 1980, EMERGENCY DEP REGION, P13; 1992, STATA VERSION 3 0; 1983, RW JOHNSON F UPDATE	31	206	206	0	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	1994	271	24					1909	1912		10.1001/jama.271.24.1909	http://dx.doi.org/10.1001/jama.271.24.1909			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NR598	8201734				2022-12-28	WOS:A1994NR59800026
J	BOUCHARD, TJ				BOUCHARD, TJ			GENES, ENVIRONMENT, AND PERSONALITY	SCIENCE			English	Editorial Material											BOUCHARD, TJ (corresponding author), UNIV MINNESOTA,DEPT PSYCHOL,MINNEAPOLIS,MN 55455, USA.							BOUCHARD TJ, 1990, SCIENCE, V250, P223, DOI 10.1126/science.2218526; BOUCHARD TJ, 1993, BASIC ISSUES PERSONA; BUSS DM, 1993, TWINS TOOL BEHAVIORA; Darwin C., 1871, DESCENT MAN SELECTIO; EAVES JL, 1989, GENES CULTURE PERSON; FORD BD, 1993, AM PSYCHOL, V48, P1294; GOLDBERG LR, 1993, AM PSYCHOL, V48, P26, DOI 10.1037/0003-066X.48.1.26; HOFFMAN LW, 1991, PSYCHOL BULL, V110, P187, DOI 10.1037/0033-2909.110.2.187; Loehlin J.C., 1992, GENES ENV PERSONALIT; LYTTON H, 1990, DEV PSYCHOL, V26, P705, DOI 10.1037/0012-1649.26.5.705; MOLENAR PCM, 1993, BEHAV GENET, V6, P519; Neale MC, 1992, METHODOLOGY GENETIC; NICHOLS RC, 1978, HOMO, V29, P158; Rowe D. C., 1994, LIMITS FAMILY INFLUE; SCARR S, 1992, CHILD DEV, V63, P1, DOI 10.2307/1130897	15	328	334	4	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 17	1994	264	5166					1700	1701		10.1126/science.8209250	http://dx.doi.org/10.1126/science.8209250			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR600	8209250				2022-12-28	WOS:A1994NR60000031
J	MALATY, HM; ENGSTRAND, L; PEDERSEN, NL; GRAHAM, DY				MALATY, HM; ENGSTRAND, L; PEDERSEN, NL; GRAHAM, DY			HELICOBACTER-PYLORI INFECTION - GENETIC AND ENVIRONMENTAL-INFLUENCES	ANNALS OF INTERNAL MEDICINE			English	Article						HELICOBACTER PYLORI; HELICOBACTER INFECTIONS; TWINS; ENVIRONMENTAL EXPOSURE; HEREDITARY DISEASES	DUODENAL-ULCER DISEASE; CAMPYLOBACTER-PYLORI; PEPSINOGEN-I; EPIDEMIOLOGY; CHILDREN; ANTIBODY; SEROEPIDEMIOLOGY; POPULATION; FAMILIES; IDENTIFICATION	Objective: To investigate the importance of genetic effects for acquiring Helicobacter pylori infection. Design: Cross-sectional study on monozygotic and dizygotic twins, reared apart and reared together. Setting: Twins from a subregistry of the Swedish Twin Registry, which includes entries for about 25 000 twin pairs who were born in Sweden. Measurements: Helicobacter pylori status was assessed as the presence of anti-H pylori IgG in 269 pairs of twins, including 36 monozygotic twin pairs reared apart, 64 monozygotic twin pairs reared together, 88 dizygotic twin pairs reared apart, and 81 dizygotic twin pairs reared together. Results: The probandwise concordance rate for H. pylori infection was higher in monozygotic twin pairs (81%) than in dizygotic twin pairs (63%) (P = 0.001). Probandwise concordance rates for H. pylori infection among 124 pairs of twins reared apart were 82% and 66% for monozygotic and dizygotic twins, respectively (P = 0.003). The correlation coefficient was 0.66 for monozygotic twins reared apart, and it provides the best single estimate of the relative importance of genetic effects (heritability) for variation in the acquisition of H. pylori infection. The heritability estimate from model-fitting analyses was 0.57, a similar result. The remaining variance was accounted for by shared rearing environmental (20%) and nonshared environmental factors (23%). The latter contribute to differences, not similarities, among family members. Conclusion: This twin study showed that genetic effects influence the acquisition of H. pylori infection because of greater similarities within the monozygotic twin pairs. Further, sharing the same rearing environment also contributes to the familiar tendency for acquiring H. pylori infection.	UNIV UPPSALA HOSP, DEPT CLIN MICROBIOL, S-75185 UPPSALA, SWEDEN; KAROLINSKA INST, DIV EPIDEMIOL, S-17177 STOCKHOLM, SWEDEN; BAYLOR COLL MED, HOUSTON, TX USA	Uppsala University; Uppsala University Hospital; Karolinska Institutet; Baylor College of Medicine	MALATY, HM (corresponding author), VET AFFAIRS MED CTR, 111D, 2002 HOLCOMBE BLVD, HOUSTON, TX 77030 USA.		Graham, David/AAL-2165-2021		NIA NIH HHS [AG-10175, AG-04563] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG010175, R01AG004563] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ASAKA M, 1992, GASTROENTEROLOGY, V102, P760, DOI 10.1016/0016-5085(92)90156-S; BLASER MJ, 1992, CLIN INFECT DIS, V15, P386, DOI 10.1093/clind/15.3.386; DEGIACOMA C, 1991, J PEDIATR-US, V119, P205, DOI 10.1016/S0022-3476(05)80728-0; DEHESA M, 1991, J CLIN MICROBIOL, V29, P1128, DOI 10.1128/JCM.29.6.1128-1131.1991; DIXON MF, 1991, J GASTROEN HEPATOL, V6, P125, DOI 10.1111/j.1440-1746.1991.tb01451.x; DRUMM B, 1990, NEW ENGL J MED, V322, P359, DOI 10.1056/NEJM199002083220603; DWYER B, 1988, SCAND J INFECT DIS, V20, P349, DOI 10.3109/00365548809032465; EVANS DJ, 1989, GASTROENTEROLOGY, V96, P1004, DOI 10.1016/0016-5085(89)91616-8; FRASER AG, 1992, ALIMENT PHARM THERAP, V6, P389; GRAHAM DY, 1991, DIGEST DIS SCI, V36, P1084, DOI 10.1007/BF01297451; GRAHAM DY, 1991, J GASTROEN HEPATOL, V6, P105, DOI 10.1111/j.1440-1746.1991.tb01448.x; GRAHAM DY, 1991, GASTROENTEROLOGY, V100, P1495, DOI 10.1016/0016-5085(91)90644-Z; GRAHAM DY, 1992, EUR J GASTROEN HEPAT, V4, pS1; GRAHAM DY, 1989, GASTROEN CLIN BIOL, V13, pB84; HOPKINS RJ, 1990, ARCH INTERN MED, V150, P2347, DOI 10.1001/archinte.150.11.2347; JENSEN KG, 1972, PEPTIC ULCER GENETIC, P1; JONES DM, 1986, J MED MICROBIOL, V22, P57, DOI 10.1099/00222615-22-1-57; JONES DM, 1987, BRIT MED J, V294, P615, DOI 10.1136/bmj.294.6572.615-a; MALATY HM, 1991, SCAND J GASTROENTERO, V26, P927, DOI 10.3109/00365529108996244; MALATY HM, 1992, GASTROENTEROLOGY, V103, P813, DOI 10.1016/0016-5085(92)90011-M; MARSHALL BJ, 1990, REV INFECT DIS, V12, pS87; MCCONNELL RB, 1980, GENETICS HETEROGENEI, P31; MEGRAUD F, 1992, DIGEST DIS SCI, V37, P769, DOI 10.1007/BF01296437; MEGRAUD F, 1989, J CLIN MICROBIOL, V27, P1870; MITCHELL HM, 1992, J INFECT DIS, V166, P149, DOI 10.1093/infdis/166.1.149; MITCHELL HM, 1987, LANCET, V2, P681; MORRIS A, 1986, NEW ZEAL MED J, V99, P657; Neale MC, 1992, METHODOLOGY GENETIC; NEIEDERMAN JC, 1964, CLIN GENET, V9, P81; NORA JJ, 1989, MED GENETICS PRINCIP, P261; ODERDA G, 1991, DIGEST DIS SCI, V36, P572, DOI 10.1007/BF01297021; ODERDA G, 1989, LANCET, V1, P690; PEDERSEN NL, 1984, ACTA GENET MED GEMEL, V33, P243, DOI 10.1017/S0001566000007285; PEDERSEN NL, 1991, ACTA GENET MED GEMEL, V40, P7, DOI 10.1017/S0001566000006681; PLOMIN R, 1990, BEHAVIORAL GENETICS; ROTTER JI, 1979, NEW ENGL J MED, V300, P63, DOI 10.1056/NEJM197901113000203; ROTTER JI, 1993, PROGR MED GENETICS, P1; SCHUBERT TT, 1989, AM J GASTROENTEROL, V84, P637; TAYLOR DN, 1991, EPIDEMIOL REV, V13, P42, DOI 10.1093/oxfordjournals.epirev.a036078	39	213	217	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	1994	120	12					982	986		10.7326/0003-4819-120-12-199406150-00002	http://dx.doi.org/10.7326/0003-4819-120-12-199406150-00002			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NQ964	8185146				2022-12-28	WOS:A1994NQ96400002
J	POWARS, DR				POWARS, DR			SICKLE-CELL DISEASE IN NONBLACK PERSONS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							HAPLOTYPES; ANEMIA; GENE				POWARS, DR (corresponding author), UNIV SO CALIF,LOS ANGELES CTY MED CTR,LOS ANGELES,CA 90033, USA.							DELIYANNIS GA, 1955, BRIT MED J, V2, P301, DOI 10.1136/bmj.2.4934.301; LEHMANN H, 1974, MANS HEMOGLOBINS; LIVINGSTONE F B, 1989, American Journal of Human Biology, V1, P289, DOI 10.1002/ajhb.1310010309; Livingstone FB, 1967, ABNORMAL HEMOGLOBINS; ONER C, 1992, HUM GENET, V89, P99, DOI 10.1007/BF00207052; OZSOYLU S, 1977, SCAND J HAEMATOL, V19, P85; PAGNIER J, 1984, P NATL ACAD SCI-BIOL, V81, P1771, DOI 10.1073/pnas.81.6.1771; ROGERS ZR, 1989, JAMA-J AM MED ASSOC, V261, P2991, DOI 10.1001/jama.261.20.2991; SCHILERO G, 1991, SCOPE, V15, P1; SCHROEDER WA, 1990, J AFR HIST, V31, P163, DOI 10.1017/S0021853700024981	10	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	1994	271	23					1885	1885		10.1001/jama.271.23.1885	http://dx.doi.org/10.1001/jama.271.23.1885			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NP959	8196149				2022-12-28	WOS:A1994NP95900036
J	BERTOLETTI, A; SETTE, A; CHISARI, FV; PENNA, A; LEVRERO, M; DECARLI, M; FIACCADORI, F; FERRARI, C				BERTOLETTI, A; SETTE, A; CHISARI, FV; PENNA, A; LEVRERO, M; DECARLI, M; FIACCADORI, F; FERRARI, C			NATURAL VARIANTS OF CYTOTOXIC EPITOPES ARE T-CELL RECEPTOR ANTAGONISTS FOR ANTIVIRAL CYTOTOXIC T-CELLS	NATURE			English	Article							ANTIGEN-PRESENTING CELLS; CLASS-I MHC; INFECTED-CELLS; VIRUS; HEPATITIS; COMPLEXES; SELECTION; RESPONSES; SURFACE; ESCAPE	IT has been suggested that mutations within immunodominant cytotoxic T-lymphocyte (CTL) epitopes may be exploited by viruses to evade protective immune responses critical for clearance(1-4). Viral escape could originate from passive mechanisms, such as mutations within crucial CTL epitopes, either affecting major histocompatibility complex binding or T-cell antigen receptor (TCR) recognition. Additionally, it has recently been shown that substitutions of TCR contact sites can yield analogue peptides that can still interact with the T-cell receptor but be unable to deliver a full stimulatory signal, thus inducing anergy(5) or acting as an antagonist for the TCR(6-8). We report here that hepatitis B virus isolates derived from two chronically infected patients display variant epitopes that act as natural TCR antagonists with the capacity to inhibit the CTL response to the wild-type epitope. During natural infection, TCR antagonist mutations of CTL epitopes could contribute to the development of viral persistence, especially if the antiviral CTL response is monospecific or the epitope is strongly immunodominant.	UNIV PARMA, CATTEDRA MALATTIE INFETT, I-43100 PARMA, ITALY; CYTEL CORP, LA JOLLA, CA 92037 USA; SCRIPPS RES INST, DEPT MOLEC & EXPTL MED, LA JOLLA, CA 92037 USA; UNIV ROMA LA SAPIENZA, FDN A CESALPINO, ROME, ITALY; UNIV ROMA LA SAPIENZA, MED CLIN 1, ROME, ITALY; UNIV FLORENCE, CATTEDRA IMMUNOL CLIN & ALLERGOL, I-50134 FLORENCE, ITALY	University of Parma; Scripps Research Institute; Sapienza University Rome; Sapienza University Rome; University of Florence			Ferrari, Carlo/D-5663-2017; Sette, Alessandro/AFO-8916-2022; Chisari, Francis V/A-3086-2008; Bertoletti, Antonio/AAD-4830-2022; Levrero, Massimo/G-5680-2016	Ferrari, Carlo/0000-0002-5461-6842; Bertoletti, Antonio/0000-0002-2942-0485; Chisari, Francis/0000-0002-4832-1044; Levrero, Massimo/0000-0002-4978-0875; Ferrari, Carlo/0000-0002-7843-4963				ANDO K, 1993, J EXP MED, V178, P1541, DOI 10.1084/jem.178.5.1541; BERTOLETTI A, 1991, P NATL ACAD SCI USA, V88, P10445, DOI 10.1073/pnas.88.23.10445; BERTOLETTI A, 1993, J VIROL, V67, P2376, DOI 10.1128/JVI.67.4.2376-2380.1993; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; CHRISTINCK ER, 1991, NATURE, V352, P67, DOI 10.1038/352067a0; DECAMPOSLIMA PO, 1993, SCIENCE, V260, P98, DOI 10.1126/science.7682013; DEMAGISTRIS MT, 1992, CELL, V68, P625, DOI 10.1016/0092-8674(92)90139-4; FALK K, 1991, J EXP MED, V174, P425, DOI 10.1084/jem.174.2.425; GALIBERT F, 1979, NATURE, V281, P646, DOI 10.1038/281646a0; GUILHOT S, 1992, J VIROL, V66, P2670, DOI 10.1128/JVI.66.5.2670-2678.1992; HOUGHTON M, 1991, HEPATOLOGY, V14, P381, DOI 10.1016/0270-9139(91)91430-9; HU WS, 1990, SCIENCE, V250, P1227, DOI 10.1126/science.1700865; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; JAMESON SC, 1993, J EXP MED, V177, P1541, DOI 10.1084/jem.177.6.1541; KORBA BE, 1987, J VIROL, V61, P1318, DOI 10.1128/JVI.61.5.1318-1324.1987; MCMICHAEL A, 1993, SCIENCE, V260, P1771, DOI 10.1126/science.8511585; MISSALE G, 1993, J EXP MED, V177, P751, DOI 10.1084/jem.177.3.751; NAYERSINA R, 1993, J IMMUNOL, V150, P4659; PENNA A, 1991, J EXP MED, V174, P1565, DOI 10.1084/jem.174.6.1565; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; PLEOGH H, 1993, NATURE, V364, P16; RACIOPPI L, 1993, J EXP MED, V177, P1047, DOI 10.1084/jem.177.4.1047; RUPPERT J, 1993, P NATL ACAD SCI USA, V90, P2671, DOI 10.1073/pnas.90.7.2671; RUPPERT J, 1993, CELL, V74, P1; SETTE A, IN PRESS MOL IMMUN; SLOANLANCASTER J, 1993, NATURE, V363, P156, DOI 10.1038/363156a0; SYMER DE, 1992, J EXP MED, V176, P1421, DOI 10.1084/jem.176.5.1421; TUTTLEMAN JS, 1986, CELL, V47, P451, DOI 10.1016/0092-8674(86)90602-1	29	502	515	0	8	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 2	1994	369	6479					407	410		10.1038/369407a0	http://dx.doi.org/10.1038/369407a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NP174	8196768				2022-12-28	WOS:A1994NP17400059
J	GOSTIN, LO				GOSTIN, LO			LAW AND MEDICINE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REFORM		JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,BALTIMORE,MD	Johns Hopkins University	GOSTIN, LO (corresponding author), GEORGETOWN UNIV,CTR LAW,WASHINGTON,DC, USA.							GOLD JA, 1993, JAMA-J AM MED ASSOC, V270, P2964, DOI 10.1001/jama.270.24.2964; GOSTIN LO, 1993, AM J LAW MED, V19, P1; GRAETZ MJ, 1993, NEW ENGL J MED, V329, P1735, DOI 10.1056/NEJM199312023292313; Jacobs M S, 1993, J Law Med Ethics, V21, P163, DOI 10.1111/j.1748-720X.1993.tb01240.x	4	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1679	1680						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NN117	8182848				2022-12-28	WOS:A1994NN11700027
J	WIKLUND, RA; BARASH, PG				WIKLUND, RA; BARASH, PG			ANESTHESIOLOGY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LARYNGEAL MASK AIRWAY; PULSE OXIMETRY; RANDOMIZED EVALUATION; CHILDREN; SEDATION; CARE		YALE NEW HAVEN MED CTR,NEW HAVEN,CT	Yale University	WIKLUND, RA (corresponding author), YALE UNIV,SCH MED,NEW HAVEN,CT, USA.							ALEXANDER R, 1993, ANAESTHESIA, V48, P231, DOI 10.1111/j.1365-2044.1993.tb06909.x; BENUMOF JL, 1992, ANESTHESIOLOGY, V77, P843, DOI 10.1097/00000542-199211000-00001; Chong J L, 1993, J Cardiothorac Vasc Anesth, V7, P137; EICHHORN JH, 1993, ANESTHESIOLOGY, V78, P423; GILGER MA, 1993, GASTROINTEST ENDOSC, V39, P392, DOI 10.1016/S0016-5107(93)70112-1; GOUDSOUZIAN NG, 1993, ANESTHESIOLOGY, V79, P919, DOI 10.1097/00000542-199311000-00008; JOHNSTONE RE, 1993, ANESTH ANALG, V76, P840; MANULI MA, 1993, AM J ROENTGENOL, V160, P577, DOI 10.2214/ajr.160.3.8430557; MOLLER JT, 1993, ANESTHESIOLOGY, V78, P445, DOI 10.1097/00000542-199303000-00007; MOLLER JT, 1993, ANESTHESIOLOGY, V78, P436, DOI 10.1097/00000542-199303000-00006; MORRAY JP, 1993, ANESTHESIOLOGY, V78, P461, DOI 10.1097/00000542-199303000-00009; NELSON MD, 1993, AM J ROENTGENOL, V160, P581, DOI 10.2214/ajr.160.3.8430558; PENNANT JH, 1993, ANESTHESIOLOGY, V79, P144; ROCKEFELLER JD, 1993, ANESTH ANALG, V76, P689, DOI 10.1213/00000539-199304000-00001; ROSENBERG H, 1992, ANESTHESIOLOGY, V77, P1054, DOI 10.1097/00000542-199211000-00040; Shapiro B A, 1993, J Cardiothorac Vasc Anesth, V7, P135, DOI 10.1016/1053-0770(93)90204-X; WARNER MA, 1993, JAMA-J AM MED ASSOC, V270, P1437, DOI 10.1001/jama.270.12.1437; 1993, JAMA-J AM MED ASSOC, V270, P1463; 1993, PEDIATRICS, V92, P471	19	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1655	1656						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182834				2022-12-28	WOS:A1994NN11700013
J	DUNCAN, J; WARD, R; SHAPIRO, K				DUNCAN, J; WARD, R; SHAPIRO, K			DIRECT MEASUREMENT OF ATTENTIONAL DWELL TIME IN HUMAN VISION	NATURE			English	Article							VISUAL-ATTENTION; SEARCH; PARALLEL; CORTEX	IN vision, attentional limitations are reflected in interference or reduced accuracy when two objects must be identified at once in a brief display(1,2). In our experiments a brief temporal separation was introduced between the two objects to be identified. We measured how long the first object continued to interfere with the second, and hence the time course of the first object's attentional demand. According to conventional serial models, attention is assigned rapidly to one object after another, with a dwell time of only a few dozen milliseconds per item(3,4). But we report here that interference lasts for several hundred milliseconds-an order of magnitude more than the prediction of conventional models. We suggest that visual attention is not a high-speed switching mechanism, but a sustained state during which relevant objects become available to influence behaviour. This conclusion is consistent with recent physiological results in the monkey(5).	UNIV CALGARY,DEPT PSYCHOL,CALGARY T2N 1N4,AB,CANADA	University of Calgary	DUNCAN, J (corresponding author), MRC,APPL PSYCHOL UNIT,15 CHAUCER RD,CAMBRIDGE CB2 2EF,ENGLAND.		Shapiro, Kimron/AAC-9685-2019	Shapiro, Kimron/0000-0002-0419-1460; Duncan, John/0000-0002-9695-2764; Duncan, John S/0000-0002-1373-0681				BERGEN JR, 1983, NATURE, V303, P696, DOI 10.1038/303696a0; BROADBENT DE, 1987, PERCEPT PSYCHOPHYS, V42, P105, DOI 10.3758/BF03210498; BUNDESEN C, 1990, PSYCHOL REV, V97, P523, DOI 10.1037/0033-295X.97.4.523; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; DUNCAN J, 1980, PSYCHOL REV, V87, P272, DOI 10.1037/0033-295X.87.3.272; FAGOT C, 1992, J EXP PSYCHOL HUMAN, V18, P1058, DOI 10.1037/0096-1523.18.4.1058; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; PASHLER H, 1987, ATTENTION PERFORM, V12, P63; Posner M.I., 1978, CHRONOMETRIC EXPLORA; POSNER MI, 1984, J NEUROSCI, V4, P1863; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SPERLING G, 1971, SCIENCE, V174, P307, DOI 10.1126/science.174.4006.307; TOWNSEND JT, 1971, PERCEPT PSYCHOPHYS, V10, P161, DOI 10.3758/BF03205778; TREISMAN AM, 1969, PSYCHOL REV, V76, P282, DOI 10.1037/h0027242; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; WEICHSELGARTNER E, 1987, SCIENCE, V238, P778, DOI 10.1126/science.3672124; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P812, DOI 10.1037/0096-1523.16.4.812	18	485	492	2	36	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 26	1994	369	6478					313	315		10.1038/369313a0	http://dx.doi.org/10.1038/369313a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NN109	8183369				2022-12-28	WOS:A1994NN10900047
J	ROCA, J; WANG, JC				ROCA, J; WANG, JC			DNA TRANSPORT BY A TYPE-II DNA TOPOISOMERASE - EVIDENCE IN FAVOR OF A 2-GATE MECHANISM	CELL			English	Article							NALIDIXIC-ACID; GYRASE; CLEAVAGE; PROTEIN; PURIFICATION; HELIX	DNA substrates in which a supercoiled DNA is singly linked to a nicked or relaxed DNA ring were used to analyze the transport of one DNA ring through another by yeast DNA topoisomerase II. The enzyme binds preferentially to the supercoiled DNA and promotes decatenation efficiently upon binding of a nonhydrolyzable ATP analog. Analysis of the reaction products shows that the nicked or relaxed DNA ring released is not associated with the enzyme-supercoiled DNA complex. These results favor a two-gate model in which the DNA ring being transported can exit from the interior of the enzyme through a gate on the opposite side of the entrance gate, which is irreversibly closed upon binding of the nonhydrolizable ATP analog.			ROCA, J (corresponding author), HARVARD UNIV, DEPT BIOCHEM & MOLEC BIOL, 7 DIVIN AVE, CAMBRIDGE, MA 02138 USA.		Roca, Joaquim/AAP-1077-2020	Roca, Joaquim/0000-0003-1462-954X	NIGMS NIH HHS [GM24544] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024544, R37GM024544] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARZILAI R, 1973, J MOL BIOL, V74, P739, DOI 10.1016/0022-2836(73)90062-4; CARON PR, 1994, DNA TOPOISOMERASES T; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; HOROWITZ DS, 1987, J BIOL CHEM, V262, P5339; Hsieh TS, 1990, DNA TOPOLOGY ITS BIO, P243; KIRCHHAUSEN T, 1985, CELL, V41, P933, DOI 10.1016/S0092-8674(85)80074-X; KRASNOW MA, 1983, CELL, V32, P1313, DOI 10.1016/0092-8674(83)90312-4; LEE CH, 1981, P NATL ACAD SCI-BIOL, V78, P2838, DOI 10.1073/pnas.78.5.2838; LINDSLEY JE, 1993, NATURE, V361, P749, DOI 10.1038/361749a0; LINDSLEY JE, 1993, J BIOL CHEM, V268, P8096; LIU LF, 1983, J BIOL CHEM, V258, P5365; MAXWELL A, 1986, ADV PROTEIN CHEM, V38, P69, DOI 10.1016/S0065-3233(08)60526-4; MIZUUCHI K, 1980, P NATL ACAD SCI-BIOL, V77, P1847, DOI 10.1073/pnas.77.4.1847; MORRISON A, 1979, CELL, V17, P175, DOI 10.1016/0092-8674(79)90305-2; MORRISON A, 1980, MECHANISTIC STUDIES, P785; POMMIER Y, 1989, BIOCHEMISTRY-US, V28, P1002; RADLOFF R, 1967, P NATL ACAD SCI USA, V57, P1514, DOI 10.1073/pnas.57.5.1514; REECE RJ, 1991, CRIT REV BIOCHEM MOL, V26, P335, DOI 10.3109/10409239109114072; ROCA J, 1993, J BIOL CHEM, V268, P14250; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; ROWE TC, 1984, J BIOL CHEM, V259, P9177; SANDER M, 1983, J BIOL CHEM, V258, P8421; SUGINO A, 1978, P NATL ACAD SCI USA, V75, P4838, DOI 10.1073/pnas.75.10.4838; SUGINO A, 1977, P NATL ACAD SCI USA, V74, P4767, DOI 10.1073/pnas.74.11.4767; THOMAS CA, 1979, ANAL BIOCHEM, V93, P158, DOI 10.1016/S0003-2697(79)80130-X; TSE YC, 1980, J BIOL CHEM, V255, P5560; VOLOGODSKII AV, 1992, J MOL BIOL, V227, P1224, DOI 10.1016/0022-2836(92)90533-P; WANG JC, 1991, J BIOL CHEM, V266, P6659; WANG JC, 1982, COLD SPRING HARB SYM, V47, P85, DOI 10.1101/SQB.1983.047.01.011; WANG JC, 1985, ANNU REV BIOCHEM, V54, P665, DOI 10.1146/annurev.biochem.54.1.665; WANG JC, 1970, BIOPOLYMERS, V9, P489, DOI 10.1002/bip.1970.360090410; WANG JC, 1980, MECHANISTIC STUDIES, P769; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0; WORLAND ST, 1989, J BIOL CHEM, V264, P4412; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x	36	243	246	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 20	1994	77	4					609	616		10.1016/0092-8674(94)90222-4	http://dx.doi.org/10.1016/0092-8674(94)90222-4			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NM832	8187179				2022-12-28	WOS:A1994NM83200015
J	KOZONO, H; WHITE, J; CLEMENTS, J; MARRACK, P; KAPPLER, J				KOZONO, H; WHITE, J; CLEMENTS, J; MARRACK, P; KAPPLER, J			PRODUCTION OF SOLUBLE MHC CLASS-II PROTEINS WITH COVALENTLY BOUND SINGLE PEPTIDES	NATURE			English	Article							T-CELL HYBRIDOMAS; TRANSGENIC MICE; ANTIGEN; RECOGNITION; THYMOCYTES; COMPLEX; CD8; MOLECULES; SELECTION; TOLERANCE	THE alpha beta T-cell receptors (TCRs) react with complex ligands composed of peptides bound to major histocompatibility complex (MHC) proteins. In the absence of foreign antigens the peptides bound to MHC molecules come from the proteins of the host itself(1-5). Interactions between TCRs and these self-peptide-MHC ligands work positively to drive T-cell development in the thymus(6-9) and negatively to delete or inactivate T cells with potential self-reactivity(10-12). On the cell surface, MHC proteins are associated with many different self peptides, making it impossible to know which self peptide was involved in positive or negative interactions with a particular T cell. These studies as well as in vitro studies on TCR-peptide-MHC interactions would be aided by a means of producing MHC molecules containing a single peptide. We have tackled this problem for MHC class II proteins by genetically attaching the peptide by a flexible peptide linker to the amino terminus of the class II beta-chain. Here we report that a secreted, soluble form of this covalent peptide-MHC complex can be expressed in insect cells. The peptide is engaged by the peptide-binding groove of the secreted MHC molecule and this complex is recognized by T cells bearing receptors specific for that combination.	UNIV COLORADO,HLTH SCI CTR,DEPT IMMUNOL,DENVER,CO 80206; UNIV COLORADO,HLTH SCI CTR,DEPT BIOPHYS,DENVER,CO 80206; UNIV COLORADO,HLTH SCI CTR,DEPT BIOCHEM,DENVER,CO 80206; UNIV COLORADO,HLTH SCI CTR,DEPT GENET,DENVER,CO 80206; UNIV COLORADO,HLTH SCI CTR,DEPT MED,DENVER,CO 80206	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	KOZONO, H (corresponding author), NATL JEWISH CTR IMMUNOL & RESP MED,HOWARD HUGHES MED INST,DEPT MED,DENVER,CO 80206, USA.		Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687; , Haruo/0000-0003-3352-0638				BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; HANSBURG D, 1983, J IMMUNOL, V131, P319; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; LECHLER RI, 1985, J IMMUNOL, V135, P2914; LEE NA, 1992, J EXP MED, V175, P1013, DOI 10.1084/jem.175.4.1013; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; MATHIS DJ, 1983, CELL, V32, P745, DOI 10.1016/0092-8674(83)90060-0; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; NEWCOMB JR, 1993, J IMMUNOL, V150, P499; ROBEY EA, 1992, CELL, V69, P1089, DOI 10.1016/0092-8674(92)90631-L; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; SADEGHNASSERI S, 1991, NATURE, V353, P167, DOI 10.1038/353167a0; SHARMA SD, 1991, P NATL ACAD SCI USA, V88, P11465, DOI 10.1073/pnas.88.24.11465; SHERMAN LA, 1992, SCIENCE, V258, P815, DOI 10.1126/science.1439792; SHIMONKEVITZ R, 1984, J IMMUNOL, V133, P2067; SPRENT J, 1988, IMMUNOL REV, V101, P173, DOI 10.1111/j.1600-065X.1988.tb00737.x; STEM LJ, 1992, CELL, V68, P465; WHITE J, 1983, J IMMUNOL, V130, P1033; WHITE J, 1993, J EXP MED, V177, P119, DOI 10.1084/jem.177.1.119	25	261	297	0	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 12	1994	369	6476					151	154		10.1038/369151a0	http://dx.doi.org/10.1038/369151a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NK971	8177320				2022-12-28	WOS:A1994NK97100050
J	MATUSIEWICZ, SP; FERGUSSON, RJ; GREENING, AP; CROMPTON, GK; BURNS, SM				MATUSIEWICZ, SP; FERGUSSON, RJ; GREENING, AP; CROMPTON, GK; BURNS, SM			PNEUMOCYSTIS-CARINII IN BRONCHOALVEOLAR LAVAGE FLUID AND BRONCHIAL WASHINGS	BRITISH MEDICAL JOURNAL			English	Article							INFECTION		CITY HOSP EDINBURGH,REG VIRUS LAB,EDINBURGH EH10 5SB,MIDLOTHIAN,SCOTLAND		MATUSIEWICZ, SP (corresponding author), WESTERN GEN HOSP,RESP UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.							LEIGH TR, 1991, THORAX, V46, P743; LIPSCHIK GY, 1992, LANCET, V340, P203, DOI 10.1016/0140-6736(92)90469-J; PETERS SE, 1992, J PATHOL, V166, P195, DOI 10.1002/path.1711660217; PIFER LL, 1978, PEDIATRICS, V61, P35	4	15	15	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 7	1994	308	6938					1206	1207		10.1136/bmj.308.6938.1206	http://dx.doi.org/10.1136/bmj.308.6938.1206			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK956	8180538	Green Published			2022-12-28	WOS:A1994NK95600020
J	NOMURA, A; SHIGEMOTO, R; NAKAMURA, Y; OKAMOTO, N; MIZUNO, N; NAKANISHI, S				NOMURA, A; SHIGEMOTO, R; NAKAMURA, Y; OKAMOTO, N; MIZUNO, N; NAKANISHI, S			DEVELOPMENTALLY-REGULATED POSTSYNAPTIC LOCALIZATION OF A METABOTROPIC GLUTAMATE-RECEPTOR IN RAT ROD BIPOLAR CELLS	CELL			English	Article							PROTEIN-KINASE-C; CULTURED MUSCLE-CELLS; ALPHA-SUBUNIT GENE; MAMMALIAN RETINA; EXPRESSION; CONDUCTANCE; IMMUNOREACTIVITY; TRANSMITTER; DIVERSITY; MOUSE	The retinal bipolar cell receiving glutamate transmission from photoreceptors mediates a key process in segregating visual signals into ON center and OFF center pathways. This transmission involves a G protein-coupled metabotropic glutamate receptor (mGluR). Immunocytochemical and immunoelectron microscopic studies indicate the restricted localization of a specific mGluR subtype, mGluR6, at the postsynaptic site of the rat rod bipolar cell. This specialization is developmentally regulated: mGluR6 is initially distributed in both the soma and dendrites and is finally concentrated on the postsynaptic site. The mGluR6 localization is reversed when photoreceptors degenerate in the mutant rat with retinal dystrophy. Evidence is thus presented indicating specialized, developmentally regulated receptor distribution in the central nervous system and the crucial role of mGluR6 in photoreceptor-bipolar cell synaptic transmission.	KYOTO UNIV,FAC MED,DEPT OPHTHALMOL,KYOTO 606,JAPAN; TOKYO MED & DENT UNIV,SCH MED,DEPT ANAT,TOKYO 113,JAPAN	Kyoto University; Tokyo Medical & Dental University (TMDU)	NOMURA, A (corresponding author), KYOTO UNIV,FAC MED,DEPT MORPHOL BRAIN SCI,KYOTO 606,JAPAN.		Shigemoto, Ryuichi/E-3628-2013	Shigemoto, Ryuichi/0000-0001-8761-9444				ASHMORE JF, 1980, J PHYSIOL-LONDON, V300, P115, DOI 10.1113/jphysiol.1980.sp013155; BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; BOYCOTT BB, 1973, J COMP NEUROL, V148, P91, DOI 10.1002/cne.901480106; CHEN TY, 1993, NATURE, V362, P764, DOI 10.1038/362764a0; DEVRIES SH, 1993, CELL, V72, P139, DOI 10.1016/S0092-8674(05)80033-9; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; GOLDMAN D, 1989, NEURON, V3, P219, DOI 10.1016/0896-6273(89)90035-4; GREFERATH U, 1990, J COMP NEUROL, V301, P433, DOI 10.1002/cne.903010308; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; Harlow E, 1988, ANTIBODIES LABORATOR, P471; HAYASHI Y, 1993, NATURE, V366, P687, DOI 10.1038/366687a0; KAITZ M, 1979, VISION RES, V19, P79, DOI 10.1016/0042-6989(79)90124-X; KANEKO A, 1989, J PHYSIOL-LONDON, V410, P613, DOI 10.1113/jphysiol.1989.sp017551; KARSCHIN A, 1990, J NEUROPHYSIOL, V63, P860, DOI 10.1152/jn.1990.63.4.860; KLARSFELD A, 1989, NEURON, V2, P1229, DOI 10.1016/0896-6273(89)90307-3; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; MILLER RF, 1986, TRENDS NEUROSCI, V9, P211, DOI 10.1016/0166-2236(86)90061-5; NAKAJIMA Y, 1993, J BIOL CHEM, V268, P11868; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NAWY S, 1991, NEURON, V7, P677, DOI 10.1016/0896-6273(91)90380-I; NAWY S, 1990, NATURE, V346, P269, DOI 10.1038/346269a0; NEGISHI K, 1988, NEUROSCI LETT, V94, P247, DOI 10.1016/0304-3940(88)90025-0; NEW HV, 1986, NATURE, V323, P809, DOI 10.1038/323809a0; OKAMOTO N, 1994, J BIOL CHEM, V269, P1231; PENG HB, 1991, NEURON, V6, P237; PIETTE J, 1990, NATURE, V345, P353, DOI 10.1038/345353a0; PRODY CA, 1992, NUCLEIC ACIDS RES, V20, P2367, DOI 10.1093/nar/20.9.2367; ROSS EM, 1989, NEURON, V3, P141, DOI 10.1016/0896-6273(89)90027-5; SHIELLS RA, 1990, P ROY SOC B-BIOL SCI, V242, P91, DOI 10.1098/rspb.1990.0109; SHIGEMOTO R, 1993, NEUROSCI LETT, V163, P53, DOI 10.1016/0304-3940(93)90227-C; SZEL A, 1992, EXP EYE RES, V55, P47; TESSIERLAVIGNE M, 1991, PRINCIPLES NEURAL SC, P400; VARDI N, 1993, VISUAL NEUROSCI, V10, P473, DOI 10.1017/S0952523800004697; WASSLE H, 1991, VISUAL NEUROSCI, V7, P99, DOI 10.1017/S095252380001097X; WEIDMAN TA, 1968, ARCH OPHTHALMOL-CHIC, V79, P470, DOI 10.1001/archopht.1968.03850040472015	35	363	368	1	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 6	1994	77	3					361	369		10.1016/0092-8674(94)90151-1	http://dx.doi.org/10.1016/0092-8674(94)90151-1			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NK970	8181056				2022-12-28	WOS:A1994NK97000007
J	KOSHLAND, DE				KOSHLAND, DE			THE 2-COMPONENT PATHWAY COMES TO EUKARYOTES	SCIENCE			English	Editorial Material							RESPONSE REGULATOR; BACTERIAL CHEMOTAXIS; PHOSPHORYLATION; IDENTIFICATION; SYSTEM; MODEL				KOSHLAND, DE (corresponding author), UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720, USA.							CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; HESS JF, 1988, CELL, V53, P79, DOI 10.1016/0092-8674(88)90489-8; HESS JF, 1988, NATURE, V336, P139, DOI 10.1038/336139a0; KOSHLAND DE, 1977, SCIENCE, V196, P1055, DOI 10.1126/science.870969; KREBS EG, 1956, BIOCHIM BIOPHYS ACTA, V20, P150, DOI 10.1016/0006-3002(56)90273-6; MORIMOTO BH, 1991, P NATL ACAD SCI USA, V88, P10835, DOI 10.1073/pnas.88.23.10835; NINFA AJ, 1986, P NATL ACAD SCI USA, V83, P5909, DOI 10.1073/pnas.83.16.5909; NINFA AJ, 1986, P NATL ACAD SCI USA, V83, P5905; OTA IM, 1993, SCIENCE, V262, P566, DOI 10.1126/science.8211183; PARKINSON JS, 1993, CELL, V73, P857, DOI 10.1016/0092-8674(93)90267-T; SANDERS DA, 1989, J BIOL CHEM, V264, P21770; STOCK JB, 1990, NATURE, V344, P395, DOI 10.1038/344395a0	12	22	23	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 22	1993	262	5133					532	532		10.1126/science.8211179	http://dx.doi.org/10.1126/science.8211179			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC935	8211179				2022-12-28	WOS:A1993MC93500029
J	CHIRUVOLU, S; WALKER, S; ISRAELACHVILI, J; SCHMITT, FJ; LECKBAND, D; ZASADZINSKI, JA				CHIRUVOLU, S; WALKER, S; ISRAELACHVILI, J; SCHMITT, FJ; LECKBAND, D; ZASADZINSKI, JA			HIGHER-ORDER SELF-ASSEMBLY OF VESICLES BY SITE-SPECIFIC BINDING	SCIENCE			English	Article							ELECTRON-MICROSCOPY; MEMBRANE-FUSION; RECOGNITION; LIPOSOMES; ADHESION; BILAYERS; FORCES; SYSTEM	The association of lipid molecules into spherical vesicles in solution as a result of nonspecific intermolecular forces constitutes a primary self-assembly process. Such vesicles can undergo a secondary self-assembly into higher order structures in a controlled and reversible manner by means of site-specific ligand-receptor (biotin-streptavidin) coupling. Cryoelectron microscopy shows these structures to be composed of tethered, rather than adhering, vesicles in their original, unstressed state. In contrast, vesicles aggregated by nonspecific, such as van der Waals, forces are deformed and stressed, producing unstable structures. Vesicle association by site-specific binding provides a practical mechanism for the production of stable, yet controllable, microstructured biomaterials.	UNIV CALIF SANTA BARBARA,DEPT CHEM ENGN,SANTA BARBARA,CA 93106	University of California System; University of California Santa Barbara					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047334] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM47334] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1992, INTERMOLECULAR SURFA; BAILEY SM, 1990, LANGMUIR, V6, P1326, DOI 10.1021/la00097a024; BELLARE JR, 1988, J ELECTRON MICR TECH, V10, P87, DOI 10.1002/jemt.1060100111; BLANKENBURG R, 1989, BIOCHEMISTRY-US, V28, P8214, DOI 10.1021/bi00446a037; Cevc G., 1985, PHOSPHOLIPID BILAYER; CHERNOMORDIK LV, 1987, BIOCHIM BIOPHYS ACTA, V906, P309, DOI 10.1016/0304-4157(87)90016-5; EVANS E, 1987, J PHYS CHEM-US, V91, P4219, DOI 10.1021/j100300a003; Fendler J. H., 1982, MEMBRANE MIMETIC CHE; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; GRATZL M, 1976, FEBS LETT, V62, P142, DOI 10.1016/0014-5793(76)80038-5; Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8; HASHIMOTO K, 1986, BIOCHIM BIOPHYS ACTA, V856, P556, DOI 10.1016/0005-2736(86)90147-1; HELM CA, 1992, BIOCHEMISTRY-US, V31, P1794, DOI 10.1021/bi00121a030; HUI SW, 1988, BIOCHIM BIOPHYS ACTA, V941, P130, DOI 10.1016/0005-2736(88)90173-3; ISRAELACHVILI JN, 1986, SURFACTANTS SOLUTION, V4, P3; LASIC DD, 1993, LIPOSOMES PHYSICS AP; LEE KD, 1993, BIOPHYS J, V64, P905, DOI 10.1016/S0006-3495(93)81453-X; LOUGHREY HC, 1990, BIOCHIM BIOPHYS ACTA, V1028, P73, DOI 10.1016/0005-2736(90)90267-R; MARRA J, 1986, BIOPHYS J, V50, P815, DOI 10.1016/S0006-3495(86)83522-6; MAYER LD, 1986, BIOCHIM BIOPHYS ACTA, V858, P161, DOI 10.1016/0005-2736(86)90302-0; MULLER W, 1993, SCIENCE, V262, P1706, DOI 10.1126/science.8259513; PAPAHADJOPOULOS D, 1990, J BIOENERG BIOMEMBR, V22, P157, DOI 10.1007/BF00762944; POWERS DD, 1992, BIOTECHNOL PROGR, V8, P436, DOI 10.1021/bp00017a011; SERVUSS RM, 1987, PHYSICS COMPLEX SUPE, P85; SOWERS AE, 1987, CELL FUSION; WENNERSTROM H, 1979, PHYS REP, V52, P1, DOI 10.1016/0370-1573(79)90087-5; WHITE JM, 1992, SCIENCE, V258, P917, DOI 10.1126/science.1439803; Wilchek M, 1990, AVIDIN BIOTIN TECHNO; WIMLEY WC, 1990, BIOCHEMISTRY-US, V29, P1296, DOI 10.1021/bi00457a027	29	175	179	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 17	1994	264	5166					1753	1756		10.1126/science.8209255	http://dx.doi.org/10.1126/science.8209255			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR600	8209255				2022-12-28	WOS:A1994NR60000040
J	WALDEN, CC; HEGELE, RA				WALDEN, CC; HEGELE, RA			APOLIPOPROTEIN-E IN HYPERLIPIDEMIA	ANNALS OF INTERNAL MEDICINE			English	Review							POLYMERASE CHAIN-REACTION; RECEPTOR-BINDING ACTIVITY; BASE-PAIR SUBSTITUTIONS; AMINO-ACID-SEQUENCE; HUMAN-E APOPROTEIN; E MESSENGER-RNA; III HYPERLIPOPROTEINEMIA; E POLYMORPHISM; E GENE; ENZYMATIC AMPLIFICATION	Purpose: To review DNA analysis of apolipoprotein E used to assess patients with hyperlipidemia. Data Sources and Study Selection: 44 basic science studies of molecular analysis; 42 basic science studies of the biochemical, cellular biological, and molecular biological features of apolipoprotein E; and 29 clinical investigational studies, meta-analyses, and case series of patients with mutations in apolipoprotein E. Data Extraction: Methods of DNA analysis were reviewed, using specific examples in human disease, and the role of apolipoprotein E in normal and disordered lipoprotein metabolism was reviewed. Genetic analysis of apolipoprotein E in populations and particularly in persons with type III hyperlipoproteinemia is reviewed. Data Synthesis: In the general population, common DNA variants of apolipoprotein E are consistently associated with modest differences in plasma lipids and lipoproteins. Homozygosity for the E2 isoform of apolipoprotein E predisposes some patients to the development of type III hyperlipoproteinemia, a condition that involves an additional genetic or environmental factor for full clinical expression. Rare mutations of apolipoprotein E also cause hyperlipidemia. Conclusions: DNA variation of apolipoprotein E is one of several genetic and environmental factors that interact in a complex manner to affect plasma lipoproteins. DNA analysis of apolipoprotein E can be used in persons with hyperlipidemia to identify those with type III hyperlipoproteinemia and in relatives of affected persons to identify those who are predisposed.	ST MICHAELS HOSP, DNA RES LAB, TORONTO M5B 1W8, ON, CANADA; UNIV TORONTO, TORONTO, ON, CANADA	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto			Hegele, Robert/AAF-6482-2020; Hegele, Robert/G-3301-2011	Hegele, Robert/0000-0003-2861-5325; 				BAKKER E, 1985, LANCET, V1, P655; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BLUE ML, 1983, P NATL ACAD SCI-BIOL, V80, P283, DOI 10.1073/pnas.80.1.283; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BRESLOW JL, 1989, J CLIN INVEST, V84, P373, DOI 10.1172/JCI114176; BREWERHB, 1991, ATHEROSCLER REV, V23, P51; BROCKERVRIENDS AHJT, 1992, ANN HEMATOL, V64, P2, DOI 10.1007/BF01811464; CURTISS LK, 1985, DIABETES, V34, P452, DOI 10.2337/diabetes.34.5.452; DALLONGEVILLE J, 1992, J LIPID RES, V33, P447; DAS HK, 1985, J BIOL CHEM, V260, P6240; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DEKNIJFF P, 1991, ATHEROSCLEROSIS, V90, P169, DOI 10.1016/0021-9150(91)90111-F; DEKNIJFF P, 1991, J CLIN INVEST, V88, P643, DOI 10.1172/JCI115349; DURRINGTON PN, 1989, HYPERLIPIDAEMIA DIAG, P157; EISENSTEIN BI, 1990, NEW ENGL J MED, V322, P178; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P203, DOI 10.1073/pnas.82.1.203; EMI M, 1988, GENOMICS, V3, P373, DOI 10.1016/0888-7543(88)90130-9; ENGELKE DR, 1988, P NATL ACAD SCI USA, V85, P544, DOI 10.1073/pnas.85.2.544; ERLICH HA, 1992, ANNU REV GENET, V26, P479, DOI 10.1146/annurev.ge.26.120192.002403; FARESE RV, 1992, J INTERN MED, V231, P643, DOI 10.1111/j.1365-2796.1992.tb01253.x; FISCHER SG, 1983, P NATL ACAD SCI-BIOL, V80, P1579, DOI 10.1073/pnas.80.6.1579; FOJO SS, 1992, J INTERN MED, V231, P669, DOI 10.1111/j.1365-2796.1992.tb01256.x; FREDRICKSON DS, 1967, NEW ENGL J MED, V276, P215, DOI 10.1056/NEJM196701262760406; FUNKE H, 1986, CLIN CHEM, V32, P1285; GHISELLI G, 1981, SCIENCE, V214, P1239, DOI 10.1126/science.6795720; GITSCHIER J, 1985, NATURE, V314, P738, DOI 10.1038/314738a0; GREGG RE, 1986, J CLIN INVEST, V78, P815, DOI 10.1172/JCI112645; GREGG RE, 1988, CLIN CHEM, V34, pB28; Haber C, 1984, Pediatr Dermatol, V1, P261, DOI 10.1111/j.1525-1470.1984.tb01128.x; HAVEL RJ, 1989, METABOLIC BASIS INHE, P1129; HEGELE RA, 1987, GENET EPIDEMIOL, V4, P163, DOI 10.1002/gepi.1370040302; HEGELE RA, 1991, DIS MARKERS, V9, P73; HEGELE RA, 1986, NEW ENGL J MED, V315, P1509, DOI 10.1056/NEJM198612113152403; HIGUCHI R, 1988, NATURE, V332, P543, DOI 10.1038/332543a0; HIXSON JE, 1990, J LIPID RES, V31, P545; HORIE Y, 1992, J BIOL CHEM, V267, P1962; HUNKAPILLER T, 1991, SCIENCE, V254, P59, DOI 10.1126/science.1925562; HUSSAIN MM, 1991, J BIOL CHEM, V266, P13936; IMPRAIM CC, 1987, BIOCHEM BIOPH RES CO, V142, P710, DOI 10.1016/0006-291X(87)91472-0; INNIS MA, 1988, P NATL ACAD SCI USA, V85, P9436, DOI 10.1073/pnas.85.24.9436; JENKINS DJA, 1993, METABOLISM, V42, P585, DOI 10.1016/0026-0495(93)90217-C; KAMBOH MI, 1990, ELECTROPHORESIS, V11, P314, DOI 10.1002/elps.1150110408; KRAWCZAK M, 1989, NUCLEIC ACIDS RES, V17, P2197, DOI 10.1093/nar/17.6.2197; LAHIRI DK, 1991, NUCLEIC ACIDS RES, V19, P5444, DOI 10.1093/nar/19.19.5444; LALAZAR A, 1988, J BIOL CHEM, V263, P3542; LALAZAR A, 1989, J BIOL CHEM, V264, P8447; LEE MS, 1987, SCIENCE, V237, P175, DOI 10.1126/science.3110950; LEITERSDORF E, 1988, NUCLEIC ACIDS RES, V16, P7215, DOI 10.1093/nar/16.14.7215; LI HH, 1988, NATURE, V335, P414, DOI 10.1038/335414a0; LI WH, 1988, J LIPID RES, V29, P245; LINTON MF, 1991, J CLIN INVEST, V88, P270, DOI 10.1172/JCI115288; LOH EY, 1989, SCIENCE, V243, P217, DOI 10.1126/science.2463672; LOHSE P, 1991, J BIOL CHEM, V266, P10479; LOHSE P, 1992, J BIOL CHEM, V267, P13642; LYONS J, 1992, CANCER, V69, P1527, DOI 10.1002/1097-0142(19920315)69:6+<1527::AID-CNCR2820691304>3.0.CO;2-N; Mahley Jr RWRS, 1989, METABOLIC BASIS INHE, P1195; MAHLEY RW, 1991, JAMA-J AM MED ASSOC, V265, P78, DOI 10.1001/jama.265.1.78; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MANN WA, 1989, BIOCHIM BIOPHYS ACTA, V1005, P239, DOI 10.1016/0005-2760(89)90043-X; MANTTARI M, 1991, METABOLISM, V40, P217, DOI 10.1016/0026-0495(91)90179-Z; MCLEAN JW, 1983, J BIOL CHEM, V258, P8993; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; MORGAN GJ, 1989, LANCET, V1, P928; MORIYAMA K, 1992, BIOCHIM BIOPHYS ACTA, V1128, P58, DOI 10.1016/0005-2760(92)90257-V; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NATHANS D, 1975, ANNU REV BIOCHEM, V44, P273, DOI 10.1146/annurev.bi.44.070175.001421; NESTRUCK AC, 1987, METABOLISM, V36, P743, DOI 10.1016/0026-0495(87)90110-7; OCHMAN H, 1988, GENETICS, V120, P621; OJALA JP, 1991, J INTERN MED, V230, P397, DOI 10.1111/j.1365-2796.1991.tb00464.x; OMALLEY JP, 1990, METABOLISM, V39, P150, DOI 10.1016/0026-0495(90)90068-N; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; PAABO S, 1989, P NATL ACAD SCI USA, V86, P1939, DOI 10.1073/pnas.86.6.1939; PAABO S, 1988, NUCLEIC ACIDS RES, V16, P9775, DOI 10.1093/nar/16.20.9775; PAIK YK, 1985, P NATL ACAD SCI USA, V82, P3445, DOI 10.1073/pnas.82.10.3445; RALL SC, 1989, J CLIN INVEST, V83, P1095, DOI 10.1172/JCI113988; RALL SC, 1982, P NATL ACAD SCI-BIOL, V79, P4696, DOI 10.1073/pnas.79.15.4696; RALL SC, 1983, J CLIN INVEST, V72, P1288, DOI 10.1172/JCI111085; RALL SC, 1983, J CLIN INVEST, V71, P1023, DOI 10.1172/JCI110829; RALL SC, 1982, J BIOL CHEM, V257, P4171; RALL SC, 1992, J INTERN MED, V231, P653, DOI 10.1111/j.1365-2796.1992.tb01254.x; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHAEFER EJ, 1986, J CLIN INVEST, V78, P1206, DOI 10.1172/JCI112704; SHIMANO H, 1992, P NATL ACAD SCI USA, V89, P1750, DOI 10.1073/pnas.89.5.1750; SIDRANSKY D, 1991, SCIENCE, V252, P706, DOI 10.1126/science.2024123; SIMONBOUY B, 1991, CLIN GENET, V40, P218; SMIT M, 1988, HUM GENET, V78, P90, DOI 10.1007/BF00291243; SMIT M, 1990, J LIPID RES, V31, P45; SMITH HO, 1970, J MOL BIOL, V51, P379, DOI 10.1016/0022-2836(70)90149-X; SMITH JD, 1988, J BIOL CHEM, V263, P8300; SOUTAR AK, 1992, J INTERN MED, V231, P633, DOI 10.1111/j.1365-2796.1992.tb01252.x; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; TIKKANEN MJ, 1990, ARTERIOSCLEROSIS, V10, P285, DOI 10.1161/01.ATV.10.2.285; TRIGLIA T, 1988, NUCLEIC ACIDS RES, V16, P8186, DOI 10.1093/nar/16.16.8186; UTERMANN G, 1982, HUM GENET, V60, P344, DOI 10.1007/BF00569216; UTERMANN G, 1977, NATURE, V269, P604, DOI 10.1038/269604a0; VANDENMAAGDENBERG AMJM, 1993, AM J HUM GENET, V52, P937; WARDELL MR, 1987, J CLIN INVEST, V80, P483, DOI 10.1172/JCI113096; WARDELL MR, 1989, J BIOL CHEM, V264, P21205; WARTELL RM, 1990, NUCLEIC ACIDS RES, V18, P2699, DOI 10.1093/nar/18.9.2699; WEINTRAUB MS, 1987, J CLIN INVEST, V80, P1571, DOI 10.1172/JCI113243; WEISGRABER KH, 1982, J BIOL CHEM, V257, P2518; WEISGRABER KH, 1981, J BIOL CHEM, V256, P9077; WHITE R, 1988, SCI AM, V258, P40, DOI 10.1038/scientificamerican0288-40; WHITE R, 1985, NATURE, V313, P101, DOI 10.1038/313101a0; WHITE TJ, 1989, TRENDS GENET, V5, P185, DOI 10.1016/0168-9525(89)90073-5; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; YOUNG LS, 1989, BRIT MED J, V298, P14, DOI 10.1136/bmj.298.6665.14; ZANNIS VI, 1982, J LIPID RES, V23, P911; ZANNIS VI, 1981, AM J HUM GENET, V33, P11; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; 1990, NEW ENGL J MED, V323, P70	115	87	96	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	1994	120	12					1026	1036		10.7326/0003-4819-120-12-199406150-00009	http://dx.doi.org/10.7326/0003-4819-120-12-199406150-00009			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NQ964	8185134				2022-12-28	WOS:A1994NQ96400009
J	LAPTHORN, AJ; HARRIS, DC; LITTLEJOHN, A; LUSTBADER, JW; CANFIELD, RE; MACHIN, KJ; MORGAN, FJ; ISAACS, NW				LAPTHORN, AJ; HARRIS, DC; LITTLEJOHN, A; LUSTBADER, JW; CANFIELD, RE; MACHIN, KJ; MORGAN, FJ; ISAACS, NW			CRYSTAL-STRUCTURE OF HUMAN CHORIONIC-GONADOTROPIN	NATURE			English	Article							HUMAN CHORIOGONADOTROPIN-BETA; SITE-DIRECTED MUTAGENESIS; HUMAN LUTEINIZING-HORMONE; RECEPTOR-BINDING; GLYCOPROTEIN HORMONES; DISULFIDE BONDS; TERMINAL REGION; ALPHA-SUBUNIT; IMMUNOLOGICAL PROPERTIES; BIOLOGICAL PROPERTIES	The three-dimensional structure of human chorionic gonadotropin shows that each of its two different subunits has a similar topology, with three disulphide bonds forming a cystine knot. This same folding motif Is found in some protein growth factors. The heterodimer is stabilized by a segment of the beta-subunit which wraps around the alpha-subunit and is covalently linked like a seat belt by the disulphide Cys 26-Cys 110. This extraordinary feature appears to be essential not only for the association of these heterodimers but also for receptor binding by the glycoprotein hormones.	UNIV GLASGOW,DEPT CHEM,GLASGOW G12 8QQ,SCOTLAND; COLUMBIA UNIV,DEPT MED,NEW YORK,NY 10032; ST VINCENTS INST MED RES,MELBOURNE,VIC 3065,AUSTRALIA; LATROBE UNIV,DEPT BIOCHEM,MELBOURNE,VIC 3083,AUSTRALIA	University of Glasgow; Columbia University; St. Vincent's Institute of Medical Research; La Trobe University				Littlejohn, Allison/0000-0003-1784-3365; Lapthorn, Adrian/0000-0002-2197-8134				BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BIRKEN S, 1988, ENDOCRINOLOGY, V123, P572, DOI 10.1210/endo-123-1-572; Blithe D.L., 1994, GLYCOPROTEIN HORMONE, P156; BRICOGNE G, 1990, ACTA CRYSTALLOGR A, V46, P284, DOI 10.1107/S0108767389012882; BRUNGER AT, 1992, XPLOR MANUAL; CHEN F, 1992, MOL ENDOCRINOL, V6, P914, DOI 10.1210/me.6.6.914; CHEN F, 1991, BIOCHEMISTRY-US, V30, P10171, DOI 10.1021/bi00106a014; CHEN F, 1991, J BIOL CHEM, V266, P6904; CHEN HC, 1982, J BIOL CHEM, V257, P4446; HARRIS DC, 1989, J BIOL CHEM, V264, P6705; HOLMGREN A, 1976, EUR J BIOCHEM, V70, P377, DOI 10.1111/j.1432-1033.1976.tb11027.x; HUANG JN, 1993, MOL CELL ENDOCRINOL, V90, P211, DOI 10.1016/0303-7207(93)90154-C; HUTH JR, 1992, J BIOL CHEM, V267, P8870; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; JONES TA, 1985, METHOD ENZYMOL, V115, P157; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; KEUTMANN HT, 1988, BIOCHEMISTRY-US, V27, P8939, DOI 10.1021/bi00425a010; KEUTMANN HT, 1992, MOL CELL ENDOCRINOL, V86, pC1, DOI 10.1016/0303-7207(92)90168-6; KEUTMANN HT, 1983, BIOCHEMISTRY-US, V22, P3067, DOI 10.1021/bi00282a007; KEUTMANN HT, 1987, P NATL ACAD SCI USA, V84, P2038, DOI 10.1073/pnas.84.7.2038; KEUTMANN HT, 1989, MOL ENDOCRINOL, V3, P526, DOI 10.1210/mend-3-3-526; LUSTBADER JW, 1989, BIOCHEMISTRY-US, V28, P9239, DOI 10.1021/bi00450a001; MANJUNATH P, 1982, J BIOL CHEM, V257, P7109; MATZUK MM, 1989, J BIOL CHEM, V264, P2409; MCDONALD NQ, 1991, NATURE, V354, P411, DOI 10.1038/354411a0; MCFARLAND KC, 1989, SCIENCE, V245, P494, DOI 10.1126/science.2502842; MERZ WE, 1979, EUR J BIOCHEM, V101, P541, DOI 10.1111/j.1432-1033.1979.tb19749.x; MISE T, 1981, J BIOL CHEM, V256, P6587; MISE T, 1980, J BIOL CHEM, V255, P8516; MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407; MURRAYRUST J, 1993, STRUCTURE, V1, P153, DOI 10.1016/0969-2126(93)90029-G; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OEFNER C, 1992, EMBO J, V11, P3921, DOI 10.1002/j.1460-2075.1992.tb05485.x; PARSONS TF, 1979, J BIOL CHEM, V254, P6010; PUETT D, 1994, GLYCOPROTEIN HORMONE, P122; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; REBOIS RV, 1987, J BIOL CHEM, V262, P3891; RYAN RJ, 1987, RECENT PROG HORM RES, V43, P383; Sairam M.R., 1983, Hormonal Proteins and Peptides, V11, P1; SAIRAM MR, 1989, FASEB J, V3, P1915, DOI 10.1096/fasebj.3.8.2542111; SAIRAM MR, 1992, MOL CELL ENDOCRINOL, V85, P227, DOI 10.1016/0303-7207(92)90261-4; SAIRAM MR, 1985, SCIENCE, V229, P65, DOI 10.1126/science.2990039; SCHLUNEGGER MP, 1993, J MOL BIOL, V231, P445, DOI 10.1006/jmbi.1993.1293; SHELDRICK GM, 1990, ACTA CRYSTALLOGR A, V46, P467, DOI 10.1107/S0108767390000277; SUGANUMA N, 1989, J BIOL CHEM, V264, P19302; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Ward D.N., 1979, ANIMAL MODELS RES FE, P151; WEISS J, 1992, NEW ENGL J MED, V326, P179, DOI 10.1056/NEJM199201163260306; XIA HY, 1994, ENDOCRINOLOGY, V134, P1768, DOI 10.1210/en.134.4.1768; 1992, SERC CCP4 DAR LAB CO	51	787	833	2	33	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 9	1994	369	6480					455	461		10.1038/369455a0	http://dx.doi.org/10.1038/369455a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ286	8202136				2022-12-28	WOS:A1994NQ28600047
J	MILES, SH				MILES, SH			PHYSICIANS AND THEIR PATIENTS SUICIDES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LIFE-SUSTAINING TREATMENT; ASSISTED SUICIDE; ETHICAL DILEMMAS; HOPELESSLY ILL; EUTHANASIA; COUNTERTRANSFERENCE; QUALITY; DEATH; CARE; PREFERENCES		UNIV MINNESOTA,SCH MED,MINNEAPOLIS,MN; CTR BIOMED ETH,MINNEAPOLIS,MN	University of Minnesota System; University of Minnesota Twin Cities	MILES, SH (corresponding author), HENNEPIN CTY MED CTR,DEPT MED,MINNEAPOLIS,MN, USA.							ANGELL M, 1989, NEW ENGL J MED, V321, P120; BACH JR, 1992, ARCH PHYS MED REHAB, V73, P179; BENOLIEL JQ, 1987, OMEGA-J DEATH DYING, V18, P341, DOI 10.2190/4Y6G-XQAP-0XYN-LRW9; BONICA JJ, 1991, MT SINAI J MED, V58, P191; BRODY H, 1992, NEW ENGL J MED, V327, P1384, DOI 10.1056/NEJM199211053271912; BUTLER RN, 1975, AM J PSYCHIAT, V132, P893; CAIN J, 1990, OBSTET GYNECOL, V76, P149; CAINE ED, 1993, JAMA-J AM MED ASSOC, V270, P875, DOI 10.1001/jama.270.7.875; CAMPBELL CS, 1992, J MED ETHICS, V18, P128, DOI 10.1136/jme.18.3.128; CASSEL CK, 1990, NEW ENGL J MED, V323, P750, DOI 10.1056/NEJM199009133231110; CHEMTOB CM, 1988, AM J PSYCHIAT, V145, P224; CLARKE PJ, 1981, AM J ORTHOPSYCHIAT, V51, P71, DOI 10.1111/j.1939-0025.1981.tb01349.x; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; CONWELL Y, 1991, NEW ENGL J MED, V325, P1101; CRUZ MTC, 1993, AM J LAW MED, V18, P369; DIEKSTRA RFW, 1993, ANN MED, V25, P5, DOI 10.3109/07853899309147850; GOLDSTEIN LS, 1984, AM J PSYCHOTHER, V38, P392, DOI 10.1176/appi.psychotherapy.1984.38.3.392; Gomez Carlos F., 1991, REGULATING DEATH EUT; GOODWIN JS, 1990, JAMA-J AM MED ASSOC, V264, P326; GREENE MG, 1989, GERONTOLOGIST, V29, P808, DOI 10.1093/geront/29.6.808; HELME T, 1993, BRIT J PSYCHIAT, V163, P456, DOI 10.1192/bjp.163.4.456; HENDIN H, 1981, AM J PSYCHOTHER, V35, P469, DOI 10.1176/appi.psychotherapy.1981.35.4.469; JORSTAD J, 1987, ACTA PSYCHIAT SCAN S, V336, P76; KASS LR, 1980, JAMA-J AM MED ASSOC, V244, P1811, DOI 10.1001/jama.244.16.1811; KASS LR, 1991, PUBLIC INTEREST  WIN, P25; Lifton Robert Jay, 1986, NAZI DOCTORS, P417; MALTSBERGER JT, 1974, ARCH GEN PSYCHIAT, V30, P625; MAX MB, 1990, ANN INTERN MED, V113, P885, DOI 10.7326/0003-4819-113-11-885; MODESTIN J, 1987, BRIT J MED PSYCHOL, V60, P379, DOI 10.1111/j.2044-8341.1987.tb02757.x; ORENTLICHER D, 1990, JAMA-J AM MED ASSOC, V263, P1198, DOI 10.1001/jama.1990.03440090027010; PELLEGRINO ED, 1993, JAMA-J AM MED ASSOC, V270, P874, DOI 10.1001/jama.270.7.874; PICK IB, 1985, INT J PSYCHOANAL, V66, P157; QUILL TE, 1991, ARCH INTERN MED, V151, P463; QUILL TE, 1993, JAMA-J AM MED ASSOC, V270, P870, DOI 10.1001/jama.270.7.870; QUILL TE, 1991, NEW ENGL J MED, V324, P691, DOI 10.1056/NEJM199103073241010; QUILL TE, 1992, NEW ENGL J MED, V327, P1380, DOI 10.1056/NEJM199211053271911; ROENN HS, 1993, ANN INTERN MED, V119, P121; ROSNER F, 1992, NEW YORK STATE J MED, V92, P388; ROTOV M, 1970, AM J PSYCHOTHER, V24, P216; SCHEIDERMAYER DL, 1989, NEW ENGL J MED, V321, P120; SCHNEIDERMAN LJ, 1993, J CLIN ETHIC, V4, P28; SINGER PA, 1990, NEW ENGL J MED, V322, P1881, DOI 10.1056/NEJM199006283222610; STARR TJ, 1986, J GEN INTERN MED, V1, P373, DOI 10.1007/BF02596420; TENO J, 1991, J AM GERIATR SOC, V39, P827, DOI 10.1111/j.1532-5415.1991.tb02707.x; UHLMANN RF, 1991, ARCH INTERN MED, V151, P495, DOI 10.1001/archinte.151.3.495; UHLMANN RF, 1988, J GERONTOL, V43, pM115, DOI 10.1093/geronj/43.5.M115; WANZER SH, 1989, NEW ENGL J MED, V320, P844, DOI 10.1056/NEJM198903303201306; Wolk-Wasserman D, 1987, Crisis, V8, P69	48	48	48	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	1994	271	22					1786	1788		10.1001/jama.271.22.1786	http://dx.doi.org/10.1001/jama.271.22.1786			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NN725	8196123				2022-12-28	WOS:A1994NN72500030
J	PREUSS, D; RHEE, SY; DAVIS, RW				PREUSS, D; RHEE, SY; DAVIS, RW			TETRAD ANALYSIS POSSIBLE IN ARABIDOPSIS WITH MUTATION OF THE QUARTET (QRT) GENES	SCIENCE			English	Article							POLLEN; EXPRESSION; TOMATO	Two Arabidopsis thaliana genes, QRT1 and QRT2, are required for pollen separation during normal development. In qrt mutants, the outer walls of the four meiotic products of the pollen mother cell are fused, and pollen grains are released in tetrads. Pollen is viable and fertile, and the cytoplasmic pollen contents are discrete. Pollination with a single tetrad usually yields four seeds, and genetic analysis confirmed that marker loci segregate in a 2:2 ratio within these tetrads. These mutations allow tetrad analysis to be performed in Arabidopsis and define steps in pollen cell wall development.	STANFORD UNIV, DEPT BIOL SCI, STANFORD, CA 94305 USA	Stanford University	PREUSS, D (corresponding author), STANFORD UNIV, DEPT BIOCHEM, STANFORD, CA 94305 USA.							Blackmore S, 1988, ONTOGENY SYSTEMATICS, P83; CHERRY JM, 1992, PLANT MOL BIOL REP, V10, P308; ESCHRICH W., 1964, STAIN TECHNOL, V39, P303; FOGEL S, 1981, MOL BIOL YEAST SACCH, P289; HESLOPHARRISON J, 1970, STAIN TECHNOL, V45, P115, DOI 10.3109/10520297009085351; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; KNAPP EDGAR, 1960, CANADIAN JOUR GENETICS AND CYTOL, V2, P89; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; MASCARENHAS JP, 1993, PLANT CELL, V5, P1303, DOI 10.1105/tpc.5.10.1303; MCCORMICK S, 1993, PLANT CELL, V5, P1265, DOI 10.1105/tpc.5.10.1265; MORTIMER RK, 1981, MOL BIOL YEAST SACCH, P11; PERKINS DD, 1962, GENET RES, V3, P315, DOI 10.1017/S0016672300035084; PERKINS DD, 1953, GENETICS, V38, P187; PERKINS DD, 1974, GENETICS, V77, P459; PERKINS DD, 1949, GENETICS, V34, P607; PERKINS DD, 1955, J CELL COMPAR PHY S2, V45; PREUSS D, 1993, GENE DEV, V7, P974, DOI 10.1101/gad.7.6.974; REGAN SM, 1990, PLANT CELL, V2, P877, DOI 10.1105/tpc.2.9.877; STIEGLITZ H, 1977, DEV BIOL, V57, P87, DOI 10.1016/0012-1606(77)90356-6; TWELL D, 1990, DEVELOPMENT, V109, P705; TWELL D, 1989, MOL GEN GENET, V217, P240, DOI 10.1007/BF02464887	22	270	295	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	1994	264	5164					1458	1460		10.1126/science.8197459	http://dx.doi.org/10.1126/science.8197459			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NP221	8197459				2022-12-28	WOS:A1994NP22100042
J	YANKULOV, K; BLAU, J; PURTON, T; ROBERTS, S; BENTLEY, DL				YANKULOV, K; BLAU, J; PURTON, T; ROBERTS, S; BENTLEY, DL			TRANSCRIPTIONAL ELONGATION BY RNA-POLYMERASE-II IS STIMULATED BY TRANSACTIVATORS	CELL			English	Article							C-MYC GENE; IMMUNODEFICIENCY-VIRUS TYPE-1; LONG TERMINAL REPEAT; HIV-1 TAT; XENOPUS-OOCYTES; SEQUENCE REQUIREMENTS; PREMATURE TERMINATION; DROSOPHILA-MELANOGASTER; MAMMALIAN-CELLS; ADENOVIRUS E1A	We report that a variety of transactivators stimulate elongation by RNA polymerase II. Activated transcription complexes have high processivity and are able to read through pausing and termination sites efficiently. In contrast, nonactivated and ''squelched'' transcription mostly arrests prematurely. Activators differ in the extent to which they stimulate processivity; for example, GAL4-VP16 and GAL4-E1a are more effective than GAL4-AH. The stimulation of elongation can be as important as the stimulation of initiation in activating expression of a reporter gene. We suggest that setting the competence of polymerase II to elongate is an integral part of the initiation step that is controlled by activators cooperating with the general transcription factors.			YANKULOV, K (corresponding author), IMPERIAL CANC RES FUND, MOLEC GENET DIFFERENTIAT LAB, 44 LINCOLNS INN FIELDS, LONDON WC2A 3PX, ENGLAND.			Yankulov, Krassimir/0000-0001-9440-9234; Bentley, David/0000-0002-8414-4647				BENGAL E, 1991, MOL CELL BIOL, V11, P1195, DOI 10.1128/MCB.11.3.1195; BENTLEY DL, 1989, GENE DEV, V3, P1179, DOI 10.1101/gad.3.8.1179; BENTLEY DL, 1988, CELL, V53, P245, DOI 10.1016/0092-8674(88)90386-8; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; BERKHOUT B, 1992, J VIROL, V66, P139, DOI 10.1128/JVI.66.1.139-149.1992; CADENA DL, 1987, J BIOL CHEM, V262, P12468; CISEK LJ, 1991, METHOD ENZYMOL, V200, P301; CULLEN BR, 1993, CELL, V73, P417, DOI 10.1016/0092-8674(93)90126-B; Drapkin R, 1993, CURR OPIN CELL BIOL, V5, P469, DOI 10.1016/0955-0674(93)90013-G; EICK D, 1986, NUCLEIC ACIDS RES, V14, P8331, DOI 10.1093/nar/14.21.8331; EMERMAN M, 1987, EMBO J, V6, P3755, DOI 10.1002/j.1460-2075.1987.tb02710.x; FLINT KJ, 1991, ONCOGENE, V6, P2019; FLORES O, 1991, P NATL ACAD SCI USA, V88, P9999, DOI 10.1073/pnas.88.22.9999; GIARDINA C, 1992, GENE DEV, V6, P2190, DOI 10.1101/gad.6.11.2190; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; GINIGER E, 1987, NATURE, V330, P670, DOI 10.1038/330670a0; GREENBLATT J, 1993, NATURE, V364, P401, DOI 10.1038/364401a0; HAIR A, 1993, MOL CELL BIOL, V13, P7925, DOI 10.1128/MCB.13.12.7925; HENIKOFF S, 1987, GENETICS, V117, P711; HERRMANN CH, 1989, MOL CELL BIOL, V9, P5412, DOI 10.1128/MCB.9.12.5412; KAO SY, 1987, NATURE, V330, P489, DOI 10.1038/330489a0; KATO H, 1992, GENE DEV, V6, P655, DOI 10.1101/gad.6.4.655; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; LASPIA MF, 1990, GENE DEV, V4, P2397, DOI 10.1101/gad.4.12b.2397; LASPIA MF, 1989, CELL, V59, P283, DOI 10.1016/0092-8674(89)90290-0; LEE HS, 1992, GENE DEV, V6, P284, DOI 10.1101/gad.6.2.284; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; LIN YS, 1988, CELL, V54, P659, DOI 10.1016/S0092-8674(88)80010-2; LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y; LU XB, 1993, J VIROL, V67, P1752, DOI 10.1128/JVI.67.4.1752-1760.1993; MARCINIAK RA, 1991, EMBO J, V10, P4189, DOI 10.1002/j.1460-2075.1991.tb04997.x; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078, DOI 10.1128/MCB.12.5.2078; MECHTI N, 1991, MOL CELL BIOL, V11, P2832, DOI 10.1128/MCB.11.5.2832; MELLITS KH, 1988, EMBO J, V7, P2849, DOI 10.1002/j.1460-2075.1988.tb03141.x; MEULIA T, 1993, MOL CELL BIOL, V13, P5647, DOI 10.1128/MCB.13.9.5647; MIDDLETON KM, 1990, MOL CELL BIOL, V10, P727, DOI 10.1128/MCB.10.2.727; MILLER AD, 1983, P NATL ACAD SCI-BIOL, V80, P4709, DOI 10.1073/pnas.80.15.4709; MIRKOVITCH J, 1992, MOL BIOL CELL, V3, P1085, DOI 10.1091/mbc.3.10.1085; MOBERG KH, 1992, ONCOGENE, V7, P411; NEPVEU A, 1986, EMBO J, V5, P2859, DOI 10.1002/j.1460-2075.1986.tb04580.x; PAYNE JM, 1989, J BIOL CHEM, V264, P19621; RAMAMURTHY V, 1990, MOL CELL BIOL, V10, P1484, DOI 10.1128/MCB.10.4.1484; ROBERTS S, 1992, GENE DEV, V6, P1562, DOI 10.1101/gad.6.8.1562; ROBERTS S, 1992, EMBO J, V11, P1085, DOI 10.1002/j.1460-2075.1992.tb05147.x; ROUGVIE AE, 1990, MOL CELL BIOL, V10, P6041, DOI 10.1128/MCB.10.11.6041; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; SADOWSKI I, 1988, NATURE, V335, P563, DOI 10.1038/335563a0; SERIZAWA H, 1993, NATURE, V363, P371, DOI 10.1038/363371a0; SHELDON M, 1993, MOL CELL BIOL, V13, P1251, DOI 10.1128/MCB.13.2.1251; SOUTHGATE CD, 1991, GENE DEV, V5, P2496, DOI 10.1101/gad.5.12b.2496; SPENCER CA, 1993, MOL CELL BIOL, V13, P1296, DOI 10.1128/MCB.13.2.1296; SPENCER CA, 1990, GENE DEV, V4, P75, DOI 10.1101/gad.4.1.75; STEVENS A, 1989, BIOCHEM BIOPH RES CO, V159, P508, DOI 10.1016/0006-291X(89)90022-3; STROBL LJ, 1992, EMBO J, V11, P3307, DOI 10.1002/j.1460-2075.1992.tb05409.x; TAMM I, 1977, P NATL ACAD SCI USA, V74, P5011, DOI 10.1073/pnas.74.11.5011; TILEY LS, 1992, GENE DEV, V6, P2077, DOI 10.1101/gad.6.11.2077; TIMMERS HTM, 1991, GENE DEV, V5, P1946, DOI 10.1101/gad.5.11.1946; TOOHEY MG, 1989, GENE DEV, V3, P265, DOI 10.1101/gad.3.3.265; TREISMAN R, 1985, NATURE, V315, P72, DOI 10.1038/315072a0; WRIGHT S, 1991, P NATL ACAD SCI USA, V88, P11383, DOI 10.1073/pnas.88.24.11383; ZHOU Q, 1992, GENE DEV, V6, P1964, DOI 10.1101/gad.6.10.1964	61	226	228	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	1994	77	5					749	759		10.1016/0092-8674(94)90058-2	http://dx.doi.org/10.1016/0092-8674(94)90058-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NQ123	8205623				2022-12-28	WOS:A1994NQ12300014
J	AGUILAR, F; HARRIS, CC; SUN, T; HOLLSTEIN, M; CERUTTI, P				AGUILAR, F; HARRIS, CC; SUN, T; HOLLSTEIN, M; CERUTTI, P			GEOGRAPHIC-VARIATION OF P53 MUTATIONAL PROFILE IN NONMALIGNANT HUMAN LIVER	SCIENCE			English	Article							HEPATITIS-B VIRUS; HUMAN HEPATOCELLULAR CARCINOMAS; TUMOR-SUPPRESSOR GENE; 17P ALLELIC DELETIONS; CODON 249; AFLATOXIN; CHINA; 8-HYDROXYGUANINE; ABERRATIONS; MUTAGENESIS	Fifty-eight percent of hepatocellular carcinomas (HCCs) from Qidong, China, contain an AGG to AGT mutation at codon 249 of the p53 tumor suppressor gene, a mutation that is rarely seen in HCCs from Western countries. The population of Qidong is exposed to high levels of aflatoxin B-1 (AFB(1)), a fungal toxin that has been shown to induce the same mutation in cultured human HCC cells. To investigate the role of AFB(1) and of these p53 mutations in hepatocarcinogenesis, normal liver samples from the United States, Thailand, and Qidong (where AFB(1) exposures are negligible, low, and high, respectively) were examined for p53 mutations. The frequency of the AGG to AGT mutation at codon 249 paralleled the level of AFB(1) exposure, which supports the hypothesis that this toxin has a causative-and probably early-role in hepatocarcinogenesis.	SWISS INST EXPTL CANC RES,DEPT CARCINOGENESIS,CH-1066 EPALINGES,SWITZERLAND; NCI,DIV CANC ETIOL,HUMAN CARCINOGENESIS LAB,BETHESDA,MD 20892; CHINESE ACAD MED SCI,INST CANC,BEIJING 100021,PEOPLES R CHINA; INT AGCY RES CANC,MECH CARCINOGENESIS UNIT,F-69372 LYON 08,FRANCE	Swiss Institute Experimental Cancer Research; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chinese Academy of Medical Sciences - Peking Union Medical College; World Health Organization; International Agency for Research on Cancer (IARC)								AGUILAR F, 1993, P NATL ACAD SCI USA, V90, P8586, DOI 10.1073/pnas.90.18.8586; BAKER SJ, 1990, CANCER RES, V50, P7717; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; CERUTTI RA, 1991, CANCER CELLS, V3, P1; CHALLEN C, 1992, HEPATOLOGY, V16, P1362, DOI 10.1002/hep.1840160610; CHENG KC, 1992, J BIOL CHEM, V267, P166; COURSAGET P, 1993, BRIT J CANCER, V67, P1395, DOI 10.1038/bjc.1993.258; FELLEYBOSCO E, 1991, NUCLEIC ACIDS RES, V19, P2913, DOI 10.1093/nar/19.11.2913; HARRIS CC, 1986, CANCER SURV, V5, P765; HAYWARD N, 1993, NATURE, V352, P764; HOSONO S, 1993, ONCOGENE, V8, P491; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; JAPP EJ, 1993, LANCET, V341, P251; KRESS S, 1992, CANCER RES, V52, P3220; LEADON SA, 1981, CANCER RES, V41, P5125; LEHMAN TA, 1991, CANCER RES, V51, P4090; LI DZ, 1993, CARCINOGENESIS, V14, P169, DOI 10.1093/carcin/14.2.169; MORIYA M, 1991, MUTAT RES, V254, P281, DOI 10.1016/0921-8777(91)90067-Y; MUNOZ N, 1987, EPIDEMIOLOGY HEPATOC, P13; MURAKAMI Y, 1991, CANCER RES, V51, P5520; NISHIDA N, 1993, CANCER RES, V53, P368; NOSE H, 1993, CANCER, V72, P355, DOI 10.1002/1097-0142(19930715)72:2<355::AID-CNCR2820720208>3.0.CO;2-W; ODA T, 1991, CANCER RES, V51, P6358; ODA T, 1991, CANCER RES, V51, P3674; OZTURK M, 1991, LANCET, V338, P1356, DOI 10.1016/0140-6736(91)92236-U; POURZAND C, 1993, MUTAT RES, V288, P113, DOI 10.1016/0027-5107(93)90213-Y; ROSS RK, 1992, LANCET, V339, P943, DOI 10.1016/0140-6736(92)91528-G; SCORSONE KA, 1992, CANCER RES, V52, P1635; SHEN JC, 1992, CANCER RES, V52, P6098; SHIEH YSC, 1993, INT J CANCER, V54, P558; SIDRANSKY D, 1991, SCIENCE, V252, P706, DOI 10.1126/science.2024123; TANAKA S, 1993, CANCER RES, V53, P2884; VANRENSBURG SJ, 1985, BRIT J CANCER, V51, P713, DOI 10.1038/bjc.1985.107; WANG TCV, 1980, BIOCHEMISTRY-US, V19, P1692, DOI 10.1021/bi00549a027; WOOD ML, 1990, BIOCHEMISTRY-US, V29, P7024, DOI 10.1021/bi00482a011; YEH FS, 1989, CANCER RES, V49, P2506	36	248	250	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 27	1994	264	5163					1317	1319		10.1126/science.8191284	http://dx.doi.org/10.1126/science.8191284			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NN767	8191284				2022-12-28	WOS:A1994NN76700042
J	LI, TY; JANDA, KD; ASHLEY, JA; LERNER, RA				LI, TY; JANDA, KD; ASHLEY, JA; LERNER, RA			ANTIBODY-CATALYZED CATIONIC CYCLIZATION	SCIENCE			English	Article							CANDIDA-ALBICANS; CYCLASE; OXIDOSQUALENE; STRATEGY; BAIT	Two major goals for the design of new catalysts are the facilitation of chemical transformations and control of product outcome. An antibody has been induced that efficiently catalyzes a cationic cyclization in which an acyclic olefinic sulfonate ester substrate is converted almost exclusively (98 percent) to a cyclic alcohol. The key to the catalysis of the reaction and the restriction of the product complexity is the use of antibody binding energy to rigidly enforce a concerted mechanism in accord with the design of the hapten. Thus, the ability to direct binding energy allows the experimenter to dictate a reaction mechanism which is an otherwise difficult task in chemistry. New catalysts, for cationic cyclization may be of general use in the formation of carbon-carbon and carbon-heteroatom bonds leading to multiring molecules including steroids and heterocyclic compounds.	SCRIPPS RES INST, DEPT MOLEC BIOL, LA JOLLA, CA 92037 USA; Scripps Res Inst, DEPT CHEM, LA JOLLA, CA 92037 USA	Scripps Research Institute; Scripps Research Institute					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043858, R29GM043858] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-43858] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABE I, 1993, CHEM REV, V93, P2189, DOI 10.1021/cr00022a009; ASHLEY JA, 1992, J ORG CHEM, V57, P6691, DOI 10.1021/jo00051a003; Bartlett P. A., 1984, ASYMMETRIC SYNTHESIS, V3, P341; BARTON DHR, 1975, J CHEM SOC PERK T 1, P1134, DOI 10.1039/p19750001134; BUNTEL CJ, 1992, J AM CHEM SOC, V114, P9711, DOI 10.1021/ja00050a090; COLIN EW, 1981, SILICON ORGANIC SYNT, P15; COOK MJ, 1971, J CHEM SOC B, P1330, DOI 10.1039/j29710001330; COREY EJ, 1966, J AM CHEM SOC, V88, P4750, DOI 10.1021/ja00972a056; COREY EJ, 1991, J AM CHEM SOC, V113, P8172, DOI 10.1021/ja00021a056; CORNFORT.JW, 1965, J AM CHEM SOC, V87, P3224, DOI 10.1021/ja01092a038; Engvall E, 1980, Methods Enzymol, V70, P419; ESCHENMOSER A, 1955, HELV CHIM ACTA, V38, P1890, DOI 10.1002/hlca.19550380728; EVANS DA, 1979, TETRAHEDRON LETT, P411; FLEMING I, 1976, J CHEM SOC CHEM COMM, P182, DOI 10.1039/c39760000182; GASSMAN PG, 1968, J CHEM SOC CHEM COMM, P69; JANDA KD, 1991, J AM CHEM SOC, V113, P5427, DOI 10.1021/ja00014a039; JANDA KD, 1990, J AM CHEM SOC, V112, P1274, DOI 10.1021/ja00159a074; JANDA KD, 1993, SCIENCE, V259, P490, DOI 10.1126/science.8424171; JANDA KD, 1990, BIOTECHNOL PROGR, V6, P178, DOI 10.1021/bp00003a002; JANDA KD, 1987, 198TH NAT M AM CHEM; JOHNSON WS, 1968, ACCOUNTS CHEM RES, V1, P1, DOI 10.1021/ar50001a001; JOHNSON WS, 1987, J AM CHEM SOC, V109, P5582; JOHNSON ZBW, 1964, J AM CHEM SOC, V86, P1959; KASANO M, 1991, CHEM PHARM BULL, V39, P239; KATRITZKY AR, 1992, HETEROCYCLES, V33, P1011; KELLY R, 1990, GENE, V87, P177, DOI 10.1016/0378-1119(90)90299-7; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; MANDAVA N, 1968, CAN J CHEMISTRY, V46, P2761, DOI 10.1139/v68-458; MARCH J, 1985, ADV ORG CHEM, P312; MAUDGAL RK, 1958, J AM CHEM SOC, V80, P2589, DOI 10.1021/ja01543a063; MULLHEIN LJ, 1972, CHEM SOC REV, V259, P259; OLAH GA, 1992, CARBONIUM IONS; SCHROEPFER GJ, 1982, ANNU REV BIOCHEM, V51, P555, DOI 10.1146/annurev.bi.51.070182.003011; SCHULTZ PG, 1993, ACCOUNTS CHEM RES, V26, P39; SHARPLESS KB, 1968, THESIS STANFORD U; SHEVLIN CG, 1994, BIOORG MED CHEM LETT, V4, P297, DOI 10.1016/S0960-894X(01)80132-3; SHOKAT KM, 1989, NATURE, V338, P269, DOI 10.1038/338269a0; STORK G, 1955, J AM CHEM SOC, V77, P5968; Sutherland J. K., 1991, COMP ORG SYNTH, V5, P341; UNO T, 1992, J AM CHEM SOC, V114, P6573, DOI 10.1021/ja00042a055; VANTAMELEN EE, 1982, J AM CHEM SOC, V104, P6480, DOI 10.1021/ja00387a070; WILLETT JD, 1967, J BIOL CHEM, V242, P4182; WOODWARD RB, 1953, J AM CHEM SOC, V75, P2023, DOI 10.1021/ja01104a535	43	72	73	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 27	1994	264	5163					1289	1293		10.1126/science.8191282	http://dx.doi.org/10.1126/science.8191282			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	NN767	8191282				2022-12-28	WOS:A1994NN76700034
J	YIN, XM; OLTVAI, ZN; KORSMEYER, SJ				YIN, XM; OLTVAI, ZN; KORSMEYER, SJ			BH1 AND BH2 DOMAINS OF BCL-2 ARE REQUIRED FOR INHIBITION OF APOPTOSIS AND HETERODIMERIZATION WITH BAX	NATURE			English	Article							PROGRAMMED CELL-DEATH; CHROMOSOMAL BREAKPOINT; PROTOONCOGENE BCL-2; SEQUENCE SIMILARITY; GENE; PROTEIN; EXPRESSION; SURVIVAL; THYMOCYTES; PREVENTION	BCL-2 was isolated from the t(14;18) chromosomal breakpoint in follicular B-cell lymphoma(1-3). Bcl-2 has the unique oncogenic role of extending cell survival by inhibiting a variety of apoptotic deaths(4-13). An emerging family of Bcl-2 -related proteins share two highly conserved regions(14-20) referred to here as Bcl-2 homology 1 and 2 (BH1 and BH2) domains (Fig. 1). This includes Bax which heterodimerizes with Bcl-2 and when overexpressed counteracts Bcl-2(14). We report here that site-specific mutagenesis of Bcl-2 establishes the two domains as novel dimerization motifs. Substitution of Gly 145 in BH1 domain or Trp 188 in BH2 domain completely abrogated Bcl-2's death-repressor activity in interleukin-3 deprivation, gamma-irradiation and glucocorticoid-induced apoptosis. Mutations that affected Bcl-2's function also disrupted its heterodimerization with Bax, yet still permitted Bcl-2 homodimerization. These results establish a functional role for the BH1 and BH2 domains and suggest Bcl-2 exerts its action through heterodimerization with Bax.			YIN, XM (corresponding author), WASHINGTON UNIV,SCH MED,HOWARD HUGHES MED INST,DIV MOLEC ONCOL,ST LOUIS,MO 63110, USA.							ALLSOPP TE, 1993, CELL, V73, P295, DOI 10.1016/0092-8674(93)90230-N; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; CORMACK B, 1991, CURRENT PROTOCOLS MO; CREIGHTON TE, 1984, PROTEINS STRUCTURES, pCH1; FERNANDEZSARABIA MJ, 1993, NATURE, V366, P274, DOI 10.1038/366274a0; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; HENGARTNER MO, 1994, CELL, V76, P665, DOI 10.1016/0092-8674(94)90506-1; HENGARTNER MO, 1994, NATURE, V369, P318, DOI 10.1038/369318a0; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; LIN EY, 1993, J IMMUNOL, V151, P1979; LOMANT AJ, 1976, J MOL BIOL, V104, P243, DOI 10.1016/0022-2836(76)90011-5; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; NEILAN JG, 1993, J VIROL, V67, P4391, DOI 10.1128/JVI.67.7.4391-4394.1993; NUNEZ G, 1990, J IMMUNOL, V144, P3602; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; SETO M, 1988, EMBO J, V7, P123, DOI 10.1002/j.1460-2075.1988.tb02791.x; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; UCKER DS, 1989, J IMMUNOL, V143, P3461; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VAUX DL, 1992, SCIENCE, V258, P1955, DOI 10.1126/science.1470921; VEIS DJ, 1993, J IMMUNOL, V151, P2546; WILLIAMS GT, 1993, CELL, V74, P777, DOI 10.1016/0092-8674(93)90457-2; Wyllie A H, 1980, Int Rev Cytol, V68, P251	30	1195	1301	1	24	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 26	1994	369	6478					321	323		10.1038/369321a0	http://dx.doi.org/10.1038/369321a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NN109	8183370				2022-12-28	WOS:A1994NN10900050
J	PAOLELLA, DN; PALMER, CR; SCHEPARTZ, A				PAOLELLA, DN; PALMER, CR; SCHEPARTZ, A			DNA TARGETS FOR CERTAIN BZIP PROTEINS DISTINGUISHED BY AN INTRINSIC BEND	SCIENCE			English	Article							LEUCINE ZIPPER; GEL-ELECTROPHORESIS; CAP PROTEIN; BINDING; HETERODIMERS; REPRESSOR; REGIONS; YEAST; FOS; JUN	In spite of the large amount of sequence conservation among the DNA binding segments of basic region leucine zipper (bZIP) proteins, these proteins can discriminate differently between target sequences that differ in half-site spacing. Here it is shown that the half-site spacing preferences of bZIP proteins are the result of (i) the differential intrinsic curvature in target binding sites that differ by insertion or deletion of a single base pair and (ii) the ability of some bZIP proteins to overcome this intrinsic curvature through a mechanism dependent on basic segment residues.	YALE UNIV,DEPT CHEM,TRAINING PROGRAM BIOPHYS,NEW HAVEN,CT 06511; YALE UNIV,DEPT MOLEC BIOPHYS & BIOCHEM,NEW HAVEN,CT 06511	Yale University; Yale University								DALMAWEISZHAUSZ DD, 1991, NUCLEIC ACIDS RES, V19, P611, DOI 10.1093/nar/19.3.611; DEGROOT RP, 1994, UNPUB ONCOGENE, V9, P463; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; GARNER MM, 1981, NUCLEIC ACIDS RES, V9, P3047, DOI 10.1093/nar/9.13.3047; GARTENBERG MR, 1990, P NATL ACAD SCI USA, V87, P6034, DOI 10.1073/pnas.87.16.6034; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HOPE IA, 1985, CELL, V43, P177, DOI 10.1016/0092-8674(85)90022-4; KERPPOLA TK, 1993, MOL CELL BIOL, V13, P5479, DOI 10.1128/MCB.13.9.5479; KERPPOLA TK, 1991, SCIENCE, V254, P1210, DOI 10.1126/science.1957173; KERPPOLA TK, 1991, CELL, V66, P317, DOI 10.1016/0092-8674(91)90621-5; KIM J, 1989, GENE, V85, P15, DOI 10.1016/0378-1119(89)90459-9; KIM J, 1993, P NATL ACAD SCI USA, V90, P4513, DOI 10.1073/pnas.90.10.4513; KONIG P, 1993, J MOL BIOL, V233, P139, DOI 10.1006/jmbi.1993.1490; KOO HS, 1990, BIOCHEMISTRY-US, V29, P4227, DOI 10.1021/bi00469a027; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LIUJOHNSON HN, 1986, CELL, V47, P995, DOI 10.1016/0092-8674(86)90814-7; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; MCKNIGHT SL, 1991, SCI AM, V264, P54, DOI 10.1038/scientificamerican0491-54; METALLO SJ, UNPUB; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; PAOLELLA DN, UNPUB; PU WT, 1991, P NATL ACAD SCI USA, V88, P6901, DOI 10.1073/pnas.88.16.6901; REECE RJ, 1993, SCIENCE, V261, P909, DOI 10.1126/science.8346441; SELLERS JW, 1990, MOL CELL BIOL, V10, P5077, DOI 10.1128/MCB.10.10.5077; SHAKKED Z, UNPUB XRAY CRYSTALLO; STEITZ TA, 1990, Q REV BIOPHYS, V23, P205, DOI 10.1017/S0033583500005552; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; ZINKEL SS, 1987, NATURE, V328, P178, DOI 10.1038/328178a0	30	75	76	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 20	1994	264	5162					1130	1133		10.1126/science.8178171	http://dx.doi.org/10.1126/science.8178171			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NM146	8178171				2022-12-28	WOS:A1994NM14600028
J	THOMPSON, JS; LING, XF; GRUNSTEIN, M				THOMPSON, JS; LING, XF; GRUNSTEIN, M			HISTONE H3 AMINO-TERMINUS IS REQUIRED FOR TELOMERIC AND SILENT MATING LOCUS REPRESSION IN YEAST	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL STATES; N-TERMINUS; INVIVO	HETEROCHROMATIN is a cytologically visible form of condensed chromatin capable of repressing genes in eukaryotic cells. For the yeast Saccharomyces cerevisiae, despite the absence of observable heterochromatin, there is genetic and chromatin structure data which indicate that there are heterochromatin-like repressive structures(1-2). Genes experience position effects at the silent mating loci and the telomeres, resulting in a repressed state that is inherited in an epigenetic manner. The histone H4 amino terminus is required for repression at these loci(3,4). Additional studies have indicated that the histone H3 N terminus is not important for silent mating locus repression(5,6), but redundancy of repressive elements at the silent mating loci may be responsible for masking its role. Here we report that histone H3 is required for full repression at yeast telomeres and at partially disabled silent mating loci, and that the acetylatable lysine residues of H3 play an important role in silencing.	UNIV CALIF LOS ANGELES, DEPT BIOL, LOS ANGELES, CA 90024 USA	University of California System; University of California Los Angeles	THOMPSON, JS (corresponding author), UNIV CALIF LOS ANGELES, INST MOLEC BIOL, LOS ANGELES, CA 90024 USA.		Thompson, Jeff/HGB-3965-2022	Thompson, Jeff/0000-0002-9281-2596; Ling, Bruce/0000-0002-5386-3884				APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; DURRIN LK, 1991, CELL, V65, P1023, DOI 10.1016/0092-8674(91)90554-C; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; JOHNSON LM, 1992, EMBO J, V11, P2201, DOI 10.1002/j.1460-2075.1992.tb05279.x; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; LAURENSON P, 1992, MICROBIOL REV, V56, P543, DOI 10.1128/MMBR.56.4.543-560.1992; MANN RK, 1992, EMBO J, V11, P3297, DOI 10.1002/j.1460-2075.1992.tb05408.x; MORGAN BA, 1991, MOL CELL BIOL, V11, P4111, DOI 10.1128/MCB.11.8.4111; PILLUS L, 1989, CELL, V59, P637, DOI 10.1016/0092-8674(89)90009-3; SCHUSTER T, 1986, CELL, V45, P445, DOI 10.1016/0092-8674(86)90330-2; THOMPSON JS, 1994, MOL CELL BIOL, V14, P446, DOI 10.1128/MCB.14.1.446; THOMPSON JS, 1993, COLD SPRING HARB SYM, V58, P247, DOI 10.1101/SQB.1993.058.01.029; TURNER BM, 1992, J CELL, V69, P375; van Holde KE., 1989, SPRINGER SERIES MOL	18	210	214	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	1994	369	6477					245	247		10.1038/369245a0	http://dx.doi.org/10.1038/369245a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NM067	8183346				2022-12-28	WOS:A1994NM06700060
J	COWAN, SW; ROSENBUSCH, JP				COWAN, SW; ROSENBUSCH, JP			FOLDING PATTERN DIVERSITY OF INTEGRAL MEMBRANE-PROTEINS	SCIENCE			English	Editorial Material							PHOTOSYNTHETIC REACTION CENTER; ESCHERICHIA-COLI; RHODOPSEUDOMONAS-VIRIDIS; CHANNELS; BACTERIORHODOPSIN; BINDING; PORINS; MODEL		UNIV BASEL,BIOZENTRUM,CH-4056 BASEL,SWITZERLAND	University of Basel								ANDERSSON H, 1992, J BIOL CHEM, V267, P1491; BAUER K, 1989, J BIOL CHEM, V264; BERG HC, 1969, BIOCHIM BIOPHYS ACTA, V183, P65, DOI 10.1016/0005-2736(69)90130-8; BRETSCHER MS, 1971, J MOL BIOL, V58, P775, DOI 10.1016/0022-2836(71)90039-8; CHARBIT A, 1988, J MOL BIOL, V201, P487, DOI 10.1016/0022-2836(88)90630-4; CHEN R, 1980, P NATL ACAD SCI-BIOL, V77, P4592, DOI 10.1073/pnas.77.8.4592; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; DEISENHOFER J, 1989, EMBO J, V8, P2149, DOI 10.1002/j.1460-2075.1989.tb08338.x; ENGELMAN DM, 1982, BIOPHYS J, V37, P187, DOI 10.1016/S0006-3495(82)84662-6; FISCHBARG J, 1993, P NATL ACAD SCI USA, V90, P11658, DOI 10.1073/pnas.90.24.11658; Fringeli U. P., 1992, INTERNAL REFLECTION, P255; GREENBLATT RE, 1985, FEBS LETT, V193, P125, DOI 10.1016/0014-5793(85)80136-8; GUY HR, 1990, TRENDS NEUROSCI, V13, P201; GUY HR, 1989, P NATL ACAD SCI USA, V86, P508; HARRIS P, 1993, BIOCHEM SOC T, V21, P9; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; JAHNIG F, 1990, TRENDS BIOCHEM SCI, V15, P93, DOI 10.1016/0968-0004(90)90188-H; JONES TA, 1993, MANUAL O; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MCLACHLAN AD, 1976, J MOL BIOL, V103, P271, DOI 10.1016/0022-2836(76)90313-2; MICHEL H, 1986, EMBO J, V5, P1149, DOI 10.1002/j.1460-2075.1986.tb04340.x; MIELKE DL, 1988, J BIOL CHEM, V263, P3177; NAKAE T, 1976, BIOCHEM BIOPH RES CO, V71, P877, DOI 10.1016/0006-291X(76)90913-X; NIKAIDO H, 1992, MOL MICROBIOL, V6, P435, DOI 10.1111/j.1365-2958.1992.tb01487.x; PARKER MW, 1994, NATURE, V367, P292, DOI 10.1038/367292a0; PAUL C, 1985, EMBO J, V4, P1593, DOI 10.1002/j.1460-2075.1985.tb03822.x; PAUPTIT RA, 1991, J STRUCT BIOL, V107, P136, DOI 10.1016/1047-8477(91)90017-Q; ROSENBUSCH JP, 1974, J BIOL CHEM, V249, P8019; SCHINDLER H, 1978, P NATL ACAD SCI USA, V75, P3751, DOI 10.1073/pnas.75.8.3751; SCHIRMER T, 1993, PROTEIN SCI, V2, P1361, DOI 10.1002/pro.5560020820; STEITZ TA, 1981, BIOPHYS J, V37, P124; TURNER RJ, 1993, BIOCHIM BIOPHYS ACTA, V1202, P161, DOI 10.1016/0167-4838(93)90078-6; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; VANDENBUSSCHE G, BIOCHEMISTRY-US, V3199, P9; VOGEL H, 1986, J MOL BIOL, V190, P191, DOI 10.1016/0022-2836(86)90292-5; WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242; WEITE W, 1991, BIOCHIM BIOPHYS ACTA, V1080, P271; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494	41	79	81	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 13	1994	264	5161					914	916		10.1126/science.8178151	http://dx.doi.org/10.1126/science.8178151			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NK974	8178151				2022-12-28	WOS:A1994NK97400024
J	SMELLIE, JM; POULTON, A; PRESCOD, NP				SMELLIE, JM; POULTON, A; PRESCOD, NP			RETROSPECTIVE STUDY OF CHILDREN WITH RENAL SCARRING ASSOCIATED WITH REFLUX AND URINARY-INFECTION	BRITISH MEDICAL JOURNAL			English	Article							VESICOURETERAL REFLUX; PYELONEPHRITIS; MANAGEMENT; THERAPY; SCARS	Objective-To review the histories of children with bilateral renal scarring and severe vesicoureteric reflux to determine whether an improvement in early management might reduce the risk of scarring. Design-Retrospective study of medical records and discussion with parents. Setting-Outpatient departments of two teaching hospitals. Patients-52 children aged 1-12 years participating in a randomised comparison of medical and surgical management. All had a history of symptomatic urinary tract infection. Two thirds presented with fever and two with hypertension or renal failure. In only one out of 32 children examined by antenatal ultrasonography was an abnormality suspected. Results-There was delay in diagnosis or appropriate imaging or effective treatment of urinary infection in 50 of the 52 children. In 41 there was delay in diagnosis; there was delay in treating a confirmed infection in 45; no antibacterial prophylaxis was prescribed before imaging in 28; and investigation of the urinary tract was delayed in 33. The severity of scarring was significantly related to delay in diagnosis (X(2) for trend 7-43, P=0.01). Four children of mothers known to have reflux nephropathy were not investigated until they developed urinary tract infection. Conclusions-Efforts to reduce the incidence and severity of renal scarring should be directed towards rapid diagnosis and effective early management of urinary tract infection in infancy and childhood. Siblings and offspring of known patients with severe reflux nephropathy should be investigated for reflux.	HOSP SICK CHILDREN,DEPT PAEDIAT NEPHROL,LONDON WC1N 3JH,ENGLAND; GUYS HOSP,DEPT PAEDIAT NEPHROL,LONDON SE1 9RT,ENGLAND	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust								AGGARWAL VK, 1989, ARCH DIS CHILD, V64, P1538, DOI 10.1136/adc.64.11.1538; Bailey R R, 1984, Contrib Nephrol, V39, P40; BURGE DM, 1992, J UROLOGY, V148, P1743, DOI 10.1016/S0022-5347(17)37018-0; GORDON AC, 1990, BRIT J UROL, V65, P407, DOI 10.1111/j.1464-410X.1990.tb14766.x; HAYCOCK GB, 1986, ARCH DIS CHILD, V61, P1155, DOI 10.1136/adc.61.12.1155; JADRESIC L, 1993, BRIT MED J, V307, P761, DOI 10.1136/bmj.307.6907.761; MILLER T, 1981, KIDNEY INT, V19, P654, DOI 10.1038/ki.1981.65; RANSLEY PG, 1981, KIDNEY INT, V20, P733, DOI 10.1038/ki.1981.204; RANSLEY PG, 1978, BRIT J RADIOL      S, V14, P1; RISDON RA, 1993, PEDIATR NEPHROL, V7, P361, DOI 10.1007/BF00857538; Smellie J, 1975, Kidney Int Suppl, V4, pS65; SMELLIE JM, 1981, KIDNEY INT, V20, P717, DOI 10.1038/ki.1981.201; SMELLIE JM, 1992, J UROLOGY, V148, P1676, DOI 10.1016/S0022-5347(17)37000-3; SMELLIE JM, 1985, BRIT MED J, V290, P1957, DOI 10.1136/bmj.290.6486.1957; SMELLIE JM, 1992, PEDIATR NEPHROL, V6, P223, DOI 10.1007/BF00878353; SMELLIE JM, 1992, FORFAR ARNEILS TXB P, P1031; WIKSTAD I, 1990, PEDIATR NEPHROL, V4, P331, DOI 10.1007/BF00862511; WINBERG J, 1982, PEDIATR CLIN N AM, V29, P801; WINTER AL, 1983, J UROLOGY, V129, P1190, DOI 10.1016/S0022-5347(17)52634-8; 1990, BRIT J GEN PRACT, V40, P146; 1991, J R COLL PHYSICIANS, V25, P36; 1987, BRIT MED J, V295, P237; 1980, PEDIATRICS, V67, P392; 1990, BRIT MED J, V301, P1082	24	125	128	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 7	1994	308	6938					1193	1196		10.1136/bmj.308.6938.1193	http://dx.doi.org/10.1136/bmj.308.6938.1193			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK956	8180534	Green Published			2022-12-28	WOS:A1994NK95600016
J	OKANO, Y; STEEN, VD; MEDSGER, TA				OKANO, Y; STEEN, VD; MEDSGER, TA			AUTOANTIBODY REACTIVE WITH RNA POLYMERASE-III IN SYSTEMIC-SCLEROSIS	ANNALS OF INTERNAL MEDICINE			English	Article						RNA POLYMERASE-III; SCLERODERMA, SYSTEMIC; AUTOANTIBODIES; SKIN DISEASE; BIOLOGICAL MARKERS	ANTICENTROMERE ANTIBODIES; CLINICAL CORRELATIONS; SERUM AUTOANTIBODIES; TRANSCRIPTION; SCLERODERMA; ASSOCIATIONS; STIMULATION; PROTEINS; MARKERS	Objective: To determine the clinical significance of anti-RNA polymerase III antibody in systemic sclerosis (SSc). Design: A point prevalence study of autoantibody to RNA polymerase III and longitudinal examination of its clinical significance in patients with SSc and in controls. Setting: University medical center rheumatology practice. Patients: Two hundred fifty-two consecutive new patients with SSc and 170 controls (150 patients with other connective tissue diseases and 20 normal volunteers). Measurements: The presence of anti-RNA polymerase III antibody was determined by immunoprecipitation, immunoblotting, and immunodepletion studies. Main Results: Serum specimens from 57 of the 252 patients with SSc (23%; 95% CI, 18% to 28%) reacted with RNA polymerase III, compared with none of the specimens from 170 controls (0%; 95% CI, 0% to 2%). In 40 of these 57 specimens, immunoprecipitation studies also showed the presence of RNA polymerase I or II, or both. Anti-RNA polymerase III antibody was detected in sera from 50 of the 111 patients (45%) who had SSc with diffuse cutaneous involvement (dcSSc), 7 of 114 patients (6%) who had SSc with limited cutaneous involvement, and none of 27 patients with an SSc overlap syndrome (P < 0.001). Among patients with dcSSc, anti-RNA polymerase III antibody was more common than antitopoisomerase I antibody (45% compared with 27%; P = 0.008). Patients with anti-RNA polymerase III antibody had a statistically significant higher mean maximum skin thickness score but statistically significant lower frequencies of telangiectasias, inflammatory myopathy, restrictive lung disease, and serious cardiac abnormalities than did patients with antitopoisomerase I antibody. Conclusion: Anti-RNA polymerase III antibody is a new marker autoantibody for many patients who have SSc with diffuse or extensive cutaneous involvement.	UNIV PITTSBURGH, SCH MED,DEPT MED,DIV RHEUMATOL & CLIN IMMUNOL, 985 SCAIFE HALL, PITTSBURGH, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh					NCRR NIH HHS [5M01RR00056] Funding Source: Medline; NIAMS NIH HHS [AR21393] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R18AR021393] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; CATOGGIO LJ, 1983, ANN RHEUM DIS, V42, P23, DOI 10.1136/ard.42.1.23; FRITZLER MJ, 1980, AM J MED, V69, P520, DOI 10.1016/0002-9343(80)90462-3; GEIDUSCHEK EP, 1988, ANNU REV BIOCHEM, V57, P873, DOI 10.1146/annurev.bi.57.070188.004301; HIRAKATA M, 1993, J CLIN INVEST, V91, P2665, DOI 10.1172/JCI116505; KOVELMAN R, 1990, GENE DEV, V4, P646, DOI 10.1101/gad.4.4.646; KUWANA M, 1993, J CLIN INVEST, V91, P1399, DOI 10.1172/JCI116343; MCCARTY GA, 1983, ARTHRITIS RHEUM, V26, P1, DOI 10.1002/art.1780260101; Medsger Jr TA, 1989, ARTHRITIS ALLIED CON, V11th, P1118; MEDSGER TA, 1971, ANN INTERN MED, V74, P714, DOI 10.7326/0003-4819-74-5-714; MEDSGER TA, 1985, CURRENT TOPICS RHEUM, P16; OKANO Y, 1992, ARTHRITIS RHEUM, V35, pS38; OKANO Y, 1992, ARTHRITIS RHEUM-US, V35, P95, DOI 10.1002/art.1780350114; OKANO Y, 1990, ARTHRITIS RHEUM, V33, P1822, DOI 10.1002/art.1780331210; OKANO Y, 1991, J IMMUNOL, V146, P535; REIMER G, 1988, ARTHRITIS RHEUM, V31, P525, DOI 10.1002/art.1780310409; REIMER G, 1986, J IMMUNOL, V137, P3802; REIMER G, 1987, J CLIN INVEST, V79, P65, DOI 10.1172/JCI112809; RODNAN G P, 1979, Clinics in Rheumatic Diseases, V5, P5; SENTENAC A, 1985, CRC CR REV BIOCH MOL, V18, P31, DOI 10.3109/10409238509082539; STEEN VD, 1988, ARTHRITIS RHEUM, V31, P196, DOI 10.1002/art.1780310207; STEEN VD, 1984, ARTHRITIS RHEUM, V27, P125, DOI 10.1002/art.1780270202; Tan E.M., 1989, ADV IMMUNOL, V44, P151, DOI [10.1016/S0065-2776(08)60641-0, DOI 10.1016/S0065-2776(08)60641-0]; THOMPSON NE, 1989, J BIOL CHEM, V264, P11511; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WEINER ES, 1988, ARTHRITIS RHEUM, V31, P378, DOI 10.1002/art.1780310309; YOSHINAGA S, 1986, EMBO J, V5, P343, DOI 10.1002/j.1460-2075.1986.tb04218.x	27	184	186	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1993	119	10					1005	1013		10.7326/0003-4819-119-10-199311150-00007	http://dx.doi.org/10.7326/0003-4819-119-10-199311150-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MG672	8214977				2022-12-28	WOS:A1993MG67200007
J	SNYDMAN, DR; WERNER, BG; DOUGHERTY, NN; GRIFFITH, J; RUBIN, RH; DIENSTAG, JL; ROHRER, RH; FREEMAN, R; JENKINS, R; LEWIS, D; HAMMER, S; OROURKE, E; GRADY, GF; FAWAZ, K; KAPLAN, MM; HOFFMAN, MA; KATZ, AT; DORAN, M				SNYDMAN, DR; WERNER, BG; DOUGHERTY, NN; GRIFFITH, J; RUBIN, RH; DIENSTAG, JL; ROHRER, RH; FREEMAN, R; JENKINS, R; LEWIS, D; HAMMER, S; OROURKE, E; GRADY, GF; FAWAZ, K; KAPLAN, MM; HOFFMAN, MA; KATZ, AT; DORAN, M			CYTOMEGALOVIRUS IMMUNE GLOBULIN PROPHYLAXIS IN LIVER-TRANSPLANTATION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL	ANNALS OF INTERNAL MEDICINE			English	Article						LIVER TRANSPLANTATION; CYTOMEGALIC INCLUSION DISEASE; IMMUNOGLOBULINS, INTRAVENOUS; CYTOMEGALOVIRUSES	BONE-MARROW TRANSPLANTATION; VIRUS DISEASE; RECIPIENTS; GANCICLOVIR; IMMUNOGLOBULIN; INFECTIONS; PNEUMONIA; COMBINATION; PREVENTION; ACYCLOVIR	Objective: To study the effect of cytomegalovirus immune globulin (CMVIG) on prevention of cytomegalovirus (CMV) disease and its complications in patients receiving liver transplants. Design: Randomized, multicenter, placebo-controlled, double-blind trial. Setting: Four university-affiliated transplant centers in Boston (Boston Center for Liver Transplantation). Patients: One hundred forty-one liver transplant recipients completed the study. Intervention: CMVIG or placebo (1% albumin) given in a dose of 150 mg/kg body weight within 72 hours of the transplant, then at weeks 2, 4, 6, and 8, and at 100 mg/kg at weeks 12 and 16. Measurements: Patients were observed for 1 year after transplantation for the development of CMV infection, disease, pneumonia, as well as for opportunistic fungal infections, graft survival, and mortality. Weekly cultures were taken of urine, buffy coat, and throat wash for CMV for 2 months, then monthly, and at any clinical illness. Results: Using a Cox proportional hazards model, CMVIG was shown to reduce severe CMV-associated disease (multi-organ CMV disease, CMV pneumonia, or invasive fungal disease associated with CMV infection) from 26% to 12% (relative risk, 0.39; 95% CI, 0.17 to 0.89). When we controlled for the use of monoclonal antibodies to T cells (OKT3), CMVIG use was still protective (relative risk, 0.39; CI, 0.17 to 0.90). Rates of CMV disease were reduced from 31% to 19% (relative risk, 0.56; CI, 0.3 to 1.1) in CMVIG recipients although no effect on rates of CMV infection, graft survival, or patient survival at 1 year were shown. When we controlled for the urgency of transplantation and OKT3 use, a reduction in CMV disease (relative risk, 0.22; CI, 0.06 to 0.81) was shown for globulin recipients for all serologic groups except for the highest risk group (the CMV-seropositive donor, CMV-seronegative group). Conclusion: CMVIG reduced the rate of severe CMV-associated disease in patients undergoing orthotopic liver transplantation. No effect of CMVIG on CMV donor-positive, recipient-negative liver transplant recipients was shown, suggesting a need for additional prophylactic strategies.			SNYDMAN, DR (corresponding author), TUFTS UNIV NEW ENGLAND MED CTR, BOX 238, 750 WASHINGTON ST, BOSTON, MA 02111 USA.		Snydman, David R/O-3889-2014	Snydman, David R/0000-0003-0119-3978; Dienstag, Jules/0000-0001-7024-0980	NIDDK NIH HHS [R10 DK31389] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK031389] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BALFOUR HH, 1989, NEW ENGL J MED, V320, P1381, DOI 10.1056/NEJM198905253202105; CHATTERJEE SN, 1978, JAMA-J AM MED ASSOC, V240, P2446, DOI 10.1001/jama.240.22.2446; COX DR, 1972, J R STAT SOC B, V34, P187; EMANUEL D, 1988, ANN INTERN MED, V109, P777, DOI 10.7326/0003-4819-109-10-777; GEORGE MJ, 1992, 32ND INT C ANT AG CH; GLEAVES CA, 1984, J CLIN MICROBIOL, V19, P917, DOI 10.1128/JCM.19.6.917-919.1984; HO M, 1983, TRANSPLANT P, V15, P2768; HO M, 1982, CURRENT TOPICS INFEC; HODINKA RL, 1991, MANUAL CLIN MICROBIO, P829; MARTIN FM, 1992, 14 INT C TRNASPL SOC; MASIH AS, 1988, AM J SURG PATHOL, V12, P362, DOI 10.1097/00000478-198805000-00004; MERIGAN TC, 1992, NEW ENGL J MED, V326, P1182, DOI 10.1056/NEJM199204303261803; NIGHTING, 1990, JAMA-J AM MED ASSOC, V264, P168; PRENTICE RL, 1979, BIOMETRICS, V35, P861, DOI 10.2307/2530120; RAND KH, 1978, NEW ENGL J MED, V298, P951, DOI 10.1056/NEJM197804272981705; REED EC, 1988, ANN INTERN MED, V109, P783, DOI 10.7326/0003-4819-109-10-783; RUBIN RH, 1989, ANTIMICROB AGENTS CH, V33, P1975, DOI 10.1128/AAC.33.11.1975; RUBIN RH, 1989, JAMA-J AM MED ASSOC, V261, P3607; SALIBA F, 1987, TRANSPLANT P, V19, P4081; SCHMIDT GM, 1988, TRANSPLANTATION, V46, P905; SINGH N, 1988, J INFECT DIS, V158, P124, DOI 10.1093/infdis/158.1.124; SNYDMAN DR, 1984, TRANSPLANTATION, V38, P553, DOI 10.1097/00007890-198411000-00026; SNYDMAN DR, 1987, NEW ENGL J MED, V317, P1049, DOI 10.1056/NEJM198710223171703; SNYDMAN DR, 1991, TRANSPLANT P, V23, P1357; STRATTA RJ, 1991, TRANSPLANTATION, V51, P90, DOI 10.1097/00007890-199101000-00014; STRATTA RJ, 1992, ARCH SURG-CHICAGO, V127, P55; STRATTA RJ, 1989, ARCH SURG-CHICAGO, V124, P1443; SULLIVAN KM, 1990, NEW ENGL J MED, V323, P705, DOI 10.1056/NEJM199009133231103; WERNER BG, 1988, 28TH INTERSCIENCE C	29	185	187	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1993	119	10					984	991		10.7326/0003-4819-119-10-199311150-00004	http://dx.doi.org/10.7326/0003-4819-119-10-199311150-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MG672	8214995				2022-12-28	WOS:A1993MG67200004
J	BRUERA, E; MACEACHERN, T; RIPAMONTI, C; HANSON, J				BRUERA, E; MACEACHERN, T; RIPAMONTI, C; HANSON, J			SUBCUTANEOUS MORPHINE FOR DYSPNEA IN CANCER-PATIENTS	ANNALS OF INTERNAL MEDICINE			English	Note									CROSS CANC INST, EDMONTON T6G 1Z2, ALBERTA, CANADA; NATL CANC INST, MILAN, ITALY	University of Alberta; Fondazione IRCCS Istituto Nazionale Tumori Milan	BRUERA, E (corresponding author), EDMONTON GEN HOSP, PALLIAT CARE PROGRAM, ROOM 9439, 11111 JASPER AVE, EDMONTON T5K 0L4, AB, CANADA.		Bruera, Eduardo/AAA-1550-2022; Ripamonti, Carla I/C-4557-2017	Ripamonti, Carla I/0000-0001-5495-5054				BILLINGS JA, 1985, OUTPATIENT MANAGEMEN, P83; Bruera E, 1990, J Pain Symptom Manage, V5, P341, DOI 10.1016/0885-3924(90)90027-H; FOLEY KM, 1985, NEW ENGL J MED, V313, P84, DOI 10.1056/NEJM198507113130205; FOLSTEIN MF, 1984, CANCER, V53, P2250; REUBEN DB, 1986, CHEST, V89, P234, DOI 10.1378/chest.89.2.234; WASSERMAN K, 1988, ANNU REV MED, V39, P503, DOI 10.1146/annurev.med.39.1.503; WOODCOCK A, 1982, BRIT MED J, V1, P96; WOODCOCK AA, 1981, NEW ENGL J MED, V305, P1611, DOI 10.1056/NEJM198112313052703	8	143	146	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	1993	119	9					906	907		10.7326/0003-4819-119-9-199311010-00007	http://dx.doi.org/10.7326/0003-4819-119-9-199311010-00007			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MD711	8215003				2022-12-28	WOS:A1993MD71100007
J	PADOVAN, E; CASORATI, G; DELLABONA, P; MEYER, S; BROCKHAUS, M; LANZAVECCHIA, A				PADOVAN, E; CASORATI, G; DELLABONA, P; MEYER, S; BROCKHAUS, M; LANZAVECCHIA, A			EXPRESSION OF 2 T-CELL RECEPTOR-ALPHA CHAINS - DUAL RECEPTOR T-CELLS	SCIENCE			English	Article							ALLELIC EXCLUSION; GENES; RECOGNITION; CLONES; RAG-1	Although many T cells carry two in-frame V(alpha) rearrangements, the products of both V(alpha) rearrangements have never been shown simultaneously on the surface of normal cells. With the use of monoclonal antibodies to V(alpha)2, V(alpha)12, and V(alpha)24, up to one-third of mature T cells expressed two V(alpha) chains as part of two functional and independent T cell receptors (TCRs). Thus, the ''one cell, one receptor'' rule does not apply to a large subset of alphabeta T cells. Cells that belong to this dual TCR subset may be specific for a broader range of antigens than cells with a single receptor, which may be important for autoimmunity and alloreactivity.	BASEL INST IMMUNOL,GRENZACHERSTR 487,CH-4005 BASEL,SWITZERLAND; DIBIT HS RAFFAELE,I-20132 MILAN,ITALY; F HOFFMANN LA ROCHE & CO LTD,PHARMA RES NEW TECHNOL,CH-4002 BASEL,SWITZERLAND	Roche Holding			Dellabona, Paolo/G-5416-2012; Casorati, Giulia/J-7141-2018	Dellabona, Paolo/0000-0002-1414-633X; Casorati, Giulia/0000-0002-5102-4112; Padovan, Elisabetta/0000-0002-8212-508X				ASHWELL JD, 1990, ANNU REV IMMUNOL, V8, P139, DOI 10.1146/annurev.immunol.8.1.139; BOITEL B, 1992, J EXP MED, V175, P765, DOI 10.1084/jem.175.3.765; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; BRANDLE D, 1992, P NATL ACAD SCI USA, V89, P9529, DOI 10.1073/pnas.89.20.9529; BURNET FM, 1959, CLONAL SELECTION THE; CASANOVA JL, 1991, J EXP MED, V174, P1371, DOI 10.1084/jem.174.6.1371; CASANOVA JL, 1990, NUCLEIC ACIDS RES, V18, P4028, DOI 10.1093/nar/18.13.4028; COUEZ D, 1991, INT IMMUNOL, V3, P719, DOI 10.1093/intimm/3.7.719; Furutani M, 1989, Int Immunol, V1, P281, DOI 10.1093/intimm/1.3.281; KUIDA K, 1991, INT IMMUNOL, V3, P75, DOI 10.1093/intimm/3.1.75; MALISSEN M, 1988, CELL, V55, P49, DOI 10.1016/0092-8674(88)90008-6; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; UEMATSU Y, 1988, CELL, V52, P831, DOI 10.1016/0092-8674(88)90425-4	14	446	449	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 15	1993	262	5132					422	424		10.1126/science.8211163	http://dx.doi.org/10.1126/science.8211163			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB859	8211163				2022-12-28	WOS:A1993MB85900058
J	HOHNLOSER, SH; WOOSLEY, RL				HOHNLOSER, SH; WOOSLEY, RL			DRUG-THERAPY - SOTALOL	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SUSTAINED VENTRICULAR TACHYARRHYTHMIAS; III ANTIARRHYTHMIC AGENTS; PARKINSON-WHITE SYNDROME; ISOLATED CARDIAC-MUSCLE; RECTIFIER K+-CURRENT; Q-T INTERVAL; MYOCARDIAL-INFARCTION; ATRIAL-FIBRILLATION; ORAL SOTALOL; SUPRAVENTRICULAR TACHYARRHYTHMIAS		GEORGETOWN UNIV,DEPT MED & PHARMACOL,WASHINGTON,DC	Georgetown University	HOHNLOSER, SH (corresponding author), UNIV HOSP FREIBURG,DEPT CARDIOL,HUGSTETTERSTR 55,D-79106 FREIBURG,GERMANY.		Woosley, Raymond/AAE-4874-2020	Woosley, Raymond/0000-0002-2588-328X				ABERG G, 1969, LIFE SCI PT 1 PHYSI, V8, P353, DOI 10.1016/0024-3205(69)90228-8; ANASTASIOUNANA MI, 1991, AM J CARDIOL, V67, P511, DOI 10.1016/0002-9149(91)90013-B; ANDERSON JL, 1989, CIRCULATION, V79, P610, DOI 10.1161/01.CIR.79.3.610; ANDERSON JL, 1986, J AM COLL CARDIOL, V8, P752, DOI 10.1016/S0735-1097(86)80414-4; ANTONACCIO MJ, 1990, AM J CARDIOL, V65, pA12; ANTTILA M, 1976, ACTA PHARMACOL TOX, V39, P118; BAN T, 1985, N-S ARCH PHARMACOL, V329, P77, DOI 10.1007/BF00695196; BERGER F, 1989, N-S ARCH PHARMACOL, V340, P696, DOI 10.1007/BF00717747; BERGLUND G, 1980, EUR J CLIN PHARMACOL, V18, P321, DOI 10.1007/BF00561389; BERTRIX L, 1986, CARDIOVASC RES, V20, P358, DOI 10.1093/cvr/20.5.358; BLAIR AD, 1981, CLIN PHARMACOL THER, V29, P457, DOI 10.1038/clpt.1981.63; BLINKS JR, 1967, ANN NY ACAD SCI, V139, P673, DOI 10.1111/j.1749-6632.1967.tb41237.x; BORGGREFE M, 1983, CIRCULATION, V68, P271; BORGGREFE M, 1992, CIRCULATION, V86, P533; BROOKS H, 1970, CIRCULATION, V42, P99, DOI 10.1161/01.CIR.42.1.99; BURCKHARDT D, 1983, CARDIOLOGY, V70, P114, DOI 10.1159/000173639; CAMM AJ, 1990, AM J CARDIOL, V65, pA67; CAMPBELL TJ, 1985, BRIT HEART J, V54, P86; CARMELIET E, 1985, J PHARMACOL EXP THER, V232, P817; COBBE SM, 1983, CIRCULATION, V68, P865, DOI 10.1161/01.CIR.68.4.865; COBBE SM, 1985, CARDIOVASC RES, V19, P69, DOI 10.1093/cvr/19.2.69; CULLING W, 1984, CARDIOVASC RES, V18, P397, DOI 10.1093/cvr/18.7.397; DEEDWANIA PC, 1990, AM J CARDIOL, V65, pA43; ECHT DS, 1982, AM J CARDIOL, V50, P1082, DOI 10.1016/0002-9149(82)90421-0; Edvardsson N, 1980, Eur Heart J, V1, P335; ELONEN E, 1979, BRIT MED J, V1, P1184, DOI 10.1136/bmj.1.6172.1184; FUNCKBRENTANO C, 1991, CIRCULATION, V83, P536, DOI 10.1161/01.CIR.83.2.536; GOLDSTEIN RE, 1973, CHEST, V64, P619, DOI 10.1378/chest.64.5.619; GOMOLL AW, 1973, ARCH INT PHARMACOD T, V205, P338; HANYOK J J, 1990, Cardiovascular Drugs and Therapy, V4, P603, DOI 10.1007/BF00357038; HOFFMANN RP, 1969, DIS CHEST, V55, P229, DOI 10.1378/chest.55.3.229; HOHNLOSER SH, 1992, AM HEART J, V123, P1220, DOI 10.1016/S0002-8703(10)80002-X; HOHNLOSER SH, 1993, AM J CARDIOL, V71, P475, DOI 10.1016/0002-9149(93)90464-N; HOHNLOSER SH, 1987, AM HEART J, V114, P1, DOI 10.1016/0002-8703(87)90299-7; HOHNLOSER SH, 1992, PACE, V15, P551; HONDEGHEM LM, 1990, CIRCULATION, V81, P686, DOI 10.1161/01.CIR.81.2.686; HUTTON I, 1972, BRIT HEART J, V34, P787; IZUMI T, 1982, N-S ARCH PHARMACOL, V318, P340, DOI 10.1007/BF00501175; JACKMAN WM, 1988, PROG CARDIOVASC DIS, V31, P115, DOI 10.1016/0033-0620(88)90014-X; JULIAN DG, 1982, LANCET, V1, P1142; JURKIEWICZ NK, 1993, CIRC RES, V72, P75, DOI 10.1161/01.RES.72.1.75; JUULMOLLER S, 1990, CIRCULATION, V82, P1932, DOI 10.1161/01.CIR.82.6.1932; KATO R, 1986, J AM COLL CARDIOL, V7, P116, DOI 10.1016/S0735-1097(86)80268-6; KAUMANN AJ, 1968, SCIENCE, V161, P293, DOI 10.1126/science.161.3838.293; KAUMANN AJ, 1968, J PHARMACOL EXP THER, V164, P326; KEHOE RF, 1990, AM J CARDIOL, V65, pA58; KHAN MI, 1972, AM J CARDIOL, V30, P832, DOI 10.1016/0002-9149(72)90007-0; KIENZLE MG, 1988, AM J CARDIOL, V61, P1012, DOI 10.1016/0002-9149(88)90117-8; KUCHAR DL, 1989, AM J CARDIOL, V64, P33, DOI 10.1016/0002-9149(89)90648-6; KUNZE KP, 1987, CIRCULATION, V75, P1050, DOI 10.1161/01.CIR.75.5.1050; LAAKSO M, 1981, EUR HEART J, V2, P353, DOI 10.1093/oxfordjournals.eurheartj.a061216; LAAKSO M, 1981, LANCET, V2, P1168; LEVINE JH, 1989, CIRCULATION, V80, P1063, DOI 10.1161/01.CIR.80.4.1063; LIDELL C, 1985, AM HEART J, V109, P970, DOI 10.1016/0002-8703(85)90237-6; LISH PM, 1967, CURR THER RES CLIN E, V9, P311; LISH PM, 1965, J PHARMACOL EXP THER, V149, P161; LYNCH JJ, 1984, J CARDIOVASC PHARM, V6, P1132; MAHMARIAN JJ, 1987, CIRCULATION, V76, P324, DOI 10.1161/01.CIR.76.2.324; MANZ M, 1985, Z KARDIOL, V74, P500; MARSHALL RJ, 1983, BRIT J PHARMACOL, V78, P165, DOI 10.1111/j.1476-5381.1983.tb09377.x; MASON JW, 1993, NEW ENGL J MED, V329, P452, DOI 10.1056/NEJM199308123290702; MASON JW, 1993, NEW ENGL J MED, V329, P445, DOI 10.1056/NEJM199308123290701; MCKIBBIN JK, 1984, BRIT HEART J, V51, P157; NADEMANEE K, 1985, CIRCULATION, V72, P555, DOI 10.1161/01.CIR.72.3.555; NADEMANEE K, 1990, AM J CARDIOL, V65, pA53; NADEMANEE K, 1985, J AM COLL CARDIOL, V5, P438; NAKAYA H, 1984, EUR J PHARMACOL, V104, P335, DOI 10.1016/0014-2999(84)90410-2; NATTEL S, 1991, DRUGS, V41, P672, DOI 10.2165/00003495-199141050-00002; NATTEL S, 1989, J AM COLL CARDIOL, V13, P1190, DOI 10.1016/0735-1097(89)90283-0; OHARE MF, 1983, EUR J CLIN PHARMACOL, V24, P521, DOI 10.1007/BF00609896; PARMLEY WW, 1972, J CLIN PHARMACOL N D, V12, P127, DOI 10.1002/j.1552-4604.1972.tb00041.x; PATTERSON E, 1984, J PHARMACOL EXP THER, V230, P519; PATTERSON E, 1984, PHARMACOLOGY, V28, P121, DOI 10.1159/000137953; PATTERSON E, 1988, AM HEART J, V116, P1223, DOI 10.1016/0002-8703(88)90444-9; PODRID PJ, 1987, AM J CARDIOL, V59, pE38, DOI 10.1016/0002-9149(87)90200-1; RIZOS I, 1984, AM J CARDIOL, V53, P1022, DOI 10.1016/0002-9149(84)90630-1; RUDER MA, 1989, J AM COLL CARDIOL, V13, P145, DOI 10.1016/0735-1097(89)90563-9; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; SANGUINETTI MC, 1992, HYPERTENSION, V19, P228, DOI 10.1161/01.HYP.19.3.228; SCHMITT C, 1991, AM J CARDIOL, V68, P1183, DOI 10.1016/0002-9149(91)90191-M; SCHNELLE K, 1979, J CLIN PHARMACOL, V19, P516, DOI 10.1002/j.1552-4604.1979.tb02517.x; SCHNELLE K, 1973, J PHARM SCI, V62, P362, DOI 10.1002/jps.2600620303; SENGES J, 1984, CIRCULATION, V69, P577, DOI 10.1161/01.CIR.69.3.577; SINGH BN, 1970, BRIT J PHARMACOL, V39, P675, DOI 10.1111/j.1476-5381.1970.tb09893.x; SINGH SN, 1989, AM J CARDIOL, V64, P943, DOI 10.1016/0002-9149(89)90850-3; SOMANI P, 1968, J PHARMACOL EXP THER, V164, P317; SOTANIEMI EA, 1979, CLIN PHARMACOL THER, V26, P153; SOYKA LF, 1990, AM J CARDIOL, V65, pA74; STEINBECK G, 1992, NEW ENGL J MED, V327, P987, DOI 10.1056/NEJM199210013271404; STEINBECK G, 1993, NEW ENGL J MED, V328, P71; STEINBECK G, 1986, J AM COLL CARDIOL, V8, P949, DOI 10.1016/S0735-1097(86)80440-5; STRAUSS HC, 1970, CIRC RES, V26, P661, DOI 10.1161/01.RES.26.6.661; SUNDQUIST H, 1980, CURR THER RES CLIN E, V28, pS38; SUNDQUIST HK, 1975, ANN CLIN RES, V7, P442; SUTTORP MJ, 1991, AM J CARDIOL, V68, P1163, DOI 10.1016/0002-9149(91)90188-Q; TEO KK, 1985, CHEST, V87, P113, DOI 10.1378/chest.87.1.113; THUMALA A, 1971, AM HEART J, V82, P439, DOI 10.1016/0002-8703(71)90228-6; TJANDRAMAGA TB, 1976, BRIT J CLIN PHARMACO, V3, P259, DOI 10.1111/j.1365-2125.1976.tb00601.x; TOUBOUL P, 1984, AM HEART J, V107, P888, DOI 10.1016/0002-8703(84)90823-8; Vanoli E., 1993, European Heart Journal, V14, P88; VELEBIT V, 1982, CIRCULATION, V65, P886, DOI 10.1161/01.CIR.65.5.886; WANG T, 1986, AM J CARDIOL, V57, P1160, DOI 10.1016/0002-9149(86)90692-2; WARD DE, 1993, NEW ENGL J MED, V329, P498, DOI 10.1056/NEJM199308123290710; WICHTER T, 1992, CIRCULATION, V86, P29, DOI 10.1161/01.CIR.86.1.29; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; 1993, CIRCULATION, V87, P323	106	149	153	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	1994	331	1					31	38						8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NU951	8202100				2022-12-28	WOS:A1994NU95100008
J	CALDWELL, SH; BRANTLEY, K; DENT, J; KEELEY, RC; PRUETT, T; ANGLE, JF; GAFFEY, M; WALDRON, P; METZGER, DL; STEVENSON, WC; ISHITANI, M; DICKSON, RC; DYE, KR				CALDWELL, SH; BRANTLEY, K; DENT, J; KEELEY, RC; PRUETT, T; ANGLE, JF; GAFFEY, M; WALDRON, P; METZGER, DL; STEVENSON, WC; ISHITANI, M; DICKSON, RC; DYE, KR			THE HEPATOPULMONARY SYNDROME MASQUERADING AS PULMONARY LANGERHANS-CELL HISTIOCYTOSIS	ANNALS OF INTERNAL MEDICINE			English	Note							LIVER-TRANSPLANTATION; EOSINOPHILIC GRANULOMA; CIRRHOSIS; FAILURE; DISEASE; LUNG		UNIV VIRGINIA, HLTH SCI CTR, DIV CARDIOL, CHARLOTTESVILLE, VA 22908 USA; UNIV VIRGINIA, HLTH SCI CTR, DEPT TRANSPLANTAT SURG, CHARLOTTESVILLE, VA 22908 USA; UNIV VIRGINIA, HLTH SCI CTR, DEPT RADIOL, CHARLOTTESVILLE, VA 22908 USA; UNIV VIRGINIA, HLTH SCI CTR, DEPT PATHOL, CHARLOTTESVILLE, VA 22908 USA; UNIV VIRGINIA, HLTH SCI CTR, DEPT PEDIAT, CHARLOTTESVILLE, VA 22908 USA; COMMUNITY HOSP ROANOKE VALLEY, ROANOKE, VA USA	University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	CALDWELL, SH (corresponding author), UNIV VIRGINIA, HLTH SCI CTR, DIV GASTROENTEROL HEPATOL & NUTR, BOX 145, CHARLOTTESVILLE, VA 22908 USA.			Metzger, Daniel/0000-0002-1715-4319				BASSET F, 1978, AM REV RESPIR DIS, V118, P811; Berry D H, 1987, Hematol Oncol Clin North Am, V1, P23; DAOUD FS, 1972, J CLIN INVEST, V51, P1076, DOI 10.1172/JCI106899; ERIKSSON LS, 1990, HEPATOLOGY, V12, P1350, DOI 10.1002/hep.1840120616; ERIKSSON LS, 1991, HEPATOLOGY, V14, P575, DOI 10.1002/hep.1840140328; FRIEDMAN PJ, 1981, MEDICINE, V60, P385, DOI 10.1097/00005792-198111000-00001; GREENBERGER JS, 1981, MEDICINE, V60, P311, DOI 10.1097/00005792-198109000-00001; HA SY, 1992, PEDIATRICS, V89, P466; HIND CRK, 1981, GUT, V22, P1042, DOI 10.1136/gut.22.12.1042; KOMP DM, 1981, AM J PEDIAT HEMATOL, V3, P165; KROWKA MJ, 1989, CLIN CHEST MED, V10, P593; KROWKA MJ, 1985, MAYO CLIN PROC, V60, P407, DOI 10.1016/S0025-6196(12)60852-0; KROWKA MJ, 1993, CHEST, V104, P515, DOI 10.1378/chest.104.2.515; LEBLANC A, 1981, GASTROENTEROLOGY, V80, P134; MARCY TW, 1985, LUNG, V163, P129, DOI 10.1007/BF02713816; RAND EB, 1992, J PEDIATR GASTR NUTR, V15, P202, DOI 10.1097/00005176-199208000-00019; STOLLER JK, 1990, HEPATOLOGY, V11, P54, DOI 10.1002/hep.1840110111	17	9	9	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1994	121	1					34	36		10.7326/0003-4819-121-1-199407010-00006	http://dx.doi.org/10.7326/0003-4819-121-1-199407010-00006			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PN271	8198345				2022-12-28	WOS:A1994PN27100006
J	MOND, DJ; KHAN, A				MOND, DJ; KHAN, A			LUCITE-BALL PLOMBAGE	NEW ENGLAND JOURNAL OF MEDICINE			English	Note											MOND, DJ (corresponding author), LONG ISL JEWISH MED CTR,NEW HYDE PK,NY 11042, USA.								0	2	2	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 16	1994	330	24					1723	1723						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR109	8190134				2022-12-28	WOS:A1994NR10900005
J	DANTZKER, DR; STEINBERG, H				DANTZKER, DR; STEINBERG, H			PULMONARY AND CRITICAL CARE MEDICINE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OBSTRUCTIVE SLEEP-APNEA; MONOCLONAL-ANTIBODY; TISSUE OXYGENATION; SEPTIC SHOCK; ENDOTOXIN; FAILURE; PH		LONG ISL JEWISH MED CTR,NEW HYDE PK,NY 11042	Northwell Health	DANTZKER, DR (corresponding author), ALBERT EINSTEIN COLL MED,BRONX,NY 10467, USA.							BENNETT WP, 1993, CANCER RES, V53, P4817; BORING CC, 1992, CA-CANCER J CLIN, V42, P19, DOI 10.3322/canjclin.42.1.19; DANTZKER DR, 1991, AM REV RESPIR DIS, V143, P675, DOI 10.1164/ajrccm/143.3.675; FISHER CJ, 1993, CRIT CARE MED, V21, P318, DOI 10.1097/00003246-199303000-00006; GRUM CM, 1984, J APPL PHYSIOL, V56, P1065, DOI 10.1152/jappl.1984.56.4.1065; GUTIERREZ G, 1992, LANCET, V339, P195, DOI 10.1016/0140-6736(92)90002-K; KIM JS, 1992, J NCI MONOGR, V13, P101; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P887, DOI 10.1164/ajrccm/147.4.887; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P1162, DOI 10.1164/ajrccm/147.5.1162; KRYGER MH, 1993, CHEST, V104, P2, DOI 10.1378/chest.104.1.2; MAYNARD N, 1993, JAMA-J AM MED ASSOC, V270, P1203, DOI 10.1001/jama.270.10.1203; MOHSENIFAR Z, 1993, ANN INTERN MED, V119, P794, DOI 10.7326/0003-4819-119-8-199310150-00004; RICHARDSON GE, 1993, SEMIN ONCOL, V20, P105; RONCO JJ, 1991, AM REV RESPIR DIS, V143, P1267, DOI 10.1164/ajrccm/143.6.1267; Sabichi A L, 1993, Oncology (Williston Park), V7, P19; Shapiro L, 1993, New Horiz, V1, P13; SHEPARD JW, 1990, MAYO CLIN PROC, V65, P1260, DOI 10.1016/S0025-6196(12)62750-5; VINCENT JL, 1992, CHEST, V101, P810, DOI 10.1378/chest.101.3.810; WARREN HS, 1993, J EXP MED, V177, P89, DOI 10.1084/jem.177.1.89; WRIGHT CE, 1992, CARDIOVASC RES, V26, P48, DOI 10.1093/cvr/26.1.48; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; ZIEGLER EJ, 1991, NEW ENGL J MED, V324, P429, DOI 10.1056/NEJM199102143240701	22	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1709	1710						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182865				2022-12-28	WOS:A1994NN11700044
J	MAGOVERN, GJ; MAGOVERN, JA				MAGOVERN, GJ; MAGOVERN, JA			CARDIOTHORACIC SURGERY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOMYOPLASTY		MED COLL PENN,PITTSBURGH,PA	Drexel University	MAGOVERN, GJ (corresponding author), ALLEGHENY GEN HOSP,PITTSBURGH,PA, USA.							ALLEN MS, 1993, J THORAC CARDIOV SUR, V106, P1048, DOI 10.1016/S0022-5223(19)33976-5; BIRKMEYER JD, 1992, LANCET, V340, P520, DOI 10.1016/0140-6736(92)91717-M; Blackstone E H, 1992, J Heart Valve Dis, V1, P3; GRANDJEAN PA, 1991, J CARDIAC SURG, V6, P80; MAGOVERN JA, 1993, ANN THORAC SURG, V56, P418, DOI 10.1016/0003-4975(93)90873-G; 1993, UPDATED INFORMATION	6	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1658	1660		10.1001/jama.1994.03510450030016	http://dx.doi.org/10.1001/jama.1994.03510450030016			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182836				2022-12-28	WOS:A1994NN11700015
J	TARCZYHORNOCH, P; HODSON, WA				TARCZYHORNOCH, P; HODSON, WA			NEONATOLOGY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INHALED NITRIC-OXIDE; PERSISTENT PULMONARY-HYPERTENSION; LIQUID VENTILATION; NEWBORN; GAS				TARCZYHORNOCH, P (corresponding author), UNIV WASHINGTON,SCH MED,SEATTLE,WA, USA.			Tarczy-Hornoch, Peter/0000-0003-1047-179X				BERGER JI, 1993, AM REV RESPIR DIS, V147, P1080, DOI 10.1164/ajrccm/147.5.1080; DAVIDSON D, 1993, AM REV RESPIR DIS, V147, P1078, DOI 10.1164/ajrccm/147.5.1078; FUHRMAN BP, 1991, CRIT CARE MED, V19, P712, DOI 10.1097/00003246-199105000-00019; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; GREENSPAN JS, 1990, J PEDIATR-US, V117, P106, DOI 10.1016/S0022-3476(05)82457-6; KINSELLA JP, 1993, J PEDIATR-US, V123, P103, DOI 10.1016/S0022-3476(05)81551-3; MOHLEBOETANI JC, 1993, JAMA-J AM MED ASSOC, V270, P1442, DOI 10.1001/jama.270.12.1442; NEWMAN TB, 1992, PEDIATRICS, V89, P809; OSHEA TM, 1992, PEDIATRICS, V90, P888; ROBERTS JD, 1992, LANCET, V340, P818, DOI 10.1016/0140-6736(92)92686-A; SHAFFER TH, 1992, PEDIATR PULM, V14, P102, DOI 10.1002/ppul.1950140208; VANDEBOR M, 1992, PEDIATRICS, V89, P359; WATCHKO JF, 1992, PEDIATRICS, V90, P707; WOLFSON MR, 1992, J APPL PHYSIOL, V72, P1024, DOI 10.1152/jappl.1992.72.3.1024; 1992, AM COLLEGE OBSTETRIC, V170, P1; 1992, PEDIATRICS, V89, P819; 1992, PEDIATRICS, V90, P775	17	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1682	1684						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182850				2022-12-28	WOS:A1994NN11700029
J	ZOOK, EG				ZOOK, EG			PLASTIC-SURGERY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECONSTRUCTION				ZOOK, EG (corresponding author), SO ILLINOIS UNIV,SCH MED,SPRINGFIELD,IL, USA.							KHOURI RK, 1991, PLAST RECONSTR SURG, V87, P108, DOI 10.1097/00006534-199101000-00017; MCCARTHY JG, 1992, PLAST RECONSTR SURG, V89, P1, DOI 10.1097/00006534-199289010-00001; MUSTOE TA, 1994, ARCH SURG-CHICAGO, V129, P213; POSNICK JC, 1993, NEUROSURGERY, V32, P785, DOI 10.1227/00006123-199305000-00011; POSNICK JC, 1993, PLAST RECONSTR SURG, V92, P1027, DOI 10.1097/00006534-199311000-00005; POSNICK JC, 1994, PLAST RECONSTR SURG, V93, P11; ROBSON MC, 1992, LANCET, V339, P23, DOI 10.1016/0140-6736(92)90143-Q; SHAFFER JW, 1993, 62ND ANN M AM SOC PL; SHAH M, 1992, LANCET, V339, P213, DOI 10.1016/0140-6736(92)90009-R; ZAMBONI WA, 1993, PLAST RECONSTR SURG, V91, P1110, DOI 10.1097/00006534-199305000-00022; ZUKER RM, 1992, CLIN PLAST SURG, V19, P833	11	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1703	1704						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182862				2022-12-28	WOS:A1994NN11700041
J	WHITEHEAD, M				WHITEHEAD, M			WHO CARES ABOUT EQUITY IN THE NHS	BRITISH MEDICAL JOURNAL			English	Article							HEALTH	The concept of equity in relation to the National Health Service in Britain encompasses not one but at least eight distinct principles. Until the 1980s the NHS had a good record of incorporating these principles into practice. Throughout the 1980s, however, there has been a pronounced change, with the gradual introduction of business values into the service, culminating in the market based reforms of the 1990s. Several recent policies seem to be taking the NHS away from the goal of an equitable system -for example, the new arrangements for community care and the incentives within contracting to select patients on financial grounds. To restore equity as a value demands priority for ethical values, monitoring of policies for their effects on equity, some national planning, and a new debate about the entitlement to services such as continuing care.			WHITEHEAD, M (corresponding author), OLD SCH,ASH MAGNA,WHITCHURCH SY13 4DR,SHROPS,ENGLAND.							BEECHAM L, 1994, BRIT MED J, V308, P11, DOI 10.1136/bmj.308.6920.11; BUTLER J, 1994, EVALUATING NHS REFOR; CALMAN M, 1993, GOING PRIVATE WHY PE; COULTER A, 1993, BRIT MED J, V306, P433, DOI 10.1136/bmj.306.6875.433; DIXON J, IN PRESS BMJ; GILLAM SJ, 1992, BRIT J GEN PRACT, V42, P54; GLENNERSTER H, 1992, FOOTHOLD FUNDHOLDING; Godber G., 1975, HLTH SERVICE PRESENT; GRAY A, 1945, MINISTRY HLTH HOSPIT; HOLLAND WW, 1986, LANCET, V2, P1089; KLEIN R, 1989, POLITICS NATIONAL HL; Laing W., 1992, GOING PRIVATE INDEPE; Light D, 1990, Health Serv J, V100, P1513; Merrison A., 1979, REPORT ROYAL COMMISS; MOORE W, 1992, HLTH SERVICE J  0305, P6; PARSONS LG, 1945, MINISTRY HLTH HOSPIT; PRINGLE M, 1989, BRIT MED J, V299, P470, DOI 10.1136/bmj.299.6697.470; ROYSTON GHD, 1992, SOCIO ECON PLAN SCI, V26, P169, DOI 10.1016/0038-0121(92)90008-S; SCHWARTZ WB, 1984, NEW ENGL J MED, V310, P52, DOI 10.1056/NEJM198401053100120; SHELDON TA, 1993, BRIT MED J, V306, P835, DOI 10.1136/bmj.306.6881.835; VANDOOSLAER E, 1993, EQUITY FINANCE DELIV; WEBSTER C, 1988, HIST NHS, V1; 1994, COLLEGE SURVEY SURGI; 1992, COMPENDIUM HLTH STAT; 1990, NHS CONTINUING CARE; 1993, COMMUNITY CARE FUNDI, P309; 1937, BRIT HLTH SERVICE; 1991, FINANCING PRIVATE RE	28	40	40	1	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 14	1994	308	6939					1284	1287		10.1136/bmj.308.6939.1284	http://dx.doi.org/10.1136/bmj.308.6939.1284			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM147	8205024	Green Published			2022-12-28	WOS:A1994NM14700024
J	STEHLE, T; YAN, YW; BENJAMIN, TL; HARRISON, SC				STEHLE, T; YAN, YW; BENJAMIN, TL; HARRISON, SC			STRUCTURE OF MURINE POLYOMAVIRUS COMPLEXED WITH AN OLIGOSACCHARIDE RECEPTOR FRAGMENT	NATURE			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; SIALYLOLIGOSACCHARIDE RECEPTORS; SIALIC-ACID; RESOLUTION; BINDING; VP1	THE polyomaviruses are non-enveloped, icosahedrally symmetrical particles with circular double-stranded DNA genomes(1,2). The outer shell of the virion contains 360 copies of viral protein VP1 (M(r) similar to 42K) arranged in pentamers(3). We report here the structure at 3.65 Angstrom resolution of murine polyomavirus ('polyoma') complexed with an oligosaccharide receptor fragment. This structure has been determined using the previously described model of simian virus 40 (SV40)(4). Although very similar in structure to SV40, polyoma has interesting biological differences. Cell-surface N-acetyl neuraminic acid (sialic acid) is required for polyoma infectivity, but not for SV40. Polyoma attaches to the surface of susceptible cells by stereospecific recognition of oligosaccharides terminating in (alpha 2,3)-linked sialic acid(5,6). Studies of pathogenicity show that the specificity of viral binding to such oligosaccharides is an important determinant of the virus' ability to establish a disseminated infection and to induce tumours in the natural host. The complex described here shows how polyoma recognizes the receptor fragment and how strains with different receptor specificities can distinguish between alternative ligands. The results also suggest an explanation for the large disparity in pathogenicity exhibited by strains differing in only one amino-acid residue of Vp1(7,8).	HARVARD UNIV,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02138; HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115	Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	STEHLE, T (corresponding author), HARVARD UNIV,DEPT BIOCHEM & MOLEC BIOL,CAMBRIDGE,MA 02138, USA.							BRICOGNE G, 1976, ACTA CRYSTALLOGR A, V32, P832, DOI 10.1107/S0567739476001691; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CAHAN LD, 1983, VIROLOGY, V130, P281, DOI 10.1016/0042-6822(83)90083-1; CRAWFORD LV, 1969, FUNDAMENTAL TECHNIQU, P75; Eckhart W., 1990, VIROLOGY, P1593; Flint S. J, 1981, DNA TUMOR VIRUSES; FREUND R, 1991, J VIROL, V65, P335, DOI 10.1128/JVI.65.1.335-341.1991; FREUND R, 1991, J VIROL, V65, P350, DOI 10.1128/JVI.65.1.350-355.1991; FRIED H, 1981, VIROLOGY, V109, P188, DOI 10.1016/0042-6822(81)90485-2; JONES TA, 1985, METHOD ENZYMOL, V115, P157; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; POPPE L, 1989, EUR J BIOCHEM, V180, P337, DOI 10.1111/j.1432-1033.1989.tb14653.x; QUIOCHO FA, 1989, PURE APPL CHEM, V61, P1293, DOI 10.1351/pac198961071293; RAYMENT I, 1982, NATURE, V295, P110, DOI 10.1038/295110a0; SABESAN S, 1991, CARBOHYD RES, V218, P27, DOI 10.1016/0008-6215(91)84084-R; SAUTER NK, 1992, BIOCHEMISTRY-US, V31, P9609, DOI 10.1021/bi00155a013; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; WRIGHT CS, 1990, J MOL BIOL, V215, P635, DOI 10.1016/S0022-2836(05)80174-3; 1979, CCP4 SERC COLL COMP	22	267	276	0	21	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 12	1994	369	6476					160	163		10.1038/369160a0	http://dx.doi.org/10.1038/369160a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NK971	8177322				2022-12-28	WOS:A1994NK97100053
J	PALLADINO, F; LAROCHE, T; GILSON, E; AXELROD, A; PILLUS, L; GASSER, SM				PALLADINO, F; LAROCHE, T; GILSON, E; AXELROD, A; PILLUS, L; GASSER, SM			SIR3 AND SIR4 PROTEINS ARE REQUIRED FOR THE POSITIONING AND INTEGRITY OF YEAST TELOMERES	CELL			English	Article							SALIVARY-GLAND NUCLEI; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; CHROMATIN STRUCTURE; TOPOISOMERASE-II; BINDING-PROTEIN; DNA; RAP1; REPLICATION; CHROMOSOMES	Heritable inactivation of genes occurs in specific chromosomal domains located at the silent mating type loci and at telomeres of S. cerevisiae. The SIR genes (for silent information regulators) are trans-acting factors required for this repression mechanism. We show here that the SIR3 and SIR4 gene products have a sub-nuclear localization similar to the telomere-associated RAP1 protein, which is found primarily in foci at the nuclear periphery of fixed yeast spheroplasts. In strains defficient for either SIR3 or SIR4, telomeres lose their perinuclear localization, as monitored by RAP1 immunofluorescence. The length of the telomeric repeat shortens in sir3 and sir4 mutant strains, and the mitotic stability of chromosome V is reduced. These data suggest that SIR3 and SIR4 are required for both the integrity and subnuclear localization of yeast telomeres, the loss of which correlates with loss of telomere-associated gene repression.	UNIV CALIF BERKELEY,DEPT MOLEC & CELLULAR BIOL,BERKELEY,CA 94720; UNIV COLORADO,DEPT MOLEC CELLULAR & DEV BIOL,BOULDER,CO 80309	University of California System; University of California Berkeley; University of Colorado System; University of Colorado Boulder	PALLADINO, F (corresponding author), SWISS INST EXPTL CANC RES,CH-1066 EPALINGES,SWITZERLAND.			Gasser, Susan/0000-0003-3610-9123	NIGMS NIH HHS [GM31105] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031105, R37GM031105] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; BOUTEILLE M, 1974, CELL NUCLEUS, V1, P5; BRAND AH, 1987, CELL, V51, P709, DOI 10.1016/0092-8674(87)90094-8; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P210, DOI 10.1128/MCB.8.1.210; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; DIFFLEY JFX, 1989, NATURE, V342, P24, DOI 10.1038/342024a0; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; GASSER SM, 1986, J MOL BIOL, V188, P613, DOI 10.1016/S0022-2836(86)80010-9; GILSON E, 1993, J MOL BIOL, V231, P293, DOI 10.1006/jmbi.1993.1283; Gilson Eric, 1993, Trends in Cell Biology, V3, P128, DOI 10.1016/0962-8924(93)90175-Z; GOTTSCHLING DE, 1992, P NATL ACAD SCI USA, V89, P4062, DOI 10.1073/pnas.89.9.4062; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801; HARLOW E, 1988, ANTIBODIES LABORATOR; HARTWELL LH, 1985, GENETICS, V110, P381; HEGEMANN JH, 1988, MOL CELL BIOL, V8, P2523, DOI 10.1128/MCB.8.6.2523; HOCHSTRASSER M, 1986, J CELL BIOL, V102, P112, DOI 10.1083/jcb.102.1.112; HOFMANN JFX, 1989, CELL, V57, P725, DOI 10.1016/0092-8674(89)90788-5; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; KIMMERLY WJ, 1987, MOL CELL BIOL, V7, P4225, DOI 10.1128/MCB.7.12.4225; KLEIN F, 1992, J CELL BIOL, V117, P935, DOI 10.1083/jcb.117.5.935; KYRION G, 1993, GENE DEV, V7, P1146, DOI 10.1101/gad.7.7a.1146; KYRION G, 1992, MOL CELL BIOL, V12, P5159, DOI 10.1128/MCB.12.11.5159; LAURENSON P, 1992, MICROBIOL REV, V56, P543, DOI 10.1128/MMBR.56.4.543-560.1992; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; LIPPS HJ, 1982, P NATL ACAD SCI-BIOL, V79, P2495, DOI 10.1073/pnas.79.8.2495; LONGTINE MS, 1989, CURR GENET, V16, P225, DOI 10.1007/BF00422108; LONGTINE MS, 1992, MOL CELL BIOL, V12, P1997, DOI 10.1128/MCB.12.5.1997; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; MAHONEY DJ, 1989, MOL CELL BIOL, V9, P4621, DOI 10.1128/MCB.9.11.4621; MARSHALL M, 1987, MOL CELL BIOL, V7, P4441, DOI 10.1128/MCB.7.12.4441; MATHOG D, 1984, NATURE, V308, P414, DOI 10.1038/308414a0; MCCARROLL RM, 1988, CELL, V54, P5135; PALLADINO F, 1994, IN PRESS COLD SPRING, V58; Rabl C, 1885, MORPHOL JB, V10, P214; RINE J, 1987, GENETICS, V116, P9; Rose MD., 1990, METHODS YEAST GENETI; RUTHER U, 1983, EMBO J, V2, P1791, DOI 10.1002/j.1460-2075.1983.tb01659.x; Sandell L L, 1992, Trends Cell Biol, V2, P10, DOI 10.1016/0962-8924(92)90138-D; SHOEMAN RL, 1990, J BIOL CHEM, V265, P9055; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; SIKORSKI RS, 1989, GENETICS, V122, P19; SINGH J, 1992, GENE DEV, V6, P186, DOI 10.1101/gad.6.2.186; SUSSEL L, 1991, P NATL ACAD SCI USA, V88, P7749, DOI 10.1073/pnas.88.17.7749; VOURCH C, 1993, EXP CELL RES, V205, P142, DOI 10.1006/excr.1993.1068; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; WRIGHT JH, 1992, GENE DEV, V6, P197, DOI 10.1101/gad.6.2.197	50	353	361	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 5	1993	75	3					543	555		10.1016/0092-8674(93)90388-7	http://dx.doi.org/10.1016/0092-8674(93)90388-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MF830	8221893				2022-12-28	WOS:A1993MF83000016
J	RABENECK, L; GYORKEY, F; GENTA, RM; GYORKEY, P; FOOTE, LW; RISSER, JMH				RABENECK, L; GYORKEY, F; GENTA, RM; GYORKEY, P; FOOTE, LW; RISSER, JMH			THE ROLE OF MICROSPORIDIA IN THE PATHOGENESIS OF HIV-RELATED CHRONIC DIARRHEA	ANNALS OF INTERNAL MEDICINE			English	Article						HUMAN IMMUNODEFICIENCY VIRUS INFECTIONS; DIARRHEA; ASTERISK-MICROSPORIDIA INFECTIONS; ENTEROCYTOZOON-BIENEUSI; ACQUIRED IMMUNODEFICIENCY SYNDROME	ACQUIRED IMMUNODEFICIENCY SYNDROME; SMALL-INTESTINAL MICROSPORIDIOSIS; AIDS PATIENTS; ENTEROCYTOZOON-BIENEUSI; PREVALENCE; MICROSCOPY	Objective: To determine whether infection with Microsporidia leads to diarrhea in patients with human immunodeficiency virus (HIV) infection. Design: Case-control study. Setting: Primary care outpatient HIV clinic at a Veterans Affairs medical center. Patients: One hundred six HIV-infected men, 55 with and 51 without chronic diarrhea. Measurements: Each patient underwent upper endoscopy and flexible sigmoidoscopy to obtain duodenal, rectal, and sigmoid colonic biopsy specimens. At the time of endoscopy, a fresh stool was obtained for culture, ova and parasite assessment, and Cryptosporidium examination. Biopsy tissue was examined using electron microscopy to detect Microsporidia. Results: The microsporidian parasite Enterocytozoon bieneusi was detected in the duodenal biopsy specimens of 31 of 106 men (29%); 24 of 106 men (23%) had other enteric pathogens. No significant difference was observed in the occurrence of microsporidiosis in patients with (18 of 55 [33%]) and without (13 of 51 [25%]) chronic diarrhea (odds ratio, 1.42; 95% CI, 0.61 to 3.31). A similar nonsignificant difference was observed after controlling for CD4 count and other enteric pathogens (odds ratio, 1.66; 95% CI, 0.68 to 4.06). Among patients with microsporidiosis, no difference was observed in the intensity of infection (defined by the presence of few, moderate, or abundant organisms) among cases and controls (P > 0.2). Conclusions: This is the first report to document the presence of E. bieneusi in HIV-positive patients without gastrointestinal symptoms. No significant difference was observed in the occurrence of E. bieneusi infection in HIV-infected patients with or without chronic diarrhea. Thus, the association between microsporidiosis and diarrhea, if one exists, may not be as strong as is currently believed.	BAYLOR COLL MED, HOUSTON, TX 77030 USA; VET AFFAIRS ELECTRON MICROSCOPY PROGRAM, HOUSTON, TX USA; VET AFFAIRS RES CTR AIDS & HIV INFECT, HOUSTON, TX USA	Baylor College of Medicine	RABENECK, L (corresponding author), VET AFFAIRS MED CTR, 2002 HOLCOMBE BLVD, HOUSTON, TX 77030 USA.				NCRR NIH HHS [RR-05425] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Bryan R T, 1991, Prog Clin Parasitol, V2, P1; CALI A, 1990, J PROTOZOOL, V37, P145, DOI 10.1111/j.1550-7408.1990.tb05885.x; CANNING EU, 1990, T ROY SOC TROP MED H, V84, P181, DOI 10.1016/0035-9203(90)90247-C; CHLEBOWSKI RT, 1989, AM J GASTROENTEROL, V84, P1288; Churukian CJ, 1982, J HISTOTECHNOL, V5, P127; DOBBINS WO, 1985, GASTROENTEROLOGY, V88, P738, DOI 10.1016/0016-5085(85)90145-3; GOODGAME RW, 1993, J INFECT DIS, V167, P704, DOI 10.1093/infdis/167.3.704; GREENSON JK, 1991, ANN INTERN MED, V114, P366, DOI 10.7326/0003-4819-114-5-366; KOTLER DP, 1990, ANN INTERN MED, V113, P444; LAUGHON BE, 1988, GASTROENTEROLOGY, V94, P984, DOI 10.1016/0016-5085(88)90557-4; MODIGLIANI R, 1985, GUT, V26, P179, DOI 10.1136/gut.26.2.179; NELSON JA, 1988, LANCET, V1, P259; ORENSTEIN JM, 1990, HUM PATHOL, V21, P475; ORENSTEIN JM, 1992, AIDS, V6, P195, DOI 10.1097/00002030-199202000-00009; POL S, 1993, NEW ENGL J MED, V328, P95, DOI 10.1056/NEJM199301143280204; RIJPSTRA AC, 1988, J INFECT DIS, V157, P827, DOI 10.1093/infdis/157.4.827; SCHATTENKERK JKME, 1991, LANCET, V337, P895, DOI 10.1016/0140-6736(91)90215-B; SHADDUCK JA, 1989, REV INFECT DIS, V11, P203; WEBER R, 1992, NEW ENGL J MED, V326, P161, DOI 10.1056/NEJM199201163260304; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; 1987, MMWR, V36	21	119	119	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	1993	119	9					895	899		10.7326/0003-4819-119-9-199311010-00005	http://dx.doi.org/10.7326/0003-4819-119-9-199311010-00005			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MD711	8215001				2022-12-28	WOS:A1993MD71100005
J	KANAGAWA, O; VAUPEL, BA; GAYAMA, S; KOEHLER, G; KOPF, M				KANAGAWA, O; VAUPEL, BA; GAYAMA, S; KOEHLER, G; KOPF, M			RESISTANCE OF MICE DEFICIENT IN IL-4 TO RETROVIRUS-INDUCED IMMUNODEFICIENCY SYNDROME (MAIDS)	SCIENCE			English	Article							T-CELLS; LYMPHOCYTES-T; VIRUS; AIDS; INFECTION; SUSCEPTIBILITY; PATHOGENESIS; SUPERANTIGEN; PROGRESSION; DISEASE	The murine acquired immunodeficiency syndrome (MAIDS) is induced by a defective murine leukemia virus and has many symptoms similar to those found in patients infected with the human immunodeficiency virus. The presence of both B cells and CD4+ T cells is critical for the development of the disease. Furthermore, a Th2 cytokine response dominates during the progression of the disease. When interleukin-4 (IL-4)-deficient mice that are defective in Th2 cytokine responses were infected, there was no lethality, and the development of the T cell abnormalities associated with MAIDS was delayed. These data suggest that IL-4 or a Th2 response is involved in the development of retrovirus-induced immunodeficiency in mice.	MAX PLANCK INST IMMUNBIOL,W-7800 FREIBURG,GERMANY	Max Planck Society	KANAGAWA, O (corresponding author), WASHINGTON UNIV,SCH MED,DEPT PATHOL & MED,ST LOUIS,MO 63110, USA.		Kopf, Manfred/B-6907-2009	Kopf, Manfred/0000-0002-0628-7140	PHS HHS [A130803] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BRADLEY LM, 1991, J EXP MED, V174, P547, DOI 10.1084/jem.174.3.547; BUDD RC, 1987, J IMMUNOL, V138, P3120; CHATTOPADHYAY SK, 1989, P NATL ACAD SCI USA, V86, P3862, DOI 10.1073/pnas.86.10.3862; CLERICI M, 1993, IMMUNOL TODAY, V14, P107, DOI 10.1016/0167-5699(93)90208-3; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; GAZZINELLI RT, 1992, J IMMUNOL, V148, P182; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; HARTLEY JW, 1989, J VIROL, V63, P1223, DOI 10.1128/JVI.63.3.1223-1231.1989; HUANG M, 1992, J VIROL, V66, P2398, DOI 10.1128/JVI.66.4.2398-2406.1992; HUGIN AW, 1991, SCIENCE, V252, P424, DOI 10.1126/science.1850169; JOLICOEUR P, 1991, FASEB J, V5, P2398, DOI 10.1096/fasebj.5.10.2065888; KANAGAWA O, 1992, J IMMUNOL, V149, P9; KANAGAWA O, UNPUB; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; Kopf M.H., UNPUB; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; LUCEY DR, 1990, AIDS RES HUM RETROV, V6, P427, DOI 10.1089/aid.1990.6.427; MAKINO M, 1991, IMMUNOGENETICS, V33, P345, DOI 10.1007/BF00216693; MORSE HC, 1992, AIDS, V6, P607, DOI 10.1097/00002030-199207000-00001; MOSIER DE, 1987, J EXP MED, V165, P1737, DOI 10.1084/jem.165.6.1737; MURALIDHAR G, 1992, J EXP MED, V175, P1589, DOI 10.1084/jem.175.6.1589; SWAIN SL, 1990, J IMMUNOL, V145, P3796; TEPPER RI, 1990, CELL, V62, P457, DOI 10.1016/0092-8674(90)90011-3	23	111	120	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 8	1993	262	5131					240	242		10.1126/science.8211142	http://dx.doi.org/10.1126/science.8211142			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA665	8211142				2022-12-28	WOS:A1993MA66500034
J	SCHWARTZ, DC; LI, XJ; HERNANDEZ, LI; RAMNARAIN, SP; HUFF, EJ; WANG, YK				SCHWARTZ, DC; LI, XJ; HERNANDEZ, LI; RAMNARAIN, SP; HUFF, EJ; WANG, YK			ORDERED RESTRICTION MAPS OF SACCHAROMYCES-CEREVISIAE CHROMOSOMES CONSTRUCTED BY OPTICAL MAPPING	SCIENCE			English	Article							INDIVIDUAL DNA-MOLECULES; GEL-ELECTROPHORESIS; RESOLUTION; ORIENTATION; GENOME; YEAST; MODEL; CHROMATIN; INSITU	A light microscope-based technique for rapidly constructing ordered physical maps of chromosomes has been developed. Restriction enzyme digestion of elongated individual DNA molecules (about 0.2 to 1.0 megabases in size) was imaged by fluorescence microscopy after fixation in agarose gel. The size of the resulting individual restriction fragments was determined by relative fluorescence intensity and apparent molecular contour length. Ordered restriction maps were then created from genomic DNA without reliance on cloned or amplified sequences for hybridization or analytical gel electrophoresis. Initial application of optical mapping is described for Saccharomyces cerevisiae chromosomes.			SCHWARTZ, DC (corresponding author), NYU,DEPT CHEM,WM KECK LAB BIOMOLEC IMAGING,NEW YORK,NY 10003, USA.				NHGRI NIH HHS [HG00225-01] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000225] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ATKINS EDT, 1992, BIOPOLYMERS, V32, P911, DOI 10.1002/bip.360320803; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CAVALLISFORZA LL, 1990, AM J HUM GENET, V46, P649; CHUMAKOV I, 1992, NATURE, V359, P380, DOI 10.1038/359380a0; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Doi M., 1988, THEORY POLYM DYNAMIC; GURRIERI S, 1990, BIOCHEMISTRY-US, V29, P3401; HENG HHQ, 1992, P NATL ACAD SCI USA, V89, P9509, DOI 10.1073/pnas.89.20.9509; HOLZWARTH G, 1987, NUCLEIC ACIDS RES, V15, P10031, DOI 10.1093/nar/15.23.10031; LAWRENCE JB, 1988, CELL, V52, P51; LINK AJ, 1991, GENETICS, V127, P681; MAIER E, 1992, NAT GENET, V1, P273, DOI 10.1038/ng0792-273; MANUELIDIS L, 1982, J CELL BIOL, V95, P619, DOI 10.1083/jcb.95.2.619; NOOLANDI J, 1989, SCIENCE, V243, P1456, DOI 10.1126/science.2928779; Roberts T M, 1975, CRC Crit Rev Biochem, V3, P349; SCHWARTZ D, 1985, THESIS COLUMBIA U; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; SCHWARTZ DC, 1989, NATURE, V338, P520, DOI 10.1038/338520a0; SMITH SB, 1989, SCIENCE, V243, P203, DOI 10.1126/science.2911733; STELLWAGEN J, 1989, NUCLEIC ACIDS RES, V17, P1537, DOI 10.1093/nar/17.4.1537; VANDENENGH G, 1992, SCIENCE, V257, P1410, DOI 10.1126/science.1388286; YANAGIDA M, 1986, APPLICATIONS FLUORES, P321; ZIMM BH, 1991, J CHEM PHYS, V94, P2187, DOI 10.1063/1.459890	23	285	315	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 1	1993	262	5130					110	114		10.1126/science.8211116	http://dx.doi.org/10.1126/science.8211116			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ635	8211116				2022-12-28	WOS:A1993LZ63500035
J	BERNER, ES; WEBSTER, GD; SHUGERMAN, AA; JACKSON, JR; ALGINA, J; BAKER, AL; BALL, EV; COBBS, CG; DENNIS, VW; FRENKEL, EP; HUDSON, LD; MANCALL, EL; RACKLEY, CE; TAUNTON, D				BERNER, ES; WEBSTER, GD; SHUGERMAN, AA; JACKSON, JR; ALGINA, J; BAKER, AL; BALL, EV; COBBS, CG; DENNIS, VW; FRENKEL, EP; HUDSON, LD; MANCALL, EL; RACKLEY, CE; TAUNTON, D			PERFORMANCE OF 4 COMPUTER-BASED DIAGNOSTIC SYSTEMS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DECISION-SUPPORT SYSTEM; MEDICAL REFERENCE QMR; KNOWLEDGE BASE; CONSULTATION SERVICE; INTERNIST-I; DXPLAIN; ILIAD	Background. Computer-based diagnostic systems are available commercially, but there has been limited evaluation of their performance. We assessed the diagnostic capabilities of four internal medicine diagnostic systems: Dxplain, Iliad, Meditel, and QMR. Methods. Ten expert clinicians created a set of 105 diagnostically challenging clinical case summaries involving actual patients. Clinical data were entered into each program with the vocabulary provided by the program's developer. Each of the systems produced a ranked list of possible diagnoses for each patient, as did the group of experts. We calculated scores on several performance measures for each computer program. Results. No single computer program scored better than the others on all performance measures. Among all cases and all programs, the proportion of correct diagnoses ranged from 0.52 to 0.71, and the mean proportion of relevant diagnoses ranged from 0.19 to 0.37. On average, less than half the diagnoses on the experts' original list of reasonable diagnoses were suggested by any of the programs. However, each program suggested an average of approximately two additional diagnoses per case that the experts found relevant but had not originally considered. Conclusions. The results provide a profile of the strengths and limitations of these computer programs. The programs should be used by physicians who can identify and use the relevant information and ignore the irrelevant information that can be produced.	INFORMED INC,ST DAVIDS,PA; UNIV FLORIDA,GAINESVILLE,FL; UNIV CHICAGO,CHICAGO,IL 60637; CLEVELAND CLIN FDN,CLEVELAND,OH 44195; UNIV WASHINGTON,SEATTLE,WA 98195; HAHNEMANN UNIV,PHILADELPHIA,PA 19102; GEORGETOWN UNIV,WASHINGTON,DC; BAPTIST MED CTR MONTCLAIR,BIRMINGHAM,AL; UNIV TEXAS,DALLAS,TX 75230	State University System of Florida; University of Florida; University of Chicago; Cleveland Clinic Foundation; University of Washington; University of Washington Seattle; Drexel University; Georgetown University; University of Texas System; University of Texas Dallas	BERNER, ES (corresponding author), UNIV ALABAMA,SCH MED,OFF EDUC DEV,933 19TH ST S,BIRMINGHAM,AL 35294, USA.			Algina, James/0000-0001-6924-655X; Berner, Eta/0000-0003-4319-2949	NATIONAL LIBRARY OF MEDICINE [R01LM005125] Funding Source: NIH RePORTER; NLM NIH HHS [LM05125] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		BANKOWITZ RA, 1989, METHOD INFORM MED, V28, P352; BANKOWITZ RA, 1992, METHOD INFORM MED, V31, P3; BANKOWITZ RA, 1989, ANN INTERN MED, V110, P824, DOI 10.7326/0003-4819-110-10-824; BANKOWITZ RA, 1987, 11TH P ANN S COMP AP, P68; BANKOWITZ RA, 1991, 15TH P ANN S COMP AP, P609; BARNESS LA, 1974, AM J DIS CHILD, V127, P852, DOI 10.1001/archpedi.1974.02110250078011; BARNETT GO, 1982, NEW ENGL J MED, V307, P493, DOI 10.1056/NEJM198208193070808; BARNETT GO, 1987, JAMA-J AM MED ASSOC, V258, P67, DOI 10.1001/jama.258.1.67; BERMAN L, 1991, METHOD INFORM MED, V30, P90; BLEICH HL, 1971, NEW ENGL J MED, V284, P141; DEDOMBAL FT, 1989, INT J BIOMED COMPUT, V24, P9, DOI 10.1016/0020-7101(89)90003-2; DETORE AW, 1988, AM J MED, V85, P399, DOI 10.1016/0002-9343(88)90593-1; FELDMAN MJ, 1991, COMPUT METH PROG BIO, V35, P261, DOI 10.1016/0169-2607(91)90004-D; FIRST MB, 1985, COMPUT BIOMED RES, V18, P137, DOI 10.1016/0010-4809(85)90041-2; Georgakis D. C., 1990, Fourteenth Annual Symposium on Computer Applications in Medical Care. Standards in Medical Informatics. A Conference of the American Medical Informatics Association, P815; Giuse D. A., 1990, Artificial Intelligence in Medicine, V2, P21, DOI 10.1016/0933-3657(90)90014-I; GUTHRIE D, 1981, PSYCHOL BULL, V90, P189, DOI 10.1037/0033-2909.90.1.189; HAMMERSLEY JR, 1988, 12TH P ANN S COMP AP, P229; HECKERLING PS, 1991, MED INFORM, V16, P363, DOI 10.3109/14639239109067658; LAU LM, 1992, COMPUT BIOMED RES, V25, P314, DOI 10.1016/0010-4809(92)90022-3; MASARIE FE, 1985, COMPUT BIOMED RES, V18, P458, DOI 10.1016/0010-4809(85)90022-9; MIDDLETON B, 1991, METHOD INFORM MED, V30, P256; MILLER R, 1986, M D COMPUT, V3, P34; Miller R. A., 1992, MEDINFO 92. Proceedings of the Seventh World Congress on Medical Informatics, P512; MILLER RA, 1990, J MED PHILOS, V15, P581, DOI 10.1093/jmp/15.6.581; MILLER RA, 1990, METHOD INFORM MED, V29, P1; MILLER RA, 1982, NEW ENGL J MED, V307, P468, DOI 10.1056/NEJM198208193070803; MILLER RA, 1986, WESTERN J MED, V145, P816; MILLER RA, 1994, J AM MED INFORM ASSN, V1, P8, DOI 10.1136/jamia.1994.95236141; NELSON S J, 1985, Journal of Medical Systems, V9, P379, DOI 10.1007/BF00992575; OSHEA JS, 1975, AM J DIS CHILD, V129, P199, DOI 10.1001/archpedi.1975.02120390033007; RAND TG, 1992, ACP OBS, V12, P10; REGGIA JA, 1985, COMPUTER ASSISTED ME; Salomon G., 1991, EDUC RESEARCHER, V20, P2, DOI DOI 10.3102/0013189X020003002; SCHWARTZ WB, 1987, NEW ENGL J MED, V316, P685, DOI 10.1056/NEJM198703123161109; SHAFFER JP, 1986, J AM STAT ASSOC, V81, P826, DOI 10.2307/2289016; SHORTLIFFE EH, 1987, JAMA-J AM MED ASSOC, V258, P61, DOI 10.1001/jama.258.1.61; SHORTLIFFE EH, 1993, ARTIF INTELL MED, V5, P93, DOI 10.1016/0933-3657(93)90011-Q; SHORTLIFFE EH, 1990, MED INFORMATICS COMP; SWENDER PT, 1974, AM J DIS CHILD, V127, P859, DOI 10.1001/archpedi.1974.02110250085012; Trace D., 1990, Fourteenth Annual Symposium on Computer Applications in Medical Care. Standards in Medical Informatics. A Conference of the American Medical Informatics Association, P635; VONESH EF, 1986, BIOMETRICS, V42, P601, DOI 10.2307/2531210; WARNER HR, 1989, METHOD INFORM MED, V28, P370; WAXMAN HS, 1990, MEDICINE, V69, P125, DOI 10.1097/00005792-199005000-00001; Weber P. S., 2001, KNOWLEDGE COUPLING N, V37, P227; WEXLER JR, 1975, AM J DIS CHILD, V129, P203, DOI 10.1001/archpedi.1975.02120390037008; 1991, MEDITEL COMPUTER ASS; 1992, QMR QUICK MED REFERE; 1992, ILIAD; 1992, DXPLAIN	50	198	202	0	3	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 23	1994	330	25					1792	1796		10.1056/NEJM199406233302506	http://dx.doi.org/10.1056/NEJM199406233302506			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR295	8190157				2022-12-28	WOS:A1994NR29500006
J	RAYMAN, RB; DAVIS, JR				RAYMAN, RB; DAVIS, JR			AVIATION MEDICINE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERFORMANCE		AMER AIRLINES INC,DALLAS FT WORTH AIRP,TX		RAYMAN, RB (corresponding author), AEROSP MED ASSOC,ALEXANDRIA,VA 22301, USA.							ANDERSON SA, 1994, FINAL REPORT PHASE 3; BROADHURST AD, 1980, AVIAT SPACE ENVIR MD, V51, P176; COTTRELL JJ, 1989, JAMA-J AM MED ASSOC, V262, P1653, DOI 10.1001/jama.262.12.1653; HASTINGS JS, 1993, FEDERAL AIR SURG WIN; HORDINSKY JR, 1991, AM912 US DEP TRANSP; JOHNSTON RS, 1977, NASA SP377 REP, pCH18; MAPOU RL, 1993, AVIAT SPACE ENVIR MD, V64, P158; NICOGOSSIAN AE, 1985, FUNDAMENTALS AEROSPA, pCH29; NICOGOSSIAN AE, 1989, SPACE PHYSL MED, pCH12; RAYMAN RB, 1990, CLIN AVIATION MED, P122; RICHARDSON LA, 1993, 64TH ANN SCI M AER M, P143; WHINNERY JE, 1988, AVIAT SPACE ENVIR MD, V59, P711; 1982, JAMA-J AM MED ASSOC, V247, P1007; 1993, PRESIDENTS HLTH SECU, P26; 1992, AVIAT SPACE ENV MED, V63, P375	15	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1657	1658						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182835				2022-12-28	WOS:A1994NN11700014
J	RETTIG, J; HEINEMANN, SH; WUNDER, F; LORRA, C; PARCEJ, DN; DOLLY, JO; PONGS, O				RETTIG, J; HEINEMANN, SH; WUNDER, F; LORRA, C; PARCEJ, DN; DOLLY, JO; PONGS, O			INACTIVATION PROPERTIES OF VOLTAGE-GATED K+ CHANNELS ALTERED BY PRESENCE OF BETA-SUBUNIT	NATURE			English	Article							POTASSIUM CHANNELS; RAT-BRAIN; FUNCTIONAL EXPRESSION; DENDROTOXIN ACCEPTOR; BINDING-PROPERTIES; MOLECULAR-BIOLOGY; XENOPUS OOCYTES; IK(A) CHANNELS; ION CHANNELS; BOVINE BRAIN	Structural and functional diversity of voltage-gated K(v)1-type potassium channels in rat brain is enhanced by the association of two different types of subunits, the membrane-bound, pore-forming alpha-subunits and a peripheral beta-subunit. We have cloned a beta-subunit (K-v beta 1) that is specifically expressed in the rat nervous system. Association of K-v beta 1 with alpha-subunits confers rapid A-type inactivation on non-inactivating K(v)1 channels (delayed rectifiers) in expression systems in vitro. This effect is mediated by an inactivating ball domain in the K-v beta 1 amino terminus.	MAX PLANCK INST BIOPHYS CHEM,MEMBRANBIOPHYS ABT,D-37077 GOTTINGEN,GERMANY; MAX PLANCK GESELL ZFDW,AG MOLEK & ZELLULARE BIOPHYS,D-07747 JENA,GERMANY; UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,DEPT BIOCHEM,WOLFSON LABS,LONDON SW7 2AY,ENGLAND	Max Planck Society; Max Planck Society; Imperial College London	RETTIG, J (corresponding author), ZENTRUM MOLEK NEUROBIOL HAMBURG,INST NEURALE SIGNALVERARBEITUNG,MARTINISTR 52,D-20246 HAMBURG,GERMANY.		Dolly, Oliver/G-1532-2012; Parcej, David/AAW-7306-2020; Dolly, Oliver/ABH-6677-2020; Rettig, Jens/K-5103-2013	Dolly, Oliver/0000-0002-0861-5320; Dolly, Oliver/0000-0002-0861-5320; Rettig, Jens/0000-0001-6160-3954; Wunder, Frank/0000-0002-1311-2357; Heinemann, Stefan H./0000-0002-4144-0251				BECKH S, 1990, EMBO J, V9, P777, DOI 10.1002/j.1460-2075.1990.tb08173.x; BUTLER A, 1989, SCIENCE, V243, P943, DOI 10.1126/science.2493160; CATTERALL WA, 1992, PHYSIOL REV, V72, pS15, DOI 10.1152/physrev.1992.72.suppl_4.S15; CHABALA LD, 1993, J GEN PHYSIOL, V102, P713, DOI 10.1085/jgp.102.4.713; CHRISTIE MJ, 1990, NEURON, V4, P405, DOI 10.1016/0896-6273(90)90052-H; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; CROW T, 1988, TRENDS NEUROSCI, V11, P136, DOI 10.1016/0166-2236(88)90138-5; GRUPE A, 1990, EMBO J, V9, P1749, DOI 10.1002/j.1460-2075.1990.tb08299.x; GUTMAN GA, 1993, NEUROSCIENCES, V5, P101; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; HULLIN R, 1992, EMBO J, V11, P885, DOI 10.1002/j.1460-2075.1992.tb05126.x; ISOM LL, 1992, SCIENCE, V256, P839, DOI 10.1126/science.1375395; JAN LY, 1992, CELL, V69, P715, DOI 10.1016/0092-8674(92)90280-P; JAN LY, 1990, TRENDS NEUROSCI, V13, P415, DOI 10.1016/0166-2236(90)90123-R; KUES WA, 1992, EUR J NEUROSCI, V4, P1296, DOI 10.1111/j.1460-9568.1992.tb00155.x; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; NEEFY A, 1993, SCIENCE, V262, P575; NELSON RM, 1989, ANAL BIOCHEM, V180, P147, DOI 10.1016/0003-2697(89)90103-6; PARCEJ DN, 1989, BIOCHEM J, V257, P899, DOI 10.1042/bj2570899; PARCEJ DN, 1992, BIOCHEMISTRY-US, V31, P11084, DOI 10.1021/bi00160a018; PONGS O, 1992, PHYSIOL REV, V72, pS69, DOI 10.1152/physrev.1992.72.suppl_4.S69; RAICHLE ME, 1983, ANN NEUROL, V13, P2, DOI 10.1002/ana.410130103; REHM H, 1988, P NATL ACAD SCI USA, V85, P4919, DOI 10.1073/pnas.85.13.4919; REID PF, 1992, FEBS LETT, V302, P31, DOI 10.1016/0014-5793(92)80277-N; RETTIG J, 1992, EMBO J, V11, P2473, DOI 10.1002/j.1460-2075.1992.tb05312.x; RUDY B, 1988, NEURON, V1, P649, DOI 10.1016/0896-6273(88)90164-X; RUDY B, 1988, NEUROSCIENCE, V25, P729, DOI 10.1016/0306-4522(88)90033-4; RUPPERSBERG JP, 1991, NATURE, V352, P711, DOI 10.1038/352711a0; RUPPERSBERG JP, 1990, NATURE, V345, P535, DOI 10.1038/345535a0; RUPPERSBERG JP, 1991, NATURE, V353, P657, DOI 10.1038/353657a0; Sambrook J, 1989, MOL CLONING LABORATO; SCOTT VES, 1990, J BIOL CHEM, V265, P20094; SCOTT VES, 1994, P NATL ACAD SCI USA, V91, P1637, DOI 10.1073/pnas.91.5.1637; SCOTT VES, 1994, BIOCHEMISTRY-US, V33, P1617, DOI 10.1021/bi00173a001; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; STOCKER M, 1991, P ROY SOC B-BIOL SCI, V245, P101, DOI 10.1098/rspb.1991.0094; STUHMER W, 1988, FEBS LETT, V242, P199, DOI 10.1016/0014-5793(88)81015-9; STUHMER W, 1989, EMBO J, V8, P3235, DOI 10.1002/j.1460-2075.1989.tb08483.x; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WILSON GF, 1993, NATURE, V366, P433, DOI 10.1038/366433a0; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520	43	750	764	0	50	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 26	1994	369	6478					289	294		10.1038/369289a0	http://dx.doi.org/10.1038/369289a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NN109	8183366				2022-12-28	WOS:A1994NN10900039
J	PITTET, D; TARARA, D; WENZEL, RP				PITTET, D; TARARA, D; WENZEL, RP			NOSOCOMIAL BLOOD-STREAM INFECTION IN CRITICALLY ILL PATIENTS - EXCESS LENGTH OF STAY, EXTRA COSTS, AND ATTRIBUTABLE MORTALITY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BLOOD-STREAM INFECTIONS; FACTORS INFLUENCING PROGNOSIS; GRAM-NEGATIVE BACTEREMIA; HOSPITAL STAY; EPISODES; RISK	Objective.-To determine the excess length of stay, extra costs, and mortality attributable to nosocomial bloodstream infection in critically ill patients. Design.-Pairwise-matched (1:1) case-central study. Setting.-Surgical intensive care unit (SICU) in a tertiary health care institution. Patients.-All patients admitted in the SICU between July 1, 1988, and June 30, 1990, were eligible. Cases were defined as patients with nosocomial bloodstream infection; controls were selected according to matching variables in a stepwise fashion. Methods.-Matching variables were primary diagnosis for admission, age, sex, length of stay before the day of infection in cases, and total number of discharge diagnoses. Matching was successful for 89% of the cohort; 86 matched case-control pairs were studied. Main Outcome Measures.-Crude and attributable mortality, excess length of hospital and SICU stay, and overall costs. Results.-Nosocomial bloodstream infection complicated 2.67 per 100 admissions to the SICU during the study period. The crude mortality rates from cases and controls were 50% and 15%, respectively (P<.01); thus, the estimated attributable mortality rate was 35% (95% confidence interval, 25% to 45%). The median length of hospital stay significantly differed between cases and controls (40 vs 26 days, respectively; P<.01). When only matched pairs who survived bloodstream infection were considered (n=41), cases stayed in the hospital a median of 54 days vs 30 days for controls (P<.01), and cases stayed in the SICU a median of 15 days vs 7 days for controls (P<.01). Thus, extra hospital and SICU length of stay attributable to bloodstream infection was 24 and 8 days, respectively. Extra costs attributable to the infection averaged $40 000 per survivor. Conclusions.-The attributable mortality from nosocomial bloodstream infection is high in critically ill patients. The infection is associated with a doubling of the SICU stay, an excess length of hospital stay of 24 days in survivors, and a significant economic burden.	UNIV IOWA HOSP & CLIN,DEPT INTERNAL MED,DIV GEN MED CLIN EPIDEMIOL & HLTH SERV RES,IOWA CITY,IA 52242	University of Iowa								BANERJEE SN, 1991, AM J MED, V91, pS86, DOI 10.1016/0002-9343(91)90349-3; BISHOP YMM, 1975, DISCRETE MULTIVARIAT, P492; BODEY GP, 1965, ARCH INTERN MED, V116, P266, DOI 10.1001/archinte.1965.03870020106019; BRODERICK A, 1990, AM J EPIDEMIOL, V131, P734, DOI 10.1093/oxfordjournals.aje.a115558; BRYAN CS, 1986, AM J EPIDEMIOL, V123, P113, DOI 10.1093/oxfordjournals.aje.a114205; BRYAN CS, 1983, REV INFECT DIS, V5, P629; CONOVER WJ, 1980, PRACTICAL NONPARAMET, P363; CRAVEN DE, 1988, ARCH INTERN MED, V148, P1161, DOI 10.1001/archinte.148.5.1161; DASCHNER FD, 1982, INTENS CARE MED, V8, P5; DELEON SP, 1984, AM J MED, V77, P639, DOI 10.1016/0002-9343(84)90354-1; DOMINGUEZDEVILLOTA E, 1987, INTENS CARE MED, V13, P390; DONOWITZ LG, 1982, CRIT CARE MED, V10, P355, DOI 10.1097/00003246-198206000-00001; DUGGAN JM, 1985, J HOSP INFECT, V6, P406, DOI 10.1016/0195-6701(85)90057-X; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; GATELL JM, 1988, REV INFECT DIS, V10, P203; HALEY RW, 1991, AM J MED, V91, pS32, DOI 10.1016/0002-9343(91)90341-T; KREGER BE, 1980, AM J MED, V68, P332, DOI 10.1016/0002-9343(80)90101-1; LANDRY SL, 1989, AM J INFECT CONTROL, V17, P323, DOI 10.1016/0196-6553(89)90001-1; MARTIN MA, 1989, ANN INTERN MED, V110, P9, DOI 10.7326/0003-4819-110-1-9; MCCABE WR, 1962, ARCH INTERN MED, V110, P856, DOI 10.1001/archinte.1962.03620240038007; MCGOWAN JE, 1985, REV INFECT DIS, V7, pS357; MCGOWAN JE, 1975, J INFECT DIS, V132, P316, DOI 10.1093/infdis/132.3.316; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; PITTET D, 1993, PREVENTION CONTROL N, P512; PITTET D, 1992, HOSPITAL INFECTIONS, P405; ROSE R, 1977, SOUTHERN MED J, V70, P1267, DOI 10.1097/00007611-197711000-00005; Schlesselman JJ, 1982, CASE CONTROL STUDIES; SPENGLER RF, 1978, JAMA-J AM MED ASSOC, V240, P2455, DOI 10.1001/jama.240.22.2455; WEINSTEIN MP, 1983, REV INFECT DIS, V5, P54; WENZEL RP, 1988, INT J EPIDEMIOL, V17, P225, DOI 10.1093/ije/17.1.225; WEY SB, 1988, ARCH INTERN MED, V148, P2642, DOI 10.1001/archinte.148.12.2642; 1990, MMWR MORB MORTAL WKL, V39, P31; 1989, PHS891260 PUBL	33	1093	1116	0	29	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	1994	271	20					1598	1601		10.1001/jama.271.20.1598	http://dx.doi.org/10.1001/jama.271.20.1598			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NL758	8182812				2022-12-28	WOS:A1994NL75800028
J	GRABSTEIN, KH; EISENMAN, J; SHANEBECK, K; RAUCH, C; SRINIVASAN, S; FUNG, V; BEERS, C; RICHARDSON, J; SCHOENBORN, MA; AHDIEH, M; JOHNSON, L; ALDERSON, MR; WATSON, JD; ANDERSON, DM; GIRI, JG				GRABSTEIN, KH; EISENMAN, J; SHANEBECK, K; RAUCH, C; SRINIVASAN, S; FUNG, V; BEERS, C; RICHARDSON, J; SCHOENBORN, MA; AHDIEH, M; JOHNSON, L; ALDERSON, MR; WATSON, JD; ANDERSON, DM; GIRI, JG			CLONING OF A T-CELL GROWTH-FACTOR THAT INTERACTS WITH THE BETA-CHAIN OF THE INTERLEUKIN-2 RECEPTOR	SCIENCE			English	Article							COLONY-STIMULATING FACTOR; HUMAN PERIPHERAL-BLOOD; IL-2 RECEPTOR; B-CELLS; PURIFICATION; PROLIFERATION; EXPRESSION; MOLECULE; LINES	A cytokine was identified that stimulated the proliferation of T lymphocytes, and a complementary DNA clone encoding this new T cell growth factor was isolated. The cytokine, designated interleukin-15 (IL-15), is produced by a wide variety of cells and tissues and shares many biological properties with IL-2. Monoclonal antibodies to the beta chain of the IL-2 receptor inhibited the biological activity of IL-15, and IL-15 competed for binding with IL-2, indicating that IL-15 uses components of the IL-2 receptor.			GRABSTEIN, KH (corresponding author), IMMUNEX RES & DEV CORP,51 UNIV ST,SEATTLE,WA 98101, USA.							ANDERSON DM, 1990, CELL, V63, P235, DOI 10.1016/0092-8674(90)90304-W; BAZAN JF, 1990, IMMUNOL TODAY, V11, P350, DOI 10.1016/0167-5699(90)90139-Z; BAZAN JF, 1992, SCIENCE, V257, P410, DOI 10.1126/science.1631562; BENVENISTE EN, 1986, NATURE, V321, P610, DOI 10.1038/321610a0; BRANDHUBER BJ, 1987, SCIENCE, V238, P1707, DOI 10.1126/science.3500515; DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208; GILLIS S, 1977, NATURE, V268, P154, DOI 10.1038/268154a0; GIRI J, COMMUNICATION; GRABSTEIN K, 1986, J EXP MED, V163, P1405, DOI 10.1084/jem.163.6.1405; GRABSTEIN K, COMMUNICATION; GREENBERGER JS, 1983, FED PROC, V42, P2762; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; PARK LS, 1986, J BIOL CHEM, V261, P4177; PRICE V, 1987, GENE, V55, P287, DOI 10.1016/0378-1119(87)90288-5; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SRINIVASAN S, 1993, PROTEIN SCI, V2, P277; Suzuki J, 1989, Int Immunol, V1, P373, DOI 10.1093/intimm/1.4.373; SWAIN SL, 1991, CURR OPIN IMMUNOL, V3, P304, DOI 10.1016/0952-7915(91)90028-Y; TAKESHITA T, 1989, J EXP MED, V169, P1323, DOI 10.1084/jem.169.4.1323; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TRINCHIERI G, 1984, J EXP MED, V160, P1147, DOI 10.1084/jem.160.4.1147; URDAL DL, 1984, J CHROMATOGR, V296, P171, DOI 10.1016/S0021-9673(01)96410-6; WIDMER MB, 1987, J EXP MED, V166, P1447, DOI 10.1084/jem.166.5.1447; YODOI J, 1985, J IMMUNOL, V134, P1623; ZUBLER RH, 1984, J EXP MED, V160, P1170, DOI 10.1084/jem.160.4.1170	27	1299	1424	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 13	1994	264	5161					965	968		10.1126/science.8178155	http://dx.doi.org/10.1126/science.8178155			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NK974	8178155				2022-12-28	WOS:A1994NK97400035
J	WEST, MA; LUCOCQ, JM; WATTS, C				WEST, MA; LUCOCQ, JM; WATTS, C			ANTIGEN-PROCESSING AND CLASS-II MHC PEPTIDE-LOADING COMPARTMENTS IN HUMAN B-LYMPHOBLASTOID CELLS	NATURE			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; INTRACELLULAR-TRANSPORT; INVARIANT CHAIN; LATE ENDOSOMES; LYMPHOCYTES-B; MOLECULES; TRANSFERRIN; COMPLEX; PH; LOCALIZATION	THE peptide/class II major histocompatibility complex (MHC) complexes recognized by CD4(+) T cells have been characterized at the structural(1) and biochemical(2-4) levels and studies on the transport and maturation of class II MHC indicate that specialized sites may be involved in peptide acquisition(5-11). Here we report the characterization of the compartments involved in antigen processing and class II MHC loading relative to distinct functional domains of the endocytic pathway in antigen-specific human B lymphocytes(12-14). Peroxidase-mediated crosslinking analysis(15) in intact cells demonstrates that peptide loading of class II MHC takes place in a compartment accessible to membrane immunoglobulin but not to transferrin receptors, although processing may be initiated within the latter domain. The density of membrane vesicles carrying newly assembled class II MHC complexes was distinct from early and late endosomes and dense lysosomes. Endocytosed antigen-gold complexes enter a class II MHC-rich compartment morphologically very similar to that described previously(9) and within the time frame of biochemically detectable peptide loading.	UNIV BERN,DEPT ANAT,CH-3000 BERN,SWITZERLAND	University of Bern	WEST, MA (corresponding author), UNIV DUNDEE,INST MED SCI,DEPT BIOCHEM,DUNDEE DD1 4HN,SCOTLAND.			lucocq, john/0000-0002-5191-0093; Watts, Colin/0000-0001-6183-2087	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AJIOKA RS, 1986, P NATL ACAD SCI USA, V83, P6445, DOI 10.1073/pnas.83.17.6445; BLUM JS, 1991, J BIOL CHEM, V266, P22091; Brodsky F M, 1992, Trends Cell Biol, V2, P109, DOI 10.1016/0962-8924(92)90015-F; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; CRESSWELL P, 1985, P NATL ACAD SCI USA, V82, P8188, DOI 10.1073/pnas.82.23.8188; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; DAVIDSON HW, 1989, J CELL BIOL, V109, P85, DOI 10.1083/jcb.109.1.85; DAVIDSON HW, 1991, CELL, V67, P105, DOI 10.1016/0092-8674(91)90575-J; DAVIDSON HW, 1990, J IMMUNOL, V144, P4101; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; GUY K, 1982, EUR J IMMUNOL, V12, P942, DOI 10.1002/eji.1830121109; HARDING CV, 1993, J IMMUNOL, V151, P3988; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; KILLISCH I, 1992, J CELL SCI, V103, P211; KISHIDA Y, 1975, J CELL BIOL, V64, P331, DOI 10.1083/jcb.64.2.331; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; LUCOCQ JM, 1993, FINE STRUCTURE IMMUN, P279; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; PIETERS J, 1991, J CELL BIOL, V115, P1213, DOI 10.1083/jcb.115.5.1213; RENFREW CA, 1991, J BIOL CHEM, V266, P4348; RIJNBOUTT S, 1992, J BIOL CHEM, V267, P15665; ROEDERER M, 1987, J CELL PHYSIOL, V131, P200, DOI 10.1002/jcp.1041310209; ROOSNEK E, 1988, J IMMUNOL, V140, P4079; RUDENSKY AY, 1992, NATURE, V359, P429, DOI 10.1038/359429a0; SLOT JW, 1991, J CELL BIOL, V113, P123, DOI 10.1083/jcb.113.1.123; STOORVOGEL W, 1991, CELL, V65, P417, DOI 10.1016/0092-8674(91)90459-C; STOORVOGEL W, 1991, J BIOL CHEM, V266, P5438	30	342	342	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 12	1994	369	6476					147	151		10.1038/369147a0	http://dx.doi.org/10.1038/369147a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NK971	8177319				2022-12-28	WOS:A1994NK97100049
J	FALK, BW; BRUENING, G				FALK, BW; BRUENING, G			WILL TRANSGENIC CROPS GENERATE NEW VIRUSES AND NEW DISEASES	SCIENCE			English	Editorial Material							TOBACCO MOSAIC-VIRUS; RNA RECOMBINATION; GENETIC-RECOMBINATION; SYSTEMIC INFECTION; PLANT-VIRUSES; SEQUENCE; REPLICATION; GENOME; RESISTANCE; MUTANTS		UNIV CALIF DAVIS,CTR ENGN PLANTS RESISTANCE AGAINST PATHOGENS,DAVIS,CA	University of California System; University of California Davis	FALK, BW (corresponding author), UNIV CALIF DAVIS,DEPT PLANT PATHOL,DAVIS,CA 95616, USA.			Yan, Zhiyong/0000-0001-8253-0694				ALLISON R, 1990, P NATL ACAD SCI USA, V87, P1820, DOI 10.1073/pnas.87.5.1820; ALLISON RF, 1989, VIROLOGY, V172, P321, DOI 10.1016/0042-6822(89)90134-7; ANGENENT GC, 1989, VIROLOGY, V171, P271, DOI 10.1016/0042-6822(89)90537-0; BEACHY RN, 1990, ANNU REV PHYTOPATHOL, V28, P451, DOI 10.1146/annurev.py.28.090190.002315; BECK CI, 1993, BIO-TECHNOL, V11, P1524, DOI 10.1038/nbt1293-1524; BUJARSKI JJ, 1986, NATURE, V321, P528, DOI 10.1038/321528a0; CARR JP, 1991, MOL PLANT MICROBE IN, V4, P579, DOI 10.1094/MPMI-4-579; CASCONE PJ, 1993, SCIENCE, V260, P801, DOI 10.1126/science.8484119; CHEO PC, 1970, PHYTOPATHOLOGY, V60, P41, DOI 10.1094/Phyto-60-41; DAWSON WO, 1992, ANNU REV PLANT PHYS, V43, P527, DOI 10.1146/annurev.pp.43.060192.002523; DEJONG W, 1992, P NATL ACAD SCI USA, V89, P6808, DOI 10.1073/pnas.89.15.6808; EDWARDS MC, 1992, VIROLOGY, V189, P389, DOI 10.1016/0042-6822(92)90722-2; FALK BW, UNPUB; GAL S, 1992, VIROLOGY, V187, P525, DOI 10.1016/0042-6822(92)90455-X; GREENE AE, 1994, SCIENCE, V263, P1423, DOI 10.1126/science.8128222; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; Lommel S.A., 1991, J CELL BIOCHEM, V15, P151; MALYSHENKO SI, 1993, J GEN VIROL, V74, P1149, DOI 10.1099/0022-1317-74-6-1149; MAYO MA, 1991, J GEN VIROL, V72, P2591, DOI 10.1099/0022-1317-72-10-2591; NAGY PD, 1993, P NATL ACAD SCI USA, V90, P6390, DOI 10.1073/pnas.90.14.6390; NAGY PD, 1992, J VIROL, V66, P6824, DOI 10.1128/JVI.66.11.6824-6828.1992; POWELLABEL P, 1986, SCIENCE, V232, P738, DOI DOI 10.1126/SCIENCE.3457472; RISSLER J, 1993, PERILS AMIDST PROMIS; SCHOELZ JE, 1993, PLANT CELL, V5, P1669, DOI 10.1105/tpc.5.11.1669; SCHOLTHOF KBG, 1993, PLANT PHYSIOL, V102, P7, DOI 10.1104/pp.102.1.7; SULZINSKI MA, 1982, VIROLOGY, V121, P12, DOI 10.1016/0042-6822(82)90114-3; VANDERKUYL AC, 1991, VIROLOGY, V183, P731, DOI 10.1016/0042-6822(91)91002-X; WHITE KA, 1994, J VIROL, V68, P14, DOI 10.1128/JVI.68.1.14-24.1994; WILSON TMA, 1993, P NATL ACAD SCI USA, V90, P3134, DOI 10.1073/pnas.90.8.3134	29	64	80	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAR 11	1994	263	5152					1395	1396		10.1126/science.8179685	http://dx.doi.org/10.1126/science.8179685			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MZ927	8179685				2022-12-28	WOS:A1994MZ92700019
J	GUILLEMOT, F; LO, LC; JOHNSON, JE; AUERBACH, A; ANDERSON, DJ; JOYNER, AL				GUILLEMOT, F; LO, LC; JOHNSON, JE; AUERBACH, A; ANDERSON, DJ; JOYNER, AL			MAMMALIAN ACHAETE-SCUTE HOMOLOG-1 IS REQUIRED FOR THE EARLY DEVELOPMENT OF OLFACTORY AND AUTONOMIC NEURONS	CELL			English	Article							PERIPHERAL NERVOUS-SYSTEM; GROWTH-FACTOR RECEPTOR; DROSOPHILA-MELANOGASTER; DNA-BINDING; NEGATIVE REGULATOR; CELL-ADHESION; GENE-COMPLEX; ADULT-MOUSE; STEM-CELLS; DIFFERENTIATION	The mouse Mash-1 gene, like its Drosophila homologs of the achaete-scute complex (AS-C), encodes a transcription factor expressed in neural precursors. We created a null allele of this gene by homologous recombination in embryonic stem cells. Mice homozygous for the mutation die at birth with apparent breathing and feeding defects. The brain and spinal cord of the mutants appear normal, but their olfactory epithelium and sympathetic, parasympathetic, and enteric ganglia are severely affected. In the olfactory epithelium, neuronal progenitors die at an early stage, whereas the nonneuronal supporting cells are present. In sympathetic ganglia, the mutation arrests the development of neuronal precursors, preventing the generation of sympathetic neurons, but does not affect glial precursor cells. These observations suggest that Mash-1, like its Drosophila homologs of the AS-C, controls a basic operation in development of neuronal progenitors in distinct neural lineages.	CALTECH,DIV BIOL 21676,HOWARD HUGHES MED INST,PASADENA,CA 91106; UNIV TORONTO,DEPT MOLEC & MED GENET,TORONTO M5S 1A1,ONTARIO,CANADA	California Institute of Technology; Howard Hughes Medical Institute; University of Toronto	GUILLEMOT, F (corresponding author), MT SINAI HOSP,SAMUEL LUNENFELD RES INST,TORONTO M5G 1X5,ONTARIO,CANADA.		Guillemot, Francois/AAV-1482-2021	/0000-0002-8605-2746				AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; ALONSO MC, 1988, EMBO J, V7, P2585, DOI 10.1002/j.1460-2075.1988.tb03108.x; ANDERSON DJ, 1989, NEURON, V3, P1, DOI 10.1016/0896-6273(89)90110-4; ANDERSON DJ, 1993, ANNU REV NEUROSCI, V16, P129, DOI 10.1146/annurev.ne.16.030193.001021; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BIRREN SJ, 1993, IN PRESS DEVELOPMENT, V119; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; CABRERA CV, 1991, EMBO J, V10, P2965, DOI 10.1002/j.1460-2075.1991.tb07847.x; CALOF AL, 1989, NEURON, V3, P115, DOI 10.1016/0896-6273(89)90120-7; CAMPOSORTEGA JA, 1991, ANNU REV NEUROSCI, V14, P399, DOI 10.1146/annurev.ne.14.030191.002151; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; COCHARD P, 1978, P NATL ACAD SCI USA, V75, P2986, DOI 10.1073/pnas.75.6.2986; Cook HC, 1990, THEORY PRACTICE HIST, P177; CUSCHIERI A, 1975, J ANAT, V119, P277; CUSCHIERI A, 1975, J ANAT, V119, P471; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; DOMINGUEZ M, 1993, EMBO J, V12, P2049, DOI 10.1002/j.1460-2075.1993.tb05854.x; DUNCAN M, 1992, DEV BIOL, V154, P1, DOI 10.1016/0012-1606(92)90042-F; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; FARBMAN AI, 1980, DEV BIOL, V74, P205, DOI 10.1016/0012-1606(80)90062-7; FERREIRO B, 1992, MECH DEVELOP, V40, P25; GARRELL J, 1991, BIOESSAYS, V13, P493, DOI 10.1002/bies.950131002; GEISERT EE, 1989, NEUROSCI LETT, V102, P137, DOI 10.1016/0304-3940(89)90068-2; GHYSEN A, 1988, GENE DEV, V2, P495, DOI 10.1101/gad.2.5.495; GHYSEN A, 1989, TRENDS GENET, V5, P251, DOI 10.1016/0168-9525(89)90097-8; GONZALEZ F, 1989, EMBO J, V8, P3553, DOI 10.1002/j.1460-2075.1989.tb08527.x; GOULDING MD, 1991, EMBO J, V10, P1135, DOI 10.1002/j.1460-2075.1991.tb08054.x; GRAZIADEI GAM, 1980, NEUROSCIENCE, V5, P1239; Graziadei P. P., 1978, DEV SENSORY SYSTEMS, V9, P55; GRAZIADEI PPC, 1979, J NEUROCYTOL, V8, P1, DOI 10.1007/BF01206454; GUIILLEMOT F, 1993, MECH DEVELOP, V42, P171; GUILLEMOT F, 1992, DEVELOPMENT, V114, P743; HARLAND RM, 1991, METHOD CELL BIOL, V36, P675; HUNT P, 1992, ANNU REV CELL BIOL, V8, P227, DOI 10.1146/annurev.cb.08.110192.001303; JAN YN, 1990, TRENDS NEUROSCI, V13, P493, DOI 10.1016/0166-2236(90)90083-M; JARMAN AP, 1993, IN PRESS DEVELOPMENT, V119; JIMENEZ F, 1990, NEURON, V5, P81, DOI 10.1016/0896-6273(90)90036-F; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; JOHNSON JE, 1992, DEVELOPMENT, V114, P75; JOHNSON JE, 1992, P NATL ACAD SCI USA, V89, P3596, DOI 10.1073/pnas.89.8.3596; JOYNER AL, 1989, NATURE, V338, P153, DOI 10.1038/338153a0; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; KLEIN R, 1989, EMBO J, V8, P3701, DOI 10.1002/j.1460-2075.1989.tb08545.x; KLEIN SL, 1983, J COMP NEUROL, V217, P17, DOI 10.1002/cne.902170103; LEDOUARIN NM, 1986, SCIENCE, V231, P1515, DOI 10.1126/science.3952494; LEVEY MS, 1991, J NEUROSCI, V11, P3556; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; LUSKIN MB, 1993, J NEUROSCI, V13, P1730; MACKAYSIM A, 1991, J NEUROSCI, V11, P979; MAHANTHAPPA NK, 1993, NEURON, V10, P293, DOI 10.1016/0896-6273(93)90319-M; MANSOUR SL, 1993, DEVELOPMENT, V117, P13; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MCCONNELL SK, 1991, ANNU REV NEUROSCI, V14, P269, DOI 10.1146/annurev.ne.14.030191.001413; MICHELSOHN AM, 1992, NEURON, V8, P589, DOI 10.1016/0896-6273(92)90285-L; MIRAGALL F, 1988, DEV BIOL, V129, P516, DOI 10.1016/0012-1606(88)90397-1; MOTRO B, 1991, DEVELOPMENT, V113, P1207; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; PACHNIS V, 1993, IN PRESS DEVELOPMENT, V119; PATTERSON PH, 1990, CELL, V62, P1035, DOI 10.1016/0092-8674(90)90379-S; PHAM TD, 1991, J COMP NEUROL, V314, P789, DOI 10.1002/cne.903140411; PIXLEY SK, 1992, NEURON, V8, P1191, DOI 10.1016/0896-6273(92)90139-5; RUDNICKI MA, 1992, CELL, V71, P383, DOI 10.1016/0092-8674(92)90508-A; SASAI Y, 1992, GENE DEV, V6, P2650; Sieber-Blum M., 1990, Comments on Developmental Neurobiology, V1, P225; SMART IHM, 1971, J ANAT, V109, P243; STEIN R, 1988, NEURON, V1, P463, DOI 10.1016/0896-6273(88)90177-8; STEMPLE DL, 1991, NEUROSCI LETT, V124, P57, DOI 10.1016/0304-3940(91)90821-A; SUZUKI Y, 1991, CELL TISSUE RES, V266, P239, DOI 10.1007/BF00318179; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; VANDOREN M, 1992, GENE DEV, V6, P2592, DOI 10.1101/gad.6.12b.2592; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; WEINTRAUB H, 1991, SCIENCE, V251, P761, DOI 10.1126/science.1846704; YAN Q, 1988, J NEUROSCI, V8, P3481; YIP JW, 1987, DEV BRAIN RES, V32, P155, DOI 10.1016/0165-3806(87)90149-0; ZIMMERMAN K, 1993, IN PRESS DEVELOPMENT, V119	77	894	910	1	18	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 5	1993	75	3					463	476		10.1016/0092-8674(93)90381-Y	http://dx.doi.org/10.1016/0092-8674(93)90381-Y			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MF830	8221886				2022-12-28	WOS:A1993MF83000009
J	LEVENTHAL, LJ; BOYCE, EG; ZURIER, RB				LEVENTHAL, LJ; BOYCE, EG; ZURIER, RB			TREATMENT OF RHEUMATOID-ARTHRITIS WITH GAMMA-LINOLENIC ACID	ANNALS OF INTERNAL MEDICINE			English	Article						ARTHRITIS, RHEUMATOID; LINOLENIC ACIDS; SYNOVITIS; FATTY ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG	GAMMA-LINOLENIC ACID; CONTROLLED CLINICAL-TRIAL; UNSATURATED FATTY-ACIDS; SMOOTH-MUSCLE CELLS; INDEPENDENT MECHANISM; VITAMIN-E; SUPPRESSION; PLACEBO; PROSTAGLANDIN-E1; PROLIFERATION	Objective: To assess the clinical efficacy and side effects of gammalinolenic acid, a plant-seed-derived essential fatty acid that suppresses inflammation and joint tissue injury in animal models. Design: A randomized, double-blind, placebo-controlled, 24-week trial. Setting: Rheumatology clinic of a university hospital. Patients: Thirty-seven patients with rheumatoid arthritis and active synovitis. Intervention: Treatment with 1.4 g/d gammalinolenic acid in borage seed oil or cotton seed oil (placebo). Measurements: Physicians' and patients' global assessment of disease activity; joint tenderness, joint swelling, morning stiffness, grip strength, and ability to do daily activities. Results: Treatment with gammalinolenic acid resulted in clinically important reduction in the signs and symptoms of disease activity in patients with rheumatoid arthritis (P < 0.05). In contrast, patients given a placebo showed no change or showed worsening of disease. Gammalinolenic acid reduced the number of tender joints by 36%, the tender joint score by 45%, swollen joint count by 28%, and the swollen joint score by 41%, whereas the placebo group did not show significant improvement in any measure. Overall clinical responses (significant change in four measures) were also better in the treatment group (P < 0.05). No patients withdrew from gammalinolenic acid treatment because of adverse reactions. Conclusion: Gammalinolenic acid in doses used in this study is a well-tolerated and effective treatment for active rheumatoid arthritis. Gammalinolenic acid is available worldwide as a component of evening primrose and borage seed oils. It is usually taken in far lower doses than used in this trial. It is not approved in the United States for the treatment of any condition and should not be viewed as therapy for any disease. Further controlled studies of its use in rheumatoid arthritis are warranted.	UNIV MASSACHUSETTS, MED CTR, DIV RHEUMATOL, 55 LAKE AVE N, WORCESTER, MA 01655 USA; UNIV PENN, PHILADELPHIA, PA 19104 USA; GRAD HOSP PHILADELPHIA, PHILADELPHIA, PA 19146 USA; UNIV PENN, PRESBYTERIAN MED CTR, PHILADELPHIA, PA 19104 USA; PHILADELPHIA COLL PHARM & SCI, PHILADELPHIA, PA 19104 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Presbyterian Medical Center					PHS HHS [R01-38501] Funding Source: Medline; FDA HHS [FD-R000756] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); FDA HHS		ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BAKER DG, 1989, ARTHRITIS RHEUM, V32, P1273, DOI 10.1002/anr.1780321013; BELCH JJF, 1988, ANN RHEUM DIS, V47, P96, DOI 10.1136/ard.47.2.96; CALLEGARI PE, 1991, RHEUM DIS CLIN N AM, V17, P415; CORNWELL DG, 1979, LIPIDS, V14, P194, DOI 10.1007/BF02533871; Fantone J. C., 1985, PROSTAGLANDINS IMMUN, P123; JANTTI J, 1989, ANN RHEUM DIS, V48, P124, DOI 10.1136/ard.48.2.124; MCMURCHIE EJ, 1988, METHODS STUDYING MEM, P189; ORDWAY RW, 1989, SCIENCE, V244, P1176, DOI 10.1126/science.2471269; PAULUS HE, 1990, ARTHRITIS RHEUM, V33, P477, DOI 10.1002/art.1780330403; PULLMANMOOAR S, 1990, ARTHRITIS RHEUM, V33, P1526, DOI 10.1002/art.1780331010; SANTOLI D, 1989, J IMMUNOL, V143, P1303; SANTOLI D, 1990, J CLIN INVEST, V85, P424, DOI 10.1172/JCI114455; STEINBROCKER O, 1949, JAMA-J AM MED ASSOC, V140, P659, DOI 10.1001/jama.1949.02900430001001; TATE G, 1989, J RHEUMATOL, V16, P729; TATE GA, 1988, ARTHRITIS RHEUM, V31, P1543, DOI 10.1002/art.1780311211; TULLEKEN JE, 1990, ARTHRITIS RHEUM, V33, P1416, DOI 10.1002/art.1780330914; WARD JR, 1983, ARTHRITIS RHEUM, V26, P1303, DOI 10.1002/art.1780261102; WEINBLATT ME, 1988, ARTHRITIS RHEUM, V31, P167, DOI 10.1002/art.1780310203; WILLIAMS HJ, 1985, ARTHRITIS RHEUM-US, V28, P721, DOI 10.1002/art.1780280702; WILLIS AL, 1981, NUTR REV, V39, P289, DOI 10.1111/j.1753-4887.1981.tb06794.x; YOSHIKAWA T, 1990, J RHEUMATOL, V17, P1513; ZIBOH VA, 1987, ARCH DERMATOL, V123, pA1686, DOI 10.1001/archderm.123.12.1686a; ZURIER RB, 1990, J RHEUMATOL, V17, P1439; ZURIER RB, 1993, TXB RHEUMATOLOGY, P201	25	140	145	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	1993	119	9					867	873		10.7326/0003-4819-119-9-199311010-00001	http://dx.doi.org/10.7326/0003-4819-119-9-199311010-00001			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MD711	8214997				2022-12-28	WOS:A1993MD71100001
J	DEBAKEY, ME				DEBAKEY, ME			MEDICAL-CENTERS OF EXCELLENCE AND HEALTH REFORM	SCIENCE			English	Editorial Material											DEBAKEY, ME (corresponding author), BAYLOR COLL MED,HOUSTON,TX 77030, USA.							BISHOP JM, 1993, SCIENCE, V259, P444, DOI 10.1126/science.8424162; BULGER RJ, 1993, JAMA-J AM MED ASSOC, V269, P2548, DOI 10.1001/jama.269.19.2548; Bush, 1945, SCI THE ENDLESS FRON, DOI DOI 10.1016/j.techsoc.2019.03.007; DeBakey M E, 1976, Cardiovasc Res Cent Bull, V15, P5; DEBAKEY ME, 1964, PRESIDENTS COMMISSIO, V2, P29; Dick R.S., 1991, COMPUTER BASED PATIE; JONES RJ, 1992, AM MED ED I PROGRAMS, P4; WOOLHANDLER S, 1993, NEW ENGL J MED, V329, P400, DOI 10.1056/NEJM199308053290606; 1992, HEALTHY PEOPLE 2000, P13; 1992, NATIONAL CTR HLTH ST; 1990, MORBIDITY MORTALITY, P17	11	21	21	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 22	1993	262	5133					523	525		10.1126/science.8211176	http://dx.doi.org/10.1126/science.8211176			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC935	8211176				2022-12-28	WOS:A1993MC93500025
J	PARGE, HE; ARVAI, AS; MURTARI, DJ; REED, SI; TAINER, JA				PARGE, HE; ARVAI, AS; MURTARI, DJ; REED, SI; TAINER, JA			HUMAN CKSHS2 ATOMIC-STRUCTURE - A ROLE FOR ITS HEXAMERIC ASSEMBLY IN CELL-CYCLE CONTROL	SCIENCE			English	Article							PROTEIN-KINASE COMPLEX; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; DIVISION CYCLE; FISSION YEAST; GENE CDC28; PHOSPHORYLATION; P34CDC2; ACTIVATION; SEQUENCE	The cell cycle regulatory protein CksHs2 binds to the catalytic subunit of the cyclin-dependent kinases (Cdk's) and is essential for their biological function. The crystal structure of the protein was determined at 2.1 angstrom resolution. The CksHs2 structure is an unexpected hexamer formed by the symmetric assembly of three interlocked dimers into an unusual 12-stranded beta barrel fold that may represent a prototype for this class of protein structures. Sequence-conserved regions form the unusual beta strand exchange between the subunits of the dimer, and the metal and anion binding sites associated with the hexamer assembly. The two other sequence-conserved regions line a 12 angstrom diameter tunnel through the beta barrel and form the six exposed, charged helix pairs. Six kinase subunits can be modeled to bind the assembled hexamer without collision, and therefore this CksHs2 hexamer may participate in cell cycle control by acting as the hub for Cdk multimerization in vivo.	SCRIPPS RES INST, DEPT MOLEC BIOL, LA JOLLA, CA 92037 USA	Scripps Research Institute			Tainer, John/GWQ-4878-2022	Tainer, John/0000-0003-1659-2429				ARVAI AS, UNPUB; AZZI L, 1992, EUR J BIOCHEM, V203, P353, DOI 10.1111/j.1432-1033.1992.tb16557.x; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bondt H. L. D., 1993, NATURE, V363, P595; BRIZUELA L, 1987, EMBO J, V6, P3507, DOI 10.1002/j.1460-2075.1987.tb02676.x; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BURLEY SK, 1986, FEBS LETT, V203, P139, DOI 10.1016/0014-5793(86)80730-X; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; DESAI D, 1992, MOL BIOL CELL, V3, P571, DOI 10.1091/mbc.3.5.571; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; DUCOMMUN B, 1991, MOL CELL BIOL, V11, P6177, DOI 10.1128/MCB.11.12.6177; DUCOMMUN B, 1991, EMBO J, V10, P3311, DOI 10.1002/j.1460-2075.1991.tb04895.x; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FUREY W, 1990, AM CRYSTALLOGR ASS 2, V18, P73; GOULD KL, 1991, EMBO J, V10, P3297, DOI 10.1002/j.1460-2075.1991.tb04894.x; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; HADWIGER JA, 1989, MOL CELL BIOL, V9, P2034, DOI 10.1128/MCB.9.5.2034; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; HAYLES J, 1986, MOL GEN GENET, V202, P291, DOI 10.1007/BF00331653; HAYLES J, 1986, EMBO J, V5, P3373, DOI 10.1002/j.1460-2075.1986.tb04653.x; HILL CP, 1991, BIOCHEMISTRY-US, V30, P917, DOI 10.1021/bi00218a006; HINDLEY J, 1987, MOL CELL BIOL, V7, P504, DOI 10.1128/MCB.7.1.504; HINDLEY J, 1984, GENE, V31, P129, DOI 10.1016/0378-1119(84)90203-8; HODEL A, 1992, ACTA CRYSTALLOGR A, V48, P851, DOI 10.1107/S0108767392006044; HOWARD AJ, 1987, J APPL CRYSTALLOGR, V20, P383, DOI 10.1107/S0021889887086436; Hunt T, 1989, CURR OPIN CELL BIOL, V1, P268, DOI 10.1016/0955-0674(89)90099-9; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KUHN LA, 1992, J MOL BIOL, V228, P13, DOI 10.1016/0022-2836(92)90487-5; LESLIE AGW, 1986, CCP4 NEWSLETTER, V18, P33; LORINCZ AT, 1984, NATURE, V307, P183, DOI 10.1038/307183a0; MALLER J, 1991, CURR OPIN CELL BIOL, V3, P369; MARCOTE MJ, 1993, MOL CELL BIOL, V13, P5122, DOI 10.1128/MCB.13.8.5122; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MEYERSON M, 1992, EMBO J, V11, P2909, DOI 10.1002/j.1460-2075.1992.tb05360.x; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; MURRAY AW, 1992, NATURE, V359, P599, DOI 10.1038/359599a0; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OCONNOR PM, 1992, CANCER BIOL, V3, P409; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PIGGOTT JR, 1982, NATURE, V298, P391, DOI 10.1038/298391a0; Pines J, 1991, Trends Cell Biol, V1, P117, DOI 10.1016/0962-8924(91)90116-Q; REED SI, 1985, P NATL ACAD SCI USA, V82, P4055, DOI 10.1073/pnas.82.12.4055; REED SI, 1990, P NATL ACAD SCI USA, V87, P5697, DOI 10.1073/pnas.87.15.5697; REED SI, 1992, ANNU REV CELL BIOL, V8, P529, DOI 10.1146/annurev.cb.08.110192.002525; REED SI, 1980, GENETICS, V95, P561; RICHARDSON HE, 1990, GENE DEV, V4, P1332, DOI 10.1101/gad.4.8.1332; SIMANIS V, 1986, CELL, V45, P261, DOI 10.1016/0092-8674(86)90390-9; SOLOMON MJ, 1992, MOL BIOL CELL, V3, P13, DOI 10.1091/mbc.3.1.13; STUDIER WF, 1990, METHOD ENZYMOL, V185, P60, DOI DOI 10.1016/0076-6879(90)85008-C; STUELAND CS, 1993, MOL CELL BIOL, V13, P3744, DOI 10.1128/MCB.13.6.3744; TANG Y, 1993, GENE DEV, V7, P822, DOI 10.1101/gad.7.5.822; WEINERT TA, 1988, SCIENCE, V241, P317, DOI 10.1126/science.3291120; WITTENBERG C, 1988, CELL, V54, P1061, DOI 10.1016/0092-8674(88)90121-3	59	114	119	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 15	1993	262	5132					387	395		10.1126/science.8211159	http://dx.doi.org/10.1126/science.8211159			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB859	8211159				2022-12-28	WOS:A1993MB85900048
J	ALEXANDER, RM				ALEXANDER, RM			BREATHING WHILE TROTTING	SCIENCE			English	Editorial Material							HORSES EQUUS-CABALLUS; MAMMALIAN DIAPHRAGM; SYNCHRONIZATION				ALEXANDER, RM (corresponding author), UNIV LEEDS,DEPT PURE & APPL BIOL,LEEDS LS2 9JT,W YORKSHIRE,ENGLAND.							ALEXANDER RM, 1989, J ZOOL, V218, P69, DOI 10.1111/j.1469-7998.1989.tb02526.x; ALEXANDER RM, 1988, ELASTIC MECHANISMS A; ALTRINGHAM JD, 1991, J EXP BIOL, V157, P381; BAUDINETTE RV, 1987, J EXP BIOL, V129, P251; BRAMBLE DM, 1983, SCIENCE, V219, P251, DOI 10.1126/science.6849136; BRAMBLE DM, 1993, SCIENCE, V262, P235, DOI 10.1126/science.8211141; GRIFFITHS RI, 1992, P ROY SOC B-BIOL SCI, V249, P199, DOI 10.1098/rspb.1992.0104; KUETHE DO, 1988, J EXP BIOL, V136, P1; PENNYCUICK CJ, 1975, J EXP BIOL, V63, P775; YOUNG IS, 1992, J EXP BIOL, V166, P19; YOUNG IS, 1992, J EXP BIOL, V164, P283	11	18	19	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 8	1993	262	5131					196	197		10.1126/science.8211137	http://dx.doi.org/10.1126/science.8211137			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA665	8211137				2022-12-28	WOS:A1993MA66500021
J	COPELAND, NG; JENKINS, NA; GILBERT, DJ; EPPIG, JT; MALTAIS, LJ; MILLER, JC; DIETRICH, WF; WEAVER, A; LINCOLN, SE; STEEN, RG; STEIN, LD; NADEAU, JH; LANDER, ES				COPELAND, NG; JENKINS, NA; GILBERT, DJ; EPPIG, JT; MALTAIS, LJ; MILLER, JC; DIETRICH, WF; WEAVER, A; LINCOLN, SE; STEEN, RG; STEIN, LD; NADEAU, JH; LANDER, ES			A GENETIC-LINKAGE MAP OF THE MOUSE - CURRENT APPLICATIONS AND FUTURE-PROSPECTS	SCIENCE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; FRAGMENT LENGTH POLYMORPHISMS; RECOMBINANT CONGENIC STRAINS; TYROSINASE-RELATED PROTEIN; HUMAN PRADER-WILLI; COAT COLOR LOCUS; RETINAL DEGENERATION; POINT MUTATION; MESSENGER-RNA; W-LOCUS	Technological advances have made possible the development of high-resolution genetic linkage maps for the mouse. These maps in turn offer exciting prospects for understanding mammalian genome evolution through comparative mapping, for developing mouse models of human disease, and for identifying the function of all genes in the organism.	WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02142 USA; MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA; JACKSON LAB, BAR HARBOR, ME 04609 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Jackson Laboratory	COPELAND, NG (corresponding author), NCI, FREDERICK CANC RES & DEV CTR, ABL BASIC RES PROGRAM, FREDERICK, MD 21702 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R37HG000198, R01HG000198] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NCI [N01CO074101] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74101] Funding Source: Medline; NHGRI NIH HHS [HG00198] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ALLEN RC, 1993, SCIENCE, V259, P990, DOI 10.1126/science.7679801; ARNHEITER H, 1990, CELL, V62, P51, DOI 10.1016/0092-8674(90)90239-B; ARRATIA R, 1991, GENOMICS, V11, P806, DOI 10.1016/0888-7543(91)90004-X; AVNER P, 1988, TRENDS GENET, V4, P18, DOI 10.1016/0168-9525(88)90123-0; BALDWIN CT, 1992, NATURE, V355, P637, DOI 10.1038/355637a0; BALLING R, 1988, CELL, V55, P531, DOI 10.1016/0092-8674(88)90039-6; BIDDLE FG, 1987, GENOME, V29, P389, DOI 10.1139/g87-067; BIRKENMEIER EH, 1989, J CLIN INVEST, V83, P1258, DOI 10.1172/JCI114010; BONHOMME F, 1979, CR ACAD SCI D NAT, V289, P545; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; BRILLIANT MH, 1991, SCIENCE, V252, P566, DOI 10.1126/science.1673574; BUCHHALTER JR, 1993, EPILEPSIA, V34, pS31; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; CAMPER SA, 1990, GENOMICS, V8, P586, DOI 10.1016/0888-7543(90)90050-5; CECI JD, 1989, GENOMICS, V5, P699, DOI 10.1016/0888-7543(89)90111-0; CECI JD, UNPUB; CHABOT B, 1988, NATURE, V335, P88, DOI 10.1038/335088a0; CHAREST NJ, 1991, MOL ENDOCRINOL, V5, P573, DOI 10.1210/mend-5-4-573; CHARTIER FL, 1992, NAT GENET, V1, P132, DOI 10.1038/ng0592-132; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; CONNELL G, 1991, P NATL ACAD SCI USA, V88, P723, DOI 10.1073/pnas.88.3.723; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; COPELAND NG, 1990, CELL, V63, P175, DOI 10.1016/0092-8674(90)90298-S; COPELAND NG, UNPUB; CORNALL RJ, 1991, GENOMICS, V10, P874, DOI 10.1016/0888-7543(91)90175-E; CORNALL RJ, 1991, NATURE, V353, P262, DOI 10.1038/353262a0; DARLING SM, 1992, BIOESSAYS, V14, P359, DOI 10.1002/bies.950140602; DAUTIGNY A, 1986, NATURE, V321, P867, DOI 10.1038/321867a0; Davisson MT, 1989, GENETIC VARIANTS STR, P432; Dick J E, 1991, Mol Genet Med, V1, P77; Dick J E, 1991, Semin Immunol, V3, P367; DIETRICH W, 1992, GENETICS, V131, P423; DIETRICH W, 1993, GENETIC MAPS; DIETRICH WF, IN PRESS CELL; DISTECHE CM, 1992, NAT GENET, V1, P333, DOI 10.1038/ng0892-333; Eicher E. M., 1981, Mammalian genetics and cancer. The Jackson Laboratory fiftieth anniversity symposium., P7; EPSTEIN DJ, 1991, CELL, V67, P767, DOI 10.1016/0092-8674(91)90071-6; Festing MFW, 1979, INBRED STRAINS BIOME; FISHER RS, 1989, BRAIN RES REV, V14, P245, DOI 10.1016/0165-0173(89)90003-9; GARDNER JM, 1992, SCIENCE, V257, P1121, DOI 10.1126/science.257.5073.1121; GASPAR ML, 1991, P NATL ACAD SCI USA, V88, P8606, DOI 10.1073/pnas.88.19.8606; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GODFREY P, 1993, NAT GENET, V4, P227, DOI 10.1038/ng0793-227; GROOT PC, 1992, FASEB J, V6, P2826, DOI 10.1096/fasebj.6.10.1634045; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Haldane JBS, 1915, J GENET, V5, P133, DOI 10.1007/BF02985370; HAMMER MF, 1989, P NATL ACAD SCI USA, V86, P3261, DOI 10.1073/pnas.86.9.3261; HARDY J, 1988, TRENDS NEUROSCI, V11, P89, DOI 10.1016/0166-2236(88)90148-8; HEARNE CM, 1991, MAMM GENOME, V1, P273, DOI 10.1007/BF00352339; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; HINO O, 1993, P NATL ACAD SCI USA, V90, P730, DOI 10.1073/pnas.90.2.730; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOLLAND JM, 1988, CLIN DERMATOL, V6, P159, DOI 10.1016/0738-081X(88)90081-8; HOOD L, COMMUNICATION; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; HUNT P, 1992, ANNU REV CELL BIOL, V8, P227, DOI 10.1146/annurev.cb.08.110192.001303; JACKSON IJ, 1988, P NATL ACAD SCI USA, V85, P4392, DOI 10.1073/pnas.85.12.4392; JACKSON IJ, 1992, EMBO J, V11, P527, DOI 10.1002/j.1460-2075.1992.tb05083.x; JOHNSTON M C, 1991, Journal of Craniofacial Genetics and Developmental Biology, V11, P277; JUSTICE MJ, 1990, GENETICS, V125, P855; KINGSLEY DM, 1992, CELL, V71, P399, DOI 10.1016/0092-8674(92)90510-J; KOBORI JA, 1986, SCIENCE, V234, P173, DOI 10.1126/science.3018929; KRUMLAUF R, 1992, BIOESSAYS, V14, P245, DOI 10.1002/bies.950140408; KRUMLAUF R, 1993, TRENDS GENET, V9, P106, DOI 10.1016/0168-9525(93)90203-T; KUSUMI K, 1993, MAMM GENOME, V4, P391, DOI 10.1007/BF00360591; KWON BS, 1987, P NATL ACAD SCI USA, V84, P7473, DOI 10.1073/pnas.84.21.7473; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LANDER ES, 1989, GENETICS, V121, P185; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LEFF SE, 1992, NAT GENET, V2, P259, DOI 10.1038/ng1292-259; Leiter E H, 1987, Birth Defects Orig Artic Ser, V23, P221; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LIN SC, 1993, NATURE, V364, P208, DOI 10.1038/364208a0; LINCOLN SE, 1992, GENOMICS, V14, P604, DOI 10.1016/S0888-7543(05)80158-2; LOVE JM, 1990, NUCLEIC ACIDS RES, V18, P4123, DOI 10.1093/nar/18.14.4123; LUETTEKE NC, 1993, CELL, V73, P263, DOI 10.1016/0092-8674(93)90228-I; LUNDIN LG, 1993, GENOMICS, V16, P1, DOI 10.1006/geno.1993.1133; Lyon ML, 1989, GENETIC VARIANTS STR, P773; MANN GB, 1993, CELL, V73, P249, DOI 10.1016/0092-8674(93)90227-H; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; MOEN CJA, 1991, MAMM GENOME, V1, P217, DOI 10.1007/BF00352328; NADEAU J H, 1991, P269; NADEAU JH, 1984, P NATL ACAD SCI-BIOL, V81, P814, DOI 10.1073/pnas.81.3.814; NADEAU JH, 1992, MAMM GENOME, V3, P202, DOI 10.1007/BF00355720; OZCELIK T, 1992, NAT GENET, V2, P265, DOI 10.1038/ng1292-265; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; PENDLETON JW, 1993, P NATL ACAD SCI USA, V90, P6300, DOI 10.1073/pnas.90.13.6300; PETERS J, 1993, MOUSE GENOME, V91, P19; PRINS JB, 1993, SCIENCE, V260, P695, DOI 10.1126/science.8480181; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; READHEAD C, 1987, CELL, V48, P703, DOI 10.1016/0092-8674(87)90248-0; REEVES RH, 1990, GENOMICS, V8, P141, DOI 10.1016/0888-7543(90)90236-N; REEVES RH, 1991, MAMM GENOME, V1, P158, DOI 10.1007/BF00351062; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; RISE ML, 1991, SCIENCE, V253, P669, DOI 10.1126/science.1871601; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; SCHIMMANG T, 1992, DEVELOPMENT, V116, P799; SCHNIEKE A, 1983, NATURE, V304, P315, DOI 10.1038/304315a0; SCHUGHART K, 1989, P NATL ACAD SCI USA, V86, P7067, DOI 10.1073/pnas.86.18.7067; SHIROISHI T, 1990, IMMUNOGENETICS, V31, P79, DOI 10.1007/BF00661217; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; SILVER LM, IN PRESS MAMMALIAN S, V4; SIRACUSA LD, 1989, GENETICS, V122, P669; STAEHELI P, 1988, MOL CELL BIOL, V8, P4518, DOI 10.1128/MCB.8.10.4518; STEINMEYER K, 1991, NATURE, V354, P304, DOI 10.1038/354304a0; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; SUNDBERG JP, 1990, J INVEST DERMATOL, V95, pS62, DOI 10.1111/1523-1747.ep12505816; SUTER U, 1992, P NATL ACAD SCI USA, V89, P4382, DOI 10.1073/pnas.89.10.4382; SUTER U, 1992, NATURE, V356, P241, DOI 10.1038/356241a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; TASSABEHJI M, 1992, NATURE, V355, P635, DOI 10.1038/355635a0; TASSABEHJI M, 1993, NAT GENET, V3, P26, DOI 10.1038/ng0193-26; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; THOMAS KR, 1991, CELL, V67, P969, DOI 10.1016/0092-8674(91)90369-A; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; Tokuda M, 1935, J HERED, V26, P481, DOI 10.1093/oxfordjournals.jhered.a104011; TRAVIS GH, 1989, NATURE, V338, P70, DOI 10.1038/338070a0; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; UEMATSU Y, 1986, EMBO J, V5, P2123, DOI 10.1002/j.1460-2075.1986.tb04475.x; VERES G, 1987, SCIENCE, V237, P415, DOI 10.1126/science.3603027; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WEBER JL, 1990, GENOMICS, V7, P524, DOI 10.1016/0888-7543(90)90195-Z; WEBER JL, 1989, AM J HUM GENET, V44, P388; WHITE RA, 1992, NAT GENET, V2, P80, DOI 10.1038/ng0992-80; WILKIE TM, 1992, NAT GENET, V1, P85, DOI 10.1038/ng0592-85; WOYCHIK RP, 1985, NATURE, V318, P36, DOI 10.1038/318036a0; WOYCHIK RP, 1990, NATURE, V346, P850, DOI 10.1038/346850a0; YOSHIDA H, 1990, NATURE, V345, P442, DOI 10.1038/345442a0; ZIMMERER EJ, 1987, IMMUNOGENETICS, V25, P274, DOI 10.1007/BF00404701; ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U	137	562	568	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	1993	262	5130					57	66		10.1126/science.8211130	http://dx.doi.org/10.1126/science.8211130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ635	8211130				2022-12-28	WOS:A1993LZ63500024
J	IMAIZUMI, T; AIBARA, K				IMAIZUMI, T; AIBARA, K			LOFFLERS ENDOCARDITIS	NEW ENGLAND JOURNAL OF MEDICINE			English	Note											IMAIZUMI, T (corresponding author), KYUSHU UNIV,SCH MED,HIGASHI KU,FUKUOKA 812,JAPAN.								0	0	0	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	1994	331	1					24	24						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NU951	8202098				2022-12-28	WOS:A1994NU95100006
J	BALASCH, J; ARROYO, V; FABREGUES, F; SALO, J; JIMENEZ, W; PARE, JC; VANRELL, JA				BALASCH, J; ARROYO, V; FABREGUES, F; SALO, J; JIMENEZ, W; PARE, JC; VANRELL, JA			NEUROHORMONAL AND HEMODYNAMIC-CHANGES IN SEVERE CASES OF THE OVARIAN HYPERSTIMULATION SYNDROME	ANNALS OF INTERNAL MEDICINE			English	Article						OVARIAN HYPERSTIMULATION SYNDROME; HEMODYNAMICS; VASODILATION; RENIN-ANGIOTENSIN SYSTEM; VASOPRESSINS	INVITRO FERTILIZATION; PLASMA NOREPINEPHRINE; NITRIC-OXIDE; RENIN; HORMONE; VASODILATION; CIRRHOSIS; PRORENIN; RELEASE; PATHOGENESIS	Objective: To evaluate systemic hemodynamics, endogenous vasoactive neurohormonal factors (renin-angiotensin and sympathetic nervous systems, antidiuretic hormone, atrial natriuretic factor, and renal prostaglandins), and renal function in the severe ovarian hyperstimulation syndrome. Design: Prospective longitudinal study. Setting: Assisted-reproduction unit of a tertiary care hospital in Barcelona, Spain. Patients: 31 consecutive patients having in vitro fertilization with development of ascites because of severe ovarian hyperstimulation syndrome. Measurements: Mean arterial pressure; cardiac output; peripheral vascular resistance; hematocrit concentration; renal function; plasma renin activity; plasma aldosterone, norepinephrine, antidiuretic hormone, and atrial natriuretic peptide determinations; and urinary excretion of prostaglandin E(2) and 6-keto-prostaglandin-F-1 were measured during the syndrome and 4 to 5 weeks after recovery (baseline). Results: During the syndrome, patients showed increased hematocrits (mean of the paired difference, 0.047; 95% CI, 0.029 to 0.064), decreased mean arterial pressure (-16.6 mm Hg; CI, -19.8 to -13.6), increased cardiac output (2.6 L/min; CI, 2.13 to 3.17), and reduced peripheral vascular resistance (-709 dyne/s.cm(-5); CI, -792 to -627). This was accompanied by marked increases of plasma renin (14.4 ng/L.s; CI, 9.87 to 18.90), norepinephrine (1.857 nmol/L; CI, 0.533 to 3.161), antidiuretic hormone (3.3 pg/mL; CI, 1.89 to 4.71), and atrial natriuretic peptide levels (9.7 fmol/mL; CI, 6.1 to 13.2). Hemoconcentration developed in 16 patients (mean of the paired difference in hematocrit concentration, 0.082; CI, 0.063 to 0.101) but not in 15 others (0.009; CI, 0.003 to 0.021). Both groups showed similar values for arterial pressure, cardiac output, and peripheral vascular resistance, but patients with hemoconcentration had higher (P < 0.05) levels of renin (mean, 20.97 ng/L.s [CI, 13.3 to 28.63] compared with 7.83 ng/L.s [CI, 4.08 to 11.58]), norepinephrine (3.907 nmol/L [CI, 3.057 to 4.757] compared with 2.417 [CI, 2.035 to 2.799]), and antidiuretic hormone (6.0 pg/mL [CI, 4.1 to 7.9] compared with 2.4 [CI, 1.7 to 3.03]). Conclusions: In addition to increased capillary permeability, severe ovarian hyperstimulation syndrome is consistently associated with arteriolar vasodilation. The simultaneous occurrence of these disorders leads to hyperdynamic circulatory dysfunction with marked stimulation of the sympathetic nervous system, renin-angiotensin system, and antidiuretic hormone.	UNIV BARCELONA, FAC MED, HOSP CLIN & PROV, LIVER UNIT, BARCELONA, SPAIN; UNIV BARCELONA, FAC MED, HOSP CLIN & PROV, HORMONAL LAB, BARCELONA, SPAIN; UNIV BARCELONA, FAC MED, HOSP CLIN & PROV, CARDIOL UNIT, BARCELONA, SPAIN	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona	BALASCH, J (corresponding author), UNIV BARCELONA, FAC MED, HOSP CLIN & PROV, DEPT OBSTET & GYNECOL, CASANOVA 143, E-08036 BARCELONA, SPAIN.		Salo, Joan/AAB-3175-2020; Arroyo, Vicente/F-9189-2015	Salo, Joan/0000-0001-5292-9274; Arroyo, Vicente/0000-0002-2728-1848; Jimenez, Wladimiro/0000-0002-9376-0214				BALASCH J, 1991, FERTIL STERIL, V56, P1077; BALASCH J, 1992, FERTIL STERIL, V58, P991; BERGH PA, 1992, J ASSIST REPROD GEN, V9, P429, DOI 10.1007/BF01204048; BORENSTEIN R, 1989, FERTIL STERIL, V51, P791; BOSCH J, 1980, GASTROENTEROLOGY, V78, P92; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; CHANDRARATNA PA, 1984, AM J CARDIOL, V53, P234, DOI 10.1016/0002-9149(84)90718-5; CLIVE DM, 1984, NEW ENGL J MED, V310, P563, DOI 10.1056/NEJM198403013100905; CONRAD KP, 1993, FASEB J, V7, P566, DOI 10.1096/fasebj.7.6.7682524; Garza R., 1977, HDB RADIOIMMUNOASSAY; GINES P, 1988, HEPATOLOGY, V8, P636, DOI 10.1002/hep.1840080333; GLORIOSO N, 1986, SCIENCE, V233, P1422, DOI 10.1126/science.3529392; GOLAN A, 1988, FERTIL STERIL, V50, P912; Golan A, 1989, Obstet Gynecol Surv, V44, P430, DOI 10.1097/00006254-198906000-00004; GREGA GJ, 1984, EDEMA, P405; GROSSMAN SH, 1982, HYPERTENSION, V4, P566, DOI 10.1161/01.HYP.4.4.566; HAYASHI T, 1992, P NATL ACAD SCI USA, V89, P11259, DOI 10.1073/pnas.89.23.11259; ITSKOVITZ J, 1987, P NATL ACAD SCI USA, V84, P7285, DOI 10.1073/pnas.84.20.7285; KARPATI L, 1980, CLIN SCI, V59, P369, DOI 10.1042/cs0590369; KEETON TK, 1980, PHARMACOL REV, V32, P81; MAGNESS RR, 1989, AM J PHYSIOL, V256, pE536, DOI 10.1152/ajpendo.1989.256.4.E536; NAVOT D, 1992, FERTIL STERIL, V58, P249; NAVOT D, 1987, FERTIL STERIL, V48, P57; ONG ACM, 1991, CLIN ENDOCRINOL, V34, P43, DOI 10.1111/j.1365-2265.1991.tb01734.x; PEREZAYUSO RM, 1984, KIDNEY INT, V26, P72, DOI 10.1038/ki.1984.136; PEULER JD, 1977, LIFE SCI, V21, P625, DOI 10.1016/0024-3205(77)90070-4; POLISHUK WZ, 1969, FERTIL STERIL, V20, P443; PRIDE SM, 1984, AM J OBSTET GYNECOL, V148, P670, DOI 10.1016/0002-9378(84)90771-3; RIMOLA A, 1988, CLIN SCI, V74, P613, DOI 10.1042/cs0740613; ROBERTSON AL, 1972, CIRC RES, V31, P923, DOI 10.1161/01.RES.31.6.923; ROBERTSON GL, 1992, KIDNEY PHYSL PATHOPH, P1595; SCHENKER JG, 1978, FERTIL STERIL, V30, P255; SCHRIER RW, 1991, OBSTET GYNECOL, V77, P632; SEALEY JE, 1986, AM J MED, V81, P1041, DOI 10.1016/0002-9343(86)90402-X; SMITZ J, 1990, HUM REPROD, V5, P933, DOI 10.1093/oxfordjournals.humrep.a137223; SPARKS HV, 1984, EDEMA, P425; YARALI H, 1993, FERTIL STERIL, V59, P657; 1991, LANCET, V338, P1111	38	56	58	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1994	121	1					27	33		10.7326/0003-4819-121-1-199407010-00005	http://dx.doi.org/10.7326/0003-4819-121-1-199407010-00005			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PN271	8198344				2022-12-28	WOS:A1994PN27100005
J	YOON, HS; HAJDUK, PJ; PETROS, AM; OLEJNICZAK, ET; MEADOWS, RP; FESIK, SW				YOON, HS; HAJDUK, PJ; PETROS, AM; OLEJNICZAK, ET; MEADOWS, RP; FESIK, SW			SOLUTION STRUCTURE OF A PLECKSTRIN-HOMOLOGY DOMAIN	NATURE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; BINDING-PROTEIN; 3-DIMENSIONAL STRUCTURE; N-15-LABELED PROTEINS; DISTANCE GEOMETRY; CRYSTAL-STRUCTURE; CHEMICAL-SHIFTS; C-ALPHA; KINASE; NMR	Pleckstrin(1), the major protein kinase C substrate of platelets, contains domains of about 100 amino acids at the amino and carboxy termini that have been found in a number of proteins, including serine/threonine kinases, GTPase-activating proteins, phospholipases and cytoskeletal proteins(2-5). These conserved sequences, termed pleckstrin-homology (PH) domains, are thought to be involved in signal transduction. But the details of the function and binding partners of the PH domains have not been characterized. Here we report the solution structure of the N-terminal pleckstrin-homology domain of pleckstrin determined using heteronuclear three-dimensional nuclear magnetic resonance spectroscopy. The structure consists of an up-and-down beta-barrel of seven antiparallel beta-strands and a C-terminal amphiphilic alpha-helix that caps one end of the barrel. The overall topology of the domain is similar to that of the retinol-binding protein family of structures(6-10).	ABBOTT LABS,DIV PHARMACEUT DISCOVERY,ABBOTT PK,IL 60064	Abbott Laboratories			Yoon, Ho Sup/A-2193-2011	Yoon, Ho Sup/0000-0002-8243-3904				BAX A, 1990, J MAGN RESON, V88, P425, DOI 10.1016/0022-2364(90)90202-K; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BRUNGER AT, 1992, X PLOR 3 1 MANUAL; CARSON M, 1987, J MOL GRAPHICS, V5, P103, DOI 10.1016/0263-7855(87)80010-3; CIFUENTES ME, 1993, J BIOL CHEM, V268, P11586; CLUBB RT, 1992, J MAGN RESON, V97, P213, DOI 10.1016/0022-2364(92)90252-3; FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8; GRZESLEK S, 1992, J AM CHEM SOC, V114, P6261; HASLAM RJ, 1993, NATURE, V363, P309, DOI 10.1038/363309b0; HUBER R, 1987, J MOL BIOL, V195, P423, DOI 10.1016/0022-2836(87)90661-9; JONES TA, 1988, EMBO J, V7, P1597, DOI 10.1002/j.1460-2075.1988.tb02985.x; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; KAY LE, 1990, J MAGN RESON, V86, P110, DOI 10.1016/0022-2364(90)90215-U; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; KUSZEWSKI J, 1992, J BIOMOL NMR, V2, P33, DOI 10.1007/BF02192799; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; NEWCOMER ME, 1984, EMBO J, V3, P1451, DOI 10.1002/j.1460-2075.1984.tb01995.x; NILGES M, 1988, FEBS LETT, V229, P317, DOI 10.1016/0014-5793(88)81148-7; PAPLZ MZ, 1986, NATURE, V324, P383; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; SACCHETTINI JC, 1989, J MOL BIOL, V208, P327, DOI 10.1016/0022-2836(89)90392-6; SHAW G, 1993, BIOCHEM BIOPH RES CO, V195, P1145, DOI 10.1006/bbrc.1993.2164; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; TOUHARA K, 1994, J BIOL CHEM, V269, P10217; TYRES M, 1988, NATURE, V333, P470; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; Wuthrich K., 1986, NMR PROTEINS NUCL AC	30	200	203	0	6	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 23	1994	369	6482					672	675		10.1038/369672a0	http://dx.doi.org/10.1038/369672a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NT459	8208296	Green Accepted			2022-12-28	WOS:A1994NT45900062
J	WENDLING, F; MARASKOVSKY, E; DEBILI, N; FLORINDO, C; TEEPE, M; TITEUX, M; METHIA, N; BRETONGORIUS, J; COSMAN, D; VAINCHENKER, W				WENDLING, F; MARASKOVSKY, E; DEBILI, N; FLORINDO, C; TEEPE, M; TITEUX, M; METHIA, N; BRETONGORIUS, J; COSMAN, D; VAINCHENKER, W			C-MPL LIGAND IS A HUMORAL REGULATOR OF MEGAKARYOCYTOPOIESIS	NATURE			English	Article							COLONY-STIMULATING FACTOR; FACTOR RECEPTOR SUPERFAMILY; MOLECULAR-CLONING; GAMMA-CHAIN; B-CELLS; GROWTH; PURIFICATION; MEMBER; THROMBOPOIETIN; IDENTIFICATION	MEGAKARYOCYTOPOIESIS is the cellular developmental process that leads to platelet production. At least two humoral growth factors mag be necessary for megakaryocyte proliferation and maturation. One is a megakaryocyte-colony stimulating factor (MK-CSF) which induces the proliferation and differentiation of megakaryocyte progenitors(1,2), and the second, thrombopoietin, is a megakaryocyte maturation factor(3). Neither of these factors has been fully characterized. The proto-oncogene c-mpl, an orphan member of the haematopoietin receptor family(4-6), is specifically involved in megakaryocyte regulation(7). Here we present evidence that the c-mpl-encoded receptor binds a ligand (c-Mpl ligand) which is a humoral factor implicated in platelet homeostasis. Our results suggest that c-Mpl ligand, thrombopoietin and MK-CSF might be the same molecule.	HOP HENRI MONDOR,INSERM,U91,F-94010 CRETEIL,FRANCE; IMMUNEX RES & DEV CORP,SEATTLE,WA 98101	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	WENDLING, F (corresponding author), INST GUSTAVE ROUSSY,INSERM,U362,F-94805 VILLEJUIF,FRANCE.			Vainchenker, William/0000-0003-4705-202X				BRIZZARD BL, 1994, BIOTECHNIQUES, V16, P730; DEBILI N, 1993, BLOOD, V82, P84, DOI 10.1182/blood.V82.1.84.bloodjournal82184; FANSLOW WC, 1992, J IMMUNOL, V149, P655; GOODWIN RG, 1993, EUR J IMMUNOL, V23, P2631, DOI 10.1002/eji.1830231037; HOFFMAN R, 1985, J CLIN INVEST, V75, P1174, DOI 10.1172/JCI111813; HOFFMAN R, 1989, BLOOD, V74, P1196; HOPP TP, 1988, BIO-TECHNOL, V6, P1204, DOI 10.1038/nbt1088-1204; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; MAZUR EM, 1985, EXP HEMATOL, V13, P1164; MAZUR EM, 1990, BLOOD, V76, P290; MCDONALD TP, 1988, EXP HEMATOL, V16, P201; MCDONALD TP, 1973, P SOC EXP BIOL MED, V144, P1006; MCMAHAN CJ, 1991, EMBO J, V10, P2821, DOI 10.1002/j.1460-2075.1991.tb07831.x; METCALF D, 1984, HEMATOPOIETIC COLONY, P124; METHIA N, 1993, BLOOD, V82, P1395; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SKODA RC, 1993, EMBO J, V12, P2645, DOI 10.1002/j.1460-2075.1993.tb05925.x; VIGON I, 1993, ONCOGENE, V8, P2607; VIGON I, 1992, P NATL ACAD SCI USA, V89, P5640, DOI 10.1073/pnas.89.12.5640; WILLIAMS N, 1982, J CELL PHYSIOL, V110, P101, DOI 10.1002/jcp.1041100116; ZIEGLER SF, 1991, NEW BIOL, V3, P1242	23	649	698	0	7	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 16	1994	369	6481					571	574		10.1038/369571a0	http://dx.doi.org/10.1038/369571a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR294	8202160				2022-12-28	WOS:A1994NR29400053
J	RADER, DJ; HOEG, JM; BREWER, HB				RADER, DJ; HOEG, JM; BREWER, HB			QUANTITATION OF PLASMA APOLIPOPROTEINS IN THE PRIMARY AND SECONDARY PREVENTION OF CORONARY-ARTERY DISEASE	ANNALS OF INTERNAL MEDICINE			English	Review						CORONARY DISEASE; APOLIPOPROTEINS; ATHEROSCLEROSIS; CHOLESTEROL; TRIGLYCERIDES	HIGH-DENSITY-LIPOPROTEINS; ISCHEMIC-HEART-DISEASE; FAMILIAL COMBINED HYPERLIPIDEMIA; ACUTE MYOCARDIAL-INFARCTION; MIDDLE-AGED MEN; CHEMISTRY STANDARDIZATION PROJECT; B-CONTAINING LIPOPROTEINS; A-I; RISK-FACTORS; SERUM LIPOPROTEIN(A)	Purpose: To review current knowledge of apolipoprotein quantitation used in the clinical management of persons with or at risk for the development of premature coronary artery disease. Data Sources: The English-language literature was analyzed using MEDLINE (1975 to 1993) with key words ''apolipoproteins,'' ''quantitation,'' and ''coronary artery disease.'' Article bibliographies were also reviewed to obtain additional references. Study Selection: Published, peer-reviewed retrospective and prospective studies relevant to the association of plasma apolipoprotein levels with coronary artery disease in humans. Data Synthesis: Most studies concerned apolipoprotein A-I (apo A-I), apolipoprotein B (apo B), and lipoprotein(a) [Lp(a)]. In retrospective cross-sectional studies, apo A-I levels were not substantially more predictive of coronary artery disease than were high-density lipoprotein (HDL) cholesterol levels. In contrast, levels of apo B and Lp(a) were often more strongly associated with coronary artery disease than were traditional lipid measurements. In studies of the relation between apolipoprotein levels in children and premature coronary artery disease in their parents, Lp(a) levels, but not apo A-I and apo B levels, were consistently predictive of familial coronary artery disease. Prospective studies have yielded variable results for all three apolipoproteins. Low apo A-I levels were consistently associated with coronary artery disease in six prospective studies but were not more predictive than HDL levels. Apolipoprotein B levels were strongly associated with coronary artery disease in four of five prospective studies but were more predictive of coronary artery disease than were total cholesterol levels in only two of the four studies. Lipoprotein(a) levels were strongly associated with coronary artery disease in five of seven prospective studies but were not associated in two of the four largest studies. Conclusions: Too few large prospective studies of apolipoprotein quantitation using validated assay methods, both in general unselected populations and in subgroups of persons with premature coronary artery disease or family histories of premature coronary artery disease, are available to make definitive recommendations concerning clinical utility. The data do not support use of apolipoprotein quantitation as a screening tool to predict coronary artery disease risk in the general population. However, the data suggest that quantitation of apo B and Lp(a) may be indicated in subgroups of persons with premature coronary artery disease or with family histories of premature coronary artery disease. In these persons, an increased apo B or Lp(a) level or both could be a clinical indication for more aggressive treatment of low-density lipoprotein cholesterol.	NHLBI, MOLEC DIS BRANCH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	RADER, DJ (corresponding author), UNIV PENN, MED CTR, INST HUMAN GENE THERAPY, 3400 SPRUCE ST, PHILADELPHIA, PA 19104 USA.							ALAUPOVIC P, 1988, CLIN CHEM, V34, pB13; ALAUPOVIC P, 1991, PROG LIPID RES, V30, P105, DOI 10.1016/0163-7827(91)90008-S; ALBERS JJ, 1978, METABOLISM, V27, P479, DOI 10.1016/0026-0495(78)90102-6; ALBERS JJ, 1977, J LIPID RES, V18, P331; ALBERS JJ, 1992, CLIN CHEM, V38, P658; ALBERS JJ, 1990, CLIN CHEM, V36, P2019; ALBERS JJ, 1989, CLIN LAB MED, V9, P137, DOI 10.1016/S0272-2712(18)30646-2; ALBERS JJ, 1976, METABOLISM, V25, P633, DOI 10.1016/0026-0495(76)90060-3; AMOUYEL P, 1993, ARTERIOSCLER THROMB, V13, P1640, DOI 10.1161/01.ATV.13.11.1640; ARMSTRONG VW, 1986, ATHEROSCLEROSIS, V62, P249, DOI 10.1016/0021-9150(86)90099-7; AUSTIN MA, 1992, AM J HUM GENET, V51, P829; AUSTIN MA, 1991, ARTERIOSCLER THROMB, V11, P2, DOI 10.1161/01.ATV.11.1.2; AVOGARO P, 1979, LANCET, V1, P901; AVOGARO P, 1980, ATHEROSCLEROSIS, V37, P69, DOI 10.1016/0021-9150(80)90094-5; BALLANTYNE FC, 1982, METABOLISM, V31, P433, DOI 10.1016/0026-0495(82)90230-X; BARBIR M, 1988, BRIT HEART J, V60, P397; BARBIR M, 1992, LANCET, V340, P1500, DOI 10.1016/0140-6736(92)92756-6; BARD JM, 1991, PROG LIPID RES, V30, P267, DOI 10.1016/0163-7827(91)90024-Y; BERG K, 1979, CLIN GENET, V16, P347; BERG K, 1976, LANCET, V1, P499; BLANKENHORN DH, 1990, CIRCULATION, V81, P470, DOI 10.1161/01.CIR.81.2.470; BLANKENHORN DH, 1987, JAMA-J AM MED ASSOC, V257, P3233, DOI 10.1001/jama.257.23.3233; BOERWINKLE E, 1992, J CLIN INVEST, V90, P52, DOI 10.1172/JCI115855; BON GB, 1984, ATHEROSCLEROSIS, V53, P69, DOI 10.1016/0021-9150(84)90106-0; BRADBY GVH, 1978, LANCET, V2, P1271; BRENSIKE JF, 1984, CIRCULATION, V69, P313, DOI 10.1161/01.CIR.69.2.313; BREWER HB, 1991, PROG LIPID RES, V30, P139; BREWER HB, 1983, ANN INTERN MED, V98, P623, DOI 10.7326/0003-4819-98-5-623; BREWER HB, 1989, HEART DISEASE TXB CA, P121; BROWN G, 1990, NEW ENGL J MED, V323, P1289, DOI 10.1056/NEJM199011083231901; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; BRUNZELL JD, 1983, J LIPID RES, V24, P147; BRUNZELL JD, 1984, ARTERIOSCLEROSIS, V4, P79, DOI 10.1161/01.ATV.4.2.79; BUCHWALD H, 1990, NEW ENGL J MED, V323, P946, DOI 10.1056/NEJM199010043231404; BURING JE, 1992, CIRCULATION, V85, P22, DOI 10.1161/01.CIR.85.1.22; CAMPEAU L, 1984, NEW ENGL J MED, V311, P1329, DOI 10.1056/NEJM198411223112101; CANNER PL, 1986, J AM COLL CARDIOL, V8, P1245, DOI 10.1016/S0735-1097(86)80293-5; CARLSON LA, 1989, J INTERN MED, V226, P271, DOI 10.1111/j.1365-2796.1989.tb01393.x; CASTELLI WP, 1986, JAMA-J AM MED ASSOC, V256, P2835, DOI 10.1001/jama.256.20.2835; CASTELLI WP, 1986, AM HEART J, V112, P432, DOI 10.1016/0002-8703(86)90296-6; CHAIT A, 1980, EUR J CLIN INVEST, V10, P17, DOI 10.1111/j.1365-2362.1980.tb00004.x; COHEN JC, 1993, J CLIN INVEST, V91, P1630, DOI 10.1172/JCI116370; COLEMAN MP, 1992, ATHEROSCLEROSIS, V92, P177, DOI 10.1016/0021-9150(92)90276-M; COOPER GR, 1992, CURR OPIN LIPIDOL, V3, P356; CORTNER JA, 1991, J INHERIT METAB DIS, V14, P915, DOI 10.1007/BF01800473; DAHLEN G, 1975, CLIN GENET, V7, P334; DAHLEN GH, 1986, CIRCULATION, V74, P758, DOI 10.1161/01.CIR.74.4.758; DAVIGNON J, 1988, ARTERIOSCLEROSIS, V8, P1, DOI 10.1161/01.ATV.8.1.1; DEBACKER G, 1982, ATHEROSCLEROSIS, V42, P197, DOI 10.1016/0021-9150(82)90150-2; DEEB SS, 1990, AM J HUM GENET, V46, P822; DIEPLINGER H, 1993, J CLIN INVEST, V91, P397, DOI 10.1172/JCI116213; DURRINGTON PN, 1986, BRIT HEART J, V56, P206, DOI 10.1136/hrt.56.3.206; DURRINGTON PN, 1988, LANCET, V1, P1070; EICHNER JE, 1993, AM J CARDIOL, V71, P160, DOI 10.1016/0002-9149(93)90732-R; FAGER G, 1981, ARTERIOSCLEROSIS, V1, P273, DOI 10.1161/01.ATV.1.4.273; FAGER G, 1980, ATHEROSCLEROSIS, V36, P67, DOI 10.1016/0021-9150(80)90199-9; FRANZEN J, 1986, ATHEROSCLEROSIS, V59, P37, DOI 10.1016/0021-9150(86)90030-4; FREEDMAN DS, 1986, NEW ENGL J MED, V315, P721, DOI 10.1056/NEJM198609183151202; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; FRUCHART JC, 1992, CLIN CHEM, V38, P793; GENEST J, 1991, AM J CARDIOL, V67, P1039, DOI 10.1016/0002-9149(91)90862-F; GENEST J, 1992, J AM COLL CARDIOL, V19, P792, DOI 10.1016/0735-1097(92)90520-W; GENEST JJ, 1991, ATHEROSCLEROSIS, V90, P149, DOI 10.1016/0021-9150(91)90109-G; GENEST JJ, 1992, CIRCULATION, V85, P2025, DOI 10.1161/01.CIR.85.6.2025; GETZ GS, 1988, ARCH PATHOL LAB MED, V112, P1048; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1533, DOI 10.1172/JCI107331; GORDON BR, 1992, AM J CARDIOL, V70, P1010, DOI 10.1016/0002-9149(92)90352-Y; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; GREGG RE, 1988, CLIN CHEM, V34, pB28; GRUNDY SM, 1990, ARCH INTERN MED, V150, P1579; GRUNDY SM, 1987, ARTERIOSCLEROSIS, V7, P203; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; GRUNDY SM, 1989, ARCH INTERN MED, V149, P505, DOI 10.1001/archinte.149.3.505; GURAKAR A, 1985, ATHEROSCLEROSIS, V57, P293, DOI 10.1016/0021-9150(85)90041-3; GUYTON JR, 1985, ARTERIOSCLEROSIS, V5, P265, DOI 10.1161/01.ATV.5.3.265; HAFFNER SM, 1992, METABOLISM, V41, P194, DOI 10.1016/0026-0495(92)90152-Z; HAMSTEN A, 1986, ATHEROSCLEROSIS, V59, P223, DOI 10.1016/0021-9150(86)90051-1; HAZZARD WR, 1973, J CLIN INVEST, V52, P1569, DOI 10.1172/JCI107333; HEARN JA, 1992, AM J CARDIOL, V69, P736, DOI 10.1016/0002-9149(92)90497-M; HIXSON JE, 1991, ARTERIOSCLER THROMB, V11, P1237, DOI 10.1161/01.ATV.11.5.1237; HOEFLER G, 1988, ARTERIOSCLEROSIS, V8, P398, DOI 10.1161/01.ATV.8.4.398; HOFF HF, 1988, CIRCULATION, V77, P1238, DOI 10.1161/01.CIR.77.6.1238; ISHIKAWA T, 1978, EUR J CLIN INVEST, V8, P179, DOI 10.1111/j.1365-2362.1978.tb00832.x; JAMES RW, 1986, ATHEROSCLEROSIS, V60, P49, DOI 10.1016/0021-9150(86)90086-9; JAUHIAINEN M, 1991, ATHEROSCLEROSIS, V89, P59, DOI 10.1016/0021-9150(91)90007-P; JONAS A, 1991, BIOCHIM BIOPHYS ACTA, V1084, P205, DOI 10.1016/0005-2760(91)90062-M; JOVICIC A, 1993, ATHEROSCLEROSIS, V98, P59, DOI 10.1016/0021-9150(93)90223-H; KANE JP, 1990, JAMA-J AM MED ASSOC, V264, P3007, DOI 10.1001/jama.264.23.3007; KLADETZKY RG, 1980, ARTERY, V7, P191; KOSTNER GM, 1981, ATHEROSCLEROSIS, V38, P51, DOI 10.1016/0021-9150(81)90103-9; KOSTNER GM, 1991, ARCH DIS CHILD, V66, P1054, DOI 10.1136/adc.66.9.1054; KOTTKE BA, 1986, MAYO CLIN PROC, V61, P313, DOI 10.1016/S0025-6196(12)61947-8; KUKITA H, 1985, ATHEROSCLEROSIS, V55, P143, DOI 10.1016/0021-9150(85)90093-0; KUKITA H, 1984, ATHEROSCLEROSIS, V51, P261, DOI 10.1016/0021-9150(84)90173-4; KWITEROVICH PO, 1993, AM J CARDIOL, V71, P631, DOI 10.1016/0002-9149(93)91002-Y; KWITEROVICH PO, 1992, AM J CARDIOL, V69, P1015, DOI 10.1016/0002-9149(92)90856-T; LABEUR C, 1992, CLIN CHEM, V38, P2261; LABEUR C, 1992, CURR OPIN LIPIDOL, V3, P372; LACKNER C, 1991, J CLIN INVEST, V87, P2153, DOI 10.1172/JCI115248; LEHTONEN A, 1986, ATHEROSCLEROSIS, V59, P215, DOI 10.1016/0021-9150(86)90050-X; LEITERSDORF E, 1986, ATHEROSCLEROSIS, V59, P75, DOI 10.1016/0021-9150(86)90035-3; LEVINSON SS, 1992, ARCH PATHOL LAB MED, V116, P1350; LINTON MF, 1993, J LIPID RES, V34, P521; LOSCALZO J, 1990, ARTERIOSCLEROSIS, V10, P672, DOI 10.1161/01.ATV.10.5.672; MACIEJKO JJ, 1983, NEW ENGL J MED, V309, P385, DOI 10.1056/NEJM198308183090701; MAEDA S, 1989, ATHEROSCLEROSIS, V78, P145, DOI 10.1016/0021-9150(89)90218-9; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; MARCOVINA S, 1988, RES CLIN LAB, V18, P319, DOI 10.1007/BF02919090; MARCOVINA SM, 1993, ARTERIOSCLER THROMB, V13, P1037, DOI 10.1161/01.ATV.13.7.1037; MARCOVINA SM, 1991, CLIN CHEM, V37, P1676; MARCOVINA SM, 1991, CURR OPIN LIPIDOL, V2, P355; MASER RE, 1993, DIABETES CARE, V16, P755, DOI 10.2337/diacare.16.5.755; MATSUNAGA T, 1991, P NATL ACAD SCI USA, V88, P2793, DOI 10.1073/pnas.88.7.2793; MBEWU AD, 1990, ATHEROSCLEROSIS, V85, P1, DOI 10.1016/0021-9150(90)90177-K; MCLEAN JW, 1987, NATURE, V330, P132, DOI 10.1038/330132a0; MENOTTI A, 1989, ANN MED, V21, P175, DOI 10.3109/07853898909149929; MILES LA, 1990, THROMB HAEMOSTASIS, V63, P331; MILLER NE, 1981, BRIT MED J, V282, P1741, DOI 10.1136/bmj.282.6278.1741; MILLER NE, 1987, AM HEART J, V113, P589, DOI 10.1016/0002-8703(87)90638-7; MILLER WG, 1992, CURR OPIN LIPIDOL, V3, P361; MOSCA L, 1991, CIRCULATION, V84, P546; MURAI A, 1986, ATHEROSCLEROSIS, V59, P199, DOI 10.1016/0021-9150(86)90048-1; NAITO HK, 1985, ANN NY ACAD SCI, V454, P230, DOI 10.1111/j.1749-6632.1985.tb11862.x; NG DS, 1994, J CLIN INVEST, V93, P223, DOI 10.1172/JCI116949; NOMA A, 1983, ATHEROSCLEROSIS, V49, P1, DOI 10.1016/0021-9150(83)90002-3; NORUM RA, 1982, NEW ENGL J MED, V306, P1513, DOI 10.1056/NEJM198206243062503; ONITIRI AC, 1980, CLIN CHIM ACTA, V108, P25, DOI 10.1016/0009-8981(80)90288-0; PARRA HJ, 1992, ARTERIOSCLER THROMB, V12, P701, DOI 10.1161/01.ATV.12.6.701; PEDROBOTET J, 1992, STROKE, V23, P1556, DOI 10.1161/01.STR.23.11.1556; PUCHOIS P, 1987, ATHEROSCLEROSIS, V68, P35, DOI 10.1016/0021-9150(87)90091-8; RADER DJ, 1993, METABOLISM, V42, P1429, DOI 10.1016/0026-0495(93)90194-S; RADER DJ, 1993, J CLIN INVEST, V91, P443, DOI 10.1172/JCI116221; RADER DJ, 1992, JAMA-J AM MED ASSOC, V267, P1109, DOI 10.1001/jama.267.8.1109; RADER DJ, 1993, JAMA-J AM MED ASSOC, V270, P865, DOI 10.1001/jama.270.7.865; RADER DJ, 1994, IN PRESS J CLIN INVE; REARDON MF, 1985, CIRCULATION, V71, P881, DOI 10.1161/01.CIR.71.5.881; REINHART RA, 1990, ARCH INTERN MED, V150, P1629, DOI 10.1001/archinte.150.8.1629; RHOADS GG, 1986, JAMA-J AM MED ASSOC, V256, P2540, DOI 10.1001/jama.256.18.2540; RIDKER PM, 1993, JAMA-J AM MED ASSOC, V270, P2195, DOI 10.1001/jama.270.18.2195; RIESEN WF, 1980, ATHEROSCLEROSIS, V37, P157, DOI 10.1016/0021-9150(80)90104-5; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; ROSE HG, 1973, AM J MED, V54, P148, DOI 10.1016/0002-9343(73)90218-0; ROSENGREN A, 1990, BRIT MED J, V301, P1248, DOI 10.1136/bmj.301.6763.1248; ROSSOUW JE, 1990, NEW ENGL J MED, V323, P1112, DOI 10.1056/NEJM199010183231606; RUBIN EM, 1991, NATURE, V353, P265, DOI 10.1038/353265a0; SALONEN JT, 1985, AM J CARDIOL, V56, P226, DOI 10.1016/0002-9149(85)90839-2; SANDHOLZER C, 1992, ARTERIOSCLER THROMB, V12, P1214, DOI 10.1161/01.ATV.12.10.1214; SANDHOLZER C, 1991, HUM GENET, V86, P607; SANDHOLZER C, 1992, J CLIN INVEST, V89, P1040, DOI 10.1172/JCI115645; SANDKAMP M, 1990, CLIN CHEM, V36, P20; Santamarina-Fojo S., 1992, CURR OPIN LIPIDOL, V3, P186; SCANU AM, 1991, ANN INTERN MED, V115, P209, DOI 10.7326/0003-4819-115-3-209; SCHAEFER EJ, 1982, ARTERIOSCLEROSIS, V2, P16, DOI 10.1161/01.ATV.2.1.16; SCHAEFER EJ, 1994, JAMA-J AM MED ASSOC, V271, P999, DOI 10.1001/jama.271.13.999; SCHMIDT SB, 1985, AM J CARDIOL, V55, P1459, DOI 10.1016/0002-9149(85)90953-1; SCHREINER PJ, 1993, ARTERIOSCLER THROMB, V13, P826, DOI 10.1161/01.ATV.13.6.826; SCHULTZ JR, 1993, NATURE, V365, P762, DOI 10.1038/365762a0; SCHWARTZ CC, 1989, INT CONGR SER, V826, P321; SEED M, 1990, NEW ENGL J MED, V322, P1494, DOI 10.1056/NEJM199005243222104; SHAH PK, 1992, CIRCULATION, V85, P1279, DOI 10.1161/01.CIR.85.4.1279; SIGURDSSON G, 1992, AM J CARDIOL, V69, P1251, DOI 10.1016/0002-9149(92)91215-P; SNIDERMAN A, 1980, P NATL ACAD SCI-BIOL, V77, P604, DOI 10.1073/pnas.77.1.604; SNIDERMAN AD, 1982, ANN INTERN MED, V97, P833, DOI 10.7326/0003-4819-97-6-833; SNIDERMAN AD, 1990, ARTERIOSCLEROSIS, V10, P665, DOI 10.1161/01.ATV.10.5.665; SOMA MR, 1993, ARCH INTERN MED, V153, P1462, DOI 10.1001/archinte.153.12.1462; SRINIVASAN SR, 1991, CIRCULATION, V84, P160, DOI 10.1161/01.CIR.84.1.160; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P373, DOI 10.1056/NEJM199108083250601; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; SWENSON TL, 1991, DIABETES METAB REV, V7, P139, DOI 10.1002/dmr.5610070303; TALL AR, 1990, J CLIN INVEST, V86, P379, DOI 10.1172/JCI114722; TENG B, 1983, P NATL ACAD SCI-BIOL, V80, P6662, DOI 10.1073/pnas.80.21.6662; TENG B, 1986, J CLIN INVEST, V77, P663, DOI 10.1172/JCI112360; UTERMANN G, 1989, SCIENCE, V246, P904, DOI 10.1126/science.2530631; VANBOCKXMEER FM, 1992, LANCET, V340, P879, DOI 10.1016/0140-6736(92)93288-X; VEGA GL, 1990, ARTERIOSCLEROSIS, V10, P668, DOI 10.1161/01.ATV.10.5.668; VELLA JC, 1993, CLIN CHEM, V39, P477; VENKATESAN S, 1993, ARTERIOSCLER THROMB, V13, P1110, DOI 10.1161/01.ATV.13.7.1110; VERGANI C, 1978, CLIN CHIM ACTA, V87, P127, DOI 10.1016/0009-8981(78)90066-9; WALD NJ, 1994, LANCET, V343, P75, DOI 10.1016/S0140-6736(94)90814-1; WANNER C, 1993, ANN INTERN MED, V119, P263, DOI 10.7326/0003-4819-119-4-199308150-00002; WARDEN CH, 1993, SCIENCE, V261, P469, DOI 10.1126/science.8332912; WATTS GF, 1992, LANCET, V339, P563, DOI 10.1016/0140-6736(92)90863-X; WHAYNE TF, 1981, ATHEROSCLEROSIS, V39, P411, DOI 10.1016/0021-9150(81)90026-5; WIKLUND O, 1990, LANCET, V335, P1360, DOI 10.1016/0140-6736(90)91242-3; WILCKEN DEL, 1993, J PEDIATR-US, V123, P519, DOI 10.1016/S0022-3476(05)80944-8; ZENKER G, 1986, STROKE, V17, P942, DOI 10.1161/01.STR.17.5.942	188	177	182	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	1994	120	12					1012	1025		10.7326/0003-4819-120-12-199406150-00008	http://dx.doi.org/10.7326/0003-4819-120-12-199406150-00008			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NQ964	8185133				2022-12-28	WOS:A1994NQ96400008
J	LEEVERS, SJ; PATERSON, HF; MARSHALL, CJ				LEEVERS, SJ; PATERSON, HF; MARSHALL, CJ			REQUIREMENT FOR RAS IN RAF ACTIVATION IS OVERCOME BY TARGETING RAF TO THE PLASMA-MEMBRANE	NATURE			English	Article							PROTEIN-KINASE; MONOCLONAL-ANTIBODIES; PHOSPHORYLATION; ASSOCIATION; P21(RAS); P21RAS; MUTANT; CELLS	A CONSERVED tyrosine kinase-activated signal transduction pathway has recently been identified that comprises the plasma membrane-bound small guanine-nucleotide-binding protein Ras and the protein kinases Raf, MAP-kinase kinase and MAP kinase(1,2). GTP-bound Ras interacts directly with the amino-terminal regulatory domain of Raf(3-8), but although Ras and Raf can be coimmunoprecipitated from ligand-stimulated cells(9,10), Ras-GTP does not stimulate the kinase activity of Raf in vitro(6). Furthermore, we have failed to detect Ras in preparations of active detergent-solubilized Raf, demonstrating that once it is activated, Raf does not require Ras. Whereas Raf is normally cytosolic, in cells expressing active Ras, Raf is associated with the plasma membrane. This led us to investigate whether Ras is required to localize Raf to the plasma membrane in order for Raf to become activated. We fused the membrane localization signal of K-Ras(4B) to the carboxy terminus of Raf. This protein is constitutively active and can be further activated by epidermal growth factor, independently of Ras. Our results indicate that Ras functions as a regulated, membrane-bound anchor for Raf, and that other signal(s) also contribute to Raf activation.	INST CANC RES,CHESTER BEATTY LABS,CELL & MOLEC BIOL SECT,LONDON SW3 6JB,ENGLAND	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK								ALESSI DR, 1994, EMBO J, V13, P1610, DOI 10.1002/j.1460-2075.1994.tb06424.x; BRUDER JT, 1992, GENE DEV, V6, P545, DOI 10.1101/gad.6.4.545; DICKSON B, 1994, CURR OPIN GENET DEV, V4, P64, DOI 10.1016/0959-437X(94)90092-2; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FABIAN JR, 1993, MOL CELL BIOL, V13, P7170, DOI 10.1128/MCB.13.11.7170; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; FINNEY RE, 1993, CURR BIOL, V3, P805, DOI 10.1016/0960-9822(93)90214-9; FORCE T, 1994, P NATL ACAD SCI USA, V91, P1270, DOI 10.1073/pnas.91.4.1270; FURTH ME, 1982, J VIROL, V43, P294, DOI 10.1128/JVI.43.1.294-304.1982; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; HALLBERG B, 1994, J BIOL CHEM, V269, P3913; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; KOIDE H, 1993, P NATL ACAD SCI USA, V90, P8683, DOI 10.1073/pnas.90.18.8683; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; LEEVERS SJ, 1992, EMBO J, V11, P569, DOI 10.1002/j.1460-2075.1992.tb05088.x; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; SCHAAP D, 1993, J BIOL CHEM, V268, P20232; SCHULTZ AM, 1985, VIROLOGY, V146, P78, DOI 10.1016/0042-6822(85)90054-6; SOZERI O, 1992, ONCOGENE, V7, P2259; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; TRAVERSE S, 1993, ONCOGENE, V8, P3175; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; VOTJEK AB, 1993, CELL, V74, P205; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; WILLIAMS NG, 1992, P NATL ACAD SCI USA, V89, P2922, DOI 10.1073/pnas.89.7.2922; ZHANG XF, 1993, NATURE, V364, P398	29	951	967	1	23	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 2	1994	369	6479					411	414		10.1038/369411a0	http://dx.doi.org/10.1038/369411a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NP174	8196769				2022-12-28	WOS:A1994NP17400060
J	RELMAN, AS				RELMAN, AS			MEDICAL-PRACTICE UNDER THE CLINTON REFORMS - AVOIDING DOMINATION BY BUSINESS	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											RELMAN, AS (corresponding author), BRIGHAM & WOMENS HOSP,BOSTON,MA 02115, USA.							RELMAN AS, 1993, NEW ENGL J MED, V328, P133, DOI 10.1056/NEJM199301143280212	1	27	27	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 18	1993	329	21					1574	1576		10.1056/NEJM199311183292113	http://dx.doi.org/10.1056/NEJM199311183292113			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MG188	8204139				2022-12-28	WOS:A1993MG18800013
J	NIGHTINGALE, SL				NIGHTINGALE, SL			PROPOSALS FOR FOLIC-ACID FORTIFICATION AND LABELING OF CERTAIN FOODS TO REDUCE RISK OF NEURAL-TUBE DEFECTS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		1993, FED REG         1014, V58, P53305; 1993, FED REG         1014, V58, P53254	2	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	1993	270	19					2283	2283		10.1001/jama.270.19.2283	http://dx.doi.org/10.1001/jama.270.19.2283			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MF993	8230583				2022-12-28	WOS:A1993MF99300005
J	EVERHART, JE				EVERHART, JE			CONTRIBUTIONS OF OBESITY AND WEIGHT-LOSS TO GALLSTONE DISEASE	ANNALS OF INTERNAL MEDICINE			English	Review							BILIARY CHOLESTEROL SATURATION; GASTRIC BYPASS-SURGERY; LOW-CALORIE DIET; GALLBLADDER-DISEASE; RISK-FACTORS; PHYSICAL-ACTIVITY; LIPID-COMPOSITION; MORBIDLY OBESE; GALL-STONES; RAPID LOSS	Objective: To examine the relation of obesity and weight loss to the formation of gallstones according to pertinent clinical and research issues. Data Sources and Extraction: Original reports obtained through a MEDLINE search from 1966 to 1992 on gallstones plus obesity or reducing diets, supplemented by a manual search of bibliographies, a Current Contents title search from 1991 to 1992 on gallstones and gallbladder, and expert opinion. Only studies of humans were cited. Data Synthesis: For women, but less so for men, obesity is a strong risk factor for gallstones, and this risk is increased during weight loss. Between 10% and 25% of obese men and women may develop gallstones within a few months of beginning a very low calorie diet, and perhaps one third of these will develop symptoms of gallstones. Persons with the highest body mass index before weight loss and those who lose weight most rapidly appear to be at the greatest risk for gallstones. Treatment with ursodeoxycholic acid (ursodiol) during weight loss dieting is the only proven prevention for the formation of gallstones. Issues to be resolved include how different diets affect the risk for developing gallstones, the identification of other risk factors for gallstone formation during weight loss, the effect of weight loss among people with preexisting gallstones, and the optimum means of preventing gallstones during weight loss. Conclusions: During weight loss, particularly-among the obese, an increased risk exists for symptomatic gallstone formation. This acute risk offers the opportunity to investigate the cause of gallstones and possibly to prevent them.			EVERHART, JE (corresponding author), NIDDKD, 5333 WESTBARD AVE, ROOM 3A-10, WESTWOOD BLDG, BETHESDA, MD 20892 USA.		Biguzzi, Felipe A/E-4724-2015					ACALOVSCHI M, 1992, INT J OBESITY, V16, P313; AMARAL JF, 1985, AM J SURG, V149, P551, DOI 10.1016/S0002-9610(85)80055-6; ANGELICO M, 1988, HEPATOLOGY, V8, P907; ANGELIN B, 1981, SCAND J GASTROENTERO, V16, P1015, DOI 10.3109/00365528109181021; BARBARA L, 1987, HEPATOLOGY, V7, P913, DOI 10.1002/hep.1840070520; BENNION LJ, 1975, J CLIN INVEST, V56, P996, DOI 10.1172/JCI108180; BOLONDI L, 1985, GUT, V26, P734, DOI 10.1136/gut.26.7.734; BOUCHARD C, 1990, AM J CLIN NUTR, V52, P946, DOI 10.1093/ajcn/52.5.946; BROOMFIELD PH, 1988, NEW ENGL J MED, V319, P1567, DOI 10.1056/NEJM198812153192403; BUSCH N, 1991, EUR J CLIN INVEST, V21, P453, DOI 10.1111/j.1365-2362.1991.tb01394.x; CRAIN K, 1990, CLIN THER, V12, P250; EINARSSON K, 1986, ATHEROSCLER REV, V15, P67; FISHER RS, 1987, DIGEST DIS SCI, V32, P1337, DOI 10.1007/BF01296658; HAFFNER SM, 1989, AM J EPIDEMIOL, V129, P587, DOI 10.1093/oxfordjournals.aje.a115171; HARTZ AJ, 1984, AM J EPIDEMIOL, V119, P71, DOI 10.1093/oxfordjournals.aje.a113727; HAY DW, 1990, SEMIN LIVER DIS, V10, P159, DOI 10.1055/s-2008-1040470; HEATON KW, 1991, EUR J GASTROEN HEPAT, V3, P745; HESHKA S, 1992, 1992 N AM ASS STUD O, pS20; HOWE RF, 1993, WASHINGTON PSOT B, P1; HOY K, 1991, INT J OBESITY S3, V15, P20; JACOB BG, 1989, NEW ENGL J MED, V320, P1352; JANOWITZ P, 1989, LEBER MAGEN DARM, V19, P190; JORGENSEN T, 1989, GUT, V30, P528, DOI 10.1136/gut.30.4.528; KAMRATH RO, 1992, AM J CLIN NUTR, V56, P255; KATO I, 1992, DIGEST DIS SCI, V37, P784, DOI 10.1007/BF01296440; KONO S, 1992, AM J EPIDEMIOL, V136, P787, DOI 10.1093/aje/136.7.787; KUCIO C, 1988, EUR J CLIN NUTR, V42, P121; LAYDE PM, 1982, J EPIDEMIOL COMMUN H, V36, P274, DOI 10.1136/jech.36.4.274; LIDDLE RA, 1989, ARCH INTERN MED, V149, P1750, DOI 10.1001/archinte.149.8.1750; LITTLE JM, 1991, LANCET, V337, P1135, DOI 10.1016/0140-6736(91)92796-5; MARKS JW, 1992, GASTROENTEROLOGY, V103, P566, DOI 10.1016/0016-5085(92)90848-S; MARKS JW, 1991, DIGEST DIS SCI, V36, P957, DOI 10.1007/BF01297147; MARZIO L, 1988, DIGEST DIS SCI, V33, P4, DOI 10.1007/BF01536623; MAURER KR, 1990, AM J EPIDEMIOL, V131, P836, DOI 10.1093/oxfordjournals.aje.a115574; MAZZELLA G, 1991, GASTROENTEROLOGY, V101, P490, DOI 10.1016/0016-5085(91)90029-K; METZGER AL, 1973, NEW ENGL J MED, V288, P333, DOI 10.1056/NEJM197302152880702; MOK HYI, 1979, GASTROENTEROLOGY, V76, P556; NORTHFIELD TC, 1975, GUT, V16, P1, DOI 10.1136/gut.16.1.1; PATTINSON NR, 1986, GASTROENTEROLOGY, V91, P697, DOI 10.1016/0016-5085(86)90641-4; PAUMGARTNER G, 1991, LANCET, V338, P1117, DOI 10.1016/0140-6736(91)91972-W; REUBEN A, 1986, EUR J CLIN INVEST, V16, P133, DOI 10.1111/j.1365-2362.1986.tb01320.x; RODA E, 1992, GASTROENTEROLOGY, V102, P372, DOI 10.1016/0016-5085(92)91833-P; SCHLIERF G, 1981, DIGESTION, V21, P44, DOI 10.1159/000198519; SCRAGG RKR, 1984, BRIT MED J, V288, P1113, DOI 10.1136/bmj.288.6424.1113; SHIFFMAN ML, 1991, AM J GASTROENTEROL, V86, P1000; SHIFFMAN ML, 1992, GASTROENTEROLOGY, V103, P214, DOI 10.1016/0016-5085(92)91115-K; SICHIERI R, 1991, AM J PUBLIC HEALTH, V81, P880, DOI 10.2105/AJPH.81.7.880; SICHIERI R, 1990, AM J EPIDEMIOL, V131, P826, DOI 10.1093/oxfordjournals.aje.a115573; STAMPFER MJ, 1992, AM J CLIN NUTR, V55, P652, DOI 10.1093/ajcn/55.3.652; STONE BG, 1992, HEPATOLOGY, V15, P795, DOI 10.1002/hep.1840150508; THIJS C, 1992, AM J EPIDEMIOL, V135, P274, DOI 10.1093/oxfordjournals.aje.a116281; TROTMAN BW, 1991, GASTROENTEROL CLIN N, V20, P111; VEZINA WC, 1990, GASTROENTEROLOGY, V98, P1000, DOI 10.1016/0016-5085(90)90025-V; WATTCHOW DA, 1983, BRIT MED J, V286, P763, DOI 10.1136/bmj.286.6367.763; WEINSTEIN MC, 1990, J GEN INTERN MED, V5, P277, DOI 10.1007/BF02600391; WHITING MJ, 1984, GASTROENTEROLOGY, V86, P243; WILLIAMS CN, 1977, AM J DIG DIS, V22, P189, DOI 10.1007/BF01072275; YANG HY, 1992, DIGEST DIS SCI, V37, P912, DOI 10.1007/BF01300390	58	160	188	1	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1993	119	10					1029	1035		10.7326/0003-4819-119-10-199311150-00010	http://dx.doi.org/10.7326/0003-4819-119-10-199311150-00010			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MG672	8214980				2022-12-28	WOS:A1993MG67200010
J	PRATTER, MR; BARTTER, T; AKERS, S; DUBOIS, J				PRATTER, MR; BARTTER, T; AKERS, S; DUBOIS, J			AN ALGORITHMIC APPROACH TO CHRONIC COUGH	ANNALS OF INTERNAL MEDICINE			English	Article						PREDNISONE; ARTHRITIS, RHEUMATOID; BONE DENSITY; BONE RESORPTION	SOLE PRESENTING MANIFESTATION; CHRONIC PERSISTENT COUGH; ASTHMA; RESPONSIVENESS; DIAGNOSIS; FREQUENCY; SPECTRUM; THERAPY	Objectives: To evaluate a stepwise approach to chronic cough that emphasized initial treatment of all patients with an antihistamine-decongestant for postnasal drip and to determine the value of routine bronchoprovocation challenge in the evaluation of chronic cough. Design: Prospective trial using an algorithm for chronic cough in immunocompetent nonsmoking outpatients. Setting: University-based pulmonary practice. Patients: Forty-five patients met the inclusion criteria. The mean duration of cough was 140 weeks (range, 3 to 2080 weeks), and the mean severity of cough as assessed by patients on a four-point scale was ''severe.'' Results: Marked improvement and resolution (mean, 3.1 and 7.1 weeks, respectively), with resolution in 96% of patients. Antihistamine-decongestant therapy was beneficial in 39 of 45 patients and was the only therapy needed for 16 patients. Bronchoprovocation challenge had a negative predictive value of 100% and a positive predictive value of 74% for cough caused by asthma. No significant relationship was found between the time to cough resolution and duration or severity of cough. Eighteen percent of patients experienced a recurrence of cough at a follow-up interval of 3 months. Conclusions: A sequential approach to chronic cough that emphasizes initial treatment with an antihistamine-decongestant is effective. Bronchoprovocation challenge is useful in evaluating patients with chronic cough but can be delayed until the initial response to antihistamine-decongestant therapy has been assessed. The 18% incidence of recurrence highlights the fact that cough often is the manifestation of a chronic or recurring process that requires chronic or episodic therapy.			PRATTER, MR (corresponding author), UMDNJ, COOPER HOSP UNIV MED CTR, ROBERT WOOD JOHNSON MED SCH, SUITE 312, 3 COOPER PLAZA, CAMDEN, NJ 08103 USA.							AKERS SM, 1992, CHEST, V101, P853, DOI 10.1378/chest.101.3.853; BRAMAN SS, 1985, PRIMARY CARE, V12, P217; CORRAO W M, 1986, Comprehensive Therapy, V12, P14; CORRAO WM, 1979, NEW ENGL J MED, V300, P633, DOI 10.1056/NEJM197903223001201; DEMEESTER TR, 1980, J THORAC CARDIOV SUR, V79, P656; DIPEDE C, 1991, CHEST, V99, P916, DOI 10.1378/chest.99.4.916; EMPEY DW, 1976, AM REV RESPIR DIS, V113, P131; HARGREAVE FE, 1981, J ALLERGY CLIN IMMUN, V68, P347, DOI 10.1016/0091-6749(81)90132-9; HARGREAVE FE, 1985, CHEST, V87, pS202, DOI 10.1378/chest.87.5_Supplement.202S; IRWIN RS, 1990, AM REV RESPIR DIS, V141, P640, DOI 10.1164/ajrccm/141.3.640; IRWIN RS, 1989, AM REV RESPIR DIS, V140, P1294, DOI 10.1164/ajrccm/140.5.1294; IRWIN RS, 1977, ARCH INTERN MED, V137, P1186, DOI 10.1001/archinte.137.9.1186; IRWIN RS, 1981, AM REV RESPIR DIS, V123, P413; IRWIN RS, 1991, CHEST, V99, P1477, DOI 10.1378/chest.99.6.1477; JOHNSON D, 1991, J ASTHMA, V28, P85, DOI 10.3109/02770909109082732; PENDER E S, 1990, Journal of Emergency Medicine, V8, P727, DOI 10.1016/0736-4679(90)90287-6; POE RH, 1989, CHEST, V95, P723, DOI 10.1378/chest.95.4.723; PRATTER MR, 1988, CHEST, V93, P898, DOI 10.1378/chest.93.5.898; PRATTER MR, 1991, CHEST, V100, P1187, DOI 10.1378/chest.100.5.1187; TOWNLEY RJ, 1987, J ALLERGY CLIN IMMUN, V80, P111, DOI 10.1016/0091-6749(87)90116-3; WYNDER EL, 1965, AM REV RESPIR DIS, V91, P679	21	203	222	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1993	119	10					977	983		10.7326/0003-4819-119-10-199311150-00003	http://dx.doi.org/10.7326/0003-4819-119-10-199311150-00003			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MG672	8214994				2022-12-28	WOS:A1993MG67200003
J	JIANG, CW; FINKBEINER, WE; WIDDICOMBE, JH; MCCRAY, PB; MILLER, SS				JIANG, CW; FINKBEINER, WE; WIDDICOMBE, JH; MCCRAY, PB; MILLER, SS			ALTERED FLUID TRANSPORT ACROSS AIRWAY EPITHELIUM IN CYSTIC-FIBROSIS	SCIENCE			English	Article							RETINAL-PIGMENT EPITHELIUM; TRACHEAL EPITHELIUM; RESPIRATORY EPITHELIA; EXTRACELLULAR ATP; SODIUM-TRANSPORT; ION-TRANSPORT; ACTIVATION; ABSORPTION; CHANNELS; MEMBRANE	In cystic fibrosis (CF), absence or dysfunction of a phosphorylation-regulated chloride channel [CF transmembrane conductance regulator (CFTR)] leads to the loss or reduction of chloride secretion into the airways. Active sodium absorption is also increased in CF, and both of these ion transport changes could alter fluid transport across the airways. Under baseline conditions, cultured human airway epithelia from normal individuals absorbed fluid, and this absorption was increased in epithelia from patients with CF. In normal and CF epithelial cultures fluid absorption was inhibited by amiloride. Adenosine 3',5'-monophosphate stimulated fluid secretion in normal epithelial cultures but not in cultures from individuals with CF. In contrast, fluid secretion induced by nucleotide triphosphates (uridine triphosphate or adenosine triphosphate) was unaltered in cultures of epithelia from patients with CF, suggesting an approach to the treatment of CF.	UNIV CALIF BERKELEY,SCH OPTOMETRY,BERKELEY,CA 94720; UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,DIV CELL & DEV,BERKELEY,CA 94720; UNIV CALIF SAN FRANCISCO,CARDIOVASC RES INST,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PATHOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV IOWA,COLL MED,DEPT PEDIAT,IOWA CITY,IA 52242	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Iowa				McCray, Paul/0000-0002-4067-577X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL042368] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 42368] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON MP, 1991, P NATL ACAD SCI USA, V88, P6003, DOI 10.1073/pnas.88.14.6003; BENOS DJ, 1982, AM J PHYSIOL, V242, pC131, DOI 10.1152/ajpcell.1982.242.3.C131; BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; BRADBURY NA, 1992, SCIENCE, V256, P530, DOI 10.1126/science.1373908; BROWN HA, 1991, MOL PHARMACOL, V40, P648; CLARKE LL, 1992, AM J PHYSIOL, V263, pC348, DOI 10.1152/ajpcell.1992.263.2.C348; DURAND J, 1981, PFLUG ARCH EUR J PHY, V392, P40, DOI 10.1007/BF00584580; EDELMAN JL, 1991, INVEST OPHTH VIS SCI, V32, P3033; HUGHES BA, 1984, J GEN PHYSIOL, V83, P875, DOI 10.1085/jgp.83.6.875; JIANG C, UNPUB; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; KNOWLES MR, 1991, NEW ENGL J MED, V325, P533, DOI 10.1056/NEJM199108223250802; LOUGHLIN GM, 1982, EXPERIENTIA, V38, P1451, DOI 10.1007/BF01955764; MASON SJ, 1991, BRIT J PHARMACOL, V103, P1649, DOI 10.1111/j.1476-5381.1991.tb09842.x; MILLER SS, 1992, PEDIATR PULMONOLOG S, V7, P278; NATHANSON I, 1983, J APPL PHYSIOL, V55, P1257, DOI 10.1152/jappl.1983.55.4.1257; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; SMITH JJ, 1993, J CLIN INVEST, V91, P1590, DOI 10.1172/JCI116365; WELSH MJ, 1980, J APPL PHYSIOL, V49, P905, DOI 10.1152/jappl.1980.49.5.905; WELSH MJ, 1990, FASEB J, V4, P2718, DOI 10.1096/fasebj.4.10.1695593; WILLUMSEN NJ, 1989, AM J PHYSIOL, V256, pC226, DOI 10.1152/ajpcell.1989.256.2.C226; WILLUMSEN NJ, 1991, AM J PHYSIOL, V261, pC332, DOI 10.1152/ajpcell.1991.261.2.C332; YAMAYA M, 1993, AM J PHYSIOL, V265, pL170, DOI 10.1152/ajplung.1993.265.2.L170; YAMAYA M, 1992, AM J PHYSIOL, V262, pL713, DOI 10.1152/ajplung.1992.262.6.L713	25	188	197	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 15	1993	262	5132					424	427		10.1126/science.8211164	http://dx.doi.org/10.1126/science.8211164			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB859	8211164				2022-12-28	WOS:A1993MB85900059
J	SCHMIEDEN, V; KUHSE, J; BETZ, H				SCHMIEDEN, V; KUHSE, J; BETZ, H			MUTATION OF GLYCINE RECEPTOR SUBUNIT CREATES BETA-ALANINE RECEPTOR RESPONSIVE TO GABA	SCIENCE			English	Article							NEURONAL NICOTINIC RECEPTOR; GATED ION CHANNELS; RAT SPINAL-CORD; STRYCHNINE-BINDING-SITE; CENTRAL-NERVOUS-SYSTEM; ACETYLCHOLINE-RECEPTOR; FUNCTIONAL EXPRESSION; XENOPUS OOCYTES; MESSENGER-RNA; AMINO-ACIDS	The amino acid at position 160 of the ligand-binding subunit, alpha1, is an important determinant of agonist and antagonist binding to the glycine receptor. Exchange of the neighboring residues, phenylalanine at position 159 and tyrosine at position 161, increased the efficacy of amino acid agonists. Whereas wild-type alpha1 channels expressed in Xenopus oocytes required 0.7 millimolar beta-alanine for a half-maximal response, the doubly mutated (F159Y, Y161F) alpha1 subunit had an affinity for beta-alanine (which was more potent than glycine) that was 110-fold that of the wild type. Also, gamma-aminobutyric acid and D-serine, amino acids that do not activate wild-type alpha1 receptors, efficiently gated the mutant channel. Thus, aromatic hydroxyl groups are crucial for ligand discrimination at inhibitory amino acid receptors.	MAX PLANCK INST BRAIN RES,DEPT NEUROCHEM,DEUTSCHORDENSTR 46,D-60528 FRANKFURT 71,GERMANY	Max Planck Society			Kuhse, Jochen/T-3864-2019					BARNARD EA, 1992, TRENDS BIOCHEM SCI, V17, P368, DOI 10.1016/0968-0004(92)90002-Q; BERTRAND D, 1992, P NATL ACAD SCI USA, V89, P1261, DOI 10.1073/pnas.89.4.1261; BETZ H, 1990, NEURON, V5, P383, DOI 10.1016/0896-6273(90)90077-S; BETZ H, 1992, Q REV BIOPHYS, V25, P381, DOI 10.1017/S0033583500004340; DELOREY TM, 1992, J BIOL CHEM, V267, P16747; DENNIS M, 1988, BIOCHEMISTRY-US, V27, P2346, DOI 10.1021/bi00407a016; GALZI JL, 1991, P NATL ACAD SCI USA, V88, P5051, DOI 10.1073/pnas.88.11.5051; GALZI JL, 1991, FEBS LETT, V294, P198, DOI 10.1016/0014-5793(91)80668-S; GALZI JL, 1990, J BIOL CHEM, V265, P10430; GRAHAM D, 1983, EUR J BIOCHEM, V131, P519, DOI 10.1111/j.1432-1033.1983.tb07292.x; GRAHAM D, 1985, BIOCHEMISTRY-US, V24, P990, DOI 10.1021/bi00325a027; GRENNINGLOH G, 1990, NEURON, V4, P963, DOI 10.1016/0896-6273(90)90149-A; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GRENNINGLOH G, 1990, EMBO J, V9, P771, DOI 10.1002/j.1460-2075.1990.tb08172.x; HORIKOSHI T, 1988, MOL BRAIN RES, V4, P97, DOI 10.1016/0169-328X(88)90002-2; KUBO T, 1985, EUR J BIOCHEM, V149, P5, DOI 10.1111/j.1432-1033.1985.tb08885.x; KUDO Y, 1988, BRIT J PHARMACOL, V94, P1051, DOI 10.1111/j.1476-5381.1988.tb11621.x; KUHSE J, 1990, NEURON, V5, P867, DOI 10.1016/0896-6273(90)90346-H; KUHSE J, 1991, FEBS LETT, V283, P73, DOI 10.1016/0014-5793(91)80557-J; KUHSE J, 1990, J BIOL CHEM, V265, P22317; LANGOSCH D, 1990, EUR J BIOCHEM, V194, P1, DOI 10.1111/j.1432-1033.1990.tb19419.x; LANGOSCH D, 1988, P NATL ACAD SCI USA, V85, P7394, DOI 10.1073/pnas.85.19.7394; OCONNOR VM, 1992, THESIS U COLLEGE LON; PARKER I, 1988, PROC R SOC SER B-BIO, V233, P201, DOI 10.1098/rspb.1988.0019; PFEIFFER F, 1982, J BIOL CHEM, V257, P9389; PRITCHETT DB, 1991, P NATL ACAD SCI USA, V88, P1421, DOI 10.1073/pnas.88.4.1421; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; RUIZGOMEZ A, 1990, BIOCHEMISTRY-US, V29, P7033, DOI 10.1021/bi00482a012; SCHMIEDEN V, 1989, EMBO J, V8, P695, DOI 10.1002/j.1460-2075.1989.tb03428.x; SCHMIEDEN V, 1992, EMBO J, V11, P2025, DOI 10.1002/j.1460-2075.1992.tb05259.x; SCHMIEDEN V, UNPUB; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SONTHEIMER H, 1989, NEURON, V2, P1491, DOI 10.1016/0896-6273(89)90195-5; VANDENBERG RJ, 1992, P NATL ACAD SCI USA, V89, P1765, DOI 10.1073/pnas.89.5.1765; WIELAND HA, 1992, J BIOL CHEM, V267, P1426; Wisden W, 1992, Curr Opin Neurobiol, V2, P263, DOI 10.1016/0959-4388(92)90113-Y; YOUNG AB, 1974, MOL PHARMACOL, V10, P790; YOUNG AB, 1973, P NATL ACAD SCI USA, V70, P2832, DOI 10.1073/pnas.70.10.2832	38	131	134	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 8	1993	262	5131					256	258		10.1126/science.8211147	http://dx.doi.org/10.1126/science.8211147			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA665	8211147				2022-12-28	WOS:A1993MA66500040
J	VENABLE, RM; ZHANG, YH; HARDY, BJ; PASTOR, RW				VENABLE, RM; ZHANG, YH; HARDY, BJ; PASTOR, RW			MOLECULAR-DYNAMICS SIMULATIONS OF A LIPID BILAYER AND OF HEXADECANE - AN INVESTIGATION OF MEMBRANE FLUIDITY	SCIENCE			English	Article							BIOLOGICAL-MEMBRANES; ROTATIONAL DIFFUSION; PHOSPHOLIPID BILAYER; RELAXATION; PARAMETERS; CRYSTALS; MICELLE; CHAIN; MODEL	Molecular dynamics simulations of a fluid-phase dipalmitoyl phosphatidylcholine lipid bilayer in water and of neat hexadecane are reported and compared with nuclear magnetic resonance spin-lattice relaxation and quasi-elastic neutron scattering data. On the 100-picosecond time scale of the present simulations, there is effectively no difference in the reorientational dynamics of the carbons in the membrane interior and in pure hexadecane. Given that the calculated fast reorientational correlation times and the ''microscopic'' lateral diffusion of the lipids show excellent agreement with the experimental results, it is concluded that the apparently high viscosity of the membrane is more closely related to molecular interactions on the surface rather than in the interior.	US FDA,CTR BIOL EVALUAT & RES,BIOPHYS LAB,8800 ROCKVILLE PIKE,BETHESDA,MD 20892	US Food & Drug Administration (FDA)								AHLSTROM P, IN PRESS J PHYS CHEM; BOCIAN DF, 1978, ANNU REV PHYS CHEM, V29, P307, DOI 10.1146/annurev.pc.29.100178.001515; BROOKS CL, 1988, PROTEINS THEORETICAL; BROWN MF, 1983, P NATL ACAD SCI-BIOL, V80, P4325, DOI 10.1073/pnas.80.14.4325; BROWN MF, 1984, J CHEM PHYS, V80, P2808, DOI 10.1063/1.447030; Cevc G., 1987, PHOSPHOLIPID BILAYER; CHARIFSON PS, 1990, J COMPUT CHEM, V10, P1182; DAMODARAN KV, 1992, BIOCHEMISTRY-US, V31, P7656, DOI 10.1021/bi00148a029; DELOOF H, 1991, BIOCHEMISTRY-US, V30, P2099, DOI 10.1021/bi00222a015; EGBERTS B, 1988, THESIS RIJKSUNIVERSI; EGBERTS E, 1988, J CHEM PHYS, V89, P3718, DOI 10.1063/1.454893; Finkelstein A., 1987, WATER MOVEMENT LIPID; FISCHER TM, 1992, BIOPHYS J, V63, P1328, DOI 10.1016/S0006-3495(92)81710-1; HARDY BJ, IN PRESS J COMPUT CH; HELLER H, 1993, J PHYS CHEM-US, V97, P8343, DOI 10.1021/j100133a034; HUGHES BD, 1982, BIOPHYS J, V37, P673; JONSSON B, 1986, J CHEM PHYS, V85, P2259, DOI 10.1063/1.451122; KLEIN ML, 1992, J CHEM SOC FARADAY T, V88, P1701, DOI 10.1039/ft9928801701; MARCELJA S, 1974, BIOCHIM BIOPHYS ACTA, V367, P165, DOI 10.1016/0005-2736(74)90040-6; OVERTON E, 1895, VIERTELJAHRESSCHR NA, V40, P159; PASTOR RW, 1991, P NATL ACAD SCI USA, V88, P892, DOI 10.1073/pnas.88.3.892; PASTOR RW, 1988, J CHEM PHYS, V89, P1112, DOI 10.1063/1.455218; PASTOR RW, 1988, J CHEM PHYS, V89, P1128, DOI 10.1063/1.455219; PASTOR RW, IN PRESS COMPUTER SI; PETERS R, 1982, P NATL ACAD SCI-BIOL, V79, P4317, DOI 10.1073/pnas.79.14.4317; RAGHAVAN K, 1992, LANGMUIR, V8, P233, DOI 10.1021/la00037a043; RAND RP, 1989, BIOCHIM BIOPHYS ACTA, V988, P351, DOI 10.1016/0304-4157(89)90010-5; ROMMEL E, 1988, J PHYS CHEM-US, V92, P2981, DOI 10.1021/j100321a053; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; SCHINDLER H, 1975, BIOCHEMISTRY-US, V14, P2283, DOI 10.1021/bi00682a001; SEELIG A, 1974, BIOCHEMISTRY-US, V13, P4839, DOI 10.1021/bi00720a024; SMALL DM, 1986, PHYSICAL CHEM LIPIDS; STOUCH TR, 1991, J COMPUT CHEM, V12, P1033, DOI 10.1002/jcc.540120816; STOUCH TR, 1993, MOL SIMULAT, V10, P317; VAZ WLC, 1991, BIOPHYS J, V60, P1553, DOI 10.1016/S0006-3495(91)82190-7; VENABLE RM, UNPUB; WATANABE K, 1989, J PHYS CHEM-US, V93, P6897, DOI 10.1021/j100356a006; WENDOLOSKI JJ, 1989, SCIENCE, V243, P636, DOI 10.1126/science.2916118; 1969, LANDOLTBORNSTEIN TAB; [No title captured]	40	320	320	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 8	1993	262	5131					223	226		10.1126/science.8211140	http://dx.doi.org/10.1126/science.8211140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA665	8211140				2022-12-28	WOS:A1993MA66500029
J	RINK, E; HILTON, S; SZCZEPURA, A; FLETCHER, J; SIBBALD, B; DAVIES, C; FREELING, P; STILWELL, J				RINK, E; HILTON, S; SZCZEPURA, A; FLETCHER, J; SIBBALD, B; DAVIES, C; FREELING, P; STILWELL, J			IMPACT OF INTRODUCING NEAR PATIENT TESTING FOR STANDARD INVESTIGATIONS IN GENERAL-PRACTICE	BRITISH MEDICAL JOURNAL			English	Article							TECHNOLOGY; CARE	Objective-To assess the clinical and economic impact of surgery based near patient testing in general practice for six commonly used biochemical and bacteriological tests. Design-After four months' monitoring, equipment for two bacteriological and four biochemical tests was introduced without cost into 12 practices using a crossover design. Structured request forms were used to monitor laboratory investigations. Setting-12 general practices in west midlands and south west Thames with list sizes above 9000. Main outcome measures-Investigation rates per 1000 consultations. Changes from baseline rates. Reasons for requesting investigations and provisional diagnoses. Cost per test and sensitivity of costs to rate of use. Results-Investigation rates for the six tests rose by 16.5% (from 78.6/1000 consultations to 91.6/1000) when equipment was available in the surgery and reverted to baseline rates when it was withdrawn. The average weekly number of tests when equipment was available ranged from 0.5 to 10.5 (mean 9.0). Cholesterol tests were used as an addition to laboratory testing, usually for screening. Midstream urine analysis was often done in the surgery instead of in the laboratory, although 30% of samples were tested by both methods. Doctors' reasons for investigation and conditions tested were largely unaffected by availability of surgery tests. Costs for surgery tests were higher for all tests except midstream urine. Conclusions-Availability of surgery based testing increased the number of tests performed. It was cost effective only for midstream urine analysis.	ST GEORGE HOSP,SCH MED,DIV GEN PRACTICE & PRIMARY CARE,LONDON SW17 0RE,ENGLAND; UNIV WARWICK,HLTH SERV RES UNIT,COVENTRY CV4 7AL,W MIDLANDS,ENGLAND	St Georges University London; University of Warwick				Szczepura, Ala/0000-0001-6244-9872				BANTA H, 1987, ANTICIPATING ASSESSI; BATSTONE G, 1990, OFFICE HLTH EC  0423, P41; DRURY M, 1990, OFFICE HLTH EC  0423, P38; FREEMAN GK, 1992, BRIT J GEN PRACT, V42, P311; GUYATT G, 1986, SOC SCI MED, V22, P393, DOI 10.1016/0277-9536(86)90046-8; HAILEY DM, 1989, LABMEDICA        JUL, P16; HARTLEY RM, 1984, BRIT MED J, V289, P735, DOI 10.1136/bmj.289.6447.735; HILTON S, 1990, BRIT J GEN PRACT, V40, P32; HOBBS FDR, 1992, BRIT J GEN PRACT, V42, P317; JENNETT B, 1992, BRIT MED J, V305, P67, DOI 10.1136/bmj.305.6845.67; MILLS KA, 1983, BRIT MED J, V287, P1033, DOI 10.1136/bmj.287.6398.1033; Szczepura A, 1992, Health Serv J, V102, P20; WILKIN D, 1984, BRIT MED J, V289, P229, DOI 10.1136/bmj.289.6439.229; 1992, NEW TECHNOLOGY MED N; 1984, MED TECHNOLOGY COSTS, P41	15	42	42	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 25	1993	307	6907					775	778		10.1136/bmj.307.6907.775	http://dx.doi.org/10.1136/bmj.307.6907.775			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LZ478	8219952	Green Published, Bronze			2022-12-28	WOS:A1993LZ47800027
J	SABA, HI; MORELLI, GA; LOGRONO, LA				SABA, HI; MORELLI, GA; LOGRONO, LA			BRIEF REPORT - TREATMENT OF BLEEDING IN HEREDITARY HEMORRHAGIC TELANGIECTASIA WITH AMINOCAPROIC ACID	NEW ENGLAND JOURNAL OF MEDICINE			English	Note							WEBER-RENDU DISEASE; MANAGEMENT; EPISTAXIS; FAMILY		JAMES A HALEY VET HOSP,TAMPA,FL 33612	US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital	SABA, HI (corresponding author), UNIV S FLORIDA,COLL MED,H LEE MOFFITT CANC CTR & RES INST,DIV HEMATOL & MED ONCOL,TAMPA,FL 33612, USA.							ABLONDI FB, 1959, P SOC EXP BIOL MED, V102, P717; ALKJAERSIG N, 1959, J BIOL CHEM, V234, P832; BIRD RM, 1957, NEW ENGL J MED, V257, P105, DOI 10.1056/NEJM195707182570303; CONLON CL, 1978, ANN INTERN MED, V89, P921, DOI 10.7326/0003-4819-89-6-921; ENDO Y, 1984, THROMB HAEMOSTASIS, V52, P369; GOLA A, 1977, Folia Haematologica (Leipzig), V104, P102; Hanes FA, 1909, B JOHNS HOPKINS HOSP, V20, P63; HANNA W, 1984, THROMB HAEMOSTASIS, V51, P275; HARDY JF, 1992, CAN J ANAESTH, V39, P353, DOI 10.1007/BF03009046; HARRISON DFN, 1982, LARYNGOSCOPE, V92, P314; HASHIMOTO K, 1972, ORAL SURG ORAL MED O, V34, P751, DOI 10.1016/0030-4220(72)90293-9; JAHNKE V, 1970, ARCHIV OTOLARYNGOL, V91, P262; JASH D K, 1973, Journal of Laryngology and Otology, V87, P895, DOI 10.1017/S002221510007777X; KWAAN HC, 1973, ARCH DERMATOL, V107, P571, DOI 10.1001/archderm.107.4.571; LARSSON SO, 1974, ACTA MED SCAND, V196, P133; MCCABE WP, 1972, PLAST RECONSTR SURG, V50, P114, DOI 10.1097/00006534-197208000-00002; MUCKLE TJ, 1964, LANCET, V2, P880; Osler W, 1901, B JOHNS HOPKINS HOSP, V12, P333; PANDOLFI M, 1978, ACTA OPHTHALMOL, V56, P75; PEERY WH, 1987, AM J MED, V82, P989, DOI 10.1016/0002-9343(87)90162-8; PLAUCHU H, 1989, AM J MED GENET, V32, P291, DOI 10.1002/ajmg.1320320302; SINGH I, 1992, UROLOGY, V40, P227, DOI 10.1016/0090-4295(92)90479-G; STEEL D, 1988, AM J CLIN PATHOL, V90, P274, DOI 10.1093/ajcp/90.3.274; STEFANINI M, 1990, J UROLOGY, V143, P559, DOI 10.1016/S0022-5347(17)40018-8; SUDARSHAN A, 1985, SOUTHERN MED J, V78, P623, DOI 10.1097/00007611-198505000-00030; SUREDA A, 1991, ACTA HAEMATOL-BASEL, V85, P119; VANCUTSEM E, 1988, J CLIN GASTROENTEROL, V10, P676; VANDERSALM TJ, 1988, J THORAC CARDIOV SUR, V95, P538; Watanabe M, 1985, Nihon Hifuka Gakkai Zasshi, V95, P11; ZOHAR Y, 1987, ARCH OTOLARYNGOL, V113, P754	30	66	68	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 23	1994	330	25					1789	1790		10.1056/NEJM199406233302504	http://dx.doi.org/10.1056/NEJM199406233302504			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR295	8190155				2022-12-28	WOS:A1994NR29500004
J	DESAUVAGE, FJ; HASS, PE; SPENCER, SD; MALLOY, BE; GURNEY, AL; SPENCER, SA; DARBONNE, WC; HENZEL, WJ; WONG, SC; KUANG, WJ; OLES, KJ; HULTGREN, B; SOLBERG, LA; GOEDDEL, DV; EATON, DL				DESAUVAGE, FJ; HASS, PE; SPENCER, SD; MALLOY, BE; GURNEY, AL; SPENCER, SA; DARBONNE, WC; HENZEL, WJ; WONG, SC; KUANG, WJ; OLES, KJ; HULTGREN, B; SOLBERG, LA; GOEDDEL, DV; EATON, DL			STIMULATION OF MEGAKARYOCYTOPOIESIS AND THROMBOPOIESIS BY THE C-MPL LIGAND	NATURE			English	Article							FACTOR RECEPTOR SUPERFAMILY; REBOUND-THROMBOCYTOSIS; PARTIAL-PURIFICATION; HUMAN ERYTHROPOIETIN; COLONY FORMATION; MESSENGER-RNA; GM-CSF; INVITRO; SEQUENCE; INVIVO	Physiological platelet synthesis is thought to require the humoral activities of meg-CSF and thrombopoietin, which respectively promote proliferation and maturation of megakaryocytic cells. A meg-CSF/thrombopoietin-like protein that is present in plasma of irradiated pigs has been purified and cloned. This protein binds to and activates the c-mpl protein, a member of the cytokine receptor superfamily. The isolated Mpl ligand shares homology with erythropoietin and stimulates both megakaryocytopoiesis and thrombopoiesis.	MAYO CLIN, DIV HEMATOL ONCOL, JACKSONVILLE, FL 32224 USA; GENENTECH INC, DEPT MOLEC BIOL, San Francisco, CA 94080 USA; GENENTECH INC, DEPT CARDIOVASC RES, San Francisco, CA 94080 USA; GENENTECH INC, DEPT PROT CHEM, San Francisco, CA 94080 USA; MAYO CLIN & MAYO FDN, DIV HEMATOL ONCOL, ROCHESTER, MN 55905 USA	Mayo Clinic; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Mayo Clinic			Solberg, Lawrence A/A-3824-2014; de Sauvage, Frederic/ABE-8400-2020	Solberg, Lawrence A/0000-0001-9550-5180; de Sauvage, Frederic/0000-0002-5275-2584; Henzel, William/0000-0003-2940-3797				BENNETT BD, 1991, J BIOL CHEM, V266, P23060; BONDURANT MC, 1986, MOL CELL BIOL, V6, P2731, DOI 10.1128/MCB.6.7.2731; CAPON DJ, 1989, NATURE, V337, P525, DOI 10.1038/337525a0; DANREA AD, 1991, MOL CELL BIOL, V11, P1980; DESAUVAGE FJ, 1992, P NATL ACAD SCI USA, V89, P9089, DOI 10.1073/pnas.89.19.9089; EBBE S, 1974, BLOOD, V44, P605, DOI 10.1182/blood.V44.4.605.605; ERICKSONMILLER CL, 1993, BRIT J HAEMATOL, V84, P197, DOI 10.1111/j.1365-2141.1993.tb03052.x; GORDON MS, 1992, BLOOD, V80, P302; GORMAN C, 1985, DNA CLONING PRACTICA, V2, P143; GRANT BW, 1987, BLOOD, V69, P1334; HARRINGTON MG, 1990, METHOD ENZYMOL, V182, P488; HEGYI E, 1990, INT J CELL CLONING, V8, P236, DOI 10.1002/stem.5530080407; HILL RJ, 1992, BLOOD, V80, P346; HILL RJ, 1992, EXP HEMATOL, V20, P354; HOFFMAN R, 1981, NEW ENGL J MED, V305, P533, DOI 10.1056/NEJM198109033051001; JACOBS K, 1985, NATURE, V313, P806, DOI 10.1038/313806a0; KITAMURA T, 1991, P NATL ACAD SCI USA, V88, P5082, DOI 10.1073/pnas.88.12.5082; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MAZUR EM, 1985, EXP HEMATOL, V13, P1164; MAZUR EM, 1981, J CLIN INVEST, V68, P733, DOI 10.1172/JCI110309; MCDONALD TP, 1973, P SOC EXP BIOL MED, V144, P1006; MCDONALD TP, 1971, J LAB CLIN MED, V77, P134; MCDONALD TP, 1976, SCAND J HAEMATOL, V16, P326; METHIA N, 1993, BLOOD, V82, P1395; NAKEFF A, 1975, ACTA HAEMATOL-BASEL, V54, P340, DOI 10.1159/000208096; NARHI LO, 1991, J BIOL CHEM, V266, P23022; ODELL TT, 1961, P SOC EXP BIOL MED, V108, P428; PALACIOS R, 1985, CELL, V41, P727, DOI 10.1016/S0092-8674(85)80053-2; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SCHEINER DP, 1980, BLOOD, V56, P183; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SHREINER DP, 1970, J CLIN INVEST, V49, P1709, DOI 10.1172/JCI106388; SKODA RC, 1993, EMBO J, V12, P2645, DOI 10.1002/j.1460-2075.1993.tb05925.x; SOUYRI M, 1990, CELL, V63, P1137, DOI 10.1016/0092-8674(90)90410-G; SPECTOR B, 1961, P SOC EXP BIOL MED, V108, P146; SPIVAK JL, 1989, BLOOD, V73, P90; STRANEVA JE, 1989, EXP HEMATOL, V17, P1122; STRANEVA JE, 1992, EXP HEMATOL, V20, P47; TAKEUCHI M, 1990, J BIOL CHEM, V265, P12127; TSUKADA J, 1993, BLOOD, V81, P866; VIGFON I, 1993, ONCOGENE, V8, P2607; VIGON I, 1992, P NATL ACAD SCI USA, V89, P5640, DOI 10.1073/pnas.89.12.5640; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WANG FF, 1985, ENDOCRINOLOGY, V116, P2286, DOI 10.1210/endo-116-6-2286; WILLIAMS N, 1982, J CELL PHYSIOL, V110, P101, DOI 10.1002/jcp.1041100116; WILLIAMS N, 1989, BLOOD CELLS, V15, P123; WONG SC, 1993, TECHNIQUES PROTEIN C, V4, P371	48	1183	1277	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	1994	369	6481					533	538		10.1038/369533a0	http://dx.doi.org/10.1038/369533a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR294	8202154				2022-12-28	WOS:A1994NR29400040
J	ABE, T; EARLY, A; SIEGERT, F; WEIJER, C; WILLIAMS, J				ABE, T; EARLY, A; SIEGERT, F; WEIJER, C; WILLIAMS, J			PATTERNS OF CELL-MOVEMENT WITHIN THE DICTYOSTELIUM SLUG REVEALED BY CELL-TYPE-SPECIFIC, SURFACE LABELING OF LIVING CELLS	CELL			English	Article							ANTERIOR-LIKE CELLS; MONOCLONAL-ANTIBODIES; PRESTALK ZONE; DISCOIDEUM; CULMINATION; MIGRATION; IDENTIFICATION; GLYCOPROTEIN; LOCALIZATION; POPULATIONS	There are cells scattered in the rear, prespore region of the Dictyostelium slug that share many of the properties of the prestalk cells and that are therefore called anterior-like cells (ALCs). By placing the gene encoding a cell surface protein under the central of an ALC-specific promoter and immunologically labeling the living cells, we analyze the movement of ALCs within the slug. There Is a posterior to anterior cellular flow, and the ALCs change their movement pattern as they enter the prestalk zone. Prestalk cells are periodically shed from the migrating slug. They must be replaced if the correct ratio of prestalk to prespore eels is to be maintained, and we present evidence for the transdifferentiation of prespore into prestalk cells, with ALCs functioning as intermediates in the transition. The slug has, therefore, a surprisingly dynamic structure, both with respect to cellular differentiation and cell movement.	UNIV MUNICH,INST ZOOL,D-80333 MUNICH,GERMANY	University of Munich	ABE, T (corresponding author), IMPERIAL CANC RES FUND,CLARE HALL LABS,S MIMMS EN6 3LD,HERTS,ENGLAND.			Weijer, Cornelis/0000-0003-2192-8150				AKIYAMA Y, 1987, DIFFERENTIATION, V35, P83, DOI 10.1111/j.1432-0436.1987.tb00153.x; BLACHKE A, 1986, DIFFERENTIATION, V32, P1; BONNER JT, 1952, AM NAT, V86, P79, DOI 10.1086/281707; BONNER JT, 1957, Q REV BIOL, V32, P232, DOI 10.1086/401874; BUHL B, 1991, DIFFERENTIATION, V46, P147, DOI 10.1111/j.1432-0436.1991.tb00875.x; CECCARELLI A, 1991, CELL, V65, P983, DOI 10.1016/0092-8674(91)90550-I; CHUNG S, 1981, CELL, V24, P785, DOI 10.1016/0092-8674(81)90104-5; DEVINE KM, 1985, DEV BIOL, V107, P364, DOI 10.1016/0012-1606(85)90318-5; EARLY AE, 1988, MOL CELL BIOL, V8, P3458, DOI 10.1128/MCB.8.8.3458; EARLY AE, 1993, DEVELOPMENT, V118, P353; EARLY AE, 1989, NUCLEIC ACIDS RES, V17, P6473; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; FRANCIS D, 1971, J EXP ZOOL, V176, P265, DOI 10.1002/jez.1401760303; GASKELL MJ, 1992, DIFFERENTIATION, V51, P171, DOI 10.1111/j.1432-0436.1992.tb00693.x; GREGG JH, 1982, DIFFERENTIATION, V21, P200, DOI 10.1111/j.1432-0436.1982.tb01214.x; GREGG JH, 1982, EXP CELL RES, V142, P229, DOI 10.1016/0014-4827(82)90427-X; HADWIGER JA, 1992, GENE DEV, V6, P38, DOI 10.1101/gad.6.1.38; HARLOW E, 1988, ANTIBODIES LABORATOR, P354; HARWOOD AJ, 1991, DIFFERENTIATION, V46, P7, DOI 10.1111/j.1432-0436.1991.tb00860.x; HOWARD PK, 1992, CELL, V71, P637, DOI 10.1016/0092-8674(92)90597-6; JERMYN KA, 1991, DEVELOPMENT, V111, P779; JERMYN KA, 1989, NATURE, V340, P144, DOI 10.1038/340144a0; KAKUTANI T, 1986, DEV BIOL, V115, P439, DOI 10.1016/0012-1606(86)90264-2; MCROBBIE SJ, 1988, DEV BIOL, V125, P59, DOI 10.1016/0012-1606(88)90058-9; MONTELL DJ, 1992, CELL, V71, P51, DOI 10.1016/0092-8674(92)90265-E; NIEHRS C, 1993, CELL, V72, P491, DOI 10.1016/0092-8674(93)90069-3; NOMURA A, 1991, PATTERN RECOGN LETT, V12, P183, DOI 10.1016/0167-8655(91)90048-Q; RAPER K, 1940, J E MITCHELL SCI SOC, V59, P241; RAPER KENNETH B., 1952, BULL TORREY BOT CLUB, V79, P25, DOI 10.2307/2482103; RUBIN J, 1975, J EMBRYOL EXP MORPH, V33, P227; SALSER SJ, 1992, NATURE, V355, P255, DOI 10.1038/355255a0; SIEGERT F, 1994, J CELL SCI, V107, P97; SIEGERT F, 1991, PHYSICA D, V49, P224, DOI 10.1016/0167-2789(91)90210-Z; SIEGERT F, 1992, P NATL ACAD SCI USA, V89, P6433, DOI 10.1073/pnas.89.14.6433; STEINBOCK O, 1993, P NATL ACAD SCI USA, V90, P7332, DOI 10.1073/pnas.90.15.7332; STERNFELD J, 1981, DIFFERENTIATION, V20, P10, DOI 10.1111/j.1432-0436.1981.tb01150.x; STERNFELD J, 1982, DEV BIOL, V93, P111, DOI 10.1016/0012-1606(82)90244-5; STERNFELD J, 1992, ROUX ARCH DEV BIOL, V201, P354, DOI 10.1007/BF00365123; TAKEUCHI I, 1977, DEV DIFFERENTIATION, P1; TI ZC, 1990, J BIOTECHNOL, V16, P233, DOI 10.1016/0168-1656(90)90039-E; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; WILLIAMS JG, 1989, CELL, V59, P1157, DOI 10.1016/0092-8674(89)90771-X	42	80	82	1	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUN 3	1994	77	5					687	699		10.1016/0092-8674(94)90053-1	http://dx.doi.org/10.1016/0092-8674(94)90053-1			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NQ123	8205618	Green Published			2022-12-28	WOS:A1994NQ12300009
J	EISENBERG, JM				EISENBERG, JM			ECONOMICS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICIAN; MEDICARE; SERVICES; FEES				EISENBERG, JM (corresponding author), GEORGETOWN UNIV,MED CTR,WASHINGTON,DC 20007, USA.							COHEN JW, 1993, INQUIRY-J HEALTH CAR, V30, P281; ESCARCE JJ, 1993, JAMA-J AM MED ASSOC, V269, P2513, DOI 10.1001/jama.269.19.2513; GINSBURG PB, 1993, JAMA-J AM MED ASSOC, V269, P2550, DOI 10.1001/jama.269.19.2550; GOLD K, 1993, HLTH CARE FINANCE RE, V14, P183; Gornick M, 1993, Health Care Financ Rev, V14, P77; HADLEY J, 1993, INQUIRY-J HEALTH CAR, V30, P226; MCCALL NT, 1993, HLTH CARE FINANCE RE, V4, P97; Miller M E, 1993, Health Care Financ Rev, V14, P25; MILLER ME, 1993, INQUIRY-J HEALTH CAR, V30, P249; POPE GC, 1992, HEALTH AFFAIR, V11, P181, DOI 10.1377/hlthaff.11.1.181; 1993, ANN REPORT C; 1993, TRENDS HLTH POLICY U; 1994, ANN REPORT C	13	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1663	1665						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NN117	8182839				2022-12-28	WOS:A1994NN11700018
J	HEUSER, MD; HAZZARD, WR				HEUSER, MD; HAZZARD, WR			GERIATRIC-MEDICINE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VITAMIN-E CONSUMPTION; DECREASED RISK; HEALTH; WOMEN; SMOKING; DISEASE; STROKE; EXERCISE; ESTROGEN; COHORT				HEUSER, MD (corresponding author), WAKE FOREST UNIV, BOWMAN GRAY SCH MED, WINSTON SALEM, NC 27157 USA.				NIA NIH HHS [AG10484] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P60AG010484] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		BRESLOW L, 1993, PREV MED, V22, P86, DOI 10.1006/pmed.1993.1006; DALY E, 1993, BRIT MED J, V307, P836, DOI 10.1136/bmj.307.6908.836; FELSON DT, 1993, NEW ENGL J MED, V329, P1141, DOI 10.1056/NEJM199310143291601; FINUCANE FF, 1993, ARCH INTERN MED, V153, P73, DOI 10.1001/archinte.153.1.73; FRIES JF, 1993, AM J MED, V94, P455, DOI 10.1016/0002-9343(93)90078-4; FRIES JF, 1980, NEW ENGL J MED, V303, P130, DOI 10.1056/NEJM198007173030304; GILPIN EA, 1993, J GEN INTERN MED, V8, P549, DOI 10.1007/BF02599637; HAZZARD WR, 1983, POSTGRAD MED, V74, P279, DOI 10.1080/00325481.1983.11698397; HIGGINS MW, 1993, JAMA-J AM MED ASSOC, V269, P2741, DOI 10.1001/jama.269.21.2741; KAWACHI I, 1993, JAMA-J AM MED ASSOC, V269, P232, DOI 10.1001/jama.269.2.232; KIM I, 1993, AM J PUBLIC HEALTH, V83, P546, DOI 10.2105/AJPH.83.4.546; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; Luepker R. V., 1993, Annals of Epidemiology, V3, pS8; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; ROOS NP, 1993, SOC SCI MED, V36, P273, DOI 10.1016/0277-9536(93)90010-2; ROSANO GMC, 1993, LANCET, V342, P133, DOI 10.1016/0140-6736(93)91343-K; SHINTON R, 1993, BMJ-BRIT MED J, V307, P231, DOI 10.1136/bmj.307.6898.231; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; TEMKINGREENER H, 1992, MILBANK Q, V70, P679, DOI 10.2307/3350216	19	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1675	1677						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182846				2022-12-28	WOS:A1994NN11700025
J	SMITH, DL; DESHAZO, RD				SMITH, DL; DESHAZO, RD			ALLERGY AND IMMUNOLOGY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASTHMA; RESPONSIVENESS; TERBUTALINE; DEATH; RISK				SMITH, DL (corresponding author), UNIV SO ALABAMA,MOBILE,AL, USA.							CALDERON E, 1992, J ALLERGY CLIN IMMUN, V90, P852, DOI 10.1016/0091-6749(92)90112-F; COCKCROFT DW, 1993, LANCET, V342, P833, DOI 10.1016/0140-6736(93)92695-P; CRETICOS PS, 1993, J ALLERGY CLIN IMMUN, V91, P227; DAMPLING E, 1993, ANN INTERN MED, V118, P770; ERNST P, 1992, JAMA-J AM MED ASSOC, V268, P3462, DOI 10.1001/jama.268.24.3462; HAAHTELA T, 1991, NEW ENGL J MED, V325, P388, DOI 10.1056/NEJM199108083250603; MULLEN M, 1993, JAMA-J AM MED ASSOC, V270, P1842, DOI 10.1001/jama.270.15.1842; PIPKORN U, 1987, NEW ENGL J MED, V316, P1506, DOI 10.1056/NEJM198706113162403; SLY RM, 1994, ANN ALLERGY, V72, P59; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; STARK BJ, 1986, J ALLERGY CLIN IMMUN, V78, P76, DOI 10.1016/0091-6749(86)90117-X; VANSCHAYCK CP, 1991, BRIT MED J, V303, P1426, DOI 10.1136/bmj.303.6815.1426; VATHENEN AS, 1988, LANCET, V1, P554; WAHEDNA I, 1993, AM REV RESPIR DIS, V148, P707, DOI 10.1164/ajrccm/148.3.707; WALKER C, 1992, AM REV RESPIR DIS, V146, P109, DOI 10.1164/ajrccm/146.1.109; 1991, J ALLERGY CLIN IMMUN, V88, P425	16	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1653	1654						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182833				2022-12-28	WOS:A1994NN11700012
J	NAKAMURA, Y; RUSSELL, SM; MESS, SA; FRIEDMANN, M; ERDOS, M; FRANCOIS, C; JACQUES, Y; ADELSTEIN, S; LEONARD, WJ				NAKAMURA, Y; RUSSELL, SM; MESS, SA; FRIEDMANN, M; ERDOS, M; FRANCOIS, C; JACQUES, Y; ADELSTEIN, S; LEONARD, WJ			HETERODIMERIZATION OF THE IL-2 RECEPTOR BETA-CHAIN AND GAMMA-CHAIN CYTOPLASMIC DOMAINS IS REQUIRED FOR SIGNALING	NATURE			English	Article							HUMAN INTERLEUKIN-2 RECEPTOR; CELL GROWTH-FACTOR; FUNCTIONAL COMPONENT; DISTINCT; EXPRESSION; CLONING; BINDING; GENE; INVOLVEMENT; RESPONSES	THE interaction of interleukin-2 (IL-2) and IL-2 receptors critically regulates the T-cell immune response following antigen activation(1,2). IL-2 can signal through high or intermediate affinity receptors which contain IL-2R alpha (refs 3, 4) + beta (refs 5-8) + gamma (ref. 9) or beta + gamma chains, respectively. IL-2R gamma is a common gamma chain, gamma(c), also shared by the IL-7 (ref. 10) and IL-4 (refs 11, 12) receptors, which when mutated results in X-linked severe combined immunodeficiency(13). Using chimaeric receptor constructs together with monoclonal or bispecific antibodies we demonstrate here that IL-2 signalling requires ligand-induced extracellular-domain-mediated heterodimerization of the beta- and gamma(c)-chain cytoplasmic domains. Anti-IL-2R alpha monoclonal antibodies trigger proliferation of cells transfected with chimaeric constructs in which the extracellular domains of IL-2R beta and gamma(c), are replaced by that of IL-2R alpha. Other experiments using chimaeric constructs indicated that IL-2 binds monomerically and monovalently to IL-2R alpha and that the beta-transmembrane domain is not required for receptor chain interactions. Finally, we provide a method for mapping residues in the gamma(c) cytoplasmic domain even in cells that constitutively express gamma(c).	NHLBI,PULM & MOLEC IMMUNOL SECT,BETHESDA,MD 20892; INST BIOL,INSERM,U211,F-44035 NANTES,FRANCE	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Institut National de la Sante et de la Recherche Medicale (Inserm)			Adelstein, Stephen/I-7936-2016; Leonard, Warren/AAA-1397-2022; Russell, Sarah M/B-9341-2009	Adelstein, Stephen/0000-0001-7221-6298; Russell, Sarah M/0000-0001-5826-9641				ASAO H, 1993, P NATL ACAD SCI USA, V90, P4127, DOI 10.1073/pnas.90.9.4127; CAO XQ, 1993, P NATL ACAD SCI USA, V90, P8464, DOI 10.1073/pnas.90.18.8464; Exley M, 1991, Semin Immunol, V3, P283; FRANCOIS C, 1993, IMMUN, V150, P4610; GNARRA JR, 1990, P NATL ACAD SCI USA, V87, P3440, DOI 10.1073/pnas.87.9.3440; HATAKEYAMA M, 1989, CELL, V59, P837, DOI 10.1016/0092-8674(89)90607-7; HATAKEYAMA M, 1989, SCIENCE, V244, P551, DOI 10.1126/science.2785715; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; KAHN CR, 1977, J CLIN INVEST, V60, P1094, DOI 10.1172/JCI108861; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; KUMAKI S, 1993, BIOCHEM BIOPH RES CO, V193, P356, DOI 10.1006/bbrc.1993.1631; LEONARD WJ, 1983, P NATL ACAD SCI-BIOL, V80, P6957, DOI 10.1073/pnas.80.22.6957; LEONARD WJ, 1994, IMMUNOL REV, V138, P61, DOI 10.1111/j.1600-065X.1994.tb00847.x; LEONARD WJ, 1982, NATURE, V300, P267, DOI 10.1038/300267a0; LEONARD WJ, 1984, NATURE, V311, P625; MINAMI Y, 1993, CELL, V73, P5; NIKAIDO T, 1984, NATURE, V311, P631, DOI 10.1038/311631a0; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOGUCHI M, 1993, J BIOL CHEM, V268, P13601; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; OTANI H, 1992, P NATL ACAD SCI USA, V89, P2789, DOI 10.1073/pnas.89.7.2789; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SHARON M, 1986, SCIENCE, V234, P859, DOI 10.1126/science.3095922; STAHL N, 1993, CELL, V74, P587, DOI 10.1016/0092-8674(93)90506-L; TAKEBE Y, 1988, MOL CELL BIOL, V8, P466, DOI 10.1128/MCB.8.1.466; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223; TSUDO M, 1986, P NATL ACAD SCI USA, V83, P9694, DOI 10.1073/pnas.83.24.9694	30	299	315	0	6	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 26	1994	369	6478					330	333		10.1038/369330a0	http://dx.doi.org/10.1038/369330a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NN109	8183373				2022-12-28	WOS:A1994NN10900053
J	AURORA, R; SRINIVASAN, R; ROSE, GD				AURORA, R; SRINIVASAN, R; ROSE, GD			RULES FOR ALPHA-HELIX TERMINATION BY GLYCINE	SCIENCE			English	Article							STAPHYLOCOCCAL NUCLEASE; GLOBULAR-PROTEINS; AMINO-ACIDS; STABILITY; LYSOZYME; POSITION; PEPTIDES; BARNASE; CHAINS; MODEL	A predictive rule for protein folding is presented that involves two recurrent glycine-based motifs that cap the carboxyl termini of cr. helices. In proteins, helices that terminated in glycine residues were found predominantly in one of these two motifs. These glycine structures had a characteristic pattern of polar and apolar residues. Visual inspection of known helical sequences was sufficient to distinguish the two motifs from each other and from internal glycines that fail to terminate helices. These glycine motifs-in which the local sequence selects between available structures-represent an example of a stereochemical rule for protein folding.	WASHINGTON UNIV, SCH MED, DEPT BIOCHEM & MOLEC BIOPHYS, ST LOUIS, MO 63110 USA	Washington University (WUSTL)				Aurora, Rajeev/0000-0002-6609-6055	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029458] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 29458] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALBER T, 1987, NATURE, V330, P41, DOI 10.1038/330041a0; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5; BELL JA, 1992, BIOCHEMISTRY-US, V31, P3590, DOI 10.1021/bi00129a006; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BORK P, 1991, BIOCHEM BIOPH RES CO, V180, P666, DOI 10.1016/S0006-291X(05)81117-9; BRUCH MD, 1991, PROTEINS, V10, P130, DOI 10.1002/prot.340100206; CHAKRABARTTY A, 1993, P NATL ACAD SCI USA, V90, P11332, DOI 10.1073/pnas.90.23.11332; COCCO MJ, IN PRESS PROTEIN SCI; CREAMER TP, 1992, P NATL ACAD SCI USA, V89, P5937, DOI 10.1073/pnas.89.13.5937; DASGUPTA S, 1993, INT J PEPT PROT RES, V41, P499; FOROOD B, 1993, P NATL ACAD SCI USA, V90, P838, DOI 10.1073/pnas.90.3.838; GREEN SM, 1992, BIOCHEMISTRY-US, V31, P5717, DOI 10.1021/bi00140a005; HARPER ET, 1993, BIOCHEMISTRY-US, V32, P7605, DOI 10.1021/bi00081a001; HOBHOM U, 1992, PROTEIN SCI, V1, P409; HOROVITZ A, 1991, J MOL BIOL, V219, P5, DOI 10.1016/0022-2836(91)90852-W; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KIM PS, 1984, NATURE, V307, P329, DOI 10.1038/307329a0; LATTMAN EE, 1993, P NATL ACAD SCI USA, V90, P439, DOI 10.1073/pnas.90.2.439; LECOMTE JTJ, 1991, J AM CHEM SOC, V113, P9663, DOI 10.1021/ja00025a037; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LESSER GJ, 1990, PROTEINS, V8, P6, DOI 10.1002/prot.340080104; LOLL PJ, 1989, PROTEINS, V5, P183, DOI 10.1002/prot.340050302; LYU PC, 1993, BIOCHEMISTRY-US, V32, P421, DOI 10.1021/bi00053a006; LYU PCC, 1992, J AM CHEM SOC, V114, P6560, DOI 10.1021/ja00042a047; MILNERWHITE EJ, 1988, J MOL BIOL, V199, P503, DOI 10.1016/0022-2836(88)90621-3; MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405; NAGARAJARAM HA, 1993, FEBS LETT, V321, P79, DOI 10.1016/0014-5793(93)80625-5; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; PICKETT SD, 1993, J MOL BIOL, V231, P825, DOI 10.1006/jmbi.1993.1329; PREISSNER R, 1991, BIOCHEM BIOPH RES CO, V180, P660, DOI 10.1016/S0006-291X(05)81116-7; PRESTA LG, 1988, SCIENCE, V240, P1632, DOI 10.1126/science.2837824; REMINGTON SJ, 1978, J MOL BIOL, V118, P81, DOI 10.1016/0022-2836(78)90245-0; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; RICHMOND TJ, 1984, J MOL BIOL, V178, P63, DOI 10.1016/0022-2836(84)90231-6; ROSE GD, 1993, ANNU REV BIOPH BIOM, V22, P381, DOI 10.1146/annurev.bb.22.060193.002121; Schellman C., 1980, PROTEIN FOLDING, P53; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; SERRANO L, 1992, J MOL BIOL, V227, P544, DOI 10.1016/0022-2836(92)90906-Z; SERRANO L, 1992, J MOL BIOL, V224, P847, DOI 10.1016/0022-2836(92)90566-3; SERRANO L, 1989, NATURE, V342, P296, DOI 10.1038/342296a0; SHOEMAKER KR, 1987, NATURE, V326, P563, DOI 10.1038/326563a0; SHORTLE D, 1990, BIOCHEMISTRY-US, V29, P8033, DOI 10.1021/bi00487a007; STICKLE DF, 1992, J MOL BIOL, V226, P1143, DOI 10.1016/0022-2836(92)91058-W; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; YUMOTO N, 1993, BIOCHEM BIOPH RES CO, V196, P1490, DOI 10.1006/bbrc.1993.2420; ZHOU HXX, 1994, PROTEINS, V18, P1, DOI 10.1002/prot.340180103; ZIMM BH, 1959, J CHEM PHYS, V31, P536	50	269	269	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 20	1994	264	5162					1126	1130		10.1126/science.8178170	http://dx.doi.org/10.1126/science.8178170			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NM146	8178170				2022-12-28	WOS:A1994NM14600027
J	BAZETTJONES, DP; LEBLANC, B; HERFORT, M; MOSS, T				BAZETTJONES, DP; LEBLANC, B; HERFORT, M; MOSS, T			SHORT-RANGE DNA LOOPING BY THE XENOPUS HMG-BOX TRANSCRIPTION FACTOR, XUBF	SCIENCE			English	Article							RNA POLYMERASE-I; RIBOSOMAL GENE ENHANCERS; RDNA PROMOTER; LAEVIS; COMPLEX; CONTAINS; DOMAINS; SEQUENCES; BINDING	Xenopus UBF (xUBF) interacts with DNA by way of multiple HMG-box domains. When xUBF binds to the ribosomal promoter, the carboxyl-terminal acidic tail and amino-terminal HMG-box interact. Binding also leads to negative DNA supercoiling and the formation of a disk-like structure, the enhancesome. Within the enhancesome, an xUBF dimer makes a low-density protein core around which DNA is looped into a single 180-base pair turn, probably by in-phase bending. The enhancesome structure suggests a mechanism for xUBF-dependent recruitment of the TATA box-binding protein complex without direct interaction between the two factors.	UNIV LAVAL,HOTEL DIEU,DEPT BIOCHIM,QUEBEC CITY G1R 2J6,PQ,CANADA; UNIV LAVAL,HOTEL DIEU,CTR RECH CANCEROL,QUEBEC CITY G1R 2J6,PQ,CANADA; UNIV CALGARY,HLTH SCI CTR,FAC MED,DEPT MED BIOCHEM & ANAT,CALGARY T2N 4N1,AB,CANADA	Laval University; Laval University; University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba				Moss, Thomas (Tom)/0000-0003-2047-4783				BACHVAROV D, 1991, NUCLEIC ACIDS RES, V19, P2331, DOI 10.1093/nar/19.9.2331; BAZETTJONES DP, 1989, MOL CELL BIOL, V9, P336, DOI 10.1128/MCB.9.1.336; BAZETTJONES DP, 1993, MICROBEAM ANAL, V2, P69; BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; BELL SP, 1990, GENE DEV, V4, P943, DOI 10.1101/gad.4.6.943; DEWINTER RFJ, 1987, J MOL BIOL, V196, P813, DOI 10.1016/0022-2836(87)90407-4; FIREK S, 1989, MOL CELL BIOL, V9, P3777, DOI 10.1128/MCB.9.9.3777; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GUIMOND A, 1992, NUCLEIC ACIDS RES, V20, P3361, DOI 10.1093/nar/20.13.3361; HALTINER MM, 1986, MOL CELL BIOL, V6, P227, DOI 10.1128/MCB.6.1.227; ICARDLIEPKALNS C, 1993, BIOCHEM BIOPH RES CO, V193, P453, DOI 10.1006/bbrc.1993.1645; JANTZEN HM, 1992, GENE DEV, V6, P1950, DOI 10.1101/gad.6.10.1950; KUHN A, 1992, P NATL ACAD SCI USA, V89, P7340, DOI 10.1073/pnas.89.16.7340; LEBLANC B, 1993, EMBO J, V12, P513, DOI 10.1002/j.1460-2075.1993.tb05683.x; LILLEY DMJ, 1992, NATURE, V357, P282, DOI 10.1038/357282a0; MCSTAY B, 1991, GENE DEV, V5, P1957, DOI 10.1101/gad.5.11.1957; MCSTAY B, 1991, EMBO J, V10, P2297, DOI 10.1002/j.1460-2075.1991.tb07766.x; MCSTAY B, 1990, GENE DEV, V4, P1240, DOI 10.1101/gad.4.7.1240; Moss T, 1985, Oxf Surv Eukaryot Genes, V2, P207; MOSS T, 1983, NATURE, V304, P562, DOI 10.1038/304562a0; MOSS T, 1992, BIOCHEM CELL BIOL, V70, P324, DOI 10.1139/o92-050; NACHALIEL N, 1989, NUCLEIC ACIDS RES, V17, P9811, DOI 10.1093/nar/17.23.9811; PIKAARD CS, 1990, MOL CELL BIOL, V10, P4816, DOI 10.1128/MCB.10.9.4816; PIKAARD CS, 1989, GENE DEV, V3, P1779, DOI 10.1101/gad.3.11.1779; PUTNAM CD, 1992, MOL CELL BIOL, V12, P4970, DOI 10.1128/MCB.12.11.4970; READ C, 1992, J BIOL CHEM, V267, P10961; READ CM, 1993, NUCLEIC ACIDS RES, V21, P3427, DOI 10.1093/nar/21.15.3427; SCHILD C, 1993, EMBO J, V12, P423, DOI 10.1002/j.1460-2075.1993.tb05674.x; SCHNAPP A, 1991, J BIOL CHEM, V266, P24588; SMITH SD, 1990, MOL CELL BIOL, V10, P3105, DOI 10.1128/MCB.10.6.3105; SOLLNERWEBB B, 1991, TRENDS BIOCHEM SCI, V16, P58, DOI 10.1016/0968-0004(91)90025-Q; STRUCK MM, 1992, J MOL BIOL, V224, P253, DOI 10.1016/0022-2836(92)90588-B; VOIT R, 1992, EMBO J, V11, P2211, DOI 10.1002/j.1460-2075.1992.tb05280.x; WINDLE JJ, 1986, MOL CELL BIOL, V6, P4585, DOI 10.1128/MCB.6.12.4585; XIE WQ, 1992, MOL CELL BIOL, V12, P1266, DOI 10.1128/MCB.12.3.1266	35	205	205	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 20	1994	264	5162					1134	1137		10.1126/science.8178172	http://dx.doi.org/10.1126/science.8178172			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NM146	8178172				2022-12-28	WOS:A1994NM14600029
J	WANG, LY; ORSER, BA; BRAUTIGAN, DL; MACDONALD, JF				WANG, LY; ORSER, BA; BRAUTIGAN, DL; MACDONALD, JF			REGULATION OF NMDA RECEPTORS IN CULTURED HIPPOCAMPAL-NEURONS BY PROTEIN PHOSPHATASE-1 AND PHOSPHATASE-2A	NATURE			English	Article							MOUSE-BRAIN NEURONS; SYNAPTIC PLASTICITY; POTASSIUM CHANNEL; OKADAIC ACID; CALYCULIN-A; PHOSPHORYLATION; KINASE; MODULATION; GLYCINE; DEPHOSPHORYLATION	PHOSPHORYLATION Of glutamate receptors is probably an important mechanism for modulating excitatory transmission(1-4). However, there is little direct evidence to indicate which protein phosphatases can dephosphorylate glutamate(5) or other ligandgated channels(6), although it is known that protein phosphatases 1 and 2A play a major part in modulating voltage(7-10) and second-messenger-gated channels(11). Here we report that in cultured hippocampal neurons, the N-methgl-D-aspartate (NMDA) receptor can be regulated by endogenous and exogenous serine/threonine protein phosphatases. Phosphatase inhibitors enhanced NMDA currents recorded using the perforated patch technique(13) or in cell-attached patches, whereas protein phosphatases 1 or 2A decreased the open probability of these channels in inside-out patches.	UNIV TORONTO,DEPT PHARMACOL,TORONTO M5S 1A8,ON,CANADA; UNIV TORONTO,DEPT ANAESTHESIA,TORONTO M5S 1A8,ON,CANADA; BROWN UNIV,DIV BIOL & MED,PROVIDENCE,RI 02912	University of Toronto; University of Toronto; Brown University	WANG, LY (corresponding author), UNIV TORONTO,DEPT PHYSIOL,MED SCI BLDG,TORONTO M5S 1A8,ON,CANADA.							BENARI Y, 1992, TRENDS NEUROSCI, V15, P333, DOI 10.1016/0166-2236(92)90049-E; BENVENISTE M, 1990, J PHYSIOL-LONDON, V428, P333, DOI 10.1113/jphysiol.1990.sp018215; BRAUTIGAN DL, 1985, J BIOL CHEM, V260, P4295; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; COHEN P, 1989, REV BIOCH, V58, P453; ERIKSSON JE, 1992, P NATL ACAD SCI USA, V89, P11093, DOI 10.1073/pnas.89.22.11093; GORDON SE, 1992, NEURON, V9, P739, DOI 10.1016/0896-6273(92)90036-D; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HUANG FL, 1976, EUR J BIOCHEM, V70, P419, DOI 10.1111/j.1432-1033.1976.tb11032.x; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; JOHNSON JW, 1992, J PHYSIOL-LONDON, V455, P339, DOI 10.1113/jphysiol.1992.sp019305; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; KATEO Y, 1986, J AM CHEM SOC, V108, P2780; MEI L, 1991, J BIOL CHEM, V266, P16063; Nairn A C, 1992, Curr Opin Neurobiol, V2, P296, DOI 10.1016/0959-4388(92)90118-5; OH Y, 1993, AM J PHYSIOL, V264, pC1489, DOI 10.1152/ajpcell.1993.264.6.C1489; Orser Beverly A., 1993, Canadian Journal of Anaesthesia, V40, pA61; RAYMOND LA, 1993, TRENDS NEUROSCI, V16, P147, DOI 10.1016/0166-2236(93)90123-4; REINHART PH, 1991, J NEUROSCI, V11, P1627; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; SUGANUMA M, 1990, CANCER RES, V50, P3521; SWOPE SL, 1992, FASEB J, V6, P2514, DOI 10.1096/fasebj.6.8.1375568; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; WANG LY, 1991, SCIENCE, V253, P1132, DOI 10.1126/science.1653455; WHITE RE, 1991, NATURE, V351, P570, DOI 10.1038/351570a0; WHITE RE, 1993, NATURE, V361, P263, DOI 10.1038/361263a0	29	183	188	0	5	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 19	1994	369	6477					230	232		10.1038/369230a0	http://dx.doi.org/10.1038/369230a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NM067	8183343				2022-12-28	WOS:A1994NM06700055
J	TERNS, MP; DAHLBERG, JE				TERNS, MP; DAHLBERG, JE			RETENTION AND 5' CAP TRIMETHYLATION OF U3 SNRNA IN THE NUCLEUS	SCIENCE			English	Article							SMALL NUCLEOLAR RNA; XENOPUS-LAEVIS; RIBOSOMAL-RNA; SEQUENCE; INVITRO; ANTIBODY; GENES; CELLS	It is shown here that maturation of the m(7)G-capped precursors of U3 small nuclear RNA (snRNA) occurs by a previously unknown pathway. In contrast to the 5' m(7)G-capped precursors of other snRNAs, this RNA is not exported to the cytoplasm but is retained in the nuclei of Xenopus laevis oocytes, where it undergoes trimethylation of its 5' cap. The m(7)G caps of most snRNA precursors are trimethylated only after transport of the RNAs to the cytoplasm. The nuclear retention and maturation of this nucleolar RNA raises the possibility that other m(7)G-capped RNAs are also retained and modified in the nucleus.	UNIV WISCONSIN,DEPT BIOMOLEC CHEM,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison			Terns, Michael/N-6435-2016		NIGMS NIH HHS [GM30220, GM14704] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM014704, R37GM030220, R01GM030220] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BASERGA SJ, 1992, GENE DEV, V6, P1120, DOI 10.1101/gad.6.6.1120; BRINGMANN P, 1983, EMBO J, V2, P1129, DOI 10.1002/j.1460-2075.1983.tb01557.x; CAIZERGUESFERRER M, 1990, MOL BIOL REP, V14, P107, DOI 10.1007/BF00360434; Cheng Y., UNPUB; Dahlberg JE, 1988, STRUCTURE FUNCTION M, P38, DOI [10.1007/978-3-642- 73020-7_2, DOI 10.1007/978-3-642-73020-7_2]; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; DEVEGVAR HEN, 1990, MOL CELL BIOL, V10, P3365, DOI 10.1128/MCB.10.7.3365; FILIPOWICZ W, 1993, MOL BIOL REP, V18, P149, DOI 10.1007/BF00986770; FOURNIER MJ, 1993, TRENDS BIOCHEM SCI, V18, P131, DOI 10.1016/0968-0004(93)90020-N; HAMM J, 1990, CELL, V63, P109, DOI 10.1016/0092-8674(90)90292-M; HAMM J, 1989, EMBO J, V8, P4179, DOI 10.1002/j.1460-2075.1989.tb08603.x; HUGHES JMX, 1991, EMBO J, V10, P4231, DOI 10.1002/j.1460-2075.1991.tb05001.x; Izaurralde E, 1992, Semin Cell Biol, V3, P279, DOI 10.1016/1043-4682(92)90029-U; JEPPESEN C, 1988, NUCLEIC ACIDS RES, V16, P2127, DOI 10.1093/nar/16.5.2127; KASS S, 1990, CELL, V60, P897, DOI 10.1016/0092-8674(90)90338-F; KISS T, 1991, CELL, V65, P517, DOI 10.1016/0092-8674(91)90469-F; LUBBEN B, 1993, NUCLEIC ACIDS RES, V21, P5377, DOI 10.1093/nar/21.23.5377; LUHRMANN R, 1990, BIOCHIM BIOPHYS ACTA, V1087, P265, DOI 10.1016/0167-4781(90)90001-I; LUND E, 1989, EMBO J, V8, P287, DOI 10.1002/j.1460-2075.1989.tb03375.x; LUND E, COMMUNICATION; MUNNS TW, 1982, BIOCHEMISTRY-US, V21, P2922, DOI 10.1021/bi00541a018; PARKER KA, 1987, MOL CELL BIOL, V7, P2899, DOI 10.1128/MCB.7.8.2899; PEUCLIS BA, 1993, CELL, V73, P1233; REDDY R, 1992, PROG MOL SUBCELL BIO, V12, P1; SAVINO R, 1992, NUCLEIC ACIDS RES, V20, P5435, DOI 10.1093/nar/20.20.5435; SAVINO R, 1990, EMBO J, V9, P2299, DOI 10.1002/j.1460-2075.1990.tb07401.x; SHIMBA S, 1992, J BIOL CHEM, V267, P13772; SINGH R, 1990, MOL CELL BIOL, V10, P939, DOI 10.1128/MCB.10.3.939; SOLLNERWEBB B, 1993, CELL, V75, P403, DOI 10.1016/0092-8674(93)90374-Y; TERNS MP, 1993, GENE DEV, V7, P1898, DOI 10.1101/gad.7.10.1898; TERNS MP, 1992, MOL CELL BIOL, V12, P3032, DOI 10.1128/MCB.12.7.3032; TYC K, 1989, EMBO J, V8, P3113, DOI 10.1002/j.1460-2075.1989.tb08463.x; TYCOWSKI KT, 1993, GENE DEV, V7, P1176, DOI 10.1101/gad.7.7a.1176	33	111	113	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 13	1994	264	5161					959	961		10.1126/science.8178154	http://dx.doi.org/10.1126/science.8178154			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NK974	8178154				2022-12-28	WOS:A1994NK97400033
J	SIKORA, K				SIKORA, K			CURRENT ISSUES IN CANCER .8. GENES, DREAMS, AND CANCER	BRITISH MEDICAL JOURNAL			English	Article							LUNG-CANCER; THERAPY; CELLS	There have been tremendous advances in our understanding of cancer from the application of molecular biology over the past decade. The disease is caused by a series of defects in the genes that accelerate growth-oncogenes-and those that slow down cellular turnover-tumour suppressor genes. The proteins they encode provide a promising hunting ground in which to design and test new anticancer drugs. Several treatment strategies are now under clinical trial entailing direct gene transfer. These include the use of gene marking to detect minimal residual disease, the production of novel cancer vaccines by the insertion of genes which uncloak cancer cells so making them visible to the host's immune system, the isolation and coupling of cancer specific molecular switches upstream of drug activating genes, and the correction of aberrant oncogenes or tumour suppressor genes. The issues in these approaches are likely to have a profound impact on the management of cancer patients as we enter the next century.			SIKORA, K (corresponding author), HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,IMPERIAL CANC RES FUND,ONCOL UNIT,LONDON W12 0NN,ENGLAND.							ANDERSON C, 1992, NATURE, V360, P399; AUSTIN EA, 1993, MOL PHARMACOL, V43, P380; AUSTIN FC, 1990, CANCER INVEST, V8, P207, DOI 10.3109/07357909009017566; BISHOP JM, 1991, CELL, V64, P235, DOI 10.1016/0092-8674(91)90636-D; BRENNER MK, 1993, LANCET, V341, P85, DOI 10.1016/0140-6736(93)92560-G; CHERFAS JB, 1992, BRIT MED J, V305, P192; CLOTHIER C, 1991, REPORT COMMITTEE ETH; CORNETTA K, 1992, BRIT J HAEMATOL, V80, P421, DOI 10.1111/j.1365-2141.1992.tb04552.x; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; DALGLEISH AG, 1994, GENE THER, V1, P83; FEARON ER, 1991, SCIENCE, V254, P713; GIBBS J, 1992, SEMIN CANCER BIOL, V6, P383; GUTIERREZ AA, 1992, LANCET, V339, P715, DOI 10.1016/0140-6736(92)90606-4; HARRIS J, IN PRESS GENE THERAP; HARRIS J, 1994, MOL ASPECTS MED, V14, P453; HAWKINS RE, 1993, J IMMUNOTHER, V14, P273, DOI 10.1097/00002371-199311000-00004; HICKMAN JA, 1992, ESO MONOGRAPHS, P33; HUBER BE, 1991, P NATL ACAD SCI USA, V88, P8039, DOI 10.1073/pnas.88.18.8039; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; JAMES N, 1993, CLIN IMMUNOL, P1773; JAMES RFL, 1991, IMMUNOLOGY, V72, P213; KIM TS, 1993, INT J CANCER, V55, P865, DOI 10.1002/ijc.2910550528; LOFTS FJ, 1993, ONCOGENE, V8, P2813; MACILWAIN C, 1993, NATURE, V362, P488, DOI 10.1038/362488b0; MARSHALL CJ, 1991, CELL, V64, P313, DOI 10.1016/0092-8674(91)90641-B; MERCER WE, 1991, CANCER RES, V51, P2897; MILLER AD, 1992, NATURE, V357, P455, DOI 10.1038/357455a0; MULLERHILL B, 1993, NATURE, V362, P491, DOI 10.1038/362491a0; NIENHUIS AW, 1991, CANCER, V67, P2700, DOI 10.1002/1097-0142(19910515)67:10+<2700::AID-CNCR2820671705>3.0.CO;2-3; NOURI AME, IN PRESS GENE THERAP; ROSENBERG SA, 1992, JAMA-J AM MED ASSOC, V268, P246; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; RUSSELL SJ, 1990, IMMUNOL TODAY, V11, P383; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; SIKORA K, IN PRESS ANN N Y ACA; SLEVIN ML, 1990, BRIT MED J, V300, P1458, DOI 10.1136/bmj.300.6737.1458; THOMAS H, 1992, ACTA ONCOL, V268, P2416; VILE RG, 1993, CANCER RES, V53, P3860; WOLL PJ, 1990, CANCER RES, V50, P3968; WU GY, 1991, BIOTHERAPY, V3, P87, DOI 10.1007/BF02175102	40	23	23	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 7	1994	308	6938					1217	1221		10.1136/bmj.308.6938.1217	http://dx.doi.org/10.1136/bmj.308.6938.1217			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK956	8180542	Green Published			2022-12-28	WOS:A1994NK95600025
J	MCNALLY, FJ; VALE, RD				MCNALLY, FJ; VALE, RD			IDENTIFICATION OF KATANIN, AN ATPASE THAT SEVERS AND DISASSEMBLES STABLE MICROTUBULES	CELL			English	Article							FLUORESCENCE ENERGY-TRANSFER; XENOPUS EGG EXTRACTS; DYNAMIC INSTABILITY; INDIVIDUAL MICROTUBULES; GOLGI-APPARATUS; PROTEIN; CELLS; TUBULIN; VISUALIZATION; STABILIZATION	Eukaryotic cells rapidly reorganize their microtubule cytoskeleton during the cell cycle, differentiation, and cell migration. In this study, we have purified a heterodimeric protein, katanin, that severs and disassembles microtubules to tubulin dimers. The disassembled tubulin can repolymerize, indicating that it is not irreversibly modified or denatured in the reaction. Katanin is a microtubule-stimulated ATPase and requires ATP hydrolysis to sever microtubules. Katanin represents a novel type of enzyme that utilizes energy from nucleotide hydrolysis to break tubulin-tubulin bonds within a microtubule polymer, a process that may aid in disassembling complex microtubule arrays within cells.			MCNALLY, FJ (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT PHARMACOL, SAN FRANCISCO, CA 94143 USA.				NIGMS NIH HHS [GM49752, GM38499] Funding Source: Medline; NINDS NIH HHS [NS07067-15] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038499, R37GM038499, R01GM049752] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAAS PW, 1989, J CELL BIOL, V109, P3085, DOI 10.1083/jcb.109.6.3085; BACALLAO R, 1989, J CELL BIOL, V109, P2817, DOI 10.1083/jcb.109.6.2817; BELMONT LD, 1990, CELL, V62, P579, DOI 10.1016/0092-8674(90)90022-7; BORDAS J, 1983, J MOL BIOL, V164, P89, DOI 10.1016/0022-2836(83)90089-X; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BUSTER D, 1991, J CELL SCI, P109; CASSIMERIS L, 1988, J CELL BIOL, V107, P2223, DOI 10.1083/jcb.107.6.2223; CHAPIN SJ, 1992, CELL MOTIL CYTOSKEL, V23, P236, DOI 10.1002/cm.970230403; DRESCHEL DN, 1992, MOL BIOL CELL, V3, P1141; DYE RB, 1992, CELL MOTIL CYTOSKEL, V21, P171, DOI 10.1002/cm.970210302; EISENBERG E, 1985, SCIENCE, V227, P999, DOI 10.1126/science.3156404; FEBVRECHEVALIER C, 1992, J CELL BIOL, V118, P585, DOI 10.1083/jcb.118.3.585; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; GARD DL, 1987, J CELL BIOL, V105, P2203, DOI 10.1083/jcb.105.5.2203; GEIGER B, 1982, J CELL BIOL, V95, P137, DOI 10.1083/jcb.95.1.137; GREENE LE, 1980, J BIOL CHEM, V255, P543; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; HO WC, 1990, EUR J CELL BIOL, V52, P315; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; KARSENTI E, 1993, CURR BIOL, V3, P208, DOI 10.1016/0960-9822(93)90334-K; KISHINO A, 1988, NATURE, V334, P74, DOI 10.1038/334074a0; KITANISHIYUMURA T, 1987, CELL MOTIL CYTOSKEL, V8, P106, DOI 10.1002/cm.970080203; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; MITCHISON TJ, 1992, MOL BIOL CELL, V3, P1309, DOI 10.1091/mbc.3.12.1309; PALLEROS DR, 1991, P NATL ACAD SCI USA, V88, P5719, DOI 10.1073/pnas.88.13.5719; PASCHAL BM, 1989, NATURE, V342, P569, DOI 10.1038/342569a0; RAPPAPORT R, 1985, J EXP ZOOL, V234, P167, DOI 10.1002/jez.1402340120; SABRY JH, 1991, J CELL BIOL, V115, P381, DOI 10.1083/jcb.115.2.381; SANDERS MA, 1989, J CELL BIOL, V108, P1751, DOI 10.1083/jcb.108.5.1751; SCHOLEY JM, 1984, J BIOL CHEM, V259, P6516; SHIINA N, 1992, EMBO J, V11, P4723, DOI 10.1002/j.1460-2075.1992.tb05577.x; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SIMON JR, 1992, CELL MOTIL CYTOSKEL, V21, P1, DOI 10.1002/cm.970210102; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; TAYLOR DL, 1981, J CELL BIOL, V89, P362, DOI 10.1083/jcb.89.2.362; TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557; VALE RD, 1987, ANNU REV CELL BIOL, V3, P347, DOI 10.1146/annurev.cb.03.110187.002023; VALE RD, 1991, CELL, V64, P827, DOI 10.1016/0092-8674(91)90511-V; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; YAMAMOTO K, 1982, J CELL BIOL, V95, P711, DOI 10.1083/jcb.95.3.711	45	400	414	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	1993	75	3					419	429		10.1016/0092-8674(93)90377-3	http://dx.doi.org/10.1016/0092-8674(93)90377-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MF830	8221885				2022-12-28	WOS:A1993MF83000005
J	SOGAARDANDERSEN, L; VALENTINHANSEN, P				SOGAARDANDERSEN, L; VALENTINHANSEN, P			PROTEIN-PROTEIN INTERACTIONS IN GENE-REGULATION - THE CAMP-CRP COMPLEX SETS THE SPECIFICITY OF A 2ND DNA-BINDING PROTEIN, THE CYTR REPRESSOR	CELL			English	Article							ESCHERICHIA-COLI K-12; MULTICOPY EXPRESSION VECTORS; AMINO-ACID SUBSTITUTIONS; AMP RECEPTOR PROTEIN; DEO OPERON; KLEBSIELLA-PNEUMONIAE; ACTIVATOR COMPLEX; STRUCTURAL MOTIF; LAC REPRESSOR; MINOR GROOVE	Maximal repression by the CytR protein depends on the formation of nucleoprotein complexes in which CytR interacts with DNA and with cAMP-cAMP receptor protein (CRP). Here we demonstrate that CytR regulates transcription from deoP2 promoters in which the entire CytR recognition sequence has been eliminated. Furthermore, CytR proteins deleted for the DNA-binding domain repress deoP2 in vivo and interact with deoP2 in vitro in a strictly cAMP-CRP-dependent fashion. These experiments show that the site of action of CytR can be specified by protein-protein interactions to cAMP-CRP, whereas CytR-DNA interactions may primarily serve to stabilize the nucleo-protein complex. This type of specificity mechanism may represent a general concept in the recruitment of DNA-binding proteins in combinatorial regulatory systems.			SOGAARDANDERSEN, L (corresponding author), ODENSE UNIV,DEPT MOLEC BIOL,DK-5230 ODENSE,DENMARK.			Sogaard-Andersen, Lotte/0000-0002-0674-0013				AMOUYAL M, 1989, CELL, V58, P545, DOI 10.1016/0092-8674(89)90435-2; BARBIER CS, 1992, J BACTERIOL, V174, P2881, DOI 10.1128/JB.174.9.2881-2890.1992; BLUM P, 1989, J BACTERIOL, V171, P538, DOI 10.1128/jb.171.1.538-546.1989; BOLIVAR F, 1978, GENE, V4, P121, DOI 10.1016/0378-1119(78)90025-2; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; CHURCHILL MEA, 1990, P NATL ACAD SCI USA, V87, P5528, DOI 10.1073/pnas.87.14.5528; CLARK DJ, 1967, J MOL BIOL, V23, P99, DOI 10.1016/S0022-2836(67)80070-6; CRAIG NL, 1984, CELL, V39, P707, DOI 10.1016/0092-8674(84)90478-1; DANDANELL G, 1987, NATURE, V325, P823, DOI 10.1038/325823a0; DECROMBRUGGHE B, 1984, SCIENCE, V224, P831, DOI 10.1126/science.6372090; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; GERLACH P, 1991, J BACTERIOL, V173, P5419, DOI 10.1128/jb.173.17.5419-5430.1991; GHOSAINI LR, 1988, BIOCHEMISTRY-US, V27, P5257, DOI 10.1021/bi00414a046; HAMMERJESPERSEN K, 1983, METABOLISM NUCLEOTID, V7, P203; HOLST B, 1992, EMBO J, V11, P3635, DOI 10.1002/j.1460-2075.1992.tb05448.x; KAPTEIN R, 1989, TOPICS MOL STRUCTURE, V10, P35; KLEINER D, 1988, J GEN MICROBIOL, V134, P1779; KOLB A, 1993, IN PRESS ANN REV BIO; LAMERICHS RMJN, 1989, BIOCHEMISTRY-US, V28, P2985, DOI 10.1021/bi00433a037; LEE DK, 1991, CELL, V67, P1241, DOI 10.1016/0092-8674(91)90300-N; LIN SY, 1975, CELL, V4, P107, DOI 10.1016/0092-8674(75)90116-6; Maniatis T., 1982, MOL CLONING; Maxam A M, 1980, Methods Enzymol, V65, P499; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Miller J.H., 1972, EXPT MOL GENETICS; MOLLEGAARD NE, 1993, J BIOL CHEM, V268, P17471; OAKLEY MG, 1990, SCIENCE, V248, P847, DOI 10.1126/science.2111578; OHALLORAN TV, 1989, CELL, V56, P119, DOI 10.1016/0092-8674(89)90990-2; PEDERSEN H, 1992, J MOL BIOL, V227, P396, DOI 10.1016/0022-2836(92)90896-R; PEDERSEN H, 1991, J BIOL CHEM, V266, P17804; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; RASMUSSEN PB, 1993, NUCLEIC ACIDS RES, V21, P879, DOI 10.1093/nar/21.4.879; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Silhavy T. J., 1984, EXPT GENE FUSIONS; SMITH DL, 1992, CELL, V68, P133, DOI 10.1016/0092-8674(92)90212-U; SOGAARDANDERSEN L, 1991, P NATL ACAD SCI USA, V88, P4921, DOI 10.1073/pnas.88.11.4921; SOGAARDANDERSEN L, 1991, MOL MICROBIOL, V5, P969, DOI 10.1111/j.1365-2958.1991.tb00772.x; SOGAARDANDERSEN L, 1990, MOL MICROBIOL, V4, P1595, DOI 10.1111/j.1365-2958.1990.tb02071.x; SOGAARDANDERSEN L, 1990, J BACTERIOL, V172, P5706, DOI 10.1128/jb.172.10.5706-5713.1990; STARK MJR, 1987, GENE, V51, P255, DOI 10.1016/0378-1119(87)90314-3; STARR DB, 1991, CELL, V67, P1231, DOI 10.1016/0092-8674(91)90299-E; STEITZ TA, 1990, Q REV BIOPHYS, V23, P205, DOI 10.1017/S0033583500005552; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8763; TULLIUS TD, 1987, TRENDS BIOCHEM SCI, V12, P297, DOI 10.1016/0968-0004(87)90145-9; TULLIUS TD, 1986, P NATL ACAD SCI USA, V83, P5469, DOI 10.1073/pnas.83.15.5469; VALENTINHANSEN P, 1982, EMBO J, V1, P1049, DOI 10.1002/j.1460-2075.1982.tb01295.x; VALENTINHANSEN P, 1978, MOL GEN GENET, V159, P191, DOI 10.1007/BF00270893; VALENTINHANSEN P, 1986, NUCLEIC ACIDS RES, V14, P2215, DOI 10.1093/nar/14.5.2215; VALENTINHANSEN P, 1984, EMBO J, V3, P179, DOI 10.1002/j.1460-2075.1984.tb01781.x; VANDYKE MW, 1982, P NATL ACAD SCI-BIOL, V79, P5470; VIDALINGIGLIARDI D, 1991, J MOL BIOL, V218, P323, DOI 10.1016/0022-2836(91)90715-I; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; WEICKERT MJ, 1992, J BIOL CHEM, V267, P15869; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	54	46	46	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 5	1993	75	3					557	566		10.1016/0092-8674(93)90389-8	http://dx.doi.org/10.1016/0092-8674(93)90389-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MF830	8221894				2022-12-28	WOS:A1993MF83000017
J	CORMACK, BP; STRUHL, K				CORMACK, BP; STRUHL, K			REGIONAL CODON RANDOMIZATION - DEFINING A TATA-BINDING PROTEIN SURFACE REQUIRED FOR RNA POLYMERASE-III TRANSCRIPTION	SCIENCE			English	Article							YEAST; COMPONENTS; TFIIIB; LESS; PROMOTERS; HOMOLOGY; COMPLEX; ENCODES	The TATA-binding protein (TBP) is required for transcription by all three nuclear RNA polymerases. TBP was subjected to regional codon randomization, a codon-based mutagenesis method that generates complex yet compact protein libraries. Analysis of 186 temperature-sensitive TBP mutants yielded 65 specifically defective in transcription by RNA polymerase III (Pol III). These mutants map to a limited TBP surface that may interact with Tds4, a component of the Pol III transcription factor TFIIIB. Strains that contain the Pol III-defective derivatives have increased amounts of messenger RNA, which suggests that competition among TBP-interacting factors for limiting quantities of TBP determines the ratio of Pol II and Pol III transcription in vivo.	HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115	Harvard University; Harvard Medical School					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030186, R37GM030186] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 30186] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BROU C, 1993, EMBO J, V12, P489, DOI 10.1002/j.1460-2075.1993.tb05681.x; BURATOWSKI S, 1992, CELL, V71, P221, DOI 10.1016/0092-8674(92)90351-C; BURATOWSKI S, 1992, SCIENCE, V255, P1130, DOI 10.1126/science.1546314; COLBERT T, 1992, GENE DEV, V6, P1940, DOI 10.1101/gad.6.10.1940; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; CORMACK BP, 1992, CELL, V69, P685, DOI 10.1016/0092-8674(92)90232-2; CORMACK BP, 1991, CELL, V65, P341, DOI 10.1016/0092-8674(91)90167-W; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; EISENMANN DM, 1992, GENE DEV, V6, P1319, DOI 10.1101/gad.6.7.1319; GLASER SM, 1992, J IMMUNOL, V1499, P3903; KASSAVETIS GA, 1992, CELL, V71, P1055, DOI 10.1016/0092-8674(92)90399-W; LEE DK, 1992, MOL CELL BIOL, V12, P5189, DOI 10.1128/MCB.12.11.5189; LEE WS, 1991, CELL, V67, P367; LOBO SM, 1992, CELL, V71, P1029, DOI 10.1016/0092-8674(92)90397-U; LOPEZDELEON A, 1992, CELL, V71, P211, DOI 10.1016/0092-8674(92)90350-L; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; SCHULTZ MC, 1992, CELL, V69, P697, DOI 10.1016/0092-8674(92)90233-3; TAGGART AKP, 1992, CELL, V71, P1015, DOI 10.1016/0092-8674(92)90396-T; TAKADA R, 1992, P NATL ACAD SCI USA, V89, P11809, DOI 10.1073/pnas.89.24.11809; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; TIMMERS HTM, 1991, GENE DEV, V5, P1946, DOI 10.1101/gad.5.11.1946; WHITE RJ, 1992, CELL, V71, P1041, DOI 10.1016/0092-8674(92)90398-V; WHITE RJ, 1992, P NATL ACAD SCI USA, V89, P1949, DOI 10.1073/pnas.89.5.1949; ZHOU Q, 1992, GENE DEV, V6, P1964, DOI 10.1101/gad.6.10.1964	24	96	99	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 8	1993	262	5131					244	248		10.1126/science.8211143	http://dx.doi.org/10.1126/science.8211143			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA665	8211143				2022-12-28	WOS:A1993MA66500036
J	DAMICO, DJ				DAMICO, DJ			MEDICAL PROGRESS - DISEASES OF THE RETINA	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; DIABETIC MACULAR EDEMA; IMMUNE-DEFICIENCY-SYNDROME; CYTOMEGALO-VIRUS RETINITIS; GRID LASER PHOTOCOAGULATION; PARS-PLANA VITRECTOMY; SUBFOVEAL NEOVASCULAR MEMBRANES; RETICULUM-CELL SARCOMA; PROLIFERATIVE VITREORETINOPATHY; CHOROIDAL NEOVASCULARIZATION		HARVARD UNIV, SCH MED, DEPT OPHTHALMOL, BOSTON, MA USA	Harvard University; Harvard Medical School	DAMICO, DJ (corresponding author), MASSACHUSETTS EYE & EAR INFIRM, DEPT OPHTHALMOL, 243 CHARLES ST, BOSTON, MA 02114 USA.							AABERG TM, 1988, AM J OPHTHALMOL, V106, P519, DOI 10.1016/0002-9394(88)90580-6; AABERG TM, 1981, OPHTHALMOLOGY, V88, P639; [Anonymous], 1991, Ophthalmology, V98, P757; [Anonymous], 1978, Ophthalmology, V85, P82; [Anonymous], 1986, Arch Ophthalmol, V104, P694; [Anonymous], 1979, Arch Ophthalmol, V97, P654; [Anonymous], 1987, Int Ophthalmol Clin, V27, P254; [Anonymous], 1991, Ophthalmology, V98, P786; AZEN SP, 1992, ARCH OPHTHALMOL-CHIC, V110, P770; AZEN SP, 1992, ARCH OPHTHALMOL-CHIC, V110, P780; BACH MC, 1985, ANN INTERN MED, V103, P381, DOI 10.7326/0003-4819-103-3-381; BARRIE T, 1982, BRIT J OPHTHALMOL, V66, P754, DOI 10.1136/bjo.66.12.754; BENSON WE, 1979, OPHTHALMOLOGY, V86, P283; BERGER AS, 1992, OPHTHALMOLOGY, V99, P969; BLUMENKRANZ MS, 1986, OPHTHALMOLOGY, V93, P296; BRESNICK GH, 1986, OPHTHALMOLOGY, V93, P989; BRESSLER NM, 1987, ARCH OPHTHALMOL-CHIC, V105, P209; BRINCHMANNHANSEN O, 1988, ARCH OPHTHALMOL-CHIC, V106, P1242; CHANG S, 1984, AM J OPHTHALMOL, V98, P180, DOI 10.1016/0002-9394(87)90353-9; CHANG S, 1988, AM J OPHTHALMOL, V106, P668, DOI 10.1016/0002-9394(88)90698-8; COCHEREAUMASSIN I, 1992, AM J OPHTHALMOL, V114, P130, DOI 10.1016/S0002-9394(14)73975-3; CROXATTO JO, 1986, AM J OPHTHALMOL, V102, P659, DOI 10.1016/0002-9394(86)90543-X; CRUMP JRC, 1992, CLIN INFECT DIS, V14, P1069, DOI 10.1093/clinids/14.5.1069; CULBERTSON WW, 1982, OPHTHALMOLOGY, V89, P1317; DAILY MJ, 1984, OPHTHALMIC SURG LAS, V15, P741; DAMICO DJ, 1986, ARCH OPHTHALMOL-CHIC, V104, P1788; DAMICO DJ, 1991, SEMIN OPHTHALMOL, V6, P11; DEJUAN E, 1985, SURV OPHTHALMOL, V30, P47, DOI 10.1016/0039-6257(85)90088-8; DESTRO M, 1989, OPHTHALMOLOGY, V96, P846; Dowling J. E., 1987, RETINA APPROACHABLE; DUGEL PU, 1991, AM J OPHTHALMOL, V112, P235, DOI 10.1016/S0002-9394(14)76723-6; DUKER JS, 1991, SURV OPHTHALMOL, V35, P327, DOI 10.1016/0039-6257(91)90183-G; Early Treatment Diabetic Retinopathy Study Res Grp, 1991, OPHTHALMOLOGY, V98, P766; EZEKOWITZ RAB, 1992, NEW ENGL J MED, V326, P1456, DOI 10.1056/NEJM199205283262203; FELSENSTEIN D, 1985, ANN INTERN MED, V103, P377, DOI 10.7326/0003-4819-103-3-377; FINE SL, 1982, ARCH OPHTHALMOL-CHIC, V100, P912; FISHER JP, 1982, OPHTHALMOLOGY, V89, P1309; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FORSTER DJ, 1990, AM J OPHTHALMOL, V110, P341, DOI 10.1016/S0002-9394(14)77012-6; FOX GM, 1991, ARCH OPHTHALMOL-CHIC, V109, P266, DOI 10.1001/archopht.1991.01080020112054; FRANK RN, 1991, OPHTHALMOLOGY, V98, P586; FREEMAN WR, 1989, AM J OPHTHALMOL, V107, P229, DOI 10.1016/0002-9394(89)90304-8; FREEMAN WR, 1984, AM J OPHTHALMOL, V97, P133, DOI 10.1016/S0002-9394(14)76082-9; FREEMAN WR, 1990, RETINA-J RET VIT DIS, V10, P195, DOI 10.1097/00006982-199010030-00008; FREEMAN WR, 1987, AM J OPHTHALMOL, V103, P527, DOI 10.1016/S0002-9394(14)74276-X; FRIBERG TR, 1984, AM J OPHTHALMOL, V98, P515, DOI 10.1016/0002-9394(84)90144-2; FUNG WE, 1991, AM J OPHTHALMOL, V112, P349, DOI 10.1016/S0002-9394(14)76743-1; GASS JDM, 1991, ARCH OPHTHALMOL-CHIC, V109, P1134, DOI 10.1001/archopht.1991.01080080094039; GASS JDM, 1990, OPHTHALMOLOGY, V97, P1288; GASS JDM, 1973, ARCH OPHTHALMOL-CHIC, V90, P206; GASS JDM, 1987, STEREOSCOPIC ATLAS M, V1, P398; GONVERS M, 1985, AM J OPHTHALMOL, V100, P239, DOI 10.1016/0002-9394(85)90788-3; GREEN WR, 1985, OPHTHALMOLOGY, V92, P615; GROSS JG, 1990, OPHTHALMOLOGY, V97, P681; GROSSBERG HS, 1989, NEW ENGL J MED, V320, P1560; GROSSNIKLAUS HE, 1990, OPHTHALMOLOGY, V97, P1342, DOI 10.1016/S0161-6420(90)32412-0; GUYER DR, 1992, AM J OPHTHALMOL, V113, P652; GUYER DR, 1992, OPHTHALMOLOGY, V99, P287; GUYER DR, 1993, ARCH OPHTHALMOL-CHIC, V111, P350, DOI 10.1001/archopht.1993.01090030068041; GUYER DR, 1992, ARCH OPHTHALMOL-CHIC, V110, P1383, DOI 10.1001/archopht.1992.01080220045019; HAN DP, 1992, AM J OPHTHALMOL, V113, P513, DOI 10.1016/S0002-9394(14)74722-1; HAWKINS BS, 1990, ARCH OPHTHALMOL-CHIC, V108, P816; HAWKINS WR, 1991, ARCH OPHTHALMOL-CHIC, V109, P1345, DOI 10.1001/archopht.1991.01080100025012; HAWKINS WR, 1992, OPHTHALMOLOGY, V99, P841; HEIMANN K, 1989, GRAEF ARCH CLIN EXP, V227, P152, DOI 10.1007/BF02169789; HEINEMANN MH, 1989, ARCH OPHTHALMOL-CHIC, V107, P1767, DOI 10.1001/archopht.1989.01070020849025; HILTON GF, 1986, OPHTHALMOLOGY, V93, P626; HIRSCH MS, 1992, NEW ENGL J MED, V326, P264, DOI 10.1056/NEJM199201233260409; HOLLAND GN, 1988, AM J OPHTHALMOL, V106, P653, DOI 10.1016/0002-9394(88)90697-6; HOLLAND GN, 1983, OPHTHALMOLOGY, V90, P859; HUTTON WL, 1980, OPHTHALMOLOGY, V87, P1071; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; JABS DA, 1992, NEW ENGL J MED, V326, P213, DOI 10.1056/NEJM199201233260401; JABS DA, 1991, ARCH OPHTHALMOL-CHIC, V109, P794, DOI 10.1001/archopht.1991.01080060058024; JABS DA, 1989, ARCH OPHTHALMOL-CHIC, V107, P75, DOI 10.1001/archopht.1989.01070010077031; KLEIN R, 1992, OPHTHALMOLOGY, V99, P933; KORETZ SH, 1986, NEW ENGL J MED, V314, P801, DOI 10.1056/NEJM198603273141301; LAMBERT HM, 1992, AM J OPHTHALMOL, V113, P257, DOI 10.1016/S0002-9394(14)71576-4; LEAN JS, 1982, T OPHTHAL SOC UK, V102, P203; LEE CM, 1991, OPHTHALMOLOGY, V98, P1594; LEHOANG P, 1989, OPHTHALMOLOGY, V96, P865; Leibowitz H M, 1980, Surv Ophthalmol, V24, P335; LEWIS H, 1989, OPHTHALMOLOGY, V96, P1403; LEWIS H, 1990, OPHTHALMOLOGY, V97, P503, DOI 10.1016/S0161-6420(90)32574-5; LINCOFF A, 1980, ARCH OPHTHALMOL-CHIC, V98, P1646; LINCOFF H, 1983, OPHTHALMOLOGY, V90, P546; LINCOFF H, 1989, OPHTHALMOLOGY, V96, P784; LORENZI M, 1991, DIABETES, V40, P653, DOI 10.2337/diabetes.40.6.653; MACHEMER R, 1991, AM J OPHTHALMOL, V112, P159, DOI 10.1016/S0002-9394(14)76695-4; Machemer R, 1977, Trans Am Ophthalmol Soc, V75, P556; MACHEMER R, 1986, AM J OPHTHALMOL, V102, P7, DOI 10.1016/0002-9394(86)90201-1; MANDELCORN MS, 1976, AM J OPHTHALMOL, V81, P561, DOI 10.1016/0002-9394(76)90117-3; MARGOLIS TP, 1991, AM J OPHTHALMOL, V112, P119, DOI 10.1016/S0002-9394(14)76690-5; MCCUEN BW, 1985, RETINA-J RET VIT DIS, V5, P189, DOI 10.1097/00006982-198500540-00001; MERIMEE TJ, 1990, NEW ENGL J MED, V322, P978, DOI 10.1056/NEJM199004053221406; MICHELS RG, 1983, AM J OPHTHALMOL, V95, P12, DOI 10.1016/0002-9394(83)90329-X; MURPHY RP, 1979, ARCH OPHTHALMOL-CHIC, V97, P700; NEWSOME DA, 1988, ARCH OPHTHALMOL-CHIC, V106, P192; Norton EW, 1973, T AM ACAD OPHTHALMOL, V77, pOP85; OLK RJ, 1986, OPHTHALMOLOGY, V93, P938; OLK RJ, 1990, OPHTHALMOLOGY, V97, P1101; PALAY DA, 1991, AM J OPHTHALMOL, V112, P250, DOI 10.1016/S0002-9394(14)76725-X; PARKE DW, 1984, AM J OPHTHALMOL, V97, P434, DOI 10.1016/S0002-9394(14)76126-4; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; RAMSAY RC, 1988, NEW ENGL J MED, V318, P208, DOI 10.1056/NEJM198801283180403; RAND LI, 1985, INVEST OPHTH VIS SCI, V26, P983; RAO NA, 1989, AM J OPHTHALMOL, V107, P218, DOI 10.1016/0002-9394(89)90303-6; REGILLO CD, 1992, AM J OPHTHALMOL, V113, P21, DOI 10.1016/S0002-9394(14)75747-2; RICE TA, 1983, AM J OPHTHALMOL, V95, P22, DOI 10.1016/0002-9394(83)90330-6; RIDLEY ME, 1992, OPHTHALMOLOGY, V99, P1153; SABATES WI, 1981, OPHTHALMOLOGY, V88, P447; SCHANZER MC, 1991, OPHTHALMOLOGY, V98, P88; SCHATZ H, 1991, ARCH OPHTHALMOL-CHIC, V109, P1549, DOI 10.1001/archopht.1991.01080110085041; SCHEIDER A, 1992, AM J OPHTHALMOL, V113, P45, DOI 10.1016/S0002-9394(14)75752-6; SHAMI MJ, 1991, AM J OPHTHALMOL, V112, P15, DOI 10.1016/S0002-9394(14)76206-3; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SHERWIN RS, 1988, JAMA-J AM MED ASSOC, V260, P37; SIDIKARO Y, 1991, OPHTHALMOLOGY, V98, P129; SISON RF, 1991, AM J OPHTHALMOL, V112, P243, DOI 10.1016/S0002-9394(14)76724-8; SISON RF, 1991, AM J OPHTHALMOL, V112, P618; SKOLNIK PR, 1992, NEW ENGL J MED, V326, P1701, DOI 10.1056/NEJM199206183262513; SMIDDY WE, 1992, ARCH OPHTHALMOL-CHIC, V110, P1172, DOI 10.1001/archopht.1992.01080200152045; STERNBERG P, 1988, OPHTHALMOLOGY, V95, P1389; TAMESIS RR, 1990, OPHTHALMOLOGY, V97, P1281; THOMAS MA, 1992, OPHTHALMOLOGY, V99, P952; TORNAMBE PE, 1989, OPHTHALMOLOGY, V96, P772; WHITE CW, 1989, NEW ENGL J MED, V320, P1197, DOI 10.1056/NEJM198905043201807; WILL JC, 1990, NEW ENGL J MED, V323, P613; WILLIAMS DF, 1989, OPHTHALMOLOGY, V96, P752; WILSON DJ, 1988, ARCH OPHTHALMOL-CHIC, V106, P100, DOI 10.1001/archopht.1988.01060130106038; YANNUZZI LA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1701; YANOFF M, 1989, OCULAR PATHOLOGY, P567; 1991, ARCH OPHTHALMOL-CHIC, V109, P1109; 1991, ARCH OPHTHALMOL-CHIC, V109, P1220; 1980, VISION PROBLEMS US D; 1991, ARCH OPHTHALMOL-CHIC, V109, P1232; 1992, ARCH OPHTHALMOL-CHIC, V110, P761; 1986, ARCH OPHTHALMOL-CHIC, V104, P503; 1992, NEW ENGL J MED, V326, P1172	139	56	62	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 14	1994	331	2					95	106		10.1056/NEJM199407143310207	http://dx.doi.org/10.1056/NEJM199407143310207			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NW712	8208273				2022-12-28	WOS:A1994NW71200007
J	DOL, JA; LOUWERSE, ES				DOL, JA; LOUWERSE, ES			WALLERIAN DEGENERATION OF THE PYRAMIDAL TRACT	NEW ENGLAND JOURNAL OF MEDICINE			English	Note											DOL, JA (corresponding author), UNIV AMSTERDAM,ACAD MED CTR,MEIBERGDREEF 9,1105 AZ AMSTERDAM,NETHERLANDS.								0	0	0	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	1994	331	2					88	88						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NW712	8208271				2022-12-28	WOS:A1994NW71200005
J	MILLS, JA				MILLS, JA			MEDICAL PROGRESS - SYSTEMIC LUPUS-ERYTHEMATOSUS	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CONNECTIVE-TISSUE DISEASE; CENTRAL-NERVOUS-SYSTEM; HISTOCOMPATIBILITY COMPLEX GENES; PULSE CYCLOPHOSPHAMIDE; IMMUNE-COMPLEXES; CONTROLLED TRIAL; LONG-TERM; INTRAVENOUS CYCLOPHOSPHAMIDE; ANTIPHOSPHOLIPID ANTIBODIES; CLINICAL-SIGNIFICANCE		HARVARD UNIV, SCH MED, BOSTON, MA USA	Harvard University; Harvard Medical School	MILLS, JA (corresponding author), MASSACHUSETTS GEN HOSP, CTR AMBULATORY CARE, BOSTON, MA 02114 USA.							ARA J, 1992, IMMUNOL LETT, V34, P195, DOI 10.1016/0165-2478(92)90213-8; ARNETT FC, 1992, RHEUM DIS CLIN N AM, V18, P865; ASHERSON RA, 1990, J RHEUMATOL, V17, P1292; ASHERSON RA, 1991, ANN RHEUM DIS, V50, P897, DOI 10.1136/ard.50.12.897; AUSTIN HA, 1984, KIDNEY INT, V25, P689, DOI 10.1038/ki.1984.75; AUSTIN HA, 1986, NEW ENGL J MED, V314, P614, DOI 10.1056/NEJM198603063141004; BAKER SB, 1979, AM J MED, V66, P727, DOI 10.1016/0002-9343(79)91109-4; BARRON KS, 1993, ARTHRITIS RHEUM, V36, P348, DOI 10.1002/art.1780360310; BELL CL, 1991, ARTHRITIS RHEUM, V34, P432, DOI 10.1002/art.1780340408; BERCZI I, 1993, J RHEUMATOL, V20, P1095; BOUMPAS DT, 1991, Q J MED, V81, P975, DOI 10.1093/qjmed/81.3.975; BOUMPAS DT, 1993, ANN INTERN MED, V119, P366, DOI 10.7326/0003-4819-119-5-199309010-00003; BOUMPAS DT, 1992, LANCET, V340, P741, DOI 10.1016/0140-6736(92)92292-N; BOUMPAS DT, 1990, J RHEUMATOL, V17, P89; BRANCH DW, 1992, OBSTET GYNECOL, V80, P614; BURGE SM, 1989, BRIT J DERMATOL, V121, P727, DOI 10.1111/j.1365-2133.1989.tb08215.x; BUYON JP, 1993, ARTHRITIS RHEUM, V36, P1263, DOI 10.1002/art.1780360911; CAIRNS D, 1992, J RHEUMATOL, V19, P1089; CALLEN JP, 1988, RHEUM DIS CLIN N AM, V14, P79; CERVERA R, 1992, ANN RHEUM DIS, V51, P156, DOI 10.1136/ard.51.2.156; CHEIGH JS, 1993, AM J KIDNEY DIS, V21, P2, DOI 10.1016/S0272-6386(12)80712-8; CLAMAN HN, 1992, JAMA-J AM MED ASSOC, V268, P2790, DOI 10.1001/jama.268.20.2790; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; DIAMOND B, 1992, ANNU REV IMMUNOL, V10, P731, DOI 10.1146/annurev.iy.10.040192.003503; DOHERTY DG, 1992, ARTHRITIS RHEUM, V35, P641, DOI 10.1002/art.1780350607; DONADIO JV, 1993, AM J KIDNEY DIS, V21, P239, DOI 10.1016/S0272-6386(12)80741-4; DRAKE CG, 1992, J CLIN IMMUNOL, V12, P149, DOI 10.1007/BF00918083; ESCALANTE A, 1992, J RHEUMATOL, V19, P800; ESDAILE JM, 1993, SEMIN ARTHRITIS RHEU, V23, P135, DOI 10.1016/S0049-0172(05)80019-8; FATHMAN CG, 1992, NEW ENGL J MED, V326, P1693, DOI 10.1056/NEJM199206183262509; FESSEL WJ, 1978, AM J MED, V64, P80, DOI 10.1016/0002-9343(78)90181-X; FRONEK Z, 1990, ARTHRITIS RHEUM, V33, P1542, DOI 10.1002/art.1780331012; FURIE RA, 1988, SEMIN ARTHRITIS RHEU, V18, P127, DOI 10.1016/0049-0172(88)90005-4; GERSHWIN ME, 1974, ARTHRITIS RHEUM, V17, P947, DOI 10.1002/art.1780170605; GIMOVSKY ML, 1991, CLIN OBSTET GYNECOL, V34, P35, DOI 10.1097/00003081-199103000-00008; GINZLER EM, 1988, RHEUM DIS CLIN N AM, V14, P67; GLEASON CB, 1993, AM HEART J, V125, P1123, DOI 10.1016/0002-8703(93)90124-R; GOSS JA, 1991, TRANSPLANTATION, V52, P805, DOI 10.1097/00007890-199111000-00009; HANLY JG, 1992, J RHEUMATOL, V19, P732; HANSON VG, 1992, J EXP MED, V176, P565, DOI 10.1084/jem.176.2.565; HARIHARAN S, 1990, CLIN NEPHROL, V34, P61; HARLEY JB, 1992, RHEUM DIS CLIN N AM, V18, P337; HARLEY JB, 1991, J CLIN IMMUNOL, V11, P297, DOI 10.1007/BF00918796; HAUPT HM, 1981, AM J MED, V71, P791, DOI 10.1016/0002-9343(81)90366-1; HAY EM, 1992, ARTHRITIS RHEUM, V35, P411, DOI 10.1002/art.1780350409; HELLMANN DB, 1987, MEDICINE, V66, P341, DOI 10.1097/00005792-198709000-00002; HESS EV, 1991, B RHEUM DIS, V40, P1; HOCHBERG MC, 1990, RHEUM DIS CLIN N AM, V16, P617; HOFFMAN BI, 1980, SEMIN ARTHRITIS RHEU, V9, P237, DOI 10.1016/0049-0172(80)90016-5; HOFFMANN RW, 1990, ARTHRITIS RHEUM-US, V33, P666, DOI 10.1002/art.1780330509; ISENBERG DA, 1982, ANN RHEUM DIS, V41, P30, DOI 10.1136/ard.41.1.30; IVERSON GL, 1993, SEMIN ARTHRITIS RHEU, V22, P242, DOI 10.1016/0049-0172(93)80072-N; JONES DRE, 1992, LANCET, V339, P1378, DOI 10.1016/0140-6736(92)91197-G; JULKUNEN HA, 1991, SCAND J RHEUMATOL, V20, P427, DOI 10.3109/03009749109096822; JUNGERS P, 1982, ARCH INTERN MED, V142, P771, DOI 10.1001/archinte.142.4.771; JUNGERS P, 1985, ARTHRITIS RHEUM, V28, P1243, DOI 10.1002/art.1780281108; KAELL AT, 1986, ARCH NEUROL-CHICAGO, V43, P273, DOI 10.1001/archneur.1986.00520030063016; KAHL LE, 1992, ARTHRITIS RHEUM, V35, P1343, DOI 10.1002/art.1780351115; KHAMASHTA MA, 1990, LANCET, V335, P1541, DOI 10.1016/0140-6736(90)91373-I; KLINMAN DM, 1991, ARTHRITIS RHEUM, V34, P1404; KLIPPEL JH, 1993, RHEUM DIS CLIN N AM, V19, P249; LEUNG WH, 1990, INT J CARDIOL, V27, P367, DOI 10.1016/0167-5273(90)90294-F; LEWIS EJ, 1992, NEW ENGL J MED, V326, P1373, DOI 10.1056/NEJM199205213262101; LIANG MH, 1991, ARTHRITIS RHEUM-US, V34, P1187, DOI 10.1002/art.1780340918; LOCKSHIN MD, 1989, ARTHRITIS RHEUM, V32, P665, DOI 10.1002/anr.1780320602; LOCKSHIN MD, 1991, NEW ENGL J MED, V324, P189, DOI 10.1056/NEJM199101173240309; LOCKSHIN MD, 1985, NEW ENGL J MED, V313, P152, DOI 10.1056/NEJM198507183130304; LOCKSHIN MD, 1993, RHEUM DIS CLIN N AM, V19, P235; LOVE PE, 1990, ANN INTERN MED, V112, P682, DOI 10.7326/0003-4819-112-9-682; MACKAY IR, 1991, SEMIN LIVER DIS, V11, P234, DOI 10.1055/s-2008-1040441; MADDISON PJ, 1985, CLIN EXP IMMUNOL, V62, P337; MAGIL AB, 1984, MEDICINE, V63, P210, DOI 10.1097/00005792-198407000-00003; MCCUNE WJ, 1988, NEW ENGL J MED, V318, P1423, DOI 10.1056/NEJM198806023182203; MCHUGH NJ, 1991, ANN RHEUM DIS, V50, P548, DOI 10.1136/ard.50.8.548; MCLAUGHLIN J, 1991, ARTHRITIS RHEUM, V34, P1268, DOI 10.1002/art.1780341010; MCNEIL HP, 1991, ADV IMMUNOL, V49, P193; MILLER JFAP, 1992, ANNU REV IMMUNOL, V10, P51, DOI 10.1146/annurev.iy.10.040192.000411; MILLER MH, 1983, MEDICINE, V62, P327, DOI 10.1097/00005792-198309000-00005; MOHAN C, 1993, J EXP MED, V177, P1367, DOI 10.1084/jem.177.5.1367; MONGEY AB, 1992, ARTHRITIS RHEUM, V35, P219, DOI 10.1002/art.1780350216; NIVED O, 1985, Q J MED, V55, P271; NOSSENT HC, 1990, ARTHRITIS RHEUM, V33, P970, DOI 10.1002/art.1780330708; NOSSENT HC, 1990, AM J MED, V89, P169, DOI 10.1016/0002-9343(90)90295-O; OLSEN ML, 1993, ARTHRITIS RHEUM, V36, P94, DOI 10.1002/art.1780360117; ORDI J, 1993, J RHEUMATOL, V20, P1321; PEREDNIA DA, 1990, ARCH INTERN MED, V150, P1806, DOI 10.1001/archinte.150.9.1806; PETRI M, 1992, MEDICINE, V71, P291, DOI 10.1097/00005792-199209000-00004; PETRI M, 1991, ARTHRITIS RHEUM, V34, P1538; PILIERO P, 1990, SEMIN ARTHRITIS RHEU, V20, P185, DOI 10.1016/0049-0172(90)90059-O; PISTINER M, 1991, SEMIN ARTHRITIS RHEU, V21, P55, DOI 10.1016/0049-0172(91)90057-7; PONTICELLI C, 1993, DRUGS, V21, P239; PRYSTOWSKY SD, 1976, MEDICINE, V55, P183, DOI 10.1097/00005792-197603000-00006; RANKI A, 1992, ARTHRITIS RHEUM, V35, P1483, DOI 10.1002/art.1780351212; RAZ E, 1992, AM J MED, V92, P109, DOI 10.1016/0002-9343(92)90027-9; REICHLIN M, 1992, ARTHRITIS RHEUM, V35, P457, DOI 10.1002/art.1780350416; REYNOLDS JC, 1982, MEDICINE, V61, P25, DOI 10.1097/00005792-198201000-00003; RICHARDSON EP, 1980, HDB CLIN NEUROLOGY, V39, P273; ROACH BA, 1993, ARTHRITIS RHEUM, V36, P682, DOI 10.1002/art.1780360516; SCHIFFERLI JA, 1986, NEW ENGL J MED, V315, P488; SCHWARTZ MM, 1993, AM J KIDNEY DIS, V21, P374, DOI 10.1016/S0272-6386(12)80263-0; SELEZNICK MJ, 1991, SEMIN ARTHRITIS RHEU, V21, P73, DOI 10.1016/0049-0172(91)90040-7; SHIGEMASA C, 1992, LANCET, V339, P1177, DOI 10.1016/0140-6736(92)90781-W; SIBLEY JT, 1992, J RHEUMATOL, V19, P47; SONTHEIMER RD, 1989, MED CLIN N AM, V73, P1073, DOI 10.1016/S0025-7125(16)30620-4; STEINBERG AD, 1991, ARTHRITIS RHEUM-US, V34, P945, DOI 10.1002/art.1780340803; STEINBERG AD, 1991, ANN INTERN MED, V115, P548, DOI 10.7326/0003-4819-115-7-548; STEINBERG AD, 1990, IMMUNOL REV, V118, P129, DOI 10.1111/j.1600-065X.1990.tb00815.x; STERNBERG EM, 1992, ANN INTERN MED, V117, P854, DOI 10.7326/0003-4819-117-10-854; STIMMLER MM, 1993, SEMIN ARTHRITIS RHEU, V22, P335, DOI 10.1016/S0049-0172(05)80012-5; STURFELT G, 1992, MEDICINE, V71, P216, DOI 10.1097/00005792-199207000-00004; SULLIVAN WD, 1984, MEDICINE, V63, P92, DOI 10.1097/00005792-198403000-00003; SUZUKI K, 1991, ARTHRITIS RHEUM, V34, P1546; SWAAK AJG, 1989, ANN RHEUM DIS, V48, P447, DOI 10.1136/ard.48.6.447; SWAAK AJG, 1986, ANN RHEUM DIS, V45, P359, DOI 10.1136/ard.45.5.359; TALAL N, 1990, J CLIN INVEST, V85, P1866, DOI 10.1172/JCI114647; TAN EM, 1989, ADV IMMUNOL, V44, P93, DOI 10.1016/S0065-2776(08)60641-0; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TERADA K, 1991, BIOCHEM BIOPH RES CO, V174, P323, DOI 10.1016/0006-291X(91)90523-A; TERBORG EJ, 1990, ARTHRITIS RHEUM-US, V33, P634, DOI 10.1002/art.1780330505; TSAO BP, 1992, J IMMUNOL, V149, P350; VANES JH, 1991, J EXP MED, V173, P461, DOI 10.1084/jem.173.2.461; WACHOLTZ MC, 1992, ARTHRITIS RHEUM, V35, P837, DOI 10.1002/art.1780350721; WALLACE DJ, 1992, ARTHRITIS RHEUM, V35, P604; WALTON AJE, 1991, ANN RHEUM DIS, V50, P463, DOI 10.1136/ard.50.7.463; WEINER DK, 1991, J RHEUMATOL, V18, P748; WENER MH, 1987, MEDICINE, V66, P85, DOI 10.1097/00005792-198703000-00001; WEST SG, 1988, ANN INTERN MED, V108, P703, DOI 10.7326/0003-4819-108-5-703; WIEDEMANN HP, 1992, J THORAC IMAG, V7, P1, DOI 10.1097/00005382-199203000-00003; WILCOX PG, 1988, CHEST, V93, P352, DOI 10.1378/chest.93.2.352; WINFIELD JB, 1992, CLIN IMMUNOL IMMUNOP, V63, P13, DOI 10.1016/0090-1229(92)90085-3; WONG KL, 1991, Q J MED, V81, P857; WYSENBEEK AJ, 1992, ANN RHEUM DIS, V51, P717, DOI 10.1136/ard.51.6.717; WYSENBEEK AJ, 1990, J RHEUMATOL, V17, P1695; YOUNG RA, 1990, ANNU REV IMMUNOL, V8, P401, DOI 10.1146/annurev.immunol.8.1.401	134	348	366	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 30	1994	330	26					1871	1879		10.1056/NEJM199406303302608	http://dx.doi.org/10.1056/NEJM199406303302608			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NT530	8196732				2022-12-28	WOS:A1994NT53000008
J	FIATARONE, MA; ONEILL, EF; RYAN, ND; CLEMENTS, KM; SOLARES, GR; NELSON, ME; ROBERTS, SB; KEHAYIAS, JJ; LIPSITZ, LA; EVANS, WJ				FIATARONE, MA; ONEILL, EF; RYAN, ND; CLEMENTS, KM; SOLARES, GR; NELSON, ME; ROBERTS, SB; KEHAYIAS, JJ; LIPSITZ, LA; EVANS, WJ			EXERCISE TRAINING AND NUTRITIONAL SUPPLEMENTATION FOR PHYSICAL FRAILTY LN VERY ELDERLY PEOPLE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-COMPOSITION; SKELETAL-MUSCLE; NURSING-HOME; STRENGTH; MEN; MORPHOLOGY; SPEED; WOMEN; AGE; OLD	Background. Although disuse of skeletal muscle and undernutrition are often cited as potentially reversible causes of frailty in elderly people, the efficacy of interventions targeted specifically at these deficits has not been carefully studied. Methods. We conducted a randomized, placebo-controlled trial comparing progressive resistance exercise training, multinutrient supplementation, both interventions, and neither in 100 frail nursing home residents over a 10-week period. Results. The mean (+/-SE) age of the 63 women and 37 men enrolled in the study was 87.1+/-0.6 years (range, 72 to 98); 94 percent of the subjects completed the study. Muscle strength increased by 113+/-8 percent in the subjects who underwent exercise training, as compared with 3+/-9 percent in the nonexercising subjects (P<0.001). Gait velocity increased by 11.8+/-3.8 percent in the exercisers but declined by 1.0+/-3.8 percent in the nonexercisers (P = 0.02). Stair-climbing power also improved in the exercisers as compared with the nonexercisers (by 28.4+/-6.6 percent vs. 3.6+/-6.7 percent, P = 0.01), as did the level of spontaneous physical activity. Cross-sectional thigh-muscle area increased by 2.7+/-1.8 percent in the exercisers but declined by 1.8+/-2.0 percent in the nonexercisers (P = 0.11). The nutritional supplement had no effect on any primary outcome measure. Total energy intake was significantly increased only in the exercising subjects who also received nutritional supplementation. Conclusions. High-intensity resistance exercise training is a feasible and effective means of Counteracting muscle weakness and physical frailty in very elderly people. in contrast, multinutrient supplementation without concomitant exercise does not reduce muscle weakness or physical frailty.	HEBREW REHABIL CTR AGED, ROSLINDALE, MA USA; HARVARD UNIV, SCH MED, DIV AGING, BOSTON, MA 02115 USA; BETH ISRAEL HOSP, DEPT MED, BOSTON, MA 02215 USA; BRIGHAM & WOMENS HOSP, DIV GERONTOL, BOSTON, MA 02115 USA; TUFTS UNIV NEW ENGLAND MED CTR, DEPT RADIAT ONCOL, DIV MED PHYS, BOSTON, MA 02111 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Tufts Medical Center	FIATARONE, MA (corresponding author), TUFTS UNIV, DEPT AGR, HUMAN NUTR RES CTR AGING, 711 WASHINGTON ST, BOSTON, MA 02111 USA.				NIA NIH HHS [AGO4390, UO1 AG09078] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [U01AG009078, P01AG004390] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANIANSSON A, 1983, SCAND J REHABIL MED, P92; [Anonymous], 1990, MED SCI SPORT EXER, V22, P265; [Anonymous], 1985, ENERGY PROTEIN REQUI; BASIOTIS PP, 1987, J NUTR, V117, P1638, DOI 10.1093/jn/117.9.1638; BASSEY EJ, 1992, CLIN SCI, V82, P321, DOI 10.1042/cs0820321; BENDALL MJ, 1989, AGE AGEING, V18, P327, DOI 10.1093/ageing/18.5.327; Blankfort-Doyle W, 1989, AGING MOTOR BEHAV, P201; BORKAN GA, 1983, J GERONTOL, V38, P673, DOI 10.1093/geronj/38.6.673; BORTZ WM, 1982, JAMA-J AM MED ASSOC, V248, P1203, DOI 10.1001/jama.248.10.1203; BROCKLEHURST JC, 1968, GERONTOL CLIN, V10, P309, DOI 10.1159/000245198; COHN SH, 1980, AM J PHYSIOL, V239, pE524, DOI 10.1152/ajpendo.1980.239.6.E524; DELORME TL, 1945, J BONE JOINT SURG, V27, P645; DRINKA PJ, 1991, J AM GERIATR SOC, V39, P1008, DOI 10.1111/j.1532-5415.1991.tb04050.x; EFTHIMIOU J, 1988, AM REV RESPIR DIS, V137, P1075, DOI 10.1164/ajrccm/137.5.1075; EVANS WJ, 1993, J NUTR, V123, P465, DOI 10.1093/jn/123.suppl_2.465; Fiatarone M A, 1990, TOP GERIATR REHABIL, V5, P63, DOI DOI 10.1097/00013614-199001000-00009; FIATARONE MA, 1990, JAMA-J AM MED ASSOC, V263, P3029, DOI 10.1001/jama.263.22.3029; FIATARONE MA, 1993, J GERONTOL, V48, P77, DOI 10.1093/geronj/48.Special_Issue.77; FIATARONE MA, 1993, J AM GERIATR SOC, V41, P333, DOI 10.1111/j.1532-5415.1993.tb06714.x; FISHER NM, 1991, ARCH PHYS MED REHAB, V72, P181; FLECK SJ, 1987, DESIGNING RESISTANCE; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; HANSENSMITH FM, 1979, BRIT J NUTR, V41, P275, DOI 10.1079/BJN19790036; HUBERT HB, 1993, J RHEUMATOL, V20, P480; JEEJEEBHOY KN, 1986, GUT, V27, P25, DOI 10.1136/gut.27.Suppl_1.25; JONES DA, 1989, Q J EXP PHYSIOL CMS, V74, P233, DOI 10.1113/expphysiol.1989.sp003268; KLITGAARD H, 1990, ACTA PHYSIOL SCAND, V140, P41, DOI 10.1111/j.1748-1716.1990.tb08974.x; LAPORTE RE, 1979, AM J EPIDEMIOL, V109, P158, DOI 10.1093/oxfordjournals.aje.a112671; LARSSON L, 1979, J APPL PHYSIOL, V46, P451, DOI 10.1152/jappl.1979.46.3.451; MCDONAGH MJN, 1984, EUR J APPL PHYSIOL, V52, P139, DOI 10.1007/BF00433384; MEREDITH CN, 1992, J AM GERIATR SOC, V40, P155, DOI 10.1111/j.1532-5415.1992.tb01937.x; MOLLOY DW, 1988, AGE AGEING, V17, P303, DOI 10.1093/ageing/17.5.303; ORY MG, 1993, J AM GERIATR SOC, V41, P283, DOI 10.1111/j.1532-5415.1993.tb06707.x; ROBERTS SB, 1992, INT J OBESITY, V16, P969; RUSSELL DM, 1983, AM J CLIN NUTR, V38, P229, DOI 10.1093/ajcn/38.2.229; VELLAS B, 1992, NUTRITION, V8, P105; WATERS R, 1990, GAIT REHABILITATION, P65; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; 1989, RECOMMENDED DIETARY	40	1938	1972	5	215	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	1994	330	25					1769	1775		10.1056/NEJM199406233302501	http://dx.doi.org/10.1056/NEJM199406233302501			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR295	8190152	Bronze			2022-12-28	WOS:A1994NR29500001
J	KAUSHANSKY, K; LOK, S; HOLLY, RD; BROUDY, VC; LIN, N; BAILEY, MC; FORSTROM, JW; BUDDLE, MM; OORT, PJ; HAGEN, FS; ROTH, GJ; PAPAYANNOPOULOU, T; FOSTER, DC				KAUSHANSKY, K; LOK, S; HOLLY, RD; BROUDY, VC; LIN, N; BAILEY, MC; FORSTROM, JW; BUDDLE, MM; OORT, PJ; HAGEN, FS; ROTH, GJ; PAPAYANNOPOULOU, T; FOSTER, DC			PROMOTION OF MEGAKARYOCYTE PROGENITOR EXPANSION AND DIFFERENTIATION BY THE C-MPL LIGAND THROMBOPOIETIN	NATURE			English	Article							STEM-CELL FACTOR; HUMAN INTERLEUKIN-6; GROWTH-FACTORS; KIT LIGAND; INVIVO; ERYTHROPOIETIN; INVITRO; PURIFICATION; SYNERGISM; MICE	THE development of blood cells including expansion of megakaryocyte progenitor cells requires the interplay of marrow stromal cells and polypeptide cytokines(1-10). Recently, characterization of c-Mpl, the receptor encoded by the proto-oncogene c-mpl, revealed structural homology with the haematopoietic cytokine receptor family(11), and its involvement in megakaryocyte development(12). We report here that the ligand for c-Mpl(13) is relatively lineage specific, works both alone and synergistically with early acting cytokines to support megakaryocyte colony formation, and acts at a late stage of development to increase megakaryocyte size, polyploidization and expression of differentiation markers. In vivo, c-Mpl ligand stimulates platelet production by greatly expanding marrow and splenic megakaryocytes and their progenitors, and by shifting the distribution of megakaryocyte ploidy to higher values. Thus, as c-Mpl ligand has the expected characteristics of the major regulator of megakaryocyte development, we propose that it be termed thrombopoietin.	ZYMOGENET INC,SEATTLE,WA 98105	Zymogenet Inc.	KAUSHANSKY, K (corresponding author), UNIV WASHINGTON,SCH MED,DIV HEMATOL,SEATTLE,WA 98195, USA.							AVANZI GC, 1988, BRIT J HAEMATOL, V69, P359, DOI 10.1111/j.1365-2141.1988.tb02374.x; AVRAHAM H, 1992, BLOOD, V80, P1679; BROUDY VC, 1988, ARCH BIOCHEM BIOPHYS, V265, P329, DOI 10.1016/0003-9861(88)90135-X; BURSTEIN SA, 1992, EXP HEMATOL, V20, P1170; CANFIELD VA, 1987, BIOCHEM BIOPH RES CO, V147, P526, DOI 10.1016/0006-291X(87)90963-6; CARRINGTON PA, 1991, BLOOD, V77, P34; CHOW FPR, 1993, EXP HEMATOL, V21, P255; DEBILI N, 1993, BLOOD, V82, P84, DOI 10.1182/blood.V82.1.84.bloodjournal82184; FOSTER DC, 1991, BIOCHEMISTRY-US, V30, P367, DOI 10.1021/bi00216a009; GEISSLER K, 1992, BLOOD, V79, P1155, DOI 10.1182/blood.V79.5.1155.bloodjournal7951155; HAN ZC, 1992, BRIT J HAEMATOL, V81, P1, DOI 10.1111/j.1365-2141.1992.tb08161.x; HILL RJ, 1992, EXP HEMATOL, V20, P354; ISHIBASHI T, 1989, P NATL ACAD SCI USA, V86, P5953, DOI 10.1073/pnas.86.15.5953; ISHIBASHI T, 1989, BLOOD, V74, P1241; JACKSON CW, 1984, BLOOD, V63, P768; JELKMANN W, 1992, PHYSIOL REV, V72, P449, DOI 10.1152/physrev.1992.72.2.449; LEARY AG, 1992, P NATL ACAD SCI USA, V89, P4013, DOI 10.1073/pnas.89.9.4013; LEE M, 1979, BLOOD, V53, P619; LOK S, 1994, NATURE, V369, P565, DOI 10.1038/369565a0; MAYANI H, 1992, EUR J HAEMATOL, V49, P225; METCALF D, 1992, TRENDS BIOCHEM SCI, V17, P286, DOI 10.1016/0968-0004(92)90436-D; METHIA N, 1993, BLOOD, V82, P1395; NEBEN TY, 1993, BLOOD, V81, P901; OGAWA M, 1993, BLOOD, V81, P2844; TERAMURA M, 1992, BLOOD, V79, P327; TSUKADA J, 1993, BLOOD, V81, P866; Vignon I, 1992, P NATL ACAD SCI USA, V89, P5640; Whetton AD, 1993, CURR OPIN CELL BIOL, V5, P1044, DOI 10.1016/0955-0674(93)90090-D	28	910	981	2	13	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 16	1994	369	6481					568	571		10.1038/369568a0	http://dx.doi.org/10.1038/369568a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR294	8202159				2022-12-28	WOS:A1994NR29400052
J	ELDER, ME; LIN, D; CLEVER, J; CHAN, AC; HOPE, TJ; WEISS, A; PARSLOW, TG				ELDER, ME; LIN, D; CLEVER, J; CHAN, AC; HOPE, TJ; WEISS, A; PARSLOW, TG			HUMAN SEVERE COMBINED IMMUNODEFICIENCY DUE TO A DEFECT IN ZAP-70, A T-CELL TYROSINE KINASE	SCIENCE			English	Article							RECEPTOR GAMMA-CHAIN; ANTIGEN RECEPTOR; MICE LACKING; ZETA-CHAIN; FUNCTIONAL COMPONENT; ACTIVATION; SELECTION	A homozygous mutation in the kinase domain of ZAP-70, a T cell receptor-associated protein tyrosine kinase, produced a distinctive form of human severe combined immunodeficiency. Manifestations of this disorder included profound immunodeficiency, absence of peripheral CD8(+) T cells, and abundant peripheral CD4(+) T cells that were refractory to T cell receptor-mediated activation. These findings demonstrate that ZAP-70 is essential for human T cell function and suggest that CD4(+) and CD8(+) T cells depend on different intracellular signaling pathways to support their development or survival.	UNIV CALIF SAN FRANCISCO, DEPT PATHOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT MICROBIOL & IMMUNOL, SAN FRANCISCO, CA 94143 USA; SALK INST, INFECT DIS LAB, SAN DIEGO, CA 92186 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Salk Institute	ELDER, ME (corresponding author), UNIV CALIF SAN FRANCISCO, DEPT PEDIAT, SAN FRANCISCO, CA 94143 USA.				NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029313] Funding Source: NIH RePORTER; NCRR NIH HHS [RR01271] Funding Source: Medline; NIAID NIH HHS [AI29313] Funding Source: Medline; NIGMS NIH HHS [GM43574] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CHAN IT, 1993, SCIENCE, V261, P1581, DOI 10.1126/science.8372352; CONLEY ME, 1992, ANNU REV IMMUNOL, V10, P215; DELWART EL, 1993, SCIENCE, V262, P1257, DOI 10.1126/science.8235655; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; KLAUSNER RD, 1991, CELL, V64, P875, DOI 10.1016/0092-8674(91)90310-U; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; KONDO M, 1993, SCIENCE, V262, P1874, DOI 10.1126/science.8266076; LIU CP, 1993, EMBO J, V12, P4863, DOI 10.1002/j.1460-2075.1993.tb06176.x; LOVE PE, 1993, SCIENCE, V261, P918, DOI 10.1126/science.7688481; MALISSEN M, 1993, EMBO J, V12, P4347, DOI 10.1002/j.1460-2075.1993.tb06119.x; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MONAFO WJ, 1992, CLIN EXP IMMUNOL, V90, P390; NAGAMINE CM, 1989, AM J HUM GENET, V45, P337; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; PERLMUTTER RM, 1993, ANNU REV IMMUNOL, V11, P451, DOI 10.1146/annurev.iy.11.040193.002315; ROSEN FS, 1984, NEW ENGL J MED, V311, P300, DOI 10.1056/NEJM198408023110506; ROSEN FS, 1984, NEW ENGL J MED, V311, P235, DOI 10.1056/NEJM198407263110406; ROTHENBERG EV, 1992, ADV IMMUNOL, V51, P85, DOI 10.1016/S0065-2776(08)60487-3; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Veillette A, 1991, Semin Immunol, V3, P143; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; VONBOEHMER H, 1993, CELL, V73, P207, DOI 10.1016/0092-8674(93)90220-K; WANGE RL, 1992, J BIOL CHEM, V267, P11685	30	423	427	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	1994	264	5165					1596	1599		10.1126/science.8202712	http://dx.doi.org/10.1126/science.8202712			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ285	8202712				2022-12-28	WOS:A1994NQ28500038
J	REICH, Z; WACHTEL, EJ; MINSKY, A				REICH, Z; WACHTEL, EJ; MINSKY, A			LIQUID-CRYSTALLINE MESOPHASES OF PLASMID DNA IN BACTERIA	SCIENCE			English	Article							DOUBLE-STRANDED DNA; CIRCULAR-DICHROISM; SUPERCOILED DNA; DEOXYRIBONUCLEIC-ACID; PHASES; ORGANIZATION; INVITRO; INVIVO; TEMPERATURE; MICROSCOPY	Bacterial plasmids may often reach a copy number larger than 1000 per cell, corresponding to a total amount of DNA that may exceed the amount of DNA within the bacterial chromosome. This observation highlights the problem of cellular accommodation of large amounts of closed-circular nucleic acids, whose interwound conformation offers negligible DNA compaction. As determined by x-ray scattering experiments conducted on intact bacteria, supercoiled plasmids segregate within the cells into dense clusters characterized by a long-range order. In vitro studies performed at physiological DNA concentrations indicated that interwound DNA spontaneously forms liquid crystalline phases whose macroscopic structural properties are determined by the features of the molecular supercoiling. Because these features respond to cellular factors, DNA supercoiling may provide a sensitive regulatory link between cellular parameters and the packaging modes of inter wound DNA in vivo.	WEIZMANN INST SCI, DEPT ORGAN CHEM, IL-76100 REHOVOT, ISRAEL	Weizmann Institute of Science								BAUER WR, 1980, SCI AM, V243, P118; BOLES TC, 1990, J MOL BIOL, V213, P931, DOI 10.1016/S0022-2836(05)80272-4; BOOY FP, 1991, CELL, V64, P1007, DOI 10.1016/0092-8674(91)90324-R; BOWATER R, 1991, BIOCHEMISTRY-US, V30, P11495, DOI 10.1021/bi00113a003; BRUGEROLLE G, 1979, BIOL CELLULAIRE, V35, P111; BUSTAMANTE C, 1991, BIOCHEMISTRY-US, V30, P5661, DOI 10.1021/bi00237a004; CHILAYA GS, 1986, MOL CRYST LIQ CRYST, V140, P243, DOI 10.1080/00268948608080157; DRLICA K, 1992, MOL MICROBIOL, V6, P425, DOI 10.1111/j.1365-2958.1992.tb01486.x; DURAND D, 1992, J PHYS II, V2, P1769, DOI 10.1051/jp2:1992233; HENRY NM, 1961, INTERPRETATION XRAY, P212; KANNAR R, 1992, CURR OPIN STRUC BIOL, V2, P369; KELLENBERGER E, 1992, FEMS MICROBIOL LETT, V100, P361, DOI 10.1016/0378-1097(92)90233-E; KELLENBERGER E, 1987, TRENDS BIOCHEM SCI, V12, P105, DOI 10.1016/0968-0004(87)90049-1; Kellenberger E., 1986, BACTERIAL CHROMATIN, P11; KELLER D, 1986, J CHEM PHYS, V84, P2972, DOI 10.1063/1.450278; KIM MH, 1986, J CHEM PHYS, V84, P2981, DOI 10.1063/1.450279; LEE FS, 1985, NUCLEIC ACIDS RES, V13, P1665, DOI 10.1093/nar/13.5.1665; LEFORESTIER A, 1991, BIOL CELL, V71, P115, DOI 10.1016/0248-4900(91)90058-U; LEPAULT J, 1987, EMBO J, V6, P1507, DOI 10.1002/j.1460-2075.1987.tb02393.x; LIVOLANT F, 1988, BIOCHEMISTRY-US, V27, P3056, DOI 10.1021/bi00408a058; LIVOLANT F, 1984, EUR J CELL BIOL, V33, P300; LIVOLANT F, 1987, J PHYS-PARIS, V48, P1051, DOI 10.1051/jphys:019870048060105100; LIVOLANT F, 1989, NATURE, V339, P724, DOI 10.1038/339724a0; LIVOLANT F, 1991, J MOL BIOL, V218, P165, DOI 10.1016/0022-2836(91)90882-7; MAESTRE MF, 1980, BIOCHEMISTRY-US, V19, P5214, DOI 10.1021/bi00564a010; MANIATIS TP, 1971, THESIS VANDERBILT U; MCCLELLAN JA, 1990, P NATL ACAD SCI USA, V87, P8373, DOI 10.1073/pnas.87.21.8373; Mitchell P, 1956, S SOC GEN MICROBIOL, V6, P150; REICH C, 1980, BIOCHEMISTRY-US, V19, P5208, DOI 10.1021/bi00564a009; REICH Z, UNPUB; RILL RL, 1986, P NATL ACAD SCI USA, V83, P342, DOI 10.1073/pnas.83.2.342; ROBINSON C, 1961, TETRAHEDRON, V13, P219, DOI 10.1016/S0040-4020(01)92215-X; RUDALL K M, 1955, Lect Sci Basis Med, V5, P217; SAMULSKI ET, 1974, LIQUID CRYSTALS PLAS, V1, P175; SAMULSKI TV, 1977, J CHEM PHYS, V67, P824, DOI 10.1063/1.434844; STRZELECKA TE, 1987, J AM CHEM SOC, V109, P4513, DOI 10.1021/ja00249a014; STRZELECKA TE, 1988, NATURE, V331, P457, DOI 10.1038/331457a0; TORBET J, 1989, EMBO J, V8, P4351, DOI 10.1002/j.1460-2075.1989.tb08622.x; VANWINKLE DH, 1990, MACROMOLECULES, V23, P4140, DOI 10.1021/ma00220a018; VINOGRAD J, 1968, J MOL BIOL, V33, P173, DOI 10.1016/0022-2836(68)90287-8; VOLOGODSKII AV, 1992, J MOL BIOL, V227, P1224, DOI 10.1016/0022-2836(92)90533-P; WANG JC, 1993, CURR OPIN GENET DEV, V3, P764, DOI 10.1016/S0959-437X(05)80096-6; WANG JC, 1969, J MOL BIOL, V43, P25, DOI 10.1016/0022-2836(69)90076-X; WANG JC, 1974, J MOL BIOL, V89, P783, DOI 10.1016/0022-2836(74)90053-9; WARING M, 1970, Journal of Molecular Biology, V54, P247, DOI 10.1016/0022-2836(70)90429-8; WHITE JH, 1969, AM J MATH, V91, P693, DOI 10.2307/2373348; YAGIL G, 1991, CRIT REV BIOCHEM MOL, V26, P475, DOI 10.3109/10409239109086791; YEVDOKIMOV YM, 1988, LIQ CRYST, V3, P1443, DOI 10.1080/02678298808086687	48	117	120	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	1994	264	5164					1460	1463		10.1126/science.8197460	http://dx.doi.org/10.1126/science.8197460			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NP221	8197460				2022-12-28	WOS:A1994NP22100043
J	EVENS, RG				EVENS, RG			RADIOLOGY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SPIN-ECHO; MR; EXPERIENCE; MANAGEMENT; PLACEMENT; CONTRAST				EVENS, RG (corresponding author), WASHINGTON UNIV,SCH MED,ST LOUIS,MO, USA.							CHUTER TAM, 1993, J VASC SURG, V18, P185, DOI 10.1016/0741-5214(93)90598-G; DENNY DF, 1993, AM J ROENTGENOL, V161, P385, DOI 10.2214/ajr.161.2.8333382; FELTCHER SW, 1993, J NATL CANCER I, V85, P1644; HAWKINS RA, 1992, SEMIN NUCL MED, V22, P268, DOI 10.1016/S0001-2998(05)80121-7; HERNANZSCHULMAN M, 1993, J NATL CANCER I, V189, P1; KRENNING EP, 1993, EUR J NUCL MED, V20, P716, DOI 10.1007/BF00181765; LI D, 1993, RADIOLOGY, V187, P401, DOI 10.1148/radiology.187.2.8475281; LOW RN, 1993, RADIOLOGY, V186, P803, DOI 10.1148/radiology.186.3.8430191; MARTIN M, 1993, SURGERY, V114, P719; MILLER L, 1993, J NUCL MED, V34, pN15; MIRICH D, 1989, RADIOLOGY, V170, P1033, DOI 10.1148/radiology.170.3.2916054; STEHLING MK, 1993, JMRI-J MAGN RESON IM, V3, P471, DOI 10.1002/jmri.1880030307; WAHL RL, 1993, J NUCL MED, V34, P1190; ZOARSKI GH, 1993, RADIOLOGY, V188, P323, DOI 10.1148/radiology.188.2.8327673; 1993, RADIOL HLTH B CDRH, V27, P1	15	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1714	1715						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182868				2022-12-28	WOS:A1994NN11700047
J	FRANKLIN, JE				FRANKLIN, JE			ADDICTION MEDICINE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ANABOLIC-STEROIDS; ALCOHOL-ABUSE; TRAUMA				FRANKLIN, JE (corresponding author), NORTHWESTERN UNIV, SCH MED, CHICAGO, IL USA.							AVINS AL, 1994, JAMA-J AM MED ASSOC, V271, P515, DOI 10.1001/jama.271.7.515; DURANT RH, 1993, NEW ENGL J MED, V328, P922, DOI 10.1056/NEJM199304013281304; EDWARDS RW, 1993, INT J ADDICT, V28, P1621, DOI 10.3109/10826089309062204; GRINSPOON L, 1994, NEW ENGL J MED, V330, P357, DOI 10.1056/NEJM199402033300513; JARLAIS DCD, 1994, JAMA-J AM MED ASSOC, V271, P121, DOI 10.1001/jama.271.2.121; JOHNSTON LD, 1993, NATIONAL SURVEY SECO; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; KLEBER HD, 1994, NEW ENGL J MED, V330, P361, DOI 10.1056/NEJM199402033300514; RIVARA FP, 1993, JAMA-J AM MED ASSOC, V270, P1962, DOI 10.1001/jama.270.16.1962; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; SCHUCKIT MA, 1980, J STUD ALCOHOL, V1, P45; SU TP, 1993, JAMA-J AM MED ASSOC, V269, P2760, DOI 10.1001/jama.269.21.2760; WATTERS JK, 1994, JAMA-J AM MED ASSOC, V271, P115, DOI 10.1001/jama.271.2.115; YESALIS CE, 1993, JAMA-J AM MED ASSOC, V270, P1217, DOI 10.1001/jama.270.10.1217	14	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1650	1651						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182831				2022-12-28	WOS:A1994NN11700010
J	JOYNT, RJ				JOYNT, RJ			NEUROLOGY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ARTERIOVENOUS-MALFORMATIONS; MOLECULAR-GENETICS; MULTIPLE-SCLEROSIS; MICROSURGERY; MENINGITIS; DISEASE; THERAPY; TRAUMA				JOYNT, RJ (corresponding author), UNIV ROCHESTER,ROCHESTER,NY, USA.							AUBOURG P, 1993, NEW ENGL J MED, V329, P745, DOI 10.1056/NEJM199309093291101; EGRE HJ, 1993, J NEUROSURG, V78, P909; GALGIANI JN, 1993, ANN INTERN MED, V119, P28, DOI 10.7326/0003-4819-119-1-199307010-00005; KALIA KK, 1993, ARCH NEUROL-CHICAGO, V50, P1293, DOI 10.1001/archneur.1993.00540120010005; LANGHORNE P, 1993, LANCET, V342, P395, DOI 10.1016/0140-6736(93)92813-9; MARTIN JB, 1993, ANN NEUROL, V34, P757, DOI 10.1002/ana.410340603; POSNER MI, 1993, SCIENCE, V262, P673, DOI 10.1126/science.8235585; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; ROSENBERG RN, 1993, ARCH NEUROL-CHICAGO, V50, P1123, DOI 10.1001/archneur.1993.00540110005001; SCHAAD UB, 1993, LANCET, V342, P457, DOI 10.1016/0140-6736(93)91592-A; SIBLEY WA, 1993, NEUROLOGY, V43, P1871, DOI 10.1212/WNL.43.10.1871; SISTI MB, 1993, J NEUROSURG, V79, P653, DOI 10.3171/jns.1993.79.5.0653; SIVA A, 1993, NEUROLOGY, V43, P1878, DOI 10.1212/WNL.43.10.1878; STEINER L, 1993, J NEUROSURG, V79, P647, DOI 10.3171/jns.1993.79.5.0647; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; 1993, J NEUROL NEUROSUR PS, V56, P1157	16	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1686	1687						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182852				2022-12-28	WOS:A1994NN11700031
J	ROBERTS, MB; STRINGER, CB; PARFITT, SA				ROBERTS, MB; STRINGER, CB; PARFITT, SA			A HOMINID TIBIA FROM MIDDLE PLEISTOCENE SEDIMENTS AT BOXGROVE, UK	NATURE			English	Article							QUATERNARY	FOSSIL hominids from the earlier Middle Pleistocene of Europe are very rare and the Mauer mandible is generally accepted as the most ancient, with an estimated age of 500 kyr(1,2). We report here on the discovery of a human tibia, in association with stone tools, from calcareous silts at the Lower Palaeolithic site of Boxgrove, West Sussex, UK3,4 (Fig. 1). The silt units are correlated by mammalian biostratigraphy to an, as yet unnamed, major temperate stage or interglacial that immediately pre-dates the Anglian cold stage(5). Accordingly, the temperate sediments are equated with oxygen isotope stage 13 (ref. 6) and are therefore roughly coeval with the Mauer mandible. The massive tibia is the oldest hominid fragment from the British Isles and provides the first information about the manufacturers of the early Acheulian industries of Europe. It is assigned to Home cf. heidelbergensis.	NAT HIST MUSEUM, DEPT PALAEONTOL, LONDON SW7 5BD, ENGLAND	Natural History Museum London	ROBERTS, MB (corresponding author), UCL, INST ARCHAEOL, FIELD ARCHAEOL UNIT, LONDON WC1H 0PY, ENGLAND.							Andrews P, 1990, OWLS CAVES FOSSILS; [Anonymous], 1992, HIGH LODGE EXCAVATIO; ARSUAGA JL, 1991, J HUM EVOL, V20, P191, DOI 10.1016/0047-2484(91)90073-5; ASHTON NM, IN PRESS J GEOL SOC; BABA H, 1990, Bulletin of the National Science Museum Series D (Anthropology), V16, P9; Bergman CA, 1990, BIG PUZZLE, P265; Bishop M.J., 1982, SP PAP PALAEONTOL, V28, P1; BOSINSKI G, 1988, 2 AD BEITR; Bridgland D.R., 1988, P GEOLOGIST ASSOC, V99, P291, DOI [10.1016/S0016-7878(88)80055-5, DOI 10.1016/S0016-7878(88)80055-5]; BRIDGLAND DR, 1990, PHILOS T ROY SOC B, V328, P307, DOI 10.1098/rstb.1990.0115; BRIDGLAND DR, 1993, QUATERNARY THAMES; COOK J, 1982, Yearbook of Physical Anthropology, V25, P19; CURRANT A, 1989, BIOL J LINN SOC, V38, P23, DOI 10.1111/j.1095-8312.1989.tb01559.x; DAY MH, 1974, AM J PHYS ANTHROPOL, V41, P367, DOI 10.1002/ajpa.1330410304; Endo B., 1970, AMUD MAN HIS CAVE SI, P231; GIBBARD PL, 1991, QUATERNARY SCI REV, V10, P23, DOI 10.1016/0277-3791(91)90029-T; GOLDBERG P, 1990, SOIL MICROMORPHOLOGY, P441; HARTWIGSCHERER S, 1993, AM J PHYS ANTHROPOL, V92, P17, DOI 10.1002/ajpa.1330920103; IMBRIE J, 1984, MILANKOVITCH CLIMA 1, P269; LUCA APS, 1980, NGANDONG FOSSIL HOMI; MACPHAIL RI, 1993, SOIL REPORT MICROMOR; Rightmire G. P., 1990, EVOLUTION HOMO ERECT; Roberts M.B., 1986, Proceedings of the Prehistoric Society, V52, P215; ROBETS MB, 1990, SEQS, P62; SHACKLETON NJ, 1987, QUATERNARY SCI REV, V6, P183, DOI 10.1016/0277-3791(87)90003-5; Stuart A.J., 1982, PLEISTOCENE VERTEBRA; STUART AJ, 1976, GEOL MAG, V113, P469, DOI 10.1017/S0016756800050779; SUTCLIFFE A J, 1976, Bulletin of the British Museum (Natural History) Geology, V27, P31; Trinkaus, 2014, SHANIDAR NEANDERTALS; van den Bogaard C., 1989, EISZEITALTER GEGENWA, V39, P62; van Kolfschoten T., 1990, Mededelingen Rijks Geologische Dienst, V43, P1; Von Koenigswald Wighart., 1992, SCHICHTEN MAUER 85 J, P101; WEST R. G., 1980, PREGLACIAL PLEISTOCE; Whiteman C.A., 1992, P GEOLOGIST ASSOC, V103, P37, DOI [10.1016/S0016-7878(08)80197-6, DOI 10.1016/S0016-7878(08)80197-6]; WHITEMAN CA, 1992, QUATERNARY SCI REV, V11, P363, DOI 10.1016/0277-3791(92)90007-U; ZAGWIJN WH, 1985, GEOL MIJNBOUW, V64, P17; ZALASIEWICZ JA, 1988, PLIOCENE MIDDLE PLEI	37	98	100	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 26	1994	369	6478					311	313		10.1038/369311a0	http://dx.doi.org/10.1038/369311a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NN109	8183368				2022-12-28	WOS:A1994NN10900046
J	DAMASIO, H; GRABOWSKI, T; FRANK, R; GALABURDA, AM; DAMASIO, AR				DAMASIO, H; GRABOWSKI, T; FRANK, R; GALABURDA, AM; DAMASIO, AR			THE RETURN OF GAGE,PHINEAS - CLUES ABOUT THE BRAIN FROM THE SKULL OF A FAMOUS PATIENT	SCIENCE			English	Article							LESIONS	When the landmark patient Phineas Gage died in 1861, no autopsy was performed, but his skull was later recovered. The brain lesion that caused the profound personality changes for which his case became famous has been presumed to have involved the left frontal region, but questions have been raised about the involvement of other regions and about the exact placement of the lesion within the vast frontal territory. Measurements from Gage's skull and modern neuroimaging techniques were used to reconstitute the accident and determine the probable location of the lesion. The damage involved both left and right prefrontal cortices in a pattern that, as confirmed by Gage's modern counterparts, causes a defect in rational decision making and the processing of emotion.	UNIV IOWA HOSP & CLIN,DEPT NEUROL,IOWA CITY,IA 52242; SALK INST BIOL STUDIES,SAN DIEGO,CA 92186; HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DEPT NEUROL,BOSTON,MA 02215	University of Iowa; Salk Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School			Tudusciuc, Oana/C-1339-2011; Damasio, Antonio/AAD-1342-2019; James, Philip John J/H-4651-2012	James, Philip John J/0000-0003-1851-9778	NINDS NIH HHS [P01 NS19632] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS019632] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], 1868, PUBL MASS MED SOC; BARBAS H, 1989, J COMP NEUROL, V286, P253; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Broca P., 1865, B SOC ANTHROPOL PAR, V6, P337; DAMASIO AR, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P217; DAMASIO AR, IN PRESS DESCARTES E; DAMASIO H, 1992, ARCH NEUROL-CHICAGO, V49, P137, DOI 10.1001/archneur.1992.00530260037016; Dehaene S, 1991, CEREB CORTEX, V1, P62, DOI 10.1093/cercor/1.1.62; Dupuy E., 1873, EXAMEN QUELQUES POIN; ESLINGER P, 1991, NEUROLOGY, V29, P1241; Ferrier D, 1878, Br Med J, V1, P399; FOX PT, 1985, J COMPUT ASSIST TOMO, V9, P141, DOI 10.1097/00004728-198501000-00025; Fuster J.M., 1989, PREFRONTAL CORTEX; GOLDMAN-RAKIC P S, 1992, Scientific American, V267, P110; Goldman-Rakic P.S., 2011, HDB PHYSL, P373, DOI DOI 10.1002/CPHY.CP010509; MACMILLAN MB, 1986, BRAIN COGNITION, V5, P67, DOI 10.1016/0278-2626(86)90062-X; PANDYA DN, 1990, PREFRONTAL CORTEX IT; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Raleigh M. J., 1993, Society for Neuroscience Abstracts, V19, P592; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; Talairach J, 1967, ATLAS ANATOMIE STERE; Talairach J., 1988, COPLANAR STEREOTAXIC; Verrey D., 1888, ARCH OPHTHALMOL PARI, V8, P289; Wernicke C., 1874, APHASISCHE SYMPTOMEN	25	782	812	2	218	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 20	1994	264	5162					1102	1105		10.1126/science.8178168	http://dx.doi.org/10.1126/science.8178168			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NM146	8178168				2022-12-28	WOS:A1994NM14600020
J	LOIS, C; ALVAREZBUYLLA, A				LOIS, C; ALVAREZBUYLLA, A			LONG-DISTANCE NEURONAL MIGRATION IN THE ADULT MAMMALIAN BRAIN	SCIENCE			English	Article							SUBEPENDYMAL LAYER; CEREBRAL-CORTEX; AVIAN BRAIN; CELLS; RAT; NEUROGENESIS; ENOLASE; SYSTEM	During the development of the mammalian brain, neuronal precursors migrate to their final destination from their site of birth in the ventricular and subventricular zones (VZ and SVZ, respectively). SVZ cells in the walls of the lateral ventricle continue to proliferate in the brain of adult mice and can generate neurons in vitro, but their fate in vivo is unknown. Here SVZ cells from adult mice that carry a neuronal-specific transgene were grafted into the brain of adult recipients. In addition, the fate of endogenous SVZ cells was examined by microinjection of tritiated thymidine or a vital dye that labeled a discrete population of SVZ cells. Grafted and endogenous SVZ cells in the lateral ventricle of adult mice migrate long distances and differentiate into neurons in the olfactory bulb.			LOIS, C (corresponding author), ROCKEFELLER UNIV,1230 YORK AVE,NEW YORK,NY 10021, USA.			Alvarez-Buylla, Arturo/0000-0003-4426-8925	NINDS NIH HHS [NS 24478] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; ALTMAN J, 1993, NEURONAL CELL DEATH, V6, P203; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; ALVAREZBUYLLA A, 1990, SCIENCE, V249, P1444, DOI 10.1126/science.1698312; ALVAREZBUYLLA A, 1988, J NEUROSCI METH, V25, P165, DOI 10.1016/0165-0270(88)90155-0; BAYER SA, 1982, SCIENCE, V216, P890, DOI 10.1126/science.7079742; BLAKEMORE WF, 1972, J NEUROCYTOL, V1, P69, DOI 10.1007/BF01098647; CLARCK SJ, 1989, J COMP NEUROL, V301, P114; COROTTO FS, 1993, NEUROSCI LETT, V149, P111, DOI 10.1016/0304-3940(93)90748-A; FARBMAN AI, 1992, CELL BIOL OLFACTION, P132; FISHELL G, 1993, NATURE, V362, P636, DOI 10.1038/362636a0; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; HATTEN ME, 1990, EXPERIENTIA, V46, P907, DOI 10.1007/BF01939383; Jacobson M., 1991, DEV NEUROBIOLOGY; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; KAPLITT M G, 1991, Molecular and Cellular Neuroscience, V2, P320, DOI 10.1016/1044-7431(91)90062-S; KISHI K, 1987, J COMP NEUROL, V258, P112, DOI 10.1002/cne.902580109; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MARANGOS PJ, 1987, ANNU REV NEUROSCI, V10, P269, DOI 10.1146/annurev.ne.10.030187.001413; MCDERMOTT KW, 1991, J ANAT, V178, P45; MOORSHEAD C, 1992, J NEUROSCI, V12, P249; MOORSHEAD C, 1993, SOC NEUR ABSTR, V19, P870; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; OKANO HJ, 1993, J NEUROSCI, V13, P2930; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; Packard D S Jr, 1973, Differentiation, V1, P397, DOI 10.1111/j.1432-0436.1973.tb00137.x; PATON JA, 1984, SCIENCE, V225, P1046, DOI 10.1126/science.6474166; PRIVAT A, 1972, J COMP NEUROL, V146, P277, DOI 10.1002/cne.901460302; RAKIC P, 1985, SCIENCE, V227, P1054, DOI 10.1126/science.3975601; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; SMART I, 1961, J COMP NEUROL, V116, P325, DOI 10.1002/cne.901160306; WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520	36	1848	1907	1	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 20	1994	264	5162					1145	1148		10.1126/science.8178174	http://dx.doi.org/10.1126/science.8178174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NM146	8178174				2022-12-28	WOS:A1994NM14600032
J	MARSH, DG; NEELY, JD; BREAZEALE, DR; GHOSH, B; FREIDHOFF, LR; EHRLICHKAUTZKY, E; SCHOU, C; KRISHNASWAMY, G; BEATY, TH				MARSH, DG; NEELY, JD; BREAZEALE, DR; GHOSH, B; FREIDHOFF, LR; EHRLICHKAUTZKY, E; SCHOU, C; KRISHNASWAMY, G; BEATY, TH			LINKAGE ANALYSIS OF IL4 AND OTHER CHROMOSOME 5Q31.1 MARKERS AND TOTAL SERUM IMMUNOGLOBULIN-E CONCENTRATIONS	SCIENCE			English	Article							POLYMERASE CHAIN-REACTION; IGE LEVELS; MAST-CELLS; GENE; INTERLEUKIN-4; EXPRESSION; ALLERGY; ASTHMA; IL-4; RESPONSIVENESS	Sib-pair analysis of 170 individuals from 11 Amish families revealed evidence for linkage of five markers in chromosome 5q31.1 with a gene controlling total serum immunoglobulin E (IgE) concentration. No linkage was found between these markers and specific IgE antibody concentrations. Analysis of total IgE within a subset of 128 IgE antibody-negative sib pairs confirmed evidence for linkage to 5q31.1, especially to the interleukin-4 gene (IL4). A combination of segregation and maximum likelihood analyses provided further evidence for this linkage. These analyses suggest that IL4 or a nearby gene in 5q31.1 regulates IgE production in a nonantigen-specific (noncognate) fashion.	JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, DEPT EPIDEMIOL, BALTIMORE, MD 21205 USA; ALLERGOL ALK LAB AS, DK-2970 HORSHOLM, DENMARK	Johns Hopkins University	MARSH, DG (corresponding author), JOHNS HOPKINS ASTHMA & ALLERGY CTR, SCH MED, 5501 HOPKINS BAYVIEW BLVD, BALTIMORE, MD 21224 USA.		Krishnaswamy, Guha/R-9076-2019; KRISHNASWAMY, GUHA/AAR-8844-2021; Ghosh, Balaram/G-1248-2010	KRISHNASWAMY, GUHA/0000-0002-9848-6197; 	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020059] Funding Source: NIH RePORTER; NCRR NIH HHS [1 P41 RR03655] Funding Source: Medline; NIAID NIH HHS [AI20059] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABE E, 1992, P NATL ACAD SCI USA, V89, P2864, DOI 10.1073/pnas.89.7.2864; ARAI N, 1989, J IMMUNOL, V142, P274; BAZARAL M, 1974, J ALLERGY CLIN IMMUN, V54, P288, DOI 10.1016/0091-6749(74)90015-3; BLUMENTHAL MN, 1990, GENETIC ENV FACTORS, pCH9; BONNEY GE, 1986, BIOMETRICS, V42, P611, DOI 10.2307/2531211; BORECKI I B, 1985, Genetic Epidemiology, V2, P327, DOI 10.1002/gepi.1370020402; BORISH L, UNPUB; BRADDING P, 1992, J EXP MED, V176, P1381, DOI 10.1084/jem.176.5.1381; BROWN MA, 1987, CELL, V50, P809, DOI 10.1016/0092-8674(87)90339-4; BRUNNER T, 1993, NATURE, V177, P605; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; CASOLARO V, 1993, GENETICS ASTHMA, P291; CLERICI M, 1993, J CLIN INVEST, V91, P759, DOI 10.1172/JCI116294; COOKSON WOCM, 1989, LANCET, V1, P1292; EHRLICHKAUTZKY E, 1991, BIOTECHNIQUES, V10, P39; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; FREIDHOFF LR, 1993, INT ARCH ALLERGY IMM, V100, P355, DOI 10.1159/000236438; GAUCHAT JF, 1993, NATURE, V365, P340, DOI 10.1038/365340a0; GAUCHAT JF, 1990, J EXP MED, V172, P463, DOI 10.1084/jem.172.2.463; GERRARD JW, 1978, AM J HUM GENET, V30, P46; HASEMAN JK, 1972, BEHAV GENET, V2, P3, DOI 10.1007/BF01066731; HENKEL G, 1992, J IMMUNOL, V149, P3239; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; KOPF M, 1993, NATURE, V362, P245, DOI 10.1038/362245a0; LEBEAU MM, 1993, P NATL ACAD SCI USA, V90, P5484, DOI 10.1073/pnas.90.12.5484; LOFTUS SK, 1993, HUM MOL GENET, V2, P1785, DOI 10.1093/hmg/2.11.1785; MACGLASHAN D, 1994, J IMMUNOL, V152, P3006; MARSH DG, 1989, COLD SPRING HARB SYM, V54, P459; MARSH DG, 1992, NAT GENET, V2, P252, DOI 10.1038/ng1292-252; MARSH DG, 1974, P NATL ACAD SCI USA, V71, P3588, DOI 10.1073/pnas.71.9.3588; MARSH DG, 1981, NEW ENGL J MED, V305, P1551, DOI 10.1056/NEJM198112243052603; MARSH DG, 1993, GENETICS ASTHMA; MARSH DG, 1994, SAMTERS IMMUNOLOGICA; MEYERS DA, 1987, AM J HUM GENET, V41, P51; MEYERS DA, 1991, GENET EPIDEMIOL, V8, P351, DOI 10.1002/gepi.1370080507; MIN LW, 1992, J IMMUNOL, V148, P1913; MINTY A, 1993, NATURE, V362, P248, DOI 10.1038/362248a0; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; MORTON NE, 1992, CLIN EXP ALLERGY, V22, P1041, DOI 10.1111/j.1365-2222.1992.tb00126.x; MOSMANN TR, 1989, ADV IMMUNOL, V46, P111, DOI 10.1016/S0065-2776(08)60652-5; MOUT R, 1991, NUCLEIC ACIDS RES, V19, P3763, DOI 10.1093/nar/19.13.3763; PLAUT M, 1989, NATURE, V339, P64, DOI 10.1038/339064a0; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; PURKERSON JM, 1992, J EXP MED, V175, P973, DOI 10.1084/jem.175.4.973; ROMAGNANI S, 1992, INT ARCH ALLERGY IMM, V98, P279, DOI 10.1159/000236199; SALK J, 1993, SCIENCE, V260, P1270, DOI 10.1126/science.8098553; SALTMAN DL, 1993, GENOMICS, V16, P726, DOI 10.1006/geno.1993.1254; SEARS MR, 1991, NEW ENGL J MED, V325, P1067, DOI 10.1056/NEJM199110103251504; SHER A, 1992, ANNU REV IMMUNOL, V10, P385, DOI 10.1146/annurev.iy.10.040192.002125; STOCK W, 1992, CYTOGENET CELL GENET, V61, P263, DOI 10.1159/000133417; SZABO SJ, 1993, MOL CELL BIOL, V13, P4793, DOI 10.1128/MCB.13.8.4793; SZENTIVANYI A, 1968, J ALLERGY, V42, P203, DOI 10.1016/S0021-8707(68)90117-2; TODD MD, 1993, J EXP MED, V177, P1663, DOI 10.1084/jem.177.6.1663; TRINCHIERI G, 1993, IMMUNOL TODAY, V14, P335, DOI 10.1016/0167-5699(93)90230-I; VERCELLI D, 1991, J ALLERGY CLIN IMMUN, V88, P285, DOI 10.1016/0091-6749(91)90087-5; WARREN CPW, 1982, J ALLERGY CLIN IMMUN, V69, P370, DOI 10.1016/0091-6749(82)90148-8; WARRINGTON JA, 1992, GENOMICS, V13, P803, DOI 10.1016/0888-7543(92)90156-M; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0; WEISSENBACH J, 1992, SCIENCE, V258, P67; WIERENGA EA, 1990, J IMMUNOL, V144, P4651; WILLMAN CL, 1993, SCIENCE, V259, P968, DOI 10.1126/science.8438156; YOUNG RP, 1992, CLIN EXP ALLERGY, V22, P205, DOI 10.1111/j.1365-2222.1992.tb03074.x	63	874	911	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	1994	264	5162					1152	1156		10.1126/science.8178175	http://dx.doi.org/10.1126/science.8178175			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NM146	8178175				2022-12-28	WOS:A1994NM14600034
J	KIM, TK; HASHIMOTO, S; KELLEHER, RJ; FLANAGAN, PM; KORNBERG, RD; HORIKOSHI, M; ROEDER, RG				KIM, TK; HASHIMOTO, S; KELLEHER, RJ; FLANAGAN, PM; KORNBERG, RD; HORIKOSHI, M; ROEDER, RG			EFFECTS OF ACTIVATION-DEFECTIVE TBP MUTATIONS ON TRANSCRIPTION INITIATION IN YEAST	NATURE			English	Article							POLYMERASE-II TRANSCRIPTION; PREINITIATION COMPLEX; BINDING-PROTEIN; BASIC REPEAT; DNA-BINDING; INVITRO; VP16	TRANSCRIPTION initiation by RNA polymerase II is effected by an ordered series of general factor interactions with core promoter elements (leading to basal activity) and further regulated by gene-specific factors acting from distal elements(1). Both the general factor TFIID (refs 2,3), including the constituent TBP (TATA-binding polypeptide)(4-7) and associated factors(8), and the interacting factor TFIIB (refs 9-11) have been implicated as targets for various activators. Towards an understanding of the basis for activator function, including the multiplicity of TBP interactions, we have now identified mutations in yeast TBP that selectively block activator (GAL4-VP16)-dependent but not basal transcription. We further show an effect of GAL4-VP16 on TFIIB recruitment to early preinitiation complexes, and that recruitment is disrupted by TBP mutations that impair its interactions with VP16 (L114K), TFIIB (L189K) or an unidentified component (K211L). Thus, GAL4-VP16 function seems to involve both direct interactions with TBP and a corresponding induction (or stabilization) of an activation-specific TBP-TFIIb-promoter complex.	STANFORD UNIV, SCH MED, DEPT CELL BIOL, STANFORD, CA 94305 USA	Stanford University	KIM, TK (corresponding author), ROCKEFELLER UNIV, BIOCHEM & MOLEC BIOL LAB, NEW YORK, NY 10021 USA.							AUBLE DT, 1993, GENE DEV, V7, P844, DOI 10.1101/gad.7.5.844; BERGER SL, 1992, CELL, V70, P251, DOI 10.1016/0092-8674(92)90100-Q; CHASMAN DI, 1989, MOL CELL BIOL, V9, P4746, DOI 10.1128/MCB.9.11.4746; CHOY B, 1993, NATURE, V366, P531, DOI 10.1038/366531a0; FLANAGAN PM, 1992, P NATL ACAD SCI USA, V89, P7659, DOI 10.1073/pnas.89.16.7659; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; GOODRICH JA, 1993, CELL, V75, P519, DOI 10.1016/0092-8674(93)90386-5; HAHN S, 1993, NATURE, V363, P672, DOI 10.1038/363672a0; HORIKOSHI M, 1988, CELL, V54, P1033, DOI 10.1016/0092-8674(88)90118-3; HORIKOSHI N, 1991, P NATL ACAD SCI USA, V88, P5124, DOI 10.1073/pnas.88.12.5124; INGLES CJ, 1991, NATURE, V351, P588, DOI 10.1038/351588a0; KASSAVETIS GA, 1992, CELL, V71, P1055, DOI 10.1016/0092-8674(92)90399-W; KEAVENEY M, 1993, NATURE, V365, P562, DOI 10.1038/365562a0; KIM K, 1994, J BIOL CHEM, V269, P4891; KIM TK, 1994, NUCLEIC ACIDS RES, V22, P251, DOI 10.1093/nar/22.2.251; KIM TK, 1993, J BIOL CHEM, V268, P20866; KIM TK, IN PRESS P NATN ACAD; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; LEE DK, 1992, MOL CELL BIOL, V12, P5189, DOI 10.1128/MCB.12.11.5189; LEE WS, 1991, CELL, V67, P365, DOI 10.1016/0092-8674(91)90188-5; LIEBERMAN PM, 1991, GENE DEV, V5, P2441, DOI 10.1101/gad.5.12b.2441; LIN YS, 1991, CELL, V64, P971, DOI 10.1016/0092-8674(91)90321-O; MEISTERERNST M, 1991, CELL, V67, P557, DOI 10.1016/0092-8674(91)90530-C; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; PTASHNE M, 1986, GENETIC SWITCH GENE, V1; RANISH JA, 1992, SCIENCE, V255, P1127, DOI 10.1126/science.1546313; ROEDER RG, 1991, TRENDS BIOCHEM SCI, V16, P402, DOI 10.1016/0968-0004(91)90164-Q; SCHENA M, 1989, GENE DEV, V3, P1590, DOI 10.1101/gad.3.10.1590; WORKMAN JL, 1988, CELL, V55, P211, DOI 10.1016/0092-8674(88)90044-X; YAMAMOTO T, 1992, P NATL ACAD SCI USA, V89, P2844, DOI 10.1073/pnas.89.7.2844	30	109	110	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 19	1994	369	6477					252	255		10.1038/369252a0	http://dx.doi.org/10.1038/369252a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NM067	8183347				2022-12-28	WOS:A1994NM06700062
J	WURM, J				WURM, J			AUSTRALIAN PHARMACEUTICAL-INDUSTRY OBSERVED	NATURE			English	Article											WURM, J (corresponding author), SACS CONSULTING GRP,525 COLLINS ST,MELBOURNE,VIC 3000,AUSTRALIA.							1992 AUSTR PHARM MAN; 1993 AUSTR PHARM MAN; 1993, AUSTR NZ BIOTECHNOLO; 1993, SCRIP REV	4	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 19	1994	369	6477					259	260		10.1038/369259a0	http://dx.doi.org/10.1038/369259a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NM067	8183348				2022-12-28	WOS:A1994NM06700063
J	GREENWOOD, RJ; MCMILLAN, TM; BROOKS, DN; DUNN, G; BROCK, D; DINSDALE, S; MURPHY, LD; PRICE, JR				GREENWOOD, RJ; MCMILLAN, TM; BROOKS, DN; DUNN, G; BROCK, D; DINSDALE, S; MURPHY, LD; PRICE, JR			EFFECTS OF CASE-MANAGEMENT AFTER SEVERE HEAD-INJURY	BRITISH MEDICAL JOURNAL			English	Article							PRACTICAL SCALE; DEFINITION; CARE	Objectives-To examine the effects of early case management for patients with severe head injury on outcome, family function, and provision of rehabilitation services. Design-Prospective controlled unmatched non-randomised study for up to two years after injury. Setting-Four district general hospitals and two university teaching hospitals, each with neurosurgical units, in east central, north, and north east London and its environs. Subjects-126 patients aged 16-60 recruited acutely and sequentially after severe head injury. All received standard rehabilitation services in each of the six hospitals and districts: case management was also provided for the 56 patients admitted to three of the hospitals. Main outcome measures-Standard measures of patients' physical and cognitive impairment; disability and handicap; and affective, behavioural, and social functioning and of relatives' affective and social functioning. Relatives' perception of burden; changes in patients' and relatives' housing, financial, vocational, recreational, and medical needs; and ongoing requirements for care and support; and the amount and type of paramedical input provided were assessed with structured questionnaires. Results-For a given severity of injury, case management increased the chance and range of contact with inpatient and outpatient rehabilitation services. However, duration of contact was not increased by case management, and there was no demonstrable improvement in outcome in the case managed group. Any trends were in favour of the control group and could be accounted for by group differences in initial severity of injury. Conclusions-Widespread introduction of early case management of patients after severe head injury is not supported, and early case management is not a substitute for improvement in provision of skilled and specialist rehabilitation for patients.	ATKINSON MORLEYS HOSP,WOLFSON REHABIL CTR,LONDON SW20 0NR,ENGLAND; ST GEORGE HOSP,SCH MED,LONDON,ENGLAND; WELLCOME NEUROSCI GRP,GLASGOW G12 0AA,LANARK,SCOTLAND; INST PSYCHIAT,DEPT BIOSTAT & COMP,LONDON SE5 8AF,ENGLAND	University of London; Queen Mary University London; St Georges University London; University of London; King's College London	GREENWOOD, RJ (corresponding author), ST BARTHOLOMEWS HOSP,DEPT NEUROL SCI,LONDON EC1A 7BE,ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		[Anonymous], 1989, CM849; BACHRACH LL, 1989, HOSP COMMUNITY PSYCH, V40, P883; BOND GR, 1988, HOSP COMMUNITY PSYCH, V39, P411; BOND MR, 1976, ACTA NEUROCHIR, V34, P57, DOI 10.1007/BF01405863; BROOK SDN, 1979, RES PSYCHOL MED, V2, P469; BROOKS DN, 1986, HLTH B, P44110; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; Burke W H, 1988, Brain Inj, V2, P313, DOI 10.3109/02699058809150902; BUSCHKE H, 1974, NEUROLOGY, V24, P1019, DOI 10.1212/WNL.24.11.1019; BUSH CT, 1990, HOSP COMMUNITY PSYCH, V41, P647; Bush G W, 1989, Brain Inj, V3, P91, DOI 10.3109/02699058909008079; CHALLIS JD, 1986, CASE MANAGEMENT COMM; DIXON TP, 1988, REHABIL COUNS BULL, V31, P325; FRANKLIN JL, 1987, AM J PUBLIC HEALTH, V77, P674, DOI 10.2105/AJPH.77.6.674; FRIEND JK, 1983, LINKAGE, V7, P8; GOERING PN, 1988, HOSP COMMUNITY PSYCH, V39, P272; Goldberg DP, 1972, DETECTION PSYCHIAT I; GOLDBERG JD, 1988, USERS GUIDE GENERAL; HENDERSON NG, 1987, BUSINESS HLTH    JAN, P7; Holloway F, 1991, Int J Soc Psychiatry, V37, P2, DOI 10.1177/002076409103700102; INTAGLIATA J, 1982, SCHIZOPHRENIA BULL, V8, P655, DOI 10.1093/schbul/8.4.655; JENNETT B, 1975, LANCET, V2, P480; KANTER J, 1989, HOSP COMMUNITY PSYCH, V40, P361; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Livingston M G, 1985, Int Rehabil Med, V7, P145; MAHONEY F I, 1965, Md State Med J, V14, P61; MATSON JD, 1986, BRAIN INJURY CASEBOO; MCKEGANEY N, 1986, POLICY POLIT, V14, P335, DOI 10.1332/030557386782628163; MCMILLAN T, 1993, NEUROLOGICAL REHABIL, P437; MCMILLAN TM, 1988, CLIN REHABIL, V2, P319; Mueller J, 1983, Psychiatr Q, V55, P17, DOI 10.1007/BF01064833; MURPHY L D, 1990, Brain Injury, V4, P95, DOI 10.3109/02699059009026153; Nelson H.E., 1982, NATIONAL ADULT READI; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Newcombe F, 1980, Int Rehabil Med, V2, P133; OVRETVEIT J, 1991, CLIN PSYCHOL FORUM, V36, P3; Price J, 1991, Health Serv J, V101, P23; PRIGITANO GP, 1986, NEUROPSYCHOLOGICAL R; RAPPOPORT M, 1980, ARCH PHYS MED REHAB, V63, P118; Raven J. C, 1958, MILL HILL VOCABULARY; Raven J.C., 1960, GUIDE STANDARD PROGR; Rey A, 1964, EXAMEN CLIN PSYCHOL, V2e; SNAITH RP, 1976, BRIT J PSYCHIAT, V128, P156, DOI 10.1192/bjp.128.2.156; TEASDALE G, 1974, LANCET, V2, P81; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047; 1989, STATISTICAL PACKAGE; 1990, EGRET EPIDEMIOLOGICA; 1987, 4 AUD COMM OCC PAP; 1988, REPORT WORKING PARTY; 1986, J R COLL PHYSICIANS, V20, P30; 1987, REML USERS MANUAL	56	27	27	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 7	1994	308	6938					1199	1205		10.1136/bmj.308.6938.1199	http://dx.doi.org/10.1136/bmj.308.6938.1199			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NK956	8180536	Green Published			2022-12-28	WOS:A1994NK95600018
J	ENGELBERG, D; KLEIN, C; MARTINETTO, H; STRUHL, K; KARIN, M				ENGELBERG, D; KLEIN, C; MARTINETTO, H; STRUHL, K; KARIN, M			THE UV RESPONSE INVOLVING THE RAS SIGNALING PATHWAY AND AP-1 TRANSCRIPTION FACTORS IS CONSERVED BETWEEN YEAST AND MAMMALS	CELL			English	Article							DEPENDENT PROTEIN-KINASE; ACID BIOSYNTHETIC GENES; SACCHAROMYCES-CEREVISIAE; TRANSLATIONAL CONTROL; ADENYLATE-CYCLASE; ACTIVATES TRANSCRIPTION; TRANSDUCTION PATHWAYS; RADIATION SENSITIVITY; NUCLEOTIDE-SEQUENCE; REGULATORY SUBUNIT	UV irradiation of mammalian cells activates AP-1 through a Ras-dependent pathway, independently of DNA damage. We show that the yeast S. cerevisiae has a remarkably similar UV response involving the AP-1 factor Gcn4, which is distinct from the DNA damage response. Transcriptional activation of HIS3 and HIS4 by Gcn4 is triggered by UV irradiation in a Ras-dependent fashion. Moreover, resistance of yeast to UV irradiation is correlated with the level of Ras activity and Gcn4 function. Like mammalian cells in which activated Ras leads to increased c-Jun synthesis and phosphorylation, the effects in yeast involve increased translation of GCN4 mRNA and a posttranslational event. However, this effect on GCN4 translation is different from the response to amino acid or purine starvation. Therefore, a UV signaling pathway involving Ras and AP-1 is an ancient and universal mechanism involved in protection against damage to cellular components other than DNA.	HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115	Harvard University; Harvard Medical School	ENGELBERG, D (corresponding author), UNIV CALIF SAN DIEGO,SCH MED,CTR MOLEC GENET,DEPT PHARMACOL,LA JOLLA,CA 92093, USA.				FOGARTY INTERNATIONAL CENTER [F05TW004865] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA050528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030186, R01GM030186] Funding Source: NIH RePORTER; FIC NIH HHS [F05 TWO4865-01] Funding Source: Medline; NCI NIH HHS [CA50528] Funding Source: Medline; NIGMS NIH HHS [GM30186] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; [Anonymous], 1985, DNA REPAIR; ARNDT K, 1986, P NATL ACAD SCI USA, V83, P8516, DOI 10.1073/pnas.83.22.8516; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BINETRUY B, 1991, NATURE, V351, P122, DOI 10.1038/351122a0; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; BOS JL, 1989, CANCER RES, V49, P4682; Broach J R, 1990, Adv Cancer Res, V54, P79, DOI 10.1016/S0065-230X(08)60809-X; BURGERING BMT, 1991, EMBO J, V10, P1103, DOI 10.1002/j.1460-2075.1991.tb08050.x; BUSCHER M, 1988, ONCOGENE, V3, P301; BUSHMAN JL, 1993, MOL CELL BIOL, V13, P4618, DOI 10.1128/MCB.13.8.4618; CAMERON S, 1988, CELL, V53, P555, DOI 10.1016/0092-8674(88)90572-7; CHANG EH, 1987, SCIENCE, V237, P1036, DOI 10.1126/science.3616624; CHEN W, 1987, CELL, V50, P1047, DOI 10.1016/0092-8674(87)90171-1; DEVARY Y, 1991, MOL CELL BIOL, V11, P2804, DOI 10.1128/MCB.11.5.2804; DEVARY Y, 1993, SCIENCE, V261, P1442, DOI 10.1126/science.8367725; DEVARY Y, 1992, CELL, V71, P1081, DOI 10.1016/S0092-8674(05)80058-3; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; DISTEL RJ, 1987, CELL, V49, P835, DOI 10.1016/0092-8674(87)90621-0; DONAHUE TF, 1983, CELL, V32, P89, DOI 10.1016/0092-8674(83)90499-3; ELLEDGE SJ, 1993, BIOESSAYS, V15, P333, DOI 10.1002/bies.950150507; ERASO P, 1985, FEBS LETT, V191, P51, DOI 10.1016/0014-5793(85)80991-1; FREDERICKSON RM, 1991, MOL CELL BIOL, V11, P2896, DOI 10.1128/MCB.11.5.2896; Friedberg E.C., 1991, MOL CELLULAR BIOL TE, P147; Haynes R.H., 1981, MOL BIOL YEAST SACCH, P371; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; HILL DE, 1986, SCIENCE, V234, P451, DOI 10.1126/science.3532321; HINNEBUSCH AG, 1984, P NATL ACAD SCI-BIOL, V81, P6442, DOI 10.1073/pnas.81.20.6442; HINNEBUSCH AG, 1985, MOL CELL BIOL, V5, P2349, DOI 10.1128/MCB.5.9.2349; HINNEBUSCH AG, 1988, MICROBIOL REV, V52, P248, DOI 10.1128/MMBR.52.2.248-273.1988; HOLBROOK NJ, 1991, NEW BIOL, V3, P825; HOPE IA, 1985, CELL, V43, P177, DOI 10.1016/0092-8674(85)90022-4; KARIN M, 1992, TRENDS BIOCHEM SCI, V17, P418, DOI 10.1016/0968-0004(92)90012-X; KARIN M, 1989, GENES SIGNAL TRANSDU, P415; KASID U, 1987, SCIENCE, V237, P1039, DOI 10.1126/science.3616625; KASID U, 1989, SCIENCE, V243, P1354, DOI 10.1126/science.2466340; KLEIN C, 1994, MOL CELL BIOL, V14, P1920, DOI 10.1128/MCB.14.3.1920; LAZARISKARATZAS A, 1992, GENE DEV, V6, P1631, DOI 10.1101/gad.6.9.1631; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; MADURA K, 1986, J BACTERIOL, V166, P914, DOI 10.1128/jb.166.3.914-923.1986; MATSUMOTO K, 1982, P NATL ACAD SCI-BIOL, V79, P2355, DOI 10.1073/pnas.79.7.2355; MBONYI K, 1990, MOL CELL BIOL, V10, P4518, DOI 10.1128/MCB.10.9.4518; MOYEROWLEY WS, 1989, GENE DEV, V3, P283, DOI 10.1101/gad.3.3.283; MUELLER PP, 1986, CELL, V45, P201, DOI 10.1016/0092-8674(86)90384-3; MUNDER T, 1989, FEBS LETT, V242, P341, DOI 10.1016/0014-5793(89)80498-3; OLIVIERO S, 1992, GENE DEV, V6, P1799, DOI 10.1101/gad.6.9.1799; OLIVIERO S, 1991, P NATL ACAD SCI USA, V88, P224, DOI 10.1073/pnas.88.1.224; PERKINS KK, 1988, EMBO J, V7, P4265, DOI 10.1002/j.1460-2075.1988.tb03324.x; RADLERPOHL A, 1993, EMBO J, V12, P1005, DOI 10.1002/j.1460-2075.1993.tb05741.x; RAYTER SI, 1992, EMBO J, V11, P4549, DOI 10.1002/j.1460-2075.1992.tb05556.x; ROLFES RJ, 1993, MOL CELL BIOL, V13, P5099, DOI 10.1128/MCB.13.8.5099; Romerdahl C A, 1989, Cancer Commun, V1, P209; SHIMM DS, 1992, RADIAT RES, V129, P149, DOI 10.2307/3578151; SKLAR MD, 1988, SCIENCE, V239, P645, DOI 10.1126/science.3277276; STRUHL K, 1985, COLD SPRING HARB SYM, V50, P489, DOI 10.1101/SQB.1985.050.01.061; STRUHL K, 1987, CELL, V50, P841, DOI 10.1016/0092-8674(87)90511-3; STRUHL K, 1988, NATURE, V332, P649, DOI 10.1038/332649a0; STRUHL K, 1982, NATURE, V300, P284, DOI 10.1038/300284a0; THEVELEIN JM, 1991, MOL MICROBIOL, V5, P1301, DOI 10.1111/j.1365-2958.1991.tb00776.x; THIREOS G, 1984, P NATL ACAD SCI-BIOL, V81, P5096, DOI 10.1073/pnas.81.16.5096; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; TZAMARIAS D, 1989, CELL, V57, P947, DOI 10.1016/0092-8674(89)90333-4; VANAELST L, 1991, J GEN MICROBIOL, V137, P341, DOI 10.1099/00221287-137-2-341; VOGT PK, 1987, P NATL ACAD SCI USA, V84, P3316, DOI 10.1073/pnas.84.10.3316; WALKER GC, 1985, ANNU REV BIOCHEM, V54, P425, DOI 10.1146/annurev.bi.54.070185.002233; WEINSTEIN IB, 1988, CANCER RES, V48, P4135; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; YAGLE K, 1990, MOL CELL BIOL, V10, P5553, DOI 10.1128/MCB.10.10.5553; ZHANG K, 1990, P NATL ACAD SCI USA, V87, P6281, DOI 10.1073/pnas.87.16.6281; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G	72	199	202	2	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 6	1994	77	3					381	390		10.1016/0092-8674(94)90153-8	http://dx.doi.org/10.1016/0092-8674(94)90153-8			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NK970	8181058				2022-12-28	WOS:A1994NK97000009
J	ROCKEY, DC; CELLO, JP				ROCKEY, DC; CELLO, JP			EVALUATION OF THE GASTROINTESTINAL-TRACT IN PATIENTS WITH IRON-DEFICIENCY ANEMIA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENTEROSCOPY; DIAGNOSIS; ENDOSCOPY; GASTRITIS	Background. Idiopathic iron-deficiency anemia in adults is assumed to be the result of occult chronic blood loss from the gastrointestinal tract. The aim of this study was to determine an effective clinical strategy for managing this common clinical problem. Methods. We prospectively studied 1 00 consecutive patients with iron-deficiency anemia, using colonoscopy and esophagogastroduodenoscopy and, in patients with negative endoscopic studies, enteroclysis (radiographic examination of the small intestine). Results. Gastrointestinal endoscopy revealed at least one lesion potentially responsible for blood loss in 62 of the 100 patients. Endoscopic examination of the upper gastrointestinal tract showed a bleeding source in 36 patients, and colonoscopy showed a lesion in 25; 1 patient had lesions in both the upper and lower gastrointestinal tracts. The most common abnormality in the upper gastrointestinal tract was peptic ulceration (duodenal ulcer in 11 patients, gastric ulcer in 5, and anastomotic ulcer in 3). Cancers, detected in 11 patients, were the most common colonic lesions. Enteroclysis was performed in 26 of the 38 patients with negative endoscopic studies, and the results were normal in all instances. Symptoms at a specific site in the gastrointestinal tract were predictive of disease in the corresponding portion of the bowel. In addition, the combination of positive tests for fecal occult blood and symptoms in the lower gastrointestinal tract had a positive predictive value of 86 percent for detecting a lesion in the lower gastrointestinal tract. Conclusions. Gastrointestinal lesions (in both the upper gastrointestinal tract and the colon) are frequently found in patients with iron-deficiency anemia. Since site-specific symptoms are predictive of abnormalities in the corresponding portion of the bowel, the initial evaluation should be directed by the location of the symptoms. Concomitant lesions of the upper and lower gastrointestinal tract are rare; thus, detection of a likely source of blood loss during the initial examination may obviate the need for further procedures.	UNIV CALIF SAN FRANCISCO,SAN FRANCISCO GEN HOSP,MED SERV,DIV GASTROENTEROL,SAN FRANCISCO,CA 94110	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco								Ahlquist DA, 1991, TXB GASTROENTEROLOGY, V1, P616; CALVEY HD, 1987, AGE AGEING, V16, P399, DOI 10.1093/ageing/16.6.399; CARSON JL, 1987, ARCH INTERN MED, V147, P85, DOI 10.1001/archinte.147.1.85; COOK IJ, 1986, BRIT MED J, V292, P1380, DOI 10.1136/bmj.292.6532.1380; COX DR, 1970, ANAL BINARY DATA, P43; CROKER JR, 1981, AGE AGEING, V10, P40, DOI 10.1093/ageing/10.1.40; FOUTCH PG, 1990, GASTROINTEST ENDOSC, V36, P337; FRIES JF, 1989, GASTROENTEROLOGY, V96, P647, DOI 10.1016/S0016-5085(89)80061-7; GRAHAM DY, 1988, AM J GASTROENTEROL, V83, P1081; HERSHKO C, 1984, BLUT, V49, P347, DOI 10.1007/BF00320209; HETZEL DJ, 1988, GASTROENTEROLOGY, V95, P903, DOI 10.1016/0016-5085(88)90162-X; KERLIN P, 1979, AUST NZ J MED, V9, P402, DOI 10.1111/j.1445-5994.1979.tb04167.x; Krevsky B, 1991, Gastroenterology, V100, P838; LAINE L, 1988, GASTROENTEROLOGY, V94, P1254, DOI 10.1016/0016-5085(88)90661-0; MAGLINTE DDT, 1987, RADIOLOGY, V163, P297, DOI 10.1148/radiology.163.2.3550876; MCCARTHY DM, 1989, GASTROENTEROLOGY, V96, P662, DOI 10.1016/S0016-5085(89)80063-0; MORRIS AJ, 1992, GUT, V33, P887, DOI 10.1136/gut.33.7.887; NEWLAND RC, 1981, CANCER, V47, P424; Peterson WL, 1989, GASTROINTESTINAL DIS, V1, P415; RESS AM, 1992, AM J SURG, V163, P94, DOI 10.1016/0002-9610(92)90259-T; SAUERBRUCH T, 1984, ENDOSCOPY, V16, P101, DOI 10.1055/s-2007-1018546; TAN C C, 1991, SMJ Singapore Medical Journal, V32, P157; WROBLEWSKI M, 1990, SCAND J GASTROENTERO, V25, P489, DOI 10.3109/00365529009095520; ZUCKERMAN G, 1992, AM J GASTROENTEROL, V87, P62; 1990, SAS STAT USERS GUIDE; 1990, SAS LANGUAGE PROCEDU; 1988, MANUAL STAGING CANCE, P69	27	393	409	0	9	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 2	1993	329	23					1691	1695		10.1056/NEJM199312023292303	http://dx.doi.org/10.1056/NEJM199312023292303			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ707	8179652				2022-12-28	WOS:A1993MJ70700003
J	SCOFIELD, SR; ENGLISH, JJ; JONES, JDG				SCOFIELD, SR; ENGLISH, JJ; JONES, JDG			HIGH-LEVEL EXPRESSION OF THE ACTIVATOR TRANSPOSASE GENE INHIBITS THE EXCISION OF DISSOCIATION IN TOBACCO COTYLEDONS	CELL			English	Article							MAIZE ELEMENT ACTIVATOR; ZEA-MAYS-L; TRANSGENIC TOBACCO; DNA MODIFICATION; PUTATIVE TRANSPOSASE; AC; PLANTS; PROTEIN; TRANSCRIPTION; SEQUENCES	A fusion of the strong cauliflower mosaic virus 35S promoter to the Activator (Ac) transposase (TPASE) gene does not trigger excision of Dissociation (Ds) continuously during tobacco cotyledon development, although once activated, the 35S promoter remains active throughout embryogeny. Epistasis studies where 35S:TPASE is in trans with later-acting fusions indicate that transient effectiveness for excision results from this fusion inhibiting its own action and that of other TPASE sources. Inhibition depends on the strength of TPASE expression, since fusions of the 35S promoter to a TPASE cDNA accumulate 30-fold lower amounts of TPASE mRNA than the 35S:TPASE gene fusion and do not inhibit excision. We discuss the role of TPASE levels in the curious relationship between Ac activity and Ac dosage in maize.	JOHN INNES INST, SAINSBURY LAB, NORWICH NR4 7UH, NORFOLK, ENGLAND	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center			Jones, Jonathan DG/J-5129-2012; Wilson, Matthew H/K-3193-2013; Scofield, Steven/C-3868-2016	Jones, Jonathan DG/0000-0002-4953-261X; 				BECKER D, 1992, P NATL ACAD SCI USA, V89, P5552, DOI 10.1073/pnas.89.12.5552; BENNETZEN JL, 1987, MOL GEN GENET, V208, P45, DOI 10.1007/BF00330420; CHANDLER VL, 1986, P NATL ACAD SCI USA, V83, P1767, DOI 10.1073/pnas.83.6.1767; CHOMET PS, 1987, EMBO J, V6, P295, DOI 10.1002/j.1460-2075.1987.tb04753.x; COUPLAND G, 1988, EMBO J, V7, P3653, DOI 10.1002/j.1460-2075.1988.tb03246.x; COUPLAND G, 1989, P NATL ACAD SCI USA, V86, P9385, DOI 10.1073/pnas.86.23.9385; De Greve H, 1982, J Mol Appl Genet, V1, P499; DEPICKER A, 1982, Journal of Molecular and Applied Genetics, V1, P561; ENGLISH J, 1993, PLANT CELL, V5, P501, DOI 10.1105/tpc.5.5.501; FEDOROFF NV, 1989, MOBILE DNA, P375; FELDMAR S, 1991, EMBO J, V10, P4003, DOI 10.1002/j.1460-2075.1991.tb04975.x; FUSSWINKEL H, 1991, MOL GEN GENET, V225, P186, DOI 10.1007/BF00269846; HARPSTER MH, 1988, MOL GEN GENET, V212, P182, DOI 10.1007/BF00322463; HEFFRON F, 1979, CELL, V18, P1153, DOI 10.1016/0092-8674(79)90228-9; HEHL R, 1990, PLANT CELL, V2, P709, DOI 10.1105/tpc.2.8.709; HEINLEIN M, 1991, MAYDICA, V36, P309; JEFFERSON RA, 1987, EMBO J, V6, P3901; JONES JDG, 1990, PLANT CELL, V2, P701, DOI 10.1105/tpc.2.8.701; JONES JDG, 1989, SCIENCE, V244, P204, DOI 10.1126/science.244.4901.204; Jones Jonathan D. G., 1992, Transgenic Research, V1, P285, DOI 10.1007/BF02525170; KEITH B, 1986, EMBO J, V5, P2419, DOI 10.1002/j.1460-2075.1986.tb04516.x; KLOSGEN RB, 1986, MOL GEN GENET, V203, P237, DOI 10.1007/BF00333960; KUNZE R, 1988, MOL GEN GENET, V214, P325, DOI 10.1007/BF00337730; KUNZE R, 1989, EMBO J, V8, P3177, DOI 10.1002/j.1460-2075.1989.tb08476.x; KUNZE R, 1987, EMBO J, V6, P1555, DOI 10.1002/j.1460-2075.1987.tb02400.x; MALIGA P, 1988, MOL GEN GENET, V214, P456, DOI 10.1007/BF00330480; MATZKE MA, 1990, DEV GENET, V11, P214, DOI 10.1002/dvg.1020110307; MCCLINTOCK B, 1948, CARNEGIE I WASH, V47, P155; McClintock B., 1963, Year Book of the Carnegie Institution of Washington 1962-1963, V62, P486; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13, DOI 10.1101/SQB.1951.016.01.004; McClintock B., 1964, Yearbook of the Carnegie Institution of Washington 1963-64, P592; MCCLINTOCK B, 1946, CARNEGIE I WASH YB, V45, P176; MCCLINTOCK B, 1947, CARNEGIE I WASHINGTO, V46, P146; McClintock B, 1955, CARNEGIE I WASH YB, V54, P245; MISRA S, 1990, CELL, V62, P269, DOI 10.1016/0092-8674(90)90365-L; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; ROMMENS CMT, 1992, MOL GEN GENET, V231, P433, DOI 10.1007/BF00292713; Sambrook J, 1989, MOL CLONING LABORATO; SCHWARTZ D, 1984, MOL GEN GENET, V196, P81, DOI 10.1007/BF00334096; SIMONS RW, 1988, ANNU REV GENET, V22, P567, DOI 10.1146/annurev.ge.22.120188.003031; SIMONS RW, 1982, PLANT CELL, V4, P573; STARLINGER P, 1987, PLANT TRANSPOSABLE E, P91; Steel RGD, 1981, PRINCIPLES PROCEDURE; WILSON C, 1990, ANNU REV CELL BIOL, V6, P679, DOI 10.1146/annurev.cellbio.6.1.679	46	55	56	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	1993	75	3					507	517		10.1016/0092-8674(93)90385-4	http://dx.doi.org/10.1016/0092-8674(93)90385-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MF830	8221890				2022-12-28	WOS:A1993MF83000013
J	WIVEL, NA; WALTERS, L				WIVEL, NA; WALTERS, L			GERM-LINE GENE MODIFICATION AND DISEASE PREVENTION - SOME MEDICAL AND ETHICAL PERSPECTIVES	SCIENCE			English	Article							TRANSGENIC MICE; MOUSE EMBRYOS; BETA-THALASSEMIA; CYSTIC-FIBROSIS; POINT MUTATION; ANIMAL-MODEL; THERAPY; RETINOBLASTOMA; EXPRESSION; DEFICIENCY	There has been considerable debate about the ethics of human germ-line gene modification. As a result of recent advances in the micromanipulation of embryos and the laboratory development of transgenic mice, a lively discussion has begun concerning both the technical feasibility and the ethical acceptability of human germ-line modification for the prevention of serious disease. This article summarizes some of the recent research on germ-line gene modification in animal models. Certain monogenic deficiency diseases that ultimately might be candidates for correction by germ-line intervention are identified. Several of the most frequently considered ethical issues relative to human germ-line gene modification are considered in the context of professional ethics, parental responsibility, and public policy. Finally, it is suggested that there is merit in continuing the discussion about human germ-line intervention, so that this technique can be carefully compared with alternative strategies for preventing genetic disease.	GEORGETOWN UNIV,KENNEDY INST ETHICS,WASHINGTON,DC 20057	Georgetown University	WIVEL, NA (corresponding author), NIH,OFF RECOMBINANT DNA ACT,BETHESDA,MD 20892, USA.							ANDERSON WF, 1980, NEW ENGL J MED, V303, P1293, DOI 10.1056/NEJM198011273032210; ANDERSON WF, 1985, J MED PHILOS, V10, P275, DOI 10.1093/jmp/10.3.275; ANDERSON WF, 1989, J MED PHILOS, V14, P681, DOI 10.1093/jmp/14.6.681; BERGER EM, 1991, J MED PHILOS, V16, P667, DOI 10.1093/jmp/16.6.667; BRADBURY MW, 1989, P NATL ACAD SCI USA, V86, P3709; BREESE GR, 1990, BRAIN RES BULL, V25, P477, DOI 10.1016/0361-9230(90)90240-Z; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; Caplan A., 1992, GENE MAPPING USING L, P128; CAVARD C, 1988, NUCLEIC ACIDS RES, V16, P2099, DOI 10.1093/nar/16.5.2099; COOKDEEGAN RM, 1990, HUM GENE THER, V1, P163, DOI 10.1089/hum.1990.1.2-163; COSTANTINI F, 1986, SCIENCE, V233, P1192, DOI 10.1126/science.3461564; COVARRUBIAS L, 1986, P NATL ACAD SCI USA, V83, P6020, DOI 10.1073/pnas.83.16.6020; Davenport Charles Benedict, 1911, HEREDITY RELATION EU; DAVIDSON BL, 1991, AM J HUM GENET, V48, P951; DAVIS BD, 1992, HUM GENE THER, V3, P361, DOI 10.1089/hum.1992.3.4-361; DORIN JR, 1992, NATURE, V359, P211, DOI 10.1038/359211a0; DRUCKER L, 1992, AM J HUM GENET, V51, P371; Duster Troy, 1990, BACKDOOR TO EUGENICS; Elias S., 1992, GENE MAPPIN GUSING L, P142; Fletcher J C, 1992, Law Med Health Care, V20, P26; FLETCHER JC, 1990, HUM GENE THER, V1, P55, DOI 10.1089/hum.1990.1.1-55; FLETCHER JC, 1983, VA LAW REV, V69, P515, DOI 10.2307/1072768; Fowler G, 1989, Theor Med, V10, P151, DOI 10.1007/BF00539880; GIESELMANN V, 1991, DEV NEUROSCI-BASEL, V13, P222, DOI 10.1159/000112164; GORDON JW, 1990, AM J MED GENET, V35, P206, DOI 10.1002/ajmg.1320350213; GORDON JW, 1983, METHOD ENZYMOL, V101, P411; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; GREAVES DR, 1990, NATURE, V343, P183, DOI 10.1038/343183a0; HALLER MH, 1972, EUGENICS HEREDITARIA; HAMILTON M, 1972, NEW GENETICS FUTURE; HAMMER RE, 1984, NATURE, V311, P65, DOI 10.1038/311065a0; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Howell Joel D, 1991, J Clin Ethics, V2, P274; JUENGST ET, 1991, J MED PHILOS, V16, P5587; Kevles Daniel J., 1985, NAME EUGENICS GENETI; KLOSS K, 1991, AM J MED GENET, V39, P196, DOI 10.1002/ajmg.1320390215; KNOPPERS BM, 1992, HUMAN DIGNITY GENETI; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; KUEHN MR, 1989, NATURE, V244, P1578; KYLE JW, 1990, P NATL ACAD SCI USA, V87, P3914, DOI 10.1073/pnas.87.10.3914; LAPPE M, 1991, J MED PHILOS, V16, P613; LESCH M, 1964, AM J MED, V36, P561, DOI 10.1016/0002-9343(64)90104-4; LIFTON RJ, 1986, NAZI DOCTORS, pCH1; LIPPMAN A, 1993, HUM GENE THER, V4, P135; LLOYD KG, 1981, NEW ENGL J MED, V305, P1106, DOI 10.1056/NEJM198111053051902; LUND T, 1990, NATURE, V345, P727, DOI 10.1038/345727a0; MAHON KA, 1988, P NATL ACAD SCI USA, V85, P1165, DOI 10.1073/pnas.85.4.1165; MASON AJ, 1986, SCIENCE, V234, P1372, DOI 10.1126/science.3097822; MATSUNAGA E, 1980, J NATL CANCER I, V65, P47; MAURON A, 1991, J MED PHILOS, V16, P648; MEYEROWITZ R, 1988, P NATL ACAD SCI USA, V85, P3955; MILLER HI, 1990, HUM GENE THER, V1, P3, DOI 10.1089/hum.1990.1.1-3; MOOLTEN FL, 1990, HUM GENE THER, V1, P125, DOI 10.1089/hum.1990.1.2-125; MOSELEY R, 1991, J MED PHILOS, V16, P641, DOI 10.1093/jmp/16.6.641; MULLER H. J., 1959, PERSPECTIVES IN BIOL AND MED, V3, P1; NEEL JV, 1993, HUM GENE THER, V4, P127, DOI 10.1089/hum.1993.4.2-127; NIRENBERG MW, 1967, SCIENCE, V157, P633, DOI 10.1126/science.157.3789.633; OVERBEEK PA, 1986, SCIENCE, V231, P1574, DOI 10.1126/science.3006249; PALEL PI, 1984, SOMAT CELL MOLEC GEN, V10, P483; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PALMITER RD, 1982, NATURE, V300, P611, DOI 10.1038/300611a0; PRATHER RS, 1986, J EXP ZOOL, V237, P347, DOI 10.1002/jez.1402370307; Proctor Robert N., 1988, RACIAL HYGIENE MED N; Ramsey Paul, 1970, FABRICATED MAN ETHIC; READHEAD C, 1987, CELL, V48, P703, DOI 10.1016/0092-8674(87)90248-0; REILLY PR, 1991, SURGICAL SOLUTION HS; SCANGOS G, 1987, ADV GENET, V24, P285, DOI 10.1016/S0065-2660(08)60011-5; SEEGMILLER JE, 1967, SCIENCE, V155, P1682, DOI 10.1126/science.155.3770.1682; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; SKOW LC, 1983, CELL, V34, P1043, DOI 10.1016/0092-8674(83)90562-7; SMITHIES O, 1993, TRENDS GENET, V9, P112, DOI 10.1016/0168-9525(93)90204-U; SMITHIES O, 1985, NATURE, V317, P230, DOI 10.1038/317230a0; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; SORIANO P, 1986, SCIENCE, V234, P1409, DOI 10.1126/science.3024318; STANBURY JB, 1989, METABOLIC BASIS INHE, P881; TANAKA A, 1990, AM J HUM GENET, V47, P567; TOUFEXIS A, 1993, TIME, V142, P49; TROUNSON A, 1983, NATURE, V305, P707, DOI 10.1038/305707a0; TYBULEWICZ VLJ, 1992, NATURE, V357, P407, DOI 10.1038/357407a0; VANDERPUTTEN H, 1985, P NATL ACAD SCI USA, V82, P6148, DOI 10.1073/pnas.82.18.6148; VOGEL F, 1979, HUM GENET, V52, P1; WALTERS L, 1991, HUM GENE THER, V2, P115, DOI 10.1089/hum.1991.2.2-115; Walters L, 1991, J Clin Ethics, V2, P267; WALTERS L, 1986, NATURE, V320, P225, DOI 10.1038/320225a0; WEATHERALL DJ, 1988, NATURE, V331, P13, DOI 10.1038/331013a0; WEATHERALL DJ, 1991, NATURE, V349, P275, DOI 10.1038/349275a0; Weindling P, 1989, HLTH RACE GERMAN POL; WOLSTENHOLME G, 1963, MAN HIST FUTURE; ZIMMERMAN BK, 1991, J MED PHILOS, V16, P593, DOI 10.1093/jmp/16.6.593; 1990, HASTINGS CTR REP, V20, P21	90	55	58	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 22	1993	262	5133					533	538		10.1126/science.8211180	http://dx.doi.org/10.1126/science.8211180			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC935	8211180				2022-12-28	WOS:A1993MC93500030
J	CHEN, DS				CHEN, DS			FROM HEPATITIS TO HEPATOMA - LESSONS FROM TYPE-B VIRAL-HEPATITIS	SCIENCE			English	Editorial Material							HUMAN HEPATOCELLULAR CARCINOMAS; ANTIGEN CARRIER MOTHERS; VACCINATION PROGRAM; VIRUS-INFECTION; VERTICAL TRANSMISSION; P53 GENE; TAIWAN; MUTATION; CHILDREN; INFANTS		NATL TAIWAN UNIV,COLL MED,DEPT INTERNAL MED,TAIPEI,TAIWAN	National Taiwan University	CHEN, DS (corresponding author), NATL TAIWAN UNIV HOSP,HEPATITIS RES CTR,TAIPEI 100,TAIWAN.			CHEN, DING-SHINN/0000-0001-7791-6154				BEASLEY RP, 1982, HEPATOLOGY, V2, pS21; BLUMBERG BS, 1965, J AMER MED ASSOC, V191, P541, DOI 10.1001/jama.1965.03080070025007; BRESSAC B, 1991, NATURE, V350, P429, DOI 10.1038/350429a0; Chen D-S, 1987, NEOPLASMS LIVER, P71; CHEN DS, 1987, JAMA-J AM MED ASSOC, V257, P2597; CHEN DS, 1993, J GASTROEN HEPATOL, V8, P470, DOI 10.1111/j.1440-1746.1993.tb01551.x; CHEN DS, IN PRESS 1993 P INT; HSU HM, 1988, JAMA-J AM MED ASSOC, V260, P2231, DOI 10.1001/jama.260.15.2231; HSU HY, 1986, J MED VIROL, V18, P301, DOI 10.1002/jmv.1890180402; HSU IC, 1991, NATURE, V350, P427, DOI 10.1038/350427a0; KANE M, 1993, MAY INT S VIR HEP LI; LIAW YF, 1988, HEPATOLOGY, V8, P493, DOI 10.1002/hep.1840080310; MURAKAMI Y, 1991, CANCER RES, V51, P5520; OZTURK M, 1991, LANCET, V338, P1356, DOI 10.1016/0140-6736(91)92236-U; SHEU JC, 1985, GASTROENTEROLOGY, V89, P259, DOI 10.1016/0016-5085(85)90324-5; STEVENS CE, 1979, J MED VIROL, V3, P237, DOI 10.1002/jmv.1890030310; STEVENS CE, 1975, NEW ENGL J MED, V292, P771, DOI 10.1056/NEJM197504102921503; TSAI SL, 1992, J CLIN INVEST, V89, P87, DOI 10.1172/JCI115590; TSEN YJ, 1991, J MED VIROL, V34, P96, DOI 10.1002/jmv.1890340205	19	296	307	2	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 15	1993	262	5132					369	370		10.1126/science.8211155	http://dx.doi.org/10.1126/science.8211155			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB859	8211155				2022-12-28	WOS:A1993MB85900039
J	JADRESIC, L; CARTWRIGHT, K; COWIE, N; WITCOMBE, B; STEVENS, D				JADRESIC, L; CARTWRIGHT, K; COWIE, N; WITCOMBE, B; STEVENS, D			INVESTIGATION OF URINARY-TRACT INFECTION IN CHILDHOOD	BRITISH MEDICAL JOURNAL			English	Article							DIAGNOSIS; CHILDREN	Objectives-To determine the number of laboratory confirmed urinary tract infections in children and to ascertain general practitioners' practices and attitudes towards their investigation and management. Design-Prospective one year survey of urine specimens submitted for bacteriological investigation; review of radiology department records; questionnaire survey of general practitioners. Setting-Gloucester health district. Subjects-432 children aged < 15 and 7143 children aged < 2 registered with a general practice in Gloucester health district and their 195 general practitioners. Results-4317 urine specimens were submitted from children aged < 15, of which 563 from 442 children were culture positive. The rate (number/100 children/practice) of culture positive urine specimens in these children varied more than 10-fold between general practices, and this correlated closely with the rate of referral of urine specimens for investigation. A follow up specimen to check for clearance of infection was taken in 22% (125/563) of infections. Of the 821 specimens submitted from children aged < 2, 103 from 89 children were positive. Of these children, 28 underwent radiological imaging. Most general practitioners would aim to obtain bacteriological confirmation of urinary tract infection on weekdays but only a minority said they would do so at weekends. They were apparently more likely to refer boys and younger children for renal tract imaging after a first urinary tract infection. Conclusions-Urinary tract infection in children was underdiagnosed, and after a confirmed infection only a minority of patients received renal tract imaging or microbiological follow up. Greater awareness of the importance of investigation and management of urinary tract infection in children is needed, and the practical difficulties faced by general practitioners must be resolved.	GLOUCESTERSHIRE ROYAL HOSP,DEPT RADIOL,GLOUCESTER GL1 3NN,ENGLAND; GLOUCESTERSHIRE ROYAL HOSP,DEPT MED AUDIT,GLOUCESTER GL1 3NN,ENGLAND; GLOUCESTERSHIRE ROYAL HOSP,PUBL HLTH LAB,GLOUCESTR GL1 3NN,ENGLAND	Gloucestershire Royal Hospital; Gloucestershire Royal Hospital; Gloucestershire Royal Hospital	JADRESIC, L (corresponding author), GLOUCESTERSHIRE ROYAL HOSP,DEPT PEDIAT,GLOUCESTER GL1 3NN,ENGLAND.							BERG UB, 1983, ARCH DIS CHILD, V58, P963, DOI 10.1136/adc.58.12.963; DITCHBURN RK, 1990, BRIT J GEN PRACT, V40, P406; FILLY R, 1974, RADIOLOGY, V113, P145, DOI 10.1148/113.1.145; HODSON C J, 1960, Clin Radiol, V11, P219, DOI 10.1016/S0009-9260(60)80047-5; JONES KV, 1990, ARCH DIS CHILD, V65, P327, DOI 10.1136/adc.65.3.327; KASS EH, 1957, ARCH INTERN MED, V100, P709, DOI 10.1001/archinte.1957.00260110025004; LITTLEWOOD JM, 1972, ARCH DIS CHILD, V47, P218, DOI 10.1136/adc.47.252.218; Smellie J, 1975, Kidney Int Suppl, V4, pS65; SMELLIE JM, 1985, BRIT MED J, V290, P1957, DOI 10.1136/bmj.290.6486.1957; SMELLIE JM, 1964, BMJ-BRIT MED J, V2, P1222, DOI 10.1136/bmj.2.5419.1222; VICKERS D, 1991, LANCET, V338, P767, DOI 10.1016/0140-6736(91)90662-9; WHITE RHR, 1987, ARCH DIS CHILD, V62, P421, DOI 10.1136/adc.62.4.421; WINBERG J, 1982, PEDIATR CLIN N AM, V29, P810; 1991, J R COLL PHYSICIANS, V25, P36; 1987, BMJ, V294, P237	15	35	35	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 25	1993	307	6907					761	764		10.1136/bmj.307.6907.761	http://dx.doi.org/10.1136/bmj.307.6907.761			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LZ478	8219946	Green Published, Bronze			2022-12-28	WOS:A1993LZ47800020
J	CHENG, S; CHANG, SY; GRAVITT, P; RESPESS, R				CHENG, S; CHANG, SY; GRAVITT, P; RESPESS, R			LONG PCR	NATURE			English	Article							POLYMERASE CHAIN-REACTION; NONPOLYPOSIS COLORECTAL-CANCER; HUMAN PAPILLOMAVIRUS INFECTION; DNA-POLYMERASE; AMPLIFICATION; HOMOLOG; TYPE-16; GENE		ROCHE MOLEC SYST INC, DEPT INFECT DIS, ALAMEDA, CA 94501 USA		CHENG, S (corresponding author), ROCHE MOLEC SYST INC, DEPT HUMAN GENET, ALAMEDA, CA 94501 USA.							BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; Bauer HM, 1992, DIAGNOSTIC MOL PATHO, P131; CHENG S, 1994, P NATL ACAD SCI USA, V91, P5695, DOI 10.1073/pnas.91.12.5695; CHENG S, 1994, NAT GENET, V7, P350, DOI 10.1038/ng0794-350; CHESTER N, 1993, ANAL BIOCHEM, V209, P284, DOI 10.1006/abio.1993.1121; CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P1717, DOI 10.1093/nar/20.7.1717; DALING JR, 1992, EPIDEMIOLOGY CERVICA, P223; DURST M, 1983, P NATL ACAD SCI-BIOL, V80, P3812, DOI 10.1073/pnas.80.12.3812; EDMONSON PF, 1992, NUCLEIC ACIDS RES, V20, P4933, DOI 10.1093/nar/20.18.4933; ERLICH HA, 1992, ANNU REV GENET, V26, P479, DOI 10.1146/annurev.ge.26.120192.002403; FISHEL R, 1993, CELL, V75, P1027, DOI 10.1016/0092-8674(93)90546-3; Good N E, 1972, Methods Enzymol, V24, P53; HO L, 1993, J VIROL, V67, P6413, DOI 10.1128/JVI.67.11.6413-6423.1993; KONG HM, 1993, J BIOL CHEM, V268, P1965; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; LAWYER FC, 1989, J BIOL CHEM, V264, P6427; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; LORINCZ AT, 1992, OBSTET GYNECOL, V79, P328, DOI 10.1097/00006250-199203000-00002; LYNCH HT, 1993, GASTROENTEROLOGY, V104, P1535, DOI 10.1016/0016-5085(93)90368-M; MEYERHANS A, 1989, CELL, V58, P901, DOI 10.1016/0092-8674(89)90942-2; MYERS TW, 1991, BIOCHEMISTRY-US, V30, P7661, DOI 10.1021/bi00245a001; Nelson DL, 1991, CURR OPIN GENET DEV, V1, P61; ROSE EA, 1991, FASEB J, V5, P46, DOI 10.1096/fasebj.5.1.1991584; SCHIFFMAN MH, 1993, JNCI-J NATL CANCER I, V85, P958, DOI 10.1093/jnci/85.12.958; SEEDORF K, 1985, VIROLOGY, V145, P181, DOI 10.1016/0042-6822(85)90214-4; WONG DM, 1991, NUCLEIC ACIDS RES, V19, P2251, DOI 10.1093/nar/19.9.2251	26	181	205	0	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUN 23	1994	369	6482					684	685		10.1038/369684a0	http://dx.doi.org/10.1038/369684a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NT459	8208299				2022-12-28	WOS:A1994NT45900065
J	DEITCHMAN, S				DEITCHMAN, S			OCCUPATIONAL AND ENVIRONMENTAL MEDICINE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESISTANT MYCOBACTERIUM-TUBERCULOSIS; MULTIPLE CHEMICAL-SENSITIVITY; ORGANIC-SOLVENTS; WORKERS; TRANSMISSION; ASSOCIATION; MORTALITY				DEITCHMAN, S (corresponding author), CTR DIS CONTROL & PREVENT, NIOSH, ATLANTA, GA 30341 USA.							AMANDUS HE, 1992, AM J IND MED, V22, P147, DOI 10.1002/ajim.4700220202; BECKSAGUE C, 1992, JAMA-J AM MED ASSOC, V268, P1280, DOI 10.1001/jama.268.10.1280; BELL IR, 1992, BIOL PSYCHIAT, V32, P218, DOI 10.1016/0006-3223(92)90105-9; BRANCATI FL, 1993, J OCCUP ENVIRON MED, V35, P161, DOI 10.1097/00043764-199302000-00017; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; HALES TR, IN PRESS ERGONOMICS; JENKINS EL, IN PRESS ANN EPIDEMI; KRISTENSEN P, 1993, AM J EPIDEMIOL, V137, P134, DOI 10.1093/oxfordjournals.aje.a116653; MACMAHON B, 1994, J OCCUP ENVIRON MED, V36, P15; MCDIARMID MA, 1993, AM J IND MED, V24, P1, DOI 10.1002/ajim.4700240102; MORATA TC, 1993, SCAND J WORK ENV HEA, V19, P245, DOI 10.5271/sjweh.1477; PEARSON ML, 1992, ANN INTERN MED, V117, P191, DOI 10.7326/0003-4819-117-3-191; SIMON GE, 1993, ANN INTERN MED, V119, P97, DOI 10.7326/0003-4819-119-2-199307150-00001; WARD E, 1992, AM J IND MED, V22, P885, DOI 10.1002/ajim.4700220610; PHS NIOSH93108 US DE; 1993, US DEP LABOR PUBLICA, V2424; 1993, FED REG         1012, V58, P52810	17	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1691	1692		10.1001/jama.271.21.1691	http://dx.doi.org/10.1001/jama.271.21.1691			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182855				2022-12-28	WOS:A1994NN11700034
J	SUZUKI, N; CHEUNG, TT; CAI, XD; ODAKA, A; OTVOS, L; ECKMAN, C; GOLDE, TE; YOUNKIN, SG				SUZUKI, N; CHEUNG, TT; CAI, XD; ODAKA, A; OTVOS, L; ECKMAN, C; GOLDE, TE; YOUNKIN, SG			AN INCREASED PERCENTAGE OF LONG AMYLOID-BETA PROTEIN SECRETED BY FAMILIAL AMYLOID-BETA PROTEIN-PRECURSOR (BETA-APP(717)) MUTANTS	SCIENCE			English	Article							ONSET ALZHEIMERS-DISEASE; APOLIPOPROTEIN-E GENOTYPE; GENETIC-LINKAGE; DOWNS-SYNDROME; MESSENGER-RNA; E TYPE-4; MUTATION; PEPTIDE; PLAQUES; ALLELE	Normal processing of the amyloid beta protein precursor (beta APP) results in secretion of a soluble 4-kilodalton protein essentially identical to the amyloid beta protein (A beta) that forms insoluble fibrillar deposits in Alzheimer's disease. Human neuroblastoma (M17) cells transfected with constructs expressing wild-type beta APP or the beta APP(717) mutants linked to familial Alzheimer's disease were compared by (i) isolation of metabolically labeled 4-kilodalton A beta from conditioned medium, digestion with cyanogen bromide, and analysis of the carboxyl-terminal peptides released, or (ii) analysis of the A beta in conditioned medium with sandwich enzyme-linked immunosorbent assays that discriminate Ap(1-40) from the longer AP(1-42). Both methods demonstrated that the 4-kilodalton Ap released from wild-type beta APP is primarily but not exclusively AP(1-40). The beta APP(717) mutations, which are located th ree residues carboxyl to A beta(43), consistently caused a 1.5- to 1.9-fold increase in the percentage of longer A beta generated. Long A beta (for example, A beta(1-42)) forms insoluble amyloid fibrils more rapidly than Ap(1-40). Thus, the beta APP(717) mutants may cause Alzheimer's disease because they secrete increased amounts of long A beta, thereby fostering amyloid deposition.	CASE WESTERN RESERVE UNIV,INST PATHOL,DIV NEUROPATHOL,CLEVELAND,OH 44106; TAKEDA CHEM IND LTD,DIV DISCOVERY RES,TSUKUBA,IBARAKI 30042,JAPAN; WISTAR INST ANAT & BIOL,PHILADELPHIA,PA 19104	Case Western Reserve University; Takeda Chemical Industries; The Wistar Institute					NIA NIH HHS [AG06656] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG006656] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AMOUYEL P, 1993, LANCET, V342, P1309; ANWAR N, 1993, LANCET, V342, P1038; BORGAONKAR DS, 1993, LANCET, V342, P625, DOI 10.1016/0140-6736(93)91458-X; BURDICK D, 1992, J BIOL CHEM, V267, P546; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; CHARTIERHARLIN MC, 1991, NATURE, V353, P844, DOI 10.1038/353844a0; CHEUNG TTP, UNPUB; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; CZECH C, 1993, LANCET, V342, P1310; DOVEY HF, 1993, NEUROREPORT, V4, P1039, DOI 10.1097/00001756-199308000-00011; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDGABER D, 1987, SCIENCE, V235, P877, DOI 10.1126/science.3810169; HARDY J, 1993, LANCET, V342, P737; HARDY J, 1991, LANCET, V337, P1342; HILBICH C, 1991, J MOL BIOL, V218, P149, DOI 10.1016/0022-2836(91)90881-6; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KONIG G, 1992, J BIOL CHEM, V267, P10804; MANN DMA, 1986, NEUROPATH APPL NEURO, V12, P447, DOI 10.1111/j.1365-2990.1986.tb00053.x; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MULLAN M, 1992, NAT GENET, V2, P340, DOI 10.1038/ng1292-340; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; MURRELL J, 1991, SCIENCE, V254, P97, DOI 10.1126/science.1925564; NARUSE S, 1991, LANCET, V337, P978, DOI 10.1016/0140-6736(91)91612-X; NOGUCHI S, 1993, LANCET, V342, P737, DOI 10.1016/0140-6736(93)91728-5; OTVOS L, 1993, EUR J BIOCHEM, V211, P249, DOI 10.1111/j.1432-1033.1993.tb19893.x; PAYAMI H, 1993, LANCET, V342, P738; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; POIRIER J, 1993, LANCET, V342, P697, DOI 10.1016/0140-6736(93)91705-Q; PRELLI F, 1988, J NEUROCHEM, V51, P648, DOI 10.1111/j.1471-4159.1988.tb01087.x; ROBAKIS NK, 1987, LANCET, V1, P384; ROPPER AH, 1980, NEUROLOGY, V30, P639, DOI 10.1212/WNL.30.6.639; SAUNDERS AM, 1993, LANCET, V342, P710, DOI 10.1016/0140-6736(93)91709-U; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; SELKOE DJ, 1986, J NEUROCHEM, V46, P1820; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; St George Hyslop P, 1992, NAT GENET, V2, P330; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; SUZUKI N, 1989, J IMMUNOL METHODS, V118, P245, DOI 10.1016/0022-1759(89)90012-4; SUZUKI N, 1993, J BIOCHEM-TOKYO, V113, P549, DOI 10.1093/oxfordjournals.jbchem.a124081; SUZUKI N, IN PRESS AM J PATHOL; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; VAN BROECKHOVEN C, 1992, NAT GENET, V2, P335, DOI 10.1038/ng1292-335; YOSHIOKA K, 1991, BIOCHEM BIOPH RES CO, V178, P1141, DOI 10.1016/0006-291X(91)91011-Z	49	1365	1441	0	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 27	1994	264	5163					1336	1340		10.1126/science.8191290	http://dx.doi.org/10.1126/science.8191290			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NN767	8191290				2022-12-28	WOS:A1994NN76700048
J	AGNEW, JR; SUTTER, RW				AGNEW, JR; SUTTER, RW			ADVERSE REACTIONS TO TETANUS TOXOID	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									CTR DIS CONTROL & PREVENT,NATL IMMUNIZAT PROGRAM,ATLANTA,GA 30333	Centers for Disease Control & Prevention - USA								WASSILAK SGF, IN PRESS VACCINES; 1991, MMWR MORB MORTAL WKL, V40, P1	2	5	5	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	1994	271	20					1629	1629		10.1001/jama.271.20.1629	http://dx.doi.org/10.1001/jama.271.20.1629			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NL758	8182821				2022-12-28	WOS:A1994NL75800040
J	LUO, XR; IKEDA, YY; PARKER, KL				LUO, XR; IKEDA, YY; PARKER, KL			A CELL-SPECIFIC NUCLEAR RECEPTOR IS ESSENTIAL FOR ADRENAL AND GONADAL DEVELOPMENT AND SEXUAL-DIFFERENTIATION	CELL			English	Article							EXPRESSION; HORMONE; HOMOLOG; PROTEIN; FTZ-F1	Studies in adrenocortical cells have implicated the orphan nuclear receptor SF-1 in the gene regulation of the steroid hydroxylases. We used targeted disruption of the Ftz-F1 gene, which encodes SF-1, to examine its role in intact mice. Despite normal survival in utero, all Ftz-F1 null animals died by postnatal day 8; these animals lacked adrenal glands and gonads and were severely deficient in corticosterone, supporting adrenocortical insufficiency as the probable cause of death. Male and female Ftz-F1 null mice had female internal genitalia, despite complete gonadal agenesis. These studies establish that the Ftz-F1 gene is essential for sexual differentiation and formation of the primary steroidogenic tissues.	DUKE UNIV,MED CTR,DEPT PHARMACOL,DURHAM,NC 27710; DUKE UNIV,MED CTR,HOWARD HUGHES MED INST,DURHAM,NC 27710	Duke University; Duke University; Howard Hughes Medical Institute	LUO, XR (corresponding author), DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710, USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048460] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL48460] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON DJ, 1993, ANNU REV NEUROSCI, V16, P129, DOI 10.1146/annurev.ne.16.030193.001021; Ballard P L, 1986, Monogr Endocrinol, V28, P1; CONTI FA, 1988, ENDOCRINOLOGY, P1810; DONOHOUE PA, 1994, IN PRESS METABOLIC B; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; GINSBURG M, 1990, DEVELOPMENT, V110, P521; HARLOW E, 1988, ANTIBODIES LABORATOR; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; HONDA S, 1993, J BIOL CHEM, V268, P7494; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; IKEDA Y, 1993, MOL ENDOCRINOL, V7, P852, DOI 10.1210/me.7.7.852; IKEDA Y, 1994, IN PRESS MOL ENDOCRI; JOSSO N, 1991, TRENDS ENDOCRIN MET, V2, P227, DOI 10.1016/1043-2760(91)90029-M; JOSSO N, 1977, RECENT PROGR HORMONE, V33, P117; Kaufman M.H., 1992, ATLAS MOUSE DEV; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8932, DOI 10.1073/pnas.86.22.8932; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LALA DS, 1992, MOL ENDOCRINOL, V6, P1249, DOI 10.1210/me.6.8.1249; LAVORGNA G, 1991, SCIENCE, V252, P848, DOI 10.1126/science.1709303; LAVORGNA G, 1993, P NATL ACAD SCI USA, V90, P3004, DOI 10.1073/pnas.90.7.3004; LI E, 1993, P NATL ACAD SCI USA, V90, P1590, DOI 10.1073/pnas.90.4.1590; LI S, 1990, NATURE, V347, P829; LOHNES D, 1993, CELL, V73, P643, DOI 10.1016/0092-8674(93)90246-M; LUBAHN DB, 1993, P NATL ACAD SCI USA, V90, P11162, DOI 10.1073/pnas.90.23.11162; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; PANG S, 1992, ENDOCRINOLOGY, V131, P181, DOI 10.1210/en.131.1.181; PFAFFLE RW, 1992, SCIENCE, V257, P1118, DOI 10.1126/science.257.5073.1118; RICE DA, 1991, MOL ENDOCRINOL, V5, P1552, DOI 10.1210/mend-5-10-1552; Sambrook J, 1989, MOL CLONING LABORATO; SCHWARTZMAN RA, 1993, ENDOCR REV, V14, P133, DOI 10.1210/er.14.2.133; SMITH C, 1991, J ANAT, V174, P171; THOMAS KR, 1987, CELL, V51, P502; TSUKIYAMA T, 1992, MOL CELL BIOL, V12, P1286, DOI 10.1128/MCB.12.3.1286; Wylie C. C., 1993, SEMIN DEV BIOL, V4, P161, DOI DOI 10.1016/J.YDBIO.2007.05.004	35	1296	1326	1	42	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 20	1994	77	4					481	490		10.1016/0092-8674(94)90211-9	http://dx.doi.org/10.1016/0092-8674(94)90211-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NM832	8187173				2022-12-28	WOS:A1994NM83200004
J	BRADBURN, DM; CARR, HF; RENWICK, I				BRADBURN, DM; CARR, HF; RENWICK, I			RADIOGRAPHS AND ALUMINUM - A PITFALL FOR THE UNWARY	BMJ-BRITISH MEDICAL JOURNAL			English	Article									MIDDLESBROUGH GEN HOSP, DEPT SURG, MIDDLESBROUGH TS5 5AZ, CLEVELAND, ENGLAND; MIDDLESBROUGH GEN HOSP, DEPT RADIOL, MIDDLESBROUGH TS5 5AZ, CLEVELAND, ENGLAND									BURRINGTON JD, 1976, JAMA-J AM MED ASSOC, V235, P2614, DOI 10.1001/jama.235.24.2614; LEVICK RK, 1977, BRIT J RADIOL, V50, P594, DOI 10.1259/0007-1285-50-596-594; SPITZ L, 1971, BMJ-BRIT MED J, V4, P469, DOI 10.1136/bmj.4.5785.469; 1976, LANCET, V2, P353	4	14	14	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 7	1994	308	6938					1226	1226		10.1136/bmj.308.6938.1226	http://dx.doi.org/10.1136/bmj.308.6938.1226			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK956	8180545	Green Published			2022-12-28	WOS:A1994NK95600028
J	PRIOLEAU, MN; HUET, J; SENTENAC, A; MECHALI, M				PRIOLEAU, MN; HUET, J; SENTENAC, A; MECHALI, M			COMPETITION BETWEEN CHROMATIN AND TRANSCRIPTION COMPLEX ASSEMBLY REGULATES GENE-EXPRESSION DURING EARLY DEVELOPMENT	CELL			English	Article							RNA POLYMERASE-II; EARLY DROSOPHILA DEVELOPMENT; FERTILIZED XENOPUS EGGS; MYC PROTO-ONCOGENE; MIDBLASTULA TRANSITION; DIFFERENTIAL EXPRESSION; HISTONE SYNTHESIS; REPLICATING DNA; BINDING PROTEIN; LAEVIS OOCYTES	Xenopus early development is characterized by a generalized absence of transcription, which resumes at the midblastula transition (MBT). We analyzed this regulation using a plasmid containing the c-myc promoter that is under the same developmental control when injected into fertilized eggs. We find that the repression of transcription can be relieved simply by preincubating the reporter plasmid with TATA binding protein (TBP). However, the repression of gene activity normally occurring before the MBT soon becomes dominant over this activation independent of cell cycle phases. This inactivation correlates with chromatin assembly, and titration of chromatin components not only relieves repression of TBP-dependent transcription but also permits the establishment of stable transcription during early development. Our data suggest that the large excess of histones represses gene activity during early development through a dynamic competition between chromatin assembly and transcription complex assembly.	CTR ETUD SACLAY, SERV BIOCHIM & GENET MOLEC, F-91191 GIF SUR YVETTE, FRANCE		PRIOLEAU, MN (corresponding author), INST JACQUES MONOD, MOLEC EMBRYOL UNIT, 2 PL JUSSIEU, F-75251 PARIS 05, FRANCE.		Prioleau, Marie-Noelle/G-9824-2014; , prioleau/S-6007-2019	, prioleau/0000-0003-2585-4005				ADAMSON ED, 1974, J MOL BIOL, V88, P263, DOI 10.1016/0022-2836(74)90481-1; ADAMSON ED, 1977, DEV BIOL, V57, P136, DOI 10.1016/0012-1606(77)90360-8; ALMOUZNI G, 1990, NUCLEIC ACIDS RES, V18, P5767, DOI 10.1093/nar/18.19.5767; ALMOUZNI G, 1990, EMBO J, V9, P573, DOI 10.1002/j.1460-2075.1990.tb08145.x; ANDREWS MT, 1987, CELL, V51, P445, DOI 10.1016/0092-8674(87)90640-4; BACHHVAROVA R, 1986, DEV BIOL, P453; BENDIG MM, 1983, P NATL ACAD SCI-BIOL, V80, P6197, DOI 10.1073/pnas.80.20.6197; BENDIG MM, 1984, MOL CELL BIOL, V4, P2109, DOI 10.1128/MCB.4.10.2109; BROWN DD, 1985, CELL, V42, P759, DOI 10.1016/0092-8674(85)90272-7; Burton N, 1991, Protein Expr Purif, V2, P432, DOI 10.1016/1046-5928(91)90105-R; COLMAN A, 1986, J EMBRYOL EXP MORPH, V97, P197; CORMACK BP, 1992, CELL, V69, P685, DOI 10.1016/0092-8674(92)90232-2; Davidson E. H., 1986, GENE ACTIVITY EARLY; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; ETKIN LD, 1985, DEV BIOL, V108, P173, DOI 10.1016/0012-1606(85)90019-3; ETKIN LD, 1984, DIFFERENTIATION, V26, P194, DOI 10.1111/j.1432-0436.1984.tb01395.x; FELSENFELD G, 1992, NATURE, V355, P219, DOI 10.1038/355219a0; Gill G, 1992, CURR OPIN GENET DEV, V2, P236, DOI 10.1016/S0959-437X(05)80279-5; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; GURDON JB, 1983, METHOD ENZYMOL, V101, P370; HARLAND R, 1988, DEVELOPMENT, V102, P837; HARLAND RM, 1980, CELL, V21, P761, DOI 10.1016/0092-8674(80)90439-0; HARTL P, 1993, J CELL BIOL, V120, P613, DOI 10.1083/jcb.120.3.613; KADONAGA JT, 1990, J BIOL CHEM, V265, P2624; KAYE PL, 1981, J EXP ZOOL, V216, P453, DOI 10.1002/jez.1402160314; KIMELMAN D, 1987, CELL, V48, P399, DOI 10.1016/0092-8674(87)90191-7; KING MW, 1986, MOL CELL BIOL, V6, P4499, DOI 10.1128/MCB.6.12.4499; KIRSCHNER M, 1985, TRENDS GENET, V1, P41, DOI 10.1016/0168-9525(85)90021-6; KNEZETIC JA, 1986, CELL, V45, P95, DOI 10.1016/0092-8674(86)90541-6; KORNBERG RD, 1991, CELL, V67, P833, DOI 10.1016/0092-8674(91)90354-2; KRIEG PA, 1985, EMBO J, V4, P3463, DOI 10.1002/j.1460-2075.1985.tb04105.x; LASKEY RA, 1977, CELL, V10, P237, DOI 10.1016/0092-8674(77)90217-3; LUND E, 1992, GENE DEV, V6, P1097, DOI 10.1101/gad.6.6.1097; MATSUI T, 1987, MOL CELL BIOL, V7, P1401, DOI 10.1128/MCB.7.4.1401; MECHALI M, 1984, CELL, V38, P55, DOI 10.1016/0092-8674(84)90526-9; MEISTERERNST M, 1990, P NATL ACAD SCI USA, V87, P9153, DOI 10.1073/pnas.87.23.9153; MIAKELYE R, 1983, J CELL BIOL, V97, P81, DOI 10.1083/jcb.97.1.81; MODAK SP, 1993, ONCOGENE, V8, P645; MOHUN TJ, 1986, EMBO J, V5, P3185, DOI 10.1002/j.1460-2075.1986.tb04628.x; NEWPORT J, 1985, COLD SPRING HARB SYM, V50, P651, DOI 10.1101/SQB.1985.050.01.079; NEWPORT J, 1982, CELL, V30, P675, DOI 10.1016/0092-8674(82)90272-0; NEWPORT J, 1982, CELL, V30, P687, DOI 10.1016/0092-8674(82)90273-2; NISHIKURA K, 1985, MOL CELL BIOL, V5, P1434, DOI 10.1128/MCB.5.6.1434; NURSE P, 1983, NATURE, V302, P378, DOI 10.1038/302378a0; PRINCIPAUD E, 1991, NUCLEIC ACIDS RES, V19, P3081, DOI 10.1093/nar/19.11.3081; RIGBY PWJ, 1993, CELL, V72, P7, DOI 10.1016/0092-8674(93)90042-O; RUSCONI S, 1981, P NATL ACAD SCI-BIOL, V78, P5051, DOI 10.1073/pnas.78.8.5051; RYOJI M, 1984, CELL, V37, P21, DOI 10.1016/0092-8674(84)90297-6; SCHULTZ MC, 1992, CELL, V69, P697, DOI 10.1016/0092-8674(92)90233-3; SHIOKAWA K, 1990, ROUX ARCH DEV BIOL, V199, P174, DOI 10.1007/BF01681491; SHIOKAWA K, 1989, ROUX ARCH DEV BIOL, V198, P78, DOI 10.1007/BF02447742; SHIOKAWA K, 1991, DEV GROWTH DIFFER, V33, P1; SPENCER CA, 1991, ADV CANCER RES, V56, P1; TAYLOR MV, 1986, EMBO J, V5, P3563, DOI 10.1002/j.1460-2075.1986.tb04683.x; van Holde KE., 1989, SPRINGER SERIES MOL; VRIZ S, 1989, EMBO J, V8, P4091, DOI 10.1002/j.1460-2075.1989.tb08593.x; WASSARMAN PM, 1981, DEV BIOL, V84, P364, DOI 10.1016/0012-1606(81)90405-X; WHITE RJ, 1992, P NATL ACAD SCI USA, V89, P1949, DOI 10.1073/pnas.89.5.1949; WILSON C, 1986, CELL, V47, P589, DOI 10.1016/0092-8674(86)90623-9; WOLFFE A P, 1990, New Biologist, V2, P211; WOLFFE AP, 1986, CELL, V47, P217, DOI 10.1016/0092-8674(86)90444-7; WOODLAND HR, 1977, DEV BIOL, V57, P118, DOI 10.1016/0012-1606(77)90359-1; WORKMAN JL, 1987, CELL, V51, P613, DOI 10.1016/0092-8674(87)90130-9; WORKMAN JL, 1993, TRENDS BIOCHEM SCI, V18, P90, DOI 10.1016/0968-0004(93)90160-O; WORKMAN JL, 1990, EMBO J, V9, P1299, DOI 10.1002/j.1460-2075.1990.tb08239.x; WYLLIE AH, 1978, DEV BIOL, V64, P178, DOI 10.1016/0012-1606(78)90069-6; ZAWEL L, 1993, PROG NUCLEIC ACID RE, V44, P67, DOI 10.1016/S0079-6603(08)60217-2	68	133	134	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	1994	77	3					439	449		10.1016/0092-8674(94)90158-9	http://dx.doi.org/10.1016/0092-8674(94)90158-9			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NK970	8181062				2022-12-28	WOS:A1994NK97000014
J	ALLEN, MC; DONOHUE, PK; DUSMAN, AE				ALLEN, MC; DONOHUE, PK; DUSMAN, AE			THE LIMIT OF VIABILITY - NEONATAL OUTCOME OF INFANTS BORN AT 22-WEEKS TO 25-WEEKS GESTATION	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BIRTH-WEIGHT INFANTS; RESPIRATORY-DISTRESS SYNDROME; INTRAVENTRICULAR HEMORRHAGE; BOVINE SURFACTANT; PRETERM INFANTS; CEREBRAL-PALSY; 800 GRAMS; LESS; MORTALITY; SURVIVAL	Background. With improved survival of preterm infants, questions have been raised about the limit of viability. To provide better information and counseling for parents of infants about to be delivered after 22 to 25 weeks' gestation, we evaluated the mortality and neonatal morbidity of preterm infants born at these gestational ages. Methods. We studied retrospectively all 142 infants born at 22 to 25 weeks' gestation (as judged by best obstetrical estimate) from May 1988 through September 1991 in a single hospital. Mortality in the first six months, including stillbirths, and neonatal morbidity (i.e., the presence of intracranial pathologic conditions, chronic lung disease, and retinopathy of prematurity) were analyzed. Results. Fifty-six infants (39 percent) survived for six months. Survival improved with increasing gestational age; none of 29 infants born at 22 weeks' gestation survived, as compared with 6 of 40 (15 percent) born at 23 weeks, 19 of 34 (56 percent) born at 24 weeks, and 31 of 39 (79 percent) born at 25 weeks. There were seven stillbirths at 22 weeks' gestation and four stillbirths at 23 weeks. The more immature the infant, the higher the incidence of neonatal complications as determined by the number of days of mechanical ventilation, the length of the hospital stay, and the presence of retinopathy of prematurity, periventricular or intraventricular hemorrhage, or periventricular leukomalacia. Only 2 percent of infants born at 23 weeks' gestation survived without severe abnormalities on cranial ultrasonography, as compared with 21 percent of those born at 24 weeks and 69 percent of those born at 25 weeks. Conclusions. We believe that aggressive resuscitation of infants born at 25 weeks' gestation is indicated, but not of those born at 22 weeks. Whether the occasional child who is born at 23 or 24 weeks' gestation and does well justifies the considerable mortality and morbidity of the majority is a question that should be discussed by parents, health care providers, and society.	JOHNS HOPKINS UNIV,SCH MED,DEPT PEDIAT,BALTIMORE,MD 21205	Johns Hopkins University	ALLEN, MC (corresponding author), JOHNS HOPKINS UNIV HOSP,DEPT PEDIAT NURSING,CMSC 210,601 N WOLFE ST,BALTIMORE,MD 21287, USA.							BENNETT FC, 1983, PEDIATRICS, V71, P319; BRITTON SB, 1981, J PEDIATR-US, V99, P937; BUCKWALD S, 1984, AM J DIS CHILD, V138, P779, DOI 10.1001/archpedi.1984.02140460069023; DONOHUE PK, 1993, PEDIATR RES, V31, pA201; GRAHAM M, 1987, LANCET, V2, P593; GRAZIANI LJ, 1986, PEDIATRICS, V78, P88; GRAZIANI LJ, 1985, J PEDIATR-US, V106, P269, DOI 10.1016/S0022-3476(85)80304-8; HACK M, 1989, NEW ENGL J MED, V321, P1642, DOI 10.1056/NEJM198912143212405; HANSEN NB, 1989, J DEV BEHAV PEDIATR, V10, P129; HIRATA T, 1983, J PEDIATR-US, V102, P741, DOI 10.1016/S0022-3476(83)80250-9; HOEKSTRA RE, 1991, PEDIATRICS, V88, P10; HOFFMAN EL, 1990, PEDIATRICS, V86, P27; KENDIG JW, 1991, NEW ENGL J MED, V324, P865, DOI 10.1056/NEJM199103283241301; LIECHTY EA, 1991, PEDIATRICS, V88, P19; NWAESEI CG, 1987, AM J OBSTET GYNECOL, V157, P890, DOI 10.1016/S0002-9378(87)80080-7; PAPILE LA, 1983, J PEDIATR-US, V103, P273, DOI 10.1016/S0022-3476(83)80366-7; ROBERTSON CMT, 1992, PEDIATRICS, V90, P750; SAIGAL S, 1989, J PEDIATR-US, V114, P839, DOI 10.1016/S0022-3476(89)80150-7; SANDERS M, 1991, PEDIATRICS, V88, P542; SHANKARAN S, 1989, J PEDIATR-US, V114, P109, DOI 10.1016/S0022-3476(89)80616-X; SHORTLAND D, 1988, J PERINAT MED, V16, P241, DOI 10.1515/jpme.1988.16.3.241; SPINNATO JA, 1984, OBSTET GYNECOL, V63, P491; STEVENSON D, 1992, J PEDIATR-US, V120, pS3, DOI 10.1016/S0022-3476(05)81226-0; WALKER EM, 1987, BRIT J OBSTET GYNAEC, V94, P670, DOI 10.1111/j.1471-0528.1987.tb03172.x; WILLIAMSON WD, 1983, AM J DIS CHILD, V137, P1181, DOI 10.1001/archpedi.1983.02140380041014	25	322	327	0	5	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 25	1993	329	22					1597	1601		10.1056/NEJM199311253292201	http://dx.doi.org/10.1056/NEJM199311253292201			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MJ546	8179651				2022-12-28	WOS:A1993MJ54600001
J	SIRMON, MD				SIRMON, MD			TOBACCO, TULIPS, AND TERMINAL CARE	ANNALS OF INTERNAL MEDICINE			English	Editorial Material											SIRMON, MD (corresponding author), UNIV SO ALABAMA, COLL MED, DIV NEPHROL HYPERTENS, 2451 FILLINGIM ST, MOBILE, AL 36617 USA.								0	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1993	119	10					1042	1043		10.7326/0003-4819-119-10-199311150-00012	http://dx.doi.org/10.7326/0003-4819-119-10-199311150-00012			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MG672	8214982				2022-12-28	WOS:A1993MG67200012
J	PASSMORE, AP; WILSONDAVIES, K; STOKER, C; SCOTT, ME				PASSMORE, AP; WILSONDAVIES, K; STOKER, C; SCOTT, ME			CHRONIC CONSTIPATION IN LONG-STAY ELDERLY PATIENTS - A COMPARISON OF LACTULOSE AND A SENNA-FIBER COMBINATION	BRITISH MEDICAL JOURNAL			English	Article							LAXATIVES	Objectives-To compare the efficacy and cost effectiveness of a senna-fibre combination and lactulose in treating constipation in long stay elderly patients. Design-Randomised, double blind, cross over study. Setting-Four hospitals in Northern Ireland, one hospital in England, and two nursing homes in England. Subjects-77 elderly patients with a history of chronic constipation in long term hospital or nursing home care. Intervention-A senna-fibre combination (10 ml daily) or lactulose (15 ml twice daily) with matching placebo for two 14 day periods, with 3-5 days before and between treatments. Main outcome measures-Stool frequency, stool consistency, and ease of evacuation; deviation from recommended dose; daily dose and cost per stool; adverse effects. Results-Mean daily bowel frequency was greater with the senna-fibre combination (0.8, 95% confidence interval 0.7 to 0.9) than lactulose (0.6, 0.5 to 0.7; t = 3.51 p less-than-or-equal-to 0.001). Scores for stool consistency and ease of evacuation were significantly higher for the senna-fibre combination than for lactulose. The recommended dose was exceeded more frequently with lactulose than the senna-fibre combination (chi2 = 8.38, p less-than-or-equal-to 0.01). As an index of the standard daily dose, the dose per stool was 1.52 for lactulose and 0.97 for the senna-fibre combination, at a cost per stool of 39.7p for lactulose and 10.3p for senna-fibre. Adverse effects were no different for the two treatments. Conclusions-Both treatments were effective and well tolerated for chronic constipation in long stay elderly patients. The senna-fibre combination was significantly more effective than lactulose at a lower cost.	WAVENEY HOSP,DEPT PHARM,BALLYMENA BT43 6HH,NORTH IRELAND; QUEENS UNIV BELFAST,DEPT THERAPEUT & PHARMACOL,DRUG UTILIZAT RES UNIT,BELFAST BT9 7BL,ANTRIM,NORTH IRELAND	Queens University Belfast	PASSMORE, AP (corresponding author), QUEENS UNIV BELFAST,DEPT GERIATR MED,WHITLA MED BLDG,97 LISBURN RD,BELFAST BT9 7BL,ANTRIM,NORTH IRELAND.							ALTMAN DG, 1991, PRACTICAL STAT MED R, P457; Andersson M, 1989, Compr Gerontol A, V3 Suppl, P8; BATEMAN DN, 1988, BRIT MED J, V297, P1420, DOI 10.1136/bmj.297.6661.1420; Connolly P, 1975, CURR MED RES OPIN, V2, P620; DEWITTE P, 1990, HEPATO-GASTROENTEROL, V37, P601; FINTELMANN V, 1977, ARZTLICHE PRAXIS, V29, P25; GODDING EW, 1988, PHARMACOLOGY, V36, P230, DOI 10.1159/000138445; HILLS M, 1979, BRIT J CLIN PHARMACO, V8, P7, DOI 10.1111/j.1365-2125.1979.tb05903.x; MACLENNAN WJ, 1975, CURR MED RES OPIN, V2, P641, DOI DOI 10.1185/03007997409111877; MARLETT JA, 1987, AM J GASTROENTEROL, V82, P333; PRIMROSE WR, 1987, AGE AGEING, V16, P25; ROUSE M, 1991, BRIT J CLIN PRACT, V45, P28; SANDERS JF, 1978, J AM GERIATR SOC, V26, P236, DOI 10.1111/j.1532-5415.1978.tb01967.x; TEDESCO FJ, 1985, AM J GASTROENTEROL, V80, P303; UPTON DR, 1988, BRIT MED J, V297, P1446, DOI 10.1136/bmj.297.6661.1446; 1988, DRUG THERAPEUTICS B, V26, P53	16	79	82	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 25	1993	307	6907					769	771		10.1136/bmj.307.6907.769	http://dx.doi.org/10.1136/bmj.307.6907.769			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LZ478	8219947	Green Published, Bronze			2022-12-28	WOS:A1993LZ47800022
J	LEVINSKY, NG				LEVINSKY, NG			RECRUITING FOR PRIMARY CARE	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											LEVINSKY, NG (corresponding author), BOSTON UNIV,MED CTR,BOSTON,MA 02118, USA.							ANDERSEN RM, 1992, ANN INTERN MED, V117, P243, DOI 10.7326/0003-4819-117-3-243; BABBOTT D, 1991, ANN INTERN MED, V114, P16, DOI 10.7326/0003-4819-114-1-16; BERNSTEIN DS, 1992, JAMA-J AM MED ASSOC, V267, P1921, DOI 10.1001/jama.1992.03480140047025; EARLEY LE, 1992, ANN INTERN MED, V116, P1080, DOI 10.7326/0003-4819-116-12-1080; FRANKS P, 1992, NEW ENGL J MED, V327, P424, DOI 10.1056/NEJM199208063270613; GREEN D, 1992, AAMCC REPORTER, V2, P1; KASSEBAUM DG, 1992, AAMC REPORTER, V2, P1; LEVIS CE, 1991, ANN INTERN MED, V114, P1; MCKAY NL, 1990, J HEALTH ECON, V9, P335, DOI 10.1016/0167-6296(90)90050-D; NORCINI JJ, 1991, ANN INTERN MED, V114, P33, DOI 10.7326/0003-4819-114-1-33; RABINOWITZ HK, 1988, NEW ENGL J MED, V319, P480, DOI 10.1056/NEJM198808253190805; SCHROEDER SA, 1992, ANN INTERN MED, V116, P583, DOI 10.7326/0003-4819-116-7-583; STEIN JH, 1991, ANN INTERN MED, V114, P79, DOI 10.7326/0003-4819-114-1-79; WHITCOMB ME, 1992, NEW ENGL J MED, V326, P1469, DOI 10.1056/NEJM199205283262205; 1992, 3RD REPORT IMPROVING; 1989, JAMA-J AM MED ASSOC, V262, P1630; 1992, ANN INTERN MED, V117, P778	17	59	59	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 4	1993	328	9					656	660		10.1056/NEJM199303043280913	http://dx.doi.org/10.1056/NEJM199303043280913			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KP680	8204112				2022-12-28	WOS:A1993KP68000013
J	OFFIT, K; LOCOCO, F; LOUIE, DC; PARSA, NZ; LEUNG, D; PORTLOCK, C; YE, BH; LISTA, F; FILIPPA, DA; ROSENBAUM, A; LADANYI, M; JHANWAR, S; DALLAFAVERA, R; CHAGANTI, RSK				OFFIT, K; LOCOCO, F; LOUIE, DC; PARSA, NZ; LEUNG, D; PORTLOCK, C; YE, BH; LISTA, F; FILIPPA, DA; ROSENBAUM, A; LADANYI, M; JHANWAR, S; DALLAFAVERA, R; CHAGANTI, RSK			REARRANGEMENT OF THE BCL-6 GENE AS A PROGNOSTIC MARKER IN DIFFUSE LARGE-CELL LYMPHOMA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NON-HODGKINS-LYMPHOMA; CONSECUTIVELY ASCERTAINED SPECIMENS; BONE-MARROW TRANSPLANTATION; FINGER ENCODING GENE; CLINICAL CORRELATIONS; CYTOGENETIC ANALYSIS; TRANSLOCATIONS; CLASSIFICATION; CHEMOTHERAPY; ABERRATIONS	Background. About 40 percent of non-Hodgkin's lymphomas are diffuse lymphomas with a large-cell component (DLLC). Current therapy can induce a longterm remission in half the patients with DLLC, but more intensive treatment has the potential to improve outcome, particularly in patients at high risk for treatment failure. Clinical and cytogenetic markers can identify subgroups at high or low risk. Rearrangement of a novel candidate proto-oncogene, bcl-6, is a possible prognostic indicator in DLLC. Methods. We performed Southern blot hybridization to detect bcl-6 and bcl-2 gene rearrangement in samples of lymphoma from 102 patients with B-cell DLLC. The results were correlated with the patients' histologic features, age, disease stage, tumor sites and bulk of disease, serum lactate dehydrogenase level, and treatment outcome. Results. Rearranged bcl-6 was found in 23 cases, and rearranged bcl-2 in 21 cases. Nineteen of the patients with rearranged bcl-6 had extranodal DLLC, two had primary splenic lymphomas, and only one had bone marrow involvement. Thirty-six months after diagnosis, the proportion with freedom from progression of disease was projected to be 82 percent (95 percent confidence interval, 66 to 98 percent) among the patients with rearranged bcl-6, as compared with 56 percent (95 percent confidence interval, 43 to 70 percent) for the patients with germ-line bcl-6 and bcl-2 and 31 percent (95 percent confidence interval, 8 to 53 percent) for the patients with rearranged bcl-2. The status of the bcl-6 gene was an independent prognostic marker of survival and freedom from disease progression in a multivariate model and added predictive value to established prognostic signs. Conclusions. Rearrangement of the bcl-6 gene correlated with a favorable clinical outcome in DLLC and may thus serve as a prognostic marker in patients with this form of malignant lymphoma.	MEM SLOAN KETTERING CANC CTR,DEPT MED,NEW YORK,NY 10021; MEM SLOAN KETTERING CANC CTR,DEPT PATHOL,NEW YORK,NY 10021; MEM SLOAN KETTERING CANC CTR,DEPT EPIDEMIOL & BIOSTAT,NEW YORK,NY 10021; MEM SLOAN KETTERING CANC CTR,CYTOGENET SERV,NEW YORK,NY 10021; COLUMBIA UNIV,COLL PHYS & SURG,DEPT PATHOL,DIV ONCOL,NEW YORK,NY; UNIV ROMA LA SAPIENZA,DIPARTIMENTO BIOPATOL UMANA,SEZ EMATOL,ROME,ITALY; CTR STUDI & RIC SANITA ESERCITO,ROME,ITALY	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Columbia University; Sapienza University Rome	OFFIT, K (corresponding author), MEM SLOAN KETTERING CANC CTR,CELL BIOL & GENET PROGRAM,BOX 192,1275 YORK AVE,NEW YORK,NY 10021, USA.		LEUNG, Denis Heng Yan/D-1439-2009; Ladanyi, Marc/AAG-8585-2019	leung, denis heng yan/0000-0002-2620-3442; lista, florigio/0000-0001-5700-4772	NATIONAL CANCER INSTITUTE [R01CA044029, P30CA008748, R01CA034775] Funding Source: NIH RePORTER; NCI NIH HHS [CA-34775, CA-44029, CA-08748] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], 1982, CANCER, V49, P2112; ARMITAGE JO, 1993, NEW ENGL J MED, V328, P1023; BARON BW, 1993, P NATL ACAD SCI USA, V90, P5262, DOI 10.1073/pnas.90.11.5262; BASTARD C, 1992, BLOOD, V79, P2527; BASTARD C, 1994, BLOOD, V83, P2423; CARBONE PP, 1971, CANCER RES, V31, P1860; CARRATO A, 1987, P AM SOC CLIN ONCOL, V6, P198; CLARK HM, 1992, J PATHOL, V166, P129, DOI 10.1002/path.1711660208; COIFFIER B, 1991, J CLIN ONCOL, V9, P211, DOI 10.1200/JCO.1991.9.2.211; COX DR, 1972, J R STAT SOC B, V34, P187; DANIEU L, 1986, CANCER RES, V46, P5372; DEVESA SS, 1992, CANCER RES, V52, pS5432; FISHER RI, 1993, NEW ENGL J MED, V328, P1002, DOI 10.1056/NEJM199304083281404; GRIBBEN JG, 1993, BLOOD, V81, P3449; GULATI SC, 1988, J CLIN ONCOL, V6, P1303, DOI 10.1200/JCO.1988.6.8.1303; International Non-Hodgkin's Lymphoma Prognostic Factors Project, 1993, NEW ENGL J MED, V329, P987; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KEMPIN S, 1983, P AM SOC CLIN ONCOL, V2, P56; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; LEROUX D, 1990, LEUKEMIA, V4, P373; LOCOCO F, 1994, BLOOD, V83, P1757, DOI 10.1182/blood.V83.7.1757.bloodjournal8371757; LOWENTHAL DA, 1987, P AM SOC CLIN ONCOL, V6, P197; MCKEITHAN TW, 1990, SEMIN ONCOL, V17, P30; MCMASTER ML, 1991, CANCER-AM CANCER SOC, V68, P233, DOI 10.1002/1097-0142(19910715)68:2<233::AID-CNCR2820680203>3.0.CO;2-Q; MITELMAN F, 1991, CATALOG CHROMOSOME A; OBRIEN JP, 1992, BLOOD, V80, pA157; OFFIT K, 1991, HEMATOL ONCOL CLIN N, V5, P853, DOI 10.1016/S0889-8588(18)30389-7; OFFIT K, 1989, BRIT J HAEMATOL, V72, P178, DOI 10.1111/j.1365-2141.1989.tb07680.x; OFFIT K, 1989, BLOOD, V74, P1876; OFFIT K, 1991, GENE CHROMOSOME CANC, V3, P189, DOI 10.1002/gcc.2870030304; OFFIT K, 1991, BLOOD, V77, P1508; RAGHOEBIER S, 1991, BLOOD, V78, P2680; RUDDERS RA, 1978, CANCER, V42, P406, DOI 10.1002/1097-0142(197808)42:2<406::AID-CNCR2820420205>3.0.CO;2-H; SIMON R, 1988, ANN INTERN MED, V109, P939, DOI 10.7326/0003-4819-109-12-939; STRAUS DJ, 1991, AM J MED, V90, P328, DOI 10.1016/0002-9343(91)90573-G; VANKRIEKEN JHJM, 1990, BLOOD, V76, P797; WARRELL RP, 1989, P AN M AM SOC CLIN, V8, P270; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; YE BHH, 1993, CANCER RES, V53, P2732; YUNIS JJ, 1989, NEW ENGL J MED, V320, P1047, DOI 10.1056/NEJM198904203201605	40	303	313	0	3	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	1994	331	2					74	80		10.1056/NEJM199407143310202	http://dx.doi.org/10.1056/NEJM199407143310202			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NW712	8208268				2022-12-28	WOS:A1994NW71200002
J	GLOWNIAK, JV; BUSHWAY, MK				GLOWNIAK, JV; BUSHWAY, MK			COMPUTER-NETWORKS AS A MEDICAL RESOURCE - ACCESSING AND USING THE INTERNET	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME DATA-BASE; INFORMATION		OREGON HLTH SCI UNIV, CTR BIOMED INFORMAT COMMUN, INFORMAT TECHNOL GRP, PORTLAND, OR 97201 USA	Oregon Health & Science University	GLOWNIAK, JV (corresponding author), VET AFFAIRS MED CTR, NUCL MED SERV, MAIL CODE 115, POB 1034, PORTLAND, OR 97207 USA.							[Anonymous], INTERNET COMPLETE RE; BRANDT KA, 1993, B MED LIBR ASSOC, V81, P285; BRENNEN PW, 1992, B MED LIBR ASSOC, V80, P294; BRINKLEY JF, 1993, COMPUT METH PROG BIO, V40, P131, DOI 10.1016/0169-2607(93)90007-8; BUTLER DL, 1992, ANN NY ACAD SCI, V670, P202, DOI 10.1111/j.1749-6632.1992.tb26091.x; COHEN AM, 1991, GUIDE NETWORKING, P75; CUTICCHIA AJ, 1993, NUCLEIC ACIDS RES, V21, P3003, DOI 10.1093/nar/21.13.3003; FISK NM, 1993, LANCET, V341, P1601, DOI 10.1016/0140-6736(93)90742-Y; FRISSE ME, 1994, ACAD MED, V69, P20, DOI 10.1097/00001888-199401000-00004; GORE A, 1991, SCI AM, V265, P150; GUARDABASSO V, 1992, ANN NY ACAD SCI, V670, P215, DOI 10.1111/j.1749-6632.1992.tb26093.x; KEHCE BP, 1993, ZEN ART INTERNET BEG; KIONG BK, 1993, COMPUT APPL BIOSCI, V9, P211; KOCHMER J, 1993, INTERNET PASSPORT N, P9; Krol E, 1992, WHOLE INTERNET USERS; LEMKIN PF, 1993, COMPUT BIOMED RES, V26, P1, DOI 10.1006/cbmr.1993.1001; MARINE A, 1993, SRI INTERNET INFORMA, P307; MCKINNEY WP, 1993, AM J MED SCI, V306, P141, DOI 10.1097/00000441-199309000-00002; POOL R, 1993, SCIENCE, V261, P841, DOI 10.1126/science.8346436; Ryer, 1993, INTERNET COMPANION B; Sparks S M, 1993, J Biocommun, V20, P2; STIX G, 1993, SCI AM, V269, P101; WOODSMALL RM, 1993, B MED LIBR ASSOC, V81, P282; 1993, FASEB J, V7, P1206	24	72	73	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	1994	271	24					1934	1939		10.1001/jama.271.24.1934	http://dx.doi.org/10.1001/jama.271.24.1934			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR598	8201738				2022-12-28	WOS:A1994NR59800031
J	CRABBE, JC; BELKNAP, JK; BUCK, KJ				CRABBE, JC; BELKNAP, JK; BUCK, KJ			GENETIC ANIMAL-MODELS OF ALCOHOL AND DRUG-ABUSE	SCIENCE			English	Review							QUANTITATIVE TRAIT LOCI; RECOMBINANT INBRED STRAINS; ETHANOL WITHDRAWAL SEIZURES; DOPAMINE-D2 RECEPTOR GENE; GAMMA-AMINOBUTYRIC ACID; NONPREFERRING NP LINES; SHORT-SLEEP MICE; PHYSICAL-DEPENDENCE; MOUSE STRAINS; LONG-SLEEP	Behavioral and pharmacological responses of selectively bred and inbred rodent lines have been analyzed to elucidate many features of drug sensitivity and the adverse effects of drugs, the underlying mechanisms of drug tolerance and dependence, and the motivational states underlying drug reward and aversion. Genetic mapping of quantitative trait loci (QTLs) has been used to identify provisional chromosomal locations of genes influencing such pharmacological responses. Recent advances in transgenic technology, representational difference analysis, and other molecular methods now make feasible the positional cloning of QTLs that influence sensitivity to drugs of abuse. This marks a new period of synthesis in pharmacogenetic research, in which networks of drug-related behaviors, their underlying pharmacological, physiological, and biochemical mechanisms, and particular genomic regions of interest are being identified.	OREGON HLTH SCI UNIV, DEPT MED PSYCHOL, PORTLAND, OR 97201 USA; OREGON HLTH SCI UNIV, DEPT PHARMACOL, PORTLAND, OR 97201 USA; OREGON HLTH SCI UNIV, VOLLUM INST ADV BIOMED RES, PORTLAND, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	CRABBE, JC (corresponding author), VET ADM MED CTR, RES SERV, PORTLAND, OR 97201 USA.				NIAAA NIH HHS [AA08621, AA06243] Funding Source: Medline; NIDA NIH HHS [DA05228] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P01AA008621, R01AA006243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA005228] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U; AKABAYASHI A, 1994, MOL BRAIN RES, V21, P55, DOI 10.1016/0169-328X(94)90377-8; ALLAN AM, 1986, LIFE SCI, V39, P2005, DOI 10.1016/0024-3205(86)90324-3; ALLEN W, 1993, AM J HUM GENET, V53, P16; BARAN A, 1975, LIFE SCI, V17, P633, DOI 10.1016/0024-3205(75)90101-0; BELKNAP J, 1993, PHARMACOLOGIST, V35, P130; Belknap J.K, 1991, GENETIC BASIS ALCOHO, P225; BELKNAP JK, 1992, ANN NY ACAD SCI, V654, P311, DOI 10.1111/j.1749-6632.1992.tb25977.x; BELKNAP JK, 1992, BEHAV GENET, V22, P677, DOI 10.1007/BF01066638; BELKNAP JK, 1993, BEHAV GENET, V23, P213, DOI 10.1007/BF01067426; BELKNAP JK, 1993, PSYCHOPHARMACOLOGY, V112, P503, DOI 10.1007/BF02244901; BELKNAP JK, 1989, LIFE SCI, V44, P2075, DOI 10.1016/0024-3205(89)90354-8; BELKNAP JK, 1987, LIFE SCI, V41, P2033, DOI 10.1016/0024-3205(87)90477-2; BELKNAP JK, 1993, PSYCHOPHARMACOLOGY, V112, P352, DOI 10.1007/BF02244932; BELKNAP JK, 1988, ALCOHOL, V5, P167, DOI 10.1016/0741-8329(88)90015-8; BELKNAP JK, UNPUB; BLUM K, 1990, JAMA-J AM MED ASSOC, V263, P2055, DOI 10.1001/jama.263.15.2055; BOLOS AM, 1990, JAMA-J AM MED ASSOC, V264, P3156; BRASE DA, 1977, J PHARMACOL EXP THER, V201, P368; BRENNAN CH, 1990, NEUROPHARMACOLOGY, V29, P429, DOI 10.1016/0028-3908(90)90163-L; BROADHURST PL, 1978, DRUGS INHERITANCE BE; BUCK KJ, 1991, J NEUROCHEM, V57, P1452, DOI 10.1111/j.1471-4159.1991.tb08313.x; BUCK KJ, 1991, J NEUROCHEM, V57, P2100, DOI 10.1111/j.1471-4159.1991.tb06428.x; BUCK KJ, UNPUB; BUCK KJ, 1994, ALCOHOL CLIN EXP RES, V18, P451; CADORET RJ, 1986, ARCH GEN PSYCHIAT, V43, P1131; CHIASSON BJ, 1992, EUR J PHARM-MOLEC PH, V227, P451, DOI 10.1016/0922-4106(92)90167-T; COLLINS AC, 1991, GENETIC BASIS ALCOHO, P323; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; COMINGS DE, 1991, JAMA-J AM MED ASSOC, V266, P1793, DOI 10.1001/jama.266.13.1793; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; CRABBE JC, 1994, J PHARMACOL EXP THER, V269, P184; CRABBE JC, 1990, ALCOHOL CLIN EXP RES, V14, P141, DOI 10.1111/j.1530-0277.1990.tb00461.x; CRABBE JC, 1994, BEHAV NEUROSCI, V108, P186, DOI 10.1037/0735-7044.108.1.186; CRABBE JC, 1985, BEHAV GENET, V15, P521, DOI 10.1007/BF01065448; CRABBE JC, 1991, J PHARMACOL EXP THER, V257, P663; CRABBE JC, 1983, NEUROBEH TOXICOL TER, V5, P181; CRABBE JC, 1993, BEHAV GENET, V23, P171, DOI 10.1007/BF01067422; CRABBE JC, 1991, GENETIC BASIS ALCOHO; CRABBE JC, IN PRESS PSYCHOPHARM; CRABBE JC, UNPUB; CUNNINGHAM C, UNPUB; CUNNINGHAM CL, 1992, PSYCHOPHARMACOLOGY, V107, P385, DOI 10.1007/BF02245166; CUNNINGHAM CL, 1994, ALCOHOL CLIN EXP RES, V18, P451; DAINS KM, 1993, SOC NEUR ABSTR, V19, P487; DIETRICH W, 1992, GENETICS, V131, P423; DUDEK BC, 1993, BEHAV GENET, V23, P179, DOI 10.1007/BF01067423; DUNWIDDIE TW, 1991, GENETIC BASIS ALCOHO, P153; EIDELBERG E, 1975, EUR J PHARMACOL, V32, P329, DOI 10.1016/0014-2999(75)90300-3; ELEFTHERIOU BE, 1975, PSYCHOPHARMACOGENETI; ELMER GI, 1988, PSYCHOPHARMACOLOGY, V96, P431, DOI 10.1007/BF02180019; ELMER GI, 1987, ALCOHOL, V4, P63, DOI 10.1016/0741-8329(87)90062-0; ELMER GI, IN PRESS PSYCHOPHARM; FELLER DJ, 1991, BRAIN RES, V545, P73, DOI 10.1016/0006-8993(91)91271-2; FINN IB, 1989, SOC NEUR ABSTR, V15, P545; FRISCHKNECHT HR, 1988, EXPERIENTIA, V44, P473, DOI 10.1007/BF01958921; GALLAHER EJ, UNPUB; GEJMAN PV, 1994, JAMA-J AM MED ASSOC, V271, P204, DOI 10.1001/jama.271.3.204; GELERNTER J, 1993, JAMA-J AM MED ASSOC, V269, P1673, DOI 10.1001/jama.269.13.1673; GENTRY RT, 1987, LIFE SCI, V40, P2191, DOI 10.1016/0024-3205(87)90010-5; GEORGE FR, 1989, TRENDS PHARMACOL SCI, V10, P78, DOI 10.1016/0165-6147(89)90083-7; Goldman D, 1993, Recent Dev Alcohol, V11, P231; GORAMASLAK G, 1991, PSYCHOPHARMACOLOGY, V104, P413, DOI 10.1007/BF02245643; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; HALEY CS, 1994, GENETICS, V136, P1195; HARRIS RA, 1989, FASEB J, V3, P1689, DOI 10.1096/fasebj.3.6.2467834; HARRIS RH, UNPUB; HEILIG M, 1993, EUR J PHARMACOL, V236, P339, DOI 10.1016/0014-2999(93)90610-T; HEN R, 1994, NIDA TECHNICAL REV M; HILBERT P, 1991, NATURE, V353, P521, DOI 10.1038/353521a0; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; JOHNSON TE, 1992, BEHAV GENET, V22, P635, DOI 10.1007/BF01066635; Kanes S. J., 1993, Society for Neuroscience Abstracts, V19, P488; KANES SJ, 1993, J PHARMACOL EXP THER, V267, P538; KNOTT SA, 1992, GENET RES, V60, P139, DOI 10.1017/S0016672300030822; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; KOSOBUD A, 1986, J PHARMACOL EXP THER, V238, P170; Kruskal J, 1978, MULTIDIMENSIONAL SCA; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; LANDER ES, 1989, GENETICS, V121, P185; LASAGNA L, 1955, JAMA-J AM MED ASSOC, V157, P1006, DOI 10.1001/jama.1955.02950290026009; Li T., COMMUNICATION; LI TK, 1993, BEHAV GENET, V23, P163, DOI 10.1007/BF01067421; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; LISITSYN NA, 1994, NAT GENET, V6, P57, DOI 10.1038/ng0194-57; LOW M, COMMUNICATION; MARKEL PD, 1994, MAMM GENOME, V5, P199, DOI 10.1007/BF00360545; MARKS MJ, 1989, PHARMACOL BIOCHEM BE, V33, P679, DOI 10.1016/0091-3057(89)90407-3; MARLEY RJ, 1988, LIFE SCI, V43, P1223, DOI 10.1016/0024-3205(88)90212-3; MCCLEARN GE, 1959, Q J STUD ALCOHOL, V20, P691; MCCLEARN GE, 1979, ALCOHOL CLIN EXP RES, V3, P255, DOI 10.1111/j.1530-0277.1979.tb05310.x; MCCLEARN GE, 1981, NATIONAL I ALCOHOL A, V6; MCINTYRE TD, 1988, J NEUROCHEM, V51, P642, DOI 10.1111/j.1471-4159.1988.tb01086.x; METTEN P, IN PRESS BEHAV PHARM; MINER LL, 1989, PHARMACOL BIOCHEM BE, V33, P469, DOI 10.1016/0091-3057(89)90532-7; MOSKOWITZ AS, 1985, BRAIN RES, V360, P108; MOSKOWITZ AS, 1985, BRAIN RES, V361, P46, DOI 10.1016/0006-8993(85)91273-9; MURPHY JM, 1989, ALCOHOL, V6, P127, DOI 10.1016/0741-8329(89)90037-2; MURPHY JM, 1987, PHARMACOL BIOCHEM BE, V26, P389, DOI 10.1016/0091-3057(87)90134-1; NESTLER EJ, 1993, NEURON, V11, P995, DOI 10.1016/0896-6273(93)90213-B; NOBLE EP, 1993, DRUG ALCOHOL DEPEN, V33, P271, DOI 10.1016/0376-8716(93)90113-5; OLIVERIO A, 1976, PHYSIOL BEHAV, V16, P577, DOI 10.1016/0031-9384(76)90218-3; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; PHILLIPS TG, UNPUB; PHILLIPS TJ, 1991, GENETIC BASIS ALCOHO, P25; PHILLIPS TJ, IN PRESS ALCOHOL CLI; PICKENS R W, 1991, Journal of Addictive Diseases, V10, P205, DOI 10.1300/J069v10n01_14; PLOMIN R, 1991, BEHAV GENET, V21, P99, DOI 10.1007/BF01066330; PLOMIN R, 1994, SCIENCE, V264, P1733, DOI 10.1126/science.8209254; POLLIO G, 1993, MOL BRAIN RES, V19, P135, DOI 10.1016/0169-328X(93)90158-L; REITH MEA, 1981, EUR J PHARMACOL, V74, P377, DOI 10.1016/0014-2999(81)90059-5; RISCH N, 1992, SCIENCE, V255, P803, DOI 10.1126/science.1536004; RISE ML, 1991, SCIENCE, V253, P669, DOI 10.1126/science.1871601; RISINGER FO, 1992, PSYCHOPHARMACOLOGY, V107, P453, DOI 10.1007/BF02245175; RISINGER FO, 1994, ALCOHOL CLIN EXP RES, V18, P451; RISINGER FO, IN PRESS PSYCHOPHARM; ROBERTS AJ, 1992, ALCOHOL CLIN EXP RES, V16, P2; RODRIGUEZ L, UNPUB; ROSSI G, IN PRESS LIFE SCI; RUBINSTEIN M, 1993, NUCLEIC ACIDS RES, V21, P2613, DOI 10.1093/nar/21.11.2613; SAMSON HH, 1992, TRENDS PHARMACOL SCI, V13, P206, DOI 10.1016/0165-6147(92)90065-E; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P2; SEARLE AG, 1994, J MED GENET, V31, P1, DOI 10.1136/jmg.31.1.1; Shuster L, 1984, NIDA Res Monogr, V54, P50; SHUSTER L, 1977, PSYCHOPHARMACOLOGY, V52, P185, DOI 10.1007/BF00439108; SHUSTER L, 1989, ANN NY ACAD SCI, V562, P56, DOI 10.1111/j.1749-6632.1989.tb21007.x; SILVER LM, 1993, MAMM GENOME, V4, pS1; STANDIFER KM, 1994, NEURON, V12, P805, DOI 10.1016/0896-6273(94)90333-6; SUZUKI T, 1990, EUR J PHARMACOL, V183, P1983, DOI 10.1016/0014-2999(90)92337-I; SUZUKI T, 1993, BRAIN RES, V602, P45, DOI 10.1016/0006-8993(93)90239-J; SUZUKI T, 1987, JPN J PHARMACOL, V45, P479, DOI 10.1254/jjp.45.479; SUZUKI T, 1988, J PHARMACOL EXP THER, V245, P164; SUZUKI T, 1992, PHARMACOL BIOCHEM BE, V42, P579, DOI 10.1016/0091-3057(92)90002-W; SUZUKI T, 1988, GENETIC ASPECTS ALCO, P157; TAKAHASHI JS, 1994, SCIENCE, V264, P1724, DOI 10.1126/science.8209253; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Taylor B. A., 1978, ORIGINS INBRED MICE, P423, DOI [10.1016/B978-0-12-507850-4.50032-9, DOI 10.1016/B978-0-12-507850-4.50032-9]; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; TOLLIVER BK, IN PRESS J PHARM EXP; VAUGHT JL, 1988, J PHARMACOL EXP THER, V245, P13; WAFFORD KA, 1990, SCIENCE, V249, P291, DOI 10.1126/science.1695761; WAFFORD KA, 1992, FEBS LETT, V313, P113, DOI 10.1016/0014-5793(92)81424-K; WAFFORD KA, 1991, NEURON, V7, P27, DOI 10.1016/0896-6273(91)90071-7; WAHLESTEDT C, 1994, TRENDS PHARMACOL SCI, V15, P42, DOI 10.1016/0165-6147(94)90107-4; WAHLESTEDT C, 1993, NATURE, V363, P260, DOI 10.1038/363260a0; WAHLESTEDT C, 1993, SCIENCE, V259, P528, DOI 10.1126/science.8380941; WALLER MB, 1984, SCIENCE, V225, P78, DOI 10.1126/science.6539502; WEISS B, 1993, NEUROSCIENCE, V55, P607, DOI 10.1016/0306-4522(93)90426-G; WISE RA, 1993, BEHAV PHARMACOL, V4, P339; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; ZHANG M, 1993, NEUROSCI LETT, V161, P223, DOI 10.1016/0304-3940(93)90299-Z; [No title captured]	153	379	381	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	1994	264	5166					1715	1723		10.1126/science.8209252	http://dx.doi.org/10.1126/science.8209252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR600	8209252				2022-12-28	WOS:A1994NR60000033
J	PLOMIN, R; OWEN, MJ; MCGUFFIN, P				PLOMIN, R; OWEN, MJ; MCGUFFIN, P			THE GENETIC-BASIS OF COMPLEX HUMAN BEHAVIORS	SCIENCE			English	Article							FAMILIAL ALZHEIMERS-DISEASE; D2-DOPAMINE RECEPTOR GENE; MALE SEXUAL ORIENTATION; X-CHROMOSOME; TWIN DATA; LINKAGE; SCHIZOPHRENIA; MARKERS; RISK; ASSOCIATION	Quantitative genetic research has built a strong case for the importance of genetic factors in many complex behavioral disorders and dimensions in the domains of psychopathology, personality, and cognitive abilities. Quantitative genetics can also provide an empirical guide and a conceptual framework for the application of molecular genetics. The success of molecular genetics in elucidating the genetic basis of behavioral disorders has largely relied on a reductionistic one gene, one disorder (OGOD) approach in which a single gene is necessary and sufficient to develop a disorder. In contrast, a quantitative trait loci (QTL) approach involves the search for multiple genes, each of which is neither necessary nor sufficient for the development of a trait. The OGOD and QTL approaches have both advantages and disadvantages for identifying genes that affect complex human behaviors.	UNIV WALES COLL MED,DEPT PSYCHIAT,CARDIFF CF4 4XN,S GLAM,WALES; UNIV WALES COLL MED,DEPT MED GENET,CARDIFF CF4 4XN,S GLAM,WALES	Cardiff University; Cardiff University	PLOMIN, R (corresponding author), PENN STATE UNIV,CTR DEV & HLTH GENET,UNIV PK,PA 16802, USA.		McGuffin, Peter/A-1565-2012; Plomin, Robert/B-8911-2008	McGuffin, Peter/0000-0002-9888-2907; Plomin, Robert/0000-0002-0756-3629	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027694] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-27694] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BAILEY JM, 1993, ARCH GEN PSYCHIAT, V50, P217; BAILEY JM, 1991, ARCH GEN PSYCHIAT, V48, P1089; BARON M, 1993, NAT GENET, V3, P49, DOI 10.1038/ng0193-49; BERGEM ALM, 1991, PSYCHIAT GENET, V2, P9; BIRD TD, 1992, GENETIC BASIS COMMON, P732; BOUCHARD TJ, 1981, SCIENCE, V212, P1055, DOI 10.1126/science.7195071; BRUNNER HG, 1993, SCIENCE, V262, P578, DOI 10.1126/science.8211186; CAMBIEN F, 1992, NATURE, V359, P641, DOI 10.1038/359641a0; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; DEFRIES JC, 1985, BEHAV GENET, V15, P467, DOI 10.1007/BF01066239; DEFRIES JC, 1993, NATURE NURTURE PSYCH, P121; Eaves L, 1989, GENES CULTURE PERSON; ELDRIDGE R, 1992, GENETIC BASIS COMMON, P775; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Fulker D. W., 1993, NATURE NURTURE PSYCH, P77; FULKER DW, 1990, AM J HUM GENET, V46, P229; FULKER DW, 1991, READ WRIT INTERDISCI, V4, P107; GELDERMANN H, 1975, THEOR APPL GENET, V46, P319, DOI 10.1007/BF00281673; GELERNTER J, 1993, JAMA-J AM MED ASSOC, V269, P1673, DOI 10.1001/jama.269.13.1673; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOTTESMAN II, 1991, SCHIZOPHRENIA GENETI; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HAMER DH, 1993, SCIENCE, V261, P321, DOI 10.1126/science.8332896; HAUSER P, 1993, NEW ENGL J MED, V328, P997, DOI 10.1056/NEJM199304083281403; HESTON LL, 1966, BRIT J PSYCHIAT, V112, P819, DOI 10.1192/bjp.112.489.819; HOLM NV, 1982, CANCER SURV, V1, P17; HUMPHRIES SE, 1988, ATHEROSCLEROSIS, V72, P89, DOI 10.1016/0021-9150(88)90069-X; KAPRIO JK, 1987, ALCOHOL CLIN EXP RES, V11, P249; KENDLER KS, 1983, AM J PSYCHIAT, V140, P1551; KING RA, 1992, GENETIC BASIS COMMON, P596; KNIGHT SJL, 1993, CELL, V74, P127, DOI 10.1016/0092-8674(93)90300-F; LANDER ES, 1989, GENETICS, V121, P185; Loehlin J., 1976, HEREDITY ENV PERSONA, DOI DOI 10.7560/730038; Loehlin J.C., 1992, GENES ENV PERSONALIT; MCGUE M, 1993, NATURE NURTURE PSYCH, P245; McGue M, 1993, NATURE NURTURE PSYCH, P59, DOI DOI 10.1037/10131-003; MCGUFFIN P, 1994, BRIT J PSYCHIAT, V164, P593, DOI 10.1192/bjp.164.5.593; MCGUFFIN P, 1986, HUM HERED, V36, P65, DOI 10.1159/000153604; McGuffin P., 1991, NEW GENETICS MENTAL, P165; McGuffin P., 1994, SEMINARS PSYCHIATRIC; Morton N. E., 1982, OUTLINE GENETIC EPID; Neale MC, 1992, METHODOLOGY GENETIC; NOBLE EP, 1993, BEHAV GENET, V23, P119, DOI 10.1007/BF01067416; OWEN M, 1994, BRIT MED J, V308, P672, DOI 10.1136/bmj.308.6930.672; OWEN MJ, 1990, TRENDS NEUROSCI, V13, P29, DOI 10.1016/0166-2236(90)90059-J; OWEN MJ, 1993, J MED GENET, V30, P638, DOI 10.1136/jmg.30.8.638; PEDERSEN NL, IN PRESS INTELLIGENC; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; PLOMIN R, 1991, BEHAV BRAIN SCI, V14, P373, DOI 10.1017/S0140525X00070278; PLOMIN R, 1994, BEHAV GENET, V24, P107, DOI 10.1007/BF01067815; PLOMIN R, 1987, BEHAV BRAIN SCI, V10, P1, DOI 10.1017/S0140525X00055941; PLOMIN R, 1990, BEHAVIORAL GENETICS; PLOMIN R, 1994, SOCIAL DEV, V3, P37; PLOMIN R, 1993, NATURE NURTURE PSYCH; Plomin R, 1991, BIOL RISK FACTORS PS, P101; Plomin R., 1994, GENETICS EXPERIENCE; RISCH N, 1990, AM J HUM GENET, V46, P229; ROBERTS CA, 1974, J VOCAT BEHAV, V4, P237, DOI 10.1016/0001-8791(74)90107-9; ROTTER JI, 1992, GENETIC BASIS COMMON, P240; Rowe D. C., 1994, LIMITS FAMILY INFLUE; SCARR S, 1992, CHILD DEV, V63, P1, DOI 10.2307/1130897; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; SCHELLENBERG GD, 1992, SCIENCE, V258, P668, DOI 10.1126/science.1411576; SCHOENFELDT LF, 1968, MEAS EVAL GUID, V1, P130, DOI 10.1080/00256307.1968.12022379; SING CF, 1987, MOL APPROACHES HUMAN, P99; SKOOG I, 1993, NEW ENGL J MED, V328, P153, DOI 10.1056/NEJM199301213280301; SMALLEY SL, 1988, ARCH GEN PSYCHIAT, V45, P953; SMITH SD, 1991, READ WRIT, V3, P285, DOI 10.1007/BF00354963; SMITH SD, 1990, J AM ACAD CHILD PSY, V29, P204, DOI 10.1097/00004583-199003000-00008; SMITH SD, 1983, SCIENCE, V219, P1345, DOI 10.1126/science.6828864; SOBELL JL, 1992, GENOMICS, V12, P1, DOI 10.1016/0888-7543(92)90398-C; SOBELL JL, 1993, AM J MED GENET, V48, P28, DOI 10.1002/ajmg.1320480108; STEVENSON J, 1992, J CHILD PSYCHOL PSYC, V33, P977, DOI 10.1111/j.1469-7610.1992.tb00919.x; TERWILLIGER JD, 1992, HUM HERED, V42, P337, DOI 10.1159/000154096; THOMPSON LA, 1991, PSYCHOL SCI, V2, P158, DOI 10.1111/j.1467-9280.1991.tb00124.x; UHL G, 1993, TRENDS NEUROSCI, V16, P83, DOI 10.1016/0166-2236(93)90128-9; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Vernon P.A., 1993, BIOL APPROACHES STUD; WADSWORTH SJ, 1994, NATURE NURTURE MIDDL, P86; WALHSTEN J, 1990, J MENT DEFIC RES, V34, P11; WICHTORIN M, 1952, BIDRAG RAKNEFARDIGHE; WOO SLC, 1991, GENES BRAIN BEHAV, P193; WRIGHT AF, 1991, NEW GENETICS MENTAL	83	728	747	1	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 17	1994	264	5166					1733	1739		10.1126/science.8209254	http://dx.doi.org/10.1126/science.8209254			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	NR600	8209254				2022-12-28	WOS:A1994NR60000035
J	GRAMM, P				GRAMM, P			WHY WE NEED MEDICAL SAVINGS ACCOUNTS	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											GRAMM, P (corresponding author), OFF SENATOR PHIL GRAMM,370 RUSSELL OFF BLDG,WASHINGTON,DC 20510, USA.								0	19	19	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 16	1994	330	24					1752	1753		10.1056/NEJM199406163302411	http://dx.doi.org/10.1056/NEJM199406163302411			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR109	8190138				2022-12-28	WOS:A1994NR10900011
J	LOK, S; KAUSHANSKY, K; HOLLY, RD; KUIJPER, JL; LOFTONDAY, CE; OORT, PJ; GRANT, FJ; HEIPEL, MD; BURKHEAD, SK; KRAMER, JM; BELL, LA; SPRECHER, CA; BLUMBERG, H; JOHNSON, R; PRUNKARD, D; CHING, AFT; MATHEWES, SL; BAILEY, MC; FORSTROM, JW; BUDDLE, MM; OSBORN, SG; EVANS, SJ; SHEPPARD, PO; PRESNELL, SR; OHARA, PJ; HAGEN, FS; ROTH, GJ; FOSTER, DC				LOK, S; KAUSHANSKY, K; HOLLY, RD; KUIJPER, JL; LOFTONDAY, CE; OORT, PJ; GRANT, FJ; HEIPEL, MD; BURKHEAD, SK; KRAMER, JM; BELL, LA; SPRECHER, CA; BLUMBERG, H; JOHNSON, R; PRUNKARD, D; CHING, AFT; MATHEWES, SL; BAILEY, MC; FORSTROM, JW; BUDDLE, MM; OSBORN, SG; EVANS, SJ; SHEPPARD, PO; PRESNELL, SR; OHARA, PJ; HAGEN, FS; ROTH, GJ; FOSTER, DC			CLONING AND EXPRESSION OF MURINE THROMBOPOIETIN CDNA AND STIMULATION OF PLATELET PRODUCTION IN-VIVO	NATURE			English	Article							FACTOR RECEPTOR SUPERFAMILY; MOLECULAR-CLONING; C-MPL; GROWTH; MEGAKARYOCYTOPOIESIS; SEQUENCE; MEMBER; IDENTIFICATION; PROTOONCOGENE; INTERLEUKIN-6	THE major regulator of circulating platelet levels is believed to be a cytokine termed thrombopoietin(1,2). It is thought to be a lineage-specific cytokine affecting the proliferation and maturation of committed cells resulting in the production of megakaryocytes and platelets. Despite considerable efforts by a number of laboratories, the unequivocal identification of thrombopoietin has proven elusive. Here we report the functional cloning of a murine complementarg DNA encoding a ligand for the receptor encoded by the c-mpl proto-oncogene (c-Mpl)3-5. The encoded polypeptide has a predicted molecular mass of 35,000 (M(r) 35K). The protein has a novel two-domain structure with an amino-terminal domain homologous with erythropoietin and a carboxy-terminal domain rich in serine, threonine and proline residues and containing seven potential N-linked glycosylation sites. Intraperitoneal injections of mice with recombinant protein increase circulating platelet levels by greater than fourfold after 7 days. These results along with those presented in the accompanying report strongly suggest that the ligand for c-Mpl is thrombopoietin.	ZYMOGENET INC,SEATTLE,WA 98105; UNIV WASHINGTON,SCH MED,DIV HEMATOL,SEATTLE,WA 98195	Zymogenet Inc.; University of Washington; University of Washington Seattle								BARR PJ, 1994, CELL, V66, P1; BENSON D, 1993, NUCLEIC ACIDS RES, V21, P2963, DOI 10.1093/nar/21.13.2963; BOISSEL JP, 1993, J BIOL CHEM, V268, P1583; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; CARRINGTON PA, 1991, BLOOD, V77, P34; CHOW FPR, 1993, EXP HEMATOL, V21, P255; FOSTER DC, 1987, BIOCHEMISTRY-US, V26, P7003, DOI 10.1021/bi00396a022; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; HANNUM C, 1994, NATURE, V368, P643, DOI 10.1038/368643a0; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; ISHIBASHI T, 1989, BLOOD, V74, P1241; KAUSHANSKY K, 1994, NATURE, V369, P568, DOI 10.1038/369568a0; LACOMBE C, 1988, J CLIN INVEST, V81, P620, DOI 10.1172/JCI113363; MCDONALD TP, 1988, EXP HEMATOL, V16, P201; MCDONALD TP, 1992, AM J PEDIAT HEMATOL, V14, P8; METHIA N, 1993, BLOOD, V82, P1395; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NEBEN TY, 1993, BLOOD, V81, P901; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; RECNY MA, 1987, J BIOL CHEM, V262, P17156; SENDA T, 1992, EMBO J, V11, P3193, DOI 10.1002/j.1460-2075.1992.tb05396.x; SHAW G, 1986, CELL, V46, P659, DOI 10.1016/0092-8674(86)90341-7; SKODA RC, 1993, EMBO J, V12, P2645, DOI 10.1002/j.1460-2075.1993.tb05925.x; SOUYRI M, 1990, CELL, V63, P1137, DOI 10.1016/0092-8674(90)90410-G; VIGON I, 1993, ONCOGENE, V8, P2607; VIGON I, 1992, P NATL ACAD SCI USA, V89, P5640, DOI 10.1073/pnas.89.12.5640; Wilks AF, 1989, GROWTH FACTORS, V2, P31, DOI 10.3109/08977198909069079	27	1009	1048	0	17	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 16	1994	369	6481					565	568		10.1038/369565a0	http://dx.doi.org/10.1038/369565a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR294	8202158				2022-12-28	WOS:A1994NR29400051
J	DARNELL, JE; KERR, IM; STARK, GR				DARNELL, JE; KERR, IM; STARK, GR			JAK-STAT PATHWAYS AND TRANSCRIPTIONAL ACTIVATION IN RESPONSE TO IFNS AND OTHER EXTRACELLULAR SIGNALING PROTEINS	SCIENCE			English	Article							INTERFERON-INDUCED TRANSCRIPTION; GUANYLATE-BINDING PROTEIN; INDUCED NUCLEAR FACTORS; MUTANT-CELL LINE; TYROSINE KINASE; GAMMA-INTERFERON; ALPHA-INTERFERON; GROWTH-FACTOR; STIMULATED TRANSCRIPTION; CYTOPLASMIC ACTIVATION	Through the study of transcriptional activation in response to interferon alpha (IFN-alpha) and interferon gamma (IFN-gamma), a previously unrecognized direct signal transduction pathway to the nucleus has been uncovered: IFN-receptor interaction at the cell surface leads to the activation of kinases of the Jak family that then phosphorylate substrate proteins called STATs (signal transducers and activators of transcription). The phosphorylated STAT proteins move to the nucleus, bind specific DNA elements, and direct transcription. Recognition of the molecules involved in the IFN-alpha and IFN-gamma pathway has led to discoveries that a number of STAT family members exist and that other polypeptide ligands also use the Jak-STAT molecules in signal transduction.	IMPERIAL CANC RES FUND,LONDON WC2A 3PX,ENGLAND; CLEVELAND CLIN FDN,RES INST,CLEVELAND,OH 44195	Cancer Research UK; Cleveland Clinic Foundation	DARNELL, JE (corresponding author), ROCKEFELLER UNIV,MOLEC CELL BIOL LAB,NEW YORK,NY 10021, USA.		Yang, Chen/G-1379-2010					AGUET M, 1988, CELL, V55, P273, DOI 10.1016/0092-8674(88)90050-5; ALMENDRAL JM, 1988, MOL CELL BIOL, V8, P2140, DOI 10.1128/MCB.8.5.2140; ARGETSINGER LS, 1993, CELL, V74, P237, DOI 10.1016/0092-8674(93)90415-M; Baron S, 1992, INTERFERON PRINCIPLE; BEADLING C, 1993, P NATL ACAD SCI USA, V90, P2719, DOI 10.1073/pnas.90.7.2719; BLANAR MA, 1988, P NATL ACAD SCI USA, V85, P4672, DOI 10.1073/pnas.85.13.4672; BONNI A, 1993, SCIENCE, V262, P1575, DOI 10.1126/science.7504325; COHEN B, 1988, EMBO J, V7, P1411, DOI 10.1002/j.1460-2075.1988.tb02958.x; COLAMONICI OR, 1992, J IMMUNOL, V148, P2126; DALE TC, 1989, P NATL ACAD SCI USA, V86, P1203, DOI 10.1073/pnas.86.4.1203; DALE TC, 1989, EMBO J, V8, P831, DOI 10.1002/j.1460-2075.1989.tb03444.x; DAVID M, 1992, SCIENCE, V257, P813, DOI 10.1126/science.1496402; DECKER T, 1989, EMBO J, V8, P2009, DOI 10.1002/j.1460-2075.1989.tb03608.x; DECKER T, 1991, EMBO J, V10, P927, DOI 10.1002/j.1460-2075.1991.tb08026.x; FIRMBACHKRAFT I, 1990, ONCOGENE, V5, P1329; FISCHER EH, 1991, SCIENCE, V253, P401, DOI 10.1126/science.1650499; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; FU XY, 1992, P NATL ACAD SCI USA, V89, P7840, DOI 10.1073/pnas.89.16.7840; FU XY, 1992, CELL, V70, P323, DOI 10.1016/0092-8674(92)90106-M; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; GARRER MM, 1981, NUCLEIC ACIDS RES, V9, P3047; GRAHAM R, 1991, SCIENCE, V251, P189, DOI 10.1126/science.1898992; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; GUSCHIN D, UNPUB; HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4; HARPUR AG, 1992, ONCOGENE, V7, P895; HEMMI S, 1994, CELL, V76, P803, DOI 10.1016/0092-8674(94)90355-7; HOLLAND S, UNPUB; IGARASHI K, 1993, MOL CELL BIOL, V13, P3984, DOI 10.1128/MCB.13.7.3984; IMPROTA T, IN PRESS P NATL ACAD; JOHN J, 1991, MOL CELL BIOL, V11, P4189, DOI 10.1128/MCB.11.8.4189; KAHN KD, 1993, P NATL ACAD SCI USA, V90, P6806; KANNO Y, 1993, MOL CELL BIOL, V13, P3951, DOI 10.1128/MCB.13.7.3951; KESSLER DS, 1990, GENE DEV, V4, P1753, DOI 10.1101/gad.4.10.1753; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; KOTANIDES H, 1993, SCIENCE, V262, P1265, DOI 10.1126/science.7694370; LAMER AC, 1993, SCIENCE, V261, P1730; LARNER AC, 1984, P NATL ACAD SCI-BIOL, V81, P6733, DOI 10.1073/pnas.81.21.6733; LARNER AC, 1986, J BIOL CHEM, V261, P453; LEE TH, 1990, MOL CELL BIOL, V10, P1982, DOI 10.1128/MCB.10.5.1982; LEUNG SY, UNPUB; LEVY D, 1990, New Biologist, V2, P923; LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383; LEVY DE, 1990, EMBO J, V9, P1105, DOI 10.1002/j.1460-2075.1990.tb08216.x; LEVY DE, 1989, GENE DEV, V3, P1362, DOI 10.1101/gad.3.9.1362; LEVY DE, 1992, INTERFERON PRINCIPLE, P161; LEW DJ, 1989, MOL CELL BIOL, V9, P5404, DOI 10.1128/MCB.9.12.5404; LEW DJ, 1991, MOL CELL BIOL, V11, P182, DOI 10.1128/MCB.11.1.182; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; MAO C, 1993, P NATL ACAD SCI USA, V90, P2880, DOI 10.1073/pnas.90.7.2880; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; MIRKOVITCH J, 1992, MOL BIOL CELL, V3, P1085, DOI 10.1091/mbc.3.10.1085; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; MULLER M, 1993, EMBO J, V12, P4221, DOI 10.1002/j.1460-2075.1993.tb06106.x; Muller M.P., UNPUB; MURDOCH GH, 1982, NATURE, V300, P192, DOI 10.1038/300192a0; OVERDUIN M, 1992, CELL, V70, P697, DOI 10.1016/0092-8674(92)90437-H; PEARSE RN, 1993, P NATL ACAD SCI USA, V90, P4314, DOI 10.1073/pnas.90.9.4314; PELLEGRINI S, 1989, MOL CELL BIOL, V9, P4605, DOI 10.1128/MCB.9.11.4605; PELLEGRINI S, COMMUNICATION; PINE R, 1990, MOL CELL BIOL, V10, P2448, DOI 10.1128/MCB.10.6.2448; PORTER ACG, 1988, EMBO J, V7, P85, DOI 10.1002/j.1460-2075.1988.tb02786.x; QURESHI SA, UNPUB; REICH N, 1987, P NATL ACAD SCI USA, V84, P6394, DOI 10.1073/pnas.84.18.6394; RUFFJAMISON S, 1993, SCIENCE, V261, P1733, DOI 10.1126/science.8378774; RUTHERFORD MN, 1988, EMBO J, V7, P751, DOI 10.1002/j.1460-2075.1988.tb02872.x; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; SCHINDLER C, 1992, P NATL ACAD SCI USA, V89, P7836, DOI 10.1073/pnas.89.16.7836; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; SCHREIBER R, COMMUNICATION; SHIRAYOSHI Y, 1988, P NATL ACAD SCI USA, V85, P5884, DOI 10.1073/pnas.85.16.5884; SHUAI K, 1993, SCIENCE, V261, P1744, DOI 10.1126/science.7690989; SHUAI K, IN PRESS CELL; SHUAI K, UNPUB; SHUAL K, 1993, NATURE, V366, P580, DOI 10.1038/366580a0; SILVENNOINEN O, 1993, NATURE, V366, P583, DOI 10.1038/366583a0; SILVENNOINEN O, 1993, P NATL ACAD SCI USA, V90, P8429, DOI 10.1073/pnas.90.18.8429; SILVENNOINEN O, 1993, SCIENCE, V261, P1736, DOI 10.1126/science.8378775; SIMS SH, 1993, MOL CELL BIOL, V13, P699; SOH J, 1994, CELL, V76, P793, DOI 10.1016/0092-8674(94)90354-9; UZE G, 1990, CELL, V60, P225, DOI 10.1016/0092-8674(90)90738-Z; VEALS SA, 1992, MOL CELL BIOL, V12, P3315, DOI 10.1128/MCB.12.8.3315; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; WAKAO H, IN PRESS EMBO J; WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0; WATLING D, UNPUB; WILKS AF, 1991, MOL CELL BIOL, V11, P2057, DOI 10.1128/MCB.11.4.2057; WILKS AF, 1989, P NATL ACAD SCI USA, V86, P1603, DOI 10.1073/pnas.86.5.1603; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; YAMAMATO K, IN PRESS MOL CELL BI; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; ZHONG Z, IN PRESS P NATL ACAD	97	4879	5043	10	376	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 3	1994	264	5164					1415	1421		10.1126/science.8197455	http://dx.doi.org/10.1126/science.8197455			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NP221	8197455				2022-12-28	WOS:A1994NP22100031
J	THIERFELDER, L; WATKINS, H; MACRAE, C; LAMAS, R; MCKENNA, W; VOSBERG, HP; SEIDMAN, JG; SEIDMAN, CE				THIERFELDER, L; WATKINS, H; MACRAE, C; LAMAS, R; MCKENNA, W; VOSBERG, HP; SEIDMAN, JG; SEIDMAN, CE			ALPHA-TROPOMYOSIN AND CARDIAC TROPONIN-T MUTATIONS CAUSE FAMILIAL HYPERTROPHIC CARDIOMYOPATHY - A DISEASE OF THE SARCOMERE	CELL			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; CHROMOSOMAL LOCALIZATION; CLINICAL MANIFESTATIONS; PATHO-PHYSIOLOGY; ADULT ISOFORMS; MUSCLE; GENE; EXPRESSION; ORGANIZATION; EXONS	We demonstrate that missense mutations (Asp175Asn; Glu180Gly) in the alpha-tropomyosin gene cause familial hypertrophic cardiomyopathy (FHC) linked to chromosome 15q2. These findings implicated components of the troponin complex as candidate genes at other FHC loci, particularly cardiac troponin T, which was mapped in this study to chromosome 1q. Missense mutations (Ile79Asn; Arg92Gln) and a mutation in the splice donor sequence of intron 15 of the cardiac troponin T gene are also shown to cause FHC. Because alpha-tropomyosin and cardiac troponin T as well as beta myosin heavy chain mutations cause the same phenotype, we conclude that FHC is a disease of the sarcomere. Further, because the splice site mutation is predicted to function as a null allele, we suggest that abnormal stoichiometry of sarcomeric proteins can cause cardiac hypertrophy.	HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT MED,DIV CARDIOL,BOSTON,MA 02115; MIL HOSP,NEONTOL UNIT,SANTIAGO,CHILE; ST GEORGE HOSP,SCH MED,DEPT CARDIOL SCI,LONDON SW17 0RE,ENGLAND; MAX PLANCK INST PHYSIOL & CLIN RES,D-61231 BAD NAUHEIM,GERMANY	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; St Georges University London; Max Planck Society	THIERFELDER, L (corresponding author), HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02115, USA.		McKenna, William J/C-3243-2008	McKenna, William J/0000-0001-7994-2460; Watkins, Hugh/0000-0002-5287-9016	NHLBI NIH HHS [HL46320, HL42467] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046320, R01HL042467] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANAN H, 1994, J CLIN INVEST, V93, P280; ANDERSON PAW, 1991, CIRC RES, V69, P73; BREITBART RE, 1986, J MOL BIOL, V188, P313, DOI 10.1016/0022-2836(86)90157-9; BRISSON JR, 1986, BIOCHEMISTRY-US, V25, P4548, DOI 10.1021/bi00364a014; BUCHER EA, 1989, J BIOL CHEM, V264, P12482; CARRIER L, 1993, NAT GENET, V4, P311, DOI 10.1038/ng0793-311; CHOU YHW, 1992, NAT GENET, V1, P295, DOI 10.1038/ng0792-295; COOPER TA, 1985, J BIOL CHEM, V260, P1140; DAVIES MJ, 1990, BRIT HEART J, V63, P263; FANANAPAZIR L, 1994, CIRCULATION, V89, P22, DOI 10.1161/01.CIR.89.1.22; FYRBERG E, 1990, J MOL BIOL, V216, P657, DOI 10.1016/0022-2836(90)90390-8; GAHLMANN R, 1987, J BIOL CHEM, V262, P16122; GREEN MR, 1986, ANNU REV GENET, V20, P671, DOI 10.1146/annurev.ge.20.120186.003323; HARDY S, 1991, EUR J BIOCHEM, V202, P431, DOI 10.1111/j.1432-1033.1991.tb16392.x; ISHII Y, 1991, J BIOL CHEM, V266, P6894; JARCHO JA, 1989, NEW ENGL J MED, V321, P1372, DOI 10.1056/NEJM198911163212005; JIN JP, 1992, J MOL BIOL, V227, P1269, DOI 10.1016/0022-2836(92)90540-Z; JIN JP, 1989, J BIOL CHEM, V264, P14471; LEESMILLER JP, 1991, BIOESSAYS, V13, P429, DOI 10.1002/bies.950130902; LESYK J, 1987, BIOCHEMISTRY-US, V26, P7035; MACLEOD AR, 1988, MOL CELL BIOL, V8, P433, DOI 10.1128/MCB.8.1.433; MALOUF NN, 1992, J BIOL CHEM, V267, P9269; MARON BJ, 1987, NEW ENGL J MED, V316, P844, DOI 10.1056/NEJM198704023161405; MARON BJ, 1987, NEW ENGL J MED, V316, P780, DOI 10.1056/NEJM198703263161305; MCAULIFFE JJ, 1991, PEDIATR RES, V29, P580, DOI 10.1203/00006450-199106010-00012; MESNARD L, 1993, FEBS LETT, V328, P139, DOI 10.1016/0014-5793(93)80981-Y; MOGAMI K, 1981, JPN J GENET, V56, P51, DOI 10.1266/jjg.56.51; OLSEN EGJ, 1992, CARDIOMYOPATHIES REA; OTT J, 1976, AM J HUM GENET, V28, P528; PAN BS, 1991, J BIOL CHEM, V266, P12432; PARKER TG, 1991, ANNU REV PHYSIOL, V53, P179; PEARLSTONE JR, 1977, J BIOL CHEM, V252, P983; PEARLSTONE JR, 1986, J BIOL CHEM, V261, P6795; PIERCE JC, 1992, METHOD ENZYMOL, V216, P549; PRASAD GL, 1991, BIOCHEM BIOPH RES CO, V177, P1068, DOI 10.1016/0006-291X(91)90647-P; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; ROSENZWEIG A, 1991, NEW ENGL J MED, V325, P1753, DOI 10.1056/NEJM199112193252501; RUIZOPAZO N, 1987, J BIOL CHEM, V262, P4755; SCHLEEF M, 1993, GENOMICS, V17, P519, DOI 10.1006/geno.1993.1361; SMILLIE LB, 1988, J BIOL CHEM, V263, P18816; TAKENAGA K, 1988, MOL CELL BIOL, V8, P5561, DOI 10.1128/MCB.8.12.5561; THIERFELDER L, 1993, P NATL ACAD SCI USA, V90, P6270, DOI 10.1073/pnas.90.13.6270; VAUGHAN KT, 1993, GENOMICS, V16, P34, DOI 10.1006/geno.1993.1136; WATKINS H, 1993, NAT GENET, V3, P333, DOI 10.1038/ng0493-333; WATKINS H, 1992, NEW ENGL J MED, V326, P1108, DOI 10.1056/NEJM199204233261703; WHITE SP, 1987, NATURE, V325, P826, DOI 10.1038/325826a0; ZOT AS, 1987, ANNU REV BIOPHYS BIO, V16, P535	47	830	863	0	21	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUN 3	1994	77	5					701	712		10.1016/0092-8674(94)90054-X	http://dx.doi.org/10.1016/0092-8674(94)90054-X			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NQ123	8205619				2022-12-28	WOS:A1994NQ12300010
J	OBRIEN, TP; GOLDBERG, MF				OBRIEN, TP; GOLDBERG, MF			OPHTHALMOLOGY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CATARACT-SURGERY; ULCERATIVE KERATITIS; CIGARETTE-SMOKING; CONTACT-LENSES; OPTIC NEURITIS; RISK; USERS				OBRIEN, TP (corresponding author), JOHNS HOPKINS UNIV, SCH MED, WILMER EYE INST, BALTIMORE, MD 21205 USA.							BECK RW, 1993, NEW ENGL J MED, V329, P1764, DOI 10.1056/NEJM199312093292403; BECK RW, 1993, OPHTHALMOLOGY, V100, P691; BRENNER MH, 1993, ARCH OPHTHALMOL-CHIC, V111, P680, DOI 10.1001/archopht.1993.01090050114040; BUEHLER PO, 1992, ARCH OPHTHALMOL-CHIC, V110, P1555, DOI 10.1001/archopht.1992.01080230055019; CHRISTEN WG, 1992, JAMA-J AM MED ASSOC, V268, P989; DONSHIK P, 1988, CLAO Journal, V14, P191; HANKINSON SE, 1992, JAMA-J AM MED ASSOC, V268, P994, DOI 10.1001/jama.268.8.994; JAVITT JC, 1993, ARCH OPHTHALMOL-CHIC, V111, P686, DOI 10.1001/archopht.1993.01090050120041; LAMBERT HM, 1992, AM J OPHTHALMOL, V113, P257, DOI 10.1016/S0002-9394(14)71576-4; MAGUIRE MG, 1992, ARCH OPHTHALMOL-CHIC, V110, P1392; MATTHEWS TD, 1992, ARCH OPHTHALMOL-CHIC, V110, P1559, DOI 10.1001/archopht.1992.01080230059020; MUFLOZ B, 1993, ARCH OPHTHALMOL-CHIC, V111, P110; SCHEIN OD, 1994, ARCH OPHTHALMOL-CHIC, V112, P186, DOI 10.1001/archopht.1994.01090140062024; SCHEIN OD, 1989, NEW ENGL J MED, V321, P773, DOI 10.1056/NEJM198909213211201; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; THANH HX, 1992, OPHTHALMOLOGY, V99, P1062; VITALE S, 1993, EPIDEMIOLOGY, V4, P195, DOI 10.1097/00001648-199305000-00003; WEST S, 1994, ARCH OPHTHALMOL-CHIC, V112, P222, DOI 10.1001/archopht.1994.01090140098031; WILHELMUS KR, IN PRESS OPHTHALMOLO; YANNUZZI LA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1701	20	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1695	1696						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182857				2022-12-28	WOS:A1994NN11700036
J	LEVINE, M; WALTER, S; LEE, H; HAINES, T; HOLBROOK, A; MOYER, V; GUYATT, G; BASS, E; BROWMAN, G; COOK, D; FARKOUH, M; GERSTEIN, H; HAYWARD, R; HAYNES, B; JAESCHKE, R; JUNIPER, E; LAUPACIS, A; NAYLOR, D; NISHIKAWA, J; OXMAN, A; PATEL, A; PHILBRICK, J; RICHARDSON, S; SAUVE, S; SACKETT, D; SINCLAIR, J; STROM, B; TROUT, KS; TUNIS, S; WILLIAMS, J; WILSON, M				LEVINE, M; WALTER, S; LEE, H; HAINES, T; HOLBROOK, A; MOYER, V; GUYATT, G; BASS, E; BROWMAN, G; COOK, D; FARKOUH, M; GERSTEIN, H; HAYWARD, R; HAYNES, B; JAESCHKE, R; JUNIPER, E; LAUPACIS, A; NAYLOR, D; NISHIKAWA, J; OXMAN, A; PATEL, A; PHILBRICK, J; RICHARDSON, S; SAUVE, S; SACKETT, D; SINCLAIR, J; STROM, B; TROUT, KS; TUNIS, S; WILLIAMS, J; WILSON, M			USERS GUIDES TO THE MEDICAL LITERATURE .4. HOW TO USE AN ARTICLE ABOUT HARM	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASSOCIATION; RISK; FLUOXETINE; MORTALITY; CHILDREN; THERAPY		MCMASTER UNIV,DEPT CLIN EPIDEMIOL & BIOSTAT,HAMILTON,ON,CANADA; MCMASTER UNIV,DEPT MED,HAMILTON,ON,CANADA; MCMASTER UNIV,OCCUPAT HLTH PROGRAM,HAMILTON,ON,CANADA; UNIV TEXAS,DEPT PEDIAT,HOUSTON,TX	McMaster University; McMaster University; McMaster University; University of Texas System			Walter, Stephen/AAB-5548-2022; Haines, Terrence/E-9372-2015; Oxman, Andrew/Y-3004-2019	Walter, Stephen/0000-0003-4157-8928; Haines, Terrence/0000-0003-3150-6154; Oxman, Andrew/0000-0002-5608-5061				BEASLEY CM, 1991, BMJ-BRIT MED J, V303, P685, DOI 10.1136/bmj.303.6804.685; BROWNER WS, 1992, JAMA-J AM MED ASSOC, V268, P228, DOI 10.1001/jama.268.2.228; CARSON JL, 1987, ARCH INTERN MED, V147, P85, DOI 10.1001/archinte.147.1.85; DEMENT JM, 1983, AM J IND MED, V4, P421, DOI 10.1002/ajim.4700040304; DOLL R, 1964, BMJ-BRIT MED J, V1, P1460, DOI 10.1136/bmj.1.5396.1460; DOLL R, 1964, BRIT MED J, V1, P1399, DOI 10.1136/bmj.1.5395.1399; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; GUYATT GH, 1994, JAMA-J AM MED ASSOC, V271, P59, DOI 10.1001/jama.271.1.59; GUYATT GH, 1993, JAMA-J AM MED ASSOC, V270, P2598, DOI 10.1001/jama.270.21.2598; HERBST AL, 1971, NEW ENGL J MED, V284, P878, DOI 10.1056/NEJM197104222841604; HIATT RA, 1986, PREV MED, V15, P652, DOI 10.1016/0091-7435(86)90070-8; HOLMES LB, 1983, TERATOLOGY, V27, P277, DOI 10.1002/tera.1420270216; KELLERMANN AL, 1993, NEW ENGL J MED, V329, P1084, DOI 10.1056/NEJM199310073291506; KRISTENSEN P, 1993, AM J EPIDEMIOL, V137, P134, DOI 10.1093/oxfordjournals.aje.a116653; OGILVIE RI, 1993, CAN MED ASSOC J, V149, P575; RAY WA, 1987, NEW ENGL J MED, V316, P363, DOI 10.1056/NEJM198702123160702; Sackett DL, 1991, CLIN EPIDEMIOLOGY BA, V2nd; SOUMERAI SB, 1992, MILBANK Q, V70, P155, DOI 10.2307/3350088; Soverchia G, 1981, Pediatr Med Chir, V3, P97; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; TEICHER MH, 1990, AM J PSYCHIAT, V147, P207; WALTER SD, 1977, AM J EPIDEMIOL, V105, P387, DOI 10.1093/oxfordjournals.aje.a112395; 1992, NEW ENGL J MED, V327, P227	23	250	258	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	1994	271	20					1615	1619		10.1001/jama.271.20.1615	http://dx.doi.org/10.1001/jama.271.20.1615			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NL758	8182815				2022-12-28	WOS:A1994NL75800032
J	STRATTON, KR; HOWE, CJ; JOHNSTON, RB; MAJEWSKI, D				STRATTON, KR; HOWE, CJ; JOHNSTON, RB; MAJEWSKI, D			ADVERSE EVENTS ASSOCIATED WITH CHILDHOOD VACCINES OTHER THAN PERTUSSIS AND RUBELLA - SUMMARY OF A REPORT FROM THE INSTITUTE-OF-MEDICINE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								In September 1993, the Institute of Medicine released a report entitled Adverse Events Associated With Childhood Vaccines: Evidence Bearing on Causality. The report examined putative serious adverse consequences associated with administration of diphtheria and tetanus toxoids; measles, mumps, and measles-mumps-rubella vaccines; oral polio vaccine and inactivated polio vaccine; hepatitis B vaccines; and Haemophilus influenzae type b (Hib) vaccines. The committee spent 18 months reviewing all available scientific and medical data, from individual case reports (published and unpublished) to controlled clinical trials. The committee found that the evidence favored the rejection of a causal relation between diphtheria and tetanus toxoids and encephalopathy, infantile spasms, and sudden infant death syndrome, and between conjugate Hib vaccines and susceptibility to Hib disease. The committee found that the evidence favored acceptance of a causal relation between diphtheria and tetanus toxoids and Guillain-Barre syndrome and brachial neuritis, between measles vaccine and anaphylaxis, between oral polio vaccine and Guillain-Barre syndrome, and between unconjugated Hib vaccine and susceptibility to Hib disease. The committee found that the evidence established causality between diphtheria and tetanus toxoids and anaphylaxis, between measles vaccine and death from measles vaccine-strain viral infection, between measles-mumps-rubella vaccine and thrombocytopenia and anaphylaxis, between oral polio vaccine and poliomyelitis and death from polio vaccine-strain viral infection, and between hepatitis B vaccine and anaphylaxis. For five vaccine-related adverse events, there was no evidence identified. For the remaining 33 vaccine-related adverse events, the evidence was inadequate to accept or reject a causal relation.	NATL ACAD SCI,INST MED,WASHINGTON,DC; MARCH DIMES BIRTH DEFECTS FDN,WHITE PLAINS,NY; YALE UNIV,SCH MED,NEW HAVEN,CT	National Academies of Sciences, Engineering & Medicine; Yale University					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI015130] Funding Source: NIH RePORTER; NIAID NIH HHS [N01-AI-15130] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BELLINI WJ, 1992, LAB INVEST, V66, pA19; COFFIN CM, 1993, PEDIATR PATHOL, V13, P102; COHN J, 1976, SCAND J HAEMATOL, V16, P226; HOWSON CP, 1992, JAMA-J AM MED ASSOC, V267, P392, DOI 10.1001/jama.267.3.392; HOWSON CP, 1992, PEDIATRICS, V89, P318; Howson CP, 1991, ADVERSE EFFECTS PERT; MARINER WK, 1992, HEALTH AFFAIR, V11, P255, DOI 10.1377/hlthaff.11.1.255; NKOWANE BM, 1987, JAMA-J AM MED ASSOC, V257, P1335, DOI 10.1001/jama.257.10.1335; POLLARD JD, 1978, J NEUROL SCI, V37, P113, DOI 10.1016/0022-510X(78)90232-0; Stratton K.R., 1994, ADVERSE EVENTS ASS C; THURSTON A, 1987, J ROY COLL GEN PRACT, V37, P41; WIGGINS CA, 1989, ANN ALLERGY, V62, P1	12	116	120	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	1994	271	20					1602	1605		10.1001/jama.271.20.1602	http://dx.doi.org/10.1001/jama.271.20.1602			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NL758	8182813				2022-12-28	WOS:A1994NL75800029
J	GREENBERG, JT; GUO, AL; KLESSIG, DF; AUSUBEL, FM				GREENBERG, JT; GUO, AL; KLESSIG, DF; AUSUBEL, FM			PROGRAMMED CELL-DEATH IN PLANTS - A PATHOGEN-TRIGGERED RESPONSE ACTIVATED COORDINATELY WITH MULTIPLE DEFENSE FUNCTIONS	CELL			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; SYRINGAE PV-SYRINGAE; TOBACCO MOSAIC-VIRUS; SALICYLIC-ACID; ARABIDOPSIS-THALIANA; HYPERSENSITIVE REACTION; DISEASE RESISTANCE; VIRAL-INFECTION; INDUCTION; APOPTOSIS	In plants, the hypersensitive response (HR) to pathogens involves rapid cell death, which is hypothesized to arise from the activation of a cell death program. We describe mutant A. thaliana plants that contain lesions in a single accelerated cell death (ACD) gene called ACD2 and that bypass the need for pathogen exposure to induce the HR. acd2 plants that develop spontaneous lesions show typical HR characteristics both within the necrotic tissue and within the healthy part of the plant, including: modification of plant cell walls, resistance to bacterial pathogens, and accumulation of defense-related gene transcripts, the signal molecule salicylic acid and an antimicrobial compound. We propose that the ACD2 gene is involved in a pathway(s) that negatively regulates a genetically programmed HR.	MASSACHUSETTS GEN HOSP,DEPT MOLEC BIOL,BOSTON,MA 02114; RUTGERS STATE UNIV,DEPT MOLEC BIOL & BIOCHEM,PISCATAWAY,NJ 08855	Harvard University; Massachusetts General Hospital; Rutgers State University New Brunswick	GREENBERG, JT (corresponding author), HARVARD UNIV,SCH MED,DEPT GENET,BOSTON,MA 02114, USA.			Greenberg, Jean/0000-0002-7213-7618	NIGMS NIH HHS [GM48707] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048707, R01GM048707] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		APOSTOL I, 1989, PLANT PHYSIOL, V90, P109, DOI 10.1104/pp.90.1.109; ASHMAN RB, 1976, J HERED, V67, P220, DOI 10.1093/oxfordjournals.jhered.a108713; BECKER F, 1993, PLANT J, V3, P875, DOI 10.1111/j.1365-313X.1993.00875.x; BOWLER C, 1989, EMBO J, V8, P31, DOI 10.1002/j.1460-2075.1989.tb03345.x; CALLIS J, 1990, J BIOL CHEM, V265, P12486; DAVIS KR, 1991, MOL PLANT MICROBE IN, V4, P477, DOI 10.1094/MPMI-4-477; DELONG A, 1993, CELL, V74, P757, DOI 10.1016/0092-8674(93)90522-R; DEMPSEY DA, 1993, PHYTOPATHOLOGY, V83, P1021, DOI 10.1094/Phyto-83-1021; DONG XN, 1991, PLANT CELL, V3, P61, DOI 10.1105/tpc.3.1.61; EDGINGTON SM, 1993, BIO-TECHNOL, V11, P787, DOI 10.1038/nbt0793-787; Emerson RA, 1923, CORNELL U AGR EXP ST, V70, P3; ENYEDI AJ, 1992, P NATL ACAD SCI USA, V89, P2480, DOI 10.1073/pnas.89.6.2480; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; GREENBERG JT, 1993, PLANT J, V4, P327, DOI 10.1046/j.1365-313X.1993.04020327.x; HE SY, 1993, CELL, V73, P1255, DOI 10.1016/0092-8674(93)90354-S; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; HENNIG J, 1993, PLANT J, V4, P593, DOI 10.1046/j.1365-313X.1993.04040593.x; HOCKENBERY DM, 1993, CELL, V75, P241, DOI 10.1016/0092-8674(93)80066-N; HOISINGTON DA, 1982, DEV BIOL, V93, P381, DOI 10.1016/0012-1606(82)90125-7; HORNBROOK AR, 1970, RADIAT BOT, V10, P113, DOI 10.1016/S0033-7560(70)80031-X; HORVITZ HR, 1982, NEUROSCI COMMENT, V1, P56; JONES JDG, 1994, CURR BIOL, V4, P867; JORGENSEN JH, 1992, EUPHYTICA, V63, P141, DOI 10.1007/BF00023919; Kerr J.F.R., 1987, P93; MALAMY J, 1992, PLANT CELL, V4, P359, DOI 10.1105/tpc.4.3.359; MALAMY J, 1992, PLANT J, V2, P643, DOI 10.1111/j.1365-313X.1992.tb00133.x; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; MAUCH F, 1993, PLANT PHYSIOL, V102, P1193, DOI 10.1104/pp.102.4.1193; MELAN MA, 1993, PLANT PHYSIOL, V101, P441, DOI 10.1104/pp.101.2.441; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; MORTIMORE CG, 1979, CAN J PLANT SCI, V59, P147; NEUFFER MG, 1975, J HERED, V66, P265, DOI 10.1093/oxfordjournals.jhered.a108627; OPPENHEIM RW, 1990, DEV BIOL, V138, P104, DOI 10.1016/0012-1606(90)90180-Q; PRYOR T, 1987, TRENDS GENET, V3, P157, DOI 10.1016/0168-9525(87)90217-4; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RASMUSSEN JB, 1991, PLANT PHYSIOL, V97, P1342, DOI 10.1104/pp.97.4.1342; ROSS AF, 1961, VIROLOGY, V14, P340, DOI 10.1016/0042-6822(61)90319-1; SCHRODER M, 1992, PLANT J, V2, P161, DOI 10.1111/j.1365-313X.1992.00161.x; SENTMAN CL, 1991, CELL, V67, P879, DOI 10.1016/0092-8674(91)90361-2; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; STROMINGER JL, 1977, MICROBIOLOGY 1977, P177; SUTHERLAND MW, 1991, PHYSIOL MOL PLANT P, V39, P79, DOI 10.1016/0885-5765(91)90020-I; TSUJI J, 1992, PLANT PHYSIOL, V98, P1304, DOI 10.1104/pp.98.4.1304; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; UKNES S, 1993, MOL PLANT MICROBE IN, V6, P692, DOI 10.1094/MPMI-6-692; ULLSTRUP AJ, 1967, PHYTOPATHOLOGY, V57, P1282; VEIS DJ, 1993, CELL, V75, P229, DOI 10.1016/0092-8674(93)80065-M; WALBOT V, 1991, PLANT CELL, V3, P851, DOI 10.1105/tpc.3.9.851; WARD ER, 1991, PLANT CELL, V3, P1085, DOI 10.1105/tpc.3.10.1085; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; WOLFF T, 1991, DEVELOPMENT, V113, P825; WYLLIE AH, 1984, J PATHOL, V142, P67, DOI 10.1002/path.1711420112; YU GL, 1993, MOL PLANT MICROBE IN, V6, P434, DOI 10.1094/MPMI-6-434	53	547	632	2	41	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 20	1994	77	4					551	563		10.1016/0092-8674(94)90217-8	http://dx.doi.org/10.1016/0092-8674(94)90217-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NM832	8187175				2022-12-28	WOS:A1994NM83200010
J	EATEN, D; BANNISTER, P; MULLEY, GP; CONNOLLY, MJ				EATEN, D; BANNISTER, P; MULLEY, GP; CONNOLLY, MJ			AXILLARY SWEATING IN CLINICAL-ASSESSMENT OF DEHYDRATION IN ILL ELDERLY PATIENTS	BRITISH MEDICAL JOURNAL			English	Article									UNIV MANCHESTER,DEPT GERIATR MED,CHEADLE SK8 2NY,CHESHIRE,ENGLAND; BARNES HOSP,ROBERT BARNES MED UNIT,CHEADLE SK8 2NY,CHESHIRE,ENGLAND; ST JAMESS UNIV HOSP,DEPT MED ELDERLY,LEEDS LS9 7TF,W YORKSHIRE,ENGLAND	University of Manchester; Saint James's University Hospital; University of Leeds								BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491; GROSS C R, 1992, Journal of Emergency Medicine, V10, P267, DOI 10.1016/0736-4679(92)90331-M; LARRABEE WF, 1984, POSTGRAD MED, V76, P37, DOI 10.1080/00325481.1984.11698794; LOWENSTEIN SR, 1986, ANN EMERG MED, V15, P528, DOI 10.1016/S0196-0644(86)80987-8; SHUSTER S, 1975, BRIT J DERMATOL, V93, P639, DOI 10.1111/j.1365-2133.1975.tb05113.x	5	44	44	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 14	1994	308	6939					1271	1271		10.1136/bmj.308.6939.1271	http://dx.doi.org/10.1136/bmj.308.6939.1271			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM147	8205020	Green Published			2022-12-28	WOS:A1994NM14700019
J	FERREIRA, A; KOSIK, KS; GREENGARD, P; HAN, HQ				FERREIRA, A; KOSIK, KS; GREENGARD, P; HAN, HQ			ABERRANT NEURITES AND SYNAPTIC VESICLE PROTEIN-DEFICIENCY IN SYNAPSIN II-DEPLETED NEURONS	SCIENCE			English	Article							HIPPOCAMPAL-NEURONS; F-ACTIN; ANTISENSE OLIGONUCLEOTIDES; BUNDLING PROTEIN; ASSOCIATION; SUPPRESSION; POLARITY; CULTURE; INVITRO; BINDING	Synapsin I and synapsin II are neuron-specific phosphoproteins that have a role in the regulation of neurotransmitter release and in the formation of nerve terminals. After depletion of synapsin II by antisense oligonucleotides, rat hippocampal neurons in culture were unable to consolidate their minor processes and did not elongate axons. These aberrant morphological changes were accompanied by an abnormal distribution of intracellular filamentous actin (F-actin). In addition, synapsin II suppression resulted in a selective decrease in the amounts of several synaptic vesicle-associated proteins. These data suggest that synapsin II participates in cytoskeletal organization during the early stages of nerve cell development.	ROCKEFELLER UNIV,MOLEC & CELLULAR NEUROSCI LAB,NEW YORK,NY 10021; HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,CTR NEUROL DIS,BOSTON,MA 02115	Rockefeller University; Harvard University; Brigham & Women's Hospital; Harvard Medical School				Ferreira, Adriana/0000-0003-3705-3918				BAHLER M, 1987, NATURE, V326, P704, DOI 10.1038/326704a0; BAINES AJ, 1986, NATURE, V319, P145, DOI 10.1038/319145a0; BAINES AJ, 1985, NATURE, V315, P410, DOI 10.1038/315410a0; BENFENATI F, 1992, NEURON, V8, P377, DOI 10.1016/0896-6273(92)90303-U; BENFENATI F, UNPUB; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; CACERES A, 1992, NEURON, V9, P607, DOI 10.1016/0896-6273(92)90025-9; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; CHILCOTE TJ, 1992, MOL BIOL CELL, V3, pA154; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; DOTTI CG, 1988, J NEUROSCI, V8, P1454; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; FESCE R, 1992, J BIOL CHEM, V267, P11281; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; GOLDENRING JR, 1986, J BIOL CHEM, V261, P8495; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; HAN HQ, 1991, NATURE, V349, P697, DOI 10.1038/349697a0; HAN HQ, IN PRESS P NATL ACAD; HIGASHIDA H, UNPUB; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; KREBS KE, 1987, AM J PHYSIOL, V253, pC500, DOI 10.1152/ajpcell.1987.253.4.C500; LU B, 1992, NEURON, V8, P521, DOI 10.1016/0896-6273(92)90280-Q; OSENSAND A, 1993, NATURE, V364, P445, DOI 10.1038/364445a0; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; PETRUCCI TC, 1987, J CELL BIOL, V105, P1355, DOI 10.1083/jcb.105.3.1355; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; SCHAEFFER E, 1994, P NATL ACAD SCI USA, V91, P3882, DOI 10.1073/pnas.91.9.3882; STEINER JP, 1987, J BIOL CHEM, V262, P905; VAITORTA F, 1992, J BIOL CHEM, V267, P11281; VALTORTA F, 1992, J BIOL CHEM, V267, P7195	30	99	101	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 13	1994	264	5161					977	979		10.1126/science.8178158	http://dx.doi.org/10.1126/science.8178158			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NK974	8178158				2022-12-28	WOS:A1994NK97400039
J	MA, PCM; ROULD, MA; WEINTRAUB, H; PABOT, CO				MA, PCM; ROULD, MA; WEINTRAUB, H; PABOT, CO			CRYSTAL-STRUCTURE OF MYOD BHLH DOMAIN-DNA COMPLEX - PERSPECTIVES ON DNA RECOGNITION AND IMPLICATIONS FOR TRANSCRIPTIONAL ACTIVATION	CELL			English	Article							C-MYC; FUNCTIONAL DOMAINS; BINDING DOMAIN; REFINEMENT; RESOLUTION; SELECTION; SITE	The crystal structure of a MyoD basic-helix-loop-helix (bHLH) domain-DNA complex has been solved and refined at 2.8 Angstrom resolution. This structure proves that bHLH and bHLH-leucine zipper (bHLH-ZIP) proteins are remarkably similar; it helps us understand subtle differences in binding preferences for these proteins; and it has surprising implications for our understanding of transcription. Specifically, Ala-114 and Thr-115, which are required for positive control in the myogenic proteins, are buried at the protein-DNA interface. These residues are not available for direct protein-protein contacts, but they may determine the conformation of Arg-111. Comparisons with Max suggest that the conformation of this arginine, which is different in the two structures, may play an important role in myogenic transcription.	MIT,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02139; FRED HUTCHINSON CANC RES CTR,HOWARD HUGHES MED INST LAB,SEATTLE,WA 98104	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Fred Hutchinson Cancer Center	MA, PCM (corresponding author), MIT,DEPT BIOL,CAMBRIDGE,MA 02139, USA.				NIGMS NIH HHS [GM31471] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031471] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; BLACKWELL TK, 1993, MOL CELL BIOL, V13, P5216, DOI 10.1128/MCB.13.9.5216; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BRUNGER AT, 1992, XPLOR MANUAL VERSION; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DAVIS RL, 1992, SCIENCE, V256, P1014; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; JORDAN SR, 1985, SCIENCE, V230, P1383; KATO GJ, 1992, GENE DEV, V6, P81, DOI 10.1101/gad.6.1.81; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; PESCE S, 1993, MOL CELL BIOL, V13, P7874, DOI 10.1128/MCB.13.12.7874; ROULD MA, 1992, ACTA CRYSTALLOGR A, V48, P751, DOI 10.1107/S0108767392003404; RUDNICKI MA, 1993, CELL, V75, P1351, DOI 10.1016/0092-8674(93)90621-V; SMITH MJ, 1990, MOL CELL BIOL, V10, P5333, DOI 10.1128/MCB.10.10.5333; STAROVASNIK MA, 1992, BIOCHEMISTRY-US, V31, P9891, DOI 10.1021/bi00156a006; SUN XH, 1991, CELL, V64, P459, DOI 10.1016/0092-8674(91)90653-G; TERWILLIGER TC, 1987, ACTA CRYSTALLOGR A, V43, P1, DOI 10.1107/S0108767387099999; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; VANANTWERP ME, 1992, P NATL ACAD SCI USA, V89, P9010, DOI 10.1073/pnas.89.19.9010; VORONOVA A, 1990, P NATL ACAD SCI USA, V87, P4722, DOI 10.1073/pnas.87.12.4722; WANG BC, 1985, METHOD ENZYMOL, V115, P90; WEINTRAUB H, 1991, GENE DEV, V5, P1377, DOI 10.1101/gad.5.8.1377; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; WINTER B, 1992, EMBO J, V11, P1843, DOI 10.1002/j.1460-2075.1992.tb05236.x; WRIGHT WE, 1991, MOL CELL BIOL, V11, P4104, DOI 10.1128/MCB.11.8.4104	29	390	417	4	59	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 6	1994	77	3					451	459		10.1016/0092-8674(94)90159-7	http://dx.doi.org/10.1016/0092-8674(94)90159-7			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NK970	8181063				2022-12-28	WOS:A1994NK97000015
J	PASCAL, SM; SINGER, AU; GISH, G; YAMAZAKI, T; SHOELSON, SE; PAWSON, T; KAY, LE; FORMANKAY, JD				PASCAL, SM; SINGER, AU; GISH, G; YAMAZAKI, T; SHOELSON, SE; PAWSON, T; KAY, LE; FORMANKAY, JD			NUCLEAR-MAGNETIC-RESONANCE STRUCTURE OF AN SH2 DOMAIN OF PHOSPHOLIPASE C-GAMMA-1 COMPLEXED WITH A HIGH-AFFINITY BINDING PEPTIDE	CELL			English	Article							GROWTH-FACTOR-RECEPTOR; SRC HOMOLOGY-2 DOMAIN; SIGNAL TRANSDUCTION; TYROSINE KINASE; LARGER PROTEINS; POINT MUTATION; EGF RECEPTOR; C-ABL; SPECTROSCOPY; EXPRESSION	The solution structure of the C-terminal SH2 domain of phospholipase C-gamma 1 (PLC-gamma 1), in complex with a phosphopeptide corresponding to its Tyr-1021 high affinity binding site on the platelet-derived growth factor receptor, has been determined by nuclear magnetic resonance spectroscopy. The topology of the SH2-phosphopeptide complex is similar to previously reported Src and Lck SH2 complexes. However, the binding site for residues C-terminal to the phosphotyrosine (pTyr) is an extended groove that contacts peptide residues at the +1 to +6 positions relative to the pTyr. This striking difference from Src and Lck reflects the fact that the PLC-gamma 1 complex involves binding of a phosphopeptide with predominantly hydrophobic residues C-terminal to the pTyr and therefore serves as a prototype for a second class of SH2-phosphopeptide interactions.	MT SINAI HOSP, SAMUEL LUNENFELD RES INST, DIV MOLEC & DEV BIOL, TORONTO M5G 1X5, ON, CANADA; UNIV TORONTO, PROT ENGN NETWORK CTR EXCELLENCE, TORONTO M5S 1A8, ON, CANADA; UNIV TORONTO, DEPT MED GENET, TORONTO M5S 1A8, ON, CANADA; UNIV TORONTO, DEPT BIOCHEM, TORONTO M5S 1A8, ON, CANADA; UNIV TORONTO, DEPT CHEM, TORONTO M5S 1A8, ON, CANADA; BRIGHAM & WOMENS HOSP, JOSLIN DIABET CTR, BOSTON, MA 02215 USA; BRIGHAM & WOMENS HOSP, DEPT MED, BOSTON, MA 02215 USA; HARVARD UNIV, SCH MED, BOSTON, MA 02215 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of Toronto; Harvard University; Brigham & Women's Hospital; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	PASCAL, SM (corresponding author), HOSP SICK CHILDREN, DIV BIOCHEM RES, 555 UNIV AVE, TORONTO M5G 1X8, ON, CANADA.		Pawson, Tony J/E-4578-2013; Gish, Gerald D/C-7228-2017	Forman-Kay, Julie/0000-0001-8265-972X				ANDERSON D, 1990, SCIENCE, V250, P979, DOI 10.1126/science.2173144; AROIAN RV, 1990, NATURE, V348, P693, DOI 10.1038/348693a0; BAX A, 1990, J MAGN RESON, V88, P425, DOI 10.1016/0022-2364(90)90202-K; BIBBINS KB, 1993, MOL CELL BIOL, V13, P7278, DOI 10.1128/MCB.13.12.7278; BOOKER GW, 1992, NATURE, V358, P684, DOI 10.1038/358684a0; BRUNGER AT, 1992, XPLOR VERSION 31 SYS; CANTLEY LC, 1991, CELL, V64, P281, DOI 10.1016/0092-8674(91)90639-G; CLAESSONWELSH L, 1989, P NATL ACAD SCI USA, V86, P4917, DOI 10.1073/pnas.86.13.4917; DELAGLIO F, 1993, NMRPIPE SYSTEM SOFTW; DOMCHEK SM, 1992, BIOCHEMISTRY-US, V31, P9865, DOI 10.1021/bi00156a002; ECK MJ, 1993, NATURE, V362, P87, DOI 10.1038/362087a0; FARROW NA, 1994, IN PRESS BIOCHEMISTR; FORMANKAY JD, 1990, BIOCHEMISTRY-US, V29, P1566, DOI 10.1021/bi00458a030; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; IKURA M, 1990, J MAGN RESON, V86, P204, DOI 10.1016/0022-2364(90)90227-Z; IKURA M, 1992, J AM CHEM SOC, V114, P2433, DOI 10.1021/ja00033a019; KAY LE, 1990, J MAGN RESON, V86, P110, DOI 10.1016/0022-2364(90)90215-U; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; LAROSE L, 1993, ONCOGENE, V8, P2493; LOGAN TM, 1992, FEBS LETT, V314, P413, DOI 10.1016/0014-5793(92)81517-P; MARENGERE LEM, 1992, J BIOL CHEM, V267, P22779; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; MAYER BJ, 1992, MOL CELL BIOL, V12, P609, DOI 10.1128/MCB.12.2.609; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; MOHAMMADI M, 1992, NATURE, V358, P681, DOI 10.1038/358681a0; MONTELIONE GT, 1992, J AM CHEM SOC, V114, P10974, DOI 10.1021/ja00053a051; MORAN MF, 1990, P NATL ACAD SCI USA, V87, P8622, DOI 10.1073/pnas.87.21.8622; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NILGES M, 1990, BIOPOLYMERS, V29, P813, DOI 10.1002/bip.360290415; NILGES M, 1988, FEBS LETT, V229, P317, DOI 10.1016/0014-5793(88)81148-7; NISHIMURA R, 1993, MOL CELL BIOL, V13, P6889, DOI 10.1128/MCB.13.11.6889; OVERDUIN M, 1992, P NATL ACAD SCI USA, V89, P11673, DOI 10.1073/pnas.89.24.11673; OVERDUIN M, 1992, CELL, V70, P697, DOI 10.1016/0092-8674(92)90437-H; PARTANEN J, 1991, EMBO J, V10, P1347, DOI 10.1002/j.1460-2075.1991.tb07654.x; PASCAL SM, 1994, J MAGN RESON SER B, V103, P197, DOI 10.1006/jmrb.1994.1031; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; PAWSON T, 1993, PHILOS T R SOC B, V340, P279, DOI 10.1098/rstb.1993.0069; PETERS KG, 1992, NATURE, V358, P678, DOI 10.1038/358678a0; PICCIONE E, 1993, BIOCHEMISTRY-US, V32, P3197, DOI 10.1021/bi00064a001; RHEE SG, 1991, TRENDS BIOCHEM SCI, V16, P297, DOI 10.1016/0968-0004(91)90122-C; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; SONGYANG Z, 1994, MOL CELL BIOL, V14, P2777, DOI 10.1128/MCB.14.4.2777; STAHL ML, 1988, NATURE, V332, P269, DOI 10.1038/332269a0; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; VALIUS M, 1993, MOL CELL BIOL, V13, P133, DOI 10.1128/MCB.13.1.133; VALIUS M, 1993, CELL, V73, P321, DOI 10.1016/0092-8674(93)90232-F; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E; ZHU GC, 1992, P NATL ACAD SCI USA, V89, P9559, DOI 10.1073/pnas.89.20.9559	60	234	239	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 6	1994	77	3					461	472		10.1016/0092-8674(94)90160-0	http://dx.doi.org/10.1016/0092-8674(94)90160-0			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NK970	8181064				2022-12-28	WOS:A1994NK97000016
J	EASTMAN, N				EASTMAN, N			MENTAL-HEALTH LAW - CIVIL-LIBERTIES AND THE PRINCIPLE OF RECIPROCITY	BRITISH MEDICAL JOURNAL			English	Article								At a conference organised by the Law Society, Mental Health Act Commission, and Institute of Psychiatry possible reform of mental health legislation in England and Wales was discussed. It was concluded that radical legal reform was required, and that the law should be designed specifically for provision of care in both hospital and the community. Reform should be based on principle rather than pragmatism, particularly the principle of reciprocity -patients' civil liberties may not be removed for the purposes of treatment if resources for that treatment are inadequate. Protection of society from nuisance or even violence is insufficient reason for detention. Legal provision for compulsion of patients, whether in hospital or the community, must be matched by specific rights to treatment.			EASTMAN, N (corresponding author), ST GEORGE HOSP,FORENS PSYCHIAT SECT,LONDON SW17 0RE,ENGLAND.							AARVOLD C, 1973, CMND5191; [Anonymous], 1993, MENTALLY INCAPACITAT; BLUGLASS R, 1993, BRIT MED J, V306, P159, DOI 10.1136/bmj.306.6871.159; BLUGLASS R, 1993, BMJ, V307, P1660; CHISWICK D, 1993, CRIMINAL BEHAVIOUR M, V2, P106; COPE R, 1993, J FORENSIC PSYCHIATR, V4, P215; DOLAN B, IN PRESS PSYCHOPATHI; EASTMAN NLG, 1993, INDEPENDENT     0723; GOSTIN L, 1977, HUMAN CONDITION, V2; GOSTIN L, 1975, HUMAN CONDITION, V1; Peay J., 1989, TRIBUNALS TRIAL STUD; 1992, REV HLTH SOCIAL SERV; 1993, COMMUNITY SUYPERVISI; 1993, TIMES           1015; 1975, CMND6244 HOM OFF; 1983, TIMES           0824; 1993, LEGAL POWERS CARE ME; CMND4557 DEP HLTH SO; 1969, CMND3987 DEP HLTH SO	19	52	54	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 1	1994	308	6920					43	45		10.1136/bmj.308.6920.43	http://dx.doi.org/10.1136/bmj.308.6920.43			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MQ096	8179659	Green Published			2022-12-28	WOS:A1994MQ09600030
J	LEGRAIN, P; CHAPON, C				LEGRAIN, P; CHAPON, C			INTERACTION BETWEEN PRP11 AND SPP91 YEAST SPLICING FACTORS AND CHARACTERIZATION OF A PRP9-PRP11-SPP91 COMPLEX	SCIENCE			English	Article							PRE-MESSENGER-RNA; U1 SNRNP; PROTEIN; GENES; BINDING; SYSTEM	Several proteins are involved in the early steps of the spliceosome assembly pathway. Protein-protein interactions have been identified between two Saccharomyces cerevisiae yeast splicing factors, PRP9 and SPP91. Here it is demonstrated that protein-protein interactions occur between SPP91 and PRP11. The combination of the prp9-1 mutant and a truncated prp11 mutant exhibits a synthetic lethal phenotype, suggestive of a common biochemical defect. The PRP9 and PRP11 proteins do not interact directly, but the PRP9 and PRP11 molecules can simultaneously bind SPP91 to form a three-molecule complex. Structurally and functionally related proteins are found in mammalian cells and are associated in a single biochemical fraction. This strongly suggests that the PRP9-SPP91-PRP11 complex is a key element of the splicing machinery.			LEGRAIN, P (corresponding author), INST PASTEUR,DEPT BIOL MOLEC,UNITE GENET MOLEC,F-75724 PARIS,FRANCE.							ABOVICH N, 1990, MOL CELL BIOL, V10, P6417, DOI 10.1128/MCB.10.12.6417; ARENAS JE, 1993, P NATL ACAD SCI USA, V90, P6771, DOI 10.1073/pnas.90.14.6771; BEHRENS SE, 1993, MOL CELL BIOL, V13, P307, DOI 10.1128/MCB.13.1.307; BEHRENS SE, IN PRESS P NATL ACAD; BENNETT M, 1993, SCIENCE, V262, P105, DOI 10.1126/science.8211113; BROSI R, 1993, SCIENCE, V262, P102, DOI 10.1126/science.8211112; BROSI R, IN PRESS J BIOL CHEM; CHANG TH, 1988, MOL CELL BIOL, V8, P2379, DOI 10.1128/MCB.8.6.2379; CHAPON C, 1992, EMBO J, V11, P3279, DOI 10.1002/j.1460-2075.1992.tb05406.x; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; GUARENTE L, 1982, P NATL ACAD SCI-BIOL, V79, P7410, DOI 10.1073/pnas.79.23.7410; HERSKOWITZ I, 1987, NATURE, V329, P219, DOI 10.1038/329219a0; KRAMER A, 1991, EMBO J, V10, P1503, DOI 10.1002/j.1460-2075.1991.tb07670.x; LEGRAIN P, 1990, EMBO J, V9, P2775, DOI 10.1002/j.1460-2075.1990.tb07465.x; LEGRAIN P, 1993, GENE DEV, V7, P1390, DOI 10.1101/gad.7.7b.1390; LEGRAIN P, 1989, CELL, V57, P573, DOI 10.1016/0092-8674(89)90127-X; LEGRAIN P, UNPUB; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; MOORE MJ, 1993, RNA WORLD, V24; NELISSEN RLH, 1991, NUCLEIC ACIDS RES, V19, P449, DOI 10.1093/nar/19.3.449; RUBY S, COMMUNICATION; RYMOND BC, 1992, MOL CELLULAR BIOL YE, P143; SCHAPPERT K, 1991, MOL GEN GENET, V226, P277, DOI 10.1007/BF00273613; SILLEKENS PTG, 1988, NUCLEIC ACIDS RES, V16, P8307, DOI 10.1093/nar/16.17.8307	26	67	71	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 1	1993	262	5130					108	110		10.1126/science.8211114	http://dx.doi.org/10.1126/science.8211114			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ635	8211114				2022-12-28	WOS:A1993LZ63500034
J	BUNDRED, NJ; DOVER, MS; ALUWIHARE, N; FARAGHER, EB; MORRISON, JM				BUNDRED, NJ; DOVER, MS; ALUWIHARE, N; FARAGHER, EB; MORRISON, JM			SMOKING AND PERIDUCTAL MASTITIS	BRITISH MEDICAL JOURNAL			English	Article							CIGARETTE-SMOKING		SELLY OAK HOSP,DEPT HISTOPATHOL,BIRMINGHAM B29 6JD,ENGLAND; SELLY OAK HOSP,DEPT SURG,BIRMINGHAM B29 6JD,ENGLAND		BUNDRED, NJ (corresponding author), UNIV HOSP S MANCHESTER,DEPT MED STAT,MANCHESTER M20 8LR,LANCS,ENGLAND.							BUNDRED NJ, 1992, BRIT J SURG, V79, P58, DOI 10.1002/bjs.1800790121; DIXON JMJ, 1985, BRIT J SURG, V70, P601; SCHAFER P, 1988, INT J EPIDEMIOL, V17, P810, DOI 10.1093/ije/17.4.810; THOMAS WG, 1982, BRIT J SURG, V69, P423, DOI 10.1002/bjs.1800690724; 1990, 1990 S BIRM HLTH AUT	5	28	29	1	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 25	1993	307	6907					772	773		10.1136/bmj.307.6907.772	http://dx.doi.org/10.1136/bmj.307.6907.772			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LZ478	8219949	Green Published, Bronze			2022-12-28	WOS:A1993LZ47800024
J	NETTLEMAN, MD; FREDRICKSON, M; GOOD, NL; HUNTER, SA				NETTLEMAN, MD; FREDRICKSON, M; GOOD, NL; HUNTER, SA			TUBERCULOSIS-CONTROL STRATEGIES - THE COST OF PARTICULATE RESPIRATORS	ANNALS OF INTERNAL MEDICINE			English	Article							RESISTANT MYCOBACTERIUM-TUBERCULOSIS; OUTBREAK; TRANSMISSION; MASKS	Objective: To assess the cost of the mandatory use of high-efficiency particulate respirators to treat patients with known or suspected tuberculosis. Design: A questionnaire was used to determine the number of high-efficiency particulate respirators required and the number of cases of tuberculosis in employees that could potentially be prevented. Indirect costs included the training and fitness testing of employees. The clinical efficacy of respirators is not known, To provide a best-case scenario, it was assumed that the respirators could prevent as many as 25% of tuberculosis cases in health care workers. Setting: 159 acute care facilities administered by the Department of Veterans Affairs. Participants: Quality improvement, infection control, and employee health specialists. Measurements: Cost of the respirators compared with their maximum predicted efficacy. Results: The use of the respirators would cost $7 million per case of tuberculosis prevented and $100 million per life saved. Conclusions: High-efficiency particulate respirators are a costly means of trying to prevent tuberculosis. Costs could be reduced by reusing masks or by restricting the number of health care workers allowed to have contact with potentially infectious patients. As the health care budget undergoes further restrictions, specific means of accommodating the cost of new regulations must be found.	VET AFFAIRS MED CTR, IOWA CITY, IA 52246 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	NETTLEMAN, MD (corresponding author), UNIV IOWA, COLL MED, 200 HAWKINS DR C42 GH, IOWA CITY, IA 52242 USA.							BARRETTCONNOR E, 1979, JAMA-J AM MED ASSOC, V241, P33, DOI 10.1001/jama.241.1.33; BECKSAGUE C, 1992, JAMA-J AM MED ASSOC, V268, P1280, DOI 10.1001/jama.268.10.1280; Dooley S W Jr, 1990, MMWR Recomm Rep, V39, P1; EATWELL J, 1987, NEW PALGRAVE DICT EC, V4, P132; EDLIN BR, 1992, NEW ENGL J MED, V326, P1514, DOI 10.1056/NEJM199206043262302; FISCHL MA, 1992, ANN INTERN MED, V117, P177, DOI 10.7326/0003-4819-117-3-177; HALEY CE, 1989, INFECT CONT HOSP EP, V10, P204, DOI 10.1086/646003; Jereb J A, 1991, MMWR CDC Surveill Summ, V40, P23; KANTOR HS, 1988, AM J MED, V84, P833, DOI 10.1016/0002-9343(88)90060-5; PEARSON ML, 1992, ANN INTERN MED, V117, P191, DOI 10.7326/0003-4819-117-3-191; PIPPIN DJ, 1987, J ORAL MAXIL SURG, V45, P319, DOI 10.1016/0278-2391(87)90352-1; SCOTT B, 1994, ARCH INTERN MED, V154, P326, DOI 10.1001/archinte.154.3.326; WEBER A, 1993, AM J INFECT CONTROL, V21, P167, DOI 10.1016/0196-6553(93)90027-2; WOODRING JH, 1986, AM J ROENTGENOL, V146, P497, DOI 10.2214/ajr.146.3.497; 1993, FED REGISTER, V58, P52810; 1993, MMWR-MORBID MORTAL W, V42, P496; 1993, EMPLOYMENT DATA T 38; 1991, MONTHLY VITAL STA S2, V39, P1	18	56	58	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1994	121	1					37	40		10.7326/0003-4819-121-1-199407010-00007	http://dx.doi.org/10.7326/0003-4819-121-1-199407010-00007			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PN271	8198346				2022-12-28	WOS:A1994PN27100007
J	MURPHY, PM				MURPHY, PM			VIRAL IMITATIONS OF HOST-DEFENSE PROTEINS - FLATTERY THAT TURNS TO BATTERY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN INTERLEUKIN-8 RECEPTOR; VACCINIA VIRUS; FUNCTIONAL EXPRESSION; HUMAN CYTOMEGALOVIRUS; HERPESVIRUS SAIMIRI; CHEMOKINE RECEPTOR; PLASMODIUM-VIVAX; MYXOMA VIRUS; HOMOLOG; CELL				MURPHY, PM (corresponding author), NIAID, HOST DEF LAB, BLDG 10, ROOM 11N-113, 9000 ROCKVILLE PIKE, BETHESDA, MD 20892 USA.							AHUJA SK, 1993, J BIOL CHEM, V268, P20691; ALBRECHT JC, 1992, J VIROL, V66, P5047, DOI 10.1128/JVI.66.8.5047-5058.1992; ALBRECHT T, 1990, INTERVIROLOGY, V31, P68, DOI 10.1159/000150140; ALCAMI A, 1992, CELL, V71, P153, DOI 10.1016/0092-8674(92)90274-G; BEATTIE E, 1991, VIROLOGY, V183, P419, DOI 10.1016/0042-6822(91)90158-8; BROWNE H, 1990, NATURE, V347, P770, DOI 10.1038/347770a0; CERRETTI DP, 1993, MOL IMMUNOL, V30, P359; CHAUDHURI A, 1993, P NATL ACAD SCI USA, V90, P10793, DOI 10.1073/pnas.90.22.10793; CHEE MS, 1990, NATURE, V344, P774, DOI 10.1038/344774a0; CHOU J, 1992, P NATL ACAD SCI USA, V89, P3266, DOI 10.1073/pnas.89.8.3266; COLOTTA F, 1993, SCIENCE, V261, P472, DOI 10.1126/science.8332913; DINARELLO CA, 1992, INFLAMMATION BASIC P, P211; EIGEN M, 1993, SCI AM, V269, P42, DOI 10.1038/scientificamerican0793-42; FLECKENSTEIN B, 1982, HERPESVIRUSES, V1, P253; GAO JL, 1993, J EXP MED, V177, P1421, DOI 10.1084/jem.177.5.1421; GOODING LR, 1992, CELL, V71, P5; HALL B F, 1991, Immunology Today, V12, pA22; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; HORUK R, 1993, SCIENCE, V261, P1182, DOI 10.1126/science.7689250; HSU DH, 1990, SCIENCE, V250, P830, DOI 10.1126/science.2173142; ISAACS SN, 1992, P NATL ACAD SCI USA, V89, P628, DOI 10.1073/pnas.89.2.628; JOHNSON GP, 1991, VIROLOGY, V181, P378, DOI 10.1016/0042-6822(91)90508-9; KADOTA J, 1991, MICROBIOL IMMUNOL, V35, P443, DOI 10.1111/j.1348-0421.1991.tb01575.x; KAPUR V, 1993, P NATL ACAD SCI USA, V90, P7676, DOI 10.1073/pnas.90.16.7676; MASSUNG RF, 1993, VIROLOGY, V197, P511, DOI 10.1006/viro.1993.1625; MILLER LH, 1976, NEW ENGL J MED, V295, P302, DOI 10.1056/NEJM197608052950602; MURPHY PM, 1993, CELL, V72, P823, DOI 10.1016/0092-8674(93)90571-7; MURPHY PM, 1994, ANNU REV IMMUNOL, V12, P593, DOI 10.1146/annurev.iy.12.040194.003113; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; NEOTE K, 1993, CELL, V72, P415, DOI 10.1016/0092-8674(93)90118-A; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; ROUVIER E, 1993, J IMMUNOL, V150, P5445; SIMS JE, 1988, SCIENCE, V241, P585, DOI 10.1126/science.2969618; UPTON C, 1992, SCIENCE, V258, P1369, DOI 10.1126/science.1455233; UPTON C, 1991, VIROLOGY, V184, P370, DOI 10.1016/0042-6822(91)90853-4; WOLD WSM, 1991, VIROLOGY, V184, P1, DOI 10.1016/0042-6822(91)90815-S	36	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	1994	271	24					1948	1952		10.1001/jama.271.24.1948	http://dx.doi.org/10.1001/jama.271.24.1948			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR598	8201740				2022-12-28	WOS:A1994NR59800033
J	CHEN, BS; CHOI, GH; NUSS, DL				CHEN, BS; CHOI, GH; NUSS, DL			ATTENUATION OF FUNGAL VIRULENCE BY SYNTHETIC INFECTIOUS HYPOVIRUS TRANSCRIPTS	SCIENCE			English	Article							CHESTNUT BLIGHT FUNGUS; ENDOTHIA-PARASITICA; BIOLOGICAL-CONTROL; VIRAL CDNA; EXPRESSION; STRAINS; VIRUS	Noninfectious, cytoplasmically transmissible viral double-stranded RNAs of the genus Hypovirus cause reduced virulence (hypovirulence) in the chestnut blight fungus Cryphonectria parasitica, providing the basis for virus-mediated biological control of a fungal disease. Synthetic transcripts corresponding to a full-length hypovirus RNA coding strand are infectious when introduced into fungal spheroplasts by electroporation. Hypovirus infections were readily established in Cryphonectria parasitica and in related fungal species not previously reported to harbor viruses. These results demonstrate the use of a synthetic mycovirus transcript to expand fungal host range, thereby broadening the potential application of virus-mediated hypovirulence to control fungal pathogenesis.	ROCHE INST MOLEC BIOL,ROCHE RES CTR,NUTLEY,NJ 07110	Roche Holding								ANAGNOSTAKIS SL, 1979, PHYTOPATHOLOGY, V69, P1226, DOI 10.1094/Phyto-69-1226; ANAGNOSTAKIS SL, 1982, SCIENCE, V215, P466, DOI 10.1126/science.215.4532.466; APPEL DN, 1984, PLANT DIS, V68, P851, DOI 10.1094/PD-69-851; BARR ME, 1978, DIAPORTHALES N AM; BUCK KW, 1985, FUNGAL VIROLOGY OVER; CHEN B, IN PRESS VIROLOGY; CHEN BS, 1993, EMBO J, V12, P2991, DOI 10.1002/j.1460-2075.1993.tb05967.x; CHOI GH, 1992, SCIENCE, V257, P800, DOI 10.1126/science.1496400; CHOI GH, 1992, EMBO J, V11, P473, DOI 10.1002/j.1460-2075.1992.tb05077.x; CHURCHILL ACL, 1991, CURR GENET, V17, P25; CRAVEN MG, 1993, J VIROL, V67, P6513, DOI 10.1128/JVI.67.11.6513-6521.1993; HILLMAN BI, 1990, PHYTOPATHOLOGY, V80, P950, DOI 10.1094/Phyto-80-950; HODGES CS, 1980, MYCOLOGIA, V72, P542, DOI 10.2307/3759528; JAYNES RA, 1980, PHYTOPATHOLOGY, V70, P453, DOI 10.1094/Phyto-70-453; LARSON TG, 1992, EMBO J, V11, P4539, DOI 10.1002/j.1460-2075.1992.tb05555.x; MICALES JA, 1986, MYCOTAXON, V26, P99; Roane MK, 1986, CHESTNUT BLIGHT OTHE, P1; SHAPIRA R, 1991, EMBO J, V10, P731, DOI 10.1002/j.1460-2075.1991.tb08004.x; VANALFEN NK, 1975, SCIENCE, V189, P890, DOI 10.1126/science.189.4206.890; VANALFEN NK, 1986, HYPOVIRULENCE ENDOTH; WICKNER RB, 1989, FASEB J, V3, P2257, DOI 10.1096/fasebj.3.11.2550303	21	104	115	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 17	1994	264	5166					1762	1764		10.1126/science.8209256	http://dx.doi.org/10.1126/science.8209256			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR600	8209256				2022-12-28	WOS:A1994NR60000043
J	ESGUERRA, M; WANG, J; FOSTER, CD; ADELMAN, JP; NORTH, RA; LEVITAN, IB				ESGUERRA, M; WANG, J; FOSTER, CD; ADELMAN, JP; NORTH, RA; LEVITAN, IB			CLONED CA2+-DEPENDENT K+ CHANNEL MODULATED BY A FUNCTIONALLY ASSOCIATED PROTEIN-KINASE	NATURE			English	Article							ACTIVATED POTASSIUM CHANNELS; PHOSPHORYLATION; CAMP; BRAIN; DEPHOSPHORYLATION; CELLS	CALCIUM-DEPENDENT potassium (K-Ca) channels carry ionic currents that regulate important cellular functions(1-3). Like some other ion channels(4-10), K-Ca channels are modulated by protein phosphorylation(2,11,15-21). The recent cloning of complementary DNAs encoding Slo K-Ca channels(12-14) has enabled K-Ca channel modulation to be investigated. We report here that protein phosphorylation modulates the activity of Drosophila Slo K-Ca channels expressed in Xenopus oocytes. Application of ATP-gamma S to detached membrane patches increases Slo channel activity by shifting channel voltage sensitivity. This modulation is blocked by a specific inhibitor of cyclic AMP-dependent protein kinase (PKA). Mutation of a single serine residue in the channel protein also blocks modulation by ATP-gamma S, demonstrating that phosphorylation of the Slo channel protein itself modulates channel activity. The results also indicate that K-Ca channels in oocyte membrane patches can be modulated by an endogenous PKA-like protein kinase which remains functionally associated with the channels in the detached patch.	BRANDEIS UNIV,DEPT BIOCHEM,WALTHAM,MA 02254; BRANDEIS UNIV,CTR COMPLEX SYST,WALTHAM,MA 02254; OREGON HLTH SCI UNIV,VOLLUM INST,PORTLAND,OR 97201	Brandeis University; Brandeis University; Oregon Health & Science University			North, Richard/GQA-6156-2022	Esguerra, Manuel/0000-0002-6934-5424				ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; BLUMENTHAL EM, 1992, J NEUROSCI, V12, P290; BUSCH AE, 1992, SCIENCE, V255, P1705, DOI 10.1126/science.1553557; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CARR DW, 1992, J BIOL CHEM, V267, P16816; CHENG HC, 1986, J BIOL CHEM, V261, P989; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; EMERICK MC, 1989, BIOCHEMISTRY-US, V28, P8367, DOI 10.1021/bi00447a016; EWALD DA, 1985, NATURE, V315, P503, DOI 10.1038/315503a0; FLOCKERZI V, 1986, NATURE, V323, P66, DOI 10.1038/323066a0; GRATECOS D, 1974, BIOCHEM BIOPH RES CO, V58, P960, DOI 10.1016/S0006-291X(74)80237-8; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; KUME H, 1989, NATURE, V341, P152, DOI 10.1038/341152a0; LANCASTER B, 1991, J NEUROSCI, V11, P23; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; LECHLEITER JD, 1988, NEURON, V1, P227, DOI 10.1016/0896-6273(88)90143-2; LEVITAN IBA, 1994, REV PHYSL, V56, P193; NUMANN R, 1991, SCIENCE, V254, P115, DOI 10.1126/science.1656525; PENNEFATHER P, 1985, P NATL ACAD SCI USA, V82, P3040, DOI 10.1073/pnas.82.9.3040; RAYMOND LA, 1993, TRENDS NEUROSCI, V16, P147, DOI 10.1016/0166-2236(93)90123-4; REHM H, 1989, BIOCHEMISTRY-US, V28, P6455, DOI 10.1021/bi00441a044; REINHART PH, 1991, J NEUROSCI, V11, P1627; SADOSHIMA JI, 1988, AM J PHYSIOL, V255, pH754, DOI 10.1152/ajpheart.1988.255.4.H754; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; WHITE RE, 1991, NATURE, V351, P570, DOI 10.1038/351570a0; WHITE RE, 1993, NATURE, V361, P263, DOI 10.1038/361263a0; WILSON GF, 1993, NATURE, V366, P433, DOI 10.1038/366433a0	29	102	105	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 16	1994	369	6481					563	565		10.1038/369563a0	http://dx.doi.org/10.1038/369563a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR294	8202157				2022-12-28	WOS:A1994NR29400050
J	KAY, GF; BARTON, SC; SURANI, MA; RASTAN, S				KAY, GF; BARTON, SC; SURANI, MA; RASTAN, S			IMPRINTING AND X-CHROMOSOME COUNTING MECHANISMS DETERMINE XIST EXPRESSION IN EARLY MOUSE DEVELOPMENT	CELL			English	Article							INACTIVATION CENTER; PREFERENTIAL INACTIVATION; EMBRYOS; GENE; METHYLATION; GENOMES; BLASTOCYSTS; MEMBRANES; NUCLEUS	In mice, X inactivation is preceded by in cis Xist expression. Initially, normal female embryos express the paternal Xist allele exclusively, preceding imprinted X inactivation in the trophectoderm Later expression of Xist alleles is random, preceding random X inactivation in the epiblast lineage. In this study using uniparental embryos, we demonstrate that Xist expression is initially dictated solely by parental imprinting, causing expression of all paternal alleles. Maternal alleles remain repressed, irrespective of X chromosome number. At the compacting morula stage, this parental imprint is erased, and the mechanism counting the X chromosomes imposes appropriate Xist expression with respect to chromosome number. Our results also suggest that Xist expression may itself be regulated by a novel imprinted maternally expressed gene.	MRC, CLIN RES CTR, COMPARAT BIOL SECT, HARROW HA1 3UJ, MIDDX, ENGLAND; WELLCOME CANCER RES CAMPAIGN, INST CANC & DEV BIOL, CAMBRIDGE CB2 1QR, ENGLAND; UNIV CAMBRIDGE, PHYSIOL LAB, CAMBRIDGE CB2 1QR, ENGLAND	Medical Research Council Clinical Trials Unit; University of Cambridge			Kay, Graham F/A-4130-2011	Surani, Azim/0000-0002-8640-4318	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALLEN ND, 1990, CELL, V61, P853, DOI 10.1016/0092-8674(90)90195-K; BABINET C, 1990, DEVELOPMENT, P81; BARTON SC, 1984, NATURE, V311, P374, DOI 10.1038/311374a0; BARTON SC, 1993, METHOD ENZYMOL, V225, P732; BARTON SC, 1985, J EMBRYOL EXP MORPH, V90, P267; BIRD AP, 1993, CURR BIOL, V3, P275, DOI 10.1016/0960-9822(93)90177-P; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1994, NATURE, V368, P154, DOI 10.1038/368154a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; ENGLER P, 1991, CELL, V65, P939, DOI 10.1016/0092-8674(91)90546-B; EPSTEIN CJ, 1978, NATURE, V274, P500, DOI 10.1038/274500a0; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KAUFMAN MH, 1989, CYTOGENET CELL GENET, V52, P15, DOI 10.1159/000132830; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; KELLY SJ, 1977, J EXP ZOOL, V200, P365, DOI 10.1002/jez.1402000307; LATHAM KE, 1994, GENE DEV, V8, P290, DOI 10.1101/gad.8.3.290; LATHAM KE, 1991, DEVELOPMENT, V113, P561; LYON MF, 1991, TRENDS GENET, V7, P69, DOI 10.1016/0168-9525(91)90271-Q; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; MANN JR, 1988, DEVELOPMENT, V104, P129; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; McLaren A., 1976, MAMMALIAN CHIMAERAS; MONK M, 1990, PHILOS T R SOC B, V326, P299, DOI 10.1098/rstb.1990.0013; MONK M, 1991, DEVELOPMENT, V112, P189; MONK M, 1978, J EMBRYOL EXP MORPH, V46, P53; NORRIS DP, 1994, CELL, V77, P41, DOI 10.1016/0092-8674(94)90233-X; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; RASTAN S, 1990, GENET RES, V56, P99, DOI 10.1017/S0016672300035163; RASTAN S, 1980, NATURE, V288, P172, DOI 10.1038/288172a0; REIK W, 1993, DEVELOPMENT, V119, P933; SAPIENZA C, 1989, DEVELOPMENT, V107, P165; SURANI MA, 1990, DEVELOPMENT, P89; SURANI MAH, 1986, CELL, V45, P127, DOI 10.1016/0092-8674(86)90544-1; SURANI MAH, 1983, SCIENCE, V222, P1034, DOI 10.1126/science.6648518; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; TAKAGI N, 1978, CYTOGENET CELL GENET, V20, P240, DOI 10.1159/000130856; THORNHILL AR, 1993, DEVELOPMENT, V118, P171; WALSH W, 1994, IN PRESS MECH DEV; WEST JD, 1977, CELL, V12, P873, DOI 10.1016/0092-8674(77)90151-9	45	214	214	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	1994	77	5					639	650		10.1016/0092-8674(94)90049-3	http://dx.doi.org/10.1016/0092-8674(94)90049-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NQ123	8205614				2022-12-28	WOS:A1994NQ12300005
J	SU, B; JACINTO, E; HIBI, M; KALLUNKI, T; KARIN, M; BEN-NERIAH, Y				SU, B; JACINTO, E; HIBI, M; KALLUNKI, T; KARIN, M; BEN-NERIAH, Y			JNK IS INVOLVED IN SIGNAL INTEGRATION DURING COSTIMULATION OF T-LYMPHOCYTES	CELL			English	Article							CELL ACTIVATION GENES; C-JUN; PROTEIN-KINASE; DNA-BINDING; CYCLOSPORINE-A; INTERLEUKIN-2 PROMOTER; NUCLEAR FACTOR; CD28 RECEPTOR; CLONAL ANERGY; MAP KINASES	T lymphocyte activation and interleukin-2 (IL-2) production require at least two signals, generated by phorbol ester (TPA) and Ca2+ ionophore or costimulation of the T cell receptor (TCR) and the CD28 auxiliary receptor. We investigated how these stimuli affect mitogen activated protein (MAP) kinases. Full activation of the MAP kinases that phosphorylate the Jun activation domain, JNK1 and JNK2, required costimulation of T cells with either TPA and Ca2+ ionophore or antibodies to TCR and CD28. Alone, each stimulus resulted in little or no activation. Similar to its effect on IL-2 induction, cyclosporin A (CsA) inhibited the synergistic activation of JNK, and a competitive inhibitor of Jun phosphorylation by JNK inhibited IL-2 promoter activation. By contrast, the MAP kinases ERK1 and ERK2 were fully activated by TPA or TCR stimulation and were not affected by Ca2+, CD28, or CsA. Hence, integration of signals that lead to T cell activation occurs at the level of JNK activation.			SU, B (corresponding author), UNIV CALIF SAN DIEGO, SCH MED, CTR MOLEC GENET, BIOMED SCI PROGRAM, DEPT PHARMACOL, LA JOLLA, CA 92093 USA.		Ben-Neriah, Yinon/L-6285-2019; Hibi, Masahiko/I-6215-2014	Hibi, Masahiko/0000-0002-9142-4444; Jacinto, Estela/0000-0001-7118-1759; Kallunki, Tuula/0000-0002-8571-383X	NCI NIH HHS [CA-50528] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA050528] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; BANERJI SS, 1991, MOL CELL BIOL, V11, P4074, DOI 10.1128/MCB.11.8.4074; BINETRUY B, 1991, NATURE, V351, P122, DOI 10.1038/351122a0; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; COCKERILL PN, 1993, P NATL ACAD SCI USA, V90, P2466, DOI 10.1073/pnas.90.6.2466; CRABTREE GR, 1989, SCIENCE, V243, P355, DOI 10.1126/science.2783497; CREWS CM, 1992, SCIENCE, V258, P478, DOI 10.1126/science.1411546; DENG TL, 1993, GENE DEV, V7, P479, DOI 10.1101/gad.7.3.479; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DOWNWARD J, 1990, NATURE, V346, P651; DURAND DB, 1988, MOL CELL BIOL, V8, P1715, DOI 10.1128/MCB.8.4.1715; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; FRASER JD, 1991, SCIENCE, V251, P313, DOI 10.1126/science.1846244; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; GUNTER KC, 1989, J IMMUNOL, V142, P3286; HANSEN JA, 1980, IMMUNOGENETICS, V10, P247, DOI 10.1007/BF01561573; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; IMBODEN JB, 1988, PROG ALLERGY, V42, P246; JAIN J, 1992, NATURE, V356, P801, DOI 10.1038/356801a0; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; JANEWAY CA, 1994, CELL, V76, P275, DOI 10.1016/0092-8674(94)90335-2; JUNE CH, 1990, IMMUNOL TODAY, V11, P211, DOI 10.1016/0167-5699(90)90085-N; KANG SM, 1992, SCIENCE, V257, P1134, DOI 10.1126/science.257.5073.1134; KYRLAKIS S, 1992, NATURE, V358, P417; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; LIN AN, 1992, CELL, V70, P777, DOI 10.1016/0092-8674(92)90311-Y; LINSLEY PS, 1993, ANNU REV IMMUNOL, V11, P191, DOI 10.1146/annurev.iy.11.040193.001203; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MATILLA PS, 1990, EMBO J, V9, P4425; MCCAFFREY PG, 1993, J BIOL CHEM, V268, P3747; MCKEON F, 1991, CELL, V66, P823, DOI 10.1016/0092-8674(91)90426-Y; MUEGGE K, 1989, SCIENCE, V246, P249, DOI 10.1126/science.2799385; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; NORTHROP JP, 1993, J BIOL CHEM, V268, P2917; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; RAO A, 1991, CRIT REV IMMUNOL, V10, P495; ROBBINS DJ, 1992, P NATL ACAD SCI USA, V89, P6924, DOI 10.1073/pnas.89.15.6924; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V173, P753; SATOH T, 1990, P NATL ACAD SCI USA, V87, P5993, DOI 10.1073/pnas.87.15.5993; SCHREIBER SL, 1992, CELL, V70, P365, DOI 10.1016/0092-8674(92)90158-9; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; SERFLING E, 1989, EMBO J, V8, P465, DOI 10.1002/j.1460-2075.1989.tb03399.x; SHAW JP, 1988, SCIENCE, V241, P202, DOI 10.1126/science.3260404; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TOCCI MJ, 1989, J IMMUNOL, V143, P718; TREISMAN R, 1992, TRENDS BIOCHEM SCI, V17, P423, DOI 10.1016/0968-0004(92)90013-Y; ULLMAN KS, 1993, GENE DEV, V7, P188, DOI 10.1101/gad.7.2.188; ULLMAN KS, 1991, SCIENCE, V254, P558, DOI 10.1126/science.1683003; VANWAUWE JP, 1980, J IMMUNOL, V124, P2708; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; WILLIAMS NG, 1992, P NATL ACAD SCI USA, V89, P2922, DOI 10.1073/pnas.89.7.2922; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; YANG-YEN H-F, 1990, New Biologist, V2, P351; ZIPFEL PF, 1989, MOL CELL BIOL, V9, P1041, DOI 10.1128/MCB.9.3.1041	59	871	891	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 3	1994	77	5					727	736		10.1016/0092-8674(94)90056-6	http://dx.doi.org/10.1016/0092-8674(94)90056-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NQ123	8205621				2022-12-28	WOS:A1994NQ12300012
J	PARTHASARATHY, RV; MARTIN, CR				PARTHASARATHY, RV; MARTIN, CR			SYNTHESIS OF POLYMERIC MICROCAPSULE ARRAYS AND THEIR USE FOR ENZYME IMMOBILIZATION	NATURE			English	Article							GLUCOSE-OXIDASE; TEMPLATE SYNTHESIS; COVALENT ELECTROPOLYMERIZATION; ELECTRONIC CONDUCTIVITIES; POLYPYRROLE FILMS; MICROTUBULES; SENSORS	CURRENT methods for immobilizing enzymes for use in bioreactors and biosensors(1-20) include adsorption on or covalent attachment to a support(2-4), micro-encapsulation(5,6), and entrapment within a membrane/film(7,8,11-20) or gel(9). The ideal immobilization method should employ mild chemical conditions, allow for large quantities of enzyme to be immobilized, provide a large surface area for enzyme-substrate contact within a small total volume, minimize barriers to mass transport of substrate and product, and provide a chemically and mechanically robust system. Here we describe a method for enzyme immobilization that satisfies all of these criteria. We have developed a template-based synthetic method that yields hollow polymeric microcapsules of uniform diameter and length. These microcapsules are arranged in a high-density array in which the individual capsules protrude from a surface like the bristles of a brush. We have developed procedures for filling these microcapsules with high concentrations of enzymes. The enzyme-loaded microcapsule arrays function as enzymatic bioreactors in both aqueous solution and organic solvents.	COLORADO STATE UNIV,DEPT CHEM,FT COLLINS,CO 80523	Colorado State University			Martin, Charles/AAA-1040-2019; Way, James Douglas/A-9408-2010	Way, James Douglas/0000-0001-9612-8508				ALMEIDA NF, 1993, BIOTECHNOL BIOENG, V42, P1037, DOI 10.1002/bit.260420904; BAKER RW, 1991, MEMBRANE SEPARATION, V2, P151; BARTLETT PN, 1987, J ELECTROANAL CHEM, V224, P37, DOI 10.1016/0022-0728(87)85082-9; BARTLETT PN, 1992, J CHEM SOC FARADAY T, V88, P2677, DOI 10.1039/ft9928802677; BURGMAYER P, 1986, HDB CONDUCTING POLYM, V1, pCH15; CAI ZH, 1989, J AM CHEM SOC, V111, P4138, DOI 10.1021/ja00193a077; DALVIE SK, 1992, BIOTECHNOL BIOENG, V40, P1174; ELLERBY LM, 1992, SCIENCE, V255, P1113, DOI 10.1126/science.1312257; FORTIER G, 1991, BIOTECHNOL BIOENG, V37, P854, DOI 10.1002/bit.260370909; FOULDS NC, 1986, J CHEM SOC FARAD T 1, V82, P1259, DOI 10.1039/f19868201259; FOULDS NC, 1988, ANAL CHEM, V60, P2473, DOI 10.1021/ac00173a008; GEORGER JH, 1987, J AM CHEM SOC, V109, P6169, DOI 10.1021/ja00254a042; GU KF, 1988, BIOREACTOR IMMOBILIZ, P59; KAJIYA Y, 1991, ANAL CHEM, V63, P49, DOI 10.1021/ac00001a009; KLEI HE, 1985, IMMOBILIZED CELLS EN, pCH4; KOOPAL CGJ, 1992, SYNTHETIC MET, V51, P397, DOI 10.1016/0379-6779(92)90295-T; MAIDAN R, 1992, ANAL CHEM, V64, P2889, DOI 10.1021/ac00047a003; MARCHESIELLO M, 1992, ELECTROCHIM ACTA, V37, P1987, DOI 10.1016/0013-4686(92)87113-E; MARCHESIELLO M, 1993, J ELECTROANAL CHEM, V358, P35, DOI 10.1016/0022-0728(93)80429-L; MARTIN CR, 1990, J AM CHEM SOC, V112, P8976, DOI 10.1021/ja00180a050; MARTIN CR, 1991, ADV MATER, V3, P457, DOI 10.1002/adma.19910030914; MARTIN CR, 1993, SYNTHETIC MET, V55, P1165, DOI 10.1016/0379-6779(93)90218-L; MARTIN CR, IN PRESS ELECTROCHIM; PENNER RM, 1988, J PHYS CHEM-US, V92, P5274, DOI 10.1021/j100329a042; POOL R, 1990, SCIENCE, V247, P1410; SOBER HA, 1968, HDB BIOCH, pC11; SUN ZS, 1992, ANAL CHEM, V64, P1112, DOI 10.1021/ac00034a008; TATSUMA T, 1993, J ELECTROANAL CHEM, V356, P245, DOI 10.1016/0022-0728(93)80523-K; UMANA M, 1986, ANAL CHEM, V58, P2979, DOI 10.1021/ac00127a018; WOLOWACZ SE, 1992, ANAL CHEM, V64, P1541, DOI 10.1021/ac00038a008; WOODWARD J, 1985, IMMOBILIZED CELLS EN; YONHIN BFY, 1993, ANAL CHEM, V65, P2067, DOI 10.1021/ac00063a022; ZAKS A, 1988, J BIOL CHEM, V263, P3194; 1972, WORTHINGTON ENZYME M, P41	34	325	351	3	182	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 26	1994	369	6478					298	301		10.1038/369298a0	http://dx.doi.org/10.1038/369298a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NN109	8183367				2022-12-28	WOS:A1994NN10900042
J	SETH, A; STERN, LJ; OTTENHOFF, THM; ENGEL, I; OWEN, MJ; LAMB, JR; KLAUSNER, RD; WILEY, DC				SETH, A; STERN, LJ; OTTENHOFF, THM; ENGEL, I; OWEN, MJ; LAMB, JR; KLAUSNER, RD; WILEY, DC			BINARY AND TERNARY COMPLEXES BETWEEN T-CELL RECEPTOR, CLASS-II MHC AND SUPERANTIGEN IN-VITRO	NATURE			English	Article							ANTIGEN RECEPTOR; LYMPHOCYTES-T; ENTEROTOXIN-B; PROTEINS; PEPTIDE; RECOGNITION; AFFINITY; HETERODIMERS; SURFACE; ANERGY	SUPERANTIGENS are proteins that in association with class II major histocompatibility complex (MHC)-bearing cells can stimulate virtually all T cells that express particular classes of the variable beta-domains of the T-cell receptor (TCR)(1). This mechanism of T-cell activation circumvents the usual requirement for peptide-specific MHC recognition. Staphylococcus aureus enterotoxin B (SEB) is a bacterial superantigen that causes food poisoning and shock(2-5). We have characterized the tertiary complex of SEB, a soluble T-cell receptor, and a soluble class II MHC molecule DR1, and the three binary complexes TCR-SEB, SEB-DR1, and the peptide-specific complex DR1-TCR. We report here that in each case the specificity of the interaction among the soluble molecules is the same as observed in biological assays. Native gel electrophoresis and plasmon resonance affinity measurements indicate that SEB-TCR complex can form in the absence of class II MHC and that SEB-TCR interaction increases the binding of DR1. The observation that a superantigen can form complexes with TCR in both the absence and presence of class II MHC may provide a mechanism for its ability to induce anergy in some circumstances and activation in others(6,7) (reviewed in ref. 8).	HARVARD UNIV,HOWARD HUGHES MED INST,CAMBRIDGE,MA 02138; NICHHD,CELL BIOL & METAB BRANCH,BETHESDA,MD 20892; IMPERIAL CANC RES FUND,LYMPHOCYTE MOLEC BIOL LAB,LONDON WC2A 3PX,ENGLAND; UNIV LONDON IMPERIAL COLL SCI TECHNOL & MED,ST MARYS HOSP,SCH MED,DEPT IMMUNOL,LONDON W2 1PG,ENGLAND	Harvard University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Cancer Research UK; Imperial College London	SETH, A (corresponding author), HARVARD UNIV,DEPT BIOCHEM & MOLEC BIOL,7 DIVIN AVE,CAMBRIDGE,MA 02138, USA.							BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; CHOI YW, 1989, P NATL ACAD SCI USA, V86, P8941, DOI 10.1073/pnas.86.22.8941; DAVIS MM, 1993, CURR OPIN IMMUNOL, V5, P45, DOI 10.1016/0952-7915(93)90079-8; DEUTSCHER MP, 1990, GUIDE PROTEIN PURIFI, P1; ENGEL I, 1992, SCIENCE, V256, P1318, DOI 10.1126/science.1598575; FAGERSTAM L, 1991, TECHNIQUES PROTEIN C, V2, P65; FLEISCHER B, 1991, J IMMUNOL, V146, P11; Gascoigne N R, 1993, Semin Immunol, V5, P13, DOI 10.1006/smim.1993.1003; HERRMANN T, 1991, J IMMUNOL, V146, P2504; HEWITT CRA, 1992, J EXP MED, V175, P1493, DOI 10.1084/jem.175.6.1493; IRWIN MJ, 1993, IMMUNOL REV, V131, P61, DOI 10.1111/j.1600-065X.1993.tb01530.x; JANEWAY CA, 1989, IMMUNOL REV, V107, P61, DOI 10.1111/j.1600-065X.1989.tb00003.x; JOHNSSON B, 1991, ANAL BIOCHEM, V198, P268, DOI 10.1016/0003-2697(91)90424-R; KARLSSON R, 1991, J IMMUNOL METHODS, V145, P229, DOI 10.1016/0022-1759(91)90331-9; KOTZIN BL, 1993, ADV IMMUNOL, V54, P99, DOI 10.1016/S0065-2776(08)60534-9; LABRECQUE N, 1993, RES IMMUNOL, V144, P175, DOI 10.1016/0923-2494(93)80113-D; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOFAS S, 1990, J CHEM SOC CHEM COMM, V21, P1526; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; MATSUI K, 1991, SCIENCE, V254, P1788, DOI 10.1126/science.1763329; Micusan V V, 1993, Semin Immunol, V5, P3, DOI 10.1006/smim.1993.1002; OHEHIR RE, 1990, P NATL ACAD SCI USA, V87, P8884, DOI 10.1073/pnas.87.22.8884; SCHOLL PR, 1989, J IMMUNOL, V143, P2583; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; STERN LJ, 1992, CELL, V68, P465, DOI 10.1016/0092-8674(92)90184-E; WEBER S, 1992, NATURE, V356, P793, DOI 10.1038/356793a0	26	168	175	0	5	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 26	1994	369	6478					324	327		10.1038/369324a0	http://dx.doi.org/10.1038/369324a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NN109	8183371				2022-12-28	WOS:A1994NN10900051
J	KIM, YJ; BJORKLUND, S; LI, Y; SAYRE, MH; KORNBERG, RD				KIM, YJ; BJORKLUND, S; LI, Y; SAYRE, MH; KORNBERG, RD			A MULTIPROTEIN MEDIATOR OF TRANSCRIPTIONAL ACTIVATION AND ITS INTERACTION WITH THE C-TERMINAL REPEAT DOMAIN OF RNA-POLYMERASE-II	CELL			English	Article							TATA-LESS PROMOTER; SACCHAROMYCES-CEREVISIAE; HEPTAPEPTIDE REPEAT; TFIID COMPLEX; GAL4; INITIATION; INVITRO; PROTEIN; BINDING; PURIFICATION	A mediator was isolated from yeast that enabled a response to the activator proteins GAL4-VP16 and GCN4 in a transcription system reconstituted with essentially homogeneous basal factors and RNA polymerase II. The mediator comprised some 20 polypeptides, including the three subunits of TFIIF and other polypeptides cross-reactive with antisera against GAL11, SUG1, SRB2, SRB4, SRB5, and SRB6 proteins. Mediator not only enabled activated transcription but also conferred 8-fold greater activity in basal transcription and 12-fold greater efficiency of phosphorylation of RNA polymerase II by the TFIIH-associated C-terminal repeat domain (CTD) kinase, indicative of mediator-CTD interaction. A holoenzyme form of RNA polymerase II was independently isolated that supported a response to activator proteins with purified basal factors. The holoenzyme proved to consist of mediator associated with core 12-subunit RNA polymerase II.			KIM, YJ (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT CELL BIOL,STANFORD,CA 94305, USA.			Kim, Young-Joon/0000-0001-5061-587X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036659, R37GM036659] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-36659] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLISON LA, 1989, P NATL ACAD SCI USA, V86, P2794, DOI 10.1073/pnas.86.8.2794; ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; BARTOLOMEI MS, 1988, MOL CELL BIOL, V8, P330, DOI 10.1128/MCB.8.1.330; CAIRNS BR, 1994, P NATL ACAD SCI USA, V91, P1950, DOI 10.1073/pnas.91.5.1950; CHASMAN DI, 1989, MOL CELL BIOL, V9, P4746, DOI 10.1128/MCB.9.11.4746; CONAWAY RC, 1993, ANNU REV BIOCHEM, V62, P161; EDWARDS AM, 1990, P NATL ACAD SCI USA, V87, P2122, DOI 10.1073/pnas.87.6.2122; FASSLER JS, 1989, MOL CELL BIOL, V9, P5602, DOI 10.1128/MCB.9.12.5602; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; FLANAGAN PM, 1990, J BIOL CHEM, V265, P11105; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; HARLOW E, 1988, ANTIBODIES LABORATOR; HENRY NL, 1992, J BIOL CHEM, V267, P23388; HIMMELFARB HJ, 1990, CELL, V63, P1299, DOI 10.1016/0092-8674(90)90425-E; KEAVENEY M, 1993, NATURE, V365, P562, DOI 10.1038/365562a0; KELLEHER RJ, 1990, CELL, V61, P1209, DOI 10.1016/0092-8674(90)90685-8; KOLESKE AJ, 1992, CELL, V69, P883, DOI 10.1016/0092-8674(92)90298-Q; KRETZSCHMAR M, 1993, P NATL ACAD SCI USA, V90, P11508, DOI 10.1073/pnas.90.24.11508; MERINO A, 1993, NATURE, V365, P227, DOI 10.1038/365227a0; NISHIZAWA M, 1990, P NATL ACAD SCI USA, V87, P5373, DOI 10.1073/pnas.87.14.5373; NONET M, 1987, CELL, V50, P909, DOI 10.1016/0092-8674(87)90517-4; NONET ML, 1989, GENETICS, V123, P715; ONEIL KT, 1991, BIOCHEMISTRY-US, V30, P9030, DOI 10.1021/bi00101a017; POON D, 1993, J BIOL CHEM, V268, P15325; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; ROBERTS SGE, 1993, NATURE, V363, P741, DOI 10.1038/363741a0; SAKURAI H, 1993, P NATL ACAD SCI USA, V90, P8382, DOI 10.1073/pnas.90.18.8382; SAYRE MH, 1992, J BIOL CHEM, V267, P23376; STRINGER KF, 1990, NATURE, V345, P783, DOI 10.1038/345783a0; SUZUKI Y, 1988, MOL CELL BIOL, V8, P4911; SWAFFIELD JC, 1992, NATURE, V357, P698, DOI 10.1038/357698a0; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; THOMPSON NE, 1989, J BIOL CHEM, V264, P11511; TIMMERS HTM, 1991, GENE DEV, V5, P1946, DOI 10.1101/gad.5.11.1946; ZHOU Q, 1992, GENE DEV, V6, P1964, DOI 10.1101/gad.6.10.1964	36	910	935	3	48	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 20	1994	77	4					599	608		10.1016/0092-8674(94)90221-6	http://dx.doi.org/10.1016/0092-8674(94)90221-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NM832	8187178				2022-12-28	WOS:A1994NM83200014
J	KYRIAKIS, JM; BANERJEE, P; NIKOLAKAKI, E; DAI, TA; RUBIE, EA; AHMAD, MF; AVRUCH, J; WOODGETT, JR				KYRIAKIS, JM; BANERJEE, P; NIKOLAKAKI, E; DAI, TA; RUBIE, EA; AHMAD, MF; AVRUCH, J; WOODGETT, JR			THE STRESS-ACTIVATED PROTEIN-KINASE SUBFAMILY OF C-JUN KINASES	NATURE			English	Article							NECROSIS-FACTOR-ALPHA; TUMOR-NECROSIS; MAP KINASE; PHOSPHORYLATION; INSULIN; TYROSINE; REQUIRES; FAMILY; DOMAIN	THE mitogen-activated protein (MAP) kinases Erk-1 and Erk-2 are proline-directed kinases that are themselves activated through concomitant phosphorylation of tyrosine and threonine residues(1-4). The kinase p54 (M(r) 54,000), which was first isolated from cycloheximide-treated rats, is proline-directed like Erks-1/2, and requires both Tyr and Ser/Thr phosphorylation(3,5,6) for activity. p54 is, however, distinct from Erks-1/2 in its substrate specificity, being unable to phosphorylate pp90(rsk) but more active in phosphorylating the c-Jun transactivation domain(5,7,8). Molecular cloning of p54 reveals a unique subfamily of extracellularly regulated kinases. Although they are 40-45% identical in sequence to Erks-1/2, unlike Erks-1/2 the p54s are only poorly activated in most cells by mitogens or phorbol esters. However, p54s are the principal c-Jun N-terminal kinases activated by cellular stress and tumour necrosis factor (TNF)-alpha, hence they are designated stress-activated protein kinases, or SAPKs. SAPKs are also activated by sphingomyelinase, which elicits a subset of cellular responses to TNF-alpha (ref. 9). SAPKs therefore define a new TNF-alpha and stress-activated signalling pathway, possibly initiated by sphingomyelin-based second messengers, which regulates the activity of c-Jun.	PRINCESS MARGARET HOSP, ONTARIO CANC INST, TORONTO M4X 1K9, ON, CANADA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	KYRIAKIS, JM (corresponding author), MASSACHUSETTS GEN HOSP E, MED SERV, DIABET RES LAB, 149 13TH ST, BOSTON, MA 02129 USA.		Woodgett, Jim/F-1087-2010	Woodgett, Jim/0000-0003-3731-5797				ADLER V, 1992, P NATL ACAD SCI USA, V89, P5341, DOI 10.1073/pnas.89.12.5341; AHN NG, 1991, J BIOL CHEM, V266, P4220; ALVAREZ E, 1991, J BIOL CHEM, V266, P15277; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BEUTLER B, 1988, ANNU REV BIOCHEM, V57, P505, DOI 10.1146/annurev.bi.57.070188.002445; BINETRUY B, 1991, NATURE, V351, P122, DOI 10.1038/351122a0; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BRENNER DA, 1989, NATURE, V337, P661, DOI 10.1038/337661a0; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; COURCHESNE WE, 1989, CELL, V58, P1107, DOI 10.1016/0092-8674(89)90509-6; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; DEVARY Y, 1992, CELL, V71, P1081, DOI 10.1016/S0092-8674(05)80058-3; DRESSLER KA, 1992, SCIENCE, V255, P1715, DOI 10.1126/science.1313189; ELION EA, 1990, CELL, V60, P649, DOI 10.1016/0092-8674(90)90668-5; GOEDDEL DV, 1986, COLD SPRING HARB SYM, V51, P597, DOI 10.1101/SQB.1986.051.01.072; GOMEZ N, 1991, NATURE, V353, P170, DOI 10.1038/353170a0; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; KYRIAKIS JM, 1990, J BIOL CHEM, V265, P17355; KYRIAKIS JM, 1991, J BIOL CHEM, V266, P10043; KYRIAKIS JM, IN PRESS FRONTIERS M; LEVIN DE, 1993, J NIH RES, V5, P49; MUKHOPADHYAY NK, 1992, J BIOL CHEM, V267, P3325; NAKIELNY S, 1992, EMBO J, V11, P2123, DOI 10.1002/j.1460-2075.1992.tb05271.x; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; PULVERER BJ, 1993, ONCOGENE, V8, P407; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; STURGILL TW, 1988, NATURE, V334, P715, DOI 10.1038/334715a0	31	2473	2531	2	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 12	1994	369	6476					156	160		10.1038/369156a0	http://dx.doi.org/10.1038/369156a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NK971	8177321				2022-12-28	WOS:A1994NK97100052
J	AINSWORTH, MA; HOGAN, DL; KOSS, MA; ISENBERG, JI				AINSWORTH, MA; HOGAN, DL; KOSS, MA; ISENBERG, JI			CIGARETTE-SMOKING INHIBITS ACID-STIMULATED DUODENAL MUCOSAL BICARBONATE SECRETION	ANNALS OF INTERNAL MEDICINE			English	Article						PEPTIC ULCER; SMOKING; DUODENAL ULCER; MUCOUS MEMBRANE; BICARBONATES	MAXIMAL GASTRIC-SECRETION; ULCER PATIENTS; PEPTIC-ULCER; HEALING RATE; NON-SMOKERS; CIMETIDINE; PROSTAGLANDIN-E2; ALCOHOL; RELAPSE; DISEASE	Objective: To determine the effect of cigarette smoking on proximal duodenal mucosal bicarbonate secretion, an important defense mechanism against acid and peptic damage. Design: Prospective study. Setting: Clinical research laboratory in a university hospital. Patients: Thirteen healthy adults (7 smokers and 6 nonsmokers) who had no history of peptic ulcer disease. Interventions: Participants smoked (1 cigarette/15 min during a period of 1 hour, smokers only) or sham smoked (puffing on an unlit cigarette) during duodenal perfusion with either saline, hydrochloric acid, or prostaglandin E2 (PGE2). Measurements: Collection of proximal duodenal secretions using a modified duodenal tube with occluding balloons and quantitation of duodenal mucosal bicarbonate secretion. Results: During sham smoking both smokers and nonsmokers had comparable basal as well as H+-stimulated and PGE2-stimulated duodenal mucosal bicarbonate secretion. Compared with sham smoking, smoking did not significantly alter basal bicarbonate secretion (201 mumol/cm per hour [95% CI, 152 to 250 mumol/cm per hour] compared with 178 mumol/cm per hour [CI, 134 to 222 mumol/cm per hour], respectively). However, compared with sham smoking, smoking markedly reduced (P < 0.01) the increase in duodenal bicarbonate secretion in response to luminal acidification by approximately 80% (from 242 mumol/cm per hour [CI, 41 to 443 mumol/cm per hour] to 53 mumol/cm per hour [CI, -107 to 197 mumol/cm per hour]); a decrease was observed in each participant. In contrast, smoking had no significant effect on the response to luminal PGE2. Conclusions. Cigarette smoking markedly inhibited acid-stimulated human duodenal mucosal bicarbonate secretion. This adverse effect of smoking may, at least in part, explain the role of cigarette smoking in the pathogenesis and natural history of duodenal ulcer disease.	UNIV CALIF SAN DIEGO, MED CTR,DEPT MED,DIV GASTROENTEROL, 225 DICKINSON ST, SAN DIEGO, CA 92103 USA; ODENSE UNIV HOSP, DK-5000 ODENSE, DENMARK	University of California System; University of California San Diego; University of Southern Denmark; Odense University Hospital			Ainsworth, Mark Andrew/AAO-6988-2020; Ainsworth, Mark Andrew/CAA-2707-2022	Ainsworth, Mark Andrew/0000-0002-4899-1048; Ainsworth, Mark Andrew/0000-0002-4899-1048	NIADDK NIH HHS [AM 33491] Funding Source: Medline; NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES [R01AM033491] Funding Source: NIH RePORTER	NIADDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NAT INST OF ARTHRITIS, DIABETES, DIGESTIVE &KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AINSWORTH MA, 1990, SCAND J GASTROENTERO, V25, P1066, DOI 10.3109/00365529008997636; BOCHENEK WJ, 1973, AM J DIG DIS, V18, P729; BROWN P, 1976, MED J AUSTRALIA, V2, P290, DOI 10.5694/j.1326-5377.1976.tb130184.x; BYNUM TE, 1972, GUT, V13, P361, DOI 10.1136/gut.13.5.361; CHIVERTON SG, 1989, J CLIN GASTROENTEROL, V11, pS29; CRYER B, 1992, ANN INTERN MED, V116, P636, DOI 10.7326/0003-4819-116-8-636; DEBAS HT, 1971, GUT, V12, P93, DOI 10.1136/gut.12.2.93; DOLL R, 1964, BRIT MED J, V1, P1399, DOI 10.1136/bmj.1.5395.1399; FLEMSTROM G, 1984, CLIN GASTROENTEROL, V13, P327; FLEMSTROM G, 1987, PHYSL GASTROINTESTIN, P1011; FRIEDMAN GD, 1974, NEW ENGL J MED, V290, P469, DOI 10.1056/NEJM197402282900901; GRANSTAM SO, 1990, J CLIN GASTROENTEROL, V12, pS19, DOI 10.1097/00004836-199001001-00005; GUGLER R, 1982, GUT, V23, P866, DOI 10.1136/gut.23.10.866; HARRISON AR, 1979, SMOKING HLTH REPORT; HULL DH, 1985, GUT, V26, P1333, DOI 10.1136/gut.26.12.1333; ISENBERG JI, 1986, GASTROENTEROLOGY, V91, P370, DOI 10.1016/0016-5085(86)90571-8; KNUTSON L, 1989, GUT, V30, P1708, DOI 10.1136/gut.30.12.1708; KORMAN MG, 1983, GASTROENTEROLOGY, V85, P871; KORMAN MG, 1982, DIGEST DIS SCI, V27, P712, DOI 10.1007/BF01393766; KORMAN MG, 1981, GASTROENTEROLOGY, V80, P1451; MALESCI A, 1988, SCAND J GASTROENTERO, V23, P602, DOI 10.3109/00365528809093919; MASSARRAT S, 1981, GUT, V22, P97, DOI 10.1136/gut.22.2.97; MCCREADY DR, 1985, GUT, V26, P1192, DOI 10.1136/gut.26.11.1192; MILLBOURN E, 1950, ACTA ANAT, V9, P1; MURTHY SNS, 1977, GASTROENTEROLOGY, V73, P758; OSTENSEN H, 1985, SCAND J GASTROENTERO, V20, P1227, DOI 10.3109/00365528509089281; PARENTE F, 1985, GUT, V26, P1327, DOI 10.1136/gut.26.12.1327; QUIGLEY EMM, 1987, GASTROENTEROLOGY, V92, P1876, DOI 10.1016/0016-5085(87)90619-6; QUIMBY GF, 1986, ANN INTERN MED, V104, P616, DOI 10.7326/0003-4819-104-5-616; SELLING JA, 1987, ANN INTERN MED, V106, P368, DOI 10.7326/0003-4819-106-3-368; SOLOMON TE, 1972, NEW ENGL J MED, V286, P1212, DOI 10.1056/NEJM197206012862211; SONNENBERG A, 1981, GASTROENTEROLOGY, V81, P1061; SONTAG S, 1984, NEW ENGL J MED, V311, P689, DOI 10.1056/NEJM198409133111101; STERN AI, 1984, GASTROENTEROLOGY, V86, P60; Trowell OA, 1934, LANCET, V1, P808; WENZL E, 1987, GASTROENTEROLOGY, V92, P709, DOI 10.1016/0016-5085(87)90022-9; WHITECROSS DP, 1974, SCAND J GASTROENTERO, V9, P399; WHITFIELD PF, 1985, BRIT J SURG, V72, P955, DOI 10.1002/bjs.1800721207; WHITFIELD PF, 1987, GUT, V28, P557, DOI 10.1136/gut.28.5.557; Wilkinson A, 1969, Gut, V10, P415; WILKINSON AR, 1971, LANCET, V2, P628; 1978, FEDERAL TRADE COMMIS, P17	42	26	27	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	1993	119	9					882	886		10.7326/0003-4819-119-9-199311010-00003	http://dx.doi.org/10.7326/0003-4819-119-9-199311010-00003			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MD711	8214999				2022-12-28	WOS:A1993MD71100003
J	CHUNG, CH				CHUNG, CH			PROTEASES IN ESCHERICHIA-COLI	SCIENCE			English	Editorial Material							ATP-DEPENDENT PROTEASE; REGULATORY SUBUNIT; HIGH-TEMPERATURES; ACTIVATED ATPASE; GENE-PRODUCT; LA; PROTEOLYSIS; PURIFICATION; CONTAINS; DEGRADATION				CHUNG, CH (corresponding author), SEOUL NATL UNIV, COLL NAT SCI, DEPT MOLEC BIOL, SEOUL 151742, SOUTH KOREA.							CHARETTE MF, 1981, P NATL ACAD SCI-BIOL, V78, P4728, DOI 10.1073/pnas.78.8.4728; CHUNG CH, 1981, P NATL ACAD SCI-BIOL, V78, P4931, DOI 10.1073/pnas.78.8.4931; GOFF SA, 1985, CELL, V41, P587, DOI 10.1016/S0092-8674(85)80031-3; GOLDBERG AL, 1976, ANNU REV BIOCHEM, V45, P747, DOI 10.1146/annurev.bi.45.070176.003531; GOLDBERG AL, 1981, METHOD ENZYMOL, V80, P680; GOLDBERG AL, 1992, EUR J BIOCHEM, V203, P9, DOI 10.1111/j.1432-1033.1992.tb19822.x; GOTTESMAN S, 1989, ANNU REV GENET, V23, P163, DOI 10.1146/annurev.ge.23.120189.001115; GOTTESMAN S, 1990, P NATL ACAD SCI USA, V87, P3513, DOI 10.1073/pnas.87.9.3513; GOTTESMAN S, 1992, MICROBIOL REV, V56, P592, DOI 10.1128/MMBR.56.4.592-621.1992; HERSHKO A, 1982, ANNU REV BIOCHEM, V51, P335, DOI 10.1146/annurev.bi.51.070182.002003; HWANG BJ, 1988, J BIOL CHEM, V263, P8727; HWANG BJ, 1987, P NATL ACAD SCI USA, V84, P5550, DOI 10.1073/pnas.84.16.5550; HWANG DS, 1990, CELL, V63, P325, DOI 10.1016/0092-8674(90)90165-B; KATAYAMAFUJIMURA Y, 1987, J BIOL CHEM, V262, P4477; KITAGAWA M, 1991, J BACTERIOL, V173, P4247, DOI 10.1128/JB.173.14.4247-4253.1991; LEE CS, 1990, FEBS LETT, V262, P310, DOI 10.1016/0014-5793(90)80216-6; LEE YS, 1988, J BIOL CHEM, V263, P6643; LINDAHL T, 1988, ANNU REV BIOCHEM, V57, P133, DOI 10.1146/annurev.bi.57.070188.001025; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; MAURIZI MR, 1992, EXPERIENTIA, V48, P178, DOI 10.1007/BF01923511; MENON AS, 1987, J BIOL CHEM, V262, P722; NOVAK P, 1986, J BIOL CHEM, V261, P420; PARK JH, 1988, J BACTERIOL, V170, P921, DOI 10.1128/jb.170.2.921-926.1988; Park S.C., UNPUB; PARK SK, IN PRESS J BIOL CHEM; SEOL JH, 1991, BIOCHEM BIOPH RES CO, V176, P730; SILBER KR, 1992, P NATL ACAD SCI USA, V89, P295, DOI 10.1073/pnas.89.1.295; SQUIRES CL, 1991, J BACTERIOL, V173, P4254, DOI 10.1128/JB.173.14.4254-4262.1991; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989; SWAMY KHS, 1983, ARCH BIOCHEM BIOPHYS, V224, P543, DOI 10.1016/0003-9861(83)90242-4; SWAMY KHS, 1981, NATURE, V292, P652, DOI 10.1038/292652a0; TOBIAS JW, 1991, SCIENCE, V254, P1374, DOI 10.1126/science.1962196; WAXMAN L, 1982, P NATL ACAD SCI-BIOL, V79, P4883, DOI 10.1073/pnas.79.16.4883; WAXMAN L, 1985, J BIOL CHEM, V260, P2022; WAXMAN L, 1986, SCIENCE, V232, P500, DOI 10.1126/science.2938257; WOO KM, 1989, J BIOL CHEM, V264, P2088; WOO KM, 1992, J BIOL CHEM, V267, P20429; YOO SJ, 1993, FEBS LETT, V327, P17, DOI 10.1016/0014-5793(93)81029-Y	39	51	51	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	1993	262	5132					372	374		10.1126/science.8211156	http://dx.doi.org/10.1126/science.8211156			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB859	8211156				2022-12-28	WOS:A1993MB85900041
J	LAWRENCE, CE; ALTSCHUL, SF; BOGUSKI, MS; LIU, JS; NEUWALD, AF; WOOTTON, JC				LAWRENCE, CE; ALTSCHUL, SF; BOGUSKI, MS; LIU, JS; NEUWALD, AF; WOOTTON, JC			DETECTING SUBTLE SEQUENCE SIGNALS - A GIBBS SAMPLING STRATEGY FOR MULTIPLE ALIGNMENT	SCIENCE			English	Article							HELIX-TURN-HELIX; AMINO-ACID-SEQUENCES; UNALIGNED DNA FRAGMENTS; PROTEIN-BINDING SITES; KLEBSIELLA-PNEUMONIAE; REGULATORY PROTEINS; MOLECULAR-STRUCTURE; SUBSTITUTION MATRICES; BIOLOGICAL SEQUENCES; NUCLEOTIDE-SEQUENCE	A wealth of protein and DNA sequence data is being generated by genome projects and other sequencing efforts. A crucial barrier to deciphering these sequences and understanding the relations among them is the difficulty of detecting subtle local residue patterns common to multiple sequences. Such patterns frequently reflect similar molecular structures and biological properties. A mathematical definition of this ''local multiple alignment'' problem suitable for full computer automation has been used to develop a new and sensitive algorithm, based on the statistical method of iterative sampling. This algorithm finds an optimized local alignment model for N sequences in N-linear time, requiring only seconds on current workstations, and allows the simultaneous detection and optimization of multiple patterns and pattern repeats. The method is illustrated as applied to helix-turn-helix proteins, lipocalins, and prenyltransferases.	HARVARD UNIV, DEPT STAT, CAMBRIDGE, MA 02138 USA; NEW YORK STATE DEPT HLTH, WADSWORTH CTR LABS & RES, BIOMETR LAB, ALBANY, NY 12201 USA	Harvard University; State University of New York (SUNY) System; Wadsworth Center	LAWRENCE, CE (corresponding author), NIH, NATL LIB MED, NATL CTR BIOTECHNOL INFORMAT, BETHESDA, MD 20894 USA.		Altschul, Stephen/R-4000-2019		NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH031154] Funding Source: NIH RePORTER; NIMH NIH HHS [NIMH MH-31154] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AITCHISON J, 1972, STATISTICAL PREDICTI; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; AKRIGG D, 1992, COMPUT APPL BIOSCI, V8, P295; ALEXANDROV NN, 1992, COMPUT APPL BIOSCI, V8, P339; ALTSCHUL SF, 1991, J MOL BIOL, V219, P555, DOI 10.1016/0022-2836(91)90193-A; ALTSCHUL SF, 1989, SIAM J APPL MATH, V49, P197, DOI 10.1137/0149012; ALTSCHUL SF, 1985, MOL BIOL EVOL, V2, P526; ALTSCHUL SF, 1989, J MOL BIOL, V207, P647, DOI 10.1016/0022-2836(89)90234-9; BACON DJ, 1986, J MOL BIOL, V191, P153, DOI 10.1016/0022-2836(86)90252-4; BAINS W, 1986, NUCLEIC ACIDS RES, V14, P159, DOI 10.1093/nar/14.1.159; BARBIER CS, 1992, J BACTERIOL, V174, P2881, DOI 10.1128/JB.174.9.2881-2890.1992; BARTON GJ, 1990, J MOL BIOL, V212, P389, DOI 10.1016/0022-2836(90)90133-7; BARTON GJ, 1987, J MOL BIOL, V198, P327, DOI 10.1016/0022-2836(87)90316-0; BERENS C, 1992, J BIOL CHEM, V267, P1945; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; BERGER MP, 1991, COMPUT APPL BIOSCI, V7, P479; BOCSKEI Z, 1992, NATURE, V360, P186, DOI 10.1038/360186a0; Boguski M. S., 1992, PROTEIN ENG PRACTICA, P57; BOGUSKI MS, 1992, NEW BIOL, V4, P408; BOGUSKI MS, 1992, NEW BIOL, V4, P247; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; BROWN M, 1993, 1ST P INT C INT SYST, P47; BRUNELLE A, 1989, J MOL BIOL, V209, P607, DOI 10.1016/0022-2836(89)90598-6; BRYANT SH, 1993, PROTEINS, V16, P92, DOI 10.1002/prot.340160110; CARDON LR, 1992, J MOL BIOL, V223, P159, DOI 10.1016/0022-2836(92)90723-W; CARRILLO H, 1988, SIAM J APPL MATH, V48, P1073, DOI 10.1137/0148063; CHAPPEY C, 1991, COMPUT APPL BIOSCI, V7, P195; CHOTHIA C, 1984, ANNU REV BIOCHEM, V53, P537; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; CONTRERAS A, 1988, NUCLEIC ACIDS RES, V16, P4025, DOI 10.1093/nar/16.9.4025; COWAN SW, 1990, PROTEINS, V8, P44, DOI 10.1002/prot.340080108; Dayhoff M. O., 1978, ATLAS PROTEIN SEQ S3, V5, P345; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; DEPIEREUX E, 1992, COMPUT APPL BIOSCI, V8, P501; DODD IB, 1990, NUCLEIC ACIDS RES, V18, P5019, DOI 10.1093/nar/18.17.5019; DODD IB, 1988, PROTEIN ENG, V2, P174, DOI 10.1093/protein/2.3.174; DOOLITTLE RF, 1992, PROTEIN SCI, V1, P191; DRUMMOND M, 1986, EMBO J, V5, P441, DOI 10.1002/j.1460-2075.1986.tb04230.x; DRUMMOND MH, 1990, MOL MICROBIOL, V4, P29, DOI 10.1111/j.1365-2958.1990.tb02012.x; FENG DF, 1985, J MOL EVOL, V21, P112, DOI 10.1007/BF02100085; FENG DF, 1987, J MOL EVOL, V25, P351, DOI 10.1007/BF02603120; FLOWER DR, 1993, PROTEIN SCI, V2, P753, DOI 10.1002/pro.5560020507; GELFAND AE, 1990, J AM STAT ASSOC, V85, P389; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; GOODMAN LA, 1974, BIOMETRIKA, V61, P215, DOI 10.2307/2334349; GRIBSKOV M, 1987, P NATL ACAD SCI USA, V84, P4355, DOI 10.1073/pnas.84.13.4355; GUSFIELD D, 1993, B MATH BIOL, V55, P141, DOI 10.1007/BF02460299; HALL P, 1989, J ROY STAT SOC B MET, V51, P459; HAUSSLER D, 1992, CIS UCSCCRL9223 U CA; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; HENIKOFF S, 1991, NEW BIOL, V3, P1148; HENIKOFF S, 1991, NUCLEIC ACIDS RES, V19, P6565, DOI 10.1093/nar/19.23.6565; HENNEKE CM, 1989, COMPUT APPL BIOSCI, V5, P141; HERTZ GZ, 1990, COMPUT APPL BIOSCI, V6, P81; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; HOLDEN HM, 1987, EMBO J, V6, P1565, DOI 10.1002/j.1460-2075.1987.tb02401.x; HUBER R, 1987, J MOL BIOL, V198, P499, DOI 10.1016/0022-2836(87)90296-8; JOHNSON MS, 1986, J MOL EVOL, V23, P267, DOI 10.1007/BF02115583; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; KOSTREWA D, 1992, J MOL BIOL, V226, P209, DOI 10.1016/0022-2836(92)90134-6; LAMERICHS RMJN, 1989, P NATL ACAD SCI USA, V86, P6863, DOI 10.1073/pnas.86.18.6863; LAWRENCE CE, 1990, PROTEINS, V7, P41, DOI 10.1002/prot.340070105; LESK AM, 1980, J MOL BIOL, V136, P225, DOI 10.1016/0022-2836(80)90373-3; LEUNG MY, 1991, J MOL BIOL, V221, P1367, DOI 10.1016/0022-2836(91)90938-3; LIPMAN DJ, 1989, P NATL ACAD SCI USA, V86, P4412, DOI 10.1073/pnas.86.12.4412; LITTLE R, 1987, STATISTICAL ANAL MIS; LIU J, 1992, R426 DEP STAT RES RE; Liu J., UNPUB; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MONACO HL, 1992, BIOPOLYMERS, V32, P457, DOI 10.1002/bip.360320425; MURATA M, 1985, P NATL ACAD SCI USA, V82, P3073, DOI 10.1073/pnas.82.10.3073; NAGATA A, 1991, P NATL ACAD SCI USA, V88, P4020, DOI 10.1073/pnas.88.9.4020; NORTH ACT, 1989, INT J BIOL MACROMOL, V11, P56, DOI 10.1016/0141-8130(89)90041-X; ORCHARD T, 1972, 6TH P BERK S MATH ST, V1, P697; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; PAPIZ MZ, 1986, NATURE, V324, P383, DOI 10.1038/324383a0; PARRYSMITH DJ, 1991, COMPUT APPL BIOSCI, V7, P233; PARRYSMITH DJ, 1992, COMPUT APPL BIOSCI, V8, P451; Peitsch M C, 1990, New Biol, V2, P197; POHL FM, 1971, NATURE-NEW BIOL, V234, P277, DOI 10.1038/newbio234277a0; POSFAI J, 1989, NUCLEIC ACIDS RES, V17, P2421, DOI 10.1093/nar/17.7.2421; QUEEN C, 1982, NUCLEIC ACIDS RES, V10, P449, DOI 10.1093/nar/10.1.449; Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3; ROLFES RJ, 1988, J BIOL CHEM, V263, P19653; ROYTBERG MA, 1992, COMPUT APPL BIOSCI, V8, P57; RUSSELL RB, 1992, PROTEINS, V14, P309, DOI 10.1002/prot.340140216; SALI A, 1990, J MOL BIOL, V212, P403, DOI 10.1016/0022-2836(90)90134-8; SANKOFF D, 1975, SIAM J APPL MATH, V28, P35, DOI 10.1137/0128004; SAWYER L, 1987, NATURE, V327, P659, DOI 10.1038/327659a0; SCHAFER WR, 1992, ANNU REV GENET, V26, P209, DOI 10.1146/annurev.ge.26.120192.001233; SCHELL MA, 1990, J BIOL CHEM, V265, P3844; SCHULER GD, 1991, PROTEINS, V9, P180, DOI 10.1002/prot.340090304; Schwartz RM, 1978, ATLAS PROTEIN SEQ S3, P353; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHEWCHUK LM, 1989, BIOCHEMISTRY-US, V28, P2340, DOI 10.1021/bi00431a053; SMITH HO, 1990, P NATL ACAD SCI USA, V87, P826, DOI 10.1073/pnas.87.2.826; SMITH RF, 1990, P NATL ACAD SCI USA, V87, P118, DOI 10.1073/pnas.87.1.118; SOBEL E, 1986, NUCLEIC ACIDS RES, V14, P363, DOI 10.1093/nar/14.1.363; SPIRO S, 1990, MOL MICROBIOL, V4, P1831, DOI 10.1111/j.1365-2958.1990.tb02031.x; STADEN R, 1989, COMPUT APPL BIOSCI, V5, P293; STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183; SUBBIAH S, 1989, J MOL BIOL, V209, P539, DOI 10.1016/0022-2836(89)90592-5; TANNER MA, 1987, J AM STAT ASSOC, V82, P528, DOI 10.2307/2289457; TAYLOR WR, 1990, METHOD ENZYMOL, V183, P456; TREISMAN J, 1992, BIOESSAYS, V14, P145, DOI 10.1002/bies.950140302; VINGRON M, 1993, P NATL ACAD SCI USA, V90, P8777, DOI 10.1073/pnas.90.19.8777; VINGRON M, 1991, J MOL BIOL, V218, P33, DOI 10.1016/0022-2836(91)90871-3; VINGRON M, 1989, COMPUT APPL BIOSCI, V5, P115; WATERMAN MS, 1984, B MATH BIOL, V46, P567, DOI 10.1016/S0092-8240(84)80060-9; WATERMAN MS, 1984, B MATH BIOL, V46, P515; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; YUAN HS, 1991, P NATL ACAD SCI USA, V88, P9558, DOI 10.1073/pnas.88.21.9558; YUDKIN MD, 1987, PROTEIN ENG, V1, P371, DOI 10.1093/protein/1.5.371; YUDKIN MD, 1989, MOL MICROBIOL, V3, P257, DOI 10.1111/j.1365-2958.1989.tb01815.x; [No title captured]	116	1249	1376	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 8	1993	262	5131					208	214		10.1126/science.8211139	http://dx.doi.org/10.1126/science.8211139			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA665	8211139				2022-12-28	WOS:A1993MA66500025
J	KAY, MA; ROTHENBERG, S; LANDEN, CN; BELLINGER, DA; LELAND, F; TOMAN, C; FINEGOLD, M; THOMPSON, AR; READ, MS; BRINKHOUS, KM; WOO, SLC				KAY, MA; ROTHENBERG, S; LANDEN, CN; BELLINGER, DA; LELAND, F; TOMAN, C; FINEGOLD, M; THOMPSON, AR; READ, MS; BRINKHOUS, KM; WOO, SLC			IN-VIVO GENE-THERAPY OF HEMOPHILIA-B - SUSTAINED PARTIAL CORRECTION IN FACTOR-IX-DEFICIENT DOGS	SCIENCE			English	Article							RETROVIRAL VECTORS; EXPRESSION; TRANSPLANTATION; MYOBLASTS; PROTEIN; SAFE; LINE	The liver represents a model organ for gene therapy. A method has been developed for hepatic gene transfer in vivo by the direct infusion of recombinant retroviral vectors into the portal vasculature, which results in the persistent expression of exogenous genes. To determine if these technologies are applicable for the treatment of hemophilia B patients, preclinical efficacy studies were done in a hemophilia B dog model. When the canine factor IX complementary DNA was transduced directly into the hepatocytes of affected dogs in vivo, the animals constitutively expressed low levels of canine factor IX for more than 5 months. Persistent expression of the clotting factor resulted in reductions of whole blood clotting and partial thromboplastin times of the treated animals. Thus, long-term treatment of hemophilia B patients may be feasible by direct hepatic gene therapy in vivo.	BAYLOR COLL MED,HOWARD HUGHES MED INST,DEPT CELL BIOL,HOUSTON,TX 77030; UNIV N CAROLINA,DEPT PATHOL,CHAPEL HILL,NC 27599; BAYLOR COLL MED,DEPT MOLEC GENET,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PEDIAT SURG,HOUSTON,TX 77030; BAYLOR COLL MED,DEPT PATHOL,HOUSTON,TX 77030; PUGET SOUND BLOOD CTR,SEATTLE,WA 98104	Baylor College of Medicine; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Puget Sound Blood Center				Kay, Mark/0000-0002-2799-2615	NHLBI NIH HHS [HL-01648-46, HL 40162] Funding Source: Medline; NIDDK NIH HHS [DK 44080] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK044080] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AXELROD JH, 1990, P NATL ACAD SCI USA, V87, P5173, DOI 10.1073/pnas.87.13.5173; BRINKHOUS KM, 1954, JAMA-J AM MED ASSOC, V154, P481, DOI 10.1001/jama.1954.02940400019005; BRINKHOUS KM, 1992, THROMB RES, V67, P329, DOI 10.1016/0049-3848(92)90008-X; BRINKHOUS KM, 1973, BLOOD, V41, P577, DOI 10.1182/blood.V41.4.577.577; BRINKHOUS KM, UNPUB; DAI Y, 1992, P NATL ACAD SCI USA, V89, P10892, DOI 10.1073/pnas.89.22.10892; EVANS JP, 1989, P NATL ACAD SCI USA, V86, P10095, DOI 10.1073/pnas.86.24.10095; GERRARD AJ, 1993, NAT GENET, V3, P180, DOI 10.1038/ng0293-180; KAY MA, 1992, P NATL ACAD SCI USA, V89, P89, DOI 10.1073/pnas.89.1.89; KAY MA, 1992, HUM GENE THER, V3, P641, DOI 10.1089/hum.1992.3.6-641; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; LANGDELL RD, 1953, J LAB CLIN MED, V41, P637; LYNCH CM, 1991, J VIROL, V65, P3887, DOI 10.1128/JVI.65.7.3887-3890.1991; MARKOWITZ D, 1988, J VIROL, V62, P1120, DOI 10.1128/JVI.62.4.1120-1124.1988; MARKOWITZ D, 1988, VIROLOGY, V167, P400, DOI 10.1016/S0042-6822(88)90101-8; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; MIYANOHARA A, 1992, NEW BIOL, V4, P238; ROBERTS HR, 1991, CLIN ASPECTS THERAPY, P1325; THOMPSON AR, 1977, J CLIN INVEST, V59, P900, DOI 10.1172/JCI108712; THOMPSON AR, 1991, CURR STUD HEMATOL BL, V58, P59; YAO SN, 1992, P NATL ACAD SCI USA, V89, P3357, DOI 10.1073/pnas.89.8.3357	21	284	308	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 1	1993	262	5130					117	119		10.1126/science.8211118	http://dx.doi.org/10.1126/science.8211118			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ635	8211118				2022-12-28	WOS:A1993LZ63500037
J	KULKARNI, ML; SURESHKUMAR, C; VENKATARAMANA, V				KULKARNI, ML; SURESHKUMAR, C; VENKATARAMANA, V			COLORINGS, FLAVORINGS, AND SUGARS IN CHILDRENS MEDICINES IN INDIA	BMJ-BRITISH MEDICAL JOURNAL			English	Article											KULKARNI, ML (corresponding author), JJM MED COLL, DEPT PAEDIAT, DAVANAGERE 577004, INDIA.							HOLMES A, 1987, BRIT DENT J, V163, P240, DOI 10.1038/sj.bdj.4806259; KOLLY M, 1989, ANN ALLERGY, V62, P21; KUMAR A, 1991, PEDIATRICS, V87, P352; POLLOCK I, 1989, BRIT MED J, V299, P649, DOI 10.1136/bmj.299.6700.649; 1989, PEDIATRICS, V73, P405	5	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 25	1993	307	6907					773	773		10.1136/bmj.307.6907.773	http://dx.doi.org/10.1136/bmj.307.6907.773			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LZ478	8219950	Bronze, Green Published			2022-12-28	WOS:A1993LZ47800025
J	SPENCE, DPS; HOTCHKISS, J; WILLIAMS, CSD; DAVIES, PDO				SPENCE, DPS; HOTCHKISS, J; WILLIAMS, CSD; DAVIES, PDO			TUBERCULOSIS AND POVERTY	BRITISH MEDICAL JOURNAL			English	Article							PULMONARY TUBERCULOSIS	Objective-To examine whether the historical link between tuberculosis and poverty still exists. Design-Retrospective study examining the notifications of all forms of tuberculosis by council ward over a six year period and correlating this with four indices of poverty; council housing, free school meals, the Townsend overall deprivation index, and the Jarman index. Setting-The 33 electoral wards of the city of Liver-pool. Subjects-344 residents of Liverpool with tuberculosis. Results-The rate of tuberculosis was correlated with all measures of poverty, the strongest correlation being with the Jarman index (r=0.73, p<0.0001). This link was independent of the high rates of tuberculosis seen in ethnic minorities. Conclusion-Tuberculosis remains strongly associated with poverty.	PUBL HLTH OBSERV,LIVERPOOL,ENGLAND; SEFTON GEN HOSP,S LIVERPOOL CHEST CLIN,CTR CARDIOTHORAC,TB RES UNIT,LIVERPOOL L15 2HE,ENGLAND		SPENCE, DPS (corresponding author), FAZAKERLEY DIST GEN HOSP,CTR AINTREE CHEST,LIVERPOOL L9 7AL,ENGLAND.							Black D., 1980, INEQUALITIES HLTH; BRUNDNEY K, 1991, AM REV RESPIR DIS, V144, P745; CITRON KM, 1987, OXFORD TXB MED, V5, P278; DAVIS PDO, 1992, THORAX, V47, P875; FRASER WM, 1947, DUNCAN LIVERPOOL; HOLLAND WW, 1969, BRIT MED J, V2, P205, DOI 10.1136/bmj.2.5651.205; JARMAN B, 1983, BRIT MED J, V286, P1705, DOI 10.1136/bmj.286.6379.1705; LEITCH AG, 1992, RESP MED, V86, P173, DOI 10.1016/S0954-6111(06)80240-4; MCMURRAY DN, 1986, AM REV RESPIR DIS, V133, P1081; MCMURRAY DN, 1992, J NUTR, V122, P738, DOI 10.1093/jn/122.suppl_3.738; NISAR M, 1992, TUBERCLE LUNG DIS, V73, P200, DOI 10.1016/0962-8479(92)90086-Y; PLATT MJ, 1991, OBSERVATORY REPORT S, V2; SCHOEMAN JH, 1991, INT J EPIDEMIOL, V20, P435, DOI 10.1093/ije/20.2.435; SEATON A, 1989, CROFTON DOUGLAS RESP, P375; STILLITOE K, 1978, POPULATION TRENDS, V13, P25; Townsend PP., 1988, HLTH DEPRIVATION INE; WHITEHEAD M, 1988, INEQUALITIES HLTH, P215; WINKELSTEIN W, 1967, ARCH ENVIRON HEALTH, V14, P162, DOI 10.1080/00039896.1967.10664708; 1990, PUBLIC HLTH COMMON D; 1988, COMMUNICABLE DISEASE; 1991, INFORMATION UNIT SMA; 1992, CENSUS 1991 PRELIMIN; 1990, MMWR, V39, P1; 1992, THORAX, V47, P770	24	192	197	1	11	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 25	1993	307	6907					759	761		10.1136/bmj.307.6907.759	http://dx.doi.org/10.1136/bmj.307.6907.759			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LZ478	8219945	Bronze, Green Published			2022-12-28	WOS:A1993LZ47800019
J	LAMBRIGHT, DG; NOEL, JP; HAMM, HE; SIGLER, PB				LAMBRIGHT, DG; NOEL, JP; HAMM, HE; SIGLER, PB			STRUCTURAL DETERMINANTS FOR ACTIVATION OF THE ALPHA-SUBUNIT OF A HETEROTRIMERIC G-PROTEIN	NATURE			English	Article							AMINO-ACID-SEQUENCE; ROD OUTER SEGMENTS; ELONGATION-FACTOR-TU; GTP-BINDING PROTEIN; ADENYLATE-CYCLASE; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; SIGNAL TRANSDUCTION; GUANINE-NUCLEOTIDES; ESCHERICHIA-COLI	The 1.8 Angstrom crystal structure of transducin alpha-GDP, when compared to that of the activated complex with GTP-gamma S, reveals the nature of the conformational changes that occur on activation of a heterotrimeric G-protein alpha-subunit. Structural changes initiated by direct contacts with the terminal phosphate of GTP propagate to regions that have been implicated in effector activation. The changes are distinct from those observed in other members of the GTPase superfamily.	YALE UNIV,SCH MED,DEPT MOLEC BIOPHYS & BIOCHEM,NEW HAVEN,CT 06510; YALE UNIV,BOYER CTR MOLEC MED,HOWARD HUGHES MED INST,NEW HAVEN,CT 06510; UNIV ILLINOIS,DEPT PHYSIOL & BIOPHYS,CHICAGO,IL 60612	Yale University; Howard Hughes Medical Institute; Yale University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital			Noel, Joseph P/A-9459-2009; Hamm, Heidi E/G-2374-2014					BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; BERLOT CH, 1992, CELL, V68, P911, DOI 10.1016/0092-8674(92)90034-A; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; BRUNGER A, 1993, X PLOR VERSION 3 1 M; BRUNGER AT, 1990, P NATL ACAD SCI USA, V87, P4849, DOI 10.1073/pnas.87.12.4849; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633; CAPON DJ, 1983, NATURE, V302, P33, DOI 10.1038/302033a0; CLARK KL, 1993, MOL CELL BIOL, V13, P1; CONKLIN BR, 1993, CELL, V73, P631, DOI 10.1016/0092-8674(93)90245-L; FAUROBERT E, 1993, EMBO J, V12, P4191, DOI 10.1002/j.1460-2075.1993.tb06103.x; FAWZI AB, 1990, BIOCHEMISTRY-US, V29, P3804, DOI 10.1021/bi00467a030; FONG HKW, 1988, P NATL ACAD SCI USA, V85, P3066, DOI 10.1073/pnas.85.9.3066; FUNG BKK, 1983, J BIOL CHEM, V258, P503; HARGRAVE PA, 1994, MOL PHARM CELL REGUL, V3, P25; HEPLER JR, 1992, TRENDS BIOCHEM SCI, V17, P383, DOI 10.1016/0968-0004(92)90005-T; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P762; HIGASHIJIMA T, 1987, J BIOL CHEM, V262, P752; HURLEY JB, 1992, J BIOENERG BIOMEMBR, V24, P219, DOI 10.1007/BF00762680; JOHN J, 1988, J BIOL CHEM, V263, P11792; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JURNAK F, 1985, SCIENCE, V230, P32, DOI 10.1126/science.3898365; KJELDGAARD M, 1992, J MOL BIOL, V223, P721, DOI 10.1016/0022-2836(92)90986-T; LAURSEN RA, 1981, J BIOL CHEM, V256, P8102; LEE E, 1992, J BIOL CHEM, V267, P1212; MAZZONI MR, 1993, J PROTEIN CHEM, V12, P215, DOI 10.1007/BF01026043; MAZZONI MR, 1991, J BIOL CHEM, V266, P14072; MILLER RT, 1988, NATURE, V334, P712, DOI 10.1038/334712a0; NAKAFUKU M, 1987, P NATL ACAD SCI USA, V84, P2140, DOI 10.1073/pnas.84.8.2140; NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0; NUKADA T, 1986, FEBS LETT, V197, P305, DOI 10.1016/0014-5793(86)80347-7; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; PFISTER C, 1993, CELL SIGNAL, V5, P235, DOI 10.1016/0898-6568(93)90015-E; RARICK HM, 1992, SCIENCE, V256, P1031, DOI 10.1126/science.1317058; ROBISHAW JD, 1986, P NATL ACAD SCI USA, V83, P1251, DOI 10.1073/pnas.83.5.1251; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; STERNWEIS PC, 1982, P NATL ACAD SCI-BIOL, V79, P4888, DOI 10.1073/pnas.79.16.4888; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P9113, DOI 10.1073/pnas.87.23.9113; STRYER L, 1983, METHOD ENZYMOL, V96, P617; THOMAS TC, 1993, P NATL ACAD SCI USA, V90, P10295, DOI 10.1073/pnas.90.21.10295; TONG L, 1991, J MOL BIOL, V217, P503, DOI 10.1016/0022-2836(91)90753-S; VANMEURS KP, 1987, P NATL ACAD SCI USA, V84, P3107, DOI 10.1073/pnas.84.10.3107; WHITEWAY M, IN PRESS MOL CELL BI; YATSUNAMI K, 1985, P NATL ACAD SCI USA, V82, P4316, DOI 10.1073/pnas.82.13.4316	44	520	536	0	17	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 23	1994	369	6482					621	628		10.1038/369621a0	http://dx.doi.org/10.1038/369621a0			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NT459	8208289				2022-12-28	WOS:A1994NT45900047
J	SPOOR, F; WOOD, B; ZONNEVELD, F				SPOOR, F; WOOD, B; ZONNEVELD, F			IMPLICATIONS OF EARLY HOMINID LABYRINTHINE MORPHOLOGY FOR EVOLUTION OF HUMAN BIPEDAL LOCOMOTION	NATURE			English	Article							SEMICIRCULAR CANALS; ENDOLYMPH FLOW; AFARENSIS; NEURONS; MODEL; EAST	The upright posture and obligatory bipedalism of modern humans are unique among living primates, The evolutionary history of this behaviour has traditionally been pursued by functional analysis of the postcranial skeleton and the preserved footprint trails of fossil hominids. Here H e report a systematic attempt to reconstruct the locomotor behaviour of early hominids by looking at a major component of the mechanism for the unconscious perception of movement, namely by examining the vestibular system of living primates and early hominids. High-resolution computed tomography was used to generate cross-sectional images of the bony labyrinth. Among the fossil hominids the earliest species to demonstrate the modern human morphology is Home erectus. In contrast, the semicircular canal dimensions in crania from southern Africa attributed to Australopithecus and Paranthropus resemble those of the extant great apes. Among early Home specimens, the canal dimensions of Stw 53 are unlike those seen in any of the hominids or great apes, whereas those of SK 847 are modern-human-like.	UNIV LIVERPOOL,DEPT HUMAN ANAT & CELL BIOL,HOMINID PALAEONTOL RES GRP,LIVERPOOL L69 3BX,ENGLAND; UNIV UTRECHT HOSP,DEPT RADIOL,UTRECHT,NETHERLANDS	University of Liverpool; Utrecht University; Utrecht University Medical Center			Spoor, Fred/C-1718-2008					Berg W, 1903, Z MORPHOL ANTHROPOL, V5, P315; BLANKS RHI, 1985, BRAIN RES, V340, P315, DOI 10.1016/0006-8993(85)90928-X; BLANKS RHI, 1975, J NEUROPHYSIOL, V38, P1250, DOI 10.1152/jn.1975.38.5.1250; Clarke R.J., 1985, P171; CURTHOYS IS, 1977, J MORPHOL, V151, P1, DOI 10.1002/jmor.1051510102; DEAN MC, 1982, AM J PHYS ANTHROPOL, V59, P157, DOI 10.1002/ajpa.1330590206; Fleagle JG, 1988, PRIMATE ADAPTATION E; GOLDBERG JM, 1971, J NEUROPHYSIOL, V34, P635, DOI 10.1152/jn.1971.34.4.635; Gray A.A., 1907, LABYRINTH ANIMALS; GRINE FE, 1993, AM J PHYS ANTHROPOL, V92, P411, DOI 10.1002/ajpa.1330920402; HADZISELIMOVIC H, 1964, ACTA ANAT, V57, P306; HARTWIGSCHERER S, 1991, J HUM EVOL, V21, P439, DOI 10.1016/0047-2484(91)90094-C; HUNT KD, 1994, J HUM EVOL, V26, P183, DOI 10.1006/jhev.1994.1011; JOHANSON DC, 1987, NATURE, V327, P205, DOI 10.1038/327205a0; Kimbel William H., 1993, P461; LATIMER B, 1989, AM J PHYS ANTHROPOL, V78, P369, DOI 10.1002/ajpa.1330780306; MATONO S, 1986, CURRENT PERPSECTIVES, P122; MCHENRY HM, 1992, AM J PHYS ANTHROPOL, V87, P407, DOI 10.1002/ajpa.1330870404; MCHENRY HM, 1986, J HUM EVOL, V15, P177, DOI 10.1016/S0047-2484(86)80044-6; MULLER M, 1994, J THEOR BIOL, V167, P239, DOI 10.1006/jtbi.1994.1066; MULLER M, 1988, J THEOR BIOL, V134, P473, DOI 10.1016/S0022-5193(88)80053-5; OMAN CM, 1987, ACTA OTO-LARYNGOL, V103, P1, DOI 10.3109/00016488709134691; RAMPRASHAD F, 1984, AM J ANAT, V169, P295, DOI 10.1002/aja.1001690306; Robinson J.T., 1972, EARLY HOMINID POSTUR; ROSE MD, 1984, AM J PHYS ANTHROPOL, V63, P371, DOI 10.1002/ajpa.1330630404; SPOOR CF, 1994, COUR FORSCH SENCKENB, V171, P251; SPOOR CF, 1993, THESIS URECHT U; SUSMAN RL, 1984, FOLIA PRIMATOL, V43, P113, DOI 10.1159/000156176; SUSMAN RL, 1989, AM J PHYS ANTHROPOL, V79, P451, DOI 10.1002/ajpa.1330790403; TENKATE JH, 1970, J EXP BIOL, V53, P501; TURKEWITSCH B. G., 1934, ZEITSCHR ANAT U ENTWICKLUNGSGESCH, V103, P551, DOI 10.1007/BF02118934; Tuttle R.H., 1987, P503; VRBA ES, 1979, AM J PHYS ANTHROPOL, V51, P117, DOI 10.1002/ajpa.1330510114; Walker A., 1981, HOMO ERECTUS PAPERS, P193; Walker Alan, 1993, P411; WOOD B, 1993, NATURE, V363, P587, DOI 10.1038/363587a0; Zonneveld F.W., 1985, P427	37	202	214	0	88	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 23	1994	369	6482					645	648		10.1038/369645a0	http://dx.doi.org/10.1038/369645a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NT459	8208290				2022-12-28	WOS:A1994NT45900054
J	ACHKAR, AA; LIE, JT; HUNDER, GG; OFALLON, WM; GABRIEL, SE				ACHKAR, AA; LIE, JT; HUNDER, GG; OFALLON, WM; GABRIEL, SE			HOW DOES PREVIOUS CORTICOSTEROID TREATMENT AFFECT THE BIOPSY FINDINGS IN GIANT-CELL (TEMPORAL) ARTERITIS	ANNALS OF INTERNAL MEDICINE			English	Article						TEMPORAL ARTERITIS; ADRENAL CORTEX HORMONES; BIOPSY; PREDNISONE	CLASSIFICATION; CRITERIA	Objective: To determine the effect of previous corticosteroid treatment on the results of temporal artery biopsy. Design: Consecutive case series. Setting: Tertiary care center. Patients: A consecutive cohort of 535 patients who had temporal artery biopsies at Mayo Clinic, Rochester, Minnesota, between 1 January 1988 and 31 December 1991. Measurements and Results: The dose and duration of corticosteroid treatment received before temporal artery biopsy and detailed clinical and laboratory data were obtained from the patients' medical records. All temporal artery biopsy slides were re-evaluated by a pathologist blinded to clinical data, previous corticosteroid treatment information, and the original pathologic diagnosis. Biopsy specimens were classified as negative for arteritis, positive for typical temporal arteritis, or positive for atypical temporal arteritis. Biopsy results were positive for 31% of patients (89 of 286) who did not receive corticosteroids before biopsy and for 35% of those (86 of 249) who did receive corticosteroids before biopsy (P = 0.4; 95% confidence interval for the difference, -4.7% to 11.5%). Patients who received corticosteroids before biopsy tended to have clinical features more suggestive of arteritis. A multiple logistic regression analysis model, controlling for these differences in clinical and laboratory features, showed that the biopsy positivity rate was unrelated to previous corticosteroid treatment. Conclusions: Although these results do not prove that histologic features are unaffected by corticosteroids, they show that, in this large, consecutive sample, the positivity rates of temporal artery biopsy were similar in untreated and corticosteroid-treated patients. Temporal artery biopsy may show arteritis even after more than 14 days of corticosteroid therapy in the presence of clinical indications of active disease.	MAYO CLIN & MAYO FDN, DEPT HLTH SCI RES, ROCHESTER, MN 55905 USA; UC DAVIS MED CTR, DEPT PATHOL, SACRAMENTO, CA 95817 USA	Mayo Clinic; University of California System; University of California Davis								AIELLO PD, 1993, OPHTHALMOLOGY, V100, P550; ALBERT DM, 1976, ARCH OPHTHALMOL-CHIC, V94, P2072; ALLISON MC, 1984, ANN RHEUM DIS, V43, P416, DOI 10.1136/ard.43.3.416; BLOCH DA, 1990, ARTHRITIS RHEUM, V33, P1137; CHMELEWSKI WL, 1992, ARCH INTERN MED, V152, P1690, DOI 10.1001/archinte.152.8.1690; COHEN DN, 1973, T AM ACAD OPHTHALMOL, V77, P74; CULLEN J F, 1976, Survey of Ophthalmology, V20, P247, DOI 10.1016/0039-6257(76)90224-1; FAUCHALD P, 1972, ANN INTERN MED, V77, P845, DOI 10.7326/0003-4819-77-6-845; HALL S, 1983, LANCET, V2, P1217; HUNDER GG, 1990, RHEUM DIS CLIN N AM, V16, P399; HUNDER GG, 1990, ARTHRITIS RHEUM, V33, P1122; HUNDER GG, 1975, ANN INTERN MED, V82, P613, DOI 10.7326/0003-4819-82-5-613; HUNDER GG, 1993, TXB RHEUMATOLOGY, P1103; KLEIN RG, 1976, MAYO CLIN PROC, V51, P504; LIE JT, 1990, RHEUM DIS CLIN N AM, V16, P269; LIE JT, 1994, J RHEUMATOL, V21, P186; MACHADO EBV, 1988, ARTHRITIS RHEUM, V31, P745, DOI 10.1002/art.1780310607; MCDONNELL PJ, 1986, OPHTHALMOLOGY, V93, P518; PONGE T, 1988, J RHEUMATOL, V15, P997; ROSNER B, 1990, FUNDAMENTALS BIOSTAT, P456	20	236	240	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	1994	120	12					987	992		10.7326/0003-4819-120-12-199406150-00003	http://dx.doi.org/10.7326/0003-4819-120-12-199406150-00003			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NQ964	8185147				2022-12-28	WOS:A1994NQ96400003
J	HARADA, A; OGUCHI, K; OKABE, S; KUNO, J; TERADA, S; OHSHIMA, T; SATOYOSHITAKE, R; TAKEI, Y; NODA, T; HIROKAWA, N				HARADA, A; OGUCHI, K; OKABE, S; KUNO, J; TERADA, S; OHSHIMA, T; SATOYOSHITAKE, R; TAKEI, Y; NODA, T; HIROKAWA, N			ALTERED MICROTUBULE ORGANIZATION IN SMALL-CALIBER AXONS OF MICE LACKING TAU-PROTEIN	NATURE			English	Article							PAIRED HELICAL FILAMENTS; MOLECULAR-STRUCTURE; NERVOUS-SYSTEM; ANTISENSE OLIGONUCLEOTIDES; CEREBELLAR NEURONS; TARGETED MUTATION; QUICK-FREEZE; GENE; LOCALIZATION; MOUSE	THE tau gene encodes a protein (Tau) that is a major neuronal microtubule-associated protein localized mostly in axons(1-4). It has microtubule-binding and tubulin-polymerizing activity in vitro(3,4) and is thought to make short crossbridges between axonal microtuhules(5,6). Further, tau-transfected non-neuronal cells extend long axon-like processes in which microtubule bundles resembling those in axons are formed(6-8). In contrast, tau antisense oligonucleotides selectively suppress axonal elongation in cultured neurons(9,10). Thus tau is thought to be essential for neuronal cell morphogenesis, especially axonal elongation and maintenance. To test this hypothesis, we used gene targeting to produce mice lacking the tau gene. We show that the nervous system of tau-deficient mice appears to be normal immunohistologically. Furthermore, axonal elongation is not affected in cultured neurons. But in some small-calibre axons, microtubule stability is decreased and microtubule organization is significantly changed. We observed an increase in microtubule-associated protein 1A which may compensate for the functions of tau in large-calibre axons. Our results argue against the suggested role of tau in axonal elongation but confirm that it is crucial in the stabilization and organization of axonal microtubules in a certain type of axon.	UNIV TOKYO,SCH MED,DEPT ANAT & CELL BIOL,BUNKYO KU,TOKYO 113,JAPAN; UNIV TOKYO,SCH PHARMACEUT SCI,DEPT NEUROPATHOL & NEUROSCI,BUNKYO KU,TOKYO 113,JAPAN; JAPANESE FDN CANC RES,INST CANC,DEPT CELL BIOL,TOSHIMA KU,TOKYO 170,JAPAN	University of Tokyo; University of Tokyo; Japanese Foundation for Cancer Research			Noda, Tetsuo/B-1667-2016; Takei, Yosuke/I-1828-2015	Takei, Yosuke/0000-0002-5026-8027; Terada, Sumio/0000-0001-5689-0186; Okabe, Shigeo/0000-0003-1216-8890				BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371; BLOOM GS, 1984, J CELL BIOL, V98, P320, DOI 10.1083/jcb.98.1.320; Bradley A, 1987, TERATOCARCINOMAS EMB, P113; CACERES A, 1991, J NEUROSCI, V11, P1515; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; DOTTI CG, 1988, J NEUROSCI, V8, P1454; GEORGIEFF IS, 1991, J CELL SCI, V100, P55; Goslin K., 1991, CULTURING NERVE CELL, P251; HARADA A, 1990, CELL STRUCT FUNCT, V15, P329, DOI 10.1247/csf.15.329; HIMMLER A, 1989, MOL CELL BIOL, V9, P1389, DOI 10.1128/MCB.9.4.1389; HIROKAWA N, 1988, J CELL BIOL, V107, P1449, DOI 10.1083/jcb.107.4.1449; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; IHARA Y, 1990, GERONTOLOGY, V36, P15; KANAI Y, 1989, J CELL BIOL, V109, P1173, DOI 10.1083/jcb.109.3.1173; KNOPS J, 1991, J CELL BIOL, V114, P725, DOI 10.1083/jcb.114.4.725; KONDO J, 1988, NEURON, V1, P827, DOI 10.1016/0896-6273(88)90130-4; LEE G, 1990, CELL MOTIL CYTOSKEL, V15, P199, DOI 10.1002/cm.970150402; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; MATUS A, 1988, ANNU REV NEUROSCI, V11, P20; MCBURNEY MW, 1991, NUCLEIC ACIDS RES, V19, P5755, DOI 10.1093/nar/19.20.5755; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; OKABE S, 1992, J CELL BIOL, V117, P105, DOI 10.1083/jcb.117.1.105; OLMSTED JB, 1986, ANNU REV CELL BIOL, V2, P421, DOI 10.1146/annurev.cb.02.110186.002225; SATOYOSHITAKE R, 1989, NEURON, V3, P229, DOI 10.1016/0896-6273(89)90036-6; SHIOMURA Y, 1987, J NEUROSCI, V7, P1461; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; UMEYAMA T, 1993, J CELL BIOL, V120, P451, DOI 10.1083/jcb.120.2.451	30	572	591	2	39	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 9	1994	369	6480					488	491		10.1038/369488a0	http://dx.doi.org/10.1038/369488a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ286	8202139				2022-12-28	WOS:A1994NQ28600058
J	GATTINONI, L; BOMBINO, M; PELOSI, P; LISSONI, A; PESENTI, A; FUMAGALLI, R; TAGLIABUE, M				GATTINONI, L; BOMBINO, M; PELOSI, P; LISSONI, A; PESENTI, A; FUMAGALLI, R; TAGLIABUE, M			LUNG STRUCTURE AND FUNCTION IN DIFFERENT STAGES OF SEVERE ADULT-RESPIRATORY-DISTRESS-SYNDROME	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXTRACORPOREAL MEMBRANE-OXYGENATION; END-EXPIRATORY PRESSURE; PULMONARY BAROTRAUMA; MECHANICAL VENTILATION; GAS-EXCHANGE; FAILURE; SYSTEM; EMPHYSEMA; CURVE	Objective.-To assess the clinical consequences of duration of adult respiratory distress syndrome (ARDS) on lung structure and function. Design.-Retrospective analysis. Setting.-A university hospital referral center for extracorporeal support. Patients.-A total of 84 patients with severe ARDS (Murray score > 2.5) recruited from 48 intensive care units (1979 to 1992), who suffered ARDS and underwent mechanical ventilation for up to 1 week (37 patients with early ARDS), between 1 and 2 weeks (24 patients with intermediate ARDS), or more than 2 weeks (23 patients with late ARDS) and subsequently underwent extracorporeal support. Main Outcome Measures.-Before beginning extracorporeal support, we measured gas exchange, pulmonary mechanics, hemodynamics, oxygen transport and delivery, incidence of barotrauma (presence of one or more thoracic tubes for pneumothorax drainage), and organ dysfunctions. In a subgroup of 16 patients, we studied lung structure by computed tomographic scan, scoring the densities and quantifying the emphysemalike lesions (bullae). Results.-Late ARDS showed lower respiratory compliance, higher dead space, higher Pace,, lower venous admixture, and lower positive end-expiratory pressure requirement compared with early ARDS (P<.01). The incidence of pneumothorax (48.8% of the entire population) was significantly (P<.01) higher in late ARDS (87%) vs intermediate ARDS (46%) and early ARDS (30%). The mortality of patients with pneumothorax (66%) was significantly (P<.01) higher compared with patients without pneumothorax (46%). The number of bullae per lung was significantly higher in late ARDS vs intermediate and early ARDS (mean [SD], 8 [4], 4.3 [5], and 1.9 [3.9], respectively; P<.01), and they were preferentially distributed in the dependent lung regions. The number of bullae per lung was significantly higher in patients with pneumothorax vs those without pneumothorax (mean [SD], 13.6 [9.8] vs 1.4 [2.1]; P=.007). The mean (SD) duration of ARDS in patients with pneumothorax was 15.3 (10.0) days vs 7.0 (6.6) days in those without pneumothorax (P=.0001). No differences within the three groups were found in computed tomographic scan densities, hemodynamics, and number of organ system dysfunctions. Conclusions.-The lung structure and function changes markedly with ARDS duration, and the late stages may be described as restrictive lung disease with superimposed emphysemalike lesions. Presence of pneumothorax affects survival and appears to be related to the lung structural changes occurring with time.	UNIV MILAN, IST RIC & CURA CARATTERE SCI, MILAN, ITALY; OSPED SAN GERARDO, MONZA, ITALY	University of Milan; San Gerardo Hospital	GATTINONI, L (corresponding author), UNIV MILAN, OSPED MAGGIORE POLICLIN, IST ANESTESIA & RIANIMAZ, VIA FRANCESCO SFORZA 35, I-20122 MILAN, ITALY.		Fumagalli, Roberto/AAB-9746-2019; Rocco, Patricia/I-7460-2012; Pesenti, Antonio/H-7483-2012	Fumagalli, Roberto/0000-0003-0398-1329; Rocco, Patricia/0000-0003-1412-7136; Pesenti, Antonio/0000-0003-2593-729X; Pelosi, Paolo/0000-0001-5055-3023; Gattinoni, Luciano/0000-0001-5380-2494				Artigas A., 1991, ADULT RESP DISTRESS, P37; BACHOFEN M, 1977, AM REV RESPIR DIS, V116, P589, DOI 10.1164/arrd.1977.116.4.589; BELL RC, 1983, ANN INTERN MED, V99, P293, DOI 10.7326/0003-4819-99-3-293; Bohr C., 1891, SKAND ARCH PHYSL, V53, P236, DOI [DOI 10.1111/J.1748-1716.1891.TB00581.X, 10.1111/j.1748-1716.1891.tb00581.x]; BONE RC, 1992, CHEST, V101, P320, DOI 10.1378/chest.101.2.320; BONE RC, 1976, AM REV RESPIR DIS, V113, pA188; CHURG A, 1983, AM REV RESPIR DIS, V127, P117, DOI 10.1164/arrd.1983.127.1.117; DANTZKER DR, 1979, AM REV RESPIR DIS, V120, P1039; GAMMON RB, 1992, CHEST, V102, P568, DOI 10.1378/chest.102.2.568; GATTINONI L, 1987, AM REV RESPIR DIS, V136, P730, DOI 10.1164/ajrccm/136.3.730; GATTINONI L, 1993, JAMA-J AM MED ASSOC, V269, P2122, DOI 10.1001/jama.269.16.2122; GATTINONI L, 1984, INTENS CARE MED, V10, P121, DOI 10.1007/BF00265800; GATTINONI L, 1987, INTENS CARE MED, V13, P19, DOI 10.1007/BF00263552; GATTINONI L, 1991, ANESTHESIOLOGY, V74, P15, DOI 10.1097/00000542-199101000-00004; GATTINONI L, 1988, ANESTHESIOLOGY, V69, P824, DOI 10.1097/00000542-198812000-00005; Gattinoni L, 1988, J Thorac Imaging, V3, P59, DOI 10.1097/00005382-198807000-00013; GREENE R, 1981, AM REV RESPIR DIS, V124, P593; HOLZAPFEL L, 1983, CRIT CARE MED, V11, P591, DOI 10.1097/00003246-198308000-00002; JARDIN F, 1982, NOUV PRESSE MED, V11, P29; KLOSE R, 1981, INTENS CARE MED, V7, P165; Kumar A, 1973, Crit Care Med, V1, P181, DOI 10.1097/00003246-197307000-00001; LAMY M, 1976, AM REV RESPIR DIS, V114, P267; LATORRE FJD, 1977, CHEST, V72, P141, DOI 10.1378/chest.72.2.141; LEMAIRE F, 1982, CHEST, V81, P654, DOI 10.1378/chest.81.5.654; Lemaire F, 1985, ACUTE RESPIRATORY FA, P521; MATAMIS D, 1984, CHEST, V86, P58, DOI 10.1378/chest.86.1.58; MAUNDER RJ, 1986, JAMA-J AM MED ASSOC, V255, P2463, DOI 10.1001/jama.255.18.2463; MOREL DR, 1985, AM REV RESPIR DIS, V132, P479; MURRAY JF, 1988, AM REV RESPIR DIS, V138, P720, DOI 10.1164/ajrccm/138.3.720; PESENTI A, 1993, INTENSIVE CRIT CARE, V12, P15; PETERSEN GW, 1983, CRIT CARE MED, V11, P67, DOI 10.1097/00003246-198302000-00002; PONTOPPIDAN H, 1985, ACUTE RESPIRATORY FA, P1; PRATT PC, 1979, AM J PATHOL, V95, P191; REHDER K, 1972, ANESTHESIOLOGY, V37, P16, DOI 10.1097/00000542-197207000-00004; ROUBY JJ, 1993, INTENS CARE MED, V19, P383, DOI 10.1007/BF01724877; SANDERS C, 1991, RADIOL CLIN N AM, V29, P1019; SLAVIN G, 1982, BRIT MED J, V285, P931, DOI 10.1136/bmj.285.6346.931; Snedecor G.W., 1980, STAT METHODS, V7; SNOW RL, 1982, AM REV RESPIR DIS, V126, P887; SUTER PM, 1985, ACUTE RESPIRATORY FA, P507; TOMASHEFSKI JF, 1983, AM J PATHOL, V112, P112; WOODRING JH, 1985, CRIT CARE MED, V13, P786, DOI 10.1097/00003246-198510000-00003; ZAPOL WM, 1979, JAMA-J AM MED ASSOC, V242, P2193, DOI 10.1001/jama.242.20.2193; ZWILLICH CW, 1974, AM J MED, V57, P161, DOI 10.1016/0002-9343(74)90440-9; 1979, EXTRACORPOREAL SUPPO	45	269	285	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	1994	271	22					1772	1779		10.1001/jama.271.22.1772	http://dx.doi.org/10.1001/jama.271.22.1772			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN725	8196122				2022-12-28	WOS:A1994NN72500028
J	SMITH, DE; LEWIS, CE; CAVENY, JL; PERKINS, LL; BURKE, GL; BILD, DE				SMITH, DE; LEWIS, CE; CAVENY, JL; PERKINS, LL; BURKE, GL; BILD, DE			LONGITUDINAL CHANGES IN ADIPOSITY ASSOCIATED WITH PREGNANCY - THE CARDIA STUDY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-FAT DISTRIBUTION; WEIGHT-GAIN; POSTPARTUM WEIGHT; METABOLIC-RATE; RISK-FACTORS; MASS INDEX; WOMEN; OBESITY; ADULTS; BLACK	Objective.-To examine the longitudinal associations between a pregnancy and persistent changes in adiposity in young black and white women. Design.-Prospective cohort study with 5 years of follow-up. Setting.-Participants recruited by community-based sampling (Birmingham, Ala; Chicago, Ill; and Minneapolis, Minn) and through the membership of a large prepaid health care plan (Oakland, Calif). Participants.-A total of 2788 women (53% black) aged 18 through 30 years were assessed at baseline (1985 through 1986) and reassessed at examination 2 (91% retention; 1987 through 1988) and examination 3 (86% retention; 1990 through 1991). Women who remained nulliparous (n=925) during the 5-year follow-up were compared with women who had a single pregnancy of 28 weeks' duration during that period and who were at least 12 months postpartum at follow-up (primiparas, n=89; multiparas, n=114). Main Outcome Measures.-Change in body weight and in waist-to-hip ratio during the 5-year period. Analyses were adjusted for demographic factors (age and education), behavioral variables (smoking and physical activity), and baseline level of adiposity. Results.-Primiparas within both race groups gained 2 to 3 kg more weight during the 5-year period than did nulliparas in both adjusted and unadjusted analyses. Primiparas also had greater increases in waist-to-hip ratio that were independent of weight gain. Multiparas did not differ from nulliparas in adiposity change in either race group. At each level of parity, black women demonstrated greater adverse changes in adiposity than did white women. Conclusions.-These data suggest that women experience modest but adverse increases in body weight and fat distribution after a first pregnancy and that these changes are persistent.	DOW CORNING CORP,MIDLAND,MI; BOWMAN GRAY SCH MED,DEPT PUBL HLTH SCI,WINSTON SALEM,NC; NHLBI,DIV EPIDEMIOL & CLIN APPLICAT,BETHESDA,MD	Corning Inc; Dow Chemical Company; Dow Corning; Wake Forest University; Wake Forest Baptist Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	SMITH, DE (corresponding author), UNIV ALABAMA,SCH MED,DIV PREVENT MED,BEHAV MED UNIT,1717 11TH AVE S,SUITE 101,BIRMINGHAM,AL 35205, USA.		West, Delia Smith/GWV-5839-2022	West, Delia Smith/0000-0002-4375-2785	NHLBI NIH HHS [N01-HC-48049, N01-HC-48048, N01-HC-48047] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048048, N01HC048047, N01HC048049] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAECKE JAH, 1983, INT J OBESITY, V7, P1; BEASLEY JM, 1979, ACTA OBSTET GYNECOL, V58, P45; BILLEWIC.WZ, 1970, BRIT J PREV SOC MED, V24, P97; BRADLEY PJ, 1985, APPETITE, V6, P235, DOI 10.1016/S0195-6663(85)80012-X; BROWN JE, 1992, INT J OBESITY, V16, P627; BURKE GL, 1991, CIRCULATION S2, V84, P700; CUTTER G R, 1991, Controlled Clinical Trials, V12, p1S; FOLSOM AR, 1993, JAMA-J AM MED ASSOC, V269, P483, DOI 10.1001/jama.269.4.483; FORSUM E, 1988, AM J CLIN NUTR, V47, P942, DOI 10.1093/ajcn/47.6.942; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; GARN SM, 1978, AM J CLIN NUTR, V31, P1302, DOI 10.1093/ajcn/31.8.1302; GREENE GW, 1988, OBSTET GYNECOL, V71, P701; HELIOVAARA M, 1981, J EPIDEMIOL COMMUN H, V35, P197, DOI 10.1136/jech.35.3.197; Jacobs David R Jr, 1989, J Cardiopulm Rehabil, V9, P448, DOI 10.1097/00008483-198911000-00003; KAYE SA, 1990, INT J OBESITY, V14, P583; KEPPEL KG, 1993, AM J PUBLIC HEALTH, V83, P1100, DOI 10.2105/AJPH.83.8.1100; KUMANYIKA S, 1987, EPIDEMIOL REV, V9, P31, DOI 10.1093/oxfordjournals.epirev.a036307; LANSKA DJ, 1985, INT J OBESITY, V9, P29; LARSSON B, 1992, AM J EPIDEMIOL, V135, P266, DOI 10.1093/oxfordjournals.aje.a116280; LEDERMAN SA, 1993, OBSTET GYNECOL, V82, P148; MCKEOWN T, 1957, J ENDOCRINOL, V15, P393, DOI 10.1677/joe.0.0150393; NEWCOMBE RG, 1982, J EPIDEMIOL COMMUN H, V36, P306, DOI 10.1136/jech.36.4.306; NOPPA H, 1980, J EPIDEMIOL COMMUN H, V34, P139, DOI 10.1136/jech.34.2.139; OHLIN A, 1990, INT J OBESITY, V14, P159; OLSEN LC, 1986, J NURSE-MIDWIFERY, V31, P177, DOI 10.1016/0091-2182(86)90070-4; PARHAM ES, 1990, J AM DIET ASSOC, V90, P550; PARKER JD, 1993, OBSTET GYNECOL, V81, P768; RODIN J, 1990, INT J OBESITY, V14, P303; ROOKUS MA, 1987, INT J OBESITY, V11, P609; ROSSNER S, 1992, INT J OBESITY, V16, P145; SHELDON JH, 1949, LANCET, V1, P869; SIDNEY S, 1992, MED SCI SPORT EXER, V24, P177; TONKELAAR I, 1990, INT J OBESITY, V14, P753; VANRAAIJ JMA, 1989, AM J CLIN NUTR, V49, P765, DOI 10.1093/ajcn/49.5.765; WAGENKNECHT LE, 1990, PREV MED, V19, P158, DOI 10.1016/0091-7435(90)90017-E; WILLIAMSON DF, 1990, ARCH INTERN MED, V150, P665, DOI 10.1001/archinte.150.3.665; WING RR, 1989, INT J OBESITY, V13, P511; WING RR, 1991, ARTERIOSCLER THROMB, V11, P1250, DOI 10.1161/01.ATV.11.5.1250	38	238	241	1	13	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	1994	271	22					1747	1751		10.1001/jama.271.22.1747	http://dx.doi.org/10.1001/jama.271.22.1747			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN725	8196117				2022-12-28	WOS:A1994NN72500023
J	SMITH, JL; ZALUZEC, EJ; WERY, JP; NIU, LW; SWITZER, RL; ZALKIN, H; SATOW, Y				SMITH, JL; ZALUZEC, EJ; WERY, JP; NIU, LW; SWITZER, RL; ZALKIN, H; SATOW, Y			STRUCTURE OF THE ALLOSTERIC REGULATORY ENZYME OF PURINE BIOSYNTHESIS	SCIENCE			English	Article							GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE; ESCHERICHIA-COLI-PURF; AMINO-ACID-SEQUENCE; NUCLEOTIDE-SEQUENCE; ENDONUCLEASE-III; SYNCHROTRON RADIATION; ANOMALOUS DISPERSION; MOLECULAR-CLONING; PROTEIN; AMIDOPHOSPHORIBOSYLTRANSFERASE	Multiwavelength anomalous diffraction (MAD) has been used to determine the structure of the regulatory enzyme of de novo synthesis of purine nucleotides, glutamine 5-phosphoribosyl-1-pyrophosphate (PRPP) amidotransferase, from Bacillus subtilis. This allosteric enzyme, a 200-kilodalton tetramer, is subject to end product regulation by purine nucleotides. The metalloenzyme from B. subtilis is a paradigm for the higher eukaryotic enzymes, which have been refractory to isolation in stable form. The two folding domains of the polypeptide are correlated with functional domains for glutamine binding and for transfer of ammonia to the substrate PRPP. Eight molecules of the feedback inhibitor adenosine monophosphate (AMP) are bound to the tetrameric enzyme in two types of binding sites: the PRPP catalytic site of each subunit and an unusual regulatory site that is immediately adjacent to each active site but is between subunits. An oxygen-sensitive [4Fe-4S] cluster in each subunit is proposed to regulate protein turnover in vivo and is distant from the catalytic site. Oxygen sensitivity of the cluster is diminished by AMP, which blocks a channel through the protein to the cluster. The structure is representative of both glutamine amidotransferases and phosphoribosyltransferases.	UNIV ILLINOIS,DEPT BIOCHEM,URBANA,IL 61801; PURDUE UNIV,DEPT BIOCHEM,W LAFAYETTE,IN 47907; UNIV TOKYO,FAC PHARMACEUT SCI,TOKYO 113,JAPAN; UNIV SCI & TECHNOL CHINA,DEPT BIOL,ANHUI,PEOPLES R CHINA	University of Illinois System; University of Illinois Urbana-Champaign; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Tokyo; Chinese Academy of Sciences; University of Science & Technology of China, CAS	SMITH, JL (corresponding author), PURDUE UNIV,DEPT BIOL SCI,W LAFAYETTE,IN 47907, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK042303, R37DK042303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024658, R37GM024658] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-42303, R37 DK042303] Funding Source: Medline; NIGMS NIH HHS [GM-24658] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AVERILL BA, 1980, J BIOL CHEM, V255, P6007; BACKES G, 1991, J AM CHEM SOC, V113, P2055, DOI 10.1021/ja00006a027; BERNLOHR DA, 1981, BIOCHEMISTRY-US, V20, P5675, DOI 10.1021/bi00523a006; BOLIN JT, 1993, AM CRYST ASS, P51; BRAYTON KA, 1994, J BIOL CHEM, V269, P5313; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; CUNNINGHAM RP, 1989, BIOCHEMISTRY-US, V28, P4450, DOI 10.1021/bi00436a049; GRANDONI JA, 1989, J BIOL CHEM, V264, P6058; Hendrickson W. A., 1985, T AM CRYSTALLOGR ASS, V21, P11; HENDRICKSON WA, 1988, PROTEINS, V4, P77, DOI 10.1002/prot.340040202; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HERSHEY HV, 1986, GENE, V43, P287, DOI 10.1016/0378-1119(86)90218-0; HOVEJENSEN B, 1986, J BIOL CHEM, V261, P6765; IWAHANA H, 1993, J BIOL CHEM, V268, P7225; IWAHANA H, 1993, BIOCHEM BIOPH RES CO, V190, P192, DOI 10.1006/bbrc.1993.1030; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KENNEDY MC, 1992, ADV INORG CHEM RAD, V38, P323, DOI 10.1016/S0898-8838(08)60067-7; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUO CF, 1992, SCIENCE, V258, P434, DOI 10.1126/science.1411536; LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805; MAKAROFF CA, 1983, J BIOL CHEM, V258, P586; MAKAROFF CA, 1986, J BIOL CHEM, V261, P1416; MANTSALA P, 1984, J BIOL CHEM, V259, P8478; MANTSALA P, 1984, J BIOL CHEM, V259, P4230; MERRITT EA, COMMUNICATION; MESSENGER LJ, 1979, J BIOL CHEM, V254, P3382; MEYER E, 1979, J BIOL CHEM, V254, P5397; MICHAELS ML, 1990, NUCLEIC ACIDS RES, V18, P3841, DOI 10.1093/nar/18.13.3841; MUSICK WDL, 1981, CRC CR REV BIOCH MOL, V11, P1, DOI 10.3109/10409238109108698; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; PAHLER A, 1990, ACTA CRYSTALLOGR A, V46, P537, DOI 10.1107/S0108767390002379; Perutz M, 1989, MECHANISMS COOPERATI; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; SAMPEI G, 1988, NUCLEIC ACIDS RES, V16, P8717, DOI 10.1093/nar/16.17.8717; SCHULZ GE, 1992, CURR OPIN STRUC BIOL, V2, P61; Smith JL, 1991, CURR OPIN STRUC BIOL, V1, P1002, DOI 10.1016/0959-440X(91)90098-E; SMITH JL, 1991, ISOMORPHOUS REPLACEM, P96; SOUCIET JL, 1988, J BIOL CHEM, V263, P3323; SUCK D, 1984, EMBO J, V3, P2423, DOI 10.1002/j.1460-2075.1984.tb02149.x; SWITZER R L, 1989, Biofactors, V2, P77; SWITZER RL, 1989, ALLOSTERIC ENZYMES, P129; TSO JY, 1982, J BIOL CHEM, V257, P3525; TSO JY, 1982, J BIOL CHEM, V257, P3532; VOLLMER SJ, 1983, J BIOL CHEM, V258, P582; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; WONG JY, 1981, BIOCHEMISTRY-US, V20, P5669, DOI 10.1021/bi00523a005; YANG W, 1990, SCIENCE, V249, P1398, DOI 10.1126/science.2169648; Zalkin H, 1993, Adv Enzymol Relat Areas Mol Biol, V66, P203; ZHOU GC, 1990, J BIOL CHEM, V265, P21152; ZHOU GC, 1993, J BIOL CHEM, V268, P10471	52	240	244	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 3	1994	264	5164					1427	1433		10.1126/science.8197456	http://dx.doi.org/10.1126/science.8197456			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NP221	8197456				2022-12-28	WOS:A1994NP22100033
J	KARP, JE; BRODER, S				KARP, JE; BRODER, S			ONCOLOGY AND HEMATOLOGY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; CHRONIC MYELOGENOUS LEUKEMIA; ADAPTER PROTEIN; TYROSINE KINASE; EGF RECEPTOR; RAS; GRB2; CELLS; SOS; TRANSFORMATION				KARP, JE (corresponding author), NCI,BETHESDA,MD 20892, USA.							BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CHARDIN P, 1993, SCIENCE, V260, P1338, DOI 10.1126/science.8493579; CIECHETTI P, 1992, SCIENCE, V257, P803; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; DIEKMANN D, 1991, NATURE, V351, P400, DOI 10.1038/351400a0; DRUKER B, 1992, BLOOD, V79, P2215; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; GISHIZKY ML, 1992, SCIENCE, V256, P836, DOI 10.1126/science.1375394; HAAG JD, 1992, CANCER RES, V52, P4021; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; JAMES GL, 1993, SCIENCE, V260, P1937, DOI 10.1126/science.8316834; KHOSRAVIFAR R, 1992, CELL GROWTH DIFFER, V3, P461; KOHL NE, 1993, SCIENCE, V260, P1934, DOI 10.1126/science.8316833; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; LU BD, 1993, BLOOD, V82, P1257; LUPU R, 1990, SCIENCE, V249, P1552, DOI 10.1126/science.2218496; MANDANAS RA, 1993, BLOOD, V82, P1838; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; PAQUETTE RL, 1993, BLOOD, V82, P590, DOI 10.1182/blood.V82.2.590.bloodjournal822590; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; SAMID D, 1993, J CLIN INVEST, V91, P2288, DOI 10.1172/JCI116457; SIMON MA, 1993, CELL, V73, P169, DOI 10.1016/0092-8674(93)90169-Q; WEN DZ, 1992, CELL, V69, P559, DOI 10.1016/0092-8674(92)90456-M	25	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1693	1695		10.1001/jama.271.21.1693	http://dx.doi.org/10.1001/jama.271.21.1693			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182856				2022-12-28	WOS:A1994NN11700035
J	STOECKLE, MY; DOUGLAS, RG				STOECKLE, MY; DOUGLAS, RG			INFECTIOUS-DISEASES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFLUENZAE TYPE-B; STREPTOCOCCUS-PNEUMONIAE; VARICELLA VACCINE; CONJUGATE VACCINE; CHILDREN; IMMUNIZATION; TRIALS; LIVE		MERCK & CO INC,WHITE HOUSE STN,NJ	Merck & Company	STOECKLE, MY (corresponding author), CORNELL UNIV,COLL MED,NEW YORK,NY, USA.							ADA G, 1993, NATURE, V364, P489, DOI 10.1038/364489a0; BUTLER JC, 1993, JAMA-J AM MED ASSOC, V270, P1826, DOI 10.1001/jama.270.15.1826; FRIEDLAND IR, 1993, PEDIATR INFECT DIS J, V12, P196, DOI 10.1097/00006454-199303000-00004; GERSHON AA, 1992, J INFECT DIS, V166, pS63, DOI 10.1093/infdis/166.Supplement_1.S63; HARDY I, 1991, NEW ENGL J MED, V325, P1545, DOI 10.1056/NEJM199111283252204; LETVIN NL, 1993, NEW ENGL J MED, V329, P1400, DOI 10.1056/NEJM199311043291908; MCDOUGAL LK, 1992, ANTIMICROB AGENTS CH, V36, P2176, DOI 10.1128/AAC.36.10.2176; MURPHY TV, 1993, JAMA-J AM MED ASSOC, V269, P246, DOI 10.1001/jama.269.2.246; MURPHY TV, 1993, J PEDIATR-US, V122, P517, DOI 10.1016/S0022-3476(05)83529-2; QUICK RE, 1993, AM J MED, V94, P149, DOI 10.1016/0002-9343(93)90176-P; SOARES S, 1993, J INFECT DIS, V168, P158, DOI 10.1093/infdis/168.1.158; SPERBER SJ, 1992, ANTIVIR RES, V17, P213, DOI 10.1016/0166-3542(92)90042-4; TAKALA AK, 1993, PEDIATR INFECT DIS J, V12, P593, DOI 10.1097/00006454-199307000-00010; WHITE CJ, 1991, PEDIATRICS, V87, P604; 1993, MMWR MORB MORTAL WKL, V42, P612; 1993, MMWR MORB MORTAL WKL, V42, P816	16	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1677	1679						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182847				2022-12-28	WOS:A1994NN11700026
J	MOYER, JH; LEETISCHLER, MJ; KWON, HY; SCHRICK, JJ; AVNER, ED; SWEENEY, WE; GODFREY, VL; CACHEIRO, NLA; WILKINSON, JE; WOYCHIK, RP				MOYER, JH; LEETISCHLER, MJ; KWON, HY; SCHRICK, JJ; AVNER, ED; SWEENEY, WE; GODFREY, VL; CACHEIRO, NLA; WILKINSON, JE; WOYCHIK, RP			CANDIDATE GENE ASSOCIATED WITH A MUTATION CAUSING RECESSIVE POLYCYSTIC KIDNEY-DISEASE IN MICE	SCIENCE			English	Article							MOUSE CHROMOSOME-2; DNA; PROTEINS; MITOSIS; REGION; MODEL; MOTIF	A line of transgenic mice was generated that contains an insertional mutation causing a phenotype similar to human autosomal recessive polycystic kidney disease. Homozygotes displayed a complex phenotype that included bilateral polycystic kidneys and an unusual liver lesion. The mutant locus was cloned and characterized through use of the transgene as a molecular marker. Additionally, a candidate polycystic kidney disease (PKD) gene was identified whose structure and expression are directly associated with the mutant locus. A complementary DNA derived from this gene predicted a peptide containing a motif that was originally identified in several genes involved in cell cycle control.	OAK RIDGE NATL LAB,DIV BIOL,OAK RIDGE,TN 37831; UNIV TENNESSEE,GRAD SCH BIOMED SCI,DIV BIOL,OAK RIDGE NATL LAB,OAK RIDGE,TN 37831; UNIV WASHINGTON,DEPT PEDIAT,SEATTLE,WA 98105; UNIV TENNESSEE,DEPT PATHOBIOL,KNOXVILLE,TN 37920	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Tennessee System; University of Tennessee Knoxville; University of Washington; University of Washington Seattle; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture			Woychik, Richard P/C-8345-2019	Woychik, Richard P/0000-0001-8196-1732	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD025323] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R13ES010067] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD25323] Funding Source: Medline; NIDDK NIH HHS [R01 DK45633-01] Funding Source: Medline; NIEHS NIH HHS [IAG 222Y01-ES-10067] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ATALA A, 1993, KIDNEY INT, V43, P1081, DOI 10.1038/ki.1993.151; Ausubel FM., 1988, CURRENT PROTOCOLS MO; AVNER E D, 1992, Journal of the American Society of Nephrology, V3, P292; AVNER ED, 1987, PEDIATR NEPHROL, V1, P587, DOI 10.1007/BF00853593; AVNER ED, 1992, P NATL ACAD SCI USA, V89, P7447, DOI 10.1073/pnas.89.16.7447; BERNSTEIN J, 1986, CAMPBELLS UROLOGY, P1760; BERNSTEIN J, 1978, PEDIATRIC KIDNEY DIS, P557; BOHNLEIN E, 1985, NUCLEIC ACIDS RES, V13, P4789, DOI 10.1093/nar/13.13.4789; COLE BR, 1990, CYSTIC KIDNEY, pCH13; COWLEY BD, 1991, J AM SOC NEPHROL, V1, P1948; DALGAARD OZ, 1971, DISEASES KIDNEY, P1252; Daoust Martin C., 1993, Journal of the American Society of Nephrology, V4, P262; FARBER E, 1956, CANCER RES, V16, P142; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GERMINO GG, 1992, GENOMICS, V13, P144, DOI 10.1016/0888-7543(92)90214-D; GERMINO GG, 1993, KIDNEY INT       S39, V43, P20; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; GORDON J, 1992, ILAR NEWS, V34, P45; GORDON JW, 1980, P NATL ACAD SCI USA, V77, P7389; Guay-Woodford L. M., 1993, Journal of the American Society of Nephrology, V4, P814; HOGAN B, 1986, MANIPULATING MOUSE E; Kimberling W. J., 1993, Journal of the American Society of Nephrology, V4, P816; Kissane J. M., 1974, PATHOLOGY KIDNEY, P69; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; LIEBERMAN E, 1971, MEDICINE, V50, P277, DOI 10.1097/00005792-197107000-00003; MCGINNIS W, 1984, CELL, V38, P675, DOI 10.1016/0092-8674(84)90262-9; MOYER JH, UNPUB; NAUTA J, 1993, PEDIATR NEPHROL, V7, P163, DOI 10.1007/BF00864387; NORBY S, 1990, LANCET, V336, P323; PETERS DJM, 1993, NAT GENET, V5, P359, DOI 10.1038/ng1293-359; REEDERS ST, 1992, NAT GENET, V1, P235, DOI 10.1038/ng0792-235; RUSSELL ES, 1977, MOUSE NEWSLETT, V56, P49; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHRICK JJ, UNPUB; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; STUBBS L, 1990, GENOMICS, V6, P645, DOI 10.1016/0888-7543(90)90499-K; TAKAHASHI H, 1991, J AM SOC NEPHROL, V1, P980; VANDERLEIJ I, 1993, P NATL ACAD SCI USA, V90, P11782, DOI 10.1073/pnas.90.24.11782; WOYCHIK RP, 1990, P NATL ACAD SCI USA, V87, P2588, DOI 10.1073/pnas.87.7.2588; WRIGHT AF, 1993, HUMAN GENET, V90, P323	41	304	310	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 27	1994	264	5163					1329	1333		10.1126/science.8191288	http://dx.doi.org/10.1126/science.8191288			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NN767	8191288	Green Submitted			2022-12-28	WOS:A1994NN76700046
J	LIN, VSY; DIMAGNO, SG; THERIEN, MJ				LIN, VSY; DIMAGNO, SG; THERIEN, MJ			HIGHLY CONJUGATED, ACETYLENYL BRIDGED PORPHYRINS - NEW MODELS FOR LIGHT-HARVESTING ANTENNA SYSTEMS	SCIENCE			English	Article							ELECTRON-TRANSFER; SPECTROSCOPIC CHARACTERIZATION; OPTICAL-PROPERTIES; DIMERS; POLYMERS; DERIVATIVES; PICOSECOND; ARRAYS	A new class of porphyrin-based chromophore systems has been prepared from ethyne-elaborated porphyrin synthons through the use of metal-mediated cross-coupling methodologies. These systems feature porphyrin chromophores wired together through single ethynyl linkages. This type of topological connectivity affords exceptional electronic interactions between the chromophores which are manifest in their room temperature photo-physics, optical spectroscopy, and electrochemistry; these spectroscopic signatures indicate that these species model many of the essential characteristics of biological light-harvesting antenna systems.	UNIV PENN,DEPT CHEM,PHILADELPHIA,PA 19104	University of Pennsylvania			DiMagno, Stephen G/H-9459-2016	DiMagno, Stephen G/0000-0001-7861-4799	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048130] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 48130-01A1.4] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON HL, 1992, TETRAHEDRON LETT, V33, P1101, DOI 10.1016/S0040-4039(00)91871-9; ANDERSON HL, 1990, ANGEW CHEM INT EDIT, V29, P1400, DOI 10.1002/anie.199014001; ANDERSON HL, 1994, INORG CHEM, V33, P972, DOI 10.1021/ic00083a022; ANDERSON S, 1993, ACCOUNTS CHEM RES, V26, P469, DOI 10.1021/ar00033a003; ARNOLD DP, 1978, J CHEM SOC PERK T 1, P366, DOI 10.1039/p19780000366; ARNOLD DP, 1992, TETRAHEDRON, V48, P8781, DOI 10.1016/S0040-4020(01)89451-5; ARNOLD DP, 1993, J AM CHEM SOC, V115, P12197, DOI 10.1021/ja00078a081; ARNOLD DP, 1993, TETRAHEDRON LETT, V34, P693, DOI 10.1016/S0040-4039(00)61655-6; BEROVA N, 1993, J AM CHEM SOC, V115, P4769, DOI 10.1021/ja00064a042; BILSEL O, 1992, J AM CHEM SOC, V114, P6528, DOI 10.1021/ja00042a037; CHANG CK, 1984, ANGEW CHEM INT EDIT, V23, P164, DOI 10.1002/anie.198401641; COLLMAN JP, 1983, J AM CHEM SOC, V105, P2694, DOI 10.1021/ja00347a029; DIMAGNO SG, 1993, J ORG CHEM, V58, P5983, DOI 10.1021/jo00074a027; DIMAGNO SG, 1993, J AM CHEM SOC, V115, P2513, DOI 10.1021/ja00059a060; Eglinton G., 1963, ADV ORG CHEM, V4, P225; ERIKSSONS, 1990, CHEM PHYS, V1146, P165; FOWLER GJS, 1993, PHOTOCHEM PHOTOBIOL, V57, P2, DOI 10.1111/j.1751-1097.1993.tb02245.x; FOX MA, 1993, CHEM ENG NEWS, V71, P38, DOI 10.1021/cen-v071n011.p038; Gouterman M., 1978, PORPHYRINS, P1, DOI DOI 10.1016/B978-0-12-220103-5.50008-8; GRACA M, 1991, J ORG CHEM, V56, P4407; GREGG BA, 1989, J AM CHEM SOC, V111, P3024, DOI 10.1021/ja00190a041; GUST D, 1990, SCIENCE, V248, P199, DOI 10.1126/science.248.4952.199; GUST D, 1993, J AM CHEM SOC, V115, P5684, DOI 10.1021/ja00066a038; HERMANT RM, 1993, J AM CHEM SOC, V115, P2080, DOI 10.1021/ja00058a088; HEVESI J, 1969, SPECTROCHIM ACTA A-M, VA 25, P1751, DOI 10.1016/0584-8539(69)80203-5; HUNTER CA, 1989, CHEM PHYS, V133, P395, DOI 10.1016/0301-0104(89)80221-6; JAEGERMANN P, 1993, MOL PHYS, V78, P1057, DOI 10.1080/00268979300100691; JOHNSON DG, 1993, J AM CHEM SOC, V115, P5692, DOI 10.1021/ja00066a039; KAGAN NE, 1977, J AM CHEM SOC, V99, P5484, DOI 10.1021/ja00458a045; Kessel D, 1990, PHOTODYNAMIC THERAPY, V2; KESSEL D, 1990, PHOTODYNAMIC THERAPY, V1; Kim J.B., 1978, PORPHYRINS STRUCTURE, P85, DOI [10.1016/b978-0-12-220101-1.5, DOI 10.1016/B978-0-12-220101-1.5]; LECOURS SM, UNPUB; LEMEST Y, 1992, INORG CHEM, V31, P835, DOI 10.1021/ic00031a028; LIN VSY, UNPUB; LINDSEY JS, 1987, J ORG CHEM, V52, P827, DOI 10.1021/jo00381a022; LUTTRULL DK, 1992, LANGMUIR, V8, P765, DOI 10.1021/la00039a006; MATSUURA K, 1993, PHOTOCHEM PHOTOBIOL, V57, P92, DOI 10.1111/j.1751-1097.1993.tb02261.x; MCGHEE EM, 1991, INORG CHEM, V30, P803, DOI 10.1021/ic00004a036; MILGROM LR, 1992, Patent No. 15099; MILLER JS, 1992, ADV MATER, V4, P498, DOI 10.1002/adma.19920040710; NAGATA T, 1990, J AM CHEM SOC, V112, P3054, DOI 10.1021/ja00164a027; NARANG SC, 1992, Patent No. 5091502; NISHIDE H, 1991, MACROMOLECULES, V24, P6306, DOI 10.1021/ma00023a037; ONEIL MP, 1992, SCIENCE, V257, P63, DOI 10.1126/science.257.5066.63; OSUKA A, 1988, J AM CHEM SOC, V110, P4454, DOI 10.1021/ja00221a079; OSUKA A, 1993, J AM CHEM SOC, V115, P4577, DOI 10.1021/ja00064a021; OSUKA A, 1991, CHEM PHYS LETT, V1181, P413; Paine J.B., 1978, PORPHYRINS A, V1, P101; PANDEY RK, 1992, TETRAHEDRON LETT, V33, P5315, DOI 10.1016/S0040-4039(00)79081-2; PANDEY RK, 1990, TETRAHEDRON LETT, V31, P7399, DOI 10.1016/S0040-4039(00)88499-3; PRATHAPAN S, 1993, J AM CHEM SOC, V115, P7519, DOI 10.1021/ja00069a068; PROESS G, 1992, TETRAHEDRON LETT, V33, P269, DOI 10.1016/0040-4039(92)88068-G; Rawls H.R., 1965, PURE APPL CHEM, V11, P371; RODRIGUEZ J, 1991, J AM CHEM SOC, V113, P1652, DOI 10.1021/ja00005a032; SAKODA K, 1991, Patent No. 5051337; SCAMPORRINO E, 1992, MACROMOLECULES, V25, P1625, DOI 10.1021/ma00032a001; SCHICK GA, 1989, J AM CHEM SOC, V111, P1344, DOI 10.1021/ja00186a030; SEGAWA H, 1992, J CHEM SOC CHEM COMM, P784, DOI 10.1039/c39920000784; SEGAWA H, 1992, J PHYS CHEM-US, V96, P503, DOI 10.1021/j100181a001; SELENSKY R, 1981, CHEM PHYS, V60, P33, DOI 10.1016/0301-0104(81)80105-X; SESSLER JL, 1993, J AM CHEM SOC, V115, P4618, DOI 10.1021/ja00064a025; Smith K. M., 1975, PORPHYRINS METALLOPO; SUSLICK KS, 1992, J AM CHEM SOC, V114, P6928, DOI 10.1021/ja00043a055; TERRELL DR, 1991, Patent No. 428214; TRONRUD DE, 1986, J MOL BIOL, V188, P443, DOI 10.1016/0022-2836(86)90167-1; TSUCHIDA E, 1991, Patent No. 464717; Turro N.J, 1991, MODERN MOL PHOTOCHEM; USHIZAWA N, 1990, Patent No. 4957615; VISSCHERS RW, 1992, BIOCHIM BIOPHYS ACTA, V1100, P259, DOI 10.1016/0167-4838(92)90480-2; VOET D, 1990, BIOCHEMISTRY-US, P591; WASIELEWSKI MR, 1990, J AM CHEM SOC, V112, P6482, DOI 10.1021/ja00174a005; WEBBER SE, 1990, CHEM REV, V90, P1469, DOI 10.1021/cr00106a005; WEISHAUPT KR, 1985, Patent No. 161606; YONEYAMA M, 1991, CHEM LETT, P929, DOI 10.1246/cl.1991.929	75	767	773	2	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 20	1994	264	5162					1105	1111		10.1126/science.8178169	http://dx.doi.org/10.1126/science.8178169			7	Multidisciplinary Sciences	Index Chemicus (IC); Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NM146	8178169				2022-12-28	WOS:A1994NM14600021
J	SOLLNER, T; BENNETT, MK; WHITEHEART, SW; SCHELLER, RH; ROTHMAN, JE				SOLLNER, T; BENNETT, MK; WHITEHEART, SW; SCHELLER, RH; ROTHMAN, JE			A PROTEIN ASSEMBLY-DISASSEMBLY PATHWAY IN-VITRO THAT MAY CORRESPOND TO SEQUENTIAL STEPS OF SYNAPTIC VESICLE DOCKING, ACTIVATION, AND FUSION	CELL			English	Article							INTEGRAL MEMBRANE-PROTEIN; SYNAPTOSOMAL-ASSOCIATED PROTEIN; VESICULAR TRANSPORT; RAT-BRAIN; IDENTIFICATION; COMPLEX; YEAST; ER; GLYCOPROTEIN; SNAP-25	The SNARE hypothesis holds that a transport vesicle chooses its target for fusion when a soluble NSF attachment protein (SNAP) receptor on the vesicle (v-SNARE) pairs with its cognate t-SNARE at the target membrane. Three synaptosomal membrane proteins have previously been identified: syntaxin, SNAP-25 (t-SNAREs), and vesicle-associated membrane protein (VAMP) (v-SNARE); all assemble with SNAPs and NSF into 20S fusion particles. We now report that in the absence of SNAP and NSF, these three SNAREs form a stable complex that can also bind synaptotagmin. Synaptotagmin is displaced by alpha-SNAP, suggesting that these two proteins share binding sites on the SNARE complex and implying that synaptotagmin operates as a ''clamp'' to prevent fusion from proceeding in the absence of a signal. The alpha-SNAP-SNARE complex can bind NSF, and NSF-dependent hydrolysis of ATP dissociates the complex, separating syntaxin, SNAP-25, and VAMP. ATP hydrolysis by NSF may provide motion to initiate bilayer fusion.	STANFORD UNIV,MED CTR,HOWARD HUGHES MED INST,DEPT MOLEC & CELLULAR PHYSIOL,STANFORD,CA 94305	Howard Hughes Medical Institute; Stanford University	SOLLNER, T (corresponding author), MEM SLOAN KETTERING CANC CTR,PROGRAM CELLULAR BIOCHEM & BIOPHYS,NEW YORK,NY 10021, USA.			Whiteheart, Sidney/0000-0001-5577-0473				BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BAXEVANIS AD, 1993, CURR OPIN GENET DEV, V3, P278, DOI 10.1016/0959-437X(93)90035-N; BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BENNETT MK, 1993, CELL, V74, P863, DOI 10.1016/0092-8674(93)90466-4; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BENTZ J, 1990, FEBS LETT, V276, P1, DOI 10.1016/0014-5793(90)80492-2; BLASI J, 1993, NATURE, V365, P160, DOI 10.1038/365160a0; BLASI J, 1993, IN PRESS EMBO J; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284; CAIN CC, 1992, J BIOL CHEM, V267, P11681; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; CLARY DO, 1990, CELL, V61, P709, DOI 10.1016/0092-8674(90)90482-T; DEBELLO WM, 1993, CELL, V74, P947, DOI 10.1016/0092-8674(93)90716-4; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; ELFRINK LA, 1993, CELL, V72, P153; HARDWICK KG, 1992, J CELL BIOL, V119, P513, DOI 10.1083/jcb.119.3.513; HARLOW E, 1988, ANTIBODIES LABORATOR; HELM CA, 1989, SCIENCE, V246, P919, DOI 10.1126/science.2814514; HESS DT, 1992, J NEUROSCI, V12, P4634; HUTTNER WB, 1993, NATURE, V365, P104, DOI 10.1038/365104a0; HUTTNER WB, 1983, J CELL BIOL, V96, P1373; INOUE A, 1992, J BIOL CHEM, V267, P10613; KAISER CA, 1990, CELL, V61, P723, DOI 10.1016/0092-8674(90)90483-U; KELLY RB, 1993, CELL, V72, P43, DOI 10.1016/S0092-8674(05)80027-3; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; MONCK JR, 1992, J CELL BIOL, V119, P1395, DOI 10.1083/jcb.119.6.1395; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; NEWMAN AP, 1992, EMBO J, V11, P3609, DOI 10.1002/j.1460-2075.1992.tb05445.x; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; ORCI L, 1989, CELL, V56, P357, DOI 10.1016/0092-8674(89)90239-0; OSHEA EK, 1989, SCIENCE, V245, P646, DOI 10.1126/science.2503872; OSTERMANN J, 1993, IN PRESS CELL, V75; OYLER GA, 1989, J CELL BIOL, V109, P3039, DOI 10.1083/jcb.109.6.3039; POPOV SV, 1993, CELL, V73, P1247, DOI 10.1016/0092-8674(93)90352-Q; REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219; SCHIAVO G, 1992, NATURE, V359, P862; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; TAGAYA M, 1993, J BIOL CHEM, V268, P2662; TRIMBLE WS, 1990, J NEUROSCI, V10, P1380; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; WATERS MG, 1992, J CELL BIOL, V1186, P1015; WHITE JM, 1992, SCIENCE, V258, P917, DOI 10.1126/science.1439803; WHITEHEART SW, 1992, J BIOL CHEM, V267, P12239; WHITEHEART SW, 1993, NATURE, V362, P353, DOI 10.1038/362353a0; WIEDENMANN B, 1985, CELL, V41, P1017, DOI 10.1016/S0092-8674(85)80082-9; WILSON DW, 1992, METHOD ENZYMOL, V219, P309; WILSON DW, 1992, J CELL BIOL, V117, P531, DOI 10.1083/jcb.117.3.531; WILSON DW, 1989, NATURE, V339, P355, DOI 10.1038/339355a0; Zerial M, 1993, CURR OPIN CELL BIOL, V5, P613, DOI 10.1016/0955-0674(93)90130-I	55	1594	1621	4	127	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 5	1993	75	3					409	418		10.1016/0092-8674(93)90376-2	http://dx.doi.org/10.1016/0092-8674(93)90376-2			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MF830	8221884				2022-12-28	WOS:A1993MF83000004
J	GULLO, L; PEZZILLI, R; MORSELLILABATE, AM; PRIORI, P; CAMPIONE, O; CASADEI, R; BRAMBATI, M; LESI, C; FRENA, A; MALESCI, A; ZERBI, A; ANDRIULLI, A; ACQUADRO, P; DAMBROSI, A; ALVISI, V; MONTALTO, G; CARROCCIO, A; DECONCA, V; MORNESE, A; MANSI, C; BATTISTINI, C; SPERTI, C; PASQUALI, C; GAETA, L; MAZZEO, M; FELDER, M				GULLO, L; PEZZILLI, R; MORSELLILABATE, AM; PRIORI, P; CAMPIONE, O; CASADEI, R; BRAMBATI, M; LESI, C; FRENA, A; MALESCI, A; ZERBI, A; ANDRIULLI, A; ACQUADRO, P; DAMBROSI, A; ALVISI, V; MONTALTO, G; CARROCCIO, A; DECONCA, V; MORNESE, A; MANSI, C; BATTISTINI, C; SPERTI, C; PASQUALI, C; GAETA, L; MAZZEO, M; FELDER, M			DIABETES AND THE RISK OF PANCREATIC-CANCER	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PAST MEDICAL HISTORY; BEVERAGE CONSUMPTION; CARCINOMA; MELLITUS; ALCOHOL; COFFEE; DISEASE; GLUCOSE; TOBACCO; DIET	Background. Diabetes and pancreatic cancer are known to be associated, but the cause of the association and whether diabetes is a risk factor for pancreatic cancer remain controversial. Methods. A total of 720 patients with pancreatic cancer and 720 control patients from 14 Italian centers were enrolled in the study. All subjects were interviewed personally and in detail about their clinical history. The diagnosis of diabetes was based on criteria recommended by the American Diabetes Association. Results. One hundred sixty-four patients with pancreatic cancer (22.8 percent) and 60 controls (8.3 percent) had diabetes. In the majority of the patients with pancreatic cancer (56.1 percent), diabetes was diagnosed either concomitantly with the cancer (in 40.2 percent), or within two years before the diagnosis of cancer (in 15.9 percent). The association between the two conditions was significant (odds ratio, 3.04; 95 percent confidence interval, 2.21 to 4.17). However, when only patients with diabetes of three or more years' duration were considered, the association was no longer significant (odds ratio, 1.43; 95 percent confidence interval, 0.98 to 2.07). All the patients with pancreatic cancer whose diabetes had been diagnosed before the cancer had non-insulin-dependent diabetes; all but one of the control patients with diabetes had the noninsulin-dependent form of the disease. Conclusions. Diabetes in patients with pancreatic cancer is frequently of recent onset and is presumably caused by the tumor. Diabetes is not a risk factor for pancreatic cancer.			GULLO, L (corresponding author), UNIV BOLOGNA,OSPED S ORSOLA,IST CLIN MED & GASTROENTEROL,VIA MASSARENTI 9,I-40138 BOLOGNA,ITALY.		Casadei, Riccardo/AAL-6053-2021; Carroccio, Antonio/K-4484-2016; Pezzilli, Raffaele/H-8280-2019; Andriulli, Angelo/B-5027-2017	Carroccio, Antonio/0000-0001-8913-7916; Pezzilli, Raffaele/0000-0001-9827-7451; Andriulli, Angelo/0000-0001-8862-7083; CASADEI, RICCARDO/0000-0001-9486-8190; Morselli/Labate, Antonio Maria/0000-0001-9318-8564; MONTALTO, Giuseppe/0000-0002-8731-8577; zerbi, alessandro/0000-0002-9176-0448				BELL ET, 1957, AM J PATHOL, V33, P499; BLOT WJ, 1978, CANCER, V42, P373, DOI 10.1002/1097-0142(197807)42:1<373::AID-CNCR2820420156>3.0.CO;2-L; CLARK CG, 1961, BRIT MED J, V2, P1259, DOI 10.1136/bmj.2.5262.1259; CUZICK J, 1989, INT J CANCER, V43, P415, DOI 10.1002/ijc.2910430312; DEMESQUITA HBB, 1992, INT J CANCER, V52, P17, DOI 10.1002/ijc.2910520105; Dixon W. J., 1990, BMDP STATISTICAL SOF; FARROW DC, 1990, INT J CANCER, V45, P816, DOI 10.1002/ijc.2910450504; FRIEDMAN GD, 1993, INT J EPIDEMIOL, V22, P30, DOI 10.1093/ije/22.1.30; GLICKSMAN AS, 1956, CANCER, V9, P1127, DOI 10.1002/1097-0142(195611/12)9:6&lt;1127::AID-CNCR2820090610&gt;3.0.CO;2-4; GOLD EB, 1985, CANCER-AM CANCER SOC, V55, P460, DOI 10.1002/1097-0142(19850115)55:2<460::AID-CNCR2820550229>3.0.CO;2-V; Grauer FW, 1939, ARCH INTERN MED, V63, P884, DOI 10.1001/archinte.1939.00180220074007; GREEN A, 1985, DIABETOLOGIA, V28, P128; GREEN RC, 1958, DIABETES, V7, P308, DOI 10.2337/diab.7.4.308; GULLO L, 1993, ITAL J GASTROENTEROL, V25, P487; Gullo L., 1993, Digestion, V54, P279; HIATT RA, 1988, INT J CANCER, V41, P794, DOI 10.1002/ijc.2910410603; JAIN M, 1991, INT J CANCER, V47, P384, DOI 10.1002/ijc.2910470313; KALAPOTHAKI V, 1993, CANCER CAUSE CONTROL, V4, P375, DOI 10.1007/BF00051341; KARMODY AJ, 1969, BRIT J SURG, V56, P362, DOI 10.1002/bjs.1800560512; KESSLER II, 1970, J NATL CANCER I, V44, P673; LAVECCHIA C, 1990, ONCOLOGY-BASEL, V47, P463; LIN RS, 1981, JAMA-J AM MED ASSOC, V245, P147; MACK TM, 1986, JNCI-J NATL CANCER I, V76, P49; Marble A, 1934, NEW ENGL J MED, V211, P339, DOI 10.1056/NEJM193408232110801; MILLS PK, 1988, CANCER-AM CANCER SOC, V61, P2578, DOI 10.1002/1097-0142(19880615)61:12&lt;2578::AID-CNCR2820611232&gt;3.0.CO;2-0; MORSIANI M, 1987, METABOLISMO OGGI, V4, P3; NORELL S, 1986, BRIT J CANCER, V54, P377, DOI 10.1038/bjc.1986.185; OMARA BA, 1985, J CHRON DIS, V38, P435, DOI 10.1016/0021-9681(85)90139-0; PERMERT J, 1994, NEW ENGL J MED, V330, P313, DOI 10.1056/NEJM199402033300503; PERMERT J, 1993, EUR J SURG, V159, P101; RAGOZZINO M, 1982, J CHRON DIS, V35, P13, DOI 10.1016/0021-9681(82)90025-X; SCHWARTZ SS, 1978, AM J DIG DIS, V23, P1107, DOI 10.1007/BF01072886; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; WHITTEMORE AS, 1983, J CHRON DIS, V36, P251, DOI 10.1016/0021-9681(83)90059-0; WYNDER EL, 1973, JNCI-J NATL CANCER I, V50, P645, DOI 10.1093/jnci/50.3.645; 1979, DIABETES, V28, P1039	36	259	274	0	9	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	1994	331	2					81	84		10.1056/NEJM199407143310203	http://dx.doi.org/10.1056/NEJM199407143310203			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NW712	8208269				2022-12-28	WOS:A1994NW71200003
J	CRAPO, RO				CRAPO, RO			CURRENT CONCEPTS - PULMONARY-FUNCTION TESTING	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							MUCUS HYPERSECRETION; HEART-FAILURE; LUNG-FUNCTION; MORTALITY; DISEASE; LABORATORIES; PERFORMANCE; GUIDELINES; SMOKING; ADULTS		UNIV UTAH,SCH MED,SALT LAKE CITY,UT	Utah System of Higher Education; University of Utah	CRAPO, RO (corresponding author), LATTER DAY ST HOSP,DIV PULM,PULM LAB,SALT LAKE CITY,UT 84143, USA.							ANNESI I, 1986, AM REV RESPIR DIS, V134, P688; [Anonymous], 1987, Am Rev Respir Dis, V136, P1285; [Anonymous], 1990, GUIDES EVALUATION PE; ANTHONISEN NR, 1986, AM REV RESPIR DIS, V133, P14, DOI 10.1164/arrd.1986.133.1.14; Bates DV, 1989, RESP FUNCTION DIS; BECKLAKE MR, 1986, AM J MED, V80, P1158, DOI 10.1016/0002-9343(86)90678-9; CAMILLI AE, 1987, AM REV RESPIR DIS, V135, P794, DOI 10.1164/arrd.1987.135.4.794; CELLI BR, 1993, MED CLIN N AM, V77, P309, DOI 10.1016/S0025-7125(16)30253-X; CLAUSEN JL, 1982, PULMONARY FUNCTION T, P1; DUNN WF, 1993, MAYO CLIN PROC, V68, P371, DOI 10.1016/S0025-6196(12)60135-9; ENRIGHT PL, 1987, OFFICE SPIROMETRY PR; ETTINGER NA, 1991, AM REV RESPIR DIS, V144, P433, DOI 10.1164/ajrccm/144.2.433; Fletcher CM, 1976, NATURAL HIST CHRONIC; FOXMAN B, 1986, AM REV RESPIR DIS, V134, P649; GARDNER RM, 1986, AM REV RESPIR DIS, V134, P628; GARDNER RM, 1986, AM REV RESPIR DIS, V134, P625; GARDNER RM, 1986, AM REV RESPIR DIS, V134, P623; Gentry S E, 1983, J Community Health, V8, P263, DOI 10.1007/BF01666779; HANKINSON JL, 1986, J OCCUP ENVIRON MED, V28, P1081, DOI 10.1097/00043764-198610000-00032; HEPPER NG, 1969, ARCH ENVIRON HEALTH, V19, P806, DOI 10.1080/00039896.1969.10666934; KANNEL WB, 1974, CIRCULATION, V49, P1160, DOI 10.1161/01.CIR.49.6.1160; LIGHT RW, 1983, ARCH INTERN MED, V143, P429, DOI 10.1001/archinte.143.3.429; MILLER A, 1987, PULMONARY FUNCTION T; Morris A, 1984, CLIN PULMONARY FUNCT; NELSON SB, 1990, CHEST, V97, P288, DOI 10.1378/chest.97.2.288; PETO R, 1983, AM REV RESPIR DIS, V128, P491, DOI 10.1164/arrd.1983.128.3.491; QUANJER PH, 1989, EUR RESP J S, V4, pS121; ROSENOW EC, 1992, CHEST, V102, P239, DOI 10.1378/chest.102.1.239; ROSENOW EC, 1988, TXB RESPIRATORY MED, V2, P1681; RUSSELL NJ, 1986, THORAX, V41, P360, DOI 10.1136/thx.41.5.360; SLY RM, 1989, J ALLERGY CLIN IMMUN, V84, P421, DOI 10.1016/0091-6749(89)90351-5; STARNES VA, 1989, J THORAC CARDIOV SUR, V98, P683; TAUSSIG LM, 1980, J PEDIATR-US, V97, P668, DOI 10.1016/S0022-3476(80)80039-4; TOCKMAN MS, 1989, AM REV RESPIR DIS, V140, pS56, DOI 10.1164/ajrccm/140.3_Pt_2.S56; WANGER J, 1991, PULMONARY FUNCTION T; WILLIAMSRUSSO P, 1992, ARCH INTERN MED, V152, P1209, DOI 10.1001/archinte.152.6.1209; Zapletal A, 1987, LUNG FUNCTION CHILDR; 1990, ANN INTERN MED, V112, P793; 1991, AM REV RESPIR DIS, V144, P1202; 1991, NIH913042 DEP HLTH H; 1983, AM REV RESPIR DIS, V128, P768; 1986, AM REV RESPIR DIS, V133, P1205; 1993, EUR RESPIR J S16, V6, P1; 1987, AM REV RESPIR DIS, V136, P1299	44	187	194	0	3	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	1994	331	1					25	30		10.1056/NEJM199407073310107	http://dx.doi.org/10.1056/NEJM199407073310107			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NU951	8202099				2022-12-28	WOS:A1994NU95100007
J	KINZLER, KW; VOGELSTEIN, B				KINZLER, KW; VOGELSTEIN, B			CLINICAL IMPLICATIONS OF BASIC RESEARCH - CANCER-THERAPY MEETS P53	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											KINZLER, KW (corresponding author), JOHNS HOPKINS UNIV,CTR ONCOL,BALTIMORE,MD 21231, USA.							LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7	1	84	88	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	1994	331	1					49	50		10.1056/NEJM199407073310113	http://dx.doi.org/10.1056/NEJM199407073310113			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NU951	8202105				2022-12-28	WOS:A1994NU95100013
J	KREISBERG, RA				KREISBERG, RA			STOPPING SHORT OF CERTAINTY	NEW ENGLAND JOURNAL OF MEDICINE			English	Note							HYPERCALCEMIA; SARCOIDOSIS; CALCITRIOL; CALCIUM; DISEASE				KREISBERG, RA (corresponding author), UNIV ALABAMA,DEPT INTERNAL MED,1808 7TH AVE S,BIRMINGHAM,AL 35233, USA.							Adams J S, 1986, Sarcoidosis, V3, P1; Adams John S., 1993, P178; ADAMS JS, 1992, SEMIN RESPIR MED, V13, P402, DOI 10.1055/s-2007-1006289; BASILE JN, 1993, J CLIN INVEST, V91, P1396, DOI 10.1172/JCI116342; BENCHETRIT E, 1994, NEW ENGL J MED, V330, P343, DOI 10.1056/NEJM199402033300509; BIKLE DD, 1992, CECIL TXB MED, P1404; KASSIRER JP, 1989, NEW ENGL J MED, V320, P1489, DOI 10.1056/NEJM198906013202211; KASSIRER JP, 1991, LEARNING CLIN REASON, P28; LEMANN J, 1984, NEW ENGL J MED, V311, P1115, DOI 10.1056/NEJM198410253111710; LUFKIN EG, 1983, MAYO CLIN PROC, V58, P447; SEYMOUR JF, 1993, BLOOD, V82, P1383; Shane Elizabeth, 1993, P153; Stewart Andrew F., 1993, P169; THRASHER DR, 1982, CLIN CHEST MED, V3, P537	14	9	9	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	1994	331	1					42	45		10.1056/NEJM199407073310110	http://dx.doi.org/10.1056/NEJM199407073310110			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NU951	8202102				2022-12-28	WOS:A1994NU95100010
J	LINZER, M				LINZER, M			BLUEBERRY MUFFINS AND MYSTERY NOVELS	ANNALS OF INTERNAL MEDICINE			English	Editorial Material											LINZER, M (corresponding author), UNIV WISCONSIN, SCH MED, CTR CLIN SCI J5-210, DEPT MED, 600 HIGHLAND AVE, MADISON, WI 53792 USA.								0	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1994	121	1					56	57		10.7326/0003-4819-121-1-199407010-00010	http://dx.doi.org/10.7326/0003-4819-121-1-199407010-00010			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PN271	8198348				2022-12-28	WOS:A1994PN27100010
J	FARINAS, I; JONES, KR; BACKUS, C; WANG, XY; REICHARDT, LF				FARINAS, I; JONES, KR; BACKUS, C; WANG, XY; REICHARDT, LF			SEVERE SENSORY AND SYMPATHETIC DEFICITS IN MICE LACKING NEUROTROPHIN-3	NATURE			English	Article							NERVE GROWTH-FACTOR; MOLECULAR-CLONING; FACTOR FAMILY; RECEPTOR; NEURONS; MEMBER; SYSTEM; BRAIN; BDNF; NGF	During development, neurotrophins help shape the nervous system by regulating neuronal survival and differentiation. Neurotrophin-3 (refs 1-5) is the most abundant neurotrophin during early development(6). Neurons responsive to neurotrophin-3 in vitro include primary sensory, sympathetic(1-4), motor(7), enteric(1) locus coeruleus(8), hippocampal and cerebellar neurons (ref. 9 for example). Here we report that mice lacking neurotrophin-3 have severe deficits in sensory and sympathetic populations. These mice lack muscle spindles and show abnormal limb positions. In contrast, motor neurons, the enteric nervous system, and the major anatomical regions of the central nervous system seem to develop normally. Comparisons with mutants deficient in other neurotrophins or their receptors(13-15) indicate that some neurons require more than one neurotrophin during embryogenesis and suggest that neurotrophin-3 functions by binding receptors in addition to its primary receptor trkC (ref. 16). In particular, neurotrophin-3 is essential for survival of sympathetic and sensory neurons that later become dependent on nerve growth factor or brain-derived neurotrophic factor.	UNIV CALIF SAN FRANCISCO,SCH MED,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; University of California System; University of California San Francisco	FARINAS, I (corresponding author), UNIV CALIF SAN FRANCISCO,SCH MED,DEPT PHYSIOL,PROGRAM NEUROSCI,SAN FRANCISCO,CA 94143, USA.		; Farinas, Isabel/L-7118-2014	JONES, KEVIN/0000-0002-3802-7562; Farinas, Isabel/0000-0003-2903-4960				ARENAS E, 1994, NATURE, V367, P368, DOI 10.1038/367368a0; BARBACID M, 1993, ONCOGENE, V8, P2033; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; BUCHMAN VL, 1993, DEVELOPMENT, V118, P989; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DICICCOBLOOM E, 1993, NEURON, V11, P1101, DOI 10.1016/0896-6273(93)90223-E; EMFORS P, 1994, NATURE, V368, P147; ERNFORS P, 1992, EUR J NEUROSCI, V4, P1140, DOI 10.1111/j.1460-9568.1992.tb00141.x; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; HENDERSON CE, 1993, NATURE, V363, P266, DOI 10.1038/363266a0; HOHN A, 1990, NATURE, V344, P339, DOI 10.1038/344339a0; IP NY, 1993, J NEUROSCI, V13, P3394; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; JONES KR, 1990, P NATL ACAD SCI USA, V87, P8060, DOI 10.1073/pnas.87.20.8060; Joyner AL, 1993, GENE TARGETING PRACT; KALCHEIM C, 1992, P NATL ACAD SCI USA, V89, P1661, DOI 10.1073/pnas.89.5.1661; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; LAMBALLE F, 1994, J NEUROSCI, V14, P14; LAMBALLE F, 1991, CELL, V66, P967, DOI 10.1016/0092-8674(91)90442-2; MAISONPIERRE PC, 1990, SCIENCE, V247, P1446, DOI 10.1126/science.2321006; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; MU XJ, 1993, J NEUROSCI, V13, P4029; PIRVOLA U, 1992, P NATL ACAD SCI USA, V89, P9915, DOI 10.1073/pnas.89.20.9915; ROSENTHAL A, 1990, NEURON, V4, P767, DOI 10.1016/0896-6273(90)90203-R; RUIT KG, 1992, NEURON, V8, P573, DOI 10.1016/0896-6273(92)90284-K; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; TESSAROLLO L, 1993, DEVELOPMENT, V118, P463; YAN Q, 1988, J NEUROSCI, V8, P3481; ZELENA J, 1964, Prog Brain Res, V13, P175, DOI 10.1016/S0079-6123(08)60144-2	30	553	565	0	6	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 23	1994	369	6482					658	661		10.1038/369658a0	http://dx.doi.org/10.1038/369658a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NT459	8208292				2022-12-28	WOS:A1994NT45900058
J	MACIAS, MJ; MUSACCHIO, A; PONSTINGL, H; NILGES, M; SARASTE, M; OSCHKINAT, H				MACIAS, MJ; MUSACCHIO, A; PONSTINGL, H; NILGES, M; SARASTE, M; OSCHKINAT, H			STRUCTURE OF THE PLECKSTRIN HOMOLOGY DOMAIN FROM BETA-SPECTRIN	NATURE			English	Article							PH DOMAIN; PROTEINS; SPECTROSCOPY; COMPLEX; NMR	The 'pleckstrin homology' or PH domain is a 100-residue protein module. It is present in many kinases, different isoforms of phospholipase C, GTPase-activating proteins and nucleotide-exchange factors(1-4). Its function is not known, but many proteins that contain a PH domain interact with GTP-binding proteins(5). The PH domain in beta-adrenergic receptor kinase may be involved in binding to the beta gamma subunits of a trimeric G-protein(3,4,6,7). We report here the three-dimensional structure of the PH domain of the cytoskeletal protein spectrin using homonuclear nuclear magnetic resonance. The core of the molecule is an antiparallel beta-sheet consisting of seven strands. The C terminus is folded into a long alpha-helix, and another helix is present in one of the surface loops. The molecule is electrostatically polarized and contains a pocket which may be involved in the binding of a ligand. There is a distant relationship to the peptidyl-prolyl-cis-trans-isomerase FKBP in which this pocket is involved in the binding of the macrocyclic compound FK506 (refs 8-11).	EUROPEAN MOLEC BIOL LAB,D-69012 HEIDELBERG,GERMANY	European Molecular Biology Laboratory (EMBL)			Macias, Maria J/K-3898-2014; Nilges, Michael/E-4803-2011	Macias, Maria J/0000-0002-6915-963X; Nilges, Michael/0000-0002-1451-8092; Musacchio, Andrea/0000-0003-2362-8784; Oschkinat, Hartmut/0000-0002-4384-9544				AUE WP, 1976, J CHEM PHYS, V64, P2229, DOI 10.1063/1.432450; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; GIESINGER C, 1988, J AM CHEM SOC, V110, P7870; HASLAM RJ, 1993, NATURE, V363, P309, DOI 10.1038/363309b0; INGLESE J, 1992, NATURE, V359, P147, DOI 10.1038/359147a0; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; MEADOWS RP, 1993, BIOCHEMISTRY-US, V32, P754, DOI 10.1021/bi00054a004; MEYER BJ, 1993, CELL, V73, P629; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; SHAW G, 1993, BIOCHEM BIOPH RES CO, V195, P1145, DOI 10.1006/bbrc.1993.2164; STANDAERT RF, 1990, NATURE, V346, P671, DOI 10.1038/346671a0; TOPSCHUG M, 1990, NATURE, V346, P674; VANDUYNE GD, 1991, SCIENCE, V252, P839, DOI 10.1126/science.1709302	14	220	225	0	7	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 23	1994	369	6482					675	677		10.1038/369675a0	http://dx.doi.org/10.1038/369675a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NT459	8208297				2022-12-28	WOS:A1994NT45900063
J	IZES, JK				IZES, JK			HEARTPAINS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	1994	271	24					1902	1902						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR598	8201724				2022-12-28	WOS:A1994NR59800006
J	MASSARO, TA; NEMEC, J; KALMAN, I				MASSARO, TA; NEMEC, J; KALMAN, I			HEALTH SYSTEM REFORM IN THE CZECH-REPUBLIC - POLICY LESSONS FROM THE INITIAL EXPERIENCE OF THE GENERAL HEALTH-INSURANCE COMPANY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARE	The Czech Republic is among the most aggressive of the former Warsaw Pact countries in encouraging competition and free-market reform. This aggressiveness was extended into the health care sector when, in 1992, a mandatory employment-based health insurance system was introduced. The move from a controlled socialist structure to an insurance-based, fee-for-service model occurred in a short time. Health care spending increased 50% in 2 years and now approaches that of many industrialized nations. Claims for reimbursements are increasing at a rate of 5% to 7% per quarter. Market incentives have changed behaviors within the medical community. Newly privatized physicians generate greater volume and consume more resources than those continuing as state employees. Policy issues requiring further evaluation include supply, distribution, and relative valuation of physician services; clinical resource allocation; and cost containment.	UNIV VIRGINIA,DEPT BUSINESS ADM,CHARLOTTESVILLE,VA 22908; GEN HLTH INSURANCE CO CZECH REPUBL,PRAGUE,CZECH REPUBLIC; KALMAN CONSULTING,FRANKFURT,GERMANY	University of Virginia	MASSARO, TA (corresponding author), UNIV VIRGINIA,HLTH SCI CTR,DEPT PEDIAT,BOX 574,CHARLOTTESVILLE,VA 22908, USA.							ALBERT A, 1992, JAMA-J AM MED ASSOC, V267, P2461, DOI 10.1001/jama.267.18.2461; BRENNER G, 1991, HEALTH AFFAIR, V10, P147, DOI 10.1377/hlthaff.10.3.147; CHOPIN K, 1992, BRIT MED J, V304, P1557, DOI 10.1136/bmj.304.6841.1557; ELLIS RP, 1990, J HEALTH ECON, V9, P375, DOI 10.1016/0167-6296(90)90001-J; GERDTHAM UG, 1992, J HEALTH ECON, V11, P63, DOI 10.1016/0167-6296(92)90025-V; JAVOR A, 1993, 2ND M WHO WORK PART; Kimberly JR, 1993, MIGRATION MANAGERIAL; RAFFEL MW, 1992, PUBLIC HEALTH REP, V107, P636; SCHIEBER GJ, 1993, HEALTH AFFAIR, V12, P294, DOI 10.1377/hlthaff.12.suppl_1.294; WLODARCZYK WC, 1993, 2ND M WHO WORK PART; Wolfe P R, 1993, Health Care Financ Rev, V14, P55; 1992, CSFR HLTH STATISTICS; 1993, WORLD HLTH STATISTIC; [No title captured]	14	15	15	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	1994	271	23					1870	1874		10.1001/jama.271.23.1870	http://dx.doi.org/10.1001/jama.271.23.1870			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NP959	8196146				2022-12-28	WOS:A1994NP95900033
J	LEWIN, GR; MCKINTOSH, E; MCMAHON, SB				LEWIN, GR; MCKINTOSH, E; MCMAHON, SB			NMDA RECEPTORS AND ACTIVITY-DEPENDENT TUNING OF THE RECEPTIVE-FIELDS OF SPINAL-CORD NEURONS	NATURE			English	Article							PERIPHERAL-NERVE INJURY; RAT DORSAL HORN; SENSORY MAP; CAT; PLASTICITY; REORGANIZATION; REGENERATION; ANTAGONIST; ACTIVATION; KAINATE	AFTER peripheral nerve section, sensory neurons regenerate but do not regain their original topographical position in the skin(1). Here we report that in the early stages of sciatic nerve regeneration, the cutaneous receptive fields (RFs) of dorsal horn neurons are larger than normal, reflecting the disorganized topography of the regenerated afferents. When nerve regeneration is complete, small contiguous RFs emerge, indicating a central compensation for the disrupted peripheral somatotopy. If the NMDA receptor antagonist MK801 is given during regeneration, RFs do not show this reorganization, but remain large and diffuse. We suggest that the coincident activity of afferents, newly innervating adjacent or overlapping cutaneous territory, acts through postsynaptic NMDA receptors(2) to strengthen the central effectiveness of these inputs at the expense of other non-adjacent and non-coincidently activated inputs. In this way, dorsal horn neurons may attain and retain restricted RFs in the face of a spatially dispersed afferent input.	UNITED MED & DENT SCH GUYS & ST THOMASS HOSP,DEPT PHYSIOL,LONDON SE1 7EH,ENGLAND; SUNY STONY BROOK,DEPT NEUROBIOL & BEHAV,STONY BROOK,NY 11794	University of London; King's College London; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook			Lewin, Gary R/B-8028-2011	McMahon, Stephen/0000-0003-4656-5536; Lewin, Gary/0000-0002-2890-6352				AGRAWAL SG, 1986, BRIT J PHARMACOL, V87, P345, DOI 10.1111/j.1476-5381.1986.tb10823.x; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; DAVIES SN, 1987, BRAIN RES, V424, P402, DOI 10.1016/0006-8993(87)91487-9; DEVOR M, 1978, NATURE, V276, P75, DOI 10.1038/276075a0; DEVOR M, 1981, J NEUROSCI, V1, P679, DOI 10.1523/JNEUROSCI.01-07-00679.1981; DICKENSON AH, 1987, NEUROPHARMACOLOGY, V26, P1235, DOI 10.1016/0028-3908(87)90275-9; DOUGHERTY PM, 1992, J NEUROSCI, V12, P3025, DOI 10.1523/JNEUROSCI.12-08-03025.1992; DYKES RW, 1979, J NEUROPHYSIOL, V42, P1461, DOI 10.1152/jn.1979.42.5.1461; FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43; HAO JX, 1991, EXP NEUROL, V113, P182, DOI 10.1016/0014-4886(91)90174-B; HEADLEY PM, 1987, J PHYSIOL-LONDON, V385, P169, DOI 10.1113/jphysiol.1987.sp016490; HEBB DO, 1949, ORG BEHAVIOR; HORCH K, 1979, J NEUROPHYSIOL, V42, P1437; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; KANO M, 1991, NEUROREPORT, V2, P77, DOI 10.1097/00001756-199102000-00003; LEWIN GR, 1993, EUR J NEUROSCI, V5, P1083, DOI 10.1111/j.1460-9568.1993.tb00962.x; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; LISNEY SJW, 1983, BRAIN RES, V259, P31, DOI 10.1016/0006-8993(83)91064-8; McMahon S B, 1993, Curr Opin Neurobiol, V3, P602, DOI 10.1016/0959-4388(93)90062-4; MORRIS RGM, 1990, PHILOS T ROY SOC B, V329, P187, DOI 10.1098/rstb.1990.0164; RANDIC M, 1993, J NEUROSCI, V13, P5228, DOI 10.1523/JNEUROSCI.13-12-05228.1993; SCHAIBLE HG, 1991, EUR J NEUROSCI, V3, P981, DOI 10.1111/j.1460-9568.1991.tb00034.x; SHLAGGER BL, 1993, NATURE, V364, P623; THOMPSON SWN, 1990, EUR J NEUROSCI, V2, P638, DOI 10.1111/j.1460-9568.1990.tb00453.x; TULLE TR, 1993, J NEUROSCI, V13, P5009; WATKINS JC, 1989, NMDA RECEPTOR, P1; WONG EHF, 1986, P NATL ACAD SCI USA, V83, P7104, DOI 10.1073/pnas.83.18.7104; WOOLF CJ, 1991, PAIN, V44, P293, DOI 10.1016/0304-3959(91)90100-C	29	28	28	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 9	1994	369	6480					482	485		10.1038/369482a0	http://dx.doi.org/10.1038/369482a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ286	8202138				2022-12-28	WOS:A1994NQ28600056
J	BLACKBURN, EH				BLACKBURN, EH			TELOMERES - NO END IN SIGHT	CELL			English	Review							YEAST TELOMERE; TETRAHYMENA; SENESCENCE; SIR3		UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	BLACKBURN, EH (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT MICROBIOL & IMMUNOL,SAN FRANCISCO,CA 94143, USA.							BAKER BS, 1987, ANEUPLOIDY A, P273; BENNETT CB, 1993, P NATL ACAD SCI USA, V90, P5613, DOI 10.1073/pnas.90.12.5613; BLACKBURN EH, 1992, ANNU REV BIOCHEM, V61, P113, DOI 10.1146/annurev.bi.61.070192.000553; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; CHIEN CT, 1993, CELL, V75, P531, DOI 10.1016/0092-8674(93)90387-6; CHIKASHIGE Y, 1994, IN PRESS SCIENCE; DAWE RK, 1994, CELL, V76, P901, DOI 10.1016/0092-8674(94)90364-6; FANG GW, 1993, CELL, V74, P875, DOI 10.1016/0092-8674(93)90467-5; GREIDER CW, 1991, CELL, V67, P645, DOI 10.1016/0092-8674(91)90058-7; LEE MS, 1994, IN PRESS COLD SPRING, V58; LEVIS RW, 1993, CELL, V75, P1083, DOI 10.1016/0092-8674(93)90318-K; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; MCEACHERN MJ, 1994, P NATL ACAD SCI USA, V91, P3453, DOI 10.1073/pnas.91.8.3453; PALLADINO F, 1993, CELL, V75, P543, DOI 10.1016/0092-8674(93)90388-7; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; SCHIERER T, 1994, IN PRESS BIOCHEMISTR; SCHULTZE P, 1994, STRUCTURE, V2, P221, DOI 10.1016/S0969-2126(00)00023-X; SHIPPEN DE, 1994, P NATL ACAD SCI USA, V91, P405, DOI 10.1073/pnas.91.1.405; YU GL, 1991, CELL, V67, P823, DOI 10.1016/0092-8674(91)90077-C; YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0	21	307	309	0	26	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUN 3	1994	77	5					621	623		10.1016/0092-8674(94)90046-9	http://dx.doi.org/10.1016/0092-8674(94)90046-9			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NQ123	8205611				2022-12-28	WOS:A1994NQ12300002
J	MEYER, K; LEUBE, MP; GRILL, E				MEYER, K; LEUBE, MP; GRILL, E			A PROTEIN PHOSPHATASE 2C INVOLVED IN ABA SIGNAL-TRANSDUCTION IN ARABIDOPSIS-THALIANA	SCIENCE			English	Article							ARTIFICIAL CHROMOSOME LIBRARY; POLYMORPHISM LINKAGE MAP; ABSCISIC-ACID; GUARD-CELLS; MOLECULAR-CLONING; STOMATAL CLOSURE; CYTOSOLIC CA-2+; K+ CHANNELS; GENE; CALCINEURIN	The plant hormone abscisic acid (ABA) mediates various responses such as stomatal closure, the maintenance of seed dormancy, and the inhibition of plant growth. All three responses are affected in the ABA-insensitive mutant abi1 of Arabidopsis thaliana, suggesting that an early step in the signaling of ABA is controlled by the ABI1 locus. The ABI1 gene was cloned by chromosome walking, and a missense mutation was identified in the structural gene of the abi1 mutant. The ABI1 gene encodes a protein with high similarity to protein serine or threonine phosphatases of type 2C with the novel feature of a putative Ca2+ binding site. Thus, the control of the phosphorylation state of cell signaling components by the ABI1 product could mediate pleiotropic hormone responses.	SWISS FED INST TECHNOL, INST PLANT SCI, CH-8092 ZURICH, SWITZERLAND	Swiss Federal Institutes of Technology Domain; ETH Zurich				Meyer, Knut/0000-0002-9534-2489				BAXENDALE S, 1991, NUCLEIC ACIDS RES, V19, P6651, DOI 10.1093/nar/19.23.6651; BLATT MR, 1993, ANNU REV PLANT PHYS, V44, P543, DOI 10.1146/annurev.pp.44.060193.002551; BLATT MR, 1990, NATURE, V346, P766, DOI 10.1038/346766a0; BURNS JM, 1993, J BIOL CHEM, V268, P17155; CHANG C, 1988, P NATL ACAD SCI USA, V85, P6856, DOI 10.1073/pnas.85.18.6856; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; DAVIES WJ, 1991, ABSCISIC ACID; ESTELLE MA, 1987, MOL GEN GENET, V206, P200, DOI 10.1007/BF00333575; FOOR F, 1992, NATURE, V360, P682; Gibson S. I., 1992, Methods in Arabidopsis research., P119; GILROY S, 1990, NATURE, V346, P769, DOI 10.1038/346769a0; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; GRILL E, 1991, MOL GEN GENET, V226, P484, DOI 10.1007/BF00260662; GRILL E, UNPUB; GUILTINAN MJ, 1990, SCIENCE, V250, P267, DOI 10.1126/science.2145628; HORNBERG C, 1984, NATURE, V310, P321, DOI 10.1038/310321a0; Huang H, 1992, PLANT MOL BIOL REP, V10, P372, DOI 10.1007/BF02668914; IRVING HR, 1992, P NATL ACAD SCI USA, V89, P1790, DOI 10.1073/pnas.89.5.1790; JENKINS GI, 1991, MOL BIOL PLANT DEV; KLEE HJ, 1987, MOL GEN GENET, V210, P282, DOI 10.1007/BF00325695; KOORNNEEF M, 1984, PHYSIOL PLANTARUM, V61, P377, DOI 10.1111/j.1399-3054.1984.tb06343.x; Koornneef M, 1984, ARABIDOPSIS INF SERV, V21, P5; LEUBE MP, UNPUB; LUAN S, 1993, P NATL ACAD SCI USA, V90, P2202, DOI 10.1073/pnas.90.6.2202; MAEDA T, 1993, MOL CELL BIOL, V13, P5408, DOI 10.1128/MCB.13.9.5408; MARCOTTE WR, 1989, PLANT CELL, V1, P969, DOI 10.2307/3868997; MCAINSH MR, 1990, NATURE, V343, P186, DOI 10.1038/343186a0; MCCARTY DR, 1991, CELL, V66, P895, DOI 10.1016/0092-8674(91)90436-3; MEYER KH, UNPUB; MUNDY J, 1990, P NATL ACAD SCI USA, V87, P1406, DOI 10.1073/pnas.87.4.1406; NAKAYAMA S, 1992, J MOL EVOL, V34, P416, DOI 10.1007/BF00162998; NAM HG, 1989, PLANT CELL, V1, P699, DOI 10.1105/tpc.1.7.699; OEDA K, 1991, EMBO J, V10, P1793, DOI 10.1002/j.1460-2075.1991.tb07704.x; OKEEFE SJ, 1992, NATURE, V357, P692, DOI 10.1038/357692a0; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; Sambrook J, 1989, MOL CLONING LABORATO; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; SCHROEDER JI, 1990, P NATL ACAD SCI USA, V87, P9305, DOI 10.1073/pnas.87.23.9305; SIMOENS C, 1986, NUCLEIC ACIDS RES, V14, P8073, DOI 10.1093/nar/14.20.8073; SKRIVER K, 1990, PLANT CELL, V2, P503, DOI 10.1105/tpc.2.6.503; STASKAWICZ B, 1987, J BACTERIOL, V169, P5789, DOI 10.1128/jb.169.12.5789-5794.1987; TAMURA S, 1989, P NATL ACAD SCI USA, V86, P1796, DOI 10.1073/pnas.86.6.1796; VALVEKENS D, 1988, P NATL ACAD SCI USA, V85, P5536, DOI 10.1073/pnas.85.15.5536; WARD ER, 1990, PLANT MOL BIOL, V14, P561, DOI 10.1007/BF00027501; ZAMBRYSKI P, 1983, EMBO J, V2, P2143, DOI 10.1002/j.1460-2075.1983.tb01715.x	46	604	639	6	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 3	1994	264	5164					1452	1455		10.1126/science.8197457	http://dx.doi.org/10.1126/science.8197457			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NP221	8197457				2022-12-28	WOS:A1994NP22100040
J	HEADRICK, LA; NEUHAUSER, D				HEADRICK, LA; NEUHAUSER, D			QUALITY HEALTH-CARE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPROVEMENT; MANAGEMENT				HEADRICK, LA (corresponding author), CASE WESTERN RESERVE UNIV,CLEVELAND,OH 44106, USA.							BATALDEN PB, 1993, MANUAL HLTH SERVICES; BERWICK DM, 1992, BRIT MED J, V304, P304, DOI 10.1136/bmj.304.6822.304; BERWICK DM, 1991, CURING HLTH CARE; BINGHAM J, 1993, MEASURING MANAGING H, V5, P35; BLUMENTHAL D, 1993, JAMA-J AM MED ASSOC, V269, P2775, DOI 10.1001/jama.269.21.2775; CLINE CB, 1993, QUAL MANAGE HLTH DEC; Deming EW., 1986, OUT CRISIS; ELLRODT AG, 1993, ACAD MED, V68, P817, DOI 10.1097/00001888-199311000-00002; HALLUM A, 1993, QUAL MANAGE HLTH DEC, P49; HEADRICK LA, 1992, ACAD MED, V67, P157, DOI 10.1097/00001888-199203000-00005; KIBBE DC, 1993, J FAM PRACTICE, V36, P304; MCEACHERN JE, 1991, J OCCUP ENVIRON MED, V33, P364; Pachciarz J A, 1992, QRB Qual Rev Bull, V18, P229; ZIMMERMAN MR, 1993, QUAL MANAGE HLTH CAR; 1993, QUAL MANAGE HLTH DEC; 1993, PRIMARY CARE PHYSICI	16	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1711	1712		10.1001/jama.271.21.1711	http://dx.doi.org/10.1001/jama.271.21.1711			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182866				2022-12-28	WOS:A1994NN11700045
J	LI, T; NICOLAOU, KC				LI, T; NICOLAOU, KC			CHEMICAL SELF-REPLICATION OF PALINDROMIC DUPLEX DNA	NATURE			English	Article							TEMPLATE-DIRECTED SYNTHESIS; TRIPLE-HELIX; HEXADEOXYNUCLEOTIDE; SYSTEMS; LINKAGE	MOLECULAR replication, a fundamental process of life, has in recent years been the subject of laboratory investigations using simple chemical systems(1-10). Whereas the work of Rebek's group(4,5) has focused on molecular architectures not known in living systems, self-replicating and template-based self-assembling systems based on nucleotides(6-8) are regarded as potential models for exploring the evolution of replicating systems on the early Earth. Previous replicating oligonucleotides have been of the single-stranded, self-complementary type: small oligonucleotide fragments are assembled on a pre-existing template and linked to form an exact copy of the template. This process cannot easily be reiterated, however, because of the strong binding of the newly formed strand to the original template. Furthermore, DNA replication in living systems operates by complementarity rather than self-complementarity-each newly assembled strand is complementary to, rather than identical to, its template-and the replication process starts and finishes with double helices. Here we report the self-replication of palindromic (symmetrical) duplex DNA-like oligonucleotides, 24 monomers long, in the absence of enzymes by means of a cycle that transfers information from template to copy and is potentially capable of extension to include non-symmetrical sequences, selection and mutation. Replication proceeds by a chemical process involving the formation of an intermediate triplex structure, and is sequence-selective in the sense that mismatches impair its efficiency. These results indicate that DNA-like double-helical molecules can replicate without assistance from proteins, a finding that may be relevant both to the appearance of replicating systems on the early Earth and to the development of new approaches to DNA amplification.	Scripps Res Inst, DEPT CHEM, LA JOLLA, CA 92037 USA; UNIV CALIF SAN DIEGO, DEPT CHEM, LA JOLLA, CA 92093 USA	Scripps Research Institute; University of California System; University of California San Diego			Li, Tianhu/G-3531-2010					ACEVEDO OL, 1987, J MOL BIOL, V197, P187, DOI 10.1016/0022-2836(87)90117-3; CHEN CB, 1985, J MOL BIOL, V181, P271, DOI 10.1016/0022-2836(85)90091-9; ESCHENMOSER A, 1992, CHEM SOC REV, V21, P1, DOI 10.1039/cs9922100001; ESCHENMOSER A, 1994, CHEM BIOL; FENG Q, 1992, SCIENCE, V256, P1179, DOI 10.1126/science.256.5060.1179; FERRIS JP, 1993, J AM CHEM SOC, V115, P12270, DOI 10.1021/ja00079a006; GEDULIN B, 1993, NOBEL S, V84, P91; GOODWIN JT, 1992, J AM CHEM SOC, V114, P9197, DOI 10.1021/ja00049a067; HOFFMANN S, 1992, ANGEW CHEM INT EDIT, V31, P1013, DOI 10.1002/anie.199210131; HUNZIKER J, 1993, HELV CHIM ACTA, V76, P259, DOI 10.1002/hlca.19930760119; INOUE T, 1983, SCIENCE, V219, P859, DOI 10.1126/science.6186026; JOYCE GF, 1989, NATURE, V338, P217, DOI 10.1038/338217a0; KANAVARIOTI A, 1992, J THEOR BIOL, V158, P207, DOI 10.1016/S0022-5193(05)80719-2; KANAVARIOTI A, 1993, J AM CHEM SOC, V115, P8537, DOI 10.1021/ja00072a003; KANAYA E, 1986, BIOCHEMISTRY-US, V25, P7423, DOI 10.1021/bi00371a026; LEUBKE KJ, 1989, J AM CHEM SOC, V111, P8733; MAHER LJ, 1990, BIOCHEMISTRY-US, V29, P8820, DOI 10.1021/bi00489a045; MILLER SL, 1987, COLD SPRING HARB SYM, V52, P17, DOI 10.1101/SQB.1987.052.01.005; ORGEL LE, 1992, NATURE, V358, P203, DOI 10.1038/358203a0; TJIVIKUA T, 1990, J AM CHEM SOC, V112, P1249, DOI 10.1021/ja00159a057; VONKIEDROWSKI G, 1991, ANGEW CHEM INT EDIT, V30, P423, DOI 10.1002/anie.199104231; VONKIEDROWSKI G, 1986, ANGEW CHEM INT EDIT, V25, P932, DOI 10.1002/anie.198609322; VONKIEDROWSKI G, 1989, ANGEW CHEM INT EDIT, V28, P1235, DOI 10.1002/anie.198912351	23	177	185	2	31	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 19	1994	369	6477					218	221		10.1038/369218a0	http://dx.doi.org/10.1038/369218a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NM067	8183341				2022-12-28	WOS:A1994NM06700051
J	TULP, A; VERWOERD, D; DOBBERSTEIN, B; PLOEGH, HL; PIETERS, J				TULP, A; VERWOERD, D; DOBBERSTEIN, B; PLOEGH, HL; PIETERS, J			ISOLATION AND CHARACTERIZATION OF THE INTRACELLULAR MHC CLASS-II COMPARTMENT	NATURE			English	Article							HLA-DR MOLECULES; INVARIANT CHAIN; HISTOCOMPATIBILITY ANTIGENS; TRANSFERRIN RECEPTOR; SURFACE EXPRESSION; FUSION INVITRO; EARLY ENDOSOME; CELL LINE; TRANSPORT; BINDING	An intracellular compartment has been isolated to which MHC class II molecules are transported on their way to the plasma membrane. They arrive with an associated invariant chain which is then proteolytically processed while MHC class II molecules acquire antigenic peptide. These loaded class II molecules then leave the compartment devoid of invariant chain and bound for the plasma membrane. This compartment represents a new stage in the endocytic/lysosomal pathway.	NETHERLANDS CANC INST,DEPT IMMUNOL,1066 CX AMSTERDAM,NETHERLANDS; NETHERLANDS CANC INST,DEPT CELLULAR BIOCHEM,1066 CX AMSTERDAM,NETHERLANDS; UNIV HEIDELBERG,ZENTRUM MOLEK BIOL,W-6900 HEIDELBERG,GERMANY; MIT,CTR CANC RES,DEPT BIOL,CAMBRIDGE,MA 02139	Netherlands Cancer Institute; Netherlands Cancer Institute; Ruprecht Karls University Heidelberg; Massachusetts Institute of Technology (MIT)				Pieters, Jean/0000-0002-5284-9757				ANDERSON MS, 1992, P NATL ACAD SCI USA, V89, P2282, DOI 10.1073/pnas.89.6.2282; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREW K, 1975, J BIOL CHEM, V250, P1434; CHEN QY, 1992, INT J CANCER, V51, P218, DOI 10.1002/ijc.2910510209; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; CRESSWELL P, 1987, CRIT REV IMMUNOL, V7, P31; FEANY MB, 1993, NATURE, V364, P537, DOI 10.1038/364537a0; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; GERMAIN RN, 1993, NATURE, V363, P725, DOI 10.1038/363725a0; GERMAIN RN, 1991, NATURE, V353, P134, DOI 10.1038/353134a0; GEUZE HJ, 1983, CELL, V32, P277, DOI 10.1016/0092-8674(83)90518-4; GODA Y, 1988, CELL, V55, P309, DOI 10.1016/0092-8674(88)90054-2; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; GRUENBERG J, 1989, J CELL BIOL, V108, P1301, DOI 10.1083/jcb.108.4.1301; GUAGLIARDI LE, 1990, NATURE, V343, P133, DOI 10.1038/343133a0; HANNIG K, 1977, CELL SEPARATION METH, V6, P95; HARDING CV, 1993, J IMMUNOL, V151, P3988; HOPKINS CR, 1983, J CELL BIOL, V97, P508, DOI 10.1083/jcb.97.2.508; HOPKINS CR, 1990, NATURE, V346, P335, DOI 10.1038/346335a0; HUBBARD AL, 1975, J CELL BIOL, V64, P438, DOI 10.1083/jcb.64.2.438; KELLY RB, 1993, NATURE, V364, P487, DOI 10.1038/364487a0; KOLDOVSKY O, 1971, BIOCHEM J, V125, P697, DOI 10.1042/bj1250697; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; KVIST S, 1982, CELL, V29, P61, DOI 10.1016/0092-8674(82)90090-3; LAMPSON LA, 1980, J IMMUNOL, V125, P293; LANZAVECCHIA A, 1992, NATURE, V357, P249, DOI 10.1038/357249a0; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MARSH M, 1987, J CELL BIOL, V104, P875, DOI 10.1083/jcb.104.4.875; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; NEEFJES JJ, 1992, EMBO J, V11, P411, DOI 10.1002/j.1460-2075.1992.tb05069.x; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; PARHAM P, 1979, J IMMUNOL, V123, P342; PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0; PIETERS J, 1991, J CELL BIOL, V115, P1213, DOI 10.1083/jcb.115.5.1213; PIETERS J, 1993, J CELL SCI, V106, P831; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; SADEGHNASSERI S, 1991, NATURE, V353, P167, DOI 10.1038/353167a0; SCHMID SL, 1988, CELL, V52, P73, DOI 10.1016/0092-8674(88)90532-6; SHAW S, 1985, HUM IMMUNOL, V12, P191, DOI 10.1016/0198-8859(85)90336-2; TEYTON L, 1990, NATURE, V348, P39, DOI 10.1038/348039a0; Teyton L, 1992, Trends Cell Biol, V2, P52, DOI 10.1016/0962-8924(92)90163-H; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TULP A, 1993, ELECTROPHORESIS, V14, P1295, DOI 10.1002/elps.11501401198; UNANUE ER, 1984, ANNU REV IMMUNOL, V2, P395, DOI 10.1146/annurev.iy.02.040184.002143; VANDERIJN M, 1983, CYTOGENET CELL GENET, V36, P525, DOI 10.1159/000131967	49	407	411	0	6	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 12	1994	369	6476					120	126		10.1038/369120a0	http://dx.doi.org/10.1038/369120a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NK971	8177317	Green Submitted			2022-12-28	WOS:A1994NK97100040
J	PATCHETT, P; ROBERTS, D				PATCHETT, P; ROBERTS, D			LESSON OF THE WEEK - DIABETIC-PATIENTS WHO DO NOT HAVE DIABETES - INVESTIGATION OF REGISTER OF DIABETIC-PATIENTS IN GENERAL-PRACTICE	BRITISH MEDICAL JOURNAL			English	Article							IMPAIRED GLUCOSE-TOLERANCE				PATCHETT, P (corresponding author), WATERLOO HOUSE SURG,MILLOM LA18 4DE,CUMBRIA,ENGLAND.							GIBBINS RL, 1988, BRIT MED J, V297, P187, DOI 10.1136/bmj.297.6642.187; HARRIS MI, 1985, DIABETES CARE, V8, P562, DOI 10.2337/diacare.8.6.562; HARRIS MI, 1992, INT TXB DIABETES MEL, V1, P3; HURWITZ B, 1993, BRIT MED J, V306, P624, DOI 10.1136/bmj.306.6878.624; KEMPLE TJ, 1991, BRIT MED J, V302, P451, DOI 10.1136/bmj.302.6774.451; KIPENSKI M, 1992, BR J GEN PRACT, V42, P508; MARBLE D, 1985, JOSLINS DIABETES MEL, P339; NABARRO J, 1987, J ROY COLL GEN PRACT, V37, P389; OBRIEN E, 1988, BRIT MED J, V297, P1211, DOI 10.1136/bmj.297.6658.1211; ODONNELL MJ, 1988, DIABETIC MED, V5, P494, DOI 10.1111/j.1464-5491.1988.tb01034.x; ROBERTSON DA, 1992, BRIT MED J, V305, P635, DOI 10.1136/bmj.305.6854.635; YUDKIN JS, 1990, BRIT MED J, V301, P397, DOI 10.1136/bmj.301.6749.397	12	6	6	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 7	1994	308	6938					1225	1226		10.1136/bmj.308.6938.1225	http://dx.doi.org/10.1136/bmj.308.6938.1225			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK956	8180544	Green Published			2022-12-28	WOS:A1994NK95600027
J	GAFVELIN, G; VONHEIJNE, G				GAFVELIN, G; VONHEIJNE, G			TOPOLOGICAL FRUSTRATION IN MULTISPANNING ESCHERICHIA-COLI INNER MEMBRANE-PROTEINS	CELL			English	Article							CHARGED AMINO-ACIDS; ESCHERICHIA-COLI; LEADER PEPTIDASE; PLASMA-MEMBRANE; INSERTION; DOMAIN; SEQUENCE; EXPORT; GENE; SECA	The topology of E. coli inner membrane proteins depends primarily on the distribution of positively charged residues in the molecule. We have constructed model proteins with four potential transmembrane stretches and have systematically explored the topological effects of lysines placed in the loops connecting the transmembrane spans. Our results indicate that membrane insertion is locally determined, with individual ''helical hairpins'' inserting independently of each other. Topologically ''frustrated'' molecules, where the charge distribution is such that different parts of the molecule would prefer to insert with incompatible orientations, adopt ''leave-one-out'' topologies in which only 3 of the 4 potential transmembrane stretches span the membrane. These results are relevant for our general understanding of both membrane protein biogenesis and the evolution of multispanning membrane proteins.			GAFVELIN, G (corresponding author), KAROLINSKA INST,NOVUM,CTR STRUCT BIOCHEM,S-14157 HUDDINGE,SWEDEN.		von Heijne, Gunnar/AAH-9389-2019; von Heijne, Gunnar/F-5576-2011	von Heijne, Gunnar/0000-0002-4490-8569				ANDERSSON H, 1993, J BIOL CHEM, V268, P21389; ANDERSSON H, 1992, J BIOL CHEM, V267, P1491; ANDERSSON H, 1993, EMBO J, V12, P683, DOI 10.1002/j.1460-2075.1993.tb05702.x; BABA T, 1990, J BACTERIOL, V172, P7005, DOI 10.1128/jb.172.12.7005-7010.1990; BIBI E, 1991, P NATL ACAD SCI USA, V88, P7271, DOI 10.1073/pnas.88.16.7271; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BOYD D, 1990, CELL, V62, P1031, DOI 10.1016/0092-8674(90)90378-R; DALBEY RE, 1987, SCIENCE, V235, P783, DOI 10.1126/science.3544218; DALBEY RE, 1986, J BIOL CHEM, V261, P3844; EHRMANN M, 1991, J BIOL CHEM, V266, P16530; ENGELMAN DM, 1981, CELL, V23, P411, DOI 10.1016/0092-8674(81)90136-7; GEISSELSODER J, 1987, BIOTECHNIQUES, V5, P786; HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786; JOHNSTON S, 1985, GENE, V34, P137, DOI 10.1016/0378-1119(85)90121-0; KUHN A, 1988, EUR J BIOCHEM, V177, P267, DOI 10.1111/j.1432-1033.1988.tb14372.x; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LEE JI, 1992, J BIOL CHEM, V267, P938; MCGOVERN K, 1991, EMBO J, V10, P2773, DOI 10.1002/j.1460-2075.1991.tb07826.x; NILSSON IM, 1990, CELL, V62, P1135, DOI 10.1016/0092-8674(90)90390-Z; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; SCHMIDT MG, 1988, J BACTERIOL, V170, P3404, DOI 10.1128/jb.170.8.3404-3414.1988; SIPOS L, 1993, EUR J BIOCHH, V213, P1133; TAYLOR EW, 1993, FEBS LETT, V325, P161, DOI 10.1016/0014-5793(93)81065-8; VONHEIJNE G, 1988, P NATL ACAD SCI USA, V85, P3363; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; VONHEIJNE G, 1994, IN PRESS ANN REV BIO, V23; WOLFE PB, 1983, J BIOL CHEM, V258, P2073; WOLFE PB, 1985, J BIOL CHEM, V260, P1836	31	141	142	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 6	1994	77	3					401	412		10.1016/0092-8674(94)90155-4	http://dx.doi.org/10.1016/0092-8674(94)90155-4			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NK970	8181060				2022-12-28	WOS:A1994NK97000011
J	BLANKENHORN, DH; AZEN, SP; KRAMSCH, DM; MACK, WJ; CASHINHEMPHILL, L; HODIS, HN; DEBOER, LWV; MAHRER, PR; MASTELLER, MJ; VAILAS, LI; ALAUPOVIC, P; HIRSCH, LJ				BLANKENHORN, DH; AZEN, SP; KRAMSCH, DM; MACK, WJ; CASHINHEMPHILL, L; HODIS, HN; DEBOER, LWV; MAHRER, PR; MASTELLER, MJ; VAILAS, LI; ALAUPOVIC, P; HIRSCH, LJ			CORONARY ANGIOGRAPHIC CHANGES WITH LOVASTATIN THERAPY - THE MONITORED ATHEROSCLEROSIS REGRESSION STUDY (MARS)	ANNALS OF INTERNAL MEDICINE			English	Article						LOVASTATIN; ATHEROSCLEROSIS; CORONARY ANGIOGRAPHY; CHOLESTEROL, DIETARY; LIPIDS AND ANTILIPEMIC AGENTS	ARTERY DISEASE; COLESTIPOL-NIACIN; HEART-DISEASE; PROGRESSION; HYPERCHOLESTEROLEMIA; DIET; CHOLESTYRAMINE; INTERVENTION; LIPOPROTEINS	Objective: To assess the effects of lipid-lowering therapy with lovastatin on coronary angiographic findings in patients with coronary artery disease and to compare the findings with those of two lipid-lowering angiographic trials using similar end points. Design: Randomized, double-blind, placebo-controlled, multicenter coronary angiographic trial. Setting: Community- and university-based cardiac catheterization laboratories. Participants: A total of 270 patients, 37 to 67 years old, with total cholesterol ranging from 4.92 to 7.64 mmol/L (190 to 295 mg/dL) and angiographically defined coronary artery disease. Intervention: A cholesterol-lowering diet and either lovastatin, 80 mg/day, or placebo. Outcome: Per-patient change in percent diameter stenosis as determined by quantitative coronary angiography (primary end point). Global change score, based on the consensus of blinded expert readers regarding angiographic change (secondary endpoint). Results: Lovastatin lowered total cholesterol level by 32%, low-density lipoprotein cholesterol by 38%, and the apolipoprotein B by 26% and raised the high-density lipoprotein cholesterol by 8.5% (P < 0.001). Average percent diameter stenosis increased 2.2% in placebo recipients and 1.6% in lovastatin recipients (P > 0.20). For lesions 50% or greater, average percent diameter stenosis increased 0.9% in placebo recipients and decreased 4.1% in lovastatin recipients (P = 0.005). The mean global change score was +0.9 (indicating progression) in the placebo group and +0.4 in the lovastatin group (P = 0.002); 13 placebo recipients and 28 lovastatin recipients had global change scores indicating regression (P < 0.02). Conclusion: Treatment with lovastatin plus diet slows the rate of progression and increases the frequency of regression in coronary artery lesions (by global change score), especially in more severe lesions (by quantitative angiography). This is the third lipid-lowering trial to show a benefit using the global change score, an end point predictive of clinical coronary events. Differences between two of these trials, using quantitative coronary angiographic end points, may have theoretical bearing on the mechanisms by which lipid-lowering therapy operates at the level of the arterial wall.	DEPT PREVENT MED, 1420 SAN PABLO ST, PMB B101, LOS ANGELES, CA 90033 USA						NHLBI NIH HHS [NHLBI-1-HL45005] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045005] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ARNTZENIUS AC, 1985, NEW ENGL J MED, V312, P805, DOI 10.1056/NEJM198503283121301; AZEN SP, 1991, ARTERIOSCLER THROMB, V11, P385, DOI 10.1161/01.ATV.11.2.385; BLANKENHORN DH, 1987, JAMA-J AM MED ASSOC, V257, P3233, DOI 10.1001/jama.257.23.3233; BRADFORD RH, 1991, ARCH INTERN MED, V151, P43, DOI 10.1001/archinte.151.1.43; BRENSIKE JF, 1984, CIRCULATION, V69, P313, DOI 10.1161/01.CIR.69.2.313; BROWN BG, 1993, CIRCULATION, V87, P1781, DOI 10.1161/01.CIR.87.6.1781; BROWN G, 1990, NEW ENGL J MED, V323, P1289, DOI 10.1056/NEJM199011083231901; BUCHWALD H, 1992, JAMA-J AM MED ASSOC, V268, P1429, DOI 10.1001/jama.268.11.1429; BUCHWALD H, 1990, NEW ENGL J MED, V323, P946, DOI 10.1056/NEJM199010043231404; CASHINHEMPHILL L, 1990, JAMA-J AM MED ASSOC, V264, P3013, DOI 10.1001/jama.264.23.3013; CASHINHEMPHILL L, 1992, MONITORED ATHEROSCLE; CHYLACK LT, 1988, ARCH OPHTHALMOL-CHIC, V106, P330; DAVIES MJ, 1991, BRIT HEART J, V65, P302; FALK E, 1992, CIRCULATION, V86, P30; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; KANE JP, 1990, JAMA-J AM MED ASSOC, V264, P3007, DOI 10.1001/jama.264.23.3007; LOSCALZO J, 1990, NEW ENGL J MED, V323, P1337, DOI 10.1056/NEJM199011083231909; MACK WJ, 1992, ARTERIOSCLER THROMB, V12, P348, DOI 10.1161/01.ATV.12.3.348; NIKKILA EA, 1984, BMJ-BRIT MED J, V289, P220, DOI 10.1136/bmj.289.6439.220; ORNISH D, 1990, LANCET, V336, P129, DOI 10.1016/0140-6736(90)91656-U; SCHULER G, 1992, CIRCULATION, V86, P1, DOI 10.1161/01.CIR.86.1.1; SMITH GD, 1992, BMJ-BRIT MED J, V304, P431, DOI 10.1136/bmj.304.6824.431; WATERS D, 1993, CIRCULATION, V87, P1067, DOI 10.1161/01.CIR.87.4.1067; WATTS GF, 1992, LANCET, V339, P563, DOI 10.1016/0140-6736(92)90863-X	24	558	574	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1993	119	10					969	976		10.7326/0003-4819-119-10-199311150-00002	http://dx.doi.org/10.7326/0003-4819-119-10-199311150-00002			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MG672	8214993				2022-12-28	WOS:A1993MG67200002
J	OTA, IM; VARSHAVSKY, A				OTA, IM; VARSHAVSKY, A			A YEAST PROTEIN SIMILAR TO BACTERIAL 2-COMPONENT REGULATORS	SCIENCE			English	Article							N-END RULE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; SHUTTLE VECTORS; SIGNAL; GENES; FAMILY; DNA; PHOSPHORYLATION; POLYSACCHARIDE	Many bacterial signaling pathways involve a two-component design. In these pathways, a sensor kinase, when activated by a signal, phosphorylates its own histidine, which then serves as a phosphoryl donor to an aspartate in a response regulator protein. The Sln1 protein of the yeast Saccharomyces cerevisiae has sequence similarities to both the histidine kinase and the response regulator proteins of bacteria. A missense mutation in SLN1 is lethal in the absence but not in the presence of the N-end rule pathway, a ubiquitin-dependent proteolytic system. The finding of SLN1 demonstrates that a mode of signal transduction similar to the bacterial two-component design operates in eukaryotes as well.	CALTECH, DIV BIOL, PASADENA, CA 91125 USA	California Institute of Technology								ALBRIGHT LM, 1989, ANNU REV GENET, V23, P311, DOI 10.1146/annurev.ge.23.120189.001523; ALEX L, COMMUNICATION; Ausubel FM., 1988, CURRENT PROTOCOLS MO; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BARKER WC, 1992, NUCLEIC ACIDS RES, V20, P2023, DOI 10.1093/nar/20.suppl.2023; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; BASSON ME, 1987, GENETICS, V117, P645; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BOURRET RB, 1991, ANNU REV BIOCHEM, V60, P401, DOI 10.1146/annurev.bi.60.070191.002153; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; FINLEY D, 1989, NATURE, V338, P394, DOI 10.1038/338394a0; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; GOTTESMAN S, 1991, MOL MICROBIOL, V5, P1599, DOI 10.1111/j.1365-2958.1991.tb01906.x; GROSS R, 1989, MOL MICROBIOL, V3, P1661, DOI 10.1111/j.1365-2958.1989.tb00152.x; HAZELBAUER GL, 1993, CELL, V73, P15, DOI 10.1016/0092-8674(93)90156-K; HRABAK EM, 1992, J BACTERIOL, V174, P3011, DOI 10.1128/JB.174.9.3011-3020.1992; HUANG JM, 1991, J BIOL CHEM, V266, P9023; JOHNSON ES, 1990, NATURE, V346, P287, DOI 10.1038/346287a0; KOSHLAND DE, 1988, BIOCHEMISTRY-US, V27, P5829, DOI 10.1021/bi00416a001; LIN ECC, 1991, ANNU REV GENET, V25, P361, DOI 10.1146/annurev.ge.25.120191.002045; MADURA K, 1993, J BIOL CHEM, V268, P12046; MAGASANIK B, 1988, TRENDS BIOCHEM SCI, V13, P475, DOI 10.1016/0968-0004(88)90234-4; NAGASAWA S, 1992, MOL MICROBIOL, V6, P799, DOI 10.1111/j.1365-2958.1992.tb01530.x; OTA IM, 1992, P NATL ACAD SCI USA, V89, P2355, DOI 10.1073/pnas.89.6.2355; OZKAYNAK E, 1987, EMBO J, V6, P1429, DOI 10.1002/j.1460-2075.1987.tb02384.x; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; POPOV KM, 1992, J BIOL CHEM, V267, P13127; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; SCHNEIDERPOETSCH HAW, 1992, PHOTOCHEM PHOTOBIOL, V56, P839, DOI 10.1111/j.1751-1097.1992.tb02241.x; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SHRADER TE, 1993, J BACTERIOL, V175, P4364, DOI 10.1128/JB.175.14.4364-4374.1993; SIKORSKI RS, 1989, GENETICS, V122, P19; STOCK JB, 1991, ANNU REV BIOPHYS BIO, V20, P109, DOI 10.1146/annurev.bb.20.060191.000545; STRUHL K, 1979, P NATL ACAD SCI USA, V76, P1035, DOI 10.1073/pnas.76.3.1035; TANG JL, 1991, MOL GEN GENET, V226, P409, DOI 10.1007/BF00260653; VARSHAVSKY A, 1992, CELL, V69, P725, DOI 10.1016/0092-8674(92)90285-K; WANNER BL, 1992, J BACTERIOL, V174, P2053, DOI 10.1128/JB.174.7.2053-2058.1992	38	370	383	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	1993	262	5133					566	569		10.1126/science.8211183	http://dx.doi.org/10.1126/science.8211183			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC935	8211183				2022-12-28	WOS:A1993MC93500040
J	POTASHKIN, J; NAIK, K; WENTZHUNTER, K				POTASHKIN, J; NAIK, K; WENTZHUNTER, K			U2AF HOMOLOG REQUIRED FOR SPLICING IN-VIVO	SCIENCE			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; MESSENGER-RNA INTRONS; BIOCHEMICAL-CHARACTERIZATION; AUXILIARY FACTOR; A-PROTEIN; U1 RNA; COMPLEX; BINDING; IDENTIFICATION; RECOGNITION	Several fission yeast temperature-sensitive mutants defective in pre-mRNA processing (prp- mutants) at the nonpermissive temperature have been identified. Here, the prp2+ gene has been cloned by its ability to complement the temperature-sensitive growth defect of a prp2- mutant. The gene also corrects the pre-mRNA splicing defect of prp2- mutants and encodes a 59-kilodalton polypeptide (PRP2). A molecular characterization indicates that PRP2 is a previously uncharacterized yeast splicing factor with extensive similarity to the mammalian splicing factor U2AF65. Thus, this study provides evidence that a U2AF homolog participates in RNA processing in vivo.			POTASHKIN, J (corresponding author), UNIV HLTH SCI CHICAGO MED SCH, DEPT PHARMACOL & MOLEC BIOL, N CHICAGO, IL 60064 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047487] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01GM47487] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BRODY E, 1985, SCIENCE, V228, P963, DOI 10.1126/science.3890181; CHOU PY, 1978, ANNU REV BIOCHEM, V47, P251, DOI 10.1146/annurev.bi.47.070178.001343; CSANK C, 1990, NUCLEIC ACIDS RES, V18, P5133, DOI 10.1093/nar/18.17.5133; FRENDEWEY D, 1985, CELL, V42, P355, DOI 10.1016/S0092-8674(85)80131-8; GEORGE DG, 1990, METHOD ENZYMOL, V183, P333; GRABOWSKI PJ, 1985, CELL, V42, P345, DOI 10.1016/S0092-8674(85)80130-6; HAYNES SR, 1992, NEW BIOL, V4, P421; KAUFER NF, 1985, NATURE, V318, P78, DOI 10.1038/318078a0; KENAN DJ, 1991, TRENDS BIOCHEM SCI, V16, P214, DOI 10.1016/0968-0004(91)90088-D; LI H, 1991, CELL, V67, P335, DOI 10.1016/0092-8674(91)90185-2; LUTZFREYERMUTH C, 1990, P NATL ACAD SCI USA, V87, P6393, DOI 10.1073/pnas.87.16.6393; MORENO S, 1991, METHOD ENZYMOL, V194, P795; POTASHKIN J, 1989, EMBO J, V8, P551, DOI 10.1002/j.1460-2075.1989.tb03409.x; POTASHKIN J, UNPUB; PRABHALA G, 1992, YEAST, V8, P171, DOI 10.1002/yea.320080303; QUERY CC, 1989, CELL, V57, P89, DOI 10.1016/0092-8674(89)90175-X; ROSENBERG GH, 1991, MOL GEN GENET, V226, P305, DOI 10.1007/BF00273617; RUSKIN B, 1988, CELL, V52, P207, DOI 10.1016/0092-8674(88)90509-0; RUSSELL P, 1989, MOL BIOL FISSION YEA, P244; RYMOND BC, 1992, MOL CELLULAR BIOL YE, P143; SCHERLY D, 1989, EMBO J, V8, P4163, DOI 10.1002/j.1460-2075.1989.tb08601.x; ZAHLER AM, 1993, SCIENCE, V260, P219, DOI 10.1126/science.8385799; ZAMORE PD, 1991, EMBO J, V10, P207, DOI 10.1002/j.1460-2075.1991.tb07937.x; ZAMORE PD, 1992, NATURE, V355, P609, DOI 10.1038/355609a0; ZAMORE PD, 1989, P NATL ACAD SCI USA, V86, P9243, DOI 10.1073/pnas.86.23.9243	25	93	95	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	1993	262	5133					573	575		10.1126/science.8211184	http://dx.doi.org/10.1126/science.8211184			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC935	8211184				2022-12-28	WOS:A1993MC93500042
J	GOUVERNEUR, VE; HOUK, KN; DEPASCUALTERESA, B; BENO, B; JANDA, KD; LERNER, RA				GOUVERNEUR, VE; HOUK, KN; DEPASCUALTERESA, B; BENO, B; JANDA, KD; LERNER, RA			CONTROL OF THE EXO-PATHWAY AND ENDO-PATHWAY OF THE DIELS-ALDER REACTION BY ANTIBODY CATALYSIS	SCIENCE			English	Article							SYNTHETIC APPLICATIONS; TRANSITION STRUCTURES; TRANS-1-N-ACYLAMINO-1,3-DIENES; N-ACYLAMINO-1,3-DIENES; STEREOSELECTIVITY; SUBSTITUENT; BUTADIENE	Catalytic antibodies that control the reaction pathways of the Diels-Alder cycloaddition have been generated. One antibody catalyzes the favored endo and the other the disfavored exo pathway to yield the respective cis and trans adducts in enantiomerically pure form. A comparison of the x-ray structure of the hapten with the calculated geometry of the transition structure showed that [2.2.2] bicyclic compounds are excellent mimics of the transition state of the Diels-Alder reaction. To achieve catalysis and the high degree of stereoselectivity shown here, the antibody must simultaneously control the conformation of the individual reactants and their relation to each other. In the case of the disfavored process, binding energy must be used to reroute the reaction along a higher energy pathway. The rerouting of reaction pathways has become a major focus of antibody catalysis and other disfavored reactions can be expected to be catalyzed so long as the energy barrier is not extreme. The energy requirements needed for absolute control of all of the stereoisomers of many Diels-Alder reactions fall in the energy range (approximately 20 kilocalories per mole) deliverable by antibody binding.	SCRIPPS RES INST, DEPT CHEM, LA JOLLA, CA 92037 USA; UNIV CALIF LOS ANGELES, DEPT CHEM & BIOCHEM, LOS ANGELES, CA 90024 USA	Scripps Research Institute; University of California System; University of California Los Angeles	GOUVERNEUR, VE (corresponding author), SCRIPPS RES INST, DEPT MOLEC BIOL, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA.		de Pascual-Teresa, Beatriz/J-4318-2012	de Pascual-Teresa, Beatriz/0000-0002-1101-0373				BERNARDI F, 1988, J AM CHEM SOC, V110, P3050, DOI 10.1021/ja00218a009; BRAISTED AC, 1990, J AM CHEM SOC, V112, P7430, DOI 10.1021/ja00176a073; BROWN FK, 1984, TETRAHEDRON LETT, V25, P4609, DOI 10.1016/S0040-4039(01)91212-2; Carruthers W., 1990, CYCLOADDITION REACTI; DANISHEFSKY S, 1979, J ORG CHEM, V44, P1180, DOI 10.1021/jo01321a040; Desimoni G., 1983, ACS MONOGRAPH, V180; Diels O, 1928, LIEBIGS ANN CHEM, V460, P98; Diels O, 1925, LIEBIGS ANN CHEM, V443, P242; Engvall E, 1980, Methods Enzymol, V70, P419; FRIGUELLI F, 1990, DIENES DIELS ADLER R; Frisch M. J, 1992, GAUSSIAN 92; HILVERT D, 1989, J AM CHEM SOC, V111, P9261, DOI 10.1021/ja00208a037; HOUK KN, 1989, J AM CHEM SOC, V111, P9172, DOI 10.1021/ja00208a006; JANDA KD, 1993, SCIENCE, V259, P490, DOI 10.1126/science.8424171; KAGAN HB, 1992, CHEM REV, V92, P1007, DOI 10.1021/cr00013a013; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; LONCHARICH RJ, 1989, J ORG CHEM, V54, P1129, DOI 10.1021/jo00266a026; OVERMAN CLE, 1977, TETRAHEDRON LETT, P1253; OVERMAN LE, 1980, J AM CHEM SOC, V102, P1454, DOI 10.1021/ja00524a057; OVERMAN LE, 1983, J AM CHEM SOC, V105, P5373, DOI 10.1021/ja00354a031; OVERMAN LE, 1978, J ORG CHEM, V43, P2164, DOI 10.1021/jo00405a017; OVERMAN LE, 1978, J AM CHEM SOC, V100, P3182, DOI 10.1021/ja00478a038; OVERMAN LE, 1981, J AM CHEM SOC, V103, P2816, DOI 10.1021/ja00400a054; OVERMAN LE, 1979, J ORG CHEM, V44, P4183, DOI 10.1021/jo01337a036; OVERMAN LE, 1978, J AM CHEM SOC, V100, P5179, DOI 10.1021/ja00484a046; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; PINDUR U, 1993, CHEM REV, V93, P741, DOI 10.1021/cr00018a006; SUCKLING CJ, 1992, BIOORG MED CHEM LETT, V2, P49, DOI 10.1016/S0960-894X(00)80653-8; TROST BM, 1991, COMPREHENSIVE ORGANI, V5, P316	29	200	202	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 8	1993	262	5131					204	208		10.1126/science.8211138	http://dx.doi.org/10.1126/science.8211138			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	MA665	8211138				2022-12-28	WOS:A1993MA66500024
J	WANG, TC; CARDIFF, RD; ZUKERBERG, L; LEES, E; ARNOLD, A; SCHMIDT, EV				WANG, TC; CARDIFF, RD; ZUKERBERG, L; LEES, E; ARNOLD, A; SCHMIDT, EV			MAMMARY HYPERPLASIA AND CARCINOMA IN MMTV-CYCLIN D1 TRANSGENIC MICE	NATURE			English	Article							CELL-CYCLE; MOUSE STRAIN; ONCOGENE; PROTEIN; EXPRESSION; GENE; INT-2; CHROMOSOME-11Q13; OVEREXPRESSION; ABNORMALITIES	Physical associations between cyclins, viral oncogenes and tumour suppressor genes imply a central role for cyclins in growth control(1,2). Cyclin D1 was identified as a candidate oncogene (PRAD1) in tumour-specific DNA rearrangements(3,4) and is suspected to be a contributor to several types of neoplasms including breast cancer(5,6). Cyclin D1 also rescues G1 cyclin-defective Saccharomyces cerevisiae(7), and is a growth-regulated genes. Despite evidence suggesting that cyclin D1 is an oncogene, its ability to transform cells directly in culture remains controversial(9-16). To evaluate its potential to deregulate growth in vivo in a physiologically relevant tissue we overexpressed cyclin D1 in mammary cells in transgenic mice. We report here that overexpression of cyclin D1 resulted in abnormal mammary cell proliferation including the development of mammary adenocarcinomas. We conclude that overexpression of cyclin D1 deregulates cell proliferation and can induce tumorigenic changes in mammary tissues, suggesting that cyclin D1 indeed plays an important oncogenic role in breast cancer.	MASSACHUSETTS GEN HOSP, CTR CANC, BOSTON, MA 02129 USA; UNIV CALIF DAVIS, SCH MED, DEPT PATHOL, DAVIS, CA 95616 USA; MASSACHUSETTS GEN HOSP, DEPT MED, ENDOCRINE ONCOL LAB, BOSTON, MA 02114 USA; MASSACHUSETTS GEN HOSP, CTR CANC, BOSTON, MA 02114 USA; MASSACHUSETTS GEN HOSP, DEPT PATHOL, BOSTON, MA 02114 USA; MASSACHUSETTS GEN HOSP, CHILDRENS SERV, BOSTON, MA 02129 USA; MASSACHUSETTS GEN HOSP, DEPT MED, GASTROINTESTINAL UNIT, BOSTON, MA 02114 USA	Harvard University; Massachusetts General Hospital; University of California System; University of California Davis; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital								BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; BORG A, 1991, BRIT J CANCER, V63, P136, DOI 10.1038/bjc.1991.28; CASEY G, 1986, MOL CELL BIOL, V6, P502, DOI 10.1128/MCB.6.2.502; FAHA B, 1992, SCIENCE, V255, P87, DOI 10.1126/science.1532458; HINDS PW, 1994, P NATL ACAD SCI USA, V91, P709, DOI 10.1073/pnas.91.2.709; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; JIANG W, 1993, ONCOGENE, V8, P3447; LAMMIE GA, 1991, CANCER CELL-MON REV, V3, P413; LAMMIE GA, 1991, ONCOGENE, V6, P439; LOVEC H, 1994, ONCOGENE, V9, P323; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; MORRIS DW, 1990, J VIROL, V64, P1794, DOI 10.1128/JVI.64.4.1794-1802.1990; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; PATHAK VK, 1987, J NATL CANCER I, V78, P327; PETERS G, 1989, P NATL ACAD SCI USA, V86, P5678, DOI 10.1073/pnas.86.15.5678; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; ROSEN PP, 1993, CANCER, V71, P3798, DOI 10.1002/1097-0142(19930615)71:12<3798::AID-CNCR2820711203>3.0.CO;2-S; ROSENBERG CL, 1991, P NATL ACAD SCI USA, V88, P9638, DOI 10.1073/pnas.88.21.9638; ROSENWALD IB, 1993, MOL CELL BIOL, V13, P7358, DOI 10.1128/MCB.13.12.7358; SCHUURING E, 1992, ONCOGENE, V7, P355; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0; YOSHIDA T, 1987, P NATL ACAD SCI USA, V84, P7305, DOI 10.1073/pnas.84.20.7305; YUE X, 1991, CELL, V65, P691, DOI 10.1016/0092-8674(91)90100-D	25	890	908	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 23	1994	369	6482					669	671		10.1038/369669a0	http://dx.doi.org/10.1038/369669a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NT459	8208295				2022-12-28	WOS:A1994NT45900061
J	LOO, S; RINE, J				LOO, S; RINE, J			SILENCERS AND DOMAINS OF GENERALIZED REPRESSION	SCIENCE			English	Article							MATING-TYPE LOCUS; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; TRANSCRIPTIONAL STATES; DIFFERENTIAL REPAIR; CHROMATIN STRUCTURE; UV DAMAGE; YEAST; HML; EXPRESSION	Gene expression can be affected by the chromosomal position of the gene. An example of this position effect is silencing of the HML and HMR mating-type loci of Saccharomyces cerevisiae. An in vitro assay revealed that silencing induced a transcription-independent general occlusion of the DNA at HMR from sequence-specific interactions of proteins with DNA. The minimum boundaries of the silenced chromatin structure were determined, as were the contributions of the E and I silencers to the size of the silenced domain. Examination of endonuclease-sensitive sites provided evidence that neither the integrity of the chromosomal duplex nor covalent linkage of the silencers to HMR was important for maintenance of the silenced structure in vitro.	UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, DIV GENET, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley					NIEHS NIH HHS [P30ESO1896-12] Funding Source: Medline; NIGMS NIH HHS [GM31105] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES001896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM031105, R01GM031105] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAM J, 1984, J MOL BIOL, V176, P307, DOI 10.1016/0022-2836(84)90492-3; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; AMATI BB, 1988, CELL, V54, P967, DOI 10.1016/0092-8674(88)90111-0; ARIS JP, 1991, METHOD ENZYMOL, V194, P735; AXELROD A, 1991, MOL CELL BIOL, V11, P1080, DOI 10.1128/MCB.11.2.1080; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; BRAND AH, 1987, CELL, V51, P709, DOI 10.1016/0092-8674(87)90094-8; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; BUTNER K, 1986, MOL CELL BIOL, V6, P4440, DOI 10.1128/MCB.6.12.4440; CHENCLELAND TA, 1993, J BIOL CHEM, V268, P1118; DIFFLEY JFX, 1992, NATURE, V357, P169, DOI 10.1038/357169a0; FELDMAN JB, 1984, J MOL BIOL, V178, P815, DOI 10.1016/0022-2836(84)90313-9; FOSS M, 1993, SCIENCE, V262, P1838, DOI 10.1126/science.8266071; GOTTSCHLING DE, 1992, P NATL ACAD SCI USA, V89, P4062, DOI 10.1073/pnas.89.9.4062; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; HAZELRIGG T, 1984, CELL, V36, P469, DOI 10.1016/0092-8674(84)90240-X; HERSKOWITZ I, 1992, MOL CELLULAR BIOL YE, V2, P583; HOFMANN JFX, 1989, CELL, V57, P725, DOI 10.1016/0092-8674(89)90788-5; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; KLAR AJS, 1984, COLD SPRING HARB SYM, V49, P77, DOI 10.1101/SQB.1984.049.01.011; KLAR AJS, 1981, CELL, V25, P517, DOI 10.1016/0092-8674(81)90070-2; LAURENSON P, 1992, MICROBIOL REV, V56, P543, DOI 10.1128/MMBR.56.4.543-560.1992; MAHONEY DJ, 1991, GENE DEV, V5, P605, DOI 10.1101/gad.5.4.605; MAHONEY DJ, 1989, MOL CELL BIOL, V9, P4621, DOI 10.1128/MCB.9.11.4621; MCNALLY FJ, 1991, MOL CELL BIOL, V11, P5648, DOI 10.1128/MCB.11.11.5648; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; MILLER AM, 1984, NATURE, V312, P247, DOI 10.1038/312247a0; NASMYTH KA, 1982, CELL, V30, P567, DOI 10.1016/0092-8674(82)90253-7; PARK EC, 1990, MOL CELL BIOL, V10, P4932, DOI 10.1128/MCB.10.9.4932; PILLUS L, 1989, CELL, V59, P637, DOI 10.1016/0092-8674(89)90009-3; RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133; RIVIER DH, 1992, SCIENCE, V256, P659, DOI 10.1126/science.1585179; SCHNELL R, 1986, MOL CELL BIOL, V6, P494, DOI 10.1128/MCB.6.2.494; SINGH J, 1992, GENE DEV, V6, P186, DOI 10.1101/gad.6.2.186; SPOFFORD JB, 1976, GENETICS BIOL DROS C, V1, P955; STRATHERN JN, 1982, CELL, V31, P183, DOI 10.1016/0092-8674(82)90418-4; SUSSEL L, 1993, MOL CELL BIOL, V13, P3919, DOI 10.1128/MCB.13.7.3919; TARTOF KD, 1984, CELL, V37, P869, DOI 10.1016/0092-8674(84)90422-7; TERLETH C, 1989, NUCLEIC ACIDS RES, V17, P4433, DOI 10.1093/nar/17.12.4433; TERLETH C, 1990, MOL CELL BIOL, V10, P4678, DOI 10.1128/MCB.10.9.4678	43	188	192	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	1994	264	5166					1768	1771		10.1126/science.8209257	http://dx.doi.org/10.1126/science.8209257			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR600	8209257				2022-12-28	WOS:A1994NR60000045
J	SHEN, WH; MOORE, CCD; IKEDA, Y; PARKER, KL; INGRAHAM, HA				SHEN, WH; MOORE, CCD; IKEDA, Y; PARKER, KL; INGRAHAM, HA			NUCLEAR RECEPTOR STEROIDOGENIC FACTOR-1 REGULATES THE MULLERIAN-INHIBITING SUBSTANCE GENE - A LINK TO THE SEX DETERMINATION CASCADE	CELL			English	Article							THYROID-HORMONE RECEPTOR; POU-SPECIFIC DOMAIN; DNA-BINDING; DETERMINING REGION; FACTOR-I; RETINOIC ACID; KEY REGULATOR; NGFI-B; EXPRESSION; SRY	Normal mate sex differentiation requires that Sertoli cells in the embryonic testes produce Mullerian inhibiting substance (MIS), a TGF beta-like hormone that causes Mullerian duct regression. In primary Sertoli cells, the orphan nuclear receptor, steroidogenic factor 1 (SF-1), regulates the MIS gene by binding to a conserved upstream regulatory element. In heterologous (HeLa) cells, MIS gene activation by SF-1 requires removal of the SF-1 ligand-binding domain, implicating a Sertoli cell-specific ligand or cofactor. Finally, the sexually dimorphic expression of SF-1 during development coincides with MIS expression and Mullerian duct regression. We propose that SF-1 regulates MIS in vivo and participates directly in the process of mammalian sex determination.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,PROGRAM BIOMED SCI,SAN FRANCISCO,CA 94143; DUKE UNIV,MED CTR,HOWARD HUGHES MED INST,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT MED,DURHAM,NC 27710; DUKE UNIV,MED CTR,DEPT PHARMACOL,DURHAM,NC 27710	University of California System; University of California San Francisco; Duke University; Howard Hughes Medical Institute; Duke University; Duke University	SHEN, WH (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT OBSTET GYNECOL & REPROD SCI,SAN FRANCISCO,CA 94143, USA.				NIDDK NIH HHS [NIDDK K11, NIDDK RO1] Funding Source: Medline; PHS HHS [R01] Funding Source: Medline	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALEXANDERBRIDGES M, 1992, J CELL BIOCHEM, V48, P129, DOI 10.1002/jcb.240480204; BANIAHMAD A, 1992, EMBO J, V11, P1015, DOI 10.1002/j.1460-2075.1992.tb05140.x; BEHRINGER RR, 1990, NATURE, V345, P167, DOI 10.1038/345167a0; BOGAN JS, 1994, CELL, V76, P603, DOI 10.1016/0092-8674(94)90501-0; CATE RL, 1986, CELL, V45, P685, DOI 10.1016/0092-8674(86)90783-X; CATE RL, 1990, HDB EXPT PHARM PEPTI, V95, P179; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DENNY P, 1992, EMBO J, V11, P3705, DOI 10.1002/j.1460-2075.1992.tb05455.x; FITZPATRICK SL, 1993, MOL ENDOCRINOL, V7, P341, DOI 10.1210/me.7.3.341; FONDELL JD, 1993, GENE DEV, V7, P1400, DOI 10.1101/gad.7.7b.1400; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GIESE K, 1994, P NATL ACAD SCI USA, V91, P3368, DOI 10.1073/pnas.91.8.3368; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; GUERRIER D, 1990, J REPROD FERTIL, V88, P695; HAQQ C, 1992, GENOMICS, V12, P665, DOI 10.1016/0888-7543(92)90291-Y; HAQQ CM, 1993, P NATL ACAD SCI USA, V90, P1097, DOI 10.1073/pnas.90.3.1097; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; HARLEY VR, 1992, SCIENCE, V255, P453, DOI 10.1126/science.1734522; HONDA S, 1993, J BIOL CHEM, V268, P7494; IKEDA Y, 1993, MOL ENDOCRINOL, V7, P852, DOI 10.1210/me.7.7.852; IKEDA Y, 1994, IN PRESS MOL ENDOCRI; INGRAHAM HA, 1990, CELL, V61, P1021, DOI 10.1016/0092-8674(90)90067-O; JOSSO N, 1991, TRENDS ENDOCRIN MET, V2, P227, DOI 10.1016/1043-2760(91)90029-M; Jost A., 1973, Recent Progress Hormone Res, V29, P1; KAUFMAN MH, 1992, ATLAS MOUSE DEVELOPM; KNEBELMANN B, 1991, P NATL ACAD SCI USA, V88, P3767, DOI 10.1073/pnas.88.9.3767; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LALA DS, 1992, MOL ENDOCRINOL, V6, P1249, DOI 10.1210/me.6.8.1249; LEE MM, 1992, ENDOCRINOLOGY, V130, P847, DOI 10.1210/en.130.2.847; LI S, 1990, NATURE, V347, P528, DOI 10.1038/347528a0; LUO X, 1994, IN PRESS CELL, V77; LYNCH JP, 1993, MOL ENDOCRINOL, V7, P776, DOI 10.1210/me.7.6.776; MCELREAVEY K, 1993, P NATL ACAD SCI USA, V90, P3368, DOI 10.1073/pnas.90.8.3368; MOORE CCD, 1992, SEMIN PERINATOL, V16, P266; MOORE CCD, 1990, MOL CELL BIOL, V10, P6013, DOI 10.1128/MCB.10.11.6013; MOROHASHI K, 1993, MOL ENDOCRINOL, V7, P1196, DOI 10.1210/me.7.9.1196; MOROHASHI K, 1992, J BIOL CHEM, V267, P17913; MUNSTERBERG A, 1991, DEVELOPMENT, V113, P613; NASRIN N, 1991, NATURE, V354, P317, DOI 10.1038/354317a0; PEPINSKY RB, 1988, J BIOL CHEM, V263, P18961; PESCHON JJ, 1992, MOL ENDOCRINOL, V6, P1403, DOI 10.1210/me.6.9.1403; PFAFFLE RW, 1992, SCIENCE, V257, P1118, DOI 10.1126/science.257.5073.1118; PICARD D, 1988, CELL, V54, P1073, DOI 10.1016/0092-8674(88)90122-5; RICE DA, 1991, MOL ENDOCRINOL, V5, P1552, DOI 10.1210/mend-5-10-1552; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; TSUKIYAMA T, 1992, MOL CELL BIOL, V12, P1286, DOI 10.1128/MCB.12.3.1286; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; VILAIN E, 1992, AM J HUM GENET, V50, P1008; WILSON CA, 1993, MOL ENDOCRINOL, V7, P247, DOI 10.1210/me.7.2.247; WILSON TE, 1993, MOL CELL BIOL, V13, P5794, DOI 10.1128/MCB.13.9.5794; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; ZWINGMAN T, 1993, P NATL ACAD SCI USA, V90, P814, DOI 10.1073/pnas.90.3.814	55	477	493	1	14	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUN 3	1994	77	5					651	661		10.1016/0092-8674(94)90050-7	http://dx.doi.org/10.1016/0092-8674(94)90050-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NQ123	8205615				2022-12-28	WOS:A1994NQ12300006
J	DUJON, B; ALEXANDRAKI, D; ANDRE, B; ANSORGE, W; BALADRON, V; BALLESTA, JPG; BANREVI, A; BOLLE, PA; BOLOTINFUKUHARA, M; BOSSIER, P; BOU, G; BOYER, J; BUITRAGO, MJ; CHERET, G; COLLEAUX, L; DALGNANFORNIER, B; DELREY, F; DION, C; DOMDEY, H; DUSTERHOFT, A; DUSTERHUS, S; ENTLAN, KD; ERFLE, H; ESTEBAN, PF; FELDMANN, H; FERNANDES, L; FOBO, GM; FRITZ, C; FUKUHARA, H; GABEL, C; GAILLON, L; CARCIACANTALEJO, JM; GARCIARAMIREZ, JJ; GENT, ME; GHAZVINI, M; GOFFEAU, A; GONZALEZ, A; GROTHUES, D; GUERREIRO, P; HEGEMANN, J; HEWITT, N; HILGER, F; HOLLENBERG, CP; HORAITIS, O; INDGE, KJ; JACQUIER, A; JAMES, CM; JAUNIAUX, JC; JIMENEZ, A; KEUCHEL, H; KIRCHRATH, L; KLEINE, K; KOTTER, P; LEGRAIN, P; LIEBL, S; LOUIS, EJ; SILVA, AME; MARCK, C; MONNIER, AL; MOSTL, D; MULLER, S; OBERMAIER, B; OLIVER, SG; PALLIER, C; PASCOLO, S; PFEIFFER, F; PHILIPPSEN, P; PLANTA, RJ; POHL, FM; POHL, TM; POHLMANN, R; PORTETELLE, D; PURNELLE, B; PUZOS, V; RAD, MR; RASMUSSEN, SW; REMACHA, M; REVUELTA, JL; RICHARD, GF; RIEGER, M; RODRIGUESPOUSADA, C; ROSE, M; RUPP, T; SANTOS, MA; SCHWAGER, C; SENSEN, C; SKALA, J; SOARES, H; SOR, F; STEGEMANN, J; TETTELIN, H; THIERRY, A; TZERMIA, M; URRESTARAZU, LA; VANDYCK, L; VANVLIETREEDIJK, JC; VALENS, M; VANDENBOL, M; VILELA, C; VISSERS, S; VON WETTSTEIN, D; VOSS, H; WIEMANN, S; XU, G; ZIMMERMANN, J; HAASEMANN, M; BECKER, I; MEWES, HW				DUJON, B; ALEXANDRAKI, D; ANDRE, B; ANSORGE, W; BALADRON, V; BALLESTA, JPG; BANREVI, A; BOLLE, PA; BOLOTINFUKUHARA, M; BOSSIER, P; BOU, G; BOYER, J; BUITRAGO, MJ; CHERET, G; COLLEAUX, L; DALGNANFORNIER, B; DELREY, F; DION, C; DOMDEY, H; DUSTERHOFT, A; DUSTERHUS, S; ENTLAN, KD; ERFLE, H; ESTEBAN, PF; FELDMANN, H; FERNANDES, L; FOBO, GM; FRITZ, C; FUKUHARA, H; GABEL, C; GAILLON, L; CARCIACANTALEJO, JM; GARCIARAMIREZ, JJ; GENT, ME; GHAZVINI, M; GOFFEAU, A; GONZALEZ, A; GROTHUES, D; GUERREIRO, P; HEGEMANN, J; HEWITT, N; HILGER, F; HOLLENBERG, CP; HORAITIS, O; INDGE, KJ; JACQUIER, A; JAMES, CM; JAUNIAUX, JC; JIMENEZ, A; KEUCHEL, H; KIRCHRATH, L; KLEINE, K; KOTTER, P; LEGRAIN, P; LIEBL, S; LOUIS, EJ; SILVA, AME; MARCK, C; MONNIER, AL; MOSTL, D; MULLER, S; OBERMAIER, B; OLIVER, SG; PALLIER, C; PASCOLO, S; PFEIFFER, F; PHILIPPSEN, P; PLANTA, RJ; POHL, FM; POHL, TM; POHLMANN, R; PORTETELLE, D; PURNELLE, B; PUZOS, V; RAD, MR; RASMUSSEN, SW; REMACHA, M; REVUELTA, JL; RICHARD, GF; RIEGER, M; RODRIGUESPOUSADA, C; ROSE, M; RUPP, T; SANTOS, MA; SCHWAGER, C; SENSEN, C; SKALA, J; SOARES, H; SOR, F; STEGEMANN, J; TETTELIN, H; THIERRY, A; TZERMIA, M; URRESTARAZU, LA; VANDYCK, L; VANVLIETREEDIJK, JC; VALENS, M; VANDENBOL, M; VILELA, C; VISSERS, S; VON WETTSTEIN, D; VOSS, H; WIEMANN, S; XU, G; ZIMMERMANN, J; HAASEMANN, M; BECKER, I; MEWES, HW			COMPLETE DNA-SEQUENCE OF YEAST CHROMOSOME-XI	NATURE			English	Article							OPEN READING FRAMES; SACCHAROMYCES-CEREVISIAE; KB SEGMENT; LEFT ARM; REVEALS 5; GENE; HOMOLOG; PROTEIN; GENOME; FRAGMENT	The complete DNA sequence of the yeast Saccharomyces cerevisiae chromosome XI has been determined. In addition to a compact arrangement of potential protein coding sequences, the 666,448-base-pair sequence has revealed general chromosome patterns; in particular, alternating regional variations in average base composition correlate with variations in local gene density along the chromosome. Significant discrepancies with the previously published genetic map demonstrate the need for using independent physical mapping criteria.	UNIV PARIS 06, INST PASTEUR, DEPT MOLEC BIOL, UFR 927, F-75724 PARIS 15, FRANCE; INST MOLEC BIOL & BIOTECHNOL, FDN RES & TECHNOL HELLAS, GR-71110 IRAKLION, GREECE; FREE UNIV BRUSSELS, PHYSIOL CELLULAIRE & GENET LEVURES LAB, B-1050 BRUSSELS, BELGIUM; EUROPEAN MOLEC BIOL LAB, D-69117 HEIDELBERG, GERMANY; UNIV SALAMANCA, DEPT GENET & MICROBIOL, E-37007 SALAMANCA, SPAIN; UNIV AUTONOMA MADRID, E-28049 MADRID, SPAIN; FAC CIENCIAS MADRID, CSIC, CTR MOLEC BIOL, E-28049 MADRID, SPAIN; FAC SCI AGRON ETAT GEMBLOUX, MICROBIOL LAB, B-5030 GEMBLOUX, BELGIUM; UNIV PARIS 11, IGM, GENET MOLEC LAB, CNRS, URA 1354, F-91405 ORSAY, FRANCE; INST GULBENKIAN CIENCIAS, GENET MOLEC LAB, P-2781 OEIRAS, PORTUGAL; CTR UNIV ORSAY, INST CURIE, BIOL SECT, F-91405 ORSAY 15, FRANCE; LAB MOLEK BIOL, D-82152 MARTINSRIED, GERMANY; UNIV GIESSEN, INST MIKROBIOL & MOLEK BIOL, D-35392 GIESSEN, GERMANY; QUIAGEN GMBH, D-40724 HILDEN, GERMANY; UNIV FRANKFURT, INST MIKROBIOL, D-60439 FRANKFURT, GERMANY; UNIV MUNICH, INST PHYSIOL CHEM PHYS BIOCHEM & ZELLBIOL, D-80336 MUNICH, GERMANY; MAX PLANCK INST BIOCHEM, MIPS, D-82152 MARTINSRIED, GERMANY; UNIV DUSSELDORF, INST MIKROBIOL, D-40225 DUSSELDORF, GERMANY; BIOTECHNOL & MOLEK BIOL FORSCH, D-69259 WILHELMSFELD, GERMANY; UNIV MANCHESTER, INST SCI & TECHNOL, MANCHESTER BIOTECHNOL CTR, MANCHESTER M60 1QD, LANCS, ENGLAND; UNIV CATHOLIQUE LOUVAIN, UNITE BIOCHIM PHYSIOL, B-1348 LOUVAIN, BELGIUM; COMMISS EUROPEAN COMMUNITIES, B-1049 BRUSSELS, BELGIUM; DEUTSCH KREBSFORSCHUNGSZENTRUM, INSERM,U375, UNITE ANGEW TUMORVIROL & VIROL APPL ONCOL,ABT 0610, D-69009 HEIDELBERG, GERMANY; JOHN RADCLIFFE HOSP, INST MOLEC MED, OXFORD OX3 9DU, ENGLAND; CTR ETUD SACLAY, CEA,DSV,DEPT BIOL CELLULAIRE & MOLEC, SERV BIOCHEM & GENET MOLEC, F-91191 GIF SUR YVETTE, FRANCE; UNIV BASEL, BIOZENTRUM, INST ANGEW MIKROBIOL, CH-4056 BASEL, SWITZERLAND; VRIJE UNIV AMSTERDAM, BIOCENTRUM AMSTERDAM, INST MOLEC BIOL SCI, DEPT BIOCHEM & MOLEC BIOL, 1081 HV AMSTERDAM, NETHERLANDS; UNIV KONSTANZ, FAK BIOL, D-78434 CONSTANCE, GERMANY; GESELL ANAL TECH & CONSULTING, D-78467 CONSTANCE, GERMANY; CARLSBERG LAB, DEPT PHYSIOL, DK-2500 COPENHAGEN, DENMARK	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Foundation for Research & Technology - Hellas (FORTH); Universite Libre de Bruxelles; Vrije Universiteit Brussel; European Molecular Biology Laboratory (EMBL); University of Salamanca; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); University of Liege; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Instituto Gulbenkian de Ciencia; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Justus Liebig University Giessen; Goethe University Frankfurt; University of Munich; Max Planck Society; Heinrich Heine University Dusseldorf; University of Manchester; Universite Catholique Louvain; Helmholtz Association; German Cancer Research Center (DKFZ); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Oxford; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Basel; University of Amsterdam; Vrije Universiteit Amsterdam; University of Konstanz	DUJON, B (corresponding author), UNIV PARIS 06, INST PASTEUR, DEPT MOLEC BIOL, CNRS, UNITE MOLEC LEVURES 1149, F-75724 PARIS 15, FRANCE.		Baladron, Victoriano/L-1758-2014; André, Bruno/D-1725-2010; Esteban, Pedro Felipe/ABF-9680-2021; Remacha, Miguel/G-1250-2016; Wiemann, Stefan/E-4424-2013; Soares, Helena/G-3065-2010; COLLEAUX, Laurence/H-6455-2017; Bossier, Peter GM/A-8118-2008; COLLEAUX, LAURENCE/AAA-8144-2022; Richard, Guy-Franck/ABB-9185-2021; del Rey, Francisco/L-7132-2014; Pfeiffer, Friedhelm/K-1757-2019; Revuelta, Jose Luis/ABG-1502-2020; Sensen, Christoph W./C-1798-2013; Santos, Maria Angeles/H-2239-2015; Garcia-Ramirez, Jose J/L-2153-2014; Ansorge, Wilhelm/AAN-8780-2020; Revuelta, Jose L/C-2324-2012; fernandes, lisete/E-6522-2016; Dujon, Bernard A/F-4971-2010; Louis, Edward/B-7920-2008; Bou, German/H-6683-2015; Mewes, Hans-Werner/A-8204-2019	Baladron, Victoriano/0000-0003-4574-8760; Esteban, Pedro Felipe/0000-0002-8760-7512; Wiemann, Stefan/0000-0003-4683-3174; Soares, Helena/0000-0001-6180-7041; Bossier, Peter GM/0000-0002-6165-9111; COLLEAUX, LAURENCE/0000-0002-0987-7648; del Rey, Francisco/0000-0002-6517-7400; Pfeiffer, Friedhelm/0000-0003-4691-3246; Revuelta, Jose Luis/0000-0001-7838-5308; Sensen, Christoph W./0000-0001-9604-8962; Santos, Maria Angeles/0000-0002-1257-7611; Garcia-Ramirez, Jose J/0000-0002-8348-3727; Revuelta, Jose L/0000-0001-7838-5308; fernandes, lisete/0000-0002-3384-2031; Louis, Edward/0000-0003-1157-3608; JACQUIER, ALAIN/0000-0001-5707-9184; Rodrigues-Pousada, Claudina/0000-0002-5075-3639; Buitrago, Maria Jose/0000-0003-1878-6067; Maia e Silva, Alexandra/0000-0001-8385-8739; Bou, German/0000-0001-8837-0062; Bolotin-Fukuhara, Monique/0000-0002-5285-5006; Mewes, Hans-Werner/0000-0002-9713-6398; Garcia-Cantalejo, Jesus/0000-0001-6465-1273; Guerreiro, Paulo/0000-0002-0070-7757	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALEXANDRAKI D, IN PRESS YEAST; ANSORGE W, 1986, J BIOCHEM BIOPH METH, V13, P315, DOI 10.1016/0165-022X(86)90038-2; BERNARDI G, 1993, GENE, V135, P57, DOI 10.1016/0378-1119(93)90049-9; BOSSIER P, IN PRESS YEAST; BOU G, 1993, YEAST, V9, P1349, DOI 10.1002/yea.320091209; BOYER J, 1993, YEAST, V9, P279, DOI 10.1002/yea.320090307; CHERET G, 1993, YEAST, V9, P1259, DOI 10.1002/yea.320091113; CHURCH GM, 1988, SCIENCE, V240, P185, DOI 10.1126/science.3353714; COLLEAUX L, 1992, YEAST, V8, P325, DOI 10.1002/yea.320080410; DANIELS DL, 1992, SCIENCE, V257, P771, DOI 10.1126/science.1379743; DERSHOWITZ A, 1993, MOL CELL BIOL, V13, P39; DUSTERHOFT A, 1992, YEAST, V8, P749, DOI 10.1002/yea.320080908; ESHEL D, 1993, P NATL ACAD SCI USA, V90, P11172, DOI 10.1073/pnas.90.23.11172; FORROVA H, 1992, YEAST, V8, P419, DOI 10.1002/yea.320080509; GARCIACANTALEJO J, 1994, YEAST, V10, P221; HONORE N, 1993, MOL MICROBIOL, V7, P207, DOI 10.1111/j.1365-2958.1993.tb01112.x; JACQUIER A, 1992, YEAST, V8, P121, DOI 10.1002/yea.320080207; JAMES CM, 1994, YEAST, V10, P257, DOI 10.1002/yea.320100212; JAMES CM, 1994, YEAST, V10, P247, DOI 10.1002/yea.320100211; KARLIN S, 1993, NUCLEIC ACIDS RES, V21, P703, DOI 10.1093/nar/21.3.703; KOONIN EV, 1994, EMBO J, V13, P493, DOI 10.1002/j.1460-2075.1994.tb06287.x; KUNST F, 1991, RES MICROBIOL, V142, P905, DOI 10.1016/0923-2508(91)90072-I; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; LI YY, 1993, P NATL ACAD SCI USA, V90, P10096, DOI 10.1073/pnas.90.21.10096; LOUIS EJ, 1992, GENETICS, V131, P559; MCCOMBIE WR, 1992, NAT GENET, V1, P124, DOI 10.1038/ng0592-124; MEYEROWITZ EM, 1985, SCIENCE, V229, P1214, DOI 10.1126/science.229.4719.1214; MORTIMER RK, 1992, YEAST, V8, P817, DOI 10.1002/yea.320081002; OKUBO K, 1992, NAT GENET, V2, P173, DOI 10.1038/ng1192-173; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; PALLIER C, 1993, YEAST, V9, P1149, DOI 10.1002/yea.320091016; PASCOLO S, 1992, YEAST, V8, P987, DOI 10.1002/yea.320081109; POHL FM, 1987, METHOD ENZYMOL, V155, P250; PURNELLE B, 1992, YEAST, V8, P977, DOI 10.1002/yea.320081108; PURNELLE B, 1994, YEAST, V10, P125, DOI 10.1002/yea.320100112; PURNELLE B, 1993, YEAST, V9, P1379, DOI 10.1002/yea.320091212; RASMUSSEN SW, IN PRESS YEAST; RHODE PR, 1989, GENE DEV, V3, P1926, DOI 10.1101/gad.3.12a.1926; SHARP PM, 1993, NUCLEIC ACIDS RES, V21, P179, DOI 10.1093/nar/21.2.179; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; SINGERKRUGER B, IN PRESS J CELL BIOL; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0; THIERRY A, 1992, NUCLEIC ACIDS RES, V20, P5625, DOI 10.1093/nar/20.21.5625; TZERMIA M, IN PRESS YEAST; VANDENBOL M, IN PRESS YEAST; VANVLIETREEDIJK JC, 1993, YEAST, V9, P1139, DOI 10.1002/yea.320091015; VASSAROTTI A, 1992, TRENDS BIOTECHNOL, V10, P15, DOI 10.1016/0167-7799(92)90160-W; VASSAROTTI A, IN PRESS J BIOTECH; VOYTAS DF, 1992, NATURE, V358, P717, DOI 10.1038/358717a0; WICKSTEED BL, 1994, YEAST, V10, P39, DOI 10.1002/yea.320100105; WIEMANN S, 1993, YEAST, V9, P1343, DOI 10.1002/yea.320091208; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0	52	324	683	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 2	1994	369	6479					371	378		10.1038/369371a0	http://dx.doi.org/10.1038/369371a0			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NP174	8196765				2022-12-28	WOS:A1994NP17400047
J	HARDY, MA; GOODMAN, ER				HARDY, MA; GOODMAN, ER			TRANSPLANTATION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RENAL-TRANSPLANTATION; ANTIBODIES; EXPERIENCE				HARDY, MA (corresponding author), COLUMBIA UNIV,COLL PHYS & SURG,NEW YORK,NY, USA.							BARKER CF, 1991, TXB SURGERY, P383; CACCIARELLI T, 1993, CLIN NEPHROL, V39, P335; CRAMER DV, 1993, TRANSPLANT P, V25, P23; DEIERHOI MH, 1993, ANN SURG, V217, P476, DOI 10.1097/00000658-199305010-00007; DEMETRIS AJ, 1992, HEPATOLOGY, V16, P671, DOI 10.1002/hep.1840160310; Goodman E R, 1992, Clin Transpl, P285; HARDY MA, 1991, ANN SURG, V214, P522, DOI 10.1097/00000658-199110000-00016; LINDHOLM A, 1993, TRANSPLANTATION, V56, P307, DOI 10.1097/00007890-199308000-00010; LOBO PI, 1993, TRANSPLANTATION, V55, P1063, DOI 10.1097/00007890-199305000-00023; MERION RM, 1991, HEPATOLOGY, V14, P572, DOI 10.1002/hep.1840140327; NELSON PW, 1992, AM J SURG, V164, P541, DOI 10.1016/S0002-9610(05)81197-3; NYBERG G, 1993, TRANSPLANT P, V25, P1062; STARNES VA, 1992, J THORAC CARDIOV SUR, V104, P1060; 1993, UNITED NETWORK ORGAN, V9, P46; 1993, 1993 UN NETW ORG SHA	15	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1716	1717						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182869				2022-12-28	WOS:A1994NN11700048
J	WENTZ, AC; HUGGINS, GR				WENTZ, AC; HUGGINS, GR			OBSTETRICS AND GYNECOLOGY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ORAL-CONTRACEPTIVES; PROPOSAL		JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD	Johns Hopkins University	WENTZ, AC (corresponding author), NORTHWESTERN UNIV,SCH MED,CHICAGO,IL, USA.							EWIGMAN BG, 1993, NEW ENGL J MED, V329, P821, DOI 10.1056/NEJM199309163291201; GOLLUB EL, 1993, AM J PUBLIC HEALTH, V83, P498, DOI 10.2105/AJPH.83.4.498; GRIMES DA, 1992, AM J OBSTET GYNECOL, V166, P1950, DOI 10.1016/0002-9378(92)91394-P; GRIMES DA, 1993, AM J PUBLIC HEALTH, V83, P1092, DOI 10.2105/AJPH.83.8.1092; HALE RW, 1993, AM J OBSTET GYNECOL, V168, P1833, DOI 10.1016/0002-9378(93)90698-I; LEFEVRE ML, 1993, AM J OBSTET GYNECOL, V169, P483, DOI 10.1016/0002-9378(93)90605-I; MISHELL DR, 1993, J REPROD MED, V38, P1021; TRUSSELL J, 1993, AM J PUBLIC HEALTH, V83, P1094, DOI 10.2105/AJPH.83.8.1094; TRUSSELL J, 1992, FAM PLANN PERSPECT, V24, P269, DOI 10.2307/2135857; YUZPE AA, 1982, FERTIL STERIL, V37, P508	10	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1689	1691						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182854				2022-12-28	WOS:A1994NN11700033
J	NOVOGRODSKY, A; VANICHKIN, A; PATYA, M; GAZIT, A; OSHEROV, N; LEVITZKI, A				NOVOGRODSKY, A; VANICHKIN, A; PATYA, M; GAZIT, A; OSHEROV, N; LEVITZKI, A			PREVENTION OF LIPOPOLYSACCHARIDE-INDUCED LETHAL TOXICITY BY TYROSINE KINASE INHIBITORS	SCIENCE			English	Article							TUMOR-NECROSIS-FACTOR; MOUSE PERITONEAL-MACROPHAGES; NITRIC-OXIDE; ENDOTOXIC-SHOCK; INTERLEUKIN-1; PHOSPHORYLATION; RESISTANT; RECEPTOR; MICE; MONOCYTOGENES	Septic shock results from excessive stimulation of the host immune system, especially macrophages, by lipopolysaccharide (LPS), or endotoxin, which resides on the outer membrane of bacteria. Protein tyrosine kinase inhibitors of the tyrphostin AG 126 family protect mice against LPS-induced lethal toxicity. The protection correlates with the ability of these agents to block LPS-induced production of tumor necrosis factor alpha (tNF-alpha) and nitric oxide in macrophages as well as LPS-induced production of TNF-alpha in vivo. Furthermore, this inhibitory effect correlated with the potency of AG 126 to block LPS-induced tyrosine phosphorylation of a p42(MAPK) protein substrate in the murine macrophage.	TEL AVIV UNIV,SACKLER SCH MED,IL-69978 TEL AVIV,ISRAEL; HEBREW UNIV JERUSALEM,ALEXANDER SILBERMAN INST LIFE SCI,DEPT BIOL CHEM,IL-91904 JERUSALEM,ISRAEL	Tel Aviv University; Sackler Faculty of Medicine; Hebrew University of Jerusalem	NOVOGRODSKY, A (corresponding author), FELSENSTEIN MED RES CTR,BEILINSON CAMPUS,IL-49100 PETAH TIQWA,ISRAEL.							BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; BEUTLER B, 1988, ANNU REV BIOCHEM, V57, P505, DOI 10.1146/annurev.bi.57.070188.002445; BOHMER F, UNPUB; COYNE DW, 1990, BIOCHEM BIOPH RES CO, V173, P718, DOI 10.1016/S0006-291X(05)80094-4; DING AH, 1988, J IMMUNOL, V141, P2407; DONG Z, 1993, J EXP MED, V177, P1971; DONG ZY, 1993, J LEUKOCYTE BIOL, V53, P53, DOI 10.1002/jlb.53.1.53; DONG ZY, 1993, J IMMUNOL, V151, P2717; EVERAERDT B, 1989, BIOCHEM BIOPH RES CO, V163, P378, DOI 10.1016/0006-291X(89)92146-3; GADINA M, 1991, J EXP MED, V173, P1305, DOI 10.1084/jem.173.6.1305; GAZIT A, 1989, J MED CHEM, V32, P2344, DOI 10.1021/jm00130a020; GAZIT A, UNPUB; GEUNTER CA, 1969, J APPL PHYSIOL, V26, P780; GLASER KB, 1993, BIOCHEM PHARMACOL, V45, P711, DOI 10.1016/0006-2952(93)90147-O; GREENMAN RL, 1991, JAMA-J AM MED ASSOC, V266, P1097, DOI 10.1001/jama.266.8.1097; GUY GR, 1991, J BIOL CHEM, V266, P14343; HOFFBARD AV, 1990, BLOOD, V75, P88; IWASAKI T, 1992, FEBS LETT, V298, P240, DOI 10.1016/0014-5793(92)80067-Q; KILBOURN RG, 1992, J NATL CANCER I, V84, P827, DOI 10.1093/jnci/84.11.827; KILBOURN RG, 1990, P NATL ACAD SCI USA, V87, P3629, DOI 10.1073/pnas.87.9.3629; KOHMO M, 1990, BIOCHEM J, V267, P91; LEVITZKI A, 1992, FASEB J, V6, P3275, DOI 10.1096/fasebj.6.14.1426765; MARCZIN N, 1993, AM J PHYSIOL, V265, pH110; MUNOZ E, 1992, EUR J IMMUNOL, V22, P1391, DOI 10.1002/eji.1830220610; OHLSSON K, 1990, NATURE, V348, P550, DOI 10.1038/348550a0; OKUSAWA S, 1988, J CLIN INVEST, V81, P1162, DOI 10.1172/JCI113431; Parrillo J E, 1993, N Engl J Med, V328, P1471; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; RAETZ CR, 1990, ANN REV BIOCH, V59, P124; REMICK DG, 1989, LAB INVEST, V60, P766; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; STEFANOVA I, 1993, J BIOL CHEM, V268, P20725; TSUNAWAKI S, 1984, J BIOL CHEM, V259, P4305; VICTOR I, 1993, J BIOL CHEM, V268, P18994; WALLACH D, 1988, J IMMUNOL, V140, P2994; WEINSTEIN SL, 1992, J BIOL CHEM, V267, P14955; WEINSTEIN SL, 1991, P NATL ACAD SCI USA, V88, P4148, DOI 10.1073/pnas.88.10.4148; YAISH P, 1988, SCIENCE, V242, P933, DOI 10.1126/science.3263702; ZANG X, 1993, J EXP MED, V177, P511; ZIEGLER EJ, 1982, NEW ENGL J MED, V307, P1225, DOI 10.1056/NEJM198211113072001	40	339	352	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 27	1994	264	5163					1319	1322		10.1126/science.8191285	http://dx.doi.org/10.1126/science.8191285			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NN767	8191285				2022-12-28	WOS:A1994NN76700043
J	TOMFOHRDE, J; SILVERMAN, A; BARNES, R; FERNANDEZVINA, MA; YOUNG, M; LORY, D; MORRIS, L; WUEPPER, KD; STASTNY, P; MENTER, A; BOWCOCK, A				TOMFOHRDE, J; SILVERMAN, A; BARNES, R; FERNANDEZVINA, MA; YOUNG, M; LORY, D; MORRIS, L; WUEPPER, KD; STASTNY, P; MENTER, A; BOWCOCK, A			GENE FOR FAMILIAL PSORIASIS SUSCEPTIBILITY MAPPED TO THE DISTAL END OF HUMAN-CHROMOSOME 17Q	SCIENCE			English	Article							PEDIGREE-MEMBER METHOD; LINKAGE ANALYSIS; IMMUNE-SYSTEM; INSULIN GENE; DNA; HLA; AMPLIFICATION; ASSOCIATIONS; SELECTION; ALLELES	A gene involved in psoriasis susceptibility was localized to the distal region of human chromosome 17q as a result of a genome-wide linkage analysis with polymorphic microsatellites and eight multiply affected psoriasis kindreds. In the family which showed the strongest evidence for linkage, the recombination fraction between a psoriasis susceptibility locus and D17S784 was 0.04 with a maximum two-point lod score of 5.33. There was also evidence for genetic heterogeneity and although none of the linked families showed any association with HLA-Cw6, two unlinked families showed weak levels of association. This study demonstrates that in some families, psoriasis susceptibility is due to variation at a single major genetic locus other than the human lymphocyte antigen locus.	UNIV TEXAS, SW MED CTR, DEPT PEDIAT, DALLAS, TX 75235 USA; BAYLOR UNIV, MED CTR, CTR PSORIASIS, DALLAS, TX 75246 USA; UNIV TEXAS, SW MED CTR, DEPT INTERNAL MED, DALLAS, TX 75235 USA; OREGON HLTH SCI UNIV, DEPT DERMATOL, PORTLAND, OR 97201 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Baylor University; Baylor University Medical Center; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Oregon Health & Science University			menter md, alan/A-8250-2009	Bowcock, Anne/0000-0001-8691-9090	NHLBI NIH HHS [R01 HL47145] Funding Source: Medline; NIAID NIH HHS [P01-AI2327] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047145] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAADSGAARD O, 1990, J INVEST DERMATOL, V95, pS32, DOI 10.1111/1523-1747.ep12505715; BAKER BS, 1993, BRIT J DERMATOL, V128, P493, DOI 10.1111/j.1365-2133.1993.tb00224.x; BARKER JNWN, 1991, LANCET, V338, P227, DOI 10.1016/0140-6736(91)90357-U; BECKMANN JS, 1993, HUM MOL GENET, V2, P2019, DOI 10.1093/hmg/2.12.2019; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; BOS JD, 1988, BRIT J DERMATOL, V118, P141, DOI 10.1111/j.1365-2133.1988.tb01768.x; BOWCOCK A, 1993, GENOMICS, V15, P376, DOI 10.1006/geno.1993.1071; BRANDRUP F, 1978, ARCH DERMATOL, V114, P874, DOI 10.1001/archderm.114.6.874; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; CHRISTOPHERS E, 1989, ACTA DERM-VENEREOL, P88; CIVATTE J, 1977, ANN DERMATOL VENER, V104, P525; DUVIC M, 1990, J INVEST DERMATOL, V95, pS38, DOI 10.1111/1523-1747.ep12505743; DUYK GM, 1990, P NATL ACAD SCI USA, V87, P8995, DOI 10.1073/pnas.87.22.8995; ESPINOZA LR, 1980, J RHEUMATOL, V7, P445; FEDER J, 1985, AM J HUM GENET, V37, P635; FERNANDEZVINA M, 1991, HUM IMMUNOL, V30, P60, DOI 10.1016/0198-8859(91)90072-H; FERNANDEZVINA MA, 1991, IMMUNOGENETICS, V34, P299, DOI 10.1007/BF00211994; GYAPAY G, IN PRESS NATURE GENE; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; HENSELER T, 1985, J AM ACAD DERMATOL, V13, P450, DOI 10.1016/S0190-9622(85)70188-0; JULIER C, 1991, NATURE, V354, P155, DOI 10.1038/354155a0; KARVONEN J, 1976, ANN CLIN RES, V8, P298; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LI C, 1992, GENOMICS, V13, P665, DOI 10.1016/0888-7543(92)90139-J; LI C, 1991, P NATL ACAD SCI USA, V88, P7739, DOI 10.1073/pnas.88.17.7739; LOVETT M, 1991, P NATL ACAD SCI USA, V88, P9628, DOI 10.1073/pnas.88.21.9628; MATISE TC, 1994, NAT GENET, V6, P384, DOI 10.1038/ng0494-384; MENTER A, 1991, LANCET, V338, P231, DOI 10.1016/0140-6736(91)90358-V; Ott J., 1991, ANAL HUMAN GENETIC L; PARIMOO S, 1991, P NATL ACAD SCI USA, V88, P9623, DOI 10.1073/pnas.88.21.9623; PIETRZYK JJ, 1982, ARCH DERMATOL RES, V273, P295, DOI 10.1007/BF00409258; SCHROEDER M, IN PRESS GENET EPIDE; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; THOMSON G, 1989, GENET EPIDEMIOL, V6, P155, DOI 10.1002/gepi.1370060129; TIILIKAINEN A, 1980, BRIT J DERMATOL, V102, P179, DOI 10.1111/j.1365-2133.1980.tb05690.x; WATSON W, 1972, ARCH DERMATOL, V105, P197, DOI 10.1001/archderm.105.2.197; WEEKS DE, 1988, AM J HUM GENET, V42, P315; WEEKS DE, 1992, AM J HUM GENET, V50, P859; WEISSENBACH J, 1992, NATURE, V359, P794, DOI 10.1038/359794a0	40	321	332	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 20	1994	264	5162					1141	1145		10.1126/science.8178173	http://dx.doi.org/10.1126/science.8178173			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NM146	8178173				2022-12-28	WOS:A1994NM14600031
J	VERRIJZER, CP; YOKOMORI, K; CHEN, JL; TJIAN, R				VERRIJZER, CP; YOKOMORI, K; CHEN, JL; TJIAN, R			DROSOPHILA TAF(II)150 - SIMILARITY TO YEAST GENE TSM-1 AND SPECIFIC BINDING TO CORE PROMOTER DNA	SCIENCE			English	Article							III TRANSCRIPTION FACTOR; TATA-LESS; PROTEIN; ACTIVATION; REGION; COACTIVATORS; TFIIIB; COMPONENTS; MECHANISM; COMPLEX	In Drosophila and human cells, the TATA binding protein (TBP) of the transcription factor IID (TFIID) complex is tightly associated with multiple subunits termed TBP-associated factors (TAFs) that are essential for mediating regulation of RNA polymerase II transcription. The Drosophila TAF(II)150 has now been molecularly cloned and biochemically characterized. The deduced primary amino acid sequence of dTAF(II)150 reveals a striking similarity to the essential yeast gene, TSM-1. Furthermore, like dTAF(II)150, the TSM-1 protein is found associated with the TBP in vivo, thus identifying the first yeast homolog of a TAF associated with TFIID. Both the product of TSM-1 and dTAF(II)150 bind directly to TBP and dTAF(II)250, demonstrating a functional similarity between human and yeast TAFs. Surprisingly, DNA binding studies indicate that purified recombinant dTAF(II)150 binds specifically to DNA sequences overlapping the start site of transcription. The data demonstrate that at least one of the TAFs is a sequence-specific DNA binding protein and that dTAF(II)150 together with TBP are responsible for TFIID interactions with an extended region of the core promoter.	UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley	VERRIJZER, CP (corresponding author), UNIV CALIF BERKELEY,HOWARD HUGHES MED INST,BERKELEY,CA 94720, USA.							BERGER SL, 1990, CELL, V61, P1199, DOI 10.1016/0092-8674(90)90684-7; BERGER SL, 1992, CELL, V70, P251, DOI 10.1016/0092-8674(92)90100-Q; CHIANG CM, 1993, EMBO J, V12, P2749, DOI 10.1002/j.1460-2075.1993.tb05936.x; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; COMAI L, UNPUB; CORMACK BP, 1991, CELL, V65, P341, DOI 10.1016/0092-8674(91)90167-W; DYNLACHT BD, 1993, NATURE, V363, P176, DOI 10.1038/363176a0; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; EMANUEL PA, 1993, P NATL ACAD SCI USA, V90, P8449, DOI 10.1073/pnas.90.18.8449; GILL G, 1991, CELL, V65, P333, DOI 10.1016/0092-8674(91)90166-V; Gill G, 1992, CURR OPIN GENET DEV, V2, P236, DOI 10.1016/S0959-437X(05)80279-5; GILMOUR DS, 1990, MOL CELL BIOL, V8, P4233; GOODRICH JA, 1993, CELL, V75, P519, DOI 10.1016/0092-8674(93)90386-5; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; HISATAKE K, 1993, NATURE, V362, P179, DOI 10.1038/362179a0; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; HOEY T, 1990, CELL, V61, P1179, DOI 10.1016/0092-8674(90)90682-5; KASSAVETIS GA, 1992, CELL, V71, P1055, DOI 10.1016/0092-8674(92)90399-W; KAUFMANN J, IN PRESS GENES DEV; KELEHER RJ, 1990, CELL, V61, P1209; KOKUBO T, 1993, GENE DEV, V7, P1033, DOI 10.1101/gad.7.6.1033; KOKUBO T, 1993, J BIOL CHEM, V268, P17554; LEICHT BG, 1988, GENETICS, V119, P579; LOBO SM, 1992, CELL, V71, P1029, DOI 10.1016/0092-8674(92)90397-U; PARKER CS, 1984, CELL, V36, P357, DOI 10.1016/0092-8674(84)90229-0; POON D, 1993, J BIOL CHEM, V268, P15325; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; PURNELL BA, 1993, MOL CELL BIOL, V13, P2593, DOI 10.1128/MCB.13.4.2593; RAY BL, 1991, CURR GENET, V20, P25, DOI 10.1007/BF00312761; RUPPERT S, 1993, NATURE, V362, P175, DOI 10.1038/362175a0; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; TAGGART AKP, 1992, CELL, V71, P1015, DOI 10.1016/0092-8674(92)90396-T; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; WEINZIERL ROJ, 1993, NATURE, V362, P511, DOI 10.1038/362511a0; WHITE RJ, 1992, CELL, V71, P1041, DOI 10.1016/0092-8674(92)90398-V; YOKOMONI K, UNPUB; YOKOMORI K, 1993, GENE DEV, V7, P2235, DOI 10.1101/gad.7.11.2235; YOKOMORI K, 1993, GENE DEV, V7, P2587, DOI 10.1101/gad.7.12b.2587; ZAWEL L, 1992, Current Opinion in Cell Biology, V4, P488, DOI 10.1016/0955-0674(92)90016-6; ZHOU Q, 1992, GENE DEV, V6, P1964, DOI 10.1101/gad.6.10.1964	41	200	205	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 13	1994	264	5161					933	941		10.1126/science.8178153	http://dx.doi.org/10.1126/science.8178153			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NK974	8178153				2022-12-28	WOS:A1994NK97400027
J	LISCOVITCH, M; CANTLEY, LC				LISCOVITCH, M; CANTLEY, LC			LIPID 2ND MESSENGERS	CELL			English	Review							PROTEIN-KINASE-C; ACTIVATION; PRODUCT; CELLS; ACID		HARVARD UNIV,SCH MED,DEPT CELL BIOL,BOSTON,MA 02115; WEIZMANN INST SCI,DEPT HORMONE RES,IL-76100 REHOVOT,ISRAEL	Harvard University; Harvard Medical School; Weizmann Institute of Science	LISCOVITCH, M (corresponding author), BETH ISRAEL HOSP,DIV SIGNAL TRANSDUCT,BOSTON,MA 02115, USA.		Cantley, Lewis C/D-1800-2014	Cantley, Lewis C/0000-0002-1298-7653	NIGMS NIH HHS [R01 GM041890] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AHMED S, 1992, BIOCHEM J, V287, P995, DOI 10.1042/bj2870995; AHMED S, 1993, J BIOL CHEM, V268, P10709; AUGER KR, 1989, J BIOL CHEM, V264, P20181; AUGER KR, 1989, CELL, V57, P167, DOI 10.1016/0092-8674(89)90182-7; BARBOUR SE, 1993, J BIOL CHEM, V268, P21875; BELL RM, 1991, J BIOL CHEM, V266, P4661; BOWMAN EP, 1993, J BIOL CHEM, V268, P21509; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; Cleves A, 1991, Trends Cell Biol, V1, P30, DOI 10.1016/0962-8924(91)90067-J; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; JAYADEV S, 1994, J BIOL CHEM, V269, P5757; LISCOVITCH M, 1992, TRENDS BIOCHEM SCI, V17, P393, DOI 10.1016/0968-0004(92)90007-V; LISCOVITCH M, 1994, SIGNAL ACTIVATED PHO; LIU J, 1994, J BIOL CHEM, V269, P3047; NAKANISHI H, 1993, J BIOL CHEM, V268, P13; NAOR Z, 1988, MOL ENDOCRINOL, V2, P1043, DOI 10.1210/mend-2-11-1043; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; OKAZAKI T, 1989, J BIOL CHEM, V264, P19076; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; OLSON SC, 1991, J BIOL CHEM, V266, P17236; QUEST AFG, 1994, J BIOL CHEM, V269, P2961; REINER O, 1993, NATURE, V364, P717, DOI 10.1038/364717a0; REZA F, 1994, FEBS LETT, V339, P229, DOI 10.1016/0014-5793(94)80421-4; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; SASAKI Y, 1993, FEBS LETT, V320, P47, DOI 10.1016/0014-5793(93)81655-J; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; SHARP JD, 1991, J BIOL CHEM, V266, P14850; SHINOMURA T, 1991, P NATL ACAD SCI USA, V88, P5149, DOI 10.1073/pnas.88.12.5149; SKINNER HB, 1993, EMBO J, V12, P4775, DOI 10.1002/j.1460-2075.1993.tb06166.x; YANG LJ, 1993, J BIOL CHEM, V268, P3739	34	322	337	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 6	1994	77	3					329	334		10.1016/0092-8674(94)90148-1	http://dx.doi.org/10.1016/0092-8674(94)90148-1			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NK970	8181054				2022-12-28	WOS:A1994NK97000004
J	BARRY, M				BARRY, M			METAL RESIDUES AFTER CREMATION	BRITISH MEDICAL JOURNAL			English	Article									QUEEN ELIZABETH II HOSP,WELWYN GARDEN CIT AL7 4HQ,ENGLAND									BULSTRODE CJK, 1992, 1990 P I MECH ENG JO; SMITH EHJ, 1964, J BONE JOINT SURG BR, V46, P664; Thomas HO, 1976, J BONE JOINT SURG BR, V58, P135; 1977, BRIT MED J, V2, P1620	4	8	8	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	FEB 5	1994	308	6925					390	390		10.1136/bmj.308.6925.390	http://dx.doi.org/10.1136/bmj.308.6925.390			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MV862	8179681	Green Published			2022-12-28	WOS:A1994MV86200023
J	HALL, RR; PARMAR, MKB; RICHARDS, AB; SMITH, PH				HALL, RR; PARMAR, MKB; RICHARDS, AB; SMITH, PH			PROPOSAL FOR CHANGES IN CYSTOSCOPIC FOLLOW-UP OF PATIENTS WITH BLADDER-CANCER AND ADJUVANT INTRAVESICAL CHEMOTHERAPY	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TRANSITIONAL CELL-CARCINOMA; RESEARCH-COUNCIL SUBGROUP; WORKING PARTY; RECURRENCE	A famous surgeon observed that the most important instrument for the management of superficial bladder cancer was a typewriter because it facilitated the organisation of the regular follow up examinations that are so important in controlling this disease. Cystoscopic follow up must be lifelong, and the cost, in the broadest sense, to both patient and health service is considerable. A recent study has suggested that the conventional frequency of bladder examinations may not be necessary and that most patients could be spared many cystoscopies. Instillation of cytotoxic drugs in the bladder has been shown to reduce the recurrence of tumours destroyed endoscopically and the development of new tumours elsewhere in the bladder. Because intravesical instillations are inconvenient, expensive, and may be toxic they have been reserved for patients thought to be at greatest risk of recurrence. However, two clinical trials have shown that a single cytotoxic instillation may be beneficial for low risk patients. If this is verified in everyday practice, the routine use of intravesical chemotherapy for all patients at the time of initial treatment could reduce the need for cystoscopies even further. Such changes should improve the quality of life of the 7000 new patients with superficial bladder cancer each year in England and Wales and allow savings to be made in the NHS.	MRC, CANC TRIALS OFF, CAMBRIDGE CB2 2BB, ENGLAND; BASINGSTOKE DIST GEN HOSP, BASINGSTOKE RG24 9NA, ENGLAND; ST JAMES UNIV HOSP, LEEDS LS9 7TF, W YORKSHIRE, ENGLAND	Saint James's University Hospital	HALL, RR (corresponding author), FREEMAN RD HOSP, NEWCASTLE UPON TYNE NE7 7DN, TYNE & WEAR, ENGLAND.							ABEL PD, 1988, BRIT J UROL, V62, P339, DOI 10.1111/j.1464-410X.1988.tb04361.x; BIRCH BRP, 1989, BRIT J UROL, V64, P109, DOI 10.1111/j.1464-410X.1989.tb05967.x; BOUFFIOUX C, 1991, SCAND J UROL NEPHROL, P167; KURTH KH, 1984, J UROLOGY, V132, P258, DOI 10.1016/S0022-5347(17)49582-6; Kurth KH, 1992, PROBL UROL, V6, P471; NEWLING D, 1990, BRIT J CANCER, V61, P497, DOI 10.1038/bjc.1990.112; OOSTERLINCK W, 1993, J UROLOGY, V149, P749, DOI 10.1016/S0022-5347(17)36198-0; PARMAR MKB, 1989, J UROLOGY, V142, P284, DOI 10.1016/S0022-5347(17)38731-1; RICHARDS B, 1991, BRIT J UROL, V67, P369, DOI 10.1111/j.1464-410X.1991.tb15164.x; ROBERTSON AJ, 1990, J CLIN PATHOL, V43, P17, DOI 10.1136/jcp.43.1.17; SCHULMAN CC, 1982, EUR UROL, V8, P207, DOI 10.1159/000473519; TOLLEY DA, 1988, BRIT MED J, V296, P1759, DOI 10.1136/bmj.296.6639.1759; TOLLEY DA, 1993, 49 ANN M BRIT ASS UR, P46; 1992, TNM CLASSIFICATION T	14	63	63	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	1994	308	6923					257	260		10.1136/bmj.308.6923.257	http://dx.doi.org/10.1136/bmj.308.6923.257			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MT539	8179678	Green Published			2022-12-28	WOS:A1994MT53900026
J	ALBERG, DG; SCHREIBER, SL				ALBERG, DG; SCHREIBER, SL			STRUCTURE-BASED DESIGN OF A CYCLOPHILIN-CALCINEURIN BRIDGING LIGAND	SCIENCE			English	Article							CIS-TRANS ISOMERASE; CYCLOSPORINE-A; CONFORMATION; BINDING; IMMUNOPHILIN; INHIBITION; MECHANISM; PATHWAYS; RECEPTOR; MODEL	The affinity of a flexible ligand that adopts a specific conformation when bound to its receptor should be increased with the appropriate use of conformational restraints. By determining the structure of protein-ligand complexes, such restraints can in principle be designed into the bound ligand in a rational way. A tricyclic variant (TCsA) of the immunosuppressant cyclosporin A (CsA), which inhibits the proliferation of T lymphocytes by forming a cyclophilin-CsA-calcineurin complex, was designed with the known three-dimensional structure of a cyclophilin-CsA complex. The conformational restraints in TCsA appear to be responsible for its greater affinity for cyclophilin and calcineurin relative to CsA.	HARVARD UNIV,DEPT CHEM,CAMBRIDGE,MA 02138	Harvard University					NIGMS NIH HHS [GM-38627] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038627, R37GM038627] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AEBI JD, 1988, J MED CHEM, V31, P1805, DOI 10.1021/jm00117a022; ANDRUS MN, UNPUB; BALDWIN JE, 1986, TETRAHEDRON, V42, P6551, DOI 10.1016/S0040-4020(01)88118-7; BIERER BE, 1990, P NATL ACAD SCI USA, V87, P9231, DOI 10.1073/pnas.87.23.9231; FESIK SW, 1991, BIOCHEMISTRY-US, V30, P6574, DOI 10.1021/bi00240a030; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; JORGENSEN WL, 1991, SCIENCE, V254, P954, DOI 10.1126/science.1719636; KESSLER H, 1990, HELV CHIM ACTA, V73, P1818, DOI 10.1002/hlca.19900730703; KOFRON JL, 1991, BIOCHEMISTRY-US, V30, P6127, DOI 10.1021/bi00239a007; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; LIPTON MJ, COMMUNICATION; LIU J, 1992, BIOCHEMISTRY-US, V31, P3896, DOI 10.1021/bi00131a002; LOOSLI HR, 1985, HELV CHIM ACTA, V68, P682, DOI 10.1002/hlca.19850680319; MANALAN AS, 1983, P NATL ACAD SCI-BIOL, V80, P4291, DOI 10.1073/pnas.80.14.4291; MCCAFFREY PG, 1993, J BIOL CHEM, V268, P3747; PATCHETT AA, 1992, J ANTIBIOT, V45, P94, DOI 10.7164/antibiotics.45.94; PFLUGL G, 1993, NATURE, V361, P91, DOI 10.1038/361091a0; ROSEN MK, 1993, J AM CHEM SOC, V115, P821, DOI 10.1021/ja00055a082; SCHOLTZ JM, 1989, SYNTHESIS-STUTTGART, P542; SCHREIBER SL, 1988, TETRAHEDRON LETT, V29, P6577, DOI 10.1016/S0040-4039(00)82401-6; SCHREIBER SL, 1992, CELL, V70, P365, DOI 10.1016/0092-8674(92)90158-9; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; SIGAL NH, 1991, J EXP MED, V173, P619, DOI 10.1084/jem.173.3.619; SPITZFADEN C, 1992, FEBS LETT, V300, P291, DOI 10.1016/0014-5793(92)80866-F; TAKAHASHI N, 1989, NATURE, V337, P473, DOI 10.1038/337473a0; THERIAULT Y, 1993, NATURE, V361, P88, DOI 10.1038/361088a0; WEBER C, 1991, BIOCHEMISTRY-US, V30, P6563, DOI 10.1021/bi00240a029; WENGER R, 1985, TRANSPLANT P, V18, P213; WUTHRICH K, 1991, SCIENCE, V254, P953, DOI 10.1126/science.1948082; YANG D, 1993, J AM CHEM SOC, V115, P819, DOI 10.1021/ja00055a081; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903; [No title captured]	34	57	74	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 8	1993	262	5131					248	250		10.1126/science.8211144	http://dx.doi.org/10.1126/science.8211144			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA665	8211144				2022-12-28	WOS:A1993MA66500037
J	CHAIT, BT; WANG, R; BEAVIS, RC; KENT, SBH				CHAIT, BT; WANG, R; BEAVIS, RC; KENT, SBH			PROTEIN LADDER SEQUENCING	SCIENCE			English	Article							DESORPTION MASS-SPECTROMETRY; SOLID-PHASE PEPTIDE; LASER DESORPTION; MATRIX; ACID; HYDROLYSIS; PICOMOLE; ENZYME; SITE	A new approach to protein sequencing is described. It consists of two steps: (i) ladder-generating chemistry, the controlled generation from a polypeptide chain by wet chemistry of a family of sequence-defining peptide fragments, each differing from the next by one amino acid; and (ii) data readout, a one-step readout of the resulting protein sequencing ladder by matrix-assisted laser-desorption mass spectrometry. Each amino acid was identified from the mass difference between successive peaks, and the position in the data set defined the sequence of the original peptide chain. This method was used to directly locate a phosphoserine residue in a phosphopeptide. The protein ladder sequencing method lends itself to very high sample throughput at very low per cycle cost.	SCRIPPS RES INST, LA JOLLA, CA 92037 USA; ROCKEFELLER UNIV, NEW YORK, NY 10021 USA; MEM UNIV NEWFOUNDLAND, DEPT PHYS, ST JOHNS A1B 3X7, NEWFOUNDLAND, CANADA	Scripps Research Institute; Rockefeller University; Memorial University Newfoundland			Wang, Rong/A-8721-2009		NCRR NIH HHS [RR00862] Funding Source: Medline; NIGMS NIH HHS [GM38274] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038274] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AEBERSOLD R, 1991, ANAL BIOCHEM, V199, P51, DOI 10.1016/0003-2697(91)90268-X; AEBERSOLD R, 1990, ELECTROPHORESIS, V11, P517, DOI 10.1002/elps.1150110702; Beavis R C, 1989, Rapid Commun Mass Spectrom, V3, P432, DOI 10.1002/rcm.1290031207; Beavis R C, 1989, Rapid Commun Mass Spectrom, V3, P233, DOI 10.1002/rcm.1290030708; BEAVIS RC, 1990, ANAL CHEM, V62, P1836, DOI 10.1021/ac00216a020; BEAVIS RC, 1992, ORG MASS SPECTROM, V27, P156, DOI 10.1002/oms.1210270217; BIEMANN K, 1992, ANNU REV BIOCHEM, V61, P977, DOI 10.1146/annurev.bi.61.070192.004553; CHAIT BT, 1992, SCIENCE, V257, P1885, DOI 10.1126/science.1411504; CHAIT BT, 1987, METHODS PROTEIN SEQU, P483; EDMAN P, 1949, ARCH BIOCHEM, V22, P475; EDMAN P, 1950, ACTA CHEM SCAND, V4, P283, DOI 10.3891/acta.chem.scand.04-0283; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; HEWICK RM, 1981, J BIOL CHEM, V256, P7990; HILLENKAMP F, 1991, ANAL CHEM, V63, pA1193; HUNKAPILLER MW, 1986, MICROCHARACTERIZATIO, P223; INGLIS AS, 1991, ANAL BIOCHEM, V195, P183, DOI 10.1016/0003-2697(91)90316-L; KARAS M, 1987, INT J MASS SPECTROM, V78, P53, DOI 10.1016/0168-1176(87)87041-6; KATAKUSE I, 1982, BIOMED MASS SPECTROM, V9, P64, DOI 10.1002/bms.1200090204; Konigsberg W, 1972, Methods Enzymol, V25, P326, DOI 10.1016/S0076-6879(72)25028-5; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MILTON RCD, 1992, SCIENCE, V256, P1445, DOI 10.1126/science.1604320; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; PROUD CG, 1977, FEBS LETT, V80, P435, DOI 10.1016/0014-5793(77)80493-6; RYLATT DB, 1979, FEBS LETT, V98, P71, DOI 10.1016/0014-5793(79)80154-4; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Schroeder W A, 1972, Methods Enzymol, V25, P298, DOI 10.1016/S0076-6879(72)25026-1; SELF R, 1983, BIOMED MASS SPECTROM, V10, P78, DOI 10.1002/bms.1200100206; SHIVELY JE, 1989, TRENDS BIOCHEM SCI, V14, P246, DOI 10.1016/0968-0004(89)90056-X; SMITH LA, 1983, BIOMED MASS SPECTROM, V10, P98, DOI 10.1002/bms.1200100210; Tarr G E, 1977, Methods Enzymol, V47, P335; TEMPST P, 1989, ANAL BIOCHEM, V183, P290, DOI 10.1016/0003-2697(89)90482-X; TOTTY NF, 1992, PROTEIN SCI, V1, P1215, DOI 10.1002/pro.5560010914; TSUGITA A, 1992, EUR J BIOCHEM, V206, P691, DOI 10.1111/j.1432-1033.1992.tb16975.x; Wang R., UNPUB; WETTENHALL REH, 1991, METHOD ENZYMOL, V201, P186; WONG SC, 1993, TECHNIQUES PROTEIN C, V4, P371; YAN SCB, 1989, TRENDS BIOCHEM SCI, V14, P264, DOI 10.1016/0968-0004(89)90060-1	38	261	277	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 1	1993	262	5130					89	92		10.1126/science.8211132	http://dx.doi.org/10.1126/science.8211132			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ635	8211132	Green Submitted			2022-12-28	WOS:A1993LZ63500027
J	LAMBE, M; HSIEH, CC; TRICHOPOULOS, D; EKBOM, A; PAVIA, M; ADAMI, HO				LAMBE, M; HSIEH, CC; TRICHOPOULOS, D; EKBOM, A; PAVIA, M; ADAMI, HO			TRANSIENT INCREASE IN THE RISK OF BREAST-CANCER AFTER GIVING BIRTH	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FULL-TERM PREGNANCY; REPRODUCTIVE FACTORS; AGE; PARITY; DIAGNOSIS; 1ST	Background. The effect of pregnancy on the risk of breast cancer is not clear. We tested the hypothesis that the risk of breast cancer increases transiently after pregnancy but then falls to a level below that of age-matched nulliparous women. Methods. We conducted a case-control study of a nationwide cohort in Sweden, using a computerized record linkage between the Cancer Registry and the Fertility Registry. The study; subjects were women born from 1925 through 1960 who were resident citizens of Sweden at the time of the 1960 census. A total of 12,666 patients with breast cancer were compared with 62,121 age-matched control subjects. We used conditional logistic regression to estimate odds ratios for the development of breast cancer at different ages, according to maternal age at first delivery (in uniparous as compared with nulliparous women) and age at second delivery (in biparous as compared with uniparous women). Results. Uniparous women were at higher risk of breast cancel than nulliparous women for up to 15 years after childbirth and at lower risk thereafter. The excess risk was most pronounced among women who were older at the time of their first delivery (odds ratio 5 years after delivery among women 35 years old at first delivery, 1.26; 95 percent confidence interval, 1.10 to 1.44). Women who had two pregnancies had a less striking increase in risk. Conclusions. Pregnancy has a dual effect on the risk of breast cancer: it transiently increases the risk after childbirth but reduces the risk in later years. In women with two pregnancies, the short-term adverse effect is masked by the long-term protection imparted by the first pregnancy. A plausible biologic interpretation is that pregnancy increases the short-term risk of breast dancer by stimulating the growth of cells that have undergone the early stages of malignant transformation but that it confers longterm protection by inducing the differentiation of normal mammary stem cells that have the potential for neoplastic change.	UNIV UPPSALA HOSP,CANC EPIDEMIOL UNIT,S-75185 UPPSALA,SWEDEN; HARVARD UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,BOSTON,MA 02115; UNIV REGGIO CALABRIA,FAC MED CATANZARO,CATTEDRA IGIENE,CATANZARO,ITALY	Uppsala University; Uppsala University Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Magna Graecia University of Catanzaro; Universita Mediterranea di Reggio Calabria	LAMBE, M (corresponding author), UNIV UPPSALA HOSP,DEPT SOCIAL MED,S-75185 UPPSALA,SWEDEN.			PAVIA, Maria/0000-0003-3879-1322; Lambe, Mats/0000-0002-4624-3767				Adami H O, 1990, Int J Cancer Suppl, V5, P22; BERNSTEIN L, 1986, J NATL CANCER I, V76, P1035; Breslow N. E., 1980, IARC SCI PUBLICATION, V32; BRUZZI P, 1988, BRIT MED J, V297, P1096, DOI 10.1136/bmj.297.6656.1096; HSIEH CC, 1990, INT J CANCER, V46, P796, DOI 10.1002/ijc.2910460508; JANERICH DT, 1982, AM J EPIDEMIOL, V116, P737, DOI 10.1093/oxfordjournals.aje.a113462; JOHANSSON L, 1983, 14 STAT SWED; KALACHE A, 1993, LANCET, V341, P33, DOI 10.1016/0140-6736(93)92497-H; KELSEY JL, 1993, EPIDEMIOL REV, V15, P36, DOI 10.1093/oxfordjournals.epirev.a036115; KVALE G, 1987, AM J EPIDEMIOL, V126, P842, DOI 10.1093/oxfordjournals.aje.a114721; KVALE G, 1987, AM J EPIDEMIOL, V126, P831, DOI 10.1093/oxfordjournals.aje.a114720; LOGAN WPD, 1953, LANCET, V2, P1199; LUBIN JH, 1982, J NATL CANCER I, V68, P211; MACMAHON B, 1993, CANCER, V71, P3185, DOI 10.1002/1097-0142(19930515)71:10<3185::AID-CNCR2820711047>3.0.CO;2-C; MANTEL N, 1959, J NATL CANCER I, V22, P719; MILLER WR, 1993, LANCET, V341, P25, DOI 10.1016/0140-6736(93)92489-G; NEGRI E, 1988, AM J EPIDEMIOL, V128, P1207, DOI 10.1093/oxfordjournals.aje.a115075; PANAGIOTOPOULOU K, 1990, CANCER CAUSE CONTROL, V1, P119, DOI 10.1007/BF00053162; PATHAK DR, 1986, INT J CANCER, V37, P21, DOI 10.1002/ijc.2910370105; PIKE MC, 1983, NATURE, V303, P767, DOI 10.1038/303767a0; ROSNER B, 1994, AM J EPIDEMIOL, V139, P819, DOI 10.1093/oxfordjournals.aje.a117079; RUSSO J, 1990, LAB INVEST, V62, P244; Russo J, 1982, Breast Cancer Res Treat, V2, P5, DOI 10.1007/BF01805718; TRICHOPOULOS D, 1983, INT J CANCER, V31, P701, DOI 10.1002/ijc.2910310604; VATTEN LJ, 1992, EUR J CANCER, V28A, P1148, DOI 10.1016/0959-8049(92)90476-I; Walker AM, 1991, OBSERVATION INFERENC; WILLIAMS EMI, 1990, BRIT MED J, V300, P578, DOI 10.1136/bmj.300.6724.578; WOODS KL, 1980, BRIT MED J, V281, P419, DOI 10.1136/bmj.281.6237.419; 1951, STATISTICAL ABSTRACT; 1989, 70 NAT BOARD HLTH WE; 1990, CANCER INCIDENCE SWE; 1962, CENSUS POPULATION 19, V4	32	407	417	0	8	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	1994	331	1					5	9		10.1056/NEJM199407073310102	http://dx.doi.org/10.1056/NEJM199407073310102			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NU951	8202106				2022-12-28	WOS:A1994NU95100002
J	GALLI, M; TEMPORELLI, P				GALLI, M; TEMPORELLI, P			NEGATIVE U-WAVES AS AN INDICATOR OF STRESS-INDUCED MYOCARDIAL-ISCHEMIA	NEW ENGLAND JOURNAL OF MEDICINE			English	Note											GALLI, M (corresponding author), FDN CLIN LAVORO,I-28010 VERUNO,ITALY.		Temporelli, Pier Luigi/AAB-9754-2020	Temporelli, Pier Luigi/0000-0002-6220-2471					0	2	2	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 23	1994	330	25					1791	1791						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR295	8190156				2022-12-28	WOS:A1994NR29500005
J	WEN, L; ROBERTS, SJ; VINEY, JL; WONG, FS; MALLICK, C; FINDLY, RC; PENG, QS; CRAFT, JE; OWEN, MJ; HAYDAY, AC				WEN, L; ROBERTS, SJ; VINEY, JL; WONG, FS; MALLICK, C; FINDLY, RC; PENG, QS; CRAFT, JE; OWEN, MJ; HAYDAY, AC			IMMUNOGLOBULIN-SYNTHESIS AND GENERALIZED AUTOIMMUNITY IN MICE CONGENITALLY DEFICIENT IN ALPHA-BETA(+)T CELLS	NATURE			English	Article							B-CELL; DNA ANTIBODIES; ALPHA-BETA; AUTOANTIBODIES; REPERTOIRE; RECEPTOR; IGM; EXPRESSION; INFECTION; STRAINS	Through cognate B-cell-T-cell interactions and provision of cytokines, CD4(+) T-cell antigen receptor (TCR) alpha beta(+) T cells regulate immunoglobulin isotype synthesis(1), Murine IgG1 and IgE secretion is therefore substantially T-cell-dependent, whereas IgM and IgG3 secretion is not(2,3). Here we report that in the absence of alpha beta T cells, B cells expand, differentiate and secrete copious amounts of antibodies of 'T-dependent' isotypes. Moreover, the antibodies are reactive towards self-antigens, as in patients with systemic lupus erythematosus, so autoantibodies of 'T-dependent' type can develop without the help of CD4(+) alpha beta T cells. This phenotype is not evident in mice or humans that ape congenitally deficient in specific alpha beta T-cell functions, but bears comparison with B-cell hyperactivity and autoimmunity in transplant rejection and in immunodeficiencies such as AIDS(4,5).	YALE UNIV,IMMUNOBIOL SECT,NEW HAVEN,CT 06511; YALE UNIV,RHEUMATOL SECT,NEW HAVEN,CT 06511; IMPERIAL CANC RES FUND,LONDON WC2A 3PX,ENGLAND; PFIZER INC,DIV CENT RES,GROTON,CT 06340	Yale University; Yale University; Cancer Research UK; Pfizer	WEN, L (corresponding author), YALE UNIV,DEPT BIOL,219 PROSPECT ST,NEW HAVEN,CT 06511, USA.			Wen, Li/0000-0002-8805-2934; Wong, F. Susan/0000-0002-2812-8845				ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; DEPAOLI P, 1991, CLIN EXP IMMUNOL, V83, P187, DOI 10.1111/j.1365-2249.1991.tb05612.x; DRESSER DW, 1978, NATURE, V274, P480, DOI 10.1038/274480a0; FATENEJAD S, 1993, P NATL ACAD SCI USA, V90, P12010, DOI 10.1073/pnas.90.24.12010; FISH F, 1982, J IMMUNOL, V128, P409; GOLDMAN M, 1991, IMMUNOL TODAY, V12, P223, DOI 10.1016/0167-5699(91)90034-Q; GOODNOW CC, 1992, ANNU REV IMMUNOL, V10, P489, DOI 10.1146/annurev.iy.10.040192.002421; ISAKSON PC, 1982, J EXP MED, V155, P734, DOI 10.1084/jem.155.3.734; JEVNIKAR AM, 1994, J EXP MED, V179, P1137, DOI 10.1084/jem.179.4.1137; KIKUTANI H, 1986, CELL, V47, P657, DOI 10.1016/0092-8674(86)90508-8; KLINMAN DM, 1990, J IMMUNOL, V144, P506; KLINMAN DM, 1992, J IMMUNOL, V148, P1353; KOH DR, 1992, SCIENCE, V256, P1210, DOI 10.1126/science.256.5060.1210; KORTHAUER U, 1993, NATURE, V361, P539, DOI 10.1038/361539a0; LIKE A, 1988, DIABETES, V31, P816; MARTINEZALONSO C, 1980, EUR J IMMUNOL, V10, P698, DOI 10.1002/eji.1830100908; MOMBAERTS P, 1993, NATURE, V365, P53, DOI 10.1038/365053a0; MORROW WJW, 1991, CLIN IMMUNOL IMMUNOP, V58, P163, DOI 10.1016/0090-1229(91)90134-V; PHILPOTT KL, 1992, SCIENCE, V256, P1448, DOI 10.1126/science.1604321; PRITCHARD H, 1973, CLIN EXP IMMUNOL, V13, P125; PURKERSON JM, 1992, J EXP MED, V175, P973, DOI 10.1084/jem.175.4.973; RAJAGOPALAN S, 1990, P NATL ACAD SCI USA, V87, P7020, DOI 10.1073/pnas.87.18.7020; SANO Y, 1993, IMMUNOLOGY, V80, P388; SHLOMCHIK M, 1990, J EXP MED, V171, P265, DOI 10.1084/jem.171.1.265; SOUROUJON M, 1988, J IMMUNOL, V140, P4173; TSUJI M, 1994, P NATL ACAD SCI USA, V91, P345, DOI 10.1073/pnas.91.1.345; VANSNICK JL, 1980, J EXP MED, V151, P45, DOI 10.1084/jem.151.1.45; WORTIS HH, 1968, NATURE, V220, P927	29	159	161	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 23	1994	369	6482					654	658		10.1038/369654a0	http://dx.doi.org/10.1038/369654a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NT459	8208291				2022-12-28	WOS:A1994NT45900057
J	HALL, JC				HALL, JC			THE MATING OF A FLY	SCIENCE			English	Review							MALE DROSOPHILA-MELANOGASTER; ON-TRANSIENT-A; SEXUALLY DIMORPHIC NEURONS; MOTH MANDUCA-SEXTA; GENETIC-CONTROL; COURTSHIP SONG; MOLECULAR ANALYSIS; MUTANT DROSOPHILA; NERVOUS-SYSTEM; LOVE SONG	Courtship in Drosophila is influenced by a wide variety of genes, in that many different kinds of pleiotropic mutations lead to defective courtship. This may seem to be a truism, but the broad temporal and spatial expression of most of the fly's ''neuro genes'' makes it difficult to exclude elements of such genes' actions as materially underlying reproductive behavior. ''Courtship genes'' that seem to play more particular roles were originally identified as sensory, learning, or rhythm mutations; their reproductive abnormalities have been especially informative for revealing components of male or female actions that might otherwise have gone unnoticed. Further behavioral mutations seemed originally to be courtship-specific, turned out not to have that property, and have led to a broadened perspective on the nature and action of Drosophila's sex-determination genes.			HALL, JC (corresponding author), BRANDEIS UNIV, DEPT BIOL, WALTHAM, MA 02254 USA.				NIGMS NIH HHS [GM-21473] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021473] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACKERMAN SL, 1986, J NEUROGENET, V3, P111, DOI 10.3109/01677068609106898; AIGAKI T, 1991, NEURON, V7, P557, DOI 10.1016/0896-6273(91)90368-A; ANTONY C, 1985, J CHEM ECOL, V11, P1617, DOI 10.1007/BF01012116; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; BAKER BS, 1989, NATURE, V340, P521, DOI 10.1038/340521a0; BALLING A, 1987, J NEUROGENET, V4, P65, DOI 10.3109/01677068709102334; BARTON RT, 1985, J APPL ELECTROCHEM, V15, P399, DOI 10.1007/BF00615992; BASTOCK M, 1956, EVOLUTION, V10, P421, DOI 10.2307/2407002; BATE M, 1993, DEV DROSOPHILA MELAN, V1, pCH4; BATE M, 1993, DEV DROSOPHILA MELAN, V2, pCH18; Begg M., 1951, Nature London, V168, P953, DOI 10.1038/168953a0; BELLEN HJ, 1990, BIOESSAYS, V12, P199, DOI 10.1002/bies.950120502; BELLEN HJ, 1987, DEV BIOL, V121, P432, DOI 10.1016/0012-1606(87)90180-1; BELLEN HJ, 1987, GENETICS, V115, P153; BELLEN HJ, 1992, GENETICS, V131, P365; BELOTE JM, 1987, P NATL ACAD SCI USA, V84, P8026, DOI 10.1073/pnas.84.22.8026; BENNETCLARK HC, 1970, SCI AM, V223, P84, DOI 10.1038/scientificamerican0770-84; BERNSTEIN AS, 1992, J INSECT BEHAV, V5, P15, DOI 10.1007/BF01049155; BIEL M, 1990, FEBS LETT, V269, P409, DOI 10.1016/0014-5793(90)81205-3; BLACK BC, 1988, PROGR CATECHOLAMINE, P297; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BOAKE CRB, 1991, TRENDS ECOL EVOL, V6, P225, DOI 10.1016/0169-5347(91)90027-U; BOUHOUCHE A, 1993, CAN J ZOOL, V71, P985, DOI 10.1139/z93-130; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRUNDLE S, 1986, FLY; BRUNNER A, 1992, J NEUROGENET, V8, P43, DOI 10.3109/01677069209167271; BURNET B, 1980, GENET RES, V36, P235, DOI 10.1017/S0016672300019868; Burtis K.C., 1992, SEMIN DEV BIOL, V3, P331; Burtis KC, 1993, CURR OPIN CELL BIOL, V5, P1006, DOI 10.1016/0955-0674(93)90085-5; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; CARLSON J, 1991, TRENDS NEUROSCI, V14, P520, DOI 10.1016/0166-2236(91)90004-E; CASTRILLON DH, 1993, GENETICS, V135, P489; CAYRE M, 1994, NATURE, V368, P57, DOI 10.1038/368057a0; CHALMERS DE, 1993, BIOESSAYS, V15, P755, DOI 10.1002/bies.950151110; CLINE TW, 1993, TRENDS GENET, V9, P385, DOI 10.1016/0168-9525(93)90138-8; CLINE TW, 1989, CELL, V59, P231, DOI 10.1016/0092-8674(89)90280-8; COBB M, 1990, ANIM BEHAV, V39, P1058, DOI 10.1016/S0003-3472(05)80778-X; COBB M, 1986, BEHAVIOUR, V97, P182, DOI 10.1163/156853986X00379; CONNOLLY K, 1973, BEHAVIOUR, V52, P155; COOK R, 1975, NATURE, V254, P241, DOI 10.1038/254241a0; COOK R, 1980, BIOL CYBERN, V37, P41, DOI 10.1007/BF00347641; Cowan T.M., 1984, Journal of Neurogenetics, V1, P333, DOI 10.3109/01677068409107095; COWAN TM, 1986, J NEUROGENET, V3, P187, DOI 10.3109/01677068609106849; COWLING DE, 1981, ANIM BEHAV, V29, P924, DOI 10.1016/S0003-3472(81)80030-9; DAVIS RL, 1991, TRENDS GENET, V7, P224, DOI 10.1016/0168-9525(91)90369-2; DAVIS RL, 1993, NEURON, V11, P1, DOI 10.1016/0896-6273(93)90266-T; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; DEVAY P, 1989, J NEUROGENET, V5, P119, DOI 10.3109/01677068909066202; DONG BH, 1993, NUCLEIC ACIDS RES, V21, P4085, DOI 10.1093/nar/21.17.4085; DUERR JS, 1982, P NATL ACAD SCI-BIOL, V79, P3646, DOI 10.1073/pnas.79.11.3646; DUFFY JB, 1994, ADV GENET, V31, P1, DOI 10.1016/S0065-2660(08)60394-6; DUNLAP JC, 1993, ANNU REV PHYSIOL, V55, P683, DOI 10.1146/annurev.physiol.55.1.683; EHRMAN L, 1978, GENETICS BIOL DROS B, V2, P127; EWING AW, 1978, PHYSIOL ENTOMOL, V3, P33, DOI 10.1111/j.1365-3032.1978.tb00129.x; FERVEUR JF, 1993, NATURWISSENSCHAFTEN, V80, P474, DOI 10.1007/BF01136042; FERVEUR JF, 1993, GENETICS, V133, P561; FERVEUR JF, 1989, NEUROBIOLOGY OF SENSORY SYSTEMS, P397; FERVEUR JF, UNPUB; FISCHBACH KF, 1984, J EXP BIOL, V112, P65; FOWLER GL, 1973, ADV GENET, V17, P293, DOI 10.1016/S0065-2660(08)60173-X; FREEMAN M, 1991, Current Biology, V1, P378, DOI 10.1016/0960-9822(91)90199-7; GAILEY DA, 1985, GENETICS, V111, P795; GAILEY DA, 1991, DEVELOPMENT, V113, P879; GAILEY DA, 1986, BEHAV GENET, V16, P375, DOI 10.1007/BF01071319; GAILEY DA, 1989, GENETICS, V121, P773; GAILEY DA, 1991, J COMP PHYSIOL A, V169, P685; GANETZKY B, 1994, INSECT NEUROCHEMISTRY AND NEUROPHYSIOLOGY 1993, P9; Ganetzky B, 1983, J NEUROGENET, V1, P17, DOI 10.3109/01677068309107069; GEER BW, 1962, AM NAT, V96, P175, DOI 10.1086/282220; GIEBULTOWICZ JM, 1984, J COMP NEUROL, V226, P87, DOI 10.1002/cne.902260107; GILL KULBIR S., 1963, AMER ZOOL, V3, P507; GOODWIN SF, 1993, J NEUROGENET, V8, P232; GREENACRE ML, 1993, BEHAV GENET, V23, P85, DOI 10.1007/BF01067557; GRIFFITH LC, 1993, NEURON, V10, P501, DOI 10.1016/0896-6273(93)90337-Q; GRIFFITH LC, IN PRESS P NATL ACAD; GROMKO MH, 1984, SPERM COMPETITION EV, P373; Grossfield J., 1975, HDB GENETICS, V3, P679; GROSSFIELD JOSEPH, 1966, UNIV TEX PUBLIN STUDIES ON GENETICS III MORGAN CENTENNIAL ISSUE, V6615, P147; HALL JC, 1984, DEV GENET, V4, P355; HALL JC, 1982, Q REV BIOPHYS, V15, P223, DOI 10.1017/S0033583500004844; HALL JC, 1986, TRENDS NEUROSCI, V9, P414, DOI 10.1016/0166-2236(86)90135-9; HALL JC, 1978, BEHAV GENET, V8, P125, DOI 10.1007/BF01066870; HALL JC, 1990, DEV BEHAVIOR GENETIC, P100; HALL JC, 1979, SOC NEUROSCI S, V4, P1; HALL JC, 1980, STADLER S, V12, P43; HARDIE RC, 1986, TRENDS NEUROSCI, V9, P419, DOI 10.1016/0166-2236(86)90136-0; HEISENBERG M, 1978, J COMP PHYSIOL, V124, P287, DOI 10.1007/BF00661379; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; HEISENBERG M, 1990, DEV BEHAVIOR DROSOPH, P373; HEISENBERG M, 1984, GENETICS MICROBEHAVI; HOMYK T, 1980, MOL GEN GENET, V177, P553; HOY RR, 1974, AM ZOOL, V14, P1067; Jallon J.-M., 1986, Advances in Invertebrate Reproduction, V4, P445; JALLON JM, 1988, GENET RES, V51, P17, DOI 10.1017/S0016672300023892; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; JALLON JM, 1987, EVOLUTION, V41, P294, DOI 10.1111/j.1558-5646.1987.tb05798.x; JOHNSON CD, 1981, GENETICS, V97, P261; JONES KR, 1990, NEURON, V4, P711, DOI 10.1016/0896-6273(90)90197-N; KAISER K, 1993, CURR BIOL, V3, P560, DOI 10.1016/0960-9822(93)90058-V; KALB JM, 1993, P NATL ACAD SCI USA, V90, P8093, DOI 10.1073/pnas.90.17.8093; KANDEL ER, 1987, SYNAPTIC FUNCTION, P471; KOCH WJ, 1990, J BIOL CHEM, V265, P17786; KONOPKA RJ, 1987, ANNU REV GENET, V21, P227, DOI 10.1146/annurev.genet.21.1.227; KUBLI E, 1992, BIOESSAYS, V14, P779, DOI 10.1002/bies.950141111; KUBLI E, 1983, GENE BRAIN BEHAVIOR, P99; KULKARNI SJ, 1987, GENETICS, V115, P461; KULKARNI SJ, 1988, GENETICS, V118, P267; KYRIACOU CP, 1982, ANIM BEHAV, V30, P794, DOI 10.1016/S0003-3472(82)80152-8; KYRIACOU CP, 1990, BEHAV GENET, V20, P617, DOI 10.1007/BF01065875; KYRIACOU CP, 1992, AM ZOOL, V32, P31; KYRIACOU CP, 1981, ANIM BEHAV, V29, P462, DOI 10.1016/S0003-3472(81)80106-6; KYRIACOU CP, 1980, P NATL ACAD SCI-BIOL, V77, P6729, DOI 10.1073/pnas.77.11.6729; KYRIACOU CP, 1984, NATURE, V308, P62, DOI 10.1038/308062a0; KYRIACOU CP, 1990, HEREDITY, V64, P395, DOI 10.1038/hdy.1990.50; KYRIACOU CP, 1994, TRENDS GENET, V10, P69, DOI 10.1016/0168-9525(94)90218-6; KYRIACOU CP, 1986, SCIENCE, V232, P494, DOI 10.1126/science.3083506; LAWRENCE PA, 1984, CELL, V36, P775, DOI 10.1016/0092-8674(84)90357-X; LAWRENCE PA, 1986, CELL, V45, P505, DOI 10.1016/0092-8674(86)90282-5; LILLY M, 1994, GENETICS, V136, P1087; LILLY M, 1994, DEV BIOL, V162, P1, DOI 10.1006/dbio.1994.1061; LILLY M, 1990, GENETICS, V124, P293; MANNING A, 1967, SCIENCE, V158, P136, DOI 10.1126/science.158.3797.136; MANNING A, 1967, ANIM BEHAV, V15, P239, DOI 10.1016/0003-3472(67)90006-1; MANNING A, 1962, NATURE, V194, P252, DOI 10.1038/194252a0; MANNING A., 1959, ANIMAL BEHAVIOR, V7, P60, DOI 10.1016/0003-3472(59)90031-4; Manning A., 1960, BEHAVIOUR, V15, P123, DOI DOI 10.1163/156853960X00133; MANNING A, 1965, VIEWPOINTS BIOL, V4, P125; MARKOW TA, 1987, P NATL ACAD SCI USA, V84, P6200, DOI 10.1073/pnas.84.17.6200; MARKOW TA, 1980, BEHAV NEURAL BIOL, V29, P276, DOI 10.1016/S0163-1047(80)90612-3; MARKOW TA, 1981, P NATL ACAD SCI-BIOL, V78, P430, DOI 10.1073/pnas.78.1.430; McKeown Michael, 1992, Current Opinion in Cell Biology, V4, P948, DOI 10.1016/0955-0674(92)90123-T; MCROBERT SP, 1991, J NEUROGENET, V7, P253, DOI 10.3109/01677069109167437; MCROBERT SP, 1988, EVOLUTION, V42, P1093, DOI 10.1111/j.1558-5646.1988.tb02528.x; MCROBERT SP, 1985, GENETICS, V111, P89; MLODZIK M, 1992, METHODS NEUROSCIENCE, V9, P397; NEWBY LM, 1991, J NEUROGENET, V7, P85, DOI 10.3109/01677069109066213; O'Kane CJ, 1992, CURR OPIN GENET DEV, V2, P602, DOI 10.1016/S0959-437X(05)80179-0; ODELL KMC, 1993, HEREDITY, V70, P393, DOI 10.1038/hdy.1993.55; OTOUSA JE, 1989, J NEUROGENET, V6, P41, DOI 10.3109/01677068909107099; PAGE TL, 1994, SCIENCE, V263, P1570, DOI 10.1126/science.8128243; PAILLETTE M, 1991, Bioacoustics, V3, P247; PAK WL, 1991, PROG CLIN BIOL RES, V362, P1; PATTON JG, 1993, GENE DEV, V7, P393, DOI 10.1101/gad.7.3.393; PEIXOTO AA, 1992, J MOL EVOL, V35, P411; PENNANECH M, 1991, ANN SOC ENTOMOL FR, V27, P245; PEREZREYES E, 1990, J BIOL CHEM, V265, P20430; PFLUGFELDER GO, 1990, GENETICS, V126, P91; PFLUGFELDER GO, 1992, P NATL ACAD SCI USA, V89, P1199, DOI 10.1073/pnas.89.4.1199; PHO DB, 1991, COMP BIOCHEM PHYS B, V100, P287, DOI 10.1016/0305-0491(91)90376-O; POSSIDENTE DR, 1989, DEV BIOL, V132, P448, DOI 10.1016/0012-1606(89)90241-8; RENDAHL KG, 1992, J NEUROSCI, V12, P390; RENDAHL KG, 1993, J NEUROGENET, V8, P246; RENDEL JM, 1951, EVOLUTION, V5, P226, DOI 10.2307/2405462; RIESGOESCOVAR J, 1992, J NEUROBIOL, V23, P947, DOI 10.1002/neu.480230803; ROBERTSON HM, 1983, EXPERIENTIA, V39, P333, DOI 10.1007/BF01955335; SALZ HK, 1982, GENETICS, V100, P587; SCHANER AM, 1989, J INSECT PHYSIOL, V35, P341, DOI 10.1016/0022-1910(89)90083-8; SCOTT D, 1990, ANIM BEHAV, V40, P891, DOI 10.1016/S0003-3472(05)80991-1; SCOTT D, 1987, J INSECT PHYSIOL, V33, P363, DOI 10.1016/0022-1910(87)90125-9; SCOTT D, 1988, J INSECT PHYSIOL, V34, P863, DOI 10.1016/0022-1910(88)90120-5; SCOTT D, 1993, J INSECT PHYSIOL, V39, P201, DOI 10.1016/0022-1910(93)90089-A; SCOTT D, 1988, ANIM BEHAV, V36, P1164, DOI 10.1016/S0003-3472(88)80075-7; SCOTT D, 1987, ANIM BEHAV, V35, P142, DOI 10.1016/S0003-3472(87)80219-1; SCOTT D, IN PRESS EVOLUTION; SEHGAL A, 1991, ANN NY ACAD SCI, V618, P1, DOI 10.1111/j.1749-6632.1991.tb27233.x; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; SENTRY JW, 1992, TRENDS GENET, V8, P329, DOI 10.1016/0168-9525(92)90267-8; SENTRY JW, 1993, BIOESSAYS, V15, P491, DOI 10.1002/bies.950150710; SIEGEL RW, 1984, BEHAV GENET, V14, P383, DOI 10.1007/BF01065442; SINGH RN, 1985, INT J INSECT MORPHOL, V14, P291; SLEE R, 1990, Q REV BIOL, V65, P175, DOI 10.1086/416718; SMITH LA, UNPUB; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; Spieth H.T., 1983, Genetics and Biology of Drosophila, V3c, P223; SPIETH HT, 1974, ANNU REV ENTOMOL, V19, P385, DOI 10.1146/annurev.en.19.010174.002125; STANEWSKY R, 1993, GENETICS, V135, P419; Steinmann-Zwicky M, 1990, Adv Genet, V27, P189; STOCKER RF, 1988, DEV BIOL, V127, P12, DOI 10.1016/0012-1606(88)90184-4; STOCKER RF, 1989, BEHAV GENET, V19, P371, DOI 10.1007/BF01066165; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STRAUSFELD NJ, 1984, PHOTORECEPTION VISIO, P483; STREISINGER G, 1948, EVOLUTION, V2, P187, DOI 10.2307/2405377; Sturtevant A. H., 1915, Journal of Animal Behavior Boston, V5, DOI 10.1037/h0074109; TAKAHASHI JS, 1992, SCIENCE, V258, P238, DOI 10.1126/science.1384127; TAYLOR BJ, 1992, DEVELOPMENT, V114, P625; TAYLOR BJ, 1992, GENETICS, V132, P179; TAYLOR BJ, 1989, J NEUROGENET, V5, P173, DOI 10.3109/01677068909066207; TAYLOR BJ, 1989, J NEUROGENET, V5, P193, DOI 10.3109/01677068909066208; TAYLOR BJ, IN PRESS DEV GENET; TAYLOR BJ, 1993, J NEUROGENET, V8, P251; Technau GM, 1984, J NEUROGENET, V1, P113, DOI 10.3109/01677068409107077; TEMPEL BL, 1984, P NATL ACAD SCI-BIOL, V81, P3577, DOI 10.1073/pnas.81.11.3577; THORN RS, 1989, J COMP NEUROL, V284, P489, DOI 10.1002/cne.902840402; TOMPKINS L, 1986, TRENDS GENET, V2, P14, DOI 10.1016/0168-9525(86)90162-9; Tompkins L., 1989, MBL (Marine Biology Laboratory) Lectures in Biology, V10, P229; TOMPKINS L, 1982, BEHAV GENET, V12, P295, DOI 10.1007/BF01067849; TOMPKINS L, 1980, J INSECT PHYSIOL, V26, P689, DOI 10.1016/0022-1910(80)90042-6; TOMPKINS L, 1983, BEHAV GENET, V13, P565, DOI 10.1007/BF01076402; TOMPKINS L, 1984, BEHAV GENET, V14, P411, DOI 10.1007/BF01065443; TOMPKINS L, 1989, GENETICS, V123, P535; TOMPKINS L, 1994, J NEUROGENET, V9, P207; TULLY T, 1994, SEMIN NEUROSCI, V6, P59; VAIAS LJ, 1993, BEHAV GENET, V23, P91, DOI 10.1007/BF01067558; VENARD R, 1989, NEUROBIOLOGY OF SENSORY SYSTEMS, P377; VILLELLA A, UNPUB; Von Schilcher F., 1976, Animal Behav, V24, P18, DOI 10.1016/S0003-3472(76)80095-4; von Schilcher F., 1977, Behavior Genet, V7, P251; VONBESSER H, 1990, CHROMOSOMA, V100, P37, DOI 10.1007/BF00337601; VONSCHILCHER F, 1976, BEHAV BIOL, V17, P187, DOI 10.1016/S0091-6773(76)90444-2; VONSCHILCHER F, 1979, J COMP PHYSIOL, V129, P85, DOI 10.1007/BF00679915; WANKER C, UNPUB; WEHRHAHN C, 1979, BIOL CYBERN, V32, P239, DOI 10.1007/BF00337647; WHEELER DA, 1988, BEHAV GENET, V18, P675, DOI 10.1007/BF01066850; WHEELER DA, 1989, BEHAV GENET, V19, P503, DOI 10.1007/BF01066251; WHEELER DA, 1991, SCIENCE, V251, P1082, DOI 10.1126/science.1900131; WITHERS GS, 1993, NATURE, V364, P238, DOI 10.1038/364238a0; WOLFNER MF, 1988, TRENDS GENET, V4, P333, DOI 10.1016/0168-9525(88)90052-2; Wu C F, 1992, Ion Channels, V3, P261; WU CF, 1983, SCIENCE, V220, P1076, DOI 10.1126/science.6302847; YAMAMOTO D, 1993, J NEUROGENET, V8, P152; YANG YS, 1993, MOL CELL BIOL, V13, P5593, DOI 10.1128/MCB.13.9.5593; ZAWISTOWSKI S, 1985, BEHAV GENET, V15, P561, DOI 10.1007/BF01065451; ZHU LQ, 1993, J BIOL CHEM, V268, P15994; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	226	528	541	3	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	1994	264	5166					1702	1714		10.1126/science.8209251	http://dx.doi.org/10.1126/science.8209251			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR600	8209251				2022-12-28	WOS:A1994NR60000032
J	HALL, A				HALL, A			A BIOCHEMICAL FUNCTION FOR RAS - AT LAST	SCIENCE			English	Editorial Material							PROTEIN-KINASE KINASE; ACTIVATION; RAF-1; ONCOGENE; DOMAIN		UNIV LONDON UNIV COLL,DEPT BIOCHEM,LONDON WC1E 6BT,ENGLAND	University of London; University College London	HALL, A (corresponding author), UNIV LONDON UNIV COLL,MRC,MOLEC CELL BIOL LAB,GOWER ST,LONDON WC1E 6BT,ENGLAND.							BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BONNER TI, 1985, MOL CELL BIOL, V5, P1400, DOI 10.1128/MCB.5.6.1400; DENT P, 1992, SCIENCE, V257, P1404, DOI 10.1126/science.1326789; DICKSON B, 1994, CURR OPIN GENET DEV, V4, P64, DOI 10.1016/0959-437X(94)90092-2; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; HANCOCK JF, 1989, CELL, V57, P1167, DOI 10.1016/0092-8674(89)90054-8; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; LEEVERS SJ, 1994, NATURE, V369, P411, DOI 10.1038/369411a0; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; MCCORMICK F, 1994, CURR OPIN GENET DEV, V4, P71, DOI 10.1016/0959-437X(94)90093-0; MENGSHENG Q, 1991, NEURON, V7, P937; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; SMITH MR, 1986, NATURE, V320, P540, DOI 10.1038/320540a0; STANTON VP, 1987, MOL CELL BIOL, V7, P1171, DOI 10.1128/MCB.7.3.1171; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; VANAELST L, 1993, P NATL ACAD SCI USA, V90, P6213, DOI 10.1073/pnas.90.13.6213; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; WARTMANN M, 1994, J BIOL CHEM, V269, P6695; ZHANG XF, 1993, NATURE, V364, P308, DOI 10.1038/364308a0	24	150	153	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 3	1994	264	5164					1413	1414		10.1126/science.8197454	http://dx.doi.org/10.1126/science.8197454			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NP221	8197454				2022-12-28	WOS:A1994NP22100030
J	WILKINS, RH				WILKINS, RH			NEUROLOGICAL SURGERY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BRAIN-STEM; THERAPY; GLIOMA; TUMORS; GENE; INJURIES; INVIVO; CELLS				WILKINS, RH (corresponding author), DUKE UNIV,MED CTR,DURHAM,NC, USA.							COHEN AR, 1993, NEUROSURGICAL OPERAT, V3, P435; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; EPSTEIN FJ, 1993, J NEUROSURG, V78, P408, DOI 10.3171/jns.1993.78.3.0408; EZZEDDINE ZD, 1991, NEW BIOL, V3, P608; KAMADA K, 1993, NEUROSURGERY, V33, P269, DOI 10.1227/00006123-199308000-00013; LAURENT JP, 1993, J NEUROSURG, V79, P197, DOI 10.3171/jns.1993.79.2.0197; MANWARING KH, 1991, NEUROSURGERY UPDATE, V2, P292; MARTIN N, 1992, CLIN NEUR, V38, P132; MARTUZA RL, 1991, SCIENCE, V252, P854, DOI 10.1126/science.1851332; OKA K, 1993, NEUROSURGERY, V33, P236, DOI 10.1227/00006123-199308000-00009; PIERREKAHN A, 1993, J NEUROSURG, V79, P845, DOI 10.3171/jns.1993.79.6.0845; POLLACK IF, 1993, J NEUROSURG, V78, P859, DOI 10.3171/jns.1993.78.6.0859; ROBERTSON DP, 1993, J NEUROSURG, V79, P238, DOI 10.3171/jns.1993.79.2.0238; SAMARDZIC M, 1992, J NEUROSURG, V76, P191, DOI 10.3171/jns.1992.76.2.0191; TAKAMIYA Y, 1993, J NEUROSURG, V79, P104, DOI 10.3171/jns.1993.79.1.0104; ZIMMERMAN RS, 1991, J NEUROSURG, V75, P32, DOI 10.3171/jns.1991.75.1.0032	17	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1684	1685						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182851				2022-12-28	WOS:A1994NN11700030
J	DONALDSON, LJ				DONALDSON, LJ			DOCTORS WITH PROBLEMS IN AN NHS WORKFORCE	BRITISH MEDICAL JOURNAL			English	Article							GMC	Objectives-To describe the incidence, nature, and implications of serious disciplinary problems among the medical staff of a large NHS hospital workforce. Design-Descriptive study with analysis of case records. Setting-Northern Health Region, an administrative area within-the NHS covering a population of three million. Subjects-Forty nine hospital doctors: 46 consultants and three associate specialists. Main outcome measures-The nature of the problems encountered within the doctors' practice, and the types of action taken by the employing authority. Results-Over a five year period concerns serious enough to warrant the consideration of disciplinary action were raised about 6% of all senior medical staff (49/850). Ninety six types of problem were encountered, and were categorised as poor attitude and disruptive or irresponsible behaviour (32), lack of commitment to duties (21), poor skills and inadequate knowledge (19), dishonesty (11), sexual matters (seven), disorganised practice and poor communication with colleagues (five), and other problems (one). Twenty five of the 49 doctors retired or left the employer's service, whereas 21 remained in employment after counselling or under supervision. Conclusions-Existing procedures for hospital doctors within the NHS are inadequate to deal with serious problems. Dealing with such problems requires experience, objectivity, and a willingness to tolerate unpleasantness and criticism. Because most consultants' contracts are now held by NHS trust hospitals, however, those who had developed skill over the years in handling these complex issues are now no longer involved.			DONALDSON, LJ (corresponding author), NO & YORKSHIRE REG HLTH AUTHOR,NE6 4PY NEWCASTLE TYNE,ENGLAND.							SAVAGE W, 1991, BRIT MED J, V303, P52, DOI 10.1136/bmj.303.6793.52-a; SMITH R, 1989, BRIT MED J, V298, P1502, DOI 10.1136/bmj.298.6686.1502; SMITH R, 1992, BRIT MED J, V304, P1257, DOI 10.1136/bmj.304.6837.1257; 1990, DOH HC909 DEP HLTH; 1993, 1992 GEN MED COUNC A; 1986, DHSS HC8213 DEP HLTH; 1986, HOSPITAL MED STAFFIN; 1992, PROPOSALS NEW PERFOR; 1961, MOH HM61112 MIN HLTH; 1989, 7 SECR STAT HLTH WAL	10	69	69	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 14	1994	308	6939					1277	1282		10.1136/bmj.308.6939.1277	http://dx.doi.org/10.1136/bmj.308.6939.1277			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM147	8205022	Green Published			2022-12-28	WOS:A1994NM14700022
J	POWER, C				POWER, C			NATIONAL TRENDS IN BIRTH-WEIGHT - IMPLICATIONS FOR FUTURE ADULT DISEASE	BRITISH MEDICAL JOURNAL			English	Article											POWER, C (corresponding author), INST CHILD HLTH,30 GUILFORD ST,LONDON WC1N 1EH,ENGLAND.							ALBERMAN E, 1991, ARCH DIS CHILD, V66, P1304, DOI 10.1136/adc.66.11.1304; ALBERMAN E, 1991, J ROY SOC MED, V84, P257, DOI 10.1177/014107689108400505; BARKER DJP, 1993, BRIT MED J, V306, P422, DOI 10.1136/bmj.306.6875.422; Barker DJP, 1992, FETAL INFANT ORIGINS; 1983, MORTALITY STATIS DH3	5	63	63	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 14	1994	308	6939					1270	1271		10.1136/bmj.308.6939.1270	http://dx.doi.org/10.1136/bmj.308.6939.1270			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM147	8205019	Green Published			2022-12-28	WOS:A1994NM14700018
J	NOVICK, D; COHEN, B; RUBINSTEIN, M				NOVICK, D; COHEN, B; RUBINSTEIN, M			THE HUMAN INTERFERON-ALPHA/BETA RECEPTOR - CHARACTERIZATION AND MOLECULAR-CLONING	CELL			English	Article							TYROSINE KINASE; MONOCLONAL-ANTIBODIES; CYTOKINE RECEPTORS; GAMMA RECEPTOR; HUMAN-URINE; BINDING; CELLS; PURIFICATION; PROTEINS; SEQUENCE	We describe a universal ligand-binding receptor for human interferons alpha and interferon beta (type I IFNs). A soluble 40 kDa IFN-alpha/beta receptor (p40) that blocks the activity of type I IFNs was purified from urine and sequenced. Antibodies raised against p40 completely block the activity of several type I IFNs and immunoprecipitate both a cellular 102 kDa IFN-alpha/beta receptor and its cross-linked complexes with IFN-alpha 2. The receptor is a disulfide-linked dimer, consisting of 51 kDa subunits. We isolated and expressed a 1.5 kb cDNA, coding for the IFN-alpha/beta receptor. Its 331 amino acid sequence includes a leader and a transmembrane region, while its ectodomain corresponds to p40. IFN-alpha/beta receptor is physically associated with the cytoplasmic Tyr kinase JAK1, hence, in addition to ligand binding, it is directly involved in signal transduction.			NOVICK, D (corresponding author), WEIZMANN INST SCI,DEPT MOLEC GENET & VIROL,IL-76100 REHOVOT,ISRAEL.							AGUET M, 1980, NATURE, V284, P459, DOI 10.1038/284459a0; AGUET M, 1984, VIROLOGY, V132, P211, DOI 10.1016/0042-6822(84)90105-3; AGUET M, 1988, CELL, V55, P273, DOI 10.1016/0092-8674(88)90050-5; BAZAN JF, 1990, CELL, V61, P753, DOI 10.1016/0092-8674(90)90182-E; BENOIT P, 1993, J IMMUNOL, V150, P707; BRANCA AA, 1981, NATURE, V294, P768, DOI 10.1038/294768a0; COLAMONICI OR, 1993, J BIOL CHEM, V268, P10895; EASTGATE JA, 1990, FEBS LETT, V260, P213, DOI 10.1016/0014-5793(90)80106-S; ENGELMANN H, 1989, J BIOL CHEM, V264, P11974; ENGELMANN H, 1990, J BIOL CHEM, V265, P1531; FISCHER DG, 1993, SCIENCE, V262, P250, DOI 10.1126/science.8211145; GUTKIND JS, 1991, MOL CELL BIOL, V11, P1500, DOI 10.1128/MCB.11.3.1500; HEMMI S, 1994, CELL, V76, P803, DOI 10.1016/0092-8674(94)90355-7; HO ASY, 1993, P NATL ACAD SCI USA, V90, P11267, DOI 10.1073/pnas.90.23.11267; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; JOSHI AR, 1982, J BIOL CHEM, V257, P3884; KNIGHT E, 1976, P NATL ACAD SCI USA, V73, P520, DOI 10.1073/pnas.73.2.520; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LUTFALLA G, 1993, GENOMICS, V16, P366, DOI 10.1006/geno.1993.1199; MALISZEWSKI CR, 1990, J IMMUNOL, V144, P3028; MARCON L, 1988, CLIN EXP IMMUNOL, V73, P29; MATSUDAIRA P, 1987, J BIOL CHEM, V262, P10035; MIKI T, 1989, GENE, V83, P137, DOI 10.1016/0378-1119(89)90411-3; MULLER M, 1993, NATURE, V366, P129, DOI 10.1038/366129a0; NAGATA S, 1980, NATURE, V287, P401, DOI 10.1038/287401a0; NOVICK D, 1982, J IMMUNOL, V129, P2244; NOVICK D, 1991, HYBRIDOMA, V10, P137, DOI 10.1089/hyb.1991.10.137; NOVICK D, 1989, J EXP MED, V170, P1409, DOI 10.1084/jem.170.4.1409; NOVICK D, 1992, FEBS LETT, V314, P445, DOI 10.1016/0014-5793(92)81523-O; NOVICK D, 1987, J BIOL CHEM, V262, P8483; OAKLEY BR, 1980, ANAL BIOCHEM, V105, P361, DOI 10.1016/0003-2697(80)90470-4; ORCHANSKY P, 1984, J INTERFERON RES, V4, P275, DOI 10.1089/jir.1984.4.275; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; RUBINSTEIN M, 1978, SCIENCE, V202, P1289, DOI 10.1126/science.725605; RUBINSTEIN S, 1981, J VIROL, V37, P755, DOI 10.1128/JVI.37.2.755-758.1981; Sambrook J, 1989, MOL CLONING LABORATO; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; SOH J, 1994, CELL, V76, P793, DOI 10.1016/0092-8674(94)90354-9; SOMPAYRAC LM, 1981, P NATL ACAD SCI-BIOL, V78, P7575, DOI 10.1073/pnas.78.12.7575; STAHL N, 1993, CELL, V74, P587, DOI 10.1016/0092-8674(93)90506-L; STEWART TA, 1993, SCIENCE, V260, P1942, DOI 10.1126/science.8100367; Stewart W, 1979, INTERFERON SYSTEM; TANIGUCHI T, 1980, GENE, V10, P11, DOI 10.1016/0378-1119(80)90138-9; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; UZE G, 1990, CELL, V60, P225, DOI 10.1016/0092-8674(90)90738-Z; VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L	49	585	620	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 6	1994	77	3					391	400		10.1016/0092-8674(94)90154-6	http://dx.doi.org/10.1016/0092-8674(94)90154-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NK970	8181059				2022-12-28	WOS:A1994NK97000010
J	GOODRICH, JA; HOEY, T; THUT, CJ; ADMON, A; TJIAN, R				GOODRICH, JA; HOEY, T; THUT, CJ; ADMON, A; TJIAN, R			DROSOPHILA TAF(II)40 INTERACTS WITH BOTH A VP16 ACTIVATION DOMAIN AND THE BASAL TRANSCRIPTION FACTOR-TFIIB	CELL			English	Article							TATA-BINDING PROTEIN; POLYMERASE-II TRANSCRIPTION; RNA-POLYMERASE; GAL4 DERIVATIVES; TRANS-ACTIVATOR; MECHANISM; INVITRO; GENE; COACTIVATORS; EXPRESSION	Enhancement of RNA polymerase II transcription by the viral transactivator VP16 requires the TFIID complex, which consists of the TATA-binding protein (TBP) and TBP-associated factors (TAFs). Here we report the molecular cloning, expression, and biochemical characterization of Drosophila TAF(II)40 (dTAF(II)40), a subunit of TFIID. In vitro protein-protein interaction assays revealed direct binding between dTAF(II)40 and a 39 amino acid VP16 activation domain. In addition, affinity chromatography indicated a direct binding of the basal factor TFIIB to immobilized dTAF(II)40. Since VP16 also binds TFIIB, our results suggest a ternary interaction among an activator, a coactivator, and a basal transcription factor. Antibodies directed against dTAF(II)40 inhibited activation by GAL4-VP16 without affecting basal transcription. These results, taken together with previous studies of Sp1 and dTAF(II)110, establish that different activators interact with distinct TAFs in the TFIID complex and that TAFs can contact both activators and basal factors.			GOODRICH, JA (corresponding author), UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720, USA.			Admon, Arie/0000-0003-0504-3950				ALTSCHUL SF, 1990, J MOL BIOL, V215, P4203; APRHYS CMJ, 1989, J VIROL, V63, P2798, DOI 10.1128/JVI.63.6.2798-2812.1989; BERGER SL, 1990, CELL, V61, P1199, DOI 10.1016/0092-8674(90)90684-7; BERGER SL, 1992, CELL, V70, P251, DOI 10.1016/0092-8674(92)90100-Q; BIGGIN MD, 1988, CELL, V53, P713, DOI 10.1016/0092-8674(88)90089-X; BROU C, 1993, EMBO J, V12, P489, DOI 10.1002/j.1460-2075.1993.tb05681.x; CAREY M, 1990, NATURE, V345, P361, DOI 10.1038/345361a0; CHASMAN DI, 1989, MOL CELL BIOL, V9, P4746, DOI 10.1128/MCB.9.11.4746; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; DYNLACHT BD, 1993, NATURE, V363, P176, DOI 10.1038/363176a0; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; GERSTER T, 1988, P NATL ACAD SCI USA, V85, P6347, DOI 10.1073/pnas.85.17.6347; Gill Grace, 1992, Current Biology, V2, P565, DOI 10.1016/0960-9822(92)90046-D; HA I, 1991, NATURE, V352, P689, DOI 10.1038/352689a0; HA I, 1993, GENE DEV, V7, P1021, DOI 10.1101/gad.7.6.1021; HAHN S, 1993, NATURE, V363, P672, DOI 10.1038/363672a0; HE ZG, 1993, CELL, V73, P1223, DOI 10.1016/0092-8674(93)90650-F; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; HISATAKE K, 1993, NATURE, V362, P179, DOI 10.1038/362179a0; HOEY T, 1993, CELL, V72, P247, DOI 10.1016/0092-8674(93)90664-C; HOEY T, 1990, CELL, V61, P1179, DOI 10.1016/0092-8674(90)90682-5; INGLES CJ, 1991, NATURE, V351, P588, DOI 10.1038/351588a0; JANTZEN HM, 1992, GENE DEV, V6, P1950, DOI 10.1101/gad.6.10.1950; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KELLEHER RJ, 1990, CELL, V61, P1209, DOI 10.1016/0092-8674(90)90685-8; KOKUBO T, 1993, GENE DEV, V7, P1033, DOI 10.1101/gad.7.6.1033; KRISTIE TM, 1989, EMBO J, V8, P4229, DOI 10.1002/j.1460-2075.1989.tb08608.x; KRISTIE TM, 1990, GENE DEV, V4, P2383, DOI 10.1101/gad.4.12b.2383; LI R, 1993, CELL, V73, P1207, DOI 10.1016/0092-8674(93)90649-B; LILLIE JW, 1989, NATURE, V338, P39, DOI 10.1038/338039a0; LIN YS, 1988, CELL, V54, P659, DOI 10.1016/S0092-8674(88)80010-2; LIN YS, 1991, CELL, V64, P971, DOI 10.1016/0092-8674(91)90321-O; LIN YS, 1991, NATURE, V353, P569, DOI 10.1038/353569a0; LOBO SM, 1992, CELL, V71, P1029, DOI 10.1016/0092-8674(92)90397-U; NIKOLOV DB, 1992, NATURE, V360, P40, DOI 10.1038/360040a0; PONTIUS BW, 1993, TRENDS BIOCHEM SCI, V18, P181, DOI 10.1016/0968-0004(93)90111-Y; POOLE SJ, 1985, CELL, V40, P37, DOI 10.1016/0092-8674(85)90306-X; PUGH BF, 1990, CELL, V61, P1187, DOI 10.1016/0092-8674(90)90683-6; REGIER JL, 1993, P NATL ACAD SCI USA, V90, P883, DOI 10.1073/pnas.90.3.883; ROBERTS SGE, 1993, NATURE, V363, P741, DOI 10.1038/363741a0; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; RUPPERT S, 1993, NATURE, V362, P175, DOI 10.1038/362175a0; STERN S, 1991, GENE DEV, V5, P2555, DOI 10.1101/gad.5.12b.2555; STRECK RD, 1986, EMBO J, V5, P3615, DOI 10.1002/j.1460-2075.1986.tb04690.x; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TAGGART AKP, 1992, CELL, V71, P1015, DOI 10.1016/0092-8674(92)90396-T; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212; THOMPSON CC, 1992, TRENDS GENET, V8, P232, DOI 10.1016/0168-9525(92)90121-J; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; WAMPLER SL, 1990, J BIOL CHEM, V265, P21223; WAMPLER SL, 1992, GENE DEV, V6, P1542, DOI 10.1101/gad.6.8.1542; WEINZIERL ROJ, 1993, NATURE, V362, P511, DOI 10.1038/362511a0; WHITE RJ, 1992, CELL, V71, P1041, DOI 10.1016/0092-8674(92)90398-V; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6; ZAWEL L, 1992, Current Opinion in Cell Biology, V4, P488, DOI 10.1016/0955-0674(92)90016-6; ZHOU Q, 1992, GENE DEV, V6, P1964, DOI 10.1101/gad.6.10.1964	56	392	397	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 5	1993	75	3					519	530		10.1016/0092-8674(93)90386-5	http://dx.doi.org/10.1016/0092-8674(93)90386-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MF830	8221891				2022-12-28	WOS:A1993MF83000014
J	SCHWABE, JWR; CHAPMAN, L; FINCH, JT; RHODES, D				SCHWABE, JWR; CHAPMAN, L; FINCH, JT; RHODES, D			THE CRYSTAL-STRUCTURE OF THE ESTROGEN-RECEPTOR DNA-BINDING DOMAIN BOUND TO DNA - HOW RECEPTORS DISCRIMINATE BETWEEN THEIR RESPONSE ELEMENTS	CELL			English	Article							REPRESSOR-OPERATOR COMPLEX; THYROID-HORMONE RECEPTORS; GLUCOCORTICOID RECEPTOR; RETINOIC ACID; ZINC FINGERS; AMINO-ACIDS; RECOGNITION; GENE; SPECIFICITY; REFINEMENT	The nuclear hormone receptors are a superfamily of ligand-activated DNA-binding transcription factors. We have determined the crystal structure (at 2.4 angstrom) of the fully specific complex between the DNA-binding domain from the estrogen receptor and DNA. The protein binds as a symmetrical dimer to its palindromic binding site consisting of two 6 bp consensus half sites with three intervening base pairs. This structure reveals how the protein recognizes its own half site sequence rather than that of the related glucocorticoid receptor, which differs by only two base pairs. Since all nuclear hormone receptors recognize one or the other of these two consensus half site sequences, this recognition mechanism applies generally to the whole receptor family.			SCHWABE, JWR (corresponding author), MRC,MOLEC BIOL LAB,HILLS RD,CAMBRIDGE CB2 2QH,ENGLAND.		Schwabe, John WR/A-9132-2008	Schwabe, John WR/0000-0003-2865-4383				ARNOTT S, 1972, BIOCHEM BIOPH RES CO, V47, P1504, DOI 10.1016/0006-291X(72)90243-4; BEAMER LJ, 1992, J MOL BIOL, V227, P177, DOI 10.1016/0022-2836(92)90690-L; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BRUNGER AT, 1990, ACTA CRYSTALLOGR A, V46, P46, DOI 10.1107/S0108767389009633; BRUNGER AT, 1992, XPLOR MANUAL VERSION; BUGGE TH, 1992, EMBO J, V11, P1409, DOI 10.1002/j.1460-2075.1992.tb05186.x; DANIELSEN M, 1989, CELL, V57, P1131, DOI 10.1016/0092-8674(89)90050-0; DIEKMANN S, 1989, EMBO J, V8, P1; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FREEDMAN LP, 1988, NATURE, V334, P543, DOI 10.1038/334543a0; GREEN S, 1987, NATURE, V325, P75, DOI 10.1038/325075a0; HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209; HARD T, 1990, BIOCHEMISTRY-US, V29, P5358; HARRISON SC, 1991, NATURE, V353, P715, DOI 10.1038/353715a0; HOOGSTEEN K, 1963, ACTA CRYSTALLOGR, V16, P907, DOI 10.1107/S0365110X63002437; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; KLEINHITPASS L, 1986, CELL, V46, P1053, DOI 10.1016/0092-8674(86)90705-1; KLUG A, 1987, TRENDS BIOCHEM SCI, V12, P464, DOI 10.1016/0968-0004(87)90231-3; KNEGTEL RMA, 1993, J BIOMOL NMR, V3, P1, DOI 10.1007/BF00242472; KRUST A, 1986, EMBO J, V5, P891, DOI 10.1002/j.1460-2075.1986.tb04300.x; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; KUROKAWA R, 1993, GENE DEV, V7, P1423, DOI 10.1101/gad.7.7b.1423; LEE MS, 1993, SCIENCE, V260, P1117, DOI 10.1126/science.8388124; LEE MS, 1989, SCIENCE, V245, P635, DOI 10.1126/science.2503871; LESLIE AGW, 1992, PROTEIN CRYST, V26; LUISI BF, 1991, NATURE, V352, P497, DOI 10.1038/352497a0; MADER S, 1993, NUCLEIC ACIDS RES, V21, P1125, DOI 10.1093/nar/21.5.1125; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; PARKER MG, 1991, NUCLEAR HORMONE RECE; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; PERLMANN T, 1993, GENE DEV, V7, P1411, DOI 10.1101/gad.7.7b.1411; PICARD D, 1990, CELL REGUL, V1, P281; REMEROWSKI ML, 1991, BIOCHEMISTRY-US, V30, P11620, DOI 10.1021/bi00114a003; SCHEIDEREIT C, 1986, DNA-J MOLEC CELL BIO, V5, P383, DOI 10.1089/dna.1986.5.383; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; SCHWABE JWR, 1990, NATURE, V348, P458, DOI 10.1038/348458a0; SCHWABE JWR, 1991, TRENDS BIOCHEM SCI, V16, P291, DOI 10.1016/0968-0004(91)90121-B; SEVERNE Y, 1988, EMBO J, V7, P2503, DOI 10.1002/j.1460-2075.1988.tb03097.x; SOMERS WS, 1992, NATURE, V359, P387, DOI 10.1038/359387a0; TREISMAN J, 1989, CELL, V59, P553; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; TRUSS M, 1991, MOL CELL BIOL, V11, P3247, DOI 10.1128/MCB.11.6.3247; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; WEBSTER NJG, 1988, CELL, V54, P199, DOI 10.1016/0092-8674(88)90552-1; WOLBERGER C, 1991, CELL, V67, P517, DOI 10.1016/0092-8674(91)90526-5	48	593	608	2	36	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 5	1993	75	3					567	578		10.1016/0092-8674(93)90390-C	http://dx.doi.org/10.1016/0092-8674(93)90390-C			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MF830	8221895				2022-12-28	WOS:A1993MF83000018
J	RASCHKE, RA; REILLY, BM; GUIDRY, JR; FONTANA, JR; SRINIVAS, S				RASCHKE, RA; REILLY, BM; GUIDRY, JR; FONTANA, JR; SRINIVAS, S			THE WEIGHT-BASED HEPARIN DOSING NOMOGRAM COMPARED WITH A STANDARD CARE NOMOGRAM - A RANDOMIZED CONTROLLED TRIAL	ANNALS OF INTERNAL MEDICINE			English	Article						HEPARIN; DOSE-RESPONSE RELATIONSHIP, DRUG; BODY WEIGHT; ANTICOAGULANTS; INJECTIONS, INTRAVENOUS	DEEP VENOUS THROMBOSIS; CONTINUOUS INTRAVENOUS HEPARIN; PROXIMAL-VEIN THROMBOSIS; MYOCARDIAL-INFARCTION; SUBCUTANEOUS HEPARIN; PULMONARY-EMBOLISM; INITIAL TREATMENT; UNSTABLE ANGINA; THERAPY; DOSAGE	Objective: To determine whether an intravenous heparin dosing nomogram based on body weight achieves therapeutic anticoagulation more rapidly than a ''standard care'' nomogram. Design: Randomized controlled trial. Setting: Two community teaching hospitals in Phoenix, Arizona, and Rochester, New York. Participants: One hundred fifteen patients requiring intravenous heparin treatment for venous or arterial thromboembolism or for unstable angina. Intervention: Patients were randomized to the weight-based nomogram (starting dose, 80 units/kg body weight bolus, 18 units/kg per hour infusion) or the standard care nomogram (starting dose, 5000-unit bolus, 1000 units per hour infusion). Activated partial thromboplastin time (APTT) values were monitored every 6 hours, and heparin dose adjustments were determined by the nomograms. Measurements: Activated partial thromboplastin times were measured using a widely generalizable laboratory method. The primary outcomes were the time to exceed the therapeutic threshold (APTT > 1.5 times the control) and the time to achieve therapeutic range (APTT, 1.5 to 2.3 times the control). Bleeding complications and recurrent thromboembolism were also compared. Results: Kaplan-Meier curves for the primary outcomes favored the weight-based nomogram (P < 0.001 for both). In the weight-based heparin group, 60 of 62 patients (97%) exceeded the therapeutic threshold within 24 hours, compared with 37 of 48 (77%) in the standard care group (P < 0.002). Only one major bleeding complication occurred (in a standard care patient). Recurrent thromboembolism was more frequent in the standard care group; relative risk, 5.0 (95% CI, 1.1 to 21.9). Conclusions: The weight-based heparin nomogram is widely generalizable and has proved to be effective, safe, and superior to one based on standard practice.	UNIV ROCHESTER, SCH MED, ROCHESTER, NY 14627 USA; ST MARYS HOSP, ROCHESTER, NY 14611 USA	University of Rochester	RASCHKE, RA (corresponding author), GOOD SAMARITAN HOSP, DEPT MED, 1111 E MCDOWELL RD, PHOENIX, AZ 85006 USA.			Raschke, Robert/0000-0003-3495-7065				ANDERSSON G, 1982, THROMB RES, V27, P631, DOI 10.1016/0049-3848(82)90001-9; [Anonymous], 1973, CIRCULATION S, V47, pII1; BARRITT DW, 1960, LANCET, V1, P1309; BASU D, 1972, NEW ENGL J MED, V287, P324, DOI 10.1056/NEJM197208172870703; BRAUNWALD E, 1989, CIRCULATION, V80, P410, DOI 10.1161/01.CIR.80.2.410; CAIRNS JA, 1992, CHEST, V102, pS456, DOI 10.1378/chest.102.4_Supplement.456S; CAMILLERI JF, 1988, ARCH MAL COEUR VAISS, V81, P1037; CIPOLLE RJ, 1981, CLIN PHARMACOL THER, V29, P387, DOI 10.1038/clpt.1981.53; CIPOLLE RJ, 1986, APPLIED PHARMACOKINE, P908; CONTI S, 1982, SURGERY, V92, P972; COON WW, 1969, ANN SURG, V170, P559, DOI 10.1097/00000658-196910000-00007; CRUICKSHANK MK, 1991, ARCH INTERN MED, V151, P333, DOI 10.1001/archinte.151.2.333; ELLISON MJ, 1989, CLIN PHARMACY, V8, P65; FENNERTY AG, 1985, BRIT MED J, V290, P27, DOI 10.1136/bmj.290.6461.27-a; GALLUS A, 1986, LANCET, V2, P1293; GUIDRY JR, 1991, CRIT CARE CLIN, V7, P533, DOI 10.1016/S0749-0704(18)30295-1; HANDELAND GF, 1990, EUR J CLIN PHARMACOL, V39, P107, DOI 10.1007/BF00280041; HATTERSLEY PG, 1983, JAMA-J AM MED ASSOC, V250, P1413, DOI 10.1001/jama.250.11.1413; HIRSH J, 1991, NEW ENGL J MED, V324, P1565; HOGG PJ, 1989, P NATL ACAD SCI USA, V86, P3619, DOI 10.1073/pnas.86.10.3619; HOLM HA, 1984, ACTA MED SCAND, V215, P47; HOMMES DW, 1992, ANN INTERN MED, V116, P279, DOI 10.7326/0003-4819-116-4-279; HULL RD, 1990, NEW ENGL J MED, V322, P1260, DOI 10.1056/NEJM199005033221802; HULL RD, 1986, NEW ENGL J MED, V315, P1109, DOI 10.1056/NEJM198610303151801; HULL RD, 1992, ARCH INTERN MED, V152, P1589, DOI 10.1001/archinte.152.8.1589; HULL RD, 1992, NEW ENGL J MED, V326, P975, DOI 10.1056/NEJM199204093261502; HYERS TM, 1992, CHEST, V102, pS408, DOI 10.1378/chest.102.4_Supplement.408S; HYERS TM, 1989, CHEST, V95, pS37, DOI 10.1378/chest.95.2.37S; KAPLAN K, 1987, AM J CARDIOL, V59, P241, DOI 10.1016/0002-9149(87)90792-2; KASHTAN J, 1980, AM J SURG, V140, P836, DOI 10.1016/0002-9610(80)90128-2; LANDEFELD CS, 1987, AM J MED, V82, P703, DOI 10.1016/0002-9343(87)90004-0; Levine M, 1989, HEPARIN CHEM BIOL PR, P517; NIEUWENHUIS HK, 1991, BLOOD, V78, P2337, DOI 10.1182/blood.V78.9.2337.2337; NORMAN CS, 1977, SURG GYNECOL OBSTET, V145, P338; O'Sullivan E F, 1968, Med J Aust, V2, P153; PINI M, 1990, THROMB HAEMOSTASIS, V64, P222; PRANDONI P, 1992, LANCET, V339, P441, DOI 10.1016/0140-6736(92)91054-C; RASCHKE R, 1991, AM HEART J, V121, P1849, DOI 10.1016/0002-8703(91)90066-Q; RASCHKE R, 1991, ARCH INTERN MED, V151, P2318, DOI 10.1001/archinte.1991.00400110144033; REILLY B, IN PRESS J GEN INTER; TALSTAD I, 1985, AM J CLIN PATHOL, V83, P378, DOI 10.1093/ajcp/83.3.378; THEROUX P, 1988, NEW ENGL J MED, V319, P1105, DOI 10.1056/NEJM198810273191701; THERY C, 1992, CIRCULATION, V85, P1380, DOI 10.1161/01.CIR.85.4.1380; TURPIE AGG, 1989, NEW ENGL J MED, V320, P352, DOI 10.1056/NEJM198902093200604; WEITZ JI, 1990, J CLIN INVEST, V86, P385, DOI 10.1172/JCI114723; WHEELER AP, 1988, ARCH INTERN MED, V148, P1321, DOI 10.1001/archinte.148.6.1321; WHITFIELD LR, 1980, CLIN PHARMACOL THER, V28, P509, DOI 10.1038/clpt.1980.195; WILSON JE, 1981, AM J MED, V70, P808, DOI 10.1016/0002-9343(81)90537-4; WILSON JR, 1979, AM HEART J, V97, P155, DOI 10.1016/0002-8703(79)90349-1; 1992, CAP SURVEYS, P4	50	544	561	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	1993	119	9					874	881		10.7326/0003-4819-119-9-199311010-00002	http://dx.doi.org/10.7326/0003-4819-119-9-199311010-00002			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MD711	8214998				2022-12-28	WOS:A1993MD71100002
J	CHELIMSKY, E				CHELIMSKY, E			THE POLITICAL DEBATE ABOUT HEALTH-CARE - ARE WE LOSING SIGHT OF QUALITY	SCIENCE			English	Editorial Material											CHELIMSKY, E (corresponding author), US GEN ACCOUNTING OFF,WASHINGTON,DC 20548, USA.							AARON H, 1990, SCIENCE, V247, P422; BARER ML, 1992, HEALTH AFFAIR, V11, P44, DOI 10.1377/hlthaff.11.1.44; BARER ML, 1992, HLTH AFFAIRS, V11, P45; CHELIMSKY E, 1972, M7233 MITRE CORP, P17; DANZON PM, 1992, HLTH AFFAIRS, V11, P31; DAY P, 1989, MILBANK Q, V67, P27; DETOCQUEVILLE A, 1968, DEMOCRACY AM, P172; LIU RGH, 1989, PROGRAM EVALUATION P, P240; MACRAE N, 1984, ECONOMIST       0428, P17; RUBIN HR, 1993, JAMA-J AM MED ASSOC, V270, P837; RUSSELL LB, 1989, SCIENCE, V246, P892, DOI 10.1126/science.2510299; SHADISH WR, 1987, EVALUATION STUDIES R, P395; 1987, GAOPEMD875BR, P7; 1987, GAOPEMD875BR, P1; 1986, POST HOSPITAL CARE E, P4; 1992, GAOPEMD926, P23	16	11	11	1	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 22	1993	262	5133					525	528		10.1126/science.8211177	http://dx.doi.org/10.1126/science.8211177			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	MC935	8211177				2022-12-28	WOS:A1993MC93500026
J	JENSEN, MC; BRANTZAWADZKI, MN; OBUCHOWSKI, N; MODIC, MT; MALKASIAN, D; ROSS, JS				JENSEN, MC; BRANTZAWADZKI, MN; OBUCHOWSKI, N; MODIC, MT; MALKASIAN, D; ROSS, JS			MAGNETIC-RESONANCE-IMAGING OF THE LUMBAR SPINE IN PEOPLE WITHOUT BACK PAIN	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CATEGORICAL-DATA; PREVALENCE; WOMEN	Background. The relation between abnormalities in the lumbar spine and low back pain is controversial. We examined the prevalence of abnormal findings on magnetic resonance imaging (MRI) scans of the lumbar spine in people without back pain. Methods. We performed MRI examinations on 98 asymptomatic people. The scans were read independently by two neuroradiologists who did not know the clinical status of the subjects. To reduce the possibility of bias in interpreting the studies, abnormal MRI scans from 27 people with back pain were mixed randomly with the scans from the asymptomatic people. We used the following standardized terms to classify the five intervertebral disks in the lumbosacral spine: normal, bulge (circumferential symmetric extension of the disk beyond the interspace), protrusion (focal or asymmetric extension of the disk beyond the interspace), and extrusion (more extreme extension of the disk beyond the interspace). nonintervertebral disk abnormalities, such as facet arthropathy, were also documented. Results. Thirty-six percent of the 98 asymptomatic subjects had normal disks at all levels. With the results of the two readings averaged, 52 percent of the subjects had a bulge at at least one level, 27 percent had a protrusion, and 1 percent had an extrusion. Thirty-eight percent had an abnormality of more than one intervertebral disk. The prevalence of bulges, but not of protrusions, increased with age. The most common nonintervertebral disk abnormalities were Schmorl's nodes (herniation of the disk into the vertebral-body end plate), found in 19 percent of the subjects; annular defects (disruption of the outer fibrous ring of the disk), in 14 percent; and facet arthropathy (degenerative disease of the posterior articular processes of the vertebrae), in 8 percent. The findings were similar in men and women. Conclusions. On MRI examination of the lumbar spine, many people without back pain have disk bulges or protrusions but not extrusions. Given the high prevalence of these findings and of back pain, the discovery by MRI of bulges or protrusions in people with low back pain may frequently be coincidental.	HOAG MEM HOSP,DEPT RADIOL,NEWPORT BEACH,CA 92663; RIVERSIDE MAGNET RESONANCE IMAGING,RIVERSIDE,CA; CLEVELAND CLIN,CLEVELAND,OH 44106	Cleveland Clinic Foundation				Ross, Jeffrey/0000-0001-5865-6828				BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; DEYO RA, 1987, SPINE, V12, P264, DOI 10.1097/00007632-198704000-00013; HELMS CA, 1982, COMPUT RADIOL, V6, P359, DOI 10.1016/0730-4862(82)90007-5; HIRSCH C, 1952, ACTA ORTHOP SCAND, V22, P184; HITSELBE.WE, 1968, J NEUROSURG, V28, P204, DOI 10.3171/jns.1968.28.3.0204; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LIANG KY, 1992, J R STAT SOC B, V54, P3; MCCARRON RF, 1987, SPINE, V12, P760, DOI 10.1097/00007632-198710000-00009; MCRAE DL, 1956, ACTA RADIOL, V46, P9, DOI 10.3109/00016925609170806; POWELL MC, 1986, LANCET, V2, P1366; ROBERTSON JT, 1993, SURG NEUROL, V39, P5, DOI 10.1016/0090-3019(93)90102-7; WEINREB JC, 1989, RADIOLOGY, V170, P125, DOI 10.1148/radiology.170.1.2521192; WIESEL SW, 1984, SPINE, V9, P549, DOI 10.1097/00007632-198409000-00003; YU S, 1989, RADIOLOGY, V170, P523, DOI 10.1148/radiology.170.2.2911680; YU SW, 1988, AM J NEURORADIOL, V9, P367	15	1471	1518	4	80	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	1994	331	2					69	73		10.1056/NEJM199407143310201	http://dx.doi.org/10.1056/NEJM199407143310201			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NW712	8208267	Bronze			2022-12-28	WOS:A1994NW71200001
J	MCCLOSKEY, RV; STRAUBE, RC; SANDERS, C; SMITH, SM; SMITH, CR				MCCLOSKEY, RV; STRAUBE, RC; SANDERS, C; SMITH, SM; SMITH, CR			TREATMENT OF SEPTIC SHOCK WITH HUMAN MONOCLONAL-ANTIBODY HA-1A - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL	ANNALS OF INTERNAL MEDICINE			English	Article						SHOCK, SEPTIC; GRAM-NEGATIVE BACTERIAL INFECTIONS; BACTEREMIA; HA-1A; ENDOTOXINS	GRAM-NEGATIVE BACTEREMIA; ESCHERICHIA-COLI	Objective: To compare the effectiveness of 100 mg of HA-1A and placebo in reducing the 14-day all-cause mortality rate in patients with septic shock and gramnegative bacteremia in the Centocor: HA-1A Efficacy in Septic Shock (CHESS) trial, and to assess the safety of 100 mg of HA-1A given to patients with septic shock who did not have gram-negative bacteremia. Design: Large, simple, group-sequential, randomized, double-blind, multicenter, placebo-controlled trial. Setting: 603 investigators at 513 community and university-affiliate hospitals in the United States. Patients: Within 6 hours before enrollment, the patients had been in shock with a systolic blood pressure of less than 90 mm Hg after adequate fluid challenge or had received vasopressors to maintain blood pressure. These episodes of shock began within 24 hours of enrollment. A presumptive clinical diagnosis of gramnegative infection as the cause of the shock episode and a commitment from the patients' physicians to provide full supportive care were required. Measurements: Blood cultures were obtained within 48 hours of enrollment, and death at day 14 after treatment was recorded. Adverse events occurring within 14 days after enrollment were also tabulated. Results: 2199 patients were enrolled; 621 (28.2%) met ail enrollment criteria, received HA-1A or placebo, and had confirmed gram-negative bacteremia. Mortality rates in this group were as follows: placebo, 32% (95 of 293) and HA-1A, 33% (109 of 328) (P = 0.864, Fisher exact test, two-tailed; 95% CI for the difference, -6.2% to 8.6%). Mortality rates in the patients without gramnegative bacteremia were as follows: placebo, 37% (292 of 793) and HA-1A, 41% (318 of 785) (P = 0.073, Fisher exact test, one-tailed; CI, -0.8% to 8.8%). Conclusions: In this trial, HA-1A was not effective in reducing the 14-day mortality rate in patients with gram-negative bacteremia and septic shock. These data do not support using septic shock as an indication for HA-1A treatment. If HA-1A is effective in reducing the mortality rate in patients dying from endotoxemia, these patients must be identified using other treatment criteria.	T CELL SCI, CAMBRIDGE, MA 02139 USA; SCHERING PLOUGH CORP, RES, BIOSTAT, KENILWORTH, NJ 07033 USA	Merck & Company; Schering Plough Corporation	MCCLOSKEY, RV (corresponding author), CENTOCOR INC, 200 GREAT VALLEY PKWY, MALVERN, PA 19355 USA.			Fahy, Brenda/0000-0002-5248-5164				GRANSDEN WR, 1990, REV INFECT DIS, V12, P1008; KNAUS WA, 1993, ANN INTERN MED, V118, P753, DOI 10.7326/0003-4819-118-10-199305150-00001; QUEZADO ZMN, 1993, JAMA-J AM MED ASSOC, V269, P2221, DOI 10.1001/jama.269.17.2221; SACKETT DL, 1979, NEW ENGL J MED, V301, P1410, DOI 10.1056/NEJM197912273012602; SCHWARTZ D, 1980, CLIN TRIALS, P29; WARREN HS, 1992, NEW ENGL J MED, V326, P1153, DOI 10.1056/NEJM199204233261711; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421; ZIEGLER EJ, 1982, NEW ENGL J MED, V307, P1225, DOI 10.1056/NEJM198211113072001; ZIEGLER EJ, 1991, NEW ENGL J MED, V324, P429, DOI 10.1056/NEJM199102143240701	9	350	366	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1994	121	1					1	5		10.7326/0003-4819-121-1-199407010-00001	http://dx.doi.org/10.7326/0003-4819-121-1-199407010-00001			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PN271	8198341				2022-12-28	WOS:A1994PN27100001
J	SEBASTIAN, A; HARRIS, ST; OTTAWAY, JH; TODD, KM; MORRIS, RC				SEBASTIAN, A; HARRIS, ST; OTTAWAY, JH; TODD, KM; MORRIS, RC			IMPROVED MINERAL BALANCE AND SKELETAL METABOLISM IN POSTMENOPAUSAL WOMEN TREATED WITH POTASSIUM BICARBONATE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SERUM ALKALINE-PHOSPHATASE; BONE GLA-PROTEIN; HYDROXYPROLINE EXCRETION; SODIUM-BICARBONATE; CALCIUM BALANCE; HEALTHY-MEN; ACIDOSIS; OSTEOPOROSIS; RESORPTION; OSTEOCALCIN	Background. In normal subjects, a low level of metabolic acidosis and positive acid balance (the production of more acid than is excreted) are typically present and correlate in degree with the amount of endogenous acid produced by the metabolism of foods in ordinary diets abundant in protein. Over a lifetime, the counteraction of retained endogenous acid by base mobilized from the skeleton may contribute to the decrease in bone mass that occurs normally with aging. Methods. To test that possibility, we administered potassium bicarbonate to 18 postmenopausal women who were given a constant diet (652 mg [16 mmol] of calcium and 96 g of protein per 60 kg of body weight). The potassium bicarbonate was given orally for 18 days in doses (60 to 120 mmol per day) that nearly completely neutralized the endogenous acid. Results. During the administration of potassium bicarbonate, the calcium and phosphorus balance became less negative or more positive - that is, less was excreted in comparision with the amount ingested (mean [+/-SD] change in calcium balance, +56+/-76 mg [1.4+/-1.9 mmol] per day per 60 kg; P = 0.009; change in phosphorus balance, +47+/-64 mg [1.5+/-2.1 mmol] per day per 60 kg; P = 0.007) because of reductions in urinary calcium and phosphorus excretion. The changes in calcium and phosphorus balance were positively correlated (P<0.001). Serum osteocalcin concentrations increased from 5.5+/-2.8 ng per milliliter (P<0.001), and urinary hydroxyproline excretion decreased from 28.9+/-12.3 to 26.7+/-10.8 mg per day (220+/-94 to 204+/-82 mu mol per day; P = 0.05). Net renal acid excretion decreased from 70.9+/-10.1 to 12.8+/-21.8 mmol per day, indicating nearly complete neutralization of endogenous acid. Conclusions. In postmenopausal women, the oral administration of potassium bicarbonate at a dose sufficient to neutralize endogenous acid improves calcium and phosphorus balance, reduces bone resorption, and increases the rate of bone formation.	UNIV CALIF SAN FRANCISCO,MOFFITT LONG HOSP,GEN CLIN RES CTR,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	SEBASTIAN, A (corresponding author), UNIV CALIF SAN FRANCISCO,MOFFITT LONG HOSP,DEPT MED,BOX 0126,SAN FRANCISCO,CA 94143, USA.				NIDDK NIH HHS [R01 DK32631, P01DK 39964] Funding Source: Medline; PHS HHS [M01 00079] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK032631, P01DK039964] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARNETT TR, 1986, ENDOCRINOLOGY, V119, P119, DOI 10.1210/endo-119-1-119; BARZEL US, 1969, CLIN SCI, V36, P517; BARZEL US, 1976, CALC TISS RES, V21, P417; BARZEL US, 1969, CALC TISS RES, V4, P94, DOI 10.1007/BF02279111; BARZEL US, 1971, ISRAEL J MED SCI, V7, P499; Bernstein D, 1970, OSTEOPOROSIS, P207; BROWN JP, 1984, LANCET, V1, P1091; BURNELL JM, 1971, J CLIN INVEST, V50, P327, DOI 10.1172/JCI106499; BUSHINSKY DA, 1992, AM J PHYSIOL, V263, pF510, DOI 10.1152/ajprenal.1992.263.3.F510; BUSHINSKY DA, 1992, AM J PHYSIOL, V262, pF425, DOI 10.1152/ajprenal.1992.262.3.F425; BUSHINSKY DA, 1989, REGULATION ACID BASE, P69; CHARLES P, 1985, J CLIN INVEST, V76, P2254, DOI 10.1172/JCI112234; DEACON AC, 1987, CLIN CHIM ACTA, V166, P297, DOI 10.1016/0009-8981(87)90433-5; DELLING G, 1973, VIRCHOWS ARCH A, V358, P321, DOI 10.1007/BF00543273; EPSTEIN S, 1988, ENDOCR REV, V9, P437, DOI 10.1210/edrv-9-4-437; GOLDHABER P, 1987, AM J PHYSIOL, V253, pE90, DOI 10.1152/ajpendo.1987.253.1.E90; HYLDSTRUP L, 1988, SCAND J CLIN LAB INV, V48, P611, DOI 10.3109/00365518809085780; Jaffe HL, 1932, J EXP MED, V56, P823, DOI 10.1084/jem.56.6.823; JOHANSEN JS, 1988, J CLIN ENDOCR METAB, V67, P273, DOI 10.1210/jcem-67-2-273; JONES JW, 1982, KIDNEY INT, V21, P402, DOI 10.1038/ki.1982.36; KLEIN L, 1964, METABOLISM, V13, P272, DOI 10.1016/0026-0495(64)90106-4; KLEINMAN JG, 1987, CLIN DISORDERS FLUID, P159; KRIEGER NS, 1992, AM J PHYSIOL, V262, pF442, DOI 10.1152/ajprenal.1992.262.3.F442; KURTZ I, 1983, KIDNEY INT, V24, P670, DOI 10.1038/ki.1983.210; LEMANN J, 1989, KIDNEY INT, V35, P688, DOI 10.1038/ki.1989.40; LEMANN J, 1966, J CLIN INVEST, V45, P1608, DOI 10.1172/JCI105467; LEMANN J, 1965, J CLIN INVEST, V44, P507, DOI 10.1172/JCI105164; LEMANN J, 1967, J CLIN INVEST, V46, P1318, DOI 10.1172/JCI105624; LENNON EJ, 1966, J CLIN INVEST, V45, P1601, DOI 10.1172/JCI105466; LUTZ J, 1984, AM J CLIN NUTR, V39, P281, DOI 10.1093/ajcn/39.2.281; SAKHAEE K, 1983, KIDNEY INT, V24, P348, DOI 10.1038/ki.1983.165; TETI A, 1989, J CLIN INVEST, V84, P773, DOI 10.1172/JCI114235; WACHMAN A, 1968, LANCET, V1, P958; WEIGLEY ES, 1984, J AM DIET ASSOC, V84, P417; WORSFOLD M, 1988, CLIN CHIM ACTA, V178, P225, DOI 10.1016/0009-8981(88)90228-8	35	399	409	0	12	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 23	1994	330	25					1776	1781		10.1056/NEJM199406233302502	http://dx.doi.org/10.1056/NEJM199406233302502			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR295	8190153				2022-12-28	WOS:A1994NR29500002
J	RASK, KJ; WILLIAMS, MV; PARKER, RM; MCNAGNY, SE				RASK, KJ; WILLIAMS, MV; PARKER, RM; MCNAGNY, SE			OBSTACLES PREDICTING LACK OF A REGULAR PROVIDER AND DELAYS IN SEEKING CARE FOR PATIENTS AT AN URBAN PUBLIC HOSPITAL	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note							SOCIOECONOMIC INEQUALITIES; PRENATAL-CARE; HEALTH-CARE; MEDICAID; ACCESS; POOR	Objective.-To determine the correlation among obstacles to medical care, lack of a regular source of care, and delays in seeking care.			RASK, KJ (corresponding author), EMORY UNIV,SCH MED,DEPT MED,DIV GEN INTERNAL MED,69 BUTLEER ST SE,GLENN MEM BLDG,ATLANTA,GA 30303, USA.		Rask, Kimberly/L-5742-2019; Parker, Ruth M/S-4583-2017; rask, kimberly/M-8001-2016	Rask, Kimberly/0000-0001-6806-4666; Parker, Ruth M/0000-0001-9685-6396; Williams, Mark V/0000-0001-6107-0457				ADLER NE, 1993, JAMA-J AM MED ASSOC, V269, P3140, DOI 10.1001/jama.269.24.3140; Dutton D. B., 1989, PATHWAYS HLTH ROLE S, P29; DUTTON DB, 1978, AM SOCIOL REV, V43, P348, DOI 10.2307/2094495; EPSTEIN AM, 1988, NEW ENGL J MED, V318, P1579, DOI 10.1056/NEJM198806163182405; FEINSTEIN JS, 1993, MILBANK Q, V71, P279, DOI 10.2307/3350401; HAYWARD RA, 1991, AM J PUBLIC HEALTH, V81, P434, DOI 10.2105/AJPH.81.4.434; Kiefe C I, 1993, J Community Health, V18, P271, DOI 10.1007/BF01321788; KINDIG DA, 1987, INQUIRY-J HEALTH CAR, V24, P136; LAHELMA E, 1990, SOC SCI MED, V31, P257, DOI 10.1016/0277-9536(90)90272-T; MILLER CL, 1989, AM J PUBLIC HEALTH, V79, P62, DOI 10.2105/AJPH.79.1.62; PAPPAS G, 1993, NEW ENGL J MED, V329, P103, DOI 10.1056/NEJM199307083290207; PIPER JM, 1990, JAMA-J AM MED ASSOC, V264, P2219, DOI 10.1001/jama.264.17.2219; RIPORTELLAMULLE.R, 1993, JUN ASS HLTH SERV RE; SHEA S, 1992, NEW ENGL J MED, V327, P776, DOI 10.1056/NEJM199209103271107; SMITH GD, 1990, BMJ-BRIT MED J, V301, P373, DOI 10.1136/bmj.301.6748.373; STPETER RF, 1992, JAMA-J AM MED ASSOC, V267, P2760, DOI 10.1001/jama.267.20.2760; SVITZ L, 1993, JUN ASS HLTH SERV RE; WEISSMAN J, 1989, JAMA-J AM MED ASSOC, V261, P3572, DOI 10.1001/jama.261.24.3572; WEISSMAN JS, 1991, ANN INTERN MED, V114, P325, DOI 10.7326/0003-4819-114-4-325; WENNEKER MB, 1989, JAMA-J AM MED ASSOC, V261, P253, DOI 10.1001/jama.261.2.253; YELIN EH, 1983, AM J PUBLIC HEALTH, V73, P563, DOI 10.2105/AJPH.73.5.563; YUDKOWSKY BK, 1990, PEDIATRICS, V85, P567	22	136	136	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	1994	271	24					1931	1933		10.1001/jama.271.24.1931	http://dx.doi.org/10.1001/jama.271.24.1931			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NR598	8201737				2022-12-28	WOS:A1994NR59800030
J	FISHER, CJ; DHAINAUT, JFA; OPAL, SM; PRIBBLE, JP; BALK, RA; SLOTMAN, GJ; IBERTI, TJ; RACKOW, EC; SHAPIRO, MJ; GREENMAN, RL; REINES, HD; SHELLY, MP; THOMPSON, BW; LABRECQUE, JF; CATALANO, MA; KNAUS, WA; SADOFF, JC; ASTIZ, M; CARPATI, C; BONE, RC; FREIDMAN, B; MURE, AJ; BRATHWAITE, C; SHAPIRO, E; MELHORN, L; TAYLOR, R; KEEGAN, M; OBRIEN, J; SCHEIN, R; PENA, M; WASSERLOUF, M; OROPELLO, J; BENJAMIN, E; DELGUIDICE, R; EMMANUEL, G; LIE, T; ANDERSON, L; MARSHALL, J; DEMAJO, W; ROTSTEIN, O; FOSTER, D; ABRAHAM, E; MIDDLETON, H; PERRY, C; LEVY, H; FRY, DE; SIMPSON, SQ; CROWELL, RE; NEIDHART, M; STEVENS, D; COFFMAN, T; NARASIMHAM, N; MERRICK, DK; BERGQUIST, W; MATZEL, KE; HUEBLER, M; FOULKE, GE; ALBERTSON, TE; WALBY, WF; ALLEN, RP; BAUGHMAN, R; HASSELGREN, PO; FINK, MP; FAVORITO, F; THOMPSON, BT; CORBIN, R; SHELLHORSE, GY; FRAZIER, A; WHITE, S; GARRARD, C; ACOURT, C; STORER, S; GERVICH, DH; FOSHE, D; BRASE, R; BAGDAHN, A; COONEY, R; SMITH, JS; MARTIN, LF; VINCENT, JL; FRIEDMAN, G; BERLOT, G; FLETCHER, JR; WILLIAMS, MD; WRIGHT, TF; JOHNSON, S; FEILD, C; WOLF, K; MACINTYRE, N; DUBIN, HG; DURKIN, MR; DUBIN, PK; STAUBACH, KH; FEIN, AM; SCHULMAN, DB; NIEDERMAN, MS; CHALFIN, DB; VANLEEUWEN, PAM; BOERMEESTER, MA; SCHNEIDER, AJ; BANDER, J; IMM, A; BERNARD, G; NELSON, L; STROUD, M; SAFCSAK, K; CERRA, F; RINDAL, J; MANN, H; HALPERN, N; SILVERSTEIN, J; ALICEA, M; SIBBALD, WJ; MARTIN, CM; RUTLEDGE, FS; PETTI, K; RUSSELL, JA; KRUGER, R; DRUMMOND, A; LANGE, P; SEIFERT, T; DUROCHER, A; TENAILLON, A; BOITEAU, R; LHERM, T; LOWRY, SF; COYLE, SM; BARIE, PS; DEMARIA, E; SNYDMAN, DR; SCHWAITZBERG, SD; NASRAWAY, SA; GRINDLINGER, J; SUMMER, W; DEBOISBLANC, B; WAHL, M; ALESTIG, K; GROSSMAN, J; MAKI, D; PAZ, HL; WEINER, M; BIHARI, D; CAMPBELL, D; BLEICHNER, G; DAHN, MS; LANGE, MPA; HALL, J; POHLMAN, A; WENZEL, RP; GROSSERODE, M; COSTIGAN, M; MILESKI, W; WEIGELT, J; YESTON, N; IRIZARRY, C; ROSS, J; ROBBINS, J; NIGHTINGALE, P; OWEN, K; SANDSTEDT, S; BERG, S; SIMON, GL; SENEFF, MG; CONRY, KM; ZIMMERMAN, JL; DELLINGER, RP; JOHNSTON, R; ALLEE, P; GRANDE, PO; MYHRE, E; DHAINAUT, JF; HAMY, I; MIRA, JP; HARMON, J; WHITE, J; MCKIE, L; SILVERMAN, H; TUMA, P; BENNETT, D; PORTER, JC; LAURELL, MH; JACOBS, S; ASH, S; STILES, DM; PRIOR, MJ; KNATTERUD, G; TERRIN, M; KUFERA, J; WILKENS, P; RA, K; MONROE, L; SPRUNG, C; HAMILTON, CM; MATTHAY, R; MCCABE, W; TONASCIA, J; WIEDEMAN, H; WITTES, J; CAMPION, GV; CROFT, CR; LUSTICK, R; LOOKABAUGH, J; GORDON, GS; NOE, L; BLOEDOW, D; SMITH, CG; BRANNON, D; KUSH, R; NG, D; MOORE, E; BAZEMORE, K; GALVAN, M; WAGNER, D; HARRELL, F; STABLEIN, D				FISHER, CJ; DHAINAUT, JFA; OPAL, SM; PRIBBLE, JP; BALK, RA; SLOTMAN, GJ; IBERTI, TJ; RACKOW, EC; SHAPIRO, MJ; GREENMAN, RL; REINES, HD; SHELLY, MP; THOMPSON, BW; LABRECQUE, JF; CATALANO, MA; KNAUS, WA; SADOFF, JC; ASTIZ, M; CARPATI, C; BONE, RC; FREIDMAN, B; MURE, AJ; BRATHWAITE, C; SHAPIRO, E; MELHORN, L; TAYLOR, R; KEEGAN, M; OBRIEN, J; SCHEIN, R; PENA, M; WASSERLOUF, M; OROPELLO, J; BENJAMIN, E; DELGUIDICE, R; EMMANUEL, G; LIE, T; ANDERSON, L; MARSHALL, J; DEMAJO, W; ROTSTEIN, O; FOSTER, D; ABRAHAM, E; MIDDLETON, H; PERRY, C; LEVY, H; FRY, DE; SIMPSON, SQ; CROWELL, RE; NEIDHART, M; STEVENS, D; COFFMAN, T; NARASIMHAM, N; MERRICK, DK; BERGQUIST, W; MATZEL, KE; HUEBLER, M; FOULKE, GE; ALBERTSON, TE; WALBY, WF; ALLEN, RP; BAUGHMAN, R; HASSELGREN, PO; FINK, MP; FAVORITO, F; THOMPSON, BT; CORBIN, R; SHELLHORSE, GY; FRAZIER, A; WHITE, S; GARRARD, C; ACOURT, C; STORER, S; GERVICH, DH; FOSHE, D; BRASE, R; BAGDAHN, A; COONEY, R; SMITH, JS; MARTIN, LF; VINCENT, JL; FRIEDMAN, G; BERLOT, G; FLETCHER, JR; WILLIAMS, MD; WRIGHT, TF; JOHNSON, S; FEILD, C; WOLF, K; MACINTYRE, N; DUBIN, HG; DURKIN, MR; DUBIN, PK; STAUBACH, KH; FEIN, AM; SCHULMAN, DB; NIEDERMAN, MS; CHALFIN, DB; VANLEEUWEN, PAM; BOERMEESTER, MA; SCHNEIDER, AJ; BANDER, J; IMM, A; BERNARD, G; NELSON, L; STROUD, M; SAFCSAK, K; CERRA, F; RINDAL, J; MANN, H; HALPERN, N; SILVERSTEIN, J; ALICEA, M; SIBBALD, WJ; MARTIN, CM; RUTLEDGE, FS; PETTI, K; RUSSELL, JA; KRUGER, R; DRUMMOND, A; LANGE, P; SEIFERT, T; DUROCHER, A; TENAILLON, A; BOITEAU, R; LHERM, T; LOWRY, SF; COYLE, SM; BARIE, PS; DEMARIA, E; SNYDMAN, DR; SCHWAITZBERG, SD; NASRAWAY, SA; GRINDLINGER, J; SUMMER, W; DEBOISBLANC, B; WAHL, M; ALESTIG, K; GROSSMAN, J; MAKI, D; PAZ, HL; WEINER, M; BIHARI, D; CAMPBELL, D; BLEICHNER, G; DAHN, MS; LANGE, MPA; HALL, J; POHLMAN, A; WENZEL, RP; GROSSERODE, M; COSTIGAN, M; MILESKI, W; WEIGELT, J; YESTON, N; IRIZARRY, C; ROSS, J; ROBBINS, J; NIGHTINGALE, P; OWEN, K; SANDSTEDT, S; BERG, S; SIMON, GL; SENEFF, MG; CONRY, KM; ZIMMERMAN, JL; DELLINGER, RP; JOHNSTON, R; ALLEE, P; GRANDE, PO; MYHRE, E; DHAINAUT, JF; HAMY, I; MIRA, JP; HARMON, J; WHITE, J; MCKIE, L; SILVERMAN, H; TUMA, P; BENNETT, D; PORTER, JC; LAURELL, MH; JACOBS, S; ASH, S; STILES, DM; PRIOR, MJ; KNATTERUD, G; TERRIN, M; KUFERA, J; WILKENS, P; RA, K; MONROE, L; SPRUNG, C; HAMILTON, CM; MATTHAY, R; MCCABE, W; TONASCIA, J; WIEDEMAN, H; WITTES, J; CAMPION, GV; CROFT, CR; LUSTICK, R; LOOKABAUGH, J; GORDON, GS; NOE, L; BLOEDOW, D; SMITH, CG; BRANNON, D; KUSH, R; NG, D; MOORE, E; BAZEMORE, K; GALVAN, M; WAGNER, D; HARRELL, F; STABLEIN, D			RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TUMOR-NECROSIS-FACTOR; SEPTIC SHOCK; SUBLETHAL ENDOTOXEMIA; MONOCLONAL-ANTIBODY; IL-1 RECEPTOR; MORTALITY; CACHECTIN; RABBITS; PATHOGENESIS; BACTEREMIA	Objective.-To further define the safety and efficacy of recombinant human interleukin 1 receptor antagonist (rhlL-1ra) in the treatment of sepsis syndrome. Study Design.-Randomized, double-blind, placebo-controlled, multicenter, multinational clinical trial. Population.-A total of 893 patients with sepsis syndrome received an intravenous loading dose of rhIL-1ra, 100 mg, or placebo followed by a continuous 72-hour intravenous infusion of rhIL-1ra (1.0 or 2.0 mg/kg per hour) or placebo. Outcome Measure.-Twenty-eight-day all-cause mortality. Results.-There was not a significant increase in survival time for rhIL-1ra treatment compared with placebo among all patients who received the study medication (n=893; generalized Wilcoxon statistic, P=.22) or among patients with shock at study entry (n=713; generalized Wilcoxon statistic, P=.23), the two primary efficacy analyses specified a priori for this trial. Results from secondary analyses suggest an increase in survival time with rhIL-1ra treatment among patients with dysfunction of one or more organs (n=563; linear dose-response, P=.009). Retrospective analysis demonstrated an increase In survival time with rhIL-1ra treatment among patients with a predicted risk of mortality of 24% or greater (n=580; linear dose-response, P=.005) as well as among patients with both dysfunction of one or more organs and a predicted risk of mortality of 24% or greater (n=411; linear dose-response, P=.002). Conclusions.-There was not a statistically significant increase in survival time for rhIL-1ra treatment compared with placebo among all patients who received the study medication or among patients with shock at study entry. Secondary and retrospective analyses of efficacy suggest that treatment with rhIL-1ra results in a dose-related increase in survival time among patients with sepsis who have organ dysfunction and/or a predicted risk of mortality of 24% or greater.	UNIV PARIS 05, COCHIN PORT ROYAL HOSP, DEPT INTENS CARE MED, PARIS, FRANCE; BROWN UNIV, SCH MED, DEPT MED, PROVIDENCE, RI 02912 USA; SYNERGEN INC, DEPT CLIN RES, BOULDER, CO USA; RUSH PRESBYTERIAN ST LUKES MED CTR, DEPT MED, CHICAGO, IL 60612 USA; UNIV MED & DENT NEW JERSEY, COOPER HOSP, DEPT SURG, CAMDEN, NJ 08103 USA; MT SINAI MED CTR, DEPT SURG, NEW YORK, NY 10029 USA; ST VINCENTS HOSP & MED CTR, DEPT MED, NEW YORK, NY 10011 USA; ST LOUIS UNIV, MED CTR, DEPT SURG, ST LOUIS, MO 63110 USA; VET AFFAIRS MED CTR, DEPT MED, MIAMI, FL USA; UNIV MIAMI, SCH MED, MIAMI, FL USA; VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT SURG, RICHMOND, VA 23298 USA; UNIV S MANCHESTER HOSP, INTENS CARE UNIT, MANCHESTER, LANCS, ENGLAND; MARYLAND MED RES INST, BALTIMORE, MD USA; GEORGE WASHINGTON UNIV, MED CTR, INTENS CARE RES UNIT, WASHINGTON, DC 20037 USA; USA, WALTER REED ARMY INST RES, DIV COMMUN DIS & IMMUNOL, WASHINGTON, DC USA; ST LOUIS HLTH SCI CTR, ST LOUIS, MO USA; VET AFFAIRS MED CTR, BAY PINES, FL USA; UNIV S FLORIDA, TAMPA, FL USA; TORONTO GEN HOSP, TORONTO, ON, CANADA; UNIV NEW MEXICO, MED CTR, ALBUQUERQUE, NM 87131 USA; VET AFFAIRS MED CTR, BOISE, ID USA; ST LUKES REG MED CTR, BOISE, ID USA; ST ALPHONSUS REG MED CTR, BOISE, ID USA; UNIV ERLANGEN NURNBERG, CHIRURG KLIN, W-8520 ERLANGEN, GERMANY; CALIF STATE UNIV SACRAMENTO, DAVIS MED CTR, SACRAMENTO, CA USA; UNIV CINCINNATI, MED CTR, CINCINNATI, OH 45267 USA; MASSACHUSETTS GEN HOSP, BOSTON, MA USA; CAROLINAS MED CTR, CHARLOTTE, NC USA; JOHN RADCLIFFE HOSP, OXFORD, ENGLAND; CRIT CARE ASSOCIATES, DES MOINES, IA USA; ZENT KRANKENHAUS LINKS WESER, BREMEN, GERMANY; PENN STATE UNIV, MILTON S HERSHEY MED CTR, HERSHEY, PA 17033 USA; FREE UNIV BRUSSELS, HOP ERASME, B-1070 BRUSSELS, BELGIUM; UNIV SO ALABAMA, MED CTR, MOBILE, AL USA; UNIV KENTUCKY, ALBERT B CHANDLER MED CTR, LEXINGTON, KY 40536 USA; DUKE UNIV, MED CTR, DURHAM, NC USA; UNIV LUBECK, LUBECK, GERMANY; WINTHROP UNIV HOSP, MINEOLA, NY USA; FREE UNIV AMSTERDAM HOSP, AMSTERDAM, NETHERLANDS; WAYNE STATE UNIV, HARPER HOSP, DETROIT, MI USA; VANDERBILT UNIV, SCH MED, NASHVILLE, TN 37212 USA; UNIV MINNESOTA, SCH MED, MINNEAPOLIS, MN USA; VET AFFAIRS MED CTR, BRONX, NY USA; VICTORIA HOSP, LONDON, ON, CANADA; ST PAULS HOSP, VANCOUVER, BC, CANADA; HOP CALMETTE, LILLE, FRANCE; HOP LOUISE MICHEL, EVRY, FRANCE; CORNELL UNIV, MED CTR, NEW YORK, NY 10021 USA; TUFTS UNIV NEW ENGLAND MED CTR, BOSTON, MA USA; LOUISIANA STATE UNIV, MED CTR, NEW ORLEANS, LA USA; GOTHENBURG UNIV, GOTHENBURG, SWEDEN; UNIV WISCONSIN, SCH MED, MADISON, WI USA; HAHNEMANN UNIV, PHILADELPHIA, PA USA; GUYS HOSP, LONDON, ENGLAND; CTR HOSP ARGENTEUIL, ARGENTEUIL, FRANCE; UNIV DETROIT, CTR HLTH, DETROIT, MI USA; UNIV CHICAGO, CHICAGO, IL USA; UNIV IOWA HOSP & CLIN, IOWA CITY, IA USA; UNIV TEXAS, SW MED CTR, DALLAS, TX USA; UNIV CONNECTICUT, HARTFORD HOSP, MED CTR, HARTFORD, CT USA; LINKOPING UNIV HOSP, LINKOPING, SWEDEN; BAYLOR COLL MED, HOUSTON, TX USA; UNIV LUND HOSP, LUND, SWEDEN; VET AFFAIRS MED CTR, WASHINGTON, DC USA; HOP COCHIN, PARIS, FRANCE; UNIV MARYLAND HOSP, BALTIMORE, MD USA; ST GEORGE HOSP, LONDON, ENGLAND; MALMO GEN HOSP, MALMO, SWEDEN; UNIV WALES HOSP, CARDIFF, WALES; EALING GEN HOSP, SOUTHALL, MIDDX, ENGLAND; APACHE MED SYST INC, WASHINGTON, DC USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Brown University; Rush University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Icahn School of Medicine at Mount Sinai; Saint Vincents Hospital Manhattan; Saint Louis University; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Miami; Virginia Commonwealth University; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; George Washington University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Saint Louis University; US Department of Veterans Affairs; Veterans Health Administration (VHA); State University System of Florida; University of South Florida; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of New Mexico; US Department of Veterans Affairs; Veterans Health Administration (VHA); Saint Alphonsus Regional Medical Center; University of Erlangen Nuremberg; California State University System; California State University Sacramento; University System of Ohio; University of Cincinnati; Harvard University; Massachusetts General Hospital; Carolinas Medical Center; University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Universite Libre de Bruxelles; Vrije Universiteit Brussel; University of South Alabama; University of Kentucky; Duke University; University of Lubeck; Winthrop University Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Wayne State University; Vanderbilt University; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Victoria; Western University (University of Western Ontario); St. Paul's Hospital; University of Saskatchewan; Universite de Lille - ISITE; CHU Lille; Cornell University; Tufts Medical Center; Louisiana State University System; University of Gothenburg; University of Wisconsin System; University of Wisconsin Madison; Drexel University; Guy's & St Thomas' NHS Foundation Trust; University of Detroit Mercy; University of Chicago; University of Iowa; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Hartford Hospital; University of Connecticut; Linkoping University; Baylor College of Medicine; Lund University; Skane University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; University System of Maryland; University of Maryland Baltimore; St Georges University London; Cardiff University	FISHER, CJ (corresponding author), CLEVELAND CLIN FDN, DEPT PULM & CRIT CARE MED, CRIT CARE RES UNIT, 9500 EUCLID AVE, CLEVELAND, OH 44195 USA.		Friedman, Gilberto/F-7212-2015; Friedman, Gilberto/F-7208-2015; Porter, Joanna/C-7162-2009; Barie, Philip/AAN-8811-2020; Knaus, William/AAX-2138-2020; Snydman, David R/O-3889-2014	Friedman, Gilberto/0000-0001-9369-2488; Porter, Joanna/0000-0002-7307-169X; Snydman, David R/0000-0003-0119-3978				AIURA K, 1993, INFECT IMMUN, V61, P3342, DOI 10.1128/IAI.61.8.3342-3350.1993; AREND WP, 1990, J CLIN INVEST, V85, P1694, DOI 10.1172/JCI114622; BONE RC, 1991, ANN INTERN MED, V115, P457, DOI 10.7326/0003-4819-115-6-457; BONE RC, 1989, CRIT CARE MED, V17, P389, DOI 10.1097/00003246-198905000-00002; CALANDRA T, 1990, J INFECT DIS, V161, P982, DOI 10.1093/infdis/161.5.982; CANNON JG, 1990, J INFECT DIS, V161, P79, DOI 10.1093/infdis/161.1.79; DINARELLO CA, 1993, JAMA-J AM MED ASSOC, V269, P1829, DOI 10.1001/jama.269.14.1829; DRIPPS DJ, 1991, J BIOL CHEM, V266, P10331; DRIPPS DJ, 1991, J BIOL CHEM, V266, P20311; EISENBERG SP, 1990, NATURE, V343, P341, DOI 10.1038/343341a0; FISCHER E, 1991, AM J PHYSIOL, V261, pR442, DOI 10.1152/ajpregu.1991.261.2.R442; FISCHER E, 1992, J CLIN INVEST, V89, P1551, DOI 10.1172/JCI115748; FISHER CJ, 1994, CRIT CARE MED, V22, P12, DOI 10.1097/00003246-199401000-00008; FISHER CJ, 1993, CRIT CARE MED, V21, P318, DOI 10.1097/00003246-199303000-00006; FISHER CJ, 1991, KLIN WOCHENSCHR, V69, P162; GIROIR BP, 1993, CRIT CARE MED, V21, P780, DOI 10.1097/00003246-199305000-00024; GRANOWITZ EV, 1991, LANCET, V338, P1423, DOI 10.1016/0140-6736(91)92725-H; GREENMAN RL, 1991, JAMA-J AM MED ASSOC, V266, P1097, DOI 10.1001/jama.266.8.1097; HANNUM CH, 1990, NATURE, V343, P336, DOI 10.1038/343336a0; HESSE DG, 1988, SURG GYNECOL OBSTET, V166, P147; KNAUS WA, 1993, JAMA-J AM MED ASSOC, V270, P1233, DOI 10.1001/jama.270.10.1233; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; MARKS JD, 1990, AM REV RESPIR DIS, V141, P94, DOI 10.1164/ajrccm/141.1.94; MICHIE HR, 1988, NEW ENGL J MED, V318, P1481, DOI 10.1056/NEJM198806093182301; OHLSSON K, 1990, NATURE, V348, P550, DOI 10.1038/348550a0; OKUSAWA S, 1988, J CLIN INVEST, V81, P1162, DOI 10.1172/JCI113431; PARRILLO JE, 1990, ANN INTERN MED, V113, P227, DOI 10.7326/0003-4819-113-3-227; PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008; PRENTICE RL, 1979, BIOMETRICS, V35, P861, DOI 10.2307/2530120; TRACEY KJ, 1989, LANCET, V1, P1122; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; WAAGE A, 1988, J EXP MED, V167, P1987, DOI 10.1084/jem.167.6.1987; WAAGE A, 1989, J EXP MED, V169, P333, DOI 10.1084/jem.169.1.333; WAKABAYASHI GO, 1991, FASEB J, V5, P338, DOI 10.1096/fasebj.5.3.1825816; WENZEL RP, 1988, INT J EPIDEMIOL, V17, P225, DOI 10.1093/ije/17.1.225; ZIEGLER EJ, 1991, NEW ENGL J MED, V324, P429, DOI 10.1056/NEJM199102143240701; 1990, MMWR, V39, P31	37	816	840	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	1994	271	23					1836	1843		10.1001/jama.271.23.1836	http://dx.doi.org/10.1001/jama.271.23.1836			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NP959	8196140				2022-12-28	WOS:A1994NP95900027
J	VANPEENEN, HJ				VANPEENEN, HJ			KIPP	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	1994	120	12					1041	1042		10.7326/0003-4819-120-12-199406150-00011	http://dx.doi.org/10.7326/0003-4819-120-12-199406150-00011			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NQ964	8185135				2022-12-28	WOS:A1994NQ96400011
J	GREEN, JBA				GREEN, JBA			ROADS TO NEURALNESS - EMBRYONIC NEURAL INDUCTION AS DEREPRESSION OF A DEFAULT STATE	CELL			English	Review							XENOPUS-LAEVIS; MESODERM INDUCTION; ACTIVIN RECEPTOR; AXIAL STRUCTURES; DIFFERENTIATION; EXPRESSION; MOUSE; CELLS; EGGS				GREEN, JBA (corresponding author), UNIV CALIF BERKELEY,DEPT MOLEC & CELL BIOL,BERKELEY,CA 94720, USA.		Green, Jeremy/F-3630-2010	Green, Jeremy/0000-0002-6102-2620				ANG SL, 1993, DEVELOPMENT, V118, P139; ASASHIMA M, 1991, P NATL ACAD SCI USA, V88, P6511, DOI 10.1073/pnas.88.15.6511; BEDDINGTON RSP, 1994, DEVELOPMENT, V120, P613; BLUM M, 1992, CELL, V69, P1097, DOI 10.1016/0092-8674(92)90632-M; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; DOHRMANN CE, 1993, DEV BIOL, V157, P474, DOI 10.1006/dbio.1993.1150; EBNER R, 1993, SCIENCE, V262, P900, DOI 10.1126/science.8235612; FUKUI A, 1993, DEV BIOL, V159, P131, DOI 10.1006/dbio.1993.1227; GREEN JBA, 1990, NATURE, V347, P391, DOI 10.1038/347391a0; GREEN JBA, 1992, CELL, V71, P731, DOI 10.1016/0092-8674(92)90550-V; GRUNZ H, 1989, CELL DIFFER DEV, V28, P211, DOI 10.1016/0922-3371(89)90006-3; HEMMATIBRIVANLOU A, 1994, CELL, V77, P283, DOI 10.1016/0092-8674(94)90320-4; HEMMATIBRIVANLOU A, 1992, DEV DYNAM, V194, P1, DOI 10.1002/aja.1001940102; HEMMATIBRIVANLOU A, 1994, CELL, V77, P273, DOI 10.1016/0092-8674(94)90319-0; HEMMATIBRIVANLOU A, 1992, NATURE, V359, P609, DOI 10.1038/359609a0; JONES EA, 1993, ROUX ARCH DEV BIOL, V202, P233, DOI 10.1007/BF02427884; KENGAKU M, 1993, DEVELOPMENT, V119, P1067; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; MANOVA K, 1992, MECH DEVELOP, V36, P141, DOI 10.1016/0925-4773(92)90065-R; MASSAGUE J, 1994, IN PRESS TRENDS CELL; MITRANI E, 1990, CELL, V63, P495, DOI 10.1016/0092-8674(90)90446-L; MUMMERY CL, 1993, INT J DEV BIOL, V37, P169; REBAGLIATI MR, 1993, DEV BIOL, V159, P574, DOI 10.1006/dbio.1993.1265; SAXEN L, 1989, International Journal of Developmental Biology, V33, P21; SIVE HL, 1993, GENE DEV, V7, P1, DOI 10.1101/gad.7.1.1; SLACK JMW, 1992, DEVELOPMENT, V114, P285; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; Stern C D, 1993, EXS, V65, P369; STERNCD, 1992, DEVELOPMENT, V114, P729; SYMES K, 1988, DEVELOPMENT, V104, P609; THOMSEN GH, 1993, CELL, V74, P433, DOI 10.1016/0092-8674(93)80045-G; VASSALLI A, 1994, GENE DEV, V8, P414, DOI 10.1101/gad.8.4.414; WEEKS DL, 1987, CELL, V51, P861, DOI 10.1016/0092-8674(87)90109-7	33	33	34	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 6	1994	77	3					317	320		10.1016/0092-8674(94)90145-7	http://dx.doi.org/10.1016/0092-8674(94)90145-7			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NK970	8181051				2022-12-28	WOS:A1994NK97000001
J	LONGSTRETH, GF				LONGSTRETH, GF			SUCCESSFUL TREATMENT OF REFRACTORY SPRUE WITH CYCLOSPORINE	ANNALS OF INTERNAL MEDICINE			English	Note							CELIAC SPRUE		SO CALIF PERMANENTE MED GRP, SAN DIEGO, CA USA	Kaiser Permanente; Southern California Permanente Medical Group (SCPMG); Permanente Medical Groups								BAKER AL, 1978, ANN INTERN MED, V89, P505, DOI 10.7326/0003-4819-89-4-505; BERNSTEIN EF, 1988, GASTROENTEROLOGY, V95, P199, DOI 10.1016/0016-5085(88)90312-5; DERAY G, 1992, ANN INTERN MED, V117, P578, DOI 10.7326/0003-4819-117-7-578; Kelly C P, 1990, Adv Intern Med, V35, P341; SANDBORN WJ, 1992, MAYO CLIN PROC, V67, P981, DOI 10.1016/S0025-6196(12)60930-6; THOMSON AW, 1991, BRIT MED J, V302, P4, DOI 10.1136/bmj.302.6767.4; TRIER JS, 1978, GASTROENTEROLOGY, V75, P307; TRIER JS, 1991, NEW ENGL J MED, V325, P1709, DOI 10.1056/NEJM199112123252406; WEINSTEI.WM, 1970, NEW ENGL J MED, V283, P1297, DOI 10.1056/NEJM197012102832401	9	42	42	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1993	119	10					1014	1016		10.7326/0003-4819-119-10-199311150-00008	http://dx.doi.org/10.7326/0003-4819-119-10-199311150-00008			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MG672	8214978				2022-12-28	WOS:A1993MG67200008
J	CHIEN, CT; BUCK, S; STERNGLANZ, R; SHORE, D				CHIEN, CT; BUCK, S; STERNGLANZ, R; SHORE, D			TARGETING OF SIR1 PROTEIN ESTABLISHES TRANSCRIPTIONAL SILENCING AT HM LOCI AND TELOMERES IN YEAST	CELL			English	Article							UPSTREAM ACTIVATING SEQUENCES; N-TERMINAL ACETYLTRANSFERASE; MATING-TYPE INFORMATION; DNA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; CHROMATIN STRUCTURE; REGULATORY PROTEIN; GENES; REPLICATION; REPRESSION	Previous studies suggest that the yeast SIR1 protein is involved in the establishment of transcriptional silencing at the HM mating-type loci. Here we show that a GAL4 DNA-binding domain-SIR1 hybrid protein (G(BD)-SIR1), when targeted to an HMR locus containing GAL4-binding sites (UAS(G)), can establish silencing and bypass the requirement for the silencer element HMR-E. Silencing mediated by G(BD)-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4. However, G(BD) hybrids with SIR2, SIR3, or SIR4 cannot establish silencing. Telomeric silencing, which does not require SIR1 and is normally unstable, is greatly improved by tethering G(BD)-SIR1 to the telomere. These experiments support a model in which native SIR1 protein is brought to the HM loci by proteins bound to the silencers. Telomeres appear to lack the ability to recruit SIR1, and that is why telomeric silencing is unstable.	COLUMBIA UNIV COLL PHYS & SURG, DEPT MICROBIOL, NEW YORK, NY 10032 USA	Columbia University	CHIEN, CT (corresponding author), SUNY STONY BROOK, DEPT BIOCHEM & CELL BIOL, STONY BROOK, NY 11794 USA.		Shore, David/F-6240-2015; Chien, Cheng-Ting/AAA-5200-2021	Shore, David/0000-0002-9859-143X; Chien, Cheng-Ting/0000-0002-7906-7173	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028220, R01GM040094, R56GM028220] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28220, GM40094] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAM J, 1984, J MOL BIOL, V176, P307, DOI 10.1016/0022-2836(84)90492-3; APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; BRAM RJ, 1986, EMBO J, V5, P603, DOI 10.1002/j.1460-2075.1986.tb04253.x; BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5; BRAND AH, 1987, CELL, V51, P709, DOI 10.1016/0092-8674(87)90094-8; BRILL SJ, 1988, CELL, V54, P403, DOI 10.1016/0092-8674(88)90203-6; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P210, DOI 10.1128/MCB.8.1.210; BUCHMAN AR, 1988, MOL CELL BIOL, V8, P5086, DOI 10.1128/MCB.8.12.5086; BUCHMAN AR, 1990, MOL CELL BIOL, V10, P887, DOI 10.1128/MCB.10.3.887; CHAMBERS A, 1989, MOL CELL BIOL, V9, P5516, DOI 10.1128/MCB.9.12.5516; CHENCLELAND TA, 1993, J BIOL CHEM, V268, P1118; CHIEN CT, 1991, P NATL ACAD SCI USA, V88, P9578, DOI 10.1073/pnas.88.21.9578; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; DIFFLEY JFX, 1992, NATURE, V357, P169, DOI 10.1038/357169a0; FELDMAN JB, 1984, J MOL BIOL, V178, P815, DOI 10.1016/0022-2836(84)90313-9; GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; GOTTSCHLING DE, 1992, P NATL ACAD SCI USA, V89, P4062, DOI 10.1073/pnas.89.9.4062; GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z; HARDY CFJ, 1992, MOL CELL BIOL, V12, P1209, DOI 10.1128/MCB.12.3.1209; IVY JM, 1986, MOL CELL BIOL, V6, P688, DOI 10.1128/MCB.6.2.688; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; KAYNE PS, 1988, CELL, V55, P27, DOI 10.1016/0092-8674(88)90006-2; KELEHER CA, 1992, CELL, V68, P709, DOI 10.1016/0092-8674(92)90146-4; KIMMERLY W, 1988, EMBO J, V7, P2241, DOI 10.1002/j.1460-2075.1988.tb03064.x; KIMMERLY WJ, 1987, MOL CELL BIOL, V7, P4225, DOI 10.1128/MCB.7.12.4225; LAURENT BC, 1992, GENE DEV, V6, P1707, DOI 10.1101/gad.6.9.1707; LONGTINE MS, 1989, CURR GENET, V16, P225, DOI 10.1007/BF00422108; LUSTIG AJ, 1990, SCIENCE, V250, P549, DOI 10.1126/science.2237406; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; MAHONEY DJ, 1991, GENE DEV, V5, P605, DOI 10.1101/gad.5.4.605; MARAHRENS Y, 1992, SCIENCE, V255, P817, DOI 10.1126/science.1536007; MARSH JL, 1984, GENE, V32, P481, DOI 10.1016/0378-1119(84)90022-2; MARSHALL M, 1987, MOL CELL BIOL, V7, P4441, DOI 10.1128/MCB.7.12.4441; MCNALLY FJ, 1991, MOL CELL BIOL, V11, P5648, DOI 10.1128/MCB.11.11.5648; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; MILLER AM, 1984, NATURE, V312, P247, DOI 10.1038/312247a0; MOEHLE CM, 1991, MOL CELL BIOL, V11, P2723, DOI 10.1128/MCB.11.5.2723; MULLEN JR, 1989, EMBO J, V8, P2067, DOI 10.1002/j.1460-2075.1989.tb03615.x; NASMYTH KA, 1982, CELL, V30, P567, DOI 10.1016/0092-8674(82)90253-7; PARK EC, 1992, EMBO J, V11, P2087, DOI 10.1002/j.1460-2075.1992.tb05267.x; PARK EC, 1990, MOL CELL BIOL, V10, P4932, DOI 10.1128/MCB.10.9.4932; PETERSON CL, 1992, CELL, V68, P573, DOI 10.1016/0092-8674(92)90192-F; PILLUS L, 1989, CELL, V59, P637, DOI 10.1016/0092-8674(89)90009-3; RINE J, 1987, GENETICS, V116, P9; Rivier DH, 1992, CURR OPIN GENET DEV, V2, P286, DOI 10.1016/S0959-437X(05)80286-2; ROCKMILL B, 1991, METHOD ENZYMOL, V194, P146; Rose MD., 1990, METHODS YEAST GENETI; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SHORE D, 1987, EMBO J, V6, P461, DOI 10.1002/j.1460-2075.1987.tb04776.x; SHORE D, 1987, CELL, V51, P721, DOI 10.1016/0092-8674(87)90095-X; SHORE D, 1984, EMBO J, V3, P2817, DOI 10.1002/j.1460-2075.1984.tb02214.x; SINGH J, 1992, GENE DEV, V6, P186, DOI 10.1101/gad.6.2.186; STONE EM, 1991, MOL CELL BIOL, V11, P2253, DOI 10.1128/MCB.11.4.2253; STONE EM, 1991, THESIS STATE U NEW Y; SUSSEL L, 1991, P NATL ACAD SCI USA, V88, P7749, DOI 10.1073/pnas.88.17.7749; SUSSEL L, 1993, MOL CELL BIOL, V13, P3919, DOI 10.1128/MCB.13.7.3919; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; TORNOW J, 1990, GENE, V90, P79, DOI 10.1016/0378-1119(90)90441-S; WHITEWAY M, 1987, MOL CELL BIOL, V7, P3713, DOI 10.1128/MCB.7.10.3713	62	177	181	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	1993	75	3					531	541		10.1016/0092-8674(93)90387-6	http://dx.doi.org/10.1016/0092-8674(93)90387-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MF830	8221892				2022-12-28	WOS:A1993MF83000015
J	SUN, H; CHARLES, CH; LAU, LF; TONKS, NK				SUN, H; CHARLES, CH; LAU, LF; TONKS, NK			MKP-1 (3CH134), AN IMMEDIATE-EARLY GENE-PRODUCT, IS A DUAL-SPECIFICITY PHOSPHATASE THAT DEPHOSPHORYLATES MAP KINASE IN-VIVO	CELL			English	Article							PROTEIN-KINASE; VACCINIA VIRUS; GROWTH-FACTOR; ACTIVATION; PHOSPHORYLATION; SIGNAL	Mitogenic stimulation of cells induces rapid and transient activation of MAP kinases. Here we report that a growth factor-inducible gene, 3CH134, encodes a dual specificity phosphatase that dephosphorylates and inactivates p42MAPK both in vitro and in vivo. In vitro, 3CH134 protein dephosphorylates both T183 and Y185 in p42MAPK. In serum-stimulated normal fibroblasts, the kinetics of inactivation of p42MAPK coincides with the appearance of newly synthesized 3CH134 protein, and the protein synthesis inhibitor cycloheximide leads to persistent activation of MAP kinase. Expression of 3CH134 in COS cells leads to selective dephosphorylation of p42MAPK from the spectrum of phosphotyrosyl proteins. 3CH134 blocks phosphorylation and activation of p42MAPK Mediated by serum, oncogenic Ras, or activated Raf, whereas the catalytically inactive mutant of the phosphatase, Cys-258-->Ser, augments MAP kinase phosphorylation under similar conditions. The mutant 3CH134 protein also forms a physical complex with the phosphorylated form of p42MAPK. These findings suggest that 3CH134 is a physiological MAP kinase phosphatase; we propose the name MKP-1 for this phosphatase.	UNIV ILLINOIS, COLL MED, DEPT GENET, CHICAGO, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	SUN, H (corresponding author), COLD SPRING HARBOR LAB, DEMEREC BLDG, 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA.			Lau, Lester/0000-0002-4364-2914	NATIONAL CANCER INSTITUTE [R01CA052220, R37CA053840, R01CA053840] Funding Source: NIH RePORTER; NCI NIH HHS [CA53840, CA52220] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn Natalie G., 1992, Current Opinion in Cell Biology, V4, P992, DOI 10.1016/0955-0674(92)90131-U; ALESSI DR, 1993, ONCOGENE, V8, P2015; ANDERSON NG, 1990, NATURE, V343, P651, DOI 10.1038/343651a0; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; CHARBONNEAU H, 1992, ANNU REV CELL BIOL, V8, P463, DOI 10.1146/annurev.cellbio.8.1.463; CHARLES CH, 1992, ONCOGENE, V7, P187; CHARLES CH, 1993, P NATL ACAD SCI USA, V90, P5292, DOI 10.1073/pnas.90.11.5292; COBB MH, 1991, CELL REGUL, V2, P965, DOI 10.1091/mbc.2.12.965; CREWS CM, 1993, CELL, V74, P215, DOI 10.1016/0092-8674(93)90411-I; FEIG LA, 1993, SCIENCE, V260, P767, DOI 10.1126/science.8484117; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; GOTOH Y, 1990, EUR J BIOCHEM, V193, P661, DOI 10.1111/j.1432-1033.1990.tb19384.x; GUAN K, 1992, P NATL ACAD SCI USA, V89, P12175, DOI 10.1073/pnas.89.24.12175; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; HAYSTEAD TAJ, 1990, J BIOL CHEM, V265, P16571; HOWE LR, 1992, CELL, V71, P335, DOI 10.1016/0092-8674(92)90361-F; KEYSE SM, 1992, NATURE, V359, P644, DOI 10.1038/359644a0; MCCORMICK F, 1993, NATURE, V363, P15, DOI 10.1038/363015a0; NISHIDA E, 1993, TRENDS BIOCHEM SCI, V18, P128, DOI 10.1016/0968-0004(93)90019-J; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; PELECH SL, 1993, CURR BIOL, V3, P513, DOI 10.1016/0960-9822(93)90043-N; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; SANGHERA JS, 1991, BIOCHIM BIOPHYS ACTA, V1095, P153, DOI 10.1016/0167-4889(91)90078-C; SHIBUYA EK, 1992, P NATL ACAD SCI USA, V89, P9831, DOI 10.1073/pnas.89.20.9831; TSUDA L, 1993, CELL, V72, P407, DOI 10.1016/0092-8674(93)90117-9; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; ZHAO ZH, 1993, P NATL ACAD SCI USA, V90, P4251, DOI 10.1073/pnas.90.9.4251; ZHENG CF, 1993, J BIOL CHEM, V268, P16116	28	1075	1107	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	1993	75	3					487	493		10.1016/0092-8674(93)90383-2	http://dx.doi.org/10.1016/0092-8674(93)90383-2			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MF830	8221888				2022-12-28	WOS:A1993MF83000011
J	GOODGAME, RW				GOODGAME, RW			GASTROINTESTINAL CYTOMEGALOVIRUS DISEASE	ANNALS OF INTERNAL MEDICINE			English	Review							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; IMMUNE-DEFICIENCY-SYNDROME; POLYMERASE CHAIN-REACTION; INFLAMMATORY BOWEL-DISEASE; MARROW TRANSPLANT PATIENTS; VIRUS-INFECTION; INSITU HYBRIDIZATION; ULCERATIVE-COLITIS; LIVER-TRANSPLANTATION; INCLUSION DISEASE	Objective: To describe the pathogenesis of gastrointestinal cytomegalovirus (CMV) disease, the types and locations of gastrointestinal lesions, the clinical settings in which they occur, and the specific methods available to diagnose and treat the disease. Data Sources: Relevant English-language articles were identified through a MEDLINE search from 1985 to 1992. Articles referenced in the bibliographies of these articles and others were searched by hand. Study Selection: All articles that documented the occurrence of gastrointestinal CMV infection in humans, based on the finding of typical cytomegalic cells in histologic specimens, were selected for review. Data Extraction: Studies were grouped by content pertaining to pathogenesis, clinical setting, gastrointestinal location, diagnosis, or treatment. Data Synthesis: Gastrointestinal CMV disease is an erosive or ulcerative process that can occur at any location in the gastrointestinal tract, from mouth to rectum. Cytomegalovirus infection of columnar epithelial cells, endothelial cells, myocytes, and fibroblasts causes tissue destruction and ulceration. Serious CMV disease most frequently occurs with immune deficiency, such as the acquired immunodeficiency syndrome, after organ transplantation, after cancer chemotherapy, and after steroid therapy. Symptoms and signs depend on which part of the gastrointestinal tract is involved. Diagnosis depends on a positive mucosal biopsy that shows the presence of CMV by histopathologic or other techniques. In patients with persistent immune deficiency, progressive intestinal disease and death are frequent. Treatment with ganciclovir or foscarnet often heals intestinal lesions. Conclusions: Internists should be aware of the various clinical settings and locations in the gastrointestinal tract in which CMV disease occurs. Patients with immune deficiency and gastrointestinal signs and symptoms should have imaging tests and mucosal biopsies to investigate the possibility of CMV intestinal disease. Treatment with antiviral chemotherapy improves outcome in many patients.			GOODGAME, RW (corresponding author), BAYLOR COLL MED, 1 BAYLOR PLAZA, ROOM 525D, HOUSTON, TX 77030 USA.							ALEXANDER JA, 1988, TRANSPLANTATION, V46, P378, DOI 10.1097/00007890-198809000-00008; ALLEN JI, 1981, DIGEST DIS SCI, V26, P133, DOI 10.1007/BF01312230; ANDRADE JD, 1983, AM J CLIN PATHOL, V79, P493, DOI 10.1093/ajcp/79.4.493; AQEL NM, 1991, HISTOPATHOLOGY, V18, P165, DOI 10.1111/j.1365-2559.1991.tb01460.x; ARBUSTINI E, 1992, AM J CLIN PATHOL, V98, P205; ASCHAN J, 1992, SCAND J INFECT DIS, V24, P143, DOI 10.3109/00365549209052604; AYULO M, 1980, JAMA-J AM MED ASSOC, V243, P1364, DOI 10.1001/jama.243.13.1364; BALTHAZAR EJ, 1985, AM J ROENTGENOL, V144, P1201, DOI 10.2214/ajr.144.6.1201; BALTHAZAR EJ, 1985, RADIOLOGY, V155, P585, DOI 10.1148/radiology.155.3.2988010; BENNETT MR, 1985, POSTGRAD MED, V77, P227, DOI 10.1080/00325481.1985.11699040; BERK T, 1985, AM J GASTROENTEROL, V80, P355; BLANSHARD C, 1992, J ACQ IMMUN DEF SYND, V5, pS25; BOLAND GJ, 1992, J CLIN MICROBIOL, V30, P1763, DOI 10.1128/JCM.30.7.1763-1767.1992; BONACINI M, 1991, ARCH INTERN MED, V151, P1567, DOI 10.1001/archinte.151.8.1567; BROUILLETTE DE, 1989, DIGEST DIS SCI, V34, P92, DOI 10.1007/BF01536160; BUHLES WC, 1988, REV INFECT DIS, V10, pS495; BURGART LJ, 1991, AM J CLIN PATHOL, V96, P572, DOI 10.1093/ajcp/96.5.572; CAMPBELL DA, 1977, GASTROENTEROLOGY, V72, P533; CHACHOUA A, 1987, ANN INTERN MED, V107, P133, DOI 10.7326/0003-4819-107-2-133; CHANG MH, 1992, GASTROENTEROLOGY, V103, P1022, DOI 10.1016/0016-5085(92)90038-Z; CHEN YT, 1992, TRANSPLANTATION, V53, P99, DOI 10.1097/00007890-199201000-00019; CHO SR, 1981, AM J ROENTGENOL, V136, P1213; CHOU SW, 1990, REV INFECT DIS, V12, pS727; CLAYTON F, 1989, ARCH PATHOL LAB MED, V113, P1124; CONNOLLY GM, 1989, GUT, V30, P1033, DOI 10.1136/gut.30.8.1033; CONNOLLY GM, 1990, AIDS, V4, P687, DOI 10.1097/00002030-199007000-00014; CONNOLLY GM, 1990, GUT, V31, P886, DOI 10.1136/gut.31.8.886; COOPER HS, 1977, GASTROENTEROLOGY, V72, P1253; CULPEPPERMORGAN JA, 1987, AM J GASTROENTEROL, V82, P1264; CUNNINGHAM M, 1986, AM J GASTROENTEROL, V81, P586; DELGADO R, 1992, J CLIN MICROBIOL, V30, P1876, DOI 10.1128/JCM.30.7.1876-1878.1992; DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315; DEMMLER GJ, 1988, J INFECT DIS, V158, P1177, DOI 10.1093/infdis/158.6.1177; DENT DM, 1975, S AFR MED J, V49, P669; DIEPERSLOOT RJA, 1990, ARCH INTERN MED, V150, P1749, DOI 10.1001/archinte.150.8.1749; DIETERICH DT, 1991, J ACQ IMMUN DEF SYND, V4, pS29; DIETERICH DT, 1988, REV INFECT DIS, V10, pS532; DIETHELM AG, 1976, AM J SURG, V131, P371, DOI 10.1016/0002-9610(76)90136-7; DOLGIN SE, 1990, J PEDIATR SURG, V25, P696, DOI 10.1016/0022-3468(90)90369-K; DREW WL, 1991, J ACQ IMMUN DEF SYND, V4, pS42; DREW WL, 1988, REV INFECT DIS, V10, pS468; DREW WL, 1988, J INFECT DIS, V158, P449, DOI 10.1093/infdis/158.2.449; DREW WL, 1991, J INFECT DIS, V163, P716, DOI 10.1093/infdis/163.4.716; DUMMER JS, 1990, REV INFECT DIS, V12, pS767; DUNN DL, 1990, TRANSPLANT P, V22, P678; EINSELE H, 1991, LANCET, V338, P1170, DOI 10.1016/0140-6736(91)92032-W; ELTA G, 1986, AM J GASTROENTEROL, V81, P714; ERICE A, 1989, NEW ENGL J MED, V320, P289, DOI 10.1056/NEJM198902023200505; EYREBROOK IA, 1986, GUT, V27, P1419, DOI 10.1136/gut.27.12.1419; FALCONE S, 1991, GASTROINTEST RADIOL, V16, P95, DOI 10.1007/BF01887318; FARMAN J, 1992, GASTROINTEST RADIOL, V17, P202, DOI 10.1007/BF01888548; FARMER GW, 1973, GASTROENTEROLOGY, V65, P8; FERNANDES B, 1986, CAN J SURG, V29, P453; FOUCAR E, 1981, AM J CLIN PATHOL, V76, P788, DOI 10.1093/ajcp/76.6.788; FRAGER DH, 1986, GASTROINTEST RADIOL, V11, P241, DOI 10.1007/BF02035081; FRANCIS ND, 1989, J CLIN PATHOL, V42, P1055, DOI 10.1136/jcp.42.10.1055; FRANK D, 1984, AM J GASTROENTEROL, V79, P201; FRANZIN G, 1980, ENDOSCOPY, V12, P117, DOI 10.1055/s-2007-1021725; FRANZIN G, 1981, GUT, V22, P698, DOI 10.1136/gut.22.9.698; FREEDMAN PG, 1985, AM J GASTROENTEROL, V80, P434; FREEMAN HJ, 1977, GASTROENTEROLOGY, V73, P1397; FURUKAWA Y, 1988, ACTA HAEMATOL-BASEL, V80, P216, DOI 10.1159/000205640; GANGAHAR DM, 1988, J HEART TRANSPLANT, V7, P377; GARCIA F, 1987, ARCH INTERN MED, V147, P787, DOI 10.1001/archinte.147.4.787; GERTLER SL, 1983, GASTROENTEROLOGY, V85, P1403; GLEAVES CA, 1987, AM J CLIN PATHOL, V88, P354, DOI 10.1093/ajcp/88.3.354; GOODGAME RW, 1993, AM J GASTROENTEROL, V88, P338; GOODGAME RW, 1991, J CLIN GASTROENTEROL, V13, P678, DOI 10.1097/00004836-199112000-00013; GOODMAN MD, 1973, ARCH PATHOL, V96, P281; GOODMAN ZD, 1979, DIGEST DIS SCI, V24, P376, DOI 10.1007/BF01297124; GOODRICH JM, 1991, NEW ENGL J MED, V325, P1601, DOI 10.1056/NEJM199112053252303; GRIFFITHS PD, 1988, EPIDEMIOL INFECT, V100, P1, DOI 10.1017/S095026880006550X; GRUNDY JE, 1988, LANCET, V2, P132; GRUNDY JE, 1990, REV INFECT DIS, V12, pS711; GUARDA LA, 1984, AM J CLIN PATHOL, V81, P549, DOI 10.1093/ajcp/81.5.549; GUTTMAN D, 1983, AM J GASTROENTEROL, V78, P167; HASHIMOTO H, 1987, VIRCHOWS ARCH A, V411, P441, DOI 10.1007/BF00735225; HENSON D, 1972, ARCH PATHOL, V93, P477; HINNANT KL, 1986, AM J GASTROENTEROL, V81, P944; HO M, 1990, REV INFECT DIS, V12, pS701; ICENOGLE T B, 1987, Journal of Heart Transplantation, V6, P199; IWASAKI T, 1987, ACTA PATHOL JAPON, V37, P549; JABS DA, 1992, NEW ENGL J MED, V326, P213, DOI 10.1056/NEJM199201233260401; JACOBSON MA, 1988, ANN INTERN MED, V108, P585, DOI 10.7326/0003-4819-108-4-585; JACOBSON MA, 1991, J INFECT DIS, V163, P1348, DOI 10.1093/infdis/163.6.1348; JEFFRIES DJ, 1989, J ANTIMICROB CHEMOTH, V23, P1; KANAS RJ, 1987, ORAL SURG ORAL MED O, V64, P183, DOI 10.1016/0030-4220(87)90088-0; KAWIMBE B, 1991, ARCH DIS CHILD, V66, P883, DOI 10.1136/adc.66.7.883; KEREN DF, 1975, JOHNS HOPKINS MED J, V136, P178; KNAPP AB, 1983, GASTROENTEROLOGY, V85, P1399; Koszinowski U H, 1992, Semin Immunol, V4, P71; KOTLER DP, 1989, ARCH INTERN MED, V149, P901, DOI 10.1001/archinte.149.4.901; KOTLER DP, 1991, J ACQ IMMUN DEF SYND, V4, pS36; KRAM HB, 1984, CRIT CARE MED, V12, P469, DOI 10.1097/00003246-198405000-00014; KRAM HB, 1990, DIS COLON RECTUM, V33, P1037, DOI 10.1007/BF02139220; LACHMAN RS, 1971, AMER J ROENTGENOL RA, V112, P83, DOI 10.2214/ajr.112.1.83; LAINE L, 1992, J ACQ IMMUN DEF SYND, V5, P605; LALWANI AK, 1991, ANN OTO RHINOL LARYN, V100, P484, DOI 10.1177/000348949110000611; LASKIN OL, 1987, J INFECT DIS, V155, P323, DOI 10.1093/infdis/155.2.323; LAZZAROTTO T, 1992, J CLIN MICROBIOL, V30, P1027, DOI 10.1128/JCM.30.4.1027-1029.1992; LEE WT, 1992, AUST NZ J MED, V22, P249, DOI 10.1111/j.1445-5994.1992.tb02120.x; LELAND DS, 1989, J CLIN MICROBIOL, V27, P176, DOI 10.1128/JCM.27.1.176-178.1989; LEONIDAS JC, 1973, AM J DIS CHILD, V126, P806, DOI 10.1001/archpedi.1973.02110190648013; LEPINSKI SM, 1990, GASTROENTEROLOGY, V98, P1704, DOI 10.1016/0016-5085(90)91112-J; LEVINE RS, 1964, ANN SURG, V159, P37, DOI 10.1097/00000658-196401000-00013; LEVINSON W, 1985, AM J GASTROENTEROL, V80, P445; LIETMAN PS, 1992, AM J MED, V92, pS8, DOI 10.1016/0002-9343(92)90330-E; LIN J, 1990, AM J MED, V89, P377, DOI 10.1016/0002-9343(90)90353-F; LINK H, 1992, J MED VIROL, V37, P143, DOI 10.1002/jmv.1890370213; MACHER AM, 1983, NEW ENGL J MED, V309, P1454; MARCUSEN DC, 1985, LARYNGOSCOPE, V95, P401; MARKS MP, 1986, AM J ROENTGENOL, V147, P1031, DOI 10.2214/ajr.147.5.1031; MARSANO L, 1990, J INFECT DIS, V161, P454, DOI 10.1093/infdis/161.3.454; MAYORAL JL, 1991, ARCH SURG-CHICAGO, V126, P202; MCDONALD GB, 1985, GASTROENTEROLOGY, V88, P1111, DOI 10.1016/S0016-5085(85)80068-8; MEGIBOW AJ, 1987, SEMIN ROENTGENOL, V22, P31, DOI 10.1016/0037-198X(87)90020-4; MEISELMAN MS, 1985, GASTROENTEROLOGY, V88, P171, DOI 10.1016/S0016-5085(85)80150-5; MERIGAN TC, 1990, REV INFECT DIS, V12, pS693; MEYERS JD, 1990, J INFECT DIS, V162, P373, DOI 10.1093/infdis/162.2.373; MINAMI H, 1990, JPN J MED, V29, P433; MINTZ L, 1983, ANN INTERN MED, V99, P326, DOI 10.7326/0003-4819-99-3-326; MYERSON D, 1984, HUM PATHOL, V15, P430, DOI 10.1016/S0046-8177(84)80076-3; NABESHIMA K, 1992, ACTA PATHOL JAPON, V42, P267; NAKONECZNA I, 1967, AM J CLIN PATHOL, V47, P124, DOI 10.1093/ajcp/47.2.124; NELSON MR, 1991, AM J GASTROENTEROL, V86, P876; NEVINS TE, 1992, J AM SOC NEPHROL, V2, pS270; NEWLAND JR, 1989, ORAL SURG ORAL MED O, V67, P296, DOI 10.1016/0030-4220(89)90359-9; ONG ELC, 1989, J INFECTION, V18, P73, DOI 10.1016/S0163-4453(89)93742-0; ORLOFF JJ, 1989, AM J GASTROENTEROL, V84, P794; PALESTINE AG, 1991, ANN INTERN MED, V115, P665, DOI 10.7326/0003-4819-115-9-665; PARENTE F, 1991, AM J GASTROENTEROL, V86, P1729; PARENTE F, 1991, GUT, V32, P987, DOI 10.1136/gut.32.9.987; PASTERNACK MS, 1990, REV INFECT DIS, V12, pS720; PERSONS DL, 1991, MODERN PATHOL, V4, P149; PIALOUX G, 1991, REV INFECT DIS, V13, P338; POLAND SD, 1990, J INFECT DIS, V162, P1252, DOI 10.1093/infdis/162.6.1252; POLIS MA, 1992, J ACQ IMMUN DEF SYND, V5, pS3; QUINNAN GV, 1984, JAMA-J AM MED ASSOC, V252, P72, DOI 10.1001/jama.252.1.72; RABINOWITZ M, 1988, AM J GASTROENTEROL, V83, P885; REDDY MM, 1992, J INFECT DIS, V166, P607, DOI 10.1093/infdis/166.3.607; REED EC, 1990, ANN INTERN MED, V112, P505, DOI 10.7326/0003-4819-112-7-505; RENE E, 1988, DIGEST DIS SCI, V33, P741, DOI 10.1007/BF01540440; ROBERTS WH, 1989, ARCH PATHOL LAB MED, V113, P461; ROBERTS WH, 1988, ARCH PATHOL LAB MED, V112, P1106; ROBEY SS, 1988, AM J CLIN PATHOL, V89, P666, DOI 10.1093/ajcp/89.5.666; ROCHE JK, 1981, INT J CANCER, V27, P659, DOI 10.1002/ijc.2910270513; ROCHE JK, 1977, GASTROENTEROLOGY, V72, P228; ROGERS BB, 1990, AM J PATHOL, V136, P541; ROSEN P, 1973, ARCH INTERN MED, V132, P274, DOI 10.1001/archinte.132.2.274; ROSEN P, 1971, AM J CLIN PATHOL, V55, P749; Rosen P P, 1978, Pathol Annu, V13 Pt 2, P175; RUBIN RH, 1990, REV INFECT DIS, V12, pS754; SCHOOLEY RT, 1990, REV INFECT DIS, V12, pS811; SCHWARTZ AM, 1991, LAB MED, V22, P267, DOI 10.1093/labmed/22.4.267; SCHWARTZ DL, 1989, J PEDIATR SURG, V24, P313, DOI 10.1016/S0022-3468(89)80023-5; SHIBATA D, 1988, J INFECT DIS, V158, P1185, DOI 10.1093/infdis/158.6.1185; SHIBATA M, 1992, HUM PATHOL, V23, P911, DOI 10.1016/0046-8177(92)90404-Q; SIDI S, 1979, ARCH SURG-CHICAGO, V114, P857; SMYTH RL, 1991, J INFECT DIS, V164, P1045, DOI 10.1093/infdis/164.6.1045; SOULEN MC, 1986, RADIOLOGY, V159, P705, DOI 10.1148/radiology.159.3.3704150; SPENCER GD, 1986, TRANSPLANTATION, V42, P602, DOI 10.1097/00007890-198612000-00006; SPIEGEL JS, 1980, AM J GASTROENTEROL, V73, P37; SPILLER RC, 1988, GUT, V29, P1109, DOI 10.1136/gut.29.8.1109; STILLMAN AE, 1981, AM J DIS CHILD, V135, P29, DOI 10.1001/archpedi.1981.02130250017007; STONGE G, 1982, GASTROENTEROLOGY, V83, P127; STRAYER DS, 1981, CANCER, V48, P1478, DOI 10.1002/1097-0142(19810915)48:6<1478::AID-CNCR2820480633>3.0.CO;2-D; STRICKLER JG, 1990, HUM PATHOL, V21, P443, DOI 10.1016/0046-8177(90)90208-M; SURAWICZ CM, 1988, GASTROENTEROLOGY, V94, P194, DOI 10.1016/0016-5085(88)90630-0; SUTHERLAND DER, 1979, SURGERY, V86, P386; TAMURA H, 1973, ARCH PATHOL, V96, P164; TEIXIDOR HS, 1987, RADIOLOGY, V163, P317, DOI 10.1148/radiology.163.2.3031723; THEISE ND, 1991, AM J GASTROENTEROL, V86, P1123; TYMS AS, 1989, J ANTIMICROB CHEMOTH, V23, P89, DOI 10.1093/jac/23.suppl_A.89; VALERDIZCASASOLA S, 1991, GASTROENTEROLOGY, V101, P247, DOI 10.1016/0016-5085(91)90485-4; VANDENBERG AP, 1991, J INFECT DIS, V164, P265; VANDENBERG AP, 1992, TRANSPLANT INT, V5, P101; VANTHIEL DH, 1992, TRANSPLANTATION, V54, P70, DOI 10.1097/00007890-199207000-00012; VICTORIA MS, 1985, PEDIATR INFECT DIS J, V4, P550, DOI 10.1097/00006454-198509000-00023; VILLAR LA, 1984, AM J MED, V76, P924, DOI 10.1016/0002-9343(84)91011-8; VOGEL FS, 1958, AM J PATHOL, V34, P1069; WAJSMAN R, 1989, AM J GASTROENTEROL, V84, P790; WALL SD, 1986, AM J ROENTGENOL, V146, P1; WEBER JN, 1987, GUT, V28, P482, DOI 10.1136/gut.28.4.482; WILCOX CM, 1992, AM J MED, V92, P412, DOI 10.1016/0002-9343(92)90272-D; WILCOX CM, 1990, ANN INTERN MED, V113, P589, DOI 10.7326/0003-4819-113-8-589; WILCOX CM, 1992, DIGEST DIS SCI, V37, P1288, DOI 10.1007/BF01296574; WILCOX CM, 1992, AM J MED, V93, P131, DOI 10.1016/0002-9343(92)90041-9; WILSON SE, 1989, ANN SURG, V210, P428, DOI 10.1097/00000658-198910000-00002; WONG TW, 1962, ARCH PATHOL, V74, P403; WU GD, 1989, AM J GASTROENTEROL, V84, P1517	190	352	362	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	1993	119	9					924	935		10.7326/0003-4819-119-9-199311010-00010	http://dx.doi.org/10.7326/0003-4819-119-9-199311010-00010			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MD711	8215005				2022-12-28	WOS:A1993MD71100010
J	MADISON, EL; KOBE, A; GETHING, MJ; SAMBROOK, JF; GOLDSMITH, EJ				MADISON, EL; KOBE, A; GETHING, MJ; SAMBROOK, JF; GOLDSMITH, EJ			CONVERTING TISSUE-PLASMINOGEN ACTIVATOR TO A ZYMOGEN - A REGULATORY TRIAD OF ASP-HIS-SER	SCIENCE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CRYSTAL-STRUCTURE; ALPHA-CHYMOTRYPSIN; BOVINE TRYPSINOGEN; RESOLUTION; INHIBITOR; CATALYSIS; MECHANISM; FIBRINOLYSIS; REFINEMENT	Unlike most serine proteases of the chymotrypsin family, tissue-type plasminogen activator (tPA) is secreted from cells as an active, single-chain enzyme with a catalytic efficiency only slightly lower than that of the proteolytically cleaved form. A zymogenic mutant of tPA has been engineered that displays a reduction in catalytic efficiency by a factor of 141 in the single-chain form while retaining full activity in the cleaved form. The residues introduced in the mutant, serine 292 and histidine 305, are proposed to form a hydrogen-bonded network with aspartate 477, similar to the aspartate 194-histidine 40-serine 32 network found to stabilize the zymogen chymotrypsinogen.	UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,DEPT INTERNAL MED,DALLAS,TX 75235; UNIV TEXAS,SW MED CTR,HOWARD HUGHES MED INST,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas								ANTONINI E, 1983, J MOL BIOL, V165, P543, DOI 10.1016/S0022-2836(83)80219-8; BEATTY K, 1980, J BIOL CHEM, V255, P3931; BOOSE JA, 1989, BIOCHEMISTRY-US, V28, P635, DOI 10.1021/bi00428a033; BRADY L, 1990, NATURE, V343, P767, DOI 10.1038/343767a0; CALIFF RM, 1988, AM J MED, V85, P353, DOI 10.1016/0002-9343(88)90586-4; Carrell R.W, 1986, PROTEINASE INHIBITOR, P403; CARTER P, 1991, BIOCHEMISTRY-US, V30, P6142, DOI 10.1021/bi00239a009; COLLEN D, 1986, CIRCULATION, V73, P511, DOI 10.1161/01.CIR.73.3.511; COLLEN D, 1987, J CELL BIOCHEM, V33, P77, DOI 10.1002/jcb.240330202; COREY DR, 1992, J AM CHEM SOC, V114, P1784, DOI 10.1021/ja00031a037; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; FEHLHAMMER H, 1977, J MOL BIOL, V111, P415, DOI 10.1016/S0022-2836(77)80062-4; FREER ST, 1970, BIOCHEMISTRY-US, V9, P1997, DOI 10.1021/bi00811a022; FUJINAGA M, 1987, J MOL BIOL, V195, P397, DOI 10.1016/0022-2836(87)90659-0; GERARD RD, 1989, ANNU REV PHYSIOL, V51, P245, DOI 10.1146/annurev.physiol.51.1.245; GERTLER A, 1974, BIOCHEMISTRY-US, V13, P1302, DOI 10.1021/bi00703a038; GINSBURG D, 1986, J CLIN INVEST, V78, P1673, DOI 10.1172/JCI112761; HOLMES WE, 1987, BIOCHEMISTRY-US, V26, P5133, DOI 10.1021/bi00390a036; KERR MA, 1976, BIOCHEMISTRY-US, V15, P5566, DOI 10.1021/bi00670a022; KOSSIAKOFF AA, 1977, BIOCHEMISTRY-US, V16, P654, DOI 10.1021/bi00623a016; LIAO DI, 1990, J BIOL CHEM, V265, P6528; LONSDALEECCLES JD, 1978, BIOCHEMISTRY-US, V17, P2805, DOI 10.1021/bi00607a016; MADISON EL, 1990, J BIOL CHEM, V265, P21423; MADISON EL, 1990, P NATL ACAD SCI USA, V87, P3530, DOI 10.1073/pnas.87.9.3530; MADISON EL, 1989, NATURE, V339, P721, DOI 10.1038/339721a0; PANNEKOEK H, 1986, EMBO J, V5, P2539, DOI 10.1002/j.1460-2075.1986.tb04532.x; PETERSEN LC, 1990, BIOCHEMISTRY-US, V29, P3451, DOI 10.1021/bi00466a005; PETERSEN LC, 1988, J BIOL CHEM, V263, P11189; PETERSON LC, 1993, BIOCHIM BIOPHYS ACTA, V952, P245; RAO AK, 1988, J AM COLL CARDIOL, V11, P1; ROBERTUS JD, 1972, BIOCHEMISTRY-US, V11, P4293, DOI 10.1021/bi00773a016; ROBINSON NC, 1973, BIOCHEMISTRY-US, V12, P420, DOI 10.1021/bi00727a010; Sambrook J, 1989, MOL CLONING LABORATO; SILVERBERG M, 1982, BLOOD, V60, P64; WANG DC, 1985, J MOL BIOL, V185, P595, DOI 10.1016/0022-2836(85)90074-9; WELLS TNC, 1985, NATURE, V316, P656, DOI 10.1038/316656a0	36	81	94	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 15	1993	262	5132					419	421		10.1126/science.8211162	http://dx.doi.org/10.1126/science.8211162			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB859	8211162				2022-12-28	WOS:A1993MB85900057
J	WAGNER, S; GREEN, MR				WAGNER, S; GREEN, MR			HTLV-I TAX PROTEIN STIMULATION OF DNA-BINDING OF BZIP PROTEINS BY ENHANCING DIMERIZATION	SCIENCE			English	Article							VIRUS TYPE-I; LONG TERMINAL REPEAT; CELLULAR FACTORS; LEUCINE ZIPPER; TRANSCRIPTIONAL ACTIVATOR; 21-BASE-PAIR REPEATS; TRANS-ACTIVATION; GENE-EXPRESSION; CDNA CLONES; INVITRO	The Tax protein of human T cell leukemia virus type-1 (HTLV-I) transcriptionally activates the HTLV-I promoter. This activation requires binding sites for activating transcription factor (ATF) proteins, a family of cellular proteins that contain basic region-leucine zipper (bZIP) DNA binding domains. Data are presented showing that Tax increases the in vitro DNA binding activity of multiple ATF proteins. Tax also stimulated DNA binding by other bZIP proteins, but did not affect DNA binding proteins that lack a bZIP domain. The increase in DNA binding occurred because Tax promotes dimerization of the bZIP domain in the absence of DNA, and the elevated concentration of the bZIP homodimer then facilitates the DNA binding reaction. These results help explain how Tax activates viral transcription and transforms cells.			WAGNER, S (corresponding author), UNIV MASSACHUSETTS,MED CTR,PROGRAM MOLEC MED,WORCESTER,MA 01605, USA.							ABATE C, 1990, SCIENCE, V249, P1157, DOI 10.1126/science.2118682; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; BANNISTER AJ, 1992, NUCLEIC ACIDS RES, V20, P3523, DOI 10.1093/nar/20.13.3523; BOYLE WJ, 1991, CELL, V64, P573, DOI 10.1016/0092-8674(91)90241-P; BRENNAN TJ, 1990, GENE DEV, V4, P582, DOI 10.1101/gad.4.4.582; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; FRIEDMAN AD, 1990, GENE DEV, V4, P1416, DOI 10.1101/gad.4.8.1416; FUJII M, 1988, P NATL ACAD SCI USA, V85, P8526, DOI 10.1073/pnas.85.22.8526; FUJII M, 1991, ONCOGENE, V6, P1023; FUJII M, 1992, GENE DEV, V6, P2066, DOI 10.1101/gad.6.11.2066; FUJISAWA J, 1989, J VIROL, V63, P3234, DOI 10.1128/JVI.63.8.3234-3239.1989; GIAM CZ, 1989, J BIOL CHEM, V264, P15236; GRASSMANN R, 1989, P NATL ACAD SCI USA, V86, P3351, DOI 10.1073/pnas.86.9.3351; GRUENEBERG DA, 1992, SCIENCE, V257, P1089, DOI 10.1126/science.257.5073.1089; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HANLY SM, 1989, GENE DEV, V3, P1534, DOI 10.1101/gad.3.10.1534; HARRISON SC, 1991, NATURE, V353, P715, DOI 10.1038/353715a0; HOPE IA, 1985, CELL, V43, P177, DOI 10.1016/0092-8674(85)90022-4; HUNTER T, 1992, CELL, V70, P375, DOI 10.1016/0092-8674(92)90162-6; HUNTER T, 1988, CELL, V55, P125; Jackson S P, 1992, Trends Cell Biol, V2, P104, DOI 10.1016/0962-8924(92)90014-E; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; KOENIG H, 1992, EMBO (European Molecular Biology Organization) Journal, V11, P2241; KOUZARIDES T, 1989, NATURE, V340, P568, DOI 10.1038/340568a0; KUTOH E, 1992, MOL CELL BIOL, V12, P4960, DOI 10.1128/MCB.12.11.4960; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LIN YS, 1988, CELL, V54, P659, DOI 10.1016/S0092-8674(88)80010-2; MATTHEWS MAH, 1992, MOL CELL BIOL, V12, P1986, DOI 10.1128/MCB.12.5.1986; MCKAY RDG, 1981, J MOL BIOL, V145, P471, DOI 10.1016/0022-2836(81)90540-4; MENDEL DB, 1991, SCIENCE, V254, P1762, DOI 10.1126/science.1763325; MOCH H, 1992, J VIROL, V66, P7354; NISHIO Y, 1993, MOL CELL BIOL, V13, P1854, DOI 10.1128/MCB.13.3.1854; OHTANI K, 1987, EMBO J, V6, P389, DOI 10.1002/j.1460-2075.1987.tb04767.x; OKA T, 1992, J VIROL, V66, P6686, DOI 10.1128/JVI.66.11.6686-6694.1992; OSHEA EK, 1989, SCIENCE, V243, P538, DOI 10.1126/science.2911757; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; PATEL L, 1990, NATURE, V347, P572, DOI 10.1038/347572a0; POZZATTI R, 1990, MOL CELL BIOL, V10, P413, DOI 10.1128/MCB.10.1.413; ROSEN CA, 1987, P NATL ACAD SCI USA, V84, P4919, DOI 10.1073/pnas.84.14.4919; SHIMOTOHNO K, 1986, P NATL ACAD SCI USA, V83, P8112, DOI 10.1073/pnas.83.21.8112; SIEKEVITZ M, 1987, SCIENCE, V238, P1575, DOI 10.1126/science.2825351; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SUZUKI T, 1993, P NATL ACAD SCI USA, V90, P610, DOI 10.1073/pnas.90.2.610; TALANIAN RV, 1990, SCIENCE, V249, P769, DOI 10.1126/science.2389142; TANAKA A, 1990, P NATL ACAD SCI USA, V87, P1071, DOI 10.1073/pnas.87.3.1071; TSUJIMOTO A, 1991, J VIROL, V65, P1420, DOI 10.1128/JVI.65.3.1420-1426.1991; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; Wagner S, UNPUB; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P9030; XU YL, 1990, J BIOL CHEM, V265, P20285; YIP MT, 1990, MOL BIOL MED, V7, P33; YOSHIDA M, 1987, ANNU REV IMMUNOL, V5, P541, DOI 10.1146/annurev.iy.05.040187.002545; YOSHIMURA T, 1990, EMBO J, V9, P2537, DOI 10.1002/j.1460-2075.1990.tb07434.x; ZHAO LJ, 1992, P NATL ACAD SCI USA, V89, P7070, DOI 10.1073/pnas.89.15.7070; ZHAO LJ, 1991, P NATL ACAD SCI USA, V88, P11445, DOI 10.1073/pnas.88.24.11445	56	309	314	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 15	1993	262	5132					395	399		10.1126/science.8211160	http://dx.doi.org/10.1126/science.8211160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB859	8211160				2022-12-28	WOS:A1993MB85900049
J	CASKEY, CT				CASKEY, CT			PRESYMPTOMATIC DIAGNOSIS - A 1ST STEP TOWARD GENETIC HEALTH-CARE	SCIENCE			English	Editorial Material							CYSTIC-FIBROSIS GENE; IDENTIFICATION; DISEASE; DNA		BAYLOR COLL MED,INST MOLEC GENET,HOUSTON,TX 77030	Baylor College of Medicine	CASKEY, CT (corresponding author), BAYLOR COLL MED,HOWARD HUGHES MED INST,1 BAYLOR PLAZA,HOUSTON,TX 77030, USA.							ADAMS MD, 1993, NAT GENET, V4, P373, DOI 10.1038/ng0893-373; BENNETT WM, 1990, SEMIN NEPHROL, V10, P552; BIESECKER BB, 1993, JAMA-J AM MED ASSOC, V269, P1970, DOI 10.1001/jama.269.15.1970; BLITZER MG, 1992, CLIN LAB MED, V12, P463, DOI 10.1016/S0272-2712(18)30500-6; Cao A, 1991, CURR OPIN GENET DEV, V1, P48, DOI 10.1016/0959-437X(91)80040-S; CASKEY CT, 1993, JAMA-J AM MED ASSOC, V269, P1986, DOI 10.1001/jama.269.15.1986; FODOR SPA, 1993, NATURE, V364, P555, DOI 10.1038/364555a0; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KING MC, 1993, JAMA-J AM MED ASSOC, V269, P1975, DOI 10.1001/jama.269.15.1975; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; MITANI K, 1993, TRENDS BIOTECHNOL, V11, P162, DOI 10.1016/0167-7799(93)90108-L; O'Flynn M E, 1992, Curr Probl Pediatr, V22, P159; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; WIGGS J, 1988, NEW ENGL J MED, V318, P151, DOI 10.1056/NEJM198801213180305; WILLI SM, 1991, PEDIATR CLIN N AM, V38, P555	18	22	22	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 1	1993	262	5130					48	49		10.1126/science.8211129	http://dx.doi.org/10.1126/science.8211129			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ635	8211129				2022-12-28	WOS:A1993LZ63500023
J	CUTICCHIA, AJ; CHIPPERFIELD, MA; PORTER, CJ; KEARNS, W; PEARSON, PL				CUTICCHIA, AJ; CHIPPERFIELD, MA; PORTER, CJ; KEARNS, W; PEARSON, PL			MANAGING ALL THOSE BYTES - THE HUMAN GENOME PROJECT	SCIENCE			English	Editorial Material											CUTICCHIA, AJ (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT MED,GENOME DATA BASE,2024 E MONUMENT ST,BALTIMORE,MD 21205, USA.		Kearns, William/AAE-7699-2020	Porter, Christopher/0000-0001-8636-4515				CINKOSKY MJ, 1991, SCIENCE, V252, P1273, DOI 10.1126/science.1925538; SHOWS TB, 1987, CYTOGENET CELL GENET, V46, P11	2	23	23	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 1	1993	262	5130					47	48		10.1126/science.8211128	http://dx.doi.org/10.1126/science.8211128			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ635	8211128				2022-12-28	WOS:A1993LZ63500022
J	ROTHMAN, KJ				ROTHMAN, KJ			CONFLICT-OF-INTEREST - THE NEW MCCARTHYISM IN SCIENCE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OF-INTEREST		BOSTON UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,BOSTON,MA 02215; BOSTON UNIV,SCH MED,DEPT MED,BOSTON,MA 02118; HARVARD UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,BOSTON,MA 02115	Boston University; Boston University; Harvard University; Harvard T.H. Chan School of Public Health				Rothman, Kenneth/0000-0003-2398-1705				KOSHLAND DE, 1992, SCIENCE, V257, P595, DOI 10.1126/science.1496363; MARSHALL E, 1992, SCIENCE, V257, P620, DOI 10.1126/science.257.5070.620-a; Marshall E, 1992, Science, V257, P621, DOI 10.1126/science.257.5070.621; MCNUTT RA, 1990, JAMA-J AM MED ASSOC, V263, P1371, DOI 10.1001/jama.263.10.1371; Popper K. R., 1966, HIGH TIDE PROPHECY H, V2; RELMAN AS, 1990, NEW ENGL J MED, V323, P56, DOI 10.1056/NEJM199007053230111; RELMAN AS, 1984, NEW ENGL J MED, V316, P1182; RENNIE D, 1991, JAMA-J AM MED ASSOC, V266, P266, DOI 10.1001/jama.266.2.266; ROTHMAN KJ, 1991, J CLIN EPIDEMIOL S, V44, pS23; WALTUCH AI, 1990, NEW ENGL J MED, V323, P1568	10	162	169	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 2	1993	269	21					2782	2784		10.1001/jama.269.21.2782	http://dx.doi.org/10.1001/jama.269.21.2782			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LD671	8192721				2022-12-28	WOS:A1993LD67100031
J	UREN, NG; MELIN, JA; DEBRUYNE, B; WIJNS, W; BAUDHUIN, T; CAMICI, PG				UREN, NG; MELIN, JA; DEBRUYNE, B; WIJNS, W; BAUDHUIN, T; CAMICI, PG			RELATION BETWEEN MYOCARDIAL BLOOD-FLOW AND THE SEVERITY OF CORONARY-ARTERY STENOSIS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							POSITRON-EMISSION TOMOGRAPHY; N-13 AMMONIA; NONINVASIVE QUANTIFICATION; PHYSIOLOGIC SIGNIFICANCE; SUBSELECTIVE MEASUREMENT; GEOMETRIC DIMENSIONS; RESERVE; PERFUSION; ARTERIOGRAPHY; DISEASE	Background. We assessed the relation between the severity of stenosis in a coronary artery and the degree of impairment of myocardial blood flow. Studies in laboratory animals have shown that as the degree of coronary-artery stenosis increases, the maximal coronary flow measured after maximal vasodilatation progressively decreases, with a concomitant decrease in basal flow. However, this relation has not been carefully documented in humans through measurement of myocardial blood flow. Methods, We studied 35 patients with single-vessel coronary artery disease and normal left ventricular function and 21 age-matched controls. Regional myocardial blood flow in the area supplied by the stenosed artery was measured by positron-emission tomography with oxygen-15-labeled water while the subject was at rest (basal flow) and during hyperemia induced by the intravenous administration of the vasodilator adenosine (140 mu g per kilogram of body weight per minute) or dipyridamole (0.56 mg per kilogram). Results. The mean (+/-SD) basal myocardial blood flow was 1.14+/-0.42 ml per minute per gram of tissue in the patients and 1.13+/-0.26 ml per minute per gram in the controls; during hyperemia, myocardial flow was 2.10+/-1.16 and 3.37+/-1.25 ml per minute per gram (P<0.001), respectively. Basal flow was unchanged regardless of the severity of stenosis, expressed as a percentage of the diameter of the affected vessel (range of degrees of stenosis, 17 to 87 percent). In contrast, flow during hyperemia correlated inversely and significantly with the degree of stenosis and correlated directly with the minimal luminal diameter. The coronary vasodilator reserve (defined as the ratio of flow during hyperemia to flow at base line) began to decline when the deg ree of stenosis was about 40 percent and approached unity when stenosis was 80 percent or greater. Conclusions. In humans, basal myocardial blood flow remains constant regardless of the severity of coronary-artery stenosis. However, during hyperemia, flow progressively decreases when the degree of stenosis is about 40 percent or more and does not differ significantly from basal flow when stenosis is 80 percent or greater.	HAMMERSMITH HOSP, ROYAL POSTGRAD MED SCH,CTR CLIN SCI,MRC, CYCLOTRON UNIT, LONDON W12 0HS, ENGLAND; UNIV CATHOLIQUE LOUVAIN, SCH MED, BRUSSELS, BELGIUM; CARDIOVASC CTR, AALST, BELGIUM	Imperial College London; Universite Catholique Louvain; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Cardiovascular Center Aalst			Camici, Paolo/AAN-1959-2020	Camici, Paolo/0000-0001-5584-0750; Wijns, William/0000-0002-7267-4376				ARAUJO LI, 1991, CIRCULATION, V83, P875, DOI 10.1161/01.CIR.83.3.875; BERGMANN SR, 1989, J AM COLL CARDIOL, V14, P639, DOI 10.1016/0735-1097(89)90105-8; BERGMANN SR, 1984, CIRCULATION, V70, P724, DOI 10.1161/01.CIR.70.4.724; BOL A, 1993, CIRCULATION, V87, P512, DOI 10.1161/01.CIR.87.2.512; BROWN BG, 1977, CIRCULATION, V55, P329, DOI 10.1161/01.CIR.55.2.329; CHAN SY, 1992, J AM COLL CARDIOL, V20, P979, DOI 10.1016/0735-1097(92)90201-W; COLE JS, 1976, CATHETER CARDIO DIAG, V2, P185, DOI 10.1002/ccd.1810020212; CZERNIN J, 1993, CIRCULATION, V88, P62, DOI 10.1161/01.CIR.88.1.62; DEMER LL, 1989, CIRCULATION, V79, P825, DOI 10.1161/01.CIR.79.4.825; GODFREY K, 1985, NEW ENGL J MED, V313, P1450, DOI 10.1056/NEJM198512053132305; GOLDSTEIN RA, 1987, J CLIN INVEST, V79, P1473, DOI 10.1172/JCI112976; GOULD KL, 1990, J AM COLL CARDIOL, V16, P198, DOI 10.1016/0735-1097(90)90479-9; GOULD KL, 1982, CIRCULATION, V66, P930, DOI 10.1161/01.CIR.66.5.930; GOULD KL, 1986, J AM COLL CARDIOL, V7, P775, DOI 10.1016/S0735-1097(86)80336-9; GOULD KL, 1974, AM J CARDIOL, V34, P48, DOI 10.1016/0002-9149(74)90092-7; GOULD KL, 1990, J AM COLL CARDIOL, V15, P459, DOI 10.1016/S0735-1097(10)80078-6; GOULD KL, 1974, AM J CARDIOL, V33, P87, DOI 10.1016/0002-9149(74)90743-7; GOULD KL, 1988, CIRCULATION, V78, P237, DOI 10.1161/01.CIR.78.2.237; HARRISON DG, 1984, CIRCULATION, V69, P1111, DOI 10.1161/01.CIR.69.6.1111; HERRERO P, 1990, CIRCULATION, V82, P1377, DOI 10.1161/01.CIR.82.4.1377; HOFFMAN EJ, 1986, IEEE T NUCL SCI, V33, P452, DOI 10.1109/TNS.1986.4337141; HUTCHINS GD, 1990, J AM COLL CARDIOL, V15, P1032, DOI 10.1016/0735-1097(90)90237-J; KIRKEEIDE RL, 1986, J AM COLL CARDIOL, V7, P103, DOI 10.1016/S0735-1097(86)80266-2; KLOCKE FJ, 1987, CIRCULATION, V76, P1183, DOI 10.1161/01.CIR.76.6.1183; KLOCKE FJ, 1987, CIRCULATION, V75, P34; KRIVOKAPICH J, 1989, CIRCULATION, V80, P1328, DOI 10.1161/01.CIR.80.5.1328; MCGINN AL, 1990, CIRCULATION, V81, P1319, DOI 10.1161/01.CIR.81.4.1319; REIBER JHC, 1985, CIRCULATION, V71, P280, DOI 10.1161/01.CIR.71.2.280; ROSSEN JD, 1989, CIRCULATION, V79, P566, DOI 10.1161/01.CIR.79.3.566; SCHELBERT HR, 1982, AM J CARDIOL, V49, P1197, DOI 10.1016/0002-9149(82)90045-5; SHAH A, 1985, J AM COLL CARDIOL, V5, P92, DOI 10.1016/S0735-1097(85)80089-9; SIBLEY DH, 1986, J AM COLL CARDIOL, V8, P1332, DOI 10.1016/S0735-1097(86)80305-9; SLAGER CJ, 1986, J AM COLL CARDIOL, V7, P317, DOI 10.1016/S0735-1097(86)80498-3; SPINKS TJ, 1988, IEEE T NUCL SCI, V35, P721, DOI 10.1109/23.12819; UREN NG, 1993, J AM COLL CARDIOL, V21, P612, DOI 10.1016/0735-1097(93)90092-F; UREN NG, 1993, J AM COLL CARDIOL, V22, P650, DOI 10.1016/0735-1097(93)90172-W; VANOVERSCHELDE JLJ, 1993, CIRCULATION, V87, P1513, DOI 10.1161/01.CIR.87.5.1513; WHITE CW, 1984, NEW ENGL J MED, V310, P819, DOI 10.1056/NEJM198403293101304; WILSON RF, 1987, CIRCULATION, V75, P723, DOI 10.1161/01.CIR.75.4.723; WILSON RF, 1985, CIRCULATION, V72, P82, DOI 10.1161/01.CIR.72.1.82; WILSON RF, 1986, CIRCULATION, V73, P444, DOI 10.1161/01.CIR.73.3.444	41	696	711	2	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	1994	330	25					1782	1788		10.1056/NEJM199406233302503	http://dx.doi.org/10.1056/NEJM199406233302503			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR295	8190154				2022-12-28	WOS:A1994NR29500003
J	GURNEY, ME; PU, HF; CHIU, AY; DALCANTO, MC; POLCHOW, CY; ALEXANDER, DD; CALIENDO, J; HENTATI, A; KWON, YW; DENG, HX; CHEN, WJ; ZHAI, P; SUFIT, RL; SIDDIQUE, T				GURNEY, ME; PU, HF; CHIU, AY; DALCANTO, MC; POLCHOW, CY; ALEXANDER, DD; CALIENDO, J; HENTATI, A; KWON, YW; DENG, HX; CHEN, WJ; ZHAI, P; SUFIT, RL; SIDDIQUE, T			MOTOR-NEURON DEGENERATION IN MICE THAT EXPRESS A HUMAN CU,ZN SUPEROXIDE-DISMUTASE MUTATION	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSGENIC MICE; DOWNS-SYNDROME; NEUROMUSCULAR-JUNCTION; GROWTH-FACTOR; ANIMAL-MODEL; NITRIC-OXIDE; PEROXYNITRITE; ASSAY; GENE	Mutations of human Cu,Zn superoxide dismutase (SOD) are found in about 20 percent of patients with familial amyotrophic lateral sclerosis (ALS). Expression of high levels of human SOD containing a substitution of glycine to alanine at position 93-a change that has little effect on enzyme activity-caused motor neuron disease in transgenic mice. The mice became paralyzed in one or more limbs as a result of motor neuron loss from the spinal cord and died by 5 to 6 months of age. The results show that dominant, gain-of-function mutations in SOD contribute to the pathogenesis of familial ALS.	NORTHWESTERN UNIV,SCH MED,INST NEUROSCI,CHICAGO,IL 60611; CITY HOPE NATL MED CTR,BECKMAN RES INT,DIV NEUROSCI,DUARTE,CA 91010; NORTHWESTERN UNIV,SCH MED,DEPT PATHOL,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,DEPT PHYSIOL,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,DEPT NEUROL,CHICAGO,IL 60611	Northwestern University; City of Hope; Beckman Research Institute of City of Hope; Northwestern University; Northwestern University; Northwestern University	GURNEY, ME (corresponding author), NORTHWESTERN UNIV,SCH MED,DEPT CELL & MOLEC BIOL,303 E CHICAGO AVE,CHICAGO,IL 60611, USA.		Siddique, Teepu/AAT-8166-2021; Eishingdrelo, Haifeng/R-8426-2019	Eishingdrelo, Haifeng/0000-0001-7205-1008; Deng, Han-Xiang/0000-0002-0030-8465; Kwon, Young/0000-0003-2465-9945; Siddique, Teepu/0000-0001-7293-9146				ASADA K, 1974, AGR BIOL CHEM TOKYO, V38, P471, DOI 10.1080/00021369.1974.10861178; AVRAHAM KB, 1991, J NEUROCYTOL, V20, P208, DOI 10.1007/BF01186993; AVRAHAM KB, 1988, CELL, V54, P823, DOI 10.1016/S0092-8674(88)91153-1; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1624; BORCHELT DR, IN PRESS P NATL ACAD; BOWLING AC, 1993, J NEUROCHEM, V61, P2322, DOI 10.1111/j.1471-4159.1993.tb07478.x; CEBALLOSPICOT I, 1991, BRAIN RES, V552, P198, DOI 10.1016/0006-8993(91)90084-9; CHIU AY, 1993, J COMP NEUROL, V328, P351, DOI 10.1002/cne.903280303; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; ELROYSTEIN O, 1986, EMBO J, V5, P615, DOI 10.1002/j.1460-2075.1986.tb04255.x; ENGEL WK, 1959, BRAIN, V82, P203, DOI 10.1093/brain/82.2.203; EPSTEIN CJ, 1987, P NATL ACAD SCI USA, V84, P8044, DOI 10.1073/pnas.84.22.8044; GURNEY ME, 1992, J NEUROSCI, V12, P3241, DOI 10.1523/JNEUROSCI.12-08-03241.1992; HALLEWELL RA, 1985, NUCLEIC ACIDS RES, V13, P2017, DOI 10.1093/nar/13.6.2017; HALLEWELL RA, 1986, SUPEROXIDE DISMUTASE, P249; HIRANO A, 1967, ARCH NEUROL-CHICAGO, V16, P232, DOI 10.1001/archneur.1967.00470210008002; ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U; LIPTON SA, 1993, NATURE, V364, P626, DOI 10.1038/364626a0; MULDER DW, 1982, HUMAN MOTOR NEURON D, P15; NOWICKI JP, 1991, EUR J PHARMACOL, V204, P339, DOI 10.1016/0014-2999(91)90862-K; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; SIDDIQUE T, 1991, ADV NEUROL, V56, P227; SIDDIQUE T, UNPUB; SPITZ DR, 1989, ANAL BIOCHEM, V179, P8, DOI 10.1016/0003-2697(89)90192-9	25	3327	3483	4	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 17	1994	264	5166					1772	1775		10.1126/science.8209258	http://dx.doi.org/10.1126/science.8209258			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR600	8209258				2022-12-28	WOS:A1994NR60000046
J	CALIFF, RM; BENGTSON, JR				CALIFF, RM; BENGTSON, JR			CURRENT CONCEPTS - CARDIOGENIC-SHOCK	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ACUTE MYOCARDIAL-INFARCTION; AORTIC BALLOON COUNTERPULSATION; RIGHT VENTRICULAR INFARCTION; PAPILLARY-MUSCLE RUPTURE; CORONARY ANGIOPLASTY; HEART-FAILURE; IMMEDIATE ANGIOPLASTY; THERAPY; SURGERY; PROGNOSIS		MICHIGAN HEART & VASC INST, ANN ARBOR, MI USA		CALIFF, RM (corresponding author), DUKE UNIV, MED CTR, DEPT MED, DIV CARDIOL, BOX 31123, DURHAM, NC 27710 USA.							ALONSO DR, 1973, CIRCULATION, V48, P588, DOI 10.1161/01.CIR.48.3.588; [Anonymous], 1990, LANCET, V336, P65; [Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, LANCET, V1, P397; BARDET J, 1977, AM HEART J, V93, P280, DOI 10.1016/S0002-8703(77)80245-7; BECKER LC, 1971, CIRC RES, V28, P263, DOI 10.1161/01.RES.28.2.263; BENGTSON JR, 1992, J AM COLL CARDIOL, V20, P1482, DOI 10.1016/0735-1097(92)90440-X; BEYERSDORF F, 1992, TEX HEART I J, V19, P26; COHN JN, 1974, AM J CARDIOL, V33, P209, DOI 10.1016/0002-9149(74)90276-8; COHN JN, 1992, NEW ENGL J MED, V327, P725, DOI 10.1056/NEJM199209033271010; DANIS M, 1988, JAMA-J AM MED ASSOC, V260, P797, DOI 10.1001/jama.260.6.797; DELLITALIA LJ, 1984, J AM COLL CARDIOL, V4, P931, DOI 10.1016/S0735-1097(84)80053-4; DEWOOD MA, 1980, CIRCULATION, V61, P1105, DOI 10.1161/01.CIR.61.6.1105; Dole W P, 1983, Curr Probl Cardiol, V8, P1, DOI 10.1016/0146-2806(83)90033-6; DUNKMAN WB, 1972, CIRCULATION, V46, P465, DOI 10.1161/01.CIR.46.3.465; EMANUEL LL, 1991, NEW ENGL J MED, V324, P889, DOI 10.1056/NEJM199103283241305; FORSSELL G, 1979, ACTA MED SCAND, V206, P189; FRANCIS GS, 1988, AM J CARDIOL, V62, pA9, DOI 10.1016/S0002-9149(88)80078-X; FRID DJ, 1990, CIRCULATION, V82, P430; FRIEDMAN HS, 1971, AM J MED, V50, P709, DOI 10.1016/0002-9343(71)90179-3; GACIOCH GM, 1992, J AM COLL CARDIOL, V19, P647, DOI 10.1016/S0735-1097(10)80286-4; GEWIRTZ H, 1979, BRIT HEART J, V42, P719; GHEORGHIADE M, 1988, AM HEART J, V116, P1212; GIBBONS RJ, 1993, NEW ENGL J MED, V328, P685, DOI 10.1056/NEJM199303113281003; GILLESPIE TA, 1977, AM J CARDIOL, V39, P588, DOI 10.1016/S0002-9149(77)80170-7; GOLDBERG RJ, 1991, NEW ENGL J MED, V325, P1117, DOI 10.1056/NEJM199110173251601; GOLDBERGER M, 1986, AM HEART J, V111, P497, DOI 10.1016/0002-8703(86)90054-2; GOLDSTEIN RA, 1980, NEW ENGL J MED, V303, P846, DOI 10.1056/NEJM198010093031503; GRINES CL, 1989, CIRCULATION, V80, P245, DOI 10.1161/01.CIR.80.2.245; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; HANDS ME, 1989, J AM COLL CARDIOL, V14, P40, DOI 10.1016/0735-1097(89)90051-X; HARNARAYAN C, 1970, BRIT HEART J, V32, P728; HELD AC, 1988, AM HEART J, V116, P1330, DOI 10.1016/0002-8703(88)90458-9; HUNT D, 1992, LANCET, V339, P753; JACKSON G, 1977, BRIT HEART J, V39, P598; JOHNSON SA, 1977, AM J MED, V62, P687, DOI 10.1016/0002-9343(77)90871-3; JUGDUTT, 1989, CIRCULATION, V79, P1151; JUGDUTT BI, 1988, CIRCULATION, V78, P906, DOI 10.1161/01.CIR.78.4.906; KARALIS DG, 1989, J INVASIVE CARDIOL, V1, P231; KLOCKE RK, 1991, AM HEART J, V121, P1965, DOI 10.1016/0002-8703(91)90833-4; LEE L, 1991, J AM COLL CARDIOL, V17, P599, DOI 10.1016/S0735-1097(10)80171-8; LEE L, 1988, CIRCULATION, V78, P1345, DOI 10.1161/01.CIR.78.6.1345; LEOR J, 1993, AM J MED, V94, P265, DOI 10.1016/0002-9343(93)90058-W; LUST RM, 1988, CIRCULATION, V78, P217; LYNN J, 1990, J CLIN EPIDEMIOL, V43, pS1, DOI 10.1016/0895-4356(90)90211-7; MONRAD ES, 1986, CIRCULATION, V73, P168; MULLER DWM, 1991, AM HEART J, V121, P1042, DOI 10.1016/0002-8703(91)90661-Z; NISHIMURA RA, 1983, AM J CARDIOL, V51, P373, DOI 10.1016/S0002-9149(83)80067-8; ONEILL W, 1985, CIRCULATION, V72, P309; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; PAGE DL, 1971, NEW ENGL J MED, V285, P133, DOI 10.1056/NEJM197107152850301; PASTERNAK RC, 1991, HARRISONS PRINCIPLES, V1, P953; RADFORD MJ, 1981, CIRCULATION, V64, P545, DOI 10.1161/01.CIR.64.3.545; RADFORD MJ, 1979, CIRCULATION, V60, pI39; SCHEIDT S, 1970, AM J CARDIOL, V26, P556, DOI 10.1016/0002-9149(70)90407-8; SCHEIDT S, 1973, NEW ENGL J MED, V288, P979, DOI 10.1056/NEJM197305102881901; SCHONWETTER RS, 1993, J GEN INTERN MED, V8, P295, DOI 10.1007/BF02600139; SHAWL FA, 1989, AM J CARDIOL, V64, P967, DOI 10.1016/0002-9149(89)90791-1; STACK RS, 1983, J CLIN INVEST, V72, P84, DOI 10.1172/JCI110987; SUBRAMANIAN VA, 1980, NEW YORK STATE J MED, V80, P947; TCHENG JE, 1992, ANN INTERN MED, V117, P18, DOI 10.7326/0003-4819-117-1-18; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; VERNA E, 1989, EUR HEART J, V10, P958, DOI 10.1093/oxfordjournals.eurheartj.a059420; WACKERS FJ, 1976, BRIT HEART J, V38, P906; WEI JY, 1979, ANN INTERN MED, V90, P149, DOI 10.7326/0003-4819-90-2-149; WEISS AT, 1984, AM HEART J, V108, P249, DOI 10.1016/0002-8703(84)90607-0; WILLERSON JT, 1975, AM J MED, V58, P183, DOI 10.1016/0002-9343(75)90568-9; YUSUF S, 1990, CIRCULATION, V82, P117; ZEHENDER M, 1993, NEW ENGL J MED, V328, P981, DOI 10.1056/NEJM199304083281401; ZIJLSTRA F, 1993, NEW ENGL J MED, V328, P680, DOI 10.1056/NEJM199303113281002	70	179	185	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 16	1994	330	24					1724	1730		10.1056/NEJM199406163302406	http://dx.doi.org/10.1056/NEJM199406163302406			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR109	8190135				2022-12-28	WOS:A1994NR10900006
J	MERMALL, V; MCNALLY, JG; MILLER, KG				MERMALL, V; MCNALLY, JG; MILLER, KG			TRANSPORT OF CYTOPLASMIC PARTICLES CATALYZED BY AN UNCONVENTIONAL MYOSIN IN LIVING DROSOPHILA EMBRYOS	NATURE			English	Article							ACTIN-FILAMENTS; ACANTHAMOEBA; LOCALIZATION; VESICLES; MOVEMENT; GENE	MYOSINS are actin-activated ATPases that are able to translocate along actin filaments using energy derived from ATP hydrolysis. Non-muscle cells contain conventional myosins, which are similar in sequence and structure to muscle myosin, and a number of unconventional myosins whose head sequences are similar but tail sequences are unrelated to conventional myosins(1). The myosin superfamily currently consists of nine classes(2); Duosophila 95F is an unconventional myosin(3) and the original member of class VI, which includes a homologue found in pig kidney(2). Some unconventional myosins have been suggested as mediators of some types of intracellular transport(4,5), but there is little direct evidence for this function (but see ref. 6). We have observed transport of cytoplasmic particles in live Drosophila embryos in three dimensions using computational optical sectioning microscopy. We present here evidence that this transport is actin-based, ATP-dependent and catalysed by one such unconventional myosin, the 95F myosin. This is, to our knowledge, the first direct observation of transport catalysed by an unconventional myosin in living cells.	WASHINGTON UNIV, INST BIOMED COMP, ST LOUIS, MO 63130 USA	Washington University (WUSTL)	MERMALL, V (corresponding author), WASHINGTON UNIV, DEPT BIOL, CAMPUS BOX 1137, ST LOUIS, MO 63130 USA.							ADAMS RJ, 1986, NATURE, V322, P754, DOI 10.1038/322754a0; AGARD DA, 1989, METHOD CELL BIOL, V30, P353; ALBANESI JP, 1985, J BIOL CHEM, V260, P8649; Ashburner M, 1989, DROSOPHILA LAB HDB, P1; BAINES IC, 1992, J CELL BIOL, V119, P1193, DOI 10.1083/jcb.119.5.1193; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; CHENEY RE, 1993, CELL MOTIL CYTOSKEL, V24, P215, DOI 10.1002/cm.970240402; DOBERSTEIN SK, 1993, NATURE, V365, P841, DOI 10.1038/365841a0; ELLGAARD EG, 1975, CELL DIFFER DEV, V3, P379, DOI 10.1016/0045-6039(75)90006-8; FATH KR, 1993, J CELL BIOL, V120, P117, DOI 10.1083/jcb.120.1.117; FUKUI Y, 1989, NATURE, V341, P328, DOI 10.1038/341328a0; GAIL MH, 1970, BIOPHYS J, V10, P980, DOI 10.1016/S0006-3495(70)86347-0; GREENWOOD JA, 1955, ANN MATH STAT, V26, P233, DOI 10.1214/aoms/1177728540; HARTMAN R, 1993, COMPUT METH PROG BIO, V39, P195, DOI 10.1016/0169-2607(93)90021-C; JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539; KELLERMAN KA, 1992, J CELL BIOL, V119, P823, DOI 10.1083/jcb.119.4.823; MARDIA KV, 1972, STATISTICS DIRECTION; MIYATA H, 1989, J CELL BIOL, V109, P1519, DOI 10.1083/jcb.109.4.1519; SHEETZ MP, 1983, NATURE, V303, P31, DOI 10.1038/303031a0; WAGNER MC, 1992, J CELL BIOL, V119, P163, DOI 10.1083/jcb.119.1.163; WESSELS D, 1991, CELL MOTIL CYTOSKEL, V20, P301, DOI 10.1002/cm.970200406	21	114	114	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 16	1994	369	6481					560	562		10.1038/369560a0	http://dx.doi.org/10.1038/369560a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR294	8202156				2022-12-28	WOS:A1994NR29400049
J	CHAN, AC; KADLECEK, TA; ELDER, ME; FILIPOVICH, AH; KUO, WL; IWASHIMA, M; PARSLOW, TG; WEISS, A				CHAN, AC; KADLECEK, TA; ELDER, ME; FILIPOVICH, AH; KUO, WL; IWASHIMA, M; PARSLOW, TG; WEISS, A			ZAP-70 DEFICIENCY IN AN AUTOSOMAL RECESSIVE FORM OF SEVERE COMBINED IMMUNODEFICIENCY	SCIENCE			English	Article							CELL ANTIGEN RECEPTOR; PROTEIN-TYROSINE KINASE; ZETA-CHAIN; MICE LACKING; T-CELLS; STIMULATION; THYMOCYTES; ACTIVATION; P56(LCK); P56LCK	Protein tyrosine kinases (PTKs) play an integral role in T cell activation and differentiation. Defects in the Src-family PTKs in mice and in T cell lines have resulted in variable defects in thymic development and in T cell antigen receptor (TCR) signal transduction. Here, three siblings are described with an autosomal recessive form of severe combined immunodeficiency disease (SCID) in which ZAP-70, a non-Src PTK, is absent as a result of mutations in the ZAP-70 gene. This absence is associated with defects in TCR signal transduction, suggesting an important functional role for ZAP-70.	UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT MED, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, DEPT MICROBIOL & IMMUNOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT PEDIAT, SAN FRANCISCO, CA 94143 USA; UNIV MINNESOTA, DEPT PEDIAT, MINNEAPOLIS, MN 55455 USA; UNIV CALIF SAN FRANCISCO, DEPT LAB MED, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT PATHOL, SAN FRANCISCO, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; University of California System; University of California San Francisco				Kadlecek, Theresa/0000-0002-1020-8169	NIAMS NIH HHS [AR-20684] Funding Source: Medline; NIGMS NIH HHS [GM39553] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039553] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAM N, 1991, NATURE, V350, P62, DOI 10.1038/350062a0; APPLEBY MW, 1992, CELL, V70, P751, DOI 10.1016/0092-8674(92)90309-Z; Chan A. H. Y., UNPUB; CHAN AC, 1994, SCIENCE, V264, P1599, DOI 10.1126/science.8202713; CHAN AC, 1994, ANNU REV IMMUNOL, V12, P555, DOI 10.1146/annurev.iy.12.040194.003011; CHAN AC, 1991, P NATL ACAD SCI USA, V88, P9166, DOI 10.1073/pnas.88.20.9166; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; CHAN AC, 1994, J IMMUNOL, V152, P4758; ELDER ME, UNPUB; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; KALLIONIERNI A, IN PRESS GENOMICS; KARNITZ L, 1992, MOL CELL BIOL, V12, P4521, DOI 10.1128/MCB.12.10.4521; KOLANUS W, 1993, CELL, V74, P171, DOI 10.1016/0092-8674(93)90304-9; LUO KX, 1992, MOL CELL BIOL, V12, P4724, DOI 10.1128/MCB.12.10.4724; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MONAFO WJ, 1992, CLIN EXP IMMUNOL, V90, P390; PERLMUTTER RM, 1993, ANNU REV IMMUNOL, V11, P451, DOI 10.1146/annurev.iy.11.040193.002315; RUDD CE, 1990, IMMUNOL TODAY, V11, P400, DOI 10.1016/0167-5699(90)90159-7; SAMELSON LE, 1990, P NATL ACAD SCI USA, V87, P4358, DOI 10.1073/pnas.87.11.4358; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; STRAUS DB, 1993, J EXP MED, V178, P1523, DOI 10.1084/jem.178.5.1523; TRASK BJ, 1991, AM J HUM GENET, V48, P1; Veillette A, 1991, Semin Immunol, V3, P143; WANGE RL, 1992, J BIOL CHEM, V267, P11685; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701	27	425	434	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 10	1994	264	5165					1599	1601		10.1126/science.8202713	http://dx.doi.org/10.1126/science.8202713			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ285	8202713				2022-12-28	WOS:A1994NQ28500039
J	LOMBARDI, G; SIDHU, S; BATCHELOR, R; LECHLER, R				LOMBARDI, G; SIDHU, S; BATCHELOR, R; LECHLER, R			ANERGIC T-CELLS AS SUPPRESSOR CELLS IN-VITRO	SCIENCE			English	Article							GROWTH-FACTOR-BETA; ANTIGEN-PRESENTING CELLS; RECEPTOR EXPRESSION; CLONES; PROLIFERATION; TOLERANCE; INHIBITION; INDUCTION; PEPTIDES; IL-10	T cell-mediated suppression is an established phenomenon, but its underlying mechanisms are obscure. An in vitro system was used to test the possibility that anergic T cells can act as specific suppressor cells. Anergic human T cells caused inhibition of antigen-specific and allospecific T cell proliferation. In order for the inhibition to occur, the anergic T cells had to be specific for the same antigen-presenting cells (APCs) as the T cells that were suppressed. The mechanism of this suppression appears to be competition for the APC surface and for locally produced interleukin-2.	ROYAL POSTGRAD MED SCH,DEPT IMMUNOL,LONDON W12 0NN,ENGLAND	Imperial College London								ARNOLD B, 1993, IMMUNOL TODAY, V14, P12, DOI 10.1016/0167-5699(93)90317-E; BATCHELOR JR, 1984, TRANSPLANTATION, V37, P43, DOI 10.1097/00007890-198401000-00013; DEMAGISTRIS MT, 1992, CELL, V68, P625, DOI 10.1016/0092-8674(92)90139-4; DIMUTHU R, 1991, J IMMUNOL, V147, P3261; DING L, 1993, J IMMUNOL, V151, P1224; DUBOIS CM, 1990, J EXP MED, V172, P737, DOI 10.1084/jem.172.3.737; FALK K, 1991, NATURE, V351, P290, DOI 10.1038/351290a0; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; GO C, 1993, J IMMUNOL, V150, P367; HEATH WR, 1991, P NATL ACAD SCI USA, V88, P5101, DOI 10.1073/pnas.88.12.5101; JENKINS MK, 1990, J IMMUNOL, V144, P16; JENKINS MK, 1987, J EXP MED, V165, P302, DOI 10.1084/jem.165.2.302; KARPUS WJ, 1991, J IMMUNOL, V146, P1163; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; KILSHAW PJ, 1975, NATURE, V255, P489, DOI 10.1038/255489a0; LAMB JR, 1987, EUR J IMMUNOL, V17, P1641, DOI 10.1002/eji.1830171118; LAMB JR, 1983, J EXP MED, V157, P1434, DOI 10.1084/jem.157.5.1434; LECHLER RI, 1993, TRANSPLANT SCI, V3, P6; LOMBARDI G, 1989, J IMMUNOL, V142, P753; MALEFYT RD, 1991, J EXP MED, V174, P915; MALEFYT RD, 1993, J IMMUNOL, V150, P4754; MARTINEZ OM, 1990, J IMMUNOL, V144, P2211; MILLER A, 1992, P NATL ACAD SCI USA, V89, P421, DOI 10.1073/pnas.89.1.421; QUILL H, 1987, J IMMUNOL, V138, P3704; RACIOPPI L, 1993, J EXP MED, V177, P1047, DOI 10.1084/jem.177.4.1047; SIDHU S, 1992, J EXP MED, V176, P875, DOI 10.1084/jem.176.3.875; SLOANLANCASTER J, 1993, NATURE, V363, P156, DOI 10.1038/363156a0; TANAKA T, 1993, P NATL ACAD SCI USA, V90, P5914, DOI 10.1073/pnas.90.13.5914; TILNEY NL, 1978, J IMMUNOL, V121, P1480; WALDMANN H, 1992, J AUTOIMMUN, V5, P93, DOI 10.1016/0896-8411(92)90024-K	30	361	375	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 10	1994	264	5165					1587	1589		10.1126/science.8202711	http://dx.doi.org/10.1126/science.8202711			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ285	8202711				2022-12-28	WOS:A1994NQ28500035
J	COPELAND, A; LENNON, G				COPELAND, A; LENNON, G			RAPID ARRAYED FILTER PRODUCTION USING THE ORCA ROBOT	NATURE			English	Article											COPELAND, A (corresponding author), LAWRENCE LIVERMORE NATL LAB,CTR HUMAN GENOME,BIOL & BIOTECHNOL RES PROGRAM,L-452,LIVERMORE,CA 94550, USA.		Lennon, Greg/T-4717-2019					CARRANO AV, 1989, GENOMICS, V4, P129, DOI 10.1016/0888-7543(89)90291-7; CARRANO AV, 1989, GENOME, V31, P1059, DOI 10.1139/g89-182; IOANNOU PA, 1994, NAT GENET, V6, P84, DOI 10.1038/ng0194-84; LENNON G, 1994, HIGH DENSITY GRID TE, P126; LENNON GG, 1991, TRENDS GENET, V7, P314, DOI 10.1016/0168-9525(91)90420-U; OLSEN AS, 1993, BIOTECHNIQUES, V14, P116; SCHOENY DE, 1991, J AM LAB, P42; SHLZUKA H, 1992, P NATL ACAD SCI USA, V89, P8794	8	15	16	1	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 2	1994	369	6479					421	422		10.1038/369421a0	http://dx.doi.org/10.1038/369421a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NP174	8196771				2022-12-28	WOS:A1994NP17400063
J	SURRIDGE, C				SURRIDGE, C			WATERSHED FOR THE STRUCTURE OF CYTOCHROME-C	NATURE			English	Editorial Material							CONFORMATION CHANGE							Surridge, Christopher/0000-0003-4264-5176				CLORE GM, 1990, BIOCHEMISTRY-US, V29, P5671, DOI 10.1021/bi00476a004; JENG MF, 1994, NAT STRUCT BIOL, V1, P234, DOI 10.1038/nsb0494-234; LEVITT M, 1993, STRUCTURE, V1, P223, DOI 10.1016/0969-2126(93)90011-5; OTTING G, 1989, J AM CHEM SOC, V111, P1871, DOI 10.1021/ja00187a050; QI PX, 1994, NAT STRUCT BIOL, V1, P379; TAKANO T, 1981, J MOL BIOL, V153, P95, DOI 10.1016/0022-2836(81)90529-5; TAKANO T, 1981, J MOL BIOL, V153, P79, DOI 10.1016/0022-2836(81)90528-3; XU RX, 1993, BIOCHEMISTRY-US, V32, P2473, DOI 10.1021/bi00061a004	8	2	2	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 2	1994	369	6479					426	426		10.1038/369426a0	http://dx.doi.org/10.1038/369426a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NP174	8196772	Bronze			2022-12-28	WOS:A1994NP17400064
J	ADGER, H; DEANGELIS, CD				ADGER, H; DEANGELIS, CD			ADOLESCENT MEDICINE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHLAMYDIA-TRACHOMATIS; SYPHILIS; MALES				ADGER, H (corresponding author), JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD, USA.							Cates Jr, 1990, Adolesc Med, V1, P409; ELSTER AB, 1993, AMA GUIDELINES ADOLE; GENC M, 1993, JAMA-J AM MED ASSOC, V270, P2057, DOI 10.1001/jama.270.17.2057; HANDSFIELD HH, 1990, JAMA-J AM MED ASSOC, V264, P1451; JOHNSTON LD, 1993, 933597 NAT I DRUG AB; LORION RP, 1991, MARYLAND ADOLESCENT; MCCABE E, 1993, PEDIATRICS, V92, P695; Rogers, 1993, Adolesc Med, V4, P295; ROLFS RT, 1990, AM J PUBLIC HEALTH, V80, P853, DOI 10.2105/AJPH.80.7.853; SHAFER MA, 1993, JAMA-J AM MED ASSOC, V270, P2065, DOI 10.1001/jama.270.17.2065; WASSERHEIT JN, 1992, SEX TRANSM DIS, V19, P61, DOI 10.1097/00007435-199219020-00001; Webster Linda A., 1993, Morbidity and Mortality Weekly Report, V42, P13; 1990, ADM901656 US DEP HLT; 1993, MMWR MORB MORTAL WKL, V42, P1	14	3	4	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1651	1653						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182832				2022-12-28	WOS:A1994NN11700011
J	CARANDINI, M; HEEGER, DJ				CARANDINI, M; HEEGER, DJ			SUMMATION AND DIVISION BY NEURONS IN PRIMATE VISUAL-CORTEX	SCIENCE			English	Article							CAT STRIATE CORTEX; CONTRAST-RESPONSE FUNCTION; LAYER-V NEURONS; SIMPLE CELLS; DIRECTION SELECTIVITY; INHIBITION; INVITRO; MECHANISMS	Recordings from monkey primary visual cortex (V1) were used to test a model for the visually driven responses of simple cells. According to the model, simple cells compute a linear sum of the responses of lateral geniculate nucleus (LGN) neurons. In addition, each simple cell's linear response is divided by the pooled activity of a large number of other simple cells. The cell membrane performs both operations; synaptic currents are summed and then divided by the total membrane conductance. Current and conductance are decoupled (by a complementary arrangement of excitation and inhibition) so that current depends only on the LGN inputs and conductance depends only on the cortical inputs. Closed form expressions were derived for fitting and interpreting physiological data. The model accurately predicted responses to drifting grating stimuli of various contrasts, orientations, and spatiotemporal frequencies.	STANFORD UNIV,DEPT PSYCHOL,STANFORD,CA 94305	Stanford University	CARANDINI, M (corresponding author), NYU,CTR NEURAL SCI,NEW YORK,NY 10003, USA.		Carandini, Matteo/ABD-8296-2021; Carandini, Matteo/C-1922-2008	Carandini, Matteo/0000-0003-4880-7682; Carandini, Matteo/0000-0003-4880-7682	NIMH NIH HHS [1-R29-MH50228-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH050228] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; BENARDETE EA, 1992, VISUAL NEUROSCI, V8, P483, DOI 10.1017/S0952523800004995; BERMAN NJ, 1991, J PHYSIOL-LONDON, V440, P697, DOI 10.1113/jphysiol.1991.sp018731; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; CAMPBELL FW, 1969, J PHYSIOL-LONDON, V203, P223, DOI 10.1113/jphysiol.1969.sp008861; COOMBS JS, 1955, J PHYSIOL-LONDON, V130, P396, DOI 10.1113/jphysiol.1955.sp005414; DEAN AF, 1986, EXP BRAIN RES, V62, P143; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P659, DOI 10.1113/jphysiol.1991.sp018730; FERSTER D, 1988, J NEUROSCI, V8, P1172; GROSSBERG S, 1988, NEURAL NETWORKS, V1, P17, DOI 10.1016/0893-6080(88)90021-4; HEEGER DJ, 1993, J NEUROPHYSIOL, V70, P1885, DOI 10.1152/jn.1993.70.5.1885; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; HEGGELUND P, 1981, EXP BRAIN RES, V42, P89; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JAGADEESH B, 1993, SCIENCE, V262, P1901, DOI 10.1126/science.8266083; JAGADEESH B, 1992, J NEUROSCI, V12, P1262; KOCH C, 1987, SYNAPTIC FUNCTION, P637; LI CY, 1984, PFLUG ARCH EUR J PHY, V401, P304; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; OGAWA T, 1981, BRAIN RES, V226, P315, DOI 10.1016/0006-8993(81)91105-7; PALMER LA, 1981, J NEUROPHYSIOL, V46, P260, DOI 10.1152/jn.1981.46.2.260; SHAPLEY R, 1990, ANNU REV PSYCHOL, V41, P635, DOI 10.1146/annurev.psych.41.1.635; SPERLING G, 1968, J OPT SOC AM, V58, P1133, DOI 10.1364/JOSA.58.001133; STAFSTROM CE, 1984, J NEUROPHYSIOL, V52, P278, DOI 10.1152/jn.1984.52.2.278; STAFSTROM CE, 1984, J NEUROPHYSIOL, V52, P264, DOI 10.1152/jn.1984.52.2.264; STRATFORD K, 1990, COMPUTING NEURON, P296	29	441	447	2	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 27	1994	264	5163					1333	1336		10.1126/science.8191289	http://dx.doi.org/10.1126/science.8191289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NN767	8191289				2022-12-28	WOS:A1994NN76700047
J	SUH, WK; COHENDOYLE, MF; FRUH, K; WANG, K; PETERSON, PA; WILLIAMS, DB				SUH, WK; COHENDOYLE, MF; FRUH, K; WANG, K; PETERSON, PA; WILLIAMS, DB			INTERACTION OF MHC CLASS-I MOLECULES WITH THE TRANSPORTER ASSOCIATED WITH ANTIGEN-PROCESSING	SCIENCE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MUTANT-CELL LINE; ENDOPLASMIC-RETICULUM; MONOCLONAL-ANTIBODIES; PRESENTATION PATHWAY; PEPTIDE BINDING; LYMPHOCYTES-T; HEAVY-CHAINS; RMA-S; PROTEIN	The transporter associated with antigen processing (TAP) delivers cytosolic peptides into the endoplasmic reticulum (ER) where they bind to nascent class I histocompatibility molecules. Class I-peptide complexes are then displayed at the cell surface for recognition by cytotoxic T lymphocytes. Immunoprecipitation of either TAP or class I molecules revealed an association between the transporter and diverse class I products. TAP bound preferentially to heterodimers of the class I heavy chain and beta(2)-microglobulin, and the complex subsequently dissociated in parallel with transport of class I molecules from the ER to the Golgi apparatus. The TAP-class I complexes could also be dissociated in vitro by the addition of class I-binding peptides. The association of class I molecules with TAP likely promotes efficient capture of peptides before their exposure to the lumen of the ER.	UNIV TORONTO, DEPT BIOCHEM, TORONTO M5S 1A8, ON, CANADA; Scripps Res Inst, DEPT IMMUNOL, LA JOLLA, CA 92037 USA	University of Toronto; Scripps Research Institute				Suh, Woong-Kyung/0000-0002-6420-3283; Frueh, Klaus/0000-0001-8014-3877				ANDERSON K, 1991, J EXP MED, V174, P489, DOI 10.1084/jem.174.2.489; ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; ATTAYA M, 1992, NATURE, V355, P647, DOI 10.1038/355647a0; BAAS EJ, 1992, J EXP MED, V176, P147, DOI 10.1084/jem.176.1.147; BIJLMAKERS MJ, 1993, CURR OPIN IMMUNOL, V5, P21, DOI 10.1016/0952-7915(93)90076-5; BURSHTYN DB, 1993, J IMMUNOL, V151, P3982; CERUNDOLO V, 1991, EUR J IMMUNOL, V21, P2069, DOI 10.1002/eji.1830210915; CERUNDOLO V, 1992, EUR J IMMUNOL, V22, P2243, DOI 10.1002/eji.1830220910; CHRISTINCK ER, 1991, NATURE, V352, P67, DOI 10.1038/352067a0; DEGEN E, 1991, J CELL BIOL, V112, P1099, DOI 10.1083/jcb.112.6.1099; DEVERSON EV, 1990, NATURE, V348, P738, DOI 10.1038/348738a0; ELLIOTT T, 1992, EUR J IMMUNOL, V22, P2085, DOI 10.1002/eji.1830220819; ELLIOTT T, 1992, EUR J IMMUNOL, V22, P3121, DOI 10.1002/eji.1830221214; ENGELHARD VH, 1994, CURR OPIN IMMUNOL, V6, P13, DOI 10.1016/0952-7915(94)90028-0; GASKINS HR, 1992, SCIENCE, V256, P1826, DOI 10.1126/science.1352067; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P493; GOLDBERG AL, 1992, NATURE, V357, P375, DOI 10.1038/357375a0; HEEMELS MT, 1993, SCIENCE, V262, P2059, DOI 10.1126/science.8266106; HENDERSON RA, 1992, SCIENCE, V255, P1264, DOI 10.1126/science.1546329; HUNT DF, 1992, SCIENCE, V255, P1261, DOI 10.1126/science.1546328; JACKSON MR, 1994, SCIENCE, V263, P384, DOI 10.1126/science.8278813; JONES B, 1981, NATURE, V292, P547, DOI 10.1038/292547a0; KELLY A, 1992, NATURE, V355, P641, DOI 10.1038/355641a0; KLEIJMEER MJ, 1992, NATURE, V357, P342, DOI 10.1038/357342a0; LAPHAM CK, 1993, J EXP MED, V177, P1633, DOI 10.1084/jem.177.6.1633; LEMKE H, 1979, IMMUNOL REV, V47, P175, DOI 10.1111/j.1600-065X.1979.tb00293.x; LEVY F, 1991, CELL, V67, P265, DOI 10.1016/0092-8674(91)90178-2; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; MATSUMURA M, 1992, J BIOL CHEM, V267, P23589; MOMBURG F, 1994, CURR OPIN IMMUNOL, V6, P32, DOI 10.1016/0952-7915(94)90030-2; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; MONACO JJ, 1990, SCIENCE, V250, P1723, DOI 10.1126/science.2270487; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; MORRISON LA, 1986, J EXP MED, V163, P903, DOI 10.1084/jem.163.4.903; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; NEEFJES JJ, 1993, J EXP MED, V178, P1971, DOI 10.1084/jem.178.6.1971; OZATO K, 1981, J IMMUNOL, V126, P317; OZATO K, 1980, J IMMUNOL, V125, P2473; PLUTNER H, 1992, J CELL BIOL, V119, P1097, DOI 10.1083/jcb.119.5.1097; POWIS SJ, 1991, NATURE, V354, P528, DOI 10.1038/354528a0; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; SCHUMACHER TNM, 1994, J EXP MED, V179, P533, DOI 10.1084/jem.179.2.533; SHEPHERD JC, 1993, SCIENCE, V74, P577; SMITH MH, 1986, MOL IMMUNOL, V23, P1077, DOI 10.1016/0161-5890(86)90006-4; SPIES T, 1991, NATURE, V351, P323, DOI 10.1038/351323a0; SPIES T, 1992, NATURE, V355, P644, DOI 10.1038/355644a0; SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND A, 1992, NATURE, V356, P386, DOI 10.1038/356386a0; TROWSDALE J, 1990, NATURE, V348, P741, DOI 10.1038/348741a0; URBAN RG, 1994, P NATL ACAD SCI USA, V91, P1534, DOI 10.1073/pnas.91.4.1534; VELASCO A, 1993, J CELL BIOL, V122, P39, DOI 10.1083/jcb.122.1.39; WEI ML, 1992, NATURE, V356, P443, DOI 10.1038/356443a0; WILLIAMS DB, 1989, J IMMUNOL, V142, P2796; YANG Y, 1992, J BIOL CHEM, V267, P11669; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266	56	279	282	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 27	1994	264	5163					1322	1326		10.1126/science.8191286	http://dx.doi.org/10.1126/science.8191286			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NN767	8191286				2022-12-28	WOS:A1994NN76700044
J	GAVAGHAN, H				GAVAGHAN, H			GENETICS BUSINESS BOOMING YET UNCERTAIN	NATURE			English	Article																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 26	1994	369	6478					341	342		10.1038/369341a0	http://dx.doi.org/10.1038/369341a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NN109	8183375				2022-12-28	WOS:A1994NN10900059
J	BRENNER, RA; SMITH, GS; OVERPECK, MD				BRENNER, RA; SMITH, GS; OVERPECK, MD			DIVERGENT TRENDS IN CHILDHOOD DROWNING RATES, 1971 THROUGH 1988	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note							5-YEAR TOTAL POPULATION; UNITED-STATES; CHILDREN; COUNTY; PREVENTION; ACCIDENTS; BRISBANE	Objective.-To examine national age-, race-, and sex-specific trends in unintentional drowning rates among US children aged 0 through 19 years. Design.-National mortality data published by the National Center for Health Statistics and population data from the US Bureau of the Census were used in calculating age-, race-, and sex-specific drowning rates for 1971 through 1988. Time trends were analyzed using Poisson regression techniques. Setting.-United States, 1971 through 1988. Main Outcome Measure.-Rates of death due to unintentional, non-boat-related drowning. Results.-From 1971 through 1988, there were 45 680 unintentional, non-boat-related drowning deaths among 0- through 19-year-olds in the United States. Drowning rates declined sharply in older children (-5.8% per year in 10- through 14-year-olds and -5.4% per year in 15- through 19-year-olds), declined only slightly in toddlers (-1.6% per year in 1- and 2-year-olds), and actually increased in infants (+1.6% per year in those children younger than 1 year). Conclusion.-Drowning rates in toddlers have changed little over time despite the availability of effective prevention strategies such as pool fencing. In older children, drowning rates have declined dramatically despite the lack of clear preventive initiatives. Prevention interventions targeted specifically at the infant and toddler age groups should receive priority.	JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,CTR INJURY PREVENT,BALTIMORE,MD	Johns Hopkins University	BRENNER, RA (corresponding author), NICHHD,DIV EPIDEMIOL STAT & PREVENT RES,6100 EXECUT BLVD,ROOM 7B03,BETHESDA,MD 20892, USA.			Smith, Gordon/0000-0002-2911-3071	NIAAA NIH HHS [R29AA07700] Funding Source: Medline; PHS HHS [R49/CCR302486-01] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R29AA007700] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		BAKER SP, 1992, INJURY FACT BOOK, P174; BUDNICK LD, 1985, AM J PUBLIC HEALTH, V75, P630, DOI 10.2105/AJPH.75.6.630; CASS DT, 1991, MED J AUSTRALIA, V154, P163, DOI 10.5694/j.1326-5377.1991.tb121021.x; DIETZ PE, 1974, AM J PUBLIC HEALTH, V64, P303, DOI 10.2105/AJPH.64.4.303; FELDMAN KW, 1993, CHILD ABUSE NEGLECT, V17, P329, DOI 10.1016/0145-2134(93)90055-A; FLOOD TJ, 1990, MMWR-MORBID MORTAL W, V39, P441; GRIEST KJ, 1989, PEDIATRICS, V83, P41; Gulaid J A, 1988, MMWR CDC Surveill Summ, V37, P27; HOWLAND J, 1988, ACCIDENT ANAL PREV, V20, P19, DOI 10.1016/0001-4575(88)90011-5; JENSEN LR, 1992, WESTERN J MED, V157, P641; JUMBELIC MI, 1990, JAMA-J AM MED ASSOC, V263, P1952, DOI 10.1001/jama.263.14.1952; MANN NC, 1992, PEDIATRICS, V89, P1068; McCullagh P., 1989, GENERALIZED LINEAR M, DOI DOI 10.1007/978-1-4899-3242-6; OCARROLL PW, 1988, JAMA-J AM MED ASSOC, V260, P380, DOI 10.1001/jama.260.3.380; PEARN J, 1976, MED J AUSTRALIA, V2, P942, DOI 10.5694/j.1326-5377.1976.tb115532.x; PEARN JH, 1977, MED J AUSTRALIA, V1, P432, DOI 10.5694/j.1326-5377.1977.tb130794.x; PEARN JH, 1979, AM J PUBLIC HEALTH, V69, P450, DOI 10.2105/AJPH.69.5.450; PEARN JH, 1979, PEDIATRICS, V64, P68; PITT WR, 1991, MED J AUSTRALIA, V154, P661, DOI 10.5694/j.1326-5377.1991.tb121253.x; QUAN L, 1989, PEDIATRICS, V83, P1035; SAUNDERS E, 1989, PUBLIC HEALTH REP, V104, P368; SHINABERGER CS, 1990, AM J PUBLIC HEALTH, V80, P613, DOI 10.2105/AJPH.80.5.613; WINTEMUTE GJ, 1987, AM J PUBLIC HEALTH, V77, P830, DOI 10.2105/AJPH.77.7.830; WINTEMUTE GJ, 1990, AM J DIS CHILD, V144, P663, DOI 10.1001/archpedi.1990.02150300061018; 1989, VITAL HLTH STAT 3, V26; 1989, CURRENT POPULATI P25, V917; 1967, MANUAL INT STATISTIC; 1975, VITAL STATISTICS US, V2; 1991, DHHS PHS9150213 US D; 1989, CURRENT POPULATI P25, V1045; 1990, VITAL STATISTICS US, V2; [No title captured]	32	36	36	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	1994	271	20					1606	1608		10.1001/jama.271.20.1606	http://dx.doi.org/10.1001/jama.271.20.1606			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NL758	8182814				2022-12-28	WOS:A1994NL75800030
J	KOLESNICK, R; GOLDE, DW				KOLESNICK, R; GOLDE, DW			THE SPHINGOMYELIN PATHWAY IN TUMOR-NECROSIS-FACTOR AND INTERLEUKIN-1 SIGNALING	CELL			English	Review							TRANSDUCTION PATHWAY; CERAMIDE; SPHINGOLIPIDS; FIBROBLASTS; BREAKDOWN		MEM SLOAN KETTERING CANC CTR,MOLEC & CELLULAR HEMATOL LAB,NEW YORK,NY 10021	Memorial Sloan Kettering Cancer Center	KOLESNICK, R (corresponding author), MEM SLOAN KETTERING CANC CTR,SIGNAL TRANSDUCT LAB,NEW YORK,NY 10021, USA.							BAJJALIEH SM, 1989, J BIOL CHEM, V264, P14354; BALLOU LR, 1992, J BIOL CHEM, V267, P20044; CARSON DA, 1993, LANCET, V341, P1251, DOI 10.1016/0140-6736(93)91154-E; CUADRADO A, 1993, ONCOGENE, V8, P2959; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; DOBROWSKY RT, 1993, ADV LIPID RES, V25, P91; DRESSLER KA, 1992, SCIENCE, V255, P1715, DOI 10.1126/science.1313189; FINCO TS, 1993, J BIOL CHEM, V268, P17676; HANNUN YA, 1993, ADV LIPID RES, V25, P27; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; JARVIS WD, 1994, P NATL ACAD SCI USA, V91, P73, DOI 10.1073/pnas.91.1.73; JOSEPH CK, 1993, J BIOL CHEM, V268, P20002; KENNELLY PJ, 1991, J BIOL CHEM, V266, P1555; KITANO K, 1993, BLOOD, V82, P2742; KOLESNICK RN, 1991, PROG LIPID RES, V30, P1, DOI 10.1016/0163-7827(91)90005-P; LI SF, 1993, P NATL ACAD SCI USA, V90, P9247, DOI 10.1073/pnas.90.20.9247; LIPSKY NG, 1985, J CELL BIOL, V100, P27, DOI 10.1083/jcb.100.1.27; LIU J, 1994, J BIOL CHEM, V269, P3047; MACHLEIDT T, 1994, IN PRESS J BIOL CHEM; MATHIAS S, 1993, SCIENCE, V259, P519, DOI 10.1126/science.8424175; NETA R, 1992, TUMOR NECROSIS FACTO, P4499; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; OLIVERA A, 1992, J BIOL CHEM, V267, P26121; RAINES MA, 1993, J BIOL CHEM, V268, P14572; RIVAS CI, 1994, BLOOD, V83, P2191; SCHUTZE S, 1992, CELL, V71, P765, DOI 10.1016/0092-8674(92)90553-O; VANLINT J, 1992, J BIOL CHEM, V267, P25916; WEIGMANN K, 1992, J BIOL CHEM, V267, P17997; YANAGA F, 1992, FEBS LETT, V314, P297, DOI 10.1016/0014-5793(92)81493-6; YANG ZH, 1993, J BIOL CHEM, V268, P20520	30	932	948	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 6	1994	77	3					325	328		10.1016/0092-8674(94)90147-3	http://dx.doi.org/10.1016/0092-8674(94)90147-3			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NK970	8181053				2022-12-28	WOS:A1994NK97000003
J	CHOUILLET, AM; BELL, CMJ; HISCOX, JG				CHOUILLET, AM; BELL, CMJ; HISCOX, JG			MANAGEMENT OF BREAST-CANCER IN SOUTHEAST ENGLAND	BRITISH MEDICAL JOURNAL			English	Article								Objective-To examine the extent to which management of invasive breast cancer reflected consensus guidelines in the Thames regions in 1990. Design-Population based study of case notes. Setting-Thames Cancer Registry. Subjects-All women with breast cancer diagnosed in early 1990 (417 cases) resident in the four Thames regions. Hospital records were traced for 346 cases, of which 12 were ineligible because of misclassification in initial registration and were excluded from the analysis. 334 cases were analysed. Main outcome measures-Investigations and treatment in the six months after diagnosis, stage of disease. Results-Of the 334 women identified, 86 were aged under 50. Three years after diagnosis, 74 were dead, seven (8%) aged under 50 and 67 (27%) aged 50 or over. Axillary surgery was used to stage cancer in only 155 cases (46%), although this is recommended in the guidelines. Only 79 (24%) case notes had any information recorded on stage. Stage could be determined reliably for only half of the sample. Treatment varied widely within the same age group and stage of disease. In particular, chemotherapy was not routinely given to patients under 50 with stage 11 disease. Only 17 records showed evidence that the patient was participating in a clinical trial. Conclusions-There was a lack of consensus on the management of breast cancer among clinicians in 1990. More patients should be included in clinical trials.			CHOUILLET, AM (corresponding author), THAMES CANC REGISTRY,SUTTON SM2 5PY,SURREY,ENGLAND.							BASNETT I, 1992, EUR J CANCER, V28A, P1945, DOI 10.1016/0959-8049(92)90233-R; DAY NE, 1989, BRIT J CANCER, V59, P954, DOI 10.1038/bjc.1989.203; Early Breast Cancer Trialists' Collaborative Group, 1992, LANCET, V339, P1; GULLIFORD MC, 1993, BRIT J CANCER, V67, P819, DOI 10.1038/bjc.1993.149; MCCARTHY M, 1991, EUR J CANCER, V27, P579, DOI 10.1016/0277-5379(91)90222-Y; 1993, LANCET, V341, P171; 1986, BMJ, V293, P946; 1986, BREAST CANCER SCREEN; 1987, TNM CLASSIFICATION M; 1992, LANCET, V339, P71; 1993, HLTH NATION KEY AREA; 1992, CANCER S W THAMES 19	12	77	77	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 15	1994	308	6922					168	171		10.1136/bmj.308.6922.168	http://dx.doi.org/10.1136/bmj.308.6922.168			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MR974	8204162	Green Published			2022-12-28	WOS:A1994MR97400017
J	BRAMBLE, DM; JENKINS, FA				BRAMBLE, DM; JENKINS, FA			MAMMALIAN LOCOMOTOR-RESPIRATORY INTEGRATION - IMPLICATIONS FOR DIAPHRAGMATIC AND PULMONARY DESIGN	SCIENCE			English	Article							HORSES EQUUS-CABALLUS; AIRWAY BIFURCATIONS; PERIODIC-FLOW; SYNCHRONIZATION; VENTILATION; PRESSURE	Diaphragmatic function and intrapulmonary respiratory flow in running mammals were found to differ substantially from the corresponding conditions known in resting mammals. In trotting dogs, orbital oscillations of the diaphragm were driven by inertial displacements of the viscera induced by locomotion. In turn, oscillations of the visceral mass drove pulmonary ventilation independent of diaphragmatic contractions, which primarily served to modulate visceral kinetics. Visceral displacements and loading of the anterior chest wall by the forelimbs are among the factors that contribute to an asynchronous ventilation of the lungs and interlobar gas recycling. Basic features of mammalian respiratory design, including the structure of the diaphragm and lobation of the lungs, appear to reflect the mechanical requirements of locomotor-respiratory integration.	HARVARD UNIV, DEPT ORGANISM & EVOLUT BIOL, CAMBRIDGE, MA 02138 USA; HARVARD UNIV, MUSEUM COMPARAT ZOOL, CAMBRIDGE, MA 02138 USA	Harvard University; Harvard University	BRAMBLE, DM (corresponding author), UNIV UTAH, DEPT BIOL, SALT LAKE CITY, UT 84112 USA.				NCRR NIH HHS [S07 RR07092] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [S07RR007092] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AINSWORTH DM, 1989, RESP PHYSIOL, V78, P145, DOI 10.1016/0034-5687(89)90048-0; ALEXANDER RM, 1989, J ZOOL, V218, P69, DOI 10.1111/j.1469-7998.1989.tb02526.x; ALLEN JL, 1987, J APPL PHYSIOL, V62, P223, DOI 10.1152/jappl.1987.62.1.223; ATTENBURROW DP, 1982, EQUINE VET J, V14, P69, DOI 10.1111/j.2042-3306.1982.tb02340.x; BANZETT RB, 1992, J APPL PHYSIOL, V72, P1922, DOI 10.1152/jappl.1992.72.5.1922; BAUDINETTE RV, 1987, J EXP BIOL, V129, P251; BRAMBLE DM, 1989, LIFE SCI R, V45, P133; BRAMBLE DM, 1983, SCIENCE, V219, P251, DOI 10.1126/science.6849136; BRAMBLE DM, 1989, AM ZOOL, V29, P171; BRAMBLE DM, 1986, NONLINEAR OSCIL, P130; CARRIER DR, 1987, PALEOBIOLOGY, V13, P326; CARRIER DR, 1987, EXP BIOL, V47, P33; DETROYER A, 1981, SCIENCE, V213, P237, DOI 10.1126/science.7244632; DETROYER A, 1986, HDB PHYSL RESPIRATOR, V3, pCH26; GOLDBERG MB, 1981, RESP PHYSIOL, V43, P327, DOI 10.1016/0034-5687(81)90113-4; GRIFFITHS RI, 1992, P ROY SOC B-BIOL SCI, V249, P199, DOI 10.1098/rspb.1992.0104; HORSFIELD K, 1985, GAS MIXING DISTRIBUT, P23; KOTERBA AM, 1988, J APPL PHYSIOL, V64, P337, DOI 10.1152/jappl.1988.64.1.337; Lancaster D., 1975, ACTIVE FILTER COOKBO; LAWS JW, 1965, BRIT J RADIOL, V38, P512, DOI 10.1259/0007-1285-38-451-512; LEITH D E, 1971, Federation Proceedings, V30, P556; OTIS AB, 1956, J APPL PHYSIOL, V8, P427, DOI 10.1152/jappl.1956.8.4.427; PAIVA M, 1989, RESP PHYSL ANAL APPR, V40, P245; PIIPER J, 1989, COMP PULMONARY PHYSL, P369; ROCHESTER DF, 1985, J CLIN INVEST, V75, P1397, DOI 10.1172/JCI111841; ROUSSOS C, 1986, HDB PHYSL RESPIRATOR, V3, pCH29; SILVERMAN NR, 1973, J APPL PHYSIOL, V34, P726, DOI 10.1152/jappl.1973.34.5.726; SLIJPER EJ, 1962, WHALES, P140; TSUDA A, 1990, J APPL PHYSIOL, V69, P546, DOI 10.1152/jappl.1990.69.2.546; TSUDA A, 1990, J APPL PHYSIOL, V69, P553, DOI 10.1152/jappl.1990.69.2.553; TYLER WS, 1991, COMP BIOL NORMAL LUN, V1, pCH4; WEBEL ER, 1984, PATHWAY OXYGEN; WELLS L. J., 1954, CONTR EMBRYOL CARNEGIE INST WASHINGTON, V35, P107; WEST JB, 1977, REGIONAL DIFFERENCES; YOUNG IS, 1992, J EXP BIOL, V166, P19; YOUNG IS, 1992, J EXP BIOL, V164, P283	36	105	107	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 8	1993	262	5131					235	240		10.1126/science.8211141	http://dx.doi.org/10.1126/science.8211141			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA665	8211141				2022-12-28	WOS:A1993MA66500033
J	DEWEY, ME				DEWEY, ME			AUTHORS HAVE RIGHTS TOO	BRITISH MEDICAL JOURNAL			English	Article								Without publication research can be of little value. When researchers approach publication there is ample published guidance for them on what their obligations are, and there are well known style guides within each scientific discipline including, in medicine, the Vancouver style. This article gives a series of anonymous examples to suggest that the impact of similar guides for editors has been patchy and to make some suggestions for better communication.			DEWEY, ME (corresponding author), UNIV LIVERPOOL,DEPT PSYCHIAT,POB 147,LIVERPOOL L69 3BX,ENGLAND.		Dewey, Michael E/E-2049-2010	Dewey, Michael E/0000-0002-7522-3677				Uniform requirements for manuscripts submitted to biomedical journals, 1991, BMJ, V302, P338, DOI DOI 10.1136/bmj.302.6772.338	1	13	14	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 30	1993	306	6873					318	320		10.1136/bmj.306.6873.318	http://dx.doi.org/10.1136/bmj.306.6873.318			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	KK718	8192714	Bronze, Green Published			2022-12-28	WOS:A1993KK71800026
J	DRACHMAN, DB				DRACHMAN, DB			MEDICAL PROGRESS - MYASTHENIA-GRAVIS	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							NICOTINIC ACETYLCHOLINE-RECEPTOR; T-CELL REPERTOIRE; ALPHA-SUBUNIT; LYMPHOCYTES-T; HUMAN-MUSCLE; NEUROMUSCULAR-TRANSMISSION; ESCHERICHIA-COLI; IMMUNE-RESPONSES; CLINICAL CORRELATIONS; RHEUMATOID-ARTHRITIS				DRACHMAN, DB (corresponding author), JOHNS HOPKINS UNIV, SCH MED, DEPT NEUROL, 600 N WOLFE ST, BALTIMORE, MD 21287 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023719] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS23719] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABRAMSKY O, 1975, ARCH NEUROL-CHICAGO, V32, P684, DOI 10.1001/archneur.1975.00490520054008; ABRAMSKY O, 1975, CLIN EXP IMMUNOL, V19, P11; AHLBERG R, 1993, ANN NY ACAD SCI, V681, P552, DOI 10.1111/j.1749-6632.1993.tb22938.x; AOKI T, 1985, NEUROLOGY, V35, P185, DOI 10.1212/WNL.35.2.185; APPEL SH, 1977, P NATL ACAD SCI USA, V74, P2130, DOI 10.1073/pnas.74.5.2130; ARSURA E, 1989, CLIN IMMUNOL IMMUNOP, V53, pS170, DOI 10.1016/0090-1229(89)90083-4; ASHER O, 1988, FEBS LETT, V233, P277, DOI 10.1016/0014-5793(88)80442-3; ASHIZAWA T, 1991, ADV EXP MED BIOL, V303, P255; BACH JF, 1992, J AUTOIMMUN, V5, P3, DOI 10.1016/0896-8411(92)90014-H; BALCER LJ, 1991, J NEUROIMMUNOL, V31, P115, DOI 10.1016/0165-5728(91)90017-2; BARRETT EF, 1976, BIOL CHOLINERGIC FUN, P29; BATRA P, 1987, AM J ROENTGENOL, V148, P515, DOI 10.2214/ajr.148.3.515; BEESON D, 1989, BIOCHEM SOC T, V17, P219, DOI 10.1042/bst0170219; BERZOFSKY JA, 1988, IMMUNOL REV, V106, P5, DOI 10.1111/j.1600-065X.1988.tb00771.x; BROCKE S, 1988, J CLIN INVEST, V82, P1894, DOI 10.1172/JCI113807; BROOKS EB, 1990, J NEUROIMMUNOL, V28, P83, DOI 10.1016/0165-5728(90)90043-M; BROSTOFF SW, 1984, J IMMUNOL, V133, P1938; BUCKINGHAM JM, 1976, ANN SURG, V184, P453, DOI 10.1097/00000658-197610000-00008; BUCKNALL RC, 1975, BRIT MED J, V1, P600, DOI 10.1136/bmj.1.5958.600; CARLSSON B, 1990, IMMUNOGENETICS, V31, P285, DOI 10.1007/BF02115001; CASTLEMAN B, 1966, ANN NY ACAD SCI, V135, P496, DOI 10.1111/j.1749-6632.1966.tb45497.x; CHANG C. C., 1963, ARCH INTERNATL PHARMACODYN THER, V144, P241; CHANGEUX JP, 1984, SCIENCE, V225, P1335, DOI 10.1126/science.6382611; CHRISTADOSS P, 1986, J IMMUNOL, V136, P2437; COHEN JB, 1975, ANNU REV PHARMACOL, V15, P83, DOI 10.1146/annurev.pa.15.040175.000503; COOPER JD, 1988, ANN THORAC SURG, V45, P242, DOI 10.1016/S0003-4975(10)62457-5; DAROFF RB, 1986, ARCH NEUROL-CHICAGO, V43, P843, DOI 10.1001/archneur.1986.00520080081029; Dau, 1979, PLASMAPHERESIS IMMUN, P229; DAU PC, 1977, NEW ENGL J MED, V297, P1134, DOI 10.1056/NEJM197711242972102; DRACHMAN D B, 1987, Neurology, V37, P214; Drachman Daniel B., 1993, P379; DRACHMAN DB, 1987, ANN NY ACAD SCI, V505, P90, DOI 10.1111/j.1749-6632.1987.tb51285.x; DRACHMAN DB, 1982, J NEUROSCI, V2, P232; DRACHMAN DB, 1978, NEW ENGL J MED, V298, P1116, DOI 10.1056/NEJM197805182982004; DRACHMAN DB, 1990, RES P ARNMD, V68, P183; DRACHMAN DB, 1982, NEW ENGL J MED, V307, P769, DOI 10.1056/NEJM198209233071301; DRACHMAN DB, 1985, CLIN IMMUNOL IMMUNOP, V34, P174, DOI 10.1016/0090-1229(85)90022-4; DRACHMAN DB, 1993, ANN NY ACAD SCI, V681, P515, DOI 10.1111/j.1749-6632.1993.tb22935.x; DWYER JM, 1992, NEW ENGL J MED, V326, P107; ELMQVIST D, 1964, J PHYSIOL-LONDON, V174, P417, DOI 10.1113/jphysiol.1964.sp007495; Engel A., 1979, CURRENT TOPICS NERVE, P111; ENGEL AG, 1987, ANN NY ACAD SCI, V505, P326, DOI 10.1111/j.1749-6632.1987.tb51301.x; ENGEL AG, 1976, J NEUROPATH EXP NEUR, V35, P569, DOI 10.1097/00005072-197609000-00008; ENGEL AG, 1976, ANN NY ACAD SCI, V274, P60, DOI 10.1111/j.1749-6632.1976.tb47676.x; EVOLI A, 1989, CLIN INVEST MED, V12, P104; FAMBROUGH DM, 1973, SCIENCE, V182, P293, DOI 10.1126/science.182.4109.293; FAMBROUGH DM, 1979, PHYSIOL REV, V59, P165, DOI 10.1152/physrev.1979.59.1.165; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; GALANAUD P, 1976, CELL IMMUNOL, V22, P83, DOI 10.1016/0008-8749(76)90009-5; GROB D, 1987, ANN NY ACAD SCI, V505, P472, DOI 10.1111/j.1749-6632.1987.tb51317.x; GROB D, 1981, ANN NY ACAD SCI, V377, P652, DOI 10.1111/j.1749-6632.1981.tb33764.x; GRUNEWALD J, 1991, SCAND J IMMUNOL, V34, P161, DOI 10.1111/j.1365-3083.1991.tb01533.x; HANDSCHUMACHER R E, 1990, P1264; HERTEL G, 1979, PLASMAPHERESIS IMMUN, P315; HERZOG C, 1989, J AUTOIMMUN, V2, P627, DOI 10.1016/S0896-8411(89)80002-2; HOHLFELD R, 1987, ANN NY ACAD SCI, V505, P27, DOI 10.1111/j.1749-6632.1987.tb51280.x; HOWARD FM, 1987, ANN NY ACAD SCI, V505, P526, DOI 10.1111/j.1749-6632.1987.tb51321.x; HOWARD JF, 1990, SEMIN NEUROL, V10, P89, DOI 10.1055/s-2008-1041258; JOHNS TR, 1987, ANN NY ACAD SCI, V505, P568, DOI 10.1111/j.1749-6632.1987.tb51325.x; KACHALSKY SG, 1993, FEBS LETT, V318, P264, DOI 10.1016/0014-5793(93)80525-Y; KAHAN DB, 1988, TRANSPL P S3, V20, P1; KAO I, 1977, SCIENCE, V196, P527, DOI 10.1126/science.850793; KAO I, 1977, SCIENCE, V195, P74, DOI 10.1126/science.831257; KAPLAN I, 1990, P NATL ACAD SCI USA, V87, P8100, DOI 10.1073/pnas.87.20.8100; KEESEY J, 1981, ANN NY ACAD SCI, V377, P729, DOI 10.1111/j.1749-6632.1981.tb33771.x; KEESEY JC, 1989, MUSCLE NERVE, V12, P613, DOI 10.1002/mus.880120802; KILLEN JA, 1984, J IMMUNOL, V133, P2549; KIRCHNER T, 1988, VIRCHOWS ARCH B, V54, P295; KIRSCH JR, 1991, CRIT CARE MED, V19, P1474, DOI 10.1097/00003246-199112000-00006; KISTLER J, 1982, BIOPHYS J, V37, P371, DOI 10.1016/S0006-3495(82)84685-7; KIYOKAWA T, 1991, PROTEIN ENG, V4, P463, DOI 10.1093/protein/4.4.463; KUKS JBM, 1991, J AUTOIMMUN, V4, P197, DOI 10.1016/0896-8411(91)90018-8; KUNCL RW, 1986, ANN NEUROL, V20, P740, DOI 10.1002/ana.410200617; KURODA Y, 1984, ANN NEUROL, V15, P400, DOI 10.1002/ana.410150416; KURTZKE JF, 1992, CLIN NEUROLOGY, V4, P80; LAMBERT EH, 1976, ANN NY ACAD SCI, V274, P300, DOI 10.1111/j.1749-6632.1976.tb47694.x; LANG B, 1993, ANN NY ACAD SCI, V681, P382, DOI 10.1111/j.1749-6632.1993.tb22917.x; LENNON VA, 1976, ANN NY ACAD SCI, V274, P283, DOI 10.1111/j.1749-6632.1976.tb47693.x; LINDBERG C, 1992, ACTA NEUROL SCAND, V86, P323, DOI 10.1111/j.1600-0404.1992.tb05094.x; LINDSTROM J, 1977, CLIN IMMUNOL IMMUNOP, V7, P36, DOI 10.1016/0090-1229(77)90027-7; LINDSTROM J, 1988, ADV IMMUNOL, V42, P233, DOI 10.1016/S0065-2776(08)60847-0; LINDSTROM JM, 1976, NEUROLOGY, V26, P1054, DOI 10.1212/WNL.26.11.1054; LINK H, 1991, J CLIN INVEST, V87, P2191, DOI 10.1172/JCI115253; LINK H, 1992, SCAND J IMMUNOL, V36, P405, DOI 10.1111/j.1365-3083.1992.tb02954.x; LIPSKY NG, 1989, EXP NEUROL, V105, P171, DOI 10.1016/0014-4886(89)90116-7; MASELLI RA, 1991, NEUROLOGY, V41, P1497, DOI 10.1212/WNL.41.9.1497; Matell G, 1987, Ann N Y Acad Sci, V505, P589; MELMS A, 1992, ANN NEUROL, V31, P311, DOI 10.1002/ana.410310314; MELMS A, 1989, J CLIN INVEST, V83, P785, DOI 10.1172/JCI113958; MICHELS M, 1988, ANN NEUROL, V24, P798, DOI 10.1002/ana.410240619; MOIOLA L, 1993, ANN NY ACAD SCI, V681, P198, DOI 10.1111/j.1749-6632.1993.tb22887.x; MOORTHY G, 1989, NEUROLOGY, V39, P1150, DOI 10.1212/WNL.39.9.1150; MORAES CT, 1989, NEW ENGL J MED, V320, P1293, DOI 10.1056/NEJM198905183202001; MOSSMAN S, 1986, LANCET, V1, P116; MOWAT AM, 1987, IMMUNOL TODAY, V8, P93, DOI 10.1016/0167-5699(87)90853-X; NAKANO S, 1993, NEUROLOGY, V43, pA181; NEWSOMDAVIS J, 1989, J AUTOIMMUN, V2, P101, DOI 10.1016/0896-8411(89)90121-2; NIELSEN FC, 1985, J IMMUNOL METHODS, V83, P249, DOI 10.1016/0022-1759(85)90247-9; NODA M, 1983, NATURE, V305, P818, DOI 10.1038/305818a0; OH SJ, 1992, MUSCLE NERVE, V15, P720, DOI 10.1002/mus.880150616; OKUMURA S, IN PRESS ANN NEUROL; OLANOW CW, 1987, ANN NY ACAD SCI, V505, P595, DOI 10.1111/j.1749-6632.1987.tb51328.x; ONEILL JH, 1988, BRAIN, V111, P577, DOI 10.1093/brain/111.3.577; Oosterhuis HJGH, 1993, MYASTHENIA GRAVIS, P13; OSSERMAN KE, 1958, MYASTHENIA GRAVIS, P80; PARRILLO JE, 1979, ANNU REV PHARMACOL, V19, P179, DOI 10.1146/annurev.pa.19.040179.001143; PATRICK J, 1973, SCIENCE, V180, P871, DOI 10.1126/science.180.4088.871; PENN AS, 1976, ANN NY ACAD SCI, V274, P354, DOI 10.1111/j.1749-6632.1976.tb47697.x; PENN AS, 1993, ANN NY ACAD SCI, V681, P319, DOI 10.1111/j.1749-6632.1993.tb22906.x; PERLO VP, 1975, NEUROLOGY, V25, P294, DOI 10.1212/WNL.25.3.294; PESTRONK A, 1985, MUSCLE NERVE, V8, P245, DOI 10.1002/mus.880080311; PINCHING AJ, 1976, LANCET, V2, P1373; PROTTI MP, 1990, J IMMUNOL, V144, P1711; PUMPLIN DW, 1983, J NEUROSCI, V3, P576; RAMSAY DA, 1992, BRAIN RES, V581, P198, DOI 10.1016/0006-8993(92)90709-I; REIM J, 1992, J NEUROIMMUNOL, V41, P61, DOI 10.1016/0165-5728(92)90196-R; REIM J, 1993, ANN NY ACAD SCI, V681, P325, DOI 10.1111/j.1749-6632.1993.tb22908.x; RICHMAN DP, 1979, NEUROLOGY, V29, P291, DOI 10.1212/WNL.29.3.291; ROWLAND LP, 1987, ANN NY ACAD SCI, V505, P607, DOI 10.1111/j.1749-6632.1987.tb51329.x; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; SALPETER MM, 1987, NEUROLOGY NEUROBIOLO, V23, P55; SCADDING GK, 1981, NEUROLOGY, V31, P935, DOI 10.1212/WNL.31.8.935; SCHALKE B C G, 1988, Neurology, V38, P135; SCHUMM F, 1985, J NEUROL NEUROSUR PS, V48, P332, DOI 10.1136/jnnp.48.4.332; SCHWARTZ RH, 1985, ANNU REV IMMUNOL, V3, P237, DOI 10.1146/annurev.iy.03.040185.001321; SCHWIMMBECK PL, 1989, J CLIN INVEST, V84, P1174, DOI 10.1172/JCI114282; SEYBOLD ME, 1971, ARCH NEUROL-CHICAGO, V25, P385, DOI 10.1001/archneur.1971.00490050019001; SEYBOLD ME, 1974, NEW ENGL J MED, V290, P81, DOI 10.1056/NEJM197401102900204; Simpson JA, 1960, SCOT MED J, V5, P419, DOI [10.1177/003693306000501001, DOI 10.1177/003693306000501001]; SOLIVEN BC, 1988, NEUROLOGY, V38, P514, DOI 10.1212/WNL.38.4.514; SOMMER N, 1990, ANN NEUROL, V28, P312, DOI 10.1002/ana.410280303; SOMMER N, 1991, NEUROLOGY, V41, P1270, DOI 10.1212/WNL.41.8.1270; STALBERG E, 1976, ANN NY ACAD SCI, V274, P189, DOI 10.1111/j.1749-6632.1976.tb47685.x; Stalberg E, 1979, SINGLE FIBRE ELECTRO; STANLEY EF, 1981, EXP NEUROL, V73, P390, DOI 10.1016/0014-4886(81)90274-0; STANLEY EF, 1978, SCIENCE, V200, P1285, DOI 10.1126/science.663610; STEFANSSON K, 1985, NEW ENGL J MED, V312, P221, DOI 10.1056/NEJM198501243120407; STEINMAN L, 1990, PROG BRAIN RES, V84, P117; STERZ RKM, 1985, J IMMUNOL, V134, P841; TALIB S, 1991, GENE, V98, P289, DOI 10.1016/0378-1119(91)90188-H; TESCH H, 1989, J NEUROIMMUNOL, V21, P169, DOI 10.1016/0165-5728(89)90172-0; THOMPSON HSG, 1990, IMMUNOL TODAY, V11, P396; TINDALL RSA, 1980, NEUROLOGY, V30, P554; TINDALL RSA, 1993, ANN NY ACAD SCI, V681, P539, DOI 10.1111/j.1749-6632.1993.tb22937.x; TOYKA KV, 1977, NEW ENGL J MED, V296, P125, DOI 10.1056/NEJM197701202960301; TZARTOS SJ, 1991, MOL NEUROBIOL, V5, P1, DOI 10.1007/BF02935610; VANWILGENBURG H, 1979, EUR J PHARMACOL, V55, P355; VINCENT A, 1987, ANN NY ACAD SCI, V505, P106, DOI 10.1111/j.1749-6632.1987.tb51286.x; VINCENT A, 1985, J NEUROL NEUROSUR PS, V48, P1246, DOI 10.1136/jnnp.48.12.1246; WALDMANN TA, 1986, SCIENCE, V232, P727, DOI 10.1126/science.3008337; WANG ZY, 1993, J NEUROIMMUNOL, V44, P209, DOI 10.1016/0165-5728(93)90045-Z; WEINER HL, 1991, ANN NY ACAD SCI, V636, P227, DOI 10.1111/j.1749-6632.1991.tb33454.x; WEKERLE H, 1975, NATURE, V256, P493, DOI 10.1038/256493a0; Wells HG, 1911, J INFECT DIS, V9, P147, DOI 10.1093/infdis/9.2.147; WHEATLEY LM, 1992, J IMMUNOL, V148, P3105; WILLIAMS DP, 1987, PROTEIN ENG, V1, P493, DOI 10.1093/protein/1.6.493; Willis T., 1672, ANIMA BRUTORUM, P404; WITZEMANN V, 1987, FEBS LETT, V223, P104, DOI 10.1016/0014-5793(87)80518-5; WITZEMANN V, 1990, EUR J BIOCHEM, V194, P437, DOI 10.1111/j.1432-1033.1990.tb15637.x; YAMAMOTO T, 1991, ANN NEUROL, V30, P550, DOI 10.1002/ana.410300407; YI Q, 1993, J NEUROIMMUNOL, V42, P215, DOI 10.1016/0165-5728(93)90013-O; YOUNGER DS, 1987, ANN NY ACAD SCI, V505, P832, DOI 10.1111/j.1749-6632.1987.tb51384.x; ZHANG Y, 1990, EUR J IMMUNOL, V20, P2577, DOI 10.1002/eji.1830201208; [No title captured]	164	999	1040	1	76	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 23	1994	330	25					1797	1810		10.1056/NEJM199406233302507	http://dx.doi.org/10.1056/NEJM199406233302507			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR295	8190158				2022-12-28	WOS:A1994NR29500007
J	FOX, CH				FOX, CH			IF IT AINT FIXED, DONT BREAK IT	NATURE			English	Editorial Material											FOX, CH (corresponding author), MOLEC HISTOL LABS,GAITHERSBURG,MD 20879, USA.							BURKE E, 1798, CORRESPONDENCE, V6, P9; CARBONE M, 1994, ONCOGENE, V9, P1781; FIELDS BN, 1994, NATURE, V369, P95, DOI 10.1038/369095a0; FOX CH, 1992, IMMUNOL TODAY, V13, P353, DOI 10.1016/0167-5699(92)90171-3; FOX CH, 1987, NATURE, V326, P636, DOI 10.1038/326636a0; MACILWAIN C, 1994, NATURE, V369, P91, DOI 10.1038/369091a0; SHAH KV, 1988, DEV BIOL STAND, V70, P67	7	1	1	0	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 23	1994	369	6482					602	602		10.1038/369602a0	http://dx.doi.org/10.1038/369602a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NT459	8208283	Bronze			2022-12-28	WOS:A1994NT45900022
J	NICHOLS, R; ANDREWS, PC; ZHANG, P; BERGSTROM, DE				NICHOLS, R; ANDREWS, PC; ZHANG, P; BERGSTROM, DE			A UNIVERSAL NUCLEOSIDE FOR USE AT AMBIGUOUS SITES IN DNA PRIMERS	NATURE			English	Article							HYBRIDIZATION PROBES; DUPLEX STABILITY; OLIGONUCLEOTIDES; DEOXYINOSINE; BASE; ANALOGS	A NON-DISCRIMINATORY base analogue, or universal base, would be an invaluable component of oligonucleotide probes and primers for solving the design problems that arise as a result of the degeneracy of the genetic code, or when only fragmentary peptide sequence data are available. We have designed an alternative to previous universal nucleoside candidates(1-9), a new analogue, 1-(2'-deoxy-beta-D-ribofuranosyl)-3-nitropyrrole (designated M; Fig. 1), which maximizes stacking while minimizing hydrogen-bonding interactions without sterically disrupting a DNA duplex. Oligonucleotides containing M at several sites were used as primers for sequencing and the polymerase chain reaction. The sequencing primer d(5'-CGT AAM CAM AAM ACM AT-3') is as effective as the exact match d(5'-CGT AAT CAG AAA ACA AT-3'). It is also possible to sequence using a primer containing M at several contiguous positions, for example d(5'-CGT AAT MMM MMM MMM AT-3'). Melting curves show that duplexes formed on hybridization of the sequences d(5';CCT TTT TMT TTT TGG-3') and d(5'-CCA AAA AXA AAA AGG-3'), where X is A, C, G or T, melted at a lower temperature than the corresponding duplexes containing only d(A.T) and d(C.G) base pairs, but showing little variation among different X bases (T-m range 3 degrees C).	UNIV MICHIGAN,DEPT BIOL CHEM,ANN ARBOR,MI 48109; UNIV MICHIGAN,DEPT BIOL,ANN ARBOR,MI 48109; PURDUE UNIV,DEPT MED CHEM & PHARMACOGNOSY,W LAFAYETTE,IN 47907; WALTHER CANC INST,INDIANAPOLIS,IN 46208	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Walther Cancer Institute				Andrews, Philip/0000-0001-6843-5420				BROWN DM, 1991, CARBOHYD RES, V216, P129; ERITJA R, 1986, NUCLEIC ACIDS RES, V14, P8135, DOI 10.1093/nar/14.20.8135; FRANCOIS P, 1990, TETRAHEDRON LETT, V31, P6347, DOI 10.1016/S0040-4039(00)97060-6; FUKUDA T, 1986, Z NATURFORSCH B, V41, P1571, DOI 10.1515/znb-1986-1217; GABBAY EJ, 1977, BIOORG CHEM, V3, P33; HABENER JF, 1988, P NATL ACAD SCI USA, V85, P1735, DOI 10.1073/pnas.85.6.1735; INONE H, 1985, NUCLEIC ACIDS RES, V13, P7119; KAWASE Y, 1986, NUCLEIC ACIDS RES, V14, P7727, DOI 10.1093/nar/14.19.7727; LIN PKT, 1989, NUCLEIC ACIDS RES, V17, P10373, DOI 10.1093/nar/17.24.10373; MARTIN FH, 1985, NUCLEIC ACIDS RES, V13, P8927, DOI 10.1093/nar/13.24.8927; MILLICAN TA, 1984, NUCLEIC ACIDS RES, V12, P7435, DOI 10.1093/nar/12.19.7435; NICHOLS R, 1988, J BIOL CHEM, V263, P12167; OHTSUKA E, 1985, J BIOL CHEM, V260, P2605; SEELA F, 1986, NUCLEIC ACIDS RES, V14, P1825, DOI 10.1093/nar/14.4.1825	14	102	178	1	11	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 9	1994	369	6480					492	493		10.1038/369492a0	http://dx.doi.org/10.1038/369492a0			2	Multidisciplinary Sciences	Index Chemicus (IC); Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ286	8202140	Green Published			2022-12-28	WOS:A1994NQ28600059
J	KELLER, D; KOSTER, FT; MARKS, DH; HOSBACH, P; ERDILE, LF; MAYS, JP				KELLER, D; KOSTER, FT; MARKS, DH; HOSBACH, P; ERDILE, LF; MAYS, JP			SAFETY AND IMMUNOGENICITY OF A RECOMBINANT OUTER SURFACE PROTEIN-A LYME VACCINE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BORRELIA-BURGDORFERI; DISEASE SPIROCHETE; EXPERIMENTAL-INFECTION; PASSIVE-IMMUNIZATION; ANTIBODY-RESPONSE; OSPA; MICE; HAMSTERS; REACTIVITY; DIAGNOSIS	Objective.-To evaluate the safety and immunogenicity of a recombinant outer surface lipoprotein A (OspA) Lyme vaccine in healthy adults. Design.-Randomized, double-blind, placebo-controlled trial. Setting.-Clinical research unit of a medical center. Participants.-Thirty-six healthy adult volunteers aged 18 through 65 years. Interventions.-volunteers were randomly assigned to receive two 10-mu g doses of OspA Lyme vaccine, OspA Lyme vaccine adsorbed to alum, or a buffer placebo. Subjects in the OspA Lyme vaccine group received a third dose. Patients were assessed after each vaccination for a total follow-up period of 1 year. Serum samples for antibody determination were drawn at baseline, 2 and 3 weeks after dose 1, once per week for 4 weeks after dose 2, 20 weeks after dose 2, and 1 month after dose 3. Main Outcome Measures.-Local and systemic adverse reactions and antibody levels specific for OspA. Results.-The most common reactions were local pain and tenderness at the injection site. Adverse events did not increase following the second or third dose. Two doses of both vaccine formulations elicited high-titer antibodies that inhibited replication of Borrelia burgdorferi in vitro. No differences were noted in antibody levels elicited by the adsorbed and nonadsorbed formulations. Conclusion.-Two or three doses of OspA Lyme vaccine are safe and immunogenic in adults.	CONNAUGHT LABS INC,SWIFTWATER,PA 18370; UNIV NEW MEXICO,SCH MED,DEPT MED,ALBUQUERQUE,NM 87131	University of New Mexico								ABERER E, 1989, ANN NEUROL, V26, P732, DOI 10.1002/ana.410260608; BARBOUR A G, 1988, Clinical Microbiology Reviews, V1, P399; BARBOUR AG, 1984, YALE J BIOL MED, V57, P521; BARBOUR AG, 1989, ANN INTERN MED, V110, P501, DOI 10.7326/0003-4819-110-7-501; BARBOUR AG, 1993, SCIENCE, V260, P1610, DOI 10.1126/science.8503006; BERGSTROM S, 1989, MOL MICROBIOL, V3, P479, DOI 10.1111/j.1365-2958.1989.tb00194.x; BESSLER WG, 1985, IMMUNOBIOLOGY, V170, P239, DOI 10.1016/S0171-2985(85)80095-4; BRANDT ME, 1990, INFECT IMMUN, V58, P983, DOI 10.1128/IAI.58.4.983-991.1990; CALLISTER SM, 1993, J INFECT DIS, V167, P158, DOI 10.1093/infdis/167.1.158; COLEMAN JL, 1987, J INFECT DIS, V155, P756, DOI 10.1093/infdis/155.4.756; COOKE W D, 1990, Current Opinion in Rheumatology, V2, P622; CRAFT JE, 1986, J CLIN INVEST, V78, P934, DOI 10.1172/JCI112683; DEFOORT JP, 1992, P NATL ACAD SCI USA, V89, P3879, DOI 10.1073/pnas.89.9.3879; DERES K, 1989, NATURE, V342, P561, DOI 10.1038/342561a0; DRESSLER F, 1993, J INFECT DIS, V167, P392, DOI 10.1093/infdis/167.2.392; DUFFY J, 1990, ANN ALLERGY, V65, P1; ERDILE LF, 1993, INFECT IMMUN, V61, P81, DOI 10.1128/IAI.61.1.81-90.1993; FEDER HM, 1993, PEDIATRICS, V91, P456; FIKRIG E, 1990, SCIENCE, V250, P553, DOI 10.1126/science.2237407; GERN L, 1993, J INFECT DIS, V167, P971, DOI 10.1093/infdis/167.4.971; JOHNSON RC, 1986, INFECT IMMUN, V54, P897, DOI 10.1128/IAI.54.3.897-898.1986; JOHNSON RC, 1986, INFECT IMMUN, V53, P713, DOI 10.1128/IAI.53.3.713-714.1986; KALISH RA, 1993, INFECT IMMUN, V61, P2774, DOI 10.1128/IAI.61.7.2774-2779.1993; ROEHRIG JT, 1992, J IMMUNOL, V149, P3648; SADZIENE A, 1993, J INFECT DIS, V167, P165, DOI 10.1093/infdis/167.1.165; SCHAIBLE UE, 1990, P NATL ACAD SCI USA, V87, P3768, DOI 10.1073/pnas.87.10.3768; SCHMITZ JL, 1990, INFECT IMMUN, V58, P144, DOI 10.1128/IAI.58.1.144-148.1990; SIGAL LH, 1993, J INFECT DIS, V167, P1372, DOI 10.1093/infdis/167.6.1372; SIMON MM, 1991, J INFECT DIS, V164, P123, DOI 10.1093/infdis/164.1.123; STEERE AC, 1990, J INFECT DIS, V161, P1203, DOI 10.1093/infdis/161.6.1203; 1993, MMWR MORB MORTAL WKL, V42, P345	31	84	90	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	1994	271	22					1764	1768		10.1001/jama.271.22.1764	http://dx.doi.org/10.1001/jama.271.22.1764			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN725	8196120				2022-12-28	WOS:A1994NN72500026
J	DIETRICH, RA; DELANEY, TP; UKNES, SJ; WARD, ER; RYALS, JA; DANGL, JL				DIETRICH, RA; DELANEY, TP; UKNES, SJ; WARD, ER; RYALS, JA; DANGL, JL			ARABIDOPSIS MUTANTS SIMULATING DISEASE RESISTANCE RESPONSE	CELL			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; ERYSIPHE-GRAMINIS-HORDEI; DOWNY MILDEW FUNGUS; CELL-DEATH; SALICYLIC-ACID; PLANT-DISEASE; GENE; INFECTION; BARLEY; IDENTIFICATION	We describe six Arabidopsis mutants, defining at least four loci, that spontaneously form necrotic lesions on leaves. Lesions resemble those resulting from disease, but occur in the absence of pathogen. In five mutants, lesion formation correlates with expression of histochemical and molecular markers of plant disease resistance responses and with expression of genes activated during development of broad disease resistance in plants (systemic acquired resistance [SAR]). We designate this novel mutant class Isd (for lesions simulating disease resistance response). Strikingly, four Isd mutants express substantial resistance to virulent fungal pathogen isolates. Isd mutants vary in cell type preferences for lesion onset and spread. Lesion formation can be conditional and can be induced specifically by biotic and chemical activators of SAR in Isd1 mutants.	CIBA GEIGY CORP, AGR BIOTECHNOL RES UNIT, RES TRIANGLE PK, NC 27709 USA		DIETRICH, RA (corresponding author), MAX DELBRUCK LAB, CARL VON LINNE WEG 10, D-50829 COLOGNE, GERMANY.		Delaney, Terrence P/A-2947-2008					AIST JR, 1977, PHYTOPATHOLOGY, V67, P455, DOI 10.1094/Phyto-67-455; ALEXANDER D, 1993, P NATL ACAD SCI USA, V90, P7327, DOI 10.1073/pnas.90.15.7327; BECKER F, 1993, PLANT J, V3, P875, DOI 10.1111/j.1365-313X.1993.00875.x; BISSONNETTE RP, 1992, NATURE, V359, P552, DOI 10.1038/359552a0; BROGLIE K, 1991, SCIENCE, V254, P1194, DOI 10.1126/science.254.5035.1194; BRUZZESE E, 1983, PLANT PATHOL, V32, P335, DOI 10.1111/j.1365-3059.1983.tb02841.x; CRUTE IR, 1993, CURR PLANT SCI BIOT, V14, P437; CRUTE IR, 1985, MECHANISMS RESISTANC, P80; Dangl J. L., 1992, Methods in Arabidopsis research., P393; DANGL JL, 1992, PLANT CELL, V4, P1359, DOI 10.1105/tpc.4.11.1359; DANGL JL, 1992, PLANT J, V2, P3, DOI 10.1111/j.1365-313X.1992.00003.x; Dangl JL, 1993, ADV PLANT PATHOL, V10, P127; DEBENER T, 1991, PLANT J, V1, P289, DOI 10.1046/j.1365-313X.1991.t01-7-00999.x; DELONG A, 1993, CELL, V74, P757, DOI 10.1016/0092-8674(93)90522-R; DIXON RA, 1990, ANNU REV PLANT PHYS, V41, P339, DOI 10.1146/annurev.pp.41.060190.002011; DONG XN, 1991, PLANT CELL, V3, P61, DOI 10.1105/tpc.3.1.61; Emerson RA, 1923, CORNELL U AGR EXP ST, V70, P3; ESCHRICH W., 1964, STAIN TECHNOL, V39, P303; FELDMANN KA, 1991, PLANT J, V1, P71, DOI 10.1111/j.1365-313X.1991.00071.x; GABRIEL DW, 1990, ANNU REV PHYTOPATHOL, V28, P365, DOI 10.1146/annurev.py.28.090190.002053; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; GORG R, 1993, PLANT J, V3, P857, DOI 10.1111/j.1365-313X.1993.00857.x; GREENBERG JT, 1993, PLANT J, V4, P327, DOI 10.1046/j.1365-313X.1993.04020327.x; HAHLBROCK K, 1989, ANNU REV PLANT PHYS, V40, P347, DOI 10.1146/annurev.pp.40.060189.002023; HAHLBROCK K, 1987, INNOVATIVE APPROACHE, P229; HENGARTNER MO, 1992, NATURE, V356, P494, DOI 10.1038/356494a0; JOHAL GS, 1992, SCIENCE, V258, P985, DOI 10.1126/science.1359642; Keen N. T., 1982, Advances in plant pathology Vol.1., P35; KEEN NT, 1988, ANNU REV MICROBIOL, V42, P421, DOI 10.1146/annurev.mi.42.100188.002225; KEEN NT, 1990, ANNU REV GENET, V24, P447, DOI 10.1146/annurev.ge.24.120190.002311; KEOGH RC, 1980, T BRIT MYCOL SOC, V74, P329, DOI 10.1016/S0007-1536(80)80163-X; KIRALY Z, 1972, NATURE, V239, P456, DOI 10.1038/239456a0; KIYOSAWA S., 1970, Bull. natn. Inst. agric. Sci., Tokyo, V21, P61; KOCH E, 1990, PLANT CELL, V2, P437, DOI 10.1105/tpc.2.5.437; KOGA H, 1988, PHYSIOL MOL PLANT P, V32, P395, DOI 10.1016/S0885-5765(88)80033-X; KOGA H, 1980, CAN J BOT, V58, P536, DOI 10.1139/b80-065; Kosuge T., 1983, GENETIC ENG PLANTS A, P431, DOI [10.1007/978-1-4684-4544-2_29, DOI 10.1007/978-1-4684-4544-2_29, DOI 10.1007/978-1-4684-4544-2_]; KUC J, 1982, BIOSCIENCE, V32, P854, DOI 10.2307/1309008; Lacy G. H., 1982, PHYTOPATHOGENIC PROK, V2, P149; LAMB CJ, 1989, CELL, V56, P215, DOI 10.1016/0092-8674(89)90894-5; LANGFORD AN, 1948, CAN J RES C, V26, P35, DOI 10.1139/cjr48c-006; MALAMY J, 1990, SCIENCE, V250, P1002, DOI 10.1126/science.250.4983.1002; MARCHETTI MA, 1983, PHYTOPATHOLOGY, V73, P603, DOI 10.1094/Phyto-73-603; MAUCH F, 1988, PLANT PHYSIOL, V88, P936, DOI 10.1104/pp.88.3.936; MAYAMA S, 1978, PHYSIOL PLANT PATHOL, V13, P347, DOI 10.1016/0048-4059(78)90051-6; Metraux J. P., 1991, Advances in molecular genetics of plant-microbe interactions. Vol. 1. Proceedings of the 5th international symposium on the molecular genetics of plant-microbe interactions, Interlaken, Switzerland, September 9-14, 1990., P432; METRAUX JP, 1990, SCIENCE, V250, P1004, DOI 10.1126/science.250.4983.1004; NEUFFER MG, 1975, J HERED, V66, P265, DOI 10.1093/oxfordjournals.jhered.a108627; NEUFFER MG, 1984, GENE STRUCTURE FUNCT, P123; PARKER JE, 1993, PLANT J, V4, P821, DOI 10.1046/j.1365-313X.1993.04050821.x; PRYOR T, 1987, TRENDS GENET, V3, P157, DOI 10.1016/0168-9525(87)90217-4; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RAFF MC, 1993, SCIENCE, V262, P695, DOI 10.1126/science.8235590; ROSS AF, 1961, VIROLOGY, V14, P340, DOI 10.1016/0042-6822(61)90319-1; RYALS J, 1994, IN PRESS PLANT PHYSL; STAKMAN EC, 1914, U MINN AGR EXP STA B, V138, P1; STANGHEL.ME, 1966, PHYTOPATHOLOGY, V56, P444; UKNES S, 1992, PLANT CELL, V4, P645, DOI 10.1105/tpc.4.6.645; UKNES S, 1993, MOL PLANT MICROBE IN, V6, P692, DOI 10.1094/MPMI-6-692; UKNES S, 1993, MOL BIOL SYSTEMIC AC, P1; ULLSTRUP AJ, 1967, PHYTOPATHOLOGY, V57, P1282; VERWOERD TC, 1989, NUCLEIC ACIDS RES, V17, P2362, DOI 10.1093/nar/17.6.2362; WARD ER, 1991, PLANT CELL, V3, P1085, DOI 10.1105/tpc.3.10.1085; WERNSMAN EA, 1987, PRINCIPLES CULTIVAR, P669; WHALEN MC, 1991, PLANT CELL, V3, P49, DOI 10.1105/tpc.3.1.49; WHITE RF, 1979, VIROLOGY, V99, P410, DOI 10.1016/0042-6822(79)90019-9; WILLIAMS GT, 1993, CELL, V74, P777, DOI 10.1016/0092-8674(93)90457-2; WOLTER M, 1993, MOL GEN GENET, V239, P122, DOI 10.1007/BF00281610; WOODS AM, 1988, PHYSIOL MOL PLANT P, V32, P483, DOI 10.1016/S0885-5765(88)80040-7; Yalpani Nasser, 1993, Trends in Microbiology, V1, P88, DOI 10.1016/0966-842X(93)90113-6	70	583	638	3	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 20	1994	77	4					565	577		10.1016/0092-8674(94)90218-6	http://dx.doi.org/10.1016/0092-8674(94)90218-6			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NM832	8187176				2022-12-28	WOS:A1994NM83200011
J	SOLLNERWEBB, B				SOLLNERWEBB, B			NOVEL INTRON-ENCODED SMALL NUCLEOLAR RNAS	CELL			English	Review							PRECURSOR RNA; SEQUENCES; GENE; U3				SOLLNERWEBB, B (corresponding author), JOHNS HOPKINS UNIV HOSP,DEPT BIOL CHEM,BALTIMORE,MD 21205, USA.							Baserga S., 1993, RNA WORLD, P359; BOURBON HM, 1990, GENE, V88, P187, DOI 10.1016/0378-1119(90)90031-L; CAFFARELLI E, 1987, EMBO J, V6, P3493, DOI 10.1002/j.1460-2075.1987.tb02674.x; FILIPOWICZ W, 1993, IN PRESS MOL BIOL RE; FOURNIER MJ, 1993, TRENDS BIOCHEM SCI, V18, P131, DOI 10.1016/0968-0004(93)90020-N; FRAGAPANE P, 1993, EMBO J, V12, P2921, DOI 10.1002/j.1460-2075.1993.tb05954.x; GONTAREK RR, 1993, IN PRESS GENES DEV; KASS S, 1990, CELL, V60, P897, DOI 10.1016/0092-8674(90)90338-F; KISS T, 1993, EMBO J, V12, P2913, DOI 10.1002/j.1460-2075.1993.tb05953.x; LEVERETTE RD, 1992, CELL, V71, P1215, DOI 10.1016/S0092-8674(05)80069-8; LI HV, 1990, MOL CELL BIOL, V10, P1145, DOI 10.1128/MCB.10.3.1145; LIU J, 1990, NUCLEIC ACIDS RES, V18, P6565, DOI 10.1093/nar/18.22.6565; PECULIS BA, 1993, CELL, V73, P1233, DOI 10.1016/0092-8674(93)90651-6; PRISLEI S, 1992, NUCLEIC ACIDS RES, V20, P4473, DOI 10.1093/nar/20.17.4473; REDDY R, 1981, J BIOL CHEM, V256, P8452; RIMOLDI OJ, 1993, MOL CELL BIOL, V13, P4382, DOI 10.1128/MCB.13.7.4382; RUFF EA, 1993, P NATL ACAD SCI USA, V90, P635, DOI 10.1073/pnas.90.2.635; SADOWSKI CL, 1993, GENE DEV, V7, P1535, DOI 10.1101/gad.7.8.1535; SERAPHIN B, 1993, IN PRESS TRENDS BIOC; TYC K, 1989, EMBO J, V8, P3113, DOI 10.1002/j.1460-2075.1989.tb08463.x; TYCOWSKI KT, 1993, GENE DEV, V7, P1176, DOI 10.1101/gad.7.7a.1176; YOUNG RA, 1978, P NATL ACAD SCI USA, V75, P3593, DOI 10.1073/pnas.75.8.3593	22	89	90	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 5	1993	75	3					403	405		10.1016/0092-8674(93)90374-Y	http://dx.doi.org/10.1016/0092-8674(93)90374-Y			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MF830	8221882				2022-12-28	WOS:A1993MF83000002
J	CARMICHAEL, JK				CARMICHAEL, JK			HIV LESSONS	ANNALS OF INTERNAL MEDICINE			English	Editorial Material											CARMICHAEL, JK (corresponding author), UNIV ARIZONA, COLL MED, DEPT INTERNAL MED, INFECT DIS SECT, 1501 N CAMPBELL AVE, TUCSON, AZ 85719 USA.								0	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	1993	119	9					944	944		10.7326/0003-4819-119-9-199311010-00013	http://dx.doi.org/10.7326/0003-4819-119-9-199311010-00013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MD711	8215006				2022-12-28	WOS:A1993MD71100012
J	ROBINSON, R				ROBINSON, R			ECONOMIC-EVALUATION AND HEALTH-CARE - COST-EFFECTIVENESS ANALYSIS	BRITISH MEDICAL JOURNAL			English	Article							PREVENTION; DISEASE	When different health care interventions are not expected to produce the same outcomes both the costs and the consequences of the options need to be assessed. This can be done by cost-effectiveness analysis, whereby the costs are compared with outcomes measured in natural units-for example, per life saved, per life year gained, and per pain or symptom free day. Many cost-effective analyses rely on existing published studies for effectiveness data as it is often too costly or time consuming to collect data on cost and effectiveness during a clinical trial. Where there is uncertainty about the costs and effectiveness of procedures sensitivity analysis can be used, which examines the sensitivity of the results to alternative assumptions about key variables. In this article Ray Robinson describes these methods of analysis and discusses possibilities for how the benefits of alternative interventions should be valued.			ROBINSON, R (corresponding author), UNIV SOUTHAMPTON,INST HLTH POLICY STUDIES,SOUTHAMPTON SO9 5NH,HANTS,ENGLAND.							BOYLE MH, 1983, NEW ENGL J MED, V308, P1330, DOI 10.1056/NEJM198306023082206; BRIGGS A, 1993, JAN JOINT M HLTH EC; Cairns J, 1992, Health Econ, V1, P76, DOI 10.1002/hec.4730010111; CHURCHILL DN, 1984, MED DECIS MAKING, V4, P489, DOI 10.1177/0272989X8400400411; CULYER AJ, 1981, SOC SCI MED-MED ECON, V15, P3, DOI 10.1016/0160-7995(81)90003-4; CULYER AJ, 1982, RESOURCES HLTH TECHN; Drummond MF, 1987, METHOD EC EVALUATION; HULL R, 1981, NEW ENGL J MED, V304, P1561, DOI 10.1056/NEJM198106253042602; LUDBROOK A, 1981, APPL ECON, V13, P337, DOI 10.1080/00036848100000004; MAGID D, 1992, NEW ENGL J MED, V327, P534, DOI 10.1056/NEJM199208203270806; MANDELBLATT JS, 1988, JAMA-J AM MED ASSOC, V259, P2409, DOI 10.1001/jama.259.16.2409; OSTER G, 1987, JAMA-J AM MED ASSOC, V258, P2381, DOI 10.1001/jama.258.17.2381; Parsonage M, 1992, Health Econ, V1, P71, DOI 10.1002/hec.4730010110; Percival S P, 1992, Qual Health Care, V1, P38, DOI 10.1136/qshc.1.1.38; SCULPHER MJ, 1993, BRIT J OBSTET GYNAEC, V100, P244, DOI 10.1111/j.1471-0528.1993.tb15238.x; SINTONEN H, 1990, J HEALTH ECON, V9, P85, DOI 10.1016/0167-6296(90)90042-2; SUDRE P, 1992, INT J EPIDEMIOL, V21, P146, DOI 10.1093/ije/21.1.146; UDVARHELYI IS, 1992, ANN INTERN MED, V116, P238, DOI 10.7326/0003-4819-116-3-238	18	125	132	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 25	1993	307	6907					793	795		10.1136/bmj.307.6907.793	http://dx.doi.org/10.1136/bmj.307.6907.793			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	LZ478	8219957	Green Published, Bronze			2022-12-28	WOS:A1993LZ47800036
J	NIGHTINGALE, SD; CAMERON, DW; GORDIN, FM; SULLAM, PM; COHN, DL; CHAISSON, RE; ERON, LJ; SPARTI, PD; BIHARI, B; KAUFMAN, DL; STERN, JJ; PEARCE, DD; WEINBERG, WG; LAMARCA, A; SIEGAL, FP				NIGHTINGALE, SD; CAMERON, DW; GORDIN, FM; SULLAM, PM; COHN, DL; CHAISSON, RE; ERON, LJ; SPARTI, PD; BIHARI, B; KAUFMAN, DL; STERN, JJ; PEARCE, DD; WEINBERG, WG; LAMARCA, A; SIEGAL, FP			2 CONTROLLED TRIALS OF RIFABUTIN PROPHYLAXIS AGAINST MYCOBACTERIUM-AVIUM COMPLEX INFECTION IN AIDS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; ANSAMYCIN; RIFAMPIN; CIPROFLOXACIN; BACTEREMIA; ETHAMBUTOL	Background. Disseminated Mycobacterium avium complex infection eventually develops in most patients with the acquired immunodeficiency syndrome (AIDS). This infection results in substantial morbidity and reduces survival by about six months. Methods. We conducted two randomized, double-blind, multicenter trials of daily prophylactic treatment with either rifabutin (300 mg) or placebo. All the patients had AIDS and CD4 cell counts less-than-or-equal-to 200 per cubic millimeter. The primary end point was M. avium complex bacteremia as assessed monthly by blood culture. The secondary end points were signs and symptoms associated with disseminated M. avium complex infection, adverse events, hospitalization, and survival. Results. In the first trial, M. avium complex bacteremia developed in 51 of 298 patients (17 percent) assigned to placebo and 24 of 292 patients (8 percent) assigned to rifabutin (P<0.001). In the second trial, bacteremia developed in 51 of 282 patients in the placebo group (18 percent) and 24 of 274 patients in the rifabutin group (9 percent) (P = 0.002). Rifabutin significantly delayed fatigue, fever, decline in the Karnofsky performance score (by greater-than-or-equal-to 20 percent), decline in the hemoglobin level (by more than 10 percent), elevation in alkaline phosphatase, and hospitalization. The incidence of adverse events was similar with rifabutin and placebo. Overall survival did not differ significantly between the two groups, although there were fewer deaths with rifabutin (33) than with placebo (47) during the double-blind phase (P = 0.086). The distribution of minimal inhibitory concentrations of rifabutin among the isolates of M. avium complex did not differ significantly between the treatment groups. Conclusions. Rifabutin, given prophylactically, reduces the frequency of disseminated M. avium complex infection in patients with AIDS and CD4 counts less-than-or-equal-to 200 per cubic millimeter.	VET AFFAIRS MED CTR,50 IRVING ST NW,WASHINGTON,DC 20422; VET AFFAIRS MED CTR,SAN FRANCISCO,CA; UNIV TEXAS,SW MED CTR,DALLAS,TX 75230; OTTAWA GEN HOSP,OTTAWA K1H 8L6,ONTARIO,CANADA; PUBL HLTH ADM & DIS CONTROL,DENVER,CO; JOHNS HOPKINS UNIV,SCH MED,BALTIMORE,MD 21205; COMMUNITY RES INITIAT S FLORIDA,MIAMI,FL; COMMUNITY RES INITIAT NEW YORK,NEW YORK,NY; PENN HOSP,PHILADELPHIA,PA 19107; SAN DIEGO COMMUNITY RES GRP,SAN DIEGO,CA; THERAFIRST MED CTR,FT LAUDERDALE,FL; LONG ISL JEWISH MED CTR,NEW HYDE PK,NY	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Ottawa; Ottawa Hospital Research Institute; Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine; Northwell Health				Cameron, Bill/0000-0002-0090-3539				BORCHERDING SM, 1992, ARCH INTERN MED, V152, P711, DOI 10.1001/archinte.152.4.711; CHAISSON RE, 1992, 8TH INT C AIDS AMST, V1; CHIU J, 1990, ANN INTERN MED, V113, P358, DOI 10.7326/0003-4819-113-5-358; ELLNER JJ, 1991, J INFECT DIS, V163, P1326, DOI 10.1093/infdis/163.6.1326; FRIEDEN TR, 1993, NEW ENGL J MED, V328, P521, DOI 10.1056/NEJM199302253280801; FURNEY SK, 1990, ANTIMICROB AGENTS CH, V34, P1629, DOI 10.1128/AAC.34.9.1629; HAVLIK JA, 1992, J INFECT DIS, V165, P577, DOI 10.1093/infdis/165.3.577; HEIFETS LB, 1985, AM REV RESPIR DIS, V132, P710; HEIFETS LB, 1985, ANTIMICROB AGENTS CH, V28, P570, DOI 10.1128/AAC.28.4.570; Heifets LB., 1991, DRUG SUSCEPTIBILITY; HORSBURGH CR, 1991, AM REV RESPIR DIS, V144, P557, DOI 10.1164/ajrccm/144.3_Pt_1.557; HORSBURGH CR, 1989, AM REV RESPIR DIS, V139, P4, DOI 10.1164/ajrccm/139.1.4; HORSBURGH CR, 1991, NEW ENGL J MED, V324, P1332, DOI 10.1056/NEJM199105093241906; JACOBSON MA, 1991, J INFECT DIS, V164, P994, DOI 10.1093/infdis/164.5.994; KEMPER CA, 1992, ANN INTERN MED, V116, P466, DOI 10.7326/0003-4819-116-6-466; KLEMENS SP, 1991, ANTIMICROB AGENTS CH, V35, P2026, DOI 10.1128/AAC.35.10.2026; MASUR H, 1982, JAMA-J AM MED ASSOC, V248, P3013, DOI 10.1001/jama.248.22.3013; NARANG P, 1992, 8TH INT C AIDS AMST, V2; NIGHTINGALE SD, 1992, J INFECT DIS, V165, P1082, DOI 10.1093/infdis/165.6.1082; OBRIEN RJ, 1987, REV INFECT DIS, V9, P519; OBRIEN RJ, 1990, AM REV RESPIR DIS, V141, P81; PERUCCA E, 1988, EUR J CLIN PHARMACOL, V34, P595, DOI 10.1007/BF00615223; SALFINGER M, 1988, J CLIN MICROBIOL, V26, P1225, DOI 10.1128/JCM.26.6.1225-1226.1988; SIEGAL FP, 1990, 6TH INT C AIDS SAN F, V1; YOUNG LS, 1991, LANCET, V338, P1107, DOI 10.1016/0140-6736(91)91965-W; YOUNG LS, 1988, J INFECT DIS, V157, P863, DOI 10.1093/infdis/157.5.863; 1987, MMWR MORB MORTAL WKL, V36, pS1	27	364	367	0	3	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 16	1993	329	12					828	833		10.1056/NEJM199309163291202	http://dx.doi.org/10.1056/NEJM199309163291202			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LW551	8179648				2022-12-28	WOS:A1993LW55100002
J	JONES, L				JONES, L			LETTER FROM KOSOVO - COPING WITH SERBIAN REPRESSION IN AN ALBANIAN POPULATION	BRITISH MEDICAL JOURNAL			English	Article																		MEKULI D, 1992, KOSOVA WATCH, V1, P25; MEKULI D, 1992, KOSOVA WATCH, V1, P1; RALIC P, 1992, MINORITY RIGHTS SERB, P33; RALIC P, 1992, MINORITY RIGHTS SERB, P58; 1992, URGENT ACTION APPEAL; 1992, YUGOSLAVIA HUMAN RIG, P5; 1992, YUGOSLAVIA HUMAN RIG, P58	7	5	5	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUL 10	1993	307	6896					112	114		10.1136/bmj.307.6896.112	http://dx.doi.org/10.1136/bmj.307.6896.112			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LM585	8199537	Bronze, Green Published			2022-12-28	WOS:A1993LM58500031
J	BROOK, JH; GENESE, CA; BLOLAND, PB; ZUCKER, JR; SPITALNY, KC				BROOK, JH; GENESE, CA; BLOLAND, PB; ZUCKER, JR; SPITALNY, KC			BRIEF REPORT - MALARIA PROBABLY LOCALLY ACQUIRED IN NEW-JERSEY	NEW ENGLAND JOURNAL OF MEDICINE			English	Note									CTR DIS CONTROL & PREVENT,DIV PARASIT DIS,MALARIA BRANCH,ATLANTA,GA 30341	Centers for Disease Control & Prevention - USA	BROOK, JH (corresponding author), NEW JERSEY DEPT HLTH,ENVIRONM & OCCUPAT HLTH SERV,DIV EPIDEMIOL,CN-369,TRENTON,NJ 08625, USA.							LEDERBERG J, 1992, EMERGING INFECTIONS, P78; MALDONADO YA, 1990, AM J TROP MED HYG, V42, P3, DOI 10.4269/ajtmh.1990.42.3; MALDONADO YA, 1990, AM J TROP MED HYG, V43, P440, DOI 10.4269/ajtmh.1990.43.440; 1991, MMWR-MORBID MORTAL W, V40, P106; 1991, 1990 CENSUS POPULATI; 1982, 1980 CENSUS POPULATI; 1990, MMWR-MORBID MORTAL W, V39, P91	7	33	33	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	1994	331	1					22	23		10.1056/NEJM199407073310105	http://dx.doi.org/10.1056/NEJM199407073310105			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NU951	8202097				2022-12-28	WOS:A1994NU95100005
J	DUPONT, WD; PAGE, DL; PARL, FF; VNENCAKJONES, CL; PLUMMER, WD; RADOS, MS; SCHUYLER, PA				DUPONT, WD; PAGE, DL; PARL, FF; VNENCAKJONES, CL; PLUMMER, WD; RADOS, MS; SCHUYLER, PA			LONG-TERM RISK OF BREAST-CANCER IN WOMEN WITH FIBROADENOMA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ATYPICAL HYPERPLASIA; DISEASE; DIAGNOSIS; COHORT	Background. Fibroadenomas are benign breast tumors that are commonly diagnosed in young women and are associated with a slight increase in the risk of breast cancer. These lesions vary considerably in their histologic characteristics. We assessed the correlation between the histologic features of fibroadenomas and the risk of subsequent breast cancer. Methods. We conducted a retrospective cohort study of a consecutive series of patients with fibroadenoma diagnosed between 1950 and 1968. Follow-up data were obtained for 1835 patients (90 percent of those eligible). Fibroadenomas with cysts, sclerosing adenosis, epithelial calcifications, or papillary apocrine changes were classified as complex. The rate of subsequent breast cancer among the patients was compared with the rates in two control groups, women listed in the Connecticut Tumor Registry and women chosen from among the patients' sisters-in-law. Results. The risk of invasive breast cancer was 2.17 times higher among the patients with fibroadenoma than among the controls (95 percent confidence interval, 1.5 to 3.2). The relative risk increased to 3.10 among patients with complex fibroadenomas (95 percent confidence interval, 1.9 to 5.1) and remained elevated for decades after diagnosis. Patients with benign proliferative disease in the parenchyma adjacent to the fibroadenoma had a relative risk of 3.88 (95 percent confidence interval, 2.1 to 7.3). Patients with a family history of breast cancer in whom complex fibroadenoma was diagnosed had a relative risk of 3.72, as compared with controls with a family history (95 percent confidence interval, 1.4 to 10). Two thirds of the patients had noncomplex fibroadenomas and no family history of breast cancer and did not have an increased risk. Conclusions. Fibroadenoma is a long-term risk factor for breast cancer. The risk is increased in women with complex fibroadenomas, proliferative disease, or a family history of breast cancer.	VANDERBILT UNIV,SCH MED,DEPT PATHOL,NASHVILLE,TN 37212	Vanderbilt University	DUPONT, WD (corresponding author), VANDERBILT UNIV,SCH MED,DEPT PREVENT MED,A-1124 MED CTR N,NASHVILLE,TN 37232, USA.		Dupont, William D./I-4430-2012		NCI NIH HHS [CA-50468, CA-31698] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA050468] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BRESLOW NE, 1983, J AM STAT ASSOC, V78, P1, DOI 10.2307/2287093; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; CARTER CL, 1988, AM J EPIDEMIOL, V128, P467, DOI 10.1093/oxfordjournals.aje.a114995; DIXON WJ, 1992, BMDP STATISTICAL SOF; DUPONT WD, 1993, CANCER, V71, P1258, DOI 10.1002/1097-0142(19930215)71:4<1258::AID-CNCR2820710415>3.0.CO;2-I; DUPONT WD, 1985, NEW ENGL J MED, V312, P146, DOI 10.1056/NEJM198501173120303; DUPONT WD, 1989, HUM PATHOL, V20, P723, DOI 10.1016/0046-8177(89)90063-4; Fechner R.E., 1988, DIAGNOSTIC HISTOPATH, P72; HESTON JF, 1986, NIH862652 DEPT HLTH, V70; HUTCHINSON WB, 1980, J NATL CANCER I, V65, P13; KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI; KING MC, 1993, JAMA-J AM MED ASSOC, V269, P1975, DOI 10.1001/jama.269.15.1975; KRIEGER N, 1992, AM J EPIDEMIOL, V135, P619, DOI 10.1093/oxfordjournals.aje.a116341; LONDON SJ, 1992, JAMA-J AM MED ASSOC, V267, P941, DOI 10.1001/jama.267.7.941; LONDON SJ, 1992, JAMA-J AM MED ASSOC, V267, P1780; McCullagh P., 1989, GENERALIZED LINEAR M, DOI DOI 10.1007/978-1-4899-3242-6; MCDIVITT RW, 1992, CANCER-AM CANCER SOC, V69, P1408, DOI 10.1002/1097-0142(19920315)69:6<1408::AID-CNCR2820690617>3.0.CO;2-C; MOSKOWITZ M, 1980, RADIOLOGY, V134, P289, DOI 10.1148/radiology.134.2.7352201; Page D, 1988, DIAGNOSTIC HISTOPATH; PAGE DL, 1992, HUM PATHOL, V23, P1095, DOI 10.1016/0046-8177(92)90026-Y; PALLI D, 1991, INT J CANCER, V47, P703, DOI 10.1002/ijc.2910470513; STORER BE, 1985, J AM STAT ASSOC, V80, P139, DOI 10.2307/2288064; 1990, SAS STAT USERS GUIDE, V2	23	274	290	0	6	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	1994	331	1					10	15		10.1056/NEJM199407073310103	http://dx.doi.org/10.1056/NEJM199407073310103			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NU951	8202095				2022-12-28	WOS:A1994NU95100003
J	ROSENTHAL, N				ROSENTHAL, N			DNA AND THE GENETIC-CODE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article														Rosenthal, Nadia/0000-0002-7599-7365				Berg P., 1992, DEALING GENES LANGUA; LEWIN B, 1994, GENES, V5	2	15	15	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	1994	331	1					39	41		10.1056/NEJM199407073310109	http://dx.doi.org/10.1056/NEJM199407073310109			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NU951	8202101				2022-12-28	WOS:A1994NU95100009
J	MULLINS, RJ; VEUMSTONE, J; HELFAND, M; ZIMMERGEMBECK, M; HEDGES, JR; SOUTHARD, PA; TRUNKEY, DD				MULLINS, RJ; VEUMSTONE, J; HELFAND, M; ZIMMERGEMBECK, M; HEDGES, JR; SOUTHARD, PA; TRUNKEY, DD			OUTCOME OF HOSPITALIZED INJURED PATIENTS AFTER INSTITUTION OF A TRAUMA SYSTEM IN AN URBAN AREA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARE; MORTALITY; CENTERS; IMPACT; VOLUME; DEATH	Objective.-To determine if risk of death for hospitalized injured patients changes when an urban trauma system is implemented. Design.-An analysis of the risk of death in hospitalized injured patients in 1984 and 1985 (pretrauma system), 1986 and 1987 (early trauma system), and 1990 and 1991 (established trauma system) using hospital discharge abstract data. Setting.-A total of 18 acute care hospitals in the four-county area encompassing Portland, Ore. Patients.-A cohort of 70 350 hospitalized patients with at least one discharge diagnosis indicating injury. Main Outcome Measure.-Death during hospitalization. Results.-After the trauma system was established, 77% of patients in the region with an Injury Severity Score (ISS) of 16 or greater were admitted to level I trauma centers. More than 72% of patients with an ISS less than 16 were hospitalized in nontrauma centers. Risk of death for injured patients hospitalized at level I trauma centers declined after the trauma system was established (odds ratio, 0.65; 95% confidence interval, 0.51 to 0.81). Patients who died in trauma centers after institution of the trauma system were younger and had more severe injuries, and the majority died within 1 day of admission, whereas patients who died in nontrauma centers died a median of 5 days after admission. Conclusion.-Establishment of a trauma system shifted the more seriously injured patients to level I trauma centers, where there was a significant reduction in the adjusted death rate.	OREGON HLTH SCI UNIV,CTR BIOMED INFORMAT COMMUN,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,DEPT EMERGENCY MED,PORTLAND,OR 97201; OREGON HLTH SCI UNIV,TRAUMA PROGRAM,PORTLAND,OR 97201	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	MULLINS, RJ (corresponding author), OREGON HLTH SCI UNIV,DEPT SURG L223A,DIV GEN SURG,3181 SW SAM JACKSON PK RD,PORTLAND,OR 97201, USA.		Hedges, Jerris/AAC-1847-2021; Zimmer-Gembeck, Melanie/H-3031-2015	Zimmer-Gembeck, Melanie/0000-0001-9100-010X	PHS HHS [R49/CCR-006283] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		CALES RH, 1985, JAMA-J AM MED ASSOC, V254, P1059, DOI 10.1001/jama.254.8.1059; CHAMPION HR, 1989, J TRAUMA, V29, P623, DOI 10.1097/00005373-198905000-00017; FISHER ES, 1992, JAMA-J AM MED ASSOC, V267, P1925, DOI 10.1001/jama.267.14.1925; HANNAN EL, 1989, JAMA-J AM MED ASSOC, V262, P503, DOI 10.1001/jama.262.4.503; Hedges J R, 1994, Acad Emerg Med, V1, P218; Hosmer D., 2000, APPL LOGISTIC REGRES, V2; KANE G, 1992, J TRAUMA, V32, P576, DOI 10.1097/00005373-199205000-00007; LOWE DK, 1983, J TRAUMA, V23, P503, DOI 10.1097/00005373-198306000-00011; MACKENZIE EJ, 1989, MED CARE, V27, P412, DOI 10.1097/00005650-198904000-00008; MACKENZIE EJ, 1990, J TRAUMA, V30, P681, DOI 10.1097/00005373-199006000-00005; MORRIS JA, 1990, JAMA-J AM MED ASSOC, V263, P1942, DOI 10.1001/jama.263.14.1942; ROMANO PS, 1992, 920056 AG HLTH CAR P, P57; ROY PD, 1987, CAN J SURG, V30, P17; RUTLEDGE R, 1992, J TRAUMA, V33, P29, DOI 10.1097/00005373-199207000-00007; SHACKFORD SR, 1986, J TRAUMA, V26, P812, DOI 10.1097/00005373-198609000-00006; SMITH RF, 1990, J TRAUMA, V30, P1066, DOI 10.1097/00005373-199009000-00002; 1988, PHS801260 US DEP HLT	18	263	265	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	1994	271	24					1919	1924		10.1001/jama.271.24.1919	http://dx.doi.org/10.1001/jama.271.24.1919			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR598	8201736				2022-12-28	WOS:A1994NR59800028
J	BREIMAN, RF; BUTLER, JC; TENOVER, FC; ELLIOTT, JA; FACKLAM, RR				BREIMAN, RF; BUTLER, JC; TENOVER, FC; ELLIOTT, JA; FACKLAM, RR			EMERGENCE OF DRUG-RESISTANT PNEUMOCOCCAL INFECTIONS IN THE UNITED-STATES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DAY-CARE-CENTER; STREPTOCOCCUS-PNEUMONIAE; PENICILLIN-RESISTANT; ANTIBIOTIC-RESISTANCE; INVASIVE DISEASE; VACCINE EFFICACY; MENINGITIS; POPULATIONS; CEFTRIAXONE; FAILURE	Objective.-To estimate drug susceptibility patterns of Streptococcus pneumoniae in selected hospitals in the United States and to characterize the epidemiology of invasive drug-resistant pneumococcal infections. Design.-Minimum inhibitory concentrations (MICs) for a variety of commonly used antimicrobial drugs were determined for pneumococcal isolates submitted to the Centers for Disease Control and Prevention (CDC). Risk factors for drug-resistant pneumococcal infection were evaluated. Setting.-Hospital laboratories in the United States submitting pneumococcal isolates to the CDC between October 1, 1991, and September 30, 1992. Participants.-A total of 544 persons with pneumococci isolated from normally sterile sites. Results.-A total of 13 hospitals in 12 states actively participated in an ongoing pneumococcal surveillance study. Resistance to penicillin was detected in 6.6% of isolates, including 1.3% of isolates with MICs of 2.0 mu g/mL or more (compared with <0.02% of isolates with MIC greater than or equal to 2.0 mu g/mL identified by CDC surveillance from 1979 to 1987). A total of 16.4% were resistant to at least one of the following drugs or drug classes: penicillin, cephalosporins, macrolides, combination trimethoprim and sulfamethoxazole, and chloramphenicol. Six serotypes (6B, 23F, 14, 9V, 19A, and 19F) accounted for nearly 85% of strains resistant to at least one drug class. Children were more likely than adults to be infected with strains resistant to trimethoprim-sulfamethoxazole, erythromycin, or chloramphenicol. Conclusions.-Emergence of drug-resistant pneumococcal infections will present critical challenges to clinicians for treating patients with pneumococcal disease. Widened and intensified surveillance is needed. These data suggest that current recommendations for use of 23-valent pneumococcal capsular polysaccharide vaccines should be aggressively promoted and that development and evaluation of new conjugate pneumococcal vaccines may be a crucial part of strategies for prevention.	CTR DIS CONTROL & PREVENT,NATL CTR INFECT DIS,HOSP INFECT PROGRAM,ATLANTA,GA 30333	Centers for Disease Control & Prevention - USA	BREIMAN, RF (corresponding author), CTR DIS CONTROL & PREVENT,NATL CTR INFECT DIS,DIV BACTERIAL & MYCOT DIS,ATLANTA,GA 30333, USA.							[Anonymous], 1993, M7A3 NAT COMM CLIN L; APPELBAUM PC, 1987, EUR J CLIN MICROBIOL, V6, P367, DOI 10.1007/BF02013089; BOLAN G, 1986, ANN INTERN MED, V104, P1, DOI 10.7326/0003-4819-104-1-1; BRADLEY JS, 1991, PEDIATR INFECT DIS J, V10, P871; BREIMAN RF, 1990, ARCH INTERN MED, V150, P1401, DOI 10.1001/archinte.150.7.1401; BUTLER JC, 1993, JAMA-J AM MED ASSOC, V270, P1826, DOI 10.1001/jama.270.15.1826; COFFEY TJ, 1991, MOL MICROBIOL, V5, P2255, DOI 10.1111/j.1365-2958.1991.tb02155.x; COURVALIN P, 1986, MOL GEN GENET, V205, P291, DOI 10.1007/BF00430441; DOWSON CG, 1989, MOL MICROBIOL, V3, P95, DOI 10.1111/j.1365-2958.1989.tb00108.x; DOWSON CG, 1990, P NATL ACAD SCI USA, V87, P5858, DOI 10.1073/pnas.87.15.5858; Facklam RR, 1991, MANUAL CLIN MICROBIO, P238; FIGUEIREDO AMS, 1992, ANTIMICROB AGENTS CH, V36, P886, DOI 10.1128/AAC.36.4.886; HAKENBECK R, 1980, ANTIMICROB AGENTS CH, V17, P364, DOI 10.1128/AAC.17.3.364; HANSMAN D, 1967, LANCET, V2, P264; ISTRE GR, 1987, J INFECT DIS, V156, P732, DOI 10.1093/infdis/156.5.732; JACKSON MA, 1984, PEDIATR INFECT DIS J, V3, P129, DOI 10.1097/00006454-198403000-00010; JACOBS MR, 1978, NEW ENGL J MED, V299, P735, DOI 10.1056/NEJM197810052991402; KLUGMAN KP, 1990, CLIN MICROBIOL REV, V3, P171, DOI 10.1128/CMR.3.2.171-196.1990; LAIBLE G, 1991, MOL MICROBIOL, V5, P1993, DOI 10.1111/j.1365-2958.1991.tb00821.x; LONKS JR, 1991, 31ST INT C ANT AG CH; MCDOUGAL LK, 1992, ANTIMICROB AGENTS CH, V36, P2176, DOI 10.1128/AAC.36.10.2176; MUNOZ R, 1992, MOL MICROBIOL, V6, P2461; MUNOZ R, 1991, J INFECT DIS, V164, P302, DOI 10.1093/infdis/164.2.302; PALLARES R, 1987, NEW ENGL J MED, V317, P18, DOI 10.1056/NEJM198707023170104; PEETERS CCAM, 1991, IMMUNOL LETT, V30, P267, DOI 10.1016/0165-2478(91)90036-A; RADETSKY MS, 1981, LANCET, V2, P771; RAMIREZ J, 1992, 32ND INT C ANT AG CH; RAUCH AM, 1990, AM J DIS CHILD, V144, P923, DOI 10.1001/archpedi.1990.02150320087033; REICHLER M, 1991, 31ST INT C ANT AG CH; REICHLER MR, 1992, J INFECT DIS, V166, P1346, DOI 10.1093/infdis/166.6.1346; SIMBERKOFF MS, 1986, J INFECT DIS, V153, P78, DOI 10.1093/infdis/153.1.78; SLOAS MM, 1992, PEDIATR INFECT DIS J, V11, P662; SPIKA JS, 1991, J INFECT DIS, V163, P1273, DOI 10.1093/infdis/163.6.1273; VERSALOVIC J, 1993, J INFECT DIS, V167, P850, DOI 10.1093/infdis/167.4.850; WARD J, 1981, REV INFECT DIS, V3, P254; WEINGARTEN RD, 1990, REV INFECT DIS, V12, P118; 1990, M7A2 NAT COMM CLIN L; 1989, MMWR MORB MORTAL WKL, V38, P64; 1994, MMWR MORB MORTAL WKL, V43, P23; 1989, MMWR MORB MORTAL WKL, V38, P733	40	504	516	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	1994	271	23					1831	1835		10.1001/jama.271.23.1831	http://dx.doi.org/10.1001/jama.271.23.1831			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NP959	8196139				2022-12-28	WOS:A1994NP95900026
J	CHODAK, GW				CHODAK, GW			UROLOGY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROSTATE-SPECIFIC ANTIGEN; CANCER; RISK				CHODAK, GW (corresponding author), UNIV CHICAGO,PRITZKER SCH MED,CHICAGO,IL 60637, USA.							ADOLFSSON J, 1992, BRIT J UROL, V69, P183, DOI 10.1111/j.1464-410X.1992.tb15493.x; CARTER BS, 1993, J UROLOGY, V150, P797, DOI 10.1016/S0022-5347(17)35617-3; CHODAK GW, 1994, NEW ENGL J MED, V330, P242, DOI 10.1056/NEJM199401273300403; CRAWFORD ED, 1992, JAMA-J AM MED ASSOC, V267, P2227, DOI 10.1001/jama.267.16.2227; Fleming C, 1993, JAMA, V269, P2650; FOWLER FJ, 1993, UROLOGY, V42, P622, DOI 10.1016/0090-4295(93)90524-E; GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P1571, DOI 10.1093/jnci/85.19.1571; JOHANSSON JE, 1992, JAMA-J AM MED ASSOC, V267, P2191, DOI 10.1001/jama.267.16.2191; KRAMER BS, 1993, ANN INTERN MED, V119, P914, DOI 10.7326/0003-4819-119-9-199311010-00009; LUYAO GL, 1993, JAMA-J AM MED ASSOC, V269, P2633, DOI 10.1001/jama.269.20.2633; MACFARLANE MT, 1993, J UROLOGY, V150, P132, DOI 10.1016/S0022-5347(17)35414-9; METTLIN C, 1993, CANCER, V72, P1701, DOI 10.1002/1097-0142(19930901)72:5<1701::AID-CNCR2820720534>3.0.CO;2-E; OESTERLING JE, 1993, UROLOGY, V42, P276, DOI 10.1016/0090-4295(93)90616-I; OESTERLING JE, 1993, JAMA-J AM MED ASSOC, V270, P860, DOI 10.1001/jama.270.7.860; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Wasson J H, 1993, Arch Fam Med, V2, P487, DOI 10.1001/archfami.2.5.487	16	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1717	1718						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182870				2022-12-28	WOS:A1994NN11700049
J	HELLMAN, S; WEICHSELBAUM, RR				HELLMAN, S; WEICHSELBAUM, RR			RADIATION ONCOLOGY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							B-CELL LYMPHOMA; IONIZING-RADIATION; THERAPY; RADIOTHERAPY; EXPERIENCE; ANTIBODY; CANCER				HELLMAN, S (corresponding author), UNIV CHICAGO,PRITZKER SCH MED,CHICAGO,IL 60637, USA.							[Anonymous], 1991, NEW ENGL J MED, V324, P1685; AUSTINSEYMOUR M, 1989, J NEUROSURG, V70, P13, DOI 10.3171/jns.1989.70.1.0013; CUMMINGS BJ, 1991, INT J RADIAT ONCOL, V21, P1115, DOI 10.1016/0360-3016(91)90265-6; GILL SS, 1991, INT J RADIAT ONCOL, V20, P599, DOI 10.1016/0360-3016(91)90076-G; HAIMOVITZFRIEDMAN A, 1991, CANCER RES, V51, P2552; HORIOT JC, 1992, RADIOTHER ONCOL, V25, P231, DOI 10.1016/0167-8140(92)90242-M; KAMINSKI MS, 1993, NEW ENGL J MED, V329, P459, DOI 10.1056/NEJM199308123290703; KAUFMAN DS, 1993, NEW ENGL J MED, V329, P1377, DOI 10.1056/NEJM199311043291903; LOEFFLER JS, 1990, RADIOTHER ONCOL, V17, P311, DOI 10.1016/0167-8140(90)90005-H; PRESS OW, 1993, NEW ENGL J MED, V329, P1219, DOI 10.1056/NEJM199310213291702; SAUNDERS MI, 1991, INT J RADIAT ONCOL, V21, P871, DOI 10.1016/0360-3016(91)90722-G; SCHARFEN CO, 1992, INT J RADIAT ONCOL, V24, P583; SEDDON JM, 1990, OPHTHALMOLOGY, V97, P769; VOKES EE, 1990, J CLIN ONCOL, V8, P911, DOI 10.1200/JCO.1990.8.5.911; WEICHSELBAUM RR, 1991, J NATL CANCER I, V83, P480, DOI 10.1093/jnci/83.7.480; WEICHSELBAUM RR, 1992, INT J RADIAT ONCOL, V24, P565, DOI 10.1016/0360-3016(92)91075-X	16	5	5	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1712	1714		10.1001/jama.271.21.1712	http://dx.doi.org/10.1001/jama.271.21.1712			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182867				2022-12-28	WOS:A1994NN11700046
J	PEARSON, HA				PEARSON, HA			PEDIATRICS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFLUENZAE TYPE-B; DISEASE; DECLINE				PEARSON, HA (corresponding author), YALE UNIV, SCH MED, 333 CEDAR ST, NEW HAVEN, CT USA.							ADAMS WG, 1993, JAMA-J AM MED ASSOC, V269, P221, DOI 10.1001/jama.269.2.221; BIGNALL J, 1993, LANCET, V341, P887, DOI 10.1016/0140-6736(93)93085-F; BROADHURST LE, 1993, JAMA-J AM MED ASSOC, V269, P227, DOI 10.1001/jama.269.2.227; KATTWINKEL J, 1992, PEDIATRICS, V89, P1120; MURPHY TV, 1993, JAMA-J AM MED ASSOC, V269, P246, DOI 10.1001/jama.269.2.246; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SHAPIRO ED, 1993, JAMA-J AM MED ASSOC, V269, P264, DOI 10.1001/jama.269.2.264; SHAPIRO ED, 1992, PEDIATR RES, V32, pA100; SPIERS PS, 1994, ARCH PEDIAT ADOL MED, V148, P141, DOI 10.1001/archpedi.1994.02170020027004; TAMBORLANE WV, 1983, J PEDIATR-US, V102, P805, DOI 10.1016/S0022-3476(83)80003-1; 1994, MMWR MORB MORTAL WKL, V43, P144; 1993, REPORT CHIEF MED OFF; IN PRESS J PEDIATR; 1985, MMWR MORB MORTAL WKL, V34, P201	14	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1701	1703						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182861				2022-12-28	WOS:A1994NN11700040
J	RAZIN, A; CEDAR, H				RAZIN, A; CEDAR, H			DNA METHYLATION AND GENOMIC IMPRINTING	CELL			English	Review							MOUSE EMBRYO; GENE; INACTIVATION				RAZIN, A (corresponding author), HEBREW UNIV JERUSALEM,SCH MED,DEPT CELLULAR BIOCHEM,IL-91120 JERUSALEM,ISRAEL.							ALLEN N, 1992, BIOESSAYS, V14, P857, DOI 10.1002/bies.950141211; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; BRANDEIS M, 1993, EMBO J, V12, P3669, DOI 10.1002/j.1460-2075.1993.tb06041.x; CHAILLET JR, 1991, CELL, V66, P77, DOI 10.1016/0092-8674(91)90140-T; DRISCOLL DJ, 1992, GENOMICS, V13, P917, DOI 10.1016/0888-7543(92)90001-9; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; FOREJT J, 1992, CELL, V70, P443, DOI 10.1016/0092-8674(92)90168-C; GLENN CC, 1993, HUM MOL GENET, V2, P2001, DOI 10.1093/hmg/2.12.2001; HAYASHIZAKI Y, 1994, NAT GENET, V6, P33, DOI 10.1038/ng0194-33; KAFRI T, 1993, P NATL ACAD SCI USA, V90, P10558, DOI 10.1073/pnas.90.22.10558; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; KITSBERG D, 1993, NATURE, V364, P459, DOI 10.1038/364459a0; KNOLL JHM, 1994, NAT GENET, V6, P41, DOI 10.1038/ng0194-41; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; MONK M, 1987, DEVELOPMENT, V99, P371; NICHOLLS RD, 1993, CURR OPIN GENET DEV, V3, P445, DOI 10.1016/0959-437X(93)90119-A; NORRIS DP, 1994, CELL, V77, P41, DOI 10.1016/0092-8674(94)90233-X; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; RAZIN A, 1991, MICROBIOL REV, V55, P451, DOI 10.1128/MMBR.55.3.451-458.1991; SASAKI H, 1992, GENE DEV, V6, P1843, DOI 10.1101/gad.6.10.1843; STOGER R, 1993, CELL, V73, P61, DOI 10.1016/0092-8674(93)90160-R; SUGAWARA O, 1985, CYTOGENET CELL GENET, V39, P210, DOI 10.1159/000132137; SURANI MA, 1988, TRENDS GENET, V4, P59, DOI 10.1016/0168-9525(88)90040-6; UEDA T, 1992, DEVELOPMENT, V116, P831	24	323	330	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 20	1994	77	4					473	476		10.1016/0092-8674(94)90208-9	http://dx.doi.org/10.1016/0092-8674(94)90208-9			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NM832	8187170				2022-12-28	WOS:A1994NM83200001
J	POSTHUMA, WFM; WESTENDORP, RG; VANDENBROUCKE, JP				POSTHUMA, WFM; WESTENDORP, RG; VANDENBROUCKE, JP			CARDIOPROTECTIVE EFFECT OF HORMONE REPLACEMENT THERAPY IN POSTMENOPAUSAL WOMEN - THE EVIDENCE BIASED	BRITISH MEDICAL JOURNAL			English	Article							LONG-TERM ESTROGEN; CARDIOVASCULAR-DISEASE; FOLLOW-UP; MORTALITY; INEQUALITIES; PREVENTION; COHORT; CANCER; USERS; RISK	Objective-To quantify the effect of selection of relatively: healthy women in studies reporting reduced relative risk for cardiovascular disease in postmenopausal women taking hormone replacement therapy. Design-Review of the follow up studies reported in three recent meta-analyses to determine the effect of oestrogen therapy on both total cancer and cardiovascular disease. The same standard statistical:methods as in the original analyses were used. Main outcome measures-Relative risks of total cancer and cardiovascular disease. Results-In most of the follow up studies the relative risk for total cancer was below 1. The studies that showed the largest reduction in cardiovascular disease also showed the largest reduction in cancer, indicating a healthy cohort effect. Although heterogeneity within the studies prevented pooling, the best estimate for the protective effect on total cancer was a relative risk of 0.83 among women taking oestrogen (95% confidence interval 0.71 to 0.96), while in the same studies the relative risk for cardiovascular disease was 0.57 (0.50 to 0.64). Conclusions-Unintended selection of relatively healthy women for oestrogen therapy may have influenced the reported beneficial effect of oestrogen therapy on cardiovascular disease. It is unclear how much of the cardioprotection is due to this selection. Universal preventive hormonal replacement therapy for postmenopausal women is unwarranted at present.	LEIDEN UNIV HOSP,DEPT CLIN EPIDEMIOL,2300 RC LEIDEN,NETHERLANDS	Leiden University; Leiden University Medical Center (LUMC)			Posthuma, Ward/AAW-3740-2021; Vandenbroucke, Jan/AAM-3928-2020	Vandenbroucke, Jan/0000-0001-5668-6716				ADAMI HO, 1989, INT J CANCER, V44, P833, DOI 10.1002/ijc.2910440515; ADAMI HO, 1992, CANCER CAUSE CONTROL, V3, P83, DOI 10.1007/BF00051917; AVILA MH, 1990, EPIDEMIOLOGY, V1, P128; BARRETTCONNOR E, 1991, ANN INTERN MED, V115, P455, DOI 10.7326/0003-4819-115-6-455; BRESLOW NE, 1987, STAT METHODS CANC RE, V2, P11; BURCH JC, 1974, AM J OBSTET GYNECOL, V118, P778, DOI 10.1016/0002-9378(74)90487-6; BUSH TL, 1987, CIRCULATION, V75, P1102, DOI 10.1161/01.CIR.75.6.1102; BUSH TL, 1990, MENOPAUSE BIOL CLIN, P211; BYRD BF, 1977, ANN SURG, V185, P574, DOI 10.1097/00000658-197705000-00010; CAULEY JA, 1990, AM J OBSTET GYNECOL, V163, P1438, DOI 10.1016/0002-9378(90)90602-4; COLDITZ GA, 1990, JAMA-J AM MED ASSOC, V264, P2648, DOI 10.1001/jama.264.20.2648; COOPE J, 1991, LANCET, V337, P1162; CRIQUI MH, 1988, AM J EPIDEMIOL, V128, P606, DOI 10.1093/oxfordjournals.aje.a115008; EAKER ED, 1987, CORONARY HEART DISEA, P122; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; HAMMOND CB, 1979, AM J OBSTET GYNECOL, V133, P525, DOI 10.1016/0002-9378(79)90288-6; HEMMINKI E, 1993, J CLIN EPIDEMIOL, V46, P211, DOI 10.1016/0895-4356(93)90068-C; HENDERSON BE, 1991, ARCH INTERN MED, V151, P75, DOI 10.1001/archinte.151.1.75; HERNBERG S, 1986, EPIDEMIOLOGY OCCUPAT, P269; HUNT K, 1990, BRIT J OBSTET GYNAEC, V97, P1080, DOI 10.1111/j.1471-0528.1990.tb02494.x; JACOBS HS, 1992, BMJ-BRIT MED J, V305, P1403, DOI 10.1136/bmj.305.6866.1403; KUNST AE, 1990, SOC SCI MED, V31, P141, DOI 10.1016/0277-9536(90)90055-W; LAFFERTY FW, 1985, MATURITAS, V7, P147, DOI 10.1016/0378-5122(85)90021-0; LAYDE P M, 1981, Lancet, V1, P541; MACMAHON B, 1978, CORONARY HEART DISEA, P197; MARMOT MG, 1984, LANCET, V1, P1003; MARMOT MG, 1986, LANCET, V2, P274; MEADE TW, 1992, BRIT MED BULL, V48, P276, DOI 10.1093/oxfordjournals.bmb.a072548; MONSON RR, 1990, OCCUPATIONAL EPIDEMI, P114; PETTITI DB, 1987, OBSTET GYNECOL, V70, P289; Potocki J, 1971, Pol Tyg Lek, V26, P1812; SALKEBORN M, 1992, BRIT J OBSTET GYNAEC, V99, P821; SHAPIRO S, 1979, LANCET, V1, P743; STAMPFER MJ, 1991, NEW ENGL J MED, V325, P756, DOI 10.1056/NEJM199109123251102; STAMPFER MJ, 1991, PREV MED, V20, P47, DOI 10.1016/0091-7435(91)90006-P; SULLIVAN JM, 1990, ARCH INTERN MED, V150, P2557, DOI 10.1001/archinte.150.12.2557; VANDENBROUCKE JP, 1991, LANCET, V337, P833, DOI 10.1016/0140-6736(91)92526-8; WILSON PWF, 1985, NEW ENGL J MED, V313, P1038, DOI 10.1056/NEJM198510243131702; WOLF PH, 1991, AM J OBSTET GYNECOL, V164, P489, DOI 10.1016/S0002-9378(11)80006-2; 1992, ANN INTERN MED, V117, P1038	41	148	154	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 14	1994	308	6939					1268	1269						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM147	8205018				2022-12-28	WOS:A1994NM14700017
J	REDFIELD, RJ				REDFIELD, RJ			MALE MUTATION-RATES AND THE COST OF SEX FOR FEMALES	NATURE			English	Article							DELETERIOUS MUTATIONS; RECOMBINATION; REPRODUCTION; EVOLUTION; ADVANTAGE	ALTHOUGH we do not know why sex evolved, the twofold cost of meiosis for females provides a standard against which postulated benefits of sex can be evaluated(1). The most reliable benefit is sex's ability to reduce the impact of deleterious mutations(2,3). But deleterious mutations may themselves generate a large and previously overlooked female-specific cost of sex. DNA sequence comparisons have confirmed Haldane's suggestion that most mutations arise in the male germ line(4,5); recent estimates of alpha, the ratio of male to female mutation rates, are ten, six and two in humans, primates and rodents, respectively(6-8). Consequently, male gametes may give progeny more mutations than the associated sexual recombination eliminates. Here I describe computer simulations showing that the cost of male mutations can easily exceed the benefits of recombination, causing females to produce fitter progeny by parthenogenesis than by mating. The persistence of sexual reproduction by females thus becomes even more problematic.	CANADIAN INST ADV RES,PROGRAM EVOLUT BIOL,VANCOUVER V6T 1Z4,BC,CANADA	Canadian Institute for Advanced Research (CIFAR)	REDFIELD, RJ (corresponding author), UNIV BRITISH COLUMBIA,DEPT ZOOL,6270 UNIV BLVD,VANCOUVER V6T 1Z4,BC,CANADA.		Redfield, Rosemary/K-5633-2012	Redfield, Rosemary/0000-0001-8940-587X				CHANG BHJ, 1994, P NATL ACAD SCI USA, V91, P827, DOI 10.1073/pnas.91.2.827; CHARLESWORTH B, 1990, GENET RES, V55, P199, DOI 10.1017/S0016672300025532; CROW J. F., 1970, Biomathematics. Volume 1. Mathematical topics in population genetics., P128; HALDANE JBS, 1947, ANN EUGENIC, V13, P262; Haldane JBS, 1937, AM NAT, V71, P337, DOI 10.1086/280722; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; HOWARD RS, 1994, NATURE, V367, P554, DOI 10.1038/367554a0; KIMURA M, 1966, GENETICS, V54, P1303; KONDRASHOV AS, 1984, GENET RES, V44, P199, DOI 10.1017/S0016672300026392; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; KONDRASHOV AS, 1993, HUM MUTAT, V2, P229, DOI 10.1002/humu.1380020312; MAYNARD SMITH J., 1978, EVOLUTION SEX; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; MONTANDON AJ, 1992, HUM GENET, V89, P319; MUKAI T, 1969, GENETICS, V61, P749; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; SHIMMIN LC, 1993, NATURE, V362, P745, DOI 10.1038/362745a0; SMITH JM, 1968, AM NAT, V102, P469, DOI 10.1086/282559	18	79	80	0	16	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 12	1994	369	6476					145	147		10.1038/369145a0	http://dx.doi.org/10.1038/369145a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NK971	8177318				2022-12-28	WOS:A1994NK97100048
J	LESSL, M; LANKA, E				LESSL, M; LANKA, E			COMMON MECHANISMS IN BACTERIAL CONJUGATION AND TI-MEDIATED T-DNA TRANSFER TO PLANT-CELLS	CELL			English	Review							AGROBACTERIUM-TUMEFACIENS; ENCODES				LESSL, M (corresponding author), MAX PLANCK INST MOLEC GENET,SCHUSTER ABT,IHNESTR 73,D-14195 BERLIN,GERMANY.							BALZER D, 1993, THESIS FREIE U BERLI; BEIJERSBERGEN A, 1992, SCIENCE, V256, P1324, DOI 10.1126/science.256.5061.1324; BUCHANANWOLLASTON V, 1987, NATURE, V328, P172, DOI 10.1038/328172a0; CHRISTIE PJ, 1989, P NATL ACAD SCI USA, V86, P9677, DOI 10.1073/pnas.86.24.9677; FILICHKIN SA, 1993, MOL MICROBIOL, V8, P915, DOI 10.1111/j.1365-2958.1993.tb01637.x; GHAI J, 1989, P NATL ACAD SCI USA, V86, P3109, DOI 10.1073/pnas.86.9.3109; HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x; LESSL M, 1992, NUCLEIC ACIDS RES, V20, P6099, DOI 10.1093/nar/20.22.6099; LESSL M, 1993, J BACTERIOL, V175, P6415, DOI 10.1128/jb.175.20.6415-6425.1993; MORTON TM, 1993, J BACTERIOL, V175, P4436, DOI 10.1128/JB.175.14.4436-4447.1993; OKAMOTO S, 1991, MOL GEN GENET, V228, P24, DOI 10.1007/BF00282443; PANSEGRAU W, 1994, J BIOL CHEM, V269, P2782; PANSEGRAU W, 1993, P NATL ACAD SCI USA, V90, P11538, DOI 10.1073/pnas.90.24.11538; SHIRASU K, 1993, FEMS MICROBIOL LETT, V111, P287, DOI 10.1111/j.1574-6968.1993.tb06400.x; STACHEL SE, 1986, CELL, V47, P155, DOI 10.1016/0092-8674(86)90437-X; VANPUTTEN AJ, 1987, GENE, V51, P171, DOI 10.1016/0378-1119(87)90305-2; VOGEL AM, 1992, J BACTERIOL, V174, P303, DOI 10.1128/jb.174.1.303-308.1992; WATERS VL, 1993, MOL MICROBIOL, V9, P1123, DOI 10.1111/j.1365-2958.1993.tb01242.x; WEISS AA, 1993, P NATL ACAD SCI USA, V90, P2970, DOI 10.1073/pnas.90.7.2970; Wilkins B, 1993, BACTERIAL CONJUGATIO, P105; ZAMBRYSKI PC, 1992, ANNU REV PLANT PHYS, V43, P465, DOI 10.1146/annurev.pp.43.060192.002341	21	173	186	0	12	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 6	1994	77	3					321	324		10.1016/0092-8674(94)90146-5	http://dx.doi.org/10.1016/0092-8674(94)90146-5			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NK970	8181052				2022-12-28	WOS:A1994NK97000002
J	SMITH, LM				SMITH, LM			THE FUTURE OF DNA-SEQUENCING	SCIENCE			English	Editorial Material							MASS-SPECTROMETRY; HIGH-SPEED				SMITH, LM (corresponding author), UNIV WISCONSIN,DEPT CHEM,MADISON,WI 53706, USA.							BERG CM, 1992, GENE, V113, P9, DOI 10.1016/0378-1119(92)90664-B; DRMANAC R, 1993, SCIENCE, V260, P1649, DOI 10.1126/science.8503011; DRMANAC R, 1992, INT J GENOME RES, V1, P1; FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438; FODOR SPA, 1993, NATURE, V364; Grossman PD, 1992, CAPILLARY ELECTROPHO, P215; HILLENKAMP F, 1991, ANAL CHEM, V63, pA1193; HOU WY, 1993, NUCLEIC ACIDS RES, V21, P3331, DOI 10.1093/nar/21.14.3331; HUNKAPILLER T, 1991, SCIENCE, V254, P59, DOI 10.1126/science.1925562; KIELECZAWA J, 1992, SCIENCE, V258, P1787, DOI 10.1126/science.1465615; KOSTICHKA AJ, 1992, BIO-TECHNOL, V10, P78, DOI 10.1038/nbt0192-78; KOTLER LE, 1993, P NATL ACAD SCI USA, V90, P4241, DOI 10.1073/pnas.90.9.4241; LUCKEY JA, 1993, ELECTROPHORESIS, V14, P492, DOI 10.1002/elps.1150140176; LUCKEY JA, 1993, J PHYS CHEM-US, V97, P3067, DOI 10.1021/j100114a038; MATHIES RA, 1992, NATURE, V359, P167, DOI 10.1038/359167a0; PARR GR, 1992, RAPID COMMUN MASS SP, V6, P369, DOI 10.1002/rcm.1290060603; RUIZMARTINEZ MC, 1993, ANAL CHEM, V65, P2851, DOI 10.1021/ac00068a023; STRATHMANN M, 1991, P NATL ACAD SCI USA, V88, P1247, DOI 10.1073/pnas.88.4.1247; SULSTON J, 1992, NATURE, V356, P37, DOI 10.1038/356037a0; TIETZ D, 1993, ELECTROPHORESIS, V14, P185, DOI 10.1002/elps.1150140131; WU KJ, 1993, RAPID COMMUN MASS SP, V7, P142, DOI 10.1002/rcm.1290070206	21	67	81	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 22	1993	262	5133					530	532		10.1126/science.8211178	http://dx.doi.org/10.1126/science.8211178			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC935	8211178				2022-12-28	WOS:A1993MC93500028
J	FISCHER, DG; TAL, N; NOVICK, D; BARAK, S; RUBINSTEIN, M				FISCHER, DG; TAL, N; NOVICK, D; BARAK, S; RUBINSTEIN, M			AN ANTIVIRAL SOLUBLE FORM OF THE LDL RECEPTOR-INDUCED BY INTERFERON	SCIENCE			English	Article							MONOCLONAL-ANTIBODIES; BETA-INTERFERON; FAMILIAL HYPERCHOLESTEROLEMIA; GAMMA-INTERFERON; ALPHA-INTERFERON; BINDING-PROTEIN; TREATED CELLS; HUMAN-URINE; NECROSIS; PURIFICATION	Interferons, which induce several intracellular antiviral proteins, also induce an extracellular soluble protein that inhibits vesicular stomatitis virus (VSV) infection. This 28-kilodalton soluble protein was purified to homogeneity and identified by protein sequencing as the ligand-binding domain of the human 160-kilodalton low density lipoprotein receptor (LDLR). The existence of an antiviral soluble LDLR was confirmed by immunoaffinity chromatography with monoclonal antibody to LDLR. This soluble receptor mediates most of the interferon-triggered antiviral activity against VSV, apparently by interfering with virus assembly or budding, and not by inhibiting virus attachment to cells.	WEIZMANN INST SCI,DEPT MOLEC GENET & VIROL,IL-76100 REHOVOT,ISRAEL	Weizmann Institute of Science								BEISIEGEL U, 1981, J BIOL CHEM, V256, P1923; BOUE F, 1990, CANCER IMMUNOL IMMUN, V32, P67, DOI 10.1007/BF01741727; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; CONSTANTOULAKIS P, 1993, SCIENCE, V259, P1314, DOI 10.1126/science.7680491; DOLEI A, 1981, ANTIVIR RES, V1, P367; ENGELMANN H, 1989, J BIOL CHEM, V264, P11974; GAVIN JR, 1972, SCIENCE, V178, P168, DOI 10.1126/science.178.4057.168; GERRARD TL, 1989, J INTERFERON RES, V9, P115, DOI 10.1089/jir.1989.9.115; GOODING LR, 1992, CELL, V71, P5; HAWKINS M, 1985, CANCER RES, V45, P5914; HORISBERGER MA, 1991, VIROLOGY, V180, P185, DOI 10.1016/0042-6822(91)90022-4; JONES CM, 1982, J INTERFERON RES, V2, P377, DOI 10.1089/jir.1982.2.377; KERR IM, 1978, P NATL ACAD SCI USA, V75, P256, DOI 10.1073/pnas.75.1.256; LANDSBERGER D, 1992, AM J HUM GENET, V50, P427; LEUNG DW, 1987, NATURE, V330, P537, DOI 10.1038/330537a0; LUSTER AD, 1988, J BIOL CHEM, V263, P12036; MASSARO ER, 1986, J INTERFERON RES, V6, P655, DOI 10.1089/jir.1986.6.655; MOSLEY B, 1989, CELL, V59, P335, DOI 10.1016/0092-8674(89)90295-X; NOVICK D, 1982, J IMMUNOL, V129, P2244; NOVICK D, 1983, EMBO J, V2, P1527, DOI 10.1002/j.1460-2075.1983.tb01618.x; NOVICK D, 1989, J EXP MED, V170, P1409, DOI 10.1084/jem.170.4.1409; OHTSUKI K, 1980, NATURE, V287, P65, DOI 10.1038/287065a0; OLSEN EA, 1988, J AM ACAD DERMATOL, V19, P286, DOI 10.1016/S0190-9622(88)70173-5; ROSENZWEIG IB, 1987, ATHEROSCLEROSIS, V67, P261, DOI 10.1016/0021-9150(87)90287-5; RUBIN LA, 1985, J IMMUNOL, V135, P3172; RUBINSTEIN S, 1981, J VIROL, V37, P755, DOI 10.1128/JVI.37.2.755-758.1981; SMITH CA, 1990, SCIENCE, V248, P1019, DOI 10.1126/science.2160731; SUDHOF TC, 1985, SCIENCE, V228, P815, DOI 10.1126/science.2988123; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WALLACH D, 1983, CELL IMMUNOL, V76, P390, DOI 10.1016/0008-8749(83)90382-9; WEBER W, 1984, SCIENCE, V224, P294, DOI 10.1126/science.6324343; WEIL J, 1983, NATURE, V301, P437, DOI 10.1038/301437a0; WEISMAN HF, 1990, SCIENCE, V249, P146, DOI 10.1126/science.2371562; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0	34	60	62	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 8	1993	262	5131					250	253		10.1126/science.8211145	http://dx.doi.org/10.1126/science.8211145			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MA665	8211145				2022-12-28	WOS:A1993MA66500038
J	BRONNER, G; CHULAGRAFF, Q; DOE, CQ; COHEN, B; WEIGEL, D; TAUBERT, H; JACKLE, H				BRONNER, G; CHULAGRAFF, Q; DOE, CQ; COHEN, B; WEIGEL, D; TAUBERT, H; JACKLE, H			SP1/EGR-LIKE ZINC-FINGER PROTEIN REQUIRED FOR ENDODERM SPECIFICATION AND GERM-LAYER FORMATION IN DROSOPHILA	NATURE			English	Article							EMBRYONIC TERMINI; SEGMENTATION GENE; MELANOGASTER; GASTRULATION; TAILLESS; DOMAINS; MEMBER; CELLS; SP1	Much of out present knowledge of the biological processes involved in pattern formation in Drosophila is derived from segmentation analysis(1,2). Comparatively little is known about the genetic requirement and mechanisms underlying the formation and separation of germ layers by morphogenetic movements during gastrulation(3). Here we show that the Drosophila gene huckebein (hkb), a member of the gap-gene class of segmentation genes(4,5), is required for germ-layer formation at blastoderm. Absence of the hkb product, an Spl/egr-like zinc-finger protein, causes the ectodermal and mesodermal primordia to expand at the expense of endoderm anlagen. Conversely, ectopic expression of hkb inhibits the formation of the major gastrulation fold which gives rise to the mesoderm and prevents normal segmentation in the ectoderm. Thus, hkb is necessary for endoderm development and its activity defines spatial limits within the blastoderm embryo in which the germ layers are established.	UNIV ILLINOIS,DEPT CELL & STRUCT BIOL,URBANA,IL 61801	University of Illinois System; University of Illinois Urbana-Champaign	BRONNER, G (corresponding author), MAX PLANCK INST BIOPHYS CHEM,MOLEK ENTWICKLUNGSBIOL ABT,POSTFACH 2841,D-37018 GOTTINGEN,GERMANY.		Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/C-1418-2008; Weigel, Detlef/GSJ-0799-2022	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963				BEDDINGTON RSP, 1993, CURR OPIN GENET DEV, V3, P655, DOI 10.1016/0959-437X(93)90103-V; BELLEN HJ, 1989, GENE DEV, V3, P1301; BRONNER G, 1991, MECH DEVELOP, V35, P205, DOI 10.1016/0925-4773(91)90019-3; BROWN NH, 1988, J MOL BIOL, V168, P17; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; COSTA M, 1992, DEV DROSOPHILA; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; FOE VE, 1989, DEVELOPMENT, V107, P1; HAN KY, 1993, GENE DEV, V7, P491, DOI 10.1101/gad.7.3.491; HOCH M, 1993, CURR OPIN GENET DEV, V3, P566, DOI 10.1016/0959-437X(93)90092-4; JOSEPH LJ, 1988, P NATL ACAD SCI USA, V85, P7164, DOI 10.1073/pnas.85.19.7164; KRUMLAUF R, 1993, CURR OPIN GENET DEV, V3, P621, DOI 10.1016/0959-437X(93)90098-A; LAI ZC, 1991, MECH DEVELOP, V34, P123, DOI 10.1016/0925-4773(91)90049-C; LEPTIN M, 1992, GASTRULATION, P23; MOHLER J, 1989, EMBO J, V8, P1539, DOI 10.1002/j.1460-2075.1989.tb03538.x; MORATA G, 1993, CURR OPIN GENET DEV, V3, P606, DOI 10.1016/0959-437X(93)90096-8; OLIVER G, 1993, MECH DEVELOP, V44, P3, DOI 10.1016/0925-4773(93)90012-M; PATWARDHAN S, 1991, ONCOGENE, V6, P917; PIGNONI F, 1990, CELL, V62, P151, DOI 10.1016/0092-8674(90)90249-E; ROTHE M, 1992, NATURE, V359, P156, DOI 10.1038/359156a0; RUBIN GM, 1983, NUCLEIC ACIDS RES, V11, P6341, DOI 10.1093/nar/11.18.6341; STEINGRIMSSON E, 1991, SCIENCE, V254, P418, DOI 10.1126/science.1925599; STJOHNSTON D, 1992, CELL, V68, P201; SUGGS SV, 1990, NUCLEIC ACIDS RES, V18, P4283, DOI 10.1093/nar/18.14.4283; TECHNAU G M, 1985, Wilhelm Roux's Archives of Developmental Biology, V194, P196, DOI 10.1007/BF00848247; TURNER FR, 1977, DEV BIOL, V57, P403, DOI 10.1016/0012-1606(77)90225-1; WEIGEL D, 1990, SCIENCE, V248, P495, DOI 10.1126/science.2158673; WIMMER EA, 1993, NATURE, V366, P690, DOI 10.1038/366690a0; WOLPERT L, 1992, GASTRULATION, P7; [No title captured]	30	113	113	1	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 23	1994	369	6482					664	668		10.1038/369664a0	http://dx.doi.org/10.1038/369664a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NT459	8208294				2022-12-28	WOS:A1994NT45900060
J	IWAMURA, Y; IRIKI, A; TANAKA, M				IWAMURA, Y; IRIKI, A; TANAKA, M			BILATERAL HAND REPRESENTATION IN THE POSTCENTRAL SOMATOSENSORY CORTEX	NATURE			English	Article							VERTICAL NEURONAL ARRAYS; CONSCIOUS MONKEY; RECEPTIVE-FIELD; RHESUS-MONKEY; CALLOSAL CONNECTIONS; CORPUS-CALLOSUM; PARIETAL CORTEX; M FASCICULARIS; ORGANIZATION; GYRUS	IN accordance with its important role in prehensile activity, a large cortical area is devoted to representation of the digits. Within this large cortical zone in the macaque somatosensory cortex, the complexity of neuronal receptive field characteristics increases from area 3b to areas 1 and 2 (refs 1-7). This increase in complexity continues into the upper bank of the intraparietal sulcus, where the somatosensory cortex adjoins the parietal association cortex. In this bank, callosal connections are much denser than in the more anterior part of this cortical zone(8-17). We have now discovered a substantial number of neurons with receptive fields on the bilateral hands. It was previously thought that neuronal receptive fields were restricted to the contralateral side in this cortical zone. Neurons with bilateral receptive fields were not found after lesioning the postcentral gyrus in the contralateral hemisphere. The majority of these neurons had receptive fields of the most complex types, representing multiple digits, indicating that the interhemispheric h anser of information occurs at higher levels of the hierarchical processing in each hemisphere.			IWAMURA, Y (corresponding author), TOHO UNIV,SCH MED,DEPT PHYSIOL,5-21-16 OMORI NISHI,TOKYO 143,JAPAN.							Berlucchi G., 1990, HDB NEUROPSYCHOLOGY, V4, P9; BURBAUD P, 1991, J NEUROPHYSIOL, V66, P429, DOI 10.1152/jn.1991.66.2.429; CAMINITI R, 1985, J COMP NEUROL, V237, P85, DOI 10.1002/cne.902370107; DUFFY FH, 1971, SCIENCE, V172, P273, DOI 10.1126/science.172.3980.273; EBNER FF, 1962, J NEUROPHYSIOL, V25, P380, DOI 10.1152/jn.1962.25.3.380; HUNTER M, 1975, BRAIN RES, V93, P223, DOI 10.1016/0006-8993(75)90347-9; HYVARINEN J, 1978, J PHYSIOL-LONDON, V257, P199; IWAMURA Y, 1980, BRAIN RES, V197, P516, DOI 10.1016/0006-8993(80)91139-7; IWAMURA Y, 1983, EXP BRAIN RES, V51, P315; IWAMURA Y, 1985, EXP BRAIN RES, V58, P400; IWAMURA Y, 1985, EXP BRAIN RES, V58, P412; IWAMURA Y, 1993, EXP BRAIN RES, V92, P360; IWAMURA Y, 1983, EXP BRAIN RES, V51, P327; JONES EG, 1980, NEUROSCI LETT, V19, P167, DOI 10.1016/0304-3940(80)90189-5; JONES EG, 1969, BRAIN, V92, P717, DOI 10.1093/brain/92.4.717; JONES EG, 1979, J COMP NEUROL, V188, P113, DOI 10.1002/cne.901880110; KAROL EA, 1971, BRAIN, V94, P471, DOI 10.1093/brain/94.3.471; KILLACKEY HP, 1983, J COMP NEUROL, V219, P384, DOI 10.1002/cne.902190403; MANZONI T, 1989, EXP BRAIN RES, V76, P251; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; PANDYA DN, 1982, J COMP NEUROL, V204, P196, DOI 10.1002/cne.902040208; PANDYA DN, 1969, BRAIN RES, V14, P49, DOI 10.1016/0006-8993(69)90030-4; PONS TP, 1985, J COMP NEUROL, V241, P445, DOI 10.1002/cne.902410405; POWELL TPS, 1959, B JOHNS HOPKINS HOSP, V105, P108; RIDLEY RM, 1978, EXP BRAIN RES, V31, P475; ROBINSON CJ, 1980, J COMP NEUROL, V192, P69, DOI 10.1002/cne.901920105; ROBINSON CJ, 1980, J COMP NEUROL, V192, P43, DOI 10.1002/cne.901920104; SAKATA H, 1973, BRAIN RES, V64, P85, DOI 10.1016/0006-8993(73)90172-8; SEITZER B, 1986, EXPL BRAIN RES, V62, P459; SHANKS MF, 1985, BRAIN RES REV, V9, P43, DOI 10.1016/0165-0173(85)90018-9	30	229	231	0	5	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 16	1994	369	6481					554	556		10.1038/369554a0	http://dx.doi.org/10.1038/369554a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR294	8202155				2022-12-28	WOS:A1994NR29400047
J	HABECKER, BA; LANDIS, SC				HABECKER, BA; LANDIS, SC			NORADRENERGIC REGULATION OF CHOLINERGIC DIFFERENTIATION	SCIENCE			English	Article							RAT SWEAT GLANDS; NEUROTRANSMITTER PLASTICITY INVIVO; SYMPATHETIC NEURONS; PRIMARY CULTURES; ACETYLCHOLINE SYNTHESIS; RECEPTOR GENE; INNERVATION; TARGET; INDUCTION; PHENOTYPE	When the sympathetic nerves that innervate rat sweat glands reach their targets, they are induced to switch from using norepinephrine as their neurotransmitter to acetylcholine. Catecholamines (such as norepinephrine) released by nerves growing to the sweat gland induce this phenotypic conversion by stimulating production of a cholinergic differentiation factor [sweat gland factor (SGF)] by gland cells. Here, culture of gland cells with sympathetic, but not sensory, neurons induced SGF production. Blockage of alpha(1)- or beta-adrenergic receptors prevented acquisition of the cholinergic phenotype in sympathetic neurons co-cultured with sweat glands, and sweat glands from sympathectomized animals lacked SGF. Thus, reciprocal instructive interactions, mediated in part by small molecule neurotransmitters, direct the development of this synapse.	CASE WESTERN RESERVE UNIV,SCH MED,DEPT NEUROSCI,CLEVELAND,OH 44106	Case Western Reserve University				Habecker, Beth/0000-0002-4658-8730	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023678] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-023678] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARANGO V, 1990, BRAIN RES, V516, P113, DOI 10.1016/0006-8993(90)90904-P; BUCKLAND PR, 1990, NUCLEIC ACIDS RES, V18, P682, DOI 10.1093/nar/18.3.682; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLEGG DO, 1989, DEV BIOL, V134, P30, DOI 10.1016/0012-1606(89)90075-4; COLLIE G, 1985, IN VITRO CELL DEV, V21, P257; FONNUM F, 1969, BIOCHEM J, V115, P465, DOI 10.1042/bj1150465; GLOSSMANN F, 1981, EUR J PHARMACOL, V75, P149; GRANT M, IN PRESS J NEUROSCI; GRANT MP, 1991, J NEUROSCI, V11, P3763; GRUENERT DC, 1990, IN VITRO CELL DEV B, V26, P411; HABECKER B, UNPUB; Hawrot E, 1979, Methods Enzymol, V58, P574; LANDIS SC, 1988, DEV BIOL, V126, P129, DOI 10.1016/0012-1606(88)90246-1; LANDIS SC, 1990, TRENDS NEUROSCI, V13, P344, DOI 10.1016/0166-2236(90)90147-3; LANDIS SC, 1983, DEV BIOL, V98, P349, DOI 10.1016/0012-1606(83)90365-2; LANDIS SC, 1980, DEV BIOL, V77, P348; LEBLANC G, 1986, J NEUROSCI, V6, P260; MACHIDA CA, 1990, J BIOL CHEM, V265, P12960; MAINS RE, 1973, J CELL BIOL, V59, P329, DOI 10.1083/jcb.59.2.329; PATTERSON PH, 1977, DEV BIOL, V60, P473, DOI 10.1016/0012-1606(77)90144-0; PATTERSON PH, 1977, DEV BIOL, V56, P263, DOI 10.1016/0012-1606(77)90269-X; RAO MS, 1992, DEVELOPMENT, V116, P731; RAO MS, 1990, NEURON, V5, P899, DOI 10.1016/0896-6273(90)90350-O; RAO MS, 1993, J NEUROBIOL, V24, P215, DOI 10.1002/neu.480240208; RAO MS, 1992, DEV BIOL, V150, P2811; ROHRER H, 1988, DEV BIOL, V128, P240, DOI 10.1016/0012-1606(88)90286-2; ROHRER H, 1992, DEVELOPMENT, V114, P689; SAADAT S, 1989, J CELL BIOL, V108, P1807, DOI 10.1083/jcb.108.5.1807; SCHOTZINGER RJ, 1988, NATURE, V335, P637, DOI 10.1038/335637a0; SCHOTZINGER RJ, 1990, NEURON, V5, P91, DOI 10.1016/0896-6273(90)90037-G; STEVENS LM, 1987, DEV BIOL, V123, P179, DOI 10.1016/0012-1606(87)90440-4; Tresser S. J., 1992, Society for Neuroscience Abstracts, V18, P1475; WALICKE PA, 1981, J NEUROSCI, V1, P333; YAMAMORI T, 1989, SCIENCE, V246, P1412, DOI 10.1126/science.2512641; YODLOWSKI ML, 1984, J NEUROSCI, V4, P1535; ZENG DW, 1990, P NATL ACAD SCI USA, V87, P3102, DOI 10.1073/pnas.87.8.3102	36	70	72	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 10	1994	264	5165					1602	1604		10.1126/science.8202714	http://dx.doi.org/10.1126/science.8202714			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ285	8202714				2022-12-28	WOS:A1994NQ28500040
J	BESSA, O; ALLEN, DI				BESSA, O; ALLEN, DI			TIGHT PANTS SYNDROME	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									INDIANA UNIV,SCH MED,INDIANAPOLIS,IN	Indiana University System; Indiana University-Purdue University Indianapolis								BESSA O, 1993, ARCH INTERN MED, V153, P1396, DOI 10.1001/archinte.1993.00410110088016; SPIRO HM, 1977, CLIN GASTROENTEROLOG	2	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	1994	271	20					1628	1628						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NL758	8182819				2022-12-28	WOS:A1994NL75800037
J	SAFRAN, DG; TARLOV, AR; ROGERS, WH				SAFRAN, DG; TARLOV, AR; ROGERS, WH			PRIMARY-CARE PERFORMANCE IN FEE-FOR-SERVICE AND PREPAID HEALTH-CARE SYSTEMS - RESULTS FROM THE MEDICAL OUTCOMES STUDY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MAINTENANCE ORGANIZATIONS; PATIENT SATISFACTION; CONTROLLED TRIAL; SPECIALTIES; PHYSICIANS; SELECTION; SETTINGS; BEHAVIOR; DOCTOR; HMOS	Objective.-To examine differences in the quality of primary care delivered in prepaid and fee-for-service (FFS) health care systems. Study Design.-Longitudinal study of 1208 adult patients with chronic disease whose health insurance was through a traditional indemnity (FFS) plan, an independent practice association (IPA), or a health maintenance organization (HMO). Both IPA and HMO represent prepaid care systems. Patient- and physician-provided information was obtained by self-administered questionnaires. Setting.-A total of 303 physician offices (family medicine, general internal medicine, endocrinology, or cardiology) in solo and group practices in three US cities. Outcomes Measures.-Seven indicators of primary care quality-accessibility (financial and organizational), continuity, comprehensiveness, coordination, and accountability (interpersonal and technical) of care. Performance on each was evaluated in FFS, IPA, and HMO settings. Analyses controlled for patient and physician characteristics. Results.-Financial access was highest in prepaid systems. Organizational access, continuity, and accountability were highest in the FFS system. Coordination was highest and comprehensiveness was lowest in HMOs. Conclusions.-The results mark notable differences in core dimensions of primary care quality in each of three payment systems and raise questions regarding the associated cost inefficiencies and outcomes of care. In the current health care delivery reform climate, these findings call for consideration of the relative strengths and weaknesses of each system. We suggest strategies for elevating performance in each.	TUFTS UNIV,DEPT MED,BOSTON,MA 02111; HARVARD UNIV,SCH PUBL HLTH,BOSTON,MA 02115	Tufts University; Harvard University; Harvard T.H. Chan School of Public Health	SAFRAN, DG (corresponding author), TUFTS UNIV,NEW ENGLAND MED CTR,INST HLTH,750 WASHINGTON ST,BOX 345,BOSTON,MA 02111, USA.							ADAY LA, 1975, ACCESS MED CARE, P15; ADAY LA, 1980, HLTH CARE US EQUITAB, P25; AIKEN LH, 1979, NEW ENGL J MED, V300, P1363, DOI 10.1056/NEJM197906143002404; BECKER MH, 1972, J PEDIATR-US, V81, P843, DOI 10.1016/S0022-3476(72)80118-5; BECKER MH, 1974, AM J PUBLIC HEALTH, V64, P205, DOI 10.2105/AJPH.64.3.205; BECKER MH, 1974, AM J PUBLIC HEALTH, V64, P1062, DOI 10.2105/AJPH.64.11.1062; BECKER MH, 1974, J PEDIATR-US, V84, P599, DOI 10.1016/S0022-3476(74)80689-X; BONFERRONI CE, 1936, STUDII ONORE PROF; BRESLAU N, 1981, MED CARE, V19, P741, DOI 10.1097/00005650-198107000-00005; CHARNEY E, 1967, PEDIATRICS, V40, P188; CORAH NL, 1984, J BEHAV MED, V7, P367, DOI 10.1007/BF00845270; Davies A R, 1989, Adv Health Econ Health Serv Res, V10, P183; DAVIES AR, 1988, HEALTH AFFAIR, V7, P33, DOI 10.1377/hlthaff.7.1.33; DAVIES AR, 1986, HEALTH SERV RES, V21, P429; DiMatteo MR, 1982, ACHIEVING PATIENT CO; EISENBERG JM, 1985, ANN INTERN MED, V102, P537, DOI 10.7326/0003-4819-102-4-537; GABLE J, 1993, J AM HEALTH POLICY, V1, P19; GARRITY TF, 1981, SOC SCI MED-MED PSYC, V15, P215, DOI 10.1016/0271-5384(81)90016-8; GERBERT B, 1986, MED CARE, V24, P838, DOI 10.1097/00005650-198609000-00005; GREENFIELD S, 1992, JAMA-J AM MED ASSOC, V267, P1624, DOI 10.1001/jama.267.12.1624; Held P.J., 1979, ANAL EC PERFORMANCE; HENNELLY VD, 1979, MED CARE, V17, P1012, DOI 10.1097/00005650-197910000-00004; HILLMAN AL, 1992, MED CARE, V30, P136, DOI 10.1097/00005650-199202000-00005; HUBER PJ, 1965, 5TH P BERK S BERK, P221; JACKSONBEECK M, 1983, JAMA-J AM MED ASSOC, V250, P2826, DOI 10.1001/jama.250.20.2826; KASTELLER J, 1975, J HEALTH SOC BEHAV, V17, P328; KRAVITZ RL, 1992, JAMA-J AM MED ASSOC, V267, P1617, DOI 10.1001/jama.267.12.1617; LAIRSON DR, 1987, INQUIRY-J HEALTH CAR, V24, P276; LOFGREN RP, 1990, J GEN INTERN MED, V5, P501, DOI 10.1007/BF02600880; LUFT HS, 1978, NEW ENGL J MED, V298, P1336, DOI 10.1056/NEJM197806152982404; LUFT HS, 1981, HLTH MAINTENANCE ORG; MANNING WG, 1984, NEW ENGL J MED, V310, P1505, DOI 10.1056/NEJM198406073102305; MARQUIS MS, 1983, MED CARE, V21, P821, DOI 10.1097/00005650-198308000-00006; MECHANIC D, 1975, MED CARE, V13, P189, DOI 10.1097/00005650-197503000-00001; MECHANIC D, 1983, MED CARE, V21, P338, DOI 10.1097/00005650-198303000-00006; MURRAY JP, 1988, J FAM PRACTICE, V26, P576; Poland M L, 1976, JOGN Nurs, V5, P45, DOI 10.1111/j.1552-6909.1976.tb02292.x; RAO CR, 1972, J AM STAT ASSOC, V67, P112, DOI 10.2307/2284708; ROGERS WM, 1992, MEASURING FUNCTIONIN; ROULIDIS ZC, 1993, 10TH ANN C ASS HLTH; ROWLAND D, 1987, HEALTH AFFAIR, V6, P87, DOI 10.1377/hlthaff.6.1.87; RUBIN HR, 1993, JAMA-J AM MED ASSOC, V270, P835, DOI 10.1001/jama.270.7.835; SCHLESINGER M, 1986, MILBANK Q, V64, P189, DOI 10.2307/3349970; SHERBOURNE CD, 1991, ANTECEDENTS ADHERENC; SHORTELL SM, 1977, J HEALTH SOC BEHAV, V18, P139, DOI 10.2307/2955378; SPITZ B, 1979, J HEALTH POLIT POLIC, V3, P497, DOI 10.1215/03616878-3-4-497; STARFIELD BH, 1976, MED CARE, V14, P625, DOI 10.1097/00005650-197607000-00008; TARLOV AR, 1989, JAMA-J AM MED ASSOC, V262, P925, DOI 10.1001/jama.262.7.925; Ware J E Jr, 1983, Eval Program Plann, V6, P291, DOI 10.1016/0149-7189(83)90009-5; WARE JE, 1986, LANCET, V1, P1017; WARE JE, 1976, PB288330; WASSON JH, 1984, JAMA-J AM MED ASSOC, V252, P2413; WELCH WP, 1987, J HEALTH POLIT POLIC, V12, P723, DOI 10.1215/03616878-12-4-723; Wilensky G R, 1986, Health Aff (Millwood), V5, P66, DOI 10.1377/hlthaff.5.1.66; WOLINSKY FD, 1983, MED CARE, V21, P531, DOI 10.1097/00005650-198305000-00006; 1993, MEDICAID STATES TURN; 1988, QUALITY MED CARE INF; 1978, REPORT STUDY MANPOWE	58	150	151	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	1994	271	20					1579	1586		10.1001/jama.271.20.1579	http://dx.doi.org/10.1001/jama.271.20.1579			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NL758	8182810				2022-12-28	WOS:A1994NL75800025
J	PARKHURST, SM; MENEELY, PM				PARKHURST, SM; MENEELY, PM			SEX DETERMINATION AND DOSAGE COMPENSATION - LESSONS FROM FLIES AND WORMS	SCIENCE			English	Review							SEGMENTATION GENE RUNT; OVARIAN TUMOR PROTEIN; LOOP-HELIX PROTEINS; ZINC-FINGER PROTEIN; PAN-NEURAL GENE; X-A RATIO; GERM-LINE; DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; C-ELEGANS	In both Drosophila melanogaster and Caenorhabditis elegans somatic sex determination, germline sex determination, and dosage compensation are controlled by means of a chromosomal signal known as the X:A ratio. A variety of mechanisms are used for establishing and implementing the chromosomal signal, and these do not appear to be similar in the two species. Instead, the study of sex determination and dosage compensation is providing more general lessons about different types of signaling pathways used to control alternative developmental states of cells and organisms.			PARKHURST, SM (corresponding author), FRED HUTCHINSON CANC RES CTR, DIV BASIC SCI, 1124 COLUMBIA ST, SEATTLE, WA 98104 USA.							AHRINGER J, 1992, EMBO J, V11, P2303, DOI 10.1002/j.1460-2075.1992.tb05289.x; AHRINGER J, 1991, NATURE, V349, P346, DOI 10.1038/349346a0; BAKER BS, 1989, NATURE, V340, P521, DOI 10.1038/340521a0; Ballabio A, 1992, CURR OPIN GENET DEV, V2, P439, DOI 10.1016/S0959-437X(05)80155-8; BARTON MK, 1990, GENETICS, V125, P29; BELL LR, 1991, CELL, V65, P229, DOI 10.1016/0092-8674(91)90157-T; BELL LR, 1988, CELL, V55, P1037, DOI 10.1016/0092-8674(88)90248-6; BELOTHE J, 1992, SEMIN DEV BIOL, V3, P319; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; BENGAL E, 1992, CELL, V68, P507, DOI 10.1016/0092-8674(92)90187-H; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; BIER E, 1992, GENE DEV, V6, P2137, DOI 10.1101/gad.6.11.2137; BONE JR, 1994, GENE DEV, V8, P96, DOI 10.1101/gad.8.1.96; BOPP D, 1991, GENE DEV, V5, P403, DOI 10.1101/gad.5.3.403; BOPP D, 1993, DEVELOPMENT, V118, P797; Bridges CB, 1925, AM NAT, V59, P127, DOI 10.1086/280023; Bridges CB, 1921, SCIENCE, V54, P252, DOI 10.1126/science.54.1394.252; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Burtis K.C., 1992, SEMIN DEV BIOL, V3, P331; CABRERA CV, 1991, EMBO J, V10, P2965, DOI 10.1002/j.1460-2075.1991.tb07847.x; CAUDY M, 1988, CELL, V55, P1061, DOI 10.1016/0092-8674(88)90250-4; CLINE TW, 1986, GENETICS, V113, P641; CLINE TW, 1988, GENETICS, V119, P829; CLINE TW, 1993, TRENDS GENET, V9, P385, DOI 10.1016/0168-9525(93)90138-8; CRONMILLER C, 1988, GENE DEV, V2, P1666, DOI 10.1101/gad.2.12a.1666; CRONMILLER C, 1986, DEV GENET, V7, P205, DOI 10.1002/dvg.1020070406; DELONG L, 1993, GENETICS, V133, P875; Dobzhansky T, 1934, J GENET, V28, P349, DOI 10.1007/BF02981760; DUFFY JB, 1991, GENE DEV, V5, P2176, DOI 10.1101/gad.5.12a.2176; EICHER EM, 1986, ANNU REV GENET, V20, P327, DOI 10.1146/annurev.ge.20.120186.001551; ELLIS HM, 1990, CELL, V61, P27, DOI 10.1016/0092-8674(90)90212-W; Ellis Richard, COMMUNICATION; ERICKSON JW, 1993, GENE DEV, V7, P1688, DOI 10.1101/gad.7.9.1688; ERICKSON JW, 1991, SCIENCE, V251, P1071, DOI 10.1126/science.1900130; FECHNER PY, 1993, J CLIN ENDOCR METAB, V76, P1248, DOI 10.1210/jc.76.5.1248; GARRELL J, 1990, CELL, V61, P39, DOI 10.1016/0092-8674(90)90213-X; GOODFELLOW PN, 1988, DEVELOPMENT, V102, P251; GOODFELLOW PN, 1993, ANNU REV GENET, V27, P71, DOI 10.1146/annurev.ge.27.120193.000443; GOODWIN EB, 1993, CELL, V75, P329, DOI 10.1016/0092-8674(93)80074-O; GORMAN M, 1993, CELL, V72, P39, DOI 10.1016/0092-8674(93)90048-U; GRAHAM PL, 1993, GENETICS, V133, P919; GRANADINO B, 1990, EMBO J, V9, P2597, DOI 10.1002/j.1460-2075.1990.tb07441.x; GRANADINO B, 1992, GENETICS, V130, P597; GRANADINO B, 1993, DEVELOPMENT, V118, P813; GRANT SG, 1988, ANNU REV GENET, V22, P199, DOI 10.1146/annurev.ge.22.120188.001215; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; GUBBAY J, 1990, DEVELOPMENT, V109, P647; HENIKOFF S, 1993, CELL, V72, P1, DOI 10.1016/0092-8674(93)90040-W; HODGKIN J, 1993, GENETICS, V133, P543; HODGKIN J, 1985, TRENDS GENET, V1, P85, DOI 10.1016/0168-9525(85)90032-0; HODGKIN J, 1990, NATURE, V344, P721, DOI 10.1038/344721a0; HUNTER CP, 1992, NATURE, V355, P551, DOI 10.1038/355551a0; JAFFE E, 1986, TRENDS GENET, V2, P316, DOI 10.1016/0168-9525(86)90287-8; JEPPESEN P, 1993, CELL, V74, P281, DOI 10.1016/0092-8674(93)90419-Q; KAGOSHIMA H, 1993, TRENDS GENET, V9, P338, DOI 10.1016/0168-9525(93)90026-E; KAY GF, 1993, CELL, V72, P171, DOI 10.1016/0092-8674(93)90658-D; KEYES LN, 1992, CELL, V68, P933, DOI 10.1016/0092-8674(92)90036-C; KIMBLE J, 1989, NEMATODE CAENORHABDI, P191; KLEIN RD, 1993, CELL, V72, P349, DOI 10.1016/0092-8674(93)90113-5; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; KURODA MI, 1991, CELL, V66, P935, DOI 10.1016/0092-8674(91)90439-6; KUWABARA PE, 1992, MOL BIOL CELL, V3, P461, DOI 10.1091/mbc.3.4.461; LUCCHESI JC, 1981, CHROMOSOMA, V82, P217, DOI 10.1007/BF00286106; LUCCHESI JC, 1987, ADV GENET, V24, P371, DOI 10.1016/S0065-2660(08)60013-9; MARSH JL, 1978, NATURE, V272, P249, DOI 10.1038/272249a0; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; McKeown Michael, 1992, Current Opinion in Cell Biology, V4, P948, DOI 10.1016/0955-0674(92)90123-T; MENEELY PM, IN PRESS GENETICS; MEVELNINIO M, 1991, EMBO J, V10, P2259, DOI 10.1002/j.1460-2075.1991.tb07762.x; MIGEON BR, 1979, CELL, V18, P637, DOI 10.1016/0092-8674(79)90118-1; NONET ML, 1991, NATURE, V351, P65, DOI 10.1038/351065a0; NOTHIGER R, 1989, DEVELOPMENT, V107, P505; OGATA T, 1992, J MED GENET, V29, P226, DOI 10.1136/jmg.29.4.226; OKKEMA PG, 1991, EMBO J, V10, P171, DOI 10.1002/j.1460-2075.1991.tb07933.x; OLIVER B, 1987, GENE DEV, V1, P913, DOI 10.1101/gad.1.9.913; OLIVER B, 1990, GENETICS, V125, P535; OLIVER B, 1993, DEVELOPMENT, V119, P897; PALMER MJ, 1993, GENETICS, V134, P545; PARKHURST SM, 1990, CELL, V63, P1179, DOI 10.1016/0092-8674(90)90414-A; PARKHURST SM, 1993, DEVELOPMENT, V117, P737; Parkhurst Susan M., 1992, Current Biology, V2, P629, DOI 10.1016/0960-9822(92)90097-T; PAULI D, 1993, DEVELOPMENT, V119, P123; PAULI D, 1990, TRENDS GENET, V6, P259, DOI 10.1016/0168-9525(90)90208-N; PERRY MD, 1993, GENE DEV, V7, P216, DOI 10.1101/gad.7.2.216; PLENEFISCH JD, 1989, GENETICS, V121, P57; PREAT T, 1990, NATURE, V347, P87, DOI 10.1038/347087a0; SALZ HK, 1992, GENETICS, V130, P547; SALZ HK, 1987, GENETICS, V117, P221; SAMUELS ME, 1991, MOL CELL BIOL, V11, P3584, DOI 10.1128/MCB.11.7.3584; SCHEDL T, 1988, GENETICS, V119, P43; SCHUPBACH T, 1985, GENETICS, V109, P529; SCHUPBACH T, 1982, DEV BIOL, V89, P117, DOI 10.1016/0012-1606(82)90300-1; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SPENCE AM, 1990, CELL, V60, P981, DOI 10.1016/0092-8674(90)90346-G; STEINHAUER WR, 1989, MOL CELL BIOL, V9, P5726, DOI 10.1128/MCB.9.12.5726; STEINHAUER WR, 1992, GENE DEV, V6, P233, DOI 10.1101/gad.6.2.233; Steinmann-Zwicky M, 1990, Adv Genet, V27, P189; STEINMANNZWICKY M, 1988, EMBO J, V7, P3889, DOI 10.1002/j.1460-2075.1988.tb03275.x; STEINMANNZWICKY M, 1994, DEVELOPMENT, V120, P707; STEINMANNZWICKY M, 1993, DEVELOPMENT, V117, P763; STEINMANNZWICKY M, 1992, BIOESSAYS, V14, P513, DOI 10.1002/bies.950140803; STEINMANNZWICKY M, 1989, CELL, V57, P157, DOI 10.1016/0092-8674(89)90181-5; STEINMANNZWICKY M, 1992, SEM DEV BIOL, V3, P341; TORRES M, 1992, GENET RES, V59, P189, DOI 10.1017/S0016672300030470; TORRES M, 1989, EMBO J, V8, P3079, DOI 10.1002/j.1460-2075.1989.tb08459.x; TORRES M, 1991, DEVELOPMENT, V113, P715; TRENT C, 1991, MECH DEVELOP, V34, P43, DOI 10.1016/0925-4773(91)90090-S; TURNER BM, 1992, CELL, V69, P375, DOI 10.1016/0092-8674(92)90417-B; VANDOREN M, 1991, DEVELOPMENT, V113, P245; Villeneuve A.M., 1990, Advances in Genetics, V27, P117; YOUNGERSHEPHERD S, 1992, CELL, V70, P911, DOI 10.1016/0092-8674(92)90242-5; ZARKOWER D, 1993, NUCLEIC ACIDS RES, V21, P3691, DOI 10.1093/nar/21.16.3691; ZARKOWER D, 1992, CELL, V70, P237, DOI 10.1016/0092-8674(92)90099-X	116	108	129	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 13	1994	264	5161					924	932		10.1126/science.8178152	http://dx.doi.org/10.1126/science.8178152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NK974	8178152				2022-12-28	WOS:A1994NK97400026
J	HEITMANN, BL; SORENSEN, TIA; KEIDING, N; SKAKKEBAEK, NE				HEITMANN, BL; SORENSEN, TIA; KEIDING, N; SKAKKEBAEK, NE			PREDICTING THE ADULT HEIGHT OF SHORT CHILDREN	BRITISH MEDICAL JOURNAL			English	Article							GROWTH-HORMONE THERAPY		UNIV COPENHAGEN,STAT RES UNIT,DK-2200 COPENHAGEN N,DENMARK; UNIV COPENHAGEN HOSP,RIGSHOSP,DEPT GROWTH & REPROD,DK-2100 COPENHAGEN,DENMARK	University of Copenhagen; Rigshospitalet; University of Copenhagen	HEITMANN, BL (corresponding author), KOMMUNE HOSP COPENHAGEN,INST PREVENT MED,COPENHAGEN HLTH SERV,DK-1399 COPENHAGEN K,DENMARK.			Heitmann, Berit Lilienthal/0000-0002-6809-4504				CHRISTENSEN U, 1981, HUM BIOL, V53, P403; LESAGE C, 1991, J PEDIATR-US, V119, P29, DOI 10.1016/S0022-3476(05)81034-0; SORENSEN TIA, 1988, AM J EPIDEMIOL, V127, P104, DOI 10.1093/oxfordjournals.aje.a114770; STANHOPE R, 1992, HORM RES, V38, P9, DOI 10.1159/000182563; WIT JM, 1989, ACTA PAEDIATR SCAND, V78, P426, DOI 10.1111/j.1651-2227.1989.tb11103.x	5	1	1	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 7	1994	308	6938					1207	1207		10.1136/bmj.308.6938.1207	http://dx.doi.org/10.1136/bmj.308.6938.1207			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK956	8180539	Green Published			2022-12-28	WOS:A1994NK95600021
J	MCCLELLAND, DBL; PHILLIPS, P				MCCLELLAND, DBL; PHILLIPS, P			ERRORS IN BLOOD-TRANSFUSION IN BRITAIN - SURVEY OF HOSPITAL HEMATOLOGY DEPARTMENTS	BRITISH MEDICAL JOURNAL			English	Article											MCCLELLAND, DBL (corresponding author), ROYAL INFIRM,EDINBURGH & S E SCOTLAND BLOOD TRANSFUS SERV,EDINBURGH EH3 9HB,SCOTLAND.							LINDEN JV, 1992, TRANSFUSION, V32, P601, DOI 10.1046/j.1537-2995.1992.32792391030.x; MURPHY WG, 1989, VOX SANG, V57, P59, DOI 10.1111/j.1423-0410.1989.tb04985.x; Roberts B, 1991, STANDARD HAEMATOLOGY; SAZAMA K, 1990, TRANSFUSION, V30, P583, DOI 10.1046/j.1537-2995.1990.30790385515.x	4	85	85	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 7	1994	308	6938					1205	1206		10.1136/bmj.308.6938.1205	http://dx.doi.org/10.1136/bmj.308.6938.1205			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK956	8180537	Green Published			2022-12-28	WOS:A1994NK95600019
J	LEI, KJ; SHELLY, LL; PAN, CJ; SIDBURY, JB; CHOU, JY				LEI, KJ; SHELLY, LL; PAN, CJ; SIDBURY, JB; CHOU, JY			MUTATIONS IN THE GLUCOSE-6-PHOSPHATASE GENE THAT CAUSE GLYCOGEN-STORAGE-DISEASE TYPE-1A	SCIENCE			English	Article							MICROSOMAL GLUCOSE-6-PHOSPHATASE; MULTIFUNCTIONAL GLUCOSE-6-PHOSPHATASE; ENDOPLASMIC-RETICULUM; SYSTEM; SPECIFICITY; PROTEINS	Glycogen storage disease (GSD) type 1a is caused by the deficiency Of D-glucose-6-phosphatase (G6Pase), the key enzyme in glucose homeostasis. Despite both a high incidence and morbidity, the molecular mechanisms underlying this deficiency have eluded characterization. In the present study, the molecular and biochemical characterization of the human G6Pase complementary DNA, its gene, and the expressed protein, which is indistinguishable from human microsomal G6Pase, are reported. Several mutations in the G6Pase gene of affected individuals that completely inactivate the enzyme have been identified. These results establish the molecular basis of this disease and open the way for future gene therapy.	NICHHD, HUMAN GENET BRANCH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)								ARION WJ, 1980, J BIOL CHEM, V255, P396; ARION WJ, 1972, J BIOL CHEM, V247, P2558; BEAUDET AL, 1991, HARRISONS PRINCIPLES, P1854; BURCHELL A, 1988, CLIN CHIM ACTA, V173, P183, DOI 10.1016/0009-8981(88)90256-2; COUNTAWAY JL, 1988, J BIOL CHEM, V263, P2673; GLUECKSOHNWAELSCH S, 1979, CELL, V16, P225, DOI 10.1016/0092-8674(79)90001-1; HERS H. G., 1964, ADVAN METAB DISORDERS, V1, P1; Hers HG, 1989, METABOLIC BASIS INHE, P425; HOLLIDAY R, 1993, MUTAT RES, V285, P61, DOI 10.1016/0027-5107(93)90052-H; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; JORGENSON RA, 1980, J BIOL CHEM, V255, P5907; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LANGE AJ, 1980, J BIOL CHEM, V255, P8381; LEI JK, UNPUB; NORDLIE RC, 1983, J BIOL CHEM, V258, P9739; NORDLIE RC, 1985, ENZYMES BIOL MEMBR, P349; RIPLEY LS, 1990, ANNU REV GENET, V24, P189, DOI 10.1146/annurev.ge.24.120190.001201; RUPPERT S, 1990, CELL, V61, P895, DOI 10.1016/0092-8674(90)90200-X; SCHULZE HU, 1986, J BIOL CHEM, V261, P6571; SHELLY LL, UNPUB; SINGH J, 1981, BIOCHIM BIOPHYS ACTA, V678, P477, DOI 10.1016/0304-4165(81)90129-X; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; WADDELL ID, 1991, BIOCHEM J, V275, P133, DOI 10.1042/bj2750133	24	300	312	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	1993	262	5133					580	583		10.1126/science.8211187	http://dx.doi.org/10.1126/science.8211187			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC935	8211187	Green Submitted			2022-12-28	WOS:A1993MC93500045
J	TZIANABOS, AO; ONDERDONK, AB; ROSNER, B; CISNEROS, RL; KASPER, DL				TZIANABOS, AO; ONDERDONK, AB; ROSNER, B; CISNEROS, RL; KASPER, DL			STRUCTURAL FEATURES OF POLYSACCHARIDES THAT INDUCE INTRAABDOMINAL ABSCESSES	SCIENCE			English	Article							STREPTOCOCCUS-PNEUMONIAE TYPE-1; GROUP-B STREPTOCOCCUS; BACTEROIDES-FRAGILIS; CAPSULAR POLYSACCHARIDE; IMMUNOCHEMICAL CHARACTERIZATION; NEISSERIA-MENINGITIDIS; ANTIGENS; STRAINS; COMPLEX	The capsular polysaccharide complex from Bacteroides fragilis promotes the formation of intra-abdominal abscesses-a pathologic host response to infecting microorganisms. This complex consists of two distinct polysaccharides, each with repeating units that have positively charged amino groups and negatively charged carboxyl or phosphate groups. Analysis of these polysaccharides as well as other charged carbohydrates before and after chemical modification revealed that these oppositely charged groups are required for the induction of intra-abdominal abscesses in a rat model.	HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115; HARVARD UNIV,BETH ISRAEL HOSP,SCH MED,DIV INFECT DIS,BOSTON,MA 02215	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	TZIANABOS, AO (corresponding author), HARVARD UNIV,BRIGHAM & WOMENS HOSP,SCH MED,CHANNING LAB,BOSTON,MA 02115, USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007061] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BAUMANN H, 1992, BIOCHEMISTRY-US, V31, P4081, DOI 10.1021/bi00131a026; BHATTACHARJEE AK, 1975, J BIOL CHEM, V250, P1926; GORBACH SL, 1974, NEW ENGL J MED, V290, P1177, DOI 10.1056/NEJM197405232902106; HEYNS K., 1967, CARBOHYD RES, V3, P340, DOI 10.1016/S0008-6215(00)82210-7; JENNINGS HJ, 1980, BIOCHEMISTRY-US, V19, P4712, DOI 10.1021/bi00561a026; JENNINGS HJ, 1985, J IMMUNOL, V134, P2651; JENNINGS HJ, 1983, BIOCHEMISTRY-US, V22, P1258, DOI 10.1021/bi00274a042; KASPER DL, 1975, J INFECT DIS, V132, P440, DOI 10.1093/infdis/132.4.440; KASPER DL, 1983, J BACTERIOL, V153, P991, DOI 10.1128/JB.153.2.991-997.1983; LINDBERG B, 1980, CARBOHYD RES, V78, P111, DOI 10.1016/S0008-6215(00)83664-2; LINDBERG B, 1977, CARBOHYD RES, V58, P177, DOI 10.1016/S0008-6215(00)83413-8; ONDERDONK AB, 1977, J INFECT DIS, V136, P82, DOI 10.1093/infdis/136.1.82; PANTOSTI A, 1991, INFECT IMMUN, V59, P2075, DOI 10.1128/IAI.59.6.2075-2082.1991; PANTOSTI A, 1993, J CLIN MICROBIOL, V31, P1850, DOI 10.1128/JCM.31.7.1850-1855.1993; POLK BF, 1977, ANN INTERN MED, V86, P569, DOI 10.7326/0003-4819-86-5-569; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reeves RE, 1941, J BIOL CHEM, V139, P511; SHAPIRO ME, 1986, J IMMUNOL, V137, P341; TAYLOR RL, 1972, BIOCHEMISTRY-US, V11, P1383, DOI 10.1021/bi00758a009; TZIANABOS AO, 1992, J BIOL CHEM, V267, P18230; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; WESSELS MR, 1987, J BIOL CHEM, V262, P8262	22	210	220	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 15	1993	262	5132					416	419		10.1126/science.8211161	http://dx.doi.org/10.1126/science.8211161			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB859	8211161				2022-12-28	WOS:A1993MB85900056
J	TOPOL, E; CALIFF, R; VANDEWERF, F; ARMSTRONG, PW; AYLWARD, P; BARBASH, G; BATES, E; BETRIU, A; BOISSEL, JP; CHESEBRO, J; COL, J; DEBONO, D; GORE, J; GUERCI, A; HAMPTON, J; HIRSH, J; HOLMES, D; HORGAN, J; KLEIMAN, N; MARDER, V; MORRIS, D; OHMAN, M; PFISTERER, M; ROSS, A; RUTSCH, W; SADOWSKI, Z; SIMOONS, M; VAHANIAN, A; WEAVER, WD; WHITE, H; WILCOX, R				TOPOL, E; CALIFF, R; VANDEWERF, F; ARMSTRONG, PW; AYLWARD, P; BARBASH, G; BATES, E; BETRIU, A; BOISSEL, JP; CHESEBRO, J; COL, J; DEBONO, D; GORE, J; GUERCI, A; HAMPTON, J; HIRSH, J; HOLMES, D; HORGAN, J; KLEIMAN, N; MARDER, V; MORRIS, D; OHMAN, M; PFISTERER, M; ROSS, A; RUTSCH, W; SADOWSKI, Z; SIMOONS, M; VAHANIAN, A; WEAVER, WD; WHITE, H; WILCOX, R			AN INTERNATIONAL RANDOMIZED TRIAL COMPARING 4 THROMBOLYTIC STRATEGIES FOR ACUTE MYOCARDIAL-INFARCTION	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TISSUE PLASMINOGEN-ACTIVATOR; CLINICAL-TRIALS; ALTEPLASE; PATENCY; HEPARIN; THERAPY	Background. The relative efficacy of streptokinase and tissue plasminogen activator and the roles of intravenous as compared with subcutaneous heparin as adjunctive therapy in acute myocardial infarction are unresolved questions. The current trial was designed to compare new, aggressive thrombolytic strategies with standard thrombolytic regimens in the treatment of acute myocardial infarction. Our hypothesis was that newer thrombolytic strategies that produce earlier and sustained reperfusion would improve survival. Methods. In 15 countries and 1081 hospitals, 41,021 patients with evolving myocardial infarction were randomly assigned to four different thrombolytic strategies, consisting of the use of streptokinase and subcutaneous heparin, streptokinase and intravenous heparin, accelerated tissue plasminogen activator (t-PA) and intravenous heparin, or a combination of streptokinase plus t-PA with intravenous heparin. (''Accelerated'' refers to the administration of t-PA over a period of 1 1/2 hours - with two thirds of the dose given in the first 30 minutes - rather than the conventional period of 3 hours.) The primary end point was 30-day mortality. Results. The mortality rates in the four treatment groups were as follows: streptokinase and subcutaneous heparin, 7.2 percent; streptokinase and intravenous heparin, 7.4 percent; accelerated t-PA and intravenous heparin, 6.3 percent; and the combination of both thrombolytic agents with intravenous heparin, 7.0 percent. This represented a 14 percent reduction (95 percent confidence interval, 5.9 to 21.3 percent) in mortality for accelerated t-PA as compared with the two streptokinase-only strategies (P = 0.001). The rates of hemorrhagic stroke were 0.49 percent, 0.54 percent, 0.72 percent, and 0.94 percent in the four groups, respectively, which represented a significant excess of hemorrhagic strokes for accelerated t-PA (P = 0.03) and for the combination strategy (P<0.001), as compared with streptokinase only. A combined end point of death or disabling stroke was significantly lower in the accelerated-t-PA group than in the streptokinase-only groups (6.9 percent vs. 7.8 percent, P = 0.006). Conclusions. The findings of this large-scale trial indicate that accelerated t-PA given with intravenous heparin provides a survival benefit over previous standard thrombolytic regimens.	DUKE UNIV, MED CTR, COORDINATING CTR, DURHAM, NC 27710 USA; CATHOLIC UNIV LEUVEN, INTERMEDIATE COORDINATING CTR, B-3000 LOUVAIN, BELGIUM	Duke University; KU Leuven	TOPOL, E (corresponding author), CLEVELAND CLIN FDN, DEPT CARDIOL, 1 CLIN CTR, CLEVELAND, OH 44195 USA.		Simes, Robert John/P-1497-2014					[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1990, Lancet, V336, P65; [Anonymous], 1986, Lancet, V1, P397; BLEICH SD, 1990, AM J CARDIOL, V66, P1412, DOI 10.1016/0002-9149(90)90525-6; CALIFF RM, 1991, CIRCULATION, V83, P1543, DOI 10.1161/01.CIR.83.5.1543; CARNEY RJ, 1992, J AM COLL CARDIOL, V20, P17, DOI 10.1016/0735-1097(92)90131-6; DEBONO DP, 1992, BRIT HEART J, V67, P122; GRANGER C, 1991, CIRCULATION S2, V84, P573; GRINES CL, 1991, CIRCULATION, V84, P540, DOI 10.1161/01.CIR.84.2.540; HSIA J, 1990, NEW ENGL J MED, V323, P1433, DOI 10.1056/NEJM199011223232101; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; LINCOFF AM, 1993, CIRCULATION, V87, P1792; NEUHAUS KL, 1989, J AM COLL CARDIOL, V14, P1566, DOI 10.1016/0735-1097(89)90399-9; NEUHAUS KL, 1992, J AM COLL CARDIOL, V19, P885, DOI 10.1016/0735-1097(92)90265-O; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; TOPOL EJ, 1988, CIRCULATION, V77, P1100, DOI 10.1161/01.CIR.77.5.1100; TOPOL EJ, 1992, J AM COLL CARDIOL, V19, P1123, DOI 10.1016/0735-1097(92)90312-B; TOPOL EJ, 1991, PROG CARDIOVASC DIS, V34, P165, DOI 10.1016/0033-0620(91)90011-A; VANDEWERF F, 1990, LANCET, V336, P71; 1993, LANCET, V339, P753	20	3196	3297	0	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 2	1993	329	10					673	682		10.1056/nejm199309023291001	http://dx.doi.org/10.1056/nejm199309023291001			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LU583	8204123	Bronze, Green Published			2022-12-28	WOS:A1993LU58300001
J	FIORE, MC; SMITH, SS; JORENBY, DE; BAKER, TB				FIORE, MC; SMITH, SS; JORENBY, DE; BAKER, TB			THE EFFECTIVENESS OF THE NICOTINE PATCH FOR SMOKING CESSATION - A METAANALYSIS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							TRANSDERMAL NICOTINE; CONTROLLED TRIAL; PHARMACOKINETIC PROPERTIES; REPLACEMENT THERAPY; CHEWING-GUM; SUBSTITUTION; EFFICACY; PROGRAMS; BEHAVIOR	Objective-To estimate the overall efficacy and optimal use of the nicotine patch for treating tobacco dependence. Data Sources.-Nicotine patch efficacy studies published through September 1993, identified through MEDLINE, Psychological Abstracts, and Food and Drug Administration new drug applications. Study Selection.-Double-blind, placebo-controlled nicotine patch studies of 4 weeks or longer with random assignment of subjects, biochemical confirmation of abstinence, and subjects not selected on the basis of specific diseases (eg, coronary artery disease). Data Extraction.-Pooled abstinence rates and combined odds ratios (ORs) at end of treatment and 6-month follow-up were examined overall and in terms of patch type (16-hour vs 24-hour), patch treatment duration, dosage reduction (weaning), counseling format (individual vs group), and intensity of adjuvant behavioral counseling. Data Synthesis.-Across 17 studies (n=5098 patients) meeting inclusion criteria, overall abstinence rates for the active patch were 27% (vs 13% for placebo) at the end of treatment and 22% (vs 9% for placebo) at 6 months. The combined ORs for efficacy of active patch vs placebo patch were 2.6 at the end of treatment and 3.0 at 6 months. The active patch was superior to the placebo patch regardless of patch type (16-hour vs 24-hour), patch treatment duration, weaning, counseling format, or counseling intensity. The 16-hour and 24-hour patches appeared equally efficacious, and extending treatment beyond 8 weeks did not appear to increase efficacy. The pooled abstinence data showed that intensive behavioral counseling had a reliable but modest positive impact on quit rates. Conclusions.-The nicotine patch is an effective aid to quitting smoking across different patch-use strategies. Active patch subjects were more than twice as likely to quit smoking as individuals wearing a placebo patch, and this effect was present at both high and low intensities of counseling. The nicotine patch is an effective smoking cessation aid and has the potential to improve public health significantly.	UNIV WISCONSIN,SCH MED,DEPT MED,DIV GEN INTERNAL MED,MADISON,WI; UNIV WISCONSIN,DEPT PSYCHOL,MADISON,WI 53706	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	FIORE, MC (corresponding author), UNIV WISCONSIN,SCH MED,CTR TOBACCO RES & INTERVENT,7275 MED SCI CTR,1300 UNIV AVE,MADISON,WI 53706, USA.			Smith, Stevens/0000-0002-6824-2829				ABELIN T, 1989, METHOD FIND EXP CLIN, V11, P205; ABELIN T, 1989, LANCET, V1, P7; Ball J.C., 2012, EFFECTIVENESS METHAD; BENOWITZ NL, 1993, DRUGS, V45, P157, DOI 10.2165/00003495-199345020-00001; BRESLOW NE, 1980, STATISTICAL METHODS, P1; BUCHKREMER G, 1989, ADDICT BEHAV, V14, P229, DOI 10.1016/0306-4603(89)90054-3; BUCHKREMER G, 1988, NERVENARZT, V59, P488; CEPEDABENITO A, 1993, J CONSULT CLIN PSYCH, V61, P822, DOI 10.1037/0022-006X.61.5.822; DAUGHTON DM, 1991, ARCH INTERN MED, V151, P749, DOI 10.1001/archinte.151.4.749; DICKERSIN K, 1992, EPIDEMIOL REV, V14, P154, DOI 10.1093/oxfordjournals.epirev.a036084; FIORE MC, 1990, JAMA-J AM MED ASSOC, V263, P2760, DOI 10.1001/jama.263.20.2760; FIORE MC, 1992, JAMA-J AM MED ASSOC, V268, P2687, DOI 10.1001/jama.268.19.2687; FIORE MC, 1994, CHEST, V105, P524, DOI 10.1378/chest.105.2.524; Fleiss JL, 1981, STAT METHODS RATES P; FOULDS J, 1992, PSYCHOPHARMACOLOGY, V106, P421, DOI 10.1007/BF02245429; GLOVER ED, 1993, HEALTH VALUES, V17, P69; GLYNN TJ, 1990, PHS NIH903064 US DEP; HARTMAN N, 1991, AM J PSYCHIAT, V148, P374; Hedges L, 1985, STATISTICAL METHODS; HUGHES JR, 1993, J CONSULT CLIN PSYCH, V61, P751, DOI 10.1037/0022-006X.61.5.751; Hughes JR, 1993, HEALTH VALUES, V17, P25; HURT RD, 1990, MAYO CLIN PROC, V65, P1529, DOI 10.1016/S0025-6196(12)62186-7; HURT RD, 1994, JAMA-J AM MED ASSOC, V271, P595, DOI 10.1001/jama.271.8.595; HURT RD, 1993, CLIN PHARMACOL THER, V54, P98, DOI 10.1038/clpt.1993.117; KOTTKE TE, 1988, JAMA-J AM MED ASSOC, V259, P2883; KRUMPE P, 1989, American Review of Respiratory Disease, V139, pA337; LAM W, 1987, LANCET, V2, P27; LEVENTHAL H, 1989, SMOKING HUMAN BEHAVI, P313; LICHTENSTEIN E, 1992, J FAM PRACTICE, V34, P739; MANTEL N, 1959, J NATL CANCER I, V22, P719; MCAFEE T, 1993, JAMA-J AM MED ASSOC, V269, P1939, DOI 10.1001/jama.1993.03500150047014; MCKENNA JP, 1992, AM FAM PHYSICIAN, V45, P2595; MEIERLAMMERMAN E, 1990, EUR RESPIR J S10, V3, pS168; MOSTELLER F, 1992, STAT SCI, V7, P227; MULLIGAN SC, 1990, CLIN PHARMACOL THER, V47, P331, DOI 10.1038/clpt.1990.36; ORLEANS CT, 1994, JAMA-J AM MED ASSOC, V271, P601, DOI 10.1001/jama.271.8.601; ORLEANS CT, 1993, NICOTINE ADDICTION P, P145; PALMER KJ, 1992, DRUGS, V44, P498, DOI 10.2165/00003495-199244030-00011; RENNARD S, 1991, CHEST, V100, pS5; ROSE JE, 1990, CLIN PHARMACOL THER, V47, P323, DOI 10.1038/clpt.1990.35; RUSSELL MAH, 1993, BRIT MED J, V306, P1308, DOI 10.1136/bmj.306.6888.1308; SCHS DPL, 1993, ARCH INTERN MED, V153, P1881; TONNESEN P, 1991, NEW ENGL J MED, V325, P311, DOI 10.1056/NEJM199108013250503; WESTMAN EC, 1993, ARCH INTERN MED, V153, P1917, DOI 10.1001/archinte.153.16.1917; 1992, PROSTEP NICOTINE TRA; 1992, HABITROL NICOTINE TR; 1993, BRIT MED J, V306, P1304; 1992, 1 KAB PHARM STUD; 1992, NICOTROL NICOTINE TR; 1992, 9001 EL PHARM RES CO; 1992, 9003 EL PHARM RES CO; 1991, NICODERM NICOTINE TR; 1988, CDC888406 US DEP HLT; 1992, FDA3087 CIBA GEIGY C; 1991, 011 MAR MERR DOW STU; 1991, 010 MAR MERR DOW STU; 1992, 8801 EL PHARM RES CO; 1992, 7 KAB PHARM STUD; 1988, SAS STAT USERS GUIDE; 1991, JAMA-J AM MED ASSOC, V266, P3133; 1992, 8802 EL PHARM RES CO	61	490	504	1	33	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	1994	271	24					1940	1947		10.1001/jama.271.24.1940	http://dx.doi.org/10.1001/jama.271.24.1940			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR598	8201739				2022-12-28	WOS:A1994NR59800032
J	FONTHAM, ETH; CORREA, P; REYNOLDS, P; WUWILLIAMS, A; BUFFLER, PA; GREENBERG, RS; CHEN, VW; ALTERMAN, T; BOYD, P; AUSTIN, DF; LIFF, J				FONTHAM, ETH; CORREA, P; REYNOLDS, P; WUWILLIAMS, A; BUFFLER, PA; GREENBERG, RS; CHEN, VW; ALTERMAN, T; BOYD, P; AUSTIN, DF; LIFF, J			ENVIRONMENTAL TOBACCO-SMOKE AND LUNG-CANCER IN NONSMOKING WOMEN - A MULTICENTER STUDY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PASSIVE SMOKING; RISK-FACTORS; EXPOSURE; VALIDATION; COTININE	Objective.-To determine the relative risk (RR) of lung cancer in lifetime never smokers associated with environmental tobacco smoke (ETS) exposure. Design.-Multicenter population-based case-control study. Setting.-Five metropolitan areas in the United States: Atlanta, Ga, Houston, Tex, Los Angeles, Calif, New Orleans, La, and the San Francisco Bay Area, Calif. Patients or Other Participants or Other Participants.-Female lifetime never smokers: 653 cases with histologically confirmed lung cancer and 1253 controls selected by random digit dialing and random sampling from the Health Care Financing Administration files for women aged 65 years and older. Main Outcome Measure.-The RR of lung cancer, estimated by adjusted odds ratio (OR) with 95% confidence interval (Cl), associated with ETS exposure. Results.-Tobacco use by spouse(s) was associated with a 30% excess risk of lung cancer: all types of primary lung carcinoma (adjusted OR=1.29; P<.05), pulmonary adenocarcinoma (adjusted OR=1.28; P<.05), and other primary carcinomas of the lung (adjusted OR=1.37; P=.18). An increasing RR of lung cancer was observed with increasing pack-years of spousal ETS exposure (trend P=.03), such that an 80% excess risk of lung cancer was observed for subjects with 80 or more pack-years of exposure from a spouse (adjusted OR=1.79; 95% Cl=0.99 to 3.25). The excess risk of lung cancer among women ever exposed to ETS during adult life in the household was 24%; in the workplace, 39%; and in social settings, 50%. When these sources were considered jointly, an increasing risk of lung cancer with increasing duration of exposure was observed (trend P=.001). At the highest level of exposure, there was a 75% increased risk. No significant association was found between exposure during childhood to household ETS exposure from mother, father, or other household members; however, women who were exposed during childhood had higher RRs associated with adult-life ETS exposures than women with no childhood exposure. At the highest level of adult smoke-years of exposure, the ORs for women with and without childhood exposures were 3.25 (95% Cl, 2.42 to 7.46) and 1.77 (95% Cl, 0.98 to 3.19), respectively. Conclusion.-Exposure to ETS during adult life increases risk of lung cancer in lifetime nonsmokers.	CALIF DEPT HLTH SERV,EMERYVILLE,CA; UNIV SO CALIF,SCH MED,LOS ANGELES,CA; UNIV TEXAS,HLTH SCI CTR,SCH PUBL HLTH,HOUSTON,TX; EMORY UNIV,SCH PUBL HLTH,ATLANTA,GA; CALIF PULB HLTH FDN,EMERYVILLE,CA	California Department of Health Care Services; University of Southern California; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Emory University	FONTHAM, ETH (corresponding author), LOUISIANA STATE UNIV,MED CTR,DEPT PATHOL,1901 PERDIDO ST,NEW ORLEANS,LA 70112, USA.		Alterman, Toni/AAB-5639-2022	Alterman, Toni/0000-0003-1512-4367	NATIONAL CANCER INSTITUTE [R01CA040095] Funding Source: NIH RePORTER; NCI NIH HHS [CA40095] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AKIBA S, 1986, CANCER RES, V46, P4804; [Anonymous], 1986, ENV TOBACCO SMOKE ME; BROWNSON RC, 1987, AM J EPIDEMIOL, V125, P25, DOI 10.1093/oxfordjournals.aje.a114509; BROWNSON RC, 1992, AM J PUBLIC HEALTH, V82, P1525, DOI 10.2105/AJPH.82.11.1525; BRUNNEMANN KD, 1992, CARCINOGENESIS, V13, P2415, DOI 10.1093/carcin/13.12.2415; BUFFLER PA, 1984, LUNG CANCER CAUSES P, P83; BUTLER TL, 1988, THESIS U CALIFORNIA; CHAN WC, 1982, CANCER CAMPAIGN, V6, P199; CORREA P, 1983, LANCET, V2, P595; COULTAS DB, 1989, AM J EPIDEMIOL, V130, P338, DOI 10.1093/oxfordjournals.aje.a115340; COULTAS DB, 1990, AM J PUBLIC HEALTH, V80, P988, DOI 10.2105/AJPH.80.8.988; GAO YT, 1987, INT J CANCER, V40, P604, DOI 10.1002/ijc.2910400505; GARFINKEL L, 1981, JNCI-J NATL CANCER I, V66, P1061, DOI 10.1093/jnci/66.6.1061; GARFINKEL L, 1985, J NATL CANCER I, V75, P463; GENG GY, 1988, SMOKING HLTH 1987, P483; HALEY NJ, 1983, AM J PUBLIC HEALTH, V73, P1204, DOI 10.2105/AJPH.73.10.1204; HALEY NJ, 1989, ENVIRON RES, V49, P127, DOI 10.1016/S0013-9351(89)80027-1; HIRAYAMA T, 1984, PREV MED, V13, P680, DOI 10.1016/S0091-7435(84)80017-1; HOFFMANN D, 1984, PREV MED, V13, P608, DOI 10.1016/S0091-7435(84)80011-0; HOLE DJ, 1989, BRIT MED J, V299, P423, DOI 10.1136/bmj.299.6696.423; HUMBLE CG, 1987, AM J PUBLIC HEALTH, V77, P598, DOI 10.2105/AJPH.77.5.598; INOUE R, 1988, SMOKING HLTH 1987, P283; JANERICH DT, 1990, NEW ENGL J MED, V323, P632, DOI 10.1056/NEJM199009063231003; JARVIS MJ, 1987, AM J PUBLIC HEALTH, V77, P1435, DOI 10.2105/AJPH.77.11.1435; KABAT GC, 1984, CANCER, V53, P1214, DOI 10.1002/1097-0142(19840301)53:5<1214::AID-CNCR2820530532>3.0.CO;2-8; KALANDIDI A, 1990, CANCER CAUSE CONTROL, V1, P15, DOI 10.1007/BF00053179; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES; KOO LC, 1987, INT J CANCER, V39, P162, DOI 10.1002/ijc.2910390207; LAM TH, 1987, BRIT J CANCER, V6, P673; LAM WK, 1985, THESIS U HONG KONG H; LANGONE JJ, 1973, BIOCHEMISTRY-US, V12, P5025, DOI 10.1021/bi00748a032; LEE PN, 1986, BRIT J CANCER, V54, P97, DOI 10.1038/bjc.1986.157; LEMARCHAND L, 1991, CANCER CAUSE CONTROL, V2, P11, DOI 10.1007/BF00052356; LIU ZY, 1991, INT J EPIDEMIOL, V20, P26, DOI 10.1093/ije/20.1.26; MATTSON ME, 1989, JAMA-J AM MED ASSOC, V261, P867, DOI 10.1001/jama.261.6.867; PERSHAGEN G, 1987, AM J EPIDEMIOL, V125, P17, DOI 10.1093/oxfordjournals.aje.a114504; PRON GE, 1988, AM J EPIDEMIOL, V127, P267, DOI 10.1093/oxfordjournals.aje.a114802; RIBOLI E, 1990, CANCER CAUSE CONTROL, V1, P243, DOI 10.1007/BF00117476; RIES LAG, 1991, NIH912789 PUBL; Schlesselman JJ, 1982, CASE CONTROL STUDIES; SHIMIZU H, 1988, TOHOKU J EXP MED, V154, P389, DOI 10.1620/tjem.154.389; SOBUE T, 1990, GAN NO RINSHO, V36, P329; STOCKWELL HG, 1992, J NATL CANCER I, V84, P1417, DOI 10.1093/jnci/84.18.1417; SVENSSON C, 1989, ACTA ONCOL, V28, P623, DOI 10.3109/02841868909092282; TRICHOPOULOS D, 1983, LANCET, V2, P667; WU AH, 1985, JNCI-J NATL CANCER I, V74, P747; WUWILLIAMS AH, 1990, RISK ANAL, V10, P39, DOI 10.1111/j.1539-6924.1990.tb01018.x; WYNDER EL, 1983, EPIDEMIOL REV, V5, P177, DOI 10.1093/oxfordjournals.epirev.a036258	48	202	207	1	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	1994	271	22					1752	1759		10.1001/jama.271.22.1752	http://dx.doi.org/10.1001/jama.271.22.1752			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NN725	8196118				2022-12-28	WOS:A1994NN72500024
J	HALACHMI, S; MARDEN, E; MARTIN, G; MACKAY, H; ABBONDANZA, C; BROWN, M				HALACHMI, S; MARDEN, E; MARTIN, G; MACKAY, H; ABBONDANZA, C; BROWN, M			ESTROGEN RECEPTOR-ASSOCIATED PROTEINS - POSSIBLE MEDIATORS OF HORMONE-INDUCED TRANSCRIPTION	SCIENCE			English	Article							HUMAN GLUCOCORTICOID RECEPTOR; DNA-BINDING; TRANSACTIVATION DOMAINS; FUNCTIONAL DOMAINS; GENE ACTIVATION; IDENTIFICATION; EXPRESSION; MULTIPLE; INHIBITION; REGION	The estrogen receptor is a transcription factor which, when bound to estradiol, binds DNA and regulates expression of estrogen-responsive genes. A 160-kilodalton estrogen receptor-associated protein, ERAP160, was identified that exhibits estradiol-dependent binding to the receptor. Mutational analysis of the receptor shows that its ability to activate transcription parallels its ability to bind ERAP160. Antiestrogens are unable to promote ERAP160 binding and can block the estrogen-dependent interaction of the receptor and ERAP160 in a dose-dependent manner. This evidence suggests that ERAP160 may mediate estradiol-dependent transcriptional activation by the estrogen receptor. Furthermore, the ability of antiestrogens to block estrogen receptor-ERAP160 complex formation could account for their therapeutic effects in breast cancer.	HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115; DANA FARBER CANC INST,DIV NEOPLAST DIS MECHANISMS,BOSTON,MA 02115; HARVARD UNIV,SCH MED,PROGRAM BIOL & BIOMED SCI,BOSTON,MA 02115; FAC MED & CHIRURG NAPLES,INST PATOL GEN & ONCOL,I-80138 NAPLES,ITALY	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Naples Federico II			Brown, Myles/AAX-5332-2021; Brown, Myles/B-6906-2008	Brown, Myles/0000-0002-8213-1658; ABBONDANZA, Ciro/0000-0001-5346-4835; Halachmi, Shlomit/0000-0001-5921-9515				ABBONDANZA C, 1993, STEROIDS, V58, P4, DOI 10.1016/0039-128X(93)90011-B; ALLAN GF, 1992, J BIOL CHEM, V267, P19513; BANIAHMAD A, 1993, J CELL BIOCHEM, V51, P151, DOI 10.1002/jcb.240510206; BASTIAN LS, 1991, MOL ENDOCRINOL, V5, P619, DOI 10.1210/mend-5-5-619; BEEKMAN JM, 1993, MOL ENDOCRINOL, V7, P1266, DOI 10.1210/me.7.10.1266; BERRY M, 1990, EMBO J, V9, P2811, DOI 10.1002/j.1460-2075.1990.tb07469.x; BROWN M, 1990, J BIOL CHEM, V265, P11238; BROWN MA, UNPUB; DANIELIAN PS, 1992, EMBO J, V11, P1025, DOI 10.1002/j.1460-2075.1992.tb05141.x; DAUVOIS S, 1992, P NATL ACAD SCI USA, V89, P4037, DOI 10.1073/pnas.89.9.4037; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FAWELL SE, 1990, P NATL ACAD SCI USA, V87, P6883, DOI 10.1073/pnas.87.17.6883; GIGUERE V, 1986, CELL, V46, P645, DOI 10.1016/0092-8674(86)90339-9; GRONEMEYER H, 1993, J RECEPTOR RES, V13, P667, DOI 10.3109/10799899309073686; HALACHMI S, UNPUB; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; KRUST A, 1986, EMBO J, V5, P891, DOI 10.1002/j.1460-2075.1986.tb04300.x; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; KUMAR V, 1986, EMBO J, V5, P2231, DOI 10.1002/j.1460-2075.1986.tb04489.x; KUMAR V, 1988, CELL, V55, P145, DOI 10.1016/0092-8674(88)90017-7; LEES JA, 1989, NUCLEIC ACIDS RES, V17, P5477, DOI 10.1093/nar/17.14.5477; LEES JA, 1989, J STEROID BIOCHEM, V34, P33, DOI 10.1016/0022-4731(89)90063-0; MARTINEZ E, 1991, MOL CELL BIOL, V11, P2937, DOI 10.1128/MCB.11.6.2937; MEYER ME, 1989, CELL, V57, P433, DOI 10.1016/0092-8674(89)90918-5; Parker MG, 1993, CURR OPIN CELL BIOL, V5, P499, DOI 10.1016/0955-0674(93)90016-J; RATKO TA, 1989, CANCER RES, V49, P4472; REESE JC, 1991, J BIOL CHEM, V266, P10880; RUSCONI S, 1987, EMBO J, V6, P1309, DOI 10.1002/j.1460-2075.1987.tb02369.x; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; SEGARS JH, 1993, MOL CELL BIOL, V13, P2258, DOI 10.1128/MCB.13.4.2258; TORA L, 1989, CELL, V59, P477, DOI 10.1016/0092-8674(89)90031-7; TORA L, 1988, NATURE, V333, P185, DOI 10.1038/333185a0; TORA L, 1989, EMBO J, V8, P1981, DOI 10.1002/j.1460-2075.1989.tb03604.x; WEBSTER NJG, 1988, CELL, V54, P199, DOI 10.1016/0092-8674(88)90552-1; WHITE JH, 1988, COLD SPRING HARB SYM, V53, P819, DOI 10.1101/SQB.1988.053.01.093; WHITE R, 1987, MOL ENDOCRINOL, V1, P735, DOI 10.1210/mend-1-10-735	37	573	588	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 3	1994	264	5164					1455	1458		10.1126/science.8197458	http://dx.doi.org/10.1126/science.8197458			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NP221	8197458				2022-12-28	WOS:A1994NP22100041
J	GORE, JM; DALEN, JE				GORE, JM; DALEN, JE			CARDIOVASCULAR-DISEASE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHOLESTEROL; ASPIRIN		UNIV ARIZONA, HLTH SCI CTR, TUCSON, AZ USA	University of Arizona; University of Arizona Health Sciences	GORE, JM (corresponding author), UNIV MASSACHUSETTS, SCH MED, WORCESTER, MA USA.							[Anonymous], 1993, Lancet, V342, P767; HAMPTON J, 1993, LANCET, V342, P759; JOHNSON CL, 1993, JAMA-J AM MED ASSOC, V269, P3002, DOI 10.1001/jama.269.23.3002; MILLER VT, 1993, NEUROLOGY, V43, P32, DOI 10.1212/WNL.43.1_Part_1.32; ROSS AM, 1993, NEW ENGL J MED, V329, P1615; SMITH GD, 1993, BMJ-BRIT MED J, V306, P1367, DOI 10.1136/bmj.306.6889.1367; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; TURPIE AGG, 1993, NEW ENGL J MED, V329, P524, DOI 10.1056/NEJM199308193290802; WARSHAFSKY S, 1993, ANN INTERN MED, V119, P599, DOI 10.7326/0003-4819-119-7_Part_1-199310010-00009; 1993, LANCET, V342, P1255	10	14	14	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1660	1661		10.1001/jama.271.21.1660	http://dx.doi.org/10.1001/jama.271.21.1660			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182837				2022-12-28	WOS:A1994NN11700016
J	LIPKIN, M; LINK, RN; SCHWARTZ, MD				LIPKIN, M; LINK, RN; SCHWARTZ, MD			GENERAL INTERNAL-MEDICINE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FECAL OCCULT BLOOD; COLORECTAL-CANCER; USERS GUIDES; THERAPY; RISK; MORTALITY; EFFICACY; MEN		BELLEVUE HOSP CTR, NEW YORK, NY USA; GOUVERNEUR HOSP, NEW YORK, NY USA	Bellevue Hospital Center	LIPKIN, M (corresponding author), NYU, MED CTR, NEW YORK, NY 10016 USA.			Lipkin, Mack/0000-0001-9970-0725; Schwartz, Mark/0000-0002-7123-0060				ATKINS D, 1993, ANN INTERN MED, V119, P136, DOI 10.7326/0003-4819-119-2-199307150-00008; BUTLER JC, 1993, JAMA-J AM MED ASSOC, V270, P1826, DOI 10.1001/jama.270.15.1826; COHEN JJ, 1993, ANN INTERN MED, V119, P1125, DOI 10.7326/0003-4819-119-11-199312010-00010; GROVER SA, 1993, JAMA-J AM MED ASSOC, V270, P2218, DOI 10.1001/jama.270.18.2218; GUYATT GH, 1993, JAMA-J AM MED ASSOC, V270, P2598, DOI 10.1001/jama.270.21.2598; HOBSON RW, 1993, NEW ENGL J MED, V328, P221, DOI 10.1056/NEJM199301283280401; HOLLEMAN DR, 1993, J GEN INTERN MED, V8, P63, DOI 10.1007/BF02599985; KELLERMANN AL, 1993, NEW ENGL J MED, V329, P1084, DOI 10.1056/NEJM199310073291506; KROENKE K, 1993, J GEN INTERN MED, V8, P530, DOI 10.1007/BF02599633; LEVINSON W, 1993, J GEN INTERN MED, V8, P318, DOI 10.1007/BF02600146; MANDEL JS, 1993, NEW ENGL J MED, V328, P1365, DOI 10.1056/NEJM199305133281901; MATERSON BJ, 1993, NEW ENGL J MED, V328, P914, DOI 10.1056/NEJM199304013281303; NABULSI AA, 1993, NEW ENGL J MED, V328, P1069, DOI 10.1056/NEJM199304153281501; OXMAN AD, 1993, JAMA-J AM MED ASSOC, V270, P2093; RAVID M, 1993, ANN INTERN MED, V118, P577, DOI 10.7326/0003-4819-118-8-199304150-00001; SAUVE JS, 1993, JAMA-J AM MED ASSOC, V270, P2843, DOI 10.1001/jama.270.23.2843; SCHAPIRA MM, 1993, ANN INTERN MED, V118, P838, DOI 10.7326/0003-4819-118-11-199306010-00002; SELBY JV, 1993, ANN INTERN MED, V118, P1, DOI 10.7326/0003-4819-118-1-199301010-00001; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; TAMAYO SG, 1993, J GEN INTERN MED, V8, P69, DOI 10.1007/BF02599986; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; WALKER EA, 1993, J GEN INTERN MED, V8, P436, DOI 10.1007/BF02599621; YINGLING KW, 1993, J GEN INTERN MED, V8, P231	23	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1672	1673						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182844				2022-12-28	WOS:A1994NN11700023
J	PELLEGRINO, ED				PELLEGRINO, ED			ETHICS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNIVERSAL HEALTH-INSURANCE; FINANCIAL INCENTIVES; PROMOTE QUALITY; CARE; PHYSICIANS; SYSTEM; COMPETITION; ECONOMY; REFORM; 1990S				PELLEGRINO, ED (corresponding author), GEORGETOWN UNIV, WASHINGTON, DC USA.							AGICH GJ, 1985, SOC SCI MED, V21, P623, DOI 10.1016/0277-9536(85)90201-1; BLANK RH, 1988, RATIONING MED, P80; EISENBERG JM, 1985, ANN INTERN MED, V102, P537, DOI 10.7326/0003-4819-102-4-537; EMANUEL EJ, 1993, NEW ENGL J MED, V329, P879, DOI 10.1056/NEJM199309163291213; ENTHOVEN A, 1989, NEW ENGL J MED, V320, P94, DOI 10.1056/NEJM198901123200205; ENTHOVEN A, 1989, NEW ENGL J MED, V320, P29, DOI 10.1056/NEJM198901053200106; ENTHOVEN AC, 1991, JAMA-J AM MED ASSOC, V265, P2532, DOI 10.1001/jama.265.19.2532; GINZBERG E, 1983, JAMA-J AM MED ASSOC, V249, P1857, DOI 10.1001/jama.249.14.1857; HEMENWAY D, 1990, NEW ENGL J MED, V322, P1059, DOI 10.1056/NEJM199004123221507; HILLMAN AL, 1989, NEW ENGL J MED, V321, P86, DOI 10.1056/NEJM198907133210205; HILLMAN AL, 1987, NEW ENGL J MED, V317, P1743, DOI 10.1056/NEJM198712313172725; HIRSHFELD EB, 1992, U PENN LAW REV, V140, P1809, DOI 10.2307/3312431; IGLEHART JK, 1992, NEW ENGL J MED, V327, P742, DOI 10.1056/NEJM199209033271029; MECHANIC D, 1992, U PENN LAW REV, V140, P1713, DOI 10.2307/3312429; MENZEL PT, 1987, J MED PHILOS, V12, P63, DOI 10.1093/jmp/12.1.63; MILLER FH, 1992, AM J LAW MED, V18, P37; MORREIM EH, 1991, ARCH INTERN MED, V151, P443, DOI 10.1001/archinte.151.3.443; Pelligrino E D, 1986, J Contemp Health Law Policy, V2, P23; POVAR G, 1988, ANN INTERN MED, V109, P419, DOI 10.7326/0003-4819-109-5-419; RICE T, 1993, JAMA-J AM MED ASSOC, V270, P1357, DOI 10.1001/jama.270.11.1357; RULIDIS ZC, IN PRESS CLIN RES; SULMASY DP, 1985, ANN INTERN MED, V102, P537	22	30	30	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1668	1670		10.1001/jama.271.21.1668	http://dx.doi.org/10.1001/jama.271.21.1668			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182842				2022-12-28	WOS:A1994NN11700021
J	WATTS, NB; BLEVINS, LS				WATTS, NB; BLEVINS, LS			ENDOCRINOLOGY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONVERTING ENZYME-INHIBITION; DIABETIC NEPHROPATHY; THYROXINE				WATTS, NB (corresponding author), EMORY UNIV, SCH MED, ATLANTA, GA USA.							CAMPBELL NRC, 1992, ANN INTERN MED, V117, P1010, DOI 10.7326/0003-4819-117-12-1010; DEMKE DM, 1989, NEW ENGL J MED, V321, P1341; HARMON SM, 1991, ANN INTERN MED, V115, P658, DOI 10.7326/0003-4819-115-8-658_2; HAVRANKOVA J, 1992, ANN INTERN MED, V117, P445, DOI 10.7326/0003-4819-117-5-445_3; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; RAVID M, 1993, ANN INTERN MED, V118, P577, DOI 10.7326/0003-4819-118-8-199304150-00001; REICHARD P, 1993, NEW ENGL J MED, V329, P304, DOI 10.1056/NEJM199307293290502; REINCKE M, 1992, J CLIN ENDOCR METAB, V75, P826, DOI 10.1210/jc.75.3.826; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SOLOMON BL, 1993, CLIN ENDOCRINOL, V38, P39, DOI 10.1111/j.1365-2265.1993.tb00970.x; SPERBER AD, 1992, ARCH INTERN MED, V152, P183, DOI 10.1001/archinte.152.1.183; WATTS NB, 1991, CLIN CHEM, V37, P2027	12	5	5	1	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1666	1668						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182841				2022-12-28	WOS:A1994NN11700020
J	VLADECK, BC				VLADECK, BC			MEDICARE HOME HEALTH INITIATIVE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											VLADECK, BC (corresponding author), HLTH CARE FINANCING ADM,WASHINGTON,DC, USA.								0	9	9	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	1994	271	20					1566	1566						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NL758	8182796				2022-12-28	WOS:A1994NL75800006
J	LAUNBJERG, J; FRUERGAARD, P; MADSEN, JK; MORTENSEN, LS; HANSEN, JF				LAUNBJERG, J; FRUERGAARD, P; MADSEN, JK; MORTENSEN, LS; HANSEN, JF			10-YEAR MORTALITY IN PATIENTS WITH SUSPECTED ACUTE MYOCARDIAL-INFARCTION	BRITISH MEDICAL JOURNAL			English	Article							CORONARY-CARE UNIT; CHEST PAIN; CONFIRMED DIAGNOSIS; 5-YEAR MORTALITY; UNSTABLE ANGINA; RISK-FACTORS; FOLLOW-UP; PROGNOSIS; SURVIVAL	Objective-To describe the 10 year mortality in patients with suspected acute myocardial infarction. Design-Follow up of all patients below 76 years of age admitted with acute chest pain to 16 coronary care units participating in the Danish verapamil infarction trial in 1979-81. Subjects-Of the 5993 patients included, 2586 had definite infarction, 402 had probable infarction, and 3005 did not have infarction. Main outcome measures-Death and cause of death. Standardised mortality ratio (observed mortality/expected mortality in background population). Results-The estimated 10 year mortalities were 58.8%, 55.5%, and 42.8% in patients with definite, probable, and no infarction, respectively (P<0.0001). Stratified Cox's analysis identified a hazard ratio for mortality of 1.25 (95% confidence interval 1.08 to 1.44) for probable infarction compared with no infarction and of 1.15 (1.00 to 1.32) for definite compared with probable infarction. The standardised mortality ratio in the first year was 7.1 (6.5 to 7.8) for definite infarction, 5.0 (3.6 to 6.3) for probable infarction, and 4.7 (4.2 to 5.2) for no infarction. From the second year and onwards the annual standardised mortality ratio in the three groups did not differ significantly. Cardiac causes of deaths were recorded in 89%, 84%, and 71% of the deaths in patients with definite, probable, and no infarction, respectively. Conclusions-The 10 year mortality of patients with and without infarction is significantly higher than in the background population. Most deaths are caused by coronary heart disease, and these patients should consequently be further evaluated at the time of discharge and followed up closely.	CENT HOSP HILLEROD,DEPT MED B,DK-3400 HILLEROD,DENMARK; UNIC,DANISH COMP CTR RES & EDUC,DK-8200 AARHUS,DENMARK; HVIDOVRE UNIV HOSP,DEPT CARDIOL,DK-2650 HVIDOVRE,DENMARK	University of Copenhagen	LAUNBJERG, J (corresponding author), UNIV COPENHAGEN HOSP,RIGSHOSP,DEPT MED B2124,BLEGDAMSVEJ,DK-2100 COPENHAGEN,DENMARK.							DAVIES HA, 1982, JAMA-J AM MED ASSOC, V248, P2274, DOI 10.1001/jama.248.18.2274; ENGBY B, 1985, ACTA MED SCAND, V217, P465; FRORUP E, 1988, STATISTICAL YB, V92, P37; GRANBORG J, 1986, AM J CARDIOL, V57, P203, DOI 10.1016/0002-9149(86)90891-X; Henning R, 1981, Eur Heart J, V2, P65; HERLITZ J, 1988, CARDIOLOGY, V75, P250, DOI 10.1159/000174381; JOHANSSON S, 1984, AM J EPIDEMIOL, V119, P610, DOI 10.1093/oxfordjournals.aje.a113778; LAUNBJERG J, 1993, CORONARY ARTERY DIS, V4, P195, DOI 10.1097/00019501-199302000-00010; LAUNBJERG J, 1991, AM HEART J, V122, P1270, DOI 10.1016/0002-8703(91)90565-Y; LAUNBJERG J, 1990, CLIN PHYSIOL, V10, P273, DOI 10.1111/j.1475-097X.1990.tb00096.x; MADSEN JK, 1982, ACTA MED SCAND, V211, P453; MADSEN JK, 1987, AM J CARDIOL, V59, P1064, DOI 10.1016/0002-9149(87)90849-6; MARTIN CA, 1983, CIRCULATION, V68, P961, DOI 10.1161/01.CIR.68.5.961; MERRILEES MA, 1984, BRIT MED J, V288, P356, DOI 10.1136/bmj.288.6414.356; METCALFE MJ, 1990, BRIT HEART J, V63, P267; MULCAHY R, 1985, AM HEART J, V109, P753, DOI 10.1016/0002-8703(85)90634-9; PARISI AF, 1989, CIRCULATION, V80, P1176, DOI 10.1161/01.CIR.80.5.1176; POHJOLA S, 1980, BRIT HEART J, V43, P176, DOI 10.1136/hrt.43.2.176; Rose G, 1982, CARDIOVASCULAR SURVE; SCHROEDER JS, 1980, NEW ENGL J MED, V303, P1, DOI 10.1056/NEJM198007033030101; SMYLLIE HC, 1986, BRIT MED J, V293, P541, DOI 10.1136/bmj.293.6546.541-a; WIELGOSZ AT, 1984, AM HEART J, V108, P67, DOI 10.1016/0002-8703(84)90546-5; WILCOX RG, 1981, BRIT MED J, V282, P431, DOI 10.1136/bmj.282.6262.431; WONG ND, 1989, AM J EPIDEMIOL, V130, P469, DOI 10.1093/oxfordjournals.aje.a115360; 1984, EUR HEART J, V5, P516; 1983, NEW ENGL J MED, V309, P331	26	23	25	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 7	1994	308	6938					1196	1199		10.1136/bmj.308.6938.1196	http://dx.doi.org/10.1136/bmj.308.6938.1196			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK956	8180535	Green Published			2022-12-28	WOS:A1994NK95600017
J	NIGHTINGALE, SL				NIGHTINGALE, SL			MEDICAL DEVICE TRACKING RULE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											NIGHTINGALE, SL (corresponding author), US FDA,OFF HLTH AFFAIRS,PARKLAWN BLDG,5600 FISHERS LN,ROCKVILLE,MD 20857, USA.							1993, FED REG         0816, V58, P43442	1	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	1993	270	19					2283	2283		10.1001/jama.270.19.2283	http://dx.doi.org/10.1001/jama.270.19.2283			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MF993	8230583				2022-12-28	WOS:A1993MF99300006
J	KAWACHI, I; COLDITZ, GA; STAMPFER, MJ; WILLETT, WC; MANSON, JE; ROSNER, B; HUNTER, DJ; HENNEKENS, CH; SPEIZER, FE				KAWACHI, I; COLDITZ, GA; STAMPFER, MJ; WILLETT, WC; MANSON, JE; ROSNER, B; HUNTER, DJ; HENNEKENS, CH; SPEIZER, FE			SMOKING CESSATION IN RELATION TO TOTAL MORTALITY-RATES IN WOMEN - A PROSPECTIVE COHORT STUDY	ANNALS OF INTERNAL MEDICINE			English	Article						SMOKING CESSATION; MORTALITY; WOMENS HEALTH; SMOKING	CORONARY HEART-DISEASE; ALCOHOL-CONSUMPTION; PHYSICAL-ACTIVITY; BRITISH DOCTORS; DEPRESSION; RISK; QUESTIONNAIRE; DEATH; MEN	Objective: To examine the temporal relationship between stopping smoking and total mortality rates among middle-aged women. Design: Prospective cohort study with 12 years of follow-up. Setting: Registered nurses residing in the United States. Participants: 117 001 female registered nurses, ages 30 to 55 years, who were free of manifest coronary heart disease, stroke, and cancer (except nonmelanoma skin cancer) in 1976. Main Outcome Measures: Total mortality, further categorized into deaths from cardiovascular diseases, cancers, and violent deaths. Results: A total of 2847 deaths (933 among ''never smokers,'' 799 among former smokers, and 1115 among current smokers) occurred during 1.37 million person-years of follow-up. The multivariate relative risks for total mortality compared with never smokers were 1.87 (95% CI, 1.65 to 2.13) for current smokers and 1.29 (CI, 1.14 to 1.46) for former smokers. Participants who started smoking before the age of 15 years had the highest risks for total mortality (multivariate relative risk, 3.15; CI, 2.16 to 4.59), cardiovascular disease mortality (relative risk, 9.94; Cl, 5.15 to 19.19), and deaths from external causes of injury (relative risk, 5.39; CI, 1.84 to 15.78). Compared with continuing smokers, former smokers had a 24% reduction in risk for cardiovascular disease mortality within 2 years of quitting. The excess risks for total mortality and both cardiovascular disease and total cancer mortality among former smokers approached the level of that for never smokers after 10 to 14 years of abstinence. The health benefits of cessation were clearly present regardless of the age at starting and daily number of cigarettes smoked. Conclusions: The risk of cigarette smoking on total mortality among former smokers decreases nearly to that of never smokers 10 to 14 years after cessation.	HARVARD UNIV, BRIGHAM & WOMENS HOSP, SCH MED, BOSTON, MA 02115 USA; HARVARD UNIV, SCH PUBL HLTH, BOSTON, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health			Colditz, Graham/A-3963-2009	Colditz, Graham/0000-0002-7307-0291	NATIONAL CANCER INSTITUTE [R37CA040356, R01CA040356] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594] Funding Source: NIH RePORTER; NCI NIH HHS [CA 40356] Funding Source: Medline; NHLBI NIH HHS [HL 34594] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDA RF, 1990, JAMA-J AM MED ASSOC, V264, P1541, DOI 10.1001/jama.264.12.1541; BERLIN JA, 1990, AM J EPIDEMIOL, V132, P612, DOI 10.1093/oxfordjournals.aje.a115704; BEST E. W. R., 1961, Canadian Journal of Public Health, V52, P99; COLDITZ GA, 1987, INT J EPIDEMIOL, V16, P392, DOI 10.1093/ije/16.3.392; COLDITZ GA, 1992, J SMOKING RELATED DI, V3, P145; DOLL R, 1976, BRIT MED J, V2, P1525, DOI 10.1136/bmj.2.6051.1525; DOLL R, 1956, BRIT MED J, V2, P1071, DOI 10.1136/bmj.2.5001.1071; DOLL R, 1980, BRIT MED J, V280, P967, DOI 10.1136/bmj.280.6219.967; DUNN JE, 1960, AM J PUBLIC HEALTH N, V50, P1475, DOI 10.2105/AJPH.50.10.1475; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; GLASS RM, 1990, JAMA-J AM MED ASSOC, V264, P1583; GLASSMAN AH, 1990, JAMA-J AM MED ASSOC, V264, P1546, DOI 10.1001/jama.264.12.1546; HAMMOND E C, 1958, J Am Med Assoc, V166, P1159; HAMMOND E. CUYLER, 1966, NAT CANCER INST MONOGR, V19, P127; HENNEKENS CH, 1979, LANCET, V1, P1390; KAHN HAROLD A., 1966, NAT CANCER INST MONOGR, V19, P1; LACROIX AZ, 1991, NEW ENGL J MED, V324, P1619, DOI 10.1056/NEJM199106063242303; MANSON JE, 1991, LANCET, V338, P774, DOI 10.1016/0140-6736(91)90664-B; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; MYERS AH, 1987, AM J PUBLIC HEALTH, V77, P628, DOI 10.2105/AJPH.77.5.628; PEREZSTABLE EJ, 1990, AM J PUBLIC HEALTH, V80, P1500, DOI 10.2105/AJPH.80.12.1500; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; ROBINS J, 1987, J CHRON DIS, V40, pS139, DOI 10.1016/S0021-9681(87)80018-8; ROBINS J, 1989, STAT MED, V8, P679, DOI 10.1002/sim.4780080608; ROGOT E, 1980, PUBLIC HEALTH REP, V95, P213; ROTHMAN KJ, 1979, NIH791649 PHS PUBL; SMITH GD, 1992, LANCET, V340, P709; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; STAMPFER MJ, 1988, NEW ENGL J MED, V319, P267, DOI 10.1056/NEJM198808043190503; STAMPFER MJ, 1985, NEW ENGL J MED, V313, P1044, DOI 10.1056/NEJM198510243131703; 1972, PHS PUBL, V1693; 1990, DHHS CDC908416 PUBL; 1989, DHHS CDC898411 PUBL	34	202	209	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1993	119	10					992	1000		10.7326/0003-4819-119-10-199311150-00005	http://dx.doi.org/10.7326/0003-4819-119-10-199311150-00005			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MG672	8214996				2022-12-28	WOS:A1993MG67200005
J	KINOSHITA, J				KINOSHITA, J			SINGAPORE - ENTERING THE SCIENTIFIC MAINSTREAM - SELECTIVELY	SCIENCE			English	Editorial Material																			0	2	2	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 15	1993	262	5132					353	354		10.1126/science.8211153	http://dx.doi.org/10.1126/science.8211153			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB859	8211153				2022-12-28	WOS:A1993MB85900025
J	STONE, R				STONE, R			THE CHINA-AMERICA CONNECTION	SCIENCE			English	Editorial Material																			0	3	3	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 15	1993	262	5132					350	350		10.1126/science.8211152	http://dx.doi.org/10.1126/science.8211152			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB859	8211152				2022-12-28	WOS:A1993MB85900022
J	TSOU, CL				TSOU, CL			CONFORMATIONAL FLEXIBILITY OF ENZYME ACTIVE-SITES	SCIENCE			English	Editorial Material							THERMAL-DENATURATION; INACTIVATION; DISSOCIATION; GUANIDINE				TSOU, CL (corresponding author), ACAD SINICA,INST BIOPHYS,NATL LAB BIOMACROMOLEC,15 DATUN RD,BEIJING 100101,PEOPLES R CHINA.							CREIGHTON TE, 1990, BIOCHEM J, V270, P1; EDWARDS RA, 1990, BIOCHEMISTRY-US, V29, P11001, DOI 10.1021/bi00501a019; ENGELHARD M, 1976, EUR J BIOCHEM, V67, P447, DOI 10.1111/j.1432-1033.1976.tb10709.x; HO YS, 1979, NATURE, V277, P245, DOI 10.1038/277245a0; KOSHLAND DE, 1976, FEBS LETT, V62, pE47, DOI 10.1016/0014-5793(76)80853-8; LEE HJ, 1988, BIOCHIM BIOPHYS ACTA, V955, P119, DOI 10.1016/0167-4838(88)90185-9; LIN YZ, 1990, BIOCHIM BIOPHYS ACTA, V1038, P247, DOI 10.1016/0167-4838(90)90212-X; LINDSAY CD, 1990, EUR J BIOCHEM, V192, P133, DOI 10.1111/j.1432-1033.1990.tb19206.x; LIU W, 1987, BIOCHIM BIOPHYS ACTA, V916, P455, DOI 10.1016/0167-4838(87)90192-0; MA YZ, 1991, BIOCHEM J, V277, P207, DOI 10.1042/bj2770207; MILLER JF, 1978, BIOCHEM BIOPH RES CO, V81, P610, DOI 10.1016/0006-291X(78)91579-6; NOZAIS M, 1992, BIOCHEMISTRY-US, V31, P1210, DOI 10.1021/bi00119a034; TSOU CL, 1986, TRENDS BIOCHEM SCI, V11, P427, DOI 10.1016/0968-0004(86)90178-7; TSOU CL, 1989, CHINESE SCI BULL, V34, P393; TSOU CL, 1988, ADV ENZYMOL, V61, P388; WEST SM, 1990, BIOCHEM J, V265, P45, DOI 10.1042/bj2650045; XIAO J, 1993, BIOCHIM BIOPHYS ACTA, V1164, P54, DOI 10.1016/0167-4838(93)90111-4; YAO QZ, 1984, BIOCHEMISTRY-US, V23, P2740, DOI 10.1021/bi00307a032; ZHANG YL, 1993, BIOCHIM BIOPHYS ACTA, V1164, P61, DOI 10.1016/0167-4838(93)90112-5; ZHOU HM, 1993, BIOCHEM J, V291, P103, DOI 10.1042/bj2910103	20	197	212	0	33	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 15	1993	262	5132					380	381		10.1126/science.8211158	http://dx.doi.org/10.1126/science.8211158			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB859	8211158				2022-12-28	WOS:A1993MB85900046
J	RYAN, M				RYAN, M			RUSSIAN REPORT - HEALTH-CARE IN MOSCOW	BRITISH MEDICAL JOURNAL			English	Article								In the Russian Federation privatisation is affecting the health care sector as much as it is industry and commerce. That the general public support the transfer of state clinics to the private sector is a mark of their dissatisfaction with the old state run system. Doctors too see better opportunities to practise good medicine and be paid better for doing so. In Moscow the health department has set up a commission to license all clinics providing treatment, which should ensure standards of safety, training, and equipment. The Russian Federation is also trying to establish a medical insurance system to cover its citizens for health care, but in Moscow and elsewhere its implementation has been delayed by arguments and bureaucracy. In the meantime the health of Muscovites remains poor, with a high incidence of birth defects, and illnesses among the young.			RYAN, M (corresponding author), UNIV COLL SWANSEA,CTR RUSSIAN & E EUROPEAN STUDIES,SWANSEA SA2 8PP,W GLAM,WALES.							GURVICH V, 1993, NEZAVISIMAYA GAZETA, P2; PROTAS L, 1993, MED GAZETA, V54, P2; RYAN M, 1993, SOCIAL TRENDS CONT R, P214; SMIRNOV F, 1993, MED GAZETA, P2; 1993, MED GAZETA, P8; 1993, MED GAZETA, V48, P2	6	3	3	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 25	1993	307	6907					782	784		10.1136/bmj.307.6907.782	http://dx.doi.org/10.1136/bmj.307.6907.782			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LZ478	8219954	Green Published, Bronze			2022-12-28	WOS:A1993LZ47800029
J	BONNIN, MJ; PEPE, PE; KIMBALL, KT; CLARK, PS				BONNIN, MJ; PEPE, PE; KIMBALL, KT; CLARK, PS			DISTINCT CRITERIA FOR TERMINATION OF RESUSCITATION IN THE OUT-OF-HOSPITAL SETTING	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUDDEN CARDIAC-ARREST; IMPROVING SURVIVAL; LIFE-SUPPORT; EMERGENCY; FIELD; GUIDELINES; CPR	Objective.-To identify distinct criteria for appropriate on-scene termination of resuscitation efforts for out-of-hospital cardiac arrest when on-scene interventions fail to restore spontaneous circulation. Design.-For 18 months, all out-of-hospital cardiac arrests were evaluated prospectively for survival to hospital discharge and for all established survival predictors including age, gender, presenting cardiac rhythm, whether it was a witnessed event, performance of basic cardiopulmonary resuscitation by bystanders, and interval to paramedic arrival and return of spontaneous circulation (ROSC). Setting.-A large municipality with a single, centralized emergency medical services program. Patients.-All normothermic adults treated for out-of-hospital, unmonitored, primary cardiac arrest. Interventions.-Standard advanced cardiac life support provided at the scene by paramedics. Main Outcome Measures.-The number and circumstances of patients achieving survival to hospital discharge following failure to achieve on-scene ROSC. Results.-Of 1461 consecutive primary cardiac arrests, 139 were monitored (paramedic witnessed), including 59 that occurred en route to the hospital. Of the 1322 unmonitored patients, 370 achieved ROSC at the scene. Only six (0.6%) of the 952 who did not achieve ROSC at the scene survived, and all six were readily identifiable as having persistent ventricular fibrillation. Excluding those patients with persistent ventricular fibrillation, all survivors achieved ROSC within 25 minutes after paramedic arrival. Conclusions.-Excluding patients with persistent ventricular fibrillation, resuscitative efforts can be terminated at the scene when normothermic adults with unmonitored, out-of-hospital, primary cardiac arrest do not regain spontaneous circulation within 25 minutes following standard advanced cardiac life support. These criteria should now be validated in several large centers with high survival rates.	CITY HOUSTON CTR RESUSCITAT & EMERGENCY MED SERV,410 BAGBY,SUITE 300,HOUSTON,TX 77002; BAYLOR COLL MED,DEPT MED,HOUSTON,TX 77030	Baylor College of Medicine								APRAHAMIAN C, 1986, ANN EMERG MED, V15, P445, DOI 10.1016/S0196-0644(86)80185-8; AUERBACH PS, 1987, JAMA-J AM MED ASSOC, V258, P1487, DOI 10.1001/jama.258.11.1487; BECKER LB, 1993, ANN EMERG MED, V22, P354, DOI 10.1016/S0196-0644(05)80465-2; BONNIN MJ, 1989, ANN EMERG MED, V18, P507, DOI 10.1016/S0196-0644(89)80834-0; COBB LA, 1976, MED CLIN N AM, V60, P283, DOI 10.1016/S0025-7125(16)31909-5; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; CUMMINS RO, 1991, ANN EMERG MED, V20, P861; CURRY DG, 1989, MED CONTROL MANUAL; EISENBERG MS, 1985, ANN EMERG MED, V14, P1106, DOI 10.1016/S0196-0644(85)80932-X; Eliastam M, 1977, JACEP, V6, P525, DOI 10.1016/S0361-1124(77)80422-X; FOSNOCHT DE, 1993, ANN EMERG MED, V22, P919; FRANK M, 1989, ANN EMERG MED, V18, P594, DOI 10.1016/S0196-0644(89)80853-4; GEEHR EC, 1986, NEW ENGL J MED, V314, P1189; GRAY WA, 1991, NEW ENGL J MED, V325, P1393, DOI 10.1056/NEJM199111143252001; JAKOBSSON J, 1987, ACTA MED SCAND, V222, P123; KELLERMANN AL, 1993, ANN EMERG MED, V22, P47, DOI 10.1016/S0196-0644(05)80249-5; KELLERMANN AL, 1988, ANN EMERG MED, V17, P589, DOI 10.1016/S0196-0644(88)80398-6; KELLERMANN AL, 1987, AM J EMERG MED, V5, P548, DOI 10.1016/0735-6757(87)90197-5; LEVINE RL, 1992, JAMA-J AM MED ASSOC, V267, P2935, DOI 10.1001/jama.267.21.2935; LEWIS LM, 1990, AM J EMERG MED, V8, P118, DOI 10.1016/0735-6757(90)90196-7; LOW R, 1993, PREHOSPITAL DISAST S, V8, pS69; MOORE TJ, 1989, HEART FAILURE CRITIC, P186; OCONNOR R, 1993, PREHOSP DISAST ME S2, V8, pS57; OMARCAIGH AS, 1993, MAYO CLIN PROC, V68, P332, DOI 10.1016/S0025-6196(12)60126-8; PEPE PE, 1993, ANN EMERG MED, V22, P17, DOI 10.1016/S0196-0644(05)80244-6; PEPE PE, 1993, CRIT CARE MED, V21, P1279, DOI 10.1097/00003246-199309000-00009; PEPE PE, 1985, ANN EMERG MED, V14, P1085, DOI 10.1016/S0196-0644(85)80927-6; PEPE PE, 1990, PROBL CRIT CARE, V4, P470; PEPE PE, 1990, UPDATE EMERGENCY INT, P565; PEPE PE, 1990, PREHOSP DISASTER MED, V5, P59; SCHMIDT TA, 1993, ANN EMERG MED, V22, P918; SMITH JP, 1985, ANN EMERG MED, V14, P1093; SMITH JP, 1985, WESTERN J MED, V143, P402; STONE CK, 1993, PREHOSP DISAST ME S2, V8, pS68; VANHOEYWEGHEN R, 1989, RESUSCITATION, V17, pS137, DOI 10.1016/0300-9572(89)90098-1; WARNER LL, 1985, CHEST, V87, P22, DOI 10.1378/chest.87.1.22; WASSON JH, 1985, NEW ENGL J MED, V313, P793, DOI 10.1056/NEJM198509263131306; WEAVER WD, 1986, ANN EMERG MED, V15, P1181; WEAVER WD, 1991, NEW ENGL J MED, V325, P1437, DOI 10.1056/NEJM199111143252008; WOLFORD RW, 1988, ANN EMERG MED, V17, P410; 1986, JAMA-J AM MED ASSOC, V255, P2841; 1992, JAMA-J AM MED ASSOC, V268, P2171; 1989, RESPONSE TIME 1ST RE; 1989, PREHOSP DISAST MED, V4, P163; 1991, CPH145 US DEP COMM E	45	148	149	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 22	1993	270	12					1457	1462		10.1001/jama.270.12.1457	http://dx.doi.org/10.1001/jama.270.12.1457			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LX173	8204131				2022-12-28	WOS:A1993LX17300031
J	GLASER, WA				GLASER, WA			THE UNITED-STATES NEEDS A HEALTH SYSTEM LIKE OTHER COUNTRIES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROMOTE QUALITY; INSURANCE; PLAN; COMPETITION; ECONOMY; 1990S	Every developed country except the United States has a comprehensive health system for coverage, service provision, and finance. Social policy in the United States once was guided by thinkers who realized this, and the Social Security system-complete except for health insurance-resulted. The climate of thinking changed, and health policy for some time has been dominated by classical economists who argue that free competitive markets will solve all problems. They justify their arguments by claiming that the only alternative is full government takeovers of service and financing, as in Canada. While this debate has dragged along, problems in the United States have become grave. Instead of reviving the institutional economics and social policies that once served the United States well, the Clinton administration has turned policy over to devotees of managed competition. But the problem is how to organize the country, and national health insurance-easily observed in other countries-is superior to the current chaos and free-market utopias in the United States. Important aims would be achieved, such as expanding coverage, obtaining stable revenue, and containing costs. Important political barriers can be overcome, such as resistance by small business. Such a health system includes machinery for setting goals and implementing results, involving collaboration among providers, payers, and government.			GLASER, WA (corresponding author), NEW SCH SOCIAL RES,DEPT HLTH SERV MANAGEMENT,66 5TH AVE,NEW YORK,NY 10011, USA.							BARER ML, 1992, HEALTH AFFAIR, V11, P44, DOI 10.1377/hlthaff.11.1.44; BROWN ER, 1993, CHANGING US HLTH CAR; BUSH GHW, 1992, PRESIDENTS COMPREHEN, P69; BUTLER S, 1989, NATIONAL HLTH SYSTEM; COULAM RF, 1991, HLTH CARE FINANCE RE, V12, P61; COULAM RF, 1991, HLTH CARE FINANCE RE, V12, P69; COULAM RF, 1991, HLTH CARE FINANCE RE, V12, P46; ENTHOVEN A, 1989, NEW ENGL J MED, V320, P94, DOI 10.1056/NEJM198901123200205; ENTHOVEN A, 1989, NEW ENGL J MED, V320, P29, DOI 10.1056/NEJM198901053200106; Enthoven Alain C., 1988, THEORY PRACTICE MANA; FALK IS, 1936, SECURITY SICKNESS; GABEL JR, 1993, J AM HEALTH POLICY, V3, P19; GFEENBERG W, 1979, COMPETITION HLTH CAR; GLASER W, 1991, HLTH INSURANCE PRACT; GLASER WA, 1993, MILBANK Q, V71, P97, DOI 10.2307/3350276; GLASER WA, 1983, J HLTH POLIT POLICY, V8, P359; GLASER WA, 1978, HLTH INSURANCE BARGA; GLASER WA, 1987, PAYING HOSPITAL; HIMMELSTEIN DU, 1989, NEW ENGL J MED, V320, P102, DOI 10.1056/NEJM198901123200206; Kosterlitz J, 1993, Natl J (Wash), V25, P1746; LANGWELL I, 1982, PHS833327 US DEP HLT; LANGWELL K, 1992, EFFECTS MANAGED CARE; MCCORMICK B, 1993, AM MED NEWS, V3, P30; MUNTS R, 1967, BARGAINING HLTH LABO; PAULY MV, 1991, HEALTH AFFAIR, V10, P5, DOI 10.1377/hlthaff.10.1.5; POEN MM, 1979, HS TRUMAN VERSUS MED, pCH1; PRIEST D, 1993, WASH POST       0126, P12; ROBINSON JC, 1988, JAMA-J AM MED ASSOC, V260, P2676, DOI 10.1001/jama.260.18.2676; ROEMER MI, 1991, NATIONAL HLTH SYSTEM; SIMMONS HE, 1992, NEW ENGL J MED, V327, P1525, DOI 10.1056/NEJM199211193272113; Socolar D, 1992, J Am Health Policy, V2, P45; STARR P, 1993, HEALTH AFFAIR, V12, P7, DOI 10.1377/hlthaff.12.suppl_1.7; 1992, 21ST CENTURY AM HLTH	33	19	19	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 25	1993	270	8					980	984		10.1001/jama.270.8.980	http://dx.doi.org/10.1001/jama.270.8.980			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LT567	8192735				2022-12-28	WOS:A1993LT56700030
J	COHEN, JS; FIHN, SD; BOYKO, EJ; JONSEN, AR; WOOD, RW				COHEN, JS; FIHN, SD; BOYKO, EJ; JONSEN, AR; WOOD, RW			ATTITUDES TOWARD ASSISTED SUICIDE AND EUTHANASIA AMONG PHYSICIANS IN WASHINGTON-STATE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOPELESSLY ILL; AID	Background. Despite considerable public interest in legalizing physician-assisted suicide and euthanasia, little is known about physicians' attitude's toward these practices. Methods. We sent questionnaires to 1355 randomly selected physicians in the state of Washington, including all hematologists and oncologists and a disproportionately high number of internists, family practitioners, psychiatrists, and general surgeons. To avoid ambiguity in our survey, instead of ''physician-assisted suicide,'' we used the phrase ''prescription of medication [e.g., narcotics or barbiturates] or the counseling of an ill patient so he or she may use an overdose to end his or her own life.'' Instead of ''euthanasia,'' we used the phrase ''deliberate administration of an overdose of medication to an ill patient at his or her request with the primary intent to end his or her life.'' Results. Of the 1355 eligible physicians who received our questionnaire, 938 (69 percent) responded. Forty-eight percent of the respondents agreed with the statement that euthanasia is never ethically justified, and 42 percent disagreed. Fifty-four percent thought euthanasia should be legal in some situations, but only 33 percent stated that they would be willing to perform euthanasia. Thirty-nine percent of respondents agreed with the statement that physician-assisted suicide is never ethically justified, and 50 percent disagreed. Fifty-three percent thought assisted suicide should be legal in some situations, but only 40 percent stated that they would be willing to assist a patient in committing suicide. Of the groups surveyed, hematologists and oncologists were most likely to oppose euthanasia and assisted suicide, and psychiatrists were most likely to support these practices. Conclusions. The attitudes toward physician-assisted suicide and euthanasia of physicians in Washington State are polarized. A slight majority favors legalizing physician-assisted suicide and euthanasia in at least some situations, but most would be unwilling to participate in these practices themselves.	UNIV MINNESOTA, MINNEAPOLIS, MN 55455 USA; VET AFFAIRS MED CTR, DIV GEN MED, SEATTLE, WA 98108 USA; UNIV WASHINGTON, DEPT MED, SEATTLE, WA USA; UNIV WASHINGTON, DEPT MED HIST & ETH, SEATTLE, WA 98195 USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	COHEN, JS (corresponding author), VET AFFAIRS MED CTR, GEN INTERNAL MED SECT, 1 VET DR, MINNEAPOLIS, MN 55417 USA.		Boyko, Edward J/G-2484-2017; Fihn, Stephan/ABA-1040-2020	Boyko, Edward J/0000-0002-3695-192X; 				ANNAS GJ, 1993, NEW ENGL J MED, V328, P1573, DOI 10.1056/NEJM199305273282121; Battin M, 1992, Law Med Health Care, V20, P133; BENRUBI GI, 1992, NEW ENGL J MED, V326, P197, DOI 10.1056/NEJM199201163260311; BLENDON RJ, 1992, JAMA-J AM MED ASSOC, V267, P2658, DOI 10.1001/jama.267.19.2658; BRODY H, 1992, NEW ENGL J MED, V327, P1384, DOI 10.1056/NEJM199211053271912; CARALIS PV, 1992, CRIT CARE MED, V20, P683, DOI 10.1097/00003246-199205000-00023; CASSEL CK, 1990, NEW ENGL J MED, V323, P750, DOI 10.1056/NEJM199009133231110; CELOCRUZ MT, 1992, AM J LAW MED, V18, P369; CONVERSE PE, 1964, IDEOLOGY DISCONTENT; CROSBY C, 1992, INTERNIST        MAR, P16; FRIED TR, 1993, ARCH INTERN MED, V153, P722, DOI 10.1001/archinte.153.6.722; HEILIG S, 1988, SAN FRANCISCO MED, V61, P24; HEILIG S, 1988, SAN FRANCISCO MED, V61, P34; HENDIN H, 1993, AM J PSYCHIAT, V150, P143; KAMISAR Y, 1993, HASTINGS CENT REP, V23, P32, DOI 10.2307/3563366; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P419; MISBIN RI, 1991, NEW ENGL J MED, V325, P1307, DOI 10.1056/NEJM199110313251811; ORENTLICHER D, 1992, JAMA-J AM MED ASSOC, V267, P2229; OVERMYER M, 1991, PHYSICIANS MANAGE, V31, P40; QUILL TE, 1993, JAMA-J AM MED ASSOC, V270, P870, DOI 10.1001/jama.270.7.870; QUILL TE, 1992, NEW ENGL J MED, V327, P1380, DOI 10.1056/NEJM199211053271911; SINGER PA, 1990, NEW ENGL J MED, V322, P1881, DOI 10.1056/NEJM199006283222610; SNEDECOR GW, 1980, STATISTICAL METHODS, P93; WANZER SH, 1989, NEW ENGL J MED, V320, P844, DOI 10.1056/NEJM198903303201306; Weir R F, 1992, Law Med Health Care, V20, P116, DOI 10.1111/j.1748-720X.1992.tb01178.x; 1988, WITHHOLDING WITHDRAW; 1991, INFORMAL SURVEY WSMA; 1992, ANN INTERN MED, V117, P947	28	197	198	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 14	1994	331	2					89	94		10.1056/NEJM199407143310206	http://dx.doi.org/10.1056/NEJM199407143310206			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NW712	8208272				2022-12-28	WOS:A1994NW71200006
J	GEE, SH; MONTANARO, F; LINDENBAUM, MH; CARBONETTO, S				GEE, SH; MONTANARO, F; LINDENBAUM, MH; CARBONETTO, S			DYSTROGLYCAN-ALPHA, A DYSTROPHIN-ASSOCIATED GLYCOPROTEIN, IS A FUNCTIONAL AGRIN RECEPTOR	CELL			English	Article							CULTURED MUSCLE-CELLS; TORPEDO ELECTRIC ORGAN; NICOTINIC ACETYLCHOLINE-RECEPTOR; DUCHENNE MUSCULAR-DYSTROPHY; ORIGINAL SYNAPTIC SITES; SKELETAL-MUSCLE; NEUROMUSCULAR-JUNCTIONS; MOTOR NEURONS; BASAL LAMINA; CHROMOSOMAL LOCALIZATION	Aggregation of acetylcholine receptors (AChRs) on skeletal muscle fibers is thought to be mediated by the basal lamina protein agrin. Structural similarities shared by agrin and laminin suggested that the laminin receptor dystroglycan-alpha, part of a dystrophin-receptor complex, might also bind agrin. We show here that dystroglycan-alpha and dystrophin-related protein (DRP/utrophin) are concentrated within AChR aggregates in cultures of C2 myotubes and that agrin binds specifically to dystroglycan-alpha in in vitro assays. This binding is calcium dependent and is inhibited by monoclonal antibody (MAb) IIH6 against dystroglycan-alpha, heparin, and laminin, but not by fibronectin. In S27 cells, which do not aggregate AChRs spontaneously, agrin and laminin binding to dystroglycan-alpha are dramatically decreased. Moreover, MAb IIH6 significantly inhibits agrin-induced AChR aggregation on C2 cells. We conclude that dystroglycan-alpha is an agrin-binding protein and part of a dystrophin-receptor complex involved in AChR aggregation.			GEE, SH (corresponding author), MCGILL UNIV,MONTREAL GEN HOSP,RES INST,NEUROSCI RES CTR,MONTREAL H3G 1A4,PQ,CANADA.		Montanaro, Federica/GRJ-5139-2022	Montanaro, Federica/0000-0002-3338-0498				ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880; ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P731, DOI 10.1113/jphysiol.1977.sp011879; BEWICK GS, 1992, NEUROREPORT, V3, P857, DOI 10.1097/00001756-199210000-00009; BURDEN SJ, 1979, J CELL BIOL, V82, P412, DOI 10.1083/jcb.82.2.412; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COHEN MW, 1992, J NEUROSCI, V12, P2982, DOI 10.1523/JNEUROSCI.12-08-02982.1992; DOUVILLE PJ, 1988, J BIOL CHEM, V263, P14964; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; FERTUCK H C, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1376, DOI 10.1073/pnas.71.4.1376; FERTUCK HC, 1976, J CELL BIOL, V69, P144, DOI 10.1083/jcb.69.1.144; FRANK E, 1979, J CELL BIOL, V83, P143, DOI 10.1083/jcb.83.1.143; FROEHNER SC, 1991, J CELL BIOL, V114, P1, DOI 10.1083/jcb.114.1.1; GEE SH, 1993, J BIOL CHEM, V268, P14972; GODFREY EW, 1984, J CELL BIOL, V99, P615, DOI 10.1083/jcb.99.2.615; GORDON H, 1989, DEV BIOL, V135, P1, DOI 10.1016/0012-1606(89)90152-8; GORDON H, 1993, J NEUROSCI, V13, P586; HENDERSON LP, 1984, J NEUROSCI, V4, P3140; HIRANO Y, 1989, J NEUROSCI, V9, P1555; IBRAGHIMOVBESKROVNAYA O, 1993, HUM MOL GENET, V2, P1651, DOI 10.1093/hmg/2.10.1651; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; JENTOFT N, 1990, TRENDS BIOCHEM SCI, V15, P291, DOI 10.1016/0968-0004(90)90014-3; Khurana T S, 1991, Neuromuscul Disord, V1, P185, DOI 10.1016/0960-8966(91)90023-L; KHURANA TS, 1990, J BIOL CHEM, V265, P16717; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; KLIETSCH R, 1993, CIRC RES, V72, P349, DOI 10.1161/01.RES.72.2.349; LINDENBAUM MH, 1993, CURR BIOL, V3, P109, DOI 10.1016/0960-9822(93)90167-M; MA JY, 1993, J BIOL CHEM, V268, P25108; MAGILLSOLC C, 1990, J EXP BIOL, V153, P1; MAGILLSOLC C, 1988, J CELL BIOL, V107, P1825, DOI 10.1083/jcb.107.5.1825; MATSUMURA K, 1992, NATURE, V359, P320, DOI 10.1038/359320a0; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; MATSUMURA K, 1994, MUSCLE NERVE, V17, P2, DOI 10.1002/mus.880170103; NASTUK MA, 1991, NEURON, V7, P807, DOI 10.1016/0896-6273(91)90283-6; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; OHLENDIECK K, 1993, NEUROLOGY, V43, P795, DOI 10.1212/WNL.43.4.795; OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685; OTT U, 1982, EUR J BIOCHEM, V123, P63, DOI 10.1111/j.1432-1033.1982.tb06499.x; PENG HB, 1982, J NEUROSCI, V2, P1760; PHILLIPS WD, 1993, J CELL BIOL, V123, P729, DOI 10.1083/jcb.123.3.729; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; REIST NE, 1987, J CELL BIOL, V105, P2457, DOI 10.1083/jcb.105.6.2457; ROBERDS SL, 1993, J BIOL CHEM, V268, P23739; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1992, J NEUROSCI, V12, P3535; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; SALPETER MM, 1985, PROG NEUROBIOL, V25, P297, DOI 10.1016/0301-0082(85)90018-8; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SANES JR, 1978, J CELL BIOL, V78, P176, DOI 10.1083/jcb.78.1.176; SASAKI M, 1988, J BIOL CHEM, V263, P16536; SEALOCK R, 1991, J CELL BIOL, V113, P1133, DOI 10.1083/jcb.113.5.1133; SHIMIZU T, 1989, BIOMED RES-TOKYO, V10, P405, DOI 10.2220/biomedres.10.405; SILBERSTEIN L, 1982, NATURE, V295, P143, DOI 10.1038/295143a0; SUNADA Y, 1994, IN PRESS J BIOL CHEM; SWOPE SL, 1993, J BIOL CHEM, V268, P25152; TAWIL NJ, 1990, BIOCHEMISTRY-US, V29, P6540, DOI 10.1021/bi00479a028; TIMPL R, 1982, METHOD ENZYMOL, V82, P831; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; TURNER DC, 1989, J NEUROSCI, V9, P3287; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; VOGEL Z, 1983, J NEUROSCI, V3, P1058; WAKAYAMA Y, 1989, J NEUROL SCI, V91, P191, DOI 10.1016/0022-510X(89)90087-7; WALLACE BG, 1990, J NEUROSCI, V10, P3576; WALLACE BG, 1991, NEURON, V6, P869, DOI 10.1016/0896-6273(91)90227-Q; WALLACE BG, 1988, J CELL BIOL, V107, P267, DOI 10.1083/jcb.107.1.267; YANG B, 1994, J BIOL CHEM, V269, P6040; YOSHIDA M, 1990, J BIOCHEM-TOKYO, V108, P748, DOI 10.1093/oxfordjournals.jbchem.a123276; YURCHENCO PD, 1993, J BIOL CHEM, V268, P8356; ZUBRZYCKAGAARN EE, 1991, EXP CELL RES, V192, P278, DOI 10.1016/0014-4827(91)90187-Y	75	460	473	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUN 3	1994	77	5					675	686		10.1016/0092-8674(94)90052-3	http://dx.doi.org/10.1016/0092-8674(94)90052-3			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NQ123	8205617				2022-12-28	WOS:A1994NQ12300008
J	MARCUSSON, EG; HORAZDOVSKY, BF; CEREGHINO, JL; GHARAKHANIAN, E; EMR, SD				MARCUSSON, EG; HORAZDOVSKY, BF; CEREGHINO, JL; GHARAKHANIAN, E; EMR, SD			THE SORTING RECEPTOR FOR YEAST VACUOLAR CARBOXYPEPTIDASE-Y IS ENCODED BY THE VPS10 GENE	CELL			English	Article							LYSOSOME-LIKE VACUOLE; SACCHAROMYCES-CEREVISIAE; SECRETORY PATHWAY; PROTEIN-KINASE; GOLGI-COMPLEX; MUTANTS; TRANSPORT; DNA; BIOGENESIS; VPS34	The S. cerevisiae VPS10 (vacuolar protein sorting) gene encodes a type I transmembrane protein of 1577 amino acids required for the sorting of the soluble vacuolar protein carboxypeptidase Y (CPY). Mutations in VPS10 result in the selective missorting and secretion of CPY; all other vacuolar proteins tested are delivered to the vacuole in vps10 mutants. Chemical cross-linking studies demonstrate that Vps10p and the Golgi-modified precursor form of CPY directly interact. A single amino acid change in the CPY vacuolar sorting signal prevents this interaction. Vps10p also interacts with a hybrid protein containing the CPY sorting signal fused to the normally secreted enzyme invertase. Subcellular fractionation indicates that the majority of Vps10p is localized to a late Golgi compartment where vacuolar proteins are sorted. We propose that VPS10 encodes a CPY sorting receptor that executes multiple rounds of sorting by cycling between the late Golgi and a prevacuolar endosome-like compartment.	UNIV CALIF SAN DIEGO,SCH MED,HOWARD HUGHES MED INST,LA JOLLA,CA 92093	Howard Hughes Medical Institute; University of California System; University of California San Diego	MARCUSSON, EG (corresponding author), UNIV CALIF SAN DIEGO,SCH MED,DIV CELLULAR & MOLEC MED,LA JOLLA,CA 92093, USA.			Marcusson, Eric/0000-0002-0504-8674	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM015638, R01GM032703] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32703, GM15638] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BANKAITIS VA, 1986, P NATL ACAD SCI USA, V83, P9075, DOI 10.1073/pnas.83.23.9075; DIECKMANN CL, 1985, J BIOL CHEM, V260, P1513; GLICKMAN JN, 1993, J CELL BIOL, V123, P99, DOI 10.1083/jcb.123.1.99; GRAHAM TR, 1991, J CELL BIOL, V114, P207, DOI 10.1083/jcb.114.2.207; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; HERMAN PK, 1991, CELL, V64, P425, DOI 10.1016/0092-8674(91)90650-N; HORAZDOVSKY BF, 1993, J BIOL CHEM, V268, P4953; HORAZDOVSKY BF, 1994, IN PRESS EMBO J, V13; JOHNSON LM, 1987, CELL, V48, P875, DOI 10.1016/0092-8674(87)90084-5; JONES EW, 1977, GENETICS, V85, P23; KLIONSKY DJ, 1989, EMBO J, V8, P2241, DOI 10.1002/j.1460-2075.1989.tb08348.x; KLIONSKY DJ, 1988, MOL CELL BIOL, V8, P2105, DOI 10.1128/MCB.8.5.2105; KLIONSKY DJ, 1990, MICROBIOL REV, V54, P266, DOI 10.1128/MMBR.54.3.266-292.1990; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; Miller J.H., 1972, EXPT MOL GENETICS; NOTHWEHR SF, 1993, J CELL BIOL, V121, P1197, DOI 10.1083/jcb.121.6.1197; OLIVER SG, 1992, NATURE, V357, P38, DOI 10.1038/357038a0; PARAVICINI G, 1992, MOL BIOL CELL, V3, P415, DOI 10.1091/mbc.3.4.415; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; SEEGER M, 1992, EMBO J, V11, P2811, DOI 10.1002/j.1460-2075.1992.tb05348.x; Sherman F, 1979, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; STEVENS TH, 1986, J CELL BIOL, V102, P1551, DOI 10.1083/jcb.102.5.1551; VALLS LA, 1987, CELL, V48, P887, DOI 10.1016/0092-8674(87)90085-7; VANDYCK L, 1992, YEAST, V8, P769, DOI 10.1002/yea.320080910; VIDA TA, 1993, J CELL BIOL, V121, P1245, DOI 10.1083/jcb.121.6.1245; VIDA TA, 1990, J CELL BIOL, V111, P2871, DOI 10.1083/jcb.111.6.2871; WILCOX CA, 1992, MOL BIOL CELL, V3, P1353, DOI 10.1091/mbc.3.12.1353	36	406	418	1	20	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 20	1994	77	4					579	586		10.1016/0092-8674(94)90219-4	http://dx.doi.org/10.1016/0092-8674(94)90219-4			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NM832	8187177				2022-12-28	WOS:A1994NM83200012
J	GREBER, UF; WILLETTS, M; WEBSTER, P; HELENIUS, A				GREBER, UF; WILLETTS, M; WEBSTER, P; HELENIUS, A			STEPWISE DISMANTLING OF ADENOVIRUS-2 DURING ENTRY INTO CELLS	CELL			English	Article							SEMLIKI FOREST VIRUS; INCOMING INFLUENZA-VIRUS; EPIDERMAL GROWTH-FACTOR; HELA-CELLS; STRUCTURAL PROTEINS; ELECTRON-MICROSCOPY; POLYPEPTIDE-IX; EARLY EVENTS; TYPE-2; INVIVO	Adenoviruses enter their host cells by receptor-mediated endocytosis and acid-activated penetration from endosomes into the cytosol and deliver their DNA genome into the nucleus. Our results show that incoming adenovirus type 2 particles undergo a stepwise disassembly program necessary to allow progress of the virus in the entry pathway and release of the genome into the nucleus. The fibers are released, the penton base structures dissociated, the proteins connecting the DNA to the inside surface of the capsid degraded or shed, and the capsid-stabilizing minor proteins eliminated. The uncoating process starts immediately upon endocytic uptake with the loss of fibers and ends with the uptake of dissociated hexon proteins and DNA into the nucleus.			GREBER, UF (corresponding author), YALE UNIV, SCH MED, DEPT CELL BIOL, NEW HAVEN, CT 06510 USA.		Greber, Urs F/G-9458-2015	Greber, Urs F/0000-0003-2278-120X; Webster, Paul/0000-0002-1980-6931	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI018599, R01AI018599] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 18599] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AKUSJARVI G, 1981, J VIROL, V38, P469; ANDERSON CW, 1973, J VIROL, V12, P241, DOI 10.1128/JVI.12.2.241-252.1973; BAUM SG, 1972, J VIROL, V10, P211, DOI 10.1128/JVI.10.2.211-219.1972; BLUMENTHAL R, 1986, BIOCHEMISTRY-US, V25, P2231, DOI 10.1021/bi00356a057; BOUDIN ML, 1980, VIROLOGY, V101, P144, DOI 10.1016/0042-6822(80)90491-2; BOUDIN ML, 1979, VIROLOGY, V92, P125, DOI 10.1016/0042-6822(79)90219-8; BURNETT RM, 1985, J MOL BIOL, V185, P125, DOI 10.1016/0022-2836(85)90187-1; CHARDONN.Y, 1970, VIROLOGY, V40, P462, DOI 10.1016/0042-6822(70)90189-3; CHARDONNET Y, 1972, VIROLOGY, V48, P342, DOI 10.1016/0042-6822(72)90045-1; COLBY WW, 1981, J VIROL, V39, P977, DOI 10.1128/JVI.39.3.977-980.1981; COTTEN M, 1993, J VIROL, V67, P3777, DOI 10.1128/JVI.67.7.3777-3785.1993; DEFER C, 1990, J VIROL, V64, P3661, DOI 10.1128/JVI.64.8.3661-3673.1990; DEVAUX C, 1987, VIROLOGY, V161, P121, DOI 10.1016/0042-6822(87)90177-2; DEVAUX C, 1990, J MOL BIOL, V215, P567, DOI 10.1016/S0022-2836(05)80169-X; EVERITT E, 1975, VIROLOGY, V67, P197, DOI 10.1016/0042-6822(75)90417-1; EVERITT E, 1973, VIROLOGY, V52, P130, DOI 10.1016/0042-6822(73)90404-2; FITZGERALD DJP, 1983, CELL, V32, P607, DOI 10.1016/0092-8674(83)90480-4; FURCINITTI PS, 1989, EMBO J, V8, P3563, DOI 10.1002/j.1460-2075.1989.tb08528.x; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; GRABLE M, 1992, J VIROL, V66, P723; GREBER UF, 1990, EMBO J, V9, P1495, DOI 10.1002/j.1460-2075.1990.tb08267.x; GRIFFITHS G, 1993, FINE STRUCTURE IMMUN; GRUNHAUS A, 1992, SEMIN VIROL, V3, P237; GRUTTER M, 1974, J MOL BIOL, V89, P163, DOI 10.1016/0022-2836(74)90168-5; HARLOW E, 1988, ANTIBODIES LABORATOR; HELENIUS A, 1982, J GEN VIROL, V58, P47, DOI 10.1099/0022-1317-58-1-47; HELENIUS A, 1992, CELL, V69, P577, DOI 10.1016/0092-8674(92)90219-3; HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404; JAFFE HA, 1992, NAT GENET, V1, P372, DOI 10.1038/ng0892-372; JORNVALL H, 1980, EUR J BIOCHEM, V104, P237, DOI 10.1111/j.1432-1033.1980.tb04421.x; KIELIAN M, 1990, MOL BIOL MED, V7, P17; KIELIAN M, 1986, J CELL BIOL, V98, P139; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAVER WG, 1969, VIROLOGY, V39, P599, DOI 10.1016/0042-6822(69)90111-1; LAWRENCE WILLIAM C., 1967, J VIROL, V1, P851; LYON M, 1978, VIROLOGY, V87, P81, DOI 10.1016/0042-6822(78)90160-5; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; MANE SM, 1989, ARCH BIOCHEM BIOPHYS, V268, P360, DOI 10.1016/0003-9861(89)90597-3; MANGEL WF, 1993, NATURE, V361, P274, DOI 10.1038/361274a0; MARSH M, 1989, ADV VIRUS RES, V36, P107, DOI 10.1016/S0065-3527(08)60583-7; MARTIN K, 1991, J VIROL, V65, P232, DOI 10.1128/JVI.65.1.232-244.1991; MELLMAN I, 1992, J EXP BIOL, V172, P39; MILES BD, 1980, VIROLOGY, V105, P265, DOI 10.1016/0042-6822(80)90177-4; MORGAN C, 1969, J VIROL, V4, P777, DOI 10.1128/JVI.4.5.777-796.1969; MULLIGAN RC, 1993, SCIENCE, V260, P926, DOI 10.1126/science.8493530; Nevins J R, 1980, Methods Enzymol, V65, P768; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; PASTAN I, 1986, CONCEPTS VIRAL PATHO, V2, P141; PAUZA CD, 1991, ADV EXP MED BIOL, V300, P111; PETTERSSON U, 1971, VIROLOGY, V43, P123, DOI 10.1016/0042-6822(71)90230-3; PHILIPSON L, 1983, CURR TOP MICROBIOL, V109, P1; PHILIPSON L, 1968, J VIROL, V2, P1064, DOI 10.1128/JVI.2.10.1064-1075.1968; PRAGE L, 1970, VIROLOGY, V42, P341, DOI 10.1016/0042-6822(70)90278-3; RAGOT T, 1993, NATURE, V361, P647, DOI 10.1038/361647a0; RIGAUT KD, 1991, J VIROL, V65, P2622, DOI 10.1128/JVI.65.5.2622-2628.1991; ROBERTS MM, 1986, SCIENCE, V232, P1148, DOI 10.1126/science.3704642; ROSENFELD MA, 1992, CELL, V68, P143, DOI 10.1016/0092-8674(92)90213-V; ROSENFELD MA, 1991, SCIENCE, V252, P431, DOI 10.1126/science.2017680; SEGLEN PO, 1983, METHOD ENZYMOL, V96, P737; SETH P, 1984, J VIROL, V51, P650, DOI 10.1128/JVI.51.3.650-655.1984; SINGH I, 1992, J VIROL, V66, P7049, DOI 10.1128/JVI.66.12.7049-7058.1992; STEWART PL, 1991, CELL, V67, P145, DOI 10.1016/0092-8674(91)90578-M; STEWART PL, 1993, EMBO J, V12, P2589, DOI 10.1002/j.1460-2075.1993.tb05919.x; SUSSENBACH JS, 1967, VIROLOGY, V33, P567, DOI 10.1016/0042-6822(67)90056-6; SVENSSON U, 1985, J VIROL, V55, P442, DOI 10.1128/JVI.55.2.442-449.1985; TIHANYI K, 1993, J BIOL CHEM, V268, P1780; VALENTINE RC, 1965, J MOL BIOL, V13, P13, DOI 10.1016/S0022-2836(65)80076-6; VANOOSTRUM J, 1985, J VIROL, V56, P439, DOI 10.1128/JVI.56.2.439-448.1985; VARGA MJ, 1991, J VIROL, V65, P6061, DOI 10.1128/JVI.65.11.6061-6070.1991; WEBSTER A, 1993, CELL, V72, P97, DOI 10.1016/0092-8674(93)90053-S; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; WILLIAMS JF, 1970, J GEN VIROL, V9, P251, DOI 10.1099/0022-1317-9-3-251; WITTELS M, 1991, VIRUS RES, V18, P271, DOI 10.1016/0168-1702(91)90024-P; [No title captured]	74	668	688	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	1993	75	3					477	486		10.1016/0092-8674(93)90382-Z	http://dx.doi.org/10.1016/0092-8674(93)90382-Z			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MF830	8221887	Green Accepted			2022-12-28	WOS:A1993MF83000010
J	NISWANDER, L; TICKLE, C; VOGEL, A; BOOTH, I; MARTIN, GR				NISWANDER, L; TICKLE, C; VOGEL, A; BOOTH, I; MARTIN, GR			FGF-4 REPLACES THE APICAL ECTODERMAL RIDGE AND DIRECTS OUTGROWTH AND PATTERNING OF THE LIMB	CELL			English	Article							FIBROBLAST GROWTH-FACTOR; CHICK WING BUD; RETINOIC ACID; QUANTITATIVE-ANALYSIS; POLARIZING ACTIVITY; LOCAL APPLICATION; MOUSE EMBRYO; EXPRESSION; CELLS; ZPA	The apical ectodermal ridge plays a key role in limb development. We show that recombinant FGF-4 can substitute for the ridge to provide all the signals necessary for virtually complete outgrowth and patterning of the chick limb. FGF-4 stimulates proliferation of cells in the distal mesenchyme and maintains a signal from the posterior to the distal mesenchyme that appears to be required for elaboration of skeletal elements in the normal proximodistal sequence. Moreover, retinoic acid, which is capable of providing polarizing activity, can supply this signal. This suggests that polarizing activity plays a role in patterning along the proximodistal axis, in addition to its well-established role in anteroposterior patterning. Taken together, the data suggest a simple mechanism whereby FGF-4 links growth and pattern formation during limb development.	UNIV CALIF SAN FRANCISCO, PROGRAM DEV BIOL, SAN FRANCISCO, CA 94143 USA; UNIV COLL & MIDDLESEX SCH MED, DEPT ANAT & DEV BIOL, LONDON W1P 6DB, ENGLAND	University of California System; University of California San Francisco; University of London; University College London	NISWANDER, L (corresponding author), UNIV CALIF SAN FRANCISCO, SCH MED, DEPT ANAT, SAN FRANCISCO, CA 94143 USA.		Niswander, Lee/D-3976-2013	Niswander, Lee/0000-0002-9959-0594	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD025331, R01HD025331] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL043821] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL 43821] Funding Source: Medline; NICHD NIH HHS [HD-25331] Funding Source: Medline; Wellcome Trust Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission)		ANDERSON R, 1993, DEVELOPMENT, V117, P1421; AONO H, 1988, DEV BIOL, V128, P136, DOI 10.1016/0012-1606(88)90275-8; DELAPEYRIERE O, 1993, DEVELOPMENT, V118, P601; DELLIBOVI P, 1988, MOL CELL BIOL, V8, P2933, DOI 10.1128/MCB.8.7.2933; GLOBUS M, 1976, DIFFERENTIATION, V6, P91, DOI 10.1111/j.1432-0436.1976.tb01474.x; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAN JK, 1993, DEV BIOL, V158, P549, DOI 10.1006/dbio.1993.1212; HAUB O, 1991, DEVELOPMENT, V112, P397; Hinchliffe J. R., 1980, DEV VERTEBRATE LIMB; HINCHLIFFE JR, 1981, J EMBRYOL EXP MORPH, V62, P63; JOSEPHSILVERSTEIN J, 1989, J CELL BIOL, V108, P2459, DOI 10.1083/jcb.108.6.2459; KLAGSBRUN M, 1991, CELL, V67, P229, DOI 10.1016/0092-8674(91)90173-V; LYONS KM, 1990, DEVELOPMENT, V109, P833; MACCABE JA, 1974, DEV BIOL, V39, P69, DOI 10.1016/S0012-1606(74)80009-6; MACCABE JA, 1991, J EXP ZOOL, V257, P208, DOI 10.1002/jez.1402570209; MANSUKHANI A, 1990, P NATL ACAD SCI USA, V87, P4378, DOI 10.1073/pnas.87.11.4378; NISWANDER L, 1992, DEVELOPMENT, V114, P755; NISWANDER L, 1993, NATURE, V361, P68, DOI 10.1038/361068a0; ORRURTREGER A, 1991, DEVELOPMENT, V113, P1419; PETERS KG, 1992, DEVELOPMENT, V114, P233; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; REITER RS, 1982, DEV BIOL, V93, P28, DOI 10.1016/0012-1606(82)90235-4; RILEY BB, 1993, DEVELOPMENT, V118, P95; Saunders J. W., 1968, EPITHELIAL MESENCHYM, P78; SAUNDERS JW, 1948, J EXP ZOOL, V108, P363, DOI 10.1002/jez.1401080304; SAVAGE MP, 1993, IN PRESS DEV DYN; SOLURSH M, 1984, CELL DIFFER DEV, V15, P17, DOI 10.1016/0045-6039(84)90025-3; SUMMERBELL D, 1983, J EMBRYOL EXP MORPH, V78, P269; SUMMERBELL D, 1974, J EMBRYOL EXP MORPH, V32, P651; SUMMERBELL D, 1973, NATURE, V244, P492, DOI 10.1038/244492a0; SUZUKI HR, 1992, DEV BIOL, V150, P219, DOI 10.1016/0012-1606(92)90020-H; TABIN CJ, 1991, CELL, V66, P199, DOI 10.1016/0092-8674(91)90612-3; TICKLE C, 1985, DEV BIOL, V109, P82, DOI 10.1016/0012-1606(85)90348-3; TICKLE C, 1982, NATURE, V296, P564, DOI 10.1038/296564a0; TICKLE C, 1975, NATURE, V254, P199, DOI 10.1038/254199a0; TODT WL, 1987, DEVELOPMENT, V101, P501; VOGEL A, 1993, DEVELOPMENT, V119, P199; WILKINSON DG, 1989, DEVELOPMENT, V105, P131; WILSON DJ, 1987, DEVELOPMENT, V99, P99	40	573	584	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 5	1993	75	3					579	587		10.1016/0092-8674(93)90391-3	http://dx.doi.org/10.1016/0092-8674(93)90391-3			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	MF830	8221896				2022-12-28	WOS:A1993MF83000019
J	TSAO, YH; EVANS, DF; WENNERSTROM, H				TSAO, YH; EVANS, DF; WENNERSTROM, H			LONG-RANGE ATTRACTIVE FORCE BETWEEN HYDROPHOBIC SURFACES OBSERVED BY ATOMIC-FORCE MICROSCOPY	SCIENCE			English	Article							SILICON-NITRIDE POWDERS	There is evidence from atomic force microscopy for a long-range attractive force between hydrophobic surfaces that is virtually identical to that observed with the surface forces apparatus. This force is present in the nonaqueous solvent ethylene glycol. A possible molecular mechanism involves in-plane polarized domains of solid-like monolayers adsorbed on mica, and a theoretical model has been developed that accounts for many of the observations.	LUND UNIV,CTR CHEM,DIV PHYS CHEM,S-22100 LUND,SWEDEN	Lund University	TSAO, YH (corresponding author), UNIV MINNESOTA,DEPT CHEM ENGN & MAT SCI,MINNEAPOLIS,MN 55455, USA.				NIGMS NIH HHS [GM34341] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034341] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ATTARD P, 1989, J PHYS CHEM-US, V93, P6441, DOI 10.1021/j100354a032; BENNIG G, 1988, PHYS REV LETT, V56, P930; BERGSTROM L, 1990, COLLOID SURFACE, V49, P183, DOI 10.1016/0166-6622(90)80101-9; BERGSTROM L, 1989, J AM CERAM SOC, V72, P103, DOI 10.1111/j.1151-2916.1989.tb05961.x; BURNHAM NA, 1992, SCANNING TUNNELING M, pCH2; CHRISTENSON HK, 1990, J PHYS CHEM-US, V94, P8004, DOI 10.1021/j100384a002; Derjaguin B, 1934, KOLLOID Z, V69, P155, DOI 10.1007/BF01433225; ISRAELACHVILI J, 1982, NATURE, V300, P341, DOI 10.1038/300341a0; KURIHARA K, 1990, CHEM LETT, V9, P1553; LEE GU, 1992, THESIS U MINNESOTA; MCCONNELL HM, 1984, P NATL ACAD SCI USA, V81, P3249, DOI 10.1073/pnas.81.10.3249; MOHWALD H, 1990, ANNU REV PHYS CHEM, V41, P411; OKAHATA Y, 1981, BER BUNSEN PHYS CHEM, V85, P789, DOI 10.1002/bbpc.19810850811; PARKER JL, 1992, LANGMUIR, V8, P757, DOI 10.1021/la00039a003; PASHLEY RM, 1985, SCIENCE, V229, P1088, DOI 10.1126/science.4035349; PODGORNIK R, 1989, J CHEM PHYS, V91, P5840, DOI 10.1063/1.457535; SCALES PJ, 1992, THIN SOLID FILMS, V215, P223, DOI 10.1016/0040-6090(92)90442-E; TSAO YH, 1993, LANGMUIR, V9, P779, DOI 10.1021/la00027a029; TSAO YH, 1991, LANGMUIR, V7, P3154, DOI 10.1021/la00060a039	19	206	214	2	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 22	1993	262	5133					547	550		10.1126/science.8211182	http://dx.doi.org/10.1126/science.8211182			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC935	8211182				2022-12-28	WOS:A1993MC93500033
J	COLLINS, F; GALAS, D				COLLINS, F; GALAS, D			A NEW 5-YEAR PLAN FOR THE UNITED-STATES HUMAN GENOME PROJECT	SCIENCE			English	Article									US DOE,OFF HLTH & ENVIRONM RES,WASHINGTON,DC 20585	United States Department of Energy (DOE)	COLLINS, F (corresponding author), NIH,NATL CTR HUMAN GENOME RES,BETHESDA,MD 20892, USA.							[Anonymous], 1988, MAPPING SEQUENCING H; OLSON MV, 1989, SCIENCE, V245, P143; 1990, UNDERSTANDING OUR GE	3	251	262	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 1	1993	262	5130					43	46		10.1126/science.8211127	http://dx.doi.org/10.1126/science.8211127			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LZ635	8211127				2022-12-28	WOS:A1993LZ63500021
J	MOCEK, FW; WARD, WW; WOLFSON, SE; RUMAGE, WT; WIEMAN, TJ				MOCEK, FW; WARD, WW; WOLFSON, SE; RUMAGE, WT; WIEMAN, TJ			ELIMINATION OF RECURRENT HYPERPLASTIC POLYPS BY ERADICATION OF HELICOBACTER-PYLORI	ANNALS OF INTERNAL MEDICINE			English	Note							TRIPOTASSIUM DICITRATO BISMUTHATE; DUODENAL-ULCER; CONTROLLED TRIAL; CIMETIDINE; CAMPYLOBACTER; TABLETS		UNIV LOUISVILLE, SCH MED,JAMES GRAHAM BROWN CANC CTR,DEPT SURG, DIV SURG ONCOL, LOUISVILLE, KY 40292 USA; NORTON HOSP, LOUISVILLE, KY USA	University of Louisville								GREGORY MA, 1982, S AFR MED J, V62, P52; HAMILTON I, 1986, GUT, V27, P106, DOI 10.1136/gut.27.1.106; LAMBERT JR, 1987, GASTROENTEROLOGY, V92, P1488; MARSHALL BJ, 1985, MED J AUSTRALIA, V142, P436, DOI 10.5694/j.1326-5377.1985.tb113443.x; MARTIN DF, 1981, LANCET, V1, P7; SALMON PR, 1974, GUT, V15, P189, DOI 10.1136/gut.15.3.189; VANTRAPPEN G, 1980, GUT, V21, P329, DOI 10.1136/gut.21.4.329; WAUTERS GV, 1990, AM J GASTROENTEROL, V85, P1395	8	21	21	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	1994	120	12					1007	1008		10.7326/0003-4819-120-12-199406150-00006	http://dx.doi.org/10.7326/0003-4819-120-12-199406150-00006			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NQ964	8185131				2022-12-28	WOS:A1994NQ96400006
J	JARMAN, AP; GRELL, EH; ACKERMAN, L; JAN, LY; JAN, YN				JARMAN, AP; GRELL, EH; ACKERMAN, L; JAN, LY; JAN, YN			ATONAL IS THE PRONEURAL GENE FOR DROSOPHILA PHOTORECEPTORS	NATURE			English	Article							NEURONAL DIFFERENTIATION; NEURAL DEVELOPMENT; NERVOUS-SYSTEM; VISUAL-SYSTEM; EYE; RETINA; MELANOGASTER; NEUROGENESIS; EXPRESSION; HEDGEHOG	THE Drosophila peripheral nervous system comprises four major types of sensory element: external sense organs (such as mechanosensory bristles), chordotonal organs (internal stretch receptors), multiple dendritic neurons, and photoreceptors. During development, the selection of neural precursors for external sense organs requires the proneural genes of the achaete-scute complex, which encode basic-helix-loop-helix transcription factors(1-3). These genes do not, however, control precursor selection for chordotonal organs or photoreceptors(4,5), raising the question of whether other proneural genes exist(6) or a different mechanism of neurogenesis operates. Here we show that atonal (ato), originally isolated as a proneural gene for chordotonal organs(7), is also the proneural gene for photoreceptors. Pattern formation in the Drosophila eye involves a succession of cell fate specifications. Of the eight photoreceptors within each ommatidium of the compound eye, the photoreceptor R8 is the first to appear in the eye imaginal disc, right behind the morphogenetic furrow(8-10). The appearance of other photoreceptors (R1-7) follows in a defined sequence that is thought to arise by induction from R8 (refs 8, 9, 11, 12). We find that photoreceptor formation requires the function of atonal at the morphogenetic furrow and that atonal is specifically required for R8 selection. Formation of other photoreceptors does not directly require atonal function, but does depend on R8 selection by atonal. Thus, photoreceptors are selected by two mechanisms: R8 by a proneural mechanism, and R1-7 by local recruitment.	UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	JARMAN, AP (corresponding author), UNIV CALIF SAN FRANCISCO,HOWARD HUGHES MED INST,SAN FRANCISCO,CA 94143, USA.			Jan, Lily/0000-0003-3938-8498; Jan, Yuh Nung/0000-0003-1367-6299; Jarman, Andrew/0000-0003-4036-5701				BAKER NE, 1990, SCIENCE, V250, P1370, DOI 10.1126/science.2175046; BAKER NE, 1989, NATURE, V340, P150, DOI 10.1038/340150a0; BANERJEE U, 1990, NEURON, V4, P177, DOI 10.1016/0896-6273(90)90093-U; BASLER K, 1991, BIOESSAYS, V13, P621, DOI 10.1002/bies.950131202; BRAND AH, 1993, DEVELOPMENT, V118, P401; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; CAMPUZANO S, 1992, TRENDS GENET, V8, P202, DOI 10.1016/0168-9525(92)90234-U; DAMBLYCHAUDIERE C, 1987, GENE DEV, V1, P297, DOI 10.1101/gad.1.3.297; FISCHBACH KF, 1984, DEV BIOL, V104, P219, DOI 10.1016/0012-1606(84)90050-2; GHYSEN A, 1989, TRENDS GENET, V5, P251, DOI 10.1016/0168-9525(89)90097-8; GHYSEN A, 1993, GENE DEV, V7, P723, DOI 10.1101/gad.7.5.723; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; HEBERLEIN U, 1993, DEV BIOL, V160, P51, DOI 10.1006/dbio.1993.1285; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; JIMENEZ F, 1987, J NEUROGENET, V4, P179, DOI 10.3109/01677068709102340; KARPILOW J, 1989, GENE DEV, V3, P1834, DOI 10.1101/gad.3.12a.1834; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; MCIVER S, 1985, COMPREHENSIVE INSECT, V6; MEYEROWITZ EM, 1978, DEV BIOL, V62, P112, DOI 10.1016/0012-1606(78)90096-9; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; READY DF, 1989, TRENDS NEUROSCI, V12, P102, DOI 10.1016/0166-2236(89)90166-5; RUBIN GM, 1991, TRENDS GENET, V7, P372, DOI 10.1016/0168-9525(91)90258-R; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	25	415	419	0	9	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 2	1994	369	6479					398	400		10.1038/369398a0	http://dx.doi.org/10.1038/369398a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NP174	8196767				2022-12-28	WOS:A1994NP17400056
J	FOEGE, W				FOEGE, W			PREVENTIVE MEDICINE AND PUBLIC-HEALTH	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											FOEGE, W (corresponding author), TASK FORCE CHILD SURVIVAL & DEV,ATLANTA,GA, USA.							[Anonymous], 1993, WORLD DEV REPORT 199; FOEGE WH, 1993, JAMA-J AM MED ASSOC, V270, P1859, DOI 10.1001/jama.270.15.1859; HOPKINS DR, 1993, AM J TROP MED HYG, V49, P281, DOI 10.4269/ajtmh.1993.49.281; Jezek Z, 1988, HUMAN MONKEYPOX; MCGINNIS JM, 1993, JAMA-J AM MED ASSOC, V270, P2207, DOI 10.1001/jama.270.18.2207; 1990, HLTH PEOPLE 2000 NAT; 1980, PROMOTING HLTH PREVE; 1993, MMWR MORB MORTAL WKL, V42, P1	8	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1704	1705		10.1001/jama.271.21.1704	http://dx.doi.org/10.1001/jama.271.21.1704			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182863				2022-12-28	WOS:A1994NN11700042
J	PAGES, F; RAGUENEAU, M; ROTTAPEL, R; TRUNEH, A; NUNES, J; IMBERT, J; OLIVE, D				PAGES, F; RAGUENEAU, M; ROTTAPEL, R; TRUNEH, A; NUNES, J; IMBERT, J; OLIVE, D			BINDING OF PHOSPHATIDYLINOSITOL-3-OH KINASE TO CD28 IS REQUIRED FOR T-CELL SIGNALING	NATURE			English	Article							MOLECULAR-CLONING; ACTIVATION; EXPRESSION; 3-KINASE; IDENTIFICATION; ACCUMULATION; PROTEINS; SUBUNIT; HOMOLOG; SYSTEM	THE engagement of CD28 with its ligand B7.1/CD80 results in potent costimulation of T-cell activation initiated through the CD3/T-cell receptor complex(1,2). The biochemical basis of CD28 costimulatory function is poorly understood. The signalling pathways used by CD28 are unlike those used by the CD3/T-cell receptor in that they are resistant to cyclosporin A and independent of changes in cyclic AMP concentrations(3). These differences suggest that each pathway provides unique biochemical information which is required for T-cell activation. We report here that CD28 becomes tyrosine-phosphorylated following interaction with B7.1/CD80, which induces formation of a complex with phosphatidylinositol-3-OH kinase, mediated by the SH2 domains of the p85 subunit of the kinase. Phosphatidylinositol-3-OH kinase is a heterodimer of this 85K regulatory subunit and a 110K catalytic subunit, and is a common substrate for most receptor tyrosine kinases and some cytokine receptors(4,5), binding through its SH2 domain to phosphotyrosine in the motif Tyr-X-X-Met in the CD28 sequence, which is highly conserved between human, mouse and rat(6-8) and lies in the intracellular domain. We show that CD28 mutants that have their kinase-binding site deleted or the tyrosine at position 173 substituted by phenylalanine do not associate with the kinase after CD28 stimulation and cannot stimulate production of interleukin-2. Our results suggest that phosphatidylinositol-3-OH kinase is critical for signalling by CD28.	INSERM,U119,F-13009 MARSEILLE,FRANCE; SMITHKLINE BEECHAM PHARMACEUT,KING OF PRUSSIA,PA 19406	Institut National de la Sante et de la Recherche Medicale (Inserm); GlaxoSmithKline			NUNES, Jacques A/F-4952-2013; Imbert, Jean/AAG-1165-2020; Truneh, Alem/ABB-7891-2020; Imbert, Jean/G-3248-2013	NUNES, Jacques A/0000-0003-4865-0400; Imbert, Jean/0000-0002-0478-9593; Imbert, Jean/0000-0002-0478-9593; Rottapel, Robert/0000-0002-6024-5558				ARUFFO A, 1987, P NATL ACAD SCI USA, V84, P8573, DOI 10.1073/pnas.84.23.8573; CLARK GJ, 1992, IMMUNOGENETICS, V35, P54; COUEZ D, 1994, MOL IMMUNOL, V31, P47, DOI 10.1016/0161-5890(94)90137-6; GROSS JA, 1990, J IMMUNOL, V144, P3201; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; JUNE CH, 1987, P NATL ACAD SCI USA, V84, P1384; KOULOVA L, 1991, J EXP MED, V173, P759, DOI 10.1084/jem.173.3.759; LINSLEY PS, 1991, J EXP MED, V173, P721, DOI 10.1084/jem.173.3.721; MCGLADE CJ, 1992, MOL CELL BIOL, V12, P991, DOI 10.1128/MCB.12.3.991; NUNES J, 1993, INT IMMUNOL, V5, P311, DOI 10.1093/intimm/5.3.311; OTSU M, 1991, CELL, V65, P91, DOI 10.1016/0092-8674(91)90411-Q; REMILLARD B, 1991, J BIOL CHEM, V266, P14167; ROTTAPEL R, 1991, MOL CELL BIOL, V11, P3043, DOI 10.1128/MCB.11.6.3043; THOMPSON PA, 1992, ONCOGENE, V7, P719; WARD SG, 1992, EUR J IMMUNOL, V22, P45, DOI 10.1002/eji.1830220108; WRD SG, 1993, EUR J IMMUNOL, V23, P2572	17	350	376	0	13	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 26	1994	369	6478					327	329		10.1038/369327a0	http://dx.doi.org/10.1038/369327a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NN109	8183372				2022-12-28	WOS:A1994NN10900052
J	MAJEED, FA; COOK, DG; ANDERSON, HR; HILTON, S; BUNN, S; STONES, C				MAJEED, FA; COOK, DG; ANDERSON, HR; HILTON, S; BUNN, S; STONES, C			USING PATIENT AND GENERAL-PRACTICE CHARACTERISTICS TO EXPLAIN VARIATIONS IN CEI CERVICAL SMEAR UPTAKES RATES	BRITISH MEDICAL JOURNAL			English	Article							PROVIDING CENSUS-DATA; UNDERPRIVILEGED AREAS; INNER LONDON; HEALTH; POPULATION; CARE	Objectives-To produce practice and patient variables for general practices from census and family health services authority data, and to determine the importance of these variables in explaining variation in cervical smear uptake rates between practices. Design-Population based study examining variations in cervical smear uptake rates among 126 general practices using routine data. Setting-Merton, Sutton, and Wandsworth Family Health Services Authority, which covers parts of inner and outer London. Main outcome measure-Percentage of women aged 25-64 years registered with a general practitioner who had undergone a cervical smear test during the five and a half years preceding 31 March 1992. Results-Cervical smear uptake rates varied from 16.5% to 94.1%. The estimated percentage of practice population from ethnic minority groups correlated negatively with uptake rates (r=-0.42), as did variables associated with social deprivation such as overcrowding (r=-0.42), not owning a ear (r=-0.41), and unemployment (r=-0.40). Percentage of practice population under 5 years of age correlated positively with uptake rate (r=0.42). Rates were higher in practices with a female partner than in those without (66.6% v 49.1%; difference 17.5% (95% confidence interval 10.5% to 24.5%)), and in computerised than in non-computerised practices (64.5% v 50.5%; 14.0% (6.4% to 21.6%)). Rates were higher in larger practices. In a stepwise multiple regression model that explained 52% of variation, five factors were significant predictors of uptake rates: presence of a female partner; children under 5; overcrowding; number of women aged 35-44 as percentage of all women aged 25-64; change of address in past year. Conclusions-Over half of variation in cervical smear uptake rates can be explained by patient and practice variables derived from census and family health services authority data; these variables may have a role in explaining variations in performance of general practices and in producing adjusted measures of practice performance. Practices with a female partner had substantially higher uptake rates.	ST GEORGE HOSP,SCH MED,DEPT GEN PRACTICE,LONDON SW17 0RE,ENGLAND; MERTON SUTTON & WANDSWORTH FAMILY HLTH SERV AUTH,LONDON SW15 2SW,ENGLAND	St Georges University London	MAJEED, FA (corresponding author), ST GEORGE HOSP,SCH MED,DEPT PUBL HLTH SCI,LONDON SW17 0RE,ENGLAND.			Cook, Derek/0000-0002-9723-5759; Majeed, Azeem/0000-0002-2357-9858				Amery J, 1992, Health Trends, V24, P119; BAKER D, 1991, BRIT MED J, V303, P225, DOI 10.1136/bmj.303.6796.225; BAKER R, 1992, BRIT J GEN PRACT, V42, P415; BALARAJAN R, 1992, BRIT MED J, V304, P529, DOI 10.1136/bmj.304.6826.529; BEARDOW R, 1989, BMJ-BRIT MED J, V299, P98, DOI 10.1136/bmj.299.6691.98; BOWLING A, 1989, BRIT MED J, V298, P545, DOI 10.1136/bmj.298.6673.545; CHASE HD, 1991, BRIT J GEN PRACT, V41, P63; FOY C, 1987, J ROY COLL GEN PRACT, V37, P451; GILLAM SJ, 1992, BRIT J GEN PRACT, V42, P54; HUTCHINSON A, 1987, J ROY COLL GEN PRACT, V37, P448; JACOBSON B, 1992, BRIT MED J, V305, P1344, DOI 10.1136/bmj.305.6865.1344; JARMAN B, 1984, BRIT MED J, V289, P1587, DOI 10.1136/bmj.289.6458.1587; JARMAN B, 1983, BRIT MED J, V286, P1705, DOI 10.1136/bmj.286.6379.1705; LAWRENCE M, 1990, BRIT MED J, V300, P1501, DOI 10.1136/bmj.300.6738.1501; LEESE B, 1989, BRIT MED J, V298, P932, DOI 10.1136/bmj.298.6678.932; MCAVOY BR, 1988, HLTH TRENDS, V20, P11; SHROFF KJ, 1988, BRIT MED J, V297, P1317, DOI 10.1136/bmj.297.6659.1317; USHERWOOD TP, 1985, J ROY COLL GEN PRACT, V35, P395; [No title captured]	19	75	75	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 14	1994	308	6939					1272	1276		10.1136/bmj.308.6939.1272	http://dx.doi.org/10.1136/bmj.308.6939.1272			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM147	8205021	Green Published			2022-12-28	WOS:A1994NM14700020
J	TURRIGIANO, G; ABBOTT, LF; MARDER, E				TURRIGIANO, G; ABBOTT, LF; MARDER, E			ACTIVITY-DEPENDENT CHANGES IN THE INTRINSIC-PROPERTIES OF CULTURED NEURONS	SCIENCE			English	Article							LONG-TERM POTENTIATION; CALCIUM; INDUCTION; BEHAVIOR; CURRENTS	Learning and memory arise through activity-dependent modifications of neural circuits. Although the activity dependence of synaptic efficacy has been studied extensively, less is known about how activity shapes the intrinsic electrical properties of neurons. Lobster stomatogastric ganglion neurons fire in bursts when receiving synaptic and modulatory input but fire tonically when pharmacologically isolated. Long-term isolation in culture changed their intrinsic activity from tonic firing to burst firing. Rhythmic stimulation reversed this transition through a mechanism that was mediated by a rise in intracellular calcium concentration. These data suggest that neurons regulate their conductances to maintain stable activity patterns and that the intrinsic properties of a neuron depend on its recent history of activation.	BRANDEIS UNIV,CTR COMPLEX SYST,WALTHAM,MA 02254	Brandeis University	TURRIGIANO, G (corresponding author), BRANDEIS UNIV,DEPT BIOL,WALTHAM,MA 02254, USA.				NIMH NIH HHS [MH46742] Funding Source: Medline; NINDS NIH HHS [NS17813] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046742, R37MH046742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017813] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABBOTT LF, 1993, NEURAL COMPUT, V5, P83; ALKON DL, 1984, SCIENCE, V226, P1037, DOI 10.1126/science.6093258; FIELDS RD, 1990, J NEUROSCI, V10, P2950; FRANKLIN JL, 1992, J NEUROSCI, V12, P1726; Harris-Warrick RM, 1992, DYNAMICAL BIOL NETWO; HARRISWARRICK RM, 1991, ANNU REV NEUROSCI, V14, P39, DOI 10.1146/annurev.ne.14.030191.000351; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; HONG SJ, 1993, BRAIN RES, V605, P121, DOI 10.1016/0006-8993(93)91363-W; KATER SB, 1991, J NEUROSCI, V11, P891; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SIEGEL M, UNPUB; Turrigiano G. G., 1993, Society for Neuroscience Abstracts, V19, P17; TURRIGIANO GG, 1993, J NEUROPHYSIOL, V69, P1993, DOI 10.1152/jn.1993.69.6.1993; TURRIGIANO GG, UNPUB	19	365	369	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 13	1994	264	5161					974	977		10.1126/science.8178157	http://dx.doi.org/10.1126/science.8178157			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NK974	8178157				2022-12-28	WOS:A1994NK97400038
J	FIELDS, BN				FIELDS, BN			AIDS - TIME TO TURN TO BASIC SCIENCE	NATURE			English	Editorial Material											FIELDS, BN (corresponding author), HARVARD UNIV,SCH MED,DEPT MICROBIOL & MOLEC GENET,200 LONGWOOD AVE,BOSTON,MA 02115, USA.								0	35	34	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 12	1994	369	6476					95	96		10.1038/369095a0	http://dx.doi.org/10.1038/369095a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NK971	8177331				2022-12-28	WOS:A1994NK97100021
J	CROWE, MA; JAMES, WD				CROWE, MA; JAMES, WD			X-LINKED ICHTHYOSIS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							STEROID SULFATASE DEFICIENCY; DELETIONS; CDNA		WALTER REED ARMY MED CTR,DERMATOL SERV,WASHINGTON,DC 20307	United States Department of Defense; United States Army; Walter Reed National Military Medical Center								BALLABIO A, 1987, P NATL ACAD SCI USA, V84, P4519, DOI 10.1073/pnas.84.13.4519; LANCER HA, 1982, ARCH DERMATOL, V118, P875, DOI 10.1001/archderm.1982.01650230003003; LYKKESFELDT G, 1984, OBSTET GYNECOL, V64, P49; LYKKESFELDT G, 1983, LANCET, V2, P1456; RAND RE, 1983, J AM ACAD DERMATOL, V8, P285, DOI 10.1016/S0190-9622(83)80322-3; SEVER RJ, 1968, J AMER MED ASSOC, V206, P2283, DOI 10.1001/jama.206.10.2283; YEN PH, 1987, CELL, V49, P443, DOI 10.1016/0092-8674(87)90447-8	7	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 17	1993	270	19					2265	2266		10.1001/jama.270.19.2265	http://dx.doi.org/10.1001/jama.270.19.2265			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MF993	8230579				2022-12-28	WOS:A1993MF99300001
J	BRUNNER, HG; NELEN, M; BREAKEFIELD, XO; ROPERS, HH; VANOOST, BA				BRUNNER, HG; NELEN, M; BREAKEFIELD, XO; ROPERS, HH; VANOOST, BA			ABNORMAL-BEHAVIOR ASSOCIATED WITH A POINT MUTATION IN THE STRUCTURAL GENE FOR MONOAMINE OXIDASE-A	SCIENCE			English	Article							CEREBROSPINAL-FLUID MONOAMINE; HUMAN-SKIN FIBROBLASTS; NORRIE DISEASE; PRENATAL-DIAGNOSIS; X-CHROMOSOME; NORWAY RATS; AGGRESSION; INHIBITORS; DELETION; ACID	Genetic and metabolic studies have been done on a large kindred in which several males are affected by a syndrome of borderline mental retardation and abnormal behavior. The types of behavior that occurred include impulsive aggression, arson, attempted rape, and exhibitionism. Analysis of 24-hour urine samples indicated markedly disturbed monoamine metabolism. This syndrome was associated with a complete and selective deficiency of enzymatic activity of monoamine oxidase A (MAOA). In each of five affected males, a point mutation was identified in the eighth exon of the MAOA structural gene, which changes a glutamine to a termination codon. Thus, isolated complete MAOA deficiency in this family is associated with a recognizable behavioral phenotype that includes disturbed regulation of impulsive aggression.	UNIV HOSP NIJMEGEN,DEPT HUMAN GENET,6500 HB NIJMEGEN,NETHERLANDS; MASSACHUSETTS GEN HOSP,CTR NEUROSCI,BOSTON,MA 02129	Radboud University Nijmegen; Harvard University; Massachusetts General Hospital	BRUNNER, HG (corresponding author), UNIV HOSP NIJMEGEN,DEPT HUMAN GENET,GEERT GROOTEPLEIN 20,6525 GA NIJMEGEN,NETHERLANDS.		Nelen, Marcel R./L-4542-2015; Brunner, Han/C-9928-2013		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021921] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 21921] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BACH AWJ, 1988, P NATL ACAD SCI USA, V85, P4934, DOI 10.1073/pnas.85.13.4934; BERGER W, 1992, NAT GENET, V1, P199, DOI 10.1038/ng0692-199; BLEEKERWAGEMAKERS EM, 1988, OPHTHALMIC PAED GEN, V9, P137, DOI 10.3109/13816818809031489; BLIER P, 1986, J PHARMACOL EXP THER, V237, P987; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREAKEFIELD XO, 1981, GENETIC RES STRATEGI, P129; BROWN GL, 1979, PSYCHIAT RES, V1, P131, DOI 10.1016/0165-1781(79)90053-2; BRUNNER HG, 1993, AM J HUM GENET, V52, P1032; CHEN ZY, 1992, NUCLEIC ACIDS RES, V19, P537; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COCCARO EF, 1989, BRIT J PSYCHIAT, V155, P52, DOI 10.1192/S0007125000291769; COHEN RM, 1982, PSYCHOPHARMACOLOGY, V78, P137, DOI 10.1007/BF00432251; COLLINS FA, 1992, AM J MED GENET, V42, P127, DOI 10.1002/ajmg.1320420126; DELACHAPELLE A, 1985, CLIN GENET, V28, P317; DONNAI D, 1988, J MED GENET, V25, P73, DOI 10.1136/jmg.25.2.73; EDELSTEIN SB, 1981, BIOCHEM BIOPH RES CO, V98, P836, DOI 10.1016/0006-291X(81)91187-6; EDELSTEIN SB, 1986, CELL MOL NEUROBIOL, V6, P121, DOI 10.1007/BF00711066; EDELSTEIN SB, 1978, J NEUROCHEM, V31, P1247, DOI 10.1111/j.1471-4159.1978.tb06249.x; EICHELMAN B, 1975, PHARMACOL BIOCHEM BE, V3, P601, DOI 10.1016/0091-3057(75)90180-X; EICHELMAN BS, 1973, BIOL PSYCHIAT, V6, P143; GREENSHAW AJ, 1989, BIOL PSYCHIAT, V25, P1014, DOI 10.1016/0006-3223(89)90289-8; HIGLEY JD, 1992, ARCH GEN PSYCHIAT, V49, P436; HOTAMISLIGIL GS, 1991, AM J HUM GENET, V49, P383; HSU YPP, 1988, J NEUROCHEM, V51, P1321, DOI 10.1111/j.1471-4159.1988.tb03105.x; KANTAK KM, 1980, PHARMACOL BIOCHEM BE, V12, P173, DOI 10.1016/0091-3057(80)90351-2; KRUESI MJP, 1990, ARCH GEN PSYCHIAT, V47, P419; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LINNOILA M, 1983, LIFE SCI, V33, P2609, DOI 10.1016/0024-3205(83)90344-2; MORDEN B, 1968, PHYSIOL BEHAV, V3, P425, DOI 10.1016/0031-9384(68)90073-5; MURPHY DL, 1983, ANTIDEPRESSANTS, P209; NIKULINA EM, 1992, AGGRESSIVE BEHAV, V18, P65, DOI 10.1002/1098-2337(1992)18:1<65::AID-AB2480180108>3.0.CO;2-Y; PICKAR D, 1982, ARCH GEN PSYCHIAT, V39, P535; POPOVA NK, 1991, AGGRESSIVE BEHAV, V17, P207, DOI 10.1002/1098-2337(1991)17:4<207::AID-AB2480170403>3.0.CO;2-2; Reis D J, 1972, Res Publ Assoc Res Nerv Ment Dis, V50, P266; SIMS KB, 1989, NEURON, V2, P1069, DOI 10.1016/0896-6273(89)90231-6; SLEIGHT AJ, 1988, BRIT J PHARMACOL, V93, P303, DOI 10.1111/j.1476-5381.1988.tb11435.x; TRONCONE LRP, 1991, PHYSIOL BEHAV, V50, P173, DOI 10.1016/0031-9384(91)90517-R; TUFIK S, 1978, PHARMACOLOGY, V16, P98, DOI 10.1159/000136753; VALZELLI L, 1982, PHARMACOL RES COMMUN, V14, P1, DOI 10.1016/S0031-6989(82)80047-7; Valzelli L., 1981, PSYCHOBIOLOGY AGGRES; VANDENOUWELAND AMW, 1992, NAT GENET, V2, P99, DOI 10.1038/ng1092-99; WINSLOW JT, 1983, PSYCHOPHARMACOLOGY, V81, P286, DOI 10.1007/BF00427564; ZHU DP, 1989, AM J MED GENET, V33, P485, DOI 10.1002/ajmg.1320330415	43	1090	1123	6	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	OCT 22	1993	262	5133					578	580		10.1126/science.8211186	http://dx.doi.org/10.1126/science.8211186			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC935	8211186				2022-12-28	WOS:A1993MC93500044
J	CHEN, LHY				CHEN, LHY			EXTENDING THE POISSON APPROXIMATION	SCIENCE			English	Editorial Material							STEIN METHOD				CHEN, LHY (corresponding author), NATL UNIV SINGAPORE, DEPT MATH, LOWER KENT RIDGE RD, SINGAPORE 0511, SINGAPORE.		Chen, Louis/E-7050-2016					ARRATIA R, 1990, ANN STAT, V18, P539, DOI 10.1214/aos/1176347615; ARRATIA R, 1989, ANN PROBAB, V17, P9, DOI 10.1214/aop/1176991491; Arratia R., 1990, STAT SCI, P403, DOI [10.1214/ss/1177012015, DOI 10.1214/SS/1177012015]; Barbour A.D., 1992, POISSON APPROXIMATIO; BARBOUR AD, 1992, ANN PROBAB, V20, P1843, DOI 10.1214/aop/1176989531; BARBOUR AD, 1988, J APPL PROBAB A, V25, P175; CHEN LHY, 1975, ANN PROBAB, V3, P534, DOI 10.1214/aop/1176996359; KARLIN S, 1990, P NATL ACAD SCI USA, V87, P2264, DOI 10.1073/pnas.87.6.2264; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; STEIN C, 1972, 6TH P BERK S MATH ST, V2, P583; WATERMAN MS, 1989, APPLIED MATH SCI, V77	12	3	3	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 15	1993	262	5132					379	380		10.1126/science.8211157	http://dx.doi.org/10.1126/science.8211157			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MB859	8211157				2022-12-28	WOS:A1993MB85900045
J	ROSSOR, M				ROSSOR, M			FORTNIGHTLY REVIEW - ALZHEIMERS-DISEASE	BRITISH MEDICAL JOURNAL			English	Article							CEREBROSPINAL-FLUID; PROTEIN; PRECURSOR; ATROPHY; TACRINE; GENE; TAU				ROSSOR, M (corresponding author), ST MARYS HOSP,LONDON W2 1NY,ENGLAND.		Rossor, Martin/C-1598-2008	Rossor, Martin/0000-0001-8215-3120				BURNS A, 1990, BRIT J PSYCHIAT, V157, P72, DOI 10.1192/bjp.157.1.72; DAVIS KL, 1992, NEW ENGL J MED, V327, P1253, DOI 10.1056/NEJM199210293271801; DELAMONTE SM, 1992, ANN NEUROL, V32, P733, DOI 10.1002/ana.410320606; FARLOW M, 1992, JAMA-J AM MED ASSOC, V268, P2523, DOI 10.1001/jama.268.18.2523; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; JOBST KA, 1992, LANCET, V340, P1179; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KESSLAK JP, 1991, NEUROLOGY, V41, P51, DOI 10.1212/WNL.41.1.51; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MULLAN M, 1992, BRIT MED J, V305, P1108, DOI 10.1136/bmj.305.6862.1108; MURPHY M, 1992, LANCET, V340, P1512, DOI 10.1016/0140-6736(92)92765-8; NAVARATNAM DS, 1991, LANCET, V337, P447, DOI 10.1016/0140-6736(91)93391-L; ONEILL D, 1992, LANCET, V339, P41, DOI 10.1016/0140-6736(92)90155-V; ROSSOR MN, 1993, J NEUROL NEUROSUR PS, V56, P583, DOI 10.1136/jnnp.56.6.583; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Whitehouse P. J., 1993, DEMENTIA	18	21	21	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 25	1993	307	6907					779	782		10.1136/bmj.307.6907.779	http://dx.doi.org/10.1136/bmj.307.6907.779			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LZ478	8219953	Bronze, Green Published			2022-12-28	WOS:A1993LZ47800028
J	TROSHINSKY, MB; KANE, GC; VARGA, J; CATER, JR; FISH, JE; JIMENEZ, SA; CASTELL, DO				TROSHINSKY, MB; KANE, GC; VARGA, J; CATER, JR; FISH, JE; JIMENEZ, SA; CASTELL, DO			PULMONARY-FUNCTION AND GASTROESOPHAGEAL REFLUX IN SYSTEMIC-SCLEROSIS	ANNALS OF INTERNAL MEDICINE			English	Article						GASTROESOPHAGEAL REFLUX; SCLERODERMA, SYSTEMIC; RESPIRATORY FUNCTION TESTS; ESOPHAGEAL MOTILITY DISORDERS; SMOKING	INTERSTITIAL LUNG-DISEASE; GASTROINTESTINAL MANIFESTATIONS; DIFFUSING-CAPACITY; SURGICAL-TREATMENT; D-PENICILLAMINE; SCLERODERMA; ACID; PATHOGENESIS; SURVIVAL; THERAPY	Objective: To determine the relations among esophageal dysfunction, gastroesophageal reflux, and lung involvement in patients with systemic sclerosis. Design: Retrospective review of esophageal motility, esophageal pH, and pulmonary function data. Setting: University hospital outpatient clinic and community. Patients: 39 consecutively referred patients who were grouped according to the presence or absence of abnormal distal (pH <4.0 for >5% of the 24-hour monitoring period) or proximal (pH <4.0 for >1% of the 24-hour period) gastroesophageal acid reflux. Patients were also grouped according to the presence or absence of distal esophageal peristalsis. Measurements: Esophageal manometry, dual-probe (distal and proximal) esophageal 24-hour pH measurements, and pulmonary function studies (forced vital capacity, forced expiratory volume at 1 second, total lung capacity, and single-breath carbon monoxide diffusing capacity [DL(CO)]). Results: The mean total lung capacity (values as percentage predicted) was 87.1% +/- 11.2% (SD) for patients with abnormal proximal reflux and 77.8% +/- 21.6% for patients with normal proximal reflux (difference, 9.3%; 95% CI, -1.4% to 20.0%). The mean forced vital capacity for these patients was 91.1% +/- 12.4% and 85.4% +/- 25.6%, respectively (difference, 5.7%; CI, -6.9% to 18.1%). The mean total lung capacity was 83.8% +/- 15.4% for patients with abnormal distal reflux and 77.9% +/- 22.7% for patients with normal distal reflux (difference, 5.9%; CI, -7.6% to 19.4%). Among potential confounders of pulmonary measures, only smoking was related to decreased pulmonary function (smoking related to decreased DL(CO) P < 0.01). Smoking was more common in patients with abnormal distal reflux than in those with normal distal reflux (65% compared with 25%, P = 0.03). After adjusting for smoking, the difference in mean DL(CO) between patients with abnormal compared with normal distal reflux was 7.19% (CI, -8.5% to 22.9%). Conclusion: Important measures of lung volume indicative of interstitial lung disease (total lung capacity, forced vital capacity) do not appear to be related to abnormal gastroesophageal acid reflux in patients with systemic sclerosis.	GRAD HOSP PHILADELPHIA, DEPT MED, PHILADELPHIA, PA 19146 USA; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DIV PULM MED, PHILADELPHIA, PA 19107 USA; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, DIV RHEUMATOL, PHILADELPHIA, PA 19107 USA	University of Pennsylvania; Pennsylvania Medicine; Jefferson University; Jefferson University				Jimenez, Sergio/0000-0001-5213-1203	NIAMS NIH HHS [AR19106, AR42309] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042309] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ALTMAN RD, 1991, ARTHRITIS RHEUM, V34, P403, DOI 10.1002/art.1780340405; [Anonymous], 1987, AM REV RESPIR DIS, V136, P1285; [Anonymous], 1987, AM REV RESPIR DIS, V136, P1299; BAGG LR, 1979, THORAX, V34, P224, DOI 10.1136/thx.34.2.224; BRAITMAN LE, 1991, ANN INTERN MED, V114, P515, DOI 10.7326/0003-4819-114-6-515; CASTELL JA, 1990, AM J PHYSIOL, V258, pG173, DOI 10.1152/ajpgi.1990.258.2.G173; CHERNOW B, 1979, DIGEST DIS SCI, V24, P839, DOI 10.1007/BF01324899; COHEN S, 1980, GASTROENTEROLOGY, V79, P155; CONRAD SA, 1984, PULMONARY FUNCTION T, P112; DANGELO WA, 1969, AM J MED, V46, P428, DOI 10.1016/0002-9343(69)90044-8; DECLERCK LS, 1987, ARTHRITIS RHEUM, V30, P643; DOBHAN R, 1993, AM J GASTROENTEROL, V88, P25; GOLDMAN HI, 1959, AM REV TUBERC PULM, V79, P457; HARRISON NK, 1991, AM REV RESPIR DIS, V144, P706, DOI 10.1164/ajrccm/144.3_Pt_1.706; Hosmer D., 2000, APPL LOGISTIC REGRES, V2; JOHNSON DA, 1989, ARCH INTERN MED, V149, P589, DOI 10.1001/archinte.149.3.589; JOHNSON LF, 1974, AM J GASTROENTEROL, V62, P325; KEOGH BA, 1980, CHEST, V78, P856, DOI 10.1378/chest.78.6.856; KNUDSON RJ, 1976, AM REV RESPIR DIS, V113, P587; LARRAIN A, 1991, CHEST, V99, P1330, DOI 10.1378/chest.99.6.1330; LEROY EC, 1988, J RHEUMATOL, V15, P202; MANSFIELD LE, 1981, ANN ALLERGY, V47, P431; MANSFIELD LE, 1978, ANN ALLERGY, V41, P224; MANSFIELD LE, 1989, J ASTHMA, V26, P271, DOI 10.3109/02770908909073263; MCCARTHY DS, 1988, SEMIN ARTHRITIS RHEU, V17, P271, DOI 10.1016/0049-0172(88)90012-1; MILLER A, 1983, AM REV RESPIR DIS, V127, P270; MORAN TJ, 1955, ARCH PATHOL, V60, P122; OGILVIE CM, 1957, J CLIN INVEST, V36, P1, DOI 10.1172/JCI103402; PACK AI, 1990, AM REV RESPIR DIS, V141, P1391, DOI 10.1164/ajrccm/141.6.1391; PERRINFAYOLLE M, 1989, CHEST, V96, P40, DOI 10.1378/chest.96.1.40; PETERSGOLDEN M, 1984, AM J MED, V77, P1027, DOI 10.1016/0002-9343(84)90183-9; POIRIER TJ, 1972, AM J GASTROENTEROL, V58, P30; ROOK AH, 1992, ARCH DERMATOL, V128, P337, DOI 10.1001/archderm.128.3.337; SEIBOLD JR, 1989, TXB RHEUMATOLOGY, P1215; SILMAN AJ, 1991, ANN RHEUM DIS, V50, P267, DOI 10.1136/ard.50.4.267; SILVER RM, 1990, RHEUM DIS CLIN N AM, V16, P199; Snedecor G. W, 1989, STAT METHODS, V8th; SONTAG SJ, 1990, GASTROENTEROLOGY, V99, P613, DOI 10.1016/0016-5085(90)90945-W; STEEN VD, 1985, ARTHRITIS RHEUM, V28, P882, DOI 10.1002/art.1780280807; TEABEAUT JR, 1952, AM J PATHOL, V28, P51; TUCHMAN DN, 1984, GASTROENTEROLOGY, V87, P872; YARZE JC, 1993, AM J GASTROENTEROL, V88, P870; YOUSEM SA, 1990, HUM PATHOL, V21, P467, DOI 10.1016/0046-8177(90)90002-M	43	48	48	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 1	1994	121	1					6	10		10.7326/0003-4819-121-1-199407010-00002	http://dx.doi.org/10.7326/0003-4819-121-1-199407010-00002			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	PN271	8198350				2022-12-28	WOS:A1994PN27100002
J	LICHTIGER, S; PRESENT, DH; KORNBLUTH, A; GELERNT, I; BAUER, J; GALLER, G; MICHELASSI, F; HANAUER, S				LICHTIGER, S; PRESENT, DH; KORNBLUTH, A; GELERNT, I; BAUER, J; GALLER, G; MICHELASSI, F; HANAUER, S			CYCLOSPORINE IN SEVERE ULCERATIVE-COLITIS REFRACTORY TO STEROID-THERAPY	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLAMMATORY BOWEL-DISEASE; INTRAVENOUS TREATMENT; CROHNS-DISEASE; DOUBLE-BLIND; SYSTEM; TRIAL	Background. There has been no new effective drug therapy for patients with severe ulcerative colitis since corticosteroids were introduced almost 40 years ago. In an uncontrolled study, 80 percent of 32 patients with active ulcerative colitis refractory to corticosteroid therapy had a response to cyclosporine therapy. Methods. We conducted a randomized, double-blind, controlled trial in which cyclosporine (4 mg per kilogram of body weight per day) or placebo was administered by continuous intravenous infusion to 20 patients with severe ulcerative colitis whose condition had not improved after at least seven days of intravenous corticosteroid therapy. A response to therapy was defined as an improvement in a numerical symptom score (0 indicated no symptoms, and 21 severe symptoms) leading to discharge from the hospital and treatment with oral medications. Failure to respond to therapy resulted in colectomy, but some patients in the placebo group who had no response and no urgent need for surgery were subsequently treated with cyclosporine. Results. Nine of 11 patients (82 percent) treated with cyclosporine had a response within a mean of seven days, as compared with 0 of 9 patients who received placebo (P<0.001). The mean clinical-activity score fell from 13 to 6 in the cyclosporine group, as compared with a decrease from 14 to 13 in the placebo group. All five patients in the placebo group who later received cyclosporine therapy had a response. Conclusions. Intravenous cyclosporine therapy is rapidly effective for patients with severe corticosteroid-resistant ulcerative colitis.	CUNY MT SINAI SCH MED,DEPT MED,DIV GASTROENTEROL,NEW YORK,NY 10029; CUNY MT SINAI SCH MED,DEPT SURG,NEW YORK,NY 10029; UNIV CHICAGO,MED CTR,DEPT MED,DIV GASTROENTEROL,CHICAGO,IL 60637; UNIV CHICAGO,MED CTR,DEPT SURG,CHICAGO,IL 60637	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; University of Chicago; University of Chicago Medical Center; University of Chicago; University of Chicago Medical Center								ACTIS G C, 1992, Gastroenterology, V102, pA588; ATKINSON K, 1983, TRANSPLANT P, V15, P2446; BRYNSKOV J, 1989, NEW ENGL J MED, V321, P845, DOI 10.1056/NEJM198909283211301; CHALMERS TC, 1982, RANDOMIZED CLIN THER, P235; COCKBURN ITR, 1989, J AUTOIMMUN, V2, P723, DOI 10.1016/S0896-8411(89)80010-1; DEGROEN PC, 1987, NEW ENGL J MED, V317, P861, DOI 10.1056/NEJM198710013171404; EDWARDS FC, 1963, GUT, V4, P300; JARNEROT G, 1985, GASTROENTEROLOGY, V89, P1005; KORNBLUTH A, 1991, AM J GASTROENTEROL, V86, P1356; LICHTIGER S, 1990, MT SINAI J MED, V57, P315; LICHTIGER S, 1990, LANCET, V336, P16, DOI 10.1016/0140-6736(90)91521-B; LOCKHARTMUMMERY HE, 1960, GUT, V1, P87, DOI 10.1136/gut.1.2.87; MACDERMOTT RP, 1988, ADV IMMUNOL, V42, P285, DOI 10.1016/S0065-2776(08)60848-2; MCPHERSON K, 1974, NEW ENGL J MED, V290, P501, DOI 10.1056/NEJM197402282900907; MEYERS S, 1983, GASTROENTEROLOGY, V85, P351; PALESTINE AG, 1986, AM J MED, V81, P419, DOI 10.1016/0002-9343(86)90292-5; SANDBORN WJ, 1992, MAYO CLIN PROC, V67, P981, DOI 10.1016/S0025-6196(12)60930-6; SANDBORN WJ, 1991, J CLIN PHARMACOL, V31, P76, DOI 10.1002/j.1552-4604.1991.tb01890.x; SANDBORN WJ, 1992, J PEDIATR GASTR NUTR, V15, P125, DOI 10.1097/00005176-199208000-00004; TRUELOVE SC, 1974, LANCET, V1, P1067; VONGRAFFENRIED B, 1986, TRANSPLANT P, V18, P876; 1990, BR J DERMATOL S36, V122, P3	22	1324	1367	0	21	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 30	1994	330	26					1841	1845		10.1056/NEJM199406303302601	http://dx.doi.org/10.1056/NEJM199406303302601			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NT530	8196726				2022-12-28	WOS:A1994NT53000001
J	VLADECK, BC				VLADECK, BC			THE HEALTH-CARE QUALITY IMPROVEMENT PROGRAM - A PROGRESS REPORT	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											VLADECK, BC (corresponding author), HLTH CARE FINANCING ADM,BALTIMORE,MD, USA.								0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	1994	271	24					1896	1896		10.1001/jama.271.24.1896	http://dx.doi.org/10.1001/jama.271.24.1896			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR598	8201720				2022-12-28	WOS:A1994NR59800002
J	TAKAHASHI, JS; PINTO, LH; VITATERNA, MH				TAKAHASHI, JS; PINTO, LH; VITATERNA, MH			FORWARD AND REVERSE GENETIC APPROACHES TO BEHAVIOR IN THE MOUSE	SCIENCE			English	Review							LONG-TERM POTENTIATION; ARTIFICIAL CHROMOSOME LIBRARY; FRAGMENT LENGTH POLYMORPHISMS; STRUCTURE FUNCTIONAL-ANALYSIS; MESSENGER-RNA LEVELS; II MUTANT MICE; SYNAPTIC PLASTICITY; TRANSGENIC MICE; HUMAN GENOME; LINKAGE MAP	Modern molecular genetic and genomic approaches are revolutionizing the study of behavior in the mouse. ''Reverse genetics'' (from gene to phenotype) with targeted gene transfer provides a powerful tool to dissect behavior and has been used successfully to study the effects of null mutations in genes implicated in the regulation of long-term potentiation and spatial learning in mice. In addition, ''forward genetics'' (from phenotype to gene) with high-efficiency mutagenesis in the mouse can uncover unknown genes and has been used to isolate a behavioral mutant of the circadian system. With the recent availability of high-density genetic maps and physical mapping resources, positional cloning of virtually any mutation is now feasible in the mouse. Together, these approaches permit a molecular analysis of both known and previously unknown genes regulating behavior.			TAKAHASHI, JS (corresponding author), NORTHWESTERN UNIV, NATL SCI FDN, SCI & TECHNOL CTR BIOL TIMING, DEPT NEUROBIOL & PHYSIOL, EVANSTON, IL 60208 USA.		Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012	Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878	NATIONAL EYE INSTITUTE [R01EY008467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049241, R37MH039592, R01MH039592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000015] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NEI NIH HHS [EY08467] Funding Source: Medline; NIDCD NIH HHS [T32 DC000015] Funding Source: Medline; NIMH NIH HHS [MH39592, MH49241] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ABELIOVICH A, 1993, CELL, V75, P1263, DOI 10.1016/0092-8674(93)90614-V; ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; AVNER P, 1988, TRENDS GENET, V4, P18, DOI 10.1016/0168-9525(88)90123-0; BAILEY DW, 1971, TRANSPLANTATION, V11, P325, DOI 10.1097/00007890-197103000-00013; BEIER DR, 1993, MAMM GENOME, V4, P627, DOI 10.1007/BF00360898; BENSON D, 1993, NUCLEIC ACIDS RES, V21, P2963, DOI 10.1093/nar/21.13.2963; BENZER S, 1973, SCI AM, V229, P24, DOI 10.1038/scientificamerican1273-24; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Birren BW, 1993, PULSED FIELD GEL ELE, DOI [10.1016/B978-0-12-101290-8.50002-X, DOI 10.1016/B978-0-12-101290-8.50002-X]; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; BREEN M, 1994, HUM MOL GENET, V3, P621, DOI 10.1093/hmg/3.4.621; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; BULTMAN SJ, 1992, CELL, V71, P1195, DOI 10.1016/S0092-8674(05)80067-4; BURKE DT, 1987, SCIENCE, V236, P806, DOI 10.1126/science.3033825; CAPECCHI MR, 1994, SCI AM, V270, P52, DOI 10.1038/scientificamerican0394-52; CAPECCHI MR, 1989, TRENDS GENET, V5, P70, DOI 10.1016/0168-9525(89)90029-2; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; CATTANACH BM, 1993, NAT GENET, V3, P56, DOI 10.1038/ng0193-56; CHAPMAN VM, 1993, MAMM GENOME, V4, P293, DOI 10.1007/BF00357087; CHARTIER FL, 1992, NAT GENET, V1, P132, DOI 10.1038/ng0592-132; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; COLLINS F, 1993, SCIENCE, V262, P43, DOI 10.1126/science.8211127; COLLINS FS, 1992, NAT GENET, V1, P3, DOI 10.1038/ng0492-3; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; COULSON A, 1986, P NATL ACAD SCI USA, V83, P7821, DOI 10.1073/pnas.83.20.7821; COX RD, 1993, METHOD ENZYMOL, V225, P637; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; DANCIGER M, 1990, GENOMICS, V6, P428, DOI 10.1016/0888-7543(90)90472-7; DANCIGER M, 1993, GENOMICS, V16, P361, DOI 10.1006/geno.1993.1198; DIANZANI I, 1993, TRENDS GENET, V9, P403, DOI 10.1016/0168-9525(93)90100-V; DIETRICH W, 1992, GENETICS, V131, P423; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; DIETRICH WF, IN PRESS NATURE GENE; DOVE WF, 1987, GENETICS, V116, P5; DRIEVER W, 1994, TRENDS GENET, V10, P152, DOI 10.1016/0168-9525(94)90091-4; DUDAI Y, 1988, ANNU REV NEUROSCI, V11, P537, DOI 10.1146/annurev.ne.11.030188.002541; DUNLAP JC, 1993, ANNU REV PHYSIOL, V55, P683, DOI 10.1146/annurev.physiol.55.1.683; DUYK GM, 1990, P NATL ACAD SCI USA, V87, P8995, DOI 10.1073/pnas.87.22.8995; EDERY I, 1994, SCIENCE, V263, P237, DOI 10.1126/science.8284676; EICHENBAUM H, 1992, BEHAV NEURAL BIOL, V57, P2, DOI 10.1016/0163-1047(92)90724-I; EWER J, 1992, J NEUROSCI, V12, P3321; FESTING MFW, 1989, GENETIC VARIANTS STR, P636; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Ginsburg Benson E., 1992, V8, P3; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; GRANT SGN, 1994, TRENDS NEUROSCI, V17, P71, DOI 10.1016/0166-2236(94)90077-9; GREEN ED, 1990, SCIENCE, V250, P94, DOI 10.1126/science.2218515; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Greenspan R.J., 1990, Seminars in the Neurosciences, V2, P145; Greenspan Ralph J., 1992, V8, P93; GRIDLEY T, 1987, TRENDS GENET, V3, P162, DOI 10.1016/0168-9525(87)90218-6; Hall J.C., 1990, Advances in Insect Physiology, V22, P221, DOI 10.1016/S0065-2806(08)60007-7; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; HALL JC, 1990, ANNU REV GENET, V24, P659; HANAHAN D, 1989, SCIENCE, V246, P1265, DOI 10.1126/science.2686032; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARDIN PE, 1992, P NATL ACAD SCI USA, V89, P11711, DOI 10.1073/pnas.89.24.11711; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1974, SCIENCE, V183, P46, DOI 10.1126/science.183.4120.46; Hasties ND, 1989, GENETIC VARIANTS STR, P559; HAWKINS RD, 1993, ANNU REV NEUROSCI, V16, P625, DOI 10.1146/annurev.ne.16.030193.003205; HEARNE CM, 1992, TRENDS GENET, V8, P288, DOI 10.1016/0168-9525(92)90256-4; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; HILBERG F, 1993, NATURE, V365, P179, DOI 10.1038/365179a0; HITOTSUMACHI S, 1985, P NATL ACAD SCI USA, V82, P6619, DOI 10.1073/pnas.82.19.6619; Hogan B, 1994, MANIPULATING MOUSE E; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; JACOB HJ, 1991, CELL, V67, P213, DOI 10.1016/0092-8674(91)90584-L; JACOB HJ, 1992, NAT GENET, V2, P56, DOI 10.1038/ng0992-56; JAENISCH R, 1988, SCIENCE, V240, P1468, DOI 10.1126/science.3287623; JOHNSON RS, 1992, CELL, V71, P577, DOI 10.1016/0092-8674(92)90592-Z; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Joyner AL, 1993, GENE TARGETING PRACT; Joyner Alexandra L., 1994, Current Opinion in Neurobiology, V4, P37, DOI 10.1016/0959-4388(94)90029-9; KING TR, 1991, MAMM GENOME, V1, P37, DOI 10.1007/BF00350844; KINGSLEY DM, 1992, CELL, V71, P399, DOI 10.1016/0092-8674(92)90510-J; Klein D.C., 1991, SUPRACHIASMATIC NUCL; KLEIN J, 1989, GENETIC VARIANTS STR, P797; KONOPKA RJ, 1987, ANNU REV GENET, V21, P227, DOI 10.1146/annurev.genet.21.1.227; KUSUMI K, 1993, MAMM GENOME, V4, P391, DOI 10.1007/BF00360591; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; LARIN Z, 1991, P NATL ACAD SCI USA, V88, P4123, DOI 10.1073/pnas.88.10.4123; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Lynch G. Robert, 1992, V8, P251; Lyon MF, 1989, GENETIC VARIANTS STR, P632; Lyon ML, 1989, GENETIC VARIANTS STR, P773; MADISON DV, 1991, ANNU REV NEUROSCI, V14, P379, DOI 10.1146/annurev.ne.14.030191.002115; MANLY KF, 1993, MAMM GENOME, V4, P303, DOI 10.1007/BF00357089; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MCDONALD JD, 1990, P NATL ACAD SCI USA, V87, P1965, DOI 10.1073/pnas.87.5.1965; MCNAUGHTON BL, 1993, ANNU REV PHYSIOL, V55, P375, DOI 10.1146/annurev.physiol.55.1.375; MEIJER JH, 1989, PHYSIOL REV, V69, P671, DOI 10.1152/physrev.1989.69.3.671; MEISLER MH, 1992, TRENDS GENET, V8, P341, DOI 10.1016/0168-9525(92)90278-C; MILLER MW, 1993, GENE DEV, V7, P454, DOI 10.1101/gad.7.3.454; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; NADEAU JH, 1989, TRENDS GENET, V5, P82, DOI 10.1016/0168-9525(89)90031-0; NADEAU JH, 1989, GENETIC VARIANTS STR, P506; NELSON DL, 1994, YAC LIBRARIES USERS; NEUMANN PE, 1991, P NATL ACAD SCI USA, V88, P5408, DOI 10.1073/pnas.88.12.5408; NORTH MA, 1993, MAMM GENOME, V4, P466, DOI 10.1007/BF00364779; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; ODELL TJ, IN PRESS SCIENCE; OLSON M, 1989, SCIENCE, V245, P1434, DOI 10.1126/science.2781285; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PATERSON AH, 1988, NATURE, V335, P721, DOI 10.1038/335721a0; PAYLOR R, 1993, PSYCHOBIOLOGY, V21, P11; Peters J., 1992, V8, P67; PIERCE JC, 1992, MAMM GENOME, V3, P550, DOI 10.1007/BF00350620; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P223, DOI 10.1007/BF01417856; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; RALPH MR, 1988, SCIENCE, V241, P1225, DOI 10.1126/science.3413487; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; RIKKE BA, 1991, GENOMICS, V11, P895, DOI 10.1016/0888-7543(91)90012-4; Rinchik E.M., 1990, GENOME ANAL, P121; RINCHIK EM, 1991, TRENDS GENET, V7, P15, DOI 10.1016/0168-9525(91)90016-J; RINCHIK EM, 1990, P NATL ACAD SCI USA, V87, P896, DOI 10.1073/pnas.87.3.896; RINCHIK EM, 1990, P NATL ACAD SCI USA, V87, P1416, DOI 10.1073/pnas.87.4.1416; RISE ML, 1991, SCIENCE, V253, P669, DOI 10.1126/science.1871601; ROBINSON C, 1992, TRENDS BIOTECHNOL, V10, P1, DOI 10.1016/0167-7799(92)90156-P; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; ROSBASH M, 1989, NEURON, V3, P387, DOI 10.1016/0896-6273(89)90199-2; ROSSANT J, 1992, GENE DEV, V6, P1, DOI 10.1101/gad.6.1.1; ROSSANT J, 1993, PHILOS T R SOC B, V339, P207, DOI 10.1098/rstb.1993.0018; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; RUSSELL LB, 1989, P NATL ACAD SCI USA, V86, P3704, DOI 10.1073/pnas.86.10.3704; RUSSELL WL, 1965, NUCLEONICS, V23, P53; RUSSELL WL, 1979, P NATL ACAD SCI USA, V76, P5818, DOI 10.1073/pnas.76.11.5818; RUSSELL WL, 1962, P NATL ACAD SCI USA, V48, P1724, DOI 10.1073/pnas.48.10.1724; SCHEDL A, 1993, NATURE, V362, P258, DOI 10.1038/362258a0; SCHUMAN EM, 1994, ANNU REV NEUROSCI, V17, P153, DOI 10.1146/annurev.neuro.17.1.153; SCHWARTZ WJ, 1990, J NEUROSCI, V10, P3685; SELBY PB, 1981, MOUSE BIOMEDICAL RES, V1, P264; SELDIN MF, 1988, J EXP MED, V167, P688, DOI 10.1084/jem.167.2.688; SHEDLOVSKY A, 1986, GENET RES, V47, P135, DOI 10.1017/S0016672300022977; SHEDLOVSKY A, 1988, P NATL ACAD SCI USA, V85, P180, DOI 10.1073/pnas.85.1.180; SHEDLOVSKY A, 1993, GENETICS, V134, P1205; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; STEVENS CF, 1993, CELL, V72, P55, DOI 10.1016/S0092-8674(05)80028-5; STRAUSS WM, 1993, SCIENCE, V259, P1904, DOI 10.1126/science.8096090; Takahashi J S, 1991, Curr Opin Neurobiol, V1, P556, DOI 10.1016/S0959-4388(05)80028-5; TAKAHASHI JS, 1993, CURR OPIN GENET DEV, V3, P301, DOI 10.1016/0959-437X(93)90038-Q; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.ne.17.030194.003003; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Taylor B. A., 1978, ORIGINS INBRED MICE, P423, DOI [10.1016/B978-0-12-507850-4.50032-9, DOI 10.1016/B978-0-12-507850-4.50032-9]; TODD JA, 1991, NATURE, V351, P542, DOI 10.1038/351542a0; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; WEBER JL, 1989, AM J HUM GENET, V44, P388; WILLIAMS RW, IN PRESS MAMMAL GENO; Worden, 1974, NEUROSCIENCES 3RD ST, P437; WOYCHIK RP, 1993, NATURE, V363, P375, DOI 10.1038/363375a0; YAGI T, 1993, NATURE, V366, P742, DOI 10.1038/366742a0; ZEHETNER G, 1994, NATURE, V367, P489, DOI 10.1038/367489a0	160	180	196	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 17	1994	264	5166					1724	1733		10.1126/science.8209253	http://dx.doi.org/10.1126/science.8209253			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR600	8209253	Green Accepted			2022-12-28	WOS:A1994NR60000034
J	PRICE, R; COHEN, S				PRICE, R; COHEN, S			A MORAL QUESTION FOR PATENT LEGISLATION .1.	NATURE			English	Article								In considering the grounds on which to award patents for applications of germline gene therapy, the European Patent Office may have to decide on the basis of ''morality''. This should not be its job.			PRICE, R (corresponding author), TAYLOR JOYNSON GARRETT,LONDON EC4Y 0DX,ENGLAND.								0	1	1	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 16	1994	369	6481					589	589		10.1038/369589a0	http://dx.doi.org/10.1038/369589a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR294	8202163	Bronze			2022-12-28	WOS:A1994NR29400059
J	JANIN, A; SOCIE, G; DEVERGIE, A; ARACTINGI, S; ESPEROU, H; VEROLA, MO; GLUCKMAN, E				JANIN, A; SOCIE, G; DEVERGIE, A; ARACTINGI, S; ESPEROU, H; VEROLA, MO; GLUCKMAN, E			FASCIITIS IN CHRONIC GRAFT-VERSUS-HOST DISEASE - A CLINICOPATHOLOGICAL STUDY OF 14 CASES	ANNALS OF INTERNAL MEDICINE			English	Article						GRAFT VS HOST DISEASE; FASCIITIS; BONE MARROW TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS; EDEMA	EOSINOPHILIA-MYALGIA-SYNDROME; BONE-MARROW TRANSPLANTATION; TOXIC OIL SYNDROME; DIFFUSE FASCIITIS; PERIPHERAL NEUROPATHY; SYSTEMIC SCLERODERMA; MANIFESTATIONS; TISSUE; SKIN; POLYMYOSITIS	Objective: To describe the clinicopathologic features of fasciitis in patients with chronic graft-versus-host disease (GVHD) after allogeneic bone marrow transplantation from human leukocyte antigen (HLA)identical donors. Design: A retrospective cohort study. Setting: Tertiary care center. Patients: Patients who had allogeneic bone marrow transplantation and developed chronic GVHD with clinical and pathologic signs of fasciitis. Main Outcome Measure: Analysis of clinical presentations and of deep cutaneo-muscular biopsy specimens. Results: Between January 1974 and January 1991, 14 of 475 patients who had allogeneic bone marrow transplantation developed chronic GVHD that began with the sicca syndrome and liver or digestive tract involvement, or both, 60 to 170 days after the graft was received. Sudden and painful skin swelling was reported 350 to 3745 days after the graft was received. Follow-up over 2 to 7 years showed failure of the fasciitis to respond to steroid therapy or to any conventional treatment of chronic GVHD. Although 7 patients showed moderate improvement, the others remained functionally disabled because of skin tightness, joint stiffness, contractures, and sores. Patients with fasciitis in chronic GVHD had no specific immunogenetic profile and no history of L-tryptophan intake or phytonadione injections. Conclusion: Among alloimmune syndromes, fasciitis is a distinct entity that leads to functional disability. This rare form of chronic GVHD may provide clues to understanding the mechanisms involved in fasciitis from other causes.	HOP ST LOUIS, UNITE GREFFE MOELLE OSSEUSE TREFLE 3, F-75010 PARIS, FRANCE; HOP ST LOUIS, DERMATOL SERV, F-75010 PARIS, FRANCE; HOP ST LOUIS, CENT ANAT PATHOL LAB, F-75010 PARIS, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	JANIN, A (corresponding author), HOP CALMETTE, DEPT PATHOL C, BD J LECLERCQ, F-59800 LILLE, FRANCE.			Aractingi, Selim/0000-0002-7766-2673				ALONSORUIZ A, 1986, SEMIN ARTHRITIS RHEU, V15, P200, DOI 10.1016/0049-0172(86)90017-X; ANDERSON BA, 1982, ARCH NEUROL-CHICAGO, V39, P188, DOI 10.1001/archneur.1982.00510150058015; BARNES L, 1979, AM J PATHOL, V96, P493; BOTET MVV, 1980, J AM ACAD DERMATOL, V2, P36; CAPERTON EM, 1976, ARTHRITIS RHEUM, V19, P792; CHOSIDOW O, 1992, J AM ACAD DERMATOL, V26, P49, DOI 10.1016/0190-9622(92)70005-Z; CRAMER SF, 1982, ARCH PATHOL LAB MED, V106, P85; DEEG HJ, 1984, BRIT J HAEMATOL, V57, P185, DOI 10.1111/j.1365-2141.1984.tb08521.x; FELDMAN SR, 1992, J AM ACAD DERMATOL, V26, P95, DOI 10.1016/0190-9622(92)70014-7; FERRIER MC, 1988, DERMATOLOGICA, V176, P299, DOI 10.1159/000248740; FLEISCHMAJER R, 1977, ARTHRITIS RHEUM, V20, P975, DOI 10.1002/art.1780200410; FLEISCHMAJER R, 1972, ARCH DERMATOL, V105, P59, DOI 10.1001/archderm.105.1.59; FLEISCHMAJER R, 1978, ARCH DERMATOL, V114, P1320, DOI 10.1001/archderm.114.9.1320; GODEAU P, 1977, NOUV PRESSE MED, V6, P4039; GRAHAMBROWN RAC, 1983, CLIN EXP DERMATOL, V8, P531, DOI 10.1111/j.1365-2230.1983.tb01820.x; GRAZE PR, 1979, AM J MED, V66, P611, DOI 10.1016/0002-9343(79)91171-9; GUSTAFSSON R, 1991, ARTHRITIS RHEUM-US, V34, P414, DOI 10.1002/art.1780340406; HERRICK MK, 1991, HUM PATHOL, V22, P12, DOI 10.1016/0046-8177(91)90055-T; JANIN A, 1993, THORAX, V48, P57, DOI 10.1136/thx.48.1.57; JANINMERCIER A, 1981, VIRCHOWS ARCH A, V394, P177, DOI 10.1007/BF00431676; JANINMERCIER A, 1981, ACTA DERM-VENEREOL, V61, P187; JANINMERCIER A, 1984, AM J PATHOL, V115, P296; KAHN MF, 1991, MALADIES SYSTEMIQUES, P465; KERR LD, 1992, J RHEUMATOL, V19, P294; KRIEG T, 1988, J AM ACAD DERMATOL, V18, P457, DOI 10.1016/S0190-9622(88)70070-5; LAWLEY TJ, 1977, ANN INTERN MED, V87, P707, DOI 10.7326/0003-4819-87-6-707; LIN JD, 1992, HUM PATHOL, V23, P429, DOI 10.1016/0046-8177(92)90091-G; MADDISON PJ, 1991, ANN RHEUM DIS, V50, P887, DOI 10.1136/ard.50.Suppl_4.887; MARKUSSE HM, 1990, J RHEUMATOL, V17, P692; MARTINEZTELLO FJ, 1982, VIRCHOWS ARCH A, V397, P261, DOI 10.1007/BF00496569; NOGUCHI H, 1992, AM J PATHOL, V140, P521; NOGUCHI H, 1990, FASEB J, V4, pA1943; NORIEGA AR, 1982, LANCET, V2, P697; OWEN WF, 1990, P NATL ACAD SCI USA, V87, P8647, DOI 10.1073/pnas.87.21.8647; PHELPS RG, 1988, J AM ACAD DERMATOL, V18, P313, DOI 10.1016/S0190-9622(88)70046-8; PIER N, 1983, BRIT MED J, V286, P2024, DOI 10.1136/bmj.286.6383.2024; PINCUS SH, 1987, BLOOD, V70, P572; RODNAN GP, 1975, ARTHRITIS RHEUM, V18, P422; SATSANGI J, 1992, J NEUROL, V239, P91, DOI 10.1007/BF00862980; SAURAT JH, 1981, INT J DERMATOL, V20, P249, DOI 10.1111/j.1365-4362.1981.tb04329.x; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; SHULMAN HM, 1978, AM J PATHOL, V91, P545; Shulman L E, 1975, Trans Assoc Am Physicians, V88, P70; SMITH BE, 1990, NEUROLOGY, V40, P1035, DOI 10.1212/WNL.40.7.1035; SPIELVOGEL RL, 1977, ARCH DERMATOL, V113, P1424, DOI 10.1001/archderm.113.10.1424; STORB R, 1989, BRIT J HAEMATOL, V72, P567, DOI 10.1111/j.1365-2141.1989.tb04325.x; SULLIVAN KM, 1981, BLOOD, V57, P267, DOI 10.1182/blood.V57.2.267.267; TEN RM, 1990, CLIN EXP IMMUNOL, V82, P313; TUTSCHKA PJ, 1987, PROGR BONE MARROW TR, P457; URBANOMARQUEZ A, 1986, NEUROLOGY, V36, P1091, DOI 10.1212/WNL.36.8.1091; VANDENBERGH V, 1987, AM J MED, V83, P139, DOI 10.1016/0002-9343(87)90509-2; VERITY MA, 1991, HUM PATHOL, V22, P3, DOI 10.1016/0046-8177(91)90054-S; ZWAAN FE, 1980, LANCET, V1, P1081; 1989, MMWR-MORBID MORTAL W, V38, P785; 1990, MMWR-MORBID MORTAL W, V39, P789	55	91	93	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	1994	120	12					993	998		10.7326/0003-4819-120-12-199406150-00004	http://dx.doi.org/10.7326/0003-4819-120-12-199406150-00004			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NQ964	8185148				2022-12-28	WOS:A1994NQ96400004
J	OSSWALD, S; BROOKS, R; ONUNAIN, SS; CURWIN, JH; ROELKE, M; RADVANY, P; RUSKIN, JN; MCGOVERN, BA				OSSWALD, S; BROOKS, R; ONUNAIN, SS; CURWIN, JH; ROELKE, M; RADVANY, P; RUSKIN, JN; MCGOVERN, BA			ASYSTOLE AFTER EXERCISE IN HEALTHY-PERSONS	ANNALS OF INTERNAL MEDICINE			English	Note							ORGANIC HEART-DISEASE; UP TILT; HYPOTENSION-BRADYCARDIA; CARDIAC ASYSTOLE; SYNCOPE		MASSACHUSETTS GEN HOSP, CARDIAC ARRHYTHMIA SERV, BOSTON, MA 02114 USA; ST PETERS HOSP, ALBANY, NY USA	Harvard University; Massachusetts General Hospital			Osswald, Stefan/A-6904-2018	Osswald, Stefan/0000-0002-9240-6731				ABISAMRA F, 1988, PACE, V11, P1202, DOI 10.1111/j.1540-8159.1988.tb03973.x; FLEG JL, 1983, ARCH INTERN MED, V143, P1821, DOI 10.1001/archinte.143.9.1821; GRUBB BP, 1993, MED SCI SPORT EXER, V25, P24, DOI 10.1249/00005768-199301000-00005; HIRATA T, 1987, J ELECTROCARDIOL, V20, P280, DOI 10.1016/S0022-0736(87)80027-4; HUYCKE EC, 1987, ANN INTERN MED, V106, P844, DOI 10.7326/0003-4819-106-6-844; KASSIRER JP, 1993, NEW ENGL J MED, V329, P50, DOI 10.1056/NEJM199307013290110; MILSTEIN S, 1989, J AM COLL CARDIOL, V14, P1626, DOI 10.1016/0735-1097(89)90006-5; MILSTEIN S, 1990, AM J CARDIOL, V65, P1339, DOI 10.1016/0002-9149(90)91324-Y; OLEARY DS, 1993, J APPL PHYSIOL, V74, P1748, DOI 10.1152/jappl.1993.74.4.1748; ROWELL LB, 1990, J APPL PHYSIOL, V69, P407, DOI 10.1152/jappl.1990.69.2.407; SAKAGUSHI S, 1993, PACE, V16, P893; SCHLESINGER Z, 1973, JAMA-J AM MED ASSOC, V226, P1119, DOI 10.1001/jama.1973.03230090043016; SHALEV Y, 1991, J AM COLL CARDIOL, V18, P746, DOI 10.1016/0735-1097(91)90798-E; SOBEL BE, 1988, HEART DISEASE, V2, P884; SRA JS, 1991, ANN INTERN MED, V114, P1013, DOI 10.7326/0003-4819-114-12-1013; SRA JS, 1993, NEW ENGL J MED, V328, P1085, DOI 10.1056/NEJM199304153281504; Thoren P, 1979, Rev Physiol Biochem Pharmacol, V86, P1, DOI 10.1007/BFb0031531; VICTOR RG, 1987, J CLIN INVEST, V79, P508, DOI 10.1172/JCI112841; WAXMAN MB, 1992, CAN J PHYSIOL PHARM, V70, P882, DOI 10.1139/y92-118	19	29	30	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	1994	120	12					1008	1011		10.7326/0003-4819-120-12-199406150-00007	http://dx.doi.org/10.7326/0003-4819-120-12-199406150-00007			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NQ964	8185132				2022-12-28	WOS:A1994NQ96400007
J	TAME, JRH; MURSHUDOV, GN; DODSON, EJ; NEIL, TK; DODSON, GG; HIGGINS, CF; WILKINSON, AJ				TAME, JRH; MURSHUDOV, GN; DODSON, EJ; NEIL, TK; DODSON, GG; HIGGINS, CF; WILKINSON, AJ			THE STRUCTURAL BASIS OF SEQUENCE-INDEPENDENT PEPTIDE BINDING BY OPPA PROTEIN	SCIENCE			English	Article							ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; OLIGOPEPTIDE PERMEASE; TRANSPORT; RECOGNITION; ENCODES; GENE; MAPS	Specific protein-ligand interactions are critical for cellular function, and most proteins select their partners with sharp discrimination. However, the oligopeptide-binding protein of Salmonella typhimurium (OppA) binds peptides of two to five amino acid residues without regard to sequence. The crystal structure of OppA reveals a three-domain organization, unlike other periplasmic binding proteins. In OppA-peptide complexes, the ligands are completely enclosed in the protein interior, a mode of binding that normally imposes tight specificity. The protein fulfills the hydrogen bonding and electrostatic potential of the ligand main chain and accommodates the peptide side chains in voluminous hydrated cavities.	UNIV YORK,DEPT CHEM,YORK YO1 5DD,N YORKSHIRE,ENGLAND; UNIV OXFORD,JOHN RADCLIFFE HOSP,INST MOLEC MED,IMPERIAL CANC RES FUND LABS,OXFORD OX3 9DU,ENGLAND; UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT CLIN BIOCHEM,OXFORD OX3 9DU,ENGLAND	University of York - UK; Cancer Research UK; University of Oxford; University of Oxford				Wilkinson, Anthony/0000-0003-4577-9479				ABOUHAMAD WN, 1991, MOL MICROBIOL, V5, P1035, DOI 10.1111/j.1365-2958.1991.tb01876.x; AMES BN, 1973, P NATL ACAD SCI USA, V70, P456, DOI 10.1073/pnas.70.2.456; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; Brtinger A. T., 1990, X PLOR VERSION 2 1; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; FICKEL TE, 1973, NATURE-NEW BIOL, V241, P161, DOI 10.1038/newbio241161a0; GLOVER ID, UNPUB; GOODELL EW, 1987, J BACTERIOL, V169, P3861, DOI 10.1128/jb.169.8.3861-3865.1987; GUYER CA, 1986, J BACTERIOL, V168, P775, DOI 10.1128/jb.168.2.775-779.1986; HAMMOND SM, 1987, NATURE, V327, P730, DOI 10.1038/327730a0; HANSON MS, 1992, INFECT IMMUN, V60, P2257, DOI 10.1128/IAI.60.6.2257-2266.1992; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; HIGGINS C, 1987, NATURE, V327, P655, DOI 10.1038/327655a0; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; HILES ID, 1986, EUR J BIOCHEM, V158, P561, DOI 10.1111/j.1432-1033.1986.tb09791.x; JONES TA, 1991, O MANUAL; Kleywegt G. J., UNPUB; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUEHN MJ, 1993, SCIENCE, V262, P1234, DOI 10.1126/science.7901913; MADDEN DR, 1991, NATURE, V353, P321, DOI 10.1038/353321a0; MOWBRAY SL, 1992, J MOL BIOL, V225, P155, DOI 10.1016/0022-2836(92)91033-L; NAVARRO C, 1993, MOL MICROBIOL, V9, P1181, DOI 10.1111/j.1365-2958.1993.tb01247.x; OH BH, 1993, J BIOL CHEM, V268, P11348; OLSON ER, 1991, J BACTERIOL, V173, P234, DOI 10.1128/jb.173.1.234-244.1991; PAYNE JW, 1971, ADV ENZYMOL RAMB, V35, P187; PAYNE JW, 1968, J BIOL CHEM, V243, P6292; Quiocho FA, 1991, CURR OPIN STRUC BIOL, V1, P922, DOI 10.1016/0959-440X(91)90087-A; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; TAN R, 1993, MICROBIOL REV, V57, P320; TOLLEY SP, 1988, J MOL BIOL, V204, P493, DOI 10.1016/0022-2836(88)90591-8; 1986, CCP4 SUITE PROGRAMS	32	211	215	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 10	1994	264	5165					1578	1581						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ285	8202710				2022-12-28	WOS:A1994NQ28500032
J	CALLAHAN, CM				CALLAHAN, CM			BAPTISM	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	1994	271	22					1746	1746						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN725	8196116				2022-12-28	WOS:A1994NN72500022
J	WITTE, MH; BORGS, P; WAY, DL; BERNAS, M; RAMIREZ, G; WITTE, CL				WITTE, MH; BORGS, P; WAY, DL; BERNAS, M; RAMIREZ, G; WITTE, CL			KAPOSIS-SARCOMA, VASCULAR-PERMEABILITY, AND SCIENTIFIC INTEGRITY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note								On March 13, 1992, Nakamura et al published an article in the journal Science reporting that sulfated polysaccharide peptidoglycan (SP-PG) inhibited the growth and vascular hyperpermeability characteristics of Kaposi's sarcoma-related cells and lesions in nude mice. While examining their key composite Fig 3, A through E, and related Table 2, we were surprised by several photographic features and other irregularities in the figures, which we explored further through a series of experiments. We were unable to confirm some of the pivotal findings. We communicated our concerns to Science but our letter was rejected. After submission of additional analysis, the matter was reopened by Science, but again our correspondence was rejected. Despite extensive review, the salient points raised in our initial correspondence remain unanswered or only tangentially addressed. The original conclusions by Nakamura et al are still not only highly dubious, but the validity of the peer review process and self-correcting nature of scientific inquiry are also called into question.			WITTE, MH (corresponding author), UNIV ARIZONA,COLL MED,DEPT SURG,1501 N CAMPBELL AVE,TUCSON,AZ 85724, USA.							NAKAMURA S, 1992, SCIENCE, V255, P1437, DOI 10.1126/science.1371891; PARVING HH, 1977, SCAND J CLIN LAB INV, V37, P643, DOI 10.3109/00365517709100658	2	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	1994	271	22					1769	1771						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN725	8196121				2022-12-28	WOS:A1994NN72500027
J	CAMPANELLI, JT; ROBERDS, SL; CAMPBELL, KP; SCHELLER, RH				CAMPANELLI, JT; ROBERDS, SL; CAMPBELL, KP; SCHELLER, RH			ROLE FOR DYSTROPHIN-ASSOCIATED GLYCOPROTEINS AND UTROPHIN IN AGRIN-INDUCED ACHR CLUSTERING	CELL			English	Article							ACETYLCHOLINE-RECEPTOR AGGREGATION; DUCHENNE MUSCULAR-DYSTROPHY; TORPEDO ELECTRIC ORGAN; NEUROMUSCULAR-JUNCTIONS; SKELETAL-MUSCLE; MOTOR NEURONS; CELL-SURFACE; EXTRACELLULAR-MATRIX; TISSUE DISTRIBUTION; CULTURED MYOTUBES	Synapse formation is characterized by the accumulation of molecules at the site of contact between pre- and postsynaptic cells. Agrin, a protein implicated in the regulation of this process, causes the clustering of acetylcholine receptors (AChRs). Here we characterize an agrin-binding site on the surface of muscle cells, show that this site corresponds to alpha-dystroglycan, and present evidence that alpha-dystroglycan is functionally related to agrin activity. Furthermore, we demonstrate that alpha-dystroglycan and adhalin, components of the dystrophin-associated glycoprotein complex, as well as utrophin, colocalize with agrin-induced AChR clusters. Thus, agrin may function by initiating or stabilizing a synapse-specific membrane cytoskeleton that in turn serves as a scaffold upon which synaptic molecules are concentrated.	UNIV IOWA,COLL MED,DEPT PHYSIOL & BIOPHYS,IOWA CITY,IA 52242	University of Iowa	CAMPANELLI, JT (corresponding author), STANFORD UNIV,HOWARD HUGHES MED INST,DEPT CELLULAR & MOLEC PHYSIOL,STANFORD,CA 94305, USA.		Roberds, Steven L/AAP-4985-2020	Roberds, Steven L/0000-0003-0676-272X; Campbell, Kevin/0000-0003-2066-5889				ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; ARAHATA K, 1988, NATURE, V333, P861, DOI 10.1038/333861a0; BENNETT V, 1990, PHYSIOL REV, V70, P1029, DOI 10.1152/physrev.1990.70.4.1029; BEVAN S, 1977, J PHYSIOL-LONDON, V267, P195, DOI 10.1113/jphysiol.1977.sp011808; BLOCH RJ, 1989, J CELL BIOL, V108, P481, DOI 10.1083/jcb.108.2.481; BONILLA E, 1988, CELL, V54, P447, DOI 10.1016/0092-8674(88)90065-7; BUONANNO A, 1986, J BIOL CHEM, V261, P1452; BUTLER MH, 1992, J BIOL CHEM, V267, P6213; BYERS TJ, 1991, J CELL BIOL, V115, P411, DOI 10.1083/jcb.115.2.411; CAMPANELLI JT, 1991, CELL, V67, P909, DOI 10.1016/0092-8674(91)90364-5; CAMPANELLI JT, 1993, THESIS STANFORD U ST; COHEN MW, 1992, J NEUROSCI, V12, P2982, DOI 10.1523/JNEUROSCI.12-08-02982.1992; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; FERTUCK H C, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1376, DOI 10.1073/pnas.71.4.1376; FROEHNER SC, 1990, NEURON, V5, P403, DOI 10.1016/0896-6273(90)90079-U; GAARN EEZ, 1988, NATURE, V333, P466; GEE SH, 1993, J BIOL CHEM, V268, P14972; GODFREY EW, 1984, J CELL BIOL, V99, P615, DOI 10.1083/jcb.99.2.615; GORDON H, 1989, DEV BIOL, V135, P1, DOI 10.1016/0012-1606(89)90152-8; HIRANO Y, 1989, J NEUROSCI, V9, P1551; HOCH W, 1994, IN PRESS EMBO J; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1988, NEW ENGL J MED, V318, P1363, DOI 10.1056/NEJM198805263182104; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; KHURANA TS, 1990, J BIOL CHEM, V265, P16717; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; LOVE DR, 1991, P NATL ACAD SCI USA, V88, P3243, DOI 10.1073/pnas.88.8.3243; LUNA EJ, 1992, SCIENCE, V258, P955, DOI 10.1126/science.1439807; MAGILLSOLC C, 1990, J EXP BIOL, V153, P1; MAGILLSOLC C, 1988, J CELL BIOL, V107, P1825, DOI 10.1083/jcb.107.5.1825; MARRS JA, 1993, J CELL BIOL, V123, P149, DOI 10.1083/jcb.123.1.149; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; MATSUMURA K, 1994, MUSCLE NERVE, V17, P2, DOI 10.1002/mus.880170103; NASTUK MA, 1991, NEURON, V7, P807, DOI 10.1016/0896-6273(91)90283-6; NELSON WJ, 1992, SCIENCE, V258, P948, DOI 10.1126/science.1439806; NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; PHILLIPS WD, 1993, J CELL BIOL, V123, P729, DOI 10.1083/jcb.123.3.729; PHILLIPS WD, 1991, SCIENCE, V251, P568, DOI 10.1126/science.1703661; PODLESKI TR, 1988, J NEUROBIOL, V19, P167, DOI 10.1002/neu.480190206; REIST NE, 1992, NEURON, V8, P865, DOI 10.1016/0896-6273(92)90200-W; ROBERDS SL, 1993, J BIOL CHEM, V268, P23739; RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z; RUPP F, 1992, J NEUROSCI, V12, P3535; RUPP F, 1991, NEURON, V6, P811, DOI 10.1016/0896-6273(91)90177-2; STEINBACH JH, 1981, DEV BIOL, V84, P267, DOI 10.1016/0012-1606(81)90394-8; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V; WAGNER KR, 1993, NEURON, V10, P511, DOI 10.1016/0896-6273(93)90338-R; WALLACE BG, 1990, J NEUROSCI, V10, P3576; WALLACE BG, 1989, J NEUROSCI, V9, P1294; WALLACE BG, 1992, J NEUROBIOL, V23, P592, DOI 10.1002/neu.480230512; WALLACE BG, 1988, J CELL BIOL, V107, P267, DOI 10.1083/jcb.107.1.267; WALLACE BG, 1986, J CELL BIOL, V102, P783, DOI 10.1083/jcb.102.3.783; WATKINS SC, 1988, NATURE, V333, P863, DOI 10.1038/333863a0; YEADON JE, 1991, J CELL BIOL, V115, P1069, DOI 10.1083/jcb.115.4.1069	59	345	349	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUN 3	1994	77	5					663	674		10.1016/0092-8674(94)90051-5	http://dx.doi.org/10.1016/0092-8674(94)90051-5			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NQ123	8205616				2022-12-28	WOS:A1994NQ12300007
J	GINTY, DD; BONNI, A; GREENBERG, ME				GINTY, DD; BONNI, A; GREENBERG, ME			NERVE GROWTH-FACTOR ACTIVATES A RAS-DEPENDENT PROTEIN-KINASE THAT STIMULATES C-FOS TRANSCRIPTION PHOSPHORYLATION OF CREB	CELL			English	Article							MULTIPLE SEQUENCE ELEMENTS; CAMP RESPONSE ELEMENT; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; PC12 CELLS; MEMBRANE DEPOLARIZATION; SOMATOSTATIN GENE; NUCLEAR-PROTEIN; MAP KINASES; RECEPTOR	A mechanism by which the nerve growth factor (NGF) signal is transduced to the nucleus to induce gene expression has been characterized. An NGF-inducible, Ras-dependent protein kinase has been identified that catalyzes the phosphorylation of the cyclic AMP response element-binding protein (CREB) at Ser-133. Phosphorylation of Ser-133 stimulates the ability of CREB to activate transcription in NGF-treated cells. These findings suggest that CREB has a more widespread function than previously believed and functions in the nucleus as a general mediator of growth factor responses.	HARVARD UNIV, SCH MED, PROGRAM NEUROSCI, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School	GINTY, DD (corresponding author), HARVARD UNIV, SCH MED, DEPT MICROBIOL & MOLEC GENET, BOSTON, MA 02115 USA.				NCI NIH HHS [R01 CA43855] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043855] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; BERKOWITZ LA, 1989, MOL CELL BIOL, V9, P4272, DOI 10.1128/MCB.9.10.4272; BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; CAREY M, 1990, NATURE, V345, P361, DOI 10.1038/345361a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; DEFRANCO C, 1993, MOL ENDOCRINOL, V7, P365, DOI 10.1210/me.7.3.365; FISCH TM, 1989, GENE DEV, V3, P198, DOI 10.1101/gad.3.2.198; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; GREENBERG ME, 1985, J BIOL CHEM, V260, P4101; GREENBERG ME, 1984, NATURE, V311, P433, DOI 10.1038/311433a0; Greene LA., 1982, ADV CELL NEUROBIOL, V3, P373, DOI [10.1016/B978-0-12-008303-9.50016-5, DOI 10.1016/B978-0-12-008303-9.50016-5]; HALEGOUA S, 1991, CURR TOP MICROBIOL, V165, P119; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; HAWLEY RJ, 1992, J NEUROSCI, V12, P2573; HAYES TE, 1987, P NATL ACAD SCI USA, V84, P1272, DOI 10.1073/pnas.84.5.1272; HEMPSTEAD BL, 1992, NEURON, V9, P883, DOI 10.1016/0896-6273(92)90241-5; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; KAPLAN DR, 1991, NATURE, V350, P158, DOI 10.1038/350158a0; KIM KS, 1993, J BIOL CHEM, V268, P15689; KLEIN R, 1991, CELL, V65, P189, DOI 10.1016/0092-8674(91)90419-Y; KRIEG J, 1988, J BIOL CHEM, V263, P11473; LEONARD DGB, 1987, MOL CELL BIOL, V7, P3156, DOI 10.1128/MCB.7.9.3156; Lo D C, 1992, Curr Opin Neurobiol, V2, P336, DOI 10.1016/0959-4388(92)90125-5; LOEB DM, 1991, CELL, V66, P961, DOI 10.1016/0092-8674(91)90441-Z; MALLER JL, 1990, BIOCHEMISTRY-US, V29, P3157, DOI 10.1021/bi00465a001; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; MATRISIAN LM, 1985, EMBO J, V4, P1435, DOI 10.1002/j.1460-2075.1985.tb03799.x; MOBLEY WC, 1976, BIOCHEMISTRY-US, V15, P5543, DOI 10.1021/bi00670a019; MONTMINY MR, 1987, NATURE, V328, P175, DOI 10.1038/328175a0; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; QIU MS, 1991, NEURON, V7, P937, DOI 10.1016/0896-6273(91)90339-2; RIVERA VM, 1993, MOL CELL BIOL, V13, P6260, DOI 10.1128/MCB.13.10.6260; SADOWSKI HB, 1993, SCIENCE, V261, P1739, DOI 10.1126/science.8397445; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; SHENG M, 1990, NEURON, V4, P477, DOI 10.1016/0896-6273(90)90106-P; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; TAYLOR LK, 1994, J BIOL CHEM, V269, P308; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; THOMAS SM, 1992, CELL, V68, P1031, DOI 10.1016/0092-8674(92)90075-N; TREISMAN R, 1985, CELL, V42, P889, DOI 10.1016/0092-8674(85)90285-5; TREISMAN R, 1992, TRENDS BIOCHEM SCI, V17, P423, DOI 10.1016/0968-0004(92)90013-Y; VISVADER J, 1988, P NATL ACAD SCI USA, V85, P9474, DOI 10.1073/pnas.85.24.9474; VOLONTE C, 1992, J BIOL CHEM, V267, P21663; WANG HCR, 1992, MOL BIOL CELL, V3, P1329, DOI 10.1091/mbc.3.12.1329; WOOD KW, 1992, CELL, V68, P1041, DOI 10.1016/0092-8674(92)90076-O; YOON JK, 1993, J BIOL CHEM, V268, P9148	53	692	706	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	1994	77	5					713	725		10.1016/0092-8674(94)90055-8	http://dx.doi.org/10.1016/0092-8674(94)90055-8			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NQ123	8205620				2022-12-28	WOS:A1994NQ12300011
J	SOLOMON, JA; PELLI, DG				SOLOMON, JA; PELLI, DG			THE VISUAL FILTER MEDIATING LETTER IDENTIFICATION	NATURE			English	Article							SPATIAL-FREQUENCIES; HUMAN-VISION; DISCRIMINATION; MASKING; NOISE; EFFICIENCY; CONTRAST; SHAPE	WE hear periodic sounds, or tones, by means of parallel auditory filters, each tuned to a band of temporal frequency(1), and we see periodic patterns, or gratings, by means of parallel visual filters, each tuned to a band of spatial frequency(2). Beyond helping us to see gratings, do these visual filters participate in everyday tasks such as reading and object recognition? After all, grating visibility only requires the distinguishing of pattern from blank, whereas object recognition, for example letter identification, requires classification by the observer into one of many learned categories. Here we make use of results from hearing research(3), applying to vision a noise-masking paradigm that reveals the filter(s) mediating any threshold task. We find that letter-identificatian and grating-detection filters are identical, showing that the recognition of these objects at one size is mediated and constrained by a single visual filter, or 'channel'.	SYRACUSE UNIV,INST SENSORY RES,SYRACUSE,NY 13244	Syracuse University								BARLOW HB, 1962, J PHYSIOL-LONDON, V160, P155, DOI 10.1113/jphysiol.1962.sp006838; BURGESS AE, 1981, SCIENCE, V214, P93, DOI 10.1126/science.7280685; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V197, P551, DOI 10.1113/jphysiol.1968.sp008574; Farah M.J., 1990, VISUAL AGNOSIA DISOR; Fletcher H, 1940, REV MOD PHYS, V12, P0047, DOI 10.1103/RevModPhys.12.47; GINSBURG AP, 1980, P SID, V21, P219; GRAHAM N, 1987, VISION RES, V27, P1997, DOI 10.1016/0042-6989(87)90063-0; Graham N.V.S, 1989, VISUAL PATTERN ANAL; HARMON LD, 1973, SCIENCE, V180, P1194, DOI 10.1126/science.180.4091.1194; HENNING GB, 1981, J OPT SOC AM, V71, P574, DOI 10.1364/JOSA.71.000574; Kucera H., 1967, COMPUTATIONAL ANAL P; LEGGE GE, 1985, VISION RES, V25, P239, DOI 10.1016/0042-6989(85)90117-8; NACHMIAS J, 1974, VISION RES, V14, P1039, DOI 10.1016/0042-6989(74)90175-8; PANTLE A, 1968, SCIENCE, V162, P1146, DOI 10.1126/science.162.3858.1146-a; PARISH DH, 1991, VISION RES, V31, P1399, DOI 10.1016/0042-6989(91)90060-I; PATTERSON RD, 1980, J ACOUST SOC AM, V67, P229, DOI 10.1121/1.383732; PATTERSON RD, 1974, J ACOUST SOC AM, V55, P802, DOI 10.1121/1.1914603; PAVEL M, 1987, J OPT SOC AM A, V4, P2355, DOI 10.1364/JOSAA.4.002355; Pelli D. G., 1990, VISION CODING EFFICI, P3; Pelli Denis Guillermo, 1981, THESIS U CAMBRIDGE; PELLI DG, 1991, VISION RES, V31, P1337, DOI 10.1016/0042-6989(91)90055-A; PELLI DG, 1983, PERCEPTION, V12, pA6; PELLI DG, 1980, INVESTIGATIVE OPHT S, V19, pA44; PELLI DG, 1990, 1990 TECH DIGEST SER, V3, P144; STROMEYER CF, 1972, J OPT SOC AM, V62, P1221, DOI 10.1364/JOSA.62.001221; THOMAS JP, 1979, J OPT SOC AM, V69, P652, DOI 10.1364/JOSA.69.000652; VANTREES HL, 1968, ESTIMATION MODULATIO; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; WATSON AB, 1981, VISION RES, V21, P1115, DOI 10.1016/0042-6989(81)90014-6; WILSON HR, 1983, VISION RES, V23, P873, DOI 10.1016/0042-6989(83)90055-X	30	256	260	1	22	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 2	1994	369	6479					395	397		10.1038/369395a0	http://dx.doi.org/10.1038/369395a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NP174	8196766				2022-12-28	WOS:A1994NP17400055
J	BRANDSPIGEL, K; BRAWER, MK				BRANDSPIGEL, K; BRAWER, MK			STAGING FOR PROSTATE-CANCER	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ANTIGEN		UNIV WASHINGTON,SEATTLE,WA	University of Washington; University of Washington Seattle								BRAWER MK, 1993, J UROLOGY, V150, P106, DOI 10.1016/S0022-5347(17)35409-5; BRAWER MK, 1991, ACTA ONCOL, V30, P161, DOI 10.3109/02841869109092342; BRAWER MK, 1992, J UROLOGY, V147, P841, DOI 10.1016/S0022-5347(17)37401-3; CATALONA WJ, 1991, NEW ENGL J MED, V324, P1156, DOI 10.1056/NEJM199104253241702; CHYBOWSKI FM, 1991, J UROLOGY, V145, P313, DOI 10.1016/S0022-5347(17)38325-8	5	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	1994	271	20					1628	1629						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NL758	8182820				2022-12-28	WOS:A1994NL75800039
J	MAEDA, T; WURGLERMURPHY, SM; SAITO, H				MAEDA, T; WURGLERMURPHY, SM; SAITO, H			A 2-COMPONENT SYSTEM THAT REGULATES AN OSMOSENSING MAP KINASE CASCADE IN YEAST	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; SHUTTLE VECTORS; PROTEIN; GENE; CHEMOTAXIS; HOMOLOGIES; STRAINS	IN the prokaryotic two-component signal transduction systems, recognition of an environmental stimulus by a sensor molecule results in the activation of its histidine kinase domain and phosphorylation of a histidine residue within that domain(1-3). This phosphate group is then transferred to an aspartate residue in the receiver domain of a cognate response regulator molecule, resulting in the activation of its output function. Although a few eukaryotic proteins were identified recently that show sequence similarity to the prokaryotic sensors or response regulators, it has not been clear whether they constituted a part of a 'two-component' system(4-7). Here we describe a two-component system in Saccharomyces cerevisiae that regulates an osmosensing MAP kinase cascade(8,9).	HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV TUMOR IMMUNOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02115	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School			Maeda, Tatsuya/L-5540-2019; Saito, Haruo/AAF-6113-2019	Saito, Haruo/0000-0001-7891-1689				ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; BOGUSLAWSKI G, 1987, P NATL ACAD SCI USA, V84, P5848, DOI 10.1073/pnas.84.16.5848; BOGUSLAWSKI G, 1992, J GEN MICROBIOL, V138, P2425, DOI 10.1099/00221287-138-11-2425; BOURRET RB, 1991, ANNU REV BIOCHEM, V60, P401, DOI 10.1146/annurev.bi.60.070191.002153; BREWSTER JL, 1993, SCIENCE, V259, P1760, DOI 10.1126/science.7681220; BROWN JL, 1993, J BACTERIOL, V175, P6908, DOI 10.1128/jb.175.21.6908-6915.1993; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; DOI K, 1994, EMBO J, V13, P61, DOI 10.1002/j.1460-2075.1994.tb06235.x; GUAN KL, 1992, J BIOL CHEM, V267, P10024; JAMES P, 1992, GENE, V122, P101, DOI 10.1016/0378-1119(92)90037-P; MAEDA T, 1993, MOL CELL BIOL, V13, P5408, DOI 10.1128/MCB.13.9.5408; MAGER WH, 1993, MOL MICROBIOL, V10, P253, DOI 10.1111/j.1365-2958.1993.tb01951.x; MILNE GT, 1993, GENE DEV, V7, P1755, DOI 10.1101/gad.7.9.1755; NAGASAWA S, 1992, MOL MICROBIOL, V6, P799, DOI 10.1111/j.1365-2958.1992.tb01530.x; OTA IM, 1992, P NATL ACAD SCI USA, V89, P2355, DOI 10.1073/pnas.89.6.2355; OTA IM, 1993, SCIENCE, V262, P566, DOI 10.1126/science.8211183; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; SCHNEIDERPOETSCH HAW, 1991, FEBS LETT, V281, P245, DOI 10.1016/0014-5793(91)80403-P; SIKORSKI RS, 1989, GENETICS, V122, P19; STOCK A, 1985, P NATL ACAD SCI USA, V82, P7989, DOI 10.1073/pnas.82.23.7989; STOCK JB, 1991, ANNU REV BIOPHYS BIO, V20, P109, DOI 10.1146/annurev.bb.20.060191.000545; STOUT V, 1990, J BACTERIOL, V172, P659, DOI 10.1128/jb.172.2.659-669.1990; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; WARD Y, 1994, NATURE, V367, P651, DOI 10.1038/367651a0	25	930	971	2	26	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	MAY 19	1994	369	6477					242	245		10.1038/369242a0	http://dx.doi.org/10.1038/369242a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NM067	8183345				2022-12-28	WOS:A1994NM06700059
J	FATH, I; SCHWEIGHOFFER, F; REY, I; MULTON, MC; BOIZIAU, J; DUCHESNE, M; TOCQUE, B				FATH, I; SCHWEIGHOFFER, F; REY, I; MULTON, MC; BOIZIAU, J; DUCHESNE, M; TOCQUE, B			CLONING OF A GRB2 ISOFORM WITH APOPTOTIC PROPERTIES	SCIENCE			English	Article							SH3 DOMAINS; PROTEIN; AFFINITY	Growth factor receptor-bound protein 2 (Grb2) links tyrosine-phosphorylated proteins to a guanine nucleotide releasing factor of the son of sevenless (Sos) class by attaching to the former by its Src homology 2 (SH2) moiety and to the latter by its SH3 domains. An isoform of grb2 complementary DNA (cDNA) was cloned that has a deletion in the SH2 domain. The protein encoded by this cDNA, Grb3-3, did not bind to phosphorylated epidermal growth factor receptor (EGFR) but retained functional SH3 domains and inhibited EGF-induced transactivation of a Ras-responsive element. The messenger RNA encoding Grb3-3 was expressed in high amounts in the thymus of rats at an age when massive negative selection of thymocytes occurs. Microinjection of Grb3-3 into Swiss 3T3 fibroblasts induced apoptosis. These findings indicate that Grb3-3, by acting as a dominant negative protein over Grb2 and by suppressing proliferative signals, may trigger active programmed cell death.	RHONE POULENC RORER,CTR RECH VITRY ALFORTVILLE,F-94403 VITRY,FRANCE	Sanofi-Aventis								BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; CICCHETTI P, 1992, SCIENCE, V257, P803, DOI 10.1126/science.1379745; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; DUCHESNE M, 1993, SCIENCE, V259, P525, DOI 10.1126/science.7678707; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; GALE NW, 1993, NATURE, V363, P88, DOI 10.1038/363088a0; GAZIT A, 1989, J MED CHEM, V32, P2344, DOI 10.1021/jm00130a020; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; JACOBSON MD, 1993, NATURE, V361, P365, DOI 10.1038/361365a0; L'allemain G, 1989, GROWTH FACTORS, V1, DOI 10.3109/08977198909000255; LEHMANN JM, 1990, NUCLEIC ACIDS RES, V18, P1048, DOI 10.1093/nar/18.4.1048; LI N, 1993, NATURE, V363, P85, DOI 10.1038/363085a0; LOWENSTEIN EJ, 1992, CELL, V70, P431, DOI 10.1016/0092-8674(92)90167-B; MATUOKA K, 1992, P NATL ACAD SCI USA, V89, P9015, DOI 10.1073/pnas.89.19.9015; MAYER BJ, 1991, P NATL ACAD SCI USA, V88, P627, DOI 10.1073/pnas.88.2.627; MONTGOMERY RA, 1991, J IMMUNOL, V147, P554; OLIVIER JP, 1993, CELL, V73, P179, DOI 10.1016/0092-8674(93)90170-U; PELLICI G, 1992, CELL, V70, P93; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; REY I, UNPUB; ROZAKISADCOCK M, 1993, NATURE, V363, P83, DOI 10.1038/363083a0; Sambrook J, 1989, MOL CLONING LABORATO; SCHWEIGHOFFER F, 1993, MOL CELL BIOL, V13, P39, DOI 10.1128/MCB.13.1.39; SCHWEIGHOFFER F, 1992, SCIENCE, V256, P825, DOI 10.1126/science.1317056; SCOLLAY RG, 1980, EUR J IMMUNOL, V10, P210, DOI 10.1002/eji.1830100310; SOSNOWSKI RG, 1993, J CELL BIOL, V121, P113, DOI 10.1083/jcb.121.1.113; WAKSMAN G, 1992, NATURE, V358, P646, DOI 10.1038/358646a0; WASYLYK C, 1988, EMBO J, V7, P7952	31	98	102	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 13	1994	264	5161					971	974		10.1126/science.8178156	http://dx.doi.org/10.1126/science.8178156			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NK974	8178156				2022-12-28	WOS:A1994NK97400037
J	STEVENSON, RN; UMACHANDRAN, V; RANJADAYALAN, K; ROBERTS, RH; TIMMIS, AD				STEVENSON, RN; UMACHANDRAN, V; RANJADAYALAN, K; ROBERTS, RH; TIMMIS, AD			EARLY EXERCISE TESTING AFTER TREATMENT WITH THROMBOLYTIC DRUGS FOR ACUTE MYOCARDIAL-INFARCTION - IMPORTANCE OF RECIPROCAL ST SEGMENT DEPRESSION	BRITISH MEDICAL JOURNAL			English	Article							MULTIVESSEL CORONARY-DISEASE; PROGNOSTIC VALUE; PREDICTIVE VALUE; ARTERY DISEASE; STRESS TEST; ELEVATION; ANGIOGRAPHY; LEADS; ECG	Objective-To investigate the clinical importance of reciprocal ST depression induced by exercise testing early after acute myocardial infarction in patients treated with thrombolysis. Design-Prospective observational study. Setting-District general hospital in London. Subjects-202 patients (170 men) aged 33-69 with acute myocardial infarction treated with thrombolysis. Main outcome measures-All patients underwent exercise testing and coronary arteriography. ST depression induced by exercise was classified as either reciprocal (associated with ST elevation) or isolated (occurring on its own). The relation between reciprocal ST depression and the following end points was studied: characteristics of the infarct, left ventricular ejection fraction, extent of coronary artery disease on arteriography, and presence of angina induced by exercise. Results-Reciprocal ST depression occurred almost exclusively in Q wave infarctions and was associated with a lower overall ejection fi action than isolated ST depression. It tended to be associated with persistent occlusion of the coronary artery related to the infarct and did not indicate remote ischaemia due to multivessel coronary disease. Unlike isolated ST depression, reciprocal ST depression was not associated with angina induced by exercise. Conclusions-Reciprocal ST depression induced by exercise is usually associated with extensive Q wave infarctions and persistent occlusion of the artery related to the infarct. It does not seem to indicate reversible ischaemia and should not be used as a non-invasive marker of multivessel disease in the assessment of requirements for further investigation soon after acute myocardial infarction.	LONDON CHEST HOSP,DEPT CARDIOL,LONDON E2 9JX,ENGLAND; NEWHAM DIST GEN HOSP,DEPT CARDIOL,LONDON E13 8SL,ENGLAND	University of London; Queen Mary University London								AKHRAS F, 1985, BRIT MED J, V290, P1931, DOI 10.1136/bmj.290.6486.1931; COMACANELLA I, 1991, EUR HEART J, V12, P909, DOI 10.1093/eurheartj/12.8.909; DEFEYTER PJ, 1982, CIRCULATION, V66, P527, DOI 10.1161/01.CIR.66.3.527; DILLAHUNT PH, 1979, CHEST, V76, P150, DOI 10.1378/chest.76.2.150; DUNN RF, 1980, CIRCULATION, V62, P726, DOI 10.1161/01.CIR.62.4.726; FORTUIN NJ, 1970, AM J MED, V49, P459, DOI 10.1016/S0002-9343(70)80039-0; FUBINI A, 1986, BRIT HEART J, V55, P535; FULLER CM, 1981, ANN INTERN MED, V94, P734, DOI 10.7326/0003-4819-94-6-734; HERBERT WG, 1991, AM HEART J, V122, P993, DOI 10.1016/0002-8703(91)90463-R; JENNINGS K, 1983, BRIT MED J, V287, P634, DOI 10.1136/bmj.287.6393.634; KOTLER TS, 1990, ANN INTERN MED, V113, P684, DOI 10.7326/0003-4819-113-9-684; LAHIRI A, 1980, BRIT HEART J, V43, P582; MIRVIS DM, 1988, AM HEART J, V116, P1308, DOI 10.1016/0002-8703(88)90456-5; NORRELL MS, 1989, J AM COLL CARDIOL, V13, P1270; PATTERSON RE, 1983, AM J CARDIOL, V51, P361, DOI 10.1016/S0002-9149(83)80066-6; QUYYUMI AA, 1986, LANCET, V1, P347; SALCEDO JR, 1981, AM J CARDIOL, V48, P1003, DOI 10.1016/0002-9149(81)90312-X; SANDLER H, 1968, AM HEART J, V75, P325, DOI 10.1016/0002-8703(68)90089-6; SCHARTZ KM, 1981, ANN INTERN MED, V94, P727; STARLING MR, 1980, AM J CARDIOL, V46, P909, DOI 10.1016/0002-9149(80)90344-6; SULLIVAN ID, 1984, BRIT HEART J, V52, P147; THEROUX P, 1979, NEW ENGL J MED, V301, P341, DOI 10.1056/NEJM197908163010701; WATERS DD, 1980, CIRCULATION, V61, P286, DOI 10.1161/01.CIR.61.2.286; WEINER DA, 1978, CIRCULATION, V58, P887, DOI 10.1161/01.CIR.58.5.887; 1985, NEW ENGL J MED, V53, P457	25	2	2	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 7	1994	308	6938					1189	1192		10.1136/bmj.308.6938.1189	http://dx.doi.org/10.1136/bmj.308.6938.1189			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK956	8180533	Green Published			2022-12-28	WOS:A1994NK95600014
J	FISHBEIN, MC; SIEGEL, RJ; THOMPSON, CE; HOPKINS, LC				FISHBEIN, MC; SIEGEL, RJ; THOMPSON, CE; HOPKINS, LC			SUDDEN-DEATH OF A CARRIER OF X-LINKED EMERGY-DREIFUSS MUSCULAR-DYSTROPHY	ANNALS OF INTERNAL MEDICINE			English	Article						MUSCULAR DYSTROPHY; DEATH, SUDDEN, CARDIAC; ARRHYTHMIA; CARRIER STATE; MYOCARDIAL DISEASES	KEARNS-SAYRE SYNDROME; DILATED CARDIOMYOPATHY; MYOTONIC-DYSTROPHY; DISEASE; FEATURES	Objective: To report a sudden death in a female carrier of Emery-Dreifuss muscular dystrophy and to describe the cardiac abnormalities associated with this disease. Study Design: Case series. Setting: University hospital. Patients: A 45-year-old carrier who died suddenly and two affected men who also died of cardiac manifestations of Emery-Dreifuss muscular dystrophy. Measurements: Post-mortem gross pathologic and histopathologic study of the heart. Results: All three hearts showed a unique pattern of pathologic findings. Marked loss of atrial myocardium had occurred. Myocardium had been replaced by adipose and fibrous tissue. The conduction system showed no significant abnormalities. Varying degrees of interstitial and replacement fibrosis were present in the ventricular myocardium. Conclusions: Emery-Dreifuss muscular dystrophy is associated with characteristic pathologic changes in the heart that can cause death in female carriers and affected men. Female carriers should be identified and evaluated because of the risk for sudden cardiac death.	CTR HANDICAPPED CHILDREN & TEENAGERS, SAN FRANCISCO, CA USA; EMORY UNIV, SCH MED, ATLANTA, GA 30322 USA	Emory University	FISHBEIN, MC (corresponding author), CEDARS SINAI MED CTR, DEPT PATHOL, DIV CARDIOL, ROOM 8732, 8700 BEVERLY BLVD, LOS ANGELES, CA 90048 USA.							BERKO BA, 1987, NEW ENGL J MED, V316, P1186, DOI 10.1056/NEJM198705073161904; BIALER MG, 1991, CLIN CARDIOL, V14, P411, DOI 10.1002/clc.4960140509; CLARK DS, 1975, CHEST, V68, P727, DOI 10.1378/chest.68.5.727; FLOREK RC, 1990, WESTERN J MED, V153, P24; FRANK R, 1978, ARCH MAL COEUR VAISS, V71, P963; FUJITA M, 1979, HUM PATHOL, V10, P15, DOI 10.1016/S0046-8177(79)80069-6; GRIGG LE, 1985, J AM COLL CARDIOL, V6, P254, DOI 10.1016/S0735-1097(85)80286-2; HOPKINS LC, 1981, ANN NEUROL, V10, P230, DOI 10.1002/ana.410100306; HOPKINS LC, 1992, HDB CLIN NEUROLOGY, V18, P145; ITO T, 1990, JPN CIRC J, V54, P1214, DOI 10.1253/jcj.54.1214; KENNEL AJ, 1974, MAYO CLIN PROC, V49, P838; MERCHUT MP, 1990, J NEUROL, V237, P316, DOI 10.1007/BF00314751; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; MOORMAN JR, 1985, MEDICINE, V64, P371, DOI 10.1097/00005792-198511000-00002; PAPADIMITRIOU A, 1984, PEDIATR RES, V18, P1023, DOI 10.1203/00006450-198418100-00023; PERLOFF JK, 1967, AM J MED, V42, P179, DOI 10.1016/0002-9343(67)90017-4; ROBERTS NK, 1979, AM J CARDIOL, V44, P1396, DOI 10.1016/0002-9149(79)90459-4; SMITH ER, 1977, AM HEART J, V94, P428, DOI 10.1016/S0002-8703(77)80035-5; WATERS DD, 1975, NEW ENGL J MED, V293, P1017, DOI 10.1056/NEJM197511132932004	19	56	57	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	1993	119	9					900	905		10.7326/0003-4819-119-9-199311010-00006	http://dx.doi.org/10.7326/0003-4819-119-9-199311010-00006			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MD711	8215002				2022-12-28	WOS:A1993MD71100006
J	IGLEHART, JK				IGLEHART, JK			THE STRUGGLE BETWEEN MANAGED CARE AND FEE-FOR-SERVICE PRACTICE	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							REFORM											ANGELL M, 1993, NEW ENGL J MED, V328, P1778, DOI 10.1056/NEJM199306173282409; Angell M, 1993, Kennedy Inst Ethics J, V3, P279; ANGELL M, 1993, NEW ENGL J MED, V329, P1569, DOI 10.1056/NEJM199311183292110; BALZ D, 1994, WASHINGTON POST 1120, pA10; BLENDON RJ, 1994, J AM HEALTH POLICY, V4, P42; BLENDON RJ, 1994, JAMA-J AM MED ASSOC, V271, P1539, DOI 10.1001/jama.271.19.1539; BRODER D, 1994, WASHINGTON POST 0223, pA17; CLEMENT DG, 1994, JAMA-J AM MED ASSOC, V271, P1487, DOI 10.1001/jama.271.19.1487; COTTON P, 1994, JAMA-J AM MED ASSOC, V271, P731; GABEL J, 1994, HEALTH AFFAIR, V13, P327, DOI 10.1377/hlthaff.13.1.327; HILZENRATH DS, 1994, WASHINGTON POST 0606, P1; IGLEHART JK, 1982, NEW ENGL J MED, V307, P451, DOI 10.1056/NEJM198208123070734; IGLEHART JK, 1993, NEW ENGL J MED, V329, P1593, DOI 10.1056/NEJM199311183292129; KARL J, 1994, NEW YORK POST   0517, P4; LUNDBERG GD, 1994, JAMA-J AM MED ASSOC, V271, P1530, DOI 10.1001/jama.271.19.1530; MILLER RH, 1994, JAMA-J AM MED ASSOC, V271, P1512, DOI 10.1001/jama.271.19.1512; MORSE LJ, 1993, NEW ENGL J MED, V329, P804, DOI 10.1056/NEJM199309093291112; NASH DB, 1994, HLTH POLICY NEWSLETT; NEEL J, 1994, PERVAPORATION MEMBRA, P1; Pear Robert, 1994, NY TIMES        0309, pA13; PIANIN E, 1994, WASHINGTON POST 0527; RELMAN AS, 1993, NEW ENGL J MED, V329, P1574, DOI 10.1056/NEJM199311183292113; RUNDLE RL, 1994, WALL STREET J   0513, pA2; SOMERVILLE J, 1994, AM MED NEWS     0516, P3; SULLIVAN K, 1994, NY TIMES        0530, P15; THOMPSON S, 1994, CALIFORNIA PHYSI MAR, P62; WELLSTONE PD, 1993, NEW ENGL J MED, V328, P1489, DOI 10.1056/NEJM199305203282013; 1994, EFFECTS MANAGED CARE; 1993, GAOHRD943 GEN ACC OF; 1994, AM MED NEWS     0411, P3	30	45	45	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	1994	331	1					63	67		10.1056/NEJM199407073310129	http://dx.doi.org/10.1056/NEJM199407073310129			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NU951	8202118				2022-12-28	WOS:A1994NU95100035
J	LIE, RT; WILCOX, AJ; SKJAERVEN, R				LIE, RT; WILCOX, AJ; SKJAERVEN, R			A POPULATION-BASED STUDY OF THE RISK OF RECURRENCE OF BIRTH-DEFECTS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLEFT-PALATE; MALFORMATIONS; LIP	Background. Certain birth defects are known to recur in families, but most estimates of the risk of recurrence have come from clinic-based studies. In this study we estimated the risk of recurrent birth defects using a population-based registry. Methods. The study was based on the records of the first and second infants delivered by 371,933 women from 1967 through 1989. The records are maintained by the Medical Birth Registry of Norway. For the 9192 women whose first infant had a birth defect, we determined the relative risk of similar and dissimilar defects in the second infant. The reference population was women whose first infant had no defect. Results. Among first infants, 2.5 percent had a birth defect. The mothers of affected first infants were 2.4 times as likely as other women to have second infants with any registered defect. This increased risk was due primarily to an increased (7.6 times higher) risk of the same defect in the second infant as in the first (95 percent confidence interval, 6.5 to 8.8) and secondarily to a slightly increased (1.5 times higher) risk of a different defect in the second infant (95 percent confidence interval, 1.3 to 1.7). Among the women who lived in the same municipality during both pregnancies, the relative risk of having a second infant with the same defect was 11.6, as compared with 5.1 among the women who moved to another municipality after the birth of their first infant (P<0.001). Conclusions. Among women whose first infant has a birth defect, the risk of the same defect in the second infant is substantially increased and the risk of a different. defect in the second infant is slightly increased. Environment plays a strong part in repeated defects.	UNIV BERGEN,MED INFORMAT & STAT SECT,BERGEN,NORWAY; NATL INST PUBL HLTH,OSLO,NORWAY; NIEHS,EPIDEMIOL BRANCH,RES TRIANGLE PK,NC 27709	University of Bergen; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	LIE, RT (corresponding author), HAUKELAND HOSP,MED BIRTH REGISTRY NORWAY,MFH BLDG,N-5021 BERGEN,NORWAY.		Wilcox, Allen J/C-7723-2019	Wilcox, Allen J/0000-0002-3376-1311				CZEIZEL AE, 1988, MULTIPLE CONGENITAL; ENGELMAN L, 1990, BMDP STATISTICAL SOF, V2, P721; FARRALL M, 1992, AM J HUM GENET, V50, P270; FRASER FC, 1982, LANCET, V2, P144; HARPER PS, 1988, PRACTICAL GENETIC CO; KALTER H, 1983, NEW ENGL J MED, V308, P491, DOI 10.1056/NEJM198303033080904; KHOURY MJ, 1987, AM J MED GENET, V28, P159, DOI 10.1002/ajmg.1320280123; KHOURY MJ, 1983, PEDIATRICS, V71, P815; KNOX EG, 1991, EPIDEMIOLOGY CONGENI; KURNIT DM, 1987, AM J HUM GENET, V41, P979; LIE RT, IN PRESS BIOMETRICS; MITCHELL LE, 1992, AM J HUM GENET, V51, P323; RASMUSSEN SA, 1990, AM J HUM GENET, V46, P478; ROSENDAHL K, 1992, ACTA PAEDIATR, V81, P177, DOI 10.1111/j.1651-2227.1992.tb12198.x; SKJAERVEN R, 1988, AM J EPIDEMIOL, V128, P1352, DOI 10.1093/oxfordjournals.aje.a115088; SMITH DW, 1976, MAJOR PROBLEMS CLIN, V7, P16; VOLLSET SE, 1991, J AM STAT ASSOC, V86, P404, DOI 10.2307/2290585; WARKANY J, 1978, TERATOLOGY, V17, P187; Wilson JG, 1973, ENV BIRTH DEFECTS	19	96	98	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 7	1994	331	1					1	4		10.1056/NEJM199407073310101	http://dx.doi.org/10.1056/NEJM199407073310101			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NU951	8202094	Bronze			2022-12-28	WOS:A1994NU95100001
J	FEAGAN, BG; MCDONALD, JWD; ROCHON, J; LAUPACIS, A; FEDORAK, RN; KINNEAR, D; SAIBIL, F; GROLL, A; ARCHAMBAULT, A; GILLIES, R; VALBERG, B; IRVINE, EJ				FEAGAN, BG; MCDONALD, JWD; ROCHON, J; LAUPACIS, A; FEDORAK, RN; KINNEAR, D; SAIBIL, F; GROLL, A; ARCHAMBAULT, A; GILLIES, R; VALBERG, B; IRVINE, EJ			LOW-DOSE CYCLOSPORINE FOR THE TREATMENT OF CROHNS-DISEASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLAMMATORY BOWEL-DISEASE; DOUBLE-BLIND; LONG-TERM; AUTOIMMUNE-DISEASES; DRUG-TREATMENT; ACTIVITY INDEX; AZATHIOPRINE; TRIAL; 6-MERCAPTOPURINE; PLACEBO	Background. Long-term corticosteroid therapy for Crohn's disease is associated with important types of morbidity, such as osteoporosis. Safe and effective alternative treatments are required. Although a short-term benefit of cyclosporine in active Crohn's disease has been suggested, the long-term safety and efficacy of this treatment have not been established. Methods. We conducted a randomized, double-blind, placebo-controlled evaluation of the effect of 18 months of low-dose cyclosporine treatment on the course of Crohn's disease. Adult patients whose disease had been active within the previous two years were randomly assigned to receive cyclosporine (151 patients) or placebo (154 patients) in addition to their usual therapy. Randomization was stratified according to center and score on the Crohn's Disease Activity Index (193 patients had scores of 150 or less, and 112 had scores greater than 150). The primary outcome measure was clinically important worsening of Crohn's disease, defined as a 100-point increase in the Crohn's Disease Activity Index from the patient's base-line value. Secondary outcomes were the use of prednisone and 5-aminosalicylates, mean score on the Crohn's Disease Activity Index and mean quality-of-life score, and the need for surgery. Results. The condition of more patients worsened with cyclosporine than with placebo (91 of 151, or 60.3 percent, vs. 80 of 154, or 51.9 percent; P = 0.10). The median time to worsening of disease in patients receiving cyclosporine was 338 days, as compared with 492 days in patients receiving placebo (P = 0.25; relative risk, 1.22; 95 percent confidence interval, 0.86 to 1.72). Analyses of the mean Crohn's Disease Activity Index and quality-of-life scores and of the use of prednisone and 5-aminosalicylates also failed to demonstrate benefit. Conclusions. In our patient population, the addition of low-dose cyclosporine to conventional treatment for Crohn's disease did not improve symptoms or reduce requirements for other forms of therapy.	UNIV ALBERTA,DEPT MED,DIV GASTROENTEROL,EDMONTON,AB,CANADA; MCMASTER UNIV,DEPT MED,DIV GASTROENTEROL,HAMILTON,ON,CANADA; QUEENS UNIV,DEPT MED,DIV GASTROENTEROL,KINGSTON K7L 3N6,ON,CANADA; UNIV WESTERN ONTARIO,DEPT MED,LONDON,ON,CANADA; UNIV WESTERN ONTARIO,DEPT EPIDEMIOL & BIOSTAT,LONDON,ON,CANADA; MCGILL UNIV,DEPT MED,DIV GASTROENTEROL,MONTREAL,PQ,CANADA; UNIV MONTREAL,FAC MED,MONTREAL H3C 3J7,PQ,CANADA; UNIV TORONTO,DEPT MED,DIV GASTROENTEROL,TORONTO,ON,CANADA; UNIV OTTAWA,DEPT MED,OTTAWA,ON,CANADA; UNIV OTTAWA,DEPT EPIDEMIOL & COMMUNITY MED,OTTAWA,ON,CANADA	University of Alberta; McMaster University; Queens University - Canada; Western University (University of Western Ontario); Western University (University of Western Ontario); McGill University; Universite de Montreal; University of Toronto; University of Ottawa; University of Ottawa			Feagan, Brian/G-3292-2011; Feagan, Brian G/M-4283-2015	Fedorak, Richard/0000-0002-7382-0080				BERTANI T, 1991, KIDNEY INT, V40, P243, DOI 10.1038/ki.1991.206; BEST WR, 1979, GASTROENTEROLOGY, V77, P843; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; BRYNSKOV J, 1989, NEW ENGL J MED, V321, P845, DOI 10.1056/NEJM198909283211301; COHEN J, 1988, STATISTICAL POWER AN; COX DR, 1972, J R STAT SOC B, V34, P187; DIXON WJ, 1988, BMDP STATISTICAL SOF, V2; ELLIS CN, 1991, NEW ENGL J MED, V324, P277, DOI 10.1056/NEJM199101313240501; FEUTREN G, 1992, NEW ENGL J MED, V326, P1654, DOI 10.1056/NEJM199206183262502; HANAUER SB, 1993, AM J GASTROENTEROL, V88, P646; HAWTHORNE AB, 1989, DRUGS, V38, P267, DOI 10.2165/00003495-198938020-00007; Hocking R.R., 1985, ANAL LINEAR MODELS; IRVINE EJ, 1994, GASTROENTEROLOGY, V106, P287, DOI 10.1016/0016-5085(94)90585-1; JENNRICH RI, 1986, BIOMETRICS, V42, P805, DOI 10.2307/2530695; KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI; KLEIN M, 1974, GASTROENTEROLOGY, V66, P916; LENNARDJONES JE, 1981, DIGEST DIS SCI, V26, P364, DOI 10.1007/BF01308381; MALCHOW H, 1984, GASTROENTEROLOGY, V86, P249; MASUDA K, 1989, LANCET, V1, P1093; ODONOGHUE DP, 1978, LANCET, V2, P955, DOI 10.1016/S0140-6736(78)92524-2; PALESTINE AG, 1986, NEW ENGL J MED, V314, P1293, DOI 10.1056/NEJM198605153142005; PRESENT DH, 1980, NEW ENGL J MED, V302, P981, DOI 10.1056/NEJM198005013021801; PRESENT DH, 1989, ANN INTERN MED, V111, P641, DOI 10.7326/0003-4819-111-8-641; ROSANO TG, 1986, TRANSPLANT P, V18, P35; ROSENBERG JL, 1975, AM J DIG DIS, V20, P721, DOI 10.1007/BF01070829; SINGLETON JW, 1981, DIGEST DIS SCI, V26, P368, DOI 10.1007/BF01308382; SINGLETON JW, 1979, GASTROENTEROLOGY, V77, P870; SUMMERS RW, 1979, GASTROENTEROLOGY, V77, P847; TUGWELL P, 1990, LANCET, V335, P1051, DOI 10.1016/0140-6736(90)92630-Z; VONGRAFFENRIED B, 1986, TRANSPLANT P, V18, P876; WILLOUGHBY JM, 1971, LANCET, V2, P944; 1990, SAS PROCEDURES GUIDE	32	234	240	0	4	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 30	1994	330	26					1846	1851		10.1056/NEJM199406303302602	http://dx.doi.org/10.1056/NEJM199406303302602			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NT530	8196727				2022-12-28	WOS:A1994NT53000002
J	NODA, K; GLOVER, BJ; LINSTEAD, P; MARTIN, C				NODA, K; GLOVER, BJ; LINSTEAD, P; MARTIN, C			FLOWER COLOR INTENSITY DEPENDS ON SPECIALIZED CELL-SHAPE CONTROLLED BY A MYB-RELATED TRANSCRIPTION FACTOR	NATURE			English	Article							ANTIRRHINUM-MAJUS; GENE; HOMOLOGY; ARABIDOPSIS; EXPRESSION; ACTIVATOR; PATTERNS; PROTEINS; PRODUCTS; LOCUS	Flower colour is determined primarily by the production of pigments, usually anthocyanins or carotenoids, but the shade and intensity of the colour are often changed by other factors such as vacuolar compounds, pH and metal ions(1,2). Pigmentation can also be affected by the shape of epidermal cells, especially those facing prospective pollinators(3,4). A conical shape is believed to increase the proportion of incident light that enters the epidermal cells, enhancing light absorption by the floral pigments, and thus the intensity of their colour. We have identified a gene (mixta) that affects the intensity of pigmentation of epidermal cells in Antirrhinum majus petals. The cells of the corolla lobes fail to differentiate into their normal conical form in mixta mutants. We have cloned the mixta gene by transposon tagging; its sequence reveals that it encodes a Myb-related protein that probably participates in the transcriptional control of epidermal cell shape.	JOHN INNES INST,NORWICH NR4 7UH,NORFOLK,ENGLAND	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	NODA, K (corresponding author), NIPPON OIL CO LTD,766 HIGASHI TOYOI,KUDAMATSU,YAMAGUCHI 744,JAPAN.							AVILA J, 1993, PLANT J, V3, P553, DOI 10.1046/j.1365-313X.1993.03040553.x; Brouillard R., 1988, FLAVONOIDS ADV RES 1, P525, DOI DOI 10.1007/978-1-4899-2913-6_16; CHUCK G, 1993, PLANT CELL, V5, P371, DOI 10.1105/tpc.5.4.371; COEN ES, 1986, CELL, V47, P285, DOI 10.1016/0092-8674(86)90451-4; GOFF SA, 1991, GENE DEV, V5, P298, DOI 10.1101/gad.5.2.298; GROTEWOLD E, 1991, P NATL ACAD SCI USA, V88, P4587, DOI 10.1073/pnas.88.11.4587; HUISKAMP M, 1994, CELL, V76, P555; JACKSON D, 1991, PLANT CELL, V3, P115, DOI 10.1105/tpc.3.2.115; KAY QON, 1981, BOT J LINN SOC, V83, P57, DOI 10.1111/j.1095-8339.1981.tb00129.x; Kay QON, 1988, PLANTS TODAY     JUL, P109; KEVAN PG, 1985, P NATL ACAD SCI USA, V82, P4750, DOI 10.1073/pnas.82.14.4750; Lassner MW., 1989, PLANT MOL BIOL REP, V7, P116, DOI DOI 10.1007/BF02669627; LUO D, 1991, PLANT J, V1, P59, DOI 10.1111/j.1365-313X.1991.00059.x; MARKS MD, 1989, PLANT CELL, V1, P1043, DOI 10.1105/tpc.1.11.1043; MARTIN C, 1985, EMBO J, V4, P1625, DOI 10.1002/j.1460-2075.1985.tb03829.x; OPPENHEIMER DG, 1991, CELL, V67, P483, DOI 10.1016/0092-8674(91)90523-2; PAZARES J, 1987, EMBO J, V6, P3553, DOI 10.1002/j.1460-2075.1987.tb02684.x; Plaskitt K. A., 1988, Molecular Plant-Microbe Interactions, V1, P10, DOI 10.1094/MPMI-1-010; SMITH AM, 1983, PLANTA, V159, P570, DOI 10.1007/BF00409147; SOMMER H, 1990, EMBO J, V9, P605, DOI 10.1002/j.1460-2075.1990.tb08152.x; STUBBE H, 1966, GENETIK ZYTOLOGIE AN	21	334	365	8	113	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 23	1994	369	6482					661	664		10.1038/369661a0	http://dx.doi.org/10.1038/369661a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NT459	8208293				2022-12-28	WOS:A1994NT45900059
J	MCFARLAND, LV; SURAWICZ, CM; GREENBERG, RN; FEKETY, R; ELMER, GW; MOYER, KA; MELCHER, SA; BOWEN, KE; COX, JL; NOORANI, Z; HARRINGTON, G; RUBIN, M; GREENWALD, D				MCFARLAND, LV; SURAWICZ, CM; GREENBERG, RN; FEKETY, R; ELMER, GW; MOYER, KA; MELCHER, SA; BOWEN, KE; COX, JL; NOORANI, Z; HARRINGTON, G; RUBIN, M; GREENWALD, D			RANDOMIZED PLACEBO-CONTROLLED TRIAL OF SACCHAROMYCES-BOULARDII IN COMBINATION WITH STANDARD ANTIBIOTICS FOR CLOSTRIDIUM-DIFFICILE DISEASE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VANCOMYCIN THERAPY; PSEUDOMEMBRANOUS COLITIS; HOSPITALIZED-PATIENTS; BIOTHERAPEUTIC AGENT; ORAL VANCOMYCIN; RISK-FACTORS; DIARRHEA; RELAPSE; INFECTION; TOXIN	Objective.-To determine the safety and efficacy of a new combination treatment for patients with Clostridium difficile-associated disease (CDD). The treatment combines the yeast Saccharomyces boulardii with an antibiotic (vancomycin hydrochloride or metronidazole). Design.-A double-blind, randomized, placebo-controlled, parallel-group intervention study in patients with active CDD. Patients received standard antibiotics and S boulardii or placebo for 4 weeks, and were followed up for an additional 4 weeks after therapy. Effectiveness was determined by comparing the recurrence of CDD in the two groups using multivariate analysis to control for other risk factors for CDD. Setting.-National referral study of ambulatory or hospitalized patients from three main study coordinating centers. Patients.-A total of 124 eligible consenting adult patients, including 64 who were enrolled with an initial episode of CDD, and 60 who had a history of at least one prior CDD episode. Patients who were immunosuppressed due to acquired immunodeficiency syndrome or cancer chemotherapy within 3 months were not eligible. Intervention.-Treatment with oral S boulardii (1 g/d for 4 weeks) or placebo in combination with a standard antibiotic. Main Outcome Measure.-Recurrence of active CDD. Results.-A history of CDD episodes dramatically increased the likelihood of further recurrences. Multivariate analysis revealed that patients treated with S boulardii and standard antibiotics had a significantly lower relative risk (RR) of CDD recurrence (RR, 0.43; 95% confidence interval, 0.20 to 0.97) compared with placebo and standard antibiotics. The efficacy of S boulardii was significant (recurrence rate 34.6%, compared with 64.7% on placebo; P=.04) in patients with recurrent CDD, but not in patients with initial CDD (recurrence rate 19.3% compared with 24.2% on placebo; P=.86). There were no serious adverse reactions associated with S boulardii. Conclusions.-The combination of standard antibiotics and S boulardii was shown to be an effective and safe therapy for these patients with recurrent CDD; no benefit of S boulardii was demonstrated for those with an initial episode of CDD.	UNIV WASHINGTON,SCH MED,DEPT MED,DIV GASTROENTEROL,SEATTLE,WA 98195; BIOCODEX INC,SEATTLE,WA; UNIV KENTUCKY,DEPT MED,DIV INFECT DIS,LEXINGTON,KY 40506; VET AFFAIRS MED CTR,LEXINGTON,KY; UNIV MICHIGAN,DEPT INTERNAL MED,DIV INFECT DIS,ANN ARBOR,MI 48109; COLUMBIA UNIV,COLL PHYS & SURG,DEPT MED,NEW YORK,NY	University of Washington; University of Washington Seattle; University of Kentucky; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; University of Michigan System; University of Michigan; Columbia University	MCFARLAND, LV (corresponding author), UNIV WASHINGTON,SCH PHARM,DEPT MED CHEM,BG-20,SEATTLE,WA 98195, USA.							BARTLETT JG, 1980, GASTROENTEROLOGY, V78, P431; BENDER BS, 1986, LANCET, V2, P11, DOI 10.1016/S0140-6736(86)92559-6; BENNETT RG, 1990, GERIATRICS, V45, P77; BERG R, 1993, J INFECT DIS, V168, P1314, DOI 10.1093/infdis/168.5.1314; BLEHAUT H, 1989, BIOPHARM DRUG DISPOS, V10, P353, DOI 10.1002/bdd.2510100403; BODDY AV, 1991, PHARMACEUT RES, V8, P796, DOI 10.1023/A:1015822605815; BOWMAN RA, 1986, FEMS MICROBIOL LETT, V34, P31, DOI 10.1016/0378-1097(86)90265-X; BRESLOW NE, 1987, STATISTICAL METHODS, V2, P107; BROWN E, 1990, INFECT CONT HOSP EP, V11, P283; CLABOTS CR, 1992, J INFECT DIS, V166, P561, DOI 10.1093/infdis/166.3.561; ELMER GW, 1987, ANTIMICROB AGENTS CH, V31, P129, DOI 10.1128/AAC.31.1.129; FEKETY R, 1993, JAMA-J AM MED ASSOC, V269, P71, DOI 10.1001/jama.269.1.71; FEKETY R, 1989, AM J MED, V86, P15, DOI 10.1016/0002-9343(89)90223-4; GEORGE WL, 1979, NEW ENGL J MED, V301, P414, DOI 10.1056/NEJM197908233010806; GERDING DN, 1986, ARCH INTERN MED, V146, P95, DOI 10.1001/archinte.146.1.95; GORBACH SL, 1987, LANCET, V2, P1519; JOHNSON LL, 1989, J CLIN MICROBIOL, V27, P2218, DOI 10.1128/JCM.27.10.2218-2221.1989; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; KIMMEY MB, 1990, DIGEST DIS SCI, V35, P897, DOI 10.1007/BF01536805; KLEIN SM, 1993, PHARMACEUT RES, V10, P1615, DOI 10.1023/A:1018924820333; Krammer M., 1993, Z GASTROENTEROL, V31, P73; MCFARLAND LV, 1990, J INFECT DIS, V162, P678, DOI 10.1093/infdis/162.3.678; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; MCFARLAND LV, 1993, ACUTE INFECT DIARRHE, P563; MULLIGAN ME, 1979, CURR MICROBIOL, V3, P173, DOI 10.1007/BF02601862; NORD CE, 1990, J CHEMOTHERAPY, V2, P218, DOI 10.1080/1120009X.1990.11739021; POTHOULAKIS C, 1993, GASTROENTEROLOGY, V104, P1108, DOI 10.1016/0016-5085(93)90280-P; ROBERTS MC, 1994, J ANTIMICROB CHEMOTH, V33, P419, DOI 10.1093/jac/33.3.419; SCHWANN A, 1987, EUR J CLIN MICROBIOL, V6, P51; SURAWICZ CM, 1989, AM J GASTROENTEROL, V84, P1285; SURAWICZ CM, 1989, GASTROENTEROLOGY, V96, P981, DOI 10.1016/0016-5085(89)91613-2; TVEDE M, 1989, LANCET, V1, P1156; WALTERS BAJ, 1983, GUT, V24, P206, DOI 10.1136/gut.24.3.206; YOUNG G, 1986, GASTROENTEROLOGY, V90, P1098, DOI 10.1016/0016-5085(86)90914-5; YOUNG GP, 1985, GASTROENTEROLOGY, V89, P1038, DOI 10.1016/0016-5085(85)90206-9	36	591	614	0	22	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 22	1994	271	24					1913	1918		10.1001/jama.271.24.1913	http://dx.doi.org/10.1001/jama.271.24.1913			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NR598	8201735				2022-12-28	WOS:A1994NR59800027
J	KURMAN, RJ; HENSON, DE; HERBST, AL; NOLLER, KL; SCHIFFMAN, MH; BONFIGLIO, T; BUCK, H; CRUM, C; CURTIN, JP; GREENBERG, M; HATCH, K; JENSON, AB; JOHNSON, P; JONES, H; KAMINETSKY, H; KLEIN, L; KOSS, L; KRUMHOLZ, B; LEE, N; LUFF, R; MANDELBLATT, J; REID, R; RICHART, R; SEDLACEK, T; SNEIDERMAN, C; SOLOMON, D; STOLER, M; TAUB, F; TRIMBLE, E; TUCKER, E; TWIGGS, LB; WILKINSON, E; ATKINSON, B; AVERETTE, HE; CREASMAN, W; FRYHOFER, S; NOY, J; NIELSEN, M; NOLLER, K; PARK, R; WESTHOFF, D				KURMAN, RJ; HENSON, DE; HERBST, AL; NOLLER, KL; SCHIFFMAN, MH; BONFIGLIO, T; BUCK, H; CRUM, C; CURTIN, JP; GREENBERG, M; HATCH, K; JENSON, AB; JOHNSON, P; JONES, H; KAMINETSKY, H; KLEIN, L; KOSS, L; KRUMHOLZ, B; LEE, N; LUFF, R; MANDELBLATT, J; REID, R; RICHART, R; SEDLACEK, T; SNEIDERMAN, C; SOLOMON, D; STOLER, M; TAUB, F; TRIMBLE, E; TUCKER, E; TWIGGS, LB; WILKINSON, E; ATKINSON, B; AVERETTE, HE; CREASMAN, W; FRYHOFER, S; NOY, J; NIELSEN, M; NOLLER, K; PARK, R; WESTHOFF, D			INTERIM GUIDELINES FOR MANAGEMENT OF ABNORMAL CERVICAL CYTOLOGY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN PAPILLOMAVIRUS INFECTION; PAPANICOLAOU SMEAR; ENDOCERVICAL CELLS; BETHESDA SYSTEM; YOUNG-WOMEN; CANCER; ADENOCARCINOMA; DIAGNOSIS; EPIDEMIOLOGY; NEOPLASIA		JOHNS HOPKINS UNIV, DEPT PATHOL, BALTIMORE, MD USA; NCI, EARLY DETECT BRANCH, BETHESDA, MD USA; NCI, ENVIRONM EPIDEMIOL BRANCH, BETHESDA, MD 20892 USA; UNIV MASSACHUSETTS, DEPT OBSTET & GYNECOL, WORCESTER, MA USA; UNIV CHICAGO, SCH MED, DEPT OBSTET & GYNECOL, CHICAGO, IL 60637 USA; UNIV ROCHESTER, SCH MED, ROCHESTER, NY USA; UNIV KANSAS, LAWRENCE, KS USA; BRIGHAM & WOMENS HOSP, BOSTON, MA USA; MEM HOSP CANC & ALLIED DIS, NEW YORK, NY USA; GRAD HOSP PHILADELPHIA, PHILADELPHIA, PA USA; UNIV ARIZONA, TUCSON, AZ USA; GEORGETOWN UNIV, SCH MED, WASHINGTON, DC USA; CTR DIS CONTROL & PREVENT, ATLANTA, GA USA; VANDERBILT UNIV SCH MED, NASHVILLE, TN USA; AMER COLL OBSTETRICIANS & GYNECOLOGISTS, WASHINGTON, DC USA; EMORY UNIV, SCH MED, ATLANTA, GA USA; MONTEFIORE MED CTR, BRONX, NY USA; LONG ISL JEWISH MED CTR, NEW HYDE PK, NY USA; SACRED HEART HOSP, ALLENTOWN, PA USA; MEM SLOAN KETTERING CANC CTR, NEW YORK, NY USA; CARSON CTR, SOUTHFIELD, MI USA; SLOANE HOSP WOMEN, NEW YORK, NY USA; NATL LIB MED, BETHESDA, MD USA; CLEVELAND CLIN FDN, CLEVELAND, OH USA; SYNCHROCELL, SILVER SPRING, MD USA; AMER SOC CLIN PATHOLOGISTS, CHICAGO, IL USA; UNIV MINNESOTA, SCH MED, MINNEAPOLIS, MN USA; UNIV FLORIDA, COLL MED, GAINESVILLE, FL USA; AMER SOC CLIN PATHOLOGISTS, PHILADELPHIA, PA USA; AMER CANC SOC, MIAMI, FL USA; SOC GYNECOL ONCOLOGISTS, CHARLESTON, SC USA; AMER COLL PHYSICIANS, ATLANTA, GA USA; AMER ACAD FAMILY PRACTICE, HOUSTON, TX USA; COLL AMER PATHOLOGISTS, WICHITA, KS USA; AMER COLL OBSTETRICIANS & GYNECOLOGISTS, WORCESTER, MA USA; GYNECOL ONCOL GRP, PHILADELPHIA, PA USA; AMER SOC INTERNAL MED, JEFFERSON CITY, MO USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Massachusetts System; University of Massachusetts Worcester; University of Chicago; University of Rochester; University of Kansas; Harvard University; Brigham & Women's Hospital; Memorial Sloan Kettering Cancer Center; University of Pennsylvania; Pennsylvania Medicine; University of Arizona; Georgetown University; Centers for Disease Control & Prevention - USA; Vanderbilt University; Emory University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Northwell Health; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Cleveland Clinic Foundation; University of Minnesota System; University of Minnesota Twin Cities; State University System of Florida; University of Florida; American Cancer Society; American College of Physicians; College of American Pathologists	KURMAN, RJ (corresponding author), JOHNS HOPKINS UNIV, SCH MED, DEPT OBSTET GYNECOL, 600 N WOLFE ST, 711 PATHOL, BALTIMORE, MD 21287 USA.		, Leo/GRX-9887-2022; Schiffman, Mark/B-9766-2015					AUGUST N, 1991, J REPROD MED, V36, P89; BAUER HM, 1991, JAMA-J AM MED ASSOC, V265, P472, DOI 10.1001/jama.265.4.472; BRINTON LA, 1987, J NATL CANCER I, V79, P23; BRODER S, 1992, JAMA-J AM MED ASSOC, V267, P1892, DOI 10.1001/jama.267.14.1892; BROWN MS, 1985, GYNECOL ONCOL, V22, P149, DOI 10.1016/0090-8258(85)90020-4; CARMICHAEL JA, 1985, OBSTET GYNECOL SURG, V40, P545; CHRISTOPHERSON WM, 1976, CANCER, V38, P1357, DOI 10.1002/1097-0142(197609)38:3<1357::AID-CNCR2820380340>3.0.CO;2-A; COX JT, 1992, OBSTET GYNECOL, V80, P389; ELIAS A, 1983, ACTA CYTOL, V27, P225; HERBST AL, 1992, CLIN OBSTET GYNECOL, V35, P22, DOI 10.1097/00003081-199203000-00006; HERRERO R, 1992, INT J EPIDEMIOL, V21, P1050, DOI 10.1093/ije/21.6.1050; KIVLAHAN C, 1986, ACTA CYTOL, V30, P258; KRISTENSEN GB, 1991, ACTA CYTOL, V35, P47; Kurman RJ, 1994, BETHESDA SYSTEM REPO; LORINCZ AT, 1992, OBSTET GYNECOL, V79, P328, DOI 10.1097/00006250-199203000-00002; MILLER AB, 1991, CAN MED ASSOC J, V145, P1301; MITCHELL H, 1991, LANCET, V337, P265, DOI 10.1016/0140-6736(91)90870-U; MONTZ FJ, 1992, OBSTET GYNECOL, V80, P385; MUNOZ N, 1992, INT AGENCY RES CANCE, V119; NASIELL K, 1986, OBSTET GYNECOL, V67, P665, DOI 10.1097/00006250-198605000-00012; PARAZZINI F, 1990, GYNECOL ONCOL, V39, P40, DOI 10.1016/0090-8258(90)90396-3; PATTEN SF, 1978, MONOGRAPHS CLIN CYTO, P92; PETERS RK, 1986, JNCI-J NATL CANCER I, V76, P423; SCHIFFMAN MH, 1992, JNCI-J NATL CANCER I, V84, P394, DOI 10.1093/jnci/84.6.394; SCHIFFMAN MH, 1993, JNCI-J NATL CANCER I, V85, P958, DOI 10.1093/jnci/85.12.958; SCHWARTZ SM, 1986, AM J EPIDEMIOL, V124, P1045, DOI 10.1093/oxfordjournals.aje.a114474; SOLOMON D, 1989, JAMA-J AM MED ASSOC, V262, P931; Vooijs G P, 1987, Ned Tijdschr Geneeskd, V131, P1662; VOOIJS PG, 1985, ACTA CYTOL, V29, P323; 1989, NATIONAL HLTH INTERV	30	488	505	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	1994	271	23					1866	1869		10.1001/jama.271.23.1866	http://dx.doi.org/10.1001/jama.271.23.1866			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NP959	8196145				2022-12-28	WOS:A1994NP95900032
J	TAKAYAMA, JI; BERGMAN, AB; CONNELL, FA				TAKAYAMA, JI; BERGMAN, AB; CONNELL, FA			CHILDREN IN FOSTER-CARE IN THE STATE OF WASHINGTON - HEALTH-CARE UTILIZATION AND EXPENDITURES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUPERVISION; CALIFORNIA; SERVICES; SYSTEM; POLICY	Objective.-To determine and compare health care utilization and expenditures of children in foster care with those of other children and to identify and describe high-cost children in foster care. Design.-Analysis of the Medicaid program claims data in the state of Washington. Population.-A total of 1631 children in foster care and 5316 children in the Aid to Families With Dependent Children (AFDC) program in 1990. The children were ages O through 7 years and eligible for Medicaid continuously during the study year. Main Outcome Measures.-Health care utilization and expenditures classified by types of health service and health care provider; proportion of children with 1990 expenditures exceeding $10 000 and most prominent diagnoses associated with their health care utilization. Results.-Mental health services were used by 25% of children in foster care compared with 3% of AFDC children (P<.001), and supportive services of visiting nurses and physical therapists were used by 13% of children in foster care and 1% of AFDC children (P<.001). Twice as many children in foster care than AFDC children used medical equipment or specialist services or were hospitalized (P<.001). Mean health care expenditures in 1990 were $3075 for children in foster care and $543 for AFDC children (P<.001). High-cost children included 8% of children in foster care and 0.4% of AFDC children. Among the high-cost children in foster care (n=106), 59% had mental disorders and 31% had congenital conditions. Conclusions.-Results suggest a higher prevalence and greater complexity of illnesses, particularly mental disorders, among children in foster care. Despite the high utilization and cost of mental health services, previous research suggests there may be underutilization of these services compared with need. Appropriate allocation of resources is essential if foster care agencies are to adequately meet the diverse and compelling needs of children in foster care.	UNIV WASHINGTON,ROBERT WOOD JOHNSON CLIN SCHOLARS PROGRAM,SEATTLE,WA; UNIV WASHINGTON,SCH PUBL HLTH & COMMUNITY MED,SEATTLE,WA 98195; UNIV WASHINGTON,HARBORVIEW MED CTR,DEPT PEDIAT,SEATTLE,WA 98104	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harborview Medical Center; University of Washington; University of Washington Seattle								BENEDICT MI, 1991, CHILD WELFARE, V70, P45; BRIGHT RA, 1989, J CLIN EPIDEMIOL, V42, P937, DOI 10.1016/0895-4356(89)90158-3; BUTLER JA, 1985, PEDIATRICS, V76, P495; CURTIS PA, 1993, CHILD WELFARE, V72, P533; DUGGER CW, 1991, NY TIMES        0908, pA17; FAMULARO R, 1992, J AM ACAD CHILD PSY, V31, P863, DOI 10.1097/00004583-199209000-00013; HALFON N, 1987, PEDIATRICS, V80, P183; HALFON N, 1992, PEDIATRICS, V89, P1238; HALFON N, 1992, PEDIATRICS, V89, P1230; HOCHSTADT NJ, 1987, CHILD ABUSE NEGLECT, V11, P53, DOI 10.1016/0145-2134(87)90033-0; JACOBS J, 1988, J CLIN EPIDEMIOL, V41, P215, DOI 10.1016/0895-4356(88)90124-2; JENKINS S, 1985, AM J ORTHOPSYCHIAT, V55, P267, DOI 10.1111/j.1939-0025.1985.tb03441.x; LEFKOWITZ DC, 1991, 14 DEP HLTH HUM SERV; Lewis Neil A., 1991, NEW YORK TIMES  0714, pA1; LOWRY MA, 1989, CHILDRENS RIGHTS PRO; MARCUS FF, 1989, NY TIMES        0109, pA15; Moffatt M E, 1985, Health Soc Work, V10, P129; PELTON LH, 1987, J SOC SOC WELFARE, V16, P37; Rosner B., 2010, FUNDAMENTALS BIOSTAT; SAUNDERS EJ, 1993, CHILD WELFARE, V72, P341; Schor E L, 1989, Pediatr Rev, V10, P209, DOI 10.1542/pir.10-7-209; SCHOR EL, 1981, CHILD WELFARE, V60, P313; SCHOR EL, 1982, PEDIATRICS, V69, P521; SHAH CP, 1974, CAN J PUBLIC HEALTH, V65, P34; SWIRE MR, 1978, CHILD WELFARE, V57, P563; SWIRE MR, 1977, CHILD WELFARE, V56, P635; TATARA T, 1993, 9 AM PUBL WELF ASS; TRUPIN E, 1988, WASHINGTON STATE CHI; WEINSTEIN J, 1990, CALIFORNIA W LAW REV, V26, P319; WHITE RB, 1987, CHILD WELFARE, V66, P387; ZILL N, 1990, HLTH OUR NATIONS CHI, V190, P1; 1991, STATE AM CHILDREN 19; 1987, PEDIATRICS, V79, P644; 1992, PEDIATRICS, V89, P681; 1988, STANDARDS HLTH CARE; 1992, NY TIMES        1213, pA48; 1991, COSTS LENGTHS STAY C	37	99	99	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	1994	271	23					1850	1855		10.1001/jama.271.23.1850	http://dx.doi.org/10.1001/jama.271.23.1850			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	NP959	8196142				2022-12-28	WOS:A1994NP95900029
J	BANNER, W; PENTEL, PR				BANNER, W; PENTEL, PR			MEDICAL TOXICOLOGY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLASMA CHOLINESTERASE ACTIVITY; FULMINANT HEPATIC-FAILURE; COCAINE INTOXICATION; TOXICITY; VASOCONSTRICTION; ACETYLCYSTEINE; MICE		UNIV UTAH,SALT LAKE CITY,UT; HENNEPIN CTY MED CTR,MINNEAPOLIS,MN; UNIV MINNESOTA,MINNEAPOLIS,MN 55455	Utah System of Higher Education; University of Utah; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities	BANNER, W (corresponding author), PRIMARY CHILDRENS MED CTR,SALT LAKE CITY,UT 84103, USA.							[Anonymous], 1991, PREVENTING LEAD POIS; CATRAVAS JD, 1981, J PHARMACOL EXP THER, V217, P350; DERLET RW, 1989, ANN EMERG MED, V18, P542, DOI 10.1016/S0196-0644(89)80840-6; GELLERT GA, 1993, JAMA-J AM MED ASSOC, V270, P69, DOI 10.1001/jama.270.1.69; GOLD JA, 1993, JAMA-J AM MED ASSOC, V270, P2964, DOI 10.1001/jama.270.24.2964; GOLDFRANK LR, 1991, ANN EMERG MED, V20, P165, DOI 10.1016/S0196-0644(05)81217-X; HARRISON PM, 1991, NEW ENGL J MED, V324, P1852, DOI 10.1056/NEJM199106273242604; HOFFMAN RS, 1992, ANN EMERG MED, V21, P247, DOI 10.1016/S0196-0644(05)80883-2; HOFFMAN RS, 1992, J PHARMACOL EXP THER, V263, P698; HOFFMAN RS, 1993, VET HUM TOXICOL, V35, P349; KEAYS R, 1991, BRIT MED J, V303, P1026, DOI 10.1136/bmj.303.6809.1026; LANGE RA, 1989, NEW ENGL J MED, V321, P1557, DOI 10.1056/NEJM198912073212301; LANGE RA, 1990, ANN INTERN MED, V112, P897, DOI 10.7326/0003-4819-112-12-897; ROTH D, 1988, NEW ENGL J MED, V319, P673, DOI 10.1056/NEJM198809153191103; THOMPSON ML, 1979, BIOCHEM PHARMACOL, V28, P2389, DOI 10.1016/0006-2952(79)90705-6; WATSON AP, 1992, ENVIRON HEALTH PERSP, V98, P259, DOI 10.2307/3431280	16	2	2	1	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1681	1682		10.1001/jama.271.21.1681	http://dx.doi.org/10.1001/jama.271.21.1681			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182849				2022-12-28	WOS:A1994NN11700028
J	RUSSELL, RM				RUSSELL, RM			NUTRITION	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DISEASE-SPECIFIC MORTALITY; VITAMIN-E CONSUMPTION; MYOCARDIAL-INFARCTION; INTERVENTION TRIALS; CANCER INCIDENCE; RISK; SUPPLEMENTATION; POPULATION; LINXIAN; WOMEN				RUSSELL, RM (corresponding author), TUFTS UNIV,BOSTON,MA 02111, USA.							BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; KARDINAAL AFM, 1993, LANCET, V342, P1379, DOI 10.1016/0140-6736(93)92751-E; LI JY, 1993, J NATL CANCER I, V85, P1492, DOI 10.1093/jnci/85.18.1492; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; SENTI FR, 1984, ASSESSMENT FOLATE NU; STAMPFER MJ, 1993, JAMA-J AM MED ASSOC, V270, P2726, DOI 10.1001/jama.270.22.2726; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; STAMPFER MJ, 1992, JAMA-J AM MED ASSOC, V268, P877, DOI 10.1001/jama.268.7.877; WERLER MM, 1993, JAMA-J AM MED ASSOC, V269, P1257, DOI 10.1001/jama.269.10.1257; 1993, FED REG         0106, V58, P632; 1993, FED REG         0106, V58, P2066; 1994, NEW ENGL J MED, V330, P1029	14	1	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 1	1994	271	21					1687	1689		10.1001/jama.271.21.1687	http://dx.doi.org/10.1001/jama.271.21.1687			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN117	8182853				2022-12-28	WOS:A1994NN11700032
J	POMERANTZ, LM; BENNETT, J				POMERANTZ, LM; BENNETT, J			FUNGI AS A CAUSE OF OTITIS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									NIAID,BETHESDA,MD	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)								HALL PJ, 1993, OTOLARYNG HEAD NECK, V108, P167, DOI 10.1177/019459989310800210; PETRAK RM, 1985, J INFECT DIS, V151, P196, DOI 10.1093/infdis/151.1.196	2	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 25	1994	271	20					1628	1628						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NL758	8182818				2022-12-28	WOS:A1994NL75800038
J	WILLIAMS, SGJ; WESTABY, D				WILLIAMS, SGJ; WESTABY, D			FORTNIGHTLY REVIEW - MANAGEMENT OF VARICEAL HEMORRHAGE	BRITISH MEDICAL JOURNAL			English	Article							BLEEDING ESOPHAGEAL-VARICES; INJECTION SCLEROTHERAPY; PORTAL-HYPERTENSION; BALLOON TAMPONADE; NATURAL-HISTORY; GASTRIC VARICES; CIRRHOSIS; EFFICACY; TRIAL		CHELSEA & WESTMINSTER HOSP,DEPT GASTROENTEROL,LONDON SW10 9NH,ENGLAND; CHARING CROSS HOSP,LONDON,ENGLAND	Imperial College London; Imperial College London								BOSCH J, 1989, MED CLIN N AM, V73, P931, DOI 10.1016/S0025-7125(16)30646-0; BOSCH J, 1992, GASTROINTEST CLIN N, V38, P50; BURROUGHS AK, 1992, DIGEST DIS, V10, P30, DOI 10.1159/000171385; CALES P, 1988, GASTROEN CLIN BIOL, V12, P245; CHRISTENSEN E, 1981, GASTROENTEROLOGY, V81, P944; CONN HO, 1993, HEPATOLOGY, V17, P148, DOI 10.1016/0270-9139(93)90205-2; FLEISCHER D, 1983, GASTROENTEROLOGY, V84, P538; GIMSON AES, 1992, GASTROINTEST ENDOSC, V38, P31; GIMSON AES, 1993, LANCET, V342, P392; HASSAN F, 1992, DIGEST DIS S1, V10, P38; IWATSUKI S, 1992, BAILLIERE CLIN GASTR, V6, P517, DOI 10.1016/0950-3528(92)90036-E; LAINE L, 1993, ANN INTERN MED, V119, P1, DOI 10.7326/0003-4819-119-1-199307010-00001; MCKEE R, 1990, DIGESTION, V45, P60, DOI 10.1159/000200264; MERICAN I, 1992, EUR J GASTROEN HEPAT, V4, P511; PANES J, 1988, DIGEST DIS SCI, V33, P454, DOI 10.1007/BF01536031; POLSON RJ, 1989, HEPATOLOGY, V10, P279, DOI 10.1002/hep.1840100304; RAMAGE JK, 1992, GASTROINTEST ENDOSC, V38, P95; RAMOND MJ, 1989, HEPATOLOGY, V10, P488, DOI 10.1002/hep.1840100415; SEE A, 1986, GASTROEN CLIN BIOL, V10, P604; SHEMESH E, 1990, J CLIN GASTROENTEROL, V12, P5, DOI 10.1097/00004836-199002000-00003; SHIELDS R, 1992, J HEPATOL, V16, P128, DOI 10.1016/S0168-8278(05)80105-9; SPENCE RAJ, 1992, GASTROINTEST ENDOSC, V38, P78; STIEGMANN GV, 1992, NEW ENGL J MED, V326, P1527, DOI 10.1056/NEJM199206043262304; SUNG JJY, 1993, LANCET, V342, P637, DOI 10.1016/0140-6736(93)91758-E; TERBLANCHE J, 1989, NEW ENGL J MED, V320, P1393, DOI 10.1056/NEJM198905253202107; TERBLANCHE J, 1981, ANN SURG, V194, P521, DOI 10.1097/00000658-198110000-00015; VLAVIANOS P, 1989, BRIT MED J, V298, P1158, DOI 10.1136/bmj.298.6681.1158; WESTABY D, 1989, HEPATOLOGY, V9, P274, DOI 10.1002/hep.1840090219; WILLIAMS SGJ, 1993, GUT               S1, V34, pS48	29	33	34	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAY 7	1994	308	6938					1213	1217						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NK956	8180541				2022-12-28	WOS:A1994NK95600024
J	GOSTIN, LO; TUREKBREZINA, J; POWERS, M; KOZLOFF, R; FADEN, R; STEINAUER, DD				GOSTIN, LO; TUREKBREZINA, J; POWERS, M; KOZLOFF, R; FADEN, R; STEINAUER, DD			PRIVACY AND SECURITY OF PERSONAL INFORMATION IN A NEW HEALTH-CARE SYSTEM	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROTECTION		PRESIDENTS TASK FORCE NATL HLTH CARE REFORM,WASHINGTON,DC; US DEPT HHS,OFF ASSISTANT SECRETARY PLANNING & EVALUAT,WASHINGTON,DC 20201; GEORGETOWN UNIV,KENNEDY INST ETH,WASHINGTON,DC 20057; KUNITZ & ASSOCIATES,ROCKVILLE,MD; JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT HLTH POLICY & MANAGEMENT,BALTIMORE,MD 21218; NATL INST STAND & TECHNOL,GAITHERSBURG,MD	Georgetown University; Johns Hopkins University; National Institute of Standards & Technology (NIST) - USA	GOSTIN, LO (corresponding author), AMER SOC LAW MED & ETH,OFF EXECUT DIRECTOR,765 COMMONWEALTH AVE,16TH FLOOR,BOSTON,MA 02215, USA.							ALLEN AL, 1987, UNEASY ACCESS PRIVAC; [Anonymous], 1986, HIST THEORY INFORM C; BENN S, 1971, NOMOS, V12, P1; BENNETT CJ, 1991, SCI TECHNOL HUM VAL, V16, P51, DOI 10.1177/016224399101600103; BRANNIGAN V, 1977, NBS PUBLICATION, V46; Brannigan V M, 1984, J Med Syst, V8, P501, DOI 10.1007/BF02321768; BROPHY JT, 1992, WORKGROUP ELECTRONIC; BRUCE JAC, 1988, PRIVACY CONFIDENTIAL; CHLAPOWSKI FS, 1991, BOSTON U LAW REV, P133; CONTRUBIS J, 1992, 92896A1 LIBR C PUBL; DICK RS, 1991, COMPUTER BASED PATIE, P31; ELIE B, 1992, MINIMUM REQUIREMENTS; FANNING JP, 1989, JUL PUBL HLTH SERV C; FANNING JP, 1992, PRIVACY PUBLIC ISSUE; FLAHERTY D, 1993, ENSURING PRIVACY DAT; FLAHERTY DH, 1992, CAN PUBLIC ADMIN, V35, P75, DOI 10.1111/j.1754-7121.1992.tb00680.x; FLAHERTY DH, 1989, PROTECTING PRIVACY S, P15; FRAWLEY KA, 1993, CONFIDENCE, V1, P1; FRIED CHARLES, 1970, ANATOMY VALUES PROBL, P142; Fulton D K, 1987, Top Health Rec Manage, V8, P73; Gabrieli E R, 1990, J Am Med Rec Assoc, V61, P26; Gavison R., 1984, PHILOS DIMENSIONS PR, V89, P346; Gellman R M, 1984, North Carol Law Rev, V62, P255; GOLDBERG J, 1992, LEARS, V5, P40; GOLDBERG J, 1992, LEARS, V5, P42; Gostin L. O., 1987, AM J LAW MED, V12, P461; GOSTIN LO, 1993, JAMA-J AM MED ASSOC, V269, P255, DOI 10.1001/jama.269.2.255; Marx Gary T., 1986, SOCIAL FABRIC DIMENS, P135; PARENT WA, 1983, PHILOS PUBLIC AFF, V12, P271; PLESSER RL, 1991, PRIVACY PROTECTION U; POWERS M, 1991, AIDS WOMEN NEXT GENE, P221; REIMAN J, 1976, PHILOS PUBLIC AFF, V6, P38; ROSENBERG R, 1989, PUBLICATION, V1003; ROTENBERG M, 1991, GOV INFORM Q, V8, P79, DOI 10.1016/0740-624X(91)90026-5; Rothfeder Jeffrey, 1992, PRIVACY SALE COMPUTE; ROWE M, 1989, LAWS GOVERNING CONFI, P1; ROZOVSKY FA, 1989, CONSENT TREATMENT PR; SMITH RE, 1990, PRIVACY J; SMITH RE, 1992, PRIVACY J; SMITH RR, 1985, REPORT COLLECTION US; Thomson Judith, 1984, PHILOS DIMENSIONS PR, P272; TRUBOW GB, 1987, PRIVACY LAW PRACTICE; TURKINGTON RC, 1992, PRIVACY CASES MATERI, P59; WALLER A, 1991, COMPUTER BASED PATIE; Warren S. D., 1984, PHILOS DIMENSIONS PR, P75; Westin A. F., 1977, COMPUTERS HLTH RECOR; WRIGHT T, 1992, HLTH CARE TECHNOLOGY; YENNEY SL, 1990, BUSINESS HLTH    SEP, P41; 1993, ELECTRONIC PATIENT R, V1, P6; 1991, GAOMTEC915 US GEN AC; 1990, COMPUTERS RISK SAFE, P2; 1993, NATIONAL HLTH INFORM; 1981, HARVARD CIVIL RIGHTS, P265; 1977, PERSONAL PRIVACY INF; 1990, EQUIFAX REPORT CONSU; 1986, OTACIT296 OFF TECHN; 1981, GUIDELINES PROTECTIO, P1; 1987, OTACIT310 OFF TECHN; 1993, HLTH INFORMATION PRI; 1992, ELECTRONIC PATIENT R, V1, P1; 1992, ELECTRONIC PATIENT R, P1; 1973, RECORDS COMPUTERS RI; 1993, AUTOMATED MED RECORD; 1992, INT ETHICAL GUIDELIN; 1992, WORKSHOP ELECTRONIC; 1991, INTRO USE PERSONAL I, P19; 1988, OAI068800800 US DEP; LEGAL OPINIONS CONFI	68	77	78	1	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 24	1993	270	20					2487	2493						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	MG671	8192748				2022-12-28	WOS:A1993MG67100032
J	CHERUBIN, CE; SAPIRA, JD				CHERUBIN, CE; SAPIRA, JD			THE MEDICAL COMPLICATIONS OF DRUG-ADDICTION AND THE MEDICAL ASSESSMENT OF THE INTRAVENOUS-DRUG-USER - 25 YEARS LATER	ANNALS OF INTERNAL MEDICINE			English	Review							HUMAN-IMMUNODEFICIENCY-VIRUS; STAPHYLOCOCCUS-AUREUS ENDOCARDITIS; PULMONARY MAINLINE GRANULOMATOSIS; B STREPTOCOCCAL ENDOCARDITIS; IMMUNE-DEFICIENCY SYNDROME; INTRANASAL COCAINE ABUSE; LEFT-SIDED ENDOCARDITIS; AIDS-RELATED COMPLEX; HEPATITIS-C VIRUS; HTLV-II INFECTION	Purpose: To review changes in the medical complications of drug abuse that have occurred since the authors reviewed them 25 years ago. Data Source: Manual search of the internal medicine and subspecialty literature of the past three decades that was selected by the authors. Study Selection: Selected studies were of three types-baseline studies for the period ending in 1968, studies after 1968 that emphasized changes from baseline, and studies after 1968 that emphasized change (or the absence of change) and the manner in which clinicians conceptualized problems. Data Extraction: We extracted data that showed changes in the diseases, the appearance of new diseases, or the disappearance of formerly common diseases. Results of Data Synthesis: The diseases complicating drug abuse are now more widely disseminated than they were in the last 25 years. Some former ''diseases of addiction'' such as tetanus and malaria are now rare. Diseases (such as human immunodeficiency virus infection) not known to exist or rare 25 years ago now occur frequently. The drugs of abuse have also changed; for example, cocaine is now much more common. Conclusions: Treating the acute medical problems (mostly infectious diseases) in poor, undereducated, and often noncompliant intravenous drug users is far more complex than previously described. Although some features have remained constant, the emergence of human immunodeficiency virus infection and changes in patterns of drug use have radically altered patient management.	VET AFFAIRS MED CTR, DEPT MED, 111-JC, 915 N GRAND BLVD, ST LOUIS, MO 63106 USA; VET AFFAIRS MED CTR, WILKES BARRE, PA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA)								ABRAMS B, 1979, ANN INTERN MED, V90, P789, DOI 10.7326/0003-4819-90-5-789; AGUILAR GL, 1979, ARCH OPHTHALMOL-CHIC, V97, P96, DOI 10.1001/archopht.1979.01020010036008; AKRIVIADIS EA, 1989, ANN INTERN MED, V110, P838, DOI 10.7326/0003-4819-110-10-838; APPEL RG, 1990, ANN INTERN MED, V113, P892, DOI 10.7326/0003-4819-113-11-892; ARRUDA JAL, 1975, ARCH INTERN MED, V135, P535, DOI 10.1001/archinte.135.4.535; ASCHER DP, 1991, REV INFECT DIS, V13, P1048; BACH MC, 1988, REV INFECT DIS, V10, P424; BADDOUR LM, 1991, REV INFECT DIS, V13, P963; BADILLET G, 1983, ANN DERMATOL VENER, V110, P691; BALDWIN WA, 1993, CHEST, V103, P21, DOI 10.1378/chest.103.1.21; BARG NL, 1985, AM J MED, V78, P569, DOI 10.1016/0002-9343(85)90397-3; BARTHELEMY F, 1981, J FR OPHTALMOL, V4, P637; BARTTER T, 1988, ARCH INTERN MED, V148, P1421, DOI 10.1001/archinte.148.6.1421; BERENGUER J, 1991, REV INFECT DIS, V13, P115; BIDERMAN P, 1987, AM J SURG, V154, P526, DOI 10.1016/0002-9610(87)90270-4; BIGGAR RJ, 1991, J INFECT DIS, V163, P57, DOI 10.1093/infdis/163.1.57; BISBE J, 1992, CLIN INFECT DIS, V15, P910, DOI 10.1093/clind/15.6.910; BLANCK RR, 1984, INT J ADDICT, V19, P221, DOI 10.3109/10826088409057177; BLASER MJ, 1986, REV INFECT DIS, V8, P21; BRANCOS MA, 1991, SEMIN ARTHRITIS RHEU, V21, P81, DOI 10.1016/0049-0172(91)90041-W; BRANDSTETTER RD, 1980, JAMA-J AM MED ASSOC, V243, P1073, DOI 10.1001/jama.243.10.1073; BRAUNSTEIN H, 1991, REV INFECT DIS, V13, P8; BRETTLE RP, 1992, J INFECTION, V25, P121, DOI 10.1016/0163-4453(92)93874-P; BRODY SL, 1990, AM J MED, V88, P325, DOI 10.1016/0002-9343(90)90484-U; BUSH MN, 1984, NEW YORK STATE J MED, V84, P618; BUTI M, 1991, J INFECT DIS, V163, P1351, DOI 10.1093/infdis/163.6.1351; CALANDRA T, 1985, EUR J CLIN MICROBIOL, V4, P340, DOI 10.1007/BF02013665; CARBONE L, 1989, AM J MED, V87, P389, DOI 10.1016/S0002-9343(89)80819-8; CASADEVALL A, 1992, AM J MED, V92, P587, DOI 10.1016/0002-9343(92)90774-6; CELIKEL TH, 1984, AM REV RESPIR DIS, V130, P510; CHAMBERS HF, 1983, MEDICINE, V62, P170, DOI 10.1097/00005792-198305000-00004; CHAMBERS HF, 1988, ANN INTERN MED, V109, P619, DOI 10.7326/0003-4819-109-8-619; CHAMBERS HF, 1987, ANN INTERN MED, V106, P833, DOI 10.7326/0003-4819-106-6-833; CHANDRASEKAR PH, 1986, REV INFECT DIS, V8, P904; Cherubin C. E., 1991, Infectious Diseases Newsletter, V10, P85, DOI 10.1016/0278-2316(91)90018-U; CHERUBIN CE, 1967, ARCH ENVIRON HEALTH, V14, P802, DOI 10.1080/00039896.1967.10664845; CHERUBIN CE, 1968, AM J EPIDEMIOL, V88, P215, DOI 10.1093/oxfordjournals.aje.a120880; CHERUBIN CE, 1968, ARCH INTERN MED, V121, P156, DOI 10.1001/archinte.121.2.156; CHERUBIN CE, 1971, ARCH INTERN MED, V128, P309, DOI 10.1001/archinte.1971.00310200145021; CHERUBIN CE, 1967, ANN INTERN MED, V67, P23, DOI 10.7326/0003-4819-67-1-23; CHERUBIN CE, 1968, ANN INTERN MED, V69, P739, DOI 10.7326/0003-4819-69-4-739; CHERUBIN CE, 1968, ANN INTERN MED, V69, P1091, DOI 10.7326/0003-4819-69-6-1091; CHMEL H, 1973, AM J MED SCI, V266, P225, DOI 10.1097/00000441-197309000-00009; CHOKSHI SK, 1989, ANN INTERN MED, V111, P1039, DOI 10.7326/0003-4819-111-12-1039; CHUSID MJ, 1975, ANN INTERN MED, V82, P682, DOI 10.7326/0003-4819-82-5-682; CITRON BP, 1970, NEW ENGL J MED, V283, P1003, DOI 10.1056/NEJM197011052831901; CONCHA M, 1992, AM J EPIDEMIOL, V136, P1338, DOI 10.1093/oxfordjournals.aje.a116446; CONRAD SA, 1984, J INFECT DIS, V149, P826, DOI 10.1093/infdis/149.5.826; CRANE LR, 1986, REV INFECT DIS, V8, P364; CRAVEN DE, 1986, AM J MED, V80, P770, DOI 10.1016/0002-9343(86)90614-5; CRAVEN DE, 1986, J INFECT DIS, V153, P988, DOI 10.1093/infdis/153.5.988; CUCCO RA, 1987, AM REV RESPIR DIS, V136, P179, DOI 10.1164/ajrccm/136.1.179; CUNNINGHAM EE, 1980, AM J MED, V68, P47, DOI 10.1016/0002-9343(80)90164-3; D'ERMO F, 1979, Bollettino di Oculistica, V58, P15; DAGOSTINO RS, 1979, JAMA-J AM MED ASSOC, V241, P277; DALLY S, 1981, NOUV PRESSE MED, V10, P1941; DAVIES SJ, 1989, PERITON DIALYSIS INT, V9, P61; DAVIS LL, 1983, J NATL MED ASSOC, V75, P1225; DELANEY K, 1991, AM J MED, V91, P92, DOI 10.1016/0002-9343(91)90080-H; DINUBILE MJ, 1990, AM J MED, V88, pN45; DOFT BH, 1980, ARCH OPHTHALMOL-CHIC, V98, P859, DOI 10.1001/archopht.1980.01020030853010; DOUGLAS FG, 1971, ANN INTERN MED, V75, P865, DOI 10.7326/0003-4819-75-6-865; DOUGLASS RE, 1986, AM SURGEON, V52, P377; DOWELL ME, 1992, AM J MED, V93, P481, DOI 10.1016/0002-9343(92)90574-U; DROUHET E, 1981, Bulletin de la Societe Francaise de Mycologie Medicale, V10, P179; DUPONT B, 1985, J INFECT DIS, V152, P577, DOI 10.1093/infdis/152.3.577; DWORKIN RJ, 1989, LANCET, V2, P1071; EDWARDS JE, 1974, MEDICINE, V53, P47, DOI 10.1097/00005792-197401000-00002; ENZENSBERGER R, 1984, DEUT MED WOCHENSCHR, V109, P899, DOI 10.1055/s-2008-1069293; ESTEBAN JI, 1989, LANCET, V2, P294; FEIGAL E, 1991, J INFECT DIS, V164, P36, DOI 10.1093/infdis/164.1.36; FELDMAN AJ, 1987, SURG GYNECOL OBSTET, V157, P340; FRANCIS DP, 1984, AM J MED, V76, P69, DOI 10.1016/0002-9343(84)90752-6; FRICCHIONE LF, 1991, REV INFECT DIS, V13, P774; FRIEDMAN.CT, 1973, AM J TROP MED HYG, V22, P302, DOI 10.4269/ajtmh.1973.22.302; GALLAGHER PG, 1986, REV INFECT DIS, V8, P175; GAWORZEWSKA E, 1988, EPIDEMIOL INFECT, V100, P257, DOI 10.1017/S095026880006739X; GETNICK RA, 1974, AM J OPHTHALMOL, V77, P680, DOI 10.1016/0002-9394(74)90531-5; GIANNINI AJ, 1991, RESIDENT STAFF PHYSI, V37, P47; GILBERT DN, 1991, ANTIMICROB AGENTS CH, V35, P79, DOI 10.1128/AAC.35.1.79; GLASSOCK RJ, 1990, ANN INTERN MED, V112, P35, DOI 10.7326/0003-4819-112-1-35; GLATT MM, 1965, LANCET, V2, P171; GOODMAN SJ, 1970, J AMER MED ASSOC, V212, P480, DOI 10.1001/jama.1970.03170160068021; GRAVES MK, 1992, SOUTHERN MED J, V85, P378, DOI 10.1097/00007611-199204000-00010; GREENMAN RL, 1984, ANTIMICROB AGENTS CH, V25, P16, DOI 10.1128/AAC.25.1.16; GREIGER JC, 1934, JAMA-J AM MED ASSOC, V98, P1494; GUIDA B, 1990, ANN INTERN MED, V113, P559, DOI 10.7326/0003-4819-113-7-559; HALL RW, 1976, ARCH INTERN MED, V136, P1173, DOI 10.1001/archinte.136.10.1173; HALPERN M, 1992, AM J MED, V92, P437, DOI 10.1016/0002-9343(92)90277-I; HAMEROFF SB, 1970, NEUROLOGY, V20, P261, DOI 10.1212/WNL.20.3.261; HAVERKOS HW, 1990, J INFECT DIS, V161, P894, DOI 10.1093/infdis/161.5.894; HAVERKOS HW, 1991, J SUBST ABUSE TREAT, V8, P269, DOI 10.1016/0740-5472(91)90050-K; HELPERN M, 1934, AM J SURG, V26, P142; HELPERN Milton, 1934, American Journal of Surgery, V26, P111, DOI 10.1016/S0002-9610(34)90424-4; HERZLICH BC, 1988, ANN INTERN MED, V109, P335, DOI 10.7326/0003-4819-109-4-335; HICKS CB, 1987, ANN INTERN MED, V107, P492, DOI 10.7326/0003-4819-107-4-492; HO KL, 1978, CHEST, V74, P116, DOI 10.1378/chest.74.1.116a; HOFFMAN CK, 1989, RADIOLOGY, V172, P463, DOI 10.1148/radiology.172.2.2748827; HOLTOM PD, 1992, AM J MED, V93, P9, DOI 10.1016/0002-9343(92)90673-Y; HOLTZ HA, 1985, ANN INTERN MED, V102, P203, DOI 10.7326/0003-4819-102-2-203; HOOK EW, 1992, AM J MED, V93, P477, DOI 10.1016/0002-9343(92)90573-T; HOPEWELL PC, 1992, CLIN INFECT DIS, V15, P540, DOI 10.1093/clind/15.3.540; HOPKINS GB, 1972, J AMER MED ASSOC, V221, P909, DOI 10.1001/jama.221.8.909; HRIBALOVA V, 1988, ANN INTERN MED, V108, P772, DOI 10.7326/0003-4819-108-5-772_2; INGRAM CW, 1989, REV INFECT DIS, V11, P741; JACOBSON MA, 1988, AM J MED, V85, P172, DOI 10.1016/S0002-9343(88)80337-1; JOACHIM HENRY, 1940, JOUR AMER MED ASSOC, V115, P205; Kearns JJ, 1936, ARCH PATHOL, V21, P837; KEAY S, 1991, REV INFECT DIS, V13, P383; KENDRICK WC, 1977, ANN INTERN MED, V86, P381, DOI 10.7326/0003-4819-86-4-381; KHABBAZ RF, 1991, J INFECT DIS, V163, P252, DOI 10.1093/infdis/163.2.252; KIM JM, 1991, REV INFECT DIS, V13, P624; KING WW, 1991, AM J MED, V91, P425, DOI 10.1016/0002-9343(91)90162-Q; KIRMANI N, 1980, ANN ALLERGY, V45, P235; KISSNER DG, 1987, AM REV RESPIR DIS, V136, P1250, DOI 10.1164/ajrccm/136.5.1250; KOFF RS, 1973, NEW ENGL J MED, V288, P946, DOI 10.1056/NEJM197305032881806; KOMSHIAN SV, 1990, REV INFECT DIS, V12, P693; KORZENIOWSKI O, 1982, ANN INTERN MED, V97, P496, DOI 10.7326/0003-4819-97-4-496; KRAMER ED, 1988, DIAGN MICR INFEC DIS, V10, P181, DOI 10.1016/0732-8893(88)90038-7; KUDROW DB, 1988, ANN INTERN MED, V109, P984, DOI 10.7326/0003-4819-109-12-984; KURTZMAN RS, 1970, RADIOLOGY, V96, P23, DOI 10.1148/96.1.23; LANCE SE, 1988, OPHTHALMOLOGY, V95, P947, DOI 10.1016/S0161-6420(88)33087-3; LANGE RA, 1989, NEW ENGL J MED, V321, P1557, DOI 10.1056/NEJM198912073212301; LANGE RA, 1990, ANN INTERN MED, V112, P897, DOI 10.7326/0003-4819-112-12-897; LATKIN CA, 1992, INT J ADDICT, V27, P717, DOI 10.3109/10826089209068763; LEDGERWOOD AM, 1974, ARCH SURG-CHICAGO, V109, P496; LEE H, 1989, SCIENCE, V244, P471, DOI 10.1126/science.2655084; LEE HH, 1990, J INFECT DIS, V162, P347, DOI 10.1093/infdis/162.2.347; LEEN CLS, 1991, J ANTIMICROB CHEMOTH, V28, P83, DOI 10.1093/jac/28.suppl_A.83; LEITMAN BS, 1988, AM J ROENTGENOL, V151, P614, DOI 10.2214/ajr.151.3.614-a; LENTNEK AL, 1990, ARCH INTERN MED, V150, P89, DOI 10.1001/archinte.150.1.89; LETTAU LA, 1987, NEW ENGL J MED, V317, P1256, DOI 10.1056/NEJM198711123172004; LEVINE DP, 1982, ANN INTERN MED, V97, P330, DOI 10.7326/0003-4819-97-3-330; LEVINE DP, 1986, REV INFECT DIS, V8, P374; LEVINE DP, 1991, INFECTIONS INTRAVENO; LEVINE WC, 1991, J INFECT DIS, V164, P81, DOI 10.1093/infdis/164.1.81; LEWIS JW, 1980, CHEST, V78, P613, DOI 10.1378/chest.78.4.613; LOHR KM, 1987, SEMIN ARTHRITIS RHEU, V17, P90, DOI 10.1016/0049-0172(87)90032-1; LOPEZCORTES L, 1989, J INFECT DIS, V159, P804, DOI 10.1093/infdis/159.4.804; LOURIA DB, 1967, ANN INTERN MED, V67, P1, DOI 10.7326/0003-4819-67-1-1; LOWENSTEIN DH, 1987, AM J MED, V83, P841, DOI 10.1016/0002-9343(87)90640-1; MARR JS, 1979, NEW YORK STATE J MED, V79, P727; MASLOW JN, 1992, CLIN INFECT DIS, V14, P1166, DOI 10.1093/clinids/14.4.1166; MASUCCI EF, 1982, ARCH NEUROL-CHICAGO, V39, P304, DOI 10.1001/archneur.1982.00510170046013; MATLOW AG, 1990, REV INFECT DIS, V12, P703; MCALLISTER CJ, 1979, SOUTHERN MED J, V72, P162, DOI 10.1097/00007611-197902000-00015; MCCARROLL KA, 1991, J THORAC IMAG, V6, P30, DOI 10.1097/00005382-199101000-00006; MCCARTHY M, 1993, LANCET, V341, P1407, DOI 10.1016/0140-6736(93)90965-J; McGinn J. T., 1970, CLIN RES, V18; MCGINN JT, 1974, NEW YORK STATE J MED, V74, P92; MCILROY MA, 1989, REV INFECT DIS, V11, P578; MCMILLANR L, 1937, JAMA-J AM MED ASSOC, V109, P1194; MELLINGER M, 1982, B NARCOTICS, V34, P61; MENCHEL S, 1983, AM J PATHOL, V112, P195; MENDA KB, 1973, ANN INTERN MED, V78, P25, DOI 10.7326/0003-4819-78-1-25; MILLER A, 1991, AM J MED, V90, P678; MILLS J, 1976, ANN INTERN MED, V84, P29, DOI 10.7326/0003-4819-84-1-29; MIRO JM, 1987, J INFECT DIS, V156, P857, DOI 10.1093/infdis/156.5.857; MORROW R, 1983, ARCH INTERN MED, V143, P161, DOI 10.1001/archinte.143.1.161; Most H, 1940, AM J PUBLIC HEALTH N, V30, P403, DOI 10.2105/AJPH.30.4.403; MURRAY RJ, 1988, CHEST, V93, P427, DOI 10.1378/chest.93.2.427; MUSHER DM, 1990, ANN INTERN MED, V113, P872, DOI 10.7326/0003-4819-113-11-872; MYERS EM, 1988, LARYNGOSCOPE, V98, P213; NADEMANEE K, 1989, ANN INTERN MED, V111, P876, DOI 10.7326/0003-4819-111-11-876; NADLER J, 1975, INT J ADDICT, V10, P135, DOI 10.3109/10826087509026710; NAHASS RG, 1990, J INFECT DIS, V162, P967, DOI 10.1093/infdis/162.4.967; NAVARRO C, 1984, AM J MED, V76, P1124, DOI 10.1016/0002-9343(84)90869-6; NEWTONJOHN HF, 1984, MED J AUSTRALIA, V140, P780, DOI 10.5694/j.1326-5377.1984.tb132597.x; NORIEGA ER, 1975, AM J MED, V59, P29, DOI 10.1016/0002-9343(75)90318-6; NOSKIN GA, 1991, REV INFECT DIS, V13, P606; NOVICK DM, 1988, J INFECT DIS, V158, P795, DOI 10.1093/infdis/158.4.795; OCONNOR PG, 1992, AM J MED, V93, P382, DOI 10.1016/0002-9343(92)90166-9; PAGE JB, 1990, LANCET, V335, P1439, DOI 10.1016/0140-6736(90)91456-K; PARE JAP, 1979, MEDICINE, V58, P229; PARE JP, 1989, AM REV RESPIR DIS, V139, P233, DOI 10.1164/ajrccm/139.1.233; PASTAN RS, 1977, ANN INTERN MED, V87, P22, DOI 10.7326/0003-4819-87-1-22; PATEL AN, 1972, ANN INTERN MED, V76, P823, DOI 10.7326/0003-4819-76-5-823; PATEL RC, 1987, ANN INTERN MED, V107, P186, DOI 10.7326/0003-4819-107-2-186; PEREZTRALLERO E, 1990, J INFECT DIS, V161, P152, DOI 10.1093/infdis/161.1.152; PODZAMCZER D, 1986, J INFECT DIS, V153, P1182, DOI 10.1093/infdis/153.6.1182; POGUE VA, 1989, AM J MED, V86, P183, DOI 10.1016/0002-9343(89)90266-0; POLSKY B, 1986, ANN INTERN MED, V104, P38, DOI 10.7326/0003-4819-104-1-38; POTTS SG, 1990, LANCET, V336, P1385, DOI 10.1016/0140-6736(90)92943-C; PREBLE E, 1969, INT J ADDICT, V4, P1, DOI 10.3109/10826086909061998; QUINN RW, 1992, SOUTHERN MED J, V85, P796, DOI 10.1097/00007611-199208000-00002; RAMSEY RG, 1970, AM J CARDIOL, V25, P608, DOI 10.1016/0002-9149(70)90600-4; RAUCHER B, 1989, AM J MED, V86, P169, DOI 10.1016/0002-9343(89)90263-5; REICHMAN LB, 1979, ARCH INTERN MED, V139, P337, DOI 10.1001/archinte.139.3.337; REINER NE, 1976, JAMA-J AM MED ASSOC, V235, P1861, DOI 10.1001/jama.235.17.1861; REYES MF, 1969, PSEUDOMONAS ENDOCARD, V52, P173; RICHTER RW, 1971, J AMER MED ASSOC, V216, P1172, DOI 10.1001/jama.216.7.1172; ROTH D, 1988, NEW ENGL J MED, V319, P673, DOI 10.1056/NEJM198809153191103; RUBIN RB, 1989, AM J MED, V86, P551, DOI 10.1016/0002-9343(89)90383-5; RUMBAUGH CL, 1971, RADIOLOGY, V101, P335, DOI 10.1148/101.2.335; RYBAK MJ, 1991, ANTIMICROB AGENTS CH, V35, P696, DOI 10.1128/AAC.35.4.696; RYBAK MJ, 1992, ANTIMICROB AGENTS CH, V36, P1109, DOI 10.1128/AAC.36.5.1109; SALANOVA V, 1984, POSTGRAD MED J, V60, P429, DOI 10.1136/pgmj.60.704.429; SAMIES JH, 1986, AM J MED, V80, P685, DOI 10.1016/0002-9343(86)90825-9; SAPICO FL, 1980, REV INFECT DIS, V2, P196; SAPIRA JD, 1968, AM J MED, V45, P555, DOI 10.1016/0002-9343(68)90172-1; SAPIRA JD, 1975, DRUG AUBSE GUIDE CLI; SCHEIDEGGER C, 1989, REV INFECT DIS, V11, P486; SCHEIDEGGER C, 1991, ANN INTERN MED, V115, P576, DOI 10.7326/0003-4819-115-7-576_1; SCHLAMM HT, 1989, AM J MED, V86, P11, DOI 10.1016/0002-9343(89)90222-2; SCHREIBER SN, 1971, NEW ENGL J MED, V284, P368, DOI 10.1056/NEJM197102182840708; SCHREIBER SN, 1972, J BONE JOINT SURG AM, VA 54, P1683, DOI 10.2106/00004623-197254080-00008; SCHWARTZ RH, 1993, SOUTH MED J, V86, P318, DOI 10.1097/00007611-199303000-00014; SCHWARTZMAN WA, 1991, AM J MED, V90, P595, DOI 10.1016/S0002-9343(05)80011-7; SCULLY BE, 1987, INFECTION, V15, P169, DOI 10.1007/BF01646041; SELWYN PA, 1992, NEW ENGL J MED, V327, P1697, DOI 10.1056/NEJM199212103272401; SERVANT JB, 1985, T OPHTHAL SOC UK, V104, P297; SHANKLAND GS, 1986, BRIT MED J, V292, P1106, DOI 10.1136/bmj.292.6528.1106-a; SHEKAR R, 1985, J INFECT DIS, V151, P203, DOI 10.1093/infdis/151.2.203; SHESSER R, 1981, ANN EMERG MED, V10, P213, DOI 10.1016/S0196-0644(81)80166-7; SIMMONDS P, 1990, LANCET, V336, P1469, DOI 10.1016/0140-6736(90)93179-S; SINGH VR, 1990, J INFECT DIS, V162, P783, DOI 10.1093/infdis/162.3.783; SIRERA G, 1991, REV INFECT DIS, V13, P509; SMALL PM, 1993, NEW ENGL J MED, V328, P1137, DOI 10.1056/NEJM199304223281601; SMALL PM, 1991, NEW ENGL J MED, V324, P289, DOI 10.1056/NEJM199101313240503; SMALL PM, 1990, ANTIMICROB AGENTS CH, V34, P1227, DOI 10.1128/AAC.34.6.1227; SMITH AM, 1992, INT J ADDICT, V27, P435, DOI 10.3109/10826089209068752; SMITH HWB, 1987, ANN INTERN MED, V107, P13, DOI 10.7326/0003-4819-107-1-13; SMITH SM, 1986, J ANTIMICROB CHEMOTH, V17, P287, DOI 10.1093/jac/17.3.287; SMYTH EG, 1988, J INFECTION, V16, P169, DOI 10.1016/S0163-4453(88)94022-4; SOIN JS, 1975, CHEST, V67, P325, DOI 10.1378/chest.67.3.325; SOMERS WJ, 1986, J UROLOGY, V136, P111, DOI 10.1016/S0022-5347(17)44750-1; SPENCE MR, 1987, ANN INTERN MED, V107, P587, DOI 10.7326/0003-4819-107-4-587; SREEPADA TK, 1974, NEW ENGL J MED, V290, P19, DOI 10.1056/NEJM197401032900105; STAVE GM, 1989, AM J MED, V86, P115, DOI 10.1016/0002-9343(89)90242-8; STEEL E, 1992, AM J DRUG ALCOHOL AB, V18, P167, DOI 10.3109/00952999208992829; STERK C, 1988, LANCET, V1, P1052; STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101; STEVENS R, 1991, STREET ADDICT ROLE T; STRAUSS J, 1989, NEW ENGL J MED, V321, P625, DOI 10.1056/NEJM198909073211001; SUGAR HS, 1971, AM J OPHTHALMOL, V71, P1055, DOI 10.1016/0002-9394(71)90575-7; SUNDERAM G, 1986, JAMA-J AM MED ASSOC, V256, P362, DOI 10.1001/jama.256.3.362; SWAN SK, 1985, AM J OPHTHALMOL, V100, P408, DOI 10.1016/0002-9394(85)90502-1; SZABO S, 1990, REV INFECT DIS, V12, P412; TEBAS P, 1991, J INFECT DIS, V163, P204, DOI 10.1093/infdis/163.1.204-a; THEUER CP, 1990, J INFECT DIS, V162, P8, DOI 10.1093/infdis/162.1.8; TRESER G, 1974, AM J MED, V57, P687, DOI 10.1016/0002-9343(74)90842-0; TUAZON CU, 1975, JAMA-J AM MED ASSOC, V231, P1272, DOI 10.1001/jama.231.12.1272; TUAZON CU, 1975, ANN INTERN MED, V82, P788, DOI 10.7326/0003-4819-82-6-788; TUAZON CU, 1974, J INFECT DIS, V129, P725, DOI 10.1093/infdis/129.6.725; TUAZON CU, 1974, J INFECT DIS, V129, P327, DOI 10.1093/infdis/129.3.327; VARTIAN CV, 1985, AM J MED, V78, P703, DOI 10.1016/0002-9343(85)90418-8; VOLLUM DI, 1970, BRIT MED J, V2, P647, DOI 10.1136/bmj.2.5710.647; WATANAKUNAKORN C, 1991, CHEST, V100, P569, DOI 10.1378/chest.100.2.569; Weiss S R, 1970, Int Surg, V53, P123; WHITESIDE CM, 1989, AM J MED, V87, P225, DOI 10.1016/S0002-9343(89)80703-X; WIDROW CA, 1991, AM J MED, V91, P129, DOI 10.1016/0002-9343(91)90004-H; WITT DJ, 1987, AM J MED, V82, P900, DOI 10.1016/0002-9343(87)90150-1; WOODS KF, 1986, AM J MED, V80, P126, DOI 10.1016/0002-9343(86)90062-8; YELLIN AE, 1977, ARCH SURG-CHICAGO, V112, P981; YU VL, 1986, NEW ENGL J MED, V315, P91, DOI 10.1056/NEJM198607103150204; YU YJ, 1983, J NEUROSURG, V58, P109, DOI 10.3171/jns.1983.58.1.0109; 1991, MMWR MORBID MORTAL W, V40, P129; 1987, DIV EPIDEMIOLOGY STA; 1990, MED LETT DRUGS THER, V32, P92; 1991, MMWR MORBID MORTAL W, V40, P585; 1991, MMWR MORB MORTAL WEE, V40, P485; 1992, TUBERCULOSIS TREATME, P11	262	191	195	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1993	119	10					1017	1028		10.7326/0003-4819-119-10-199311150-00009	http://dx.doi.org/10.7326/0003-4819-119-10-199311150-00009			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MG672	8214979				2022-12-28	WOS:A1993MG67200009
J	CUJEC, B; POLASEK, P; MAYERS, I; JOHNSON, D				CUJEC, B; POLASEK, P; MAYERS, I; JOHNSON, D			POSITIVE END-EXPIRATORY PRESSURE INCREASES THE RIGHT-TO-LEFT SHUNT IN MECHANICALLY VENTILATED PATIENTS WITH PATENT FORAMEN OVALE	ANNALS OF INTERNAL MEDICINE			English	Article						POSITIVE-PRESSURE RESPIRATION; HEART SEPTAL DEFECTS, ATRIAL; RESPIRATORY INSUFFICIENCY; RESPIRATION, ARTIFICIAL; ASTERISK-SHUNTING, RIGHT TO LEFT	RIGHT VENTRICULAR INFARCTION; REDUCE INTRAPULMONARY SHUNT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; CONTRAST ECHOCARDIOGRAPHY; CARDIAC-OUTPUT; SITTING POSITION; PULMONARY-EDEMA; HYPOXEMIA; PEEP; PERFORMANCE	Objective: To determine the effect of the presence of a patent foramen ovale on the right-to-left shunt in patients with respiratory failure who receive positive end-expiratory pressure (PEEP). Design: Convenience sample with randomized application of PEEP. Setting: General intensive care unit of a university teaching hospital. Patients: A total of 46 mechanically ventilated patients with respiratory failure requiring an inspired oxygen concentration of at least 50% and a PEEP of at least 5 cm of H2O. Intervention: Randomized application of PEEP (0 and 10 cm of H2O). Measurements: A patent foramen ovale was detected by saline contrast transesophageal echocardiography. The alveolar-to-arterial oxygen difference and the right-to-left shunt were calculated from arterial and venous blood gas sampling. Results: In patients without a patent foramen ovale (n =39), the alveolar-to-arterial oxygen difference and the shunt fraction decreased (-50 mm Hg [95% CI, -21 to -67] and -0.05 [CI, -0.03 to -0.07], respectively) after adding PEEP (10 cm of H2O). In patients with a patent foramen ovale (n = 7), minimal changes were noted in the alveolar-to-arterial oxygen difference (4 mm Hg, P > 0.2), but the shunt fraction increased (0.05, CI, 0 to 0.09). Adding PEEP (10 cm of H2O) increased the shunt fraction in 6 of 7 (86%) patients with a patent foramen ovale, whereas the shunt increased in only 7 of 39 (18%) patients without a patent foramen ovale (P < 0.007). Conclusions: A patent foramen ovale was found in 7 of 46 patients (15%; CI, 6% to 29%) with acute respiratory failure. This condition is a common cause of lack of improvement in oxygenation with the addition of PEEP in the mechanically ventilated patient. In patients with a patent foramen ovale, the right-to-left shunt is usually increased by using PEEP.			CUJEC, B (corresponding author), UNIV SASKATCHEWAN, ROYAL UNIV HOSP, DIV CARDIOL, SASKATOON S7N 0W0, SASKATCHEWAN, CANADA.							BALDWIN RT, 1991, ANN THORAC SURG, V52, P865, DOI 10.1016/0003-4975(91)91230-S; BERK JL, 1982, HDB CRITICAL CARE, P87; BLACK S, 1990, ANESTHESIOLOGY, V72, P436, DOI 10.1097/00000542-199003000-00007; BONE RC, 1989, CHEST, V96, P114, DOI 10.1378/chest.96.1.114; BRANDT L, 1990, ADV EXP MED BIOL, V277, P489; BURNETT RW, 1974, CLIN CHEM, V20, P1499; CLEMENTS FM, 1990, BRIT J ANAESTH, V64, P331, DOI 10.1093/bja/64.3.331; COX D, 1991, AM J MED, V91, P653, DOI 10.1016/0002-9343(91)90220-R; DANTZKER DR, 1980, CHEST, V77, P636, DOI 10.1378/chest.77.5.636; DORINSKY PM, 1983, CHEST, V84, P210, DOI 10.1378/chest.84.2.210; FESSLER HE, 1992, AM REV RESPIR DIS, V146, P4, DOI 10.1164/ajrccm/146.1.4; GOLDMAN AP, 1991, AM HEART J, V121, P1224, DOI 10.1016/0002-8703(91)90685-B; GUDIPATI CV, 1991, AM HEART J, V121, P919, DOI 10.1016/0002-8703(91)90212-Z; GUGGIARI M, 1988, ANESTH ANALG, V67, P192; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; HUGOD C, 1979, ARCH ENVIRON HEALTH, V34, P12, DOI 10.1080/00039896.1979.10667360; JARDIN F, 1981, NEW ENGL J MED, V304, P387, DOI 10.1056/NEJM198102123040703; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KONSTADT SN, 1991, ANESTHESIOLOGY, V74, P212, DOI 10.1097/00000542-199102000-00003; LANGHOLZ D, 1991, J AM COLL CARDIOL, V18, P1112, DOI 10.1016/0735-1097(91)90775-5; LEJEUNE P, 1991, J APPL PHYSIOL, V70, P1867, DOI 10.1152/jappl.1991.70.4.1867; LEMAIRE F, 1982, ANESTHESIOLOGY, V57, P233, DOI 10.1097/00000542-198209000-00016; LEVINE BD, 1991, ANN INTERN MED, V114, P569, DOI 10.7326/0003-4819-114-7-569; LIGHT RB, 1986, AM REV RESPIR DIS, V134, P520; LYNCH JJ, 1984, AM J CARDIOL, V53, P1478, DOI 10.1016/S0002-9149(84)91617-5; LYNCH JP, 1979, J APPL PHYSIOL, V46, P315, DOI 10.1152/jappl.1979.46.2.315; MALO J, 1984, J APPL PHYSIOL, V57, P1002, DOI 10.1152/jappl.1984.57.4.1002; MATSUMOTO M, 1980, AM J CARDIOL, V46, P95, DOI 10.1016/0002-9149(80)90611-6; MAYERS I, 1989, RESP PHYSIOL, V75, P247, DOI 10.1016/0034-5687(89)90068-6; MINK SN, 1981, J APPL PHYSIOL, V50, P517, DOI 10.1152/jappl.1981.50.3.517; MOORTHY SS, 1974, ANESTHESIOLOGY, V41, P405, DOI 10.1097/00000542-197410000-00022; Movsowitz C, 1992, J Am Soc Echocardiogr, V5, P259; PICK RA, 1982, CHEST, V82, P345, DOI 10.1378/chest.82.3.345; RAVENSCRAFT SA, 1992, CRIT CARE MED, V20, P434, DOI 10.1097/00003246-199203000-00023; ROHLF FJ, 1981, STATISTICAL TABLES, P81; ROSSAINT R, 1993, NEW ENGL J MED, V328, P399, DOI 10.1056/NEJM199302113280605; SCHARF SM, 1982, J APPL PHYSIOL, V52, P254, DOI 10.1152/jappl.1982.52.1.254; SEWARD JB, 1990, MAYO CLIN PROC, V65, P1193, DOI 10.1016/S0025-6196(12)62744-X; SIOSTRZONEK P, 1992, J AM COLL CARDIOL, V19, P1192, DOI 10.1016/0735-1097(92)90323-F; SIOSTRZONEK P, 1991, AM J CARDIOL, V68, P1247, DOI 10.1016/0002-9149(91)90206-Z; STETZ CW, 1982, AM REV RESPIR DIS, V126, P1001; TAHVANAINEN J, 1982, CRIT CARE MED, V10, P758, DOI 10.1097/00003246-198211000-00012; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; THOMPSON RC, 1991, MAYO CLIN PROC, V66, P391, DOI 10.1016/S0025-6196(12)60663-6	44	63	64	2	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	1993	119	9					887	894		10.7326/0003-4819-119-9-199311010-00004	http://dx.doi.org/10.7326/0003-4819-119-9-199311010-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	MD711	8215000				2022-12-28	WOS:A1993MD71100004
J	NEELY, A; WEI, XY; OLCESE, R; BIRNBAUMER, L; STEFANI, E				NEELY, A; WEI, XY; OLCESE, R; BIRNBAUMER, L; STEFANI, E			POTENTIATION BY THE BETA-SUBUNIT OF THE RATIO OF THE IONIC CURRENT TO THE CHARGE MOVEMENT IN THE CARDIAC CALCIUM-CHANNEL	SCIENCE			English	Article							SKELETAL-MUSCLE; BETA-SUBUNIT; VENTRICULAR MYOCYTES; GUINEA-PIG; EXPRESSION; RECEPTOR	The voltage-activated rabbit cardiac calcium channel alpha1 subunit was expressed in Xenopus oocytes. The charge movement of its voltage sensor was measured and related to the opening of the ion-conducting pore. The half-activation potential for charge movement was 35 millivolts more negative than that for pore opening. Coexpression of the cardiac calcium channel beta subunit reduced this difference without affecting charge movement. Thus, intramolecular coupling between the voltage sensor and the channel pore opening can be facilitated by a regulatory subunit.	BAYLOR COLL MED, DEPT CELL BIOL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT MED ENDOCRINOL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DIV NEUROSCI, HOUSTON, TX 77030 USA; BAYLOR COLL MED, DEPT NEUROL, HOUSTON, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	NEELY, A (corresponding author), BAYLOR COLL MED, DEPT MOLEC PHYSIOL & BIOPHYS, HOUSTON, TX 77030 USA.		Neely, Alan/A-8715-2009	Neely, Alan/0000-0002-6007-2159	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL037044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038970] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL37044] Funding Source: Medline; NIAMS NIH HHS [AR38970] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADAMS BA, 1990, NATURE, V346, P569, DOI 10.1038/346569a0; ADAMS DJ, 1979, J PHYSIOL-LONDON, V291, P467, DOI 10.1113/jphysiol.1979.sp012826; ARMSTRONG CM, 1973, J GEN PHYSIOL, V62, P375, DOI 10.1085/jgp.62.4.375; BEAN BP, 1989, J GEN PHYSIOL, V94, P65, DOI 10.1085/jgp.94.1.65; BENZANILLA F, 1991, SCIENCE, V254, P679; CATTERALL WA, 1991, SCIENCE, V253, P1499, DOI 10.1126/science.1654596; HADLEY RW, 1989, J PHYSIOL-LONDON, V415, P601, DOI 10.1113/jphysiol.1989.sp017738; LACERDA AE, 1991, NATURE, V352, P527, DOI 10.1038/352527a0; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; NISHIMURA S, 1993, FEBS LETT, V324, P283, DOI 10.1016/0014-5793(93)80135-H; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; PEROZO E, 1992, BIOPHYS J, V62, P160, DOI 10.1016/S0006-3495(92)81802-7; RAKOWSKI RF, 1993, J GEN PHYSIOL, V101, P117, DOI 10.1085/jgp.101.1.117; SHIROKOV R, 1992, J GEN PHYSIOL, V99, P863, DOI 10.1085/jgp.99.6.863; SINGER D, 1991, SCIENCE, V253, P1553, DOI 10.1126/science.1716787; TAGLIALATELA M, 1992, BIOPHYS J, V61, P78, DOI 10.1016/S0006-3495(92)81817-9; TANABE T, 1987, NATURE, V328, P313, DOI 10.1038/328313a0; VARADI G, 1991, NATURE, V352, P159, DOI 10.1038/352159a0; WEI XY, 1991, J BIOL CHEM, V266, P21943	19	222	225	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 22	1993	262	5133					575	578		10.1126/science.8211185	http://dx.doi.org/10.1126/science.8211185			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	MC935	8211185				2022-12-28	WOS:A1993MC93500043
J	SLATER, CA; SICKEL, JZ; VISVESVARA, GS; PABICO, RC; GASPARI, AA				SLATER, CA; SICKEL, JZ; VISVESVARA, GS; PABICO, RC; GASPARI, AA			SUCCESSFUL TREATMENT OF DISSEMINATED ACANTHAMOEBA INFECTION IN AN IMMUNOCOMPROMISED PATIENT	NEW ENGLAND JOURNAL OF MEDICINE			English	Note							AMEBIC MENINGOENCEPHALITIS; PATHOGENICITY; CULBERTSONI; NAEGLERIA; VARIETY; AIDS		UNIV ROCHESTER,MED CTR,DEPT DERMATOL,ROCHESTER,NY 14642; UNIV ROCHESTER,MED CTR,DEPT PATHOL,ROCHESTER,NY 14642; UNIV ROCHESTER,MED CTR,DEPT MED,NEPHROL UNIT,ROCHESTER,NY 14642; CTR DIS CONTROL & PREVENT,NATL CTR INFECT DIS,DIV PARASIT DIS,ATLANTA,GA 30341	University of Rochester; University of Rochester; University of Rochester; Centers for Disease Control & Prevention - USA					NIAMS NIH HHS [R01 29 AR40933] Funding Source: Medline	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		CLELAND PG, 1982, ARCH NEUROL-CHICAGO, V39, P56, DOI 10.1001/archneur.1982.00510130058016; DONNELLY H, 1988, J INFECT DIS, V157, P985, DOI 10.1093/infdis/157.5.985; DUMA RJ, 1976, ANTIMICROB AGENTS CH, V10, P370, DOI 10.1128/AAC.10.2.370; FERRANTE A, 1991, PARASITE IMMUNOL, V13, P31, DOI 10.1111/j.1365-3024.1991.tb00261.x; FERRANTE A, 1984, INT J PARASITOL, V14, P53, DOI 10.1016/0020-7519(84)90011-0; FRIEDLAND LR, 1992, PEDIATR INFECT DIS J, V11, P404, DOI 10.1097/00006454-199205000-00012; GARDNER HAR, 1991, NEUROLOGY, V41, P1993, DOI 10.1212/WNL.41.12.1993; GONZALEZ MM, 1986, ARCH PATHOL LAB MED, V110, P749; HELTON J, 1993, AM J DERMATOPATH, V15, P146, DOI 10.1097/00000372-199304000-00008; IYENGAR V, 1992, 32ND INT C ANT AG CH, P292; LALITHA MK, 1985, J CLIN MICROBIOL, V21, P666, DOI 10.1128/JCM.21.4.666-667.1985; MA P, 1990, REV INFECT DIS, V12, P490; MARTINEZ AJ, 1982, J NEUROPATH EXP NEUR, V41, P548, DOI 10.1097/00005072-198209000-00007; MARTINEZ AJ, 1991, REV INFECT DIS, V13, pS399; OFORIKWAKYE SK, 1986, J NEUROSURG, V64, P505, DOI 10.3171/jns.1986.64.3.0505; RUTHERFORD I, 1991, REV INFECT DIS, V13, pS416; TOMLINSON G, 1991, REV INFECT DIS, V13, pS436; VISVESVARA GS, 1990, J CLIN MICROBIOL, V28, P2750, DOI 10.1128/JCM.28.12.2750-2756.1990; VISVESVARA GS, 1983, J CLIN MICROBIOL, V18, P1405, DOI 10.1128/JCM.18.6.1405-1412.1983; VISVESVARA GS, 1990, J PROTOZOOL, V37, pS25, DOI 10.1111/j.1550-7408.1990.tb01142.x; WANG P, 1990, TRANSPLANT P, V22, P1186	21	74	75	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 14	1994	331	2					85	87		10.1056/NEJM199407143310204	http://dx.doi.org/10.1056/NEJM199407143310204			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NW712	8208270	Bronze			2022-12-28	WOS:A1994NW71200004
J	GUZDER, SN; SUNG, P; BAILLY, V; PRAKASH, L; PRAKASH, S				GUZDER, SN; SUNG, P; BAILLY, V; PRAKASH, L; PRAKASH, S			RAD25 IS A DNA HELICASE REQUIRED FOR RNA REPAIR AND RNA-POLYMERASE-II TRANSCRIPTION	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE; ENDONUCLEASE; INITIATION; ENCODES; RAD10; PROTEIN; ATPASE; STRAND; CTD	THE RAD25 gene of Saccharomyces cerevisiae functions in nucleotide excision repair of ultraviolet-damaged DNA and is also required for cell viability(1). The RAD25 protein shows remarkable homology to the protein encoded by the human nucleotide-excision-repair gene XPB (ERCC3), mutations in which cause the cancer-prone disease xeroderma pigmentosum and also Cockayne's syndrome(1). Here we purify RAD25 protein from S. cerevisiae and show that it contains single-stranded DNA-dependent ATPase and DNA helicase activities. Extract from the conditional lethal mutant rad25-ts(24) exhibits a thermolabile transcriptional defect which can be corrected by the addition of RAD25 protein, indicating a direct and essential role of RAD25 in RNA polymerase II transcription. The protein encoded by the rad25(799am) allele is defective in DNA repair but is proficient in RNA polymerase II transcription, indicating that RAD25 DNA-repair activity is separable from its transcription function. The rad25 Arg-392 encoded product, which contains a mutation in the ATP-binding motif, is defective in RNA polymerase II transcription, suggesting that the RAD25-encoded DNA helicase functions in DNA duplex opening during transcription initiation.	UNIV TEXAS,MED BRANCH,SEALY CTR MOLEC SCI,GALVESTON,TX 77555	University of Texas System; University of Texas Medical Branch Galveston			Prakash, Louise/C-7891-2012; Prakash, Satya/C-6420-2013	Prakash, Louise/0000-0001-9143-6261; Prakash, Satya/0000-0001-7228-1444				BAILLY V, 1992, P NATL ACAD SCI USA, V89, P8273, DOI 10.1073/pnas.89.17.8273; BUNICK D, 1982, CELL, V29, P877, DOI 10.1016/0092-8674(82)90449-4; CONOWAY RC, 1989, P NATL ACAD SCI USA, V86, P7356; FEAVER WJ, 1991, CELL, V67, P1223, DOI 10.1016/0092-8674(91)90298-D; FEAVER WJ, 1993, CELL, V75, P1379, DOI 10.1016/0092-8674(93)90624-Y; GUZDER SN, 1994, NATURE, V367, P91, DOI 10.1038/367091a0; HABRAKEN Y, 1993, NATURE, V366, P365, DOI 10.1038/366365a0; KOLESKE AJ, 1992, CELL, V69, P883, DOI 10.1016/0092-8674(92)90298-Q; LEADON SA, 1992, J BIOL CHEM, V267, P23175; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; PARK E, 1992, P NATL ACAD SCI USA, V89, P11416, DOI 10.1073/pnas.89.23.11416; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; QIU HF, 1993, GENE DEV, V7, P2161, DOI 10.1101/gad.7.11.2161; SAWADOGO M, 1984, J BIOL CHEM, V259, P5321; SCHAEFFER L, 1993, SCIENCE, V260, P58, DOI 10.1126/science.8465201; SUNG P, 1987, P NATL ACAD SCI USA, V84, P6045, DOI 10.1073/pnas.84.17.6045; SUNG P, 1993, J BIOL CHEM, V268, P26391; SUNG P, 1987, P NATL ACAD SCI USA, V84, P8951, DOI 10.1073/pnas.84.24.8951; SUNG P, 1993, NATURE, V365, P852, DOI 10.1038/365852a0; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; SUNG P, 1994, J BIOL CHEM, V269, P8303; SWEDER KS, 1993, SCIENCE, V262, P439, DOI 10.1126/science.8211165; SWEDER KS, 1992, P NATL ACAD SCI USA, V89, P10696, DOI 10.1073/pnas.89.22.10696; SWEDER KS, 1994, J BIOL CHEM, V269, P1852; TOMKINSON AE, 1993, NATURE, V362, P860, DOI 10.1038/362860a0; WOONTNER M, 1991, MOL CELL BIOL, V11, P4555, DOI 10.1128/MCB.11.9.4555	26	166	168	0	6	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON, ENGLAND N1 9XW	0028-0836			NATURE	Nature	JUN 16	1994	369	6481					578	581		10.1038/369578a0	http://dx.doi.org/10.1038/369578a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NR294	8202161				2022-12-28	WOS:A1994NR29400055
J	MISHKIN, M				MISHKIN, M			METALLIC SURGICAL CLIPS AND MAGNETIC-RESONANCE-IMAGING	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ANEURYSM				MISHKIN, M (corresponding author), THOMAS JEFFERSON UNIV HOSP,PHILADELPHIA,PA, USA.							BECKER RL, 1988, AM J NEURORADIOL, V9, P885; DUJOVNY M, 1985, NEUROSURGERY, V17, P543, DOI 10.1227/00006123-198510000-00002; KANAL E, 1993, RADIOLOGY, V187, P612, DOI 10.1148/radiology.187.3.8497603; KLUCZNIK RP, 1993, RADIOLOGY, V187, P885; NEW PFG, 1983, RADIOLOGY, V147, P1139; 1993, ACR B, V5, P11	6	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 15	1994	271	23					1886	1886		10.1001/jama.271.23.1886	http://dx.doi.org/10.1001/jama.271.23.1886			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NP959	8196150				2022-12-28	WOS:A1994NP95900039
J	NAYLOR, M; BROOTEN, D; JONES, R; LAVIZZOMOUREY, R; MEZEY, M; PAULY, M				NAYLOR, M; BROOTEN, D; JONES, R; LAVIZZOMOUREY, R; MEZEY, M; PAULY, M			COMPREHENSIVE DISCHARGE PLANNING FOR THE HOSPITALIZED ELDERLY - A RANDOMIZED CLINICAL-TRIAL	ANNALS OF INTERNAL MEDICINE			English	Article						COST SAVINGS; OUTCOME ASSESSMENT (HEALTH CARE)	PROSPECTIVE PAYMENT SYSTEM; POSTHOSPITAL NEEDS; CARE; READMISSIONS; QUALITY	Objective: To study the effects of a comprehensive discharge planning protocol, designed specifically for the elderly and implemented by nurse specialists, on patient and caregiver outcomes and cost of care. Design: Randomized clinical trial. Setting: Hospital of the University of Pennsylvania. Patients: 276 patients and 125 caregivers. Patients were 70 years and older and were placed in selected medical and surgical cardiac diagnostic-related groups. Measurements: Group differences in patient outcomes (length of initial hospital stay, length of time between initial hospital discharge and readmission, and rehospitalization rates) and charges for care (charges for initial hospitalization, rehospitalizations, health services after discharge, and nurse specialist services) were measured 2, 6, and 12 weeks after discharge. Results: From the initial hospital discharge to 6 weeks after discharge, patients in the medical intervention group had fewer readmissions, fewer total days rehospitalized, lower readmission charges, and lower charges for health care services after discharge. No differences in these outcomes were found between the surgical intervention and control groups during this period. Conclusions: Study findings support the need for comprehensive discharge planning designed for the elderly and implemented by nurse specialists to improve their outcomes after hospital discharge and to achieve cost savings. The findings also suggest that this intervention had its greatest effect in delaying or preventing rehospitalization of patients in the medical intervention group during the first 6 weeks after discharge.	US DEPT HHS, AGCY HLTH CARE POLICY & RES, ROCKVILLE, MD 20852 USA; NYU, DIV NURSING, NEW YORK, NY 10003 USA; UNIV PENN, WHARTON SCH, PHILADELPHIA, PA 19104 USA; UNIV PENN, LEONARD DAVIS INST HLTH ECON, PHILADELPHIA, PA 19104 USA	Agency for Healthcare Research & Quality; New York University; University of Pennsylvania; University of Pennsylvania	NAYLOR, M (corresponding author), UNIV PENN, SCH NURSING, 420 GUARDIAN DR, PHILADELPHIA, PA 19104 USA.				NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR002095] Funding Source: NIH RePORTER; NINR NIH HHS [NR02095-05] Funding Source: Medline	NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))		ANDERSON GF, 1984, NEW ENGL J MED, V311, P1349, DOI 10.1056/NEJM198411223112105; Brooten D, 1988, Image J Nurs Sch, V20, P64; FINK A, 1987, JAMA-J AM MED ASSOC, V258, P1905, DOI 10.1001/jama.258.14.1905; JOHNSON H, 1985, CONTINUITY CARE ADV, P229; JONES EW, 1989, HEALTH SERV RES, V24, P643; KENNEDY L, 1987, GERONTOLOGIST, V27, P577, DOI 10.1093/geront/27.5.577; MANTON KG, 1993, HEALTH SERV RES, V28, P269; NAYLOR M, 1991, CRITICAL CARE NURSIN; NAYLOR M, 1986, HLTH STATUS HLTH CAR; NEIDLINGER L, 1987, NURS ECON, V5, P225; PAULY M, 1992, IMPROVING HLTH POLIC, P155; ROGERS WH, 1990, JAMA-J AM MED ASSOC, V264, P1989, DOI 10.1001/jama.264.15.1989; SMITH DM, 1988, MED CARE, V26, P699, DOI 10.1097/00005650-198807000-00005; Van Gelder S, 1986, Pride Inst J Long Term Home Health Care, V5, P3; WEINBERGER M, 1988, MED CARE, V26, P1092, DOI 10.1097/00005650-198811000-00007; WERTHEIMER DS, 1990, GERONTOLOGIST, V30, P837; WOLOCK I, 1987, SOC WORK HEALTH CARE, V12, P61, DOI 10.1300/J010v12n04_05; 1989, MEDICARE PROSPECTIVE; 1993, MEDICARE PROSPECTIVE; 1992, VITAL HLTH STATIS 13, V112; 1992, MEDICARE PROSPECTIVE	21	490	511	2	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	1994	120	12					999	1006		10.7326/0003-4819-120-12-199406150-00005	http://dx.doi.org/10.7326/0003-4819-120-12-199406150-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NQ964	8185149				2022-12-28	WOS:A1994NQ96400005
J	KAJIWARA, K; BERSON, EL; DRYJA, TP				KAJIWARA, K; BERSON, EL; DRYJA, TP			DIGENIC RETINITIS-PIGMENTOSA DUE TO MUTATIONS AT THE UNLINKED PERIPHERIN/RDS AND ROM1 LOCI	SCIENCE			English	Article							SYNDROME TYPE-I; SLOW RDS GENE; NULL MUTATION; LOCALIZATION; LINKAGE; DEGENERATION; FAMILY; CHROMOSOME-11; DYSTROPHY; HETEROGENEITY	In spite of recent advances in identifying genes causing monogenic human disease, very little is known about the genes involved in polygenic disease. Three families were identified with mutations in the unlinked photoreceptor-specific genes ROM1 and peripherin/RDS, in which only double heterozygotes develop retinitis pigmentosa (RP). These findings indicate that the allelic and nonallelic heterogeneity known to be a feature of monogenic RP is complicated further by interactions between unlinked mutations causing digenic RP. Recognition of the inheritance pattern exemplified by these three families might facilitate the identification of other examples of digenic inheritance in human disease.	HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,HOWE LAB OPHTHALMOL,BOSTON,MA 02114; HARVARD UNIV,MASSACHUSETTS EYE & EAR INFIRM,SCH MED,BERMAN GUND LAB STUDY RETINAL DEGENERAT,BOSTON,MA 02114	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary					NATIONAL EYE INSTITUTE [R37EY000169, R01EY000169, R01EY008683] Funding Source: NIH RePORTER; NEI NIH HHS [EY08683, EY00169] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALMAGHTHEH M, 1994, HUM MOL GENET, V3, P351, DOI 10.1093/hmg/3.2.351; BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; BASCOM RA, 1992, AM J HUM GENET, V51, P1028; BASCOM RA, 1993, HUM MOL GENET, V2, P385, DOI 10.1093/hmg/2.4.385; BERSON EL, 1979, ARCH OPHTHALMOL-CHIC, V97, P1286, DOI 10.1001/archopht.1979.01020020028006; BERSON EL, 1993, INVEST OPHTH VIS SCI, V34, P1659; BERSON EL, 1993, ARCH OPHTHALMOL-CHIC, V111, P761, DOI 10.1001/archopht.1993.01090060049022; BERSON EL, 1976, T AM ACAD OPHTHALMOL, V81, P659; BLANTON SH, 1991, GENOMICS, V11, P857, DOI 10.1016/0888-7543(91)90008-3; CHEN JD, 1989, AM J HUM GENET, V45, P401; DRYJA TP, 1992, EYE, V6, P1; FARRAR GJ, 1991, GENOMICS, V11, P870, DOI 10.1016/0888-7543(91)90009-4; FARRAR GJ, 1991, NATURE, V354, P478, DOI 10.1038/354478a0; FARRAR GJ, 1992, AM J HUM GENET SA94, V51, P363; HAYS TS, 1989, MOL CELL BIOL, V9, P875, DOI 10.1128/MCB.9.3.875; INGLEHEARN CF, 1993, NAT GENET, V4, P51, DOI 10.1038/ng0593-51; JAY M, 1992, J MED GENET, V29, P906, DOI 10.1136/jmg.29.12.906; JORDAN SA, 1993, NAT GENET, V4, P54, DOI 10.1038/ng0593-54; KAJIWARA K, 1991, NATURE, V354, P480, DOI 10.1038/354480a0; KAJIWARA K, 1993, NAT GENET, V3, P208, DOI 10.1038/ng0393-208; KAJIWARA K, UNPUB; KAPLAN J, 1992, GENOMICS, V14, P979, DOI 10.1016/S0888-7543(05)80120-X; KARPE G, 1945, ACTA OPHTHALMOL, V23, P1; KIMBERLING WJ, 1992, GENOMICS, V14, P988, DOI 10.1016/S0888-7543(05)80121-1; KIMBERLING WJ, 1990, GENOMICS, V7, P245, DOI 10.1016/0888-7543(90)90546-7; KUSCH M, 1986, GENETICS, V113, P621; KWITEKBLACK AE, 1993, NAT GENET, V5, P392, DOI 10.1038/ng1293-392; LEWIS RA, 1990, GENOMICS, V7, P250, DOI 10.1016/0888-7543(90)90547-8; MCLAUGHLIN ME, 1993, NAT GENET, V4, P130, DOI 10.1038/ng0693-130; NICHOLS BE, 1993, NAT GENET, V3, P202, DOI 10.1038/ng0393-202; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; REICHEL E, 1989, AM J OPHTHALMOL, V108, P540, DOI 10.1016/0002-9394(89)90431-5; ROSENFELD PJ, 1992, NAT GENET, V1, P209, DOI 10.1038/ng0692-209; SMITH RJH, 1992, GENOMICS, V14, P995, DOI 10.1016/S0888-7543(05)80122-3; STEARNS T, 1988, GENETICS, V119, P249; TRAVIS GH, 1991, GENOMICS, V10, P733, DOI 10.1016/0888-7543(91)90457-P; WELEBER RG, 1981, INVEST OPHTH VIS SCI, V20, P392; WELEBER RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1531, DOI 10.1001/archopht.1993.01090110097033; WELLS J, 1993, NAT GENET, V3, P213, DOI 10.1038/ng0393-213; YANDELL DW, 1989, CANCER CEL, V7, P223	40	555	571	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 10	1994	264	5165					1604	1608		10.1126/science.8202715	http://dx.doi.org/10.1126/science.8202715			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NQ285	8202715				2022-12-28	WOS:A1994NQ28500041
J	BREO, DL				BREO, DL			JUNE 6, 1944 - 2 DOCTORS RELIVE D-DAY DANGERS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	1994	271	22					1799	1804		10.1001/jama.271.22.1799	http://dx.doi.org/10.1001/jama.271.22.1799			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN725	8196127				2022-12-28	WOS:A1994NN72500034
J	EDDY, DM				EDDY, DM			PRINCIPLES FOR MAKING DIFFICULT DECISIONS IN DIFFICULT TIMES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GUIDELINES		DUKE UNIV, DURHAM, NC USA	Duke University								Eddy David M., 1990, JAMA-J AM MED ASSOC, V263, P3081; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P3077, DOI 10.1001/jama.263.22.3077; EDDY DM, 1993, JAMA-J AM MED ASSOC, V270, P520; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P1839, DOI 10.1001/jama.263.13.1839; EDDY DM, 1992, AM COLL SURG B, V77, P36; Eddy DM., 1990, JAMA-J AM MED ASSOC, V263, P3084; FLEMING C, 1993, JAMA-J AM MED ASSOC, V269, P2650, DOI 10.1001/jama.269.20.2650; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; Jonsen A R, 1986, Law Med Health Care, V14, P172	9	72	72	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 8	1994	271	22					1792	1798		10.1001/jama.271.22.1792	http://dx.doi.org/10.1001/jama.271.22.1792			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NN725	8196126				2022-12-28	WOS:A1994NN72500033
J	COGNE, M; LANSFORD, TR; BOTTARO, A; ZHANG, J; GORMAN, J; YOUNG, F; CHENG, HL; ALT, FW				COGNE, M; LANSFORD, TR; BOTTARO, A; ZHANG, J; GORMAN, J; YOUNG, F; CHENG, HL; ALT, FW			CLASS SWITCH CONTROL REGION AT THE 3' END OF THE IMMUNOGLOBULIN HEAVY-CHAIN LOCUS	CELL			English	Article							BETA-GLOBIN LOCUS; MURINE-B-CELLS; GROWTH FACTOR-BETA; CONSTANT-REGION; C-EPSILON; INTERFERON-GAMMA; IGH ENHANCER; GENE; EXPRESSION; TRANSCRIPTS	We replaced the IgH 3' enhancer (3'E(H)) region with a neomycin resistance gene in ES cells and generated chimeric mice in which all mature lymphocytes were either heterozygous (3'E(H)(+/-)) or homozygous (3'E(H)(-/-)) for the mutation. In vitro activated 3'E(H)(-/-) B cells responded similarly to 3'E(H)(+/-) B cells with respect to proliferation and secretion of IgM and IgG1 but were specifically deficient in IgG2a, IgG2b, IgG3, and IgE secretion. These isotype deficiencies correlated with a deficiency in accumulation of transcripts from and class switching to affected C-H genes. In vivo, chimeric mice containing only 3'E(H)(-/-) B cells were deficient in serum IgG2a and IgG3. We propose that the 3'E(H)(-/-) mutation disrupts the activity of a regulatory region that influences heavy chain class switching to several different C-H genes that lie as far as 100 kb upstream of the mutation.	HARVARD UNIV, SCH MED, DEPT GENET, BOSTON, MA 02115 USA; FAC SCI POITIERS, INST BIOL MOLEC & INGN GENET, CNRS, URA 1172, F-86022 POITIERS, FRANCE; UNIV SIENA, POLICLIN SCOTTE, DIPARTIMENTO BIOL MOLEC, I-53100 SIENA, ITALY	Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); University of Siena	COGNE, M (corresponding author), HARVARD UNIV, CHILDRENS HOSP, SCH MED, HOWARD HUGHES MED INST, CTR BLOOD RES, BOSTON, MA 02115 USA.		Bottaro, Andrea/L-1831-2017; cogné, michel/D-7370-2015	Bottaro, Andrea/0000-0003-1712-6796; cogné, michel/0000-0002-8519-4427; Lansford, Rusty/0000-0002-2159-3699	NIAID NIH HHS [AI-31541, AI-20047] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI020047, U19AI031541, R01AI020047, U01AI031541] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALT FW, 1982, NATURE, V296, P325, DOI 10.1038/296325a0; ALT FW, 1992, IMMUNOL TODAY, V13, P306, DOI 10.1016/0167-5699(92)90043-7; BERTON MT, 1989, P NATL ACAD SCI USA, V86, P2829, DOI 10.1073/pnas.86.8.2829; BOTTARO A, 1994, EMBO J, V13, P665, DOI 10.1002/j.1460-2075.1994.tb06305.x; BURSTEIN HJ, 1991, J IMMUNOL, V147, P2950; CALVO CF, 1991, J IMMUNOL, V146, P1353; CHEN JZ, 1993, EMBO J, V12, P4635, DOI 10.1002/j.1460-2075.1993.tb06152.x; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; CHOI ORB, 1988, CELL, V55, P17, DOI 10.1016/0092-8674(88)90005-0; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; COFFMAN RL, 1986, J IMMUNOL, V136, P4538; COFFMAN RL, 1989, J EXP MED, V170, P1039, DOI 10.1084/jem.170.3.1039; CORY S, 1980, CELL, V19, P37, DOI 10.1016/0092-8674(80)90386-4; CROCE CM, 1985, BLOOD, V65, P1; CROSSLEY M, 1993, CURR OPIN GENET DEV, V3, P232, DOI 10.1016/0959-437X(93)90028-N; DARIAVACH P, 1991, EUR J IMMUNOL, V21, P1499, DOI 10.1002/eji.1830210625; DAVIS MM, 1980, SCIENCE, V209, P1360, DOI 10.1126/science.6774415; DILLON N, 1993, TRENDS GENET, V9, P134, DOI 10.1016/0168-9525(93)90208-Y; ESSER C, 1989, EMBO J, V8, P483, DOI 10.1002/j.1460-2075.1989.tb03401.x; ESSER C, 1990, ANNU REV IMMUNOL, V8, P717, DOI 10.1146/annurev.iy.08.040190.003441; FERRIER P, 1990, EMBO J, V9, P117, DOI 10.1002/j.1460-2075.1990.tb08087.x; FIERING S, 1993, P NATL ACAD SCI USA, V90, P8469, DOI 10.1073/pnas.90.18.8469; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; FLANAGAN JG, 1982, NATURE, V300, P709, DOI 10.1038/300709a0; FORRESTER WC, 1990, GENE DEV, V4, P1637, DOI 10.1101/gad.4.10.1637; GIANNINI SL, 1993, J IMMUNOL, V150, P1772; GREGOR PD, 1986, MOL CELL BIOL, V6, P1903, DOI 10.1128/MCB.6.6.1903; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; HAMILTON RG, 1987, CLIN CHEM, V33, P1707; HIRANO T, 1988, INT ARCH ALLER A IMM, V85, P47, DOI 10.1159/000234473; HONJO T, 1978, P NATL ACAD SCI USA, V75, P2140, DOI 10.1073/pnas.75.5.2140; HUMMEL M, 1987, J IMMUNOL, V138, P3539; JUNG S, 1993, SCIENCE, V259, P984, DOI 10.1126/science.8438159; KATAOKA T, 1980, P NATL ACAD SCI-BIOL, V77, P919, DOI 10.1073/pnas.77.2.919; KATAOKA T, 1981, CELL, V23, P357, DOI 10.1016/0092-8674(81)90131-8; KEARNEY JF, 1976, J IMMUNOL, V117, P1567; KIM CG, 1992, GENE DEV, V6, P928, DOI 10.1101/gad.6.6.928; KLEIN S, 1984, EMBO J, V3, P2473, DOI 10.1002/j.1460-2075.1984.tb02158.x; KOHL NE, 1986, NATURE, V319, P73, DOI 10.1038/319073a0; LAYTON JE, 1984, J EXP MED, V160, P1850, DOI 10.1084/jem.160.6.1850; LEBMAN DA, 1990, J IMMUNOL, V144, P952; LI SC, 1994, INT IMMUNOL, V6, P491, DOI 10.1093/intimm/6.4.491; LIEBERSON R, 1991, NUCLEIC ACIDS RES, V19, P933, DOI 10.1093/nar/19.4.933; LUTZKER S, 1988, CELL, V53, P177, DOI 10.1016/0092-8674(88)90379-0; LUTZKER S, 1988, MOL CELL BIOL, V8, P1849, DOI 10.1128/MCB.8.4.1849; LUTZKER S, 1988, MOBILE DNA, P691; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MATTHIAS P, 1993, MOL CELL BIOL, V13, P1547, DOI 10.1128/MCB.13.3.1547; MORTENSEN RM, 1992, MOL CELL BIOL, V12, P2391, DOI 10.1128/MCB.12.5.2391; NIKAIDO T, 1982, J BIOL CHEM, V257, P7322; NOELLE RJ, 1992, IMMUNOL TODAY, V13, P431, DOI 10.1016/0167-5699(92)90068-I; PARKS DR, 1986, HDB EXPT IMMUNOLOGY; PETTERSSON S, 1990, NATURE, V344, P165, DOI 10.1038/344165a0; RABBITTS TH, 1980, NATURE, V283, P351, DOI 10.1038/283351a0; ROTHMAN P, 1988, J EXP MED, V168, P2385, DOI 10.1084/jem.168.6.2385; ROTHMAN P, 1990, MOL CELL BIOL, V10, P1672, DOI 10.1128/MCB.10.4.1672; ROTHMAN P, 1990, INT IMMUNOL, V2, P621, DOI 10.1093/intimm/2.7.621; Sambrook J, 1989, MOL CLONING LABORATO; SCHAFFER A, 1991, IMMUNODEFICIENCY REV, V3, P15; SEN R, 1989, IMMUNOGLOBULIN GENES, P327; SERWE M, 1993, EMBO J, V12, P2321, DOI 10.1002/j.1460-2075.1993.tb05886.x; SIDERAS P, 1992, J IMMUNOL, V149, P244; SNAPPER CM, 1987, SCIENCE, V236, P944, DOI 10.1126/science.3107127; SNAPPER CM, 1988, J IMMUNOL, V140, P2121; SNAPPER CM, 1993, IMMUNOL TODAY, V14, P15, DOI 10.1016/0167-5699(93)90318-F; SPENCER CA, 1991, ADV CANCER RES, V56, P1; STAVNEZER J, 1988, P NATL ACAD SCI USA, V85, P7704, DOI 10.1073/pnas.85.20.7704; STAVNEZERNORDGREN J, 1986, EMBO J, V5, P95, DOI 10.1002/j.1460-2075.1986.tb04182.x; WABL MR, 1984, P NATL ACAD SCI-BIOL, V81, P2452, DOI 10.1073/pnas.81.8.2452; WINTER E, 1987, EMBO J, V6, P1663, DOI 10.1002/j.1460-2075.1987.tb02415.x; XU LX, 1993, P NATL ACAD SCI USA, V90, P3705, DOI 10.1073/pnas.90.8.3705; XU MZ, 1992, EMBO J, V11, P145, DOI 10.1002/j.1460-2075.1992.tb05037.x; YANCOPOULOS GD, 1986, EMBO J, V5, P3259, DOI 10.1002/j.1460-2075.1986.tb04637.x; ZALLER DM, 1985, P NATL ACAD SCI USA, V82, P5088, DOI 10.1073/pnas.82.15.5088; ZHANG J, 1993, EMBO J, V12, P3529, DOI 10.1002/j.1460-2075.1993.tb06027.x	76	234	239	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 3	1994	77	5					737	747		10.1016/0092-8674(94)90057-4	http://dx.doi.org/10.1016/0092-8674(94)90057-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NQ123	8205622				2022-12-28	WOS:A1994NQ12300013
J	ROWLANDS, T; BAUMANN, P; JACKSON, SP				ROWLANDS, T; BAUMANN, P; JACKSON, SP			THE TATA-BINDING PROTEIN - A GENERAL TRANSCRIPTION FACTOR IN EUKARYOTES AND ARCHAEBACTERIA	SCIENCE			English	Article							POLYMERASE-III TRANSCRIPTION; DEPENDENT RNA-POLYMERASES; ACTIVATION DOMAIN BINDS; CRYSTAL-STRUCTURE; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE-SEQUENCE; MUTATIONAL ANALYSIS; FUNCTIONAL DOMAINS; PYROCOCCUS-WOESEI	The TATA-binding protein TBP appears to be essential for all transcription in eukaryotic cell nuclei, which suggests that its function was established early in evolution. Archaebacteria constitute a kingdom of organisms distinct from eukaryotes and eubacteria. Archaebacterial gene regulatory sequences often map to TATA box-like motifs. Here it is shown that the archaebacterium Pyrococcus woesei expresses a protein with structural and functional similarity to eukaryotic TBP molecules. This suggests that TBP's role in transcription was established before the archaebacterial and eukaryotic lineages diverged and that the transcription systems of archaebacteria and eukaryotes are fundamentally homologous.	UNIV CAMBRIDGE,WELLCOME CANC RES CAMPAIGN INST,CAMBRIDGE CB2 1QR,CAMBS,ENGLAND; UNIV CAMBRIDGE,DEPT ZOOL,CAMBRIDGE CB2 1QR,CAMBS,ENGLAND	University of Cambridge; University of Cambridge			Dry, Kate/I-2328-2014; Jackson, Stephen Philip/R-4548-2019	Jackson, Stephen Philip/0000-0001-9317-7937; Baumann, Peter/0000-0003-4892-1485	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALLISON LA, 1985, CELL, V42, P599, DOI 10.1016/0092-8674(85)90117-5; BANNISTER AJ, 1993, NUCLEIC ACIDS RES, V21, P1289, DOI 10.1093/nar/21.5.1289; BURATOWSKI S, 1992, CELL, V71, P221, DOI 10.1016/0092-8674(92)90351-C; BURATOWSKI S, 1993, P NATL ACAD SCI USA, V90, P5633, DOI 10.1073/pnas.90.12.5633; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; BURLEY S, COMMUNICATION; CAMMARANO P, 1992, J MOL EVOL, V34, P396, DOI 10.1007/BF00162996; CARLES C, 1991, J BIOL CHEM, V266, P24092; CHASMAN DI, 1993, P NATL ACAD SCI USA, V90, P8174, DOI 10.1073/pnas.90.17.8174; COLBERT T, 1992, GENE DEV, V6, P1940, DOI 10.1101/gad.6.10.1940; CRETI R, 1993, NUCLEIC ACIDS RES, V21, P2942, DOI 10.1093/nar/21.12.2942; CRETI R, 1991, J MOL EVOL, V33, P332, DOI 10.1007/BF02102864; FIKES JD, 1990, NATURE, V346, P291, DOI 10.1038/346291a0; HAIN J, 1992, NUCLEIC ACIDS RES, V20, P5423, DOI 10.1093/nar/20.20.5423; HAUSNER W, 1991, J MOL BIOL, V222, P495, DOI 10.1016/0022-2836(91)90492-O; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; HISATAKE K, 1993, NATURE, V363, P744, DOI 10.1038/363744a0; HOEY T, 1990, CELL, V61, P1179, DOI 10.1016/0092-8674(90)90682-5; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; HOFFMANN A, 1990, GENE DEV, V4, P1141, DOI 10.1101/gad.4.7.1141; HORIKOSHI N, 1991, P NATL ACAD SCI USA, V88, P5124, DOI 10.1073/pnas.88.12.5124; HUDEPOHL U, 1990, P NATL ACAD SCI USA, V87, P5851, DOI 10.1073/pnas.87.15.5851; INGLES CJ, 1991, NATURE, V351, P588, DOI 10.1038/351588a0; INOSTROZA JA, 1992, CELL, V70, P477; JACKSON SP, IN PRESS TRENDS GENE; JANKNECHT R, 1991, P NATL ACAD SCI USA, V88, P8972, DOI 10.1073/pnas.88.20.8972; KAO CC, 1990, SCIENCE, V248, P1646, DOI 10.1126/science.2194289; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; KLENK HP, 1992, P NATL ACAD SCI USA, V89, P407, DOI 10.1073/pnas.89.1.407; LANGER D, 1993, NUCLEIC ACIDS RES, V21, P2251, DOI 10.1093/nar/21.9.2251; LEE WS, 1991, CELL, V67, P365, DOI 10.1016/0092-8674(91)90188-5; LIU X, 1993, MOL CELL BIOL, V13, P3291, DOI 10.1128/MCB.13.6.3291; LOPEZDELEON A, 1992, CELL, V71, P211, DOI 10.1016/0092-8674(92)90350-L; MALDONADO E, 1990, MOL CELL BIOL, V10, P6335, DOI 10.1128/MCB.10.12.6335; MCANDREW MB, 1993, GENE, V124, P165, DOI 10.1016/0378-1119(93)90390-O; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; NIKOLOV DB, 1992, NATURE, V369, P49; OUZOUNIS C, 1992, CELL, V71, P189, DOI 10.1016/0092-8674(92)90347-F; PUHLER G, 1989, P NATL ACAD SCI USA, V86, P4569, DOI 10.1073/pnas.86.12.4569; REITER WD, 1990, P NATL ACAD SCI USA, V87, P9509, DOI 10.1073/pnas.87.24.9509; RIGBY PWJ, 1993, CELL, V72, P7, DOI 10.1016/0092-8674(93)90042-O; SETO E, 1992, P NATL ACAD SCI USA, V89, P12028, DOI 10.1073/pnas.89.24.12028; THOMM M, 1988, NUCLEIC ACIDS RES, V16, P151, DOI 10.1093/nar/16.1.151; White R.C., UNPUB; WHITE RJ, 1992, CELL, V71, P1041, DOI 10.1016/0092-8674(92)90398-V; WHITE RJ, 1992, P NATL ACAD SCI USA, V89, P1949, DOI 10.1073/pnas.89.5.1949; WHITE RJ, 1992, TRENDS GENET, V8, P284, DOI 10.1016/0168-9525(92)90255-3; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; YAMAMOTO T, 1992, P NATL ACAD SCI USA, V89, P2844, DOI 10.1073/pnas.89.7.2844	50	163	165	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 27	1994	264	5163					1326	1329		10.1126/science.8191287	http://dx.doi.org/10.1126/science.8191287			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	NN767	8191287				2022-12-28	WOS:A1994NN76700045
J	YORK, IA; ROOP, C; ANDREWS, DW; RIDDELL, SR; GRAHAM, FL; JOHNSON, DC				YORK, IA; ROOP, C; ANDREWS, DW; RIDDELL, SR; GRAHAM, FL; JOHNSON, DC			A CYTOSOLIC HERPES-SIMPLEX VIRUS PROTEIN INHIBITS ANTIGEN PRESENTATION TO CD8(+) T-LYMPHOCYTES	CELL			English	Article							HUMAN ADENOVIRUS TYPE-5; MONOCLONAL-ANTIBODIES; GLYCOPROTEIN-D; DELETION MUTANTS; CELLS; GENE; EXPRESSION; DNA; IDENTIFICATION; RECOMBINANT	Herpes simplex virus (HSV) infection of human fibroblasts rapidly renders the cells resistant to lysis by HSV-specific CD8(+) cytotoxic T lymphocytes (CTLs), which normally recognize cell surface major histocompatibility complex (MHC) class I proteins presenting viral peptides. Within 3 hr of infection with HSV, MHC class I protein complexes are retained in the endoplasmic reticulum (ER)/cis Golgi and show properties of complexes lacking antigenic peptide. The HSV immediate-early protein ICP47 is both necessary and sufficient to block transport of class I proteins and to inhibit lysis by CD8(+) CTLs. The target for ICP47 is not known, but since ICP47 does not associate with membranes, it appears that ICP47 inhibits the production or stabilization of antigenic peptides or their translocation into the ER/cis Golgi. Thus, by expressing ICP47, HSV can evade detection by CD8(+) T lymphocytes, perhaps explaining the predominance of CD4(+) rather than CD8(+) HSV-specific CTLs in vivo.	MCMASTER UNIV,DEPT BIOL,HAMILTON L8N 3Z5,ON,CANADA; MCMASTER UNIV,DEPT BIOCHEM,MOLEC VIROL & IMMUNOL PROGRAM,HAMILTON L8N 3Z5,ON,CANADA; FRED HUTCHINSON CANC RES CTR,SEATTLE,WA 98104	McMaster University; McMaster University; Fred Hutchinson Cancer Center	YORK, IA (corresponding author), MCMASTER UNIV,DEPT PATHOL,1200 MAIN ST W,HAMILTON L8N 3Z5,ON,CANADA.		York, Ian/X-9351-2019	York, Ian/0000-0002-3478-3344; Andrews, David/0000-0002-9266-7157	NCI NIH HHS [CA15029] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ANDERSSON M, 1985, CELL, V43, P251; ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130; ATKINSON PH, 1971, J BIOL CHEM, V246, P5162; BAAS EJ, 1992, J EXP MED, V176, P147, DOI 10.1084/jem.176.1.147; BEERSMA MFC, 1993, J IMMUNOL, V151, P4455; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; BONNEAU RH, 1993, VIROLOGY, V195, P62, DOI 10.1006/viro.1993.1346; BURGERT HG, 1985, CELL, V41, P987, DOI 10.1016/S0092-8674(85)80079-9; CARTER VC, 1984, J VIROL, V49, P766, DOI 10.1128/JVI.49.3.766-771.1984; DANIEL F, 1983, EMBO J, V2, P1061, DOI 10.1002/j.1460-2075.1983.tb01546.x; DELUCA NA, 1985, J VIROL, V56, P558, DOI 10.1128/JVI.56.2.558-570.1985; DELVAL M, 1992, J EXP MED, V176, P729, DOI 10.1084/jem.176.3.729; DIXON RAF, 1980, J VIROL, V36, P189, DOI 10.1128/JVI.36.1.189-203.1980; EJERCITO PM, 1968, J GEN VIROL, V2, P357, DOI 10.1099/0022-1317-2-3-357; FALK K, 1993, IMMUNOGENETICS, V38, P161, DOI 10.1007/BF00190906; FEENSTRA V, 1990, J VIROL, V64, P2096, DOI 10.1128/JVI.64.5.2096-2102.1990; FRANK I, 1989, J VIROL, V63, P3435; FRIEDMAN HM, 1984, NATURE, V309, P633, DOI 10.1038/309633a0; GOLDSTEIN DJ, 1988, J VIROL, V62, P196, DOI 10.1128/JVI.62.1.196-205.1988; GOODING LR, 1979, J IMMUNOL, V122, P1002; GOODING LR, 1992, CELL, V71, P5; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HANKE T, 1991, J VIROL, V65, P1177, DOI 10.1128/JVI.65.3.1177-1186.1991; JANIAK F, 1994, IN PRESS BIOCH J; JANIAK F, 1994, IN PRESS J BIOL CHEM; JOHNSON DC, 1987, J VIROL, V61, P2208, DOI 10.1128/JVI.61.7.2208-2216.1987; JOHNSON DC, 1988, J VIROL, V62, P1347, DOI 10.1128/JVI.62.4.1347-1354.1988; JONES B, 1981, NATURE, V292, P547, DOI 10.1038/292547a0; JONES N, 1979, P NATL ACAD SCI USA, V76, P3665, DOI 10.1073/pnas.76.8.3665; KOELLE DM, 1993, J CLIN INVEST, V91, P961, DOI 10.1172/JCI116317; LIGAS MW, 1988, J VIROL, V62, P1486, DOI 10.1128/JVI.62.5.1486-1494.1988; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; MAVROMARANAZOS P, 1986, J VIROL, V60, P807, DOI 10.1128/JVI.60.2.807-812.1986; MCCARTHY AM, 1989, J VIROL, V63, P18, DOI 10.1128/JVI.63.1.18-27.1989; MCFADDEN G, 1993, IN PRESS ADV CANCER; MCGEOCH DJ, 1985, J MOL BIOL, V181, P1, DOI 10.1016/0022-2836(85)90320-1; MCGRORY WJ, 1988, VIROLOGY, V163, P614, DOI 10.1016/0042-6822(88)90302-9; MICHALEK MT, 1993, NATURE, V363, P552, DOI 10.1038/363552a0; MINSON AC, 1986, J GEN VIROL, V67, P1001, DOI 10.1099/0022-1317-67-6-1001; MURCHIE MJ, 1982, J GEN VIROL, V62, P1, DOI 10.1099/0022-1317-62-1-1; PALFREYMAN JW, 1984, J GEN VIROL, V65, P865, DOI 10.1099/0022-1317-65-5-865; PARHAM P, 1979, J IMMUNOL, V123, P342; PFIZENMAIER K, 1977, J IMMUNOL, V119, P939; POSAVAD CM, 1992, J VIROL, V66, P6264, DOI 10.1128/JVI.66.11.6264-6272.1992; POSAVAD CM, 1993, J IMMUNOL, V151, P4865; RIDDELL SR, 1990, J IMMUNOL METHODS, V128, P189, DOI 10.1016/0022-1759(90)90210-M; RIDDELL SR, 1991, J IMMUNOL, V146, P2795; RINALDO CR, 1978, J IMMUNOL, V120, P130; ROIZMAN B, 1990, P1795; SACKS WR, 1987, J VIROL, V61, P629; SCHMID DS, 1992, HERPES SIMPLEX VIRUS, P57; SCHONRICH G, 1991, CELL, V65, P293, DOI 10.1016/0092-8674(91)90163-S; SEARS AE, 1985, J VIROL, V55, P338, DOI 10.1128/JVI.55.2.338-346.1985; SHEPHERD JC, 1993, CELL, V74, P577, DOI 10.1016/0092-8674(93)80058-M; SMIBERT CA, 1990, J VIROL, V64, P3882, DOI 10.1128/JVI.64.8.3882-3894.1990; SMITH MH, 1986, MOL IMMUNOL, V23, P1077, DOI 10.1016/0161-5890(86)90006-4; STAM NJ, 1986, J IMMUNOL, V137, P2299; TIGGES MA, 1992, J VIROL, V66, P1622, DOI 10.1128/JVI.66.3.1622-1634.1992; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; UMENE K, 1986, J GEN VIROL, V67, P1035, DOI 10.1099/0022-1317-67-6-1035; VESTEY JP, 1989, CLIN EXP IMMUNOL, V77, P384; WALKER BD, 1989, P NATL ACAD SCI USA, V86, P9514, DOI 10.1073/pnas.86.23.9514; WATSON RJ, 1980, NATURE, V285, P329, DOI 10.1038/285329a0; WAYS JP, 1986, J IMMUNOL, V137, P217; YEWDELL JW, 1992, ADV IMMUNOL, V52, P1, DOI 10.1016/S0065-2776(08)60875-5; YORK IA, 1993, J INFECT DIS, V168, P1127, DOI 10.1093/infdis/168.5.1127; ZWEERINK HJ, 1981, INFECT IMMUN, V31, P624, DOI 10.1128/IAI.31.2.624-630.1981	67	459	478	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 20	1994	77	4					525	535		10.1016/0092-8674(94)90215-1	http://dx.doi.org/10.1016/0092-8674(94)90215-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	NM832	8187174				2022-12-28	WOS:A1994NM83200008
J	FERGUSON, A; SEDGWICK, DM				FERGUSON, A; SEDGWICK, DM			JUVENILE-ONSET INFLAMMATORY BOWEL-DISEASE - HEIGHT AND BODY-MASS INDEX IN ADULT LIFE	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CROHNS-DISEASE; ULCERATIVE-COLITIS; SCOTTISH CHILDREN; GROWTH; ADOLESCENTS; SURGERY; PROGNOSIS; RESECTION	Objective-To establish the frequency of permanent growth failure in juvenile onset inflammatory bowel disease. Design-Measurement of height and weight in a geographically based cohort at a mean of 14 (range 5.2-29.5) years after diagnosis. Comparison with data from surveys of British adults in 1980 and 1987. Setting-NHS hospitals throughout Scotland. Subjects-105 Children admitted to hospital during 1968-83 who fulfilled diagnostic criteria for Crohn's disease or ulcerative colitis and lived in specified regions. 87 were aged over 18 and living in Britain at follow up. Main outcome measures-Height, weight, body mass index, and sexual maturity. Results-All patients were sexually mature. 67 of the 70 patients examined were of normal height, and three women with Crohn's disease were abnormally short. Weight and body mass index were normal in all patients with ulcerative colitis. Patients with Crohn's disease had significantly lower weight than those with ulcerative colitis (men 66.8 (9.5) kg v 78.4 (13.8) kg, P = 0.04; women 51.5 (8.2) kg v 63.0 (12.1) kg, P<0.02) irrespective of disease activity. Body mass index was also significantly lower than the normal distribution (P<0.01). Growth retardation was not mentioned as a problem for any of the 17 patients interviewed only by telephone. Conclusions-Despite growth retardation in the teenage years most young people with inflammatory bowel disease will eventually achieve normal height. Reasons for lower weight in patients with Crohn's disease remain to be established.			FERGUSON, A (corresponding author), WESTERN GEN HOSP, DEPT MED, GASTROINTESTINAL UNIT, EDINBURGH EH4 2XU, SCOTLAND.							BARTON JR, 1990, Q J MED, V75, P423; BARTON JR, 1989, GUT, V30, P618, DOI 10.1136/gut.30.5.618; BARTON JR, 1989, BRIT MED J, V298, P865, DOI 10.1136/bmj.298.6677.865; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; CASTILE RG, 1980, J PEDIATR SURG, V15, P462, DOI 10.1016/S0022-3468(80)80754-8; CLEMMONS DR, 1985, AM J CLIN NUTR, V41, P191, DOI 10.1093/ajcn/41.2.191; FARTHING MJG, 1981, GUT, V22, P933, DOI 10.1136/gut.22.11.933; FERGUSON A, IN PRESS J R COLL PH; FERGUSON A, IN PRESS GUT; GREGORY J, 1990, DIET NUTRITIONAL SUR; GRIFFITHS AM, 1993, GUT, V34, P939, DOI 10.1136/gut.34.7.939; HOMER DR, 1977, PEDIATRICS, V59, P717; KANOF ME, 1988, GASTROENTEROLOGY, V95, P1523, DOI 10.1016/S0016-5085(88)80072-6; KIRSCHNER BS, 1990, ACTA PAEDIATR SCAND, P98; KIRSCHNER BS, 1986, GASTROENTEROLOGY, V91, P830, DOI 10.1016/0016-5085(86)90683-9; KNIGHT I, 1984, HEIGHTS WEIGHTS ADUL; KUSHNER RF, 1991, AM J CLIN NUTR, V53, P161, DOI 10.1093/ajcn/53.1.161; LIPSON AB, 1990, EUR J PEDIATR, V149, P687, DOI 10.1007/BF01959522; MARKOWITZ J, 1993, J PEDIATR GASTR NUTR, V16, P373, DOI 10.1097/00005176-199305000-00005; MCLAIN BI, 1990, ARCH DIS CHILD, V65, P760, DOI 10.1136/adc.65.7.760; MOTIL KJ, 1993, GASTROENTEROLOGY, V105, P681, DOI 10.1016/0016-5085(93)90883-E; SEDGWICK DM, 1991, BRIT J SURG, V78, P171, DOI 10.1002/bjs.1800780212; SEDGWICK DM, 1991, BRIT J SURG, V78, P176, DOI 10.1002/bjs.1800780213; SEIDMAN EG, 1987, DIGEST DIS SCI, V32, pS82, DOI 10.1007/BF01312470	24	64	64	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 14	1994	308	6939					1259	1263		10.1136/bmj.308.6939.1259	http://dx.doi.org/10.1136/bmj.308.6939.1259			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NM147	8205017	Green Published			2022-12-28	WOS:A1994NM14700015
J	CHADWICK, R				CHADWICK, R			FAIRNESS IS AT ISSUE	BRITISH MEDICAL JOURNAL			English	Article																			0	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	APR 2	1994	308	6933					907	907		10.1136/bmj.308.6933.907	http://dx.doi.org/10.1136/bmj.308.6933.907			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	NE600	8198632	Green Published			2022-12-28	WOS:A1994NE60000031
J	WILLIAMS, DJ; WILLIAMS, AC; KRUCHEK, DG				WILLIAMS, DJ; WILLIAMS, AC; KRUCHEK, DG			PROBLEMS IN ASSESSING CONTENTS OF METERED-DOSE INHALERS	BRITISH MEDICAL JOURNAL			English	Article							BETA-AGONISTS; ASTHMA		ST PETERS HOSP,CHERTSEY KT16 0PZ,SURREY,ENGLAND		WILLIAMS, DJ (corresponding author), YORK HOUSE MED CTR,HEATHCOT PRACTICE,WOKING GU22 7XL,ENGLAND.							BUCHANAN N, 1987, CHILDHOOD ASTHMA WHA, P73; GLAXO GROUP LTD, 1989, Patent No. 4817822; PEARCE N, 1991, CLIN EXP ALLERGY, V21, P401, DOI 10.1111/j.1365-2222.1991.tb01679.x; SPITZER WO, 1992, NEW ENGL J MED, V326, P501, DOI 10.1056/NEJM199202203260801; VATHENEN AS, 1988, LANCET, V1, P554	5	14	14	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	SEP 25	1993	307	6907					771	772		10.1136/bmj.307.6907.771	http://dx.doi.org/10.1136/bmj.307.6907.771			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LZ478	8219948	Bronze, Green Published			2022-12-28	WOS:A1993LZ47800023
J	YOKOYAMA, T; COPELAND, NG; JENKINS, NA; MONTGOMERY, CA; ELDER, FFB; OVERBEEK, PA				YOKOYAMA, T; COPELAND, NG; JENKINS, NA; MONTGOMERY, CA; ELDER, FFB; OVERBEEK, PA			REVERSAL OF LEFT-RIGHT ASYMMETRY - A SITUS-INVERSUS MUTATION	SCIENCE			English	Article							GENETIC-LINKAGE MAP; MOUSE; DNA	A recessive mutation was identified in a family of transgenic mice that resulted in a reversal of left-right polarity (situs inversus) in 100 percent of the homozygous transgenic mice tested. Sequences that flanked the transgenic integration site were cloned and mapped to mouse chromosome 4, between the Tsha and Hxb loci. During early embryonic development, the direction of postimplantation turning, one of the earliest manifestations of left-right asymmetry, was reversed in homozygous transgenic embryos. This insertional mutation identifies a gene that controls embryonic turning and visceral left-right polarity.	BAYLOR COLL MED, INST MOLEC GENET, DEPT CELL BIOL, HOUSTON, TX 77030 USA; NCI, FREDERICK CANC RES & DEV CTR, ABL BASIC RES PROGRAM, MAMMALIAN GENET LAB, FREDERICK, MD 21702 USA; BAYLOR COLL MED, INST MOLEC GENET, DEPT CELL BIOL, HOUSTON, TX 77030 USA; BAYLOR COLL MED, CTR COMPARAT MED, HOUSTON, TX 77030 USA; BAYLOR COLL MED, HOWARD HUGHES MED INST, HOUSTON, TX 77030 USA; UNIV TEXAS, HLTH SCI CTR, DEPT PATHOL & LAB MED, HOUSTON, TX 77225 USA	Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Texas System; University of Texas Health Science Center Houston				Overbeek, Paul/0000-0001-9784-2084	NCI NIH HHS [N01-CO-74101] Funding Source: Medline; NICHD NIH HHS [HD25340] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AFZELIUS B A, 1976, Science (Washington D C), V193, P317; BRINKLEY W, COMMUNICATION; BROWN NA, 1990, DEVELOPMENT, V109, P1; BROWN NA, 1989, BIOL ASYMMETRY HANDE, P182; BRUECKNER M, 1989, P NATL ACAD SCI USA, V86, P5035, DOI 10.1073/pnas.86.13.5035; CECI JD, 1989, GENOMICS, V5, P699, DOI 10.1016/0888-7543(89)90111-0; COPELAND NG, 1991, TRENDS GENET, V7, P113, DOI 10.1016/0168-9525(91)90455-Y; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; Green EL, 1981, GENETICS PROBABILITY, P77; HSIEH C, 1991, MAMM GENOME S, V1, pS522; HUMMEL KP, 1959, J HERED, V50, P10; JENKINS NA, 1982, J VIROL, V43, P26, DOI 10.1128/JVI.43.1.26-36.1982; Kartagener H, 1935, SCHWEIZ MED WSCHR, V65, P782; LAYTON WM, 1976, J HERED, V67, P336, DOI 10.1093/oxfordjournals.jhered.a108749; LAYTON WM, 1980, ETIOLOGY MORPHOGENES, P109; LONGMIRE JL, 1987, NUCLEIC ACIDS RES, V15, P859, DOI 10.1093/nar/15.2.859; MORGAN MJ, 1978, BEHAV BRAIN SCI, V1, P270, DOI 10.1017/S0140525X00074483; MORGAN MJ, 1991, CIBA F SYMP, V162, P234; SELDON RF, 1987, CURRENT PROTOCOLS MO; THEILER K, 1989, HOUSE MOUSE ATLAS EM, P40; TORGERSEN J, 1949, ARCH PATHOL, V47, P566; WEIS JH, 1987, CURRENT PROTOCOLS MO; YOKOYAMA T, 1990, NUCLEIC ACIDS RES, V18, P7293, DOI 10.1093/nar/18.24.7293; YOKOYAMA T, UNPUB; YOST HJ, 1992, NATURE, V357, P158, DOI 10.1038/357158a0	25	431	438	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 30	1993	260	5108					679	682		10.1126/science.8480178	http://dx.doi.org/10.1126/science.8480178			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	KZ641	8480178				2022-12-28	WOS:A1993KZ64100034
